data_2kw8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kw8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo . . . . . 0 N--CA 1.49 1.286 0 CA-C-O 121.09 0.371 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.66 149.2 45.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.551 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.18 -24.47 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.094 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.5 86.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.44 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -73.4 -35.96 65.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.177 179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.98 -43.23 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.509 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.05 88.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -84.26 -19.81 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.53 131.95 51.78 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.582 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 m -92.3 152.42 19.8 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.378 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.2 tp -116.38 130.3 56.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.907 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -94.13 88.97 5.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -50.43 -11.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 110.299 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 75' ' ' ASP . 69.2 mmtt -74.52 -9.28 58.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.513 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.482 ' OE1' ' OG ' ' A' ' 97' ' ' SER . 76.7 mt-30 -106.51 16.51 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.37 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.6 126.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.774 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.33 -4.62 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.761 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.7 -167.54 36.55 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.647 ' HE ' ' HZ3' ' A' ' 209' ' ' LYS . 44.4 mtt-85 -146.92 155.24 42.13 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.973 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.8 tt -127.55 126.44 67.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.329 0.585 . . . . 0.0 109.821 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -125.14 130.55 52.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.006 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.48 79.57 59.79 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.252 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -43.6 -35.89 6.7 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.909 2.406 . . . . 0.0 112.972 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 m -49.11 -37.39 21.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.1 p -115.59 0.59 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.622 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.59 47.83 2.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.3 tp -115.04 129.32 56.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.737 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -134.34 120.66 20.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -146.72 162.47 33.59 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.241 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.64 151.68 8.83 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.826 2.35 . . . . 0.0 109.646 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -99.35 113.98 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.43 122.31 42.96 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.45 -45.73 82.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.797 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.549 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 91.5 p -70.79 104.57 2.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.152 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.0 p -82.79 99.81 9.91 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.254 0.55 . . . . 0.0 110.098 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.603 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 65.2 p -131.29 158.17 41.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.855 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.1 -26.42 68.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -83.23 -41.23 18.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.299 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.603 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 98.5 m-20 -66.46 -36.21 82.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.503 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -66.32 -14.7 62.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -75.49 -13.93 60.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -121.09 -4.49 9.54 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.38 -176.54 44.65 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.633 -1.27 . . . . 0.0 112.286 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.15 125.29 32.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.29 -0.455 . . . . 0.0 109.812 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.0 145.4 30.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.0 p -71.68 149.1 45.81 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.22 -44.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.94 -171.18 2.77 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.03 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -108.01 -56.78 2.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.809 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -91.17 46.54 1.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.59 150.27 24.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.133 0.492 . . . . 0.0 109.931 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.29 132.16 52.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.403 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.5 mtt -73.78 127.33 32.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 0.0 110.263 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.37 -0.9 68.87 Favored Glycine 0 C--O 1.23 -0.14 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -137.72 119.48 15.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.508 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -171.71 54.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.5 t30 -86.15 111.52 20.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -83.84 106.79 15.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.74 128.53 36.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.048 0.451 . . . . 0.0 112.081 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.1 mt -126.0 130.55 51.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.027 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.98 141.68 47.11 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.342 0.591 . . . . 0.0 110.768 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.48 -177.41 18.39 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.283 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.0 m-70 -82.69 150.0 27.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.1 0.476 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 129' ' ' SER . 61.2 t30 -117.59 27.96 8.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.715 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.4 mmm -45.43 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.7 p 62.82 41.03 9.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.19 0.519 . . . . 0.0 110.201 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.83 109.66 9.24 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.884 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -51.66 127.87 21.74 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.44 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.7 -25.5 14.76 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.589 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 45.9 t -82.51 177.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 117.54 0.67 . . . . 0.0 109.499 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.589 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.22 136.91 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.315 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 44.57 32.73 0.8 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.045 0.45 . . . . 0.0 110.656 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -81.89 -8.11 59.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.207 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -149.96 41.91 0.85 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.731 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 140' ' ' SER . 11.2 pt -68.08 -33.85 63.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.371 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.21 5.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.104 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 138' ' ' ILE . 23.0 t -94.57 -16.79 22.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.2 124.95 23.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.835 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.65 156.13 16.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.566 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 144' ' ' GLY . 5.6 tmtt? -56.85 127.35 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.675 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.4 ' N ' ' HD3' ' A' ' 143' ' ' LYS . . . 90.9 21.72 35.38 Favored Glycine 0 CA--C 1.516 0.139 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -82.75 134.66 35.12 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.542 ' NZ ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 mmmm -80.96 121.78 26.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.565 0.698 . . . . 0.0 112.312 -178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 94.4 mt -117.69 117.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.11 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.548 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.1 m-85 -100.32 119.02 37.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.43 144.68 44.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.73 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -116.41 136.75 52.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.411 0.624 . . . . 0.0 111.565 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 32.2 t70 -114.74 -171.07 1.86 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.54 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 4.9 p30 -21.17 -73.53 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.072 0.463 . . . . 0.0 111.658 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.2 mt-10 -138.38 26.0 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.82 147.89 45.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.369 0.604 . . . . 0.0 112.254 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -113.08 120.43 41.31 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -104.29 131.18 51.89 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.073 0.463 . . . . 0.0 111.36 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.548 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 42.4 tp10 -94.52 114.77 26.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -114.5 141.92 47.07 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.63 135.7 54.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.538 0.685 . . . . 0.0 111.428 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.3 132.27 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.875 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -105.97 -27.74 10.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 124.917 1.386 . . . . 0.0 110.709 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.84 141.12 3.68 Favored Glycine 0 C--N 1.32 -0.328 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.405 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.2 p -106.08 139.8 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.058 -0.571 . . . . 0.0 109.564 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.9 t -154.09 166.72 32.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.345 0.593 . . . . 0.0 111.557 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.03 125.95 53.14 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.665 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.07 153.97 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.805 0.336 . . . . 0.0 110.995 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 p -60.0 167.2 2.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.75 -13.69 11.68 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.949 1.766 . . . . 0.0 111.446 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 36.9 p30 -82.91 -18.49 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.881 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.445 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.2 ttmt -86.72 74.75 9.76 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.073 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -75.54 -7.54 54.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.868 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -52.57 -25.42 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.039 0.447 . . . . 0.0 110.557 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 74.4 t -75.71 -16.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.228 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.71 -13.78 10.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.665 0.745 . . . . 0.0 109.676 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.01 152.66 24.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.919 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.54 133.93 53.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -101.18 -39.07 7.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.45 30.33 0.35 Allowed Glycine 0 N--CA 1.469 0.843 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -156.23 179.31 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.262 0.553 . . . . 0.0 111.369 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.23 89.71 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -125.06 166.13 16.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.193 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.29 142.45 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 18.0 m -134.37 127.01 30.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.573 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.0 mp -113.56 126.86 55.76 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.106 0.479 . . . . 0.0 109.722 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 28.6 pt -140.32 -169.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.519 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.732 179.481 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 120.93 0.395 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.5 133.58 42.67 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.59 137.02 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.2 t -116.01 128.15 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.465 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.16 136.87 52.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.212 0.529 . . . . 0.0 110.074 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.46 25.85 Favored Glycine 0 N--CA 1.462 0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.451 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -115.61 150.1 37.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.043 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 41.8 tp -69.9 127.12 31.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.506 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.13 -24.43 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.759 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 175.01 45.81 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.532 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.5 m -153.3 151.66 30.26 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 121.375 0.607 . . . . 0.0 111.015 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -149.84 179.03 8.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.395 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.26 145.7 24.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.168 0.508 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.647 ' HZ3' ' HE ' ' A' ' 82' ' ' ARG . 88.5 tttt -74.14 80.0 1.76 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.321 -0.63 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.872 178.758 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 CA-C-O 121.221 0.425 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 162.78 29.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.063 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.22 -25.18 65.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.978 0.418 . . . . 0.0 110.247 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.13 89.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.004 0.43 . . . . 0.0 110.447 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -73.67 -33.71 64.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 110.788 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.28 -45.54 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.754 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.19 88.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.183 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -80.85 -24.11 38.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.209 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.45 141.5 58.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.712 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.6 m -139.22 119.28 13.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.578 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.2 tp -120.31 140.41 51.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.825 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.08 138.55 57.22 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.16 -10.51 59.14 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.169 0.509 . . . . 0.0 109.995 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -81.12 -8.96 59.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -90.99 11.84 21.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.529 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 m -88.63 146.36 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.121 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.8 -6.98 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 111.393 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.16 -170.76 36.41 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -146.26 148.75 32.78 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.569 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 83' ' ' ILE . 18.6 tt -122.81 121.74 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -123.49 129.31 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.429 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.5 mt -129.73 125.54 22.28 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.322 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.75 -39.23 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 t -49.92 -39.31 39.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.414 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.474 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -116.95 -2.18 9.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.464 0.173 . . . . 0.0 110.777 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m 63.18 50.88 2.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.31 130.6 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.137 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -137.1 114.68 11.12 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' PRO . 16.6 mt -145.92 111.17 4.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.4 Cg_endo -41.24 142.9 0.86 Allowed 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 121.643 1.562 . . . . 0.0 110.328 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.41 122.95 44.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.84 132.71 47.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.157 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.78 -27.96 68.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.2 p -69.34 -179.52 1.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.543 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 109' ' ' THR . 2.2 m -159.15 49.92 0.35 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.085 0.469 . . . . 0.0 110.272 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.493 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 67.5 p -108.03 155.1 20.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.73 -31.31 64.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -72.01 -48.11 47.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.466 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.493 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 72.2 m-20 -66.86 -38.56 86.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.183 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 mt -56.35 -16.14 5.14 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.6 mt -70.24 -31.7 69.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.0 m -90.63 -12.22 37.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.87 -175.06 44.72 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.911 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.14 130.66 41.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.64 143.25 33.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.838 0.352 . . . . 0.0 110.158 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 98' ' ' SER . 33.8 p -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.1 t -81.31 -50.22 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.413 ' N ' ' OE1' ' A' ' 114' ' ' GLN . 35.1 mmtt -94.5 147.64 23.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.997 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -87.45 -6.3 58.47 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -126.78 31.84 5.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.107 0.48 . . . . 0.0 111.329 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.413 ' OE1' ' N ' ' A' ' 111' ' ' LYS . 20.3 pt20 -97.59 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.568 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.23 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.987 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.9 125.1 31.67 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.697 0.284 . . . . 0.0 110.395 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.55 72.92 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.87 121.44 13.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.104 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.55 55.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -83.83 110.17 18.14 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -87.48 104.26 16.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.88 121.0 33.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.681 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.31 131.66 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.022 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.07 141.04 43.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.466 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.2 -177.76 15.81 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.536 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.473 ' O ' ' O ' ' A' ' 134' ' ' LEU . 62.1 m-70 -92.99 130.25 38.63 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.083 0.468 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -91.99 28.47 1.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -35.84 -26.2 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.368 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 64.95 34.84 8.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.403 0.62 . . . . 0.0 109.596 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.43 106.91 6.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.39 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -49.11 128.62 16.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.064 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.46 -23.03 14.2 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.615 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 49.0 t -89.69 178.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.615 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.13 135.5 49.22 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.36 -177.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 44.88 39.41 3.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.193 0.521 . . . . 0.0 110.63 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 60.6 p -81.36 -8.56 59.76 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 136' ' ' SER . 77.8 m-20 -147.6 37.99 0.92 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.8 -29.85 42.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.824 0.345 . . . . 0.0 111.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.02 6.41 4.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.815 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -97.67 -13.75 21.32 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.02 123.31 19.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.896 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 23.2 tptt -96.34 169.46 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.161 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 142' ' ' LYS . 48.9 tttm -68.0 125.8 27.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 97.06 18.73 28.34 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.0 m-20 -84.32 131.76 34.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -79.52 129.99 34.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.894 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 147' ' ' ILE . 95.9 mt -125.23 126.12 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.529 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 58.0 m-85 -103.06 118.94 37.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.563 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.53 133.67 55.8 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -103.08 132.48 49.31 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 111.084 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.559 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 50.0 t0 -110.0 -167.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.679 -1.146 . . . . 0.0 107.952 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.559 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -29.66 -72.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.978 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -136.78 29.05 2.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -131.7 150.26 52.21 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -108.75 123.74 49.48 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.378 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.52 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 40.1 m-85 -104.99 129.91 53.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.391 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.529 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 73.9 mm-40 -96.65 114.92 26.61 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.15 142.93 45.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.76 132.11 54.08 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.395 0.617 . . . . 0.0 111.238 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 144' ' ' GLY . 53.7 t -66.63 134.37 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.981 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.84 -29.18 9.66 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 124.36 1.037 . . . . 0.0 110.437 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.73 157.81 17.15 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.638 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 150.74 33.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.824 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.9 m -156.48 168.2 28.1 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.259 0.552 . . . . 0.0 111.366 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -106.06 132.0 52.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.439 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.02 159.07 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 110.931 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.545 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 71.2 p -77.79 142.44 65.46 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -47.32 -18.81 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.089 1.859 . . . . 0.0 111.604 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -81.24 -2.87 50.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.974 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.6 tptt -82.03 140.59 33.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 94.4 m95 -157.78 -22.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.849 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -56.74 -17.67 9.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.397 0.617 . . . . 0.0 110.429 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.09 -6.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.321 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 m -136.23 43.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 70.5 mm-40 -144.6 84.53 1.74 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.027 -176.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 175' ' ' GLU . 92.3 m-20 27.18 108.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.231 0.957 . . . . 0.0 112.805 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -96.84 -40.34 8.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.313 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.2 29.59 0.72 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.48 178.45 10.22 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -92.83 88.84 6.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.976 0.893 . . . . 0.0 109.511 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -131.63 167.29 19.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.91 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 15.7 tt -131.67 143.42 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.5 m -136.22 129.71 32.01 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.301 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -112.4 127.58 56.06 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.24 0.543 . . . . 0.0 110.867 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 pt -141.17 -167.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.876 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.53 0.206 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -179.858 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 167' ' ' THR . 8.3 ttm180 . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.616 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.0 139.66 48.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 110.091 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -134.45 136.9 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 111.229 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.77 134.2 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.049 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.93 138.1 51.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.542 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.6 139.98 11.39 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.8 t0 -99.05 137.05 38.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.253 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.0 tp -63.75 126.2 26.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.287 0.565 . . . . 0.0 110.881 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.24 -25.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.825 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.7 159.91 16.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.008 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.52 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 59.5 m -135.71 157.18 47.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -148.64 178.9 8.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.237 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.8 144.88 24.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.289 0.566 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.85 80.69 2.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.472 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.633 178.107 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.485 1.001 0 N-CA-C 110.847 -0.482 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.13 151.34 43.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.975 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.5 mp -55.48 -26.76 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 110.68 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.51 93.99 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.39 -32.1 64.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.674 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.58 -46.32 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.972 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.76 91.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.157 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.95 -30.12 55.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.395 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.95 158.34 11.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.869 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 p -138.56 158.84 43.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 110.62 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.4 ' CD2' ' OG ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -139.21 121.48 15.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 111.172 -178.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 77' ' ' LYS . 99.2 m-20 -81.89 110.73 17.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.796 178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -47.13 -16.13 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.226 0.536 . . . . 0.0 110.318 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 75' ' ' ASP . 87.4 tttt -67.44 -33.52 75.32 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.977 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -78.41 9.45 3.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.584 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.5 t -92.91 129.11 43.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.753 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 pt -118.29 -3.43 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.81 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.95 34.41 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -157.06 164.94 37.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.714 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.9 tt -131.07 140.23 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.712 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 m -132.87 133.17 42.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.36 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.528 ' CG2' ' HG ' ' A' ' 87' ' ' SER . 67.9 mt -133.17 129.26 20.82 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.546 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.88 -36.18 0.19 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.429 2.086 . . . . 0.0 112.147 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.528 ' HG ' ' CG2' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -47.15 -38.98 12.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.409 -177.188 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.3 p -120.55 0.23 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.828 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 60.71 54.29 3.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 tp -117.74 134.83 54.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.346 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.96 117.38 14.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.9 mt -143.65 114.02 5.55 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.38 146.67 0.67 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 121.892 1.728 . . . . 0.0 109.99 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -95.3 123.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.87 123.18 47.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.87 -46.79 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.974 0.416 . . . . 0.0 111.079 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.544 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 34.9 p -69.79 102.87 2.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 98' ' ' SER . 5.6 p -82.77 103.85 12.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.421 0.629 . . . . 0.0 110.329 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.534 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 3.0 p -142.94 157.12 44.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.944 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.526 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -54.71 -32.44 59.58 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.722 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -79.13 -45.08 20.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.687 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.544 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.8 m-20 -65.19 -34.72 79.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.242 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -61.68 -21.36 64.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.375 0.607 . . . . 0.0 111.808 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.89 -32.93 73.76 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.4 ' OG ' ' CD2' ' A' ' 74' ' ' LEU . 3.8 p -87.83 -13.58 41.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.57 -171.69 44.18 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.492 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.01 127.55 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.482 . . . . 0.0 110.057 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.73 146.46 29.77 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.844 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.5 p -74.42 151.55 39.62 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.92 -42.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.442 ' N ' HE22 ' A' ' 114' ' ' GLN . 99.2 mttt -88.29 -171.99 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.027 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 21.6 pt-20 -116.7 -9.81 11.23 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 112' ' ' GLU . 17.7 m120 -145.87 43.41 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.442 HE22 ' N ' ' A' ' 111' ' ' LYS . 1.7 pm0 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.888 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.54 131.36 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.681 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.3 mtt -71.49 128.37 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.075 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 91.17 1.97 71.71 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -141.32 123.7 15.77 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.66 -164.47 54.81 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.43 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 22.1 t-20 -92.28 108.91 20.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -85.37 103.24 14.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.038 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 128.59 36.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.384 0.611 . . . . 0.0 112.15 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.56 130.47 52.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.127 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.71 140.94 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.055 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.49 -178.34 17.59 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 134' ' ' LEU . 56.8 m-70 -93.42 140.92 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.3 p30 -106.44 29.44 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 110.549 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.0 mmm -42.22 -15.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.837 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 61.56 38.0 15.9 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.076 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -133.62 107.65 8.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.984 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -52.92 126.74 21.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.8 -24.61 11.77 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.616 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 42.4 t -86.66 -179.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.616 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.79 133.03 46.19 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.194 -178.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 47.26 40.82 11.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 111.149 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.8 p -81.6 -11.88 58.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.903 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 73.7 m-20 -149.82 42.8 0.88 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.433 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.7 pt -68.57 -35.56 70.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 0.0 112.013 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.7 1.58 2.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 138' ' ' ILE . 12.2 m -92.66 -13.71 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.161 0.505 . . . . 0.0 110.18 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.4 122.78 18.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.213 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.69 157.91 15.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.792 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.48 127.87 33.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.258 0.551 . . . . 0.0 111.147 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.23 16.51 40.43 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.72 133.84 34.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -81.52 134.56 35.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 111.852 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -127.82 121.04 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -101.76 120.24 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.8 tp -117.72 147.93 42.49 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -122.03 131.86 54.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.153 0.501 . . . . 0.0 111.584 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.9 t0 -112.08 -164.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 151' ' ' ASP . 28.4 m120 -21.95 -78.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.205 0.526 . . . . 0.0 111.406 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -136.31 26.07 3.2 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -123.48 142.22 51.22 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -108.15 120.52 42.58 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -104.14 130.32 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.152 0.501 . . . . 0.0 111.582 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -93.66 115.27 27.72 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 51.5 m-85 -116.78 138.61 51.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.631 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -118.59 136.79 53.67 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.247 0.546 . . . . 0.0 110.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.78 134.8 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.297 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.83 -24.12 11.79 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.357 1.036 . . . . 0.0 111.278 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 166.17 165.9 24.31 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.115 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.29 151.64 31.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.3 p -152.28 161.54 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.04 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -114.15 117.44 31.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.87 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.85 159.25 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.989 0.424 . . . . 0.0 111.28 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 169' ' ' ASP . 33.9 p -69.48 134.27 88.78 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.415 ' HB3' HH21 ' A' ' 196' ' ' ARG . 1.2 Cg_endo -46.25 -12.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.081 1.854 . . . . 0.0 111.749 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 167' ' ' THR . 96.0 m-20 -81.11 -8.73 59.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -85.97 70.1 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.133 0.492 . . . . 0.0 110.259 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.487 ' C ' ' H ' ' A' ' 173' ' ' VAL . 80.8 m95 -70.48 -30.47 67.28 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -48.81 -14.81 0.07 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.543 . . . . 0.0 110.464 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' A' ' 171' ' ' TRP . 86.1 t -75.08 -24.32 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.809 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.91 -6.64 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.703 0.763 . . . . 0.0 109.561 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -80.46 152.8 28.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.861 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p-10 -64.64 128.32 35.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.288 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.455 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.8 m80 -108.69 -42.69 4.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.62 0.248 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.47 23.99 0.09 OUTLIER Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -152.92 171.73 17.88 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -94.75 87.91 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -126.88 126.61 43.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.365 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.5 tt -81.04 148.23 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.43 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 7.2 m -136.68 121.19 18.26 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.375 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.35 126.64 52.34 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.28 0.562 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 29.7 pt -135.2 169.92 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.491 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.569 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 35.5 p . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.362 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 186' ' ' THR . 59.9 ttm-85 . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.48 133.29 49.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 81.8 t -135.16 136.82 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.65 131.65 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.615 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.22 136.69 52.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.48 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.45 11.73 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 47.9 p-10 -96.4 141.3 29.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.915 -0.643 . . . . 0.0 111.247 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.12 125.42 25.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.098 0.475 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 72.4 t -107.59 -23.21 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.535 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.83 177.9 45.22 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.883 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.9 m -154.1 152.63 30.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.159 0.504 . . . . 0.0 111.018 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -151.14 178.8 8.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.371 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.67 145.6 24.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.948 0.404 . . . . 0.0 110.534 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.19 79.04 0.96 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.32 -0.705 0 CA-C-O 117.854 -1.069 . . . . 0.0 110.724 178.59 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.49 1.318 0 CA-C-O 121.153 0.397 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.59 154.79 41.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.1 mm? -57.1 -27.16 61.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.707 0.289 . . . . 0.0 110.601 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.85 91.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.924 0.392 . . . . 0.0 110.041 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.29 -36.11 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.797 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -74.34 -43.9 49.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.627 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.13 86.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.27 -22.75 30.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.217 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.29 138.35 58.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.397 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -139.97 149.56 43.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.795 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 1.3 pt? -139.92 166.76 23.77 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.432 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.31 140.86 43.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.763 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.57 -2.08 40.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.196 0.522 . . . . 0.0 110.155 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -89.47 -7.25 55.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -85.84 0.33 53.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.26 135.12 26.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.73 0.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.686 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -177.95 39.83 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -147.53 151.54 36.5 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.194 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.21 123.46 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 m -123.18 128.03 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.608 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.72 116.69 13.82 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.71 -33.17 1.31 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.286 1.991 . . . . 0.0 112.376 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.0 m -50.73 -37.22 40.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.36 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -117.23 -6.79 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.252 -0.28 . . . . 0.0 110.512 -179.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.8 p 71.76 47.82 0.32 Allowed 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.64 127.51 54.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.479 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -132.82 113.9 13.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -145.0 165.43 22.21 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.001 -0.679 . . . . 0.0 112.554 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -89.01 156.38 5.82 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 123.252 2.635 . . . . 0.0 109.264 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.58 114.38 46.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.9 120.9 41.44 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.81 -45.19 83.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.985 0.421 . . . . 0.0 110.776 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 4.2 m -67.05 103.93 1.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.936 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -82.03 109.0 15.96 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 110.318 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.512 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -143.35 155.77 44.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.24 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -61.19 -28.03 68.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -80.22 -46.64 15.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.898 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.4 p-10 -68.78 -31.16 69.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.585 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -61.89 -20.39 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.84 -14.41 61.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 m -103.22 -10.22 18.94 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.82 -153.04 18.91 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.247 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.81 127.86 44.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.115 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.34 148.85 29.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 p -73.53 149.61 42.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 t -84.8 -42.22 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 9.5 tptp -90.28 -172.65 3.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.788 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.427 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 46.6 tp10 -107.04 -57.9 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.343 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.93 45.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.296 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.45 154.17 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.085 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.19 135.19 63.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 mtp -78.05 122.55 25.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.61 2.43 60.0 Favored Glycine 0 N--CA 1.461 0.314 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -140.59 128.28 21.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.076 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.68 -169.65 49.96 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.5 107.17 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -85.39 103.21 14.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.62 126.27 35.9 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.485 0.66 . . . . 0.0 112.208 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.6 mt -120.49 131.22 54.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.512 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.69 138.49 45.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.582 0.706 . . . . 0.0 110.921 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.69 -178.39 16.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.556 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 80.7 m-70 -90.79 139.69 30.49 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' SER . 64.2 t30 -102.52 28.53 5.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 109.91 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.49 -24.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.184 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 64.44 36.71 8.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.416 0.627 . . . . 0.0 109.61 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.483 ' N ' ' OG ' ' A' ' 136' ' ' SER . 26.1 mtpp -134.34 111.67 10.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.917 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.41 126.12 18.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.625 0.726 . . . . 0.0 110.226 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.6 9.7 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.564 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 58.6 t -79.09 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 117.749 0.775 . . . . 0.0 109.484 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.621 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.57 134.37 46.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.24 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 45.17 33.78 1.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.159 0.504 . . . . 0.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.2 -8.51 59.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -146.68 39.74 1.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.29 -30.02 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.863 0.363 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.06 3.36 5.55 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.135 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -95.81 -13.9 23.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.2 mt -66.21 126.4 28.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.704 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -97.2 158.84 15.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.415 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.16 138.64 58.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.434 0.635 . . . . 0.0 111.317 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.61 65.09 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -81.11 136.83 35.96 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.2 122.64 25.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.635 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mm -115.39 119.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.73 118.23 36.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 tp -119.94 154.96 33.69 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.02 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -127.32 135.68 50.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.505 0.669 . . . . 0.0 112.118 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.0 t0 -115.52 -167.04 1.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.29 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.224 0.535 . . . . 0.0 111.798 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -138.09 28.66 2.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -127.8 140.58 51.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 78.7 tt0 -103.35 122.17 44.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.572 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.533 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 55.0 m-85 -104.25 127.05 51.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.394 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 157' ' ' GLU . 39.7 mp0 -94.64 115.45 27.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.071 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.412 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -119.14 134.08 55.41 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.342 0.591 . . . . 0.0 110.718 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.04 133.42 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.736 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.4 p -103.79 -26.81 12.57 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 124.524 1.14 . . . . 0.0 110.794 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.36 165.6 19.65 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.995 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.7 p -121.79 149.21 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.5 m -153.22 164.28 38.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.088 0.47 . . . . 0.0 111.196 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -107.82 102.83 12.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.05 144.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.102 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.8 p -61.32 167.02 4.42 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.54 -14.48 11.56 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.958 1.772 . . . . 0.0 111.982 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 65.9 t0 -84.54 -20.28 31.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -85.82 81.27 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.538 . . . . 0.0 110.214 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.55 ' C ' ' H ' ' A' ' 173' ' ' VAL . 95.4 m95 -75.77 -15.16 60.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.898 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 40.7 mp0 -51.99 -6.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.146 0.498 . . . . 0.0 110.968 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 171' ' ' TRP . 73.2 t -88.65 -19.06 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.163 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.68 -6.29 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.488 0.661 . . . . 0.0 109.383 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -82.07 150.9 27.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.18 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -60.72 127.29 30.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 25.9 m170 -116.44 24.3 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.77 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 15.62 68.05 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -149.64 167.89 25.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 111.183 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.65 97.84 8.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.717 0.77 . . . . 0.0 110.734 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.73 135.09 45.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.36 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.4 tt -82.62 147.96 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 7.3 m -136.5 117.54 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.931 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.4 mp -101.73 124.19 46.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.071 0.462 . . . . 0.0 110.174 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 13.8 pt -137.38 -176.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.06 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.551 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 43.0 p . . . . . 0 CA--C 1.534 0.362 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.1 ttm180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.177 0.513 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -108.66 139.12 43.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.395 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.35 139.04 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.394 0.616 . . . . 0.0 111.467 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.53 130.63 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.79 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.81 135.65 53.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.263 0.554 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.52 153.71 20.56 Favored Glycine 0 N--CA 1.46 0.292 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 50.5 p-10 -108.18 142.27 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.728 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.08 127.87 34.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.413 0.625 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.84 -26.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.186 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.16 162.17 20.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.533 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 25.5 m -136.88 156.17 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.245 0.545 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.1 pttp -150.9 179.13 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.08 142.87 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.401 0.62 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -61.97 81.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.561 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttp . . . . . 0 C--N 1.313 -0.983 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.57 178.427 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.493 1.479 0 CA-C-O 120.988 0.328 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -73.42 158.36 35.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.227 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -25.85 30.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.32 91.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -75.08 -26.08 59.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.235 0.541 . . . . 0.0 110.474 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.8 t -79.4 -49.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.942 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.95 81.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.173 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -68.78 -32.1 71.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.334 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.24 113.3 2.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.938 0.399 . . . . 0.0 111.219 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -92.21 133.59 35.67 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.97 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.2 tp -129.57 134.85 47.96 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.757 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -94.02 132.26 38.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 69.5 mmtt -66.34 -9.5 33.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.474 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' A' ' 79' ' ' VAL . 63.7 mttp -65.44 -34.37 78.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.835 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.23 17.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.8 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 77' ' ' LYS . 4.8 p -92.31 127.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pt -122.45 -2.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.03 38.49 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -147.88 153.28 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.854 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.69 122.27 63.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m -121.35 127.96 51.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.584 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.4 mt -133.75 120.42 15.47 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.81 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.84 -32.33 1.55 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.829 1.686 . . . . 0.0 112.331 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.1 p -47.87 -37.39 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.975 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.7 p -118.32 0.12 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.476 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t 63.49 52.79 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -119.54 133.07 55.84 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -135.31 119.74 17.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 mt -145.46 167.32 14.68 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.023 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.94 150.09 7.09 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.886 2.391 . . . . 0.0 109.652 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.6 t -102.18 113.91 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.45 -45.05 85.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.972 0.415 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.5 p -71.33 106.91 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.232 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.7 p -83.79 107.14 16.02 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.094 0.473 . . . . 0.0 110.234 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.572 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 3.8 p -137.43 156.59 48.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.113 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -57.86 -36.45 72.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -74.72 -43.65 53.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.387 0.613 . . . . 0.0 112.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.572 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 92.3 m-20 -66.43 -35.45 80.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.441 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 126' ' ' HIS . 36.4 mt -65.56 -15.93 63.19 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.65 -14.18 60.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.8 m -116.53 -7.41 11.63 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.0 -163.83 28.74 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.117 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.49 130.33 47.74 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.083 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.25 147.91 34.02 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.3 p -76.47 153.79 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.06 -46.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -92.18 142.16 27.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.123 0.487 . . . . 0.0 111.179 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.4 pt-20 -62.58 -51.41 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.662 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 8.4 m120 -96.75 47.88 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.379 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -83.59 154.22 23.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.79 130.25 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.595 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.1 mtt -72.61 128.39 35.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.762 0.315 . . . . 0.0 110.948 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.522 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.19 4.91 73.7 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -140.93 120.65 13.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.257 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.64 -166.9 54.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -85.07 106.29 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.57 101.18 11.91 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.93 130.82 36.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.991 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.92 132.21 53.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.09 137.72 46.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.351 0.596 . . . . 0.0 110.596 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.19 -176.5 19.22 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.517 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 103' ' ' LEU . 76.3 m-70 -93.28 157.51 16.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.826 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.0 p-10 -122.05 29.04 7.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.585 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.2 mmt -38.15 -20.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.636 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 59.93 37.44 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.275 0.56 . . . . 0.0 109.836 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 136' ' ' SER . 58.3 tttp -136.49 107.73 6.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.767 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -58.4 130.24 45.81 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.59 0.71 . . . . 0.0 111.249 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.02 15.61 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.176 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 134' ' ' LEU . 2.0 t -96.97 177.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.443 ' H ' HG12 ' A' ' 133' ' ' VAL . 1.3 pt? -71.62 136.38 47.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.754 0.788 . . . . 0.0 112.355 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 46.45 31.92 1.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.429 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.0 p -81.75 -6.03 58.68 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.7 m-20 -146.97 43.1 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.091 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 140' ' ' SER . 31.9 pt -69.97 -30.69 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.261 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.06 7.28 2.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 138' ' ' ILE . 23.3 t -95.56 -14.71 23.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.14 123.72 18.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.81 154.21 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.62 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.93 130.61 47.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.64 21.99 41.55 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -87.0 134.77 33.45 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -81.5 129.64 34.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.529 0.68 . . . . 0.0 112.147 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 147' ' ' ILE . 90.1 mt -123.39 123.92 68.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.817 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -105.05 121.84 44.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.344 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.0 153.17 28.49 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.167 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -127.2 131.23 50.71 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.344 0.592 . . . . 0.0 111.756 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 42.0 t0 -115.04 -168.06 1.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.7 m120 -20.87 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.082 0.468 . . . . 0.0 112.137 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -140.17 25.32 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -122.83 142.3 50.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -106.33 122.08 45.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.87 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.47 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.3 m-85 -104.01 126.62 51.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.987 0.422 . . . . 0.0 111.667 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.66 117.12 29.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 19.6 m-85 -116.55 147.11 42.13 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.381 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 202' ' ' ASP . . . -123.57 134.83 53.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 110.489 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.15 133.61 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.706 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.7 p -101.1 -25.4 14.05 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 124.51 1.131 . . . . 0.0 110.349 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.08 156.3 7.99 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.356 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.34 147.82 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.639 -0.781 . . . . 0.0 109.871 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.2 p -148.64 159.59 43.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.173 0.511 . . . . 0.0 111.334 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.81 119.6 39.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.437 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.09 159.84 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.1 p -76.72 142.92 70.68 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.42 -18.55 3.76 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.89 1.727 . . . . 0.0 111.836 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -83.44 -6.67 59.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -83.36 70.63 10.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.263 0.554 . . . . 0.0 110.331 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.519 ' C ' ' H ' ' A' ' 173' ' ' VAL . 85.0 m95 -71.46 -28.53 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.57 -11.36 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.058 0.456 . . . . 0.0 110.475 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 171' ' ' TRP . 43.9 t -80.48 -22.68 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.72 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.08 -6.86 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.756 0.788 . . . . 0.0 109.282 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.01 137.08 37.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.981 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 39.9 p-10 -51.97 127.28 20.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.962 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -104.86 -43.39 5.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.46 26.33 0.1 Allowed Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -152.85 173.37 15.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.244 0.545 . . . . 0.0 111.157 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 11.5 m-20 -94.23 89.39 5.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.049 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -128.89 127.28 41.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.678 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.0 tt -82.42 146.81 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.1 m -135.91 119.31 16.83 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.547 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.75 124.73 50.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.012 0.434 . . . . 0.0 109.912 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.9 pt -135.88 173.2 14.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.79 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.176 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.689 0.28 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -102.92 131.25 49.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.6 p -133.79 137.47 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.02 130.35 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.44 136.92 52.48 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.593 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.73 147.99 19.36 Favored Glycine 0 N--CA 1.466 0.671 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -100.84 140.87 34.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.02 -0.59 . . . . 0.0 112.163 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 49.5 tp -64.46 129.44 39.89 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.212 0.529 . . . . 0.0 110.291 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.5 t -107.72 -27.07 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.35 20.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.202 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.47 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 34.6 m -135.04 156.06 49.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.201 0.524 . . . . 0.0 109.814 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -149.53 180.0 7.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.903 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.66 145.48 24.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.225 0.536 . . . . 0.0 110.787 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -74.51 81.17 1.95 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.647 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.642 178.845 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.49 1.321 0 CA-C-O 121.023 0.343 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.51 158.67 32.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.23 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.05 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.198 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.05 -52.46 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.76 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -74.08 -17.84 60.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -77.69 -54.73 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.903 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.38 84.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.272 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.55 110.77 1.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.793 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.6 m -94.35 120.48 34.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.1 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.43 ' CB ' ' HG ' ' A' ' 105' ' ' SER . 41.7 tp -113.84 129.08 56.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.61 139.82 55.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -73.31 -8.72 57.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.24 0.543 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.48 -32.77 74.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -77.17 11.48 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.1 t -91.34 123.72 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -122.42 -5.21 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.984 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.25 -169.61 38.62 Favored Glycine 0 C--N 1.316 -0.54 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -146.48 154.01 41.08 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.251 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 3.9 tt -121.89 124.54 71.6 Favored 'Isoleucine or valine' 0 C--O 1.23 0.056 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -127.53 130.86 49.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -133.63 129.13 20.31 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.569 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -35.89 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.392 2.061 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -49.41 -40.19 35.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.529 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.1 p -119.57 -0.94 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.241 0.216 . . . . 0.0 110.819 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.33 52.14 3.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.2 tp -110.61 130.7 55.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.045 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -133.21 114.83 14.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -143.92 110.51 5.17 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.73 136.7 1.88 Allowed 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.6 1.533 . . . . 0.0 110.764 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.71 123.07 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.9 mt -103.4 131.0 50.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.34 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 97' ' ' SER . 20.1 pttp -72.44 -42.84 64.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.464 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 55.5 m -74.68 103.13 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.245 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 98' ' ' SER . 53.5 p -82.36 94.41 7.37 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.281 0.562 . . . . 0.0 110.133 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.4 p -134.31 154.38 51.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.903 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -56.46 -37.35 70.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -71.86 -46.28 58.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.501 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.51 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 75.2 m-20 -66.2 -36.3 82.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.561 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.69 -16.18 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.721 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.0 mt -70.13 -27.61 64.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.43 ' HG ' ' CB ' ' A' ' 74' ' ' LEU . 3.6 m -93.36 -10.27 35.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 167.51 -174.43 42.61 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.983 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.46 130.17 38.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.294 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 147.46 29.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.865 0.364 . . . . 0.0 110.876 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.0 p -73.14 149.45 43.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.88 -43.24 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.74 141.36 28.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.18 0.514 . . . . 0.0 111.183 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.21 -16.09 41.37 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.56 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -144.27 56.51 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.31 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.45 ' NE2' ' CG ' ' A' ' 121' ' ' TYR . 3.0 tt0 -77.9 159.84 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.0 121.81 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.016 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -72.77 128.02 34.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.443 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.86 73.45 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -142.13 121.53 13.19 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 76.17 -174.71 53.13 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.491 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.9 t30 -83.79 110.43 18.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.45 ' CG ' ' NE2' ' A' ' 114' ' ' GLN . 6.8 t80 -83.52 103.59 12.98 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 130.4 36.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.109 0.48 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mt -127.42 130.65 49.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.89 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.31 140.19 46.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 110.578 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.2 179.65 20.56 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.615 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -84.81 154.78 22.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.792 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 129' ' ' SER . 14.8 p30 -121.97 29.18 7.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.655 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.3 mtt -43.46 -13.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.776 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 61.78 38.35 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.935 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -135.11 107.7 7.4 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.89 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.29 125.61 12.93 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.634 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.73 8.97 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.927 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.631 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 58.5 t -83.48 179.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.584 0.692 . . . . 0.0 109.183 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.631 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.42 132.45 43.93 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.436 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 49.13 38.08 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.219 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.17 -12.31 58.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.8 m-20 -147.98 34.06 0.83 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 140' ' ' SER . 7.3 pt -68.87 -32.19 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.425 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.63 2.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.706 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 138' ' ' ILE . 8.5 t -93.5 -14.86 26.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.48 120.29 12.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.069 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mmtt -104.93 155.72 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -53.68 114.81 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.214 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.22 21.58 5.17 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 96.9 m-20 -99.16 128.02 45.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.94 133.14 35.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.792 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 93.1 mt -126.39 125.72 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.927 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.9 123.13 48.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.725 0.298 . . . . 0.0 110.759 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -112.48 146.36 38.59 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.067 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -116.05 131.16 57.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 152' ' ' ASN . 46.9 t0 -114.27 -166.52 1.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.6 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 111.852 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -138.41 29.86 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -128.96 145.23 51.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -111.52 121.78 46.08 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -102.73 133.51 47.64 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 111.513 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.1 118.08 31.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.765 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -119.06 140.25 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.155 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.46 134.82 55.22 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.51 0.672 . . . . 0.0 110.449 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.29 135.64 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.733 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -101.46 -24.54 14.15 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 124.888 1.367 . . . . 0.0 110.764 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.58 154.08 7.32 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.294 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.9 p -98.45 129.41 48.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.832 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.4 m -132.01 149.53 52.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.296 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -109.18 116.64 32.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.343 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -133.95 153.17 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.9 p -64.56 169.09 5.51 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 -13.87 11.81 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.884 1.723 . . . . 0.0 111.71 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.58 -19.66 41.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.639 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -85.79 75.34 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 109.944 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -74.74 -9.63 58.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.041 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -53.4 -22.47 7.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 79.9 t -81.03 -10.82 12.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.049 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.13 -12.08 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.739 0.78 . . . . 0.0 110.178 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.11 157.81 20.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.376 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 66.2 t0 -66.54 131.17 45.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.42 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 31.3 m80 -101.26 -41.63 6.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.35 29.9 0.24 Allowed Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.448 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 48.5 pttt -157.44 179.25 9.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.547 . . . . 0.0 111.515 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 26.7 p30 -90.81 88.81 7.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.866 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -123.63 166.56 15.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.128 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.85 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.78 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.491 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 19.0 m -135.7 123.85 23.02 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.059 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.2 mp -111.79 125.09 53.63 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.129 0.49 . . . . 0.0 110.078 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 pt -134.32 162.1 39.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.001 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 64.6 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.413 179.225 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -110.63 138.72 46.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.303 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 50.1 t -133.33 136.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.23 128.43 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.562 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.63 136.52 52.9 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.331 0.586 . . . . 0.0 110.314 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.09 158.01 24.08 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.598 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 63.1 t0 -113.77 146.3 40.11 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.568 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.0 tp -68.04 130.82 44.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.062 0.458 . . . . 0.0 110.716 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.77 -22.85 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.5 175.89 45.96 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.329 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.9 m -154.23 154.13 32.94 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.344 0.592 . . . . 0.0 111.014 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -148.33 177.58 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.524 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.69 142.78 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.061 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.23 80.81 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.272 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 208' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.55 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.251 0 CA-C-O 121.068 0.362 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -75.68 158.05 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.09 -28.77 62.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.069 0.461 . . . . 0.0 110.095 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.52 97.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.647 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -73.63 -31.46 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.327 0.584 . . . . 0.0 110.789 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.8 t -75.48 -46.38 37.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.783 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.25 87.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.926 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.4 -30.37 64.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.342 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.56 119.68 9.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.811 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 m -93.21 156.51 16.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -138.29 122.1 17.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.918 0.389 . . . . 0.0 110.81 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 77' ' ' LYS . 99.2 m-20 -83.55 108.74 16.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -47.71 -15.39 0.06 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.082 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 75' ' ' ASP . 99.2 mttt -69.51 -8.26 45.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.77 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.61 6.45 48.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.923 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.1 t -91.06 128.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.942 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.2 -6.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.728 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.61 -167.47 35.28 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 83' ' ' ILE . 19.4 ttm180 -150.96 157.0 42.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.402 0.62 . . . . 0.0 111.07 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.4 ' N ' ' CG ' ' A' ' 82' ' ' ARG . 15.8 tt -129.88 134.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.979 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.1 t -131.53 133.3 44.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.951 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.6 mt -136.0 127.92 17.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.329 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.21 -33.08 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.41 2.073 . . . . 0.0 112.02 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -49.12 -41.93 37.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.586 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.0 p -116.09 -1.69 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.8 -0.182 . . . . 0.0 110.878 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 64.38 50.04 2.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.8 tp -113.47 130.9 56.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.259 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -134.77 116.06 14.43 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.9 mt -143.7 163.28 37.06 Favored Pre-proline 0 N--CA 1.463 0.183 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.737 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.5 157.5 6.53 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.981 2.454 . . . . 0.0 109.235 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.0 t -107.01 117.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.0 mt -101.21 129.99 47.24 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -71.06 -36.99 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.986 0.422 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.0 m -75.54 100.12 4.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 98' ' ' SER . 53.5 p -82.85 92.93 7.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.531 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 5.2 p -133.81 155.87 49.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.016 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -55.36 -32.67 62.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.402 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -76.57 -46.5 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.003 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.531 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 97.4 m-20 -66.25 -34.45 78.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.832 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.92 -18.88 59.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.63 -18.24 61.6 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.8 m -99.9 -11.25 20.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.53 -155.88 25.77 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.973 -1.108 . . . . 0.0 111.658 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.29 126.17 36.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.889 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.95 144.26 32.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -75.55 152.96 37.68 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.44 -47.96 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -92.44 137.64 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 110.853 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 14.2 pt-20 -62.89 -47.11 84.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.869 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 61.6 t-20 -96.74 47.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.404 ' NE2' ' CE1' ' A' ' 121' ' ' TYR . 3.2 tt0 -91.55 155.38 18.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.4 t -130.27 133.79 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.202 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.6 mtp -73.51 126.24 29.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.704 0.288 . . . . 0.0 110.474 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.31 67.43 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.26 120.08 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.092 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.21 -178.31 41.32 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.452 HD22 ' HG1' ' A' ' 183' ' ' THR . 61.2 t-20 -73.82 107.43 6.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.404 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 10.6 t80 -84.26 103.51 13.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.97 126.55 35.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.122 0.486 . . . . 0.0 111.495 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -121.4 131.31 54.1 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.69 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 139.17 45.01 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.311 0.577 . . . . 0.0 110.662 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.78 15.17 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.701 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -92.44 146.09 23.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.726 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.8 p30 -108.01 27.53 9.16 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.293 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -42.18 -16.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.701 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 127' ' ' ASN . 2.6 t 55.06 37.14 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.812 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -133.87 111.96 10.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.458 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.67 123.66 14.83 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.152 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.43 5.93 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.532 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 41.8 t -137.37 177.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.532 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -69.76 128.0 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.758 0.313 . . . . 0.0 110.644 -178.164 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 47.41 38.5 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 110.468 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.39 -6.02 59.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.723 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.6 t0 -151.16 39.97 0.69 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.071 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.0 pt -69.02 -30.18 45.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.49 4.14 3.28 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 49.6 m -95.69 -14.48 23.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 109.749 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.01 124.81 23.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.529 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -96.73 156.57 16.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.755 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.21 128.8 38.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.415 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 89.5 20.81 43.1 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -82.36 136.36 35.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -80.35 126.63 31.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 112.1 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.68 118.01 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 121.3 41.26 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.2 tp -114.28 142.84 45.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.984 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.17 136.42 44.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.242 0.544 . . . . 0.0 111.468 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 154' ' ' ASN . 40.9 t0 -113.0 177.0 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.347 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.452 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 19.4 p-10 -35.79 -54.46 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.409 0.623 . . . . 0.0 111.338 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 97.7 mt-10 -141.69 16.56 2.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -128.63 142.42 51.04 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -109.35 124.02 50.28 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -106.55 134.99 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.388 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.73 118.49 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.408 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -115.88 138.0 51.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.246 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.78 132.58 55.11 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.429 0.633 . . . . 0.0 110.822 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 144' ' ' GLY . 48.6 t -66.98 134.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.7 p -101.75 -28.33 12.52 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 124.443 1.089 . . . . 0.0 110.799 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.44 143.73 4.39 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.775 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.43 137.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.585 ' HG ' ' H ' ' A' ' 165' ' ' GLU . 18.8 t -159.56 171.11 20.24 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.136 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.585 ' H ' ' HG ' ' A' ' 164' ' ' SER . 15.4 pt-20 -122.53 130.27 52.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.426 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.12 157.37 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.492 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 169' ' ' ASP . 6.8 p -68.56 130.18 92.16 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.425 ' HG3' HH21 ' A' ' 196' ' ' ARG . 1.5 Cg_endo -46.38 -11.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.921 1.747 . . . . 0.0 111.648 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 167' ' ' THR . 43.1 t0 -75.69 -22.2 56.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -84.82 73.15 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.009 0.433 . . . . 0.0 110.134 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -71.69 -14.66 62.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.513 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.479 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.5 mt-10 -52.97 -34.38 55.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.216 0.531 . . . . 0.0 110.074 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -70.94 -5.22 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.024 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.77 -14.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.678 0.751 . . . . 0.0 109.969 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -86.2 177.16 7.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.835 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.3 p-10 -81.74 131.66 35.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.479 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 42.9 m80 -103.21 -41.76 5.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.9 27.13 0.13 Allowed Glycine 0 N--CA 1.471 0.98 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -157.47 179.56 9.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 111.411 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -89.98 90.25 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -121.01 166.93 13.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.081 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.9 tt -132.32 144.07 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.452 ' HG1' HD22 ' A' ' 120' ' ' ASN . 18.8 m -135.72 126.37 27.15 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.196 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.1 mp -112.55 118.23 34.52 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 12.0 pt -134.3 171.67 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.643 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.57 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.3 p . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.716 0.293 . . . . 0.0 110.892 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.57 ' NH1' ' O ' ' A' ' 186' ' ' THR . 16.7 ptp180 . . . . . 0 N--CA 1.463 0.211 0 CA-C-O 120.961 0.41 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.34 140.66 44.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.61 132.17 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.132 0.492 . . . . 0.0 111.14 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.7 t -116.22 127.31 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.512 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.19 135.56 53.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.92 157.5 25.37 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 60.6 t0 -115.11 152.49 32.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.446 -0.377 . . . . 0.0 111.161 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.562 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.95 129.24 38.09 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.085 0.469 . . . . 0.0 110.767 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.1 p -107.81 -25.97 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.011 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.68 175.29 47.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.219 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.5 m -152.67 150.26 29.28 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.194 0.521 . . . . 0.0 110.883 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -148.62 178.0 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.538 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.97 21.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.151 0.5 . . . . 0.0 110.817 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -77.08 79.82 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.744 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.561 178.422 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.483 0.863 0 N-CA-C 110.984 -0.429 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -74.58 160.29 31.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.464 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.1 mp -64.66 -21.31 66.7 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.251 0.344 . . . . 0.0 110.862 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.73 -40.28 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.49 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.29 -34.91 68.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.623 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.8 t -75.07 -45.2 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.074 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.5 87.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.02 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -84.04 -23.31 30.96 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.621 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.23 118.98 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.336 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -94.78 140.75 29.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.198 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.4 tp -115.42 140.71 48.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.452 ' C ' ' N ' ' A' ' 77' ' ' LYS . 39.2 m-20 -95.11 100.92 12.65 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -46.89 -18.06 0.06 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.452 ' N ' ' C ' ' A' ' 75' ' ' ASP . 3.2 ttmp? -65.95 -33.8 76.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.312 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 0.9 OUTLIER -80.08 13.94 2.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.817 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.1 t -91.49 127.48 43.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.633 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.15 -6.31 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.106 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.83 -173.19 43.94 Favored Glycine 0 C--N 1.321 -0.284 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.87 153.94 44.79 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.841 -177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.8 tt -125.75 131.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 t -134.01 132.02 39.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.692 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.17 128.74 19.6 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.17 -36.67 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.412 2.075 . . . . 0.0 112.376 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -48.4 -39.98 24.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.51 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.3 p -119.31 -1.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.372 0.42 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.75 50.24 4.46 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.11 131.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.574 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.79 114.66 12.09 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 93' ' ' PRO . 76.2 mt -142.53 112.35 5.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -40.05 140.61 0.79 Allowed 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.661 1.574 . . . . 0.0 110.302 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.6 t -93.15 122.02 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.66 123.47 48.55 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.484 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.06 -47.8 76.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.184 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -71.7 105.88 3.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.878 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -85.8 100.95 12.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.651 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 44.5 p -131.75 156.96 45.05 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.104 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.66 -28.99 61.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -82.87 -42.39 17.82 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.882 0.739 . . . . 0.0 111.936 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.651 ' H ' ' HG1' ' A' ' 99' ' ' THR . 98.4 m-20 -65.63 -38.09 88.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.136 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.62 -19.76 62.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.061 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.49 -33.17 70.93 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.2 m -95.58 -9.47 32.19 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 177.43 179.57 47.73 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.254 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.89 127.82 33.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.948 -0.626 . . . . 0.0 109.84 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.63 146.14 31.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.4 p -76.4 153.87 35.34 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.0 t -85.43 -48.18 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -92.26 137.72 32.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.41 0.624 . . . . 0.0 110.698 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.9 pt-20 -60.32 -47.6 85.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.161 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 98.8 m-20 -98.8 47.41 0.98 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.39 155.45 21.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.964 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.9 131.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.3 mtt -74.98 128.0 34.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.11 0.54 70.94 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -139.36 118.15 12.38 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.017 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -171.86 53.65 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.43 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 47.0 t-20 -83.66 110.81 18.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.1 102.9 13.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 128.99 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.597 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -123.96 130.45 52.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.331 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.92 138.21 47.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.318 0.58 . . . . 0.0 110.806 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.36 -179.05 17.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.259 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 134' ' ' LEU . 37.5 m-70 -86.46 144.44 27.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.455 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' SER . 8.1 t-20 -110.99 28.19 8.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.061 0.458 . . . . 0.0 110.652 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -47.37 -11.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.11 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 127' ' ' ASN . 2.3 t 56.1 40.67 30.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.024 -0.671 . . . . 0.0 109.928 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.31 105.93 7.6 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -50.42 124.94 11.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.614 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -26.4 9.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.374 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.565 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 39.7 t -82.82 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.565 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -72.88 132.33 43.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 48.85 37.79 10.68 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.93 0.395 . . . . 0.0 111.345 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -82.12 -11.4 58.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 136' ' ' SER . 83.7 m-20 -145.51 38.13 1.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -66.09 -36.13 76.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.48 3.08 1.95 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.815 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 138' ' ' ILE . 6.3 t -96.49 -11.19 25.88 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.279 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.39 122.26 18.03 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.538 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 64.4 mttp -95.57 161.46 14.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.391 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -61.12 135.12 57.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.46 19.08 57.61 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 2.6 m-20 -85.1 130.05 34.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.88 131.09 35.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.2 mt -122.57 123.09 67.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -100.63 118.67 37.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 mt -113.53 149.15 34.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.194 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -124.64 130.26 52.09 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.433 0.635 . . . . 0.0 111.416 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.7 t0 -113.52 -168.52 1.35 Allowed 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.545 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 16.9 m120 -24.86 -71.69 0.03 OUTLIER 'General case' 0 C--O 1.232 0.154 0 O-C-N 123.475 0.485 . . . . 0.0 111.579 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.62 26.6 2.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.25 146.87 44.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -111.74 118.7 36.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.735 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -105.44 127.99 53.29 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.571 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -98.82 122.75 42.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.926 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -122.08 142.32 50.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 135.02 55.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.335 0.588 . . . . 0.0 110.703 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.7 133.35 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.51 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.1 t -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.64 1.212 . . . . 0.0 111.515 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.32 149.95 6.51 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.3 t -104.8 134.38 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -135.66 151.31 50.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.444 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.72 116.87 32.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.634 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.77 154.84 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 169' ' ' ASP . 23.4 p -78.16 140.46 61.5 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.59 -18.26 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.975 1.783 . . . . 0.0 111.867 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.7 m-20 -77.4 -21.19 53.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.025 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -83.03 70.54 10.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.119 0.568 . . . . 0.0 110.176 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.538 ' C ' ' H ' ' A' ' 173' ' ' VAL . 82.0 m95 -70.48 -27.04 63.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.944 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.4 -10.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.631 0.582 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.5 t -80.95 -23.69 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.501 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.01 -5.33 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.588 0.708 . . . . 0.0 110.015 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.35 142.06 36.38 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.925 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -54.84 128.98 35.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -102.4 -42.72 5.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.49 28.52 0.15 Allowed Glycine 0 N--CA 1.471 0.985 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -157.15 179.76 8.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.999 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 8.1 m-20 -93.87 94.12 8.32 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 182' ' ' ILE . 46.1 tt0 -127.54 170.87 12.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.906 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.423 ' H ' ' HG2' ' A' ' 181' ' ' GLU . 20.6 tt -131.63 143.19 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.709 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 8.7 m -138.29 116.89 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.3 mp -102.38 119.59 39.08 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.605 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 185' ' ' ILE . 0.1 OUTLIER -130.97 -169.97 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.379 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 31.0 p . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.376 -178.857 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.45 0.167 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.3 132.44 56.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.528 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.6 136.57 50.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.091 0.472 . . . . 0.0 111.046 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.96 129.65 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.673 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.66 133.39 55.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.144 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.77 146.62 17.1 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 121.807 0.671 . . . . 0.0 111.706 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -105.32 139.12 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.714 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.18 129.16 38.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.937 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 p -106.41 -25.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.073 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.27 159.6 16.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.453 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.9 m -135.7 155.02 51.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.86 177.78 9.51 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.3 144.34 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.551 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.07 79.09 0.67 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.023 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.548 178.813 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.486 1.057 0 N-CA-C 111.262 -0.322 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.99 152.51 41.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 2.2 pt? -59.0 -23.98 62.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.402 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.48 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 95.6 mt-10 -73.07 -33.07 65.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.606 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.3 -42.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.1 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.09 92.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.405 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.1 p-10 -86.31 -15.14 41.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.669 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 71' ' ' ASN . . . -61.08 120.27 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.107 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.2 p -91.39 159.55 15.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.11 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.11 142.57 44.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -94.12 100.51 12.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -57.23 -14.93 4.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.049 0.452 . . . . 0.0 110.347 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -76.44 -14.55 60.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.146 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.47 13.17 34.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.529 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.13 135.99 24.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.988 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 pt -117.5 -3.55 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.035 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.63 34.86 Favored Glycine 0 C--N 1.317 -0.518 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -154.05 165.26 36.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.808 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 tt -134.3 140.96 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.891 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 t -133.52 135.79 44.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.362 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 mt -134.58 127.77 18.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.802 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.55 -38.34 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.357 2.038 . . . . 0.0 112.584 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -47.37 -41.01 18.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.599 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.4 p -116.69 -3.31 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.828 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.83 49.46 1.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.49 127.3 53.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.865 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -138.16 116.14 11.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.7 mt -157.71 127.52 3.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.471 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -42.96 159.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.929 0 C-N-CA 121.928 1.752 . . . . 0.0 109.703 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 t -113.61 124.66 70.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.11 128.89 49.86 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.217 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -65.05 -35.3 80.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.717 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -176.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.632 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 p -162.51 55.48 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.699 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 7.0 p -105.68 160.03 15.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.151 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.48 -32.33 71.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.603 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.4 -41.85 55.2 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.85 0.719 . . . . 0.0 112.26 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 98.3 m-20 -65.82 -39.92 91.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.553 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.78 -19.82 52.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.87 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.8 mt -69.25 -34.85 75.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.0 m -97.16 -7.71 31.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -179.0 -174.6 45.33 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.58 127.95 34.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.12 -0.54 . . . . 0.0 109.882 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.38 141.61 36.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.768 0.318 . . . . 0.0 110.715 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.4 p -71.87 147.54 47.02 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.77 -47.68 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -92.03 -170.47 2.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.657 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 113' ' ' ASN . 1.6 pt-20 -113.19 -53.86 2.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.951 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.455 ' H ' ' HG3' ' A' ' 112' ' ' GLU . 89.0 m-20 -94.42 44.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -93.37 154.54 17.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.71 133.9 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.816 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 68.5 mtt -69.66 128.39 36.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.989 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.501 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.68 1.33 77.49 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.6 123.44 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.974 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.19 -164.36 54.34 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -94.64 108.68 20.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -84.91 100.87 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.043 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 124.63 35.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.511 . . . . 0.0 111.722 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.94 132.02 54.33 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.322 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.6 138.9 45.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.375 0.607 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.69 -176.26 16.63 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.43 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 135' ' ' PHE . 15.3 m-70 -86.11 141.79 29.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.815 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' A' ' 129' ' ' SER . 32.1 t30 -109.86 26.88 10.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.214 0.531 . . . . 0.0 110.481 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -46.34 -14.29 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.778 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 129' ' ' SER . 1.4 p 55.2 41.15 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.822 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 136' ' ' SER . 30.5 mmtm -133.91 129.25 36.06 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.653 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -74.24 124.52 26.56 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.41 -28.24 6.61 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 t -78.04 170.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.621 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.22 133.16 40.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.685 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 126' ' ' HIS . 3.6 m-85 49.27 38.74 14.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 1.1 p -80.33 -61.26 2.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.282 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 136' ' ' SER . 97.9 m-20 -89.35 39.7 0.95 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.7 pt -69.78 -26.72 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.241 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.42 6.81 5.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.0 t -95.33 -13.64 24.59 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.26 118.74 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -98.4 161.57 13.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.741 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -58.38 118.54 5.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.133 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.95 21.06 7.63 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 90.9 m-20 -96.65 127.99 43.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -80.58 138.31 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.956 0.408 . . . . 0.0 111.332 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 158' ' ' TYR . 97.5 mt -129.4 123.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -101.76 119.22 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.996 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.405 ' C ' ' CD1' ' A' ' 150' ' ' TYR . 2.7 mt -110.0 158.15 18.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.346 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 149' ' ' LEU . 66.6 m-85 -141.63 121.22 13.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.092 0.472 . . . . 0.0 111.859 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 152' ' ' ASN . 13.3 t0 -114.64 -166.11 1.08 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.579 ' C ' ' O ' ' A' ' 151' ' ' ASP . 95.1 m-20 -4.4 -88.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.857 0.723 . . . . 0.0 111.32 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -138.99 30.83 2.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -121.73 140.96 51.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -102.89 120.78 41.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.196 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -105.07 125.21 50.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.725 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -94.19 115.27 27.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.501 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.6 m-85 -117.18 142.82 46.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.224 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.06 132.13 53.98 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.439 0.637 . . . . 0.0 110.501 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.7 135.87 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.269 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 14.2 p -101.75 -25.56 13.79 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.783 1.302 . . . . 0.0 110.99 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.49 177.18 34.35 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.146 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.09 149.1 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.743 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 38.9 m -152.59 161.6 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 0.0 111.099 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -99.36 120.93 40.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 196' ' ' ARG . 18.4 m -132.45 157.45 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 169' ' ' ASP . 32.1 p -82.42 135.93 46.41 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.584 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -46.37 -15.1 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.004 1.803 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 67.3 t0 -84.52 -22.61 30.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -83.95 72.42 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.062 0.458 . . . . 0.0 110.928 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 94.1 m95 -74.94 -2.22 26.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.969 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.521 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 72.4 mm-40 -54.19 -39.0 66.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.19 4.57 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.944 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.07 -15.99 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.904 0.859 . . . . 0.0 110.042 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.403 ' O ' ' CD2' ' A' ' 177' ' ' HIS . 63.4 mm-40 -89.21 166.45 13.8 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.972 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -68.18 129.42 39.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.083 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.521 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.0 m170 -103.32 -40.54 6.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.143 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.83 25.23 0.12 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -156.41 179.23 9.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.863 0.363 . . . . 0.0 110.815 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -97.36 93.36 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.802 0.81 . . . . 0.0 110.408 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -127.02 175.16 8.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.407 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -130.38 143.47 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.216 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 13.1 m -135.99 123.67 22.38 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.557 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.5 mp -112.19 121.96 46.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.455 0.645 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.27 -174.84 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.829 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.546 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 15.4 p . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.368 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 186' ' ' THR . 39.1 ttm180 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.57 140.96 35.52 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 p -140.71 144.54 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.72 0.295 . . . . 0.0 111.425 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.63 129.91 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.204 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -121.21 138.93 53.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.256 0.551 . . . . 0.0 110.507 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.66 160.96 24.98 Favored Glycine 0 N--CA 1.461 0.337 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.8 t0 -113.55 149.69 34.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.954 -0.623 . . . . 0.0 111.135 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.536 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 21.7 tp -73.42 132.39 42.92 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 59.3 t -107.96 -27.1 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.512 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.93 160.37 16.82 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.388 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 28.4 m -136.42 155.6 49.78 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -151.62 179.84 8.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.08 143.19 26.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.461 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.5 81.22 1.95 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.528 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.379 178.693 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.487 1.124 0 CA-C-O 121.166 0.403 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -77.57 163.3 26.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.163 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 2.0 pt? -60.16 -21.75 62.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.234 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.23 -39.62 94.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -73.76 -30.33 62.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.317 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -77.31 -44.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.799 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.98 85.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 61.3 t-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.75 139.72 57.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.696 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -140.82 84.21 1.93 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 111.361 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.6 tp -82.15 134.64 35.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.21 138.81 55.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.439 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -64.02 -8.73 12.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 109.78 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -64.02 -30.12 71.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.863 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.683 HE21 ' HG ' ' A' ' 97' ' ' SER . 22.6 mm100 -76.75 9.87 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.109 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.69 124.41 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -129.8 -3.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.64 -170.55 32.58 Favored Glycine 0 C--N 1.315 -0.607 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.466 ' HD2' ' H ' ' A' ' 83' ' ' ILE . 5.3 tpt180 -153.02 151.14 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.837 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.466 ' H ' ' HD2' ' A' ' 82' ' ' ARG . 5.7 tt -123.39 127.4 74.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -128.3 129.57 46.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.2 mt -135.02 122.26 15.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.284 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.28 -33.89 0.49 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.372 2.048 . . . . 0.0 112.877 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -50.38 -36.37 32.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.45 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -120.17 -6.34 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.634 0.254 . . . . 0.0 110.982 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.84 48.22 0.41 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.92 129.69 55.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.839 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -135.34 115.85 13.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.35 111.15 4.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.02 147.89 0.25 Allowed 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 121.636 1.558 . . . . 0.0 110.529 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.4 t -96.16 124.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.9 145.33 30.55 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.586 ' HZ3' HE22 ' A' ' 78' ' ' GLN . 21.8 pttp -90.41 -35.33 15.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.279 0.561 . . . . 0.0 110.961 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.683 ' HG ' HE21 ' A' ' 78' ' ' GLN . 2.1 p -76.22 97.95 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.117 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -82.66 89.98 6.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.059 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 p -133.14 157.75 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.901 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.89 -29.76 60.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.765 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.435 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 11.4 ptpt -83.29 -43.84 15.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -66.63 -34.21 77.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.635 -178.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.99 -20.93 63.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.433 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.46 -18.79 61.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.6 p -102.42 -13.11 17.41 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.21 -179.43 47.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.165 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.55 125.84 28.43 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.6 143.16 34.14 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.866 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 46.7 p -75.1 154.15 37.96 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.68 -56.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -96.4 141.22 29.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.993 0.425 . . . . 0.0 110.689 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.2 pm0 -82.47 6.65 16.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -131.27 24.89 4.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -93.75 156.16 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.195 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.2 t -133.28 133.89 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.851 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.4 mtt -67.24 127.6 33.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.995 0.426 . . . . 0.0 110.237 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 90.96 2.41 71.68 Favored Glycine 0 C--O 1.23 -0.101 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -141.06 121.87 14.4 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.067 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.18 -168.88 53.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.404 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 60.3 t-20 -87.86 110.03 20.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.52 103.67 13.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.88 127.79 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 112.105 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 mt -123.54 132.41 53.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.933 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.57 139.08 45.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.402 0.62 . . . . 0.0 110.656 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.74 -176.58 15.01 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.72 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -97.46 141.5 30.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.951 0.405 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' SER . 43.5 p-10 -102.3 27.76 6.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -21.8 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.159 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 62.09 37.29 14.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.507 ' N ' ' OG ' ' A' ' 136' ' ' SER . 63.7 mmtt -133.32 108.02 8.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.769 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -50.66 125.98 14.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.809 0.814 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.02 -30.26 7.83 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.631 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.627 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 59.4 t -76.02 178.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.355 0 CA-C-N 117.681 0.74 . . . . 0.0 109.437 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.627 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.15 136.39 48.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.778 0.323 . . . . 0.0 110.437 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 44.11 32.03 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.324 0.583 . . . . 0.0 110.561 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -81.26 -12.26 59.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.459 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 29.4 t0 -142.62 26.45 1.76 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 pt -70.16 -25.76 28.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.797 0.332 . . . . 0.0 111.581 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.11 1.11 6.27 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.459 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.1 m -95.41 -11.7 27.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 mt -63.9 124.22 20.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.008 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 145' ' ' ASP . 99.2 mttt -96.4 158.17 15.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -56.58 134.87 54.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.185 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.36 19.49 62.24 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 142' ' ' LYS . 28.7 m-20 -81.43 132.73 35.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -79.51 130.33 35.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.274 0.559 . . . . 0.0 111.515 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 147' ' ' ILE . 81.6 mt -122.92 121.68 63.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.583 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.4 120.57 40.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.118 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.73 158.83 18.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -132.96 128.11 35.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.635 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 44.4 t0 -113.89 -166.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.522 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 14.3 t-20 -21.95 -74.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.152 0.501 . . . . 0.0 111.929 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.22 27.95 1.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -122.54 144.93 48.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -108.13 122.73 47.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.032 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -106.32 127.37 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.822 0.344 . . . . 0.0 111.489 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.62 115.88 28.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.503 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -117.07 142.24 47.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.308 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.7 134.51 55.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.629 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.5 133.97 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.915 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -102.14 -25.86 13.56 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 124.544 1.153 . . . . 0.0 110.787 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.98 142.34 3.37 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.857 -1.163 . . . . 0.0 111.768 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.0 t -104.77 152.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.687 ' HG ' ' H ' ' A' ' 165' ' ' GLU . 43.5 t -168.42 178.32 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.4 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.687 ' H ' ' HG ' ' A' ' 164' ' ' SER . 96.3 mt-10 -114.79 115.13 26.52 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.36 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 12.5 m -117.0 139.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.525 ' C ' HH12 ' A' ' 196' ' ' ARG . 66.8 p -54.23 162.6 1.5 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.57 -19.76 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.194 1.929 . . . . 0.0 111.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 34.3 p30 -81.91 -19.31 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 35.1 ttpt -88.13 74.68 8.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 110.503 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -75.27 -6.1 48.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.851 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.7 -24.55 14.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.21 -3.25 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.815 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.65 -12.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.665 0.745 . . . . 0.0 109.814 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -85.6 155.63 21.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.934 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.33 132.14 47.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.62 -39.33 6.41 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.44 28.56 0.17 Allowed Glycine 0 N--CA 1.471 1.012 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -155.1 174.92 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.126 0.489 . . . . 0.0 111.284 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -90.13 89.34 7.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.692 0.758 . . . . 0.0 109.557 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -119.59 168.36 11.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.826 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.7 tt -129.95 141.32 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.226 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.404 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 11.9 m -137.11 123.4 20.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.178 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.59 122.75 48.6 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.194 0.521 . . . . 0.0 110.091 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 185' ' ' ILE . 20.4 pt -132.91 168.08 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.689 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.633 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 166' ' ' VAL . 35.2 ptt-85 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.895 0.379 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -97.57 131.41 44.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.48 133.57 61.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 111.253 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.0 t -111.28 124.06 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.02 134.16 55.04 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.06 160.88 25.49 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.5 t0 -114.56 151.43 33.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.974 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.65 129.86 38.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.443 0.639 . . . . 0.0 110.755 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 98.7 t -106.34 -24.48 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.161 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.74 163.33 23.59 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.036 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.7 m -136.6 154.46 50.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.278 0.561 . . . . 0.0 109.975 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -148.99 179.43 7.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.176 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.65 24.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.279 0.562 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.68 80.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.612 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.574 178.644 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 CA-C-O 121.299 0.458 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.18 166.93 20.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.906 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.6 mp -52.02 -28.44 17.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.607 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 71' ' ' ASN . . . -65.43 -39.73 92.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.542 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -73.81 -31.28 63.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.741 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.83 -45.88 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.821 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.51 78.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.07 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 67' ' ' ALA . 9.3 m120 -69.06 -29.25 67.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.997 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.41 100.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.848 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -96.93 111.39 23.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.395 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -111.36 128.6 56.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.542 ' H ' ' NE2' ' A' ' 78' ' ' GLN . 97.8 m-20 -71.97 138.71 48.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.267 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -64.43 0.45 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 109.877 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 75' ' ' ASP . 13.2 mptt -92.06 -8.86 44.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.585 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.542 ' NE2' ' H ' ' A' ' 75' ' ' ASP . 76.1 mt-30 -83.17 -6.62 59.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.4 m -86.96 138.03 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.68 -3.32 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.487 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.07 -160.3 24.24 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -153.59 155.98 37.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.384 0.612 . . . . 0.0 111.258 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.26 136.86 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.073 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -128.99 134.07 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.986 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 mt -133.01 74.17 74.18 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.541 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -44.76 -39.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 123.151 2.567 . . . . 0.0 112.943 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.67 -32.17 7.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.623 -177.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 89' ' ' SER . 15.7 m -117.13 -7.01 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.637 0.256 . . . . 0.0 111.158 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER 75.22 39.49 0.37 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.197 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.64 130.02 56.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.48 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -144.79 129.97 18.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.718 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -164.44 152.54 10.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.072 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 162.99 4.51 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.064 1.843 . . . . 0.0 109.739 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.29 125.0 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 102' ' ' ASN . 10.2 mt -101.43 136.11 41.83 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.81 -48.54 24.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.11 0.481 . . . . 0.0 111.485 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 123.4 28.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.177 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.4 p -81.7 64.83 6.58 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.45 0.643 . . . . 0.0 110.46 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.552 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -91.81 143.21 26.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.077 179.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 101' ' ' LYS . 15.3 pt-20 -56.33 -44.22 79.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.403 0.621 . . . . 0.0 110.742 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.493 ' N ' ' CG ' ' A' ' 100' ' ' GLU . 54.5 tttp -66.03 -46.38 78.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.808 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.552 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 2.9 m-20 -67.18 -36.97 82.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.844 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -55.04 -16.82 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.451 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.0 mt -70.63 -29.9 66.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -89.74 -10.56 45.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 178.52 41.27 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.718 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -72.37 132.16 43.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.97 150.13 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.125 0.488 . . . . 0.0 111.031 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.5 p -73.6 153.93 39.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.34 -52.2 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -91.76 141.44 28.67 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.994 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -71.39 -2.58 16.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.538 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.34 41.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.251 0.548 . . . . 0.0 111.115 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -84.86 158.1 20.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -134.49 129.7 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.628 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -73.7 127.88 34.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.43 -0.15 70.86 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -139.71 121.61 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.967 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.32 -171.86 52.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.515 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 10.2 t30 -84.03 110.13 18.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.24 99.38 10.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.78 130.44 36.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.363 0.601 . . . . 0.0 111.425 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -125.9 133.83 51.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.826 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.18 141.56 47.37 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.378 0.609 . . . . 0.0 110.71 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.9 -178.85 18.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.656 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -81.83 149.27 28.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.972 0.415 . . . . 0.0 110.748 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 129' ' ' SER . 45.1 t30 -112.48 28.44 8.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.169 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.1 mmm -47.43 -11.74 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.638 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 127' ' ' ASN . 3.1 t 54.72 41.11 32.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.982 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.4 tttt -134.52 116.2 14.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.565 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -57.33 125.61 23.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.764 0.792 . . . . 0.0 110.53 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.25 -25.87 11.96 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.871 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 58.3 t -79.9 179.07 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.626 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.28 133.31 45.97 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.768 -178.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 44.47 33.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.148 0.499 . . . . 0.0 111.06 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -82.29 -7.79 59.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.5 m-20 -147.47 38.14 0.94 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.6 pt -74.24 -25.49 19.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.84 0.352 . . . . 0.0 111.881 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.83 0.52 8.86 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.749 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.0 m -93.39 -12.24 30.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.27 0.557 . . . . 0.0 109.628 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.0 mt -65.58 125.0 23.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.204 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -96.34 158.46 15.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.677 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.05 133.06 54.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.514 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.5 59.18 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -83.52 136.91 34.1 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -81.0 130.23 34.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 111.345 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -127.13 126.64 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 148' ' ' TYR . 42.4 m-85 -107.87 120.24 41.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.191 0.519 . . . . 0.0 109.776 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.6 tp -113.59 143.93 43.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.346 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -114.82 127.88 55.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.314 0.578 . . . . 0.0 111.541 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.4 t0 -106.0 -166.12 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.545 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.6 m-20 -27.94 -71.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.695 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -137.42 22.8 2.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.754 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.27 147.83 44.49 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -113.42 118.28 34.08 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -103.45 131.51 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.407 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -93.4 117.85 30.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.347 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.2 133.18 55.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.73 133.03 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.107 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -101.0 -27.19 13.42 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 124.609 1.193 . . . . 0.0 110.63 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.53 144.35 3.98 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.86 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.47 141.32 15.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.41 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.9 p -150.06 161.93 41.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.372 0.606 . . . . 0.0 111.548 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 95.3 mt-10 -114.81 123.18 48.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.749 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.68 149.63 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.344 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.4 p -53.66 166.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.571 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -81.58 -15.59 9.68 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.854 1.703 . . . . 0.0 111.812 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 60.0 t0 -88.64 -11.09 46.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -86.95 67.81 9.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.979 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.571 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 57.3 m95 -76.53 -8.39 57.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.449 . . . . 0.0 111.856 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.9 mt-10 -53.19 -23.47 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.203 0.525 . . . . 0.0 110.937 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.63 -13.06 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.922 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.4 m -132.34 43.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.521 ' O ' ' O ' ' A' ' 176' ' ' ASP . 95.4 mt-10 -146.23 83.17 1.62 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.895 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' GLU . 66.5 t0 23.82 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.346 1.028 . . . . 0.0 113.022 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.455 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 13.2 m170 -102.13 -43.97 5.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 0.0 111.289 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.84 23.78 0.16 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -154.11 173.91 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.954 0.407 . . . . 0.0 111.237 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -96.3 88.65 4.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.242 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -131.58 130.63 42.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.037 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.6 tt -83.17 145.57 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.515 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 3.6 m -138.57 115.94 11.18 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.576 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.48 134.34 47.84 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.18 0.514 . . . . 0.0 110.711 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 34.6 pt -135.1 154.67 36.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.093 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.447 -179.661 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.6 m-85 -95.95 129.02 43.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.505 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 71.2 t -131.08 133.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.193 0.521 . . . . 0.0 111.366 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.73 126.96 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.593 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -112.77 132.93 55.02 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 110.721 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.66 14.13 Favored Glycine 0 N--CA 1.464 0.525 0 CA-C-O 121.727 0.626 . . . . 0.0 111.685 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -98.91 142.3 30.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.891 -0.655 . . . . 0.0 111.405 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.1 tp -67.09 128.54 36.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.315 0.578 . . . . 0.0 110.288 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.97 -21.7 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.216 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.5 176.12 46.87 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.009 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.0 m -154.74 153.18 30.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.161 0.505 . . . . 0.0 110.534 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -150.27 178.65 8.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.264 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -99.98 142.26 31.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -57.18 80.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.248 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ALA . 77.5 tttt . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.557 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.488 1.182 0 N-CA-C 111.362 -0.284 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 53.8 t0 -62.46 163.15 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 3.8 mm? -77.65 -13.63 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.921 -0.487 . . . . 0.0 111.069 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.35 -48.38 70.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.405 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.17 -21.83 59.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.889 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -78.07 -53.25 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.756 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.47 84.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.512 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.471 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 52.4 t-20 -76.13 -11.21 59.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.927 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 145.27 38.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.429 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -139.51 80.45 1.78 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.9 tp -80.16 147.4 31.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.52 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.54 133.69 49.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.922 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -79.89 -6.44 57.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.249 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -80.74 -10.63 59.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.98 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -94.24 5.77 50.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.62 136.47 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.97 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 pt -119.2 -10.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.72 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.44 -170.09 37.94 Favored Glycine 0 C--N 1.316 -0.545 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -147.15 152.34 38.29 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.416 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 tt -123.99 121.1 61.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 t -124.63 130.75 53.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.909 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 mt -135.15 126.77 17.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.26 -35.49 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.358 2.039 . . . . 0.0 112.5 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 t -51.14 -40.09 57.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.844 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.4 m -115.49 -4.24 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.18 49.9 1.9 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.4 tp -111.32 129.74 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.656 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -136.72 113.7 10.5 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.3 mt -145.69 107.71 4.36 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.66 135.46 3.33 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.77 1.647 . . . . 0.0 110.659 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.17 125.1 39.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 mt -108.86 120.83 43.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.193 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.72 -47.43 72.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.708 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.439 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 54.6 p -69.8 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.1 p -84.43 107.68 16.83 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.283 0.564 . . . . 0.0 110.214 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 p -137.08 166.32 23.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.026 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.442 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 16.9 pt-20 -61.9 -35.43 78.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.681 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -82.92 -37.62 23.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.559 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 76.7 m-20 -67.22 -22.88 65.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.637 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.88 -13.41 61.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.482 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' A' ' 104' ' ' LEU . 8.9 mp -76.92 -14.35 59.88 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -106.19 -15.63 14.81 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.98 -176.05 45.83 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.71 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.22 129.58 38.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.248 -0.476 . . . . 0.0 109.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.48 144.53 31.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.752 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.7 p -73.84 146.94 43.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.65 -46.69 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -91.02 144.28 25.83 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.806 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.71 -5.07 35.21 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.859 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 113' ' ' ASN . 61.2 t-20 -142.15 41.47 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.688 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -84.03 155.54 22.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.29 128.19 51.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.72 126.23 30.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.05 -6.12 61.77 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -137.21 118.99 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.668 0.271 . . . . 0.0 110.78 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.98 -172.85 54.07 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.506 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 55.8 t30 -82.54 111.72 18.8 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -85.18 103.07 13.83 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.36 121.52 32.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 111.412 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.1 mt -117.76 131.86 56.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.85 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.62 46.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.02 -178.07 20.33 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.814 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 30.2 m-70 -83.5 131.23 35.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.231 0.539 . . . . 0.0 110.863 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.9 p30 -101.52 27.02 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.4 mmm -46.05 -14.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.957 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 41.67 17.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.875 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -133.8 106.85 7.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.081 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -50.69 125.93 14.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.547 0.689 . . . . 0.0 109.985 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.25 -26.1 10.69 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.946 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.552 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 35.4 t -83.4 178.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 CA-C-N 117.736 0.768 . . . . 0.0 109.13 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.552 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.17 138.56 47.72 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.178 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 45.64 31.99 1.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.057 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.2 p -80.58 -12.31 59.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -138.56 35.94 2.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 140' ' ' SER . 8.8 pt -67.67 -41.51 85.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.09 2.09 1.69 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.961 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 138' ' ' ILE . 13.3 t -89.23 -21.65 23.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.58 121.7 15.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.143 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.441 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.7 mtmt -96.99 157.71 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.555 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -57.62 125.89 24.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.321 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.83 19.04 23.35 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 89.6 m-20 -89.86 133.24 34.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.75 134.74 37.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 111.723 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 147' ' ' ILE . 73.0 mt -127.66 124.25 62.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.379 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -105.26 122.09 45.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.024 0.44 . . . . 0.0 110.218 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.68 153.21 32.73 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.093 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -121.12 130.87 53.94 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.316 0.579 . . . . 0.0 111.334 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 23.9 t0 -112.8 -167.07 1.14 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -24.48 -74.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.449 0.468 . . . . 0.0 111.705 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -137.97 28.58 2.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -125.59 151.38 46.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -112.03 122.04 46.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.741 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.532 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 47.2 m-85 -105.52 127.9 53.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.108 0.48 . . . . 0.0 111.791 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -97.64 118.74 34.85 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -115.86 145.11 43.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.219 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.3 128.69 54.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.24 0.543 . . . . 0.0 110.374 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.1 t -68.46 135.59 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.066 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 8.5 p -100.33 -22.86 14.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 124.378 1.049 . . . . 0.0 110.16 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 152.97 -178.51 30.03 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.833 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.8 p -124.2 143.01 39.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.318 -0.941 . . . . 0.0 109.893 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.8 t -136.77 148.08 47.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 111.107 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.13 113.01 26.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.239 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.33 159.44 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.1 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.0 p -71.22 142.59 87.32 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.568 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.5 Cg_endo -48.42 -16.24 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.862 1.708 . . . . 0.0 111.772 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 61.6 t0 -83.32 -11.55 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.91 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -83.47 62.47 6.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.468 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.568 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 45.7 m95 -73.06 -21.13 60.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.675 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -51.12 -9.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.102 0.477 . . . . 0.0 110.947 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' A' ' 171' ' ' TRP . 27.4 m -77.15 -29.26 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.917 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.2 -0.65 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.618 0.723 . . . . 0.0 109.938 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 176' ' ' ASP . 76.3 mm-40 -82.28 117.44 22.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.785 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.0 p-10 -27.71 123.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.872 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -99.62 -37.63 9.06 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.62 33.2 0.62 Allowed Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -154.72 177.14 11.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.129 0.49 . . . . 0.0 111.68 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.06 88.96 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.37 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -128.74 167.42 17.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.831 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.506 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 3.2 m -136.74 127.34 27.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.0 mp -113.18 128.95 56.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.404 0.621 . . . . 0.0 110.778 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.7 pt -139.93 -167.68 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.923 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.552 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 3.3 t . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.414 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.7 ttm180 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -77.12 132.61 38.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.701 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.63 135.04 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.01 128.41 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.537 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.91 139.3 51.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.272 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.36 152.25 21.1 Favored Glycine 0 C--O 1.226 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -107.45 147.2 30.75 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.635 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.5 tp -69.83 126.28 29.25 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 121.097 0.475 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.65 -26.65 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.745 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.32 161.88 21.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.05 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.532 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 88.0 m -139.17 157.69 45.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.363 0.602 . . . . 0.0 110.11 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -149.08 178.79 8.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.384 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.33 147.25 23.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.78 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -76.9 78.95 3.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.714 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.716 178.678 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.485 1.008 0 CA-C-O 120.872 0.28 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.73 159.15 31.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.864 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.68 -23.63 66.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.7 92.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.445 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 97.0 mt-10 -73.46 -35.31 65.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.477 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.7 t -76.92 -42.96 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.755 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.83 91.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.698 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.4 p-10 -84.95 -17.87 36.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.5 ' N ' ' OD1' ' A' ' 71' ' ' ASN . . . -58.44 111.62 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.961 0.41 . . . . 0.0 110.875 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -95.46 118.46 32.23 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.228 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.9 tp -116.14 131.16 57.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.061 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.54 134.82 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -75.83 -9.29 58.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 110.254 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.4 -12.66 61.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.037 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.528 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 25.2 mt-30 -95.51 12.72 28.48 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.221 0.534 . . . . 0.0 111.028 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.4 p -90.45 128.83 42.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.741 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -120.9 -5.39 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 120.896 0.379 . . . . 0.0 111.88 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.87 41.74 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.696 HH12 ' HZ2' ' A' ' 209' ' ' LYS . 30.0 mtt85 -147.34 156.6 43.05 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.477 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.2 tt -123.63 128.28 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.427 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.1 t -128.24 130.2 47.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.47 128.88 19.36 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.399 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 -34.61 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.291 1.994 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -47.36 -39.51 15.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.457 -177.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.0 p -119.86 -1.72 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.781 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.7 p 63.6 50.4 2.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.081 0.943 . . . . 0.0 108.562 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.7 tp -113.51 133.63 55.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.397 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -135.81 111.4 9.26 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.29 113.46 8.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.6 147.46 0.39 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 110.419 176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.9 124.57 53.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -105.0 125.47 51.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.004 0.431 . . . . 0.0 110.631 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 61.2 tttp -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 110.752 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.466 ' OG ' ' OD1' ' A' ' 102' ' ' ASN . 84.7 p -71.45 103.48 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 96.31 9.57 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.608 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.5 p -134.31 160.89 36.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.947 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -57.53 -33.49 68.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.6 -45.65 21.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 0.0 111.487 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.608 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.2 m-80 -67.2 -35.38 79.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.696 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.69 -17.42 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.814 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.07 -16.79 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 t -107.93 -9.73 15.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.63 175.46 39.96 Favored Glycine 0 N--CA 1.461 0.327 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.446 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.18 127.57 32.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.008 -0.596 . . . . 0.0 109.785 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.52 24.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.893 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -72.84 150.24 42.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.1 t -84.49 -49.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -91.81 143.15 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 110.778 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.559 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 tt0 -61.92 -49.95 74.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.798 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -95.89 49.52 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.168 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 3.9 tt0 -89.15 151.47 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.2 127.6 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.966 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 129.39 36.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.812 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.03 -6.83 62.22 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -143.59 126.89 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.961 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 77.24 -162.41 51.26 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.5 HD21 ' CE1' ' A' ' 177' ' ' HIS . 41.0 t-20 -93.53 108.9 20.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -86.05 100.23 12.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.425 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.54 126.02 35.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.252 0.549 . . . . 0.0 111.043 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.3 mt -119.79 131.2 55.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.819 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.37 140.03 47.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.78 -178.49 19.58 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.405 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.42 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -84.04 141.84 30.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.736 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 61.7 t30 -109.1 28.39 8.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.185 0.517 . . . . 0.0 110.078 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.7 mmm -43.53 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.775 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.3 m 57.74 38.48 27.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.03 107.49 8.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.007 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -51.63 122.29 7.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.36 0.6 . . . . 0.0 110.045 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.12 21.82 6.48 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.316 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.494 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 24.0 t -136.57 176.61 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -69.62 130.67 43.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 0.0 110.362 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 48.44 36.39 7.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.172 0.51 . . . . 0.0 110.585 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -82.35 -10.37 59.1 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 136' ' ' SER . 72.3 m-20 -150.33 31.91 0.66 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.6 pt -70.63 -21.02 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.803 0.335 . . . . 0.0 111.567 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.6 5.1 8.0 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.481 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -99.51 -10.3 22.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.25 0.548 . . . . 0.0 109.679 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.27 126.37 27.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.618 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.3 mttp -96.76 159.66 14.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.531 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -58.15 132.33 53.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.105 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.9 21.65 57.07 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 19.2 m-20 -79.35 135.23 36.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -78.96 121.74 25.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 111.979 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.32 120.82 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.132 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -103.24 117.7 35.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.198 0.523 . . . . 0.0 109.806 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.2 tp -112.35 144.33 41.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.132 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -108.21 131.68 54.43 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.273 0.559 . . . . 0.0 111.672 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -104.77 -172.51 2.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.532 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -36.39 -63.26 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.161 0.505 . . . . 0.0 111.121 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -137.55 24.34 2.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.77 152.91 47.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -115.38 121.77 43.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.781 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -104.06 132.37 50.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.29 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -95.5 114.74 26.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -114.6 141.37 47.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.2 132.02 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.606 0.717 . . . . 0.0 111.309 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.01 134.06 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.898 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -102.86 -28.11 12.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 124.625 1.203 . . . . 0.0 110.818 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.24 141.08 3.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.877 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.1 t -106.28 147.73 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.487 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.3 p -157.26 167.5 30.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.286 0.565 . . . . 0.0 111.638 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -118.15 120.6 38.21 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.55 158.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 111.3 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.4 p -57.21 165.47 1.95 Allowed Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.2 Cg_endo -82.03 -9.43 11.79 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.967 1.778 . . . . 0.0 111.913 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 63.2 t0 -83.38 -10.53 58.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.388 . . . . 0.0 110.449 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -85.93 64.33 8.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.798 0.332 . . . . 0.0 110.69 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.552 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 86.8 m95 -73.33 -10.11 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.481 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 80.9 mm-40 -59.93 -35.41 74.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.188 0.518 . . . . 0.0 110.975 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.7 m -65.68 -8.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.243 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.5 m -136.0 43.04 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 176' ' ' ASP . 48.8 mm-40 -144.8 107.24 4.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.733 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 175' ' ' GLU . 41.0 p-10 4.27 112.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.65 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.5 ' CE1' HD21 ' A' ' 120' ' ' ASN . 40.4 m80 -102.91 -42.49 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.883 0.373 . . . . 0.0 111.028 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 136.32 29.82 0.32 Allowed Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 17.9 ptpt -153.83 173.12 16.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 8.7 p30 -95.19 88.34 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.836 0.827 . . . . 0.0 110.181 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -130.12 174.72 9.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.552 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.8 tt -130.89 143.12 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.174 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -137.79 124.08 20.56 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.313 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.9 mp -111.57 131.13 55.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.235 0.54 . . . . 0.0 110.695 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 7.5 pt -138.53 171.53 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.952 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 60.5 p . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.129 179.097 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.183 0.516 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.69 138.47 43.86 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.38 138.18 48.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.439 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 76.1 t -117.18 128.8 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.342 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.95 135.22 54.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.087 0.47 . . . . 0.0 110.346 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.77 156.96 24.52 Favored Glycine 0 N--CA 1.461 0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.574 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.19 153.82 26.48 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.049 -0.576 . . . . 0.0 111.396 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 39.4 tp -73.87 128.06 34.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.256 0.551 . . . . 0.0 110.574 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 38.1 t -109.06 -25.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.931 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.52 175.03 46.7 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.972 -1.108 . . . . 0.0 112.155 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.0 m -153.78 152.31 30.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.143 0.496 . . . . 0.0 110.826 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.14 177.14 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.19 145.19 24.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.099 0.476 . . . . 0.0 110.718 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.696 ' HZ2' HH12 ' A' ' 82' ' ' ARG . 88.3 tttt -74.44 79.69 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.904 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--N 1.314 -0.94 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.561 178.528 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.486 1.053 0 N-CA-C 111.213 -0.341 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.17 165.21 24.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.659 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.0 mm? -69.51 -16.19 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.04 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.62 95.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.283 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -73.14 -33.46 65.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.665 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.37 -45.76 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.075 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.45 89.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.025 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.02 -28.46 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.589 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.79 107.42 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.804 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.3 m -95.98 115.31 27.24 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.289 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.0 tp -115.23 126.49 54.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.277 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -69.01 139.01 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -76.13 -0.11 20.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 110.211 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -85.29 -8.99 58.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.143 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.533 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.0 mp0 -90.92 2.84 55.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.757 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 p -87.64 138.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.821 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.6 pt -120.82 -5.27 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.781 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.89 33.14 Favored Glycine 0 C--N 1.321 -0.285 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -152.75 152.69 31.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.264 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.9 tt -126.1 130.85 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.845 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -128.2 129.17 46.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.002 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.5 mt -133.59 127.83 19.77 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.543 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.65 -34.18 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.452 2.102 . . . . 0.0 112.285 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.1 p -46.98 -38.73 11.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.7 p -119.93 -0.34 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.852 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 63.81 52.68 2.11 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.7 tp -116.97 132.81 56.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.372 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -134.67 117.65 16.3 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -143.85 161.73 44.58 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.12 155.6 7.0 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.851 2.367 . . . . 0.0 108.901 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 118.24 52.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.1 mt -100.21 124.14 45.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -65.35 -48.56 72.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.807 0.337 . . . . 0.0 111.32 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.585 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 99.9 p -78.91 112.87 16.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.014 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.6 p -84.53 110.63 18.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.201 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.517 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -139.61 166.56 24.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.447 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.51 -31.07 70.94 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -81.39 -44.09 18.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.972 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.3 p-10 -66.38 -31.67 72.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.201 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.39 -21.02 66.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.43 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.21 -18.45 61.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -97.54 -13.15 21.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.06 -147.98 11.29 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.658 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.27 129.56 45.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.972 -0.614 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.484 ' CB ' HD22 ' A' ' 102' ' ' ASN . . . -107.91 148.1 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.4 p -70.39 148.25 48.6 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -82.86 -40.26 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.627 ' HZ3' ' H ' ' A' ' 176' ' ' ASP . 99.5 mttt -90.29 149.53 22.31 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.011 0.434 . . . . 0.0 111.077 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.43 -18.61 64.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.908 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -144.77 55.95 1.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.012 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.565 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 2.4 tt0 -80.67 156.36 26.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.938 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.9 t -136.0 124.35 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.83 127.24 32.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.12 -8.38 60.86 Favored Glycine 0 N--CA 1.46 0.237 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -135.27 117.77 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.69 -167.53 54.75 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.706 HD22 ' HG1' ' A' ' 183' ' ' THR . 63.8 t30 -86.65 112.54 21.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -85.03 103.47 14.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.03 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.565 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.42 122.92 33.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.362 0.601 . . . . 0.0 111.511 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.3 mt -118.34 132.05 56.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.287 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.36 48.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.381 0.61 . . . . 0.0 111.015 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.64 -178.23 16.93 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.541 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -84.24 145.79 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.649 0.261 . . . . 0.0 110.845 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 54.4 t-20 -110.8 28.45 8.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.9 mmt -43.98 -15.51 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.0 OUTLIER 58.87 39.14 24.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.303 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -133.82 107.65 8.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.611 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -50.28 126.9 15.97 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.745 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.8 12.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.533 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 17.4 t -87.94 179.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.533 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.21 136.69 48.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.258 -177.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 44.18 34.02 0.92 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.231 0.538 . . . . 0.0 110.989 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 p -82.38 -9.78 59.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -149.1 34.99 0.74 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.8 pt -69.89 -28.12 35.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.869 0.366 . . . . 0.0 111.771 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.61 0.86 4.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.606 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -92.93 -13.82 28.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.027 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -64.83 122.92 18.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.397 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mttm -95.63 157.77 15.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.574 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -55.64 133.0 50.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.796 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.6 18.29 62.24 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 16.8 m-20 -79.58 135.06 36.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -81.47 128.01 33.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.511 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.0 mt -123.38 121.7 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.06 119.33 38.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.978 0.418 . . . . 0.0 110.043 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.2 tp -118.07 138.26 52.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -106.01 135.65 47.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.07 0.462 . . . . 0.0 111.48 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 46.7 t0 -109.89 -169.83 1.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.502 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 64.8 t30 -33.67 -67.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.26 0.552 . . . . 0.0 111.099 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.89 23.78 3.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.107 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.05 147.06 49.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.575 0.702 . . . . 0.0 112.712 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.553 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 90.7 mt-10 -108.57 122.25 46.69 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.823 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.551 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 34.5 m-85 -105.02 128.29 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.114 0.483 . . . . 0.0 111.773 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -95.5 115.87 28.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -116.02 140.94 48.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.461 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.26 134.35 55.17 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.484 0.659 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 133.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -101.81 -25.84 13.68 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 124.76 1.287 . . . . 0.0 111.088 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.31 145.61 4.39 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.663 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.7 p -104.56 151.56 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -154.02 162.64 41.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.129 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.532 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 70.3 mt-10 -111.98 117.81 33.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.08 158.52 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 111.335 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.5 p -59.67 168.72 1.74 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.47 -10.69 12.05 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.948 1.765 . . . . 0.0 111.944 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.22 -3.06 58.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.202 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.6 68.32 9.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 110.865 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.425 ' C ' ' N ' ' A' ' 173' ' ' VAL . 70.7 m95 -70.48 -29.86 66.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.765 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 56.0 mp0 -49.23 -17.71 0.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.204 0.526 . . . . 0.0 110.537 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.425 ' N ' ' C ' ' A' ' 171' ' ' TRP . 90.4 t -71.48 -23.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.577 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.86 -7.37 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.608 0.718 . . . . 0.0 109.679 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -79.77 139.0 37.43 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.823 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.627 ' H ' ' HZ3' ' A' ' 111' ' ' LYS . 68.1 t0 -51.24 128.59 22.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.174 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -99.15 -39.59 8.4 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.035 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.89 29.0 0.37 Allowed Glycine 0 N--CA 1.473 1.156 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -156.63 -179.33 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.351 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -91.1 88.85 7.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.368 0.604 . . . . 0.0 109.833 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -124.33 168.31 13.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.077 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.72 142.75 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.951 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.706 ' HG1' HD22 ' A' ' 120' ' ' ASN . 9.4 m -136.84 123.35 20.87 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.388 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.04 122.81 48.04 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.32 0.581 . . . . 0.0 110.92 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 27.9 pt -134.92 -167.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.953 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.781 -179.159 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.532 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.6 m-85 -91.03 129.12 37.06 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.679 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 138.71 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.258 0.551 . . . . 0.0 111.48 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.74 127.71 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.556 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.11 135.32 54.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.167 0.508 . . . . 0.0 110.457 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.44 158.92 24.26 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 55.4 p-10 -113.74 150.24 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.387 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 40.0 tp -72.07 127.62 33.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.086 0.469 . . . . 0.0 111.017 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.6 t -106.34 -25.6 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.329 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.29 162.12 20.92 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.421 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.551 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 81.1 m -139.51 157.63 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.189 0.518 . . . . 0.0 110.032 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.553 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 19.4 pttp -149.91 178.54 8.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.6 143.63 26.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -71.28 79.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.702 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.691 178.461 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.486 1.083 0 N-CA-C 110.895 -0.463 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.76 154.81 41.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.717 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.4 mp -59.4 -27.61 66.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.689 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.46 94.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.279 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -72.58 -37.49 68.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.732 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.5 t -72.0 -44.29 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.574 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.96 89.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.33 -26.69 30.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.44 136.8 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.9 t -92.36 158.55 16.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.6 tp -122.7 127.22 48.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.0 0.428 . . . . 0.0 111.06 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -96.1 98.26 10.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.564 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 78' ' ' GLN . 29.0 mmtp -55.84 -35.51 66.49 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.119 0.485 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -51.56 -13.06 0.2 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.035 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 97' ' ' SER . 23.8 mm100 -102.55 11.09 38.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.476 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.77 124.95 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -119.39 -4.57 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.171 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.03 -162.29 35.59 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -155.97 165.36 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.574 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -131.35 139.65 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.796 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -131.66 132.84 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.053 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -131.03 127.0 21.91 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.95 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.84 -38.13 0.17 Allowed 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.256 1.971 . . . . 0.0 112.314 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.2 t -46.97 -39.55 12.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.586 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.3 p -117.9 -2.5 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.68 55.38 2.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.77 138.49 53.99 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.559 -177.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 91' ' ' GLU . 55.8 mp0 -138.98 120.1 14.6 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' PRO . 35.4 mt -143.37 109.55 5.33 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -40.74 139.48 1.28 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 121.887 1.724 . . . . 0.0 109.924 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.3 t -90.39 118.2 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.1 mt -102.37 121.73 42.87 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.058 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -64.83 -47.54 77.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.121 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 78' ' ' GLN . 70.3 m -69.7 102.13 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.311 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 98' ' ' SER . 25.2 p -81.15 98.6 8.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.457 0.646 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.6 p -136.59 157.79 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.499 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -56.38 -29.19 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -81.98 -43.58 17.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.226 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.34 -34.45 78.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -63.21 -21.31 66.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.806 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 mt -69.66 -26.51 64.43 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.4 m -93.85 -10.99 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 165.62 -170.81 40.63 Favored Glycine 0 N--CA 1.458 0.149 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.658 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.32 129.2 37.34 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.116 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.12 148.13 28.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.424 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 p -70.32 143.41 52.01 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 t -83.76 -44.64 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.43 -172.86 3.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 1.6 pm0 -119.48 -9.15 9.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.055 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -139.63 39.21 2.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.39 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -91.09 157.25 17.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.48 131.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.896 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -67.58 128.83 37.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.58 2.46 76.08 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -141.83 121.84 13.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.729 0.299 . . . . 0.0 111.107 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.83 -165.73 54.76 Favored Glycine 0 CA--C 1.517 0.218 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -89.86 109.05 20.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.59 101.77 12.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.918 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.57 128.69 36.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.423 0.63 . . . . 0.0 111.739 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -126.0 131.95 52.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.553 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.81 140.85 46.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.58 0.705 . . . . 0.0 111.096 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.1 -179.36 18.31 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -81.93 153.35 26.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 129' ' ' SER . 57.6 t30 -122.36 28.02 7.64 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.007 0.432 . . . . 0.0 111.208 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 31.9 mtt -43.82 -15.0 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.616 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 38.07 21.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.067 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.76 ' H ' ' HG ' ' A' ' 136' ' ' SER . 1.6 tppp? -134.13 121.07 20.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.835 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.18 125.66 24.51 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.98 -25.07 11.08 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.347 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.571 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 95.1 t -80.39 176.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.571 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -74.55 136.6 42.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 46.52 30.66 1.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.095 0.474 . . . . 0.0 110.953 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.76 ' HG ' ' H ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.16 -8.23 59.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.213 -178.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.9 m-20 -143.99 36.3 1.26 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 pt -69.46 -30.05 44.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 111.971 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.08 1.69 7.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.807 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 t -92.18 -15.82 27.08 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.998 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.99 119.51 11.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 53.3 mtmt -96.33 156.28 16.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -56.46 121.77 10.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 102.61 19.0 14.38 Favored Glycine 0 N--CA 1.466 0.694 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 86.5 m-20 -90.28 131.31 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -79.64 135.22 36.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.08 0.467 . . . . 0.0 111.574 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -129.31 121.78 54.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.28 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.39 120.48 40.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.1 tp -116.71 142.86 46.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.181 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.226 0.536 . . . . 0.0 111.499 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 34.7 t0 -112.09 -165.38 0.99 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.0 m-20 -22.4 -75.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.729 0.643 . . . . 0.0 111.479 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -138.26 27.23 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.002 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -125.62 142.34 51.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -108.43 121.41 44.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.903 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -105.2 131.25 52.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.55 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -94.43 115.91 28.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.2 m-85 -117.39 136.65 53.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.589 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.34 133.87 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.482 0.658 . . . . 0.0 111.0 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 144' ' ' GLY . 55.0 t -70.22 135.33 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.887 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.3 t -106.14 -24.83 12.24 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.995 1.434 . . . . 0.0 111.178 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.56 155.01 7.5 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.623 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.9 144.28 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.2 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.8 m -138.64 151.36 47.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.102 0.477 . . . . 0.0 111.298 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' A' ' 197' ' ' TYR . 96.1 mt-10 -106.02 110.26 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.314 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.2 m -130.74 153.03 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.2 p -64.11 168.48 6.09 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.8 Cg_endo -80.97 -12.63 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.923 1.748 . . . . 0.0 111.926 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -85.47 -21.53 28.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.096 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -86.64 76.5 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.501 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.563 ' C ' ' H ' ' A' ' 173' ' ' VAL . 27.1 m95 -75.35 -12.69 60.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.244 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -51.05 -8.1 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.563 ' H ' ' C ' ' A' ' 171' ' ' TRP . 32.8 m -90.21 -15.54 8.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.683 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.62 -0.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.724 0.773 . . . . 0.0 109.709 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -83.43 143.66 30.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.844 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.12 128.18 35.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.599 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -104.54 -41.88 5.59 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.757 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.73 31.08 0.21 Allowed Glycine 0 N--CA 1.473 1.114 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -154.03 174.72 14.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 3.8 m-20 -91.55 89.62 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.736 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -123.17 169.79 10.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.851 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -131.61 142.72 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.794 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 m -137.32 124.26 21.41 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.3 mp -109.56 125.06 52.13 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.611 0.719 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.4 pt -135.53 -170.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.608 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.594 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.1 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.724 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.594 ' NH1' ' O ' ' A' ' 186' ' ' THR . 12.0 ptp180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.952 0.406 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 4.8 m-85 -106.68 139.85 40.47 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.011 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 24.6 t -133.46 135.43 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.265 0.555 . . . . 0.0 110.937 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.5 t -118.42 130.28 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.692 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.77 136.54 53.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.425 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.61 150.44 19.51 Favored Glycine 0 N--CA 1.466 0.679 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.023 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -105.47 143.78 33.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.15 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.504 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.27 127.83 33.86 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 110.698 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.2 t -108.4 -23.54 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.529 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.42 177.03 46.81 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.745 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 21.8 m -154.03 151.63 29.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -150.31 179.27 8.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.603 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.83 144.42 25.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.023 0.439 . . . . 0.0 110.57 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.54 78.87 1.06 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.638 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt . . . . . 0 C--N 1.319 -0.739 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.329 178.167 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.485 0.981 0 CA-C-O 121.144 0.393 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -76.33 172.48 12.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.0 mm? -61.08 -21.59 63.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.786 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.87 95.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.31 -20.49 57.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -81.14 -51.67 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.686 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.9 90.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.967 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.45 -32.79 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.857 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 146.72 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.847 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.7 t -138.58 141.41 39.21 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.995 0.426 . . . . 0.0 110.794 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -138.43 121.64 16.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.289 -179.226 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.2 m-20 -70.31 112.1 6.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.36 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -52.81 -9.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.511 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 75' ' ' ASP . 99.4 mttt -83.19 -4.38 58.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.771 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -95.12 10.41 35.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.706 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 m -94.28 147.39 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.463 ' CD1' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -134.11 4.85 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.921 0.391 . . . . 0.0 111.695 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.5 38.25 Favored Glycine 0 C--N 1.322 -0.247 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -152.43 153.26 33.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.231 0.539 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.66 130.29 68.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 m -128.61 129.46 45.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.11 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.0 mt -135.33 116.06 11.94 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.162 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.35 -32.94 2.08 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 122.745 2.297 . . . . 0.0 112.843 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 t -50.36 -40.08 48.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.012 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.34 -6.68 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.819 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.23 47.64 0.28 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.09 129.93 56.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.761 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.79 119.1 14.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.1 mt -146.59 166.29 17.11 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.72 153.86 8.81 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.072 2.514 . . . . 0.0 108.767 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 73.6 t -104.43 121.09 55.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.25 132.47 53.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -80.15 -29.9 38.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.991 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 m -79.03 102.42 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.128 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.519 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -80.9 97.93 7.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.332 0.587 . . . . 0.0 109.882 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.567 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.0 p -141.01 158.56 43.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.104 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.83 -37.77 77.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.821 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -69.94 -46.29 65.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.83 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.567 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.5 m-80 -65.51 -38.34 89.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.777 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.3 mt -59.73 -26.46 65.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.84 -14.14 61.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -105.74 -13.13 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 175.24 -170.07 43.06 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.486 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.17 123.29 27.78 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.32 142.82 34.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.114 0.483 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.519 ' O ' ' OG ' ' A' ' 98' ' ' SER . 43.8 p -73.95 152.03 40.21 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.07 -42.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -89.51 -172.06 3.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.846 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -123.64 -8.62 7.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.977 0.418 . . . . 0.0 111.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -139.7 39.94 2.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -93.46 159.86 15.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.007 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.87 133.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.009 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.63 127.75 33.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.172 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.52 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.35 5.75 72.04 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -143.56 124.13 14.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 0.0 110.992 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.98 -164.45 54.28 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.83 107.86 19.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.27 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.81 100.01 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.8 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 127.36 36.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 0.0 112.071 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.4 mt -122.88 130.4 52.82 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.29 47.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.13 -178.49 19.01 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.601 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.533 ' O ' ' O ' ' A' ' 134' ' ' LEU . 44.6 m-70 -88.74 139.05 30.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 34.0 p30 -108.2 27.26 9.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.215 0.531 . . . . 0.0 110.323 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.8 mmm -43.87 -14.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.987 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.62 40.91 9.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.009 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -131.7 108.41 9.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.744 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 44.0 pttt -51.07 125.65 14.35 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.319 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.4 -29.76 8.44 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.593 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 58.0 t -75.54 178.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.593 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.33 137.65 46.79 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.281 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 44.37 31.81 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 110.989 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -81.97 -12.94 58.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.293 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 136' ' ' SER . 95.9 m-20 -143.19 24.96 1.76 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.1 pt -69.02 -23.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.85 0.357 . . . . 0.0 111.687 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.78 4.83 3.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.648 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.2 m -96.91 -14.63 21.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.2 0.524 . . . . 0.0 109.638 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 mt -62.43 132.27 51.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.352 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -106.97 175.18 5.59 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.946 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -69.51 135.47 50.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.68 71.51 Favored Glycine 0 N--CA 1.461 0.312 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.28 136.03 36.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -82.95 127.38 33.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.695 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 147' ' ' ILE . 81.6 mt -122.72 123.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -103.82 115.63 30.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.838 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.18 148.86 38.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.931 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -123.44 133.61 54.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.399 0.619 . . . . 0.0 111.629 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -112.14 -165.5 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 16.4 t-20 -23.99 -75.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 111.617 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -137.04 26.7 2.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -124.07 145.94 48.91 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -108.52 119.56 39.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.76 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.426 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 61.0 m-85 -104.42 129.33 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.61 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.477 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 97.7 mt-10 -95.73 117.73 31.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.021 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.52 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 50.6 m-85 -117.47 138.88 51.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.292 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -115.69 132.08 56.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.501 0.667 . . . . 0.0 111.145 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.66 134.88 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.166 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.75 -25.49 12.18 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 124.431 1.082 . . . . 0.0 111.081 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.4 161.55 19.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.395 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.5 t -128.78 155.5 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.823 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -164.16 174.46 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 0.0 111.666 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.535 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 40.1 mp0 -121.88 117.13 25.74 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.8 159.06 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 p -62.82 167.12 6.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.22 -9.95 11.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.343 2.028 . . . . 0.0 111.922 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -81.34 -11.61 59.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.808 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -86.4 73.21 10.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.369 0.605 . . . . 0.0 109.72 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.544 ' C ' ' H ' ' A' ' 173' ' ' VAL . 81.9 m95 -72.48 -27.36 62.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -50.93 -9.1 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.0 110.93 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.8 t -78.25 -21.16 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.539 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.2 m -116.18 -3.65 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.745 0.783 . . . . 0.0 109.85 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -80.64 151.76 28.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.15 -1.387 . . . . 0.0 112.157 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.87 126.5 27.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.674 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -107.17 -43.8 4.52 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.317 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 150.34 23.3 0.06 OUTLIER Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.3 173.7 15.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.157 0.503 . . . . 0.0 111.156 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.4 m-20 -95.75 88.38 4.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -124.22 127.72 48.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.403 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -81.71 146.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 7.2 m -136.29 122.09 19.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.772 0.32 . . . . 0.0 111.06 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.1 mp -107.57 126.12 52.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.317 0.58 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.7 pt -137.55 178.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.663 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 -178.794 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 121.028 0.442 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.404 ' CE1' ' OE2' ' A' ' 165' ' ' GLU . 4.5 m-85 -80.37 132.9 35.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.85 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.1 133.92 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.041 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 82.0 t -117.2 128.62 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.446 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.45 135.62 53.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.6 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.77 142.53 14.04 Favored Glycine 0 N--CA 1.465 0.596 0 CA-C-O 121.773 0.652 . . . . 0.0 111.642 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 52.3 p-10 -100.32 141.56 32.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.294 -0.953 . . . . 0.0 111.409 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.18 126.16 28.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.2 m -109.46 -22.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.421 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.04 158.14 13.44 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.802 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.426 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 25.1 m -134.85 156.18 49.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.382 0.61 . . . . 0.0 109.778 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.477 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 ptpp? -149.66 178.81 8.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.278 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.69 147.1 23.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.509 . . . . 0.0 110.549 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.32 80.02 3.07 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.814 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 51.7 tttm . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.189 178.649 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 120.797 0.249 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -68.86 163.93 23.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.177 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 tt -76.43 -14.16 60.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.307 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.44 80.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.482 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.69 -19.05 60.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.396 . . . . 0.0 110.704 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.56 -53.78 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.526 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.02 88.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.125 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -73.0 -27.94 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.523 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.89 137.02 58.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.84 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.7 p -89.78 159.27 17.12 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.182 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.1 tp -122.41 129.71 52.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.994 0.426 . . . . 0.0 111.008 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.3 m-20 -97.5 90.64 5.11 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.48 -13.53 0.13 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 75' ' ' ASP . 71.3 mmtt -71.27 -8.95 57.03 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -106.53 13.45 28.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 6.4 p -87.43 123.17 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.822 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.0 pt -120.44 -7.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.13 -169.26 40.47 Favored Glycine 0 C--N 1.317 -0.527 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -146.54 155.72 42.71 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.178 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 tp -125.79 128.94 72.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -126.93 131.39 51.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.79 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.7 mt -130.63 122.04 19.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.04 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.67 -37.16 0.28 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 122.304 2.002 . . . . 0.0 112.422 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -49.12 -37.92 23.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.25 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -118.25 -3.47 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.531 -178.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.51 51.48 1.51 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.32 128.93 55.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.132 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.59 113.54 11.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.7 mt -146.49 111.79 4.29 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.17 143.0 1.45 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.508 1.472 . . . . 0.0 110.583 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.28 119.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -102.09 121.44 42.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.076 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 66.0 tttm -64.75 -47.11 79.42 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.558 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 18.3 p -60.6 97.86 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.993 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.521 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -80.93 97.94 7.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.19 0.519 . . . . 0.0 109.803 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.589 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 65.5 p -139.49 158.45 44.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.53 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -60.59 -25.01 65.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.352 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -83.79 -45.2 13.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 111.348 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.589 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 97.5 m-20 -66.86 -35.07 79.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.444 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.5 -16.99 62.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.73 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.07 -27.22 62.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -98.75 -7.48 27.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 173.8 -170.07 43.17 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.729 -1.225 . . . . 0.0 112.146 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.14 124.35 31.7 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.69 149.81 25.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.779 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.521 ' O ' ' OG ' ' A' ' 98' ' ' SER . 6.1 p -75.28 152.03 38.27 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.1 p -88.1 -35.45 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -89.24 143.95 26.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.316 0.579 . . . . 0.0 111.096 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.509 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.1 pt-20 -70.09 -17.14 63.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.916 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.45 52.22 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.792 0.33 . . . . 0.0 111.186 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -88.75 157.98 18.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.78 134.07 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.753 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 5.2 mtp -77.87 123.82 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.23 5.07 65.96 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -140.78 120.18 13.11 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.43 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.91 -173.44 53.64 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 173' ' ' VAL . 39.7 t-20 -78.25 107.58 10.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -85.51 103.42 14.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.34 122.5 33.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.306 0.574 . . . . 0.0 111.679 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.09 128.9 56.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.74 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.01 138.54 46.25 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 110.551 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.52 17.69 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.778 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' LEU . 49.9 m-70 -87.32 142.99 27.47 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.998 0.428 . . . . 0.0 110.708 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 129' ' ' SER . 66.8 t30 -109.26 28.65 8.3 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.874 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.56 -18.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.717 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 61.8 37.39 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.941 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -133.98 106.91 7.49 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -50.18 125.61 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.88 -22.9 11.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.0 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 33.7 t -90.09 179.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 117.659 0.729 . . . . 0.0 109.352 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.606 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -71.13 135.22 47.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.878 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.04 36.07 2.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.381 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 26.3 p -81.45 -8.94 59.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 85.9 m-20 -145.9 37.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.5 pt -68.64 -32.27 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.472 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.9 5.75 2.45 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.139 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -95.27 -15.7 22.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.79 124.31 22.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.701 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.33 152.25 19.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -54.29 127.26 26.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.616 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 91.71 22.0 32.37 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -85.41 134.57 34.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -79.35 131.48 36.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 111.88 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.6 mt -127.24 125.96 67.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.532 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.63 119.93 39.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.055 0.455 . . . . 0.0 110.079 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 tp -115.66 143.39 45.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -108.07 124.82 50.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.086 0.47 . . . . 0.0 111.418 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -97.7 -173.03 2.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.525 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 5.5 p30 -30.35 -69.56 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.508 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 70.8 mm-40 -135.03 27.0 3.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.757 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 158.34 38.46 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.465 0.65 . . . . 0.0 112.463 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -116.52 122.18 43.94 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.338 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -105.91 131.92 52.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 111.25 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -96.37 115.26 27.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.984 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -113.93 141.92 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.422 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.16 131.18 54.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.488 0.661 . . . . 0.0 111.198 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 144' ' ' GLY . 47.8 t -65.37 134.33 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.08 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -100.94 -30.42 11.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 124.708 1.255 . . . . 0.0 110.299 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.46 156.69 11.04 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.207 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.54 154.74 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.916 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.9 t -167.65 178.03 5.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.578 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -113.12 127.64 56.26 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.1 m -155.52 174.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.361 . . . . 0.0 111.483 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.554 ' C ' ' H ' ' A' ' 169' ' ' ASP . 8.9 p -90.56 136.55 28.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.651 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -54.13 -0.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.191 1.927 . . . . 0.0 112.263 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.554 ' H ' ' C ' ' A' ' 167' ' ' THR . 48.5 p-10 -74.23 -18.99 60.67 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.518 ' HZ2' ' NH2' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -85.68 72.21 10.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.521 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 59.8 m95 -74.38 -4.17 34.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.185 0.516 . . . . 0.0 112.001 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.562 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.6 mt-10 -60.55 -18.2 50.92 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.45 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 4.4 m -92.86 -0.29 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.68 -6.6 7.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.513 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 69.4 mm-40 -87.56 152.22 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.206 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.42 127.33 31.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.714 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.562 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.1 m170 -119.94 27.94 8.39 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.55 76.87 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -148.84 164.91 33.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.073 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -91.91 91.37 7.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.55 0.691 . . . . 0.0 109.826 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -117.41 164.55 14.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.522 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.96 140.75 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 56.7 m -135.75 126.47 27.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.624 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.25 120.8 43.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.376 0.608 . . . . 0.0 109.684 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.2 pt -130.32 -178.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.513 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.466 0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.26 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.518 ' NH2' ' HZ2' ' A' ' 170' ' ' LYS . 20.6 ptt180 . . . . . 0 N--CA 1.458 -0.046 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.11 137.52 37.51 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.1 p -131.71 135.87 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.411 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.19 137.87 52.7 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.142 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.58 151.97 21.42 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 54.4 p-10 -110.18 147.17 34.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.923 -0.639 . . . . 0.0 111.902 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 45.4 tp -67.71 126.24 28.76 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.774 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.9 m -109.59 -23.54 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.03 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -177.78 172.71 45.38 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.213 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.8 m -152.67 151.43 30.57 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.087 0.47 . . . . 0.0 110.686 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -148.14 175.8 10.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.116 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.82 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.062 0.458 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -73.61 79.75 1.5 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.886 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.768 178.59 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.487 1.141 0 CA-C-O 120.894 0.289 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -77.14 170.76 15.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.3 -14.54 63.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.729 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.36 88.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -75.85 -22.48 56.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.449 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.09 -50.35 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.638 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.16 87.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.196 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.66 -31.41 69.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.17 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.63 109.04 1.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -96.69 113.09 24.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.113 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.0 tp -110.24 124.15 51.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 77' ' ' LYS . 98.5 m-20 -71.91 140.21 49.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.234 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -64.84 -5.4 5.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.561 . . . . 0.0 109.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 75' ' ' ASP . 69.8 mmtt -74.45 -9.33 58.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.826 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 10.4 mp0 -94.83 3.73 54.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -89.22 126.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.537 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -123.66 -7.9 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.014 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.63 -172.63 39.2 Favored Glycine 0 C--N 1.312 -0.763 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -147.82 154.32 40.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 117.457 0.628 . . . . 0.0 111.852 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 6.3 tt -123.35 123.7 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.393 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -125.9 129.67 49.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.517 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 mt -133.89 124.11 17.46 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.424 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.97 -36.02 0.34 Allowed 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.194 1.929 . . . . 0.0 112.576 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.86 -38.78 51.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.806 -177.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 m -118.94 -3.36 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 110.535 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.97 49.54 1.6 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.77 126.79 52.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -133.96 115.31 14.23 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 93' ' ' PRO . 1.2 tp -149.95 113.5 3.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.6 Cg_endo -41.87 158.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.261 1.307 . . . . 0.0 110.427 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.32 124.84 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.6 mt -104.82 123.82 48.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 63.0 tttp -66.15 -46.89 75.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.097 0.475 . . . . 0.0 110.85 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -71.75 102.83 2.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.52 97.29 9.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.581 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 5.2 p -136.33 155.17 50.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.908 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -54.19 -26.19 26.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.485 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -85.12 -47.45 10.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.475 0.655 . . . . 0.0 111.71 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.623 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -65.63 -36.43 83.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.267 -179.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.13 -19.33 61.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -70.79 -32.04 69.01 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 m -92.62 -9.73 39.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.81 176.54 43.21 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.606 -1.283 . . . . 0.0 112.407 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.74 128.01 34.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.17 28.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.001 0.429 . . . . 0.0 111.265 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.0 p -75.56 153.08 37.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.22 -46.38 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -90.54 140.91 29.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.859 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.515 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.0 pt-20 -66.81 -6.12 14.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.694 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -145.73 45.76 1.28 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.78 0.324 . . . . 0.0 110.925 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.534 ' OE1' ' CG ' ' A' ' 121' ' ' TYR . 6.0 tt0 -72.04 161.18 31.28 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.5 t -136.92 124.53 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.8 mtt -75.1 127.82 34.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.494 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.83 71.83 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -140.85 121.61 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.097 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 75.68 -172.26 54.0 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -85.66 111.66 20.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.534 ' CG ' ' OE1' ' A' ' 114' ' ' GLN . 6.0 t80 -83.67 103.25 12.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.72 128.11 36.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 111.891 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.81 131.26 53.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.764 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.13 140.18 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.407 0.622 . . . . 0.0 110.95 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.8 -177.53 17.03 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.774 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -85.84 149.32 25.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.628 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 129' ' ' SER . 50.4 p30 -114.57 27.36 9.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.945 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.5 mmm -47.94 -10.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.93 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 127' ' ' ASN . 1.4 m 55.87 42.12 29.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.327 0.584 . . . . 0.0 109.598 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.507 ' N ' ' OG ' ' A' ' 136' ' ' SER . 31.7 mmtm -132.56 110.55 10.55 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.927 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -53.92 125.25 17.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.726 0.774 . . . . 0.0 110.544 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.3 9.4 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.611 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.614 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 52.3 t -77.84 178.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 CA-C-N 117.466 0.633 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.614 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.56 135.58 47.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.974 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.07 30.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.539 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.28 -11.44 59.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.16 20.61 2.09 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.0 pt -68.06 -25.01 31.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.622 0.249 . . . . 0.0 111.419 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.25 6.09 2.46 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.0 t -98.88 -16.09 18.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.7 mt -64.91 125.02 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.075 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.444 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 22.6 ttpt -99.83 173.87 6.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.409 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 12.4 ttpt -68.57 125.25 25.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.729 0.776 . . . . 0.0 111.617 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.91 26.92 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 85.7 m-20 -85.29 133.31 34.16 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -79.49 127.18 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.302 0.572 . . . . 0.0 111.829 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.99 121.59 63.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.912 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -102.69 121.49 42.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.1 tp -118.52 144.12 46.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -113.04 130.78 56.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.297 0.57 . . . . 0.0 111.193 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.0 t0 -108.87 -172.17 2.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.516 -1.22 . . . . 0.0 107.913 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.541 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.8 m-20 -27.05 -67.7 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.163 0.506 . . . . 0.0 111.799 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.97 22.02 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.8 152.76 36.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.365 0.602 . . . . 0.0 112.461 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.17 120.79 40.93 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -106.85 130.73 54.49 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 111.075 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.297 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -113.33 141.91 46.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.31 131.57 54.28 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.532 0.682 . . . . 0.0 110.42 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.6 135.81 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.146 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -100.92 -23.09 14.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.461 1.1 . . . . 0.0 110.339 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 153.16 155.93 7.36 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.497 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.39 138.56 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.331 -0.934 . . . . 0.0 109.905 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.0 m -135.04 149.57 50.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.129 0.49 . . . . 0.0 111.601 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.49 111.54 24.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.308 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.03 158.59 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.184 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 p -67.06 168.47 10.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.535 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.3 Cg_endo -81.52 -11.09 11.85 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 122.033 1.822 . . . . 0.0 111.47 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -86.69 -14.49 42.37 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.168 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -87.37 72.26 9.81 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.143 0.496 . . . . 0.0 110.442 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 89.4 m95 -76.21 -1.72 27.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.464 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.505 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -53.56 -31.26 45.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 0.0 110.739 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.7 m -83.68 4.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.66 -16.23 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.616 0.722 . . . . 0.0 109.456 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.9 159.9 19.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.878 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.26 129.34 39.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 39.5 m80 -102.25 -38.87 7.47 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.49 29.33 0.28 Allowed Glycine 0 N--CA 1.472 1.076 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.427 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.0 ptpt -156.18 176.91 12.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.381 0.61 . . . . 0.0 111.595 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 23.9 p30 -90.69 88.62 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.893 0.854 . . . . 0.0 109.84 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.44 166.88 13.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.169 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.25 140.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.5 m -135.28 126.33 27.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.0 mp -113.77 118.29 33.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.339 0.59 . . . . 0.0 109.782 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 185' ' ' ILE . 29.3 pt -129.35 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.54 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.529 ' OG1' ' NH1' ' A' ' 196' ' ' ARG . 44.3 p . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.113 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.529 ' NH1' ' OG1' ' A' ' 186' ' ' THR . 61.0 ttm-85 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.92 0.39 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.98 127.39 42.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.54 136.92 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 126.39 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.579 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.09 136.79 52.7 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.28 0.562 . . . . 0.0 110.3 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.6 155.48 23.63 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.632 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -112.32 146.16 38.75 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.813 0.34 . . . . 0.0 111.865 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.41 128.34 36.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 121.368 0.604 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.31 -24.14 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.752 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.47 175.15 46.11 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.445 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.2 m -152.7 151.6 30.74 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 110.83 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -149.17 176.27 10.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.04 146.02 24.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.337 0.589 . . . . 0.0 111.17 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.53 79.63 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.566 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp . . . . . 0 C--N 1.318 -0.795 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.76 178.615 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.486 1.035 0 CA-C-O 120.818 0.258 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 57.8 t0 -71.64 152.89 42.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.439 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.7 mt -59.6 -24.3 63.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.715 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.78 90.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -73.41 -34.57 65.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.3 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.61 -44.17 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.606 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.81 89.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.92 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.47 -24.74 36.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.91 109.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.892 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -95.6 121.84 37.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.039 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.4 tp -115.79 127.94 55.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.986 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.42 138.38 55.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.587 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -71.19 -6.86 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.5 . . . . 0.0 110.274 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 79' ' ' VAL . 68.7 mttm -65.09 -36.68 85.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.174 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.406 HE22 HD22 ' A' ' 102' ' ' ASN . 83.7 mt-30 -76.69 13.01 1.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.316 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 77' ' ' LYS . 57.4 t -93.43 126.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.75 -4.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.87 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.22 -171.23 40.54 Favored Glycine 0 C--N 1.318 -0.468 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.27 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 4.1 tt -119.28 124.71 73.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 m -127.1 128.68 46.6 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.6 mt -131.78 129.36 21.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.355 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.31 -35.4 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.22 1.947 . . . . 0.0 112.377 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -49.71 -39.67 37.8 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.669 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.9 p -118.44 -2.31 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 123.027 0.204 . . . . 0.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.89 53.08 3.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.7 tp -113.34 131.84 55.81 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.037 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.89 115.7 15.57 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 93' ' ' PRO . 39.5 mt -143.97 111.64 5.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.7 Cg_endo -40.65 138.64 1.42 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.57 1.513 . . . . 0.0 110.811 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 68.1 t -90.96 122.93 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -100.03 136.96 39.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.338 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.79 -34.48 60.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.6 m -93.83 115.84 28.27 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.465 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.8 p -82.79 66.44 8.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.211 0.529 . . . . 0.0 110.183 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.547 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -94.65 150.73 19.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.377 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -54.16 -52.01 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.634 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.83 -41.88 95.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.368 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.547 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 3.7 m-20 -66.17 -33.47 75.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.37 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.87 -15.08 62.6 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -72.35 -23.44 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -94.08 -9.65 35.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.25 -162.94 36.63 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.853 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.08 127.84 35.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.249 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.82 26.02 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.6 p -71.45 149.75 45.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.3 t -82.92 -46.13 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -92.8 -171.55 2.75 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.297 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -106.79 -55.19 2.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.505 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -90.8 46.61 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.575 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.9 147.01 23.83 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.17 131.83 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.535 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.5 mtt -64.71 128.1 34.33 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.42 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.52 5.85 71.44 Favored Glycine 0 CA--C 1.508 -0.364 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -140.62 118.5 11.79 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.809 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.0 -168.45 54.21 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 61.1 t30 -85.99 109.11 18.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.63 103.54 13.03 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.7 126.73 36.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.806 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.5 mt -122.63 132.62 54.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.689 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.09 140.0 48.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.114 0.483 . . . . 0.0 110.587 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.99 -178.12 17.77 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -80.9 156.62 25.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 0.0 110.622 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 129' ' ' SER . 2.2 p-10 -120.95 27.47 8.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 35.0 mtt -46.24 -12.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.615 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 57.5 40.35 27.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.616 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -134.0 112.07 10.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.032 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -52.84 124.51 14.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.059 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.65 -29.73 7.66 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.779 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.588 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 95.6 t -75.22 176.68 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 117.914 0.857 . . . . 0.0 109.247 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.588 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.61 134.76 46.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.117 -178.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 46.13 32.87 1.54 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.958 0.408 . . . . 0.0 110.708 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -82.24 -9.85 59.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -146.58 28.28 1.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.5 pt -69.74 -27.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.496 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.83 0.13 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.846 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.8 m -91.27 -15.5 29.08 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.69 116.76 6.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.054 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.447 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.5 mttp -103.53 154.74 19.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -50.76 113.29 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.395 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.29 4.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.8 m-20 -101.06 128.47 47.1 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -82.99 134.61 35.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.247 0.546 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 158' ' ' TYR . 90.0 mt -123.95 124.24 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.946 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -105.08 122.01 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 110.82 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.7 mt -116.12 150.42 37.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.397 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.465 ' O ' ' SD ' ' A' ' 116' ' ' MET . 60.2 m-85 -118.36 130.19 55.86 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.087 0.47 . . . . 0.0 110.991 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.5 t0 -109.93 -170.15 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.547 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 7.5 p30 -27.03 -71.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.1 0.476 . . . . 0.0 111.602 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.542 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.7 mt-10 -137.49 31.41 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.081 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.16 138.95 48.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.324 0.583 . . . . 0.0 112.401 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -103.94 121.62 43.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.449 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 55.2 m-85 -104.42 133.46 49.27 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.294 0.568 . . . . 0.0 111.55 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -98.38 119.86 37.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.016 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 147' ' ' ILE . 31.6 m-85 -120.0 139.7 52.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.93 135.14 54.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.492 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.4 t -70.7 135.9 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.981 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 11.4 p -102.68 -23.98 13.79 Favored 'General case' 0 C--N 1.341 0.235 0 O-C-N 124.814 1.321 . . . . 0.0 110.972 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.81 154.79 7.26 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.31 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.56 146.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.551 -0.824 . . . . 0.0 109.789 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.511 ' HG ' ' N ' ' A' ' 165' ' ' GLU . 37.9 t -146.19 156.15 43.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.86 0.362 . . . . 0.0 111.178 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.511 ' N ' ' HG ' ' A' ' 164' ' ' SER . 94.8 mt-10 -109.18 118.23 36.2 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.18 156.69 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.968 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 169' ' ' ASP . 20.4 p -66.15 136.31 95.33 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.58 ' CB ' HH21 ' A' ' 196' ' ' ARG . 1.6 Cg_endo -47.77 -12.99 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.97 1.78 . . . . 0.0 111.816 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 167' ' ' THR . 55.0 t0 -86.0 -11.15 53.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.642 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -86.78 75.35 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.774 0.321 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -78.11 -5.64 52.22 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.049 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -53.43 -35.03 60.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.944 0.402 . . . . 0.0 111.191 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.45 3.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.828 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.0 t -119.53 -15.04 8.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.567 0.699 . . . . 0.0 109.773 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -85.31 163.19 18.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.047 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.35 129.62 39.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.0 -42.62 6.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.135 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.69 30.12 0.26 Allowed Glycine 0 N--CA 1.469 0.89 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -155.81 177.37 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.071 0.462 . . . . 0.0 111.236 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 61.9 m-20 -88.88 89.34 7.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.266 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -124.21 166.17 16.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.971 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.68 143.18 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.473 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 8.2 m -136.21 125.33 24.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.711 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.0 mp -112.85 125.59 54.53 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.6 pt -140.6 -177.86 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.7 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 32.1 p . . . . . 0 N--CA 1.467 0.404 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.771 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.58 HH21 ' CB ' ' A' ' 168' ' ' PRO . 29.6 ttm180 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.737 0.304 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.437 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 2.8 m-85 -84.92 129.76 34.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.57 140.07 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.165 0.507 . . . . 0.0 111.626 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.5 t -118.06 130.9 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.92 136.98 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.643 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.44 160.95 24.62 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.377 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 53.2 p-10 -112.53 146.03 39.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.175 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 37.2 tp -68.95 127.74 34.22 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.24 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.2 176.58 44.51 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.386 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.449 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 36.1 m -153.56 153.44 32.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.077 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -149.78 179.21 8.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.578 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.64 148.97 21.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.618 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -64.42 79.59 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.455 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.314 -0.938 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.661 178.059 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.483 0.866 0 N-CA-C 110.982 -0.43 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.01 166.21 23.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.692 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 3.9 mm? -69.61 -16.29 63.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 111.152 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.91 94.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.381 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 80.9 mm-40 -72.52 -33.57 66.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.91 -46.52 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.911 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.016 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 59.9 t-20 -82.9 -28.32 30.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.59 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -61.83 106.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.851 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 m -97.3 114.81 26.63 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.58 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.495 ' CB ' ' HG ' ' A' ' 105' ' ' SER . 53.2 tp -107.24 125.67 51.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.934 0.397 . . . . 0.0 111.106 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -68.23 138.48 55.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.321 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -63.92 -8.5 11.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.286 0.565 . . . . 0.0 110.207 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -70.76 -14.82 62.58 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.389 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -91.94 1.02 57.45 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.496 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.76 122.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 80' ' ' ILE . 3.9 tt -104.31 -36.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.407 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.37 -158.47 8.78 Favored Glycine 0 C--N 1.321 -0.303 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.7 mtp85 -146.9 150.6 35.53 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.52 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 3.8 tt -122.34 127.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -126.84 129.15 47.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.849 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.6 mt -133.62 117.18 14.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.2 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.92 -37.75 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.486 2.124 . . . . 0.0 112.653 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 t -49.26 -36.79 21.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.491 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' A' ' 89' ' ' SER . 6.9 m -119.87 -7.07 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.381 0.134 . . . . 0.0 111.057 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 73.33 46.02 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.663 0.744 . . . . 0.0 109.952 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.0 125.59 51.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.512 -178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -137.0 110.75 8.11 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' PRO . 18.3 mt -146.61 116.88 4.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -41.14 140.41 1.33 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.795 1.663 . . . . 0.0 109.931 176.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.35 126.82 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.407 ' CD1' ' O ' ' A' ' 102' ' ' ASN . 28.1 mt -103.11 124.97 49.56 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -70.37 -34.36 72.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.1 m -86.45 108.85 18.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.987 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -82.0 69.35 8.69 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 110.221 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.574 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.08 151.58 22.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.484 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.74 -50.14 66.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.593 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.01 -40.63 95.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.075 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.574 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 43.0 m-20 -65.64 -37.03 85.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.58 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.25 -18.09 46.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.627 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.31 -17.71 61.28 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.495 ' HG ' ' CB ' ' A' ' 74' ' ' LEU . 3.9 m -100.56 -12.14 19.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.52 -174.72 43.86 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 127.46 32.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.29 146.61 29.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 110.771 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.9 p -75.5 151.5 37.99 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.11 -50.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -90.65 139.22 30.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.72 -48.09 83.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.826 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -98.51 47.36 0.99 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.01 159.71 30.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -140.86 124.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.0 mtt -75.36 127.97 34.34 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.418 ' H ' ' HH ' ' A' ' 158' ' ' TYR . . . 92.32 -1.14 72.56 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -142.81 127.34 17.9 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.986 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 72.93 -172.98 48.71 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.455 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 41.0 t-20 -86.6 110.29 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -85.63 100.79 12.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.37 125.32 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.531 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -119.32 130.28 55.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.36 138.98 47.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 110.754 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.76 -178.57 18.8 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.323 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 42.5 m-70 -85.69 141.05 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.569 0.223 . . . . 0.0 110.581 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 129' ' ' SER . 65.3 t30 -110.44 27.68 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.124 0.488 . . . . 0.0 110.567 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -44.81 -16.18 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.854 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.56 40.88 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.069 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 136' ' ' SER . 98.4 mttt -131.25 109.46 10.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.358 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -53.31 123.87 13.1 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.511 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.91 -29.2 7.58 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.577 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 57.2 t -77.84 178.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.577 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.88 136.67 47.03 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 44.87 32.0 0.76 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.108 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.2 p -82.4 -11.92 58.24 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.96 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.449 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 35.2 t0 -141.71 25.91 1.95 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 pt -70.3 -22.33 23.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.918 0.389 . . . . 0.0 111.846 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.9 3.91 7.41 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.661 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.449 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.7 m -99.57 -11.45 20.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.111 0.481 . . . . 0.0 110.298 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.95 124.95 22.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.463 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.462 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -96.97 163.04 13.12 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.846 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -60.77 136.1 57.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.528 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.14 57.73 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 40.5 m-20 -87.61 131.62 34.35 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.529 ' NZ ' ' OE2' ' A' ' 157' ' ' GLU . 3.4 mmpt? -78.2 129.2 34.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.932 0.396 . . . . 0.0 111.726 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.1 mt -124.8 123.15 65.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -104.12 120.26 40.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.194 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.38 136.44 53.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.404 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.27 130.61 55.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 111.285 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.6 t0 -113.46 -165.46 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.524 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.3 m-20 -24.11 -75.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.174 0.512 . . . . 0.0 111.328 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -137.03 26.02 2.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -126.22 143.13 51.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -108.39 120.46 42.45 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -103.35 131.19 50.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.547 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.529 ' OE2' ' NZ ' ' A' ' 146' ' ' LYS . 70.3 tt0 -95.96 121.04 37.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.418 ' HH ' ' H ' ' A' ' 117' ' ' GLY . 36.5 m-85 -120.25 137.27 54.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.246 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.11 132.56 56.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 110.547 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.24 134.84 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.155 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.3 t -104.74 -24.29 12.94 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.468 1.105 . . . . 0.0 111.516 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.18 147.37 5.11 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.397 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.08 155.51 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.6 t -161.34 169.64 21.66 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.936 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -121.22 123.88 43.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -135.69 157.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 111.326 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 169' ' ' ASP . 16.9 p -59.16 131.3 87.28 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.563 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.1 Cg_endo -45.57 -14.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.968 1.779 . . . . 0.0 112.122 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 167' ' ' THR . 53.6 t0 -84.83 -8.58 58.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.275 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -87.82 62.74 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.576 ' C ' ' H ' ' A' ' 173' ' ' VAL . 26.9 m95 -72.24 -18.21 61.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.804 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.09 -9.64 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.166 0.508 . . . . 0.0 111.195 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 171' ' ' TRP . 24.6 m -83.39 -25.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.817 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.67 -2.33 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.622 0.725 . . . . 0.0 109.865 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 176' ' ' ASP . 95.3 mt-10 -82.18 119.9 24.65 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.78 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 175' ' ' GLU . 97.9 m-20 -28.96 119.81 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.957 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -98.86 -43.43 6.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.051 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.17 33.47 0.32 Allowed Glycine 0 N--CA 1.47 0.963 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.1 ptpt -153.6 176.29 12.24 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.235 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 50.6 p-10 -97.44 88.62 4.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.904 0.859 . . . . 0.0 110.46 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -131.0 177.11 7.69 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.282 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.3 tt -130.63 143.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.538 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 5.5 m -138.22 123.88 19.77 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.563 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.86 128.82 55.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 7.1 pt -138.61 -166.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.626 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.656 -179.005 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.404 ' HE ' ' HA ' ' A' ' 168' ' ' PRO . 7.8 tmm_? . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.602 0.239 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -100.27 134.48 43.15 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.7 138.95 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.898 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.7 t -116.97 128.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.52 133.01 54.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.453 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.06 152.99 20.74 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 64.5 t0 -111.04 149.41 30.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.783 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.543 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.54 127.73 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.207 0.527 . . . . 0.0 110.795 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.1 p -111.32 -21.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.699 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.43 176.05 47.46 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.678 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.0 m -156.86 154.51 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.824 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -150.76 178.99 8.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -90.96 148.19 22.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.285 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.411 ' O ' ' OXT' ' A' ' 210' ' ' LYS . 64.4 tttm -74.49 79.24 1.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.561 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.411 ' OXT' ' O ' ' A' ' 209' ' ' LYS . 26.7 ttpt . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.461 178.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.485 1.008 0 CA-C-O 120.988 0.328 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -77.42 171.36 15.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.71 -16.07 63.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.89 92.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.459 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -74.33 -31.97 62.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.507 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.7 t -75.01 -45.48 42.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.575 -178.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.7 89.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.853 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -77.06 -28.49 54.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.282 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.79 107.25 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.977 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.9 t -96.67 119.63 35.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.159 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.8 tp -119.05 129.48 55.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.481 -179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.45 138.87 49.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.835 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -68.78 -7.82 37.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.297 0.57 . . . . 0.0 110.246 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -73.5 -10.34 59.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.864 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.8 mp0 -91.87 1.61 57.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.02 131.27 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.882 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.1 pt -123.22 -5.5 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -178.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.0 -170.08 35.51 Favored Glycine 0 C--N 1.316 -0.573 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -146.32 150.89 36.59 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.704 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -123.02 124.8 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.3 t -130.32 131.11 45.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.621 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.5 mt -133.46 131.15 21.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.461 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.36 -35.43 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.315 2.01 . . . . 0.0 111.854 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -48.41 -39.86 23.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.519 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.6 p -119.48 -2.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.901 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 2.6 p 62.67 52.22 2.89 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -112.28 132.44 54.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.101 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -134.85 115.49 13.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.3 mt -144.09 113.65 5.32 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -41.76 147.62 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.767 1.645 . . . . 0.0 110.58 176.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.55 123.0 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.438 ' CB ' HD21 ' A' ' 102' ' ' ASN . 22.3 mt -104.25 123.75 47.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.044 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 65.8 tttm -67.38 -47.13 71.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.192 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.59 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -74.06 105.99 5.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.366 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -81.84 101.98 10.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.494 0.664 . . . . 0.0 110.199 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.528 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.8 p -135.54 164.15 28.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.33 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.969 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -83.0 -42.4 17.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.788 -179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -66.65 -35.24 79.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.231 -178.821 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -63.72 -16.34 60.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.863 -178.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.65 -16.47 60.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.8 p -106.29 -9.3 16.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.2 -172.54 44.49 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.403 -178.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.85 128.45 33.37 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.114 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.507 ' CB ' HD22 ' A' ' 102' ' ' ASN . . . -105.27 146.77 28.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.79 149.91 39.53 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.19 -41.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.434 ' HG2' ' H ' ' A' ' 112' ' ' GLU . 24.3 tttp -88.74 -173.35 4.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.78 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 35.4 tp10 -120.95 -11.33 8.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.296 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 112' ' ' GLU . 97.9 m-20 -141.57 42.09 1.73 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.234 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -89.74 160.53 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.6 t -132.02 132.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.741 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.416 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.7 mtt -68.38 128.67 37.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.209 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.31 3.02 72.88 Favored Glycine 0 N--CA 1.461 0.323 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -140.4 120.91 14.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.96 53.13 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.456 HD22 ' CB ' ' A' ' 183' ' ' THR . 2.0 t30 -95.39 110.9 22.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -84.4 103.73 13.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 128.54 36.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.281 0.563 . . . . 0.0 111.969 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.45 129.48 51.31 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.716 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 139.16 46.65 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.469 0.652 . . . . 0.0 110.888 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.56 -178.64 17.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.746 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -81.98 155.42 25.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.3 p-10 -121.82 27.04 8.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.428 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 39.0 mtt -44.08 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.004 -178.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 59.65 40.04 20.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.398 0.618 . . . . 0.0 109.613 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 136' ' ' SER . 65.4 tttm -135.59 118.55 16.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.823 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.0 124.99 21.2 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.637 0.732 . . . . 0.0 110.47 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.5 -26.1 10.53 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.816 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.564 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 98.4 t -78.97 175.69 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.774 0.787 . . . . 0.0 109.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.564 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.28 135.07 45.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.191 -178.401 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 46.26 32.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.458 . . . . 0.0 110.542 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.27 -7.59 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.512 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.6 m-20 -147.09 31.46 0.93 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -177.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.5 pt -70.73 -23.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.463 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.48 3.2 7.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.668 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -97.02 -11.6 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.79 122.45 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.608 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 60.4 mttp -96.82 151.4 19.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.489 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 161' ' ' THR . 52.2 tttp -54.74 123.77 14.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.606 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.73 19.64 19.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.5 m-20 -88.23 132.29 34.43 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -82.15 135.19 35.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.386 0.612 . . . . 0.0 111.978 -177.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 147' ' ' ILE . 96.0 mt -127.47 125.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.718 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.41 118.36 36.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.147 0.498 . . . . 0.0 109.986 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.39 144.82 43.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.314 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.416 ' O ' ' SD ' ' A' ' 116' ' ' MET . 19.2 m-85 -114.78 131.75 56.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.216 0.531 . . . . 0.0 111.271 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.8 t0 -112.41 -168.73 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.9 m120 -24.22 -74.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.04 0.448 . . . . 0.0 112.066 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -137.47 28.22 2.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.86 148.77 50.48 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -175.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.31 122.26 47.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -105.65 132.01 52.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 111.412 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -95.92 114.16 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.163 178.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -115.38 139.96 49.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 134.79 55.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.491 0.662 . . . . 0.0 111.561 178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.95 133.29 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.96 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.506 ' O ' ' NZ ' ' A' ' 143' ' ' LYS . 2.0 p -102.89 -28.44 12.04 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 124.959 1.412 . . . . 0.0 110.697 -178.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.22 152.56 7.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.82 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.29 150.15 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.742 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -152.27 161.95 41.86 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.277 0.56 . . . . 0.0 111.543 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -111.51 126.47 55.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.478 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.59 162.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.01 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.1 p -71.17 141.31 86.13 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -46.54 -17.24 0.33 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.862 1.708 . . . . 0.0 111.842 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.6 m-20 -82.77 -3.6 56.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.1 tptt -80.98 148.07 29.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 81.7 m95 -158.33 -26.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.963 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.13 -8.67 0.08 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.236 0.541 . . . . 0.0 110.531 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.574 ' H ' ' C ' ' A' ' 171' ' ' TRP . 4.8 m -74.8 -30.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.923 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.5 m -105.59 -5.13 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.756 0.789 . . . . 0.0 109.763 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 176' ' ' ASP . 77.6 mm-40 -80.02 118.38 21.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.9 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 175' ' ' GLU . 68.2 t0 -29.01 124.08 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.491 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -99.08 -40.72 7.87 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.917 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.5 29.21 0.28 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.533 ' HZ2' ' CD ' ' A' ' 181' ' ' GLU . 21.9 pttp -156.03 179.52 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 111.296 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -94.12 100.11 12.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.714 0.769 . . . . 0.0 109.79 179.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.533 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 17.1 pt-20 -138.92 174.58 10.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.922 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.1 tt -131.12 143.88 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.548 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.456 ' CB ' HD22 ' A' ' 120' ' ' ASN . 12.4 m -135.9 126.01 26.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.677 0.275 . . . . 0.0 111.239 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.6 mp -113.14 126.89 55.94 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.384 0.612 . . . . 0.0 110.643 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.1 pt -141.13 -172.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.184 -178.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.017 -179.751 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.227 0 CA-C-O 121.144 0.497 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -121.22 131.53 54.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.003 178.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.36 127.74 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.894 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 70.1 t -117.63 129.11 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.509 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.04 54.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.415 0.626 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.42 159.06 24.31 Favored Glycine 0 N--CA 1.461 0.322 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.849 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -110.17 153.35 24.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.709 -0.746 . . . . 0.0 111.873 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.9 tp -74.94 127.7 33.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.255 0.55 . . . . 0.0 110.878 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 93.1 t -107.56 -25.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.912 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 174.29 176.7 42.88 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.47 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.1 m -153.49 153.2 31.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 111.052 178.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.33 176.91 10.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.463 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.56 142.08 27.86 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.898 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.99 79.87 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.847 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.2 tttm . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.552 178.64 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.484 0.968 0 CA-C-O 120.818 0.258 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 171.58 14.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.92 -14.3 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.683 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.92 91.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -74.85 -26.09 59.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.18 -47.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.671 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -42.24 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -70.83 -31.04 67.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.82 145.46 55.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.44 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -139.26 108.13 5.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.059 0.456 . . . . 0.0 110.998 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 tt -105.13 127.05 52.72 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.056 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -74.0 137.1 43.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.414 ' N ' ' CD ' ' A' ' 76' ' ' LYS . 4.5 mptp? -67.33 -9.41 40.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 110.165 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -80.29 -11.94 59.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.497 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.71 6.92 36.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 p -88.18 138.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.1 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 pt -120.79 -5.96 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.561 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.64 -165.29 30.84 Favored Glycine 0 C--N 1.32 -0.361 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -152.57 155.0 36.54 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.61 130.17 68.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.675 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.04 130.83 51.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.553 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 mt -134.76 100.86 11.97 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.136 -178.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -67.82 -34.2 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.244 1.963 . . . . 0.0 112.404 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.5 t -52.1 -38.73 58.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 -177.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 89' ' ' SER . 25.3 t -110.31 -9.6 11.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 120.58 0.229 . . . . 0.0 110.665 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.82 43.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.413 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -115.8 130.48 56.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.819 -178.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -134.45 118.91 17.9 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.3 mt -145.31 163.13 33.92 Favored Pre-proline 0 N--CA 1.465 0.275 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.547 -177.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.78 150.27 7.3 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.052 2.501 . . . . 0.0 109.428 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.9 t -95.77 116.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.7 mt -101.83 122.55 44.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -65.76 -46.19 79.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.084 0.468 . . . . 0.0 111.046 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 p -75.3 103.91 5.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.376 -179.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 99.8 11.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.333 0.587 . . . . 0.0 110.316 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 5.4 p -132.11 160.41 36.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.685 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -56.74 -28.96 62.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.781 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.485 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 18.8 ptmt -84.25 -41.88 16.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.342 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 101' ' ' LYS . 5.4 m120 -65.76 -36.47 83.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.396 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.89 -20.58 62.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.4 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -75.58 -15.51 60.35 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.6 m -103.32 -11.49 17.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.09 -166.59 39.79 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.226 -178.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.14 125.01 28.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.61 143.28 33.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.058 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.3 p -69.19 144.06 53.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.49 -44.69 18.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -89.33 -175.08 4.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.95 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -115.42 -11.57 11.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.623 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -137.6 43.19 2.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -178.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.518 ' OE1' ' CZ ' ' A' ' 121' ' ' TYR . 5.7 pt20 -92.17 155.28 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.362 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.05 132.37 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.507 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.0 mtt -68.3 128.15 35.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.413 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 89.34 4.61 73.7 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.86 121.17 12.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.638 -179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.76 -168.88 54.6 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.618 ' ND2' ' HG1' ' A' ' 183' ' ' THR . 8.1 t30 -89.33 110.48 21.26 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.518 ' CZ ' ' OE1' ' A' ' 114' ' ' GLN . 1.7 t80 -84.74 105.22 15.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.01 120.13 34.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.998 -178.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -117.09 132.42 56.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.862 178.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 142.54 43.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.752 -179.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.02 -178.6 19.88 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.545 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -85.16 152.07 23.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.922 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 129' ' ' SER . 41.7 t30 -116.01 28.34 8.68 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -50.14 -8.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.66 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.52 ' H ' ' C ' ' A' ' 127' ' ' ASN . 3.0 t 52.51 44.18 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 109.716 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' SER . 29.3 tptp -134.15 113.53 12.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.643 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -56.01 125.17 20.39 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.415 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.45 -29.22 8.84 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.827 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.595 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 58.3 t -76.82 178.37 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 117.847 0.824 . . . . 0.0 109.384 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.595 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.38 136.51 49.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.715 0.293 . . . . 0.0 110.933 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 43.17 31.76 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.928 178.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.41 -11.66 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.108 -178.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 136' ' ' SER . 7.1 m-20 -142.24 22.1 2.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 140' ' ' SER . 4.5 pt -67.52 -29.41 45.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.61 2.43 1.33 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.793 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 138' ' ' ILE . 49.9 m -97.03 -11.46 24.45 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.19 121.15 12.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.51 172.69 7.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.766 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.35 122.1 22.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.543 0.687 . . . . 0.0 112.035 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.83 14.61 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -93.35 134.79 35.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -83.37 137.25 34.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.454 0.645 . . . . 0.0 112.074 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.65 122.85 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.001 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 73.9 m-85 -101.09 117.08 34.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.8 tp -115.1 144.96 42.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.675 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -117.05 130.69 56.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.998 0.427 . . . . 0.0 111.676 -178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.8 t0 -107.02 -167.66 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.532 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 61.6 t-20 -29.39 -68.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -138.41 21.7 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.766 179.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.44 146.33 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -176.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.37 118.87 37.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -104.21 130.69 51.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.144 0.497 . . . . 0.0 111.085 -178.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 41.5 tp10 -94.41 117.18 29.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.15 137.81 51.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.31 133.36 56.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.274 0.559 . . . . 0.0 110.566 179.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 133.39 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -25.15 12.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.537 1.148 . . . . 0.0 110.751 -179.29 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.03 153.86 7.08 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.917 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.73 155.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.576 -0.812 . . . . 0.0 109.28 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.9 p -151.7 162.3 41.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.077 0.465 . . . . 0.0 111.198 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.445 ' OE2' ' OH ' ' A' ' 197' ' ' TYR . 91.5 mt-10 -114.22 113.67 24.95 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 159.66 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.139 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.3 p -60.3 168.46 2.29 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.5 -11.52 11.71 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.905 1.736 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.58 -6.64 59.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.997 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -85.06 66.71 9.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 173' ' ' VAL . 63.1 m95 -72.29 -24.57 61.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.98 -17.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.247 0.546 . . . . 0.0 110.365 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.442 ' N ' ' C ' ' A' ' 171' ' ' TRP . 24.3 m -69.87 -27.23 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.206 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.6 m -109.73 1.0 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.554 0.692 . . . . 0.0 110.052 -179.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.83 125.86 32.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.317 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -34.95 122.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.445 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -103.07 -44.22 5.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.777 0.323 . . . . 0.0 111.309 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.69 28.06 0.17 Allowed Glycine 0 N--CA 1.47 0.932 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -153.49 173.36 15.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 22.3 m-20 -94.25 88.86 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -133.34 127.07 32.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.099 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.1 tt -81.16 148.26 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.618 ' HG1' ' ND2' ' A' ' 120' ' ' ASN . 17.5 m -135.93 125.75 25.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.843 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -111.29 127.08 55.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 111.204 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.7 pt -132.35 153.61 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.248 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 -179.198 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.445 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 4.3 m-85 -93.04 128.49 38.94 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.527 179.132 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.01 132.47 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 111.142 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.96 129.46 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.215 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.18 137.35 51.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.516 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.97 135.3 8.59 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.4 t0 -95.63 133.5 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.069 -0.566 . . . . 0.0 111.546 -178.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.401 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 44.8 tp -62.18 124.06 19.84 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.214 0.53 . . . . 0.0 110.385 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.1 -21.7 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.054 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.01 175.14 47.11 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.159 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 22.4 m -154.57 152.71 30.36 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.023 0.44 . . . . 0.0 110.628 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -150.98 177.45 10.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.116 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.18 148.77 21.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.201 0.524 . . . . 0.0 110.845 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -70.79 80.27 0.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.535 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.669 178.424 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.483 0.899 0 N-CA-C 110.8 -0.5 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.78 147.77 48.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.808 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.8 mt -55.25 -25.9 36.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.053 -178.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.9 95.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -72.58 -33.38 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.923 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.3 t -75.36 -45.68 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.056 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -38.02 88.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.98 -25.97 34.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.639 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.63 131.84 51.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.388 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.56 ' HG ' ' N ' ' A' ' 74' ' ' LEU . 19.8 t -95.92 158.92 15.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.024 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.56 ' N ' ' HG ' ' A' ' 73' ' ' SER . 44.6 tp -123.24 134.13 54.13 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -179.002 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.28 105.54 15.84 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.027 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.454 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 6.0 mptp? -63.81 -8.73 11.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.269 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -63.73 -39.47 94.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.545 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 3.6 pt20 -89.11 19.97 3.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.768 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 76' ' ' LYS . 4.3 p -84.72 126.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.568 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.5 -9.26 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.43 -166.35 37.27 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -146.88 150.57 35.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.622 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 7.8 tp -113.18 122.56 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 t -126.87 128.05 45.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.5 mt -135.62 122.31 14.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.969 -177.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.79 -34.73 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.577 2.184 . . . . 0.0 112.37 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.447 ' OG ' ' OD1' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -51.08 -39.75 56.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.488 -177.24 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 89' ' ' SER . 20.7 m -118.62 -9.01 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 122.314 0.246 . . . . 0.0 111.096 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.505 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 74.37 48.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.407 0.622 . . . . 0.0 109.833 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.18 123.49 48.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -135.46 110.44 8.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 93' ' ' PRO . 10.6 mt -149.8 115.86 3.53 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 92' ' ' LEU . 1.9 Cg_endo -39.91 143.11 0.46 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 121.832 1.688 . . . . 0.0 110.132 176.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.72 123.54 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.2 mt -105.21 138.37 41.52 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.088 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -78.71 -25.27 44.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.387 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -89.27 104.24 16.81 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -81.4 62.71 5.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.292 0.568 . . . . 0.0 110.37 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -93.84 162.83 13.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.708 179.59 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.64 -48.0 79.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.1 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 19.6 ptmt -67.27 -40.52 86.2 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.602 0.564 . . . . 0.0 111.74 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.593 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 8.7 m-80 -64.74 -37.56 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.243 -178.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.68 -20.76 61.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.63 -18.95 62.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 m -102.05 -13.83 17.37 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.25 -162.17 30.86 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.234 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.77 126.09 36.72 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.095 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -72.86 152.81 41.32 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.15 -47.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -93.19 145.36 24.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.54 -51.13 68.59 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.623 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.06 46.42 1.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.29 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.532 ' NE2' ' H ' ' A' ' 122' ' ' ALA . 10.6 tt0 -80.89 153.71 27.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.59 117.77 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.147 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.453 ' N ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.14 129.95 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.795 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.25 -8.76 57.37 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -143.99 130.9 20.4 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.439 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.29 -167.95 52.8 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 25.2 t-20 -86.77 107.22 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.587 0.232 . . . . 0.0 110.659 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.453 ' CE1' ' N ' ' A' ' 116' ' ' MET . 4.7 t80 -86.56 100.51 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.88 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.532 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.21 123.8 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.837 -179.377 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.2 mt -118.18 132.64 56.31 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.373 178.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.34 140.17 48.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.923 -178.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.75 -178.09 16.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.661 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -85.17 146.17 27.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.621 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.9 p30 -112.79 26.23 10.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 0.0 110.869 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -42.76 -19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.816 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.11 39.43 12.96 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.139 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.86 109.49 10.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.04 124.88 16.87 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.829 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.85 -25.03 10.43 Favored Glycine 0 N--CA 1.473 1.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.533 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.565 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 39.2 t -83.24 179.0 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -73.17 136.12 44.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.031 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.63 31.51 0.64 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 110.751 178.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -80.22 -7.47 58.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.719 -178.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.434 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.1 t0 -146.55 40.26 1.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.2 pt -70.65 -26.73 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.13 1.29 13.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.022 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.434 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.5 m -91.22 -17.96 25.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.087 -179.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.21 125.3 24.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.324 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -95.93 170.91 8.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.72 130.03 40.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.923 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.03 21.18 36.65 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.447 ' OD1' ' OG ' ' A' ' 87' ' ' SER . 1.7 t70 -87.49 132.28 34.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -79.56 134.9 36.49 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.391 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' TYR . 96.5 mt -126.55 125.83 67.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.16 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.31 113.62 26.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.578 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.1 tp -113.32 134.47 54.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.389 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -105.83 133.98 49.69 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -178.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 43.9 t0 -108.7 -169.28 1.47 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.471 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 13.1 t-20 -32.93 -67.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.992 0.425 . . . . 0.0 110.65 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -135.98 21.89 3.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.065 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.53 150.37 40.96 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -114.81 119.47 36.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.341 178.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -105.23 130.19 53.44 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.372 0.606 . . . . 0.0 112.016 -178.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.45 117.34 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.498 ' O ' ' N ' ' A' ' 147' ' ' ILE . 20.0 m-85 -119.58 139.37 52.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.285 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.9 137.85 52.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.874 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.79 134.18 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.862 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.3 -27.26 12.95 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.84 1.338 . . . . 0.0 111.242 -178.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.81 158.76 9.89 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.54 152.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 165.56 35.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.098 -178.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -109.55 116.53 31.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.38 157.19 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.076 0.465 . . . . 0.0 111.285 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 169' ' ' ASP . 30.9 p -73.38 136.33 78.53 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -47.47 -15.45 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.113 1.875 . . . . 0.0 111.903 -178.62 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 167' ' ' THR . 95.9 m-20 -84.03 -11.54 56.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.518 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -88.04 67.69 8.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.9 m95 -74.13 -3.93 32.6 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.608 0.568 . . . . 0.0 112.193 -178.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.1 mt-10 -53.01 -39.89 63.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.961 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.3 m -77.84 2.7 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.199 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.1 -14.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.793 0.806 . . . . 0.0 110.597 -178.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.2 mt-10 -86.47 -179.14 6.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.878 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.6 p-10 -86.51 124.76 33.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.157 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.4 m80 -103.08 -43.91 5.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.206 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 25.33 0.07 OUTLIER Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -157.26 178.36 10.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.766 0.317 . . . . 0.0 111.07 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.445 ' OD2' ' OH ' ' A' ' 158' ' ' TYR . 31.3 t0 -96.68 89.83 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.613 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -126.69 127.62 45.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.369 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -85.43 149.42 4.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.1 m -137.44 124.67 21.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.436 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.3 mp -109.85 121.39 45.12 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 12.4 pt -140.4 -173.28 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.844 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 16.2 p . . . . . 0 N--CA 1.462 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.582 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.566 ' NH1' ' O ' ' A' ' 186' ' ' THR . 57.7 ttm-85 . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.69 139.28 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.282 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.94 129.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.38 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.14 135.9 53.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.28 143.6 14.88 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 51.8 p-10 -102.7 142.64 33.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.435 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.5 tp -65.31 126.88 29.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.4 -24.77 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.528 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.74 175.58 46.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.734 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.6 m -155.04 151.4 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.179 0.514 . . . . 0.0 111.244 -179.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -151.63 178.52 9.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.32 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.79 144.92 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.307 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.27 78.99 0.36 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.853 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 78.3 tttt . . . . . 0 C--N 1.322 -0.602 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.332 178.618 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.487 1.091 0 N-CA-C 111.122 -0.376 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.8 163.48 26.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.42 -19.96 65.45 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 123.163 0.289 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.74 93.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 95.6 mt-10 -72.2 -37.13 69.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.63 -45.81 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.886 -178.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.12 85.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -85.15 -26.64 26.71 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -58.86 137.76 57.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.127 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -92.09 158.13 16.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.912 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.9 tp -127.13 127.32 44.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 111.288 -178.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.5 m-20 -100.52 103.88 15.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.973 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -62.36 -7.09 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.572 -179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.5 mttm -75.08 -13.08 60.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.322 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.438 ' OE1' ' OG ' ' A' ' 97' ' ' SER . 97.8 mm-40 -102.54 12.08 36.95 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.736 -178.465 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.447 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 7.0 p -88.16 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.254 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 pt -121.4 -7.55 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.46 -171.28 39.28 Favored Glycine 0 C--N 1.32 -0.318 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.561 HH11 ' NZ ' ' A' ' 209' ' ' LYS . 42.0 mtm180 -146.46 152.03 38.37 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.72 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 6.5 tt -121.04 122.31 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -124.15 127.75 48.24 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.437 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.29 130.81 22.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.801 -178.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.61 -38.28 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.56 2.173 . . . . 0.0 112.417 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.447 ' HG ' ' N ' ' A' ' 88' ' ' VAL . 15.3 p -46.14 -37.88 7.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.424 -177.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.4 p -120.91 -0.45 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.942 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m 59.94 54.52 4.2 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.12 136.76 52.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.03 -177.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -137.0 116.39 12.72 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' PRO . 82.7 mt -141.03 101.58 6.32 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.6 127.92 1.74 Allowed 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 121.897 1.731 . . . . 0.0 110.211 176.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.95 121.84 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.2 mt -103.19 123.27 46.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.53 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.73 -49.5 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.065 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.438 ' OG ' ' OE1' ' A' ' 78' ' ' GLN . 66.2 m -65.74 98.7 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.134 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -80.24 98.13 7.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.258 0.551 . . . . 0.0 109.86 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.631 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 69.9 p -134.31 161.13 35.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.606 -178.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.79 -27.78 66.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.918 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.81 -41.77 18.69 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.837 0.711 . . . . 0.0 112.139 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.631 ' H ' ' HG1' ' A' ' 99' ' ' THR . 98.4 m-20 -67.06 -35.12 79.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.412 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.1 mt -65.03 -18.86 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -72.7 -14.92 61.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.7 m -110.53 -9.26 14.57 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.39 -153.55 16.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.304 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -100.49 127.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.263 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 149.97 24.97 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.674 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.7 p -75.81 148.38 38.47 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.9 -47.28 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.442 ' NZ ' ' OE1' ' A' ' 175' ' ' GLU . 99.3 mttt -92.66 139.84 30.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.317 0.58 . . . . 0.0 110.989 -179.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.414 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 18.1 pt-20 -75.48 -3.18 32.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.272 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 112' ' ' GLU . 11.5 m120 -135.88 37.63 2.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 111.164 -177.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 156.26 16.52 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.5 t -124.55 135.58 63.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.4 mtp -75.93 125.7 29.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.27 66.93 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -144.77 121.38 11.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.544 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.36 178.5 32.51 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 40.9 t-20 -68.93 105.06 2.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -85.33 105.45 15.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 124.89 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.31 0.576 . . . . 0.0 111.439 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.0 mt -122.31 130.24 52.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.509 179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.6 140.16 45.19 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.305 0.574 . . . . 0.0 110.759 -178.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.45 -176.95 18.92 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.614 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -84.48 147.07 27.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.696 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.7 p30 -115.48 25.48 10.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.146 0.498 . . . . 0.0 110.984 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -41.94 -18.19 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.646 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 57.57 39.96 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.191 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.453 ' O ' ' OG ' ' A' ' 136' ' ' SER . 65.2 tttm -134.2 119.45 18.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.511 -178.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.04 124.46 21.18 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.332 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.38 -21.46 8.66 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.447 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.97 172.46 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.589 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -74.93 139.34 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.882 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 50.49 27.34 2.79 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.008 0.433 . . . . 0.0 110.969 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.9 OUTLIER -84.66 -8.99 58.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.643 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.6 m-20 -145.31 30.85 1.12 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.9 pt -70.07 -25.88 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.58 3.78 4.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.707 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.5 m -97.19 -11.65 23.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.283 -178.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.42 124.72 23.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.66 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.431 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 98.6 mttt -97.04 161.48 13.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.676 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.48 127.6 32.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.959 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 91.88 20.98 34.89 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 31.9 m-20 -83.73 136.86 34.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.08 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -80.76 122.76 27.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.5 mt -122.26 122.57 66.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -103.5 118.24 36.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.451 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.79 132.72 55.13 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -99.12 125.68 44.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.151 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 45.9 t0 -98.07 -169.05 1.75 Allowed 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.454 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 51.9 t30 -36.19 -67.03 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.124 0.488 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -135.07 25.07 3.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.208 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.85 153.05 44.7 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.491 ' CD ' ' NZ ' ' A' ' 207' ' ' LYS . 67.1 tt0 -114.6 119.0 35.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.265 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -103.84 131.55 50.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.17 119.35 35.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.129 178.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -116.69 142.08 47.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.19 129.79 53.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.461 0.648 . . . . 0.0 110.769 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' GLY . 56.2 t -68.23 134.7 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.1 t -105.15 -26.61 12.01 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 124.583 1.177 . . . . 0.0 111.256 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.99 147.87 5.57 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.304 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 17.2 t -110.56 149.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.239 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.0 p -156.92 165.87 34.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.133 -178.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -113.6 102.6 10.43 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.017 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.8 m -117.49 153.34 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 p -59.57 167.87 2.19 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.546 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.6 Cg_endo -81.77 -10.46 11.77 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.027 1.818 . . . . 0.0 112.007 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.81 -14.16 48.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.202 -178.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.64 71.21 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.028 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.546 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 90.4 m95 -75.31 -2.23 27.28 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.285 -178.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.42 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 71.5 mm-40 -54.03 -37.24 63.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.3 m -80.82 3.7 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.03 -179.03 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -119.71 -15.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.581 0.705 . . . . 0.0 110.251 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 74.4 mm-40 -86.75 175.94 7.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.027 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.5 p-10 -80.78 128.6 33.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.251 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.42 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.8 m170 -102.57 -43.28 5.67 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.043 -179.448 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.07 27.61 0.12 Allowed Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -157.65 -179.75 8.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.855 0.36 . . . . 0.0 111.094 179.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -93.01 88.46 6.14 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -117.82 167.7 11.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.922 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.37 142.94 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.002 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.7 m -136.65 125.24 23.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.596 -178.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.6 mp -110.52 120.77 43.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.4 HG22 HD12 ' A' ' 185' ' ' ILE . 13.5 pt -134.91 -167.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.767 -178.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.586 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 14.1 t . . . . . 0 N--CA 1.464 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.366 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.586 ' NH1' ' O ' ' A' ' 186' ' ' THR . 11.8 ptp180 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -105.94 139.53 40.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.07 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.7 134.22 58.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 121.023 0.439 . . . . 0.0 110.623 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.2 t -119.46 129.46 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.653 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.09 136.29 53.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.349 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.16 147.38 19.06 Favored Glycine 0 N--CA 1.466 0.653 0 CA-C-O 121.773 0.652 . . . . 0.0 112.006 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 55.4 p-10 -106.81 148.28 28.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.207 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.03 126.99 31.56 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.84 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.38 -24.38 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.037 -179.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.02 175.26 47.18 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.627 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 m -155.5 150.99 27.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.491 ' NZ ' ' CD ' ' A' ' 155' ' ' GLU . 25.8 pttm -150.81 178.16 9.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.09 146.61 23.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.561 ' NZ ' HH11 ' A' ' 82' ' ' ARG . 88.0 tttt -73.77 80.23 1.58 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.604 -179.19 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.281 178.799 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.477 0.52 0 N-CA-C 111.097 -0.386 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.84 152.05 46.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.804 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -68.39 -15.0 63.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.799 0.333 . . . . 0.0 111.393 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.5 -45.16 84.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.821 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.63 -22.44 58.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.3 t -76.97 -51.98 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.481 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.64 92.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.774 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.32 -31.17 68.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.54 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.3 138.42 57.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.004 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -141.09 85.1 1.96 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.71 -178.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.448 ' CD2' ' H ' ' A' ' 74' ' ' LEU . 1.4 pt? -75.04 172.12 12.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.523 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.1 m-20 -103.13 121.16 42.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.59 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.495 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 14.1 mptt -56.44 -9.4 0.7 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.14 0.495 . . . . 0.0 109.853 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -62.49 -35.39 79.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.76 16.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.572 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 76' ' ' LYS . 10.0 p -86.94 124.57 40.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 pt -120.64 -6.53 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.47 -168.34 39.92 Favored Glycine 0 C--N 1.318 -0.467 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.46 HH11 ' HZ2' ' A' ' 209' ' ' LYS . 38.0 mtm180 -147.68 156.09 42.42 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.538 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 6.2 tt -121.32 125.92 74.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -126.26 127.07 45.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 79.3 mt -127.44 128.01 24.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.646 -178.222 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.8 Cg_endo -83.29 -39.33 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 122.371 2.047 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 t -48.75 -37.03 17.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.579 -177.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -120.73 -2.83 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.783 -178.926 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t 62.81 55.18 2.13 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.286 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.16 133.64 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.607 -178.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -135.99 114.22 11.52 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 93' ' ' PRO . 69.9 mt -143.45 109.36 5.28 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.1 Cg_endo -39.6 142.64 0.44 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.865 1.71 . . . . 0.0 110.144 176.388 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.8 118.65 43.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -106.68 122.94 47.36 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.41 -48.47 75.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.408 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 86.6 p -61.67 100.02 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.928 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.0 p -82.97 101.29 10.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 110.006 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.474 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 70.0 p -137.29 160.49 38.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.417 -179.067 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.85 -28.38 67.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.75 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -83.33 -45.47 13.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.457 0.646 . . . . 0.0 112.116 -178.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.474 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 91.0 m-20 -65.78 -32.72 74.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.316 -179.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.61 -13.96 61.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.3 p -103.79 -13.46 16.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -177.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.96 -156.86 25.57 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.64 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.46 125.89 35.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.997 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.63 144.38 31.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -75.33 152.27 38.16 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.02 -40.22 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.67 -172.68 3.66 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.13 -178.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -126.2 -9.64 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 111.289 -177.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -138.89 37.35 2.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.108 0.48 . . . . 0.0 111.304 -177.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -93.44 161.14 14.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.855 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -131.72 132.04 62.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.773 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.7 mtt -63.69 129.04 38.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.16 75.04 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -138.54 118.92 13.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.116 0.484 . . . . 0.0 110.504 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -160.12 52.71 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.509 HD22 ' HG1' ' A' ' 183' ' ' THR . 58.0 t-20 -94.04 111.19 22.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -84.72 103.4 13.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.43 126.64 35.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 111.785 -179.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mt -122.46 130.53 53.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.477 178.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.99 139.19 46.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.774 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.61 -178.2 16.42 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.5 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -88.83 143.08 27.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.567 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 67.0 t30 -108.28 28.22 8.53 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.126 0.489 . . . . 0.0 110.676 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.17 -17.24 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.683 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.6 OUTLIER 60.98 37.73 17.92 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.283 178.805 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 136' ' ' SER . 55.2 mtmt -135.46 106.48 6.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.685 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.401 ' HD3' ' N ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -48.74 130.11 17.33 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.545 179.344 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.22 -26.33 12.38 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.549 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 27.7 t -84.97 179.14 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.549 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.63 133.08 46.36 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.178 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.42 31.91 1.43 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 110.822 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.64 -9.91 59.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.04 -178.825 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -146.95 29.36 0.99 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 140' ' ' SER . 5.5 pt -69.58 -27.83 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.805 0.336 . . . . 0.0 111.856 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.76 0.34 3.39 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.638 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 138' ' ' ILE . 11.1 t -91.75 -14.66 29.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.156 0.503 . . . . 0.0 110.18 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 mt -65.63 126.9 29.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.246 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.28 172.16 8.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.973 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.2 132.65 44.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.47 21.12 57.25 Favored Glycine 0 N--CA 1.462 0.396 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 146' ' ' LYS . 15.0 t70 -78.78 -158.89 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.451 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 7.9 tptm -146.81 129.15 15.8 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.076 -178.286 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.75 122.97 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.452 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -102.04 122.08 43.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.04 141.92 48.29 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.449 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.536 ' CE2' ' OE2' ' A' ' 155' ' ' GLU . 68.6 m-85 -107.81 131.23 54.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.208 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.8 t0 -105.47 -171.26 1.88 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.536 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.0 m-20 -35.64 -62.8 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.203 0.525 . . . . 0.0 111.273 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.49 20.87 2.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 145.03 48.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.782 -175.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.609 ' CB ' ' HZ3' ' A' ' 207' ' ' LYS . 4.5 mm-40 -106.89 121.14 43.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.43 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -107.25 129.54 54.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.487 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.83 120.94 39.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.386 177.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -117.65 138.79 51.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.49 131.81 56.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.599 0.714 . . . . 0.0 110.144 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.38 134.56 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.613 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.1 p -101.63 -26.36 13.55 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 124.368 1.043 . . . . 0.0 111.16 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.06 150.93 5.84 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.26 146.38 8.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -0.63 . . . . 0.0 109.323 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.7 t -145.79 154.22 41.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.055 0.455 . . . . 0.0 110.989 -178.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.28 119.27 38.94 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.708 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.618 ' CG2' HH21 ' A' ' 196' ' ' ARG . 29.1 m -134.88 158.78 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 111.269 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 169' ' ' ASP . 25.5 p -76.71 136.16 67.47 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.97 -15.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.077 1.851 . . . . 0.0 112.064 -178.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 167' ' ' THR . 51.3 t0 -81.81 -13.03 58.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 -178.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -85.88 77.15 9.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.358 0.599 . . . . 0.0 110.198 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.565 ' C ' ' H ' ' A' ' 173' ' ' VAL . 84.1 m95 -75.79 -20.32 58.31 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.092 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.67 -6.94 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.01 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.565 ' H ' ' C ' ' A' ' 171' ' ' TRP . 53.6 t -85.81 -24.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.669 -178.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.41 -10.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.808 0.813 . . . . 0.0 109.72 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.58 139.81 38.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.744 -176.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.43 130.59 45.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.297 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -102.05 -40.41 6.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.462 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.68 29.26 0.27 Allowed Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -156.05 179.24 9.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.244 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -90.89 92.54 8.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.371 0.605 . . . . 0.0 109.917 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -127.9 169.41 13.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.251 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.888 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.509 ' HG1' HD22 ' A' ' 120' ' ' ASN . 19.2 m -137.31 124.98 22.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.484 -178.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.34 120.95 43.92 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.342 0.592 . . . . 0.0 110.774 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.4 pt -135.12 -167.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -178.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.77 -178.979 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.618 HH21 ' CG2' ' A' ' 166' ' ' VAL . 16.0 ttp180 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 120.868 0.366 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.01 129.97 46.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.952 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.23 136.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.52 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.24 126.37 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.425 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.72 135.54 53.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.228 0.537 . . . . 0.0 110.419 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.15 163.16 25.11 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -116.21 150.72 37.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.233 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.5 tp -71.8 126.96 31.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.025 0.44 . . . . 0.0 110.71 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.39 -24.57 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.188 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.72 44.42 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.847 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.3 m -154.15 154.07 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.226 0.536 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.609 ' HZ3' ' CB ' ' A' ' 155' ' ' GLU . 20.7 pttp -149.76 177.03 10.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.335 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.34 150.87 23.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.46 ' HZ2' HH11 ' A' ' 82' ' ' ARG . 88.5 tttt -78.98 78.99 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.3 mptt . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 117.804 -1.093 . . . . 0.0 109.989 178.625 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.487 1.09 0 CA-C-O 121.057 0.357 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -79.16 173.34 12.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.67 -13.67 62.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.853 -179.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.0 92.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.266 0.555 . . . . 0.0 110.268 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -75.87 -23.62 55.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.582 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.31 -49.88 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.41 89.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.43 -31.98 70.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.972 -179.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.09 132.73 52.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.222 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.8 t -140.85 88.35 2.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.824 0.345 . . . . 0.0 111.656 -179.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.48 ' CD2' ' H ' ' A' ' 74' ' ' LEU . 1.5 pt? -79.93 170.28 16.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.489 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 38.0 p-10 -102.48 139.78 37.63 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.055 178.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.57 -7.2 6.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.497 0.665 . . . . 0.0 110.131 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 75' ' ' ASP . 65.8 tttm -64.61 -31.86 73.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.848 179.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.11 10.42 2.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.168 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.2 t -86.31 120.96 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.5 pt -120.35 -7.46 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 111.9 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.7 -170.85 41.96 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.6 mtt-85 -146.8 158.05 43.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.897 -178.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 tt -128.75 130.15 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.662 0.744 . . . . 0.0 109.322 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -130.16 131.64 45.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.071 -178.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.29 127.82 19.07 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.11 -178.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.08 -34.65 0.32 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.304 2.002 . . . . 0.0 112.031 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -48.16 -38.61 18.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.423 -177.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.5 p -118.61 -2.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.879 -178.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.57 50.77 2.08 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 tt -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -178.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -129.42 105.3 8.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.5 148.95 70.32 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -84.65 145.2 10.29 Favored 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 122.617 2.211 . . . . 0.0 109.26 177.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -94.89 112.65 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 mt -101.53 121.68 42.43 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -63.8 -46.33 85.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.329 0.585 . . . . 0.0 110.805 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m -60.03 95.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.457 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.7 p -81.87 95.0 7.2 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 110.1 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.405 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 81.7 p -135.97 159.66 41.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.124 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.25 -28.67 66.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.29 -43.52 15.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 94.2 m-20 -65.93 -36.14 82.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.565 -179.18 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.07 -21.11 63.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.52 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.27 -33.24 69.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.2 m -89.54 -10.22 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.05 -178.92 45.72 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.314 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.94 126.42 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.43 145.73 30.45 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.979 0.419 . . . . 0.0 110.968 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.8 p -73.12 150.22 42.41 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.24 -45.32 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.281 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.86 -172.32 3.32 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.962 -0.461 . . . . 0.0 110.966 -178.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 1.2 pm0 -112.58 -56.47 2.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.859 -178.371 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.405 ' H ' ' HG2' ' A' ' 112' ' ' GLU . 23.3 t-20 -90.61 44.63 1.21 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.268 -177.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -99.58 154.69 18.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.187 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.3 135.37 52.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 67.2 mtt -67.99 130.62 43.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.323 178.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.51 5.87 81.45 Favored Glycine 0 C--O 1.229 -0.18 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -142.72 120.36 11.82 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.037 -179.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.02 -168.35 54.26 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.444 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 42.4 t-20 -85.52 106.82 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -84.66 102.45 12.95 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.76 128.44 36.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.289 0.566 . . . . 0.0 111.824 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -124.59 132.56 53.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.88 178.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.35 44.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 110.606 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.19 -177.66 19.26 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.455 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.529 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -92.12 143.48 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 0.7 OUTLIER -109.53 29.23 7.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.326 0.584 . . . . 0.0 109.71 179.515 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 9.2 mmm -42.94 -14.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.693 -179.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 62.13 40.67 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -132.32 105.66 7.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.586 -179.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -50.1 125.68 12.81 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.831 0.824 . . . . 0.0 110.094 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.82 -28.84 8.56 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.699 -177.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.589 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 49.0 t -79.89 178.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.995 -0.709 . . . . 0.0 109.294 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.589 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -70.97 139.54 50.62 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.954 -178.568 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 43.7 35.01 0.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.072 0.463 . . . . 0.0 111.076 177.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.5 p -81.64 -14.56 56.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -147.45 31.97 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 140' ' ' SER . 3.6 pt -70.46 -26.65 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.703 0.287 . . . . 0.0 111.613 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.14 2.19 4.91 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.284 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 138' ' ' ILE . 9.6 t -93.66 -13.85 27.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 109.573 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.34 120.86 13.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.653 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.529 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.4 mttt -97.86 150.05 21.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.426 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.7 121.05 5.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.371 0.605 . . . . 0.0 111.463 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.67 10.48 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 3.8 m-20 -90.64 134.55 34.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.408 ' HZ1' ' HB3' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -83.63 132.61 34.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.311 0.577 . . . . 0.0 111.967 -178.41 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 147' ' ' ILE . 96.9 mt -124.59 126.27 71.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.278 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -103.17 119.95 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.173 0.511 . . . . 0.0 110.754 -178.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.42 139.48 44.33 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.638 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' SD ' ' A' ' 116' ' ' MET . 86.6 m-85 -114.81 127.26 55.62 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.194 0.521 . . . . 0.0 111.343 179.409 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.1 t0 -112.45 -166.24 1.06 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.2 p30 -22.57 -76.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.409 0.624 . . . . 0.0 111.816 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.522 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.5 mt-10 -137.53 29.37 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.749 178.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -127.66 144.5 51.07 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -109.99 120.96 44.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.14 132.7 49.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.682 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -96.05 118.03 31.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -118.32 141.39 48.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.34 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.13 55.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 110.804 178.367 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.34 133.09 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.032 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.3 p -100.76 -28.63 12.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.861 -178.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.37 150.2 5.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.842 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.74 149.1 8.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.704 -0.748 . . . . 0.0 109.462 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.6 p -150.76 160.4 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.453 . . . . 0.0 111.234 -178.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.446 ' OE2' ' OH ' ' A' ' 197' ' ' TYR . 94.9 mt-10 -107.19 117.36 33.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.554 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.38 159.12 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.229 -178.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 p -66.87 168.41 10.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.7 -11.19 11.6 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.941 1.761 . . . . 0.0 111.761 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -87.77 -5.3 58.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -85.92 71.88 10.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 0.0 110.2 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.498 ' C ' ' H ' ' A' ' 173' ' ' VAL . 92.6 m95 -70.62 -29.89 66.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.047 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.471 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 55.4 mp0 -48.53 -14.28 0.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.485 0.66 . . . . 0.0 110.523 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 171' ' ' TRP . 90.7 t -73.11 -25.85 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.923 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.29 -0.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.535 0.683 . . . . 0.0 110.513 -178.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.57 122.78 28.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.959 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -31.8 127.62 0.21 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.75 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -103.08 -42.75 5.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.017 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.29 29.24 0.15 Allowed Glycine 0 N--CA 1.471 1.029 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.39 176.78 12.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.942 0.401 . . . . 0.0 111.531 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.58 89.11 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.72 0.771 . . . . 0.0 109.404 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -122.48 167.84 12.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.028 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.7 142.57 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.233 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.444 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 4.9 m -135.99 120.35 17.99 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.114 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -106.06 128.63 53.99 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.164 0.507 . . . . 0.0 110.321 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.3 pt -137.47 -175.24 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.729 -178.456 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.001 -179.535 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.446 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 1.2 m-85 -77.79 131.25 37.52 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 142.13 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.79 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.11 130.29 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.338 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.44 134.33 54.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.29 150.04 19.93 Favored Glycine 0 N--CA 1.467 0.763 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.0 t0 -108.49 145.87 34.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.517 -0.341 . . . . 0.0 111.361 -179.169 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.8 tp -70.32 129.51 39.51 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.443 0.639 . . . . 0.0 110.709 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.81 -21.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.605 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.43 175.9 45.91 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.132 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.3 m -155.54 155.84 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.237 0.542 . . . . 0.0 110.85 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -148.15 178.35 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.421 178.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -100.35 142.89 31.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.296 0.57 . . . . 0.0 111.086 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -61.86 80.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.61 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 208' ' ' ALA . 80.8 tttt . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.075 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 CA-C-O 121.187 0.411 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.04 151.71 44.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.85 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.2 mp -55.75 -26.1 43.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -178.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -39.6 93.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.322 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -74.1 -32.03 63.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.701 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.31 -45.32 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.919 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -75.84 -28.47 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.113 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.3 141.8 58.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.38 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.6 p -139.79 122.18 16.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.8 tp -114.6 129.24 56.65 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.343 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 68.0 t0 -68.47 134.45 50.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.274 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 4.5 mptp? -64.3 -8.84 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.52 . . . . 0.0 109.923 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 79' ' ' VAL . 38.9 ttmt -64.38 -33.96 77.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.048 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.436 ' OE1' ' OD1' ' A' ' 102' ' ' ASN . 75.7 mt-30 -77.68 14.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.201 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 77' ' ' LYS . 59.9 t -95.83 127.37 47.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.78 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.477 ' H ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.11 2.61 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.694 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.26 -178.84 42.0 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -146.89 151.23 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.74 -179.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -120.47 124.33 72.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 t -128.88 129.02 45.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.8 mt -133.67 130.12 20.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.67 -178.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.22 -34.71 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.349 2.033 . . . . 0.0 111.561 179.52 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 m -47.74 -39.4 17.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.43 -176.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.0 p -121.19 -0.84 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.933 -179.288 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 61.33 54.25 3.24 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.76 133.42 56.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.419 -178.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -130.07 114.38 15.69 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 mp -136.73 103.72 9.18 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.38 130.95 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.777 1.652 . . . . 0.0 110.264 175.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.7 t -82.36 127.89 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -111.78 123.1 49.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.893 0.378 . . . . 0.0 110.068 -179.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -65.64 -45.9 81.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.741 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.9 m -66.84 100.07 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.376 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.66 97.69 10.26 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.437 0.637 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.56 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 4.8 p -137.37 155.57 49.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -51.53 -36.44 44.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -75.43 -45.75 36.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.99 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.661 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -65.23 -36.56 84.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.57 -178.215 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 mt -59.24 -21.87 60.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.439 -179.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.13 -31.19 68.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -89.19 -11.44 43.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.56 42.21 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.59 127.93 34.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.885 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 146.72 29.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.013 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.62 152.22 39.25 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.28 -51.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -93.78 139.26 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -74.12 -0.18 15.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.225 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -138.01 38.29 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.151 0.5 . . . . 0.0 110.983 -177.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.74 21.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.718 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -129.98 128.75 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.1 mtt -69.36 128.14 35.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 110.202 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.59 0.18 69.93 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -140.5 121.96 15.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.877 0.37 . . . . 0.0 110.974 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.11 -169.95 53.54 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.551 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 12.4 t30 -86.34 110.77 19.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.19 102.77 12.86 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.016 0.436 . . . . 0.0 109.91 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 129.04 36.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.589 0.709 . . . . 0.0 112.114 -178.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.87 130.44 52.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.565 178.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.87 139.35 46.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.567 0.698 . . . . 0.0 110.496 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.15 -178.8 19.31 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.669 -179.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 134' ' ' LEU . 74.7 m-70 -91.33 140.87 29.36 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.152 0.501 . . . . 0.0 110.654 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 129' ' ' SER . 26.9 t-20 -108.68 29.62 7.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.517 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mmm -43.28 -15.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.792 -179.123 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.88 38.62 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.239 0.542 . . . . 0.0 110.165 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.5 tttt -133.0 106.15 7.49 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.178 -179.107 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -51.9 125.2 14.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.807 0.813 . . . . 0.0 110.137 -179.243 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.96 -29.42 7.13 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.62 -178.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.624 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 41.3 t -81.06 -179.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.058 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.624 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.88 135.31 47.94 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.418 -178.277 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 47.66 35.81 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.155 0.502 . . . . 0.0 111.076 178.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 2.4 p -81.93 -16.88 49.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.462 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 21.3 t0 -142.85 30.57 1.46 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.7 pt -70.44 -25.91 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.825 0.345 . . . . 0.0 111.458 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.04 4.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.462 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.1 m -95.38 -11.97 26.81 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.238 0.542 . . . . 0.0 109.637 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.7 mt -63.92 124.96 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.402 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.12 155.8 16.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.589 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.03 129.32 41.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.594 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 90.03 21.53 38.73 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -86.0 137.46 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -81.64 126.99 32.42 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.68 125.19 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.261 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -104.71 115.59 30.58 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.372 0.606 . . . . 0.0 109.874 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.7 tp -116.1 144.62 43.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.307 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.511 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 50.0 m-85 -116.13 133.45 56.01 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.314 0.578 . . . . 0.0 111.49 -179.34 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.0 t0 -109.98 -168.32 1.31 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.977 178.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.553 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 65.4 t30 -29.13 -71.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.342 0.591 . . . . 0.0 111.283 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.66 25.33 3.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.95 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.93 142.9 51.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.481 0.658 . . . . 0.0 112.486 -175.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.511 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 33.6 tp10 -107.14 120.16 41.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.29 130.77 52.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.202 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -94.91 117.12 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.647 177.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -117.39 138.98 51.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.232 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.79 135.34 54.12 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.789 178.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 144' ' ' GLY . 46.7 t -68.45 132.96 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.03 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -27.74 11.46 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 124.463 1.102 . . . . 0.0 110.683 -178.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.63 154.57 8.7 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.687 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.28 144.03 19.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.786 -0.707 . . . . 0.0 109.735 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -155.26 166.1 34.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.271 0.558 . . . . 0.0 111.47 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -123.67 128.16 49.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.678 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.4 154.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 169' ' ' ASP . 10.7 p -58.39 129.79 83.97 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.91 -13.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.781 1.654 . . . . 0.0 111.963 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.3 m-20 -81.0 -11.31 59.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.995 -177.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.13 74.06 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -73.25 -15.33 61.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.527 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 3.0 pt-20 -53.24 -36.18 60.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.234 0.54 . . . . 0.0 109.873 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.71 -1.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.973 -179.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.99 -13.74 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.854 0.835 . . . . 0.0 109.919 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -86.92 172.78 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.106 -1.407 . . . . 0.0 112.279 -178.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 67.4 t0 -82.3 131.4 35.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.735 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.527 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 40.5 m80 -111.07 -42.02 4.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.552 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.52 25.67 0.09 OUTLIER Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.547 ' NZ ' ' OE1' ' A' ' 181' ' ' GLU . 0.0 OUTLIER -151.42 166.33 31.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.22 89.13 5.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.528 0.68 . . . . 0.0 110.454 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.547 ' OE1' ' NZ ' ' A' ' 179' ' ' LYS . 53.2 tt0 -130.23 129.22 43.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.271 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.64 148.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.551 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 21.6 m -136.73 122.41 19.8 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.189 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.11 125.9 52.63 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.273 0.558 . . . . 0.0 110.545 179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 35.4 pt -136.25 163.03 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.119 -178.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.504 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 59.1 p . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.29 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 186' ' ' THR . 11.3 ptp180 . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 121.257 0.551 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -106.16 133.99 49.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.152 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.91 132.38 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 43.9 t -117.95 127.73 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.52 134.33 54.11 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.353 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.45 139.92 11.34 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -98.28 140.67 32.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.622 -0.789 . . . . 0.0 111.642 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.5 tp -65.22 125.31 24.62 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.17 -21.4 5.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.421 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.39 174.69 46.49 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.199 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.5 m -154.35 151.77 29.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.824 179.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -150.45 177.6 9.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.56 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -94.43 147.31 23.37 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.342 0.591 . . . . 0.0 110.575 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -61.66 80.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.708 -179.927 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 208' ' ' ALA . 73.8 tttt . . . . . 0 C--N 1.314 -0.965 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.075 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.49 1.287 0 CA-C-O 120.766 0.236 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.05 161.6 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.46 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.469 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 9.7 mp -65.37 -19.99 66.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.634 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.8 88.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 110.036 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -74.19 -33.15 63.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.641 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.28 -44.68 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.542 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.41 86.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.923 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -83.36 -22.57 32.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.047 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.34 104.32 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -95.54 112.22 23.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.189 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tt -115.84 133.02 56.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.323 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -80.41 148.82 30.4 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.453 179.105 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -67.98 0.93 3.03 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.375 0.607 . . . . 0.0 109.588 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 75' ' ' ASP . 38.8 ttmt -62.96 -42.86 99.95 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.723 179.37 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -79.41 0.16 30.41 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.14 0.495 . . . . 0.0 110.439 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.7 t -99.56 129.71 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.576 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.57 7.09 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.731 -178.162 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.73 -172.54 35.66 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -153.31 153.18 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 111.262 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -127.7 130.77 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.706 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.445 ' OG ' ' OE2' ' A' ' 91' ' ' GLU . 9.8 m -127.77 130.98 49.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.58 117.12 16.38 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.222 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.28 -36.39 0.99 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.097 1.864 . . . . 0.0 111.534 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -52.33 -38.73 59.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.711 -177.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.05 -6.94 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.75 0.31 . . . . 0.0 110.67 -178.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.59 47.47 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.3 tp -114.15 131.46 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.784 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.445 ' OE2' ' OG ' ' A' ' 84' ' ' SER . 25.5 tp10 -133.02 116.61 16.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.218 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -146.46 165.1 21.09 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.423 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.38 161.01 8.24 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 123.206 2.604 . . . . 0.0 108.923 177.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -112.78 122.95 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.2 mt -103.32 123.97 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.33 -47.99 74.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.199 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.6 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 7.7 p -85.19 119.98 26.18 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.791 -179.583 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p -86.76 118.8 26.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.337 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.2 p -140.69 168.83 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.413 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 4.0 tm-20 -69.87 -34.44 73.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.87 -42.24 21.81 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 97' ' ' SER . 3.6 p-10 -68.75 -20.18 64.36 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.37 -17.77 63.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.218 -179.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 104' ' ' LEU . 8.1 mp -75.29 -15.98 60.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.8 m -96.69 -13.6 22.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 165.6 -149.6 16.13 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.59 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.65 126.3 38.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.401 0.619 . . . . 0.0 110.0 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.08 147.82 26.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 41.9 p -72.22 149.56 44.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 t -83.95 -46.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -88.69 -170.91 3.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.85 -178.081 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -124.31 -5.44 7.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.654 -178.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -138.87 36.09 2.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.694 0.283 . . . . 0.0 110.764 -178.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -92.55 158.92 15.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.119 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.37 132.1 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 -179.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -65.73 127.14 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 178.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.47 1.82 68.43 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -142.55 126.76 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 110.227 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 179' ' ' LYS . . . 72.55 -176.85 41.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -80.05 108.81 13.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.536 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.68 99.47 10.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.007 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.47 128.61 37.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.232 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.21 133.02 54.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.978 178.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.09 140.34 45.71 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.453 0.644 . . . . 0.0 110.916 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.16 -178.13 20.49 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.962 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -84.58 150.45 25.19 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 111.28 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 129' ' ' SER . 44.7 t30 -114.71 27.48 9.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.588 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.4 mmm -45.47 -12.72 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.532 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 127' ' ' ASN . 1.8 m 51.7 42.41 29.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 136' ' ' SER . 28.8 tptp -136.06 119.58 17.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.868 -178.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -61.9 124.47 20.85 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.855 0.836 . . . . 0.0 110.686 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.26 5.78 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.033 -177.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.47 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 22.1 t -138.53 175.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.062 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.539 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.89 130.7 43.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 111.371 -178.105 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 46.71 32.96 1.89 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.636 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -82.66 -11.14 58.59 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.853 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -144.68 21.83 1.64 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -177.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 140' ' ' SER . 6.6 pt -69.0 -27.44 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.719 0.295 . . . . 0.0 111.527 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.58 1.49 2.36 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.549 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 138' ' ' ILE . 68.7 m -95.54 -10.44 29.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.91 118.6 7.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.524 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -98.19 170.98 8.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -67.25 137.4 56.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.134 0.968 . . . . 0.0 112.409 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.53 20.3 64.37 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.781 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -90.94 134.05 34.78 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -83.46 138.23 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.548 0.689 . . . . 0.0 112.16 -178.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 158' ' ' TYR . 76.9 mt -130.82 119.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.504 179.103 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -100.47 122.72 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.3 tp -117.32 147.03 42.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.726 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -113.49 128.81 56.58 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.17 0.509 . . . . 0.0 111.134 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -109.3 -168.44 1.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 151' ' ' ASP . 92.3 m-20 -25.73 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.381 0.61 . . . . 0.0 112.312 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -138.85 23.4 2.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -124.95 144.63 50.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.66 121.74 44.19 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.536 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 56.2 m-85 -105.94 130.05 53.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.307 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.84 119.2 34.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' A' ' 147' ' ' ILE . 52.0 m-85 -116.64 138.74 51.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.167 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -114.9 132.14 56.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.35 0.595 . . . . 0.0 110.56 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.27 134.18 30.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.57 -25.11 11.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.357 1.036 . . . . 0.0 110.714 -179.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.37 164.21 23.68 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.89 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.76 152.27 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.2 t -156.88 169.11 25.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.378 0.609 . . . . 0.0 111.369 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.99 126.98 52.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.399 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -139.55 159.0 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.113 -178.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 169' ' ' ASP . 17.6 p -68.5 135.62 90.73 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.573 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.9 Cg_endo -47.17 -12.62 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.604 1.536 . . . . 0.0 111.727 -179.263 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 167' ' ' THR . 66.5 t0 -78.15 -17.7 56.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.44 -178.628 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -84.7 68.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.573 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 63.0 m95 -73.72 -24.04 59.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.379 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.36 -7.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.562 ' H ' ' C ' ' A' ' 171' ' ' TRP . 17.3 m -85.9 -9.12 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.128 -178.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.27 8.3 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 109.158 -179.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 72.4 mm-40 -83.6 143.71 29.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.443 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -55.81 120.14 6.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.801 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 41.7 m80 -111.3 -40.1 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.71 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 122.85 34.67 0.78 Allowed Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 119' ' ' GLY . 19.8 mmmt -139.03 157.08 46.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.664 -179.262 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.2 m-20 -87.96 88.57 7.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.906 0.86 . . . . 0.0 108.891 177.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 182' ' ' ILE . 42.5 tt0 -135.12 170.09 16.44 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.133 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.406 ' H ' ' HG2' ' A' ' 181' ' ' GLU . 18.1 tt -131.29 143.3 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.845 178.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 13.5 m -137.25 128.07 27.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.098 179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.4 mp -112.77 125.62 54.53 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.216 0.532 . . . . 0.0 110.325 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.9 pt -133.91 164.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.427 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.116 -179.585 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.483 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.21 142.66 45.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.77 139.05 46.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.72 129.93 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.302 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.21 135.74 53.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.999 0.428 . . . . 0.0 110.402 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.52 145.73 17.0 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.843 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -100.69 139.02 36.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.773 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.48 126.16 27.41 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.212 0.529 . . . . 0.0 110.711 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.63 -25.93 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.376 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.64 161.26 20.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.434 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.536 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 40.5 m -137.73 157.4 46.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.446 0.641 . . . . 0.0 110.07 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -148.93 179.32 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.306 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.17 144.42 25.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.467 0.651 . . . . 0.0 110.901 179.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -67.98 80.15 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.644 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 77.3 tttt . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.59 179.068 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.484 0.916 0 N-CA-C 110.846 -0.482 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.24 154.35 42.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.877 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.6 mt -56.13 -26.37 49.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 110.869 -179.153 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.92 96.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.651 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.63 -36.09 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.679 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.5 t -74.47 -44.63 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.083 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.76 92.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -80.76 -25.79 37.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.447 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.62 140.92 58.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.112 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 p -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 tp -140.83 140.0 34.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.316 -178.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.72 140.84 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.383 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -70.07 -6.0 30.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.302 0.572 . . . . 0.0 110.009 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 79' ' ' VAL . 68.5 mttm -63.21 -35.74 81.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.358 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -75.59 11.93 1.17 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.653 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 77' ' ' LYS . 96.2 t -87.8 126.09 41.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.573 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.1 pt -119.9 -9.07 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 112.058 -178.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 -170.26 38.03 Favored Glycine 0 C--N 1.321 -0.264 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.09 152.42 38.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.507 -178.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 10.1 tt -122.58 125.8 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -125.79 127.86 46.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.172 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.1 mt -131.61 126.71 21.18 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.66 -35.9 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.162 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.9 t -46.64 -37.73 8.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.403 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.1 p -120.6 -0.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 t 61.49 55.63 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.47 136.07 54.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.184 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.24 119.89 18.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -146.09 107.67 4.24 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -176.108 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.73 159.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.841 1.694 . . . . 0.0 109.898 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.6 t -110.04 124.68 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.4 mt -108.09 123.87 49.35 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -66.81 -49.64 65.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.196 0.522 . . . . 0.0 111.435 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.8 m -62.05 99.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.496 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 p -82.99 102.16 11.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.918 0.389 . . . . 0.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.656 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 80.4 p -141.86 155.17 45.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.307 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -57.86 -23.03 51.02 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -81.82 -50.11 9.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.278 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.656 ' H ' ' HG1' ' A' ' 99' ' ' THR . 1.2 p-10 -66.29 -31.56 72.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.588 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.97 -22.49 62.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.422 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -72.9 -16.53 61.56 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.6 m -106.96 -14.94 14.83 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.93 48.1 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.296 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.51 ' CB ' HD22 ' A' ' 102' ' ' ASN . . . -107.57 145.49 33.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.188 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.8 p -70.14 149.18 47.84 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.54 -45.12 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.32 -170.84 2.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.027 -178.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.98 -10.12 8.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 113' ' ' ASN . 54.3 p30 -135.45 36.35 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.929 0.395 . . . . 0.0 111.026 -177.342 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -93.82 158.74 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.927 179.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.43 131.16 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.794 -178.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.435 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 67.0 mtt -65.41 129.47 39.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.58 -2.75 74.09 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -138.49 121.26 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.867 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 74.93 -173.96 51.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.442 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 56.7 t30 -82.65 111.98 19.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -84.77 104.84 15.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.17 130.12 36.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.608 -179.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -128.74 134.31 48.4 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.42 43.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.256 0.55 . . . . 0.0 111.005 -178.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.75 -177.58 17.89 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 64.3 m-70 -87.69 140.68 29.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.675 0.274 . . . . 0.0 110.58 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 49.1 p30 -107.16 28.27 8.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.155 0.502 . . . . 0.0 110.735 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -43.31 -15.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.887 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.2 40.01 18.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.256 178.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.58 107.1 7.78 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.35 128.15 16.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.857 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.71 -26.44 11.74 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.589 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 47.7 t -83.6 179.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.589 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 137.51 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 -178.103 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 44.39 35.47 1.32 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 111.184 177.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 16.8 p -82.41 -13.46 56.77 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 136' ' ' SER . 78.4 m-20 -146.97 31.57 0.94 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.33 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.0 pt -70.84 -25.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.819 0.343 . . . . 0.0 111.825 179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.43 0.92 7.15 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.53 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -93.68 -11.68 31.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.304 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 163' ' ' VAL . 18.9 mt -65.64 120.69 13.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.537 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.508 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.05 151.9 19.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.628 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -52.07 122.82 9.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.302 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.93 21.29 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.7 m-20 -87.25 139.55 30.45 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -81.66 127.26 32.72 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.496 -178.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 158' ' ' TYR . 32.9 mm -115.02 124.25 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -105.64 115.81 30.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.95 150.86 39.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.148 -178.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -123.77 136.9 54.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.185 0.516 . . . . 0.0 111.65 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 156' ' ' TYR . 2.5 m-20 -113.7 -163.53 0.87 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.613 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.538 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 4.6 p30 -26.03 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.07 0.462 . . . . 0.0 111.438 178.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.538 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.6 mt-10 -132.94 29.86 4.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.065 178.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.412 ' OD1' ' OD1' ' A' ' 152' ' ' ASN . 28.3 m120 -127.82 145.34 50.96 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -106.29 121.78 44.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.724 179.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.588 ' CE1' ' OD2' ' A' ' 151' ' ' ASP . 19.7 m-85 -104.35 129.12 52.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.629 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.58 117.27 30.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.508 ' O ' ' N ' ' A' ' 147' ' ' ILE . 8.2 m-85 -120.53 137.85 54.16 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.859 -178.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.1 134.96 53.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.76 178.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.26 134.43 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.158 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 12.2 p -99.07 -26.96 14.05 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.486 1.116 . . . . 0.0 111.316 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.99 145.25 4.17 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.342 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 141' ' ' LEU . 58.1 t -91.8 141.46 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -139.9 151.41 45.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.756 0.312 . . . . 0.0 111.05 -177.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.43 ' OE2' ' OH ' ' A' ' 197' ' ' TYR . 95.4 mt-10 -106.47 115.94 31.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.86 159.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.232 -177.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.0 p -66.94 170.03 6.99 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.555 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.7 Cg_endo -81.68 -13.19 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.888 1.725 . . . . 0.0 111.901 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -87.87 -14.21 40.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -178.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -85.69 69.13 10.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.555 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.4 m95 -74.83 -2.44 26.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.09 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -53.37 -35.38 60.24 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.162 0.506 . . . . 0.0 111.024 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.0 m -80.88 3.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.925 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.38 -15.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.833 0.825 . . . . 0.0 109.971 -178.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.06 162.22 17.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.838 -179.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -66.76 128.16 35.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.637 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -99.29 -39.53 8.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.083 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.2 29.42 0.5 Allowed Glycine 0 N--CA 1.473 1.103 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.439 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 58.5 pttt -156.05 -179.11 7.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 43.8 m-20 -92.21 90.26 7.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.145 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -128.2 169.28 14.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.861 -178.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.9 tt -132.94 143.33 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.442 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 11.3 m -138.29 120.61 15.89 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.872 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.6 mp -108.77 126.03 52.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.958 0.409 . . . . 0.0 111.179 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.1 pt -133.89 -166.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.518 -178.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.587 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 23.4 p . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.572 -179.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.587 ' NH1' ' O ' ' A' ' 186' ' ' THR . 15.4 ttm180 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.509 0.195 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.43 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 2.7 m-85 -89.19 132.91 34.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.308 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.46 142.09 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 111.514 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 40.1 t -116.29 129.16 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.178 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.01 134.62 54.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.646 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.08 157.28 22.78 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -112.15 148.8 33.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.972 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.29 127.23 32.06 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.858 0.361 . . . . 0.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.03 -25.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.346 -178.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.6 163.18 22.15 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.616 178.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.535 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 93.6 m -139.49 159.05 43.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.058 0.456 . . . . 0.0 110.109 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -147.27 178.79 8.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -97.35 142.99 28.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.545 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.94 80.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.556 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.388 178.524 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.498 1.749 0 CA-C-O 121.015 0.34 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 58.5 t0 -76.43 152.94 36.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.1 mt -55.04 -25.0 27.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.565 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.71 -39.11 87.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.14 -32.12 63.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.6 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.18 -44.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.83 85.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.81 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -81.6 -28.46 33.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.455 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.17 111.73 1.45 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 111.218 -178.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.8 m -97.37 85.97 3.78 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.7 tp -74.4 146.74 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.335 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -94.88 111.61 23.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 179.311 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -52.61 -10.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.434 . . . . 0.0 110.198 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -70.93 -12.19 61.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.925 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -95.54 15.86 18.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.475 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.22 126.24 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.07 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.34 -3.71 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.946 0.403 . . . . 0.0 111.66 -178.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.34 -162.01 32.19 Favored Glycine 0 C--N 1.317 -0.524 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.653 ' NH1' ' HZ2' ' A' ' 209' ' ' LYS . 36.8 ptt180 -156.31 162.64 40.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.426 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -133.26 139.67 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 t -130.03 135.57 48.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.529 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.5 mt -131.89 125.55 20.31 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.734 -178.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.66 -36.29 0.34 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.46 2.107 . . . . 0.0 112.864 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.454 ' HG ' ' N ' ' A' ' 88' ' ' VAL . 28.1 p -48.21 -36.49 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.706 -176.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.8 p -119.81 -0.21 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.576 0.227 . . . . 0.0 110.65 -179.067 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.0 p 61.53 52.12 3.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 tp -115.57 134.11 55.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.714 -178.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.56 128.69 22.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.591 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 1.0 OUTLIER -161.55 130.21 3.0 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.128 -178.857 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -47.59 156.89 1.0 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.583 1.522 . . . . 0.0 110.873 177.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.5 t -107.88 125.55 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -106.48 125.38 50.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.845 0.355 . . . . 0.0 110.592 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.57 -45.35 72.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.095 0.474 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.2 m -67.68 104.83 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.577 -178.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.1 p -81.74 96.63 7.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.096 0.475 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.58 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 4.8 p -135.96 157.65 46.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.947 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -58.11 -27.33 63.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.884 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.53 -45.28 13.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.24 0.543 . . . . 0.0 111.197 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.58 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.9 m-80 -65.67 -36.68 84.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.405 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.46 -17.94 63.24 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.0 mt -71.21 -28.96 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.1 p -97.71 -8.23 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.35 -164.66 32.92 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.691 -1.242 . . . . 0.0 112.584 -178.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.591 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -92.36 127.95 38.03 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.06 146.71 28.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 -179.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.0 p -74.27 153.16 39.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.3 t -85.52 -47.04 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -92.49 -170.29 2.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.633 -178.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 11.5 pt-20 -106.97 -52.83 2.7 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.72 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 17.9 m120 -89.24 43.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.479 -178.118 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -79.6 146.33 32.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.034 0.445 . . . . 0.0 110.859 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 122.8 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.34 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.99 125.12 25.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.538 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.3 0.68 70.17 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -140.72 126.17 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.508 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.57 -172.13 48.77 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.532 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 0.4 OUTLIER -84.34 108.34 17.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.626 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.82 101.91 12.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 124.83 35.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.0 112.132 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -119.67 131.4 55.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.446 177.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.77 141.11 45.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.176 0.512 . . . . 0.0 110.594 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.68 -178.22 18.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.412 -179.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.1 m-70 -87.08 144.86 26.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.985 0.421 . . . . 0.0 110.873 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.0 t-20 -108.88 28.9 7.98 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.869 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -44.15 -13.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.742 -178.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 m 57.44 39.78 27.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.146 0.498 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -135.02 108.21 7.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.531 -178.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -51.15 127.83 20.26 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.642 -179.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.53 -26.71 11.47 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.448 -178.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 46.3 t -82.72 178.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 117.52 0.66 . . . . 0.0 109.772 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.621 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.22 136.94 48.28 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.628 -177.996 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.86 33.57 1.02 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.898 178.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.8 p -81.78 -12.01 58.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 23.4 t70 -149.12 32.84 0.74 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.094 -178.378 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.9 pt -69.58 -27.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.442 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.15 2.07 4.06 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 63.5 m -91.77 -14.85 29.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 23.1 mt -62.76 126.48 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.165 -179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -96.46 171.41 8.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -76.8 129.59 36.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.505 0.669 . . . . 0.0 111.937 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.51 21.11 49.37 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.25 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.17 -158.51 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -147.26 129.84 15.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.686 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.3 mt -126.92 124.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.814 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -102.99 120.23 40.26 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 tp -117.03 148.4 41.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 -179.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.13 131.19 53.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.12 0.486 . . . . 0.0 112.028 -178.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 152' ' ' ASN . 36.8 t0 -109.18 -167.42 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.168 177.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 151' ' ' ASP . 16.2 m120 -19.99 -76.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.56 0.538 . . . . 0.0 111.981 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -138.16 27.23 2.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.58 144.2 49.26 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -176.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -107.68 121.52 44.86 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.42 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 63.6 m-85 -105.35 128.92 53.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -178.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.461 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 98.0 mt-10 -95.83 119.44 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.236 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -116.36 143.94 44.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.67 131.77 56.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.038 0.447 . . . . 0.0 110.13 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.69 132.6 32.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.527 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -28.67 12.06 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.344 1.028 . . . . 0.0 109.906 -178.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 169.96 25.53 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.279 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.07 153.86 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.439 -0.881 . . . . 0.0 109.918 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.493 ' HG ' ' H ' ' A' ' 165' ' ' GLU . 47.3 t -153.89 166.12 33.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 111.523 -179.605 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 63.2 mm-40 -109.9 126.94 54.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.58 161.37 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.769 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.6 p -76.89 145.23 73.82 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.35 -21.81 7.72 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.867 1.711 . . . . 0.0 111.662 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.37 -2.73 53.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.805 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.596 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 21.6 tptt -80.71 150.18 29.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 83.6 m95 -157.62 -24.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.545 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.3 mt-10 -51.9 -8.56 0.07 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.111 0.482 . . . . 0.0 110.298 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 171' ' ' TRP . 7.0 m -78.41 -32.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 28.5 m -110.03 -1.35 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.451 0.643 . . . . 0.0 110.468 -178.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 176' ' ' ASP . 94.0 mt-10 -80.37 119.81 23.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.7 -179.016 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' GLU . 98.1 m-20 -30.41 120.04 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.655 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.545 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 49.9 m80 -102.85 -43.23 5.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.969 -179.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.16 29.41 0.22 Allowed Glycine 0 N--CA 1.467 0.738 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -152.57 172.7 16.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -93.86 89.47 6.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.386 178.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.26 127.5 30.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.762 -179.142 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -82.56 148.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.532 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 3.4 m -136.1 124.84 23.87 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -108.47 129.93 55.27 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.924 0.392 . . . . 0.0 110.512 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 7.1 pt -141.5 -168.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.924 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.827 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.531 0.205 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.7 m-85 -102.96 123.38 46.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.11 133.22 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.394 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 76.4 t -120.31 130.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.184 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.26 135.24 53.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.295 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.14 137.39 10.11 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.6 t0 -95.54 132.47 40.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.23 -0.485 . . . . 0.0 112.077 -178.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 47.1 tp -62.15 125.84 25.27 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.168 0.508 . . . . 0.0 110.597 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.95 -24.91 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.678 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.11 159.86 17.03 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.064 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.42 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 20.5 m -134.15 156.17 48.79 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.105 0.479 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.461 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.5 ptpp? -148.14 179.21 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.129 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.84 146.82 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.232 0.539 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.653 ' HZ2' ' NH1' ' A' ' 82' ' ' ARG . 63.7 tttp -70.36 80.8 0.55 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.655 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.766 178.562 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.486 1.038 0 N-CA-C 110.973 -0.433 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.35 146.16 48.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.634 179.471 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -49.26 -28.13 4.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.73 -179.711 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.58 93.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.353 -179.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -73.1 -33.92 65.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.748 179.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t -75.06 -45.89 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.052 -178.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.81 86.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.88 -25.33 32.61 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.372 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.76 130.62 47.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.4 t -95.64 158.88 15.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.432 ' CD2' ' OG ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -138.63 123.69 19.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.014 0.435 . . . . 0.0 110.951 -178.845 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.414 ' N ' HD12 ' A' ' 74' ' ' LEU . 98.0 m-20 -81.45 104.14 11.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.058 178.648 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -49.4 -35.84 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.242 -179.645 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -58.77 -11.49 3.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.498 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -90.41 -3.31 57.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.915 -178.724 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.34 133.27 30.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.983 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 pt -117.37 -5.73 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.933 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.72 33.77 Favored Glycine 0 C--N 1.317 -0.522 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.673 HH22 ' HZ1' ' A' ' 209' ' ' LYS . 29.5 ptt-85 -154.94 166.01 34.9 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.545 -179.775 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.77 134.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.824 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 t -123.85 130.27 52.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.242 -178.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.3 mt -133.15 111.05 12.95 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.402 -177.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.69 -36.66 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.757 2.305 . . . . 0.0 113.013 -178.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 t -47.81 -35.83 10.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.48 -177.249 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 89' ' ' SER . 4.2 m -118.96 -5.92 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 123.361 0.413 . . . . 0.0 111.432 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.15 45.69 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.737 -179.916 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.2 129.0 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.233 -178.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -135.86 115.65 13.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.361 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.1 mt -143.79 161.99 43.48 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -86.56 152.83 8.98 Favored 'Trans proline' 0 C--N 1.326 -0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 108.882 177.676 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.75 115.52 44.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.0 mt -100.18 128.26 46.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.045 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -66.22 -49.51 67.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.154 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -78.74 108.98 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 -179.092 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 98.72 11.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 109.927 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -133.06 154.8 50.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.33 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -51.55 -27.79 11.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.538 -179.607 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -83.57 -47.17 11.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.745 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.05 -33.36 75.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.593 -178.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.84 -19.35 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.807 -178.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.94 -25.13 63.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.432 ' OG ' ' CD2' ' A' ' 74' ' ' LEU . 21.6 m -91.82 -9.61 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.138 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 165.09 -154.04 24.58 Favored Glycine 0 N--CA 1.46 0.238 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.646 -179.387 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.42 125.26 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.634 -0.783 . . . . 0.0 110.061 179.591 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.23 148.03 26.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.576 -179.678 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.2 p -75.77 150.53 37.75 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.216 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 t -86.78 -56.51 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.67 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -96.74 138.65 33.99 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.301 0.572 . . . . 0.0 111.015 -179.178 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -80.55 9.09 6.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.656 -178.337 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.407 ' C ' ' OD1' ' A' ' 113' ' ' ASN . 54.8 p30 -132.88 22.78 4.21 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.139 -0.351 . . . . 0.0 111.352 -177.87 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -91.05 156.12 18.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.955 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -134.26 133.5 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.8 mtt -67.14 127.35 32.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 179.091 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.509 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.36 0.23 76.92 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.56 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -142.39 127.58 18.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.037 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.85 -171.2 45.47 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.254 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.466 ' ND2' ' HG1' ' A' ' 183' ' ' THR . 25.2 t-20 -86.77 107.84 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.773 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -84.91 99.32 10.88 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 122.76 34.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mt -117.7 131.14 56.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.296 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.95 137.91 48.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.627 0.727 . . . . 0.0 110.789 -178.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.25 -178.68 17.76 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.607 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -85.95 141.75 29.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.479 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.5 p30 -109.98 26.56 10.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -42.96 -15.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.876 -179.51 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 59.39 39.13 22.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.142 178.959 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.9 tttt -133.27 114.95 14.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.468 -179.184 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.35 125.19 21.71 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.173 -179.652 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.93 -24.68 11.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.292 -178.379 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.582 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 61.5 t -82.37 178.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.582 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -71.89 135.74 46.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.245 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 43.67 32.81 0.6 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.166 0.508 . . . . 0.0 110.892 178.381 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -81.45 -6.37 58.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.784 -178.355 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 136' ' ' SER . 94.2 m-20 -143.25 34.37 1.33 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.625 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.6 pt -68.3 -30.5 47.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.788 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.49 5.83 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.029 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 138' ' ' ILE . 49.3 m -97.57 -14.65 20.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.023 -179.359 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.11 124.67 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.288 179.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.401 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.41 154.38 17.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.664 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.19 126.44 27.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.307 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.73 25.16 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.771 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.401 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -91.28 133.47 35.38 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -80.59 142.03 34.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.166 0.508 . . . . 0.0 111.592 -178.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 158' ' ' TYR . 85.7 mt -132.74 124.41 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.352 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.03 121.9 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.076 0.465 . . . . 0.0 109.994 -178.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.18 156.53 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.445 -179.489 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 26.3 m-85 -134.55 123.37 23.77 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 152' ' ' ASN . 11.3 t0 -114.35 -165.6 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.558 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.9 m-20 -11.31 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.737 0.648 . . . . 0.0 111.504 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -139.1 28.04 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.19 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.15 148.04 41.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.191 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 74.3 mt-10 -110.29 119.75 40.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.865 178.38 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -106.04 125.03 50.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.893 -178.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -96.12 118.98 33.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.108 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.509 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.8 m-85 -118.38 144.9 45.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.014 -178.843 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' ASP . . . -120.42 131.69 54.9 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.338 0.589 . . . . 0.0 110.368 178.825 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.31 133.84 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.962 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.2 p -102.19 -27.07 13.1 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 124.701 1.251 . . . . 0.0 110.986 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 179.94 36.53 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.259 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.98 147.48 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.776 -179.531 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -151.28 159.94 44.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.083 0.468 . . . . 0.0 110.976 -178.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -107.23 118.87 37.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -132.21 154.07 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.107 0.479 . . . . 0.0 111.034 -178.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 169' ' ' ASP . 35.8 p -75.94 135.86 70.34 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.691 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.59 -15.61 0.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.104 1.869 . . . . 0.0 111.659 -178.653 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.7 m-20 -81.35 -22.75 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 -177.906 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -85.65 75.84 10.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.229 179.307 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.575 ' C ' ' H ' ' A' ' 173' ' ' VAL . 86.0 m95 -71.39 -18.67 62.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.306 -178.665 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 81.0 mm-40 -51.97 -5.72 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.974 0.416 . . . . 0.0 111.15 179.208 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.575 ' H ' ' C ' ' A' ' 171' ' ' TRP . 34.0 m -90.38 -2.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.173 -178.466 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.2 m -132.99 -6.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.63 0.729 . . . . 0.0 109.563 -179.681 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.35 159.56 24.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.093 -176.623 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -66.28 124.5 22.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.517 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.1 m170 -113.94 24.47 12.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.656 -179.13 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.31 19.16 74.88 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.117 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.16 165.74 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 28.9 p30 -97.5 87.62 4.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.71 0.767 . . . . 0.0 110.561 179.751 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -123.24 130.0 52.14 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.053 -179.389 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.9 tt -81.5 146.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.334 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.466 ' HG1' ' ND2' ' A' ' 120' ' ' ASN . 17.3 m -136.71 120.7 17.63 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.279 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -106.0 123.31 47.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.528 0.68 . . . . 0.0 110.786 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.5 pt -137.03 -169.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.645 -178.793 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.512 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.046 -178.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.8 ttm180 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -86.39 133.27 33.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.888 179.121 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 134.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 111.201 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.37 130.15 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.682 -179.548 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -119.12 137.83 53.32 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.643 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.0 145.24 17.32 Favored Glycine 0 N--CA 1.466 0.641 0 CA-C-O 121.828 0.682 . . . . 0.0 111.668 -179.213 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.9 t0 -100.57 140.24 35.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.51 -0.845 . . . . 0.0 111.414 -178.796 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 31.8 tp -65.36 128.14 34.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.26 -25.9 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.213 -178.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.81 161.79 22.05 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.728 179.133 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.9 m -142.22 157.06 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.185 0.517 . . . . 0.0 109.967 -179.263 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.52 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.6 pttm -150.82 178.97 8.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.109 179.617 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.77 144.23 26.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.777 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.673 ' HZ1' HH22 ' A' ' 82' ' ' ARG . 88.5 tttt -69.54 78.47 0.41 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.905 -179.247 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.699 178.266 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.487 1.108 0 N-CA-C 111.253 -0.326 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 56.4 t0 -76.38 159.14 30.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 84.6 mt -60.27 -24.39 64.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.765 -179.105 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.15 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.343 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.62 -34.44 67.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.654 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -75.07 -44.78 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.897 -178.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.97 87.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.955 179.853 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.0 -21.49 33.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.336 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.52 132.97 55.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.848 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -141.94 81.49 1.76 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.001 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.502 ' CD2' ' H ' ' A' ' 74' ' ' LEU . 1.7 pt? -73.35 154.87 39.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.924 179.074 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -70.31 136.7 50.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -66.39 -7.77 21.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.379 0.609 . . . . 0.0 110.364 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.95 -29.63 70.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.05 5.1 8.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.551 -178.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.37 127.62 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.74 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.493 ' H ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -135.47 8.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.269 -177.416 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.49 -174.31 39.7 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -178.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -153.16 155.16 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.346 -179.221 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.4 tt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 179.59 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -129.27 130.14 45.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.828 -178.886 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.5 mt -135.36 120.97 13.96 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.475 -178.353 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.32 -34.49 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.601 2.201 . . . . 0.0 112.472 -179.597 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -49.97 -39.24 40.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.749 -176.699 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.433 ' O ' ' CB ' ' A' ' 89' ' ' SER . 3.4 m -118.88 -7.32 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 123.309 0.381 . . . . 0.0 111.039 -178.902 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 75.77 48.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.56 0.695 . . . . 0.0 110.42 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mt -107.24 122.56 46.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.429 -179.424 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.17 109.27 10.31 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.1 mt -144.37 165.56 22.87 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.01 156.09 7.15 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.916 2.411 . . . . 0.0 108.628 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -107.24 120.01 57.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.03 119.57 39.08 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.55 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.07 -47.52 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.426 ' H ' ' HG ' ' A' ' 97' ' ' SER . 6.5 p -81.47 117.94 22.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.868 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -82.9 75.55 9.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.068 0.461 . . . . 0.0 110.163 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.562 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -90.65 142.96 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.424 179.909 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.459 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 84.0 tt0 -50.46 -56.96 9.21 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.568 -179.597 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -66.28 -32.09 73.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.318 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.562 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 10.6 m-20 -68.1 -27.06 66.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.2 -9.57 58.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.444 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.563 ' N ' ' CD1' ' A' ' 104' ' ' LEU . 8.3 mp -76.44 -14.45 60.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.01 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.5 m -112.13 -5.6 14.22 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.48 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.96 -167.68 39.14 Favored Glycine 0 C--N 1.323 -0.19 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.555 -179.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.04 128.01 38.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.686 179.413 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.95 152.55 22.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -78.19 156.07 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.279 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.6 t -84.69 -55.54 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.22 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.409 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 68.8 mmtt -94.36 137.92 32.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.111 0.481 . . . . 0.0 111.091 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.27 6.25 17.42 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.028 -178.511 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -130.19 24.53 5.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.834 0.35 . . . . 0.0 111.408 -177.432 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.409 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 11.2 pt20 -94.28 162.9 13.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.02 135.83 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.4 mtp -70.56 124.57 24.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.819 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.71 7.37 64.79 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.646 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -143.62 124.69 14.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.389 -178.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.0 -170.43 51.92 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.58 107.4 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.643 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.75 101.99 12.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.241 -179.566 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.94 128.06 36.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.362 0.601 . . . . 0.0 111.692 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.92 131.24 53.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.429 178.497 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.28 140.32 45.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.476 0.655 . . . . 0.0 111.101 -178.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.86 -179.94 19.99 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.4 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.27 156.88 27.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 129' ' ' SER . 2.6 t-20 -122.78 27.1 7.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.968 0.413 . . . . 0.0 110.844 -179.163 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.0 mtt -45.9 -13.01 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.797 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 m 54.97 40.35 31.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.006 178.705 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.468 ' O ' ' OG ' ' A' ' 136' ' ' SER . 83.4 tttt -134.04 120.67 20.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.049 -179.168 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.97 124.23 19.2 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.209 0.528 . . . . 0.0 109.973 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.37 -29.66 7.17 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.203 -177.913 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.584 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 99.5 t -76.03 177.21 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.584 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -73.27 139.21 45.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.514 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 45.0 27.57 0.29 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.149 0.499 . . . . 0.0 111.22 178.029 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -83.42 -15.65 48.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.554 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -132.47 12.98 4.55 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.511 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 140' ' ' SER . 9.7 pt -68.81 -25.83 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.927 0.394 . . . . 0.0 111.789 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.06 1.53 1.94 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.569 -179.6 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 138' ' ' ILE . 15.8 t -98.76 -11.29 22.02 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.226 0.536 . . . . 0.0 110.226 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.08 120.37 11.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.365 179.757 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -99.81 166.06 11.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.676 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -65.04 118.9 9.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.308 -179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.39 14.92 12.06 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.198 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -95.28 133.51 39.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.354 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.785 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 158' ' ' TYR . 69.2 mt -125.86 124.99 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.975 178.662 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.4 ' CD2' ' OE2' ' A' ' 157' ' ' GLU . 63.2 m-85 -99.39 114.69 27.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.979 -178.801 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 tp -113.93 142.91 45.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.94 -179.38 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -110.25 137.36 48.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.053 0.454 . . . . 0.0 111.653 -178.434 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 37.3 t70 -110.72 -172.77 2.1 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.271 178.189 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.543 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.1 m-20 -37.45 -62.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -179.478 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -137.6 23.86 2.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.865 179.349 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.85 152.2 48.11 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.641 0.734 . . . . 0.0 112.65 -175.702 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -114.81 122.02 45.08 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.299 178.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -105.11 130.99 53.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.319 0.58 . . . . 0.0 111.427 -179.015 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.4 ' OE2' ' CD2' ' A' ' 148' ' ' TYR . 80.5 mm-40 -96.4 117.76 31.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.155 178.474 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 147' ' ' ILE . 29.6 m-85 -115.92 141.49 48.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.79 130.29 55.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.552 0.691 . . . . 0.0 110.11 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.42 134.13 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.067 -179.37 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.8 p -102.0 -25.72 13.66 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 124.705 1.253 . . . . 0.0 111.132 -178.972 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 163.81 166.45 22.7 Favored Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.243 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.56 153.16 37.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.741 -179.618 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.3 t -153.38 161.44 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -178.164 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -116.48 117.1 28.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.807 -179.349 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.22 160.36 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 111.245 -178.497 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 p -57.22 168.91 0.81 Allowed Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.028 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.77 -9.11 12.2 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.094 1.863 . . . . 0.0 111.957 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.76 1.52 42.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -178.402 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.602 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 13.5 mptt -83.59 149.57 26.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.358 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 87.8 m95 -157.6 -28.99 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.173 -178.648 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.88 -8.26 0.09 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.099 0.475 . . . . 0.0 110.665 178.655 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.546 ' H ' ' C ' ' A' ' 171' ' ' TRP . 8.9 m -79.16 -25.67 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.607 -178.807 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.69 -2.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 0.0 110.402 -178.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 176' ' ' ASP . 75.4 mm-40 -81.09 119.37 23.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.977 -178.04 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.0 p-10 -30.27 122.21 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.867 179.002 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -104.43 -44.35 4.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.253 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.29 26.36 0.1 Allowed Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -154.05 173.97 15.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.186 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.37 87.02 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.248 0.547 . . . . 0.0 109.901 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -128.05 125.14 38.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -179.002 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -81.2 148.3 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.9 m -137.56 122.98 19.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.184 -179.141 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.14 125.54 52.29 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.239 0.542 . . . . 0.0 111.394 -179.546 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.2 pt -134.21 161.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.583 -179.47 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.415 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 1.3 p . . . . . 0 N--CA 1.465 0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.443 -178.876 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.3 134.01 46.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.947 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.71 135.63 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.247 -179.393 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -119.35 130.44 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.416 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.23 134.83 54.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.42 141.13 12.4 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 50.9 p-10 -100.18 141.33 33.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.636 -0.782 . . . . 0.0 111.503 -179.111 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.62 125.1 24.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 110.66 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.16 -24.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.135 -179.034 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.12 177.16 44.92 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.947 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 35.1 m -154.99 154.64 32.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.278 0.561 . . . . 0.0 110.993 -179.858 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.87 178.17 8.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.81 146.27 24.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.508 179.931 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.67 78.31 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.75 -179.118 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.419 178.279 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.486 1.077 0 CA-C-O 121.027 0.345 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.18 157.3 37.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.788 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.41 -28.96 70.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -178.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.17 90.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 -179.571 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.13 -40.97 64.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.303 0.573 . . . . 0.0 110.836 -179.572 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -73.49 -41.89 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.483 -179.0 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.64 84.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.85 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -91.57 -14.58 30.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.396 -178.665 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.12 110.77 1.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.747 -179.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.2 t -106.65 135.64 47.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.76 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.425 ' CD2' ' H ' ' A' ' 74' ' ' LEU . 1.2 pt? -128.02 174.14 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.057 -179.59 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.9 m-20 -83.65 98.63 9.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.677 178.527 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -58.5 -4.23 0.38 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.377 0.608 . . . . 0.0 110.438 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.7 mmtp -67.51 -11.18 57.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.549 -179.898 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.88 18.84 12.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.782 -179.481 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.9 t -80.03 124.29 37.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.135 178.897 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 80' ' ' ILE . 3.4 tt -106.5 -35.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.074 -179.044 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.41 -155.43 8.16 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.569 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -146.38 155.9 42.93 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.48 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.37 129.08 73.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.2 m -130.5 130.97 44.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.049 -179.276 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.7 mt -132.73 118.59 15.65 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.34 -178.269 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.82 -37.47 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.361 2.041 . . . . 0.0 112.263 -179.503 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 t -48.9 -37.75 20.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.909 -177.146 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 89' ' ' SER . 2.0 m -121.23 -6.59 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.998 -179.026 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.44 50.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.49 124.23 49.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.966 -179.556 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -132.59 107.14 8.24 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.395 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.15 116.17 5.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.088 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -41.16 146.49 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 121.817 1.678 . . . . 0.0 110.2 175.446 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.3 t -97.84 121.69 48.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 mt -103.16 117.48 34.64 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.802 0.334 . . . . 0.0 110.469 -178.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -63.62 -48.54 76.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.272 0.558 . . . . 0.0 110.483 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 90.5 p -60.95 102.66 0.21 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.415 -179.637 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 98' ' ' SER . 53.1 p -83.89 91.51 7.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.627 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -130.11 144.37 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.939 179.793 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.42 -42.94 67.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.951 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -63.57 -46.39 86.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.087 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.627 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 8.8 m-80 -68.11 -35.58 78.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 111.779 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 mt -49.46 -22.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.134 -179.47 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.99 -13.25 61.19 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.717 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -105.03 -11.12 16.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 167.3 -179.06 41.12 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.275 -179.309 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.43 126.06 29.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.785 -0.707 . . . . 0.0 109.941 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.41 150.18 25.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -76.28 153.8 35.66 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.77 -45.94 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.742 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 113' ' ' ASN . 85.6 tttt -89.2 136.24 33.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.165 0.507 . . . . 0.0 110.486 -178.366 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -62.22 -8.27 5.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.109 -178.848 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.431 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 66.1 t30 -146.4 50.31 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 -177.94 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -79.9 161.87 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.784 179.655 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.0 127.04 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 -179.314 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.4 mtt -74.19 127.29 32.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.189 179.013 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.496 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.37 1.71 74.62 Favored Glycine 0 N--CA 1.461 0.326 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -141.58 123.91 15.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.213 0.53 . . . . 0.0 110.974 -179.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.59 -170.65 50.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.428 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 55.4 t-20 -85.6 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.529 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.23 99.91 10.26 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 121.18 32.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.289 0.566 . . . . 0.0 111.323 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -116.58 130.56 56.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.699 178.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.29 137.63 47.77 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.459 0.647 . . . . 0.0 110.433 -179.322 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.39 -177.15 17.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.713 -178.902 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 134' ' ' LEU . 54.8 m-70 -90.37 137.06 32.65 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 -179.504 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 129' ' ' SER . 29.2 t-20 -105.91 28.24 7.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 109.891 -179.986 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.7 mmm -44.6 -13.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.859 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.71 40.91 15.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.684 179.481 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 19.1 mmmt -132.03 107.59 8.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.092 -179.131 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -52.36 124.18 12.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.596 0.713 . . . . 0.0 110.297 179.984 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.74 -28.05 9.27 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.946 -178.34 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.574 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 60.4 t -78.37 178.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-N 117.879 0.839 . . . . 0.0 109.047 179.415 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.574 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -70.44 134.2 47.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.239 -178.224 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 44.59 32.81 0.81 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.258 0.552 . . . . 0.0 110.585 178.529 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.7 -7.02 59.67 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.464 -178.501 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -145.79 24.02 1.37 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.577 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.1 pt -70.46 -21.5 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.699 179.848 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.24 2.97 7.96 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.6 t -99.21 -10.85 21.91 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.361 0.6 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.6 mt -64.24 124.12 20.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.662 -179.888 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 17.9 ptpt -97.42 166.31 11.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.69 123.6 19.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 179.638 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.62 26.74 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.633 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 71.4 m-20 -82.51 130.94 35.21 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.985 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -78.3 129.3 34.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 0.0 111.675 -179.118 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.3 mt -127.28 127.44 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -109.66 123.83 50.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.146 0.498 . . . . 0.0 110.682 -179.087 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.65 148.74 37.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.222 179.6 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.2 t70 -114.01 -166.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.1 m-20 -24.37 -75.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.108 0.48 . . . . 0.0 111.848 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -138.15 29.76 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -129.87 145.73 51.6 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.249 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -110.09 123.0 48.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.823 179.334 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.62 132.71 50.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 111.57 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -96.31 116.75 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.62 178.394 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 44.6 m-85 -117.17 141.59 48.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.55 -179.52 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.76 133.72 54.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.31 0.576 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.33 134.38 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.232 179.446 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.2 p -102.37 -28.57 12.16 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 124.826 1.329 . . . . 0.0 111.048 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.31 144.04 3.91 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.113 -1.041 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.4 t -103.74 149.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.523 179.757 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 t -153.68 164.25 38.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.137 0.494 . . . . 0.0 111.352 -178.683 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -110.96 117.28 32.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.777 179.728 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.37 160.14 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 169' ' ' ASP . 29.5 p -71.99 134.44 83.3 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.67 -11.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.093 1.862 . . . . 0.0 111.794 -179.093 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 167' ' ' THR . 51.5 t0 -83.4 -10.02 58.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.18 -178.841 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -88.39 70.54 9.06 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.573 0.349 . . . . 0.0 110.435 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -75.43 -6.29 49.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.082 0.467 . . . . 0.0 110.97 -179.642 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.567 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.5 mt-10 -52.77 -50.13 64.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.3 m -69.88 6.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.0 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' A' ' 172' ' ' GLU . 4.1 t -130.04 28.76 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.27 131.32 18.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.783 0.801 . . . . 0.0 111.779 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -27.77 121.66 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.962 179.642 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.567 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 53.2 m80 -107.05 -40.23 5.51 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.6 24.59 0.13 Allowed Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.38 172.9 16.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.974 0.416 . . . . 0.0 111.214 179.582 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -96.21 89.58 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 0.0 110.05 178.476 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -125.3 175.87 7.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.2 tt -129.48 142.4 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.394 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 13.0 m -136.34 124.9 23.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.136 -179.95 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.02 126.3 54.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.436 0.636 . . . . 0.0 110.463 179.242 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 28.1 pt -134.61 -169.9 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.738 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.422 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 5.1 t . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.309 -179.461 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.422 ' NH2' ' O ' ' A' ' 186' ' ' THR . 60.7 ttt180 . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.864 0.364 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.44 129.47 50.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.037 179.023 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.7 t -130.14 131.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.422 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 93.5 t -115.1 127.1 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.358 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.38 135.21 54.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.282 0.563 . . . . 0.0 110.373 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.94 159.1 25.42 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.765 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -112.12 150.66 30.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.676 -0.762 . . . . 0.0 111.456 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 11.9 tp -73.74 129.78 38.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.251 0.548 . . . . 0.0 110.62 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.97 -22.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.086 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.32 177.84 44.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.202 -179.157 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.3 m -151.65 151.17 31.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -148.96 177.83 9.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.672 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.41 146.99 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.312 0.577 . . . . 0.0 110.735 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.93 79.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.899 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 tptp . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.694 178.63 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.483 0.859 0 CA-C-O 121.052 0.355 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -79.03 172.93 13.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.543 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.4 mp -60.01 -24.84 64.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.66 -178.414 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.34 97.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.499 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.11 -30.66 62.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.083 179.665 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.47 -47.64 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.831 -178.641 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.83 88.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.064 179.379 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -75.73 -31.08 59.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.476 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.98 132.97 53.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.949 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -140.2 152.52 46.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 -179.283 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 1.3 pt? -138.01 171.91 13.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.231 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -97.93 114.8 27.0 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.359 179.001 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -46.62 -16.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 110.258 -179.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 75' ' ' ASP . 54.6 mtmt -66.99 -10.06 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -92.78 6.62 46.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.247 -178.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.04 125.2 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.657 179.544 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.37 -10.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.385 -178.136 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.07 -173.07 44.03 Favored Glycine 0 C--N 1.316 -0.577 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.691 HH22 ' NZ ' ' A' ' 209' ' ' LYS . 38.1 mtm-85 -144.82 156.9 44.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 111.567 -179.046 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.56 130.69 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 122.034 0.921 . . . . 0.0 109.225 179.751 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.2 t -132.42 133.8 44.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.543 -178.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.9 mt -134.8 126.45 17.91 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.872 -178.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.46 -35.82 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.48 2.12 . . . . 0.0 112.421 -179.16 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.52 -39.62 49.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -177.129 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.9 -1.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.237 0.215 . . . . 0.0 111.132 -178.842 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 t 61.51 49.73 4.99 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.659 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.81 131.09 55.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.792 -178.544 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -137.74 120.26 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.2 tp -153.01 112.66 2.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 113.334 -177.413 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.71 160.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.849 1.699 . . . . 0.0 110.205 175.83 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.81 122.75 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.065 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -105.68 120.88 42.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.255 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.7 -46.94 80.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.004 0.431 . . . . 0.0 111.104 -179.745 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.569 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 13.6 p -65.94 100.21 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.376 -179.709 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p -81.09 94.64 6.65 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.218 0.532 . . . . 0.0 109.871 179.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.3 p -136.66 160.44 38.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.312 -179.272 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -55.32 -42.71 74.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.047 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.88 -46.27 72.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.294 -179.453 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.569 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.9 m-20 -65.76 -38.39 88.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.2 -179.427 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.2 mt -64.88 -27.88 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.631 -179.042 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.9 mt -72.98 -17.18 61.49 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.606 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -105.33 -10.51 16.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.755 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.87 -165.49 34.54 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.568 -179.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.61 124.21 33.84 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.22 144.14 32.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.167 -179.356 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.5 p -74.24 152.25 39.76 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.84 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.89 -43.35 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.767 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -91.11 -173.17 3.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.823 0.344 . . . . 0.0 111.25 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -111.32 -58.81 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.14 -177.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -91.33 43.61 1.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.461 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -98.5 154.34 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 179.621 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.42 132.95 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.1 mtt -61.48 130.35 45.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.841 178.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.33 82.81 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -141.23 120.22 12.79 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.012 -178.76 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.29 -170.72 52.01 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.858 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -83.12 107.93 16.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.269 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -84.39 101.5 12.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.154 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.61 119.52 30.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.43 0.634 . . . . 0.0 111.643 -179.215 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 mt -115.94 130.0 56.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.242 178.411 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.93 138.28 50.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.643 0.735 . . . . 0.0 110.984 -178.566 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.09 -179.8 18.69 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.769 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -80.26 146.14 31.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.812 0.339 . . . . 0.0 110.204 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 129' ' ' SER . 41.6 p30 -112.59 27.53 9.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.07 0.462 . . . . 0.0 110.998 -179.183 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.0 mtt -43.42 -15.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.457 -179.339 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 58.42 39.34 25.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.256 179.127 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -135.57 113.83 11.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -52.73 125.92 18.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.669 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -30.28 6.91 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.195 -178.468 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.586 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 85.7 t -77.98 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.264 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.586 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.7 OUTLIER -72.94 138.85 46.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.516 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 45.26 30.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 178.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -83.85 -14.2 51.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -133.71 18.34 3.89 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.9 pt -70.28 -20.89 23.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.869 0.366 . . . . 0.0 111.934 -179.668 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.78 3.42 11.89 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 t -98.76 -13.59 20.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.29 0.567 . . . . 0.0 109.987 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.4 mt -64.62 124.8 22.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.302 179.814 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 65.7 tttt -96.5 172.0 8.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.507 -179.814 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 77.7 tttt -66.62 128.4 36.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 92.43 22.02 30.41 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.138 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 49.1 m-20 -86.59 130.8 34.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.242 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -77.7 132.58 38.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.257 0.551 . . . . 0.0 111.641 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 147' ' ' ILE . 95.6 mt -127.85 125.97 65.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.1 179.458 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -102.8 122.84 45.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.177 0.513 . . . . 0.0 110.621 -178.589 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.42 136.56 52.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.699 -179.391 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.565 ' CB ' HH11 ' A' ' 82' ' ' ARG . 93.8 m-85 -111.37 119.7 39.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.396 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.7 t0 -104.8 -165.42 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.508 ' C ' ' O ' ' A' ' 151' ' ' ASP . 91.2 m-20 -24.01 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.498 0.499 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.6 30.25 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.696 178.716 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -128.13 146.77 50.6 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.96 123.49 49.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.854 179.118 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -107.46 131.38 54.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.382 0.61 . . . . 0.0 111.3 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -97.34 118.29 33.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.828 177.909 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -115.96 140.65 49.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.82 -178.659 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.2 129.31 54.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.563 0.697 . . . . 0.0 111.155 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 144' ' ' GLY . 53.0 t -69.21 135.81 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.82 -179.58 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.61 -25.13 12.39 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.48 1.112 . . . . 0.0 111.084 -179.094 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.63 165.21 22.58 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.413 -179.539 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.8 p -125.88 151.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.671 -0.765 . . . . 0.0 109.669 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.6 p -155.6 164.38 38.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.458 . . . . 0.0 111.228 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.457 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 96.2 mt-10 -112.26 113.93 26.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.491 -179.735 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.99 157.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.457 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.479 ' H ' ' HG1' ' A' ' 167' ' ' THR . 1.3 p -65.77 168.63 8.22 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.052 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.27 -7.0 12.0 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.193 1.929 . . . . 0.0 112.105 -179.351 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.9 p-10 -82.95 -12.43 57.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.028 -178.762 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -89.44 69.85 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.784 0.434 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.77 -5.88 43.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.683 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.546 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.9 mt-10 -53.48 -40.04 65.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.351 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.481 ' O ' ' CG1' ' A' ' 173' ' ' VAL . 74.4 t -72.71 1.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.812 -179.679 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.36 28.92 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.78 129.42 19.19 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.729 0.776 . . . . 0.0 111.854 -177.021 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -29.22 123.07 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.894 179.442 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.546 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.2 m80 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.626 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.24 24.3 0.32 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.058 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -156.72 178.74 10.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.132 0.491 . . . . 0.0 111.377 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -89.68 89.2 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.521 0.677 . . . . 0.0 110.093 178.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 202' ' ' ASP . 23.5 tp10 -121.08 163.3 18.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.308 -179.197 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.6 tt -130.68 142.12 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.644 179.487 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 15.7 m -136.36 126.17 25.69 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.383 -178.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -112.36 120.32 41.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.562 0.696 . . . . 0.0 110.814 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.409 ' CG2' HH11 ' A' ' 196' ' ' ARG . 42.1 pt -139.83 -176.66 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.81 -178.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.342 -179.471 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.409 HH11 ' CG2' ' A' ' 185' ' ' ILE . 9.2 tmm_? . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.857 0.36 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.457 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.9 m-85 -80.03 135.72 36.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.976 179.571 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 75.8 t -129.67 130.98 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.087 0.47 . . . . 0.0 110.821 -179.588 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -119.53 130.56 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.748 -179.423 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.36 138.89 53.48 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.621 -179.87 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.82 152.0 19.98 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.215 -179.387 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 181' ' ' GLU . 16.2 m-20 -109.49 139.1 44.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.553 -0.823 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.69 125.38 24.1 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.027 0.442 . . . . 0.0 110.928 179.821 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.41 -25.02 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.152 -178.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.33 176.32 45.31 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.953 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.2 m -153.92 153.13 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.432 0.634 . . . . 0.0 111.038 179.842 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -147.23 177.34 9.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.382 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.35 146.61 24.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.043 0.449 . . . . 0.0 110.679 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.691 ' NZ ' HH22 ' A' ' 82' ' ' ARG . 63.8 tttp -72.12 78.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.586 -179.234 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.747 178.424 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.485 1.017 0 N-CA-C 111.027 -0.413 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.79 171.9 11.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -48.92 -31.22 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.654 -179.141 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.475 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -65.52 -38.82 90.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 81.0 mm-40 -73.97 -27.21 60.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.663 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -82.15 -46.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.243 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.54 74.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.767 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.625 ' ND2' ' N ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -69.57 -28.56 66.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -179.218 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.625 ' N ' ' ND2' ' A' ' 71' ' ' ASN . . . -61.87 138.3 58.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.986 -179.734 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -140.22 133.57 29.87 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 tp -140.9 135.1 30.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.655 -179.037 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 67.8 t0 -67.52 137.66 55.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.092 179.136 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.471 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 70.3 mmtt -65.01 -7.89 13.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.159 0.504 . . . . 0.0 110.22 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -79.96 -10.11 59.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.956 -179.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -78.34 -3.21 41.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.639 -179.268 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.15 138.6 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 -179.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -122.74 -4.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.329 -179.183 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.11 -174.04 39.26 Favored Glycine 0 C--N 1.318 -0.469 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -147.19 151.91 37.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.524 -179.027 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 83' ' ' ILE . 20.6 tt -124.31 120.67 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -118.86 128.09 54.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.665 -179.629 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.5 mt -134.62 122.12 15.46 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.579 -177.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.56 -34.17 0.57 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.404 2.069 . . . . 0.0 112.423 -179.492 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.433 ' HG ' ' CD2' ' A' ' 141' ' ' LEU . 2.0 t -49.81 -39.32 38.09 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.539 -177.496 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.77 -1.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.458 0.17 . . . . 0.0 111.072 -179.219 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 63.64 49.99 2.86 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.214 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.6 tp -115.71 132.3 56.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.315 -178.661 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -139.33 118.0 12.28 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.586 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -148.35 116.72 4.02 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.878 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 92' ' ' LEU . 2.2 Cg_endo -39.88 161.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.894 1.729 . . . . 0.0 110.307 175.227 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.92 126.98 72.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.463 ' CB ' HD21 ' A' ' 102' ' ' ASN . 22.2 mt -102.32 127.63 49.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.982 -179.192 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -71.38 -48.69 48.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.618 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -69.5 107.44 3.37 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.348 -179.225 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -81.93 99.54 9.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.192 0.52 . . . . 0.0 110.115 179.938 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.513 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.9 p -139.74 164.35 30.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 -179.264 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.96 -36.59 84.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -71.74 -47.54 53.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.567 -179.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.1 p-10 -65.97 -36.99 84.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.412 -178.766 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.16 -24.37 10.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.431 -179.112 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.0 mt -68.92 -29.37 67.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.319 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.2 t -85.33 -14.31 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.365 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.8 -172.03 38.75 Favored Glycine 0 N--CA 1.465 0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.679 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.94 127.94 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.921 -179.806 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.512 ' CB ' HD22 ' A' ' 102' ' ' ASN . . . -104.78 148.68 26.35 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.51 -179.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.523 ' O ' ' OG ' ' A' ' 98' ' ' SER . 44.7 p -75.57 154.23 36.9 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.65 -52.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -91.81 138.5 31.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 -178.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -72.84 1.41 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.023 -178.69 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -142.96 36.37 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 0.0 111.047 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.29 159.13 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.03 130.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.532 -179.672 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.7 mtt -73.15 127.86 33.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.48 67.95 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.715 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -138.73 123.95 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.089 -179.133 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.89 -173.39 44.93 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.436 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 38.8 t-20 -83.51 109.72 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -83.96 101.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.02 129.14 37.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.336 0.589 . . . . 0.0 112.062 -178.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -123.57 132.28 53.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.472 178.544 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.73 138.41 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.324 0.583 . . . . 0.0 110.601 -178.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.0 -178.54 17.43 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.439 -179.328 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -89.64 145.55 25.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.836 0.351 . . . . 0.0 110.624 -179.691 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.501 ' C ' ' H ' ' A' ' 129' ' ' SER . 60.5 t-20 -110.08 28.35 8.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 110.411 -179.754 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -46.19 -12.26 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.789 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 127' ' ' ASN . 1.2 m 56.67 40.38 29.28 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.997 179.069 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -130.74 108.73 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.194 -179.146 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -51.61 124.81 13.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.03 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.31 -29.35 8.39 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.137 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.612 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 59.6 t -77.05 179.13 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 117.69 0.745 . . . . 0.0 109.044 179.45 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.612 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.7 OUTLIER -70.32 136.61 49.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.089 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 42.55 32.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.165 0.507 . . . . 0.0 111.009 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 p -82.07 -10.7 59.12 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.36 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.23 26.86 1.62 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.537 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.92 -20.52 20.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.779 0.323 . . . . 0.0 111.838 179.917 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.84 -1.28 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.815 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t -94.09 -13.17 27.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 109.923 -179.625 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.433 ' CD2' ' HG ' ' A' ' 87' ' ' SER . 20.3 mt -64.37 123.32 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.432 -179.75 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.494 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.3 mttt -96.54 173.13 7.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.734 -179.774 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -70.1 136.36 50.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.661 -179.669 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.82 22.07 56.34 Favored Glycine 0 N--CA 1.463 0.449 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.708 179.663 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.494 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.8 m-20 -88.96 130.16 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.37 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -77.48 134.04 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 158' ' ' TYR . 77.3 mt -128.87 121.55 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.272 179.296 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -102.21 122.03 43.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.099 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.0 tp -118.97 143.83 46.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 -178.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.97 133.03 56.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.318 0.58 . . . . 0.0 111.498 -178.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.52 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.0 t0 -113.98 -166.42 1.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.282 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 151' ' ' ASP . 15.9 m120 -22.99 -74.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.064 0.459 . . . . 0.0 111.632 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -138.09 24.45 2.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -123.37 143.91 49.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.863 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -109.71 121.04 44.32 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.688 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -105.48 131.1 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.521 -178.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -94.7 118.04 31.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.399 178.53 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 147' ' ' ILE . 53.0 m-85 -117.88 139.97 50.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 -179.424 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.17 135.58 54.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.089 0.471 . . . . 0.0 110.563 178.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.66 133.91 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.096 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.92 -24.81 11.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 124.464 1.102 . . . . 0.0 111.184 -179.185 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.13 157.19 11.99 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.495 -179.648 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.1 p -123.39 151.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.548 -179.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -161.25 171.76 17.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 111.297 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -115.81 110.92 19.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.757 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.14 145.43 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.019 -178.6 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.6 p -60.18 132.85 90.24 Favored Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.569 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.4 Cg_endo -47.28 -17.88 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.873 1.715 . . . . 0.0 111.826 -179.035 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.1 -17.78 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.193 -178.494 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -87.29 72.24 9.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.847 0.459 . . . . 0.0 110.946 179.817 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.569 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 47.1 m95 -73.53 -18.52 61.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.004 -179.176 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.7 mt-10 -50.27 -7.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.062 0.458 . . . . 0.0 111.009 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.557 ' H ' ' C ' ' A' ' 171' ' ' TRP . 27.9 m -83.79 -21.84 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.671 -178.565 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.44 -1.27 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.618 0.723 . . . . 0.0 109.955 -178.744 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.511 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.8 mt-10 -83.96 125.11 31.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.065 -178.442 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 41.6 p-10 -30.92 122.32 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.703 178.882 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.0 m80 -112.36 24.25 12.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.735 -179.186 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.42 76.46 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -149.44 166.46 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 0.0 111.237 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 29.7 p30 -96.08 87.78 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.561 0.696 . . . . 0.0 110.477 179.469 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -127.24 128.31 45.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.33 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.94 147.3 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.238 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 5.2 m -138.15 122.37 18.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.179 -179.907 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.0 mp -104.82 128.26 52.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.379 0.609 . . . . 0.0 110.987 -179.756 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.1 pt -139.1 175.54 7.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.811 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.507 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.3 p . . . . . 0 N--CA 1.464 0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.819 -179.335 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 186' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 . . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -126.06 132.65 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.505 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.49 137.86 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.159 0.504 . . . . 0.0 110.969 -179.428 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.2 t -120.01 131.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.356 -179.535 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.63 135.86 53.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.61 -179.551 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.02 135.18 8.09 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 121.596 0.553 . . . . 0.0 111.762 -179.476 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -90.88 139.46 30.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.293 -179.235 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 11.7 tp -67.21 127.5 32.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.192 0.52 . . . . 0.0 110.632 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.6 m -109.01 -21.51 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.514 -178.674 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.96 175.89 46.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.031 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.6 m -155.02 153.43 30.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 110.811 179.503 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -149.39 177.98 9.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.176 179.04 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.18 142.14 30.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.859 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -58.27 80.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 208' ' ' ALA . 49.6 tttp . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.482 0.812 0 N-CA-C 110.864 -0.476 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.28 167.67 21.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.82 -19.95 65.12 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.403 0.439 . . . . 0.0 111.108 -179.377 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.11 97.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.627 -179.569 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -72.12 -36.69 69.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.785 179.52 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.9 -45.43 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.873 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.38 86.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.19 -27.09 28.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.895 -179.037 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 136.77 58.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.331 179.594 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.557 ' O ' ' NZ ' ' A' ' 101' ' ' LYS . 29.3 t -91.08 156.73 17.69 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.2 tp -120.29 125.51 48.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 -178.823 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -95.21 87.81 4.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -48.94 -33.07 10.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.029 -179.486 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -51.6 -14.78 0.36 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.243 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -100.77 14.34 31.96 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.853 -178.74 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.436 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 5.4 p -89.8 126.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.299 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.8 pt -118.5 -6.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.319 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.04 -165.08 34.33 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.03 157.34 43.58 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.273 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 92' ' ' LEU . 5.9 tt -128.63 132.3 67.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.808 0.814 . . . . 0.0 109.249 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -132.75 133.42 43.44 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.609 -178.167 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.73 126.73 18.14 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.808 -178.465 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.09 -34.71 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.54 2.16 . . . . 0.0 112.5 -179.694 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.3 t -49.27 -41.43 37.83 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.655 -177.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 1.4 p -119.91 -3.59 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 123.245 0.34 . . . . 0.0 111.094 -179.27 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 68.33 50.99 0.7 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.672 -179.585 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.27 125.02 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.789 -178.003 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -134.88 114.39 12.52 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.408 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.421 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 10.1 mt -148.59 117.39 4.01 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.736 -177.672 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 92' ' ' LEU . 1.6 Cg_endo -41.25 151.59 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.971 1.781 . . . . 0.0 110.121 176.41 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.12 121.65 52.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.1 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.9 mt -104.53 128.5 52.49 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -72.55 -39.92 67.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.942 0.401 . . . . 0.0 111.389 -179.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.9 m -72.69 102.0 3.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.073 -179.375 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.8 p -82.34 93.34 7.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 109.913 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.569 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 45.0 p -132.01 158.25 42.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.186 -178.909 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -60.62 -24.6 65.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.719 -179.261 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 65.3 tttm -83.87 -44.17 14.57 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.815 0.697 . . . . 0.0 112.158 -178.865 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.569 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 98.1 m-20 -67.26 -34.89 78.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.844 -179.706 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.1 mt -68.31 -11.48 59.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.621 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.2 mt -74.63 -14.26 60.74 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.7 -3.86 7.15 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.417 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.63 172.95 45.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.385 -179.522 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.93 127.44 32.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.531 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.4 150.02 25.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.048 0.451 . . . . 0.0 110.803 -179.153 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 p -75.35 151.23 38.24 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.3 p -87.17 -32.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.468 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.442 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 21.2 tptt -90.05 179.99 5.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.964 0.412 . . . . 0.0 110.837 -177.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 22.4 pt-20 -105.7 -16.5 14.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.058 -178.447 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -144.11 53.19 1.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -177.186 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -91.61 153.64 19.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.59 131.6 72.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.617 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.6 mtp -70.19 125.34 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.913 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.32 4.95 65.87 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.474 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -143.32 123.72 13.9 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.55 -178.339 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.59 51.84 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -178.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 6.8 t30 -83.29 108.19 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.903 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.91 102.68 13.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.477 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.53 126.11 36.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.062 0.458 . . . . 0.0 112.186 -179.4 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.82 130.41 53.96 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.468 178.85 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.39 140.02 46.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -178.035 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.94 -177.92 17.53 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.229 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -81.63 155.83 25.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 129' ' ' SER . 9.3 p30 -123.9 28.05 7.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.029 0.442 . . . . 0.0 111.171 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.2 mtt -44.05 -15.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.107 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.19 38.08 13.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.843 178.889 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.52 120.53 19.8 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.601 -179.123 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.2 124.76 21.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.0 -30.75 6.4 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -177.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.558 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 94.1 t -72.42 176.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.381 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.558 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -74.1 133.07 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.781 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 48.11 39.2 11.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.796 177.774 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 20.8 p -77.55 -68.03 0.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.287 -179.266 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.519 ' N ' ' OG ' ' A' ' 136' ' ' SER . 94.1 m-20 -88.3 41.88 1.03 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.1 pt -69.99 -26.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.293 -179.758 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.24 3.92 9.8 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.9 m -92.98 -15.1 26.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.328 -179.237 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 mt -66.4 121.28 14.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -95.84 153.14 17.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -53.67 121.91 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 -179.968 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 101.04 16.94 24.22 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.803 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 73.7 m-20 -85.09 135.89 33.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.13 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -82.33 131.4 35.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 0.0 111.796 -178.321 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.77 124.44 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.552 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -104.5 120.21 40.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.299 -178.554 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.92 158.47 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.956 -178.854 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.56 136.13 53.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 111.708 -178.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.554 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.4 t0 -112.81 -166.49 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.656 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.554 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.2 m-20 -34.73 -67.96 0.13 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.491 0.662 . . . . 0.0 111.042 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.03 29.65 2.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.074 179.643 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.82 147.72 52.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.822 0.82 . . . . 0.0 112.8 -175.495 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.74 123.45 50.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.814 178.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -104.44 133.43 49.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.582 -178.765 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -97.57 116.29 29.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.59 177.8 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -116.16 141.07 48.62 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 -178.962 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.63 131.64 54.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 178.879 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 144' ' ' GLY . 61.3 t -65.67 134.23 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.968 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -30.61 11.21 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.201 1.563 . . . . 0.0 110.916 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.79 157.78 11.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.965 -178.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.3 150.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.526 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.9 p -156.51 164.46 38.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.783 -177.704 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.446 ' OE2' ' OH ' ' A' ' 197' ' ' TYR . 94.9 mt-10 -114.19 115.63 27.78 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.232 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 158.3 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.622 0.249 . . . . 0.0 111.154 -178.074 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.456 ' H ' ' HG1' ' A' ' 167' ' ' THR . 4.3 p -60.49 167.61 3.07 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.301 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.38 -6.97 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.079 1.853 . . . . 0.0 112.192 -179.815 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 35.6 p30 -85.39 -6.97 59.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.909 -178.088 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -86.49 68.97 10.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.464 ' C ' ' H ' ' A' ' 173' ' ' VAL . 78.4 m95 -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.985 -179.299 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.534 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 98.3 mt-10 -47.17 -16.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 O-C-N 123.432 0.457 . . . . 0.0 110.666 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.464 ' H ' ' C ' ' A' ' 171' ' ' TRP . 54.4 t -74.46 -24.93 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.685 -179.055 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.58 -8.61 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.715 0.769 . . . . 0.0 110.041 -177.998 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.9 mt-10 -80.4 157.79 26.18 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.58 -176.716 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.8 p-10 -66.22 128.59 36.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.339 179.834 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.534 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 34.4 m80 -108.07 -44.47 4.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.718 -179.561 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.22 24.54 0.1 OUTLIER Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 178.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -153.39 172.5 16.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.955 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 6.7 p30 -95.05 86.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 110.211 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -128.22 125.55 39.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.735 -179.077 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.2 tt -80.82 148.43 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 8.7 m -136.8 118.63 15.14 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.385 -178.231 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.2 mp -100.32 127.26 46.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 111.185 -179.64 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 pt -139.95 -171.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -178.6 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.529 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.473 -178.77 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.446 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 3.8 m-85 -104.51 132.66 50.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.61 139.37 45.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.183 0.515 . . . . 0.0 110.997 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 80.9 t -125.2 135.81 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 -179.256 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.74 134.95 54.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.89 134.55 8.26 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -96.53 137.57 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.934 -179.082 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 40.3 tp -64.7 127.2 30.52 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.26 -23.81 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.684 -179.41 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.01 178.26 46.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.511 -179.519 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 152.41 30.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.955 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -147.94 178.16 8.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.868 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.45 144.71 25.33 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.467 -179.438 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -73.02 79.75 1.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 -179.049 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.388 178.563 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 N-CA-C 111.027 -0.413 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -76.76 170.83 15.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.883 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.39 -15.35 63.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.826 0.346 . . . . 0.0 111.309 -179.199 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 71' ' ' ASN . . . -64.03 -41.27 97.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.146 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.35 -19.65 58.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.518 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.01 -55.42 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.273 -178.613 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.77 94.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 67' ' ' ALA . 8.1 m120 -68.78 -32.74 72.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.605 -179.258 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.8 129.74 41.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.519 179.579 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -92.91 159.82 15.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.152 179.858 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.4 120.68 14.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.924 0.392 . . . . 0.0 111.105 -178.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.481 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.5 m-20 -86.56 106.5 17.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.166 178.846 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -46.64 -16.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.289 0.566 . . . . 0.0 110.69 -179.781 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.481 ' N ' ' C ' ' A' ' 75' ' ' ASP . 63.7 mttp -65.4 -12.02 48.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -97.84 8.73 44.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.463 -178.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.8 t -91.27 125.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.763 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.2 pt -122.38 -3.55 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.328 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.33 -162.03 34.61 Favored Glycine 0 C--N 1.321 -0.288 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.627 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.671 HH12 ' HZ3' ' A' ' 209' ' ' LYS . 10.8 ptp85 -157.53 164.76 37.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.943 -179.724 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.6 tt -133.08 144.51 36.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.223 179.738 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 t -134.18 135.2 42.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.82 -178.828 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 mt -129.47 76.33 78.84 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.571 -177.404 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.26 -42.05 3.48 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.996 2.464 . . . . 0.0 112.565 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -55.18 -42.68 73.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.719 -177.436 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.455 ' CG1' ' O ' ' A' ' 88' ' ' VAL . 67.8 t -107.97 5.26 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.753 0.311 . . . . 0.0 110.799 -179.075 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 t 56.1 46.23 22.0 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.139 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.96 124.56 51.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.874 -178.273 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -128.04 113.09 15.36 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.09 111.01 4.72 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.7 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.71 157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.888 1.725 . . . . 0.0 109.767 175.697 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.09 117.0 51.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.1 mt -100.47 120.83 40.58 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.843 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -66.65 -48.26 69.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 111.171 -179.709 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.561 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 23.9 p -60.13 100.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 179.874 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 98' ' ' SER . 18.6 p -82.73 97.17 8.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.349 0.595 . . . . 0.0 110.32 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.524 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 3.6 p -140.01 158.22 44.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.094 -179.275 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.2 -33.26 70.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.469 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.03 -44.47 47.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.105 -179.495 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.561 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 98.2 m-20 -65.08 -38.6 91.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.711 -178.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.6 mt -57.18 -22.32 39.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.492 -179.385 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.34 -32.88 72.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.655 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.4 m -91.33 -9.65 44.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.86 -176.87 45.6 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.401 -179.401 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.38 124.4 27.47 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.056 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.75 150.48 25.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.061 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.7 p -68.65 148.37 50.54 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.839 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.5 t -88.72 -33.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -177.097 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 170.24 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.388 . . . . 0.0 110.946 -178.851 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.17 -47.12 81.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.193 -178.026 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 113' ' ' ASN . 50.4 p30 -158.0 69.76 0.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.154 -178.336 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 121' ' ' TYR . 4.4 pt20 -76.38 175.06 9.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.246 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -132.47 125.13 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.856 0.36 . . . . 0.0 110.649 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.488 ' SD ' ' OH ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.8 127.44 32.64 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.403 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.85 -5.59 59.85 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -140.37 123.18 16.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.15 -170.24 50.17 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.074 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -83.71 107.74 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.921 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 114' ' ' GLN . 5.8 t80 -84.42 102.67 12.95 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.567 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.45 122.26 33.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.203 0.525 . . . . 0.0 111.827 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -117.67 131.11 56.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.902 178.656 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.83 139.14 46.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.262 0.553 . . . . 0.0 110.768 -178.211 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.47 -178.34 16.5 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.486 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.9 m-70 -93.74 138.59 31.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.574 -179.424 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -98.59 28.78 4.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 110.658 -179.481 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.67 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.199 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 m 59.21 36.87 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.456 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.472 ' HZ3' ' CG2' ' A' ' 133' ' ' VAL . 10.4 mtpm? -131.94 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.471 -178.898 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -48.95 124.09 8.12 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.56 -31.01 7.14 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.314 -177.915 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.616 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 61.0 t -74.67 179.35 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.616 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.7 OUTLIER -71.51 136.78 47.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.958 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 43.63 35.1 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.816 178.069 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 p -82.92 -14.15 54.7 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -141.17 26.48 2.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.409 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.2 pt -75.67 -18.08 15.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.479 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.4 18.19 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.644 -179.598 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 t -92.26 -14.05 29.48 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.357 0.598 . . . . 0.0 110.037 -179.319 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.415 ' CD2' ' OD2' ' A' ' 145' ' ' ASP . 23.8 mt -63.77 128.55 36.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.359 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -101.85 174.54 5.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.876 -179.83 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.89 124.29 23.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 93.6 16.0 47.67 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.603 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.415 ' OD2' ' CD2' ' A' ' 141' ' ' LEU . 10.4 t70 -78.83 136.42 37.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.035 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.8 132.55 35.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.979 0.419 . . . . 0.0 111.626 -178.163 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 147' ' ' ILE . 93.7 mt -129.01 127.5 66.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.686 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -104.26 120.68 41.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.027 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.63 145.31 45.54 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -119.34 135.12 54.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -178.089 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.8 t0 -110.66 -164.22 0.9 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.557 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 3.5 p-10 -26.37 -77.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.354 0.409 . . . . 0.0 111.29 179.202 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.557 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 78.6 mm-40 -134.02 30.0 3.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.096 178.949 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.479 ' OD1' ' ND2' ' A' ' 152' ' ' ASN . 33.8 m120 -128.85 148.2 50.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.956 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -109.21 123.32 49.05 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.068 179.819 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -106.3 129.72 54.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.655 -178.847 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -94.75 113.59 25.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.338 178.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -113.48 143.36 44.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.454 -178.901 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.01 132.23 54.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.262 0.553 . . . . 0.0 110.707 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 144' ' ' GLY . 99.2 t -66.6 135.71 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.52 -179.933 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.1 p -100.24 -27.27 13.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 124.593 1.183 . . . . 0.0 111.013 -178.497 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.0 156.45 8.15 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.426 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.34 139.6 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.389 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 73.9 m -136.82 151.27 48.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.786 0.326 . . . . 0.0 111.091 -178.083 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 54.9 mp0 -111.07 102.52 10.97 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.4 m -134.09 156.59 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -178.212 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.2 p -63.02 168.8 4.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.211 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.41 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -82.31 -4.04 11.64 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.179 1.919 . . . . 0.0 112.119 -179.596 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.02 -19.38 44.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.806 -178.569 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -85.96 74.37 10.15 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.817 0.447 . . . . 0.0 110.307 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.41 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 96.6 m95 -74.68 -6.16 47.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.023 -179.279 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.579 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 9.8 pt-20 -52.47 -43.63 65.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.984 0.421 . . . . 0.0 110.919 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.449 ' N ' ' CG ' ' A' ' 172' ' ' GLU . 16.8 m -71.33 4.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.976 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.81 -14.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.779 0.799 . . . . 0.0 110.215 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.7 mt-10 -87.32 172.6 9.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.018 -178.869 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -74.29 125.72 29.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.579 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 48.3 m80 -110.82 22.49 15.3 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.641 -179.37 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.78 20.98 79.27 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.356 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -151.17 168.08 25.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.137 -179.477 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -94.39 87.57 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.174 0.511 . . . . 0.0 110.236 -179.841 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -123.91 124.94 43.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.626 -178.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.4 tt -81.51 146.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.455 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.5 m -137.28 121.74 18.32 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.395 -179.123 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.0 mp -105.95 123.45 48.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 111.024 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.47 ' CG2' ' NH1' ' A' ' 196' ' ' ARG . 12.6 pt -139.01 169.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.992 -178.531 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.631 -179.21 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.47 ' NH1' ' CG2' ' A' ' 185' ' ' ILE . 7.9 tmm_? . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.2 133.0 43.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.15 141.26 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.335 0.588 . . . . 0.0 111.332 -179.398 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.7 t -121.16 131.85 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.185 -179.261 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -117.22 136.46 53.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.485 -179.838 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.25 140.69 11.99 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.445 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 53.5 p-10 -97.52 144.95 26.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.566 -0.817 . . . . 0.0 111.473 -178.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.12 126.49 29.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.062 0.458 . . . . 0.0 111.166 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.7 -25.35 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.413 -178.755 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.87 177.43 44.89 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.74 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.7 m -152.89 152.67 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.274 0.559 . . . . 0.0 111.108 -179.78 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -149.36 178.79 8.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.345 179.594 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.78 146.03 24.09 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.403 -179.773 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.671 ' HZ3' HH12 ' A' ' 82' ' ' ARG . 88.4 tttt -77.04 79.02 3.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.748 -179.1 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.562 178.057 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.253 0 CA-C-O 121.121 0.384 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -69.18 152.07 45.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.679 179.636 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.1 mm? -56.61 -27.18 57.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.64 -179.099 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.87 91.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.898 0.38 . . . . 0.0 110.411 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.38 -35.1 63.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.872 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.33 -44.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.41 88.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.766 179.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.25 -27.55 42.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.24 140.78 55.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.374 -179.505 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -139.45 147.09 40.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.756 -179.463 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 1.4 pt? -137.17 173.8 11.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 -179.515 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.12 128.5 45.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 178.489 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 0.3 OUTLIER -67.91 -10.17 51.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.346 179.996 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 79' ' ' VAL . 1.3 mppt? -63.54 -30.62 71.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.172 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.19 13.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.826 -178.964 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 76' ' ' LYS . 9.3 p -85.86 123.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.597 179.672 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.99 -5.48 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.86 -178.197 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.24 -160.26 27.04 Favored Glycine 0 C--N 1.318 -0.432 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 9.3 ttm180 -151.38 157.32 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.129 0.49 . . . . 0.0 110.924 -179.812 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.403 ' N ' ' HG3' ' A' ' 82' ' ' ARG . 3.3 tp -125.9 127.21 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.191 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -129.03 130.15 46.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.77 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 mt -136.68 123.2 13.78 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.817 -178.731 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -82.33 -30.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.462 2.108 . . . . 0.0 112.473 -179.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -48.39 -39.99 24.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.052 -176.475 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.403 ' O ' ' CB ' ' A' ' 89' ' ' SER . 3.3 p -120.53 -4.17 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.578 0.228 . . . . 0.0 111.12 -179.13 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.09 50.72 0.11 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.021 0.439 . . . . 0.0 109.967 179.895 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.6 mt -111.37 127.42 55.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 179.762 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.49 113.14 11.51 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 mt -146.09 166.48 16.92 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.395 -177.719 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.82 150.61 8.54 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 109.516 178.105 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.73 108.22 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.9 mt -101.93 121.61 42.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.29 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.03 -48.95 72.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.985 0.421 . . . . 0.0 111.176 -179.653 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.495 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 48.4 m -56.68 98.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.777 -179.411 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 85.3 p -80.6 100.56 8.69 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.393 0.616 . . . . 0.0 110.626 179.675 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -135.42 157.73 46.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.352 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -54.97 -39.17 68.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.923 179.524 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.93 -39.08 72.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.091 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 97' ' ' SER . 6.8 t-20 -62.77 -39.55 94.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 -179.406 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.97 -27.45 63.47 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.288 -178.688 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.68 -14.54 62.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.37 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -104.98 -13.96 15.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.83 -149.98 14.91 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.013 -178.326 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.34 125.2 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.84 144.34 32.71 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.719 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 p -76.84 153.32 34.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.6 t -85.81 -45.03 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.171 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -88.47 -170.97 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.222 -178.402 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -124.67 -5.28 7.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.826 -177.739 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.42 41.8 1.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.078 0.466 . . . . 0.0 110.675 -177.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.29 161.94 13.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.388 179.679 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.66 132.83 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 67.8 mtt -69.62 129.81 40.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.51 179.13 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.97 75.96 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -146.46 128.17 15.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.579 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.6 -169.7 47.23 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -85.52 103.48 14.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.506 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.94 101.3 11.6 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.8 124.31 35.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 0.0 112.042 -178.846 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -120.13 130.14 54.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.693 178.224 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.47 139.97 43.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 110.256 -178.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.24 -178.22 18.88 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.939 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -83.62 152.26 24.9 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.112 0.482 . . . . 0.0 110.767 -179.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 129' ' ' SER . 48.6 p30 -122.09 28.23 7.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.29 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.6 mtt -44.78 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.944 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 61.24 36.33 17.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.434 ' H ' ' HG ' ' A' ' 136' ' ' SER . 68.1 mttm -135.64 114.75 12.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.944 -179.213 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -56.21 126.65 27.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.687 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -30.64 6.67 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 -178.136 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 134' ' ' LEU . 97.0 t -72.36 175.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.542 ' N ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.45 128.77 36.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.392 -178.409 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 48.45 42.61 18.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 178.202 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.434 ' HG ' ' H ' ' A' ' 130' ' ' LYS . 2.4 t -75.23 -67.26 0.67 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.36 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -90.27 43.98 1.18 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.183 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 138' ' ' ILE . 39.8 pt -68.1 -26.74 35.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.675 179.525 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.16 7.47 4.16 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.246 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -96.25 -14.47 22.64 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.46 122.24 15.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.136 -179.357 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 26.6 mtpp -96.3 157.14 16.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.758 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.43 122.13 13.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.622 -179.627 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.63 18.45 23.18 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.1 m-20 -83.79 134.98 34.7 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.923 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -81.78 126.09 31.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.178 -177.335 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.89 126.78 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.295 178.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -101.94 118.1 36.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.271 -179.101 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.24 135.92 46.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.973 179.907 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.509 ' O ' ' SD ' ' A' ' 116' ' ' MET . 56.3 m-85 -114.69 127.79 55.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.325 0.583 . . . . 0.0 111.324 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 42.8 t0 -113.82 -166.6 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.348 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.512 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.1 m-20 -23.04 -75.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.062 0.458 . . . . 0.0 111.994 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -139.22 30.64 2.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.276 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -127.7 144.13 51.1 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.046 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -110.94 121.83 46.35 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.898 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -103.65 132.71 49.66 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.323 -178.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.79 115.08 27.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.166 178.785 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -114.77 146.67 40.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.574 -179.844 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.1 132.43 53.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.341 0.591 . . . . 0.0 111.022 178.073 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.11 133.41 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.631 179.56 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.82 -29.01 11.72 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 124.739 1.274 . . . . 0.0 110.395 -178.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.83 164.07 23.9 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.031 -179.355 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.92 147.45 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.911 -0.644 . . . . 0.0 109.765 -179.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.0 p -151.69 162.15 41.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.195 0.521 . . . . 0.0 111.289 -179.115 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -117.91 111.31 18.83 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.696 179.89 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.8 160.14 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.096 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -62.18 166.98 5.66 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.532 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.1 Cg_endo -82.21 -5.87 12.0 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.256 1.97 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -17.03 52.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.725 -178.78 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -87.37 73.57 9.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 70.1 m95 -73.52 -21.51 60.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.362 -179.847 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.545 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.3 mt-10 -51.06 -8.82 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.001 0.429 . . . . 0.0 110.825 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' A' ' 171' ' ' TRP . 19.5 m -83.29 -21.86 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.747 -178.792 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -0.71 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.591 0.71 . . . . 0.0 109.677 -179.051 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.533 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 97.0 mt-10 -83.55 139.65 32.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.19 -178.253 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -44.51 123.57 3.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.063 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.545 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 45.7 m80 -114.25 22.84 13.4 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.056 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.06 19.73 79.72 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.237 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -147.59 164.27 33.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.065 0.459 . . . . 0.0 111.28 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.15 89.08 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.852 179.512 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -129.23 125.53 37.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.595 -179.118 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.7 tt -79.46 148.09 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.269 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.2 m -135.95 125.44 25.1 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.908 -179.879 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.94 127.42 53.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.499 179.866 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.9 pt -136.79 176.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.622 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.584 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.9 p . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.163 -179.178 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.584 ' NH1' ' O ' ' A' ' 186' ' ' THR . 8.6 ptp180 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.135 0.493 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.58 141.68 47.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.06 178.7 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.2 t -132.09 133.99 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.151 0.5 . . . . 0.0 110.99 -179.504 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.24 133.28 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.337 -179.415 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.51 135.89 53.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.707 -179.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.07 135.64 8.75 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -179.757 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -92.13 138.65 31.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.555 -179.24 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.26 127.11 30.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.112 0.482 . . . . 0.0 110.543 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 -23.01 4.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.341 -179.036 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 173.43 178.11 43.16 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.289 -178.513 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.6 m -151.95 152.29 32.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 111.285 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -148.74 177.53 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.549 179.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.06 146.6 24.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.344 0.592 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -76.02 79.8 2.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.693 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.317 -0.824 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.718 178.443 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.485 1.029 0 CA-C-O 120.923 0.301 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 55.4 t0 -72.6 158.65 35.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.458 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 3.9 mm? -64.03 -20.53 65.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.766 -179.359 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.0 92.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.289 -179.727 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.8 -32.64 63.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 179.729 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.68 -45.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.854 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.91 90.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.026 179.839 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -79.03 -23.53 44.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.253 -179.392 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 105.1 0.51 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.868 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.6 m -96.58 80.74 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 tp -74.88 148.02 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.182 179.334 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 77' ' ' LYS . 42.4 t0 -81.31 91.13 6.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -52.74 -9.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.132 0.491 . . . . 0.0 110.364 -179.898 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 75' ' ' ASP . 17.5 tptm -79.65 -10.89 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.538 -179.803 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.572 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 9.0 pt20 -93.6 19.36 8.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.563 -178.785 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -83.0 146.26 7.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.855 -179.433 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.68 -6.04 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.83 -165.54 32.94 Favored Glycine 0 C--N 1.317 -0.473 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.461 ' NH1' ' C ' ' A' ' 92' ' ' LEU . 8.5 ttm-85 -151.52 154.47 36.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.303 0.573 . . . . 0.0 111.326 -179.258 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 tt -127.88 130.01 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.72 179.444 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -127.76 129.68 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.022 -179.155 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.3 mt -134.78 118.36 13.32 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -177.946 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.25 -33.67 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.736 2.29 . . . . 0.0 112.388 179.869 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.4 t -49.54 -39.41 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.696 -177.052 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 89' ' ' SER . 3.9 m -119.14 -6.23 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -178.777 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 75.28 49.9 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.305 0.574 . . . . 0.0 110.209 179.904 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 mt -111.0 125.45 53.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.251 -179.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -133.25 112.41 11.66 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.461 ' C ' ' NH1' ' A' ' 82' ' ' ARG . 76.6 mt -145.58 162.5 36.21 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.908 -177.03 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -88.06 152.05 6.99 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 123.118 2.545 . . . . 0.0 109.119 177.41 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.1 t -98.15 115.63 38.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.757 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 mt -101.66 122.96 44.86 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.066 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -67.23 -45.06 77.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 m -69.62 99.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.453 -179.51 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.3 p -81.69 96.27 7.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.516 0.674 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.586 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.9 p -136.99 157.3 47.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.924 -179.584 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.15 -31.97 65.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.648 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -78.27 -45.28 23.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.617 0.722 . . . . 0.0 111.295 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.636 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -66.25 -35.17 79.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.494 -178.171 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.83 -15.4 58.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.933 -178.797 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 mt -71.37 -27.22 63.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.894 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.6 m -94.31 -8.78 37.99 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.753 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.2 -158.16 28.48 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.814 -178.591 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.09 126.58 37.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.875 -0.662 . . . . 0.0 109.941 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.02 147.46 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 -179.779 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 44.5 p -71.02 147.7 48.34 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.35 -43.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -89.82 -171.32 3.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.028 -178.721 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -121.58 -9.27 8.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.982 0.42 . . . . 0.0 111.535 -178.212 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -139.36 39.86 2.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.017 0.437 . . . . 0.0 111.393 -177.66 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -91.33 157.45 17.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.098 179.713 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.4 t -132.61 131.66 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.639 179.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.6 mtt -66.93 129.3 39.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.006 178.75 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.27 3.37 75.69 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -141.77 120.98 13.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.71 -165.75 54.75 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -178.867 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.438 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 57.0 t-20 -90.23 109.98 21.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.614 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.69 102.26 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.922 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.22 129.83 37.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.474 0.654 . . . . 0.0 111.966 -179.177 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -127.04 132.35 50.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.526 178.637 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.24 141.66 45.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.556 0.693 . . . . 0.0 110.76 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.1 -179.04 20.31 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.588 -179.531 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 31.0 m-70 -81.84 145.08 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 129' ' ' SER . 22.9 t-20 -116.87 28.1 8.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmm -46.49 -12.15 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.911 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 127' ' ' ASN . 1.6 p 60.59 40.98 16.07 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.078 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 88.4 tttt -134.42 115.15 13.67 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.768 -179.087 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -57.46 126.39 27.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.668 0.747 . . . . 0.0 110.156 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.49 -22.61 17.05 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.578 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 55.6 t -84.3 177.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.073 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.578 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -72.19 133.19 44.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.607 0.241 . . . . 0.0 110.4 -178.247 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 46.16 33.0 1.59 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.297 0.57 . . . . 0.0 110.551 178.343 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 0.9 OUTLIER -81.86 -4.37 56.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.817 -178.571 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.455 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 22.8 t70 -147.09 39.76 1.02 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.605 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.69 -27.29 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.927 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.38 3.53 10.87 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.719 -179.604 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.455 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.2 m -95.35 -12.98 25.15 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.406 0.622 . . . . 0.0 109.694 -179.55 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.87 125.15 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.983 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -96.81 158.43 15.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.607 -179.837 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -61.46 128.03 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.874 -179.615 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 90.67 20.22 41.33 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.784 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -85.82 132.33 34.13 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.406 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -79.79 135.69 36.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.812 -178.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 158' ' ' TYR . 84.5 mt -127.66 122.3 58.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.542 179.302 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.443 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.0 m-85 -100.18 117.66 34.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.975 -179.071 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.48 142.37 46.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.967 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.421 ' O ' ' SD ' ' A' ' 116' ' ' MET . 34.5 m-85 -116.06 132.95 56.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 111.471 -178.842 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.0 t0 -113.94 -166.38 1.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.6 m-20 -22.54 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.539 0.524 . . . . 0.0 111.676 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -137.81 28.28 2.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.289 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -126.93 143.77 51.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.899 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -109.18 121.62 45.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.844 179.067 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -104.65 132.01 51.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.418 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.443 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 70.2 mm-40 -94.62 112.65 24.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.992 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.5 m-85 -114.39 137.38 51.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.436 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.89 54.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 111.382 178.785 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 144' ' ' GLY . 44.3 t -67.38 132.64 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.959 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -112.26 -29.39 7.57 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 124.619 1.199 . . . . 0.0 111.13 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.19 145.18 8.45 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.498 -179.765 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 97.8 t -121.86 138.24 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.784 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.5 m -159.34 171.88 18.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.693 -178.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.04 133.27 54.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.718 179.964 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 m -138.78 159.66 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.3 -178.691 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 169' ' ' ASP . 3.6 p -69.11 133.59 89.72 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.146 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.07 -13.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.046 1.831 . . . . 0.0 111.794 -178.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.1 m-20 -78.84 -22.36 46.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.903 -177.963 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -85.67 75.91 10.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.847 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.58 ' C ' ' H ' ' A' ' 173' ' ' VAL . 83.3 m95 -74.05 -20.03 60.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.992 -179.18 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 57.1 mp0 -52.24 -6.79 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.821 179.575 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.58 ' H ' ' C ' ' A' ' 171' ' ' TRP . 24.4 m -89.81 -3.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.101 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.9 -7.24 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.745 0.783 . . . . 0.0 109.012 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.18 157.03 25.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.239 -176.749 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.89 127.52 32.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.092 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -102.11 -41.44 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.075 -179.78 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 140.84 28.03 0.19 Allowed Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.498 ' NZ ' ' CD ' ' A' ' 181' ' ' GLU . 19.7 pttp -156.37 178.49 10.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 4.6 m-20 -92.19 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.72 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.498 ' CD ' ' NZ ' ' A' ' 179' ' ' LYS . 22.4 tt0 -123.18 169.39 11.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.148 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.414 ' H ' ' HG2' ' A' ' 181' ' ' GLU . 19.3 tt -130.93 143.01 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.873 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.438 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 16.0 m -136.02 123.56 22.18 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 111.489 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -111.11 123.72 50.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.405 0.621 . . . . 0.0 110.556 179.334 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.5 pt -139.77 -171.45 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.932 -178.62 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.467 0.418 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.717 -179.159 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.936 0.398 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -108.27 137.65 45.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.209 179.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 78.9 t -129.49 131.27 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.268 0.556 . . . . 0.0 110.824 -179.155 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.2 130.38 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.328 -179.755 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.47 135.86 54.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.574 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.43 147.97 18.45 Favored Glycine 0 N--CA 1.465 0.619 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.772 -179.791 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -103.32 140.22 37.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.933 -0.633 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.1 tp -66.11 125.76 26.5 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.204 0.526 . . . . 0.0 110.802 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.11 -24.21 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.042 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.88 176.63 46.04 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 119.93 -1.128 . . . . 0.0 112.102 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.7 m -153.51 151.48 29.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 110.94 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -150.09 178.39 9.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.677 179.439 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.34 144.85 24.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.157 0.503 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.45 79.55 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.763 -179.529 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.601 178.479 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.484 0.921 0 N-CA-C 111.137 -0.37 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.09 146.58 52.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.823 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.81 -28.84 66.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.77 91.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.459 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.09 -35.39 66.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.805 179.469 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.87 -43.7 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.743 -179.181 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.35 83.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -87.89 -15.5 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.563 -178.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.39 133.05 53.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.521 179.658 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.1 p -90.9 159.4 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.054 179.598 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.0 tp -125.89 135.55 52.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.956 0.407 . . . . 0.0 111.112 -179.16 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.482 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.3 m-20 -89.91 89.31 7.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.763 179.756 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 4.6 mptp? -46.8 -16.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.18 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.482 ' N ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -65.64 -35.91 82.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.285 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 18.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.563 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.2 123.01 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.888 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.94 -7.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.016 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.15 38.54 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -147.31 153.51 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.068 -178.64 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.8 tt -126.97 131.05 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.206 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.6 m -130.9 132.36 45.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.211 -178.765 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.15 129.85 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 -178.461 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.48 -35.05 0.26 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.397 2.064 . . . . 0.0 112.102 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -47.21 -38.73 12.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.491 -176.859 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.0 p -120.58 -0.54 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.845 -178.936 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 53.74 3.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.168 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.1 tp -116.06 133.84 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.34 116.37 13.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.522 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.2 mt -144.53 110.87 4.94 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -41.29 141.01 1.31 Allowed 'Trans proline' 0 N--CA 1.486 1.041 0 C-N-CA 121.79 1.66 . . . . 0.0 110.326 176.206 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.4 t -89.65 125.5 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.036 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.7 mt -108.95 122.45 47.25 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.28 -48.58 72.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.974 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 m -71.59 103.78 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.042 -179.613 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.529 ' OG ' ' O ' ' A' ' 109' ' ' THR . 3.2 m -84.32 101.48 11.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.273 0.558 . . . . 0.0 110.078 179.537 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.61 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 6.4 p -132.75 156.19 47.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.099 -179.75 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -55.83 -26.94 49.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.545 -179.505 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.32 -43.73 14.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.374 0.607 . . . . 0.0 111.947 -179.507 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.61 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 98.3 m-20 -66.44 -34.31 77.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.621 -179.138 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.4 mt -68.94 -12.67 61.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.03 -178.593 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.6 mt -76.14 -13.14 60.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.121 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -121.35 -7.52 9.26 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.52 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.6 47.58 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.832 -179.742 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.17 129.07 36.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.955 179.375 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.63 146.65 30.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.986 -179.64 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.529 ' O ' ' OG ' ' A' ' 98' ' ' SER . 32.9 p -75.41 149.92 38.47 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.791 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.46 -40.52 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.845 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -87.82 145.07 26.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 111.044 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.16 -16.9 64.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.077 -179.141 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -144.86 52.02 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.295 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -80.73 155.55 26.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.656 179.557 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -133.08 127.7 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.0 mtt -71.49 126.65 30.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.256 179.482 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.91 70.94 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.521 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -139.2 119.71 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.259 -179.161 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -164.35 54.57 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.25 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.58 HD22 ' CB ' ' A' ' 183' ' ' THR . 1.3 t30 -90.02 109.82 20.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.732 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -84.96 101.1 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.39 126.29 35.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 112.135 -178.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.4 130.92 53.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.454 178.146 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.2 139.49 45.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.46 0.647 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.89 -178.78 19.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 134' ' ' LEU . 36.0 m-70 -85.16 140.65 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 110.66 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 28.6 t-20 -108.22 28.2 8.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.388 0.614 . . . . 0.0 110.265 -179.91 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -44.28 -13.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.873 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 55.45 39.56 31.14 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.942 179.264 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.639 ' H ' ' HG ' ' A' ' 136' ' ' SER . 79.8 tttt -134.7 123.05 23.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.607 -178.782 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -64.08 123.64 19.55 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.132 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.59 25.05 5.62 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.546 -177.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.41 HG11 ' H ' ' A' ' 134' ' ' LEU . 3.0 t -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.952 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -70.26 131.72 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.43 -177.838 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 47.14 32.74 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.077 0.465 . . . . 0.0 110.893 178.251 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.639 ' HG ' ' H ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.45 -10.31 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.022 -178.948 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.5 m-20 -144.5 38.08 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.26 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -68.12 -35.24 70.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.943 0.401 . . . . 0.0 111.657 179.75 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.58 3.3 1.9 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.88 -179.381 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 138' ' ' ILE . 19.0 m -95.61 -12.61 25.35 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.127 0.489 . . . . 0.0 109.861 -179.447 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -67.42 125.28 25.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.98 159.68 14.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.708 -179.806 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -60.22 128.0 34.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -179.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.14 22.32 32.88 Favored Glycine 0 N--CA 1.463 0.444 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.935 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.86 132.4 34.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.221 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -79.93 130.19 35.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.275 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 89.5 mt -125.3 124.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.31 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -106.7 122.45 46.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.484 -178.651 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.91 148.49 39.96 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.369 -179.584 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.92 131.76 53.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.364 0.602 . . . . 0.0 111.438 -179.834 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 152' ' ' ASN . 26.2 t70 -114.64 -165.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.011 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 151' ' ' ASP . 2.3 t-20 -23.78 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.178 0.514 . . . . 0.0 111.733 179.463 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -139.61 25.6 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.911 178.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -124.05 141.62 51.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.689 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.538 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 75.5 tt0 -106.49 121.06 43.51 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.059 179.321 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.44 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.5 m-85 -104.29 128.32 52.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -95.01 117.55 30.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.571 178.652 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -117.78 141.09 48.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.186 -179.346 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.03 136.49 54.86 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.172 0.51 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.13 132.25 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.756 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.5 t -111.8 -26.78 8.78 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 124.799 1.312 . . . . 0.0 111.37 -179.067 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.27 149.66 9.61 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.418 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.74 148.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.6 p -160.3 168.76 24.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.157 0.503 . . . . 0.0 111.365 -177.987 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.453 ' OE1' ' CE1' ' A' ' 197' ' ' TYR . 1.6 pm0 -117.95 124.28 47.85 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.456 179.722 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.71 160.32 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.249 -178.412 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 169' ' ' ASP . 15.0 p -71.62 138.23 83.25 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.455 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.94 -14.9 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.012 1.808 . . . . 0.0 111.993 -178.7 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 65.4 t0 -78.96 -11.5 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.552 -177.86 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -84.77 64.53 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.182 0.515 . . . . 0.0 110.357 179.476 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 173' ' ' VAL . 86.3 m95 -70.1 -30.87 68.2 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.218 -179.716 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 41.4 mp0 -47.3 -15.97 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.212 0.53 . . . . 0.0 110.672 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 171' ' ' TRP . 87.4 t -66.13 -43.07 92.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.284 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 13.4 m -98.94 2.16 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.624 0.725 . . . . 0.0 110.506 -178.221 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.57 120.28 25.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.417 -1.265 . . . . 0.0 112.08 -178.569 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -31.79 122.81 0.28 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.506 178.846 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -105.41 -41.73 5.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.47 27.1 0.14 Allowed Glycine 0 N--CA 1.471 1.013 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -154.09 173.75 15.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.654 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -96.07 86.94 4.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.292 179.016 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -128.07 128.53 45.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.271 -179.286 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.3 tt -81.43 147.26 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.527 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.58 ' CB ' HD22 ' A' ' 120' ' ' ASN . 7.8 m -136.87 118.1 14.52 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 111.025 -179.608 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 9.7 mp -103.44 126.18 50.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.381 0.61 . . . . 0.0 110.999 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.8 pt -138.45 -177.13 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.592 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.562 ' CG2' ' HE ' ' A' ' 196' ' ' ARG . 15.2 t . . . . . 0 N--CA 1.465 0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.562 ' HE ' ' CG2' ' A' ' 186' ' ' THR . 5.6 ptp85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.917 0.389 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.453 ' CE1' ' OE1' ' A' ' 165' ' ' GLU . 4.3 m-85 -92.58 140.54 29.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.938 179.158 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.2 134.54 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 -179.437 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.4 130.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.809 -179.39 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.23 136.14 53.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.141 179.505 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.63 140.19 11.6 Favored Glycine 0 N--CA 1.468 0.813 0 CA-C-O 121.648 0.582 . . . . 0.0 111.709 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.3 t0 -96.61 140.18 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.966 -179.09 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.481 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 12.1 tp -67.45 129.15 39.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 111.004 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 79.6 t -106.93 -23.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.25 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.49 162.53 21.92 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.687 178.774 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.44 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 48.0 m -138.79 157.49 45.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.246 0.546 . . . . 0.0 109.934 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.538 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.8 pttp -150.33 178.5 8.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.097 179.864 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -96.11 140.27 31.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.768 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -61.97 79.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.482 -179.44 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 208' ' ' ALA . 99.2 mttt . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.518 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m 51.67 -147.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.702 0.287 . . . . 0.0 110.325 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.633 ' C ' ' H ' ' A' ' 57' ' ' ASP . 99.1 m-70 -80.7 12.38 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.758 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.0 mtt 55.34 -0.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.988 0.423 . . . . 0.0 111.099 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.633 ' H ' ' C ' ' A' ' 55' ' ' HIS . 73.9 m-20 -92.37 4.45 53.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.984 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.61 -37.77 70.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.648 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 61' ' ' ILE . 80.2 p -86.73 18.65 3.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.719 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -68.24 40.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.094 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.507 ' H ' ' C ' ' A' ' 59' ' ' SER . 32.6 mm -66.28 -44.67 91.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 0.0 110.355 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 64' ' ' PRO . 15.9 t0 61.24 123.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -38.06 93.0 0.06 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 123.157 0.285 . . . . 0.0 110.489 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.46 ' N ' ' O ' ' A' ' 62' ' ' ASP . 5.4 Cg_exo -73.81 157.72 47.42 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.372 1.381 . . . . 0.0 112.39 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.66 149.2 45.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.551 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.18 -24.47 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.094 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.5 86.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.44 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -73.4 -35.96 65.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.177 179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.98 -43.23 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.509 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.05 88.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -84.26 -19.81 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.53 131.95 51.78 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.582 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 m -92.3 152.42 19.8 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.378 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.2 tp -116.38 130.3 56.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.907 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -94.13 88.97 5.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -50.43 -11.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 110.299 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 75' ' ' ASP . 69.2 mmtt -74.52 -9.28 58.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.513 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.482 ' OE1' ' OG ' ' A' ' 97' ' ' SER . 76.7 mt-30 -106.51 16.51 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.37 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.6 126.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.774 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.33 -4.62 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.761 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.7 -167.54 36.55 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.647 ' HE ' ' HZ3' ' A' ' 209' ' ' LYS . 44.4 mtt-85 -146.92 155.24 42.13 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.973 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.8 tt -127.55 126.44 67.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.329 0.585 . . . . 0.0 109.821 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -125.14 130.55 52.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.006 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.48 79.57 59.79 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.252 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -43.6 -35.89 6.7 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.909 2.406 . . . . 0.0 112.972 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 m -49.11 -37.39 21.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.1 p -115.59 0.59 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.622 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.59 47.83 2.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.3 tp -115.04 129.32 56.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.737 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -134.34 120.66 20.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -146.72 162.47 33.59 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.241 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.64 151.68 8.83 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.826 2.35 . . . . 0.0 109.646 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -99.35 113.98 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.43 122.31 42.96 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.45 -45.73 82.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.797 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.549 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 91.5 p -70.79 104.57 2.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.152 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.0 p -82.79 99.81 9.91 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.254 0.55 . . . . 0.0 110.098 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.603 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 65.2 p -131.29 158.17 41.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.855 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.1 -26.42 68.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -83.23 -41.23 18.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.299 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.603 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 98.5 m-20 -66.46 -36.21 82.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.503 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -66.32 -14.7 62.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -75.49 -13.93 60.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -121.09 -4.49 9.54 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.38 -176.54 44.65 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.633 -1.27 . . . . 0.0 112.286 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.15 125.29 32.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.29 -0.455 . . . . 0.0 109.812 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.0 145.4 30.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.0 p -71.68 149.1 45.81 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.22 -44.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.94 -171.18 2.77 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.03 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -108.01 -56.78 2.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.809 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -91.17 46.54 1.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.59 150.27 24.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.133 0.492 . . . . 0.0 109.931 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.29 132.16 52.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.403 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.5 mtt -73.78 127.33 32.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 0.0 110.263 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.37 -0.9 68.87 Favored Glycine 0 C--O 1.23 -0.14 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -137.72 119.48 15.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.508 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -171.71 54.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.5 t30 -86.15 111.52 20.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -83.84 106.79 15.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.74 128.53 36.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.048 0.451 . . . . 0.0 112.081 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.1 mt -126.0 130.55 51.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.027 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.98 141.68 47.11 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.342 0.591 . . . . 0.0 110.768 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.48 -177.41 18.39 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.283 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.0 m-70 -82.69 150.0 27.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.1 0.476 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.664 ' ND2' ' HG ' ' A' ' 189' ' ' SER . 61.2 t30 -117.59 27.96 8.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.715 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.4 mmm -45.43 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.7 p 62.82 41.03 9.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.19 0.519 . . . . 0.0 110.201 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.83 109.66 9.24 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.884 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -51.66 127.87 21.74 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.44 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.7 -25.5 14.76 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.589 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 45.9 t -82.51 177.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 117.54 0.67 . . . . 0.0 109.499 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.589 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.22 136.91 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.315 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 44.57 32.73 0.8 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.045 0.45 . . . . 0.0 110.656 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -81.89 -8.11 59.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.207 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -149.96 41.91 0.85 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.731 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 140' ' ' SER . 11.2 pt -68.08 -33.85 63.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.371 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.21 5.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.104 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 138' ' ' ILE . 23.0 t -94.57 -16.79 22.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.2 124.95 23.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.835 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.65 156.13 16.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.566 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 144' ' ' GLY . 5.6 tmtt? -56.85 127.35 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.675 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.4 ' N ' ' HD3' ' A' ' 143' ' ' LYS . . . 90.9 21.72 35.38 Favored Glycine 0 CA--C 1.516 0.139 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -82.75 134.66 35.12 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.542 ' NZ ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 mmmm -80.96 121.78 26.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.565 0.698 . . . . 0.0 112.312 -178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 94.4 mt -117.69 117.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.11 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.548 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.1 m-85 -100.32 119.02 37.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.43 144.68 44.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.73 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -116.41 136.75 52.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.411 0.624 . . . . 0.0 111.565 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.54 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 32.2 t70 -114.74 -171.07 1.86 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.54 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 4.9 p30 -21.17 -73.53 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.072 0.463 . . . . 0.0 111.658 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.2 mt-10 -138.38 26.0 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.82 147.89 45.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.369 0.604 . . . . 0.0 112.254 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -113.08 120.43 41.31 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -104.29 131.18 51.89 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.073 0.463 . . . . 0.0 111.36 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.548 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 42.4 tp10 -94.52 114.77 26.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -114.5 141.92 47.07 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.63 135.7 54.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.538 0.685 . . . . 0.0 111.428 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.3 132.27 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.875 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -105.97 -27.74 10.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 124.917 1.386 . . . . 0.0 110.709 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.84 141.12 3.68 Favored Glycine 0 C--N 1.32 -0.328 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.405 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.2 p -106.08 139.8 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.058 -0.571 . . . . 0.0 109.564 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.9 t -154.09 166.72 32.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.345 0.593 . . . . 0.0 111.557 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.03 125.95 53.14 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.665 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.07 153.97 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.805 0.336 . . . . 0.0 110.995 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 p -60.0 167.2 2.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.75 -13.69 11.68 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.949 1.766 . . . . 0.0 111.446 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 36.9 p30 -82.91 -18.49 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.881 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.445 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.2 ttmt -86.72 74.75 9.76 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.073 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -75.54 -7.54 54.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.868 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -52.57 -25.42 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.039 0.447 . . . . 0.0 110.557 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 74.4 t -75.71 -16.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.228 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.71 -13.78 10.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.665 0.745 . . . . 0.0 109.676 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.01 152.66 24.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.919 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.54 133.93 53.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -101.18 -39.07 7.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.45 30.33 0.35 Allowed Glycine 0 N--CA 1.469 0.843 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -156.23 179.31 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.262 0.553 . . . . 0.0 111.369 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.23 89.71 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -125.06 166.13 16.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.193 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.29 142.45 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 18.0 m -134.37 127.01 30.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.573 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.0 mp -113.56 126.86 55.76 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.106 0.479 . . . . 0.0 109.722 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 28.6 pt -140.32 -169.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.519 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 33.3 p -138.23 152.23 48.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.732 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 19.4 m -66.32 -46.79 75.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.52 145.4 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.193 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.664 ' HG ' ' ND2' ' A' ' 127' ' ' ASN . 37.9 t -144.28 133.26 22.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.127 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 98.5 t 48.61 -85.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.931 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 189' ' ' SER . 66.0 tttm -145.67 158.85 43.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.729 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.82 -47.03 81.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 110.162 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -63.51 -39.83 95.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.058 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.8 m -60.04 171.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.4 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -97.08 -173.16 2.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.395 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -140.42 162.05 36.25 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.214 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.5 133.58 42.67 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.59 137.02 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.2 t -116.01 128.15 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.465 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.16 136.87 52.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.212 0.529 . . . . 0.0 110.074 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.46 25.85 Favored Glycine 0 N--CA 1.462 0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.451 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -115.61 150.1 37.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.043 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 41.8 tp -69.9 127.12 31.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.506 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.13 -24.43 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.759 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 175.01 45.81 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.532 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.5 m -153.3 151.66 30.26 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 121.375 0.607 . . . . 0.0 111.015 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -149.84 179.03 8.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.395 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.26 145.7 24.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.168 0.508 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.647 ' HZ3' ' HE ' ' A' ' 82' ' ' ARG . 88.5 tttt -74.14 80.0 1.76 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.321 -0.63 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.872 178.758 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.8 p -75.72 162.09 28.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.745 0.307 . . . . 0.0 110.318 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -76.36 158.48 31.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 110.123 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 55.5 ttp -59.38 -43.08 92.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.14 0.495 . . . . 0.0 110.422 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 7.7 p30 -95.84 102.77 14.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.395 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.69 -8.05 55.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.855 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 t -84.22 -92.86 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.514 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp 50.46 39.97 22.03 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.009 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mm -63.66 -44.21 98.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.929 0.395 . . . . 0.0 110.196 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.7 t0 58.88 -111.48 0.56 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.35 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -142.06 80.13 15.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -42.13 148.3 0.4 Allowed 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.063 1.842 . . . . 0.0 111.533 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 162.78 29.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.063 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.22 -25.18 65.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.978 0.418 . . . . 0.0 110.247 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.13 89.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.004 0.43 . . . . 0.0 110.447 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -73.67 -33.71 64.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 110.788 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.28 -45.54 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.754 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.19 88.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.183 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -80.85 -24.11 38.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.209 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.45 141.5 58.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.712 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.6 m -139.22 119.28 13.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.578 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.2 tp -120.31 140.41 51.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.825 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.08 138.55 57.22 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.16 -10.51 59.14 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.169 0.509 . . . . 0.0 109.995 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -81.12 -8.96 59.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -90.99 11.84 21.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.529 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 m -88.63 146.36 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.121 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.8 -6.98 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 111.393 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.16 -170.76 36.41 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -146.26 148.75 32.78 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.569 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 83' ' ' ILE . 18.6 tt -122.81 121.74 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -123.49 129.31 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.429 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.5 mt -129.73 125.54 22.28 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.322 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.75 -39.23 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 t -49.92 -39.31 39.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.414 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.474 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -116.95 -2.18 9.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.464 0.173 . . . . 0.0 110.777 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m 63.18 50.88 2.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.31 130.6 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.137 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -137.1 114.68 11.12 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' PRO . 16.6 mt -145.92 111.17 4.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.4 Cg_endo -41.24 142.9 0.86 Allowed 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 121.643 1.562 . . . . 0.0 110.328 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.41 122.95 44.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.84 132.71 47.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.157 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.78 -27.96 68.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.2 p -69.34 -179.52 1.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.543 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 109' ' ' THR . 2.2 m -159.15 49.92 0.35 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.085 0.469 . . . . 0.0 110.272 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.493 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 67.5 p -108.03 155.1 20.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.73 -31.31 64.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -72.01 -48.11 47.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.466 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.493 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 72.2 m-20 -66.86 -38.56 86.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.183 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 mt -56.35 -16.14 5.14 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.6 mt -70.24 -31.7 69.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.0 m -90.63 -12.22 37.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.87 -175.06 44.72 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.911 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.14 130.66 41.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.64 143.25 33.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.838 0.352 . . . . 0.0 110.158 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 98' ' ' SER . 33.8 p -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.1 t -81.31 -50.22 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.413 ' N ' ' OE1' ' A' ' 114' ' ' GLN . 35.1 mmtt -94.5 147.64 23.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.997 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -87.45 -6.3 58.47 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -126.78 31.84 5.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.107 0.48 . . . . 0.0 111.329 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.413 ' OE1' ' N ' ' A' ' 111' ' ' LYS . 20.3 pt20 -97.59 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.568 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.23 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.987 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.9 125.1 31.67 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.697 0.284 . . . . 0.0 110.395 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.55 72.92 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.87 121.44 13.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.104 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.55 55.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -83.83 110.17 18.14 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -87.48 104.26 16.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.88 121.0 33.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.681 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.31 131.66 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.022 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.07 141.04 43.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.466 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.2 -177.76 15.81 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.536 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.473 ' O ' ' O ' ' A' ' 134' ' ' LEU . 62.1 m-70 -92.99 130.25 38.63 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.083 0.468 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -91.99 28.47 1.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -35.84 -26.2 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.368 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 64.95 34.84 8.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.403 0.62 . . . . 0.0 109.596 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.43 106.91 6.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.39 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -49.11 128.62 16.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.064 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.46 -23.03 14.2 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.615 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 49.0 t -89.69 178.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.615 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.13 135.5 49.22 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.36 -177.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 44.88 39.41 3.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.193 0.521 . . . . 0.0 110.63 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 60.6 p -81.36 -8.56 59.76 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 136' ' ' SER . 77.8 m-20 -147.6 37.99 0.92 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.8 -29.85 42.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.824 0.345 . . . . 0.0 111.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.02 6.41 4.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.815 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -97.67 -13.75 21.32 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.02 123.31 19.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.896 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 23.2 tptt -96.34 169.46 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.161 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 142' ' ' LYS . 48.9 tttm -68.0 125.8 27.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 97.06 18.73 28.34 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.0 m-20 -84.32 131.76 34.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -79.52 129.99 34.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.894 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 147' ' ' ILE . 95.9 mt -125.23 126.12 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.529 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 58.0 m-85 -103.06 118.94 37.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.563 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.53 133.67 55.8 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -103.08 132.48 49.31 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 111.084 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.559 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 50.0 t0 -110.0 -167.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.679 -1.146 . . . . 0.0 107.952 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.559 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -29.66 -72.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.978 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -136.78 29.05 2.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -131.7 150.26 52.21 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -108.75 123.74 49.48 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.378 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.52 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 40.1 m-85 -104.99 129.91 53.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.391 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.529 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 73.9 mm-40 -96.65 114.92 26.61 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.15 142.93 45.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.76 132.11 54.08 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.395 0.617 . . . . 0.0 111.238 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 144' ' ' GLY . 53.7 t -66.63 134.37 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.981 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.84 -29.18 9.66 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 124.36 1.037 . . . . 0.0 110.437 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.73 157.81 17.15 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.638 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 150.74 33.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.824 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.9 m -156.48 168.2 28.1 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.259 0.552 . . . . 0.0 111.366 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -106.06 132.0 52.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.439 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.02 159.07 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 110.931 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.545 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 71.2 p -77.79 142.44 65.46 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -47.32 -18.81 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.089 1.859 . . . . 0.0 111.604 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -81.24 -2.87 50.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.974 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.6 tptt -82.03 140.59 33.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 94.4 m95 -157.78 -22.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.849 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -56.74 -17.67 9.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.397 0.617 . . . . 0.0 110.429 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.09 -6.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.321 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 m -136.23 43.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 70.5 mm-40 -144.6 84.53 1.74 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.027 -176.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 175' ' ' GLU . 92.3 m-20 27.18 108.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.231 0.957 . . . . 0.0 112.805 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -96.84 -40.34 8.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.313 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.2 29.59 0.72 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.48 178.45 10.22 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -92.83 88.84 6.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.976 0.893 . . . . 0.0 109.511 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -131.63 167.29 19.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.91 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 15.7 tt -131.67 143.42 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.5 m -136.22 129.71 32.01 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.301 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -112.4 127.58 56.06 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.24 0.543 . . . . 0.0 110.867 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 pt -141.17 -167.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.876 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.0 t -139.92 153.92 47.08 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.586 ' C ' ' H ' ' A' ' 189' ' ' SER . 72.8 m -78.52 -97.77 0.03 OUTLIER 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.213 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.8 t 56.39 -1.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.236 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.586 ' H ' ' C ' ' A' ' 187' ' ' CYS . 24.0 m 45.29 -114.43 0.44 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.414 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.55 128.33 69.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -92.54 -131.2 0.12 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.796 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -93.39 -3.26 53.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.886 0.374 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 194' ' ' SER . 16.7 t-20 -163.03 -125.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.768 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.499 ' N ' ' OD1' ' A' ' 193' ' ' ASN . 19.2 p -139.14 119.92 14.26 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -165.66 101.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.322 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 167' ' ' THR . 8.3 ttm180 -150.42 144.52 25.48 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.616 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.0 139.66 48.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 110.091 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -134.45 136.9 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 111.229 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.77 134.2 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.049 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.93 138.1 51.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.542 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.6 139.98 11.39 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.8 t0 -99.05 137.05 38.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.253 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.0 tp -63.75 126.2 26.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.287 0.565 . . . . 0.0 110.881 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.24 -25.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.825 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.7 159.91 16.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.008 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.52 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 59.5 m -135.71 157.18 47.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -148.64 178.9 8.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.237 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.8 144.88 24.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.289 0.566 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.85 80.69 2.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.472 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.633 178.107 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 t -60.04 -45.17 93.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.005 0.431 . . . . 0.0 110.668 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -84.29 133.03 34.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.304 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.5 ttt -73.25 -121.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 65.9 t0 -76.98 148.23 36.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.534 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -68.51 -40.07 80.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.474 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 t 57.06 3.12 0.13 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.523 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 58' ' ' ALA . 88.3 tttt -99.08 93.77 6.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.552 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -142.54 -80.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.065 -178.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 54.43 -80.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.922 0.391 . . . . 0.0 111.051 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 61' ' ' ILE . 5.1 pt20 -139.95 70.45 35.74 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.093 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -43.55 147.48 1.02 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.617 2.211 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.13 151.34 43.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.975 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.5 mp -55.48 -26.76 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 110.68 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.51 93.99 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.39 -32.1 64.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.674 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.58 -46.32 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.972 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.76 91.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.157 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.95 -30.12 55.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.395 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.95 158.34 11.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.869 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 p -138.56 158.84 43.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 110.62 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.4 ' CD2' ' OG ' ' A' ' 105' ' ' SER . 0.3 OUTLIER -139.21 121.48 15.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 111.172 -178.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 77' ' ' LYS . 99.2 m-20 -81.89 110.73 17.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.796 178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -47.13 -16.13 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.226 0.536 . . . . 0.0 110.318 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 75' ' ' ASP . 87.4 tttt -67.44 -33.52 75.32 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.977 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -78.41 9.45 3.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.584 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.5 t -92.91 129.11 43.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.753 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 pt -118.29 -3.43 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.81 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.95 34.41 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -157.06 164.94 37.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.714 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.9 tt -131.07 140.23 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.712 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 m -132.87 133.17 42.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.36 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.528 ' CG2' ' HG ' ' A' ' 87' ' ' SER . 67.9 mt -133.17 129.26 20.82 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.546 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.88 -36.18 0.19 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.429 2.086 . . . . 0.0 112.147 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.528 ' HG ' ' CG2' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -47.15 -38.98 12.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.409 -177.188 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.3 p -120.55 0.23 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.828 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 60.71 54.29 3.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 tp -117.74 134.83 54.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.346 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.96 117.38 14.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.9 mt -143.65 114.02 5.55 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.38 146.67 0.67 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 121.892 1.728 . . . . 0.0 109.99 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -95.3 123.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.87 123.18 47.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.87 -46.79 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.974 0.416 . . . . 0.0 111.079 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.544 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 34.9 p -69.79 102.87 2.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 98' ' ' SER . 5.6 p -82.77 103.85 12.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.421 0.629 . . . . 0.0 110.329 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.534 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 3.0 p -142.94 157.12 44.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.944 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.526 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -54.71 -32.44 59.58 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.722 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -79.13 -45.08 20.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.687 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.544 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.8 m-20 -65.19 -34.72 79.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.242 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -61.68 -21.36 64.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.375 0.607 . . . . 0.0 111.808 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.89 -32.93 73.76 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.4 ' OG ' ' CD2' ' A' ' 74' ' ' LEU . 3.8 p -87.83 -13.58 41.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.57 -171.69 44.18 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.492 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.01 127.55 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.482 . . . . 0.0 110.057 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.73 146.46 29.77 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.844 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.5 p -74.42 151.55 39.62 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.92 -42.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.442 ' N ' HE22 ' A' ' 114' ' ' GLN . 99.2 mttt -88.29 -171.99 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.027 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 21.6 pt-20 -116.7 -9.81 11.23 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 112' ' ' GLU . 17.7 m120 -145.87 43.41 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.442 HE22 ' N ' ' A' ' 111' ' ' LYS . 1.7 pm0 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.888 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.54 131.36 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.681 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.3 mtt -71.49 128.37 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.075 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 91.17 1.97 71.71 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -141.32 123.7 15.77 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.66 -164.47 54.81 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.43 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 22.1 t-20 -92.28 108.91 20.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -85.37 103.24 14.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.038 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 128.59 36.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.384 0.611 . . . . 0.0 112.15 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.56 130.47 52.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.127 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.71 140.94 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.055 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.49 -178.34 17.59 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 134' ' ' LEU . 56.8 m-70 -93.42 140.92 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.598 ' ND2' ' HZ3' ' A' ' 191' ' ' LYS . 53.3 p30 -106.44 29.44 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 110.549 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.0 mmm -42.22 -15.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.837 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 61.56 38.0 15.9 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.076 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -133.62 107.65 8.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.984 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -52.92 126.74 21.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.8 -24.61 11.77 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.616 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 42.4 t -86.66 -179.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.616 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.79 133.03 46.19 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.194 -178.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 47.26 40.82 11.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 111.149 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.8 p -81.6 -11.88 58.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.903 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 73.7 m-20 -149.82 42.8 0.88 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.433 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.7 pt -68.57 -35.56 70.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 0.0 112.013 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.7 1.58 2.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 138' ' ' ILE . 12.2 m -92.66 -13.71 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.161 0.505 . . . . 0.0 110.18 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.4 122.78 18.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.213 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.69 157.91 15.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.792 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.48 127.87 33.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.258 0.551 . . . . 0.0 111.147 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.23 16.51 40.43 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.72 133.84 34.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -81.52 134.56 35.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 111.852 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -127.82 121.04 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -101.76 120.24 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.8 tp -117.72 147.93 42.49 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -122.03 131.86 54.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.153 0.501 . . . . 0.0 111.584 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.9 t0 -112.08 -164.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 151' ' ' ASP . 28.4 m120 -21.95 -78.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.205 0.526 . . . . 0.0 111.406 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -136.31 26.07 3.2 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -123.48 142.22 51.22 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -108.15 120.52 42.58 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -104.14 130.32 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.152 0.501 . . . . 0.0 111.582 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -93.66 115.27 27.72 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 51.5 m-85 -116.78 138.61 51.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.631 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -118.59 136.79 53.67 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.247 0.546 . . . . 0.0 110.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.78 134.8 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.297 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.83 -24.12 11.79 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.357 1.036 . . . . 0.0 111.278 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 166.17 165.9 24.31 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.115 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.29 151.64 31.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.3 p -152.28 161.54 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.04 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -114.15 117.44 31.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.87 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.85 159.25 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.989 0.424 . . . . 0.0 111.28 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 169' ' ' ASP . 33.9 p -69.48 134.27 88.78 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.415 ' HB3' HH21 ' A' ' 196' ' ' ARG . 1.2 Cg_endo -46.25 -12.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.081 1.854 . . . . 0.0 111.749 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 167' ' ' THR . 96.0 m-20 -81.11 -8.73 59.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -85.97 70.1 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.133 0.492 . . . . 0.0 110.259 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.487 ' C ' ' H ' ' A' ' 173' ' ' VAL . 80.8 m95 -70.48 -30.47 67.28 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -48.81 -14.81 0.07 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.543 . . . . 0.0 110.464 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' A' ' 171' ' ' TRP . 86.1 t -75.08 -24.32 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.809 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.91 -6.64 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.703 0.763 . . . . 0.0 109.561 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -80.46 152.8 28.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.861 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p-10 -64.64 128.32 35.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.288 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.455 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.8 m80 -108.69 -42.69 4.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.62 0.248 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.47 23.99 0.09 OUTLIER Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -152.92 171.73 17.88 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -94.75 87.91 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -126.88 126.61 43.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.365 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.5 tt -81.04 148.23 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.43 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 7.2 m -136.68 121.19 18.26 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.375 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.35 126.64 52.34 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.28 0.562 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 29.7 pt -135.2 169.92 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.491 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.569 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 35.5 p -116.44 141.83 47.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.362 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 186' ' ' THR . 3.2 m 56.7 162.22 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.766 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.9 m -114.91 2.47 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.822 0.344 . . . . 0.0 111.488 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 55.4 m -145.07 172.98 12.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.1 m -71.12 135.26 28.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.598 ' HZ3' ' ND2' ' A' ' 127' ' ' ASN . 60.4 pttt -112.55 -165.35 0.98 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.8 0.333 . . . . 0.0 110.825 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 192' ' ' ASP . 29.5 p-10 -60.32 -42.35 95.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.897 0.379 . . . . 0.0 110.739 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' A' ' 192' ' ' ASP . 98.5 m-20 -103.17 132.55 49.35 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.424 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 84.8 p -79.55 -15.11 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 111.303 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -70.69 128.83 37.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.103 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 186' ' ' THR . 59.9 ttm-85 -145.64 145.06 30.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.886 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.48 133.29 49.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 81.8 t -135.16 136.82 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.65 131.65 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.615 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.22 136.69 52.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.48 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.45 11.73 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 47.9 p-10 -96.4 141.3 29.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.915 -0.643 . . . . 0.0 111.247 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.12 125.42 25.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.098 0.475 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 72.4 t -107.59 -23.21 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.535 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.83 177.9 45.22 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.883 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.9 m -154.1 152.63 30.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.159 0.504 . . . . 0.0 111.018 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -151.14 178.8 8.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.371 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.67 145.6 24.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.948 0.404 . . . . 0.0 110.534 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.19 79.04 0.96 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.32 -0.705 0 CA-C-O 117.854 -1.069 . . . . 0.0 110.724 178.59 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 t -65.06 137.69 57.85 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -142.16 106.51 4.8 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.923 0.392 . . . . 0.0 111.093 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.3 mmm -85.99 144.47 27.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.716 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.63 136.03 56.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.044 0.45 . . . . 0.0 110.194 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.12 -39.87 71.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.575 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 61' ' ' ILE . 58.2 m -88.75 31.93 0.82 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.369 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -72.59 10.57 0.8 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.317 0.579 . . . . 0.0 111.326 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.456 ' H ' ' C ' ' A' ' 59' ' ' SER . 57.4 mt -65.37 -45.15 94.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.206 0.527 . . . . 0.0 110.676 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 55.6 -98.62 0.09 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.942 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -151.16 78.25 7.25 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -42.96 147.44 0.66 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.095 1.863 . . . . 0.0 111.594 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.59 154.79 41.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.1 mm? -57.1 -27.16 61.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.707 0.289 . . . . 0.0 110.601 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.85 91.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.924 0.392 . . . . 0.0 110.041 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.29 -36.11 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.797 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -74.34 -43.9 49.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.627 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.13 86.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.27 -22.75 30.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.217 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.29 138.35 58.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.397 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -139.97 149.56 43.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.795 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 1.3 pt? -139.92 166.76 23.77 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.432 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.31 140.86 43.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.763 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.57 -2.08 40.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.196 0.522 . . . . 0.0 110.155 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -89.47 -7.25 55.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -85.84 0.33 53.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.26 135.12 26.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.73 0.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.686 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -177.95 39.83 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -147.53 151.54 36.5 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.194 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.21 123.46 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 m -123.18 128.03 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.608 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.72 116.69 13.82 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.71 -33.17 1.31 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.286 1.991 . . . . 0.0 112.376 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.0 m -50.73 -37.22 40.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.36 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -117.23 -6.79 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.252 -0.28 . . . . 0.0 110.512 -179.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.8 p 71.76 47.82 0.32 Allowed 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.64 127.51 54.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.479 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -132.82 113.9 13.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -145.0 165.43 22.21 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.001 -0.679 . . . . 0.0 112.554 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -89.01 156.38 5.82 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 123.252 2.635 . . . . 0.0 109.264 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.58 114.38 46.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.9 120.9 41.44 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.81 -45.19 83.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.985 0.421 . . . . 0.0 110.776 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 4.2 m -67.05 103.93 1.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.936 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -82.03 109.0 15.96 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 110.318 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.512 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -143.35 155.77 44.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.24 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -61.19 -28.03 68.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -80.22 -46.64 15.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.898 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.4 p-10 -68.78 -31.16 69.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.585 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -61.89 -20.39 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.84 -14.41 61.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 m -103.22 -10.22 18.94 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.82 -153.04 18.91 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.247 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.81 127.86 44.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.115 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.34 148.85 29.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 p -73.53 149.61 42.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 t -84.8 -42.22 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 9.5 tptp -90.28 -172.65 3.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.788 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.427 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 46.6 tp10 -107.04 -57.9 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.343 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.93 45.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.296 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.45 154.17 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.085 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.19 135.19 63.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 mtp -78.05 122.55 25.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.61 2.43 60.0 Favored Glycine 0 N--CA 1.461 0.314 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -140.59 128.28 21.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.076 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.68 -169.65 49.96 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.5 107.17 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -85.39 103.21 14.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.62 126.27 35.9 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.485 0.66 . . . . 0.0 112.208 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.6 mt -120.49 131.22 54.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.512 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.69 138.49 45.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.582 0.706 . . . . 0.0 110.921 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.69 -178.39 16.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.556 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 80.7 m-70 -90.79 139.69 30.49 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' SER . 64.2 t30 -102.52 28.53 5.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 109.91 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.49 -24.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.184 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 64.44 36.71 8.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.416 0.627 . . . . 0.0 109.61 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.483 ' N ' ' OG ' ' A' ' 136' ' ' SER . 26.1 mtpp -134.34 111.67 10.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.917 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.41 126.12 18.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.625 0.726 . . . . 0.0 110.226 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.6 9.7 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.564 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 58.6 t -79.09 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 117.749 0.775 . . . . 0.0 109.484 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.621 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.57 134.37 46.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.24 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 45.17 33.78 1.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.159 0.504 . . . . 0.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.2 -8.51 59.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -146.68 39.74 1.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.29 -30.02 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.863 0.363 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.06 3.36 5.55 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.135 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -95.81 -13.9 23.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.2 mt -66.21 126.4 28.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.704 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -97.2 158.84 15.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.415 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.16 138.64 58.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.434 0.635 . . . . 0.0 111.317 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.61 65.09 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -81.11 136.83 35.96 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.2 122.64 25.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.635 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mm -115.39 119.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.73 118.23 36.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 tp -119.94 154.96 33.69 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.02 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -127.32 135.68 50.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.505 0.669 . . . . 0.0 112.118 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.0 t0 -115.52 -167.04 1.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.29 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.224 0.535 . . . . 0.0 111.798 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -138.09 28.66 2.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -127.8 140.58 51.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 78.7 tt0 -103.35 122.17 44.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.572 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.533 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 55.0 m-85 -104.25 127.05 51.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.394 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 157' ' ' GLU . 39.7 mp0 -94.64 115.45 27.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.071 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.412 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -119.14 134.08 55.41 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.342 0.591 . . . . 0.0 110.718 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.04 133.42 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.736 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.4 p -103.79 -26.81 12.57 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 124.524 1.14 . . . . 0.0 110.794 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.36 165.6 19.65 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.995 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.7 p -121.79 149.21 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.5 m -153.22 164.28 38.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.088 0.47 . . . . 0.0 111.196 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -107.82 102.83 12.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.3 m -117.05 144.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.102 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.8 p -61.32 167.02 4.42 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.54 -14.48 11.56 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.958 1.772 . . . . 0.0 111.982 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 65.9 t0 -84.54 -20.28 31.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -85.82 81.27 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.538 . . . . 0.0 110.214 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.55 ' C ' ' H ' ' A' ' 173' ' ' VAL . 95.4 m95 -75.77 -15.16 60.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.898 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 40.7 mp0 -51.99 -6.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.146 0.498 . . . . 0.0 110.968 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 171' ' ' TRP . 73.2 t -88.65 -19.06 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.163 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.68 -6.29 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.488 0.661 . . . . 0.0 109.383 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -82.07 150.9 27.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.18 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -60.72 127.29 30.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 25.9 m170 -116.44 24.3 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.77 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 15.62 68.05 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -149.64 167.89 25.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 111.183 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.65 97.84 8.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.717 0.77 . . . . 0.0 110.734 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.73 135.09 45.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.36 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.4 tt -82.62 147.96 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 7.3 m -136.5 117.54 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.931 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.4 mp -101.73 124.19 46.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.071 0.462 . . . . 0.0 110.174 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 13.8 pt -137.38 -176.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.06 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.551 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 43.0 p -137.27 147.7 45.9 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.509 ' O ' ' SG ' ' A' ' 187' ' ' CYS . 54.1 t -98.45 34.62 1.96 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.113 0.482 . . . . 0.0 110.718 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 52.2 t -95.42 127.54 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.6 t -66.44 144.73 56.33 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.997 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.7 p -123.15 132.92 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.808 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -147.28 -62.57 0.28 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.803 0.335 . . . . 0.0 111.614 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -92.32 108.39 19.92 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.791 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.508 ' CG ' ' H ' ' A' ' 194' ' ' SER . 64.3 t30 46.44 -164.67 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.508 ' H ' ' CG ' ' A' ' 193' ' ' ASN . 2.1 p 62.2 140.71 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.435 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -136.57 143.85 43.86 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 111.362 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.1 ttm180 -69.07 135.8 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.009 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -108.66 139.12 43.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.395 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.35 139.04 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.394 0.616 . . . . 0.0 111.467 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.53 130.63 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.79 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.81 135.65 53.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.263 0.554 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.52 153.71 20.56 Favored Glycine 0 N--CA 1.46 0.292 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 50.5 p-10 -108.18 142.27 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.728 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.08 127.87 34.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.413 0.625 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.84 -26.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.186 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.16 162.17 20.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.533 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 25.5 m -136.88 156.17 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.245 0.545 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.1 pttp -150.9 179.13 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.08 142.87 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.401 0.62 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -61.97 81.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.561 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttp . . . . . 0 C--N 1.313 -0.983 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.57 178.427 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.3 m -59.35 -43.05 92.86 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.511 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 43.86 82.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.438 . . . . 0.0 110.748 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 92.8 mtp -65.11 -40.1 94.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.592 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -86.72 114.01 23.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.5 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.95 -14.15 61.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.568 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.578 ' C ' ' H ' ' A' ' 61' ' ' ILE . 83.5 p -88.14 0.1 56.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.809 0.338 . . . . 0.0 111.21 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -66.45 14.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.463 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.578 ' H ' ' C ' ' A' ' 59' ' ' SER . 29.6 mm -63.82 -45.47 97.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.101 0.476 . . . . 0.0 110.169 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 54.41 -94.39 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.188 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.87 78.99 7.2 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.595 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -43.51 147.96 0.89 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.017 1.811 . . . . 0.0 111.971 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -73.42 158.36 35.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.227 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -25.85 30.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.32 91.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -75.08 -26.08 59.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.235 0.541 . . . . 0.0 110.474 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.8 t -79.4 -49.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.942 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.95 81.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.173 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -68.78 -32.1 71.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.334 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.24 113.3 2.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.938 0.399 . . . . 0.0 111.219 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -92.21 133.59 35.67 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.97 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.2 tp -129.57 134.85 47.96 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.757 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -94.02 132.26 38.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 69.5 mmtt -66.34 -9.5 33.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.474 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' A' ' 79' ' ' VAL . 63.7 mttp -65.44 -34.37 78.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.835 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.23 17.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.8 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 77' ' ' LYS . 4.8 p -92.31 127.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pt -122.45 -2.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.03 38.49 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -147.88 153.28 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.854 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.69 122.27 63.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m -121.35 127.96 51.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.584 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.4 mt -133.75 120.42 15.47 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.81 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.84 -32.33 1.55 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.829 1.686 . . . . 0.0 112.331 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.1 p -47.87 -37.39 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.975 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.7 p -118.32 0.12 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.476 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t 63.49 52.79 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -119.54 133.07 55.84 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -135.31 119.74 17.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 mt -145.46 167.32 14.68 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.023 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.94 150.09 7.09 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.886 2.391 . . . . 0.0 109.652 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.6 t -102.18 113.91 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.45 -45.05 85.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.972 0.415 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.5 p -71.33 106.91 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.232 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.7 p -83.79 107.14 16.02 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.094 0.473 . . . . 0.0 110.234 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.572 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 3.8 p -137.43 156.59 48.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.113 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -57.86 -36.45 72.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -74.72 -43.65 53.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.387 0.613 . . . . 0.0 112.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.572 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 92.3 m-20 -66.43 -35.45 80.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.441 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 126' ' ' HIS . 36.4 mt -65.56 -15.93 63.19 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.65 -14.18 60.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.8 m -116.53 -7.41 11.63 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.0 -163.83 28.74 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.117 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.49 130.33 47.74 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.083 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.25 147.91 34.02 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.3 p -76.47 153.79 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.06 -46.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -92.18 142.16 27.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.123 0.487 . . . . 0.0 111.179 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.4 pt-20 -62.58 -51.41 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.662 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 8.4 m120 -96.75 47.88 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.379 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -83.59 154.22 23.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.79 130.25 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.595 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.1 mtt -72.61 128.39 35.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.762 0.315 . . . . 0.0 110.948 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.522 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.19 4.91 73.7 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -140.93 120.65 13.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.257 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.64 -166.9 54.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -85.07 106.29 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.57 101.18 11.91 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.93 130.82 36.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.991 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.92 132.21 53.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.09 137.72 46.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.351 0.596 . . . . 0.0 110.596 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.19 -176.5 19.22 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.517 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 103' ' ' LEU . 76.3 m-70 -93.28 157.51 16.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.826 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.0 p-10 -122.05 29.04 7.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.585 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.2 mmt -38.15 -20.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.636 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 59.93 37.44 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.275 0.56 . . . . 0.0 109.836 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 136' ' ' SER . 58.3 tttp -136.49 107.73 6.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.767 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -58.4 130.24 45.81 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.59 0.71 . . . . 0.0 111.249 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.02 15.61 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.176 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 134' ' ' LEU . 2.0 t -96.97 177.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.443 ' H ' HG12 ' A' ' 133' ' ' VAL . 1.3 pt? -71.62 136.38 47.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.754 0.788 . . . . 0.0 112.355 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 46.45 31.92 1.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.429 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.0 p -81.75 -6.03 58.68 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.7 m-20 -146.97 43.1 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.091 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 140' ' ' SER . 31.9 pt -69.97 -30.69 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.261 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.06 7.28 2.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 138' ' ' ILE . 23.3 t -95.56 -14.71 23.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.14 123.72 18.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.81 154.21 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.62 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.93 130.61 47.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.64 21.99 41.55 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -87.0 134.77 33.45 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -81.5 129.64 34.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.529 0.68 . . . . 0.0 112.147 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 147' ' ' ILE . 90.1 mt -123.39 123.92 68.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.817 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -105.05 121.84 44.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.344 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.0 153.17 28.49 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.167 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -127.2 131.23 50.71 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.344 0.592 . . . . 0.0 111.756 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 42.0 t0 -115.04 -168.06 1.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.7 m120 -20.87 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.082 0.468 . . . . 0.0 112.137 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -140.17 25.32 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -122.83 142.3 50.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -106.33 122.08 45.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.87 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.47 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.3 m-85 -104.01 126.62 51.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.987 0.422 . . . . 0.0 111.667 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.66 117.12 29.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 19.6 m-85 -116.55 147.11 42.13 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.381 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 202' ' ' ASP . . . -123.57 134.83 53.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 110.489 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.15 133.61 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.706 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.7 p -101.1 -25.4 14.05 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 124.51 1.131 . . . . 0.0 110.349 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.08 156.3 7.99 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.356 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.34 147.82 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.639 -0.781 . . . . 0.0 109.871 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.2 p -148.64 159.59 43.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.173 0.511 . . . . 0.0 111.334 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.81 119.6 39.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.437 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.09 159.84 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.1 p -76.72 142.92 70.68 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.42 -18.55 3.76 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.89 1.727 . . . . 0.0 111.836 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -83.44 -6.67 59.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -83.36 70.63 10.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.263 0.554 . . . . 0.0 110.331 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.519 ' C ' ' H ' ' A' ' 173' ' ' VAL . 85.0 m95 -71.46 -28.53 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.57 -11.36 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.058 0.456 . . . . 0.0 110.475 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 171' ' ' TRP . 43.9 t -80.48 -22.68 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.72 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.08 -6.86 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.756 0.788 . . . . 0.0 109.282 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.01 137.08 37.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.981 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 39.9 p-10 -51.97 127.28 20.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.962 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -104.86 -43.39 5.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.46 26.33 0.1 Allowed Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -152.85 173.37 15.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.244 0.545 . . . . 0.0 111.157 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 11.5 m-20 -94.23 89.39 5.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.049 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -128.89 127.28 41.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.678 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.0 tt -82.42 146.81 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.1 m -135.91 119.31 16.83 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.547 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.75 124.73 50.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.012 0.434 . . . . 0.0 109.912 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.9 pt -135.88 173.2 14.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.79 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.2 p -133.12 154.13 50.88 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 2.5 p -85.59 130.43 34.57 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.992 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.488 ' CG2' HD22 ' A' ' 193' ' ' ASN . 14.3 p -145.02 151.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.061 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.2 t -62.58 143.9 56.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.806 0.336 . . . . 0.0 110.6 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.16 -23.65 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.594 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -46.13 162.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.677 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -80.68 112.2 17.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.889 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.488 HD22 ' CG2' ' A' ' 188' ' ' VAL . 52.2 p30 -151.24 -149.34 0.3 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 36.8 t -63.46 146.34 53.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.564 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.52 140.43 51.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.485 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -71.34 141.33 50.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.466 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -102.92 131.25 49.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.6 p -133.79 137.47 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.02 130.35 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.44 136.92 52.48 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.593 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.73 147.99 19.36 Favored Glycine 0 N--CA 1.466 0.671 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -100.84 140.87 34.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.02 -0.59 . . . . 0.0 112.163 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 49.5 tp -64.46 129.44 39.89 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.212 0.529 . . . . 0.0 110.291 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.5 t -107.72 -27.07 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.35 20.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.202 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.47 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 34.6 m -135.04 156.06 49.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.201 0.524 . . . . 0.0 109.814 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -149.53 180.0 7.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.903 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.66 145.48 24.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.225 0.536 . . . . 0.0 110.787 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -74.51 81.17 1.95 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.647 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.642 178.845 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 55' ' ' HIS . 59.9 p 47.3 -124.28 1.55 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.437 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.476 ' N ' ' OG ' ' A' ' 54' ' ' SER . 76.6 t60 -100.29 45.08 0.99 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.394 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.3 ttt -61.27 -43.24 99.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.88 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -94.13 108.02 19.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.411 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.67 -9.17 58.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.039 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 m -84.55 -95.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.224 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt 45.61 27.92 0.47 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.093 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.4 mt -64.22 -48.21 86.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.384 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.3 t0 60.73 -101.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.75 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -150.05 77.45 8.38 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -42.64 147.9 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.353 2.035 . . . . 0.0 111.548 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -75.51 158.67 32.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.23 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.05 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.198 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.05 -52.46 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.76 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -74.08 -17.84 60.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -77.69 -54.73 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.903 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.38 84.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.272 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.55 110.77 1.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.793 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.6 m -94.35 120.48 34.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.1 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.43 ' CB ' ' HG ' ' A' ' 105' ' ' SER . 41.7 tp -113.84 129.08 56.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.61 139.82 55.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -73.31 -8.72 57.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.24 0.543 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.48 -32.77 74.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -77.17 11.48 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.1 t -91.34 123.72 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -122.42 -5.21 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.984 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.25 -169.61 38.62 Favored Glycine 0 C--N 1.316 -0.54 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -146.48 154.01 41.08 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.251 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 3.9 tt -121.89 124.54 71.6 Favored 'Isoleucine or valine' 0 C--O 1.23 0.056 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -127.53 130.86 49.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -133.63 129.13 20.31 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.569 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -35.89 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.392 2.061 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -49.41 -40.19 35.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.529 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.1 p -119.57 -0.94 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.241 0.216 . . . . 0.0 110.819 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.33 52.14 3.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.2 tp -110.61 130.7 55.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.045 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -133.21 114.83 14.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -143.92 110.51 5.17 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.73 136.7 1.88 Allowed 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.6 1.533 . . . . 0.0 110.764 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.71 123.07 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.9 mt -103.4 131.0 50.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.34 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 97' ' ' SER . 20.1 pttp -72.44 -42.84 64.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.464 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 55.5 m -74.68 103.13 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.245 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 98' ' ' SER . 53.5 p -82.36 94.41 7.37 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.281 0.562 . . . . 0.0 110.133 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.4 p -134.31 154.38 51.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.903 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -56.46 -37.35 70.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -71.86 -46.28 58.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.501 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.51 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 75.2 m-20 -66.2 -36.3 82.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.561 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.69 -16.18 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.721 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.0 mt -70.13 -27.61 64.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.43 ' HG ' ' CB ' ' A' ' 74' ' ' LEU . 3.6 m -93.36 -10.27 35.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 167.51 -174.43 42.61 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.983 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.46 130.17 38.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.294 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 147.46 29.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.865 0.364 . . . . 0.0 110.876 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.0 p -73.14 149.45 43.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.88 -43.24 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.74 141.36 28.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.18 0.514 . . . . 0.0 111.183 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.21 -16.09 41.37 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.56 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -144.27 56.51 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.31 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.45 ' NE2' ' CG ' ' A' ' 121' ' ' TYR . 3.0 tt0 -77.9 159.84 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.0 121.81 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.016 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -72.77 128.02 34.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.443 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.86 73.45 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -142.13 121.53 13.19 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 76.17 -174.71 53.13 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.491 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.9 t30 -83.79 110.43 18.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.45 ' CG ' ' NE2' ' A' ' 114' ' ' GLN . 6.8 t80 -83.52 103.59 12.98 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 130.4 36.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.109 0.48 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mt -127.42 130.65 49.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.89 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.31 140.19 46.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 110.578 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.2 179.65 20.56 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.615 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -84.81 154.78 22.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.792 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 129' ' ' SER . 14.8 p30 -121.97 29.18 7.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.655 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.3 mtt -43.46 -13.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.776 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 61.78 38.35 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.935 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -135.11 107.7 7.4 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.89 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.29 125.61 12.93 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.634 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.73 8.97 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.927 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.631 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 58.5 t -83.48 179.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.584 0.692 . . . . 0.0 109.183 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.631 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.42 132.45 43.93 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.436 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 49.13 38.08 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.219 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.17 -12.31 58.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.8 m-20 -147.98 34.06 0.83 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 140' ' ' SER . 7.3 pt -68.87 -32.19 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.425 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.63 2.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.706 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 138' ' ' ILE . 8.5 t -93.5 -14.86 26.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.48 120.29 12.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.069 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mmtt -104.93 155.72 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -53.68 114.81 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.214 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.22 21.58 5.17 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 96.9 m-20 -99.16 128.02 45.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.94 133.14 35.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.792 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 93.1 mt -126.39 125.72 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.927 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.9 123.13 48.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.725 0.298 . . . . 0.0 110.759 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -112.48 146.36 38.59 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.067 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -116.05 131.16 57.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 152' ' ' ASN . 46.9 t0 -114.27 -166.52 1.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.6 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 111.852 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -138.41 29.86 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -128.96 145.23 51.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -111.52 121.78 46.08 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -102.73 133.51 47.64 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 111.513 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.1 118.08 31.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.765 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -119.06 140.25 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.155 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.46 134.82 55.22 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.51 0.672 . . . . 0.0 110.449 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.29 135.64 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.733 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -101.46 -24.54 14.15 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 124.888 1.367 . . . . 0.0 110.764 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.58 154.08 7.32 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.294 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.9 p -98.45 129.41 48.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.832 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.4 m -132.01 149.53 52.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.296 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -109.18 116.64 32.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.343 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -133.95 153.17 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.9 p -64.56 169.09 5.51 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 -13.87 11.81 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.884 1.723 . . . . 0.0 111.71 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.58 -19.66 41.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.639 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -85.79 75.34 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 109.944 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -74.74 -9.63 58.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.041 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -53.4 -22.47 7.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 79.9 t -81.03 -10.82 12.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.049 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.13 -12.08 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.739 0.78 . . . . 0.0 110.178 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.11 157.81 20.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.376 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 66.2 t0 -66.54 131.17 45.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.42 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 31.3 m80 -101.26 -41.63 6.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.35 29.9 0.24 Allowed Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.448 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 48.5 pttt -157.44 179.25 9.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.547 . . . . 0.0 111.515 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 26.7 p30 -90.81 88.81 7.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.866 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -123.63 166.56 15.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.128 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.85 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.78 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.491 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 19.0 m -135.7 123.85 23.02 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.059 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.2 mp -111.79 125.09 53.63 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.129 0.49 . . . . 0.0 110.078 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 pt -134.32 162.1 39.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.001 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 64.6 p -89.36 167.93 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.413 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 98.4 m -76.19 131.94 39.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.519 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.97 151.52 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 190' ' ' VAL . 36.7 t -142.09 -149.95 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.806 0.336 . . . . 0.0 110.854 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 191' ' ' LYS . 58.1 t -58.74 166.36 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.612 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.505 ' N ' ' CG1' ' A' ' 190' ' ' VAL . 29.3 tptp -71.58 139.22 49.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.364 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 42.24 35.02 0.55 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.533 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -62.46 -51.15 68.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.757 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.7 p -169.13 164.13 11.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.719 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.61 130.15 42.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -97.77 147.09 24.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.868 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -110.63 138.72 46.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.303 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 50.1 t -133.33 136.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.23 128.43 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.562 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.63 136.52 52.9 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.331 0.586 . . . . 0.0 110.314 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.09 158.01 24.08 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.598 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 63.1 t0 -113.77 146.3 40.11 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.568 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.0 tp -68.04 130.82 44.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.062 0.458 . . . . 0.0 110.716 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.77 -22.85 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.5 175.89 45.96 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.329 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.9 m -154.23 154.13 32.94 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.344 0.592 . . . . 0.0 111.014 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -148.33 177.58 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.524 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.69 142.78 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.061 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.23 80.81 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.272 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 208' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.55 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.1 m -70.55 145.37 50.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 78.4 m80 48.57 -163.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.409 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.422 ' HG2' ' H ' ' A' ' 57' ' ' ASP . 12.6 ttt 54.45 176.93 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.164 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 42.9 p-10 -140.89 113.33 8.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.76 0.314 . . . . 0.0 110.818 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.44 -13.43 61.44 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.706 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.538 ' C ' ' H ' ' A' ' 61' ' ' ILE . 88.3 p -87.0 24.3 1.56 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.38 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.21 32.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.464 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 59' ' ' SER . 64.6 mt -62.19 -49.28 84.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.212 0.529 . . . . 0.0 110.675 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.415 ' OD1' ' OG ' ' A' ' 189' ' ' SER . 99.3 m-20 51.28 -90.8 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.092 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.481 ' CG ' ' SD ' ' A' ' 128' ' ' MET . 9.1 tt0 -151.33 79.55 6.7 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.47 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.83 144.43 1.4 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.282 1.988 . . . . 0.0 111.526 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -75.68 158.05 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.09 -28.77 62.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.069 0.461 . . . . 0.0 110.095 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.52 97.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.647 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -73.63 -31.46 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.327 0.584 . . . . 0.0 110.789 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.8 t -75.48 -46.38 37.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.783 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.25 87.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.926 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.4 -30.37 64.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.342 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.56 119.68 9.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.811 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 m -93.21 156.51 16.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -138.29 122.1 17.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.918 0.389 . . . . 0.0 110.81 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 77' ' ' LYS . 99.2 m-20 -83.55 108.74 16.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -47.71 -15.39 0.06 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.082 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 75' ' ' ASP . 99.2 mttt -69.51 -8.26 45.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.77 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.61 6.45 48.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.923 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.1 t -91.06 128.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.942 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.2 -6.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.728 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.61 -167.47 35.28 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 83' ' ' ILE . 19.4 ttm180 -150.96 157.0 42.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.402 0.62 . . . . 0.0 111.07 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.4 ' N ' ' CG ' ' A' ' 82' ' ' ARG . 15.8 tt -129.88 134.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.979 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.1 t -131.53 133.3 44.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.951 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.6 mt -136.0 127.92 17.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.329 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.21 -33.08 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.41 2.073 . . . . 0.0 112.02 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -49.12 -41.93 37.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.586 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.0 p -116.09 -1.69 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.8 -0.182 . . . . 0.0 110.878 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 64.38 50.04 2.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.8 tp -113.47 130.9 56.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.259 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -134.77 116.06 14.43 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.9 mt -143.7 163.28 37.06 Favored Pre-proline 0 N--CA 1.463 0.183 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.737 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.5 157.5 6.53 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.981 2.454 . . . . 0.0 109.235 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.0 t -107.01 117.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.0 mt -101.21 129.99 47.24 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -71.06 -36.99 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.986 0.422 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.0 m -75.54 100.12 4.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 98' ' ' SER . 53.5 p -82.85 92.93 7.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.531 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 5.2 p -133.81 155.87 49.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.016 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -55.36 -32.67 62.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.402 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -76.57 -46.5 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.003 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.531 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 97.4 m-20 -66.25 -34.45 78.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.832 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.92 -18.88 59.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.63 -18.24 61.6 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.8 m -99.9 -11.25 20.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.53 -155.88 25.77 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.973 -1.108 . . . . 0.0 111.658 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.29 126.17 36.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.889 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.95 144.26 32.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -75.55 152.96 37.68 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.44 -47.96 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -92.44 137.64 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 110.853 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 14.2 pt-20 -62.89 -47.11 84.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.869 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 61.6 t-20 -96.74 47.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.404 ' NE2' ' CE1' ' A' ' 121' ' ' TYR . 3.2 tt0 -91.55 155.38 18.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.4 t -130.27 133.79 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.202 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.6 mtp -73.51 126.24 29.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.704 0.288 . . . . 0.0 110.474 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.31 67.43 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.26 120.08 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.092 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.21 -178.31 41.32 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.452 HD22 ' HG1' ' A' ' 183' ' ' THR . 61.2 t-20 -73.82 107.43 6.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.404 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 10.6 t80 -84.26 103.51 13.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.97 126.55 35.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.122 0.486 . . . . 0.0 111.495 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -121.4 131.31 54.1 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.69 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 139.17 45.01 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.311 0.577 . . . . 0.0 110.662 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.78 15.17 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.701 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -92.44 146.09 23.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.726 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.8 p30 -108.01 27.53 9.16 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.293 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.481 ' SD ' ' CG ' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -42.18 -16.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.701 -179.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 127' ' ' ASN . 2.6 t 55.06 37.14 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.812 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -133.87 111.96 10.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.458 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.67 123.66 14.83 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.152 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.43 5.93 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.532 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 41.8 t -137.37 177.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.532 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -69.76 128.0 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.758 0.313 . . . . 0.0 110.644 -178.164 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 47.41 38.5 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 110.468 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.39 -6.02 59.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.723 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.6 t0 -151.16 39.97 0.69 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.071 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.0 pt -69.02 -30.18 45.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.49 4.14 3.28 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 49.6 m -95.69 -14.48 23.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 109.749 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.01 124.81 23.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.529 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -96.73 156.57 16.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.755 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.21 128.8 38.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.415 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 89.5 20.81 43.1 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -82.36 136.36 35.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.9 mmtt -80.35 126.63 31.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 112.1 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.68 118.01 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 121.3 41.26 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.2 tp -114.28 142.84 45.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.984 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.17 136.42 44.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.242 0.544 . . . . 0.0 111.468 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 154' ' ' ASN . 40.9 t0 -113.0 177.0 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.347 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.452 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 19.4 p-10 -35.79 -54.46 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.409 0.623 . . . . 0.0 111.338 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 97.7 mt-10 -141.69 16.56 2.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -128.63 142.42 51.04 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -109.35 124.02 50.28 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -106.55 134.99 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.388 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.73 118.49 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.408 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -115.88 138.0 51.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.246 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.78 132.58 55.11 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.429 0.633 . . . . 0.0 110.822 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 144' ' ' GLY . 48.6 t -66.98 134.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.7 p -101.75 -28.33 12.52 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 124.443 1.089 . . . . 0.0 110.799 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.44 143.73 4.39 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.775 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.43 137.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.585 ' HG ' ' H ' ' A' ' 165' ' ' GLU . 18.8 t -159.56 171.11 20.24 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.136 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.585 ' H ' ' HG ' ' A' ' 164' ' ' SER . 15.4 pt-20 -122.53 130.27 52.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.426 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.12 157.37 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.492 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 169' ' ' ASP . 6.8 p -68.56 130.18 92.16 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.425 ' HG3' HH21 ' A' ' 196' ' ' ARG . 1.5 Cg_endo -46.38 -11.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.921 1.747 . . . . 0.0 111.648 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 167' ' ' THR . 43.1 t0 -75.69 -22.2 56.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -84.82 73.15 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.009 0.433 . . . . 0.0 110.134 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -71.69 -14.66 62.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.513 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.479 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.5 mt-10 -52.97 -34.38 55.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.216 0.531 . . . . 0.0 110.074 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -70.94 -5.22 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.024 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.77 -14.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.678 0.751 . . . . 0.0 109.969 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -86.2 177.16 7.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.835 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.3 p-10 -81.74 131.66 35.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.479 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 42.9 m80 -103.21 -41.76 5.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.9 27.13 0.13 Allowed Glycine 0 N--CA 1.471 0.98 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -157.47 179.56 9.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 111.411 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -89.98 90.25 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -121.01 166.93 13.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.081 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.9 tt -132.32 144.07 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.452 ' HG1' HD22 ' A' ' 120' ' ' ASN . 18.8 m -135.72 126.37 27.15 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.196 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.1 mp -112.55 118.23 34.52 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 12.0 pt -134.3 171.67 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.643 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.57 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.3 p -125.92 131.29 52.34 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.716 0.293 . . . . 0.0 110.892 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 6.8 t -82.74 128.46 34.39 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.332 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 59' ' ' SER . 56.9 t -127.31 -94.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.439 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.415 ' OG ' ' OD1' ' A' ' 62' ' ' ASP . 42.5 m -158.55 155.4 28.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.818 0.342 . . . . 0.0 110.467 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.4 -25.88 34.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.271 0.558 . . . . 0.0 110.487 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -53.1 -26.75 17.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.053 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 52.39 37.97 23.96 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.68 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -72.36 -3.61 25.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.072 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.8 p -151.91 161.35 42.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.0 110.623 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -94.38 145.28 24.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.113 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.57 ' NH1' ' O ' ' A' ' 186' ' ' THR . 16.7 ptp180 -115.59 166.51 11.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.028 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.34 140.66 44.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.61 132.17 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.132 0.492 . . . . 0.0 111.14 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.7 t -116.22 127.31 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.512 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.19 135.56 53.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.92 157.5 25.37 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 60.6 t0 -115.11 152.49 32.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.446 -0.377 . . . . 0.0 111.161 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.562 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.95 129.24 38.09 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.085 0.469 . . . . 0.0 110.767 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.1 p -107.81 -25.97 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.011 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.68 175.29 47.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.219 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.5 m -152.67 150.26 29.28 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.194 0.521 . . . . 0.0 110.883 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -148.62 178.0 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.538 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.97 21.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.151 0.5 . . . . 0.0 110.817 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -77.08 79.82 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.744 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.561 178.422 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.409 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 56' ' ' MET . 8.4 m 46.24 -165.05 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.518 ' O ' ' CG ' ' A' ' 55' ' ' HIS . 83.8 t60 47.87 15.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.372 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 54' ' ' SER . 65.5 mtt 48.99 -173.94 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.895 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 62.7 t0 -153.9 152.23 30.38 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.879 0.371 . . . . 0.0 110.85 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.558 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -71.79 -14.13 61.9 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.78 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 61' ' ' ILE . 69.1 p -87.61 12.31 12.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.982 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -67.86 39.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.931 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' H ' ' C ' ' A' ' 59' ' ' SER . 55.3 mt -60.68 -49.66 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.716 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.2 t0 50.67 -95.75 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.012 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -151.0 86.58 4.84 Favored Pre-proline 0 C--O 1.234 0.289 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.22 155.57 41.93 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.855 2.37 . . . . 0.0 110.984 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -74.58 160.29 31.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.1 mp -64.66 -21.31 66.7 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.251 0.344 . . . . 0.0 110.862 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.73 -40.28 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.49 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.29 -34.91 68.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.623 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.8 t -75.07 -45.2 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.074 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.5 87.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.02 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -84.04 -23.31 30.96 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.621 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.23 118.98 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.336 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -94.78 140.75 29.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.198 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.4 tp -115.42 140.71 48.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.452 ' C ' ' N ' ' A' ' 77' ' ' LYS . 39.2 m-20 -95.11 100.92 12.65 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -46.89 -18.06 0.06 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.452 ' N ' ' C ' ' A' ' 75' ' ' ASP . 3.2 ttmp? -65.95 -33.8 76.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.312 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 0.9 OUTLIER -80.08 13.94 2.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.817 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.1 t -91.49 127.48 43.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.633 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.15 -6.31 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.106 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.83 -173.19 43.94 Favored Glycine 0 C--N 1.321 -0.284 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.87 153.94 44.79 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.841 -177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.8 tt -125.75 131.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 t -134.01 132.02 39.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.692 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.17 128.74 19.6 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.17 -36.67 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.412 2.075 . . . . 0.0 112.376 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -48.4 -39.98 24.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.51 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.3 p -119.31 -1.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.372 0.42 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.75 50.24 4.46 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.11 131.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.574 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.79 114.66 12.09 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 93' ' ' PRO . 76.2 mt -142.53 112.35 5.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -40.05 140.61 0.79 Allowed 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.661 1.574 . . . . 0.0 110.302 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.6 t -93.15 122.02 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.66 123.47 48.55 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.484 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.06 -47.8 76.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.184 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -71.7 105.88 3.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.878 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -85.8 100.95 12.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.651 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 44.5 p -131.75 156.96 45.05 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.104 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.66 -28.99 61.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -82.87 -42.39 17.82 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.882 0.739 . . . . 0.0 111.936 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.651 ' H ' ' HG1' ' A' ' 99' ' ' THR . 98.4 m-20 -65.63 -38.09 88.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.136 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.62 -19.76 62.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.061 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.49 -33.17 70.93 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.2 m -95.58 -9.47 32.19 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 177.43 179.57 47.73 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.254 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.89 127.82 33.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.948 -0.626 . . . . 0.0 109.84 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.63 146.14 31.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.4 p -76.4 153.87 35.34 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.0 t -85.43 -48.18 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -92.26 137.72 32.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.41 0.624 . . . . 0.0 110.698 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.9 pt-20 -60.32 -47.6 85.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.161 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 98.8 m-20 -98.8 47.41 0.98 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.39 155.45 21.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.964 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.9 131.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.3 mtt -74.98 128.0 34.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.11 0.54 70.94 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -139.36 118.15 12.38 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.017 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -171.86 53.65 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.43 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 47.0 t-20 -83.66 110.81 18.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.1 102.9 13.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 128.99 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.597 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -123.96 130.45 52.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.331 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.92 138.21 47.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.318 0.58 . . . . 0.0 110.806 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.36 -179.05 17.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.259 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 134' ' ' LEU . 37.5 m-70 -86.46 144.44 27.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.455 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' SER . 8.1 t-20 -110.99 28.19 8.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.061 0.458 . . . . 0.0 110.652 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -47.37 -11.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.11 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 127' ' ' ASN . 2.3 t 56.1 40.67 30.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.024 -0.671 . . . . 0.0 109.928 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.31 105.93 7.6 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -50.42 124.94 11.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.614 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -26.4 9.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.374 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.565 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 39.7 t -82.82 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.565 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -72.88 132.33 43.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 48.85 37.79 10.68 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.93 0.395 . . . . 0.0 111.345 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -82.12 -11.4 58.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 136' ' ' SER . 83.7 m-20 -145.51 38.13 1.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -66.09 -36.13 76.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.48 3.08 1.95 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.815 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 138' ' ' ILE . 6.3 t -96.49 -11.19 25.88 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.279 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.39 122.26 18.03 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.538 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 64.4 mttp -95.57 161.46 14.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.391 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -61.12 135.12 57.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.46 19.08 57.61 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 2.6 m-20 -85.1 130.05 34.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.88 131.09 35.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.2 mt -122.57 123.09 67.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -100.63 118.67 37.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 mt -113.53 149.15 34.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.194 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -124.64 130.26 52.09 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.433 0.635 . . . . 0.0 111.416 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.7 t0 -113.52 -168.52 1.35 Allowed 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.545 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 16.9 m120 -24.86 -71.69 0.03 OUTLIER 'General case' 0 C--O 1.232 0.154 0 O-C-N 123.475 0.485 . . . . 0.0 111.579 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.62 26.6 2.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.25 146.87 44.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -111.74 118.7 36.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.735 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -105.44 127.99 53.29 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.571 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -98.82 122.75 42.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.926 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -122.08 142.32 50.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 135.02 55.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.335 0.588 . . . . 0.0 110.703 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.7 133.35 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.51 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.1 t -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.64 1.212 . . . . 0.0 111.515 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.32 149.95 6.51 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.3 t -104.8 134.38 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -135.66 151.31 50.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.444 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.72 116.87 32.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.634 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.77 154.84 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 169' ' ' ASP . 23.4 p -78.16 140.46 61.5 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.59 -18.26 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.975 1.783 . . . . 0.0 111.867 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.7 m-20 -77.4 -21.19 53.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.025 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -83.03 70.54 10.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.119 0.568 . . . . 0.0 110.176 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.538 ' C ' ' H ' ' A' ' 173' ' ' VAL . 82.0 m95 -70.48 -27.04 63.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.944 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.4 -10.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.631 0.582 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.5 t -80.95 -23.69 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.501 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.01 -5.33 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.588 0.708 . . . . 0.0 110.015 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.35 142.06 36.38 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.925 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -54.84 128.98 35.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -102.4 -42.72 5.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.49 28.52 0.15 Allowed Glycine 0 N--CA 1.471 0.985 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -157.15 179.76 8.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.999 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 8.1 m-20 -93.87 94.12 8.32 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 182' ' ' ILE . 46.1 tt0 -127.54 170.87 12.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.906 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.423 ' H ' ' HG2' ' A' ' 181' ' ' GLU . 20.6 tt -131.63 143.19 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.709 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 8.7 m -138.29 116.89 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.3 mp -102.38 119.59 39.08 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.605 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 185' ' ' ILE . 0.1 OUTLIER -130.97 -169.97 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.379 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 31.0 p -134.9 151.84 51.22 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.376 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.8 p -98.29 133.2 43.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.971 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 190' ' ' VAL . 8.2 m -141.97 -40.42 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.484 ' OG ' ' OG ' ' A' ' 59' ' ' SER . 11.8 m 48.55 -91.74 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.442 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 188' ' ' VAL . 69.1 t -63.71 135.41 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.514 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 tttp 51.13 87.89 0.03 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.612 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.76 141.13 58.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.474 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -86.55 113.36 22.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.561 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 79.8 p -57.58 -34.81 69.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.043 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -90.17 56.51 3.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.035 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -78.11 127.93 33.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.689 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.3 132.44 56.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.528 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.6 136.57 50.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.091 0.472 . . . . 0.0 111.046 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.96 129.65 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.673 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.66 133.39 55.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.144 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.77 146.62 17.1 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 121.807 0.671 . . . . 0.0 111.706 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -105.32 139.12 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.714 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.18 129.16 38.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.937 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 p -106.41 -25.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.073 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.27 159.6 16.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.453 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.9 m -135.7 155.02 51.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.86 177.78 9.51 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.3 144.34 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.551 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.07 79.09 0.67 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.023 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.548 178.813 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.1 t -133.84 -13.73 2.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.539 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -105.71 127.99 53.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 20.6 ptp -69.01 163.95 23.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.884 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 40.2 p-10 -65.31 119.11 10.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 110.346 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.63 76.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.9 m -150.88 -84.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.414 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm 55.28 31.29 16.32 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.432 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 62' ' ' ASP . 35.8 mm -65.86 -44.58 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.778 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 64' ' ' PRO . 10.4 t0 61.22 119.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.519 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 62' ' ' ASP . 2.5 pt20 -38.15 93.69 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' N ' ' O ' ' A' ' 62' ' ' ASP . 6.1 Cg_exo -75.44 154.28 40.34 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.566 2.177 . . . . 0.0 111.262 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.99 152.51 41.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 2.2 pt? -59.0 -23.98 62.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.402 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.48 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 95.6 mt-10 -73.07 -33.07 65.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.606 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.3 -42.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.1 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.09 92.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.405 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.1 p-10 -86.31 -15.14 41.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.669 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 71' ' ' ASN . . . -61.08 120.27 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.107 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.2 p -91.39 159.55 15.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.11 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.11 142.57 44.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -94.12 100.51 12.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -57.23 -14.93 4.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.049 0.452 . . . . 0.0 110.347 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -76.44 -14.55 60.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.146 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.47 13.17 34.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.529 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.13 135.99 24.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.988 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 pt -117.5 -3.55 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.035 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.63 34.86 Favored Glycine 0 C--N 1.317 -0.518 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -154.05 165.26 36.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.808 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 tt -134.3 140.96 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.891 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 t -133.52 135.79 44.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.362 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 mt -134.58 127.77 18.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.802 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.55 -38.34 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.357 2.038 . . . . 0.0 112.584 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -47.37 -41.01 18.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.599 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.4 p -116.69 -3.31 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.828 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.83 49.46 1.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.49 127.3 53.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.865 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -138.16 116.14 11.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.7 mt -157.71 127.52 3.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.471 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -42.96 159.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.929 0 C-N-CA 121.928 1.752 . . . . 0.0 109.703 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 t -113.61 124.66 70.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.11 128.89 49.86 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.217 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -65.05 -35.3 80.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.717 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -176.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.632 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 p -162.51 55.48 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.699 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 7.0 p -105.68 160.03 15.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.151 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.48 -32.33 71.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.603 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.4 -41.85 55.2 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.85 0.719 . . . . 0.0 112.26 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 98.3 m-20 -65.82 -39.92 91.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.553 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.78 -19.82 52.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.87 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.8 mt -69.25 -34.85 75.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.0 m -97.16 -7.71 31.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -179.0 -174.6 45.33 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.58 127.95 34.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.12 -0.54 . . . . 0.0 109.882 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.38 141.61 36.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.768 0.318 . . . . 0.0 110.715 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.4 p -71.87 147.54 47.02 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.77 -47.68 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -92.03 -170.47 2.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.657 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 113' ' ' ASN . 1.6 pt-20 -113.19 -53.86 2.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.951 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.455 ' H ' ' HG3' ' A' ' 112' ' ' GLU . 89.0 m-20 -94.42 44.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -93.37 154.54 17.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.71 133.9 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.816 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 68.5 mtt -69.66 128.39 36.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.989 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.501 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.68 1.33 77.49 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.6 123.44 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.974 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.19 -164.36 54.34 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -94.64 108.68 20.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -84.91 100.87 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.043 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 124.63 35.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.511 . . . . 0.0 111.722 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.94 132.02 54.33 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.322 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.6 138.9 45.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.375 0.607 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.69 -176.26 16.63 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.43 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 135' ' ' PHE . 15.3 m-70 -86.11 141.79 29.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.815 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.614 HD21 ' N ' ' A' ' 190' ' ' VAL . 32.1 t30 -109.86 26.88 10.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.214 0.531 . . . . 0.0 110.481 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -46.34 -14.29 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.778 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 129' ' ' SER . 1.4 p 55.2 41.15 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.822 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 136' ' ' SER . 30.5 mmtm -133.91 129.25 36.06 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.653 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -74.24 124.52 26.56 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.41 -28.24 6.61 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 t -78.04 170.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.621 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.22 133.16 40.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.685 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 126' ' ' HIS . 3.6 m-85 49.27 38.74 14.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 1.1 p -80.33 -61.26 2.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.282 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 136' ' ' SER . 97.9 m-20 -89.35 39.7 0.95 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.7 pt -69.78 -26.72 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.241 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.42 6.81 5.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.0 t -95.33 -13.64 24.59 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.26 118.74 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -98.4 161.57 13.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.741 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -58.38 118.54 5.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.133 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.95 21.06 7.63 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 90.9 m-20 -96.65 127.99 43.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -80.58 138.31 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.956 0.408 . . . . 0.0 111.332 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 158' ' ' TYR . 97.5 mt -129.4 123.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -101.76 119.22 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.996 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.405 ' C ' ' CD1' ' A' ' 150' ' ' TYR . 2.7 mt -110.0 158.15 18.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.346 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 149' ' ' LEU . 66.6 m-85 -141.63 121.22 13.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.092 0.472 . . . . 0.0 111.859 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 152' ' ' ASN . 13.3 t0 -114.64 -166.11 1.08 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.579 ' C ' ' O ' ' A' ' 151' ' ' ASP . 95.1 m-20 -4.4 -88.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.857 0.723 . . . . 0.0 111.32 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -138.99 30.83 2.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -121.73 140.96 51.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -102.89 120.78 41.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.196 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -105.07 125.21 50.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.725 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -94.19 115.27 27.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.501 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.6 m-85 -117.18 142.82 46.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.224 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.06 132.13 53.98 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.439 0.637 . . . . 0.0 110.501 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.7 135.87 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.269 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 14.2 p -101.75 -25.56 13.79 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.783 1.302 . . . . 0.0 110.99 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.49 177.18 34.35 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.146 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.09 149.1 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.743 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 38.9 m -152.59 161.6 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 0.0 111.099 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -99.36 120.93 40.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 196' ' ' ARG . 18.4 m -132.45 157.45 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 169' ' ' ASP . 32.1 p -82.42 135.93 46.41 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.584 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -46.37 -15.1 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.004 1.803 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 67.3 t0 -84.52 -22.61 30.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -83.95 72.42 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.062 0.458 . . . . 0.0 110.928 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 94.1 m95 -74.94 -2.22 26.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.969 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.521 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 72.4 mm-40 -54.19 -39.0 66.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.19 4.57 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.944 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.07 -15.99 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.904 0.859 . . . . 0.0 110.042 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.403 ' O ' ' CD2' ' A' ' 177' ' ' HIS . 63.4 mm-40 -89.21 166.45 13.8 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.972 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -68.18 129.42 39.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.083 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.521 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.0 m170 -103.32 -40.54 6.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.143 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.83 25.23 0.12 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -156.41 179.23 9.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.863 0.363 . . . . 0.0 110.815 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -97.36 93.36 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.802 0.81 . . . . 0.0 110.408 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -127.02 175.16 8.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.407 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -130.38 143.47 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.216 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 13.1 m -135.99 123.67 22.38 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.557 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.5 mp -112.19 121.96 46.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.455 0.645 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.27 -174.84 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.829 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.546 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 15.4 p -138.53 158.46 44.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.368 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 99.6 m -62.75 -39.14 93.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.22 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.42 ' CG1' ' H ' ' A' ' 189' ' ' SER . 2.1 t -130.61 -140.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.314 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.42 ' H ' ' CG1' ' A' ' 188' ' ' VAL . 34.8 p -157.52 165.66 35.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.764 0.316 . . . . 0.0 110.437 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.614 ' N ' HD21 ' A' ' 127' ' ' ASN . 9.7 p -63.6 130.24 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.418 ' HZ2' ' CB ' ' A' ' 191' ' ' LYS . 8.9 mtpm? 45.59 -141.14 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.952 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -65.65 -80.19 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 45.88 86.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.976 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.7 t -58.84 -45.11 90.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 111.098 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -85.39 137.92 32.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.26 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 186' ' ' THR . 39.1 ttm180 -95.88 137.01 35.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.003 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.57 140.96 35.52 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 2.9 p -140.71 144.54 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.72 0.295 . . . . 0.0 111.425 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.63 129.91 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.204 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -121.21 138.93 53.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.256 0.551 . . . . 0.0 110.507 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.66 160.96 24.98 Favored Glycine 0 N--CA 1.461 0.337 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.8 t0 -113.55 149.69 34.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.954 -0.623 . . . . 0.0 111.135 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.536 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 21.7 tp -73.42 132.39 42.92 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 59.3 t -107.96 -27.1 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.512 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.93 160.37 16.82 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.388 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 28.4 m -136.42 155.6 49.78 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -151.62 179.84 8.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.08 143.19 26.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.461 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.5 81.22 1.95 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.528 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.379 178.693 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.1 t -153.82 151.56 29.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.911 0.386 . . . . 0.0 110.627 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -109.98 152.29 26.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.503 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 12.7 ptp -75.76 145.78 40.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.702 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.98 138.14 54.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.336 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.06 -41.66 73.88 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.023 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 96.1 p -150.5 -96.25 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.482 ' N ' ' OG ' ' A' ' 59' ' ' SER . 99.4 mttt 48.88 40.77 17.3 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.692 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 61' ' ' ILE . 34.2 mm -63.05 -45.11 99.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.331 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.8 t0 68.42 -123.51 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.268 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -140.78 72.17 29.42 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -43.26 145.53 1.38 Allowed 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.485 2.123 . . . . 0.0 111.391 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -77.57 163.3 26.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.163 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 2.0 pt? -60.16 -21.75 62.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.234 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.23 -39.62 94.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -73.76 -30.33 62.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.317 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -77.31 -44.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.799 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.98 85.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 61.3 t-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.75 139.72 57.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.696 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -140.82 84.21 1.93 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 111.361 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.6 tp -82.15 134.64 35.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.21 138.81 55.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.439 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -64.02 -8.73 12.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 109.78 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -64.02 -30.12 71.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.863 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.683 HE21 ' HG ' ' A' ' 97' ' ' SER . 22.6 mm100 -76.75 9.87 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.109 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.69 124.41 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -129.8 -3.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.64 -170.55 32.58 Favored Glycine 0 C--N 1.315 -0.607 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.466 ' HD2' ' H ' ' A' ' 83' ' ' ILE . 5.3 tpt180 -153.02 151.14 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.837 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.466 ' H ' ' HD2' ' A' ' 82' ' ' ARG . 5.7 tt -123.39 127.4 74.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -128.3 129.57 46.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.2 mt -135.02 122.26 15.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.284 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.28 -33.89 0.49 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.372 2.048 . . . . 0.0 112.877 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -50.38 -36.37 32.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.45 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.7 m -120.17 -6.34 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.634 0.254 . . . . 0.0 110.982 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.84 48.22 0.41 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.92 129.69 55.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.839 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -135.34 115.85 13.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -146.35 111.15 4.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.02 147.89 0.25 Allowed 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 121.636 1.558 . . . . 0.0 110.529 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.4 t -96.16 124.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.9 145.33 30.55 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.586 ' HZ3' HE22 ' A' ' 78' ' ' GLN . 21.8 pttp -90.41 -35.33 15.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.279 0.561 . . . . 0.0 110.961 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.683 ' HG ' HE21 ' A' ' 78' ' ' GLN . 2.1 p -76.22 97.95 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.117 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -82.66 89.98 6.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.059 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 p -133.14 157.75 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.901 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.89 -29.76 60.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.765 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.435 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 11.4 ptpt -83.29 -43.84 15.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -66.63 -34.21 77.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.635 -178.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.99 -20.93 63.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.433 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.46 -18.79 61.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.6 p -102.42 -13.11 17.41 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.21 -179.43 47.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.165 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.55 125.84 28.43 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.6 143.16 34.14 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.866 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 46.7 p -75.1 154.15 37.96 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.68 -56.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -96.4 141.22 29.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.993 0.425 . . . . 0.0 110.689 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.2 pm0 -82.47 6.65 16.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -131.27 24.89 4.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -93.75 156.16 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.195 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.2 t -133.28 133.89 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.851 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.4 mtt -67.24 127.6 33.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.995 0.426 . . . . 0.0 110.237 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 90.96 2.41 71.68 Favored Glycine 0 C--O 1.23 -0.101 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -141.06 121.87 14.4 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.067 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.18 -168.88 53.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.404 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 60.3 t-20 -87.86 110.03 20.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.52 103.67 13.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.88 127.79 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 112.105 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 mt -123.54 132.41 53.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.933 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.57 139.08 45.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.402 0.62 . . . . 0.0 110.656 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.74 -176.58 15.01 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.72 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -97.46 141.5 30.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.951 0.405 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' SER . 43.5 p-10 -102.3 27.76 6.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -21.8 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.159 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 62.09 37.29 14.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.507 ' N ' ' OG ' ' A' ' 136' ' ' SER . 63.7 mmtt -133.32 108.02 8.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.769 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -50.66 125.98 14.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.809 0.814 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.02 -30.26 7.83 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.631 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.627 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 59.4 t -76.02 178.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.355 0 CA-C-N 117.681 0.74 . . . . 0.0 109.437 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.627 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.15 136.39 48.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.778 0.323 . . . . 0.0 110.437 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 44.11 32.03 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.324 0.583 . . . . 0.0 110.561 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -81.26 -12.26 59.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.459 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 29.4 t0 -142.62 26.45 1.76 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 pt -70.16 -25.76 28.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.797 0.332 . . . . 0.0 111.581 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.11 1.11 6.27 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.459 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.1 m -95.41 -11.7 27.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 mt -63.9 124.22 20.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.008 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 145' ' ' ASP . 99.2 mttt -96.4 158.17 15.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -56.58 134.87 54.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.185 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.36 19.49 62.24 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 142' ' ' LYS . 28.7 m-20 -81.43 132.73 35.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -79.51 130.33 35.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.274 0.559 . . . . 0.0 111.515 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 147' ' ' ILE . 81.6 mt -122.92 121.68 63.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.583 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.4 120.57 40.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.118 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.73 158.83 18.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -132.96 128.11 35.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.635 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 44.4 t0 -113.89 -166.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.522 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 14.3 t-20 -21.95 -74.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.152 0.501 . . . . 0.0 111.929 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.22 27.95 1.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -122.54 144.93 48.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -108.13 122.73 47.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.032 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -106.32 127.37 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.822 0.344 . . . . 0.0 111.489 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.62 115.88 28.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.503 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -117.07 142.24 47.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.308 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.7 134.51 55.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.629 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.5 133.97 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.915 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -102.14 -25.86 13.56 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 124.544 1.153 . . . . 0.0 110.787 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.98 142.34 3.37 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.857 -1.163 . . . . 0.0 111.768 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.0 t -104.77 152.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.687 ' HG ' ' H ' ' A' ' 165' ' ' GLU . 43.5 t -168.42 178.32 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.4 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.687 ' H ' ' HG ' ' A' ' 164' ' ' SER . 96.3 mt-10 -114.79 115.13 26.52 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.36 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 12.5 m -117.0 139.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.525 ' C ' HH12 ' A' ' 196' ' ' ARG . 66.8 p -54.23 162.6 1.5 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.57 -19.76 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.194 1.929 . . . . 0.0 111.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 34.3 p30 -81.91 -19.31 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 35.1 ttpt -88.13 74.68 8.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 110.503 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -75.27 -6.1 48.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.851 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.7 -24.55 14.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.21 -3.25 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.815 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.65 -12.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.665 0.745 . . . . 0.0 109.814 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -85.6 155.63 21.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.934 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.33 132.14 47.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.62 -39.33 6.41 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.44 28.56 0.17 Allowed Glycine 0 N--CA 1.471 1.012 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -155.1 174.92 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.126 0.489 . . . . 0.0 111.284 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -90.13 89.34 7.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.692 0.758 . . . . 0.0 109.557 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -119.59 168.36 11.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.826 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.7 tt -129.95 141.32 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.226 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.404 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 11.9 m -137.11 123.4 20.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.178 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.59 122.75 48.6 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.194 0.521 . . . . 0.0 110.091 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 185' ' ' ILE . 20.4 pt -132.91 168.08 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.689 -178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 187' ' ' CYS . 74.3 p -138.99 158.42 44.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.633 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' A' ' 186' ' ' THR . 98.2 m 46.33 94.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.291 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 71.3 t -61.32 -47.56 92.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.999 0.428 . . . . 0.0 110.607 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.2 p -80.92 165.79 21.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.281 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.85 130.9 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -158.71 -80.01 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.747 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.48 -41.22 96.6 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.482 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -106.88 117.68 34.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.154 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 45.6 t -61.61 -44.04 97.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 110.903 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -124.34 149.62 46.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.774 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 166' ' ' VAL . 35.2 ptt-85 -117.91 169.08 9.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -97.57 131.41 44.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.48 133.57 61.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 111.253 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.0 t -111.28 124.06 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.02 134.16 55.04 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.06 160.88 25.49 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.5 t0 -114.56 151.43 33.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.974 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.65 129.86 38.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.443 0.639 . . . . 0.0 110.755 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 98.7 t -106.34 -24.48 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.161 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.74 163.33 23.59 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.036 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.7 m -136.6 154.46 50.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.278 0.561 . . . . 0.0 109.975 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -148.99 179.43 7.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.176 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.65 24.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.279 0.562 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.68 80.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.612 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.574 178.644 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.8 t -144.03 110.76 5.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.887 0.375 . . . . 0.0 110.354 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -147.19 137.98 23.64 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.933 0.397 . . . . 0.0 110.906 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.2 mtt -65.18 -41.48 94.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.615 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -132.22 111.13 11.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.283 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.01 -59.96 2.48 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.258 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 61' ' ' ILE . 69.6 p -154.83 44.43 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.155 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -71.28 19.67 0.06 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.038 0.447 . . . . 0.0 111.325 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.518 ' H ' ' C ' ' A' ' 59' ' ' SER . 40.2 mt -63.74 -46.85 93.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.116 0.484 . . . . 0.0 110.596 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.6 t0 56.84 -100.58 0.11 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.802 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -150.26 78.92 7.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.94 136.75 4.72 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.386 2.057 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.18 166.93 20.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.906 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.6 mp -52.02 -28.44 17.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.607 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 71' ' ' ASN . . . -65.43 -39.73 92.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.542 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -73.81 -31.28 63.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.741 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.83 -45.88 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.821 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.51 78.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.07 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 67' ' ' ALA . 9.3 m120 -69.06 -29.25 67.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.997 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.41 100.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.848 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -96.93 111.39 23.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.395 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -111.36 128.6 56.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.542 ' H ' ' NE2' ' A' ' 78' ' ' GLN . 97.8 m-20 -71.97 138.71 48.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.267 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -64.43 0.45 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 109.877 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 75' ' ' ASP . 13.2 mptt -92.06 -8.86 44.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.585 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.542 ' NE2' ' H ' ' A' ' 75' ' ' ASP . 76.1 mt-30 -83.17 -6.62 59.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.4 m -86.96 138.03 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.68 -3.32 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.487 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.07 -160.3 24.24 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -153.59 155.98 37.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.384 0.612 . . . . 0.0 111.258 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.26 136.86 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.073 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -128.99 134.07 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.986 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 mt -133.01 74.17 74.18 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.541 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -44.76 -39.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 123.151 2.567 . . . . 0.0 112.943 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.67 -32.17 7.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.623 -177.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 89' ' ' SER . 15.7 m -117.13 -7.01 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.637 0.256 . . . . 0.0 111.158 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER 75.22 39.49 0.37 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.197 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.64 130.02 56.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.48 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -144.79 129.97 18.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.718 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -164.44 152.54 10.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.072 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 162.99 4.51 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.064 1.843 . . . . 0.0 109.739 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.29 125.0 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 102' ' ' ASN . 10.2 mt -101.43 136.11 41.83 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.81 -48.54 24.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.11 0.481 . . . . 0.0 111.485 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 123.4 28.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.177 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.4 p -81.7 64.83 6.58 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.45 0.643 . . . . 0.0 110.46 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.552 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -91.81 143.21 26.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.077 179.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 101' ' ' LYS . 15.3 pt-20 -56.33 -44.22 79.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.403 0.621 . . . . 0.0 110.742 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.493 ' N ' ' CG ' ' A' ' 100' ' ' GLU . 54.5 tttp -66.03 -46.38 78.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.808 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.552 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 2.9 m-20 -67.18 -36.97 82.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.844 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -55.04 -16.82 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.451 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.0 mt -70.63 -29.9 66.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -89.74 -10.56 45.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 178.52 41.27 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.718 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -72.37 132.16 43.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.97 150.13 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.125 0.488 . . . . 0.0 111.031 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.5 p -73.6 153.93 39.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.34 -52.2 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -91.76 141.44 28.67 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.994 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -71.39 -2.58 16.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.538 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.34 41.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.251 0.548 . . . . 0.0 111.115 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -84.86 158.1 20.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -134.49 129.7 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.628 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -73.7 127.88 34.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.43 -0.15 70.86 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -139.71 121.61 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.967 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.32 -171.86 52.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.515 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 10.2 t30 -84.03 110.13 18.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.24 99.38 10.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.78 130.44 36.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.363 0.601 . . . . 0.0 111.425 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -125.9 133.83 51.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.826 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.18 141.56 47.37 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.378 0.609 . . . . 0.0 110.71 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.9 -178.85 18.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.656 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -81.83 149.27 28.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.972 0.415 . . . . 0.0 110.748 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 129' ' ' SER . 45.1 t30 -112.48 28.44 8.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.169 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.1 mmm -47.43 -11.74 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.638 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 127' ' ' ASN . 3.1 t 54.72 41.11 32.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.982 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.4 tttt -134.52 116.2 14.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.565 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -57.33 125.61 23.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.764 0.792 . . . . 0.0 110.53 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.25 -25.87 11.96 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.871 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 58.3 t -79.9 179.07 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.626 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.28 133.31 45.97 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.768 -178.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 44.47 33.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.148 0.499 . . . . 0.0 111.06 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -82.29 -7.79 59.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.5 m-20 -147.47 38.14 0.94 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.6 pt -74.24 -25.49 19.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.84 0.352 . . . . 0.0 111.881 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.83 0.52 8.86 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.749 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.0 m -93.39 -12.24 30.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.27 0.557 . . . . 0.0 109.628 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.0 mt -65.58 125.0 23.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.204 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -96.34 158.46 15.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.677 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.05 133.06 54.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.514 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.5 59.18 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -83.52 136.91 34.1 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -81.0 130.23 34.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 111.345 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -127.13 126.64 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 148' ' ' TYR . 42.4 m-85 -107.87 120.24 41.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.191 0.519 . . . . 0.0 109.776 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.6 tp -113.59 143.93 43.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.346 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -114.82 127.88 55.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.314 0.578 . . . . 0.0 111.541 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.4 t0 -106.0 -166.12 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.545 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.6 m-20 -27.94 -71.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.695 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -137.42 22.8 2.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.754 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.27 147.83 44.49 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -113.42 118.28 34.08 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -103.45 131.51 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.407 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -93.4 117.85 30.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.347 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.2 133.18 55.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.2 t -67.73 133.03 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.107 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -101.0 -27.19 13.42 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 124.609 1.193 . . . . 0.0 110.63 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.53 144.35 3.98 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.86 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.47 141.32 15.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.41 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.9 p -150.06 161.93 41.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.372 0.606 . . . . 0.0 111.548 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 95.3 mt-10 -114.81 123.18 48.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.749 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.68 149.63 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.344 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.4 p -53.66 166.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.571 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -81.58 -15.59 9.68 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.854 1.703 . . . . 0.0 111.812 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 60.0 t0 -88.64 -11.09 46.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -86.95 67.81 9.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.979 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.571 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 57.3 m95 -76.53 -8.39 57.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.449 . . . . 0.0 111.856 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.9 mt-10 -53.19 -23.47 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.203 0.525 . . . . 0.0 110.937 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.63 -13.06 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.922 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.4 m -132.34 43.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.521 ' O ' ' O ' ' A' ' 176' ' ' ASP . 95.4 mt-10 -146.23 83.17 1.62 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.895 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' GLU . 66.5 t0 23.82 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.346 1.028 . . . . 0.0 113.022 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.455 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 13.2 m170 -102.13 -43.97 5.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 0.0 111.289 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.84 23.78 0.16 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -154.11 173.91 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.954 0.407 . . . . 0.0 111.237 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -96.3 88.65 4.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.242 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -131.58 130.63 42.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.037 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.6 tt -83.17 145.57 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.515 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 3.6 m -138.57 115.94 11.18 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.576 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.48 134.34 47.84 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.18 0.514 . . . . 0.0 110.711 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 34.6 pt -135.1 154.67 36.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.093 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -139.32 101.69 4.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.447 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 188' ' ' VAL . 3.7 t -174.55 -71.74 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 187' ' ' CYS . 3.5 t 57.61 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.577 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 188' ' ' VAL . 2.0 p 61.77 128.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.0 m -85.69 -14.31 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.982 0.42 . . . . 0.0 111.231 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -62.28 -42.28 99.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.401 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -88.01 100.57 13.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.391 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 194' ' ' SER . 61.4 t-20 -67.31 -108.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.996 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 193' ' ' ASN . 1.5 p 60.05 148.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.727 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.435 ' HZ1' ' CB ' ' A' ' 165' ' ' GLU . 13.9 tptm -66.53 130.17 42.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.125 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -97.77 137.3 36.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.225 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.6 m-85 -95.95 129.02 43.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.505 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 71.2 t -131.08 133.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.193 0.521 . . . . 0.0 111.366 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.73 126.96 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.593 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -112.77 132.93 55.02 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 110.721 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.66 14.13 Favored Glycine 0 N--CA 1.464 0.525 0 CA-C-O 121.727 0.626 . . . . 0.0 111.685 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -98.91 142.3 30.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.891 -0.655 . . . . 0.0 111.405 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.1 tp -67.09 128.54 36.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.315 0.578 . . . . 0.0 110.288 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.97 -21.7 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.216 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.5 176.12 46.87 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.009 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.0 m -154.74 153.18 30.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.161 0.505 . . . . 0.0 110.534 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -150.27 178.65 8.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.264 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -99.98 142.26 31.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -57.18 80.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.248 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ALA . 77.5 tttt . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.557 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.7 m -129.54 124.63 34.37 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.617 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -64.44 -43.37 94.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.446 ' HG2' ' H ' ' A' ' 57' ' ' ASP . 28.6 ttm 54.19 175.13 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.038 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' H ' ' HG2' ' A' ' 56' ' ' MET . 98.4 m-20 -63.07 140.32 58.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.921 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.17 77.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.936 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 189' ' ' SER . 7.0 m -153.18 72.27 0.94 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.718 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -71.35 41.49 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.238 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' H ' ' C ' ' A' ' 59' ' ' SER . 34.5 mt -62.42 -46.78 95.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.032 0.444 . . . . 0.0 110.75 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.7 t0 49.99 -97.25 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.197 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -150.71 85.36 5.25 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.491 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.71 151.46 41.07 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.495 2.13 . . . . 0.0 111.362 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 53.8 t0 -62.46 163.15 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 3.8 mm? -77.65 -13.63 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.921 -0.487 . . . . 0.0 111.069 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.35 -48.38 70.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.405 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.17 -21.83 59.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.889 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -78.07 -53.25 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.756 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.47 84.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.512 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.471 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 52.4 t-20 -76.13 -11.21 59.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.927 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 145.27 38.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.429 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -139.51 80.45 1.78 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.9 tp -80.16 147.4 31.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.52 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.54 133.69 49.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.922 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -79.89 -6.44 57.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.249 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -80.74 -10.63 59.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.98 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -94.24 5.77 50.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.3 p -80.62 136.47 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.97 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 pt -119.2 -10.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.72 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.44 -170.09 37.94 Favored Glycine 0 C--N 1.316 -0.545 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -147.15 152.34 38.29 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.416 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 tt -123.99 121.1 61.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 t -124.63 130.75 53.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.909 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 mt -135.15 126.77 17.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.26 -35.49 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.358 2.039 . . . . 0.0 112.5 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 t -51.14 -40.09 57.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.844 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.4 m -115.49 -4.24 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.18 49.9 1.9 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.4 tp -111.32 129.74 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.656 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -136.72 113.7 10.5 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.3 mt -145.69 107.71 4.36 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.66 135.46 3.33 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.77 1.647 . . . . 0.0 110.659 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.17 125.1 39.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 mt -108.86 120.83 43.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.193 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.72 -47.43 72.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.708 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.439 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 54.6 p -69.8 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.1 p -84.43 107.68 16.83 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.283 0.564 . . . . 0.0 110.214 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 p -137.08 166.32 23.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.026 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.442 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 16.9 pt-20 -61.9 -35.43 78.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.681 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -82.92 -37.62 23.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.559 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 76.7 m-20 -67.22 -22.88 65.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.637 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.88 -13.41 61.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.482 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' A' ' 104' ' ' LEU . 8.9 mp -76.92 -14.35 59.88 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -106.19 -15.63 14.81 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.98 -176.05 45.83 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.71 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.22 129.58 38.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.248 -0.476 . . . . 0.0 109.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.48 144.53 31.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.752 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.7 p -73.84 146.94 43.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.65 -46.69 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -91.02 144.28 25.83 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.806 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.71 -5.07 35.21 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.859 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 113' ' ' ASN . 61.2 t-20 -142.15 41.47 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.688 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -84.03 155.54 22.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.29 128.19 51.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.72 126.23 30.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.05 -6.12 61.77 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -137.21 118.99 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.668 0.271 . . . . 0.0 110.78 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.98 -172.85 54.07 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.506 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 55.8 t30 -82.54 111.72 18.8 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -85.18 103.07 13.83 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.36 121.52 32.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 111.412 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.1 mt -117.76 131.86 56.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.85 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.62 46.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.02 -178.07 20.33 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.814 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 30.2 m-70 -83.5 131.23 35.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.231 0.539 . . . . 0.0 110.863 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.9 p30 -101.52 27.02 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.4 mmm -46.05 -14.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.957 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 41.67 17.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.875 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -133.8 106.85 7.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.081 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -50.69 125.93 14.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.547 0.689 . . . . 0.0 109.985 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.25 -26.1 10.69 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.946 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.552 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 35.4 t -83.4 178.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 CA-C-N 117.736 0.768 . . . . 0.0 109.13 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.552 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.17 138.56 47.72 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.178 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 45.64 31.99 1.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.057 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.2 p -80.58 -12.31 59.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -138.56 35.94 2.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 140' ' ' SER . 8.8 pt -67.67 -41.51 85.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.09 2.09 1.69 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.961 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 138' ' ' ILE . 13.3 t -89.23 -21.65 23.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.58 121.7 15.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.143 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.441 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.7 mtmt -96.99 157.71 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.555 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -57.62 125.89 24.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.321 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.83 19.04 23.35 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 89.6 m-20 -89.86 133.24 34.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.75 134.74 37.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 111.723 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 147' ' ' ILE . 73.0 mt -127.66 124.25 62.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.379 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -105.26 122.09 45.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.024 0.44 . . . . 0.0 110.218 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.68 153.21 32.73 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.093 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -121.12 130.87 53.94 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.316 0.579 . . . . 0.0 111.334 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 23.9 t0 -112.8 -167.07 1.14 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -24.48 -74.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.449 0.468 . . . . 0.0 111.705 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -137.97 28.58 2.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -125.59 151.38 46.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -112.03 122.04 46.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.741 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.532 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 47.2 m-85 -105.52 127.9 53.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.108 0.48 . . . . 0.0 111.791 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -97.64 118.74 34.85 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -115.86 145.11 43.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.219 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.3 128.69 54.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.24 0.543 . . . . 0.0 110.374 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.1 t -68.46 135.59 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.066 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 8.5 p -100.33 -22.86 14.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 124.378 1.049 . . . . 0.0 110.16 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 152.97 -178.51 30.03 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.833 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.8 p -124.2 143.01 39.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.318 -0.941 . . . . 0.0 109.893 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.8 t -136.77 148.08 47.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 111.107 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.13 113.01 26.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.239 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.33 159.44 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.1 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.0 p -71.22 142.59 87.32 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.568 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.5 Cg_endo -48.42 -16.24 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.862 1.708 . . . . 0.0 111.772 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 61.6 t0 -83.32 -11.55 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.91 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -83.47 62.47 6.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.468 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.568 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 45.7 m95 -73.06 -21.13 60.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.675 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -51.12 -9.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.102 0.477 . . . . 0.0 110.947 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' A' ' 171' ' ' TRP . 27.4 m -77.15 -29.26 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.917 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.2 -0.65 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.618 0.723 . . . . 0.0 109.938 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 176' ' ' ASP . 76.3 mm-40 -82.28 117.44 22.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.785 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.0 p-10 -27.71 123.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.872 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -99.62 -37.63 9.06 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.62 33.2 0.62 Allowed Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -154.72 177.14 11.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.129 0.49 . . . . 0.0 111.68 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.06 88.96 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.37 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -128.74 167.42 17.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.831 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.506 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 3.2 m -136.74 127.34 27.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.0 mp -113.18 128.95 56.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.404 0.621 . . . . 0.0 110.778 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.7 pt -139.93 -167.68 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.923 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.552 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 3.3 t -139.94 157.12 46.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.414 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.529 ' N ' ' HG1' ' A' ' 186' ' ' THR . 18.7 t -78.04 155.3 30.74 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.017 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.539 ' CG1' HH22 ' A' ' 196' ' ' ARG . 3.1 p -135.31 152.33 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.394 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 59' ' ' SER . 55.1 m -147.57 -134.5 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.22 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.79 -23.42 32.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.491 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.73 -47.39 84.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.942 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 47.0 t0 47.71 72.95 0.22 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.061 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 195' ' ' LYS . 66.0 t30 -64.21 153.28 38.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.301 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 t -59.06 -43.69 91.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 110.55 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.542 ' O ' ' ND2' ' A' ' 193' ' ' ASN . 60.9 pttt -145.54 149.16 34.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.496 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.7 ttm180 -111.87 128.62 56.19 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.275 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -77.12 132.61 38.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.701 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.63 135.04 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.01 128.41 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.537 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.91 139.3 51.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.272 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.36 152.25 21.1 Favored Glycine 0 C--O 1.226 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -107.45 147.2 30.75 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.635 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.5 tp -69.83 126.28 29.25 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 121.097 0.475 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.65 -26.65 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.745 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.32 161.88 21.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.05 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.532 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 88.0 m -139.17 157.69 45.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.363 0.602 . . . . 0.0 110.11 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -149.08 178.79 8.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.384 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.33 147.25 23.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.78 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -76.9 78.95 3.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.714 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.716 178.678 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 p -75.29 158.7 32.46 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -82.0 -17.75 45.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 0.0 110.78 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.9 mtm -83.08 144.86 29.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.72 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -66.89 138.58 57.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 110.199 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.17 73.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.075 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.9 m -86.37 -91.09 0.1 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.437 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 53.3 27.96 6.75 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.058 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 63' ' ' GLN . 36.6 mt -63.07 -48.64 86.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.15 0.5 . . . . 0.0 110.966 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 43.65 -92.5 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.33 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' ILE . 5.3 pt20 -150.89 86.41 4.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.332 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.43 150.95 47.25 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.323 2.016 . . . . 0.0 111.648 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.73 159.15 31.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.864 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.68 -23.63 66.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.7 92.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.445 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 97.0 mt-10 -73.46 -35.31 65.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.477 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.7 t -76.92 -42.96 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.755 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.83 91.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.698 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.4 p-10 -84.95 -17.87 36.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.5 ' N ' ' OD1' ' A' ' 71' ' ' ASN . . . -58.44 111.62 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.961 0.41 . . . . 0.0 110.875 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -95.46 118.46 32.23 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.228 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.9 tp -116.14 131.16 57.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.061 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.54 134.82 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -75.83 -9.29 58.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 110.254 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.4 -12.66 61.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.037 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.528 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 25.2 mt-30 -95.51 12.72 28.48 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.221 0.534 . . . . 0.0 111.028 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.4 p -90.45 128.83 42.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.741 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -120.9 -5.39 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 120.896 0.379 . . . . 0.0 111.88 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.87 41.74 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.696 HH12 ' HZ2' ' A' ' 209' ' ' LYS . 30.0 mtt85 -147.34 156.6 43.05 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.477 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.2 tt -123.63 128.28 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.427 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.1 t -128.24 130.2 47.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.47 128.88 19.36 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.399 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 -34.61 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.291 1.994 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -47.36 -39.51 15.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.457 -177.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.0 p -119.86 -1.72 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.781 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.7 p 63.6 50.4 2.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.081 0.943 . . . . 0.0 108.562 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.7 tp -113.51 133.63 55.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.397 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -135.81 111.4 9.26 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.29 113.46 8.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.6 147.46 0.39 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 110.419 176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.9 124.57 53.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -105.0 125.47 51.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.004 0.431 . . . . 0.0 110.631 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 61.2 tttp -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 110.752 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.466 ' OG ' ' OD1' ' A' ' 102' ' ' ASN . 84.7 p -71.45 103.48 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 96.31 9.57 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.608 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.5 p -134.31 160.89 36.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.947 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -57.53 -33.49 68.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.6 -45.65 21.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 0.0 111.487 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.608 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.2 m-80 -67.2 -35.38 79.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.696 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.69 -17.42 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.814 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.07 -16.79 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 t -107.93 -9.73 15.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.63 175.46 39.96 Favored Glycine 0 N--CA 1.461 0.327 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.446 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.18 127.57 32.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.008 -0.596 . . . . 0.0 109.785 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.52 24.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.893 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -72.84 150.24 42.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.1 t -84.49 -49.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -91.81 143.15 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 110.778 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.559 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 tt0 -61.92 -49.95 74.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.798 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -95.89 49.52 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.168 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 3.9 tt0 -89.15 151.47 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.2 127.6 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.966 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 129.39 36.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.812 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.03 -6.83 62.22 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -143.59 126.89 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.961 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 77.24 -162.41 51.26 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.5 HD21 ' CE1' ' A' ' 177' ' ' HIS . 41.0 t-20 -93.53 108.9 20.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -86.05 100.23 12.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.425 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.54 126.02 35.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.252 0.549 . . . . 0.0 111.043 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.3 mt -119.79 131.2 55.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.819 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.37 140.03 47.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 187' ' ' CYS . . . -143.78 -178.49 19.58 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.405 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.42 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -84.04 141.84 30.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.736 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 61.7 t30 -109.1 28.39 8.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.185 0.517 . . . . 0.0 110.078 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.7 mmm -43.53 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.775 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.3 m 57.74 38.48 27.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.03 107.49 8.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.007 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -51.63 122.29 7.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.36 0.6 . . . . 0.0 110.045 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.12 21.82 6.48 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.316 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.494 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 24.0 t -136.57 176.61 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -69.62 130.67 43.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 0.0 110.362 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 48.44 36.39 7.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.172 0.51 . . . . 0.0 110.585 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -82.35 -10.37 59.1 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 136' ' ' SER . 72.3 m-20 -150.33 31.91 0.66 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.6 pt -70.63 -21.02 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.803 0.335 . . . . 0.0 111.567 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.6 5.1 8.0 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.481 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -99.51 -10.3 22.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.25 0.548 . . . . 0.0 109.679 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.8 mt -64.27 126.37 27.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.618 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.3 mttp -96.76 159.66 14.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.531 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -58.15 132.33 53.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.105 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.9 21.65 57.07 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 19.2 m-20 -79.35 135.23 36.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -78.96 121.74 25.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 111.979 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.32 120.82 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.132 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -103.24 117.7 35.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.198 0.523 . . . . 0.0 109.806 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.2 tp -112.35 144.33 41.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.132 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -108.21 131.68 54.43 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.273 0.559 . . . . 0.0 111.672 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -104.77 -172.51 2.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.532 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -36.39 -63.26 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.161 0.505 . . . . 0.0 111.121 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -137.55 24.34 2.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.77 152.91 47.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -115.38 121.77 43.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.781 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -104.06 132.37 50.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.29 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -95.5 114.74 26.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -114.6 141.37 47.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.2 132.02 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.606 0.717 . . . . 0.0 111.309 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.01 134.06 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.898 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -102.86 -28.11 12.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 124.625 1.203 . . . . 0.0 110.818 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.24 141.08 3.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.877 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.1 t -106.28 147.73 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.487 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.3 p -157.26 167.5 30.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.286 0.565 . . . . 0.0 111.638 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -118.15 120.6 38.21 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.55 158.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 111.3 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.4 p -57.21 165.47 1.95 Allowed Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.2 Cg_endo -82.03 -9.43 11.79 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.967 1.778 . . . . 0.0 111.913 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 63.2 t0 -83.38 -10.53 58.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.388 . . . . 0.0 110.449 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -85.93 64.33 8.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.798 0.332 . . . . 0.0 110.69 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.552 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 86.8 m95 -73.33 -10.11 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.481 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 80.9 mm-40 -59.93 -35.41 74.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.188 0.518 . . . . 0.0 110.975 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.7 m -65.68 -8.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.243 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.5 m -136.0 43.04 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 176' ' ' ASP . 48.8 mm-40 -144.8 107.24 4.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.733 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 175' ' ' GLU . 41.0 p-10 4.27 112.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.65 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.5 ' CE1' HD21 ' A' ' 120' ' ' ASN . 40.4 m80 -102.91 -42.49 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.883 0.373 . . . . 0.0 111.028 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 136.32 29.82 0.32 Allowed Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 17.9 ptpt -153.83 173.12 16.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 8.7 p30 -95.19 88.34 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.836 0.827 . . . . 0.0 110.181 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -130.12 174.72 9.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.552 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.8 tt -130.89 143.12 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.174 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -137.79 124.08 20.56 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.313 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.9 mp -111.57 131.13 55.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.235 0.54 . . . . 0.0 110.695 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 7.5 pt -138.53 171.53 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.952 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 60.5 p -76.55 169.32 18.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.129 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.492 ' N ' ' O ' ' A' ' 125' ' ' GLY . 16.7 m -39.24 -87.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.105 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.422 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 11.3 p -168.21 -24.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.215 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 188' ' ' VAL . 0.7 OUTLIER 60.88 119.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.047 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.1 -45.53 98.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.791 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -136.21 -179.23 5.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.691 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.27 138.14 58.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -159.42 -125.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.9 0.381 . . . . 0.0 110.827 -178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.2 p -69.77 156.79 38.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.06 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -65.38 126.86 29.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.422 ' NH2' ' O ' ' A' ' 188' ' ' VAL . 42.1 ttm180 -80.1 138.31 36.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.067 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.69 138.47 43.86 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.38 138.18 48.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.439 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 76.1 t -117.18 128.8 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.342 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.95 135.22 54.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.087 0.47 . . . . 0.0 110.346 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.77 156.96 24.52 Favored Glycine 0 N--CA 1.461 0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.574 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.19 153.82 26.48 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.049 -0.576 . . . . 0.0 111.396 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 39.4 tp -73.87 128.06 34.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.256 0.551 . . . . 0.0 110.574 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 38.1 t -109.06 -25.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.931 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.52 175.03 46.7 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.972 -1.108 . . . . 0.0 112.155 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.0 m -153.78 152.31 30.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.143 0.496 . . . . 0.0 110.826 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.14 177.14 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.19 145.19 24.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.099 0.476 . . . . 0.0 110.718 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.696 ' HZ2' HH12 ' A' ' 82' ' ' ARG . 88.3 tttt -74.44 79.69 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.904 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--N 1.314 -0.94 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.561 178.528 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' C ' ' N ' ' A' ' 55' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p 47.91 14.95 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.148 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.448 ' N ' ' C ' ' A' ' 53' ' ' GLY . 80.3 m80 47.31 88.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.516 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.423 ' HG2' ' H ' ' A' ' 57' ' ' ASP . 29.9 ttp -88.58 173.15 8.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.261 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' H ' ' HG2' ' A' ' 56' ' ' MET . 98.1 m-20 -63.43 140.36 58.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.024 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.76 -12.18 61.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.948 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 61' ' ' ILE . 24.0 p -87.44 32.56 0.71 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.876 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' C ' ' CD ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -70.41 31.31 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.613 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.512 ' H ' ' C ' ' A' ' 59' ' ' SER . 61.1 mt -59.83 -51.13 76.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.018 0.437 . . . . 0.0 110.833 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' OD2' ' NE2' ' A' ' 63' ' ' GLN . 66.1 t0 45.28 -91.4 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.185 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 61' ' ' ILE . 2.7 pt20 -148.37 90.56 4.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.824 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.5 158.46 47.77 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.583 2.189 . . . . 0.0 111.213 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.17 165.21 24.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.659 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.0 mm? -69.51 -16.19 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.04 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.62 95.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.283 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -73.14 -33.46 65.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.665 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.37 -45.76 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.075 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.45 89.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.025 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.02 -28.46 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.589 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.79 107.42 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.804 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.3 m -95.98 115.31 27.24 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.289 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.0 tp -115.23 126.49 54.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.277 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -69.01 139.01 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -76.13 -0.11 20.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 110.211 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -85.29 -8.99 58.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.143 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.533 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.0 mp0 -90.92 2.84 55.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.757 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 p -87.64 138.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.821 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.6 pt -120.82 -5.27 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.781 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.89 33.14 Favored Glycine 0 C--N 1.321 -0.285 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -152.75 152.69 31.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.264 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.9 tt -126.1 130.85 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.845 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -128.2 129.17 46.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.002 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.5 mt -133.59 127.83 19.77 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.543 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.65 -34.18 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.452 2.102 . . . . 0.0 112.285 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.1 p -46.98 -38.73 11.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.7 p -119.93 -0.34 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.852 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 63.81 52.68 2.11 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.7 tp -116.97 132.81 56.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.372 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -134.67 117.65 16.3 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -143.85 161.73 44.58 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.12 155.6 7.0 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.851 2.367 . . . . 0.0 108.901 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 118.24 52.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.1 mt -100.21 124.14 45.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -65.35 -48.56 72.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.807 0.337 . . . . 0.0 111.32 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.585 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 99.9 p -78.91 112.87 16.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.014 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.6 p -84.53 110.63 18.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.201 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.517 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -139.61 166.56 24.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.447 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.51 -31.07 70.94 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -81.39 -44.09 18.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.972 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.3 p-10 -66.38 -31.67 72.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.201 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.39 -21.02 66.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.43 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.21 -18.45 61.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -97.54 -13.15 21.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.06 -147.98 11.29 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.658 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.27 129.56 45.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.972 -0.614 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.484 ' CB ' HD22 ' A' ' 102' ' ' ASN . . . -107.91 148.1 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.4 p -70.39 148.25 48.6 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -82.86 -40.26 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.627 ' HZ3' ' H ' ' A' ' 176' ' ' ASP . 99.5 mttt -90.29 149.53 22.31 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.011 0.434 . . . . 0.0 111.077 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.43 -18.61 64.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.908 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -144.77 55.95 1.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.012 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.565 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 2.4 tt0 -80.67 156.36 26.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.938 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.9 t -136.0 124.35 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.83 127.24 32.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.12 -8.38 60.86 Favored Glycine 0 N--CA 1.46 0.237 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -135.27 117.77 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.69 -167.53 54.75 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.706 HD22 ' HG1' ' A' ' 183' ' ' THR . 63.8 t30 -86.65 112.54 21.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -85.03 103.47 14.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.03 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.565 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.42 122.92 33.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.362 0.601 . . . . 0.0 111.511 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.3 mt -118.34 132.05 56.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.287 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.36 48.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.381 0.61 . . . . 0.0 111.015 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.64 -178.23 16.93 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.541 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -84.24 145.79 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.649 0.261 . . . . 0.0 110.845 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 54.4 t-20 -110.8 28.45 8.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.9 mmt -43.98 -15.51 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.0 OUTLIER 58.87 39.14 24.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.303 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -133.82 107.65 8.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.611 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -50.28 126.9 15.97 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.745 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.8 12.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.533 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 17.4 t -87.94 179.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.533 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.21 136.69 48.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.258 -177.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 44.18 34.02 0.92 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.231 0.538 . . . . 0.0 110.989 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 p -82.38 -9.78 59.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -149.1 34.99 0.74 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.8 pt -69.89 -28.12 35.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.869 0.366 . . . . 0.0 111.771 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.61 0.86 4.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.606 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -92.93 -13.82 28.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.027 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -64.83 122.92 18.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.397 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mttm -95.63 157.77 15.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.574 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -55.64 133.0 50.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.796 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.6 18.29 62.24 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 16.8 m-20 -79.58 135.06 36.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -81.47 128.01 33.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.511 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.0 mt -123.38 121.7 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.06 119.33 38.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.978 0.418 . . . . 0.0 110.043 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.2 tp -118.07 138.26 52.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -106.01 135.65 47.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.07 0.462 . . . . 0.0 111.48 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 46.7 t0 -109.89 -169.83 1.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.502 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 64.8 t30 -33.67 -67.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.26 0.552 . . . . 0.0 111.099 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.89 23.78 3.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.107 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.05 147.06 49.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.575 0.702 . . . . 0.0 112.712 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.553 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 90.7 mt-10 -108.57 122.25 46.69 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.823 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.551 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 34.5 m-85 -105.02 128.29 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.114 0.483 . . . . 0.0 111.773 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -95.5 115.87 28.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -116.02 140.94 48.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.461 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.26 134.35 55.17 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.484 0.659 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 133.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -101.81 -25.84 13.68 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 124.76 1.287 . . . . 0.0 111.088 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.31 145.61 4.39 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.663 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.7 p -104.56 151.56 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -154.02 162.64 41.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.129 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.532 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 70.3 mt-10 -111.98 117.81 33.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.08 158.52 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 111.335 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.5 p -59.67 168.72 1.74 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.47 -10.69 12.05 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.948 1.765 . . . . 0.0 111.944 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.22 -3.06 58.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.202 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.6 68.32 9.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 110.865 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.425 ' C ' ' N ' ' A' ' 173' ' ' VAL . 70.7 m95 -70.48 -29.86 66.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.765 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 56.0 mp0 -49.23 -17.71 0.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.204 0.526 . . . . 0.0 110.537 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.425 ' N ' ' C ' ' A' ' 171' ' ' TRP . 90.4 t -71.48 -23.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.577 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.86 -7.37 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.608 0.718 . . . . 0.0 109.679 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -79.77 139.0 37.43 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.823 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.627 ' H ' ' HZ3' ' A' ' 111' ' ' LYS . 68.1 t0 -51.24 128.59 22.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.174 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -99.15 -39.59 8.4 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.035 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.89 29.0 0.37 Allowed Glycine 0 N--CA 1.473 1.156 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -156.63 -179.33 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.351 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -91.1 88.85 7.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.368 0.604 . . . . 0.0 109.833 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -124.33 168.31 13.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.077 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.72 142.75 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.951 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.706 ' HG1' HD22 ' A' ' 120' ' ' ASN . 9.4 m -136.84 123.35 20.87 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.388 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.04 122.81 48.04 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.32 0.581 . . . . 0.0 110.92 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 27.9 pt -134.92 -167.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.953 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 34.1 p -134.77 159.57 40.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.781 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 7.5 t -79.53 125.97 30.27 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.914 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.2 157.33 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.69 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.0 p -162.16 10.08 0.07 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.957 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.2 t -117.96 128.99 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.779 0.324 . . . . 0.0 110.254 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -80.15 126.88 31.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.908 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 193' ' ' ASN . 47.1 t0 -168.1 179.36 4.62 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.961 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.4 ' H ' ' CG ' ' A' ' 192' ' ' ASP . 16.4 m120 -92.81 12.71 22.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.956 0.408 . . . . 0.0 111.103 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.9 p -68.89 156.78 37.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.287 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -106.92 136.46 46.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.485 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -98.12 133.08 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.891 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.532 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.6 m-85 -91.03 129.12 37.06 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.679 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 138.71 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.258 0.551 . . . . 0.0 111.48 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.74 127.71 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.556 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.11 135.32 54.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.167 0.508 . . . . 0.0 110.457 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.44 158.92 24.26 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 55.4 p-10 -113.74 150.24 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.387 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 40.0 tp -72.07 127.62 33.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.086 0.469 . . . . 0.0 111.017 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.6 t -106.34 -25.6 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.329 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.29 162.12 20.92 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.421 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.551 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 81.1 m -139.51 157.63 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.189 0.518 . . . . 0.0 110.032 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.553 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 19.4 pttp -149.91 178.54 8.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.6 143.63 26.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -71.28 79.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.702 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.691 178.461 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.974 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.9 m -58.6 -42.86 89.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.802 0.334 . . . . 0.0 110.556 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -80.21 139.59 36.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.145 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.9 mtm -138.2 150.36 46.68 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.231 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -80.9 107.01 13.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.349 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.4 -12.73 60.91 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.277 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.617 ' C ' ' H ' ' A' ' 61' ' ' ILE . 3.2 t -86.83 10.67 15.32 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.933 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -65.71 26.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.63 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.617 ' H ' ' C ' ' A' ' 59' ' ' SER . 45.7 mt -90.88 -67.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.433 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.6 t0 59.5 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.072 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' ILE . 4.9 pt20 -151.82 72.47 8.02 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.019 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.09 146.53 0.62 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.501 2.134 . . . . 0.0 110.895 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.76 154.81 41.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.717 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.4 mp -59.4 -27.61 66.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.689 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.46 94.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.279 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -72.58 -37.49 68.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.732 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.5 t -72.0 -44.29 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.574 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.96 89.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.33 -26.69 30.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.44 136.8 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.9 t -92.36 158.55 16.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.6 tp -122.7 127.22 48.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.0 0.428 . . . . 0.0 111.06 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -96.1 98.26 10.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.564 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 78' ' ' GLN . 29.0 mmtp -55.84 -35.51 66.49 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.119 0.485 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -51.56 -13.06 0.2 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.035 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 97' ' ' SER . 23.8 mm100 -102.55 11.09 38.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.476 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.77 124.95 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -119.39 -4.57 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.171 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.03 -162.29 35.59 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -155.97 165.36 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.574 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -131.35 139.65 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.796 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -131.66 132.84 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.053 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -131.03 127.0 21.91 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.95 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.84 -38.13 0.17 Allowed 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.256 1.971 . . . . 0.0 112.314 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.2 t -46.97 -39.55 12.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.586 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.3 p -117.9 -2.5 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.68 55.38 2.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.77 138.49 53.99 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.559 -177.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 91' ' ' GLU . 55.8 mp0 -138.98 120.1 14.6 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' PRO . 35.4 mt -143.37 109.55 5.33 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -40.74 139.48 1.28 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 121.887 1.724 . . . . 0.0 109.924 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.3 t -90.39 118.2 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.1 mt -102.37 121.73 42.87 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.058 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -64.83 -47.54 77.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.121 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 78' ' ' GLN . 70.3 m -69.7 102.13 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.311 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 98' ' ' SER . 25.2 p -81.15 98.6 8.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.457 0.646 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.6 p -136.59 157.79 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.499 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -56.38 -29.19 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -81.98 -43.58 17.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.226 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.34 -34.45 78.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -63.21 -21.31 66.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.806 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 mt -69.66 -26.51 64.43 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.4 m -93.85 -10.99 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 165.62 -170.81 40.63 Favored Glycine 0 N--CA 1.458 0.149 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.658 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.32 129.2 37.34 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.116 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.12 148.13 28.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.424 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 p -70.32 143.41 52.01 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 t -83.76 -44.64 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.43 -172.86 3.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 1.6 pm0 -119.48 -9.15 9.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.055 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -139.63 39.21 2.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.39 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -91.09 157.25 17.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.48 131.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.896 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -67.58 128.83 37.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.58 2.46 76.08 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -141.83 121.84 13.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.729 0.299 . . . . 0.0 111.107 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.83 -165.73 54.76 Favored Glycine 0 CA--C 1.517 0.218 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -89.86 109.05 20.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.59 101.77 12.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.918 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.57 128.69 36.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.423 0.63 . . . . 0.0 111.739 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -126.0 131.95 52.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.553 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.81 140.85 46.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.58 0.705 . . . . 0.0 111.096 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.1 -179.36 18.31 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -81.93 153.35 26.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 129' ' ' SER . 57.6 t30 -122.36 28.02 7.64 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.007 0.432 . . . . 0.0 111.208 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 31.9 mtt -43.82 -15.0 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.616 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 38.07 21.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.067 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.76 ' H ' ' HG ' ' A' ' 136' ' ' SER . 1.6 tppp? -134.13 121.07 20.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.835 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.18 125.66 24.51 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.98 -25.07 11.08 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.347 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.571 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 95.1 t -80.39 176.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.571 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -74.55 136.6 42.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 46.52 30.66 1.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.095 0.474 . . . . 0.0 110.953 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.76 ' HG ' ' H ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.16 -8.23 59.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.213 -178.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.9 m-20 -143.99 36.3 1.26 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 pt -69.46 -30.05 44.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 111.971 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.08 1.69 7.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.807 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 t -92.18 -15.82 27.08 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.998 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.99 119.51 11.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 53.3 mtmt -96.33 156.28 16.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -56.46 121.77 10.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 102.61 19.0 14.38 Favored Glycine 0 N--CA 1.466 0.694 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 86.5 m-20 -90.28 131.31 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -79.64 135.22 36.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.08 0.467 . . . . 0.0 111.574 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -129.31 121.78 54.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.28 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.39 120.48 40.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.1 tp -116.71 142.86 46.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.181 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.226 0.536 . . . . 0.0 111.499 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 34.7 t0 -112.09 -165.38 0.99 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.0 m-20 -22.4 -75.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.729 0.643 . . . . 0.0 111.479 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -138.26 27.23 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.002 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -125.62 142.34 51.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -108.43 121.41 44.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.903 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -105.2 131.25 52.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.55 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -94.43 115.91 28.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.2 m-85 -117.39 136.65 53.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.589 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.34 133.87 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.482 0.658 . . . . 0.0 111.0 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 144' ' ' GLY . 55.0 t -70.22 135.33 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.887 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.3 t -106.14 -24.83 12.24 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.995 1.434 . . . . 0.0 111.178 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.56 155.01 7.5 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.623 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.9 144.28 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.2 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.8 m -138.64 151.36 47.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.102 0.477 . . . . 0.0 111.298 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' A' ' 197' ' ' TYR . 96.1 mt-10 -106.02 110.26 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.314 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.2 m -130.74 153.03 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.2 p -64.11 168.48 6.09 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.8 Cg_endo -80.97 -12.63 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.923 1.748 . . . . 0.0 111.926 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -85.47 -21.53 28.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.096 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -86.64 76.5 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.501 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.563 ' C ' ' H ' ' A' ' 173' ' ' VAL . 27.1 m95 -75.35 -12.69 60.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.244 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -51.05 -8.1 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.563 ' H ' ' C ' ' A' ' 171' ' ' TRP . 32.8 m -90.21 -15.54 8.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.683 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.62 -0.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.724 0.773 . . . . 0.0 109.709 -178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -83.43 143.66 30.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.844 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.12 128.18 35.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.599 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -104.54 -41.88 5.59 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.757 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.73 31.08 0.21 Allowed Glycine 0 N--CA 1.473 1.114 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -154.03 174.72 14.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 3.8 m-20 -91.55 89.62 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.736 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -123.17 169.79 10.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.851 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -131.61 142.72 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.794 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 m -137.32 124.26 21.41 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.3 mp -109.56 125.06 52.13 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.611 0.719 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.4 pt -135.53 -170.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.608 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.594 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.1 p -138.35 144.55 40.39 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.724 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 186' ' ' THR . 5.1 t 54.72 107.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.36 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.429 ' CG2' ' N ' ' A' ' 189' ' ' SER . 17.2 m -61.17 -43.32 96.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.06 0.457 . . . . 0.0 110.782 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.453 ' HG ' ' HG ' ' A' ' 59' ' ' SER . 25.9 p -76.32 165.3 25.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.104 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.8 m -80.44 130.69 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.065 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -94.84 160.89 14.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.566 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -61.34 -37.61 83.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.0 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -77.84 123.7 27.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.817 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 34.5 p -100.64 62.4 1.04 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.92 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -163.92 60.09 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.731 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.594 ' NH1' ' O ' ' A' ' 186' ' ' THR . 12.0 ptp180 -92.94 167.73 11.62 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.925 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 4.8 m-85 -106.68 139.85 40.47 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.011 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 24.6 t -133.46 135.43 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.265 0.555 . . . . 0.0 110.937 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.5 t -118.42 130.28 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.692 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.77 136.54 53.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.425 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.61 150.44 19.51 Favored Glycine 0 N--CA 1.466 0.679 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.023 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -105.47 143.78 33.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.15 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.504 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.27 127.83 33.86 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 110.698 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.2 t -108.4 -23.54 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.529 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.42 177.03 46.81 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.745 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 21.8 m -154.03 151.63 29.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -150.31 179.27 8.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.603 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.83 144.42 25.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.023 0.439 . . . . 0.0 110.57 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.54 78.87 1.06 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.638 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt . . . . . 0 C--N 1.319 -0.739 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.329 178.167 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 m -69.98 145.57 51.74 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -152.82 160.97 43.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.031 0.443 . . . . 0.0 110.97 -178.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 50.4 mtt -64.18 -39.87 94.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.78 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 55' ' ' HIS . 31.3 t0 -140.68 164.58 29.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.335 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.438 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -68.35 -37.09 80.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.417 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.3 p -84.64 -85.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.385 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.3 tttt 46.95 29.91 1.14 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.029 0.442 . . . . 0.0 111.032 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.02 -49.77 82.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.084 0.469 . . . . 0.0 110.781 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.0 t0 49.58 -94.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.313 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -150.76 86.63 4.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.619 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.79 150.41 44.45 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.43 2.086 . . . . 0.0 111.628 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -76.33 172.48 12.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.0 mm? -61.08 -21.59 63.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.786 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.87 95.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.31 -20.49 57.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -81.14 -51.67 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.686 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.9 90.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.967 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.45 -32.79 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.857 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 146.72 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.847 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.7 t -138.58 141.41 39.21 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.995 0.426 . . . . 0.0 110.794 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -138.43 121.64 16.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.289 -179.226 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.2 m-20 -70.31 112.1 6.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.36 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -52.81 -9.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.511 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 75' ' ' ASP . 99.4 mttt -83.19 -4.38 58.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.771 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -95.12 10.41 35.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.706 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 m -94.28 147.39 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.463 ' CD1' ' O ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -134.11 4.85 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.921 0.391 . . . . 0.0 111.695 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.5 38.25 Favored Glycine 0 C--N 1.322 -0.247 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -152.43 153.26 33.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.231 0.539 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.66 130.29 68.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 m -128.61 129.46 45.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.11 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.0 mt -135.33 116.06 11.94 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.162 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.35 -32.94 2.08 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 122.745 2.297 . . . . 0.0 112.843 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 t -50.36 -40.08 48.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.012 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.34 -6.68 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.819 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.23 47.64 0.28 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.09 129.93 56.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.761 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.79 119.1 14.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.1 mt -146.59 166.29 17.11 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.72 153.86 8.81 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.072 2.514 . . . . 0.0 108.767 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 73.6 t -104.43 121.09 55.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.25 132.47 53.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -80.15 -29.9 38.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.991 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 m -79.03 102.42 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.128 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.519 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -80.9 97.93 7.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.332 0.587 . . . . 0.0 109.882 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.567 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.0 p -141.01 158.56 43.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.104 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.83 -37.77 77.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.821 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -69.94 -46.29 65.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.83 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.567 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.5 m-80 -65.51 -38.34 89.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.777 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.3 mt -59.73 -26.46 65.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.84 -14.14 61.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -105.74 -13.13 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 175.24 -170.07 43.06 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.486 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.17 123.29 27.78 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.32 142.82 34.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.114 0.483 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.519 ' O ' ' OG ' ' A' ' 98' ' ' SER . 43.8 p -73.95 152.03 40.21 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.07 -42.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -89.51 -172.06 3.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.846 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -123.64 -8.62 7.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.977 0.418 . . . . 0.0 111.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -139.7 39.94 2.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -93.46 159.86 15.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.007 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.87 133.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.009 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.63 127.75 33.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.172 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.52 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.35 5.75 72.04 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -143.56 124.13 14.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 0.0 110.992 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.98 -164.45 54.28 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.83 107.86 19.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.27 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.81 100.01 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.8 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 127.36 36.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 0.0 112.071 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.4 mt -122.88 130.4 52.82 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.29 47.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.13 -178.49 19.01 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.601 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.533 ' O ' ' O ' ' A' ' 134' ' ' LEU . 44.6 m-70 -88.74 139.05 30.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 34.0 p30 -108.2 27.26 9.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.215 0.531 . . . . 0.0 110.323 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.8 mmm -43.87 -14.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.987 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.62 40.91 9.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.009 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -131.7 108.41 9.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.744 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 44.0 pttt -51.07 125.65 14.35 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.319 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.4 -29.76 8.44 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.593 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 58.0 t -75.54 178.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.593 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.33 137.65 46.79 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.281 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 44.37 31.81 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 110.989 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -81.97 -12.94 58.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.293 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 136' ' ' SER . 95.9 m-20 -143.19 24.96 1.76 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.1 pt -69.02 -23.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.85 0.357 . . . . 0.0 111.687 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.78 4.83 3.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.648 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.2 m -96.91 -14.63 21.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.2 0.524 . . . . 0.0 109.638 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 mt -62.43 132.27 51.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.352 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -106.97 175.18 5.59 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.946 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -69.51 135.47 50.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.68 71.51 Favored Glycine 0 N--CA 1.461 0.312 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.28 136.03 36.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -82.95 127.38 33.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.695 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 147' ' ' ILE . 81.6 mt -122.72 123.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -103.82 115.63 30.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.838 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.18 148.86 38.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.931 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -123.44 133.61 54.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.399 0.619 . . . . 0.0 111.629 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -112.14 -165.5 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 16.4 t-20 -23.99 -75.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 111.617 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -137.04 26.7 2.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -124.07 145.94 48.91 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -108.52 119.56 39.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.76 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.426 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 61.0 m-85 -104.42 129.33 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.61 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.477 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 97.7 mt-10 -95.73 117.73 31.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.021 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.52 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 50.6 m-85 -117.47 138.88 51.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.292 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -115.69 132.08 56.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.501 0.667 . . . . 0.0 111.145 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.66 134.88 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.166 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.75 -25.49 12.18 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 124.431 1.082 . . . . 0.0 111.081 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.4 161.55 19.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.395 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.5 t -128.78 155.5 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.823 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -164.16 174.46 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 0.0 111.666 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.535 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 40.1 mp0 -121.88 117.13 25.74 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.8 159.06 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 p -62.82 167.12 6.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.22 -9.95 11.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.343 2.028 . . . . 0.0 111.922 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -81.34 -11.61 59.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.808 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -86.4 73.21 10.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.369 0.605 . . . . 0.0 109.72 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.544 ' C ' ' H ' ' A' ' 173' ' ' VAL . 81.9 m95 -72.48 -27.36 62.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -50.93 -9.1 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.0 110.93 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.8 t -78.25 -21.16 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.539 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.2 m -116.18 -3.65 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.745 0.783 . . . . 0.0 109.85 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -80.64 151.76 28.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.15 -1.387 . . . . 0.0 112.157 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.87 126.5 27.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.674 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -107.17 -43.8 4.52 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.317 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 150.34 23.3 0.06 OUTLIER Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.3 173.7 15.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.157 0.503 . . . . 0.0 111.156 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.4 m-20 -95.75 88.38 4.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -124.22 127.72 48.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.403 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -81.71 146.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 7.2 m -136.29 122.09 19.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.772 0.32 . . . . 0.0 111.06 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.1 mp -107.57 126.12 52.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.317 0.58 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.7 pt -137.55 178.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.663 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t -139.08 161.29 37.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.3 t 57.88 -170.69 0.11 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.738 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.41 -118.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.52 0.2 . . . . 0.0 111.003 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.1 m -82.95 -9.03 59.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.937 0.398 . . . . 0.0 110.874 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 89.3 t -68.77 132.07 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.183 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.01 -45.91 92.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.979 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.4 t0 48.1 -101.04 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.429 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -95.37 162.2 13.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.856 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.9 m -59.21 -44.92 92.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.002 0.43 . . . . 0.0 110.828 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -139.84 147.09 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.087 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -111.27 149.45 31.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.241 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.404 ' CE1' ' OE2' ' A' ' 165' ' ' GLU . 4.5 m-85 -80.37 132.9 35.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.85 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.1 133.92 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.041 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 82.0 t -117.2 128.62 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.446 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.45 135.62 53.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.6 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.77 142.53 14.04 Favored Glycine 0 N--CA 1.465 0.596 0 CA-C-O 121.773 0.652 . . . . 0.0 111.642 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 52.3 p-10 -100.32 141.56 32.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.294 -0.953 . . . . 0.0 111.409 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.18 126.16 28.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.2 m -109.46 -22.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.421 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.04 158.14 13.44 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.802 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.426 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 25.1 m -134.85 156.18 49.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.382 0.61 . . . . 0.0 109.778 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.477 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 ptpp? -149.66 178.81 8.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.278 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.69 147.1 23.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.509 . . . . 0.0 110.549 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.32 80.02 3.07 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.814 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 51.7 tttm . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.189 178.649 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -68.68 145.49 53.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 110.651 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -84.47 132.2 34.58 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.173 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 20.5 ptm -151.06 171.45 17.3 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.605 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -88.72 110.3 20.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.388 0.613 . . . . 0.0 110.152 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.2 -4.21 34.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.742 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.554 ' C ' ' H ' ' A' ' 61' ' ' ILE . 89.0 p -83.22 1.05 42.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.773 0.321 . . . . 0.0 111.478 -178.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.78 14.2 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.805 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.554 ' H ' ' C ' ' A' ' 59' ' ' SER . 40.9 mt -62.25 -49.06 85.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.161 0.505 . . . . 0.0 110.609 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.6 t0 48.49 -92.81 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.508 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 61' ' ' ILE . 45.8 tt0 -150.65 86.17 5.08 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.484 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.28 155.49 41.64 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.384 2.056 . . . . 0.0 111.606 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -68.86 163.93 23.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.177 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 tt -76.43 -14.16 60.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.307 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.44 80.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.482 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.69 -19.05 60.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.396 . . . . 0.0 110.704 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.56 -53.78 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.526 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.02 88.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.125 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -73.0 -27.94 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.523 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.89 137.02 58.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.84 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.7 p -89.78 159.27 17.12 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.182 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.1 tp -122.41 129.71 52.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.994 0.426 . . . . 0.0 111.008 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.3 m-20 -97.5 90.64 5.11 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.48 -13.53 0.13 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 75' ' ' ASP . 71.3 mmtt -71.27 -8.95 57.03 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -106.53 13.45 28.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 6.4 p -87.43 123.17 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.822 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.0 pt -120.44 -7.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.13 -169.26 40.47 Favored Glycine 0 C--N 1.317 -0.527 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -146.54 155.72 42.71 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.178 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 tp -125.79 128.94 72.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -126.93 131.39 51.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.79 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.7 mt -130.63 122.04 19.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.04 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.67 -37.16 0.28 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 122.304 2.002 . . . . 0.0 112.422 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -49.12 -37.92 23.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.25 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -118.25 -3.47 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.531 -178.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.51 51.48 1.51 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.32 128.93 55.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.132 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.59 113.54 11.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.7 mt -146.49 111.79 4.29 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.17 143.0 1.45 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.508 1.472 . . . . 0.0 110.583 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.28 119.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -102.09 121.44 42.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.076 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 66.0 tttm -64.75 -47.11 79.42 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.558 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 18.3 p -60.6 97.86 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.993 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.521 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -80.93 97.94 7.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.19 0.519 . . . . 0.0 109.803 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.589 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 65.5 p -139.49 158.45 44.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.53 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -60.59 -25.01 65.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.352 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -83.79 -45.2 13.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 111.348 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.589 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 97.5 m-20 -66.86 -35.07 79.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.444 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.5 -16.99 62.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.73 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.07 -27.22 62.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -98.75 -7.48 27.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 173.8 -170.07 43.17 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.729 -1.225 . . . . 0.0 112.146 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.14 124.35 31.7 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.69 149.81 25.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.779 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.521 ' O ' ' OG ' ' A' ' 98' ' ' SER . 6.1 p -75.28 152.03 38.27 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.1 p -88.1 -35.45 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -89.24 143.95 26.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.316 0.579 . . . . 0.0 111.096 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.509 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.1 pt-20 -70.09 -17.14 63.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.916 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.45 52.22 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.792 0.33 . . . . 0.0 111.186 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -88.75 157.98 18.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.78 134.07 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.753 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 5.2 mtp -77.87 123.82 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.23 5.07 65.96 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -140.78 120.18 13.11 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.43 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.91 -173.44 53.64 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 173' ' ' VAL . 39.7 t-20 -78.25 107.58 10.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -85.51 103.42 14.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.34 122.5 33.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.306 0.574 . . . . 0.0 111.679 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.09 128.9 56.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.74 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.01 138.54 46.25 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 110.551 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.52 17.69 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.778 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' LEU . 49.9 m-70 -87.32 142.99 27.47 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.998 0.428 . . . . 0.0 110.708 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 129' ' ' SER . 66.8 t30 -109.26 28.65 8.3 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.874 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.56 -18.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.717 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 61.8 37.39 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.941 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -133.98 106.91 7.49 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -50.18 125.61 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.88 -22.9 11.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.0 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.606 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 33.7 t -90.09 179.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 117.659 0.729 . . . . 0.0 109.352 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.606 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -71.13 135.22 47.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.878 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.04 36.07 2.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.381 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 26.3 p -81.45 -8.94 59.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 85.9 m-20 -145.9 37.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.5 pt -68.64 -32.27 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.472 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.9 5.75 2.45 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.139 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -95.27 -15.7 22.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.79 124.31 22.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.701 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.33 152.25 19.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -54.29 127.26 26.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.616 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 91.71 22.0 32.37 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -85.41 134.57 34.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -79.35 131.48 36.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 111.88 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.6 mt -127.24 125.96 67.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.532 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.63 119.93 39.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.055 0.455 . . . . 0.0 110.079 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 tp -115.66 143.39 45.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -108.07 124.82 50.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.086 0.47 . . . . 0.0 111.418 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -97.7 -173.03 2.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.525 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 5.5 p30 -30.35 -69.56 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.508 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 70.8 mm-40 -135.03 27.0 3.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.757 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 158.34 38.46 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.465 0.65 . . . . 0.0 112.463 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -116.52 122.18 43.94 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.338 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -105.91 131.92 52.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 111.25 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -96.37 115.26 27.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.984 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -113.93 141.92 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.422 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.16 131.18 54.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.488 0.661 . . . . 0.0 111.198 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 144' ' ' GLY . 47.8 t -65.37 134.33 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.08 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -100.94 -30.42 11.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 124.708 1.255 . . . . 0.0 110.299 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.46 156.69 11.04 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.207 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.54 154.74 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.916 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.9 t -167.65 178.03 5.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.578 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -113.12 127.64 56.26 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.1 m -155.52 174.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.361 . . . . 0.0 111.483 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.554 ' C ' ' H ' ' A' ' 169' ' ' ASP . 8.9 p -90.56 136.55 28.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.651 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -54.13 -0.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.191 1.927 . . . . 0.0 112.263 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.554 ' H ' ' C ' ' A' ' 167' ' ' THR . 48.5 p-10 -74.23 -18.99 60.67 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.518 ' HZ2' ' NH2' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -85.68 72.21 10.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.521 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 59.8 m95 -74.38 -4.17 34.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.185 0.516 . . . . 0.0 112.001 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.562 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.6 mt-10 -60.55 -18.2 50.92 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.45 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 4.4 m -92.86 -0.29 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.68 -6.6 7.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.513 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 69.4 mm-40 -87.56 152.22 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.206 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.42 127.33 31.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.714 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.562 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.1 m170 -119.94 27.94 8.39 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.55 76.87 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -148.84 164.91 33.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.073 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -91.91 91.37 7.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.55 0.691 . . . . 0.0 109.826 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -117.41 164.55 14.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.522 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.96 140.75 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 56.7 m -135.75 126.47 27.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.624 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.25 120.8 43.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.376 0.608 . . . . 0.0 109.684 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.2 pt -130.32 -178.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.513 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.424 ' HG1' ' N ' ' A' ' 187' ' ' CYS . 3.7 t -138.67 156.9 47.02 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.424 ' N ' ' HG1' ' A' ' 186' ' ' THR . 34.0 m -85.71 113.74 22.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.039 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.95 138.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.178 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.432 ' HB3' ' HG ' ' A' ' 59' ' ' SER . 23.4 p -158.17 30.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.684 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.7 m -76.38 -154.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -85.0 37.46 0.67 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.58 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 50.54 42.16 26.34 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.049 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.77 -40.37 97.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.225 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.8 p -154.94 161.41 41.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.562 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.11 145.16 29.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.151 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.518 ' NH2' ' HZ2' ' A' ' 170' ' ' LYS . 20.6 ptt180 -86.45 169.52 12.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.082 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.11 137.52 37.51 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.1 p -131.71 135.87 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.411 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.19 137.87 52.7 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.142 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.58 151.97 21.42 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 54.4 p-10 -110.18 147.17 34.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.923 -0.639 . . . . 0.0 111.902 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 45.4 tp -67.71 126.24 28.76 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.774 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.9 m -109.59 -23.54 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.03 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -177.78 172.71 45.38 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.213 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.8 m -152.67 151.43 30.57 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.087 0.47 . . . . 0.0 110.686 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -148.14 175.8 10.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.116 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.82 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.062 0.458 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -73.61 79.75 1.5 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.886 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.768 178.59 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -70.19 142.05 52.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 0.0 110.114 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -56.44 -78.79 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.051 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.481 ' O ' ' CD ' ' A' ' 60' ' ' LYS . 28.2 ttt -154.5 -93.2 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.744 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -79.13 24.49 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.155 0.502 . . . . 0.0 110.24 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 56' ' ' MET . . . -68.99 -39.49 79.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.275 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.2 m -152.76 15.45 0.57 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.993 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' CD ' ' O ' ' A' ' 56' ' ' MET . 27.0 mtpp -81.87 35.8 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' O ' ' N ' ' A' ' 63' ' ' GLN . 60.1 mt -62.38 -49.78 82.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.375 0.607 . . . . 0.0 110.539 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 100.0 m-20 45.74 -93.35 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.399 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 61' ' ' ILE . 7.1 pt20 -150.84 81.78 6.25 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.525 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.77 146.94 38.92 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.153 1.902 . . . . 0.0 112.02 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -77.14 170.76 15.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.3 -14.54 63.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.729 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.36 88.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -75.85 -22.48 56.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.449 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.09 -50.35 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.638 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.16 87.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.196 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.66 -31.41 69.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.17 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.63 109.04 1.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -96.69 113.09 24.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.113 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.0 tp -110.24 124.15 51.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 77' ' ' LYS . 98.5 m-20 -71.91 140.21 49.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.234 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -64.84 -5.4 5.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.561 . . . . 0.0 109.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 75' ' ' ASP . 69.8 mmtt -74.45 -9.33 58.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.826 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 10.4 mp0 -94.83 3.73 54.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -89.22 126.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.537 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -123.66 -7.9 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.014 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.63 -172.63 39.2 Favored Glycine 0 C--N 1.312 -0.763 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -147.82 154.32 40.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 117.457 0.628 . . . . 0.0 111.852 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 6.3 tt -123.35 123.7 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.393 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -125.9 129.67 49.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.517 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 mt -133.89 124.11 17.46 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.424 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.97 -36.02 0.34 Allowed 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.194 1.929 . . . . 0.0 112.576 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.86 -38.78 51.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.806 -177.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 m -118.94 -3.36 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 110.535 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.97 49.54 1.6 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.77 126.79 52.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -133.96 115.31 14.23 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 93' ' ' PRO . 1.2 tp -149.95 113.5 3.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.6 Cg_endo -41.87 158.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.261 1.307 . . . . 0.0 110.427 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.32 124.84 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.6 mt -104.82 123.82 48.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 63.0 tttp -66.15 -46.89 75.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.097 0.475 . . . . 0.0 110.85 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -71.75 102.83 2.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.52 97.29 9.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.581 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 5.2 p -136.33 155.17 50.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.908 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -54.19 -26.19 26.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.485 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -85.12 -47.45 10.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.475 0.655 . . . . 0.0 111.71 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.623 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -65.63 -36.43 83.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.267 -179.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.13 -19.33 61.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -70.79 -32.04 69.01 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 m -92.62 -9.73 39.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.81 176.54 43.21 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.606 -1.283 . . . . 0.0 112.407 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.74 128.01 34.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.17 28.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.001 0.429 . . . . 0.0 111.265 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.0 p -75.56 153.08 37.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.22 -46.38 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -90.54 140.91 29.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.859 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.515 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.0 pt-20 -66.81 -6.12 14.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.694 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -145.73 45.76 1.28 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.78 0.324 . . . . 0.0 110.925 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.534 ' OE1' ' CG ' ' A' ' 121' ' ' TYR . 6.0 tt0 -72.04 161.18 31.28 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.5 t -136.92 124.53 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.8 mtt -75.1 127.82 34.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.494 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.83 71.83 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -140.85 121.61 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.097 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 75.68 -172.26 54.0 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -85.66 111.66 20.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.534 ' CG ' ' OE1' ' A' ' 114' ' ' GLN . 6.0 t80 -83.67 103.25 12.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.72 128.11 36.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 111.891 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.81 131.26 53.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.764 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.13 140.18 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.407 0.622 . . . . 0.0 110.95 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.8 -177.53 17.03 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.774 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -85.84 149.32 25.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.628 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 129' ' ' SER . 50.4 p30 -114.57 27.36 9.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.945 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.5 mmm -47.94 -10.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.93 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 127' ' ' ASN . 1.4 m 55.87 42.12 29.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.327 0.584 . . . . 0.0 109.598 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.507 ' N ' ' OG ' ' A' ' 136' ' ' SER . 31.7 mmtm -132.56 110.55 10.55 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.927 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -53.92 125.25 17.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.726 0.774 . . . . 0.0 110.544 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.3 9.4 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.611 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.614 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 52.3 t -77.84 178.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 CA-C-N 117.466 0.633 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.614 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.56 135.58 47.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.974 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.07 30.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.539 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.28 -11.44 59.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.16 20.61 2.09 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.0 pt -68.06 -25.01 31.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.622 0.249 . . . . 0.0 111.419 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.25 6.09 2.46 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.0 t -98.88 -16.09 18.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.7 mt -64.91 125.02 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.075 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.444 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 22.6 ttpt -99.83 173.87 6.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.409 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 12.4 ttpt -68.57 125.25 25.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.729 0.776 . . . . 0.0 111.617 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.91 26.92 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 85.7 m-20 -85.29 133.31 34.16 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -79.49 127.18 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.302 0.572 . . . . 0.0 111.829 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.99 121.59 63.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.912 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -102.69 121.49 42.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.1 tp -118.52 144.12 46.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -113.04 130.78 56.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.297 0.57 . . . . 0.0 111.193 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.0 t0 -108.87 -172.17 2.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.516 -1.22 . . . . 0.0 107.913 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.541 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.8 m-20 -27.05 -67.7 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.163 0.506 . . . . 0.0 111.799 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.97 22.02 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.8 152.76 36.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.365 0.602 . . . . 0.0 112.461 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.17 120.79 40.93 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -106.85 130.73 54.49 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 111.075 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.297 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -113.33 141.91 46.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.31 131.57 54.28 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.532 0.682 . . . . 0.0 110.42 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.6 135.81 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.146 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -100.92 -23.09 14.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.461 1.1 . . . . 0.0 110.339 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 153.16 155.93 7.36 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.497 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.39 138.56 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.331 -0.934 . . . . 0.0 109.905 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.0 m -135.04 149.57 50.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.129 0.49 . . . . 0.0 111.601 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.49 111.54 24.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.308 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.03 158.59 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.184 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 p -67.06 168.47 10.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.535 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.3 Cg_endo -81.52 -11.09 11.85 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 122.033 1.822 . . . . 0.0 111.47 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -86.69 -14.49 42.37 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.168 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -87.37 72.26 9.81 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.143 0.496 . . . . 0.0 110.442 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 89.4 m95 -76.21 -1.72 27.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.464 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.505 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -53.56 -31.26 45.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 0.0 110.739 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.7 m -83.68 4.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.66 -16.23 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.616 0.722 . . . . 0.0 109.456 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.9 159.9 19.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.878 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.26 129.34 39.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 39.5 m80 -102.25 -38.87 7.47 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.49 29.33 0.28 Allowed Glycine 0 N--CA 1.472 1.076 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.427 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.0 ptpt -156.18 176.91 12.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.381 0.61 . . . . 0.0 111.595 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 23.9 p30 -90.69 88.62 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.893 0.854 . . . . 0.0 109.84 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.44 166.88 13.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.169 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.25 140.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.5 m -135.28 126.33 27.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.0 mp -113.77 118.29 33.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.339 0.59 . . . . 0.0 109.782 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 185' ' ' ILE . 29.3 pt -129.35 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.54 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.529 ' OG1' ' NH1' ' A' ' 196' ' ' ARG . 44.3 p -132.19 163.09 29.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.113 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.7 p -42.88 163.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.23 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 10.7 p -93.09 128.05 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.967 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.3 p -155.23 162.94 40.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 111.045 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.28 141.01 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.793 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -143.43 -78.82 0.22 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -149.61 63.44 1.0 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 63.2 t30 56.52 35.91 26.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.0 109.823 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.3 m -75.52 147.02 40.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.945 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -88.14 138.37 31.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.194 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.529 ' NH1' ' OG1' ' A' ' 186' ' ' THR . 61.0 ttm-85 -101.8 145.86 28.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.268 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.98 127.39 42.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.9 t -133.54 136.92 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 126.39 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.579 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.09 136.79 52.7 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.28 0.562 . . . . 0.0 110.3 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.6 155.48 23.63 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.632 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -112.32 146.16 38.75 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.813 0.34 . . . . 0.0 111.865 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.41 128.34 36.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 121.368 0.604 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.31 -24.14 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.752 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.47 175.15 46.11 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.445 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.2 m -152.7 151.6 30.74 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 110.83 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -149.17 176.27 10.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.04 146.02 24.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.337 0.589 . . . . 0.0 111.17 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.53 79.63 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.566 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp . . . . . 0 C--N 1.318 -0.795 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.76 178.615 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.8 m -60.37 -43.61 96.41 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.799 0.333 . . . . 0.0 110.655 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.414 ' O ' ' O ' ' A' ' 56' ' ' MET . 59.0 t-80 -69.34 -64.3 0.9 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.473 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 55' ' ' HIS . 13.2 ttt 52.45 172.94 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.237 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -111.44 110.57 21.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.366 . . . . 0.0 110.41 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.55 -51.92 20.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.946 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -153.48 62.05 0.75 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.474 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.46 28.16 4.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.438 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.57 -47.31 92.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.233 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.5 t0 49.7 -93.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.377 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 64' ' ' PRO . 5.1 tm0? -150.8 90.5 4.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.6 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 6.2 Cg_exo -73.47 153.14 49.78 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.074 1.849 . . . . 0.0 111.622 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 57.8 t0 -71.64 152.89 42.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.439 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.7 mt -59.6 -24.3 63.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.715 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.78 90.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -73.41 -34.57 65.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.3 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.61 -44.17 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.606 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.81 89.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.92 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.47 -24.74 36.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.91 109.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.892 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -95.6 121.84 37.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.039 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.4 tp -115.79 127.94 55.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.986 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.42 138.38 55.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.587 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -71.19 -6.86 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.5 . . . . 0.0 110.274 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 79' ' ' VAL . 68.7 mttm -65.09 -36.68 85.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.174 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.406 HE22 HD22 ' A' ' 102' ' ' ASN . 83.7 mt-30 -76.69 13.01 1.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.316 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 77' ' ' LYS . 57.4 t -93.43 126.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.75 -4.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.87 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.22 -171.23 40.54 Favored Glycine 0 C--N 1.318 -0.468 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.27 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 4.1 tt -119.28 124.71 73.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 m -127.1 128.68 46.6 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.6 mt -131.78 129.36 21.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.355 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.31 -35.4 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.22 1.947 . . . . 0.0 112.377 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -49.71 -39.67 37.8 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.669 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.9 p -118.44 -2.31 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 123.027 0.204 . . . . 0.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.89 53.08 3.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.7 tp -113.34 131.84 55.81 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.037 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.89 115.7 15.57 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 93' ' ' PRO . 39.5 mt -143.97 111.64 5.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.7 Cg_endo -40.65 138.64 1.42 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.57 1.513 . . . . 0.0 110.811 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 68.1 t -90.96 122.93 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -100.03 136.96 39.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.338 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.79 -34.48 60.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.6 m -93.83 115.84 28.27 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.465 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.8 p -82.79 66.44 8.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.211 0.529 . . . . 0.0 110.183 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.547 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -94.65 150.73 19.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.377 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -54.16 -52.01 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.634 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.83 -41.88 95.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.368 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.547 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 3.7 m-20 -66.17 -33.47 75.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.37 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.87 -15.08 62.6 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -72.35 -23.44 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -94.08 -9.65 35.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.25 -162.94 36.63 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.853 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.08 127.84 35.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.249 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.82 26.02 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.6 p -71.45 149.75 45.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.3 t -82.92 -46.13 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -92.8 -171.55 2.75 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.297 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -106.79 -55.19 2.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.505 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -90.8 46.61 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.575 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.9 147.01 23.83 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.17 131.83 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.535 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.5 mtt -64.71 128.1 34.33 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.42 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.52 5.85 71.44 Favored Glycine 0 CA--C 1.508 -0.364 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -140.62 118.5 11.79 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.809 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.0 -168.45 54.21 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 61.1 t30 -85.99 109.11 18.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.63 103.54 13.03 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.7 126.73 36.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.806 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.5 mt -122.63 132.62 54.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.689 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.09 140.0 48.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.114 0.483 . . . . 0.0 110.587 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.99 -178.12 17.77 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -80.9 156.62 25.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 0.0 110.622 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 129' ' ' SER . 2.2 p-10 -120.95 27.47 8.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 35.0 mtt -46.24 -12.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.615 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 57.5 40.35 27.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.616 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -134.0 112.07 10.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.032 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -52.84 124.51 14.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.059 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.65 -29.73 7.66 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.779 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.588 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 95.6 t -75.22 176.68 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 117.914 0.857 . . . . 0.0 109.247 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.588 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.61 134.76 46.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.117 -178.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 46.13 32.87 1.54 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.958 0.408 . . . . 0.0 110.708 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -82.24 -9.85 59.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -146.58 28.28 1.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.5 pt -69.74 -27.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.496 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.83 0.13 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.846 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.8 m -91.27 -15.5 29.08 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.69 116.76 6.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.054 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.447 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.5 mttp -103.53 154.74 19.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -50.76 113.29 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.395 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.29 4.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.8 m-20 -101.06 128.47 47.1 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -82.99 134.61 35.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.247 0.546 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 158' ' ' TYR . 90.0 mt -123.95 124.24 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.946 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -105.08 122.01 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 110.82 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.7 mt -116.12 150.42 37.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.397 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.465 ' O ' ' SD ' ' A' ' 116' ' ' MET . 60.2 m-85 -118.36 130.19 55.86 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.087 0.47 . . . . 0.0 110.991 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.5 t0 -109.93 -170.15 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.547 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 7.5 p30 -27.03 -71.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.1 0.476 . . . . 0.0 111.602 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.542 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.7 mt-10 -137.49 31.41 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.081 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.16 138.95 48.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.324 0.583 . . . . 0.0 112.401 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -103.94 121.62 43.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.449 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 55.2 m-85 -104.42 133.46 49.27 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.294 0.568 . . . . 0.0 111.55 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -98.38 119.86 37.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.016 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 147' ' ' ILE . 31.6 m-85 -120.0 139.7 52.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.93 135.14 54.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.492 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.4 t -70.7 135.9 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.981 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 11.4 p -102.68 -23.98 13.79 Favored 'General case' 0 C--N 1.341 0.235 0 O-C-N 124.814 1.321 . . . . 0.0 110.972 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.81 154.79 7.26 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.31 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.56 146.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.551 -0.824 . . . . 0.0 109.789 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.511 ' HG ' ' N ' ' A' ' 165' ' ' GLU . 37.9 t -146.19 156.15 43.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.86 0.362 . . . . 0.0 111.178 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.511 ' N ' ' HG ' ' A' ' 164' ' ' SER . 94.8 mt-10 -109.18 118.23 36.2 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.18 156.69 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.968 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 169' ' ' ASP . 20.4 p -66.15 136.31 95.33 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.58 ' CB ' HH21 ' A' ' 196' ' ' ARG . 1.6 Cg_endo -47.77 -12.99 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.97 1.78 . . . . 0.0 111.816 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 167' ' ' THR . 55.0 t0 -86.0 -11.15 53.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.642 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -86.78 75.35 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.774 0.321 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -78.11 -5.64 52.22 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.049 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -53.43 -35.03 60.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.944 0.402 . . . . 0.0 111.191 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.8 m -81.45 3.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.828 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.0 t -119.53 -15.04 8.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.567 0.699 . . . . 0.0 109.773 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -85.31 163.19 18.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.047 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.35 129.62 39.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.0 -42.62 6.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.135 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.69 30.12 0.26 Allowed Glycine 0 N--CA 1.469 0.89 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -155.81 177.37 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.071 0.462 . . . . 0.0 111.236 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 61.9 m-20 -88.88 89.34 7.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.266 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -124.21 166.17 16.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.971 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.68 143.18 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.473 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 8.2 m -136.21 125.33 24.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.711 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.0 mp -112.85 125.59 54.53 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.6 pt -140.6 -177.86 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.7 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 32.1 p -138.03 153.31 49.37 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.771 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 187' ' ' CYS . 27.1 p -100.29 76.25 1.87 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.0 m -64.86 -41.99 93.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.934 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m 49.98 60.98 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.873 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 79.0 t -125.99 133.58 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.82 0.343 . . . . 0.0 110.138 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.05 -44.64 96.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 193' ' ' ASN . 35.3 t70 -88.36 -178.75 5.96 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.443 ' H ' ' CG ' ' A' ' 192' ' ' ASP . 18.1 m120 48.97 58.14 5.68 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.865 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 87.2 p -66.73 61.8 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.901 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 193' ' ' ASN . 61.6 pttt -145.49 146.67 31.55 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.615 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.58 HH21 ' CB ' ' A' ' 168' ' ' PRO . 29.6 ttm180 -142.73 135.29 27.8 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.151 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.437 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 2.8 m-85 -84.92 129.76 34.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.57 140.07 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.165 0.507 . . . . 0.0 111.626 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.5 t -118.06 130.9 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.92 136.98 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.643 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.44 160.95 24.62 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.377 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 53.2 p-10 -112.53 146.03 39.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.175 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 37.2 tp -68.95 127.74 34.22 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.24 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.2 176.58 44.51 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.386 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.449 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 36.1 m -153.56 153.44 32.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.077 178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -149.78 179.21 8.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.578 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.64 148.97 21.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.618 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -64.42 79.59 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.455 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.314 -0.938 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.661 178.059 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.52 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m -59.05 -42.9 91.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 110.886 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.609 ' C ' ' H ' ' A' ' 57' ' ' ASP . 75.9 m80 -68.25 -168.36 0.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.673 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 57' ' ' ASP . 8.0 ttt 65.58 -19.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.622 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 55' ' ' HIS . 97.4 m-20 48.96 94.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.577 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.1 -13.35 61.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.204 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.5 p -87.36 0.32 55.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.701 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -71.22 49.05 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.007 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 63' ' ' GLN . 46.6 mt -62.97 -46.82 95.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 46.65 -95.27 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.301 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ILE . 2.5 pt20 -149.19 88.01 5.18 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.652 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.79 154.42 43.54 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.725 2.284 . . . . 0.0 110.982 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.01 166.21 23.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.692 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 3.9 mm? -69.61 -16.29 63.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 111.152 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.91 94.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.381 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 80.9 mm-40 -72.52 -33.57 66.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.91 -46.52 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.911 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.016 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 59.9 t-20 -82.9 -28.32 30.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.59 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -61.83 106.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.851 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 m -97.3 114.81 26.63 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.58 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.495 ' CB ' ' HG ' ' A' ' 105' ' ' SER . 53.2 tp -107.24 125.67 51.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.934 0.397 . . . . 0.0 111.106 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -68.23 138.48 55.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.321 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -63.92 -8.5 11.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.286 0.565 . . . . 0.0 110.207 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -70.76 -14.82 62.58 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.389 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -91.94 1.02 57.45 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.496 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.76 122.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 80' ' ' ILE . 3.9 tt -104.31 -36.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.407 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.37 -158.47 8.78 Favored Glycine 0 C--N 1.321 -0.303 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.7 mtp85 -146.9 150.6 35.53 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.52 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 3.8 tt -122.34 127.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -126.84 129.15 47.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.849 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.6 mt -133.62 117.18 14.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.2 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.92 -37.75 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.486 2.124 . . . . 0.0 112.653 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 t -49.26 -36.79 21.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.491 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' A' ' 89' ' ' SER . 6.9 m -119.87 -7.07 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.381 0.134 . . . . 0.0 111.057 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 73.33 46.02 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.663 0.744 . . . . 0.0 109.952 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.0 125.59 51.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.512 -178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -137.0 110.75 8.11 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' PRO . 18.3 mt -146.61 116.88 4.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -41.14 140.41 1.33 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.795 1.663 . . . . 0.0 109.931 176.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.35 126.82 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.407 ' CD1' ' O ' ' A' ' 102' ' ' ASN . 28.1 mt -103.11 124.97 49.56 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -70.37 -34.36 72.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.1 m -86.45 108.85 18.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.987 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -82.0 69.35 8.69 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 110.221 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.574 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.08 151.58 22.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.484 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.74 -50.14 66.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.593 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.01 -40.63 95.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.075 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.574 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 43.0 m-20 -65.64 -37.03 85.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.58 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.25 -18.09 46.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.627 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.31 -17.71 61.28 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.495 ' HG ' ' CB ' ' A' ' 74' ' ' LEU . 3.9 m -100.56 -12.14 19.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.52 -174.72 43.86 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 127.46 32.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.29 146.61 29.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 110.771 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.9 p -75.5 151.5 37.99 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.11 -50.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -90.65 139.22 30.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.72 -48.09 83.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.826 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -98.51 47.36 0.99 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.01 159.71 30.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -140.86 124.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.0 mtt -75.36 127.97 34.34 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.418 ' H ' ' HH ' ' A' ' 158' ' ' TYR . . . 92.32 -1.14 72.56 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -142.81 127.34 17.9 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.986 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 72.93 -172.98 48.71 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.455 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 41.0 t-20 -86.6 110.29 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -85.63 100.79 12.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.37 125.32 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.531 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -119.32 130.28 55.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.36 138.98 47.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 110.754 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.76 -178.57 18.8 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.323 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 42.5 m-70 -85.69 141.05 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.569 0.223 . . . . 0.0 110.581 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 129' ' ' SER . 65.3 t30 -110.44 27.68 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.124 0.488 . . . . 0.0 110.567 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -44.81 -16.18 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.854 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.56 40.88 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.069 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 136' ' ' SER . 98.4 mttt -131.25 109.46 10.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.358 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -53.31 123.87 13.1 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.511 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.91 -29.2 7.58 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.577 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 57.2 t -77.84 178.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.577 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.88 136.67 47.03 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 44.87 32.0 0.76 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.108 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.2 p -82.4 -11.92 58.24 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.96 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.449 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 35.2 t0 -141.71 25.91 1.95 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 pt -70.3 -22.33 23.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.918 0.389 . . . . 0.0 111.846 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.9 3.91 7.41 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.661 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.449 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.7 m -99.57 -11.45 20.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.111 0.481 . . . . 0.0 110.298 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.95 124.95 22.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.463 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.462 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -96.97 163.04 13.12 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.846 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -60.77 136.1 57.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.528 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.14 57.73 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 40.5 m-20 -87.61 131.62 34.35 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.529 ' NZ ' ' OE2' ' A' ' 157' ' ' GLU . 3.4 mmpt? -78.2 129.2 34.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.932 0.396 . . . . 0.0 111.726 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.1 mt -124.8 123.15 65.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -104.12 120.26 40.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.194 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.38 136.44 53.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.404 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -108.27 130.61 55.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 111.285 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.6 t0 -113.46 -165.46 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.524 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.3 m-20 -24.11 -75.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.174 0.512 . . . . 0.0 111.328 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -137.03 26.02 2.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -126.22 143.13 51.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -108.39 120.46 42.45 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -103.35 131.19 50.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.547 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.529 ' OE2' ' NZ ' ' A' ' 146' ' ' LYS . 70.3 tt0 -95.96 121.04 37.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.418 ' HH ' ' H ' ' A' ' 117' ' ' GLY . 36.5 m-85 -120.25 137.27 54.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.246 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.11 132.56 56.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 110.547 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.24 134.84 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.155 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.3 t -104.74 -24.29 12.94 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.468 1.105 . . . . 0.0 111.516 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.18 147.37 5.11 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.397 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.08 155.51 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.6 t -161.34 169.64 21.66 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.936 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -121.22 123.88 43.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -135.69 157.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 111.326 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 169' ' ' ASP . 16.9 p -59.16 131.3 87.28 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.563 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.1 Cg_endo -45.57 -14.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.968 1.779 . . . . 0.0 112.122 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 167' ' ' THR . 53.6 t0 -84.83 -8.58 58.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.275 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -87.82 62.74 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.576 ' C ' ' H ' ' A' ' 173' ' ' VAL . 26.9 m95 -72.24 -18.21 61.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.804 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.09 -9.64 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.166 0.508 . . . . 0.0 111.195 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 171' ' ' TRP . 24.6 m -83.39 -25.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.817 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.67 -2.33 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.622 0.725 . . . . 0.0 109.865 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 176' ' ' ASP . 95.3 mt-10 -82.18 119.9 24.65 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.78 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 175' ' ' GLU . 97.9 m-20 -28.96 119.81 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.957 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -98.86 -43.43 6.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.051 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.17 33.47 0.32 Allowed Glycine 0 N--CA 1.47 0.963 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.1 ptpt -153.6 176.29 12.24 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.235 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 50.6 p-10 -97.44 88.62 4.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.904 0.859 . . . . 0.0 110.46 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -131.0 177.11 7.69 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.282 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.3 tt -130.63 143.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.538 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 5.5 m -138.22 123.88 19.77 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.563 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.86 128.82 55.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 7.1 pt -138.61 -166.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.626 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 188' ' ' VAL . 3.7 t -131.55 164.34 26.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.656 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.417 ' O ' ' O ' ' A' ' 188' ' ' VAL . 84.5 m -64.51 8.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.405 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 186' ' ' THR . 60.2 t 47.94 94.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.469 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.3 p -82.99 146.55 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.525 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.42 -45.37 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.059 0.457 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -86.76 45.3 1.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.444 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -91.05 94.53 9.66 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.135 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -63.15 -42.97 99.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.218 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 40.2 t -85.69 164.09 17.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.208 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.04 147.17 38.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.404 ' HE ' ' HA ' ' A' ' 168' ' ' PRO . 7.8 tmm_? -63.44 136.7 57.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.431 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -100.27 134.48 43.15 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.7 138.95 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.898 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.7 t -116.97 128.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.52 133.01 54.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.453 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.06 152.99 20.74 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 64.5 t0 -111.04 149.41 30.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.783 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.543 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.54 127.73 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.207 0.527 . . . . 0.0 110.795 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.1 p -111.32 -21.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.699 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.43 176.05 47.46 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.678 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.0 m -156.86 154.51 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.824 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -150.76 178.99 8.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -90.96 148.19 22.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.285 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.411 ' O ' ' OXT' ' A' ' 210' ' ' LYS . 64.4 tttm -74.49 79.24 1.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.561 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.411 ' OXT' ' O ' ' A' ' 209' ' ' LYS . 26.7 ttpt . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.461 178.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -63.4 141.19 58.86 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 56' ' ' MET . 80.4 t60 -150.93 145.69 25.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 -178.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 56' ' ' MET . 0.0 OUTLIER -97.63 161.07 13.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.378 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -148.75 158.05 43.88 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.094 0.473 . . . . 0.0 111.577 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.63 -8.99 58.17 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.275 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 61' ' ' ILE . 88.4 p -86.47 37.34 0.73 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.558 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -79.08 33.83 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.027 0.441 . . . . 0.0 111.034 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' H ' ' C ' ' A' ' 59' ' ' SER . 52.3 mt -63.45 -46.5 95.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.26 0.553 . . . . 0.0 110.621 -179.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 49.45 -96.27 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.341 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.9 82.43 6.0 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.713 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.54 151.24 41.73 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.455 2.103 . . . . 0.0 111.715 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -77.42 171.36 15.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.71 -16.07 63.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.89 92.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.459 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -74.33 -31.97 62.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.507 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.7 t -75.01 -45.48 42.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.575 -178.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.7 89.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.853 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -77.06 -28.49 54.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.282 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.79 107.25 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.977 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.9 t -96.67 119.63 35.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.159 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.8 tp -119.05 129.48 55.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.481 -179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.45 138.87 49.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.835 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -68.78 -7.82 37.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.297 0.57 . . . . 0.0 110.246 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -73.5 -10.34 59.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.864 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.8 mp0 -91.87 1.61 57.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.02 131.27 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.882 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.1 pt -123.22 -5.5 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -178.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.0 -170.08 35.51 Favored Glycine 0 C--N 1.316 -0.573 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -146.32 150.89 36.59 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.704 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -123.02 124.8 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.3 t -130.32 131.11 45.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.621 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.5 mt -133.46 131.15 21.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.461 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.36 -35.43 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.315 2.01 . . . . 0.0 111.854 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -48.41 -39.86 23.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.519 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.6 p -119.48 -2.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.901 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 2.6 p 62.67 52.22 2.89 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -112.28 132.44 54.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.101 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -134.85 115.49 13.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 64.3 mt -144.09 113.65 5.32 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -41.76 147.62 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.767 1.645 . . . . 0.0 110.58 176.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.55 123.0 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.438 ' CB ' HD21 ' A' ' 102' ' ' ASN . 22.3 mt -104.25 123.75 47.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.044 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 65.8 tttm -67.38 -47.13 71.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.192 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.59 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -74.06 105.99 5.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.366 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -81.84 101.98 10.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.494 0.664 . . . . 0.0 110.199 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.528 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.8 p -135.54 164.15 28.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.33 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.969 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -83.0 -42.4 17.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.788 -179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -66.65 -35.24 79.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.231 -178.821 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -63.72 -16.34 60.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.863 -178.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.65 -16.47 60.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.8 p -106.29 -9.3 16.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.2 -172.54 44.49 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.403 -178.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.85 128.45 33.37 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.114 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.507 ' CB ' HD22 ' A' ' 102' ' ' ASN . . . -105.27 146.77 28.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.79 149.91 39.53 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.19 -41.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.434 ' HG2' ' H ' ' A' ' 112' ' ' GLU . 24.3 tttp -88.74 -173.35 4.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.78 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 35.4 tp10 -120.95 -11.33 8.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.296 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 112' ' ' GLU . 97.9 m-20 -141.57 42.09 1.73 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.234 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -89.74 160.53 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.6 t -132.02 132.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.741 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.416 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.7 mtt -68.38 128.67 37.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.209 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.31 3.02 72.88 Favored Glycine 0 N--CA 1.461 0.323 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -140.4 120.91 14.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.96 53.13 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.456 HD22 ' CB ' ' A' ' 183' ' ' THR . 2.0 t30 -95.39 110.9 22.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -84.4 103.73 13.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 128.54 36.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.281 0.563 . . . . 0.0 111.969 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.45 129.48 51.31 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.716 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 139.16 46.65 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.469 0.652 . . . . 0.0 110.888 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.56 -178.64 17.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.746 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -81.98 155.42 25.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.3 p-10 -121.82 27.04 8.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.428 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 39.0 mtt -44.08 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.004 -178.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 59.65 40.04 20.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.398 0.618 . . . . 0.0 109.613 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 136' ' ' SER . 65.4 tttm -135.59 118.55 16.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.823 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.0 124.99 21.2 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.637 0.732 . . . . 0.0 110.47 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.5 -26.1 10.53 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.816 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.564 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 98.4 t -78.97 175.69 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.774 0.787 . . . . 0.0 109.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.564 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.28 135.07 45.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.191 -178.401 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 46.26 32.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.458 . . . . 0.0 110.542 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.27 -7.59 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.512 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.6 m-20 -147.09 31.46 0.93 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -177.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.5 pt -70.73 -23.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.463 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.48 3.2 7.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.668 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -97.02 -11.6 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.79 122.45 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.608 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 60.4 mttp -96.82 151.4 19.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.489 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 161' ' ' THR . 52.2 tttp -54.74 123.77 14.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.606 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.73 19.64 19.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.5 m-20 -88.23 132.29 34.43 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -82.15 135.19 35.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.386 0.612 . . . . 0.0 111.978 -177.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 147' ' ' ILE . 96.0 mt -127.47 125.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.718 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.41 118.36 36.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.147 0.498 . . . . 0.0 109.986 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.39 144.82 43.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.314 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.416 ' O ' ' SD ' ' A' ' 116' ' ' MET . 19.2 m-85 -114.78 131.75 56.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.216 0.531 . . . . 0.0 111.271 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.8 t0 -112.41 -168.73 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.9 m120 -24.22 -74.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.04 0.448 . . . . 0.0 112.066 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -137.47 28.22 2.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.86 148.77 50.48 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -175.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.31 122.26 47.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -105.65 132.01 52.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 111.412 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -95.92 114.16 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.163 178.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -115.38 139.96 49.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 134.79 55.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.491 0.662 . . . . 0.0 111.561 178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.95 133.29 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.96 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.506 ' O ' ' NZ ' ' A' ' 143' ' ' LYS . 2.0 p -102.89 -28.44 12.04 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 124.959 1.412 . . . . 0.0 110.697 -178.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.22 152.56 7.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.82 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.29 150.15 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.742 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -152.27 161.95 41.86 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.277 0.56 . . . . 0.0 111.543 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -111.51 126.47 55.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.478 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.59 162.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.01 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.1 p -71.17 141.31 86.13 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -46.54 -17.24 0.33 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.862 1.708 . . . . 0.0 111.842 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.476 ' OD1' ' NZ ' ' A' ' 191' ' ' LYS . 91.6 m-20 -82.77 -3.6 56.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.1 tptt -80.98 148.07 29.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 81.7 m95 -158.33 -26.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.963 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.13 -8.67 0.08 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.236 0.541 . . . . 0.0 110.531 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.574 ' H ' ' C ' ' A' ' 171' ' ' TRP . 4.8 m -74.8 -30.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.923 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.5 m -105.59 -5.13 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.756 0.789 . . . . 0.0 109.763 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 176' ' ' ASP . 77.6 mm-40 -80.02 118.38 21.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.9 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 175' ' ' GLU . 68.2 t0 -29.01 124.08 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.491 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -99.08 -40.72 7.87 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.917 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.5 29.21 0.28 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.533 ' HZ2' ' CD ' ' A' ' 181' ' ' GLU . 21.9 pttp -156.03 179.52 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 111.296 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -94.12 100.11 12.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.714 0.769 . . . . 0.0 109.79 179.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.533 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 17.1 pt-20 -138.92 174.58 10.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.922 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.1 tt -131.12 143.88 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.548 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.456 ' CB ' HD22 ' A' ' 120' ' ' ASN . 12.4 m -135.9 126.01 26.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.677 0.275 . . . . 0.0 111.239 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.6 mp -113.14 126.89 55.94 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.384 0.612 . . . . 0.0 110.643 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.1 pt -141.13 -172.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.184 -178.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t -139.44 147.39 41.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.017 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 6.0 t -101.17 104.19 15.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.129 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.59 139.34 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.012 -179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 190' ' ' VAL . 1.9 m -89.44 -138.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 189' ' ' SER . 4.4 t 52.84 99.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.094 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.476 ' NZ ' ' OD1' ' A' ' 169' ' ' ASP . 71.8 mmtt -84.93 -16.08 42.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.624 -178.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.36 -47.3 84.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.858 0.361 . . . . 0.0 110.987 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -64.47 -42.67 95.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.049 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.7 p 59.19 21.21 9.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -82.4 108.37 15.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.095 0.474 . . . . 0.0 110.56 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.02 125.3 13.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.174 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -121.22 131.53 54.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.003 178.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.36 127.74 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.894 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 70.1 t -117.63 129.11 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.509 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.04 54.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.415 0.626 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.42 159.06 24.31 Favored Glycine 0 N--CA 1.461 0.322 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.849 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -110.17 153.35 24.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.709 -0.746 . . . . 0.0 111.873 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.9 tp -74.94 127.7 33.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.255 0.55 . . . . 0.0 110.878 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 93.1 t -107.56 -25.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.912 -178.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 174.29 176.7 42.88 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.47 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.1 m -153.49 153.2 31.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 111.052 178.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.33 176.91 10.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.463 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.56 142.08 27.86 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.898 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.99 79.87 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.847 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.2 tttm . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.552 178.64 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -64.55 141.59 58.72 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 57' ' ' ASP . 95.8 m-70 -84.04 -18.34 37.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.746 0.307 . . . . 0.0 111.18 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.0 mtt 46.34 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.14 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 55' ' ' HIS . 48.2 t0 -142.7 145.85 33.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.525 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.85 -17.65 62.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.65 -179.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.4 m -87.46 -103.8 0.07 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.877 0.37 . . . . 0.0 110.075 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp 48.25 32.02 2.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.218 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.4 -45.14 96.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.817 0.342 . . . . 0.0 110.601 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.452 ' H ' ' CB ' ' A' ' 189' ' ' SER . 68.1 t0 52.91 -104.75 0.21 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -151.08 81.85 6.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.336 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.73 144.78 35.76 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.305 2.003 . . . . 0.0 111.731 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 171.58 14.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.92 -14.3 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.683 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.92 91.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -74.85 -26.09 59.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.18 -47.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.671 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -42.24 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -70.83 -31.04 67.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.82 145.46 55.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.44 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -139.26 108.13 5.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.059 0.456 . . . . 0.0 110.998 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 tt -105.13 127.05 52.72 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.056 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -74.0 137.1 43.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' N ' ' CD ' ' A' ' 76' ' ' LYS . 4.5 mptp? -67.33 -9.41 40.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 110.165 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -80.29 -11.94 59.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.497 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.71 6.92 36.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 p -88.18 138.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.1 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 pt -120.79 -5.96 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.561 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.64 -165.29 30.84 Favored Glycine 0 C--N 1.32 -0.361 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -152.57 155.0 36.54 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.61 130.17 68.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.675 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.04 130.83 51.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.553 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 mt -134.76 100.86 11.97 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.136 -178.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -67.82 -34.2 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.244 1.963 . . . . 0.0 112.404 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.5 t -52.1 -38.73 58.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 -177.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 89' ' ' SER . 25.3 t -110.31 -9.6 11.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 120.58 0.229 . . . . 0.0 110.665 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.82 43.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.413 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -115.8 130.48 56.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.819 -178.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -134.45 118.91 17.9 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.3 mt -145.31 163.13 33.92 Favored Pre-proline 0 N--CA 1.465 0.275 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.547 -177.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.78 150.27 7.3 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.052 2.501 . . . . 0.0 109.428 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.9 t -95.77 116.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.7 mt -101.83 122.55 44.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -65.76 -46.19 79.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.084 0.468 . . . . 0.0 111.046 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 p -75.3 103.91 5.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.376 -179.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 99.8 11.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.333 0.587 . . . . 0.0 110.316 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 5.4 p -132.11 160.41 36.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.685 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -56.74 -28.96 62.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.781 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.485 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 18.8 ptmt -84.25 -41.88 16.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.342 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 101' ' ' LYS . 5.4 m120 -65.76 -36.47 83.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.396 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.89 -20.58 62.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.4 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -75.58 -15.51 60.35 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.6 m -103.32 -11.49 17.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.09 -166.59 39.79 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.226 -178.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.14 125.01 28.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.61 143.28 33.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.058 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.3 p -69.19 144.06 53.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.49 -44.69 18.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -89.33 -175.08 4.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.95 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -115.42 -11.57 11.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.623 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -137.6 43.19 2.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -178.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.518 ' OE1' ' CZ ' ' A' ' 121' ' ' TYR . 5.7 pt20 -92.17 155.28 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.362 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.05 132.37 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.507 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.0 mtt -68.3 128.15 35.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.413 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 89.34 4.61 73.7 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.86 121.17 12.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.638 -179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.76 -168.88 54.6 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.618 ' ND2' ' HG1' ' A' ' 183' ' ' THR . 8.1 t30 -89.33 110.48 21.26 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.518 ' CZ ' ' OE1' ' A' ' 114' ' ' GLN . 1.7 t80 -84.74 105.22 15.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.01 120.13 34.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.998 -178.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -117.09 132.42 56.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.862 178.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 142.54 43.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.752 -179.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.02 -178.6 19.88 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.545 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -85.16 152.07 23.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.922 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 129' ' ' SER . 41.7 t30 -116.01 28.34 8.68 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -50.14 -8.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.66 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.52 ' H ' ' C ' ' A' ' 127' ' ' ASN . 3.0 t 52.51 44.18 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 109.716 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' SER . 29.3 tptp -134.15 113.53 12.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.643 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -56.01 125.17 20.39 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.415 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.45 -29.22 8.84 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.827 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.595 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 58.3 t -76.82 178.37 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 117.847 0.824 . . . . 0.0 109.384 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.595 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.38 136.51 49.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.715 0.293 . . . . 0.0 110.933 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 43.17 31.76 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.928 178.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.41 -11.66 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.108 -178.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 136' ' ' SER . 7.1 m-20 -142.24 22.1 2.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 140' ' ' SER . 4.5 pt -67.52 -29.41 45.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.61 2.43 1.33 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.793 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 138' ' ' ILE . 49.9 m -97.03 -11.46 24.45 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.19 121.15 12.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.51 172.69 7.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.766 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.35 122.1 22.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.543 0.687 . . . . 0.0 112.035 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.83 14.61 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -93.35 134.79 35.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -83.37 137.25 34.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.454 0.645 . . . . 0.0 112.074 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.65 122.85 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.001 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 73.9 m-85 -101.09 117.08 34.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.8 tp -115.1 144.96 42.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.675 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -117.05 130.69 56.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.998 0.427 . . . . 0.0 111.676 -178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.8 t0 -107.02 -167.66 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.532 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 61.6 t-20 -29.39 -68.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -138.41 21.7 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.766 179.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.44 146.33 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -176.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.37 118.87 37.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -104.21 130.69 51.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.144 0.497 . . . . 0.0 111.085 -178.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 41.5 tp10 -94.41 117.18 29.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.15 137.81 51.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.31 133.36 56.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.274 0.559 . . . . 0.0 110.566 179.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 133.39 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.72 -25.15 12.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.537 1.148 . . . . 0.0 110.751 -179.29 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.03 153.86 7.08 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.917 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.73 155.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.576 -0.812 . . . . 0.0 109.28 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.9 p -151.7 162.3 41.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.077 0.465 . . . . 0.0 111.198 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.445 ' OE2' ' OH ' ' A' ' 197' ' ' TYR . 91.5 mt-10 -114.22 113.67 24.95 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 159.66 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.139 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.3 p -60.3 168.46 2.29 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.5 -11.52 11.71 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.905 1.736 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.58 -6.64 59.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.997 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -85.06 66.71 9.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 173' ' ' VAL . 63.1 m95 -72.29 -24.57 61.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.98 -17.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.247 0.546 . . . . 0.0 110.365 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.442 ' N ' ' C ' ' A' ' 171' ' ' TRP . 24.3 m -69.87 -27.23 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.206 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.6 m -109.73 1.0 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.554 0.692 . . . . 0.0 110.052 -179.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.83 125.86 32.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.317 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -34.95 122.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.445 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -103.07 -44.22 5.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.777 0.323 . . . . 0.0 111.309 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.69 28.06 0.17 Allowed Glycine 0 N--CA 1.47 0.932 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -153.49 173.36 15.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 22.3 m-20 -94.25 88.86 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -133.34 127.07 32.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.099 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.1 tt -81.16 148.26 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.618 ' HG1' ' ND2' ' A' ' 120' ' ' ASN . 17.5 m -135.93 125.75 25.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.843 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -111.29 127.08 55.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 111.204 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.7 pt -132.35 153.61 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.248 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 6.9 t -140.76 162.95 34.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.49 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 3.4 t 59.78 59.02 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.851 178.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 189' ' ' SER . 14.5 m -63.21 -42.19 95.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.098 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.452 ' CB ' ' H ' ' A' ' 62' ' ' ASP . 11.3 t -74.67 166.49 23.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.86 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 87.8 t -70.36 132.12 33.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -142.1 162.8 34.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.949 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.47 -20.27 62.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.251 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 195' ' ' LYS . 51.7 t-20 -63.71 -40.52 96.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.636 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.19 -68.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.372 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 193' ' ' ASN . 27.3 tptt -66.87 130.95 44.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.877 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.49 ' NH2' ' O ' ' A' ' 187' ' ' CYS . 42.4 ttm180 -112.47 138.41 49.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.169 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.445 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 4.3 m-85 -93.04 128.49 38.94 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.527 179.132 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.01 132.47 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 111.142 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.96 129.46 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.215 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.18 137.35 51.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.516 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.97 135.3 8.59 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.4 t0 -95.63 133.5 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.069 -0.566 . . . . 0.0 111.546 -178.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.401 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 44.8 tp -62.18 124.06 19.84 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.214 0.53 . . . . 0.0 110.385 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.1 -21.7 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.054 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.01 175.14 47.11 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.159 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 22.4 m -154.57 152.71 30.36 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.023 0.44 . . . . 0.0 110.628 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -150.98 177.45 10.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.116 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.18 148.77 21.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.201 0.524 . . . . 0.0 110.845 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -70.79 80.27 0.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.535 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.669 178.424 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.567 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.1 p -61.09 -38.16 85.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.851 -0.174 . . . . 0.0 110.789 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 60.9 m170 48.27 -173.56 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.048 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 45.6 tpp -74.28 -72.51 0.28 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.141 -179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 48.19 29.43 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.111 0.481 . . . . 0.0 111.389 177.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.92 -15.07 62.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.318 -178.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.6 t -149.19 -93.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.2 tttm 52.11 21.63 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 111.42 178.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.33 -46.49 90.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.871 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 54.14 -98.53 0.08 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -151.49 78.23 7.04 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.385 -179.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.34 146.93 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.5 2.134 . . . . 0.0 110.8 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.78 147.77 48.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.808 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.8 mt -55.25 -25.9 36.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.053 -178.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.9 95.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -72.58 -33.38 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.923 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.3 t -75.36 -45.68 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.056 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -38.02 88.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.98 -25.97 34.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.639 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.63 131.84 51.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.388 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.56 ' HG ' ' N ' ' A' ' 74' ' ' LEU . 19.8 t -95.92 158.92 15.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.024 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.56 ' N ' ' HG ' ' A' ' 73' ' ' SER . 44.6 tp -123.24 134.13 54.13 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -179.002 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.28 105.54 15.84 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.027 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.454 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 6.0 mptp? -63.81 -8.73 11.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.269 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -63.73 -39.47 94.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.545 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 3.6 pt20 -89.11 19.97 3.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.768 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 76' ' ' LYS . 4.3 p -84.72 126.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.568 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.5 -9.26 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.43 -166.35 37.27 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -146.88 150.57 35.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.622 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 7.8 tp -113.18 122.56 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 t -126.87 128.05 45.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.5 mt -135.62 122.31 14.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.969 -177.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.79 -34.73 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.577 2.184 . . . . 0.0 112.37 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.447 ' OG ' ' OD1' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -51.08 -39.75 56.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.488 -177.24 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 89' ' ' SER . 20.7 m -118.62 -9.01 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 122.314 0.246 . . . . 0.0 111.096 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.505 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 74.37 48.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.407 0.622 . . . . 0.0 109.833 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.18 123.49 48.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -135.46 110.44 8.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 93' ' ' PRO . 10.6 mt -149.8 115.86 3.53 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 92' ' ' LEU . 1.9 Cg_endo -39.91 143.11 0.46 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 121.832 1.688 . . . . 0.0 110.132 176.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.72 123.54 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.2 mt -105.21 138.37 41.52 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.088 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -78.71 -25.27 44.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.387 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -89.27 104.24 16.81 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -81.4 62.71 5.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.292 0.568 . . . . 0.0 110.37 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -93.84 162.83 13.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.708 179.59 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.64 -48.0 79.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.1 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 19.6 ptmt -67.27 -40.52 86.2 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.602 0.564 . . . . 0.0 111.74 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.593 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 8.7 m-80 -64.74 -37.56 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.243 -178.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.68 -20.76 61.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.63 -18.95 62.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 m -102.05 -13.83 17.37 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.25 -162.17 30.86 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.234 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.77 126.09 36.72 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.095 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -72.86 152.81 41.32 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.15 -47.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -93.19 145.36 24.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.54 -51.13 68.59 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.623 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.06 46.42 1.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.29 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.532 ' NE2' ' H ' ' A' ' 122' ' ' ALA . 10.6 tt0 -80.89 153.71 27.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.59 117.77 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.147 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.453 ' N ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.14 129.95 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.795 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.25 -8.76 57.37 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -143.99 130.9 20.4 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.439 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.29 -167.95 52.8 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 25.2 t-20 -86.77 107.22 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.587 0.232 . . . . 0.0 110.659 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.453 ' CE1' ' N ' ' A' ' 116' ' ' MET . 4.7 t80 -86.56 100.51 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.88 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.532 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.21 123.8 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.837 -179.377 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.2 mt -118.18 132.64 56.31 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.373 178.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.34 140.17 48.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.923 -178.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.75 -178.09 16.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.661 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -85.17 146.17 27.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.621 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.9 p30 -112.79 26.23 10.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 0.0 110.869 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -42.76 -19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.816 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.11 39.43 12.96 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.139 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.86 109.49 10.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.04 124.88 16.87 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.829 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.85 -25.03 10.43 Favored Glycine 0 N--CA 1.473 1.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.533 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.565 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 39.2 t -83.24 179.0 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -73.17 136.12 44.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.031 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.63 31.51 0.64 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 110.751 178.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -80.22 -7.47 58.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.719 -178.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.434 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.1 t0 -146.55 40.26 1.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.2 pt -70.65 -26.73 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.13 1.29 13.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.022 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.434 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.5 m -91.22 -17.96 25.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.087 -179.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.7 mt -65.21 125.3 24.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.324 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -95.93 170.91 8.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.72 130.03 40.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.923 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.03 21.18 36.65 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.447 ' OD1' ' OG ' ' A' ' 87' ' ' SER . 1.7 t70 -87.49 132.28 34.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -79.56 134.9 36.49 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.391 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' TYR . 96.5 mt -126.55 125.83 67.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.16 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.31 113.62 26.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.578 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.1 tp -113.32 134.47 54.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.389 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -105.83 133.98 49.69 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -178.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 43.9 t0 -108.7 -169.28 1.47 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.471 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 13.1 t-20 -32.93 -67.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.992 0.425 . . . . 0.0 110.65 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -135.98 21.89 3.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.065 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.53 150.37 40.96 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -114.81 119.47 36.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.341 178.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -105.23 130.19 53.44 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.372 0.606 . . . . 0.0 112.016 -178.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.45 117.34 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.498 ' O ' ' N ' ' A' ' 147' ' ' ILE . 20.0 m-85 -119.58 139.37 52.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.285 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.9 137.85 52.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.874 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.79 134.18 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.862 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.3 -27.26 12.95 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.84 1.338 . . . . 0.0 111.242 -178.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.81 158.76 9.89 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.54 152.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 165.56 35.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.098 -178.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -109.55 116.53 31.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.38 157.19 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.076 0.465 . . . . 0.0 111.285 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 169' ' ' ASP . 30.9 p -73.38 136.33 78.53 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -47.47 -15.45 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.113 1.875 . . . . 0.0 111.903 -178.62 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 167' ' ' THR . 95.9 m-20 -84.03 -11.54 56.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.518 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -88.04 67.69 8.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.9 m95 -74.13 -3.93 32.6 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.608 0.568 . . . . 0.0 112.193 -178.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.1 mt-10 -53.01 -39.89 63.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.961 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.3 m -77.84 2.7 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.199 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.1 -14.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.793 0.806 . . . . 0.0 110.597 -178.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.2 mt-10 -86.47 -179.14 6.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.878 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.6 p-10 -86.51 124.76 33.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.157 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.4 m80 -103.08 -43.91 5.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.206 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 25.33 0.07 OUTLIER Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -157.26 178.36 10.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.766 0.317 . . . . 0.0 111.07 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.445 ' OD2' ' OH ' ' A' ' 158' ' ' TYR . 31.3 t0 -96.68 89.83 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.613 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -126.69 127.62 45.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.369 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -85.43 149.42 4.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.1 m -137.44 124.67 21.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.436 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.3 mp -109.85 121.39 45.12 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.108 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 12.4 pt -140.4 -173.28 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.844 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 16.2 p -138.08 166.14 24.87 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.582 -179.136 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 33.3 m -96.66 120.31 36.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.597 ' H ' HH22 ' A' ' 196' ' ' ARG . 70.5 t -144.8 -24.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 188' ' ' VAL . 82.6 p 46.78 -170.89 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.846 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 192' ' ' ASP . 3.0 m -58.89 -108.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.6 tptp 47.75 -93.86 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.584 178.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 190' ' ' VAL . 97.9 m-20 -62.41 -42.38 99.39 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 60.8 t30 55.92 36.93 28.23 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.174 178.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.1 t -93.9 169.22 10.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.91 130.16 42.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.597 HH22 ' H ' ' A' ' 188' ' ' VAL . 57.7 ttm-85 -104.2 137.88 41.48 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.69 139.28 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.282 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.94 129.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.38 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.14 135.9 53.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.28 143.6 14.88 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 51.8 p-10 -102.7 142.64 33.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.435 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.5 tp -65.31 126.88 29.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.4 -24.77 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.528 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.74 175.58 46.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.734 -179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.6 m -155.04 151.4 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.179 0.514 . . . . 0.0 111.244 -179.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -151.63 178.52 9.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.32 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.79 144.92 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.307 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.27 78.99 0.36 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.853 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 78.3 tttt . . . . . 0 C--N 1.322 -0.602 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.332 178.618 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.093 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 55' ' ' HIS . 14.3 t 47.84 92.37 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.479 178.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 54' ' ' SER . 97.7 m-70 48.58 -172.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.639 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.0 mtm -83.58 146.51 28.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.215 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 66.8 t0 -64.76 144.67 57.09 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.534 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -68.4 -35.63 77.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.799 -178.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.6 m -83.08 -83.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.423 -178.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.6 tttm 54.54 35.22 22.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.386 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 62' ' ' ASP . 29.7 mm -64.79 -44.15 96.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.286 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 64' ' ' PRO . 9.5 t0 62.03 118.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.462 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.457 ' CD ' ' O ' ' A' ' 63' ' ' GLN . 1.6 tm0? -38.32 93.96 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.302 0 O-C-N 123.48 0.487 . . . . 0.0 110.326 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' N ' ' O ' ' A' ' 62' ' ' ASP . 6.2 Cg_exo -76.23 152.71 35.46 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.684 2.256 . . . . 0.0 111.122 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.8 163.48 26.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.42 -19.96 65.45 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 123.163 0.289 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.74 93.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 95.6 mt-10 -72.2 -37.13 69.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.63 -45.81 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.886 -178.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.12 85.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -85.15 -26.64 26.71 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -58.86 137.76 57.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.127 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -92.09 158.13 16.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.912 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.9 tp -127.13 127.32 44.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 111.288 -178.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.5 m-20 -100.52 103.88 15.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.973 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -62.36 -7.09 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.572 -179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.5 mttm -75.08 -13.08 60.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.322 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.438 ' OE1' ' OG ' ' A' ' 97' ' ' SER . 97.8 mm-40 -102.54 12.08 36.95 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.736 -178.465 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.447 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 7.0 p -88.16 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.254 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.0 pt -121.4 -7.55 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.46 -171.28 39.28 Favored Glycine 0 C--N 1.32 -0.318 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.561 HH11 ' NZ ' ' A' ' 209' ' ' LYS . 42.0 mtm180 -146.46 152.03 38.37 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.72 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 6.5 tt -121.04 122.31 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -124.15 127.75 48.24 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.437 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.29 130.81 22.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.801 -178.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.61 -38.28 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.56 2.173 . . . . 0.0 112.417 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.447 ' HG ' ' N ' ' A' ' 88' ' ' VAL . 15.3 p -46.14 -37.88 7.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.424 -177.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.4 p -120.91 -0.45 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.942 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m 59.94 54.52 4.2 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.12 136.76 52.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.03 -177.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -137.0 116.39 12.72 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' PRO . 82.7 mt -141.03 101.58 6.32 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.6 127.92 1.74 Allowed 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 121.897 1.731 . . . . 0.0 110.211 176.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.95 121.84 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.2 mt -103.19 123.27 46.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.53 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.73 -49.5 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.065 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.438 ' OG ' ' OE1' ' A' ' 78' ' ' GLN . 66.2 m -65.74 98.7 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.134 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -80.24 98.13 7.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.258 0.551 . . . . 0.0 109.86 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.631 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 69.9 p -134.31 161.13 35.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.606 -178.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.79 -27.78 66.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.918 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.81 -41.77 18.69 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.837 0.711 . . . . 0.0 112.139 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.631 ' H ' ' HG1' ' A' ' 99' ' ' THR . 98.4 m-20 -67.06 -35.12 79.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.412 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.1 mt -65.03 -18.86 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -72.7 -14.92 61.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.7 m -110.53 -9.26 14.57 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.39 -153.55 16.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.304 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -100.49 127.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.263 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 149.97 24.97 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.674 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.7 p -75.81 148.38 38.47 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.9 -47.28 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.442 ' NZ ' ' OE1' ' A' ' 175' ' ' GLU . 99.3 mttt -92.66 139.84 30.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.317 0.58 . . . . 0.0 110.989 -179.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.414 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 18.1 pt-20 -75.48 -3.18 32.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.272 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 112' ' ' GLU . 11.5 m120 -135.88 37.63 2.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 111.164 -177.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 156.26 16.52 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.5 t -124.55 135.58 63.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.4 mtp -75.93 125.7 29.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.27 66.93 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -144.77 121.38 11.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.544 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.36 178.5 32.51 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 40.9 t-20 -68.93 105.06 2.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -85.33 105.45 15.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 124.89 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.31 0.576 . . . . 0.0 111.439 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.0 mt -122.31 130.24 52.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.509 179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.6 140.16 45.19 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.305 0.574 . . . . 0.0 110.759 -178.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.45 -176.95 18.92 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.614 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -84.48 147.07 27.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.696 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.7 p30 -115.48 25.48 10.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.146 0.498 . . . . 0.0 110.984 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -41.94 -18.19 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.646 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 57.57 39.96 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.191 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.453 ' O ' ' OG ' ' A' ' 136' ' ' SER . 65.2 tttm -134.2 119.45 18.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.511 -178.665 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.04 124.46 21.18 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.332 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.38 -21.46 8.66 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.447 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.97 172.46 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.589 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -74.93 139.34 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.882 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 50.49 27.34 2.79 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.008 0.433 . . . . 0.0 110.969 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.9 OUTLIER -84.66 -8.99 58.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.643 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.6 m-20 -145.31 30.85 1.12 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.9 pt -70.07 -25.88 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.58 3.78 4.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.707 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.5 m -97.19 -11.65 23.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.283 -178.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.7 mt -65.42 124.72 23.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.66 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.431 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 98.6 mttt -97.04 161.48 13.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.676 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.48 127.6 32.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.959 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 91.88 20.98 34.89 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 31.9 m-20 -83.73 136.86 34.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.08 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -80.76 122.76 27.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.5 mt -122.26 122.57 66.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -103.5 118.24 36.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.451 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.79 132.72 55.13 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -99.12 125.68 44.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.151 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 45.9 t0 -98.07 -169.05 1.75 Allowed 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.454 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 51.9 t30 -36.19 -67.03 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.124 0.488 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -135.07 25.07 3.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.208 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.85 153.05 44.7 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.491 ' CD ' ' NZ ' ' A' ' 207' ' ' LYS . 67.1 tt0 -114.6 119.0 35.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.265 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -103.84 131.55 50.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.17 119.35 35.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.129 178.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -116.69 142.08 47.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.19 129.79 53.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.461 0.648 . . . . 0.0 110.769 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' GLY . 56.2 t -68.23 134.7 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.1 t -105.15 -26.61 12.01 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 124.583 1.177 . . . . 0.0 111.256 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.99 147.87 5.57 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.304 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 17.2 t -110.56 149.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.239 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.0 p -156.92 165.87 34.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.133 -178.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -113.6 102.6 10.43 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.017 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.8 m -117.49 153.34 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 p -59.57 167.87 2.19 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.546 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.6 Cg_endo -81.77 -10.46 11.77 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.027 1.818 . . . . 0.0 112.007 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.81 -14.16 48.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.202 -178.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.64 71.21 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.028 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.546 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 90.4 m95 -75.31 -2.23 27.28 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.285 -178.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.42 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 71.5 mm-40 -54.03 -37.24 63.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.3 m -80.82 3.7 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.03 -179.03 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -119.71 -15.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.581 0.705 . . . . 0.0 110.251 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 74.4 mm-40 -86.75 175.94 7.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.027 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.5 p-10 -80.78 128.6 33.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.251 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.42 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.8 m170 -102.57 -43.28 5.67 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.043 -179.448 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.07 27.61 0.12 Allowed Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -157.65 -179.75 8.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.855 0.36 . . . . 0.0 111.094 179.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -93.01 88.46 6.14 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -117.82 167.7 11.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.922 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.37 142.94 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.002 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.7 m -136.65 125.24 23.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.596 -178.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.6 mp -110.52 120.77 43.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.4 HG22 HD12 ' A' ' 185' ' ' ILE . 13.5 pt -134.91 -167.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.767 -178.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.586 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 14.1 t -134.08 151.28 51.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.366 -178.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.2 p -96.8 -36.39 10.64 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.678 0.275 . . . . 0.0 111.387 -178.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.66 154.44 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.773 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 83.5 p -153.0 164.19 38.44 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.75 0.31 . . . . 0.0 110.665 -178.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 191' ' ' LYS . 62.3 t -116.41 130.2 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.079 -179.265 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 190' ' ' VAL . 61.5 pttt -53.01 -170.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.629 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 48.9 -173.06 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.866 179.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -64.03 126.51 27.91 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 45.0 t -153.42 163.59 39.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.763 0.316 . . . . 0.0 110.934 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -144.57 153.83 42.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.577 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.586 ' NH1' ' O ' ' A' ' 186' ' ' THR . 11.8 ptp180 -127.97 166.65 17.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.672 -179.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -105.94 139.53 40.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.07 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.7 134.22 58.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 121.023 0.439 . . . . 0.0 110.623 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.2 t -119.46 129.46 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.653 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.09 136.29 53.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.349 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.16 147.38 19.06 Favored Glycine 0 N--CA 1.466 0.653 0 CA-C-O 121.773 0.652 . . . . 0.0 112.006 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 55.4 p-10 -106.81 148.28 28.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.207 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.03 126.99 31.56 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.84 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.38 -24.38 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.037 -179.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.02 175.26 47.18 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.627 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 m -155.5 150.99 27.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.491 ' NZ ' ' CD ' ' A' ' 155' ' ' GLU . 25.8 pttm -150.81 178.16 9.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.09 146.61 23.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.561 ' NZ ' HH11 ' A' ' 82' ' ' ARG . 88.0 tttt -73.77 80.23 1.58 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.604 -179.19 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.281 178.799 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.5 m -155.38 157.36 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 0.0 110.507 -179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -99.8 105.29 17.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.201 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 95.4 mtp -134.88 144.83 47.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -178.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 66.7 t0 -75.69 137.4 40.63 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -69.01 -40.06 78.91 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.712 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p 70.39 -42.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.675 0.274 . . . . 0.0 110.979 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 58' ' ' ALA . 99.1 mttt 42.73 32.33 0.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.41 . . . . 0.0 111.438 178.702 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -67.2 -25.28 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.42 0.628 . . . . 0.0 111.311 -178.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -52.49 -43.27 64.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.608 -179.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -138.91 76.9 33.18 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.987 -178.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.06 155.82 26.19 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.564 2.176 . . . . 0.0 111.097 -178.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.84 152.05 46.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.804 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -68.39 -15.0 63.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.799 0.333 . . . . 0.0 111.393 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.5 -45.16 84.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.821 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -74.63 -22.44 58.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.3 t -76.97 -51.98 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.481 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.64 92.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.774 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.32 -31.17 68.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.54 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.3 138.42 57.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.004 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -141.09 85.1 1.96 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.71 -178.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.448 ' CD2' ' H ' ' A' ' 74' ' ' LEU . 1.4 pt? -75.04 172.12 12.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.523 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.1 m-20 -103.13 121.16 42.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.59 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.495 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 14.1 mptt -56.44 -9.4 0.7 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.14 0.495 . . . . 0.0 109.853 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -62.49 -35.39 79.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.76 16.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.572 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 76' ' ' LYS . 10.0 p -86.94 124.57 40.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 pt -120.64 -6.53 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.47 -168.34 39.92 Favored Glycine 0 C--N 1.318 -0.467 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.46 HH11 ' HZ2' ' A' ' 209' ' ' LYS . 38.0 mtm180 -147.68 156.09 42.42 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.538 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 6.2 tt -121.32 125.92 74.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -126.26 127.07 45.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 79.3 mt -127.44 128.01 24.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.646 -178.222 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.8 Cg_endo -83.29 -39.33 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 122.371 2.047 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 t -48.75 -37.03 17.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.579 -177.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -120.73 -2.83 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.783 -178.926 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t 62.81 55.18 2.13 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.286 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.16 133.64 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.607 -178.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -135.99 114.22 11.52 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 93' ' ' PRO . 69.9 mt -143.45 109.36 5.28 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.1 Cg_endo -39.6 142.64 0.44 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.865 1.71 . . . . 0.0 110.144 176.388 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.8 118.65 43.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -106.68 122.94 47.36 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.41 -48.47 75.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.408 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 86.6 p -61.67 100.02 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.928 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.0 p -82.97 101.29 10.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 110.006 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.474 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 70.0 p -137.29 160.49 38.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.417 -179.067 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.85 -28.38 67.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.75 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -83.33 -45.47 13.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.457 0.646 . . . . 0.0 112.116 -178.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.474 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 91.0 m-20 -65.78 -32.72 74.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.316 -179.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.61 -13.96 61.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.3 p -103.79 -13.46 16.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -177.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.96 -156.86 25.57 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.64 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.46 125.89 35.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.997 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.63 144.38 31.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -75.33 152.27 38.16 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.02 -40.22 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.67 -172.68 3.66 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.13 -178.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -126.2 -9.64 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 111.289 -177.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -138.89 37.35 2.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.108 0.48 . . . . 0.0 111.304 -177.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -93.44 161.14 14.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.855 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -131.72 132.04 62.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.773 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.7 mtt -63.69 129.04 38.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.16 75.04 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -138.54 118.92 13.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.116 0.484 . . . . 0.0 110.504 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -160.12 52.71 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.509 HD22 ' HG1' ' A' ' 183' ' ' THR . 58.0 t-20 -94.04 111.19 22.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -84.72 103.4 13.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.43 126.64 35.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 111.785 -179.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mt -122.46 130.53 53.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.477 178.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.99 139.19 46.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.774 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.61 -178.2 16.42 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.5 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -88.83 143.08 27.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.567 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 67.0 t30 -108.28 28.22 8.53 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.126 0.489 . . . . 0.0 110.676 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.17 -17.24 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.683 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.6 OUTLIER 60.98 37.73 17.92 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.283 178.805 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 136' ' ' SER . 55.2 mtmt -135.46 106.48 6.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.685 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.401 ' HD3' ' N ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -48.74 130.11 17.33 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.545 179.344 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.22 -26.33 12.38 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.549 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 27.7 t -84.97 179.14 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.549 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.63 133.08 46.36 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.178 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.42 31.91 1.43 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 110.822 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.64 -9.91 59.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.04 -178.825 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -146.95 29.36 0.99 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 140' ' ' SER . 5.5 pt -69.58 -27.83 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.805 0.336 . . . . 0.0 111.856 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.76 0.34 3.39 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.638 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 138' ' ' ILE . 11.1 t -91.75 -14.66 29.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.156 0.503 . . . . 0.0 110.18 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 mt -65.63 126.9 29.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.246 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.28 172.16 8.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.973 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.2 132.65 44.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.47 21.12 57.25 Favored Glycine 0 N--CA 1.462 0.396 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 146' ' ' LYS . 15.0 t70 -78.78 -158.89 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.451 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 7.9 tptm -146.81 129.15 15.8 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.076 -178.286 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.75 122.97 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.452 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -102.04 122.08 43.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.04 141.92 48.29 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.449 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.536 ' CE2' ' OE2' ' A' ' 155' ' ' GLU . 68.6 m-85 -107.81 131.23 54.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.208 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.8 t0 -105.47 -171.26 1.88 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.536 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.0 m-20 -35.64 -62.8 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.203 0.525 . . . . 0.0 111.273 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.49 20.87 2.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 145.03 48.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.782 -175.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.609 ' CB ' ' HZ3' ' A' ' 207' ' ' LYS . 4.5 mm-40 -106.89 121.14 43.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.43 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -107.25 129.54 54.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.487 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.83 120.94 39.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.386 177.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -117.65 138.79 51.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.49 131.81 56.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.599 0.714 . . . . 0.0 110.144 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.38 134.56 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.613 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.1 p -101.63 -26.36 13.55 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 124.368 1.043 . . . . 0.0 111.16 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.06 150.93 5.84 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.26 146.38 8.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -0.63 . . . . 0.0 109.323 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.7 t -145.79 154.22 41.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.055 0.455 . . . . 0.0 110.989 -178.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.28 119.27 38.94 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.708 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.618 ' CG2' HH21 ' A' ' 196' ' ' ARG . 29.1 m -134.88 158.78 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 111.269 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 169' ' ' ASP . 25.5 p -76.71 136.16 67.47 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.97 -15.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.077 1.851 . . . . 0.0 112.064 -178.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 167' ' ' THR . 51.3 t0 -81.81 -13.03 58.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 -178.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -85.88 77.15 9.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.358 0.599 . . . . 0.0 110.198 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.565 ' C ' ' H ' ' A' ' 173' ' ' VAL . 84.1 m95 -75.79 -20.32 58.31 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.092 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.67 -6.94 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.01 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.565 ' H ' ' C ' ' A' ' 171' ' ' TRP . 53.6 t -85.81 -24.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.669 -178.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.41 -10.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.808 0.813 . . . . 0.0 109.72 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.58 139.81 38.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.744 -176.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.43 130.59 45.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.297 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -102.05 -40.41 6.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.462 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.68 29.26 0.27 Allowed Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -156.05 179.24 9.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.244 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -90.89 92.54 8.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.371 0.605 . . . . 0.0 109.917 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -127.9 169.41 13.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.251 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.888 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.509 ' HG1' HD22 ' A' ' 120' ' ' ASN . 19.2 m -137.31 124.98 22.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.484 -178.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.34 120.95 43.92 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.342 0.592 . . . . 0.0 110.774 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.4 pt -135.12 -167.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -178.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t -138.6 152.4 48.1 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.77 -178.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 6.5 t -83.65 125.73 32.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.909 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.8 t -139.88 -112.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.63 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.9 t -157.47 166.4 33.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -178.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p -90.13 157.47 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt 47.72 34.26 3.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.058 178.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -156.37 166.51 33.2 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.365 -178.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 33.0 m120 48.94 66.24 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.78 178.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 78.3 p -62.32 -19.98 63.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.618 -179.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -99.2 117.35 33.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.408 -179.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.618 HH21 ' CG2' ' A' ' 166' ' ' VAL . 16.0 ttp180 -146.29 137.94 24.76 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.318 -178.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.01 129.97 46.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.952 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.23 136.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.52 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.24 126.37 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.425 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.72 135.54 53.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.228 0.537 . . . . 0.0 110.419 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.15 163.16 25.11 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -116.21 150.72 37.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.233 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.5 tp -71.8 126.96 31.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.025 0.44 . . . . 0.0 110.71 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.39 -24.57 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.188 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.72 44.42 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.847 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.3 m -154.15 154.07 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.226 0.536 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.609 ' HZ3' ' CB ' ' A' ' 155' ' ' GLU . 20.7 pttp -149.76 177.03 10.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.335 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.34 150.87 23.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.46 ' HZ2' HH11 ' A' ' 82' ' ' ARG . 88.5 tttt -78.98 78.99 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.3 mptt . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 117.804 -1.093 . . . . 0.0 109.989 178.625 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.4 p -155.64 162.41 40.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.945 0.402 . . . . 0.0 110.786 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -64.6 -7.93 12.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.387 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 96.1 mmm -67.17 154.36 41.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.341 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -144.95 168.0 21.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.465 -178.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.99 -45.7 66.74 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.032 -179.368 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.2 m -150.92 -88.22 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.8 tttt 54.41 32.86 17.39 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.787 178.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 63' ' ' GLN . 53.7 mt -61.73 -48.76 87.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.33 0.586 . . . . 0.0 110.591 -179.138 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.5 t0 48.34 -93.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.214 179.002 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 61' ' ' ILE . 1.1 tp-100 -151.16 84.43 5.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.622 -179.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.0 151.47 39.57 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.634 2.223 . . . . 0.0 111.322 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -79.16 173.34 12.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.67 -13.67 62.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.853 -179.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.0 92.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.266 0.555 . . . . 0.0 110.268 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -75.87 -23.62 55.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.582 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.31 -49.88 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.41 89.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.43 -31.98 70.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.972 -179.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.09 132.73 52.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.222 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.8 t -140.85 88.35 2.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.824 0.345 . . . . 0.0 111.656 -179.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.48 ' CD2' ' H ' ' A' ' 74' ' ' LEU . 1.5 pt? -79.93 170.28 16.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.489 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 38.0 p-10 -102.48 139.78 37.63 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.055 178.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.57 -7.2 6.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.497 0.665 . . . . 0.0 110.131 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 75' ' ' ASP . 65.8 tttm -64.61 -31.86 73.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.848 179.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.11 10.42 2.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.168 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.2 t -86.31 120.96 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.5 pt -120.35 -7.46 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 111.9 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.7 -170.85 41.96 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.6 mtt-85 -146.8 158.05 43.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.897 -178.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 tt -128.75 130.15 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.662 0.744 . . . . 0.0 109.322 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -130.16 131.64 45.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.071 -178.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.29 127.82 19.07 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.11 -178.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.08 -34.65 0.32 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.304 2.002 . . . . 0.0 112.031 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -48.16 -38.61 18.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.423 -177.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.5 p -118.61 -2.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.879 -178.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.57 50.77 2.08 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 tt -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -178.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -129.42 105.3 8.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -128.5 148.95 70.32 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -84.65 145.2 10.29 Favored 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 122.617 2.211 . . . . 0.0 109.26 177.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -94.89 112.65 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 mt -101.53 121.68 42.43 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -63.8 -46.33 85.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.329 0.585 . . . . 0.0 110.805 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m -60.03 95.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.457 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.7 p -81.87 95.0 7.2 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 110.1 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.405 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 81.7 p -135.97 159.66 41.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.124 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.25 -28.67 66.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.29 -43.52 15.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 94.2 m-20 -65.93 -36.14 82.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.565 -179.18 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.07 -21.11 63.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.52 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.27 -33.24 69.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.2 m -89.54 -10.22 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.05 -178.92 45.72 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.314 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.94 126.42 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.43 145.73 30.45 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.979 0.419 . . . . 0.0 110.968 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.8 p -73.12 150.22 42.41 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.24 -45.32 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.281 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.86 -172.32 3.32 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.962 -0.461 . . . . 0.0 110.966 -178.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 1.2 pm0 -112.58 -56.47 2.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.859 -178.371 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.405 ' H ' ' HG2' ' A' ' 112' ' ' GLU . 23.3 t-20 -90.61 44.63 1.21 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.268 -177.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -99.58 154.69 18.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.187 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.3 135.37 52.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 67.2 mtt -67.99 130.62 43.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.323 178.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.51 5.87 81.45 Favored Glycine 0 C--O 1.229 -0.18 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -142.72 120.36 11.82 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.037 -179.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.02 -168.35 54.26 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.444 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 42.4 t-20 -85.52 106.82 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -84.66 102.45 12.95 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.76 128.44 36.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.289 0.566 . . . . 0.0 111.824 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -124.59 132.56 53.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.88 178.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.35 44.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 110.606 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.19 -177.66 19.26 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.455 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.529 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -92.12 143.48 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 0.7 OUTLIER -109.53 29.23 7.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.326 0.584 . . . . 0.0 109.71 179.515 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.4 ' SD ' ' OE1' ' A' ' 63' ' ' GLN . 9.2 mmm -42.94 -14.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.693 -179.223 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 62.13 40.67 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -132.32 105.66 7.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.586 -179.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -50.1 125.68 12.81 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.831 0.824 . . . . 0.0 110.094 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.82 -28.84 8.56 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.699 -177.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.589 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 49.0 t -79.89 178.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.995 -0.709 . . . . 0.0 109.294 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.589 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -70.97 139.54 50.62 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.954 -178.568 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 43.7 35.01 0.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.072 0.463 . . . . 0.0 111.076 177.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.5 p -81.64 -14.56 56.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -147.45 31.97 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 140' ' ' SER . 3.6 pt -70.46 -26.65 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.703 0.287 . . . . 0.0 111.613 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.14 2.19 4.91 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.284 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 138' ' ' ILE . 9.6 t -93.66 -13.85 27.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 109.573 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.34 120.86 13.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.653 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.529 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.4 mttt -97.86 150.05 21.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.426 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.7 121.05 5.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.371 0.605 . . . . 0.0 111.463 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.67 10.48 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 3.8 m-20 -90.64 134.55 34.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.408 ' HZ1' ' HB3' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -83.63 132.61 34.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.311 0.577 . . . . 0.0 111.967 -178.41 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 147' ' ' ILE . 96.9 mt -124.59 126.27 71.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.278 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -103.17 119.95 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.173 0.511 . . . . 0.0 110.754 -178.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.42 139.48 44.33 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.638 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' SD ' ' A' ' 116' ' ' MET . 86.6 m-85 -114.81 127.26 55.62 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.194 0.521 . . . . 0.0 111.343 179.409 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.1 t0 -112.45 -166.24 1.06 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.2 p30 -22.57 -76.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.409 0.624 . . . . 0.0 111.816 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.522 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.5 mt-10 -137.53 29.37 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.749 178.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -127.66 144.5 51.07 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -109.99 120.96 44.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.14 132.7 49.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.682 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -96.05 118.03 31.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -118.32 141.39 48.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.34 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.13 55.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 110.804 178.367 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.34 133.09 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.032 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.3 p -100.76 -28.63 12.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.861 -178.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.37 150.2 5.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.842 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.74 149.1 8.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.704 -0.748 . . . . 0.0 109.462 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.6 p -150.76 160.4 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.453 . . . . 0.0 111.234 -178.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.446 ' OE2' ' OH ' ' A' ' 197' ' ' TYR . 94.9 mt-10 -107.19 117.36 33.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.554 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.38 159.12 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.229 -178.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 p -66.87 168.41 10.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.7 -11.19 11.6 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.941 1.761 . . . . 0.0 111.761 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -87.77 -5.3 58.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -85.92 71.88 10.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 0.0 110.2 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.498 ' C ' ' H ' ' A' ' 173' ' ' VAL . 92.6 m95 -70.62 -29.89 66.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.047 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.471 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 55.4 mp0 -48.53 -14.28 0.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.485 0.66 . . . . 0.0 110.523 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 171' ' ' TRP . 90.7 t -73.11 -25.85 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.923 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.0 m -115.29 -0.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.535 0.683 . . . . 0.0 110.513 -178.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.57 122.78 28.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.959 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -31.8 127.62 0.21 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.75 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -103.08 -42.75 5.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.017 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.29 29.24 0.15 Allowed Glycine 0 N--CA 1.471 1.029 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.39 176.78 12.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.942 0.401 . . . . 0.0 111.531 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.58 89.11 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.72 0.771 . . . . 0.0 109.404 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -122.48 167.84 12.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.028 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.7 142.57 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.233 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.444 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 4.9 m -135.99 120.35 17.99 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.114 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -106.06 128.63 53.99 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.164 0.507 . . . . 0.0 110.321 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.3 pt -137.47 -175.24 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.729 -178.456 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t -139.67 155.86 47.15 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.001 -179.535 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 20.1 m -100.14 100.45 11.29 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.012 0.434 . . . . 0.0 110.346 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.28 160.29 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 -179.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.1 t -154.13 98.75 2.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.954 0.407 . . . . 0.0 111.166 -179.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 70.8 t -125.58 130.66 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.508 -179.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.95 -161.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.857 179.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 49.31 -131.26 1.84 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.049 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.413 ' O ' ' OD1' ' A' ' 193' ' ' ASN . 45.5 p-10 -96.62 135.46 38.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 28.8 m -153.42 155.02 35.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.974 -179.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -143.22 147.28 34.6 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -113.18 119.99 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.228 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.446 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 1.2 m-85 -77.79 131.25 37.52 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 142.13 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.79 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.11 130.29 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.338 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.44 134.33 54.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.29 150.04 19.93 Favored Glycine 0 N--CA 1.467 0.763 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.0 t0 -108.49 145.87 34.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.517 -0.341 . . . . 0.0 111.361 -179.169 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.8 tp -70.32 129.51 39.51 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.443 0.639 . . . . 0.0 110.709 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.81 -21.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.605 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.43 175.9 45.91 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.132 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.3 m -155.54 155.84 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.237 0.542 . . . . 0.0 110.85 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -148.15 178.35 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.421 178.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -100.35 142.89 31.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.296 0.57 . . . . 0.0 111.086 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -61.86 80.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.61 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 208' ' ' ALA . 80.8 tttt . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.075 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -67.58 139.24 56.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.6 t60 47.68 80.66 0.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.452 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.3 ptm -87.38 -167.16 1.79 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.904 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.77 137.77 57.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.037 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.67 -51.46 27.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.176 -178.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.593 ' HG ' ' CG1' ' A' ' 190' ' ' VAL . 1.9 t -151.73 -89.75 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 48.64 38.48 11.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.89 178.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 63' ' ' GLN . 47.9 mt -67.45 -76.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 -179.419 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.5 t0 57.41 -81.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.049 178.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 61' ' ' ILE . 6.7 pt20 -150.51 72.56 9.05 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.007 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.28 141.51 2.05 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.264 1.976 . . . . 0.0 111.674 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.04 151.71 44.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.85 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.2 mp -55.75 -26.1 43.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -178.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -39.6 93.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.322 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -74.1 -32.03 63.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.701 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.31 -45.32 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.919 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -75.84 -28.47 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.113 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.3 141.8 58.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.38 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.6 p -139.79 122.18 16.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.8 tp -114.6 129.24 56.65 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.343 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 68.0 t0 -68.47 134.45 50.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.274 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 4.5 mptp? -64.3 -8.84 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.52 . . . . 0.0 109.923 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 79' ' ' VAL . 38.9 ttmt -64.38 -33.96 77.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.048 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.436 ' OE1' ' OD1' ' A' ' 102' ' ' ASN . 75.7 mt-30 -77.68 14.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.201 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 77' ' ' LYS . 59.9 t -95.83 127.37 47.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.78 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.477 ' H ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.11 2.61 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.694 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.26 -178.84 42.0 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -146.89 151.23 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.74 -179.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -120.47 124.33 72.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 t -128.88 129.02 45.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.8 mt -133.67 130.12 20.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.67 -178.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.22 -34.71 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.349 2.033 . . . . 0.0 111.561 179.52 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 m -47.74 -39.4 17.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.43 -176.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.0 p -121.19 -0.84 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.933 -179.288 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 61.33 54.25 3.24 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.76 133.42 56.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.419 -178.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -130.07 114.38 15.69 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 mp -136.73 103.72 9.18 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.38 130.95 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.777 1.652 . . . . 0.0 110.264 175.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.7 t -82.36 127.89 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -111.78 123.1 49.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.893 0.378 . . . . 0.0 110.068 -179.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -65.64 -45.9 81.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.741 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.9 m -66.84 100.07 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.376 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.66 97.69 10.26 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.437 0.637 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.56 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 4.8 p -137.37 155.57 49.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -51.53 -36.44 44.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -75.43 -45.75 36.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.99 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.661 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -65.23 -36.56 84.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.57 -178.215 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 mt -59.24 -21.87 60.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.439 -179.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.13 -31.19 68.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -89.19 -11.44 43.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.56 42.21 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.59 127.93 34.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.885 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 146.72 29.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.013 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.62 152.22 39.25 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.28 -51.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -93.78 139.26 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -74.12 -0.18 15.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.225 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -138.01 38.29 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.151 0.5 . . . . 0.0 110.983 -177.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.74 21.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.718 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -129.98 128.75 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.1 mtt -69.36 128.14 35.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 110.202 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.59 0.18 69.93 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -140.5 121.96 15.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.877 0.37 . . . . 0.0 110.974 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.11 -169.95 53.54 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.551 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 12.4 t30 -86.34 110.77 19.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.19 102.77 12.86 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.016 0.436 . . . . 0.0 109.91 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 129.04 36.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.589 0.709 . . . . 0.0 112.114 -178.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.87 130.44 52.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.565 178.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.87 139.35 46.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.567 0.698 . . . . 0.0 110.496 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.15 -178.8 19.31 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.669 -179.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 134' ' ' LEU . 74.7 m-70 -91.33 140.87 29.36 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.152 0.501 . . . . 0.0 110.654 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 129' ' ' SER . 26.9 t-20 -108.68 29.62 7.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.517 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mmm -43.28 -15.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.792 -179.123 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.88 38.62 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.239 0.542 . . . . 0.0 110.165 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.5 tttt -133.0 106.15 7.49 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.178 -179.107 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -51.9 125.2 14.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.807 0.813 . . . . 0.0 110.137 -179.243 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.96 -29.42 7.13 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.62 -178.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.624 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 41.3 t -81.06 -179.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.058 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.624 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.88 135.31 47.94 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.418 -178.277 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 47.66 35.81 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.155 0.502 . . . . 0.0 111.076 178.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 2.4 p -81.93 -16.88 49.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.462 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 21.3 t0 -142.85 30.57 1.46 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.7 pt -70.44 -25.91 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.825 0.345 . . . . 0.0 111.458 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.04 4.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.462 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.1 m -95.38 -11.97 26.81 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.238 0.542 . . . . 0.0 109.637 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.7 mt -63.92 124.96 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.402 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.12 155.8 16.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.589 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.03 129.32 41.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.594 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 90.03 21.53 38.73 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -86.0 137.46 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -81.64 126.99 32.42 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.68 125.19 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.261 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -104.71 115.59 30.58 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.372 0.606 . . . . 0.0 109.874 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.7 tp -116.1 144.62 43.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.307 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.511 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 50.0 m-85 -116.13 133.45 56.01 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.314 0.578 . . . . 0.0 111.49 -179.34 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.0 t0 -109.98 -168.32 1.31 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.977 178.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.553 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 65.4 t30 -29.13 -71.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.342 0.591 . . . . 0.0 111.283 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.66 25.33 3.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.95 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.93 142.9 51.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.481 0.658 . . . . 0.0 112.486 -175.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.511 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 33.6 tp10 -107.14 120.16 41.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.29 130.77 52.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.202 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -94.91 117.12 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.647 177.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -117.39 138.98 51.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.232 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.79 135.34 54.12 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.789 178.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 144' ' ' GLY . 46.7 t -68.45 132.96 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.03 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -27.74 11.46 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 124.463 1.102 . . . . 0.0 110.683 -178.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.63 154.57 8.7 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.687 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.28 144.03 19.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.786 -0.707 . . . . 0.0 109.735 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -155.26 166.1 34.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.271 0.558 . . . . 0.0 111.47 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -123.67 128.16 49.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.678 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.4 154.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 169' ' ' ASP . 10.7 p -58.39 129.79 83.97 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.91 -13.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.781 1.654 . . . . 0.0 111.963 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.3 m-20 -81.0 -11.31 59.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.995 -177.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.13 74.06 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -73.25 -15.33 61.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.527 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 3.0 pt-20 -53.24 -36.18 60.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.234 0.54 . . . . 0.0 109.873 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.71 -1.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.973 -179.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.99 -13.74 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.854 0.835 . . . . 0.0 109.919 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -86.92 172.78 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.106 -1.407 . . . . 0.0 112.279 -178.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 67.4 t0 -82.3 131.4 35.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.735 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.527 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 40.5 m80 -111.07 -42.02 4.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.552 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.52 25.67 0.09 OUTLIER Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.547 ' NZ ' ' OE1' ' A' ' 181' ' ' GLU . 0.0 OUTLIER -151.42 166.33 31.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.22 89.13 5.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.528 0.68 . . . . 0.0 110.454 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.547 ' OE1' ' NZ ' ' A' ' 179' ' ' LYS . 53.2 tt0 -130.23 129.22 43.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.271 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.64 148.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.551 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 21.6 m -136.73 122.41 19.8 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.189 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.11 125.9 52.63 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.273 0.558 . . . . 0.0 110.545 179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 35.4 pt -136.25 163.03 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.119 -178.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.504 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 59.1 p -82.26 164.11 21.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.29 179.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 187' ' ' CYS . 33.9 t -98.35 27.58 4.63 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.801 0.334 . . . . 0.0 111.52 -179.17 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.576 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 53.6 t -102.31 99.01 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.384 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.7 t -170.66 19.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.664 -179.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.593 ' CG1' ' HG ' ' A' ' 59' ' ' SER . 35.0 m -97.86 -3.09 9.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.016 0.436 . . . . 0.0 111.554 -179.033 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -143.43 -131.68 0.09 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.372 -178.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.26 141.48 58.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.211 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -59.39 151.24 24.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.794 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.5 t -151.28 148.05 27.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.138 0.494 . . . . 0.0 111.653 -179.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.55 134.31 53.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.868 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.576 ' NH2' ' O ' ' A' ' 188' ' ' VAL . 11.3 ptp180 -142.42 163.83 31.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.778 -178.748 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -106.16 133.99 49.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.152 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.91 132.38 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 43.9 t -117.95 127.73 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.52 134.33 54.11 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.353 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.45 139.92 11.34 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -98.28 140.67 32.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.622 -0.789 . . . . 0.0 111.642 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.5 tp -65.22 125.31 24.62 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.17 -21.4 5.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.421 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.39 174.69 46.49 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.199 -179.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.5 m -154.35 151.77 29.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.824 179.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -150.45 177.6 9.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.56 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -94.43 147.31 23.37 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.342 0.591 . . . . 0.0 110.575 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -61.66 80.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.708 -179.927 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 208' ' ' ALA . 73.8 tttt . . . . . 0 C--N 1.314 -0.965 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.075 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 p 62.69 134.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -66.38 -40.39 89.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.433 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 28.0 ttt -166.34 -18.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.138 0.494 . . . . 0.0 110.335 -178.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 65.9 t0 -52.26 137.7 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.719 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -73.44 -8.88 57.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.418 -179.46 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.5 m -85.82 33.47 0.59 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.832 0.349 . . . . 0.0 111.406 -178.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -88.46 28.2 1.15 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.209 -179.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mm -64.76 -44.68 96.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.352 0.596 . . . . 0.0 110.672 -178.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 49.69 -97.49 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.288 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -151.66 87.77 4.38 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.784 -179.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.03 151.76 50.43 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.937 1.758 . . . . 0.0 111.7 179.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.05 161.6 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.46 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.469 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 9.7 mp -65.37 -19.99 66.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.634 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.8 88.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 110.036 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -74.19 -33.15 63.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.641 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.28 -44.68 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.542 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.41 86.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.923 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -83.36 -22.57 32.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.047 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.34 104.32 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -95.54 112.22 23.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.189 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tt -115.84 133.02 56.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.323 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -80.41 148.82 30.4 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.453 179.105 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -67.98 0.93 3.03 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.375 0.607 . . . . 0.0 109.588 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 75' ' ' ASP . 38.8 ttmt -62.96 -42.86 99.95 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.723 179.37 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -79.41 0.16 30.41 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.14 0.495 . . . . 0.0 110.439 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.7 t -99.56 129.71 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.576 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.57 7.09 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.731 -178.162 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.73 -172.54 35.66 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -153.31 153.18 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 111.262 -179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -127.7 130.77 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.706 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.445 ' OG ' ' OE2' ' A' ' 91' ' ' GLU . 9.8 m -127.77 130.98 49.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.58 117.12 16.38 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.222 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.28 -36.39 0.99 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.097 1.864 . . . . 0.0 111.534 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -52.33 -38.73 59.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.711 -177.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.05 -6.94 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.75 0.31 . . . . 0.0 110.67 -178.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.59 47.47 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.3 tp -114.15 131.46 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.784 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' OE2' ' OG ' ' A' ' 84' ' ' SER . 25.5 tp10 -133.02 116.61 16.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.218 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -146.46 165.1 21.09 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.423 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.38 161.01 8.24 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 123.206 2.604 . . . . 0.0 108.923 177.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -112.78 122.95 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.2 mt -103.32 123.97 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.33 -47.99 74.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.199 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.6 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 7.7 p -85.19 119.98 26.18 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.791 -179.583 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p -86.76 118.8 26.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.337 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.2 p -140.69 168.83 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.413 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 4.0 tm-20 -69.87 -34.44 73.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.87 -42.24 21.81 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 97' ' ' SER . 3.6 p-10 -68.75 -20.18 64.36 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.37 -17.77 63.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.218 -179.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 104' ' ' LEU . 8.1 mp -75.29 -15.98 60.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.8 m -96.69 -13.6 22.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 165.6 -149.6 16.13 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.59 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.65 126.3 38.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.401 0.619 . . . . 0.0 110.0 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.08 147.82 26.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 41.9 p -72.22 149.56 44.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 t -83.95 -46.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -88.69 -170.91 3.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.85 -178.081 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -124.31 -5.44 7.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.654 -178.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -138.87 36.09 2.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.694 0.283 . . . . 0.0 110.764 -178.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -92.55 158.92 15.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.119 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.37 132.1 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 -179.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -65.73 127.14 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 178.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.47 1.82 68.43 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -142.55 126.76 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 110.227 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 179' ' ' LYS . . . 72.55 -176.85 41.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -80.05 108.81 13.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.536 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.68 99.47 10.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.007 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.47 128.61 37.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.232 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.21 133.02 54.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.978 178.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.09 140.34 45.71 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.453 0.644 . . . . 0.0 110.916 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.16 -178.13 20.49 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.962 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -84.58 150.45 25.19 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 111.28 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 129' ' ' SER . 44.7 t30 -114.71 27.48 9.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.588 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.4 mmm -45.47 -12.72 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.532 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 127' ' ' ASN . 1.8 m 51.7 42.41 29.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 136' ' ' SER . 28.8 tptp -136.06 119.58 17.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.868 -178.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -61.9 124.47 20.85 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.855 0.836 . . . . 0.0 110.686 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.26 5.78 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.033 -177.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.47 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 22.1 t -138.53 175.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.062 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.539 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.89 130.7 43.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 111.371 -178.105 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 46.71 32.96 1.89 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.636 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.3 OUTLIER -82.66 -11.14 58.59 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.853 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -144.68 21.83 1.64 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -177.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 140' ' ' SER . 6.6 pt -69.0 -27.44 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.719 0.295 . . . . 0.0 111.527 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.58 1.49 2.36 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.549 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 138' ' ' ILE . 68.7 m -95.54 -10.44 29.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.91 118.6 7.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.524 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -98.19 170.98 8.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -67.25 137.4 56.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.134 0.968 . . . . 0.0 112.409 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.53 20.3 64.37 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.781 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -90.94 134.05 34.78 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -83.46 138.23 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.548 0.689 . . . . 0.0 112.16 -178.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 158' ' ' TYR . 76.9 mt -130.82 119.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.504 179.103 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -100.47 122.72 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.3 tp -117.32 147.03 42.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.726 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -113.49 128.81 56.58 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.17 0.509 . . . . 0.0 111.134 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -109.3 -168.44 1.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 151' ' ' ASP . 92.3 m-20 -25.73 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.381 0.61 . . . . 0.0 112.312 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -138.85 23.4 2.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -124.95 144.63 50.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.66 121.74 44.19 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.536 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 56.2 m-85 -105.94 130.05 53.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.307 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.84 119.2 34.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' A' ' 147' ' ' ILE . 52.0 m-85 -116.64 138.74 51.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.167 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -114.9 132.14 56.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.35 0.595 . . . . 0.0 110.56 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.27 134.18 30.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.57 -25.11 11.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.357 1.036 . . . . 0.0 110.714 -179.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.37 164.21 23.68 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.89 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.76 152.27 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.2 t -156.88 169.11 25.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.378 0.609 . . . . 0.0 111.369 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.99 126.98 52.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.399 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -139.55 159.0 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.113 -178.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 169' ' ' ASP . 17.6 p -68.5 135.62 90.73 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.573 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.9 Cg_endo -47.17 -12.62 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.604 1.536 . . . . 0.0 111.727 -179.263 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 167' ' ' THR . 66.5 t0 -78.15 -17.7 56.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.44 -178.628 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -84.7 68.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.573 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 63.0 m95 -73.72 -24.04 59.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.379 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.36 -7.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.562 ' H ' ' C ' ' A' ' 171' ' ' TRP . 17.3 m -85.9 -9.12 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.128 -178.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.27 8.3 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 109.158 -179.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 72.4 mm-40 -83.6 143.71 29.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.443 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -55.81 120.14 6.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.801 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 41.7 m80 -111.3 -40.1 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.71 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 122.85 34.67 0.78 Allowed Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 119' ' ' GLY . 19.8 mmmt -139.03 157.08 46.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.664 -179.262 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.2 m-20 -87.96 88.57 7.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.906 0.86 . . . . 0.0 108.891 177.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 182' ' ' ILE . 42.5 tt0 -135.12 170.09 16.44 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.133 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.406 ' H ' ' HG2' ' A' ' 181' ' ' GLU . 18.1 tt -131.29 143.3 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.845 178.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 13.5 m -137.25 128.07 27.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.098 179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.4 mp -112.77 125.62 54.53 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.216 0.532 . . . . 0.0 110.325 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.9 pt -133.91 164.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.427 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.0 p -139.43 163.54 32.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.116 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 53.4 t 47.18 94.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 110.052 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 18.5 m -87.12 16.98 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.214 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.4 m -68.25 140.84 56.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.918 0.389 . . . . 0.0 110.783 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.15 -45.97 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.237 0.541 . . . . 0.0 110.273 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -58.86 144.58 43.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.625 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 192' ' ' ASP . 46.8 t0 -63.63 -23.58 67.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.14 0.495 . . . . 0.0 110.318 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 194' ' ' SER . 24.6 t-20 52.17 -121.04 1.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.132 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.482 ' H ' ' CG ' ' A' ' 193' ' ' ASN . 80.6 p -92.87 -80.52 0.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.3 0.572 . . . . 0.0 110.745 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.425 ' N ' ' OG ' ' A' ' 194' ' ' SER . 21.9 pttp -146.96 153.18 39.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.222 -179.497 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.75 120.35 24.94 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.483 . . . . 0.0 110.786 -179.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.21 142.66 45.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.77 139.05 46.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.72 129.93 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.302 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.21 135.74 53.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.999 0.428 . . . . 0.0 110.402 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.52 145.73 17.0 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.843 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -100.69 139.02 36.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.773 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.48 126.16 27.41 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.212 0.529 . . . . 0.0 110.711 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.63 -25.93 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.376 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.64 161.26 20.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.434 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.536 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 40.5 m -137.73 157.4 46.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.446 0.641 . . . . 0.0 110.07 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -148.93 179.32 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.306 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.17 144.42 25.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.467 0.651 . . . . 0.0 110.901 179.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -67.98 80.15 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.644 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 77.3 tttt . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.59 179.068 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.0 p -74.99 162.54 28.49 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -97.83 25.36 5.99 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.857 0.36 . . . . 0.0 111.325 -179.031 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 82.2 mmm -61.97 -43.85 97.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.239 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.7 t0 52.55 28.03 5.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.073 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.37 -36.93 79.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.201 -178.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 61' ' ' ILE . 15.0 m -85.87 27.08 0.91 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 -178.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -71.64 35.57 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.726 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 59' ' ' SER . 59.3 mt -62.06 -47.54 92.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 51.12 -93.2 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.958 178.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' ILE . 4.2 pt20 -150.76 80.36 6.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.088 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.33 146.37 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.266 1.977 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.24 154.35 42.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.877 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.6 mt -56.13 -26.37 49.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 110.869 -179.153 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.92 96.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.651 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.63 -36.09 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.679 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.5 t -74.47 -44.63 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.083 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.76 92.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -80.76 -25.79 37.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.447 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.62 140.92 58.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.112 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 p -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 tp -140.83 140.0 34.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.316 -178.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.72 140.84 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.383 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -70.07 -6.0 30.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.302 0.572 . . . . 0.0 110.009 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 79' ' ' VAL . 68.5 mttm -63.21 -35.74 81.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.358 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -75.59 11.93 1.17 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.653 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 77' ' ' LYS . 96.2 t -87.8 126.09 41.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.573 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 9.1 pt -119.9 -9.07 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 112.058 -178.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 -170.26 38.03 Favored Glycine 0 C--N 1.321 -0.264 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.09 152.42 38.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.507 -178.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 10.1 tt -122.58 125.8 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -125.79 127.86 46.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.172 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.1 mt -131.61 126.71 21.18 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.258 -177.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.66 -35.9 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.162 180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.9 t -46.64 -37.73 8.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.403 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.1 p -120.6 -0.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 t 61.49 55.63 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.47 136.07 54.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.184 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.24 119.89 18.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -146.09 107.67 4.24 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -176.108 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.73 159.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.841 1.694 . . . . 0.0 109.898 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.6 t -110.04 124.68 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.4 mt -108.09 123.87 49.35 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -66.81 -49.64 65.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.196 0.522 . . . . 0.0 111.435 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.8 m -62.05 99.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.496 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 p -82.99 102.16 11.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.918 0.389 . . . . 0.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.656 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 80.4 p -141.86 155.17 45.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.307 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -57.86 -23.03 51.02 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -81.82 -50.11 9.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.278 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.656 ' H ' ' HG1' ' A' ' 99' ' ' THR . 1.2 p-10 -66.29 -31.56 72.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.588 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.97 -22.49 62.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.422 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -72.9 -16.53 61.56 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.6 m -106.96 -14.94 14.83 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.93 48.1 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.296 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.51 ' CB ' HD22 ' A' ' 102' ' ' ASN . . . -107.57 145.49 33.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.188 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.8 p -70.14 149.18 47.84 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.54 -45.12 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.32 -170.84 2.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.027 -178.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.98 -10.12 8.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 113' ' ' ASN . 54.3 p30 -135.45 36.35 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.929 0.395 . . . . 0.0 111.026 -177.342 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -93.82 158.74 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.927 179.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.43 131.16 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.794 -178.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.435 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 67.0 mtt -65.41 129.47 39.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.58 -2.75 74.09 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -138.49 121.26 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.867 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 74.93 -173.96 51.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.442 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 56.7 t30 -82.65 111.98 19.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -84.77 104.84 15.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.17 130.12 36.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.608 -179.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -128.74 134.31 48.4 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.42 43.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.256 0.55 . . . . 0.0 111.005 -178.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.75 -177.58 17.89 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 64.3 m-70 -87.69 140.68 29.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.675 0.274 . . . . 0.0 110.58 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 49.1 p30 -107.16 28.27 8.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.155 0.502 . . . . 0.0 110.735 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -43.31 -15.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.887 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.2 40.01 18.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.256 178.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.58 107.1 7.78 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.35 128.15 16.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.857 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.71 -26.44 11.74 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.589 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 47.7 t -83.6 179.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.589 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 137.51 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 -178.103 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 44.39 35.47 1.32 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 111.184 177.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 16.8 p -82.41 -13.46 56.77 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 136' ' ' SER . 78.4 m-20 -146.97 31.57 0.94 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.33 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.0 pt -70.84 -25.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.819 0.343 . . . . 0.0 111.825 179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.43 0.92 7.15 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.53 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -93.68 -11.68 31.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.304 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 163' ' ' VAL . 18.9 mt -65.64 120.69 13.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.537 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.508 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.05 151.9 19.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.628 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -52.07 122.82 9.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.302 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.93 21.29 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.7 m-20 -87.25 139.55 30.45 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -81.66 127.26 32.72 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.496 -178.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 158' ' ' TYR . 32.9 mm -115.02 124.25 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -105.64 115.81 30.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.95 150.86 39.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.148 -178.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -123.77 136.9 54.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.185 0.516 . . . . 0.0 111.65 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 156' ' ' TYR . 2.5 m-20 -113.7 -163.53 0.87 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.613 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.538 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 4.6 p30 -26.03 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.07 0.462 . . . . 0.0 111.438 178.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.538 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.6 mt-10 -132.94 29.86 4.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.065 178.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.412 ' OD1' ' OD1' ' A' ' 152' ' ' ASN . 28.3 m120 -127.82 145.34 50.96 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -106.29 121.78 44.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.724 179.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.588 ' CE1' ' OD2' ' A' ' 151' ' ' ASP . 19.7 m-85 -104.35 129.12 52.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.629 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.58 117.27 30.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.508 ' O ' ' N ' ' A' ' 147' ' ' ILE . 8.2 m-85 -120.53 137.85 54.16 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.859 -178.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.1 134.96 53.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.76 178.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.26 134.43 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.158 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 12.2 p -99.07 -26.96 14.05 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.486 1.116 . . . . 0.0 111.316 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.99 145.25 4.17 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.342 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 141' ' ' LEU . 58.1 t -91.8 141.46 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -139.9 151.41 45.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.756 0.312 . . . . 0.0 111.05 -177.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.43 ' OE2' ' OH ' ' A' ' 197' ' ' TYR . 95.4 mt-10 -106.47 115.94 31.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.86 159.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.232 -177.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.0 p -66.94 170.03 6.99 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.555 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.7 Cg_endo -81.68 -13.19 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.888 1.725 . . . . 0.0 111.901 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -87.87 -14.21 40.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -178.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -85.69 69.13 10.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.555 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.4 m95 -74.83 -2.44 26.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.09 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -53.37 -35.38 60.24 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.162 0.506 . . . . 0.0 111.024 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 17.0 m -80.88 3.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.925 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.38 -15.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.833 0.825 . . . . 0.0 109.971 -178.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.06 162.22 17.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.838 -179.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -66.76 128.16 35.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.637 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -99.29 -39.53 8.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.083 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.2 29.42 0.5 Allowed Glycine 0 N--CA 1.473 1.103 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.439 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 58.5 pttt -156.05 -179.11 7.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 43.8 m-20 -92.21 90.26 7.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.145 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -128.2 169.28 14.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.861 -178.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.9 tt -132.94 143.33 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.442 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 11.3 m -138.29 120.61 15.89 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.872 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.6 mp -108.77 126.03 52.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.958 0.409 . . . . 0.0 111.179 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.1 pt -133.89 -166.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.518 -178.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.587 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 23.4 p -137.24 167.21 22.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.572 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 186' ' ' THR . 91.8 m -49.15 178.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.248 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.6 p -64.91 139.35 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 190' ' ' VAL . 20.2 p -73.42 171.4 13.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 189' ' ' SER . 16.0 m -53.36 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.223 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -59.78 -47.58 85.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.642 0.258 . . . . 0.0 111.239 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' ' 193' ' ' ASN . 39.7 t0 -166.77 -158.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.544 ' H ' ' CG ' ' A' ' 192' ' ' ASP . 99.1 m-20 50.01 34.09 7.69 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.78 178.196 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.459 ' HG ' ' CG2' ' A' ' 190' ' ' VAL . 68.8 m -155.05 155.49 34.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.559 -178.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.99 134.48 50.35 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.592 -179.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.587 ' NH1' ' O ' ' A' ' 186' ' ' THR . 15.4 ttm180 -78.15 126.59 31.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.727 -179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.43 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 2.7 m-85 -89.19 132.91 34.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.308 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.46 142.09 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 111.514 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 40.1 t -116.29 129.16 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.178 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.01 134.62 54.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.646 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.08 157.28 22.78 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -112.15 148.8 33.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.972 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.29 127.23 32.06 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.858 0.361 . . . . 0.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.03 -25.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.346 -178.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.6 163.18 22.15 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.616 178.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.535 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 93.6 m -139.49 159.05 43.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.058 0.456 . . . . 0.0 110.109 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -147.27 178.79 8.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -97.35 142.99 28.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.545 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.94 80.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.556 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.388 178.524 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.455 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 54' ' ' SER . 27.1 p 49.59 95.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.18 -45.44 93.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 -179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' ASP . 33.2 tpp 49.54 -126.3 2.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' MET . 96.7 m-20 48.44 98.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.455 179.307 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.58 75.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.113 -178.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 1.4 t -150.08 -95.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.337 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.553 ' N ' ' OG ' ' A' ' 59' ' ' SER . 68.1 mttm 45.73 33.7 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.736 179.188 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.2 mt -67.23 -30.97 51.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.79 -179.219 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 1.8 p30 48.14 -162.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.912 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.516 ' CG ' ' SD ' ' A' ' 128' ' ' MET . 15.9 tt0 -96.53 87.06 0.41 Allowed Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -44.22 141.44 4.86 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.032 1.822 . . . . 0.0 112.534 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 58.5 t0 -76.43 152.94 36.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.1 mt -55.04 -25.0 27.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.565 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.71 -39.11 87.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.14 -32.12 63.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.6 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.18 -44.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.83 85.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.81 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -81.6 -28.46 33.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.455 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.17 111.73 1.45 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 111.218 -178.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.8 m -97.37 85.97 3.78 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.7 tp -74.4 146.74 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.335 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -94.88 111.61 23.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 179.311 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -52.61 -10.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.434 . . . . 0.0 110.198 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -70.93 -12.19 61.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.925 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -95.54 15.86 18.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.475 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.22 126.24 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.07 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.34 -3.71 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.946 0.403 . . . . 0.0 111.66 -178.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.34 -162.01 32.19 Favored Glycine 0 C--N 1.317 -0.524 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.653 ' NH1' ' HZ2' ' A' ' 209' ' ' LYS . 36.8 ptt180 -156.31 162.64 40.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.426 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -133.26 139.67 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 t -130.03 135.57 48.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.529 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 70.5 mt -131.89 125.55 20.31 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.734 -178.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.66 -36.29 0.34 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.46 2.107 . . . . 0.0 112.864 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.454 ' HG ' ' N ' ' A' ' 88' ' ' VAL . 28.1 p -48.21 -36.49 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.706 -176.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 1.8 p -119.81 -0.21 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.576 0.227 . . . . 0.0 110.65 -179.067 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.0 p 61.53 52.12 3.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 tp -115.57 134.11 55.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.714 -178.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.56 128.69 22.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.591 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 1.0 OUTLIER -161.55 130.21 3.0 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.128 -178.857 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -47.59 156.89 1.0 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.583 1.522 . . . . 0.0 110.873 177.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.5 t -107.88 125.55 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -106.48 125.38 50.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.845 0.355 . . . . 0.0 110.592 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.57 -45.35 72.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.095 0.474 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.2 m -67.68 104.83 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.577 -178.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.1 p -81.74 96.63 7.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.096 0.475 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.58 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 4.8 p -135.96 157.65 46.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.947 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -58.11 -27.33 63.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.884 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.53 -45.28 13.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.24 0.543 . . . . 0.0 111.197 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.58 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.9 m-80 -65.67 -36.68 84.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.405 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.46 -17.94 63.24 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.0 mt -71.21 -28.96 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.1 p -97.71 -8.23 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.35 -164.66 32.92 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.691 -1.242 . . . . 0.0 112.584 -178.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.591 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -92.36 127.95 38.03 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.06 146.71 28.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 -179.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.0 p -74.27 153.16 39.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.3 t -85.52 -47.04 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -92.49 -170.29 2.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.633 -178.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 11.5 pt-20 -106.97 -52.83 2.7 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.72 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 17.9 m120 -89.24 43.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.479 -178.118 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -79.6 146.33 32.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.034 0.445 . . . . 0.0 110.859 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 122.8 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.34 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.99 125.12 25.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.538 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.3 0.68 70.17 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -140.72 126.17 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.508 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.57 -172.13 48.77 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.532 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 0.4 OUTLIER -84.34 108.34 17.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.626 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.82 101.91 12.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 124.83 35.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.0 112.132 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -119.67 131.4 55.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.446 177.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.77 141.11 45.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.176 0.512 . . . . 0.0 110.594 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.68 -178.22 18.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.412 -179.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.1 m-70 -87.08 144.86 26.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.985 0.421 . . . . 0.0 110.873 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.0 t-20 -108.88 28.9 7.98 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.869 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.516 ' SD ' ' CG ' ' A' ' 63' ' ' GLN . 0.9 OUTLIER -44.15 -13.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.742 -178.872 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 m 57.44 39.78 27.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.146 0.498 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -135.02 108.21 7.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.531 -178.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -51.15 127.83 20.26 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.642 -179.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.53 -26.71 11.47 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.448 -178.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 46.3 t -82.72 178.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 117.52 0.66 . . . . 0.0 109.772 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.621 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.22 136.94 48.28 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.628 -177.996 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.86 33.57 1.02 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.898 178.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.8 p -81.78 -12.01 58.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 23.4 t70 -149.12 32.84 0.74 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.094 -178.378 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.9 pt -69.58 -27.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.442 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.15 2.07 4.06 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 63.5 m -91.77 -14.85 29.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 23.1 mt -62.76 126.48 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.165 -179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -96.46 171.41 8.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -76.8 129.59 36.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.505 0.669 . . . . 0.0 111.937 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.51 21.11 49.37 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.25 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.17 -158.51 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -147.26 129.84 15.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.686 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.3 mt -126.92 124.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.814 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -102.99 120.23 40.26 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 tp -117.03 148.4 41.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 -179.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.13 131.19 53.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.12 0.486 . . . . 0.0 112.028 -178.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 152' ' ' ASN . 36.8 t0 -109.18 -167.42 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.168 177.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 151' ' ' ASP . 16.2 m120 -19.99 -76.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.56 0.538 . . . . 0.0 111.981 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -138.16 27.23 2.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.58 144.2 49.26 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -176.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -107.68 121.52 44.86 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.42 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 63.6 m-85 -105.35 128.92 53.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -178.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.461 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 98.0 mt-10 -95.83 119.44 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.236 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -116.36 143.94 44.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.67 131.77 56.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.038 0.447 . . . . 0.0 110.13 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.69 132.6 32.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.527 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -28.67 12.06 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.344 1.028 . . . . 0.0 109.906 -178.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 169.96 25.53 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.279 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.07 153.86 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.439 -0.881 . . . . 0.0 109.918 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.493 ' HG ' ' H ' ' A' ' 165' ' ' GLU . 47.3 t -153.89 166.12 33.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 111.523 -179.605 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 63.2 mm-40 -109.9 126.94 54.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.58 161.37 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.769 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.6 p -76.89 145.23 73.82 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.35 -21.81 7.72 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.867 1.711 . . . . 0.0 111.662 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.37 -2.73 53.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.805 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.596 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 21.6 tptt -80.71 150.18 29.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 83.6 m95 -157.62 -24.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.545 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.3 mt-10 -51.9 -8.56 0.07 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.111 0.482 . . . . 0.0 110.298 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 171' ' ' TRP . 7.0 m -78.41 -32.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 28.5 m -110.03 -1.35 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.451 0.643 . . . . 0.0 110.468 -178.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 176' ' ' ASP . 94.0 mt-10 -80.37 119.81 23.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.7 -179.016 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' GLU . 98.1 m-20 -30.41 120.04 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.655 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.545 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 49.9 m80 -102.85 -43.23 5.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.969 -179.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.16 29.41 0.22 Allowed Glycine 0 N--CA 1.467 0.738 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -152.57 172.7 16.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -93.86 89.47 6.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.386 178.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.26 127.5 30.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.762 -179.142 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -82.56 148.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.532 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 3.4 m -136.1 124.84 23.87 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -108.47 129.93 55.27 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.924 0.392 . . . . 0.0 110.512 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 7.1 pt -141.5 -168.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.924 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.8 t -138.0 147.47 44.24 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.1 p -98.35 -7.84 28.11 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.692 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.5 t -76.24 64.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.731 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.5 p -78.91 156.1 28.74 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.551 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.469 ' CG1' ' OD1' ' A' ' 193' ' ' ASN . 5.1 p -143.64 142.55 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.428 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -85.46 -11.89 53.22 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.963 0.411 . . . . 0.0 110.969 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 192' ' ' ASP . 64.9 t0 -63.86 -37.22 86.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.686 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.469 ' OD1' ' CG1' ' A' ' 190' ' ' VAL . 42.4 p30 -146.82 169.27 19.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.765 -179.326 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.1 m -121.61 85.2 2.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.219 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -148.93 129.7 14.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.972 -179.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -145.36 142.93 29.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.994 -179.012 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.7 m-85 -102.96 123.38 46.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.11 133.22 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.394 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 76.4 t -120.31 130.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.184 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.26 135.24 53.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.295 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.14 137.39 10.11 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.6 t0 -95.54 132.47 40.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.23 -0.485 . . . . 0.0 112.077 -178.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 47.1 tp -62.15 125.84 25.27 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.168 0.508 . . . . 0.0 110.597 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.95 -24.91 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.678 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.11 159.86 17.03 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.064 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.42 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 20.5 m -134.15 156.17 48.79 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.105 0.479 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.461 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.5 ptpp? -148.14 179.21 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.129 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.84 146.82 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.232 0.539 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.653 ' HZ2' ' NH1' ' A' ' 82' ' ' ARG . 63.7 tttp -70.36 80.8 0.55 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.655 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.766 178.562 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.3 t -60.13 -44.83 94.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.965 0.412 . . . . 0.0 110.522 -179.654 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -77.82 138.18 38.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.149 179.522 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' A' ' 56' ' ' MET . 0.0 OUTLIER -96.35 142.43 28.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.665 -179.653 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -74.85 141.41 44.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.475 179.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.53 -17.88 62.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.87 -178.777 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 61' ' ' ILE . 52.8 m -86.92 -1.24 57.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.683 -178.596 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -68.91 37.72 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.199 -179.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.536 ' H ' ' C ' ' A' ' 59' ' ' SER . 67.3 mt -61.14 -50.15 81.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.052 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.1 t0 57.45 -98.5 0.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.906 179.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.441 ' CG ' ' SD ' ' A' ' 128' ' ' MET . 21.4 tt0 -151.66 77.74 7.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -43.46 138.86 4.91 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 122.404 2.069 . . . . 0.0 110.973 -179.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.35 146.16 48.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.634 179.471 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -49.26 -28.13 4.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.73 -179.711 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.58 93.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.353 -179.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -73.1 -33.92 65.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.748 179.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t -75.06 -45.89 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.052 -178.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.81 86.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.88 -25.33 32.61 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.372 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.76 130.62 47.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.4 t -95.64 158.88 15.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.432 ' CD2' ' OG ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -138.63 123.69 19.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.014 0.435 . . . . 0.0 110.951 -178.845 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.414 ' N ' HD12 ' A' ' 74' ' ' LEU . 98.0 m-20 -81.45 104.14 11.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.058 178.648 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -49.4 -35.84 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.242 -179.645 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -58.77 -11.49 3.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.498 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -90.41 -3.31 57.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.915 -178.724 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.34 133.27 30.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.983 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 pt -117.37 -5.73 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.933 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.72 33.77 Favored Glycine 0 C--N 1.317 -0.522 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.673 HH22 ' HZ1' ' A' ' 209' ' ' LYS . 29.5 ptt-85 -154.94 166.01 34.9 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.545 -179.775 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.77 134.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.824 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 t -123.85 130.27 52.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.242 -178.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.3 mt -133.15 111.05 12.95 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.402 -177.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.69 -36.66 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.757 2.305 . . . . 0.0 113.013 -178.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 t -47.81 -35.83 10.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.48 -177.249 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 89' ' ' SER . 4.2 m -118.96 -5.92 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 123.361 0.413 . . . . 0.0 111.432 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.15 45.69 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.737 -179.916 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.2 129.0 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.233 -178.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -135.86 115.65 13.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.361 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.1 mt -143.79 161.99 43.48 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -86.56 152.83 8.98 Favored 'Trans proline' 0 C--N 1.326 -0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 108.882 177.676 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.75 115.52 44.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.0 mt -100.18 128.26 46.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.045 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -66.22 -49.51 67.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.154 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -78.74 108.98 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 -179.092 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 98.72 11.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 109.927 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -133.06 154.8 50.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.33 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -51.55 -27.79 11.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.538 -179.607 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -83.57 -47.17 11.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.745 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.05 -33.36 75.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.593 -178.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.84 -19.35 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.807 -178.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.94 -25.13 63.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.432 ' OG ' ' CD2' ' A' ' 74' ' ' LEU . 21.6 m -91.82 -9.61 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.138 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 165.09 -154.04 24.58 Favored Glycine 0 N--CA 1.46 0.238 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.646 -179.387 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.42 125.26 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.634 -0.783 . . . . 0.0 110.061 179.591 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.23 148.03 26.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.576 -179.678 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.2 p -75.77 150.53 37.75 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.216 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 t -86.78 -56.51 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.67 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -96.74 138.65 33.99 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.301 0.572 . . . . 0.0 111.015 -179.178 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -80.55 9.09 6.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.656 -178.337 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.407 ' C ' ' OD1' ' A' ' 113' ' ' ASN . 54.8 p30 -132.88 22.78 4.21 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.139 -0.351 . . . . 0.0 111.352 -177.87 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -91.05 156.12 18.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.955 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -134.26 133.5 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.8 mtt -67.14 127.35 32.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 179.091 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.509 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.36 0.23 76.92 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.56 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -142.39 127.58 18.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.037 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.85 -171.2 45.47 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.254 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.466 ' ND2' ' HG1' ' A' ' 183' ' ' THR . 25.2 t-20 -86.77 107.84 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.773 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -84.91 99.32 10.88 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 122.76 34.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mt -117.7 131.14 56.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.296 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.95 137.91 48.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.627 0.727 . . . . 0.0 110.789 -178.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.25 -178.68 17.76 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.607 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -85.95 141.75 29.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.479 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.5 p30 -109.98 26.56 10.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.441 ' SD ' ' CG ' ' A' ' 63' ' ' GLN . 0.9 OUTLIER -42.96 -15.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.876 -179.51 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 59.39 39.13 22.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.142 178.959 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.9 tttt -133.27 114.95 14.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.468 -179.184 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.35 125.19 21.71 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.173 -179.652 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.93 -24.68 11.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.292 -178.379 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.582 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 61.5 t -82.37 178.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.582 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -71.89 135.74 46.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.245 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 43.67 32.81 0.6 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.166 0.508 . . . . 0.0 110.892 178.381 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -81.45 -6.37 58.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.784 -178.355 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 136' ' ' SER . 94.2 m-20 -143.25 34.37 1.33 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.625 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.6 pt -68.3 -30.5 47.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.788 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.49 5.83 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.029 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 138' ' ' ILE . 49.3 m -97.57 -14.65 20.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.023 -179.359 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.11 124.67 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.288 179.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.401 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.41 154.38 17.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.664 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.19 126.44 27.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.307 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.73 25.16 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.771 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.401 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -91.28 133.47 35.38 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -80.59 142.03 34.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.166 0.508 . . . . 0.0 111.592 -178.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 158' ' ' TYR . 85.7 mt -132.74 124.41 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.352 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.03 121.9 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.076 0.465 . . . . 0.0 109.994 -178.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.18 156.53 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.445 -179.489 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 26.3 m-85 -134.55 123.37 23.77 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 152' ' ' ASN . 11.3 t0 -114.35 -165.6 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.558 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.9 m-20 -11.31 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.737 0.648 . . . . 0.0 111.504 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -139.1 28.04 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.19 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.15 148.04 41.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.191 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 74.3 mt-10 -110.29 119.75 40.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.865 178.38 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -106.04 125.03 50.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.893 -178.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -96.12 118.98 33.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.108 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.509 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.8 m-85 -118.38 144.9 45.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.014 -178.843 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' ASP . . . -120.42 131.69 54.9 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.338 0.589 . . . . 0.0 110.368 178.825 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.31 133.84 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.962 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.2 p -102.19 -27.07 13.1 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 124.701 1.251 . . . . 0.0 110.986 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 179.94 36.53 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.259 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.98 147.48 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.776 -179.531 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -151.28 159.94 44.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.083 0.468 . . . . 0.0 110.976 -178.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -107.23 118.87 37.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -132.21 154.07 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.107 0.479 . . . . 0.0 111.034 -178.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 169' ' ' ASP . 35.8 p -75.94 135.86 70.34 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.691 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.59 -15.61 0.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.104 1.869 . . . . 0.0 111.659 -178.653 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.7 m-20 -81.35 -22.75 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 -177.906 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -85.65 75.84 10.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.229 179.307 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.575 ' C ' ' H ' ' A' ' 173' ' ' VAL . 86.0 m95 -71.39 -18.67 62.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.306 -178.665 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 81.0 mm-40 -51.97 -5.72 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.974 0.416 . . . . 0.0 111.15 179.208 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.575 ' H ' ' C ' ' A' ' 171' ' ' TRP . 34.0 m -90.38 -2.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.173 -178.466 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.2 m -132.99 -6.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.63 0.729 . . . . 0.0 109.563 -179.681 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.35 159.56 24.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.093 -176.623 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -66.28 124.5 22.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.517 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.1 m170 -113.94 24.47 12.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.656 -179.13 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.31 19.16 74.88 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.117 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.16 165.74 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 28.9 p30 -97.5 87.62 4.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.71 0.767 . . . . 0.0 110.561 179.751 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -123.24 130.0 52.14 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.053 -179.389 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.9 tt -81.5 146.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.334 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.466 ' HG1' ' ND2' ' A' ' 120' ' ' ASN . 17.3 m -136.71 120.7 17.63 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.279 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -106.0 123.31 47.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.528 0.68 . . . . 0.0 110.786 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.5 pt -137.03 -169.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.645 -178.793 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.512 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 0.6 OUTLIER -134.35 130.59 37.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.046 -178.907 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 11.1 t -88.36 110.61 20.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.085 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.405 ' CG2' ' NH2' ' A' ' 196' ' ' ARG . 35.6 m -140.06 165.96 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.225 -178.904 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.3 t -54.36 147.59 13.32 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.742 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 191' ' ' LYS . 64.5 t -59.51 -49.02 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.397 -178.84 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 190' ' ' VAL . 44.2 tttp 52.42 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.159 178.398 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.57 ' CG ' ' H ' ' A' ' 193' ' ' ASN . 53.1 p-10 -66.93 -117.36 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.972 179.515 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.57 ' H ' ' CG ' ' A' ' 192' ' ' ASP . 98.4 m-20 -96.56 131.89 42.72 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.357 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.4 m -153.81 155.58 36.08 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 111.22 -178.576 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -99.79 142.76 30.85 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.179 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.8 ttm180 -139.56 134.76 32.61 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.513 -178.695 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -86.39 133.27 33.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.888 179.121 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 134.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 111.201 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.37 130.15 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.682 -179.548 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -119.12 137.83 53.32 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.643 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.0 145.24 17.32 Favored Glycine 0 N--CA 1.466 0.641 0 CA-C-O 121.828 0.682 . . . . 0.0 111.668 -179.213 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.9 t0 -100.57 140.24 35.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.51 -0.845 . . . . 0.0 111.414 -178.796 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 31.8 tp -65.36 128.14 34.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.26 -25.9 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.213 -178.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.81 161.79 22.05 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.728 179.133 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.9 m -142.22 157.06 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.185 0.517 . . . . 0.0 109.967 -179.263 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.52 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.6 pttm -150.82 178.97 8.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.109 179.617 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.77 144.23 26.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.777 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.673 ' HZ1' HH22 ' A' ' 82' ' ' ARG . 88.5 tttt -69.54 78.47 0.41 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.905 -179.247 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.699 178.266 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 54' ' ' SER . 7.1 t 48.1 20.34 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.803 178.823 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.2 m80 47.28 -161.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.989 179.857 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.446 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 20.1 tpp -86.15 169.92 12.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.564 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 66.4 t0 -137.69 146.02 43.3 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.131 0.491 . . . . 0.0 110.858 -179.013 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -69.48 -44.39 71.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.854 -179.091 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 t -155.77 71.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.651 0.262 . . . . 0.0 111.049 -178.463 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -69.01 -5.92 24.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.559 0.695 . . . . 0.0 111.572 -179.142 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' ASP . 15.6 mm -66.3 -31.51 53.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.0 -179.096 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 64' ' ' PRO . 37.5 t0 57.17 110.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.704 179.528 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 62' ' ' ASP . 5.2 tp60 -38.1 93.0 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 123.158 0.286 . . . . 0.0 110.459 -179.361 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.486 ' N ' ' O ' ' A' ' 62' ' ' ASP . 6.2 Cg_exo -76.5 150.94 32.49 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 122.585 2.19 . . . . 0.0 111.253 -178.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 56.4 t0 -76.38 159.14 30.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 84.6 mt -60.27 -24.39 64.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.765 -179.105 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.15 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.343 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.62 -34.44 67.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.654 179.765 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -75.07 -44.78 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.897 -178.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.97 87.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.955 179.853 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.0 -21.49 33.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.336 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.52 132.97 55.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.848 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -141.94 81.49 1.76 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.001 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.502 ' CD2' ' H ' ' A' ' 74' ' ' LEU . 1.7 pt? -73.35 154.87 39.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.924 179.074 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -70.31 136.7 50.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -66.39 -7.77 21.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.379 0.609 . . . . 0.0 110.364 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.95 -29.63 70.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.05 5.1 8.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.551 -178.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.37 127.62 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.74 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.493 ' H ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -135.47 8.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.269 -177.416 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.49 -174.31 39.7 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -178.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -153.16 155.16 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.346 -179.221 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.4 tt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 179.59 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -129.27 130.14 45.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.828 -178.886 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.5 mt -135.36 120.97 13.96 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.475 -178.353 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.32 -34.49 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.601 2.201 . . . . 0.0 112.472 -179.597 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -49.97 -39.24 40.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.749 -176.699 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.433 ' O ' ' CB ' ' A' ' 89' ' ' SER . 3.4 m -118.88 -7.32 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 123.309 0.381 . . . . 0.0 111.039 -178.902 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 75.77 48.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.56 0.695 . . . . 0.0 110.42 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mt -107.24 122.56 46.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.429 -179.424 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.17 109.27 10.31 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.1 mt -144.37 165.56 22.87 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.01 156.09 7.15 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.916 2.411 . . . . 0.0 108.628 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -107.24 120.01 57.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.03 119.57 39.08 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.55 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.07 -47.52 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.426 ' H ' ' HG ' ' A' ' 97' ' ' SER . 6.5 p -81.47 117.94 22.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.868 -179.842 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -82.9 75.55 9.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.068 0.461 . . . . 0.0 110.163 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.562 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -90.65 142.96 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.424 179.909 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.459 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 84.0 tt0 -50.46 -56.96 9.21 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.568 -179.597 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -66.28 -32.09 73.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.318 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.562 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 10.6 m-20 -68.1 -27.06 66.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.2 -9.57 58.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.444 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.563 ' N ' ' CD1' ' A' ' 104' ' ' LEU . 8.3 mp -76.44 -14.45 60.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.01 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.5 m -112.13 -5.6 14.22 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.48 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.96 -167.68 39.14 Favored Glycine 0 C--N 1.323 -0.19 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.555 -179.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.04 128.01 38.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.686 179.413 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.95 152.55 22.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.465 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -78.19 156.07 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.279 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.6 t -84.69 -55.54 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.22 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.409 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 68.8 mmtt -94.36 137.92 32.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.111 0.481 . . . . 0.0 111.091 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.27 6.25 17.42 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.028 -178.511 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -130.19 24.53 5.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.834 0.35 . . . . 0.0 111.408 -177.432 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.409 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 11.2 pt20 -94.28 162.9 13.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.02 135.83 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.4 mtp -70.56 124.57 24.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.819 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.71 7.37 64.79 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.646 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -143.62 124.69 14.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.389 -178.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.0 -170.43 51.92 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.58 107.4 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.643 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.75 101.99 12.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.241 -179.566 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.94 128.06 36.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.362 0.601 . . . . 0.0 111.692 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.92 131.24 53.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.429 178.497 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.28 140.32 45.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.476 0.655 . . . . 0.0 111.101 -178.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.86 -179.94 19.99 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.4 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.27 156.88 27.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 129' ' ' SER . 2.6 t-20 -122.78 27.1 7.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.968 0.413 . . . . 0.0 110.844 -179.163 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.0 mtt -45.9 -13.01 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.797 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 m 54.97 40.35 31.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.006 178.705 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.468 ' O ' ' OG ' ' A' ' 136' ' ' SER . 83.4 tttt -134.04 120.67 20.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.049 -179.168 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.97 124.23 19.2 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.209 0.528 . . . . 0.0 109.973 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.37 -29.66 7.17 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.203 -177.913 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.584 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 99.5 t -76.03 177.21 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.584 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -73.27 139.21 45.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.514 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 45.0 27.57 0.29 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.149 0.499 . . . . 0.0 111.22 178.029 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -83.42 -15.65 48.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.554 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -132.47 12.98 4.55 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.511 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 140' ' ' SER . 9.7 pt -68.81 -25.83 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.927 0.394 . . . . 0.0 111.789 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.06 1.53 1.94 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.569 -179.6 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 138' ' ' ILE . 15.8 t -98.76 -11.29 22.02 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.226 0.536 . . . . 0.0 110.226 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.08 120.37 11.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.365 179.757 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -99.81 166.06 11.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.676 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -65.04 118.9 9.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.308 -179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.39 14.92 12.06 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.198 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -95.28 133.51 39.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.354 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.785 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 158' ' ' TYR . 69.2 mt -125.86 124.99 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.975 178.662 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.4 ' CD2' ' OE2' ' A' ' 157' ' ' GLU . 63.2 m-85 -99.39 114.69 27.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.979 -178.801 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 tp -113.93 142.91 45.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.94 -179.38 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -110.25 137.36 48.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.053 0.454 . . . . 0.0 111.653 -178.434 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 37.3 t70 -110.72 -172.77 2.1 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.271 178.189 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.543 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.1 m-20 -37.45 -62.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -179.478 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -137.6 23.86 2.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.865 179.349 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.85 152.2 48.11 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.641 0.734 . . . . 0.0 112.65 -175.702 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -114.81 122.02 45.08 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.299 178.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -105.11 130.99 53.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.319 0.58 . . . . 0.0 111.427 -179.015 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.4 ' OE2' ' CD2' ' A' ' 148' ' ' TYR . 80.5 mm-40 -96.4 117.76 31.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.155 178.474 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 147' ' ' ILE . 29.6 m-85 -115.92 141.49 48.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.79 130.29 55.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.552 0.691 . . . . 0.0 110.11 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.42 134.13 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.067 -179.37 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.8 p -102.0 -25.72 13.66 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 124.705 1.253 . . . . 0.0 111.132 -178.972 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 163.81 166.45 22.7 Favored Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.243 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.56 153.16 37.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.741 -179.618 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.3 t -153.38 161.44 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -178.164 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -116.48 117.1 28.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.807 -179.349 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.22 160.36 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 111.245 -178.497 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 p -57.22 168.91 0.81 Allowed Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.028 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.77 -9.11 12.2 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.094 1.863 . . . . 0.0 111.957 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.76 1.52 42.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -178.402 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.602 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 13.5 mptt -83.59 149.57 26.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.358 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 87.8 m95 -157.6 -28.99 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.173 -178.648 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.88 -8.26 0.09 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.099 0.475 . . . . 0.0 110.665 178.655 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.546 ' H ' ' C ' ' A' ' 171' ' ' TRP . 8.9 m -79.16 -25.67 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.607 -178.807 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.69 -2.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 0.0 110.402 -178.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 176' ' ' ASP . 75.4 mm-40 -81.09 119.37 23.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.977 -178.04 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.0 p-10 -30.27 122.21 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.867 179.002 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -104.43 -44.35 4.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.253 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.29 26.36 0.1 Allowed Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -154.05 173.97 15.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.186 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.37 87.02 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.248 0.547 . . . . 0.0 109.901 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -128.05 125.14 38.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -179.002 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -81.2 148.3 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.9 m -137.56 122.98 19.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.184 -179.141 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.14 125.54 52.29 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.239 0.542 . . . . 0.0 111.394 -179.546 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.2 pt -134.21 161.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.583 -179.47 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.415 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 1.3 p -133.53 152.88 51.97 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.443 -178.876 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 14.2 p -93.5 138.57 31.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.195 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.9 p -142.3 140.06 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.842 0.353 . . . . 0.0 110.999 -178.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.4 m -65.99 147.32 53.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.201 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.0 m -71.58 132.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -165.43 -169.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.107 -178.348 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 192' ' ' ASP . 49.3 p-10 -71.08 142.06 50.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.062 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 49.61 33.14 5.58 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.9 178.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 87.0 p -64.22 135.21 56.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.344 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -150.66 155.11 38.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.919 0.39 . . . . 0.0 110.84 -179.151 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -129.8 143.15 50.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.429 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.3 134.01 46.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.947 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.71 135.63 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.247 -179.393 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -119.35 130.44 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.416 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.23 134.83 54.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.42 141.13 12.4 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 50.9 p-10 -100.18 141.33 33.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.636 -0.782 . . . . 0.0 111.503 -179.111 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.62 125.1 24.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 110.66 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.16 -24.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.135 -179.034 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.12 177.16 44.92 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.947 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 35.1 m -154.99 154.64 32.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.278 0.561 . . . . 0.0 110.993 -179.858 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.87 178.17 8.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.81 146.27 24.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.508 179.931 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.67 78.31 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.75 -179.118 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.419 178.279 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.096 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 p -157.88 161.84 38.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.853 0.358 . . . . 0.0 110.873 -179.622 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -87.02 -11.47 50.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.4 mtm 48.55 -163.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.554 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 50.48 31.13 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.505 178.834 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.31 -12.81 61.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.942 -178.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 61' ' ' ILE . 98.7 p -87.61 11.32 15.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.909 0.385 . . . . 0.0 111.26 -178.896 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -60.16 71.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.002 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 59' ' ' SER . 2.6 mt -68.41 -75.16 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-O 121.366 0.603 . . . . 0.0 110.207 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 50.95 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.029 179.781 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 61' ' ' ILE . 4.4 pt20 -132.36 78.84 67.15 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.466 -179.5 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.05 170.56 17.65 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.021 2.48 . . . . 0.0 111.668 179.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.18 157.3 37.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.788 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.41 -28.96 70.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -178.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.17 90.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 -179.571 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -73.13 -40.97 64.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.303 0.573 . . . . 0.0 110.836 -179.572 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -73.49 -41.89 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.483 -179.0 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.64 84.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.85 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -91.57 -14.58 30.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.396 -178.665 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.12 110.77 1.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.747 -179.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.2 t -106.65 135.64 47.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.76 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.425 ' CD2' ' H ' ' A' ' 74' ' ' LEU . 1.2 pt? -128.02 174.14 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.057 -179.59 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.9 m-20 -83.65 98.63 9.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.677 178.527 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -58.5 -4.23 0.38 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.377 0.608 . . . . 0.0 110.438 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.7 mmtp -67.51 -11.18 57.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.549 -179.898 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.88 18.84 12.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.782 -179.481 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.9 t -80.03 124.29 37.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.135 178.897 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 80' ' ' ILE . 3.4 tt -106.5 -35.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.074 -179.044 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.41 -155.43 8.16 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.569 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -146.38 155.9 42.93 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.48 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.37 129.08 73.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.2 m -130.5 130.97 44.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.049 -179.276 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.7 mt -132.73 118.59 15.65 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.34 -178.269 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.82 -37.47 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.361 2.041 . . . . 0.0 112.263 -179.503 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 t -48.9 -37.75 20.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.909 -177.146 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 89' ' ' SER . 2.0 m -121.23 -6.59 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.998 -179.026 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.44 50.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.49 124.23 49.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.966 -179.556 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -132.59 107.14 8.24 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.395 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.15 116.17 5.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.088 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -41.16 146.49 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 121.817 1.678 . . . . 0.0 110.2 175.446 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.3 t -97.84 121.69 48.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 mt -103.16 117.48 34.64 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.802 0.334 . . . . 0.0 110.469 -178.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -63.62 -48.54 76.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.272 0.558 . . . . 0.0 110.483 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 90.5 p -60.95 102.66 0.21 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.415 -179.637 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 98' ' ' SER . 53.1 p -83.89 91.51 7.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.627 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -130.11 144.37 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.939 179.793 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 59' ' ' SER . 1.4 tt0 -53.42 -42.94 67.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.951 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -63.57 -46.39 86.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.087 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.627 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 8.8 m-80 -68.11 -35.58 78.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 111.779 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 mt -49.46 -22.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.134 -179.47 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.99 -13.25 61.19 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.717 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -105.03 -11.12 16.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 167.3 -179.06 41.12 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.275 -179.309 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.43 126.06 29.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.785 -0.707 . . . . 0.0 109.941 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.41 150.18 25.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -76.28 153.8 35.66 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.77 -45.94 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.742 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 113' ' ' ASN . 85.6 tttt -89.2 136.24 33.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.165 0.507 . . . . 0.0 110.486 -178.366 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -62.22 -8.27 5.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.109 -178.848 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.431 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 66.1 t30 -146.4 50.31 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 -177.94 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -79.9 161.87 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.784 179.655 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.0 127.04 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 -179.314 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.4 mtt -74.19 127.29 32.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.189 179.013 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.496 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.37 1.71 74.62 Favored Glycine 0 N--CA 1.461 0.326 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -141.58 123.91 15.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.213 0.53 . . . . 0.0 110.974 -179.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.59 -170.65 50.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.428 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 55.4 t-20 -85.6 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.529 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.23 99.91 10.26 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 121.18 32.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.289 0.566 . . . . 0.0 111.323 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -116.58 130.56 56.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.699 178.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.29 137.63 47.77 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.459 0.647 . . . . 0.0 110.433 -179.322 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.39 -177.15 17.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.713 -178.902 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 134' ' ' LEU . 54.8 m-70 -90.37 137.06 32.65 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 -179.504 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 129' ' ' SER . 29.2 t-20 -105.91 28.24 7.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 109.891 -179.986 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.7 mmm -44.6 -13.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.859 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.71 40.91 15.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.684 179.481 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 19.1 mmmt -132.03 107.59 8.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.092 -179.131 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -52.36 124.18 12.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.596 0.713 . . . . 0.0 110.297 179.984 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.74 -28.05 9.27 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.946 -178.34 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.574 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 60.4 t -78.37 178.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-N 117.879 0.839 . . . . 0.0 109.047 179.415 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.574 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -70.44 134.2 47.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.239 -178.224 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 44.59 32.81 0.81 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.258 0.552 . . . . 0.0 110.585 178.529 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.7 -7.02 59.67 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.464 -178.501 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -145.79 24.02 1.37 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.577 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.1 pt -70.46 -21.5 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.699 179.848 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.24 2.97 7.96 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.6 t -99.21 -10.85 21.91 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.361 0.6 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.6 mt -64.24 124.12 20.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.662 -179.888 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 17.9 ptpt -97.42 166.31 11.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.69 123.6 19.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 179.638 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.62 26.74 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.633 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 71.4 m-20 -82.51 130.94 35.21 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.985 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -78.3 129.3 34.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 0.0 111.675 -179.118 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.3 mt -127.28 127.44 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -109.66 123.83 50.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.146 0.498 . . . . 0.0 110.682 -179.087 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.65 148.74 37.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.222 179.6 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.2 t70 -114.01 -166.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.1 m-20 -24.37 -75.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.108 0.48 . . . . 0.0 111.848 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -138.15 29.76 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -129.87 145.73 51.6 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.249 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -110.09 123.0 48.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.823 179.334 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.62 132.71 50.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 111.57 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -96.31 116.75 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.62 178.394 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 44.6 m-85 -117.17 141.59 48.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.55 -179.52 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.76 133.72 54.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.31 0.576 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.33 134.38 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.232 179.446 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.2 p -102.37 -28.57 12.16 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 124.826 1.329 . . . . 0.0 111.048 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.31 144.04 3.91 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.113 -1.041 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.4 t -103.74 149.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.523 179.757 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 t -153.68 164.25 38.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.137 0.494 . . . . 0.0 111.352 -178.683 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -110.96 117.28 32.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.777 179.728 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.37 160.14 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 169' ' ' ASP . 29.5 p -71.99 134.44 83.3 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.67 -11.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.093 1.862 . . . . 0.0 111.794 -179.093 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 167' ' ' THR . 51.5 t0 -83.4 -10.02 58.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.18 -178.841 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -88.39 70.54 9.06 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.573 0.349 . . . . 0.0 110.435 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -75.43 -6.29 49.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.082 0.467 . . . . 0.0 110.97 -179.642 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.567 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.5 mt-10 -52.77 -50.13 64.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.3 m -69.88 6.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.0 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' A' ' 172' ' ' GLU . 4.1 t -130.04 28.76 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.27 131.32 18.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.783 0.801 . . . . 0.0 111.779 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -27.77 121.66 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.962 179.642 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.567 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 53.2 m80 -107.05 -40.23 5.51 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.6 24.59 0.13 Allowed Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.38 172.9 16.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.974 0.416 . . . . 0.0 111.214 179.582 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -96.21 89.58 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 0.0 110.05 178.476 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -125.3 175.87 7.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.2 tt -129.48 142.4 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.394 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 13.0 m -136.34 124.9 23.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.136 -179.95 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.02 126.3 54.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.436 0.636 . . . . 0.0 110.463 179.242 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 28.1 pt -134.61 -169.9 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.738 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.422 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 5.1 t -139.39 158.15 44.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.309 -179.461 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.5 m -62.08 162.31 9.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.002 179.151 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 10.4 p -120.03 129.6 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.04 -178.751 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.6 p -77.91 165.75 23.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.333 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.0 m -61.86 -25.11 36.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.475 -179.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -56.62 142.57 39.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.371 179.695 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -88.33 8.14 28.95 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.301 -179.048 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -62.17 140.87 58.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.272 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.9 t -97.53 106.58 18.92 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.155 -179.499 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -171.24 96.36 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.804 -179.089 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.422 ' NH2' ' O ' ' A' ' 186' ' ' THR . 60.7 ttt180 -146.06 136.8 24.28 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.389 -179.355 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.44 129.47 50.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.037 179.023 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.7 t -130.14 131.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.422 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 93.5 t -115.1 127.1 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.358 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.38 135.21 54.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.282 0.563 . . . . 0.0 110.373 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.94 159.1 25.42 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.765 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -112.12 150.66 30.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.676 -0.762 . . . . 0.0 111.456 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 11.9 tp -73.74 129.78 38.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.251 0.548 . . . . 0.0 110.62 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.97 -22.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.086 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.32 177.84 44.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.202 -179.157 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.3 m -151.65 151.17 31.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -148.96 177.83 9.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.672 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.41 146.99 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.312 0.577 . . . . 0.0 110.735 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.93 79.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.899 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 tptp . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.694 178.63 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.528 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.0 t -60.66 -44.77 96.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.865 -179.466 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.667 ' CD2' ' H ' ' A' ' 56' ' ' MET . 23.5 p-80 -62.31 -114.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.837 179.402 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.667 ' H ' ' CD2' ' A' ' 55' ' ' HIS . 37.3 tpp 50.47 -115.38 0.84 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.355 178.626 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.7 113.41 23.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.978 0.418 . . . . 0.0 110.118 179.657 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.64 -52.28 27.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.252 -178.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 m -154.98 57.88 0.66 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.671 0.272 . . . . 0.0 110.766 -178.505 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -99.3 39.69 1.27 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.641 -178.705 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.3 mt -61.83 -49.83 82.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.692 -179.494 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.8 t0 52.23 -99.05 0.08 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.61 85.77 5.2 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.326 -179.544 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.25 149.5 40.58 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.754 2.303 . . . . 0.0 111.226 179.669 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -79.03 172.93 13.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.543 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.4 mp -60.01 -24.84 64.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.66 -178.414 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.34 97.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.499 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.11 -30.66 62.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.083 179.665 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.47 -47.64 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.831 -178.641 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.83 88.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.064 179.379 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -75.73 -31.08 59.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.476 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.98 132.97 53.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.949 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -140.2 152.52 46.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 -179.283 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 1.3 pt? -138.01 171.91 13.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.231 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -97.93 114.8 27.0 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.359 179.001 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -46.62 -16.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 110.258 -179.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 75' ' ' ASP . 54.6 mtmt -66.99 -10.06 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -92.78 6.62 46.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.247 -178.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.04 125.2 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.657 179.544 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.37 -10.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.385 -178.136 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.07 -173.07 44.03 Favored Glycine 0 C--N 1.316 -0.577 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.691 HH22 ' NZ ' ' A' ' 209' ' ' LYS . 38.1 mtm-85 -144.82 156.9 44.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 111.567 -179.046 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.56 130.69 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 122.034 0.921 . . . . 0.0 109.225 179.751 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.2 t -132.42 133.8 44.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.543 -178.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.9 mt -134.8 126.45 17.91 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.872 -178.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.46 -35.82 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.48 2.12 . . . . 0.0 112.421 -179.16 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.52 -39.62 49.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -177.129 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.9 -1.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.237 0.215 . . . . 0.0 111.132 -178.842 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 t 61.51 49.73 4.99 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.659 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.81 131.09 55.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.792 -178.544 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -137.74 120.26 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.2 tp -153.01 112.66 2.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 113.334 -177.413 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.71 160.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.849 1.699 . . . . 0.0 110.205 175.83 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.81 122.75 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.065 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -105.68 120.88 42.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.255 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.7 -46.94 80.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.004 0.431 . . . . 0.0 111.104 -179.745 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.569 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 13.6 p -65.94 100.21 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.376 -179.709 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p -81.09 94.64 6.65 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.218 0.532 . . . . 0.0 109.871 179.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.3 p -136.66 160.44 38.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.312 -179.272 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -55.32 -42.71 74.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.047 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.88 -46.27 72.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.294 -179.453 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.569 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.9 m-20 -65.76 -38.39 88.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.2 -179.427 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.2 mt -64.88 -27.88 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.631 -179.042 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.9 mt -72.98 -17.18 61.49 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.606 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -105.33 -10.51 16.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.755 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.87 -165.49 34.54 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.568 -179.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.61 124.21 33.84 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.22 144.14 32.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.167 -179.356 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.5 p -74.24 152.25 39.76 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.84 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.89 -43.35 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.767 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -91.11 -173.17 3.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.823 0.344 . . . . 0.0 111.25 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -111.32 -58.81 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.14 -177.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -91.33 43.61 1.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.461 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -98.5 154.34 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 179.621 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.42 132.95 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.1 mtt -61.48 130.35 45.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.841 178.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.33 82.81 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -141.23 120.22 12.79 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.012 -178.76 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.29 -170.72 52.01 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.858 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -83.12 107.93 16.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.269 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -84.39 101.5 12.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.154 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.61 119.52 30.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.43 0.634 . . . . 0.0 111.643 -179.215 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 mt -115.94 130.0 56.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.242 178.411 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.93 138.28 50.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.643 0.735 . . . . 0.0 110.984 -178.566 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.09 -179.8 18.69 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.769 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -80.26 146.14 31.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.812 0.339 . . . . 0.0 110.204 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 129' ' ' SER . 41.6 p30 -112.59 27.53 9.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.07 0.462 . . . . 0.0 110.998 -179.183 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.0 mtt -43.42 -15.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.457 -179.339 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 58.42 39.34 25.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.256 179.127 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -135.57 113.83 11.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -52.73 125.92 18.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.669 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -30.28 6.91 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.195 -178.468 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.586 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 85.7 t -77.98 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.264 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.586 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.7 OUTLIER -72.94 138.85 46.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.516 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 45.26 30.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 178.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -83.85 -14.2 51.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -133.71 18.34 3.89 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.9 pt -70.28 -20.89 23.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.869 0.366 . . . . 0.0 111.934 -179.668 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.78 3.42 11.89 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 t -98.76 -13.59 20.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.29 0.567 . . . . 0.0 109.987 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.4 mt -64.62 124.8 22.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.302 179.814 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 65.7 tttt -96.5 172.0 8.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.507 -179.814 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.429 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 77.7 tttt -66.62 128.4 36.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 92.43 22.02 30.41 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.138 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 49.1 m-20 -86.59 130.8 34.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.242 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -77.7 132.58 38.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.257 0.551 . . . . 0.0 111.641 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 147' ' ' ILE . 95.6 mt -127.85 125.97 65.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.1 179.458 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -102.8 122.84 45.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.177 0.513 . . . . 0.0 110.621 -178.589 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.42 136.56 52.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.699 -179.391 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.565 ' CB ' HH11 ' A' ' 82' ' ' ARG . 93.8 m-85 -111.37 119.7 39.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.396 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.7 t0 -104.8 -165.42 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.508 ' C ' ' O ' ' A' ' 151' ' ' ASP . 91.2 m-20 -24.01 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.498 0.499 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.6 30.25 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.696 178.716 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -128.13 146.77 50.6 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.96 123.49 49.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.854 179.118 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -107.46 131.38 54.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.382 0.61 . . . . 0.0 111.3 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -97.34 118.29 33.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.828 177.909 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -115.96 140.65 49.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.82 -178.659 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.2 129.31 54.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.563 0.697 . . . . 0.0 111.155 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 144' ' ' GLY . 53.0 t -69.21 135.81 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.82 -179.58 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.61 -25.13 12.39 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.48 1.112 . . . . 0.0 111.084 -179.094 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.63 165.21 22.58 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.413 -179.539 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.8 p -125.88 151.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.671 -0.765 . . . . 0.0 109.669 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.6 p -155.6 164.38 38.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.458 . . . . 0.0 111.228 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.457 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 96.2 mt-10 -112.26 113.93 26.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.491 -179.735 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.99 157.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.457 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.479 ' H ' ' HG1' ' A' ' 167' ' ' THR . 1.3 p -65.77 168.63 8.22 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.052 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.27 -7.0 12.0 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.193 1.929 . . . . 0.0 112.105 -179.351 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.9 p-10 -82.95 -12.43 57.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.028 -178.762 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -89.44 69.85 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.784 0.434 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.77 -5.88 43.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.683 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.546 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.9 mt-10 -53.48 -40.04 65.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.351 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.481 ' O ' ' CG1' ' A' ' 173' ' ' VAL . 74.4 t -72.71 1.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.812 -179.679 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.36 28.92 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.78 129.42 19.19 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.729 0.776 . . . . 0.0 111.854 -177.021 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -29.22 123.07 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.894 179.442 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.546 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.2 m80 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.626 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.24 24.3 0.32 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.058 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -156.72 178.74 10.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.132 0.491 . . . . 0.0 111.377 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -89.68 89.2 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.521 0.677 . . . . 0.0 110.093 178.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 202' ' ' ASP . 23.5 tp10 -121.08 163.3 18.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.308 -179.197 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.6 tt -130.68 142.12 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.644 179.487 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 15.7 m -136.36 126.17 25.69 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.383 -178.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -112.36 120.32 41.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.562 0.696 . . . . 0.0 110.814 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.409 ' CG2' HH11 ' A' ' 196' ' ' ARG . 42.1 pt -139.83 -176.66 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.81 -178.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.3 p -139.88 166.69 23.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.342 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 52.0 t 48.73 90.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.597 178.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.68 -45.68 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.921 -179.45 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 t -58.64 168.82 1.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.882 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 74.2 t -107.17 120.79 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.696 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.43 144.61 38.14 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 -178.619 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -88.44 87.12 7.18 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.207 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 194' ' ' SER . 54.9 t-20 -155.95 101.51 2.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.444 -178.821 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 193' ' ' ASN . 13.9 p 52.22 178.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.337 179.43 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.95 136.23 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.342 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.409 HH11 ' CG2' ' A' ' 185' ' ' ILE . 9.2 tmm_? -87.74 142.78 27.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.953 -179.572 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.457 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.9 m-85 -80.03 135.72 36.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.976 179.571 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 75.8 t -129.67 130.98 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.087 0.47 . . . . 0.0 110.821 -179.588 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -119.53 130.56 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.748 -179.423 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.36 138.89 53.48 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.621 -179.87 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.82 152.0 19.98 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.215 -179.387 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 181' ' ' GLU . 16.2 m-20 -109.49 139.1 44.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.553 -0.823 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.69 125.38 24.1 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.027 0.442 . . . . 0.0 110.928 179.821 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -107.41 -25.02 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.152 -178.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.33 176.32 45.31 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.953 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.2 m -153.92 153.13 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.432 0.634 . . . . 0.0 111.038 179.842 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -147.23 177.34 9.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.382 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.35 146.61 24.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.043 0.449 . . . . 0.0 110.679 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.691 ' NZ ' HH22 ' A' ' 82' ' ' ARG . 63.8 tttp -72.12 78.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.586 -179.234 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.747 178.424 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.6 p -75.1 161.28 29.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.711 0.291 . . . . 0.0 110.342 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -74.02 143.56 45.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.035 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.5 mtp -115.07 146.47 41.26 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.803 0.335 . . . . 0.0 110.641 -179.188 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 55.7 t0 -94.13 18.26 11.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.321 0.581 . . . . 0.0 110.89 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.62 -19.1 62.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.075 -179.127 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 1.8 t -150.01 -94.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.704 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' N ' ' OG ' ' A' ' 59' ' ' SER . 29.4 ttpt 47.57 27.27 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.097 178.234 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.53 -44.37 96.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.827 -178.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.2 t0 71.72 -126.56 0.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.852 179.896 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -140.62 70.7 31.29 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -42.68 129.57 5.21 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.507 2.138 . . . . 0.0 111.027 -179.538 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.79 171.9 11.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -48.92 -31.22 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.654 -179.141 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.475 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -65.52 -38.82 90.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.535 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 81.0 mm-40 -73.97 -27.21 60.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.663 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -82.15 -46.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.243 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.54 74.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.767 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.625 ' ND2' ' N ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -69.57 -28.56 66.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -179.218 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.625 ' N ' ' ND2' ' A' ' 71' ' ' ASN . . . -61.87 138.3 58.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.986 -179.734 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -140.22 133.57 29.87 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 tp -140.9 135.1 30.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.655 -179.037 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 67.8 t0 -67.52 137.66 55.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.092 179.136 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.471 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 70.3 mmtt -65.01 -7.89 13.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.159 0.504 . . . . 0.0 110.22 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -79.96 -10.11 59.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.956 -179.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -78.34 -3.21 41.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.639 -179.268 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.15 138.6 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 -179.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -122.74 -4.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.329 -179.183 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.11 -174.04 39.26 Favored Glycine 0 C--N 1.318 -0.469 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -147.19 151.91 37.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.524 -179.027 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 83' ' ' ILE . 20.6 tt -124.31 120.67 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -118.86 128.09 54.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.665 -179.629 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.5 mt -134.62 122.12 15.46 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.579 -177.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.56 -34.17 0.57 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.404 2.069 . . . . 0.0 112.423 -179.492 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.433 ' HG ' ' CD2' ' A' ' 141' ' ' LEU . 2.0 t -49.81 -39.32 38.09 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.539 -177.496 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.77 -1.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.458 0.17 . . . . 0.0 111.072 -179.219 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 63.64 49.99 2.86 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.214 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.6 tp -115.71 132.3 56.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.315 -178.661 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -139.33 118.0 12.28 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.586 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -148.35 116.72 4.02 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.878 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 92' ' ' LEU . 2.2 Cg_endo -39.88 161.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.894 1.729 . . . . 0.0 110.307 175.227 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.92 126.98 72.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.463 ' CB ' HD21 ' A' ' 102' ' ' ASN . 22.2 mt -102.32 127.63 49.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.982 -179.192 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -71.38 -48.69 48.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.618 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -69.5 107.44 3.37 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.348 -179.225 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -81.93 99.54 9.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.192 0.52 . . . . 0.0 110.115 179.938 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.513 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.9 p -139.74 164.35 30.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 -179.264 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.96 -36.59 84.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -71.74 -47.54 53.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.567 -179.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.1 p-10 -65.97 -36.99 84.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.412 -178.766 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.16 -24.37 10.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.431 -179.112 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.0 mt -68.92 -29.37 67.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.319 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.2 t -85.33 -14.31 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.365 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.8 -172.03 38.75 Favored Glycine 0 N--CA 1.465 0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.679 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.94 127.94 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.921 -179.806 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.512 ' CB ' HD22 ' A' ' 102' ' ' ASN . . . -104.78 148.68 26.35 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.51 -179.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.523 ' O ' ' OG ' ' A' ' 98' ' ' SER . 44.7 p -75.57 154.23 36.9 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.65 -52.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -91.81 138.5 31.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 -178.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -72.84 1.41 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.023 -178.69 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -142.96 36.37 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 0.0 111.047 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.29 159.13 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.03 130.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.532 -179.672 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.7 mtt -73.15 127.86 33.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.48 67.95 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.715 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -138.73 123.95 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.089 -179.133 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.89 -173.39 44.93 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.436 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 38.8 t-20 -83.51 109.72 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -83.96 101.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.02 129.14 37.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.336 0.589 . . . . 0.0 112.062 -178.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -123.57 132.28 53.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.472 178.544 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.73 138.41 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.324 0.583 . . . . 0.0 110.601 -178.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.0 -178.54 17.43 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.439 -179.328 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -89.64 145.55 25.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.836 0.351 . . . . 0.0 110.624 -179.691 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.501 ' C ' ' H ' ' A' ' 129' ' ' SER . 60.5 t-20 -110.08 28.35 8.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 110.411 -179.754 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -46.19 -12.26 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.789 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 127' ' ' ASN . 1.2 m 56.67 40.38 29.28 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.997 179.069 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -130.74 108.73 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.194 -179.146 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -51.61 124.81 13.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.03 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.31 -29.35 8.39 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.137 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.612 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 59.6 t -77.05 179.13 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 117.69 0.745 . . . . 0.0 109.044 179.45 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.612 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.7 OUTLIER -70.32 136.61 49.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.089 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 42.55 32.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.165 0.507 . . . . 0.0 111.009 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 p -82.07 -10.7 59.12 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.36 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.23 26.86 1.62 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.537 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.92 -20.52 20.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.779 0.323 . . . . 0.0 111.838 179.917 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.84 -1.28 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.815 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t -94.09 -13.17 27.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 109.923 -179.625 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.433 ' CD2' ' HG ' ' A' ' 87' ' ' SER . 20.3 mt -64.37 123.32 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.432 -179.75 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.494 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.3 mttt -96.54 173.13 7.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.734 -179.774 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -70.1 136.36 50.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.661 -179.669 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.82 22.07 56.34 Favored Glycine 0 N--CA 1.463 0.449 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.708 179.663 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.494 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.8 m-20 -88.96 130.16 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.37 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -77.48 134.04 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 158' ' ' TYR . 77.3 mt -128.87 121.55 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.272 179.296 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -102.21 122.03 43.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.099 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.0 tp -118.97 143.83 46.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 -178.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.97 133.03 56.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.318 0.58 . . . . 0.0 111.498 -178.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.52 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.0 t0 -113.98 -166.42 1.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.282 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 151' ' ' ASP . 15.9 m120 -22.99 -74.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.064 0.459 . . . . 0.0 111.632 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -138.09 24.45 2.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -123.37 143.91 49.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.863 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -109.71 121.04 44.32 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.688 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -105.48 131.1 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.521 -178.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -94.7 118.04 31.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.399 178.53 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 147' ' ' ILE . 53.0 m-85 -117.88 139.97 50.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 -179.424 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.17 135.58 54.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.089 0.471 . . . . 0.0 110.563 178.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.66 133.91 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.096 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.92 -24.81 11.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 124.464 1.102 . . . . 0.0 111.184 -179.185 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.13 157.19 11.99 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.495 -179.648 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.1 p -123.39 151.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.548 -179.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -161.25 171.76 17.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 111.297 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -115.81 110.92 19.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.757 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.14 145.43 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.019 -178.6 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.6 p -60.18 132.85 90.24 Favored Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.569 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.4 Cg_endo -47.28 -17.88 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.873 1.715 . . . . 0.0 111.826 -179.035 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.1 -17.78 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.193 -178.494 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -87.29 72.24 9.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.847 0.459 . . . . 0.0 110.946 179.817 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.569 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 47.1 m95 -73.53 -18.52 61.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.004 -179.176 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.7 mt-10 -50.27 -7.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.062 0.458 . . . . 0.0 111.009 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.557 ' H ' ' C ' ' A' ' 171' ' ' TRP . 27.9 m -83.79 -21.84 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.671 -178.565 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.44 -1.27 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.618 0.723 . . . . 0.0 109.955 -178.744 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.511 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.8 mt-10 -83.96 125.11 31.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.065 -178.442 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 41.6 p-10 -30.92 122.32 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.703 178.882 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.0 m80 -112.36 24.25 12.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.735 -179.186 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.42 76.46 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -149.44 166.46 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 0.0 111.237 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 29.7 p30 -96.08 87.78 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.561 0.696 . . . . 0.0 110.477 179.469 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -127.24 128.31 45.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.33 -179.444 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.94 147.3 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.238 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 5.2 m -138.15 122.37 18.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.179 -179.907 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.0 mp -104.82 128.26 52.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.379 0.609 . . . . 0.0 110.987 -179.756 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.1 pt -139.1 175.54 7.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.811 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.507 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.3 p -133.4 160.15 38.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.819 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.544 ' C ' HH12 ' A' ' 196' ' ' ARG . 1.7 p -66.79 150.54 48.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.014 179.738 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.455 ' N ' HH12 ' A' ' 196' ' ' ARG . 14.7 p -58.64 -45.54 90.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.296 -179.49 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.436 ' N ' ' CG1' ' A' ' 188' ' ' VAL . 90.9 p 45.16 -168.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.424 179.177 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 65.6 t -126.66 127.2 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 195' ' ' LYS . 59.5 pttt -161.89 160.7 28.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.462 -178.598 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 194' ' ' SER . 96.9 m-20 -78.8 173.01 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.39 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 1.9 m120 67.56 -25.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.139 179.289 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.601 ' H ' ' C ' ' A' ' 192' ' ' ASP . 13.4 m 43.64 89.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.501 179.196 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.459 ' O ' ' NZ ' ' A' ' 191' ' ' LYS . 25.3 pttm -143.17 149.57 38.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.81 -178.938 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.544 HH12 ' C ' ' A' ' 187' ' ' CYS . 0.8 OUTLIER -133.63 140.82 47.32 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.317 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -126.06 132.65 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.505 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.49 137.86 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.159 0.504 . . . . 0.0 110.969 -179.428 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.2 t -120.01 131.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.356 -179.535 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.63 135.86 53.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.61 -179.551 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.02 135.18 8.09 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 121.596 0.553 . . . . 0.0 111.762 -179.476 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -90.88 139.46 30.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.293 -179.235 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 11.7 tp -67.21 127.5 32.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.192 0.52 . . . . 0.0 110.632 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.6 m -109.01 -21.51 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.514 -178.674 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.96 175.89 46.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.031 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.6 m -155.02 153.43 30.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 110.811 179.503 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -149.39 177.98 9.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.176 179.04 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.18 142.14 30.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.859 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -58.27 80.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 208' ' ' ALA . 49.6 tttp . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.593 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -58.55 -41.95 86.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.835 0.35 . . . . 0.0 110.956 -179.544 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.492 ' CD2' ' H ' ' A' ' 55' ' ' HIS . 10.2 p80 -88.16 118.04 27.46 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.483 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtt -96.4 159.41 14.96 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.449 -179.69 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' OD2' ' OG ' ' A' ' 59' ' ' SER . 50.7 t0 -63.54 140.84 58.91 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.31 -5.26 38.46 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.706 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.429 ' OG ' ' OD2' ' A' ' 57' ' ' ASP . 94.5 p -84.67 42.9 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.194 -178.046 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -82.55 26.7 0.55 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.107 -179.288 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mt -63.55 -45.77 96.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.126 -178.892 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 46.89 -97.39 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.3 178.827 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -150.74 85.56 5.19 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.653 -179.053 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.32 150.44 36.83 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.908 2.406 . . . . 0.0 110.864 179.442 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.28 167.67 21.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.82 -19.95 65.12 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.403 0.439 . . . . 0.0 111.108 -179.377 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.11 97.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.627 -179.569 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -72.12 -36.69 69.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.785 179.52 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.9 -45.43 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.873 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.38 86.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.19 -27.09 28.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.895 -179.037 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 136.77 58.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.331 179.594 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.557 ' O ' ' NZ ' ' A' ' 101' ' ' LYS . 29.3 t -91.08 156.73 17.69 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.2 tp -120.29 125.51 48.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 -178.823 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -95.21 87.81 4.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -48.94 -33.07 10.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.029 -179.486 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -51.6 -14.78 0.36 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.243 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -100.77 14.34 31.96 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.853 -178.74 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.436 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 5.4 p -89.8 126.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.299 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.8 pt -118.5 -6.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.319 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.04 -165.08 34.33 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.03 157.34 43.58 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.273 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 92' ' ' LEU . 5.9 tt -128.63 132.3 67.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.808 0.814 . . . . 0.0 109.249 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -132.75 133.42 43.44 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.609 -178.167 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.73 126.73 18.14 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.808 -178.465 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.09 -34.71 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.54 2.16 . . . . 0.0 112.5 -179.694 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.3 t -49.27 -41.43 37.83 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.655 -177.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 1.4 p -119.91 -3.59 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 123.245 0.34 . . . . 0.0 111.094 -179.27 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 68.33 50.99 0.7 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.672 -179.585 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.27 125.02 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.789 -178.003 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -134.88 114.39 12.52 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.408 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.421 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 10.1 mt -148.59 117.39 4.01 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.736 -177.672 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 92' ' ' LEU . 1.6 Cg_endo -41.25 151.59 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.971 1.781 . . . . 0.0 110.121 176.41 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.12 121.65 52.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.1 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.9 mt -104.53 128.5 52.49 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -72.55 -39.92 67.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.942 0.401 . . . . 0.0 111.389 -179.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.9 m -72.69 102.0 3.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.073 -179.375 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.8 p -82.34 93.34 7.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 109.913 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.569 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 45.0 p -132.01 158.25 42.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.186 -178.909 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -60.62 -24.6 65.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.719 -179.261 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 65.3 tttm -83.87 -44.17 14.57 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.815 0.697 . . . . 0.0 112.158 -178.865 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.569 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 98.1 m-20 -67.26 -34.89 78.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.844 -179.706 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.1 mt -68.31 -11.48 59.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.621 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.2 mt -74.63 -14.26 60.74 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.7 -3.86 7.15 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.417 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.63 172.95 45.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.385 -179.522 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.93 127.44 32.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.531 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.4 150.02 25.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.048 0.451 . . . . 0.0 110.803 -179.153 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 p -75.35 151.23 38.24 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.3 p -87.17 -32.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.468 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.442 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 21.2 tptt -90.05 179.99 5.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.964 0.412 . . . . 0.0 110.837 -177.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 22.4 pt-20 -105.7 -16.5 14.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.058 -178.447 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -144.11 53.19 1.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -177.186 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -91.61 153.64 19.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.59 131.6 72.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.617 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.6 mtp -70.19 125.34 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.913 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.32 4.95 65.87 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.474 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -143.32 123.72 13.9 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.55 -178.339 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.59 51.84 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -178.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 6.8 t30 -83.29 108.19 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.903 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.91 102.68 13.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.477 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.53 126.11 36.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.062 0.458 . . . . 0.0 112.186 -179.4 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.82 130.41 53.96 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.468 178.85 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.39 140.02 46.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -178.035 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.94 -177.92 17.53 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.229 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -81.63 155.83 25.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.557 ' ND2' ' CG2' ' A' ' 188' ' ' VAL . 9.3 p30 -123.9 28.05 7.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.029 0.442 . . . . 0.0 111.171 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.2 mtt -44.05 -15.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.107 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.19 38.08 13.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.843 178.889 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.52 120.53 19.8 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.601 -179.123 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.2 124.76 21.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.0 -30.75 6.4 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -177.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.558 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 94.1 t -72.42 176.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.381 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.558 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -74.1 133.07 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.781 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 48.11 39.2 11.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.796 177.774 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 20.8 p -77.55 -68.03 0.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.287 -179.266 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.519 ' N ' ' OG ' ' A' ' 136' ' ' SER . 94.1 m-20 -88.3 41.88 1.03 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.1 pt -69.99 -26.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.293 -179.758 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.24 3.92 9.8 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.9 m -92.98 -15.1 26.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.328 -179.237 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 mt -66.4 121.28 14.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -95.84 153.14 17.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -53.67 121.91 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 -179.968 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 101.04 16.94 24.22 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.803 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 73.7 m-20 -85.09 135.89 33.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.13 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -82.33 131.4 35.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 0.0 111.796 -178.321 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.77 124.44 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.552 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -104.5 120.21 40.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.299 -178.554 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.92 158.47 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.956 -178.854 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.56 136.13 53.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 111.708 -178.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.554 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.4 t0 -112.81 -166.49 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.656 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.554 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.2 m-20 -34.73 -67.96 0.13 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.491 0.662 . . . . 0.0 111.042 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.03 29.65 2.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.074 179.643 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.82 147.72 52.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.822 0.82 . . . . 0.0 112.8 -175.495 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.74 123.45 50.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.814 178.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -104.44 133.43 49.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.582 -178.765 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -97.57 116.29 29.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.59 177.8 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -116.16 141.07 48.62 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 -178.962 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.63 131.64 54.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 178.879 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 144' ' ' GLY . 61.3 t -65.67 134.23 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.968 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -30.61 11.21 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.201 1.563 . . . . 0.0 110.916 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.79 157.78 11.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.965 -178.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.3 150.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.526 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.9 p -156.51 164.46 38.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.783 -177.704 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.446 ' OE2' ' OH ' ' A' ' 197' ' ' TYR . 94.9 mt-10 -114.19 115.63 27.78 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.232 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 158.3 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.622 0.249 . . . . 0.0 111.154 -178.074 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.456 ' H ' ' HG1' ' A' ' 167' ' ' THR . 4.3 p -60.49 167.61 3.07 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.301 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.38 -6.97 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.079 1.853 . . . . 0.0 112.192 -179.815 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 35.6 p30 -85.39 -6.97 59.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.909 -178.088 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -86.49 68.97 10.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.464 ' C ' ' H ' ' A' ' 173' ' ' VAL . 78.4 m95 -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.985 -179.299 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.534 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 98.3 mt-10 -47.17 -16.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 O-C-N 123.432 0.457 . . . . 0.0 110.666 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.464 ' H ' ' C ' ' A' ' 171' ' ' TRP . 54.4 t -74.46 -24.93 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.685 -179.055 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.58 -8.61 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.715 0.769 . . . . 0.0 110.041 -177.998 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.9 mt-10 -80.4 157.79 26.18 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.58 -176.716 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.8 p-10 -66.22 128.59 36.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.339 179.834 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.534 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 34.4 m80 -108.07 -44.47 4.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.718 -179.561 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.22 24.54 0.1 OUTLIER Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 178.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -153.39 172.5 16.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.955 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 6.7 p30 -95.05 86.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 110.211 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -128.22 125.55 39.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.735 -179.077 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.2 tt -80.82 148.43 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 8.7 m -136.8 118.63 15.14 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.385 -178.231 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.2 mp -100.32 127.26 46.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 111.185 -179.64 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 pt -139.95 -171.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -178.6 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 27.9 p -137.13 156.64 48.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.473 -178.77 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 13.7 t -93.41 80.93 4.38 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.65 -179.347 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.557 ' CG2' ' ND2' ' A' ' 127' ' ' ASN . 67.9 t -127.87 130.27 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.821 -178.881 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.9 t -160.33 85.3 0.72 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.399 -178.664 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 76.4 t -146.55 85.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.183 -178.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.9 tttm 45.27 -125.9 1.16 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.726 179.16 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -99.43 133.94 43.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.537 ' CG ' ' H ' ' A' ' 194' ' ' SER . 40.2 t-20 -154.82 -148.15 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.562 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.537 ' H ' ' CG ' ' A' ' 193' ' ' ASN . 90.4 p -72.74 158.01 36.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -71.86 131.98 43.77 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -75.85 136.28 40.17 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.198 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.446 ' OH ' ' OE2' ' A' ' 165' ' ' GLU . 3.8 m-85 -104.51 132.66 50.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.61 139.37 45.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.183 0.515 . . . . 0.0 110.997 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 80.9 t -125.2 135.81 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 -179.256 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.74 134.95 54.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.89 134.55 8.26 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -96.53 137.57 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.934 -179.082 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 40.3 tp -64.7 127.2 30.52 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.26 -23.81 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.684 -179.41 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.01 178.26 46.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.511 -179.519 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 152.41 30.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.955 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -147.94 178.16 8.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.868 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.45 144.71 25.33 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.467 -179.438 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -73.02 79.75 1.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 -179.049 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.388 178.563 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.2 p -74.16 158.2 34.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.823 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.736 ' CG ' ' H ' ' A' ' 56' ' ' MET . 82.7 t60 47.66 -170.7 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.712 179.427 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.736 ' H ' ' CG ' ' A' ' 55' ' ' HIS . 64.8 mtt -130.14 164.21 24.94 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.751 0.31 . . . . 0.0 110.286 -179.377 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 50.1 p-10 -61.47 146.75 47.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.654 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.85 -38.17 82.79 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.617 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.479 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 99.0 p -148.39 -95.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.179 -178.565 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' N ' ' OG ' ' A' ' 59' ' ' SER . 76.5 tttt 50.85 40.32 24.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.225 178.231 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 63' ' ' GLN . 42.2 mt -61.73 -48.21 89.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.825 -178.841 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 47.02 -94.3 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.274 178.835 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 2.3 pt20 -150.83 85.29 5.22 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.902 -179.106 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.36 153.81 40.37 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.817 2.344 . . . . 0.0 111.027 179.602 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -76.76 170.83 15.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.883 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.39 -15.35 63.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.826 0.346 . . . . 0.0 111.309 -179.199 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 71' ' ' ASN . . . -64.03 -41.27 97.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.146 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.35 -19.65 58.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.518 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.01 -55.42 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.273 -178.613 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.77 94.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 67' ' ' ALA . 8.1 m120 -68.78 -32.74 72.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.605 -179.258 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.8 129.74 41.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.519 179.579 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -92.91 159.82 15.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.152 179.858 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.4 120.68 14.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.924 0.392 . . . . 0.0 111.105 -178.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.5 m-20 -86.56 106.5 17.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.166 178.846 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -46.64 -16.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.289 0.566 . . . . 0.0 110.69 -179.781 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.481 ' N ' ' C ' ' A' ' 75' ' ' ASP . 63.7 mttp -65.4 -12.02 48.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -97.84 8.73 44.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.463 -178.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.8 t -91.27 125.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.763 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.2 pt -122.38 -3.55 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.328 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.33 -162.03 34.61 Favored Glycine 0 C--N 1.321 -0.288 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.627 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.671 HH12 ' HZ3' ' A' ' 209' ' ' LYS . 10.8 ptp85 -157.53 164.76 37.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.943 -179.724 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.6 tt -133.08 144.51 36.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.223 179.738 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 t -134.18 135.2 42.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.82 -178.828 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 mt -129.47 76.33 78.84 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.571 -177.404 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.26 -42.05 3.48 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.996 2.464 . . . . 0.0 112.565 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -55.18 -42.68 73.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.719 -177.436 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.455 ' CG1' ' O ' ' A' ' 88' ' ' VAL . 67.8 t -107.97 5.26 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.753 0.311 . . . . 0.0 110.799 -179.075 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 t 56.1 46.23 22.0 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.139 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.96 124.56 51.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.874 -178.273 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -128.04 113.09 15.36 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.09 111.01 4.72 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.7 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -41.71 157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.888 1.725 . . . . 0.0 109.767 175.697 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.09 117.0 51.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.1 mt -100.47 120.83 40.58 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.843 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -66.65 -48.26 69.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 111.171 -179.709 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.561 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 23.9 p -60.13 100.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 179.874 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 98' ' ' SER . 18.6 p -82.73 97.17 8.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.349 0.595 . . . . 0.0 110.32 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.524 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 3.6 p -140.01 158.22 44.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.094 -179.275 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.2 -33.26 70.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.469 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.03 -44.47 47.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.105 -179.495 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 98.2 m-20 -65.08 -38.6 91.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.711 -178.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.6 mt -57.18 -22.32 39.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.492 -179.385 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.34 -32.88 72.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.655 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.4 m -91.33 -9.65 44.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.86 -176.87 45.6 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.401 -179.401 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.38 124.4 27.47 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.056 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.75 150.48 25.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.061 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.7 p -68.65 148.37 50.54 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.839 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.5 t -88.72 -33.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -177.097 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 170.24 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.388 . . . . 0.0 110.946 -178.851 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.17 -47.12 81.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.193 -178.026 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 113' ' ' ASN . 50.4 p30 -158.0 69.76 0.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.154 -178.336 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 121' ' ' TYR . 4.4 pt20 -76.38 175.06 9.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.246 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -132.47 125.13 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.856 0.36 . . . . 0.0 110.649 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.488 ' SD ' ' OH ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.8 127.44 32.64 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.403 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.85 -5.59 59.85 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -140.37 123.18 16.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.15 -170.24 50.17 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.074 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -83.71 107.74 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.921 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 114' ' ' GLN . 5.8 t80 -84.42 102.67 12.95 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.567 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.45 122.26 33.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.203 0.525 . . . . 0.0 111.827 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -117.67 131.11 56.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.902 178.656 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.83 139.14 46.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.262 0.553 . . . . 0.0 110.768 -178.211 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.47 -178.34 16.5 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.486 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.9 m-70 -93.74 138.59 31.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.574 -179.424 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -98.59 28.78 4.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 110.658 -179.481 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -40.67 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.199 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 m 59.21 36.87 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.456 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.472 ' HZ3' ' CG2' ' A' ' 133' ' ' VAL . 10.4 mtpm? -131.94 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.471 -178.898 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -48.95 124.09 8.12 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.56 -31.01 7.14 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.314 -177.915 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.616 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 61.0 t -74.67 179.35 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.616 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.7 OUTLIER -71.51 136.78 47.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.958 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 43.63 35.1 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.816 178.069 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 p -82.92 -14.15 54.7 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -141.17 26.48 2.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.409 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.2 pt -75.67 -18.08 15.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.479 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.4 18.19 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.644 -179.598 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 t -92.26 -14.05 29.48 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.357 0.598 . . . . 0.0 110.037 -179.319 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.415 ' CD2' ' OD2' ' A' ' 145' ' ' ASP . 23.8 mt -63.77 128.55 36.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.359 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -101.85 174.54 5.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.876 -179.83 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.89 124.29 23.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 93.6 16.0 47.67 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.603 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.415 ' OD2' ' CD2' ' A' ' 141' ' ' LEU . 10.4 t70 -78.83 136.42 37.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.035 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.8 132.55 35.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.979 0.419 . . . . 0.0 111.626 -178.163 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 147' ' ' ILE . 93.7 mt -129.01 127.5 66.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.686 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -104.26 120.68 41.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.027 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.63 145.31 45.54 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -119.34 135.12 54.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -178.089 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.8 t0 -110.66 -164.22 0.9 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.557 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 3.5 p-10 -26.37 -77.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.354 0.409 . . . . 0.0 111.29 179.202 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.557 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 78.6 mm-40 -134.02 30.0 3.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.096 178.949 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.479 ' OD1' ' ND2' ' A' ' 152' ' ' ASN . 33.8 m120 -128.85 148.2 50.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.956 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -109.21 123.32 49.05 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.068 179.819 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -106.3 129.72 54.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.655 -178.847 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -94.75 113.59 25.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.338 178.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -113.48 143.36 44.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.454 -178.901 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.01 132.23 54.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.262 0.553 . . . . 0.0 110.707 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 144' ' ' GLY . 99.2 t -66.6 135.71 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.52 -179.933 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.1 p -100.24 -27.27 13.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 124.593 1.183 . . . . 0.0 111.013 -178.497 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.0 156.45 8.15 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.426 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.34 139.6 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.389 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 73.9 m -136.82 151.27 48.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.786 0.326 . . . . 0.0 111.091 -178.083 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 54.9 mp0 -111.07 102.52 10.97 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.4 m -134.09 156.59 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -178.212 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.2 p -63.02 168.8 4.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.211 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.41 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -82.31 -4.04 11.64 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.179 1.919 . . . . 0.0 112.119 -179.596 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.02 -19.38 44.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.806 -178.569 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -85.96 74.37 10.15 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.817 0.447 . . . . 0.0 110.307 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.41 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 96.6 m95 -74.68 -6.16 47.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.023 -179.279 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.579 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 9.8 pt-20 -52.47 -43.63 65.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.984 0.421 . . . . 0.0 110.919 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.449 ' N ' ' CG ' ' A' ' 172' ' ' GLU . 16.8 m -71.33 4.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.976 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.81 -14.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.779 0.799 . . . . 0.0 110.215 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.7 mt-10 -87.32 172.6 9.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.018 -178.869 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -74.29 125.72 29.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.579 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 48.3 m80 -110.82 22.49 15.3 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.641 -179.37 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.78 20.98 79.27 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.356 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -151.17 168.08 25.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.137 -179.477 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -94.39 87.57 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.174 0.511 . . . . 0.0 110.236 -179.841 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -123.91 124.94 43.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.626 -178.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.4 tt -81.51 146.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.455 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.5 m -137.28 121.74 18.32 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.395 -179.123 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.0 mp -105.95 123.45 48.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 111.024 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.47 ' CG2' ' NH1' ' A' ' 196' ' ' ARG . 12.6 pt -139.01 169.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.992 -178.531 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.5 p -135.45 158.65 43.83 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.631 -179.21 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.6 m -84.28 131.53 34.72 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.55 153.23 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.746 0.307 . . . . 0.0 110.973 -178.511 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.452 ' HG ' ' H ' ' A' ' 190' ' ' VAL . 89.8 p -77.61 -130.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.976 179.845 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.452 ' H ' ' HG ' ' A' ' 189' ' ' SER . 3.9 t -74.8 -120.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.528 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -108.32 18.37 21.12 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.775 0.321 . . . . 0.0 111.504 -179.603 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.36 -41.85 94.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.332 -179.134 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -95.71 31.6 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.261 -179.5 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.27 -166.35 0.21 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.426 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -68.87 139.75 55.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.379 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.47 ' NH1' ' CG2' ' A' ' 185' ' ' ILE . 7.9 tmm_? -69.9 142.09 53.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.452 -179.847 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.2 133.0 43.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.15 141.26 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.335 0.588 . . . . 0.0 111.332 -179.398 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.7 t -121.16 131.85 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.185 -179.261 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -117.22 136.46 53.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.485 -179.838 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.25 140.69 11.99 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.445 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 53.5 p-10 -97.52 144.95 26.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.566 -0.817 . . . . 0.0 111.473 -178.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.12 126.49 29.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.062 0.458 . . . . 0.0 111.166 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.7 -25.35 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.413 -178.755 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.87 177.43 44.89 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.74 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.7 m -152.89 152.67 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.274 0.559 . . . . 0.0 111.108 -179.78 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -149.36 178.79 8.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.345 179.594 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.78 146.03 24.09 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.403 -179.773 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.671 ' HZ3' HH12 ' A' ' 82' ' ' ARG . 88.4 tttt -77.04 79.02 3.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.748 -179.1 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.562 178.057 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.1 p -63.33 -27.73 69.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.956 0.408 . . . . 0.0 110.474 179.865 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -78.12 127.57 32.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.135 -179.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.4 mtt -138.18 154.21 49.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 111.185 -179.052 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -47.14 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.073 179.747 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.48 -61.92 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.46 -178.742 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.0 m -94.44 -101.48 0.15 Allowed 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 120.928 0.394 . . . . 0.0 110.008 -179.404 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 44.24 25.81 0.13 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.285 178.877 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 61' ' ' ILE . 57.2 mt -65.25 -46.35 90.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.692 -179.141 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 56.24 -98.87 0.09 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -151.15 77.8 7.41 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.419 -179.641 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -43.32 140.84 3.57 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.145 1.897 . . . . 0.0 111.71 -179.553 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -69.18 152.07 45.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.679 179.636 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.1 mm? -56.61 -27.18 57.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.64 -179.099 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.87 91.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.898 0.38 . . . . 0.0 110.411 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -74.38 -35.1 63.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.872 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.33 -44.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.41 88.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.766 179.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.25 -27.55 42.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.24 140.78 55.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.374 -179.505 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -139.45 147.09 40.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.756 -179.463 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 1.4 pt? -137.17 173.8 11.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 -179.515 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.12 128.5 45.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 178.489 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 0.3 OUTLIER -67.91 -10.17 51.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.346 179.996 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 79' ' ' VAL . 1.3 mppt? -63.54 -30.62 71.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.172 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.19 13.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.826 -178.964 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 76' ' ' LYS . 9.3 p -85.86 123.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.597 179.672 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.99 -5.48 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.86 -178.197 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.24 -160.26 27.04 Favored Glycine 0 C--N 1.318 -0.432 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 9.3 ttm180 -151.38 157.32 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.129 0.49 . . . . 0.0 110.924 -179.812 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.403 ' N ' ' HG3' ' A' ' 82' ' ' ARG . 3.3 tp -125.9 127.21 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.191 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -129.03 130.15 46.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.77 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 mt -136.68 123.2 13.78 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.817 -178.731 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -82.33 -30.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.462 2.108 . . . . 0.0 112.473 -179.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -48.39 -39.99 24.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.052 -176.475 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.403 ' O ' ' CB ' ' A' ' 89' ' ' SER . 3.3 p -120.53 -4.17 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.578 0.228 . . . . 0.0 111.12 -179.13 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.09 50.72 0.11 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.021 0.439 . . . . 0.0 109.967 179.895 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.6 mt -111.37 127.42 55.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 179.762 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.49 113.14 11.51 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 mt -146.09 166.48 16.92 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.395 -177.719 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.82 150.61 8.54 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 109.516 178.105 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.73 108.22 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.9 mt -101.93 121.61 42.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.29 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.03 -48.95 72.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.985 0.421 . . . . 0.0 111.176 -179.653 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.495 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 48.4 m -56.68 98.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.777 -179.411 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 85.3 p -80.6 100.56 8.69 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.393 0.616 . . . . 0.0 110.626 179.675 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -135.42 157.73 46.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.352 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -54.97 -39.17 68.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.923 179.524 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.93 -39.08 72.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.091 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 97' ' ' SER . 6.8 t-20 -62.77 -39.55 94.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 -179.406 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.97 -27.45 63.47 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.288 -178.688 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.68 -14.54 62.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.37 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -104.98 -13.96 15.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.83 -149.98 14.91 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.013 -178.326 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.34 125.2 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.84 144.34 32.71 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.719 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 p -76.84 153.32 34.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.6 t -85.81 -45.03 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.171 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -88.47 -170.97 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.222 -178.402 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -124.67 -5.28 7.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.826 -177.739 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.42 41.8 1.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.078 0.466 . . . . 0.0 110.675 -177.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.29 161.94 13.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.388 179.679 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.66 132.83 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 67.8 mtt -69.62 129.81 40.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.51 179.13 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.97 75.96 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -146.46 128.17 15.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.579 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.6 -169.7 47.23 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -85.52 103.48 14.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.506 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.94 101.3 11.6 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.8 124.31 35.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 0.0 112.042 -178.846 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -120.13 130.14 54.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.693 178.224 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.47 139.97 43.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 110.256 -178.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.24 -178.22 18.88 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.939 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -83.62 152.26 24.9 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.112 0.482 . . . . 0.0 110.767 -179.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 129' ' ' SER . 48.6 p30 -122.09 28.23 7.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.29 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.6 mtt -44.78 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.944 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 61.24 36.33 17.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.434 ' H ' ' HG ' ' A' ' 136' ' ' SER . 68.1 mttm -135.64 114.75 12.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.944 -179.213 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -56.21 126.65 27.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.687 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -30.64 6.67 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 -178.136 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 134' ' ' LEU . 97.0 t -72.36 175.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.542 ' N ' ' CG1' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.45 128.77 36.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.392 -178.409 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 48.45 42.61 18.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 178.202 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.434 ' HG ' ' H ' ' A' ' 130' ' ' LYS . 2.4 t -75.23 -67.26 0.67 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.36 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -90.27 43.98 1.18 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.183 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 138' ' ' ILE . 39.8 pt -68.1 -26.74 35.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.675 179.525 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.16 7.47 4.16 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.246 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -96.25 -14.47 22.64 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.46 122.24 15.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.136 -179.357 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 26.6 mtpp -96.3 157.14 16.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.758 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.43 122.13 13.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.622 -179.627 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.63 18.45 23.18 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.1 m-20 -83.79 134.98 34.7 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.923 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -81.78 126.09 31.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.178 -177.335 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.89 126.78 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.295 178.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -101.94 118.1 36.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.271 -179.101 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.24 135.92 46.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.973 179.907 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.509 ' O ' ' SD ' ' A' ' 116' ' ' MET . 56.3 m-85 -114.69 127.79 55.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.325 0.583 . . . . 0.0 111.324 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 42.8 t0 -113.82 -166.6 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.348 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.512 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.1 m-20 -23.04 -75.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.062 0.458 . . . . 0.0 111.994 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -139.22 30.64 2.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.276 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -127.7 144.13 51.1 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.046 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -110.94 121.83 46.35 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.898 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -103.65 132.71 49.66 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.323 -178.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.79 115.08 27.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.166 178.785 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -114.77 146.67 40.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.574 -179.844 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.1 132.43 53.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.341 0.591 . . . . 0.0 111.022 178.073 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.11 133.41 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.631 179.56 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.82 -29.01 11.72 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 124.739 1.274 . . . . 0.0 110.395 -178.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.83 164.07 23.9 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.031 -179.355 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.92 147.45 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.911 -0.644 . . . . 0.0 109.765 -179.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.0 p -151.69 162.15 41.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.195 0.521 . . . . 0.0 111.289 -179.115 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -117.91 111.31 18.83 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.696 179.89 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.8 160.14 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.096 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -62.18 166.98 5.66 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.532 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.1 Cg_endo -82.21 -5.87 12.0 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.256 1.97 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -17.03 52.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.725 -178.78 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -87.37 73.57 9.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 70.1 m95 -73.52 -21.51 60.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.362 -179.847 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.545 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.3 mt-10 -51.06 -8.82 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.001 0.429 . . . . 0.0 110.825 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' A' ' 171' ' ' TRP . 19.5 m -83.29 -21.86 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.747 -178.792 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -0.71 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.591 0.71 . . . . 0.0 109.677 -179.051 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.533 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 97.0 mt-10 -83.55 139.65 32.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.19 -178.253 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -44.51 123.57 3.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.063 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.545 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 45.7 m80 -114.25 22.84 13.4 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.056 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.06 19.73 79.72 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.237 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -147.59 164.27 33.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.065 0.459 . . . . 0.0 111.28 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.15 89.08 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.852 179.512 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -129.23 125.53 37.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.595 -179.118 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.7 tt -79.46 148.09 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.269 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.2 m -135.95 125.44 25.1 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.908 -179.879 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.94 127.42 53.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.499 179.866 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.9 pt -136.79 176.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.622 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.584 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.9 p -134.67 166.13 23.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.163 -179.178 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 15.1 p -53.7 -177.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.202 179.747 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.04 124.18 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.86 0.362 . . . . 0.0 110.679 -179.785 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 194' ' ' SER . 48.4 t -81.65 134.36 35.47 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.249 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.8 p -105.41 2.43 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.019 0.438 . . . . 0.0 110.952 -179.277 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -72.17 100.75 2.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.347 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 68.0 t0 48.23 -107.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.993 179.202 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -85.08 114.16 22.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.168 179.295 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 189' ' ' SER . 27.3 m -59.23 134.16 56.75 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.686 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -152.17 147.16 26.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 -178.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.584 ' NH1' ' O ' ' A' ' 186' ' ' THR . 8.6 ptp180 -159.14 168.01 27.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.58 141.68 47.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.06 178.7 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.2 t -132.09 133.99 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.151 0.5 . . . . 0.0 110.99 -179.504 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.24 133.28 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.337 -179.415 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.51 135.89 53.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.707 -179.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.07 135.64 8.75 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -179.757 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -92.13 138.65 31.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.555 -179.24 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.26 127.11 30.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.112 0.482 . . . . 0.0 110.543 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 -23.01 4.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.341 -179.036 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 173.43 178.11 43.16 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.289 -178.513 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.6 m -151.95 152.29 32.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 111.285 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -148.74 177.53 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.549 179.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.06 146.6 24.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.344 0.592 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -76.02 79.8 2.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.693 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.317 -0.824 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.718 178.443 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.473 ' O ' ' ND1' ' A' ' 55' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 t 47.57 19.83 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.463 . . . . 0.0 110.731 179.49 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 53' ' ' GLY . 76.9 m80 -80.0 163.19 24.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.86 -179.672 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.5 mtm -72.68 146.87 46.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.272 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.38 137.47 57.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.87 -40.48 79.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.471 -178.871 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 61' ' ' ILE . 1.9 p 60.11 15.34 5.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.352 179.276 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -76.66 32.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.41 -179.381 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.449 ' H ' ' C ' ' A' ' 59' ' ' SER . 43.9 mt -62.3 -47.78 91.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.19 0.519 . . . . 0.0 110.861 -178.905 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 47.66 -94.76 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.281 179.206 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -149.99 86.2 5.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.872 -179.177 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.86 151.55 40.38 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.578 2.185 . . . . 0.0 111.326 179.722 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 55.4 t0 -72.6 158.65 35.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.458 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 3.9 mm? -64.03 -20.53 65.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.766 -179.359 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.0 92.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.289 -179.727 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.8 -32.64 63.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 179.729 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.68 -45.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.854 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.91 90.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.026 179.839 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -79.03 -23.53 44.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.253 -179.392 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 105.1 0.51 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.868 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.6 m -96.58 80.74 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 tp -74.88 148.02 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.182 179.334 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 77' ' ' LYS . 42.4 t0 -81.31 91.13 6.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -52.74 -9.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.132 0.491 . . . . 0.0 110.364 -179.898 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 75' ' ' ASP . 17.5 tptm -79.65 -10.89 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.538 -179.803 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.572 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 9.0 pt20 -93.6 19.36 8.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.563 -178.785 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -83.0 146.26 7.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.855 -179.433 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.68 -6.04 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.83 -165.54 32.94 Favored Glycine 0 C--N 1.317 -0.473 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.461 ' NH1' ' C ' ' A' ' 92' ' ' LEU . 8.5 ttm-85 -151.52 154.47 36.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.303 0.573 . . . . 0.0 111.326 -179.258 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 tt -127.88 130.01 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.72 179.444 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -127.76 129.68 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.022 -179.155 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.3 mt -134.78 118.36 13.32 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -177.946 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.25 -33.67 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.736 2.29 . . . . 0.0 112.388 179.869 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.4 t -49.54 -39.41 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.696 -177.052 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 89' ' ' SER . 3.9 m -119.14 -6.23 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -178.777 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 75.28 49.9 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.305 0.574 . . . . 0.0 110.209 179.904 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 mt -111.0 125.45 53.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.251 -179.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -133.25 112.41 11.66 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.461 ' C ' ' NH1' ' A' ' 82' ' ' ARG . 76.6 mt -145.58 162.5 36.21 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.908 -177.03 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -88.06 152.05 6.99 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 123.118 2.545 . . . . 0.0 109.119 177.41 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.1 t -98.15 115.63 38.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.757 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 mt -101.66 122.96 44.86 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.066 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -67.23 -45.06 77.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 m -69.62 99.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.453 -179.51 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.3 p -81.69 96.27 7.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.516 0.674 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.586 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.9 p -136.99 157.3 47.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.924 -179.584 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.15 -31.97 65.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.648 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -78.27 -45.28 23.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.617 0.722 . . . . 0.0 111.295 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.636 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -66.25 -35.17 79.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.494 -178.171 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.83 -15.4 58.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.933 -178.797 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 mt -71.37 -27.22 63.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.894 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.6 m -94.31 -8.78 37.99 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.753 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.2 -158.16 28.48 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.814 -178.591 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.09 126.58 37.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.875 -0.662 . . . . 0.0 109.941 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.02 147.46 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 -179.779 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 44.5 p -71.02 147.7 48.34 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.35 -43.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -89.82 -171.32 3.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.028 -178.721 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -121.58 -9.27 8.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.982 0.42 . . . . 0.0 111.535 -178.212 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -139.36 39.86 2.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.017 0.437 . . . . 0.0 111.393 -177.66 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -91.33 157.45 17.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.098 179.713 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.4 t -132.61 131.66 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.639 179.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.6 mtt -66.93 129.3 39.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.006 178.75 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.27 3.37 75.69 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -141.77 120.98 13.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.71 -165.75 54.75 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -178.867 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.438 ' OD1' ' OG1' ' A' ' 183' ' ' THR . 57.0 t-20 -90.23 109.98 21.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.614 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.69 102.26 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.922 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.22 129.83 37.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.474 0.654 . . . . 0.0 111.966 -179.177 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -127.04 132.35 50.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.526 178.637 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.24 141.66 45.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.556 0.693 . . . . 0.0 110.76 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.1 -179.04 20.31 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.588 -179.531 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 31.0 m-70 -81.84 145.08 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 129' ' ' SER . 22.9 t-20 -116.87 28.1 8.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmm -46.49 -12.15 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.911 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 127' ' ' ASN . 1.6 p 60.59 40.98 16.07 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.078 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 88.4 tttt -134.42 115.15 13.67 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.768 -179.087 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -57.46 126.39 27.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.668 0.747 . . . . 0.0 110.156 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.49 -22.61 17.05 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.578 ' CG1' ' H ' ' A' ' 134' ' ' LEU . 55.6 t -84.3 177.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.073 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.578 ' H ' ' CG1' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -72.19 133.19 44.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.607 0.241 . . . . 0.0 110.4 -178.247 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 46.16 33.0 1.59 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.297 0.57 . . . . 0.0 110.551 178.343 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 0.9 OUTLIER -81.86 -4.37 56.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.817 -178.571 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.455 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 22.8 t70 -147.09 39.76 1.02 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.605 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.69 -27.29 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.927 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.38 3.53 10.87 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.719 -179.604 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.455 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.2 m -95.35 -12.98 25.15 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.406 0.622 . . . . 0.0 109.694 -179.55 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.87 125.15 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.983 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -96.81 158.43 15.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.607 -179.837 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -61.46 128.03 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.874 -179.615 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 90.67 20.22 41.33 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.784 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -85.82 132.33 34.13 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.406 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -79.79 135.69 36.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.812 -178.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 158' ' ' TYR . 84.5 mt -127.66 122.3 58.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.542 179.302 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.443 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.0 m-85 -100.18 117.66 34.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.975 -179.071 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.48 142.37 46.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.967 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.421 ' O ' ' SD ' ' A' ' 116' ' ' MET . 34.5 m-85 -116.06 132.95 56.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 111.471 -178.842 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.0 t0 -113.94 -166.38 1.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.6 m-20 -22.54 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.539 0.524 . . . . 0.0 111.676 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -137.81 28.28 2.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.289 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -126.93 143.77 51.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.899 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -109.18 121.62 45.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.844 179.067 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -104.65 132.01 51.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.418 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.443 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 70.2 mm-40 -94.62 112.65 24.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.992 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.5 m-85 -114.39 137.38 51.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.436 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.89 54.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 111.382 178.785 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 144' ' ' GLY . 44.3 t -67.38 132.64 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.959 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -112.26 -29.39 7.57 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 124.619 1.199 . . . . 0.0 111.13 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.19 145.18 8.45 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.498 -179.765 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 97.8 t -121.86 138.24 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.784 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.5 m -159.34 171.88 18.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.693 -178.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.04 133.27 54.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.718 179.964 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 m -138.78 159.66 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.3 -178.691 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 169' ' ' ASP . 3.6 p -69.11 133.59 89.72 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.146 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.07 -13.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.046 1.831 . . . . 0.0 111.794 -178.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.1 m-20 -78.84 -22.36 46.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.903 -177.963 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -85.67 75.91 10.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.847 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.58 ' C ' ' H ' ' A' ' 173' ' ' VAL . 83.3 m95 -74.05 -20.03 60.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.992 -179.18 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 57.1 mp0 -52.24 -6.79 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.821 179.575 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.58 ' H ' ' C ' ' A' ' 171' ' ' TRP . 24.4 m -89.81 -3.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.101 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.9 -7.24 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.745 0.783 . . . . 0.0 109.012 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.18 157.03 25.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.239 -176.749 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.89 127.52 32.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.092 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -102.11 -41.44 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.075 -179.78 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 140.84 28.03 0.19 Allowed Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.498 ' NZ ' ' CD ' ' A' ' 181' ' ' GLU . 19.7 pttp -156.37 178.49 10.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 4.6 m-20 -92.19 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.72 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.498 ' CD ' ' NZ ' ' A' ' 179' ' ' LYS . 22.4 tt0 -123.18 169.39 11.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.148 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.414 ' H ' ' HG2' ' A' ' 181' ' ' GLU . 19.3 tt -130.93 143.01 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.873 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.438 ' OG1' ' OD1' ' A' ' 120' ' ' ASN . 16.0 m -136.02 123.56 22.18 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 111.489 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.9 mp -111.11 123.72 50.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.405 0.621 . . . . 0.0 110.556 179.334 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.5 pt -139.77 -171.45 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.932 -178.62 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t -138.81 155.02 48.49 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.717 -179.159 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 10.9 t -105.75 77.98 1.3 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 189' ' ' SER . 11.4 p -143.43 131.99 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.216 -179.43 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 1.5 m 174.25 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.875 -179.428 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 191' ' ' LYS . 7.3 p -149.4 -45.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 111.842 -179.185 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.49 ' N ' ' CG1' ' A' ' 190' ' ' VAL . 63.3 tttp -93.83 -81.92 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.829 -178.89 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -69.16 140.76 54.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.019 179.399 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 193' ' ' ASN . 53.4 p-10 -94.71 148.99 21.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.465 -179.742 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.4 t 48.28 82.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.708 179.248 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -159.54 70.7 0.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.977 -178.185 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -146.51 144.6 29.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.574 -178.83 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -108.27 137.65 45.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.209 179.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 78.9 t -129.49 131.27 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.268 0.556 . . . . 0.0 110.824 -179.155 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.2 130.38 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.328 -179.755 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.47 135.86 54.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.574 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.43 147.97 18.45 Favored Glycine 0 N--CA 1.465 0.619 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.772 -179.791 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -103.32 140.22 37.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.933 -0.633 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.1 tp -66.11 125.76 26.5 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.204 0.526 . . . . 0.0 110.802 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.11 -24.21 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.042 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.88 176.63 46.04 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 119.93 -1.128 . . . . 0.0 112.102 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.7 m -153.51 151.48 29.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 110.94 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -150.09 178.39 9.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.677 179.439 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.34 144.85 24.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.157 0.503 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.45 79.55 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.763 -179.529 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.601 178.479 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 55' ' ' HIS . 50.8 m -58.41 -44.69 89.12 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.3 -0.16 . . . . 0.0 110.619 -179.471 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 56' ' ' MET . 36.9 t-80 51.57 102.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.631 178.816 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.488 ' O ' ' O ' ' A' ' 55' ' ' HIS . 95.5 mmm -56.41 -118.86 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.999 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 58.8 t0 46.1 19.72 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.286 0.565 . . . . 0.0 111.086 178.324 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 56' ' ' MET . . . -73.27 -11.85 60.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.276 -179.005 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 t -149.41 -73.52 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.64 -178.383 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 55.38 17.79 2.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.24 0.543 . . . . 0.0 111.231 178.538 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.4 mt -66.38 -45.27 89.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.726 -179.105 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.1 t0 53.42 -100.05 0.1 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.109 179.122 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -149.81 88.67 4.82 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.808 -179.119 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.38 153.21 39.84 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 122.454 2.103 . . . . 0.0 111.137 179.476 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.09 146.58 52.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.823 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.81 -28.84 66.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.77 91.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.459 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.09 -35.39 66.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.805 179.469 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.87 -43.7 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.743 -179.181 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.35 83.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -87.89 -15.5 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.563 -178.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.39 133.05 53.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.521 179.658 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.1 p -90.9 159.4 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.054 179.598 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.0 tp -125.89 135.55 52.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.956 0.407 . . . . 0.0 111.112 -179.16 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.482 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.3 m-20 -89.91 89.31 7.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.763 179.756 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 4.6 mptp? -46.8 -16.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.18 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.482 ' N ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -65.64 -35.91 82.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.285 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 18.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.563 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.2 123.01 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.888 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.94 -7.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.016 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.15 38.54 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -147.31 153.51 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.068 -178.64 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.8 tt -126.97 131.05 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.206 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.6 m -130.9 132.36 45.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.211 -178.765 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.15 129.85 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 -178.461 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.48 -35.05 0.26 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.397 2.064 . . . . 0.0 112.102 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -47.21 -38.73 12.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.491 -176.859 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 2.0 p -120.58 -0.54 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.845 -178.936 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 53.74 3.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.168 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.1 tp -116.06 133.84 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.34 116.37 13.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.522 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.2 mt -144.53 110.87 4.94 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -41.29 141.01 1.31 Allowed 'Trans proline' 0 N--CA 1.486 1.041 0 C-N-CA 121.79 1.66 . . . . 0.0 110.326 176.206 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.4 t -89.65 125.5 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.036 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.7 mt -108.95 122.45 47.25 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.28 -48.58 72.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.974 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 m -71.59 103.78 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.042 -179.613 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.529 ' OG ' ' O ' ' A' ' 109' ' ' THR . 3.2 m -84.32 101.48 11.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.273 0.558 . . . . 0.0 110.078 179.537 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.61 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 6.4 p -132.75 156.19 47.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.099 -179.75 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -55.83 -26.94 49.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.545 -179.505 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.32 -43.73 14.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.374 0.607 . . . . 0.0 111.947 -179.507 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.61 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 98.3 m-20 -66.44 -34.31 77.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.621 -179.138 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.4 mt -68.94 -12.67 61.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.03 -178.593 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.6 mt -76.14 -13.14 60.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.121 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.8 m -121.35 -7.52 9.26 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.52 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.6 47.58 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.832 -179.742 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.17 129.07 36.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.955 179.375 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.63 146.65 30.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.986 -179.64 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.529 ' O ' ' OG ' ' A' ' 98' ' ' SER . 32.9 p -75.41 149.92 38.47 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.791 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.46 -40.52 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.845 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -87.82 145.07 26.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 111.044 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.16 -16.9 64.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.077 -179.141 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -144.86 52.02 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.295 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -80.73 155.55 26.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.656 179.557 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -133.08 127.7 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.0 mtt -71.49 126.65 30.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.256 179.482 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.91 70.94 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.521 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -139.2 119.71 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.259 -179.161 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -164.35 54.57 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.25 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.58 HD22 ' CB ' ' A' ' 183' ' ' THR . 1.3 t30 -90.02 109.82 20.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.732 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -84.96 101.1 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.39 126.29 35.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 112.135 -178.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.4 130.92 53.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.454 178.146 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.2 139.49 45.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.46 0.647 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.89 -178.78 19.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 134' ' ' LEU . 36.0 m-70 -85.16 140.65 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 110.66 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 28.6 t-20 -108.22 28.2 8.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.388 0.614 . . . . 0.0 110.265 -179.91 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -44.28 -13.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.873 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 55.45 39.56 31.14 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.942 179.264 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.639 ' H ' ' HG ' ' A' ' 136' ' ' SER . 79.8 tttt -134.7 123.05 23.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.607 -178.782 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -64.08 123.64 19.55 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.132 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.59 25.05 5.62 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.546 -177.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.41 HG11 ' H ' ' A' ' 134' ' ' LEU . 3.0 t -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.952 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -70.26 131.72 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.43 -177.838 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 47.14 32.74 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.077 0.465 . . . . 0.0 110.893 178.251 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.639 ' HG ' ' H ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.45 -10.31 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.022 -178.948 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.5 m-20 -144.5 38.08 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.26 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -68.12 -35.24 70.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.943 0.401 . . . . 0.0 111.657 179.75 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.58 3.3 1.9 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.88 -179.381 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 138' ' ' ILE . 19.0 m -95.61 -12.61 25.35 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.127 0.489 . . . . 0.0 109.861 -179.447 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -67.42 125.28 25.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.98 159.68 14.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.708 -179.806 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -60.22 128.0 34.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -179.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.14 22.32 32.88 Favored Glycine 0 N--CA 1.463 0.444 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.935 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.86 132.4 34.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.221 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -79.93 130.19 35.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.275 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 89.5 mt -125.3 124.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.31 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -106.7 122.45 46.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.484 -178.651 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.91 148.49 39.96 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.369 -179.584 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.92 131.76 53.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.364 0.602 . . . . 0.0 111.438 -179.834 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 152' ' ' ASN . 26.2 t70 -114.64 -165.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.011 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 151' ' ' ASP . 2.3 t-20 -23.78 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.178 0.514 . . . . 0.0 111.733 179.463 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -139.61 25.6 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.911 178.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -124.05 141.62 51.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.689 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.538 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 75.5 tt0 -106.49 121.06 43.51 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.059 179.321 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.44 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.5 m-85 -104.29 128.32 52.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -95.01 117.55 30.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.571 178.652 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -117.78 141.09 48.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.186 -179.346 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.03 136.49 54.86 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.172 0.51 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.13 132.25 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.756 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.5 t -111.8 -26.78 8.78 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 124.799 1.312 . . . . 0.0 111.37 -179.067 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.27 149.66 9.61 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.418 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.74 148.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.6 p -160.3 168.76 24.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.157 0.503 . . . . 0.0 111.365 -177.987 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.453 ' OE1' ' CE1' ' A' ' 197' ' ' TYR . 1.6 pm0 -117.95 124.28 47.85 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.456 179.722 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.71 160.32 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.249 -178.412 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 169' ' ' ASP . 15.0 p -71.62 138.23 83.25 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.455 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.94 -14.9 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.012 1.808 . . . . 0.0 111.993 -178.7 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 169' ' ' ASP . 65.4 t0 -78.96 -11.5 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.552 -177.86 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -84.77 64.53 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.182 0.515 . . . . 0.0 110.357 179.476 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 173' ' ' VAL . 86.3 m95 -70.1 -30.87 68.2 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.218 -179.716 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 41.4 mp0 -47.3 -15.97 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.212 0.53 . . . . 0.0 110.672 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 171' ' ' TRP . 87.4 t -66.13 -43.07 92.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.284 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 13.4 m -98.94 2.16 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.624 0.725 . . . . 0.0 110.506 -178.221 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.57 120.28 25.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.417 -1.265 . . . . 0.0 112.08 -178.569 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -31.79 122.81 0.28 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.506 178.846 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -105.41 -41.73 5.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.47 27.1 0.14 Allowed Glycine 0 N--CA 1.471 1.013 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -154.09 173.75 15.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.654 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -96.07 86.94 4.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.292 179.016 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -128.07 128.53 45.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.271 -179.286 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.3 tt -81.43 147.26 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.527 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.58 ' CB ' HD22 ' A' ' 120' ' ' ASN . 7.8 m -136.87 118.1 14.52 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 111.025 -179.608 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 9.7 mp -103.44 126.18 50.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.381 0.61 . . . . 0.0 110.999 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.8 pt -138.45 -177.13 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.592 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.562 ' CG2' ' HE ' ' A' ' 196' ' ' ARG . 15.2 t -138.45 147.57 43.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 -179.459 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 72.8 m -104.47 42.16 1.23 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.306 -179.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 62.5 t -119.27 130.88 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.288 -179.47 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -133.56 107.47 8.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.144 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 193' ' ' ASN . 9.1 t -133.38 161.43 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 -179.551 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.94 -41.19 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.928 -179.039 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -59.08 -49.24 78.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.486 ' O ' ' OD1' ' A' ' 193' ' ' ASN . 42.9 p30 -99.32 79.95 2.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.824 -179.575 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.9 t -59.04 -43.99 91.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.041 -179.354 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -122.21 139.74 53.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.99 -179.704 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.562 ' HE ' ' CG2' ' A' ' 186' ' ' THR . 5.6 ptp85 -95.16 160.78 14.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.876 -179.572 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.453 ' CE1' ' OE1' ' A' ' 165' ' ' GLU . 4.3 m-85 -92.58 140.54 29.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.938 179.158 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.2 134.54 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 -179.437 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.4 130.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.809 -179.39 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.23 136.14 53.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.141 179.505 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.63 140.19 11.6 Favored Glycine 0 N--CA 1.468 0.813 0 CA-C-O 121.648 0.582 . . . . 0.0 111.709 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.3 t0 -96.61 140.18 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.966 -179.09 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.481 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 12.1 tp -67.45 129.15 39.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 111.004 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 79.6 t -106.93 -23.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.25 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.49 162.53 21.92 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.687 178.774 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.44 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 48.0 m -138.79 157.49 45.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.246 0.546 . . . . 0.0 109.934 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.538 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.8 pttp -150.33 178.5 8.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.097 179.864 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -96.11 140.27 31.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.768 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -61.97 79.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.482 -179.44 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 208' ' ' ALA . 99.2 mttt . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.518 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo . . . . . 0 N--CA 1.49 1.286 0 CA-C-O 121.09 0.371 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.66 149.2 45.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.551 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.18 -24.47 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.094 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.5 86.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.44 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -73.4 -35.96 65.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.177 179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.98 -43.23 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.509 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.05 88.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -84.26 -19.81 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.53 131.95 51.78 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.582 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 m -92.3 152.42 19.8 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.378 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.2 tp -116.38 130.3 56.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.907 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -94.13 88.97 5.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 79' ' ' VAL . 45.0 mmtm -50.43 -11.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 75' ' ' ASP . 69.2 mmtt -74.52 -9.28 58.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.513 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.632 ' NE2' ' OG ' ' A' ' 97' ' ' SER . 30.6 mt-30 -106.51 16.51 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.37 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.9 p -90.6 126.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.774 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.33 -4.62 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.761 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.7 -167.54 36.55 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.483 ' HE ' ' NZ ' ' A' ' 209' ' ' LYS . 44.4 mtt-85 -146.92 155.24 42.13 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.973 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.617 HD12 HD13 ' A' ' 123' ' ' LEU . 8.8 tt -127.55 126.44 67.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.329 0.585 . . . . 0.0 109.821 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -125.14 130.55 52.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.006 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.48 79.57 59.79 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.252 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -43.6 -35.89 6.7 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.909 2.406 . . . . 0.0 112.972 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 m -49.11 -37.39 21.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -115.59 0.59 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.622 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.59 47.83 2.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.3 tp -115.04 129.32 56.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.737 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -134.34 120.66 20.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -146.72 162.47 33.59 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.241 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.64 151.68 8.83 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.826 2.35 . . . . 0.0 109.646 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -99.35 113.98 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.43 122.31 42.96 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.45 -45.73 82.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.797 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.632 ' OG ' ' NE2' ' A' ' 78' ' ' GLN . 91.5 p -70.79 104.57 2.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.152 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.0 p -82.79 99.81 9.91 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.254 0.55 . . . . 0.0 110.098 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.2 p -131.29 158.17 41.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.855 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.1 -26.42 68.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -83.23 -41.23 18.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.299 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -66.46 -36.21 82.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.503 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.0 mt -66.32 -14.7 62.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -75.49 -13.93 60.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -121.09 -4.49 9.54 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.38 -176.54 44.65 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.633 -1.27 . . . . 0.0 112.286 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.15 125.29 32.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.29 -0.455 . . . . 0.0 109.812 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.0 145.4 30.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.0 p -71.68 149.1 45.81 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.22 -44.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.94 -171.18 2.77 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.03 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -108.01 -56.78 2.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.809 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -91.17 46.54 1.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.59 150.27 24.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.133 0.492 . . . . 0.0 109.931 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.29 132.16 52.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.403 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.5 mtt -73.78 127.33 32.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 0.0 110.263 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.37 -0.9 68.87 Favored Glycine 0 C--O 1.23 -0.14 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -137.72 119.48 15.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.508 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -171.71 54.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.5 t30 -86.15 111.52 20.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -83.84 106.79 15.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.74 128.53 36.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.048 0.451 . . . . 0.0 112.081 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.617 HD13 HD12 ' A' ' 83' ' ' ILE . 10.1 mt -126.0 130.55 51.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.027 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.98 141.68 47.11 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.342 0.591 . . . . 0.0 110.768 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.48 -177.41 18.39 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.283 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.0 m-70 -82.69 150.0 27.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.1 0.476 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 129' ' ' SER . 61.2 t30 -117.59 27.96 8.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.715 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.4 mmm -45.43 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.7 p 62.82 41.03 9.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.19 0.519 . . . . 0.0 110.201 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.83 109.66 9.24 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.884 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -51.66 127.87 21.74 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.44 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.7 -25.5 14.76 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.782 HG12 ' H ' ' A' ' 134' ' ' LEU . 45.9 t -82.51 177.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 117.54 0.67 . . . . 0.0 109.499 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.782 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.22 136.91 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.315 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 44.57 32.73 0.8 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.045 0.45 . . . . 0.0 110.656 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -81.89 -8.11 59.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.207 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -149.96 41.91 0.85 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.731 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.2 pt -68.08 -33.85 63.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.371 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.21 5.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.104 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -94.57 -16.79 22.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.2 124.95 23.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.835 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.65 156.13 16.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.566 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 144' ' ' GLY . 5.6 tmtt? -56.85 127.35 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.675 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.436 ' N ' ' HD3' ' A' ' 143' ' ' LYS . . . 90.9 21.72 35.38 Favored Glycine 0 CA--C 1.516 0.139 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -82.75 134.66 35.12 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.542 ' NZ ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 mmmm -80.96 121.78 26.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.565 0.698 . . . . 0.0 112.312 -178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 94.4 mt -117.69 117.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.11 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.548 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.1 m-85 -100.32 119.02 37.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.43 144.68 44.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.73 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -116.41 136.75 52.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.411 0.624 . . . . 0.0 111.565 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' A' ' 152' ' ' ASN . 32.2 t70 -114.74 -171.07 1.86 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.9 p30 -21.17 -73.53 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.072 0.463 . . . . 0.0 111.658 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.496 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.2 mt-10 -138.38 26.0 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.82 147.89 45.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.369 0.604 . . . . 0.0 112.254 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -113.08 120.43 41.31 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CE2' HG21 ' A' ' 206' ' ' THR . 65.9 m-85 -104.29 131.18 51.89 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.073 0.463 . . . . 0.0 111.36 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.548 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 42.4 tp10 -94.52 114.77 26.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -114.5 141.92 47.07 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.63 135.7 54.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.538 0.685 . . . . 0.0 111.428 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.3 132.27 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.875 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -105.97 -27.74 10.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 124.917 1.386 . . . . 0.0 110.709 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.84 141.12 3.68 Favored Glycine 0 C--N 1.32 -0.328 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.405 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.2 p -106.08 139.8 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.058 -0.571 . . . . 0.0 109.564 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.9 t -154.09 166.72 32.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.345 0.593 . . . . 0.0 111.557 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.03 125.95 53.14 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.665 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.07 153.97 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.805 0.336 . . . . 0.0 110.995 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 p -60.0 167.2 2.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.75 -13.69 11.68 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.949 1.766 . . . . 0.0 111.446 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 36.9 p30 -82.91 -18.49 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.881 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.445 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.2 ttmt -86.72 74.75 9.76 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.073 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.401 ' CE3' HG21 ' A' ' 174' ' ' VAL . 94.0 m95 -75.54 -7.54 54.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.868 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -52.57 -25.42 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.039 0.447 . . . . 0.0 110.557 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.662 ' O ' HG21 ' A' ' 183' ' ' THR . 74.4 t -75.71 -16.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.228 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.401 HG21 ' CE3' ' A' ' 171' ' ' TRP . 2.6 t -108.71 -13.78 10.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.665 0.745 . . . . 0.0 109.676 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.01 152.66 24.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.919 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.54 133.93 53.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -101.18 -39.07 7.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.45 30.33 0.35 Allowed Glycine 0 N--CA 1.469 0.843 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -156.23 179.31 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.262 0.553 . . . . 0.0 111.369 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.23 89.71 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -125.06 166.13 16.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.193 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.29 142.45 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.662 HG21 ' O ' ' A' ' 173' ' ' VAL . 18.0 m -134.37 127.01 30.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.573 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.56 126.86 55.76 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.106 0.479 . . . . 0.0 109.722 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.48 HG22 HG22 ' A' ' 198' ' ' VAL . 28.6 pt -140.32 -169.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.519 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.732 179.481 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 120.93 0.395 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.5 133.58 42.67 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 173' ' ' VAL . 93.4 t -133.59 137.02 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.2 t -116.01 128.15 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.465 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.16 136.87 52.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.212 0.529 . . . . 0.0 110.074 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.46 25.85 Favored Glycine 0 N--CA 1.462 0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.451 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -115.61 150.1 37.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.043 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 41.8 tp -69.9 127.12 31.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.506 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.13 -24.43 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.759 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 175.01 45.81 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.532 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.412 HG21 ' CE2' ' A' ' 156' ' ' TYR . 16.5 m -153.3 151.66 30.26 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 121.375 0.607 . . . . 0.0 111.015 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -149.84 179.03 8.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.395 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.26 145.7 24.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.168 0.508 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.483 ' NZ ' ' HE ' ' A' ' 82' ' ' ARG . 88.5 tttt -74.14 80.0 1.76 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.321 -0.63 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.872 178.758 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 CA-C-O 121.221 0.425 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 162.78 29.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.063 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 66' ' ' LEU . 1.2 tt -60.22 -25.18 65.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.978 0.418 . . . . 0.0 110.247 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.13 89.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.004 0.43 . . . . 0.0 110.447 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 71.0 mm-40 -73.67 -33.71 64.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 110.788 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.28 -45.54 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.754 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.19 88.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.183 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -80.85 -24.11 38.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.209 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.45 141.5 58.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.712 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.6 m -139.22 119.28 13.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.578 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD13 HD21 ' A' ' 102' ' ' ASN . 35.2 tp -120.31 140.41 51.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.825 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.08 138.55 57.22 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 79' ' ' VAL . 14.4 mptt -82.16 -10.51 59.14 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.169 0.509 . . . . 0.0 109.995 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -81.12 -8.96 59.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -90.99 11.84 21.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.529 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 76' ' ' LYS . 14.7 m -88.63 146.36 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.121 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.8 -6.98 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 111.393 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.16 -170.76 36.41 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -146.26 148.75 32.78 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.569 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -122.81 121.74 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -123.49 129.31 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.429 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 50.5 mt -129.73 125.54 22.28 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.322 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.5 Cg_endo -82.75 -39.23 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 t -49.92 -39.31 39.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.414 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -116.95 -2.18 9.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.464 0.173 . . . . 0.0 110.777 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m 63.18 50.88 2.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.484 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -108.31 130.6 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.137 -178.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -137.1 114.68 11.12 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.628 HD22 ' HA2' ' A' ' 106' ' ' GLY . 16.6 mt -145.92 111.17 4.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.4 Cg_endo -41.24 142.9 0.86 Allowed 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 121.643 1.562 . . . . 0.0 110.328 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.41 122.95 44.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.84 132.71 47.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.157 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.78 -27.96 68.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.416 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 93.2 p -69.34 -179.52 1.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.543 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -159.15 49.92 0.35 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.085 0.469 . . . . 0.0 110.272 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.5 p -108.03 155.1 20.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.73 -31.31 64.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -72.01 -48.11 47.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.466 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.45 HD21 HD13 ' A' ' 74' ' ' LEU . 12.5 m120 -66.86 -38.56 86.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.183 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 134' ' ' LEU . 12.7 mt -56.35 -16.14 5.14 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.6 mt -70.24 -31.7 69.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.0 m -90.63 -12.22 37.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.628 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 170.87 -175.06 44.72 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.911 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.14 130.66 41.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 97' ' ' SER . . . -104.64 143.25 33.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.838 0.352 . . . . 0.0 110.158 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.8 p -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.445 HG21 HD11 ' A' ' 185' ' ' ILE . 84.1 t -81.31 -50.22 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -94.5 147.64 23.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.997 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -87.45 -6.3 58.47 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -126.78 31.84 5.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.107 0.48 . . . . 0.0 111.329 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -97.59 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.568 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.23 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.987 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.9 125.1 31.67 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.697 0.284 . . . . 0.0 110.395 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.55 72.92 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.87 121.44 13.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.104 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.55 55.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -83.83 110.17 18.14 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -87.48 104.26 16.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.486 ' O ' HD22 ' A' ' 123' ' ' LEU . . . -92.88 121.0 33.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.681 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 122' ' ' ALA . 2.4 mm? -117.31 131.66 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.022 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.07 141.04 43.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.466 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.2 -177.76 15.81 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.536 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.473 ' O ' ' O ' ' A' ' 134' ' ' LEU . 62.1 m-70 -92.99 130.25 38.63 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.083 0.468 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -91.99 28.47 1.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -35.84 -26.2 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.368 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 64.95 34.84 8.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.403 0.62 . . . . 0.0 109.596 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.43 106.91 6.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.39 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -49.11 128.62 16.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.064 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.46 -23.03 14.2 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.809 HG12 ' H ' ' A' ' 134' ' ' LEU . 49.0 t -89.69 178.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.809 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.13 135.5 49.22 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.36 -177.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 44.88 39.41 3.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.193 0.521 . . . . 0.0 110.63 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 60.6 p -81.36 -8.56 59.76 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 136' ' ' SER . 77.8 m-20 -147.6 37.99 0.92 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.8 -29.85 42.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.824 0.345 . . . . 0.0 111.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.02 6.41 4.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.815 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -97.67 -13.75 21.32 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.02 123.31 19.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.896 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 23.2 tptt -96.34 169.46 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.161 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 142' ' ' LYS . 48.9 tttm -68.0 125.8 27.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 97.06 18.73 28.34 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.0 m-20 -84.32 131.76 34.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -79.52 129.99 34.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.894 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.9 mt -125.23 126.12 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.529 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 58.0 m-85 -103.06 118.94 37.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.563 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.702 HD13 ' N ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -115.53 133.67 55.8 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.702 ' N ' HD13 ' A' ' 149' ' ' LEU . 20.6 m-85 -103.08 132.48 49.31 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 111.084 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 50.0 t0 -110.0 -167.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.679 -1.146 . . . . 0.0 107.952 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.519 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -29.66 -72.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.978 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -136.78 29.05 2.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -131.7 150.26 52.21 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -108.75 123.74 49.48 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.378 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 40.1 m-85 -104.99 129.91 53.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.391 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.529 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 73.9 mm-40 -96.65 114.92 26.61 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.15 142.93 45.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.76 132.11 54.08 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.395 0.617 . . . . 0.0 111.238 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 144' ' ' GLY . 53.7 t -66.63 134.37 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.981 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.5 OUTLIER -106.84 -29.18 9.66 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 124.36 1.037 . . . . 0.0 110.437 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.73 157.81 17.15 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.638 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 150.74 33.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.824 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.9 m -156.48 168.2 28.1 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.259 0.552 . . . . 0.0 111.366 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -106.06 132.0 52.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.439 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.02 159.07 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 110.931 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.545 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 71.2 p -77.79 142.44 65.46 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -47.32 -18.81 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.089 1.859 . . . . 0.0 111.604 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -81.24 -2.87 50.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.974 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.6 tptt -82.03 140.59 33.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 94.4 m95 -157.78 -22.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.849 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -56.74 -17.67 9.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.397 0.617 . . . . 0.0 110.429 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.09 -6.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.321 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 185' ' ' ILE . 2.9 m -136.23 43.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 70.5 mm-40 -144.6 84.53 1.74 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.027 -176.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 175' ' ' GLU . 92.3 m-20 27.18 108.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.231 0.957 . . . . 0.0 112.805 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -96.84 -40.34 8.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.313 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.2 29.59 0.72 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.48 178.45 10.22 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -92.83 88.84 6.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.976 0.893 . . . . 0.0 109.511 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -131.63 167.29 19.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.91 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 15.7 tt -131.67 143.42 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.585 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.5 m -136.22 129.71 32.01 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.301 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -112.4 127.58 56.06 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.24 0.543 . . . . 0.0 110.867 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.607 HD13 HG11 ' A' ' 174' ' ' VAL . 3.4 pt -141.17 -167.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.876 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.53 0.206 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -179.858 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 167' ' ' THR . 8.3 ttm180 . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.616 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.0 139.66 48.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 110.091 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -134.45 136.9 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 111.229 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.77 134.2 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.049 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.93 138.1 51.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.542 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.6 139.98 11.39 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.8 t0 -99.05 137.05 38.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.253 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.0 tp -63.75 126.2 26.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.287 0.565 . . . . 0.0 110.881 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.24 -25.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.825 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.7 159.91 16.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.008 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.412 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 59.5 m -135.71 157.18 47.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 206' ' ' THR . 20.2 ptmt -148.64 178.9 8.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.237 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.8 144.88 24.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.289 0.566 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.85 80.69 2.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.472 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.633 178.107 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.485 1.001 0 N-CA-C 110.847 -0.482 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.13 151.34 43.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.975 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.5 mp -55.48 -26.76 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 110.68 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.51 93.99 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.4 mt-10 -73.39 -32.1 64.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.674 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.58 -46.32 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.972 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.76 91.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.157 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.95 -30.12 55.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.395 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.95 158.34 11.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.869 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 p -138.56 158.84 43.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 110.62 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.647 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -139.21 121.48 15.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 111.172 -178.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.647 ' N ' HD13 ' A' ' 74' ' ' LEU . 99.2 m-20 -81.89 110.73 17.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.796 178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -47.13 -16.13 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.226 0.536 . . . . 0.0 110.318 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 75' ' ' ASP . 87.4 tttt -67.44 -33.52 75.32 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.977 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -78.41 9.45 3.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.584 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.5 t -92.91 129.11 43.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.753 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 pt -118.29 -3.43 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.81 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.95 34.41 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -157.06 164.94 37.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.714 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.9 tt -131.07 140.23 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.712 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 m -132.87 133.17 42.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.36 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' CG2' ' OG ' ' A' ' 87' ' ' SER . 67.9 mt -133.17 129.26 20.82 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.546 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.88 -36.18 0.19 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.429 2.086 . . . . 0.0 112.147 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.418 ' OG ' ' CG2' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -47.15 -38.98 12.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.409 -177.188 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.3 p -120.55 0.23 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.828 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 60.71 54.29 3.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 tp -117.74 134.83 54.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.346 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.96 117.38 14.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 83' ' ' ILE . 58.9 mt -143.65 114.02 5.55 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.9 Cg_endo -42.38 146.67 0.67 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 121.892 1.728 . . . . 0.0 109.99 176.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -95.3 123.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.87 123.18 47.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.87 -46.79 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.974 0.416 . . . . 0.0 111.079 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.9 p -69.79 102.87 2.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 98' ' ' SER . 5.6 p -82.77 103.85 12.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.421 0.629 . . . . 0.0 110.329 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 p -142.94 157.12 44.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.944 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -54.71 -32.44 59.58 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.722 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -79.13 -45.08 20.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.687 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HA ' HD21 ' A' ' 102' ' ' ASN . 9.3 m120 -65.19 -34.72 79.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.242 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 134' ' ' LEU . 17.0 mt -61.68 -21.36 64.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.375 0.607 . . . . 0.0 111.808 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.89 -32.93 73.76 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.477 ' OG ' HD23 ' A' ' 74' ' ' LEU . 3.8 p -87.83 -13.58 41.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.57 -171.69 44.18 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.492 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.01 127.55 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.482 . . . . 0.0 110.057 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.73 146.46 29.77 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.844 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 109' ' ' THR . 5.5 p -74.42 151.55 39.62 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.92 -42.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.464 ' N ' HE22 ' A' ' 114' ' ' GLN . 99.2 mttt -88.29 -171.99 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.027 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -116.7 -9.81 11.23 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -145.87 43.41 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.464 HE22 ' N ' ' A' ' 111' ' ' LYS . 1.7 pm0 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.888 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.54 131.36 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.681 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.3 mtt -71.49 128.37 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.075 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 91.17 1.97 71.71 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -141.32 123.7 15.77 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.66 -164.47 54.81 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.43 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 22.1 t-20 -92.28 108.91 20.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -85.37 103.24 14.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.038 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 128.59 36.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.384 0.611 . . . . 0.0 112.15 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.56 130.47 52.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.127 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.71 140.94 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.055 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.49 -178.34 17.59 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 134' ' ' LEU . 56.8 m-70 -93.42 140.92 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.3 p30 -106.44 29.44 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 110.549 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.0 mmm -42.22 -15.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.837 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 61.56 38.0 15.9 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.076 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -133.62 107.65 8.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.984 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -52.92 126.74 21.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.8 -24.61 11.77 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 134' ' ' LEU . 42.4 t -86.66 -179.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.816 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.79 133.03 46.19 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.194 -178.228 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 47.26 40.82 11.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 111.149 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.8 p -81.6 -11.88 58.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.903 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 73.7 m-20 -149.82 42.8 0.88 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.7 pt -68.57 -35.56 70.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 0.0 112.013 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.7 1.58 2.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.2 m -92.66 -13.71 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.161 0.505 . . . . 0.0 110.18 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.4 122.78 18.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.213 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.69 157.91 15.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.792 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.48 127.87 33.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.258 0.551 . . . . 0.0 111.147 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.23 16.51 40.43 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.72 133.84 34.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -81.52 134.56 35.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 111.852 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -127.82 121.04 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -101.76 120.24 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.8 tp -117.72 147.93 42.49 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -122.03 131.86 54.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.153 0.501 . . . . 0.0 111.584 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.9 t0 -112.08 -164.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 151' ' ' ASP . 28.4 m120 -21.95 -78.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.205 0.526 . . . . 0.0 111.406 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -136.31 26.07 3.2 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -123.48 142.22 51.22 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -108.15 120.52 42.58 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 206' ' ' THR . 75.0 m-85 -104.14 130.32 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.152 0.501 . . . . 0.0 111.582 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -93.66 115.27 27.72 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 51.5 m-85 -116.78 138.61 51.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.631 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -118.59 136.79 53.67 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.247 0.546 . . . . 0.0 110.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.78 134.8 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.297 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.5 OUTLIER -107.83 -24.12 11.79 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.357 1.036 . . . . 0.0 111.278 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 166.17 165.9 24.31 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.115 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.29 151.64 31.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.3 p -152.28 161.54 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.04 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -114.15 117.44 31.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.87 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.85 159.25 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.989 0.424 . . . . 0.0 111.28 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 169' ' ' ASP . 33.9 p -69.48 134.27 88.78 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.459 ' HB3' HH21 ' A' ' 196' ' ' ARG . 1.2 Cg_endo -46.25 -12.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.081 1.854 . . . . 0.0 111.749 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 167' ' ' THR . 96.0 m-20 -81.11 -8.73 59.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -85.97 70.1 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.133 0.492 . . . . 0.0 110.259 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.467 ' C ' ' N ' ' A' ' 173' ' ' VAL . 80.8 m95 -70.48 -30.47 67.28 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.441 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -48.81 -14.81 0.07 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.543 . . . . 0.0 110.464 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.467 ' N ' ' C ' ' A' ' 171' ' ' TRP . 86.1 t -75.08 -24.32 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.809 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.91 -6.64 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.703 0.763 . . . . 0.0 109.561 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -80.46 152.8 28.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.861 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p-10 -64.64 128.32 35.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.288 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.441 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.8 m80 -108.69 -42.69 4.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.62 0.248 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.47 23.99 0.09 OUTLIER Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -152.92 171.73 17.88 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -94.75 87.91 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -126.88 126.61 43.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.365 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.5 tt -81.04 148.23 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 184' ' ' LEU . 7.2 m -136.68 121.19 18.26 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.375 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.516 HD12 ' C ' ' A' ' 183' ' ' THR . 10.4 mp -105.35 126.64 52.34 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.28 0.562 . . . . 0.0 111.149 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 29.7 pt -135.2 169.92 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.491 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.569 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 35.5 p . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.362 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 186' ' ' THR . 59.9 ttm-85 . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.48 133.29 49.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 81.8 t -135.16 136.82 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.65 131.65 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.615 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.526 ' O ' HG22 ' A' ' 161' ' ' THR . . . -115.22 136.69 52.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.48 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.45 11.73 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 47.9 p-10 -96.4 141.3 29.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.915 -0.643 . . . . 0.0 111.247 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.12 125.42 25.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.098 0.475 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 72.4 t -107.59 -23.21 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.535 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.83 177.9 45.22 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.883 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 156' ' ' TYR . 15.9 m -154.1 152.63 30.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.159 0.504 . . . . 0.0 111.018 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -151.14 178.8 8.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.371 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.67 145.6 24.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.948 0.404 . . . . 0.0 110.534 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.19 79.04 0.96 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.32 -0.705 0 CA-C-O 117.854 -1.069 . . . . 0.0 110.724 178.59 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.49 1.318 0 CA-C-O 121.153 0.397 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.59 154.79 41.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.1 mm? -57.1 -27.16 61.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.707 0.289 . . . . 0.0 110.601 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.85 91.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.924 0.392 . . . . 0.0 110.041 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.2 mt-10 -74.29 -36.11 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.797 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -74.34 -43.9 49.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.627 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.13 86.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.27 -22.75 30.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.217 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.29 138.35 58.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.397 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -139.97 149.56 43.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.795 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.764 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.3 pt? -139.92 166.76 23.77 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.432 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.31 140.86 43.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.763 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 79' ' ' VAL . 70.2 mmtt -79.57 -2.08 40.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.196 0.522 . . . . 0.0 110.155 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -89.47 -7.25 55.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -85.84 0.33 53.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 76' ' ' LYS . 7.8 p -88.26 135.12 26.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.73 0.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.686 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -177.95 39.83 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -147.53 151.54 36.5 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.194 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 83' ' ' ILE . 14.7 tt -126.21 123.46 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 m -123.18 128.03 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.608 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.72 116.69 13.82 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.71 -33.17 1.31 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.286 1.991 . . . . 0.0 112.376 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.449 ' CB ' HD23 ' A' ' 141' ' ' LEU . 3.0 m -50.73 -37.22 40.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.36 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -117.23 -6.79 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.252 -0.28 . . . . 0.0 110.512 -179.024 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.8 p 71.76 47.82 0.32 Allowed 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.64 127.51 54.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.479 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -132.82 113.9 13.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -145.0 165.43 22.21 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.001 -0.679 . . . . 0.0 112.554 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -89.01 156.38 5.82 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 123.252 2.635 . . . . 0.0 109.264 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.58 114.38 46.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.9 120.9 41.44 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.81 -45.19 83.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.985 0.421 . . . . 0.0 110.776 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 4.2 m -67.05 103.93 1.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.936 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -82.03 109.0 15.96 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 110.318 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.512 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -143.35 155.77 44.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.24 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -61.19 -28.03 68.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -80.22 -46.64 15.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.898 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.4 p-10 -68.78 -31.16 69.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.585 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -61.89 -20.39 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.84 -14.41 61.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.613 ' OG ' HD22 ' A' ' 74' ' ' LEU . 19.9 m -103.22 -10.22 18.94 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.82 -153.04 18.91 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.247 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.81 127.86 44.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.115 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -108.34 148.85 29.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 p -73.53 149.61 42.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.574 HG21 HD11 ' A' ' 185' ' ' ILE . 4.3 t -84.8 -42.22 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 9.5 tptp -90.28 -172.65 3.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.788 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 46.6 tp10 -107.04 -57.9 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.343 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.93 45.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.296 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.45 154.17 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.085 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.19 135.19 63.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 mtp -78.05 122.55 25.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.61 2.43 60.0 Favored Glycine 0 N--CA 1.461 0.314 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -140.59 128.28 21.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.076 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.68 -169.65 49.96 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.5 107.17 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -85.39 103.21 14.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.62 126.27 35.9 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.485 0.66 . . . . 0.0 112.208 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.441 HD13 HD12 ' A' ' 83' ' ' ILE . 11.6 mt -120.49 131.22 54.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.512 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.69 138.49 45.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.582 0.706 . . . . 0.0 110.921 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.69 -178.39 16.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.556 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 80.7 m-70 -90.79 139.69 30.49 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' SER . 64.2 t30 -102.52 28.53 5.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 109.91 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.49 -24.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.184 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 64.44 36.71 8.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.416 0.627 . . . . 0.0 109.61 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.458 ' N ' ' OG ' ' A' ' 136' ' ' SER . 26.1 mtpp -134.34 111.67 10.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.917 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.41 126.12 18.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.625 0.726 . . . . 0.0 110.226 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.6 9.7 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.564 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.76 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.6 t -79.09 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 117.749 0.775 . . . . 0.0 109.484 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.76 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.57 134.37 46.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.24 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 45.17 33.78 1.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.159 0.504 . . . . 0.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.458 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.2 -8.51 59.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -146.68 39.74 1.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.29 -30.02 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.863 0.363 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.06 3.36 5.55 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.135 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -95.81 -13.9 23.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.449 HD23 ' CB ' ' A' ' 87' ' ' SER . 15.2 mt -66.21 126.4 28.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.704 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -97.2 158.84 15.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.415 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.16 138.64 58.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.434 0.635 . . . . 0.0 111.317 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.61 65.09 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -81.11 136.83 35.96 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.2 122.64 25.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.635 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mm -115.39 119.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.73 118.23 36.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 tp -119.94 154.96 33.69 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.02 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -127.32 135.68 50.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.505 0.669 . . . . 0.0 112.118 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.0 t0 -115.52 -167.04 1.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.29 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.224 0.535 . . . . 0.0 111.798 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -138.09 28.66 2.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -127.8 140.58 51.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.522 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 78.7 tt0 -103.35 122.17 44.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.572 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.445 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 55.0 m-85 -104.25 127.05 51.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.394 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 157' ' ' GLU . 39.7 mp0 -94.64 115.45 27.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.071 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -119.14 134.08 55.41 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.342 0.591 . . . . 0.0 110.718 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.04 133.42 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.736 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.4 p -103.79 -26.81 12.57 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 124.524 1.14 . . . . 0.0 110.794 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.36 165.6 19.65 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.995 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.7 p -121.79 149.21 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 198' ' ' VAL . 19.5 m -153.22 164.28 38.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.088 0.47 . . . . 0.0 111.196 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -107.82 102.83 12.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.437 HG22 HG11 ' A' ' 198' ' ' VAL . 11.3 m -117.05 144.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.102 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.8 p -61.32 167.02 4.42 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.54 -14.48 11.56 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.958 1.772 . . . . 0.0 111.982 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 65.9 t0 -84.54 -20.28 31.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -85.82 81.27 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.538 . . . . 0.0 110.214 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.547 ' C ' ' H ' ' A' ' 173' ' ' VAL . 95.4 m95 -75.77 -15.16 60.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.898 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.624 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 40.7 mp0 -51.99 -6.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.146 0.498 . . . . 0.0 110.968 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 171' ' ' TRP . 73.2 t -88.65 -19.06 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.163 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.68 -6.29 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.488 0.661 . . . . 0.0 109.383 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -82.07 150.9 27.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.18 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -60.72 127.29 30.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 25.9 m170 -116.44 24.3 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.77 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 15.62 68.05 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -149.64 167.89 25.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 111.183 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.65 97.84 8.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.717 0.77 . . . . 0.0 110.734 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.73 135.09 45.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.36 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.4 tt -82.62 147.96 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 173' ' ' VAL . 7.3 m -136.5 117.54 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.931 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 184' ' ' LEU . 10.4 mp -101.73 124.19 46.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.071 0.462 . . . . 0.0 110.174 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 110' ' ' VAL . 13.8 pt -137.38 -176.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.06 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.551 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 43.0 p . . . . . 0 CA--C 1.534 0.362 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.1 ttm180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.177 0.513 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -108.66 139.12 43.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.395 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 164' ' ' SER . 3.4 p -135.35 139.04 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.394 0.616 . . . . 0.0 111.467 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.53 130.63 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.79 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.81 135.65 53.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.263 0.554 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.52 153.71 20.56 Favored Glycine 0 N--CA 1.46 0.292 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 50.5 p-10 -108.18 142.27 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.728 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.08 127.87 34.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.413 0.625 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 159' ' ' ALA . 91.7 t -107.84 -26.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.186 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.16 162.17 20.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 25.5 m -136.88 156.17 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.245 0.545 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.522 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.1 pttp -150.9 179.13 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.08 142.87 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.401 0.62 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -61.97 81.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.561 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttp . . . . . 0 C--N 1.313 -0.983 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.57 178.427 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.493 1.479 0 CA-C-O 120.988 0.328 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -73.42 158.36 35.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.227 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -54.71 -25.85 30.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.893 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.32 91.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.5 mt-10 -75.08 -26.08 59.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.235 0.541 . . . . 0.0 110.474 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.8 t -79.4 -49.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.942 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.95 81.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.173 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -68.78 -32.1 71.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.334 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.24 113.3 2.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.938 0.399 . . . . 0.0 111.219 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -92.21 133.59 35.67 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.97 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.521 HD13 ' ND2' ' A' ' 102' ' ' ASN . 61.2 tp -129.57 134.85 47.96 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.757 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -94.02 132.26 38.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.568 ' O ' HG12 ' A' ' 79' ' ' VAL . 69.5 mmtt -66.34 -9.5 33.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.474 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 79' ' ' VAL . 63.7 mttp -65.44 -34.37 78.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.835 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.23 17.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.8 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.8 p -92.31 127.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pt -122.45 -2.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.03 38.49 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.479 ' O ' HD23 ' A' ' 149' ' ' LEU . 32.4 mtm180 -147.88 153.28 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.854 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 83' ' ' ILE . 16.1 tt -124.69 122.27 63.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m -121.35 127.96 51.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.584 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.4 mt -133.75 120.42 15.47 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.81 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.84 -32.33 1.55 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.829 1.686 . . . . 0.0 112.331 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.1 p -47.87 -37.39 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.975 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.7 p -118.32 0.12 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.476 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t 63.49 52.79 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -119.54 133.07 55.84 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -135.31 119.74 17.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 mt -145.46 167.32 14.68 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.023 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.94 150.09 7.09 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.886 2.391 . . . . 0.0 109.652 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.6 t -102.18 113.91 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.45 -45.05 85.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.972 0.415 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.5 p -71.33 106.91 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.232 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.7 p -83.79 107.14 16.02 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.094 0.473 . . . . 0.0 110.234 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.8 p -137.43 156.59 48.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.113 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -57.86 -36.45 72.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -74.72 -43.65 53.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.387 0.613 . . . . 0.0 112.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.521 ' ND2' HD13 ' A' ' 74' ' ' LEU . 8.3 m120 -66.43 -35.45 80.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.441 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 126' ' ' HIS . 36.4 mt -65.56 -15.93 63.19 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.65 -14.18 60.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.8 m -116.53 -7.41 11.63 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.0 -163.83 28.74 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.117 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -101.49 130.33 47.74 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.083 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.25 147.91 34.02 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.3 p -76.47 153.79 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.06 -46.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -92.18 142.16 27.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.123 0.487 . . . . 0.0 111.179 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.4 pt-20 -62.58 -51.41 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.662 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 88.1 m-20 -96.75 47.88 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.379 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -83.59 154.22 23.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.79 130.25 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.595 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.43 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.1 mtt -72.61 128.39 35.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.762 0.315 . . . . 0.0 110.948 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.522 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.19 4.91 73.7 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -140.93 120.65 13.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.257 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.64 -166.9 54.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -85.07 106.29 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.57 101.18 11.91 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.93 130.82 36.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.991 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.92 132.21 53.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.09 137.72 46.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.351 0.596 . . . . 0.0 110.596 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.404 ' HA3' ' CD2' ' A' ' 135' ' ' PHE . . . -145.19 -176.5 19.22 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.517 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 103' ' ' LEU . 76.3 m-70 -93.28 157.51 16.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.826 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.0 p-10 -122.05 29.04 7.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.585 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.2 mmt -38.15 -20.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.636 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 59.93 37.44 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.275 0.56 . . . . 0.0 109.836 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 136' ' ' SER . 58.3 tttp -136.49 107.73 6.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.767 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.469 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -58.4 130.24 45.81 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.59 0.71 . . . . 0.0 111.249 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.02 15.61 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.176 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 134' ' ' LEU . 2.0 t -96.97 177.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.616 ' H ' HG12 ' A' ' 133' ' ' VAL . 1.3 pt? -71.62 136.38 47.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.754 0.788 . . . . 0.0 112.355 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.4 m-85 46.45 31.92 1.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.429 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.0 p -81.75 -6.03 58.68 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.7 m-20 -146.97 43.1 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.091 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.9 pt -69.97 -30.69 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.261 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.06 7.28 2.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 t -95.56 -14.71 23.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.14 123.72 18.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.81 154.21 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.62 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.93 130.61 47.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.64 21.99 41.55 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 37.7 m-20 -87.0 134.77 33.45 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -81.5 129.64 34.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.529 0.68 . . . . 0.0 112.147 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 90.1 mt -123.39 123.92 68.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.817 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -105.05 121.84 44.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.344 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 82' ' ' ARG . 2.3 mt -113.0 153.17 28.49 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.167 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -127.2 131.23 50.71 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.344 0.592 . . . . 0.0 111.756 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 42.0 t0 -115.04 -168.06 1.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 89.5 m-20 -20.87 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.082 0.468 . . . . 0.0 112.137 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -140.17 25.32 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -122.83 142.3 50.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -106.33 122.08 45.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.87 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.47 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.3 m-85 -104.01 126.62 51.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.987 0.422 . . . . 0.0 111.667 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.66 117.12 29.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 19.6 m-85 -116.55 147.11 42.13 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.381 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.57 134.83 53.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 110.489 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 55.7 t -70.15 133.61 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.706 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.7 p -101.1 -25.4 14.05 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 124.51 1.131 . . . . 0.0 110.349 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.08 156.3 7.99 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.356 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.34 147.82 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.639 -0.781 . . . . 0.0 109.871 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.2 p -148.64 159.59 43.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.173 0.511 . . . . 0.0 111.334 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.81 119.6 39.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.437 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.09 159.84 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.1 p -76.72 142.92 70.68 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.42 -18.55 3.76 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.89 1.727 . . . . 0.0 111.836 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -83.44 -6.67 59.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -83.36 70.63 10.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.263 0.554 . . . . 0.0 110.331 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.498 ' C ' ' H ' ' A' ' 173' ' ' VAL . 85.0 m95 -71.46 -28.53 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.57 -11.36 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.058 0.456 . . . . 0.0 110.475 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 171' ' ' TRP . 43.9 t -80.48 -22.68 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.72 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -110.08 -6.86 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.756 0.788 . . . . 0.0 109.282 -178.631 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.01 137.08 37.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.981 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 39.9 p-10 -51.97 127.28 20.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.962 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -104.86 -43.39 5.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.46 26.33 0.1 Allowed Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -152.85 173.37 15.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.244 0.545 . . . . 0.0 111.157 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 11.5 m-20 -94.23 89.39 5.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.049 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -128.89 127.28 41.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.678 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.0 tt -82.42 146.81 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.453 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.1 m -135.91 119.31 16.83 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.547 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -105.75 124.73 50.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.012 0.434 . . . . 0.0 109.912 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.538 HD13 HG11 ' A' ' 174' ' ' VAL . 8.9 pt -135.88 173.2 14.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.79 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.176 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.689 0.28 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -102.92 131.25 49.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.6 p -133.79 137.47 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.02 130.35 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.44 136.92 52.48 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.593 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.73 147.99 19.36 Favored Glycine 0 N--CA 1.466 0.671 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -100.84 140.87 34.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.02 -0.59 . . . . 0.0 112.163 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 49.5 tp -64.46 129.44 39.89 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.212 0.529 . . . . 0.0 110.291 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 159' ' ' ALA . 64.5 t -107.72 -27.07 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.125 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.35 20.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.202 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.47 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 34.6 m -135.04 156.06 49.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.201 0.524 . . . . 0.0 109.814 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 206' ' ' THR . 20.6 ptmt -149.53 180.0 7.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.903 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.66 145.48 24.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.225 0.536 . . . . 0.0 110.787 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -74.51 81.17 1.95 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.647 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.642 178.845 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.49 1.321 0 CA-C-O 121.023 0.343 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.5 m-20 -75.51 158.67 32.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.23 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.05 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.198 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.05 -52.46 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.76 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 5.2 pt-20 -74.08 -17.84 60.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 65' ' ' ASP . 49.3 t -77.69 -54.73 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.903 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.38 84.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.272 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.55 110.77 1.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.793 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.6 m -94.35 120.48 34.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.1 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.514 HD11 ' OE1' ' A' ' 78' ' ' GLN . 41.7 tp -113.84 129.08 56.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.61 139.82 55.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -73.31 -8.72 57.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.24 0.543 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.48 -32.77 74.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.514 ' OE1' HD11 ' A' ' 74' ' ' LEU . 85.7 mt-30 -77.17 11.48 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.1 t -91.34 123.72 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -122.42 -5.21 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.984 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.25 -169.61 38.62 Favored Glycine 0 C--N 1.316 -0.54 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -146.48 154.01 41.08 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.251 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.9 tt -121.89 124.54 71.6 Favored 'Isoleucine or valine' 0 C--O 1.23 0.056 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -127.53 130.86 49.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -133.63 129.13 20.31 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.569 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -35.89 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.392 2.061 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -49.41 -40.19 35.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.529 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -119.57 -0.94 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.241 0.216 . . . . 0.0 110.819 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.33 52.14 3.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.2 tp -110.61 130.7 55.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.045 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -133.21 114.83 14.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 83' ' ' ILE . 50.4 mt -143.92 110.51 5.17 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.73 136.7 1.88 Allowed 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.6 1.533 . . . . 0.0 110.764 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.71 123.07 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.9 mt -103.4 131.0 50.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.34 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 97' ' ' SER . 20.1 pttp -72.44 -42.84 64.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.464 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 55.5 m -74.68 103.13 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.245 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.5 p -82.36 94.41 7.37 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.281 0.562 . . . . 0.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.416 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 2.4 p -134.31 154.38 51.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.903 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -56.46 -37.35 70.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -71.86 -46.28 58.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.501 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.502 ' ND2' HD13 ' A' ' 74' ' ' LEU . 6.9 m120 -66.2 -36.3 82.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.561 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.69 -16.18 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.721 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.0 mt -70.13 -27.61 64.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -93.36 -10.27 35.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 167.51 -174.43 42.61 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.983 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.46 130.17 38.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.294 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 147.46 29.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.865 0.364 . . . . 0.0 110.876 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.0 p -73.14 149.45 43.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.88 -43.24 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.74 141.36 28.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.18 0.514 . . . . 0.0 111.183 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.21 -16.09 41.37 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.56 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -144.27 56.51 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.31 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.45 ' NE2' ' CG ' ' A' ' 121' ' ' TYR . 3.0 tt0 -77.9 159.84 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.0 121.81 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.016 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -72.77 128.02 34.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.443 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.86 73.45 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -142.13 121.53 13.19 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 76.17 -174.71 53.13 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.491 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.9 t30 -83.79 110.43 18.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.45 ' CG ' ' NE2' ' A' ' 114' ' ' GLN . 6.8 t80 -83.52 103.59 12.98 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 130.4 36.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.109 0.48 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 HD12 ' A' ' 83' ' ' ILE . 7.9 mt -127.42 130.65 49.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.89 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.31 140.19 46.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 110.578 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.2 179.65 20.56 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.615 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -84.81 154.78 22.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.792 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 129' ' ' SER . 14.8 p30 -121.97 29.18 7.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.655 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.3 mtt -43.46 -13.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.776 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 61.78 38.35 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.935 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -135.11 107.7 7.4 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.89 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.29 125.61 12.93 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.634 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.73 8.97 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.927 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.5 t -83.48 179.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.584 0.692 . . . . 0.0 109.183 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.778 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.42 132.45 43.93 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.436 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 49.13 38.08 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.219 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.17 -12.31 58.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.8 m-20 -147.98 34.06 0.83 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 140' ' ' SER . 7.3 pt -68.87 -32.19 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.425 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.63 2.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.706 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 138' ' ' ILE . 8.5 t -93.5 -14.86 26.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.48 120.29 12.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.069 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mmtt -104.93 155.72 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -53.68 114.81 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.214 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.22 21.58 5.17 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 96.9 m-20 -99.16 128.02 45.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.94 133.14 35.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.792 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 93.1 mt -126.39 125.72 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.927 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.9 123.13 48.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.725 0.298 . . . . 0.0 110.759 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -112.48 146.36 38.59 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.067 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -116.05 131.16 57.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 152' ' ' ASN . 46.9 t0 -114.27 -166.52 1.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.6 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 111.852 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -138.41 29.86 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -128.96 145.23 51.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -111.52 121.78 46.08 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -102.73 133.51 47.64 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 111.513 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.1 118.08 31.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.765 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.416 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 41.3 m-85 -119.06 140.25 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.155 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.46 134.82 55.22 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.51 0.672 . . . . 0.0 110.449 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.29 135.64 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.733 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -101.46 -24.54 14.15 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 124.888 1.367 . . . . 0.0 110.764 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.58 154.08 7.32 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.294 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 163' ' ' VAL . 9.9 p -98.45 129.41 48.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.832 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.4 m -132.01 149.53 52.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.296 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -109.18 116.64 32.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.343 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -133.95 153.17 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.9 p -64.56 169.09 5.51 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 -13.87 11.81 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.884 1.723 . . . . 0.0 111.71 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.58 -19.66 41.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.639 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -85.79 75.34 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 109.944 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -74.74 -9.63 58.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.041 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -53.4 -22.47 7.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.78 ' O ' HG21 ' A' ' 183' ' ' THR . 79.9 t -81.03 -10.82 12.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.049 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.13 -12.08 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.739 0.78 . . . . 0.0 110.178 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.11 157.81 20.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.376 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 66.2 t0 -66.54 131.17 45.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.42 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 31.3 m80 -101.26 -41.63 6.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.35 29.9 0.24 Allowed Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.448 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 48.5 pttt -157.44 179.25 9.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.547 . . . . 0.0 111.515 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 26.7 p30 -90.81 88.81 7.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.866 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -123.63 166.56 15.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.128 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.85 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.78 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.78 HG21 ' O ' ' A' ' 173' ' ' VAL . 19.0 m -135.7 123.85 23.02 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.059 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 183' ' ' THR . 10.2 mp -111.79 125.09 53.63 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.129 0.49 . . . . 0.0 110.078 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.477 HG22 HG13 ' A' ' 198' ' ' VAL . 36.2 pt -134.32 162.1 39.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.001 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 64.6 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.413 179.225 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -110.63 138.72 46.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.303 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.503 HG11 HG11 ' A' ' 173' ' ' VAL . 50.1 t -133.33 136.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.23 128.43 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.562 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.63 136.52 52.9 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.331 0.586 . . . . 0.0 110.314 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.09 158.01 24.08 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.598 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 63.1 t0 -113.77 146.3 40.11 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.568 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.0 tp -68.04 130.82 44.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.062 0.458 . . . . 0.0 110.716 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.77 -22.85 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.5 175.89 45.96 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.329 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 207' ' ' LYS . 60.9 m -154.23 154.13 32.94 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.344 0.592 . . . . 0.0 111.014 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 206' ' ' THR . 63.8 pttt -148.33 177.58 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.524 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.69 142.78 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.061 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.23 80.81 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.272 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 208' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.55 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.251 0 CA-C-O 121.068 0.362 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -75.68 158.05 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 66' ' ' LEU . 1.7 tt -57.09 -28.77 62.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.069 0.461 . . . . 0.0 110.095 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.52 97.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.647 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 97.7 mt-10 -73.63 -31.46 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.327 0.584 . . . . 0.0 110.789 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.8 t -75.48 -46.38 37.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.783 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.25 87.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.926 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.4 -30.37 64.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.342 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.56 119.68 9.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.811 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 m -93.21 156.51 16.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -138.29 122.1 17.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.918 0.389 . . . . 0.0 110.81 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.634 ' N ' HD13 ' A' ' 74' ' ' LEU . 99.2 m-20 -83.55 108.74 16.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 11.7 mptt -47.71 -15.39 0.06 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.082 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.479 ' N ' ' C ' ' A' ' 75' ' ' ASP . 99.2 mttt -69.51 -8.26 45.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.77 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.61 6.45 48.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.923 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.1 t -91.06 128.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.942 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.2 -6.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.728 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.61 -167.47 35.28 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 83' ' ' ILE . 19.4 ttm180 -150.96 157.0 42.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.402 0.62 . . . . 0.0 111.07 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.4 ' N ' ' CG ' ' A' ' 82' ' ' ARG . 15.8 tt -129.88 134.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.979 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.1 t -131.53 133.3 44.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.951 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.6 mt -136.0 127.92 17.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.329 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.21 -33.08 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.41 2.073 . . . . 0.0 112.02 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -49.12 -41.93 37.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.586 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -116.09 -1.69 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.8 -0.182 . . . . 0.0 110.878 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 64.38 50.04 2.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.8 tp -113.47 130.9 56.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.259 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -134.77 116.06 14.43 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.9 mt -143.7 163.28 37.06 Favored Pre-proline 0 N--CA 1.463 0.183 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.737 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.5 157.5 6.53 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.981 2.454 . . . . 0.0 109.235 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.0 t -107.01 117.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.0 mt -101.21 129.99 47.24 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -71.06 -36.99 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.986 0.422 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.0 m -75.54 100.12 4.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 98' ' ' SER . 53.5 p -82.85 92.93 7.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.2 p -133.81 155.87 49.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.016 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -55.36 -32.67 62.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.402 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -76.57 -46.5 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.003 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -66.25 -34.45 78.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.832 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.92 -18.88 59.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.63 -18.24 61.6 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.8 m -99.9 -11.25 20.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.53 -155.88 25.77 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.973 -1.108 . . . . 0.0 111.658 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.29 126.17 36.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.889 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.95 144.26 32.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -75.55 152.96 37.68 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.44 -47.96 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -92.44 137.64 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 110.853 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 14.2 pt-20 -62.89 -47.11 84.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.869 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 61.6 t-20 -96.74 47.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.404 ' NE2' ' CE1' ' A' ' 121' ' ' TYR . 3.2 tt0 -91.55 155.38 18.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.4 t -130.27 133.79 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.202 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.6 mtp -73.51 126.24 29.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.704 0.288 . . . . 0.0 110.474 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.31 67.43 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.26 120.08 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.092 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.21 -178.31 41.32 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -73.82 107.43 6.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.404 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 10.6 t80 -84.26 103.51 13.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.97 126.55 35.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.122 0.486 . . . . 0.0 111.495 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -121.4 131.31 54.1 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.69 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 139.17 45.01 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.311 0.577 . . . . 0.0 110.662 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.78 15.17 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.701 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -92.44 146.09 23.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.726 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.8 p30 -108.01 27.53 9.16 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.293 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -42.18 -16.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.701 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 127' ' ' ASN . 2.6 t 55.06 37.14 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.812 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -133.87 111.96 10.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.458 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.67 123.66 14.83 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.152 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.43 5.93 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 134' ' ' LEU . 41.8 t -137.37 177.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.761 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -69.76 128.0 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.758 0.313 . . . . 0.0 110.644 -178.164 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 47.41 38.5 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 110.468 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.39 -6.02 59.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.723 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.6 t0 -151.16 39.97 0.69 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.071 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.0 pt -69.02 -30.18 45.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.49 4.14 3.28 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 49.6 m -95.69 -14.48 23.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 109.749 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.01 124.81 23.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.529 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -96.73 156.57 16.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.755 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.21 128.8 38.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.415 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.5 20.81 43.1 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.403 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 30.0 m-20 -82.36 136.36 35.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.495 ' NZ ' HG11 ' A' ' 204' ' ' VAL . 27.9 mmtt -80.35 126.63 31.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 112.1 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.68 118.01 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 121.3 41.26 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.2 tp -114.28 142.84 45.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.984 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.17 136.42 44.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.242 0.544 . . . . 0.0 111.468 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 154' ' ' ASN . 40.9 t0 -113.0 177.0 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.347 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' A' ' 153' ' ' GLU . 19.4 p-10 -35.79 -54.46 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.409 0.623 . . . . 0.0 111.338 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 97.7 mt-10 -141.69 16.56 2.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -128.63 142.42 51.04 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -109.35 124.02 50.28 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CE2' HG21 ' A' ' 206' ' ' THR . 56.7 m-85 -106.55 134.99 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.388 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.73 118.49 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.408 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -115.88 138.0 51.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.246 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.78 132.58 55.11 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.429 0.633 . . . . 0.0 110.822 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 48.6 t -66.98 134.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.7 p -101.75 -28.33 12.52 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 124.443 1.089 . . . . 0.0 110.799 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.44 143.73 4.39 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.775 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.43 137.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 18.8 t -159.56 171.11 20.24 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.136 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -122.53 130.27 52.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.426 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.12 157.37 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.492 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 169' ' ' ASP . 6.8 p -68.56 130.18 92.16 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.452 ' HG3' HH21 ' A' ' 196' ' ' ARG . 1.5 Cg_endo -46.38 -11.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.921 1.747 . . . . 0.0 111.648 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 167' ' ' THR . 43.1 t0 -75.69 -22.2 56.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -84.82 73.15 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.009 0.433 . . . . 0.0 110.134 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -71.69 -14.66 62.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.513 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.479 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.5 mt-10 -52.97 -34.38 55.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.216 0.531 . . . . 0.0 110.074 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.714 ' O ' HG21 ' A' ' 183' ' ' THR . 97.2 t -70.94 -5.22 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.024 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.77 -14.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.678 0.751 . . . . 0.0 109.969 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -86.2 177.16 7.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.835 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.3 p-10 -81.74 131.66 35.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.479 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 42.9 m80 -103.21 -41.76 5.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.9 27.13 0.13 Allowed Glycine 0 N--CA 1.471 0.98 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -157.47 179.56 9.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 111.411 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -89.98 90.25 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -121.01 166.93 13.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.081 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.9 tt -132.32 144.07 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.714 HG21 ' O ' ' A' ' 173' ' ' VAL . 18.8 m -135.72 126.37 27.15 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.196 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -112.55 118.23 34.52 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.409 HG22 HG13 ' A' ' 198' ' ' VAL . 12.0 pt -134.3 171.67 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.643 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.57 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.3 p . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.716 0.293 . . . . 0.0 110.892 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.57 ' NH1' ' O ' ' A' ' 186' ' ' THR . 16.7 ptp180 . . . . . 0 N--CA 1.463 0.211 0 CA-C-O 120.961 0.41 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.34 140.66 44.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.409 HG13 HG22 ' A' ' 185' ' ' ILE . 47.4 t -129.61 132.17 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.132 0.492 . . . . 0.0 111.14 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.7 t -116.22 127.31 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.512 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.19 135.56 53.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.92 157.5 25.37 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 60.6 t0 -115.11 152.49 32.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.446 -0.377 . . . . 0.0 111.161 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.562 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.95 129.24 38.09 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.085 0.469 . . . . 0.0 110.767 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.495 HG11 ' NZ ' ' A' ' 146' ' ' LYS . 5.1 p -107.81 -25.97 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.011 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.68 175.29 47.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.219 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.428 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.5 m -152.67 150.26 29.28 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.194 0.521 . . . . 0.0 110.883 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -148.62 178.0 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.538 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.97 21.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.151 0.5 . . . . 0.0 110.817 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -77.08 79.82 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.744 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.561 178.422 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.483 0.863 0 N-CA-C 110.984 -0.429 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -74.58 160.29 31.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.1 mp -64.66 -21.31 66.7 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.251 0.344 . . . . 0.0 110.862 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.73 -40.28 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.49 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.3 mt-10 -72.29 -34.91 68.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.623 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.8 t -75.07 -45.2 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.074 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.5 87.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.02 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -84.04 -23.31 30.96 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.621 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.23 118.98 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.336 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -94.78 140.75 29.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.198 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 ' CB ' ' A' ' 105' ' ' SER . 57.4 tp -115.42 140.71 48.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.452 ' C ' ' N ' ' A' ' 77' ' ' LYS . 39.2 m-20 -95.11 100.92 12.65 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -46.89 -18.06 0.06 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.452 ' N ' ' C ' ' A' ' 75' ' ' ASP . 3.2 ttmp? -65.95 -33.8 76.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.312 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 0.9 OUTLIER -80.08 13.94 2.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.817 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.467 HG11 ' NH1' ' A' ' 82' ' ' ARG . 89.1 t -91.49 127.48 43.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.633 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.15 -6.31 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.106 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.83 -173.19 43.94 Favored Glycine 0 C--N 1.321 -0.284 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.497 ' O ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -141.87 153.94 44.79 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.841 -177.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.8 tt -125.75 131.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 t -134.01 132.02 39.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.692 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.17 128.74 19.6 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.17 -36.67 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.412 2.075 . . . . 0.0 112.376 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -48.4 -39.98 24.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.51 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.3 p -119.31 -1.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.372 0.42 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.75 50.24 4.46 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.11 131.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.574 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.79 114.66 12.09 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 83' ' ' ILE . 76.2 mt -142.53 112.35 5.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -40.05 140.61 0.79 Allowed 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.661 1.574 . . . . 0.0 110.302 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.6 t -93.15 122.02 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.66 123.47 48.55 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.484 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.06 -47.8 76.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.184 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -71.7 105.88 3.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.878 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -85.8 100.95 12.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.5 p -131.75 156.96 45.05 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.104 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.66 -28.99 61.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -82.87 -42.39 17.82 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.882 0.739 . . . . 0.0 111.936 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.63 -38.09 88.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.136 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.62 -19.76 62.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.061 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.49 -33.17 70.93 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.45 ' CB ' HD22 ' A' ' 74' ' ' LEU . 16.2 m -95.58 -9.47 32.19 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 177.43 179.57 47.73 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.254 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.89 127.82 33.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.948 -0.626 . . . . 0.0 109.84 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.63 146.14 31.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.4 p -76.4 153.87 35.34 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.0 t -85.43 -48.18 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -92.26 137.72 32.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.41 0.624 . . . . 0.0 110.698 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.9 pt-20 -60.32 -47.6 85.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.161 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 98.8 m-20 -98.8 47.41 0.98 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.39 155.45 21.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.964 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.9 131.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.409 ' SD ' HD22 ' A' ' 149' ' ' LEU . 65.3 mtt -74.98 128.0 34.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.11 0.54 70.94 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -139.36 118.15 12.38 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.017 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -171.86 53.65 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -83.66 110.81 18.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.1 102.9 13.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 128.99 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.597 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.5 HD13 HD12 ' A' ' 83' ' ' ILE . 6.5 mt -123.96 130.45 52.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.331 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.92 138.21 47.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.318 0.58 . . . . 0.0 110.806 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.36 -179.05 17.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.259 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 134' ' ' LEU . 37.5 m-70 -86.46 144.44 27.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.455 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 129' ' ' SER . 8.1 t-20 -110.99 28.19 8.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.061 0.458 . . . . 0.0 110.652 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -47.37 -11.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.11 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 127' ' ' ASN . 2.3 t 56.1 40.67 30.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.024 -0.671 . . . . 0.0 109.928 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.31 105.93 7.6 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -50.42 124.94 11.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.614 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -26.4 9.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.374 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.803 HG12 ' H ' ' A' ' 134' ' ' LEU . 39.7 t -82.82 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.803 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -72.88 132.33 43.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.482 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 48.85 37.79 10.68 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.93 0.395 . . . . 0.0 111.345 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -82.12 -11.4 58.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 136' ' ' SER . 83.7 m-20 -145.51 38.13 1.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -66.09 -36.13 76.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB2' ' CG ' ' A' ' 197' ' ' TYR . . . -68.48 3.08 1.95 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.815 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 138' ' ' ILE . 6.3 t -96.49 -11.19 25.88 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.279 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.39 122.26 18.03 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.538 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 64.4 mttp -95.57 161.46 14.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.391 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -61.12 135.12 57.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.46 19.08 57.61 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 2.6 m-20 -85.1 130.05 34.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.88 131.09 35.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.2 mt -122.57 123.09 67.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -100.63 118.67 37.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.5 mt -113.53 149.15 34.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.194 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -124.64 130.26 52.09 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.433 0.635 . . . . 0.0 111.416 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.7 t0 -113.52 -168.52 1.35 Allowed 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 90.9 m-20 -24.86 -71.69 0.03 OUTLIER 'General case' 0 C--O 1.232 0.154 0 O-C-N 123.475 0.485 . . . . 0.0 111.579 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.62 26.6 2.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.25 146.87 44.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -111.74 118.7 36.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.735 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.492 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.7 m-85 -105.44 127.99 53.29 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.571 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -98.82 122.75 42.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.926 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -122.08 142.32 50.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 135.02 55.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.335 0.588 . . . . 0.0 110.703 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.7 133.35 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.51 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.1 t -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.64 1.212 . . . . 0.0 111.515 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.32 149.95 6.51 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.3 t -104.8 134.38 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -135.66 151.31 50.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.444 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.72 116.87 32.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.634 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.77 154.84 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 169' ' ' ASP . 23.4 p -78.16 140.46 61.5 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.59 -18.26 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.975 1.783 . . . . 0.0 111.867 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.7 m-20 -77.4 -21.19 53.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.025 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -83.03 70.54 10.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.119 0.568 . . . . 0.0 110.176 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.528 ' C ' ' H ' ' A' ' 173' ' ' VAL . 82.0 m95 -70.48 -27.04 63.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.944 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.4 -10.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.631 0.582 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.5 t -80.95 -23.69 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.501 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.01 -5.33 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.588 0.708 . . . . 0.0 110.015 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.35 142.06 36.38 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.925 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -54.84 128.98 35.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -102.4 -42.72 5.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.49 28.52 0.15 Allowed Glycine 0 N--CA 1.471 0.985 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -157.15 179.76 8.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.999 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 8.1 m-20 -93.87 94.12 8.32 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 182' ' ' ILE . 46.1 tt0 -127.54 170.87 12.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.906 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.409 ' H ' ' HG2' ' A' ' 181' ' ' GLU . 20.6 tt -131.63 143.19 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.709 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.496 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.7 m -138.29 116.89 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -102.38 119.59 39.08 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.605 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -130.97 -169.97 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.379 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 31.0 p . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.376 -178.857 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.45 0.167 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' A' ' 139' ' ' ALA . 4.9 m-85 -117.3 132.44 56.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.528 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 185' ' ' ILE . 48.3 t -135.6 136.57 50.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.091 0.472 . . . . 0.0 111.046 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.96 129.65 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.673 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.66 133.39 55.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.144 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.77 146.62 17.1 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 121.807 0.671 . . . . 0.0 111.706 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -105.32 139.12 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.714 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.18 129.16 38.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.937 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 p -106.41 -25.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.073 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.27 159.6 16.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.453 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.492 HG21 ' CE2' ' A' ' 156' ' ' TYR . 29.9 m -135.7 155.02 51.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.86 177.78 9.51 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.3 144.34 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.551 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.07 79.09 0.67 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.023 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.548 178.813 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.486 1.057 0 N-CA-C 111.262 -0.322 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.99 152.51 41.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.691 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.2 pt? -59.0 -23.98 62.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.402 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.6 mt-10 -73.07 -33.07 65.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.606 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.3 -42.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.1 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.09 92.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.405 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.1 p-10 -86.31 -15.14 41.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.669 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.08 120.27 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.107 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.2 p -91.39 159.55 15.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.11 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.11 142.57 44.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -94.12 100.51 12.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -57.23 -14.93 4.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.049 0.452 . . . . 0.0 110.347 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -76.44 -14.55 60.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.146 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.47 13.17 34.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.529 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.13 135.99 24.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.988 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.408 HD13 ' HB3' ' A' ' 96' ' ' LYS . 4.4 pt -117.5 -3.55 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.035 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.63 34.86 Favored Glycine 0 C--N 1.317 -0.518 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -154.05 165.26 36.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.808 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 tt -134.3 140.96 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.891 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 t -133.52 135.79 44.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.362 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 14.0 mt -134.58 127.77 18.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.802 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.55 -38.34 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.357 2.038 . . . . 0.0 112.584 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -47.37 -41.01 18.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.599 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.4 p -116.69 -3.31 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.828 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.83 49.46 1.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -107.49 127.3 53.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.865 -178.37 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.649 ' N ' HD13 ' A' ' 90' ' ' LEU . 83.2 tt0 -138.16 116.14 11.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.645 HD23 ' HD2' ' A' ' 93' ' ' PRO . 2.7 mt -157.71 127.52 3.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.471 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.645 ' HD2' HD23 ' A' ' 92' ' ' LEU . 1.3 Cg_endo -42.96 159.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.929 0 C-N-CA 121.928 1.752 . . . . 0.0 109.703 176.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 t -113.61 124.66 70.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.11 128.89 49.86 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.217 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HB3' HD13 ' A' ' 80' ' ' ILE . 62.8 pttt -65.05 -35.3 80.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.717 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -176.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.632 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 p -162.51 55.48 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.699 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.0 p -105.68 160.03 15.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.151 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.48 -32.33 71.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.603 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.4 -41.85 55.2 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.85 0.719 . . . . 0.0 112.26 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 102' ' ' ASN . 9.4 m120 -65.82 -39.92 91.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.553 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.9 mt -59.78 -19.82 52.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.87 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.467 HD23 ' NE2' ' A' ' 126' ' ' HIS . 15.8 mt -69.25 -34.85 75.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.0 m -97.16 -7.71 31.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -179.0 -174.6 45.33 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . . . -83.58 127.95 34.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.12 -0.54 . . . . 0.0 109.882 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.422 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.38 141.61 36.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.768 0.318 . . . . 0.0 110.715 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.4 p -71.87 147.54 47.02 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.77 -47.68 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -92.03 -170.47 2.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.657 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 113' ' ' ASN . 1.6 pt-20 -113.19 -53.86 2.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.951 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.456 ' H ' ' HG3' ' A' ' 112' ' ' GLU . 89.0 m-20 -94.42 44.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.37 154.54 17.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.71 133.9 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.816 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.458 ' SD ' HD22 ' A' ' 149' ' ' LEU . 68.5 mtt -69.66 128.39 36.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.989 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.481 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.68 1.33 77.49 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.6 123.44 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.974 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.19 -164.36 54.34 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -94.64 108.68 20.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -84.91 100.87 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.043 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 124.63 35.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.511 . . . . 0.0 111.722 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.94 132.02 54.33 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.322 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.6 138.9 45.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.375 0.607 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.69 -176.26 16.63 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.43 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 135' ' ' PHE . 15.3 m-70 -86.11 141.79 29.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.815 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 129' ' ' SER . 32.1 t30 -109.86 26.88 10.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.214 0.531 . . . . 0.0 110.481 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -46.34 -14.29 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.778 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 129' ' ' SER . 1.4 p 55.2 41.15 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.822 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 136' ' ' SER . 30.5 mmtm -133.91 129.25 36.06 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.653 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -74.24 124.52 26.56 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.41 -28.24 6.61 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 134' ' ' LEU . 4.2 t -78.04 170.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.22 133.16 40.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.685 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 126' ' ' HIS . 3.6 m-85 49.27 38.74 14.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 1.1 p -80.33 -61.26 2.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.282 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 136' ' ' SER . 97.9 m-20 -89.35 39.7 0.95 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.7 pt -69.78 -26.72 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.241 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.42 6.81 5.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.0 t -95.33 -13.64 24.59 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.26 118.74 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -98.4 161.57 13.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.741 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -58.38 118.54 5.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.133 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.95 21.06 7.63 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 90.9 m-20 -96.65 127.99 43.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -80.58 138.31 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.956 0.408 . . . . 0.0 111.332 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 158' ' ' TYR . 97.5 mt -129.4 123.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -101.76 119.22 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.996 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.458 HD22 ' SD ' ' A' ' 116' ' ' MET . 2.7 mt -110.0 158.15 18.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.346 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 149' ' ' LEU . 66.6 m-85 -141.63 121.22 13.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.092 0.472 . . . . 0.0 111.859 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 152' ' ' ASN . 13.3 t0 -114.64 -166.11 1.08 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.579 ' C ' ' O ' ' A' ' 151' ' ' ASP . 95.1 m-20 -4.4 -88.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.857 0.723 . . . . 0.0 111.32 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -138.99 30.83 2.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -121.73 140.96 51.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -102.89 120.78 41.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.196 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.457 ' CE2' HG21 ' A' ' 206' ' ' THR . 90.7 m-85 -105.07 125.21 50.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.725 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -94.19 115.27 27.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.481 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.6 m-85 -117.18 142.82 46.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.224 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.06 132.13 53.98 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.439 0.637 . . . . 0.0 110.501 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.7 135.87 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.269 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 14.2 p -101.75 -25.56 13.79 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.783 1.302 . . . . 0.0 110.99 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.49 177.18 34.35 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.146 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.09 149.1 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.743 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.42 ' O ' HG12 ' A' ' 198' ' ' VAL . 38.9 m -152.59 161.6 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 0.0 111.099 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -99.36 120.93 40.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 196' ' ' ARG . 18.4 m -132.45 157.45 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 169' ' ' ASP . 32.1 p -82.42 135.93 46.41 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.584 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -46.37 -15.1 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.004 1.803 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 67.3 t0 -84.52 -22.61 30.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -83.95 72.42 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.062 0.458 . . . . 0.0 110.928 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 94.1 m95 -74.94 -2.22 26.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.969 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.467 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 72.4 mm-40 -54.19 -39.0 66.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.743 ' O ' HG21 ' A' ' 183' ' ' THR . 17.9 m -75.19 4.57 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.944 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.07 -15.99 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.904 0.859 . . . . 0.0 110.042 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.403 ' O ' ' CD2' ' A' ' 177' ' ' HIS . 63.4 mm-40 -89.21 166.45 13.8 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.972 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -68.18 129.42 39.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.083 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.467 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.0 m170 -103.32 -40.54 6.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.143 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.83 25.23 0.12 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -156.41 179.23 9.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.863 0.363 . . . . 0.0 110.815 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -97.36 93.36 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.802 0.81 . . . . 0.0 110.408 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -127.02 175.16 8.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.407 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -130.38 143.47 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.216 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.743 HG21 ' O ' ' A' ' 173' ' ' VAL . 13.1 m -135.99 123.67 22.38 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.557 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 183' ' ' THR . 10.5 mp -112.19 121.96 46.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.455 0.645 . . . . 0.0 110.982 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.27 -174.84 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.829 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.546 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 15.4 p . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.368 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 186' ' ' THR . 39.1 ttm180 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.57 140.96 35.52 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 164' ' ' SER . 2.9 p -140.71 144.54 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.72 0.295 . . . . 0.0 111.425 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.63 129.91 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.204 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -121.21 138.93 53.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.256 0.551 . . . . 0.0 110.507 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.66 160.96 24.98 Favored Glycine 0 N--CA 1.461 0.337 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.8 t0 -113.55 149.69 34.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.954 -0.623 . . . . 0.0 111.135 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.536 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 21.7 tp -73.42 132.39 42.92 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 159' ' ' ALA . 59.3 t -107.96 -27.1 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.512 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.93 160.37 16.82 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.388 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.457 HG21 ' CE2' ' A' ' 156' ' ' TYR . 28.4 m -136.42 155.6 49.78 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -151.62 179.84 8.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.08 143.19 26.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.461 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.5 81.22 1.95 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.528 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.379 178.693 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.487 1.124 0 CA-C-O 121.166 0.403 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -77.57 163.3 26.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.163 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.631 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.0 pt? -60.16 -21.75 62.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.234 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.23 -39.62 94.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.1 mm-40 -73.76 -30.33 62.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.317 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -77.31 -44.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.799 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.98 85.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 61.3 t-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.75 139.72 57.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.696 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -140.82 84.21 1.93 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 111.361 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.6 tp -82.15 134.64 35.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.21 138.81 55.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.439 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -64.02 -8.73 12.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 109.78 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -64.02 -30.12 71.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.863 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -76.75 9.87 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.109 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.69 124.41 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -129.8 -3.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.64 -170.55 32.58 Favored Glycine 0 C--N 1.315 -0.607 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' HD2' ' H ' ' A' ' 83' ' ' ILE . 5.3 tpt180 -153.02 151.14 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.837 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 92' ' ' LEU . 5.7 tt -123.39 127.4 74.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -128.3 129.57 46.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.462 HG21 HD21 ' A' ' 141' ' ' LEU . 45.2 mt -135.02 122.26 15.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.284 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -82.28 -33.89 0.49 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.372 2.048 . . . . 0.0 112.877 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.464 ' CB ' HD23 ' A' ' 141' ' ' LEU . 1.6 m -50.38 -36.37 32.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.45 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.628 HG23 HD23 ' A' ' 90' ' ' LEU . 18.7 m -120.17 -6.34 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.634 0.254 . . . . 0.0 110.982 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.84 48.22 0.41 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.628 HD23 HG23 ' A' ' 88' ' ' VAL . 3.7 mm? -109.92 129.69 55.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.839 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.617 ' O ' HD12 ' A' ' 92' ' ' LEU . 97.2 mt-10 -135.34 115.85 13.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.617 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.1 tp -146.35 111.15 4.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.4 Cg_endo -41.02 147.89 0.25 Allowed 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 121.636 1.558 . . . . 0.0 110.529 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.4 t -96.16 124.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.9 145.33 30.55 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -90.41 -35.33 15.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.279 0.561 . . . . 0.0 110.961 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.631 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 2.1 p -76.22 97.95 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.117 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -82.66 89.98 6.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.059 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 p -133.14 157.75 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.901 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.89 -29.76 60.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.765 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 11.4 ptpt -83.29 -43.84 15.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.631 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 3.1 m-20 -66.63 -34.21 77.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.635 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.99 -20.93 63.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.433 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.46 -18.79 61.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.6 p -102.42 -13.11 17.41 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.21 -179.43 47.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.165 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.55 125.84 28.43 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.6 143.16 34.14 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.866 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 46.7 p -75.1 154.15 37.96 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.68 -56.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -96.4 141.22 29.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.993 0.425 . . . . 0.0 110.689 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.2 pm0 -82.47 6.65 16.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -131.27 24.89 4.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -93.75 156.16 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.195 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.2 t -133.28 133.89 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.851 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.4 mtt -67.24 127.6 33.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.995 0.426 . . . . 0.0 110.237 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 90.96 2.41 71.68 Favored Glycine 0 C--O 1.23 -0.101 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -141.06 121.87 14.4 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.067 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.18 -168.88 53.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -87.86 110.03 20.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.52 103.67 13.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.88 127.79 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 112.105 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 HD12 ' A' ' 83' ' ' ILE . 6.1 mt -123.54 132.41 53.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.933 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.57 139.08 45.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.402 0.62 . . . . 0.0 110.656 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.74 -176.58 15.01 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.72 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -97.46 141.5 30.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.951 0.405 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' SER . 43.5 p-10 -102.3 27.76 6.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -21.8 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.159 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 62.09 37.29 14.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.477 ' N ' ' OG ' ' A' ' 136' ' ' SER . 63.7 mmtt -133.32 108.02 8.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.769 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -50.66 125.98 14.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.809 0.814 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.02 -30.26 7.83 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.631 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 134' ' ' LEU . 59.4 t -76.02 178.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.355 0 CA-C-N 117.681 0.74 . . . . 0.0 109.437 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.756 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -71.15 136.39 48.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.778 0.323 . . . . 0.0 110.437 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.3 m-85 44.11 32.03 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.324 0.583 . . . . 0.0 110.561 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -81.26 -12.26 59.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 29.4 t0 -142.62 26.45 1.76 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.2 pt -70.16 -25.76 28.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.797 0.332 . . . . 0.0 111.581 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.11 1.11 6.27 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.1 m -95.41 -11.7 27.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.464 HD23 ' CB ' ' A' ' 87' ' ' SER . 18.3 mt -63.9 124.22 20.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.008 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 145' ' ' ASP . 99.2 mttt -96.4 158.17 15.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -56.58 134.87 54.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.185 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.36 19.49 62.24 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 142' ' ' LYS . 28.7 m-20 -81.43 132.73 35.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -79.51 130.33 35.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.274 0.559 . . . . 0.0 111.515 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.6 mt -122.92 121.68 63.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.583 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.4 120.57 40.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.118 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.0 OUTLIER -110.73 158.83 18.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -132.96 128.11 35.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.635 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.517 ' O ' ' C ' ' A' ' 152' ' ' ASN . 44.4 t0 -113.89 -166.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.517 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.3 t-20 -21.95 -74.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.152 0.501 . . . . 0.0 111.929 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.22 27.95 1.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -122.54 144.93 48.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -108.13 122.73 47.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.032 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.469 ' CE2' HG21 ' A' ' 206' ' ' THR . 71.8 m-85 -106.32 127.37 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.822 0.344 . . . . 0.0 111.489 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.62 115.88 28.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.503 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.517 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 22.4 m-85 -117.07 142.24 47.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.308 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.7 134.51 55.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.629 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.5 133.97 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.915 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -102.14 -25.86 13.56 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 124.544 1.153 . . . . 0.0 110.787 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.98 142.34 3.37 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.857 -1.163 . . . . 0.0 111.768 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 141' ' ' LEU . 10.0 t -104.77 152.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.5 t -168.42 178.32 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.4 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.79 115.13 26.52 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.36 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 12.5 m -117.0 139.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.543 ' C ' HH12 ' A' ' 196' ' ' ARG . 66.8 p -54.23 162.6 1.5 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.57 -19.76 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.194 1.929 . . . . 0.0 111.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 34.3 p30 -81.91 -19.31 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 35.1 ttpt -88.13 74.68 8.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 110.503 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -75.27 -6.1 48.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.851 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.7 -24.55 14.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.745 ' O ' HG21 ' A' ' 183' ' ' THR . 94.2 t -78.21 -3.25 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.815 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.65 -12.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.665 0.745 . . . . 0.0 109.814 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -85.6 155.63 21.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.934 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.33 132.14 47.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.62 -39.33 6.41 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.44 28.56 0.17 Allowed Glycine 0 N--CA 1.471 1.012 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -155.1 174.92 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.126 0.489 . . . . 0.0 111.284 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -90.13 89.34 7.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.692 0.758 . . . . 0.0 109.557 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -119.59 168.36 11.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.826 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.7 tt -129.95 141.32 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.226 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.745 HG21 ' O ' ' A' ' 173' ' ' VAL . 11.9 m -137.11 123.4 20.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.178 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.598 HD12 ' C ' ' A' ' 183' ' ' THR . 11.0 mp -112.59 122.75 48.6 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.194 0.521 . . . . 0.0 110.091 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 pt -132.91 168.08 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.689 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.633 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 166' ' ' VAL . 35.2 ptt-85 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.895 0.379 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -97.57 131.41 44.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.465 HG21 HG22 ' A' ' 166' ' ' VAL . 42.3 t -131.48 133.57 61.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 111.253 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.0 t -111.28 124.06 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.02 134.16 55.04 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.06 160.88 25.49 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.5 t0 -114.56 151.43 33.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.974 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.65 129.86 38.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.443 0.639 . . . . 0.0 110.755 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 98.7 t -106.34 -24.48 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.161 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.74 163.33 23.59 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.036 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.469 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.7 m -136.6 154.46 50.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.278 0.561 . . . . 0.0 109.975 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -148.99 179.43 7.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.176 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.65 24.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.279 0.562 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.68 80.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.612 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.574 178.644 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 CA-C-O 121.299 0.458 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.18 166.93 20.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.906 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.6 mp -52.02 -28.44 17.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.607 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 71' ' ' ASN . . . -65.43 -39.73 92.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.542 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 71.5 mm-40 -73.81 -31.28 63.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.741 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.83 -45.88 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.821 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.51 78.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.07 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 67' ' ' ALA . 9.3 m120 -69.06 -29.25 67.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.997 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.41 100.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -96.93 111.39 23.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.395 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -111.36 128.6 56.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.8 m-20 -71.97 138.71 48.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.267 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 79' ' ' VAL . 1.3 mppt? -64.43 0.45 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 109.877 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 75' ' ' ASP . 13.2 mptt -92.06 -8.86 44.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.585 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -83.17 -6.62 59.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 76' ' ' LYS . 5.4 m -86.96 138.03 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.68 -3.32 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.487 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.07 -160.3 24.24 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -153.59 155.98 37.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.384 0.612 . . . . 0.0 111.258 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.26 136.86 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.073 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -128.99 134.07 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.986 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.598 ' CG2' HD21 ' A' ' 141' ' ' LEU . 2.5 mt -133.01 74.17 74.18 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.541 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -44.76 -39.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 123.151 2.567 . . . . 0.0 112.943 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.752 ' OG ' HD23 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -48.67 -32.17 7.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.623 -177.406 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 89' ' ' SER . 15.7 m -117.13 -7.01 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.637 0.256 . . . . 0.0 111.158 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER 75.22 39.49 0.37 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.197 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.64 130.02 56.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.48 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -144.79 129.97 18.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.763 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -164.44 152.54 10.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.072 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 162.99 4.51 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.064 1.843 . . . . 0.0 109.739 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.29 125.0 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 102' ' ' ASN . 10.2 mt -101.43 136.11 41.83 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.81 -48.54 24.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.11 0.481 . . . . 0.0 111.485 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 123.4 28.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.177 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.4 p -81.7 64.83 6.58 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.45 0.643 . . . . 0.0 110.46 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.552 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -91.81 143.21 26.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.077 179.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 101' ' ' LYS . 15.3 pt-20 -56.33 -44.22 79.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.403 0.621 . . . . 0.0 110.742 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.493 ' N ' ' CG ' ' A' ' 100' ' ' GLU . 54.5 tttp -66.03 -46.38 78.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.808 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.552 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 2.9 m-20 -67.18 -36.97 82.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.844 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -55.04 -16.82 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.451 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.447 ' O ' HD11 ' A' ' 134' ' ' LEU . 55.0 mt -70.63 -29.9 66.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -89.74 -10.56 45.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 178.52 41.27 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.763 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -72.37 132.16 43.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.97 150.13 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.125 0.488 . . . . 0.0 111.031 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.5 p -73.6 153.93 39.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.34 -52.2 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -91.76 141.44 28.67 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.994 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -71.39 -2.58 16.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.538 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.34 41.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.251 0.548 . . . . 0.0 111.115 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -84.86 158.1 20.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -134.49 129.7 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.628 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -73.7 127.88 34.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.43 -0.15 70.86 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -139.71 121.61 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.967 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.32 -171.86 52.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -84.03 110.13 18.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.24 99.38 10.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.78 130.44 36.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.363 0.601 . . . . 0.0 111.425 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -125.9 133.83 51.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.826 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.18 141.56 47.37 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.378 0.609 . . . . 0.0 110.71 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.9 -178.85 18.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.656 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -81.83 149.27 28.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.972 0.415 . . . . 0.0 110.748 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 129' ' ' SER . 45.1 t30 -112.48 28.44 8.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.169 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.1 mmm -47.43 -11.74 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.638 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 127' ' ' ASN . 3.1 t 54.72 41.11 32.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.982 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.4 tttt -134.52 116.2 14.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.565 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -57.33 125.61 23.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.764 0.792 . . . . 0.0 110.53 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.25 -25.87 11.96 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.871 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.798 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.3 t -79.9 179.07 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.798 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.28 133.31 45.97 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.768 -178.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.5 m-30 44.47 33.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.148 0.499 . . . . 0.0 111.06 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -82.29 -7.79 59.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.5 m-20 -147.47 38.14 0.94 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.6 pt -74.24 -25.49 19.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.84 0.352 . . . . 0.0 111.881 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.83 0.52 8.86 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.749 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.0 m -93.39 -12.24 30.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.27 0.557 . . . . 0.0 109.628 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.752 HD23 ' OG ' ' A' ' 87' ' ' SER . 21.0 mt -65.58 125.0 23.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.204 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -96.34 158.46 15.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.677 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.05 133.06 54.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.514 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.5 59.18 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.421 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 38.4 m-20 -83.52 136.91 34.1 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -81.0 130.23 34.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 111.345 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -127.13 126.64 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 148' ' ' TYR . 42.4 m-85 -107.87 120.24 41.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.191 0.519 . . . . 0.0 109.776 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.6 tp -113.59 143.93 43.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.346 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -114.82 127.88 55.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.314 0.578 . . . . 0.0 111.541 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.4 t0 -106.0 -166.12 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.6 m-20 -27.94 -71.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.695 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -137.42 22.8 2.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.754 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.27 147.83 44.49 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -113.42 118.28 34.08 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.416 ' CE2' HG21 ' A' ' 206' ' ' THR . 68.4 m-85 -103.45 131.51 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.407 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -93.4 117.85 30.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.347 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.2 133.18 55.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 45.2 t -67.73 133.03 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.107 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -101.0 -27.19 13.42 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 124.609 1.193 . . . . 0.0 110.63 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.53 144.35 3.98 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.86 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.47 141.32 15.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.41 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.9 p -150.06 161.93 41.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.372 0.606 . . . . 0.0 111.548 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 95.3 mt-10 -114.81 123.18 48.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.749 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.68 149.63 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.344 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.4 p -53.66 166.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.571 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -81.58 -15.59 9.68 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.854 1.703 . . . . 0.0 111.812 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 60.0 t0 -88.64 -11.09 46.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.502 ' O ' HG22 ' A' ' 173' ' ' VAL . 13.6 ttmm -86.95 67.81 9.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.979 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.571 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 57.3 m95 -76.53 -8.39 57.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.449 . . . . 0.0 111.856 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.9 mt-10 -53.19 -23.47 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.203 0.525 . . . . 0.0 110.937 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 170' ' ' LYS . 33.3 m -77.63 -13.06 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.922 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 185' ' ' ILE . 4.4 m -132.34 43.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.521 ' O ' ' O ' ' A' ' 176' ' ' ASP . 95.4 mt-10 -146.23 83.17 1.62 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.895 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' GLU . 66.5 t0 23.82 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.346 1.028 . . . . 0.0 113.022 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.455 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 13.2 m170 -102.13 -43.97 5.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 0.0 111.289 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.84 23.78 0.16 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -154.11 173.91 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.954 0.407 . . . . 0.0 111.237 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -96.3 88.65 4.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.242 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -131.58 130.63 42.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.037 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.6 tt -83.17 145.57 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.483 ' C ' HD12 ' A' ' 184' ' ' LEU . 3.6 m -138.57 115.94 11.18 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.576 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -104.48 134.34 47.84 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.18 0.514 . . . . 0.0 110.711 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.724 HG22 HG22 ' A' ' 198' ' ' VAL . 34.6 pt -135.1 154.67 36.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.093 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.447 -179.661 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.404 HH21 HG21 ' A' ' 198' ' ' VAL . 56.0 ttp180 . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.6 m-85 -95.95 129.02 43.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.505 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.724 HG22 HG22 ' A' ' 185' ' ' ILE . 71.2 t -131.08 133.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.193 0.521 . . . . 0.0 111.366 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.73 126.96 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.593 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -112.77 132.93 55.02 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 110.721 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.66 14.13 Favored Glycine 0 N--CA 1.464 0.525 0 CA-C-O 121.727 0.626 . . . . 0.0 111.685 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -98.91 142.3 30.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.891 -0.655 . . . . 0.0 111.405 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.1 tp -67.09 128.54 36.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.315 0.578 . . . . 0.0 110.288 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.97 -21.7 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.216 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.5 176.12 46.87 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.009 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.416 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.0 m -154.74 153.18 30.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.161 0.505 . . . . 0.0 110.534 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -150.27 178.65 8.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.264 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -99.98 142.26 31.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -57.18 80.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.248 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ALA . 77.5 tttt . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.557 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.488 1.182 0 N-CA-C 111.362 -0.284 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' O ' HG23 ' A' ' 69' ' ' VAL . 53.8 t0 -62.46 163.15 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.8 mm? -77.65 -13.63 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.921 -0.487 . . . . 0.0 111.069 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.35 -48.38 70.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.405 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.17 -21.83 59.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.889 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 65' ' ' ASP . 85.7 t -78.07 -53.25 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.756 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.47 84.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.512 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.471 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 52.4 t-20 -76.13 -11.21 59.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.927 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 145.27 38.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.429 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -139.51 80.45 1.78 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.674 HD13 ' ND2' ' A' ' 102' ' ' ASN . 51.9 tp -80.16 147.4 31.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.52 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.54 133.69 49.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.922 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 79' ' ' VAL . 15.7 tptm -79.89 -6.44 57.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.249 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -80.74 -10.63 59.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.98 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -94.24 5.77 50.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 76' ' ' LYS . 8.3 p -80.62 136.47 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.97 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.411 HD13 ' HB2' ' A' ' 96' ' ' LYS . 7.5 pt -119.2 -10.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.72 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.44 -170.09 37.94 Favored Glycine 0 C--N 1.316 -0.545 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -147.15 152.34 38.29 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.416 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.2 tt -123.99 121.1 61.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 t -124.63 130.75 53.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.909 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 141' ' ' LEU . 16.5 mt -135.15 126.77 17.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -82.26 -35.49 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.358 2.039 . . . . 0.0 112.5 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.506 ' OG ' HD23 ' A' ' 141' ' ' LEU . 2.3 t -51.14 -40.09 57.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.844 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.4 m -115.49 -4.24 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.18 49.9 1.9 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.4 tp -111.32 129.74 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.656 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -136.72 113.7 10.5 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 83' ' ' ILE . 54.3 mt -145.69 107.71 4.36 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.2 Cg_endo -41.66 135.46 3.33 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.77 1.647 . . . . 0.0 110.659 176.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.17 125.1 39.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 74' ' ' LEU . 20.5 mt -108.86 120.83 43.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.193 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 80' ' ' ILE . 88.4 tttt -66.72 -47.43 72.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.708 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.6 p -69.8 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.1 p -84.43 107.68 16.83 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.283 0.564 . . . . 0.0 110.214 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 p -137.08 166.32 23.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.026 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.442 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 16.9 pt-20 -61.9 -35.43 78.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.681 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -82.92 -37.62 23.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.559 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.674 ' ND2' HD13 ' A' ' 74' ' ' LEU . 6.5 m120 -67.22 -22.88 65.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.637 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.88 -13.41 61.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.482 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.9 mp -76.92 -14.35 59.88 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -106.19 -15.63 14.81 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 172.98 -176.05 45.83 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.71 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.22 129.58 38.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.248 -0.476 . . . . 0.0 109.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.48 144.53 31.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.752 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.7 p -73.84 146.94 43.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.65 -46.69 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -91.02 144.28 25.83 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.806 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.71 -5.07 35.21 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.859 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 113' ' ' ASN . 61.2 t-20 -142.15 41.47 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.688 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -84.03 155.54 22.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.29 128.19 51.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.72 126.23 30.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 98.05 -6.12 61.77 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -137.21 118.99 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.668 0.271 . . . . 0.0 110.78 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.98 -172.85 54.07 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.476 HD21 ' HB3' ' A' ' 181' ' ' GLU . 2.4 t-20 -82.54 111.72 18.8 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -85.18 103.07 13.83 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.36 121.52 32.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 111.412 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.1 mt -117.76 131.86 56.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.85 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.62 46.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.02 -178.07 20.33 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.814 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 30.2 m-70 -83.5 131.23 35.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.231 0.539 . . . . 0.0 110.863 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.9 p30 -101.52 27.02 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.4 mmm -46.05 -14.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.957 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 41.67 17.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.875 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -133.8 106.85 7.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.081 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -50.69 125.93 14.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.547 0.689 . . . . 0.0 109.985 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.25 -26.1 10.69 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.946 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.788 HG12 ' H ' ' A' ' 134' ' ' LEU . 35.4 t -83.4 178.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 CA-C-N 117.736 0.768 . . . . 0.0 109.13 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.788 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.17 138.56 47.72 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.178 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 45.64 31.99 1.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.057 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.2 p -80.58 -12.31 59.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -138.56 35.94 2.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 140' ' ' SER . 8.8 pt -67.67 -41.51 85.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.09 2.09 1.69 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.961 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 138' ' ' ILE . 13.3 t -89.23 -21.65 23.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.506 HD23 ' OG ' ' A' ' 87' ' ' SER . 12.2 mt -65.58 121.7 15.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.143 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.441 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.7 mtmt -96.99 157.71 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.555 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -57.62 125.89 24.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.321 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.83 19.04 23.35 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 89.6 m-20 -89.86 133.24 34.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.75 134.74 37.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 111.723 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 73.0 mt -127.66 124.25 62.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.379 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -105.26 122.09 45.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.024 0.44 . . . . 0.0 110.218 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.68 153.21 32.73 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.093 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -121.12 130.87 53.94 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.316 0.579 . . . . 0.0 111.334 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 23.9 t0 -112.8 -167.07 1.14 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -24.48 -74.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.449 0.468 . . . . 0.0 111.705 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -137.97 28.58 2.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -125.59 151.38 46.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -112.03 122.04 46.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.741 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' A' ' 117' ' ' GLY . 47.2 m-85 -105.52 127.9 53.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.108 0.48 . . . . 0.0 111.791 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.6 mt-10 -97.64 118.74 34.85 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -115.86 145.11 43.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.219 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.3 128.69 54.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.24 0.543 . . . . 0.0 110.374 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.1 t -68.46 135.59 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.066 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 8.5 p -100.33 -22.86 14.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 124.378 1.049 . . . . 0.0 110.16 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 152.97 -178.51 30.03 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.833 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.8 p -124.2 143.01 39.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.318 -0.941 . . . . 0.0 109.893 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.8 t -136.77 148.08 47.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 111.107 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.13 113.01 26.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.239 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.33 159.44 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.1 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.0 p -71.22 142.59 87.32 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.568 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.5 Cg_endo -48.42 -16.24 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.862 1.708 . . . . 0.0 111.772 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 61.6 t0 -83.32 -11.55 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.91 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.521 ' O ' HG22 ' A' ' 173' ' ' VAL . 19.9 tptt -83.47 62.47 6.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.468 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.568 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 45.7 m95 -73.06 -21.13 60.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.675 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -51.12 -9.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.102 0.477 . . . . 0.0 110.947 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 170' ' ' LYS . 27.4 m -77.15 -29.26 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.917 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.457 HG11 HD13 ' A' ' 185' ' ' ILE . 1.7 m -107.2 -0.65 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.618 0.723 . . . . 0.0 109.938 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 176' ' ' ASP . 76.3 mm-40 -82.28 117.44 22.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.785 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.0 p-10 -27.71 123.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.872 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -99.62 -37.63 9.06 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.62 33.2 0.62 Allowed Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -154.72 177.14 11.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.129 0.49 . . . . 0.0 111.68 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.06 88.96 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.37 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.476 ' HB3' HD21 ' A' ' 120' ' ' ASN . 56.4 tt0 -128.74 167.42 17.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.831 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.603 ' C ' HD12 ' A' ' 184' ' ' LEU . 3.2 m -136.74 127.34 27.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.603 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.18 128.95 56.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.404 0.621 . . . . 0.0 110.778 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.457 HD13 HG11 ' A' ' 174' ' ' VAL . 8.7 pt -139.93 -167.68 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.923 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.552 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 3.3 t . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.414 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.7 ttm180 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -77.12 132.61 38.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.701 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.63 135.04 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.01 128.41 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.537 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.91 139.3 51.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.272 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.36 152.25 21.1 Favored Glycine 0 C--O 1.226 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -107.45 147.2 30.75 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.635 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.5 tp -69.83 126.28 29.25 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 121.097 0.475 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -106.65 -26.65 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.745 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.32 161.88 21.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.05 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 207' ' ' LYS . 88.0 m -139.17 157.69 45.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.363 0.602 . . . . 0.0 110.11 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.436 ' N ' HG22 ' A' ' 206' ' ' THR . 20.1 ptmt -149.08 178.79 8.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.384 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.33 147.25 23.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.78 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -76.9 78.95 3.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.714 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.716 178.678 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.485 1.008 0 CA-C-O 120.872 0.28 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.73 159.15 31.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.864 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.68 -23.63 66.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.7 92.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.715 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 97.0 mt-10 -73.46 -35.31 65.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.477 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.7 t -76.92 -42.96 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.755 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.83 91.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.698 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.4 p-10 -84.95 -17.87 36.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.44 111.62 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.961 0.41 . . . . 0.0 110.875 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -95.46 118.46 32.23 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.228 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.505 HD11 ' OE1' ' A' ' 78' ' ' GLN . 47.9 tp -116.14 131.16 57.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.061 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.54 134.82 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 79' ' ' VAL . 70.4 mmtt -75.83 -9.29 58.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 110.254 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.4 -12.66 61.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.037 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.535 ' OE1' ' ND2' ' A' ' 102' ' ' ASN . 94.0 mt-30 -95.51 12.72 28.48 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.221 0.534 . . . . 0.0 111.028 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 76' ' ' LYS . 5.4 p -90.45 128.83 42.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.741 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -120.9 -5.39 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 120.896 0.379 . . . . 0.0 111.88 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.87 41.74 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.918 HH12 ' HZ3' ' A' ' 209' ' ' LYS . 30.0 mtt85 -147.34 156.6 43.05 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.477 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.581 HD12 HD13 ' A' ' 123' ' ' LEU . 8.2 tt -123.63 128.28 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.427 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.1 t -128.24 130.2 47.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.47 128.88 19.36 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.399 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 -34.61 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.291 1.994 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -47.36 -39.51 15.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.457 -177.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -119.86 -1.72 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.781 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.7 p 63.6 50.4 2.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.081 0.943 . . . . 0.0 108.562 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.418 HD11 HD23 ' A' ' 92' ' ' LEU . 33.7 tp -113.51 133.63 55.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.397 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.822 ' O ' HD22 ' A' ' 92' ' ' LEU . 80.9 tt0 -135.81 111.4 9.26 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.8 OUTLIER -138.29 113.46 8.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.114 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.2 Cg_endo -41.6 147.46 0.39 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 110.419 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.9 124.57 53.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -105.0 125.47 51.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.004 0.431 . . . . 0.0 110.631 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 61.2 tttp -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 110.752 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.617 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 84.7 p -71.45 103.48 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 96.31 9.57 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 2.5 p -134.31 160.89 36.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.947 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -57.53 -33.49 68.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.6 -45.65 21.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 0.0 111.487 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.617 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 3.4 m120 -67.2 -35.38 79.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.696 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.69 -17.42 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.814 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.07 -16.79 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 t -107.93 -9.73 15.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' CA ' HD12 ' A' ' 92' ' ' LEU . . . 171.63 175.46 39.96 Favored Glycine 0 N--CA 1.461 0.327 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.446 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -72.18 127.57 32.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.008 -0.596 . . . . 0.0 109.785 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.52 24.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.893 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -72.84 150.24 42.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.1 t -84.49 -49.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -91.81 143.15 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 110.778 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 tt0 -61.92 -49.95 74.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.798 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -95.89 49.52 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.168 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 3.9 tt0 -89.15 151.47 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.2 127.6 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.966 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 129.39 36.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.812 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.03 -6.83 62.22 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -143.59 126.89 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.961 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 77.24 -162.41 51.26 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.536 HD22 ' CE1' ' A' ' 177' ' ' HIS . 41.0 t-20 -93.53 108.9 20.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -86.05 100.23 12.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.425 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.54 126.02 35.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.252 0.549 . . . . 0.0 111.043 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 83' ' ' ILE . 9.3 mt -119.79 131.2 55.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.819 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.37 140.03 47.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.78 -178.49 19.58 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.405 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.42 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -84.04 141.84 30.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.736 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 61.7 t30 -109.1 28.39 8.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.185 0.517 . . . . 0.0 110.078 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.7 mmm -43.53 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.775 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.3 m 57.74 38.48 27.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.03 107.49 8.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.007 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -51.63 122.29 7.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.36 0.6 . . . . 0.0 110.045 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.12 21.82 6.48 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.316 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.737 HG12 ' H ' ' A' ' 134' ' ' LEU . 24.0 t -136.57 176.61 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.737 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -69.62 130.67 43.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 0.0 110.362 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.2 m-85 48.44 36.39 7.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.172 0.51 . . . . 0.0 110.585 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -82.35 -10.37 59.1 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 136' ' ' SER . 72.3 m-20 -150.33 31.91 0.66 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.6 pt -70.63 -21.02 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.803 0.335 . . . . 0.0 111.567 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.6 5.1 8.0 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.481 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -99.51 -10.3 22.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.25 0.548 . . . . 0.0 109.679 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.429 ' O ' HG21 ' A' ' 163' ' ' VAL . 17.8 mt -64.27 126.37 27.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.618 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.3 mttp -96.76 159.66 14.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.531 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -58.15 132.33 53.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.105 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.9 21.65 57.07 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 19.2 m-20 -79.35 135.23 36.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -78.96 121.74 25.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 111.979 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.32 120.82 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.132 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -103.24 117.7 35.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.198 0.523 . . . . 0.0 109.806 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.2 tp -112.35 144.33 41.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.132 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.42 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 60.8 m-85 -108.21 131.68 54.43 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.273 0.559 . . . . 0.0 111.672 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -104.77 -172.51 2.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.5 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -36.39 -63.26 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.161 0.505 . . . . 0.0 111.121 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -137.55 24.34 2.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.77 152.91 47.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -115.38 121.77 43.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.781 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -104.06 132.37 50.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.29 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -95.5 114.74 26.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -114.6 141.37 47.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.2 132.02 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.606 0.717 . . . . 0.0 111.309 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.01 134.06 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.898 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -102.86 -28.11 12.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 124.625 1.203 . . . . 0.0 110.818 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.24 141.08 3.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.877 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 199' ' ' VAL . 13.1 t -106.28 147.73 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.487 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.3 p -157.26 167.5 30.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.286 0.565 . . . . 0.0 111.638 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -118.15 120.6 38.21 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.55 158.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 111.3 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.4 p -57.21 165.47 1.95 Allowed Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.2 Cg_endo -82.03 -9.43 11.79 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.967 1.778 . . . . 0.0 111.913 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 63.2 t0 -83.38 -10.53 58.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.388 . . . . 0.0 110.449 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.581 ' O ' HG22 ' A' ' 173' ' ' VAL . 38.1 mmtt -85.93 64.33 8.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.798 0.332 . . . . 0.0 110.69 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.552 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 86.8 m95 -73.33 -10.11 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.457 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 80.9 mm-40 -59.93 -35.41 74.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.188 0.518 . . . . 0.0 110.975 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.849 HG23 HG13 ' A' ' 174' ' ' VAL . 4.7 m -65.68 -8.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.243 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.849 HG13 HG23 ' A' ' 173' ' ' VAL . 17.5 m -136.0 43.04 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 176' ' ' ASP . 48.8 mm-40 -144.8 107.24 4.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.733 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 175' ' ' GLU . 41.0 p-10 4.27 112.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.65 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.536 ' CE1' HD22 ' A' ' 120' ' ' ASN . 40.4 m80 -102.91 -42.49 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.883 0.373 . . . . 0.0 111.028 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 136.32 29.82 0.32 Allowed Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 17.9 ptpt -153.83 173.12 16.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 8.7 p30 -95.19 88.34 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.836 0.827 . . . . 0.0 110.181 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -130.12 174.72 9.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.552 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.8 tt -130.89 143.12 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.174 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.601 ' C ' HD12 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -137.79 124.08 20.56 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.313 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -111.57 131.13 55.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.235 0.54 . . . . 0.0 110.695 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.669 HG21 HG11 ' A' ' 174' ' ' VAL . 7.5 pt -138.53 171.53 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.952 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 60.5 p . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.129 179.097 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.183 0.516 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.69 138.47 43.86 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.532 HG12 HG22 ' A' ' 185' ' ' ILE . 31.4 m -135.38 138.18 48.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.439 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 163' ' ' VAL . 76.1 t -117.18 128.8 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.342 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.95 135.22 54.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.087 0.47 . . . . 0.0 110.346 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.77 156.96 24.52 Favored Glycine 0 N--CA 1.461 0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.574 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.19 153.82 26.48 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.049 -0.576 . . . . 0.0 111.396 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.433 HD11 ' O ' ' A' ' 205' ' ' GLY . 39.4 tp -73.87 128.06 34.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.256 0.551 . . . . 0.0 110.574 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 38.1 t -109.06 -25.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.931 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.433 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.52 175.03 46.7 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.972 -1.108 . . . . 0.0 112.155 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.0 m -153.78 152.31 30.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.143 0.496 . . . . 0.0 110.826 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.14 177.14 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.19 145.19 24.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.099 0.476 . . . . 0.0 110.718 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.918 ' HZ3' HH12 ' A' ' 82' ' ' ARG . 88.3 tttt -74.44 79.69 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.904 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--N 1.314 -0.94 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.561 178.528 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.486 1.053 0 N-CA-C 111.213 -0.341 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.17 165.21 24.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.659 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -69.51 -16.19 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.04 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.62 95.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.283 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 89.7 mt-10 -73.14 -33.46 65.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.665 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.37 -45.76 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.075 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.45 89.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.025 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.02 -28.46 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.589 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.79 107.42 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.804 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.3 m -95.98 115.31 27.24 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.289 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.0 tp -115.23 126.49 54.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.277 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -69.01 139.01 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.555 ' O ' HG12 ' A' ' 79' ' ' VAL . 13.9 mptt -76.13 -0.11 20.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 110.211 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -85.29 -8.99 58.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.143 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.533 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.0 mp0 -90.92 2.84 55.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.757 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 76' ' ' LYS . 11.1 p -87.64 138.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.821 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.6 pt -120.82 -5.27 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.781 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.89 33.14 Favored Glycine 0 C--N 1.321 -0.285 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -152.75 152.69 31.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.264 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 83' ' ' ILE . 17.9 tt -126.1 130.85 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.845 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -128.2 129.17 46.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.002 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 67.5 mt -133.59 127.83 19.77 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.543 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.65 -34.18 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.452 2.102 . . . . 0.0 112.285 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.1 p -46.98 -38.73 11.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.7 p -119.93 -0.34 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.852 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 63.81 52.68 2.11 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.7 tp -116.97 132.81 56.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.372 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -134.67 117.65 16.3 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -143.85 161.73 44.58 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.12 155.6 7.0 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.851 2.367 . . . . 0.0 108.901 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 118.24 52.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.416 ' CB ' HD22 ' A' ' 102' ' ' ASN . 10.1 mt -100.21 124.14 45.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -65.35 -48.56 72.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.807 0.337 . . . . 0.0 111.32 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.585 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 99.9 p -78.91 112.87 16.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.014 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.6 p -84.53 110.63 18.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.201 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.517 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -139.61 166.56 24.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.447 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.51 -31.07 70.94 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -81.39 -44.09 18.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.972 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.3 p-10 -66.38 -31.67 72.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.201 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.39 -21.02 66.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.43 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.21 -18.45 61.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -97.54 -13.15 21.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 170.06 -147.98 11.29 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.658 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.27 129.56 45.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.972 -0.614 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 102' ' ' ASN . . . -107.91 148.1 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.4 p -70.39 148.25 48.6 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 185' ' ' ILE . 26.0 t -82.86 -40.26 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -90.29 149.53 22.31 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.011 0.434 . . . . 0.0 111.077 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.43 -18.61 64.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.908 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -144.77 55.95 1.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.012 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.565 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 2.4 tt0 -80.67 156.36 26.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.938 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.9 t -136.0 124.35 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.83 127.24 32.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 99.12 -8.38 60.86 Favored Glycine 0 N--CA 1.46 0.237 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -135.27 117.77 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.69 -167.53 54.75 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.48 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 63.8 t30 -86.65 112.54 21.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -85.03 103.47 14.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.03 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.565 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.42 122.92 33.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.362 0.601 . . . . 0.0 111.511 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.406 HD13 HD12 ' A' ' 83' ' ' ILE . 15.3 mt -118.34 132.05 56.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.287 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.36 48.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.381 0.61 . . . . 0.0 111.015 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.64 -178.23 16.93 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.541 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.4 ' HD2' HD12 ' A' ' 134' ' ' LEU . 78.8 m-70 -84.24 145.79 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.649 0.261 . . . . 0.0 110.845 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 54.4 t-20 -110.8 28.45 8.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.9 mmt -43.98 -15.51 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.0 OUTLIER 58.87 39.14 24.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.303 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -133.82 107.65 8.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.611 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -50.28 126.9 15.97 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.745 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.8 12.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.818 HG12 ' H ' ' A' ' 134' ' ' LEU . 17.4 t -87.94 179.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.818 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.21 136.69 48.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.258 -177.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.414 ' HA ' HG23 ' A' ' 138' ' ' ILE . 3.4 m-85 44.18 34.02 0.92 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.231 0.538 . . . . 0.0 110.989 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 p -82.38 -9.78 59.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -149.1 34.99 0.74 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.414 HG23 ' HA ' ' A' ' 135' ' ' PHE . 6.8 pt -69.89 -28.12 35.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.869 0.366 . . . . 0.0 111.771 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.61 0.86 4.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.606 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -92.93 -13.82 28.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.027 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -64.83 122.92 18.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.397 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mttm -95.63 157.77 15.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.574 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -55.64 133.0 50.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.796 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.6 18.29 62.24 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 16.8 m-20 -79.58 135.06 36.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -81.47 128.01 33.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.511 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.0 mt -123.38 121.7 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.06 119.33 38.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.978 0.418 . . . . 0.0 110.043 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.2 tp -118.07 138.26 52.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -106.01 135.65 47.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.07 0.462 . . . . 0.0 111.48 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 46.7 t0 -109.89 -169.83 1.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 64.8 t30 -33.67 -67.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.26 0.552 . . . . 0.0 111.099 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.89 23.78 3.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.107 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.05 147.06 49.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.575 0.702 . . . . 0.0 112.712 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.543 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 90.7 mt-10 -108.57 122.25 46.69 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.823 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.494 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 34.5 m-85 -105.02 128.29 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.114 0.483 . . . . 0.0 111.773 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -95.5 115.87 28.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -116.02 140.94 48.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.461 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.26 134.35 55.17 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.484 0.659 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 133.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -101.81 -25.84 13.68 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 124.76 1.287 . . . . 0.0 111.088 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.31 145.61 4.39 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.663 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 163' ' ' VAL . 3.7 p -104.56 151.56 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -154.02 162.64 41.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.129 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.532 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 70.3 mt-10 -111.98 117.81 33.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.08 158.52 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 111.335 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.5 p -59.67 168.72 1.74 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.445 ' HA ' HH11 ' A' ' 196' ' ' ARG . 2.8 Cg_endo -81.47 -10.69 12.05 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.948 1.765 . . . . 0.0 111.944 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.22 -3.06 58.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.202 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.6 68.32 9.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 110.865 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.425 ' C ' ' N ' ' A' ' 173' ' ' VAL . 70.7 m95 -70.48 -29.86 66.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.765 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 56.0 mp0 -49.23 -17.71 0.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.204 0.526 . . . . 0.0 110.537 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.425 ' N ' ' C ' ' A' ' 171' ' ' TRP . 90.4 t -71.48 -23.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.577 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.421 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -107.86 -7.37 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.608 0.718 . . . . 0.0 109.679 -178.169 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -79.77 139.0 37.43 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.823 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -51.24 128.59 22.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.174 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -99.15 -39.59 8.4 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.035 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.89 29.0 0.37 Allowed Glycine 0 N--CA 1.473 1.156 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -156.63 -179.33 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.351 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -91.1 88.85 7.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.368 0.604 . . . . 0.0 109.833 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -124.33 168.31 13.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.077 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.72 142.75 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.951 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 184' ' ' LEU . 9.4 m -136.84 123.35 20.87 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.388 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -109.04 122.81 48.04 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.32 0.581 . . . . 0.0 110.92 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.513 HD11 HG21 ' A' ' 110' ' ' VAL . 27.9 pt -134.92 -167.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.953 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.781 -179.159 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.445 HH11 ' HA ' ' A' ' 168' ' ' PRO . 55.5 ttp180 . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.532 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.6 m-85 -91.03 129.12 37.06 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.679 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 138.71 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.258 0.551 . . . . 0.0 111.48 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.74 127.71 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.556 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.11 135.32 54.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.167 0.508 . . . . 0.0 110.457 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.44 158.92 24.26 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 55.4 p-10 -113.74 150.24 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.387 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 40.0 tp -72.07 127.62 33.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.086 0.469 . . . . 0.0 111.017 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.6 t -106.34 -25.6 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.329 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.29 162.12 20.92 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.421 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.494 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 81.1 m -139.51 157.63 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.189 0.518 . . . . 0.0 110.032 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.543 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 19.4 pttp -149.91 178.54 8.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.6 143.63 26.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -71.28 79.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.702 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.691 178.461 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.486 1.083 0 N-CA-C 110.895 -0.463 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.76 154.81 41.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.717 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.4 mp -59.4 -27.61 66.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.689 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.46 94.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.279 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.8 mt-10 -72.58 -37.49 68.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.732 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.5 t -72.0 -44.29 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.574 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.96 89.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.33 -26.69 30.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.44 136.8 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.9 t -92.36 158.55 16.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.529 HD13 ' CB ' ' A' ' 105' ' ' SER . 55.6 tp -122.7 127.22 48.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.0 0.428 . . . . 0.0 111.06 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -96.1 98.26 10.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.564 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.419 ' C ' ' N ' ' A' ' 78' ' ' GLN . 29.0 mmtp -55.84 -35.51 66.49 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.119 0.485 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -51.56 -13.06 0.2 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.035 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.419 ' N ' ' C ' ' A' ' 76' ' ' LYS . 94.7 mm-40 -102.55 11.09 38.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.476 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.77 124.95 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -119.39 -4.57 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.171 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.03 -162.29 35.59 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -155.97 165.36 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.574 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.8 tt -131.35 139.65 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.796 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -131.66 132.84 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.053 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -131.03 127.0 21.91 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.95 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.84 -38.13 0.17 Allowed 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.256 1.971 . . . . 0.0 112.314 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.2 t -46.97 -39.55 12.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.586 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 90' ' ' LEU . 1.3 p -117.9 -2.5 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.68 55.38 2.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -120.77 138.49 53.99 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.559 -177.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 91' ' ' GLU . 55.8 mp0 -138.98 120.1 14.6 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.593 HD22 ' HA2' ' A' ' 106' ' ' GLY . 35.4 mt -143.37 109.55 5.33 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -40.74 139.48 1.28 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 121.887 1.724 . . . . 0.0 109.924 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.3 t -90.39 118.2 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.1 mt -102.37 121.73 42.87 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.058 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -64.83 -47.54 77.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.121 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.3 m -69.7 102.13 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.311 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 98' ' ' SER . 25.2 p -81.15 98.6 8.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.457 0.646 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.6 p -136.59 157.79 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.499 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -56.38 -29.19 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -81.98 -43.58 17.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.226 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.34 -34.45 78.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -63.21 -21.31 66.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.806 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 mt -69.66 -26.51 64.43 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.529 ' CB ' HD13 ' A' ' 74' ' ' LEU . 23.4 m -93.85 -10.99 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.593 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 165.62 -170.81 40.63 Favored Glycine 0 N--CA 1.458 0.149 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.658 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.32 129.2 37.34 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.116 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.12 148.13 28.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.424 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 p -70.32 143.41 52.01 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 185' ' ' ILE . 7.6 t -83.76 -44.64 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.43 -172.86 3.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.6 pm0 -119.48 -9.15 9.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.055 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -139.63 39.21 2.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.39 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -91.09 157.25 17.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.48 131.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.896 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -67.58 128.83 37.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.58 2.46 76.08 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -141.83 121.84 13.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.729 0.299 . . . . 0.0 111.107 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.83 -165.73 54.76 Favored Glycine 0 CA--C 1.517 0.218 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -89.86 109.05 20.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.59 101.77 12.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.918 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.57 128.69 36.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.423 0.63 . . . . 0.0 111.739 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -126.0 131.95 52.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.553 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.81 140.85 46.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.58 0.705 . . . . 0.0 111.096 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.1 -179.36 18.31 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -81.93 153.35 26.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 129' ' ' SER . 57.6 t30 -122.36 28.02 7.64 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.007 0.432 . . . . 0.0 111.208 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 31.9 mtt -43.82 -15.0 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.616 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 38.07 21.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.067 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 136' ' ' SER . 1.6 tppp? -134.13 121.07 20.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.835 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.18 125.66 24.51 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.98 -25.07 11.08 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.347 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 134' ' ' LEU . 95.1 t -80.39 176.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.721 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -74.55 136.6 42.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.391 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 46.52 30.66 1.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.095 0.474 . . . . 0.0 110.953 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.16 -8.23 59.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.213 -178.738 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.9 m-20 -143.99 36.3 1.26 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 pt -69.46 -30.05 44.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 111.971 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.08 1.69 7.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.807 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 t -92.18 -15.82 27.08 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.998 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.99 119.51 11.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 53.3 mtmt -96.33 156.28 16.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -56.46 121.77 10.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.61 19.0 14.38 Favored Glycine 0 N--CA 1.466 0.694 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 86.5 m-20 -90.28 131.31 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -79.64 135.22 36.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.08 0.467 . . . . 0.0 111.574 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -129.31 121.78 54.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.28 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.39 120.48 40.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.1 tp -116.71 142.86 46.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.181 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.226 0.536 . . . . 0.0 111.499 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 34.7 t0 -112.09 -165.38 0.99 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.0 m-20 -22.4 -75.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.729 0.643 . . . . 0.0 111.479 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -138.26 27.23 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.002 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -125.62 142.34 51.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -108.43 121.41 44.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.903 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.433 ' CE2' HG21 ' A' ' 206' ' ' THR . 79.6 m-85 -105.2 131.25 52.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.55 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -94.43 115.91 28.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.2 m-85 -117.39 136.65 53.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.589 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.34 133.87 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.482 0.658 . . . . 0.0 111.0 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.22 135.33 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.887 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.3 t -106.14 -24.83 12.24 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.995 1.434 . . . . 0.0 111.178 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.56 155.01 7.5 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.623 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.9 144.28 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.2 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.8 m -138.64 151.36 47.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.102 0.477 . . . . 0.0 111.298 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -106.02 110.26 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.314 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.2 m -130.74 153.03 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.2 p -64.11 168.48 6.09 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.8 Cg_endo -80.97 -12.63 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.923 1.748 . . . . 0.0 111.926 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -85.47 -21.53 28.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.096 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -86.64 76.5 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.501 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.543 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 27.1 m95 -75.35 -12.69 60.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.244 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -51.05 -8.1 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' A' ' 171' ' ' TRP . 32.8 m -90.21 -15.54 8.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.683 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.646 HG11 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER -120.62 -0.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.724 0.773 . . . . 0.0 109.709 -178.474 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -83.43 143.66 30.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.844 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.12 128.18 35.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.599 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -104.54 -41.88 5.59 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.757 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.73 31.08 0.21 Allowed Glycine 0 N--CA 1.473 1.114 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -154.03 174.72 14.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 3.8 m-20 -91.55 89.62 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.736 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -123.17 169.79 10.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.851 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -131.61 142.72 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.794 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.571 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.9 m -137.32 124.26 21.41 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -109.56 125.06 52.13 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.611 0.719 . . . . 0.0 110.902 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.646 HD13 HG11 ' A' ' 174' ' ' VAL . 8.4 pt -135.53 -170.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.608 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.594 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.1 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.724 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.594 ' NH1' ' O ' ' A' ' 186' ' ' THR . 12.0 ptp180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.952 0.406 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -106.68 139.85 40.47 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.011 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 24.6 t -133.46 135.43 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.265 0.555 . . . . 0.0 110.937 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.5 t -118.42 130.28 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.692 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 161' ' ' THR . . . -118.77 136.54 53.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.425 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.61 150.44 19.51 Favored Glycine 0 N--CA 1.466 0.679 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.023 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -105.47 143.78 33.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.15 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.504 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.27 127.83 33.86 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 110.698 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.2 t -108.4 -23.54 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.529 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.42 177.03 46.81 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.745 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 156' ' ' TYR . 21.8 m -154.03 151.63 29.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -150.31 179.27 8.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.603 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.83 144.42 25.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.023 0.439 . . . . 0.0 110.57 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.54 78.87 1.06 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.638 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt . . . . . 0 C--N 1.319 -0.739 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.329 178.167 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.485 0.981 0 CA-C-O 121.144 0.393 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 69' ' ' VAL . 48.0 t0 -76.33 172.48 12.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -61.08 -21.59 63.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.786 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.87 95.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.31 -20.49 57.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 65' ' ' ASP . 66.3 t -81.14 -51.67 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.686 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.9 90.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.967 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.45 -32.79 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.857 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 146.72 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.847 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.7 t -138.58 141.41 39.21 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.995 0.426 . . . . 0.0 110.794 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -138.43 121.64 16.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.289 -179.226 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.704 ' N ' HD13 ' A' ' 74' ' ' LEU . 96.2 m-20 -70.31 112.1 6.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.36 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.523 ' O ' HG22 ' A' ' 79' ' ' VAL . 28.4 mmtp -52.81 -9.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.511 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 75' ' ' ASP . 99.4 mttt -83.19 -4.38 58.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.771 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -95.12 10.41 35.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.706 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 76' ' ' LYS . 14.7 m -94.28 147.39 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -134.11 4.85 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.921 0.391 . . . . 0.0 111.695 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.5 38.25 Favored Glycine 0 C--N 1.322 -0.247 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -152.43 153.26 33.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.231 0.539 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 83' ' ' ILE . 16.0 tt -128.66 130.29 68.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 m -128.61 129.46 45.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.11 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 19.0 mt -135.33 116.06 11.94 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.162 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 4.7 Cg_exo -78.35 -32.94 2.08 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 122.745 2.297 . . . . 0.0 112.843 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 t -50.36 -40.08 48.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.012 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.34 -6.68 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.819 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.23 47.64 0.28 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.09 129.93 56.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.761 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.79 119.1 14.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.1 mt -146.59 166.29 17.11 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.72 153.86 8.81 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.072 2.514 . . . . 0.0 108.767 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 73.6 t -104.43 121.09 55.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.25 132.47 53.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -80.15 -29.9 38.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.991 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 m -79.03 102.42 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.128 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -80.9 97.93 7.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.332 0.587 . . . . 0.0 109.882 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 p -141.01 158.56 43.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.104 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.83 -37.77 77.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.821 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -69.94 -46.29 65.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.83 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.51 -38.34 89.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.777 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.3 mt -59.73 -26.46 65.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.84 -14.14 61.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -105.74 -13.13 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 175.24 -170.07 43.06 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.486 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.17 123.29 27.78 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.32 142.82 34.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.114 0.483 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.401 ' O ' ' OG ' ' A' ' 98' ' ' SER . 43.8 p -73.95 152.03 40.21 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.455 HG21 HD11 ' A' ' 185' ' ' ILE . 4.2 t -86.07 -42.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -89.51 -172.06 3.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.846 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -123.64 -8.62 7.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.977 0.418 . . . . 0.0 111.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -139.7 39.94 2.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -93.46 159.86 15.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.007 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.87 133.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.009 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.63 127.75 33.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.172 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.52 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.35 5.75 72.04 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -143.56 124.13 14.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 0.0 110.992 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.98 -164.45 54.28 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.83 107.86 19.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.27 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.81 100.01 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.8 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 127.36 36.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 0.0 112.071 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.4 mt -122.88 130.4 52.82 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.29 47.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.13 -178.49 19.01 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.601 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.533 ' O ' ' O ' ' A' ' 134' ' ' LEU . 44.6 m-70 -88.74 139.05 30.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 34.0 p30 -108.2 27.26 9.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.215 0.531 . . . . 0.0 110.323 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.8 mmm -43.87 -14.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.987 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.62 40.91 9.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.009 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -131.7 108.41 9.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.744 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 44.0 pttt -51.07 125.65 14.35 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.319 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.4 -29.76 8.44 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.725 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.0 t -75.54 178.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.725 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.33 137.65 46.79 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.281 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.508 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.3 m-85 44.37 31.81 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 110.989 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -81.97 -12.94 58.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.293 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 136' ' ' SER . 95.9 m-20 -143.19 24.96 1.76 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.508 HD13 ' CD2' ' A' ' 135' ' ' PHE . 4.1 pt -69.02 -23.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.85 0.357 . . . . 0.0 111.687 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.78 4.83 3.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.648 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.2 m -96.91 -14.63 21.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.2 0.524 . . . . 0.0 109.638 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.484 ' O ' HG21 ' A' ' 163' ' ' VAL . 15.0 mt -62.43 132.27 51.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.352 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -106.97 175.18 5.59 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.946 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -69.51 135.47 50.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.68 71.51 Favored Glycine 0 N--CA 1.461 0.312 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.28 136.03 36.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -82.95 127.38 33.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.695 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.6 mt -122.72 123.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -103.82 115.63 30.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.838 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.18 148.86 38.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.931 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -123.44 133.61 54.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.399 0.619 . . . . 0.0 111.629 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -112.14 -165.5 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 16.4 t-20 -23.99 -75.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 111.617 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -137.04 26.7 2.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -124.07 145.94 48.91 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -108.52 119.56 39.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.76 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.455 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.0 m-85 -104.42 129.33 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.61 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.477 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 97.7 mt-10 -95.73 117.73 31.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.021 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.52 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 50.6 m-85 -117.47 138.88 51.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.292 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -115.69 132.08 56.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.501 0.667 . . . . 0.0 111.145 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.66 134.88 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.166 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -105.75 -25.49 12.18 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 124.431 1.082 . . . . 0.0 111.081 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.4 161.55 19.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.395 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.519 HG13 HG22 ' A' ' 199' ' ' VAL . 10.5 t -128.78 155.5 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.823 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -164.16 174.46 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 0.0 111.666 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.535 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 40.1 mp0 -121.88 117.13 25.74 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.8 159.06 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 p -62.82 167.12 6.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.22 -9.95 11.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.343 2.028 . . . . 0.0 111.922 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -81.34 -11.61 59.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.808 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -86.4 73.21 10.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.369 0.605 . . . . 0.0 109.72 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.527 ' C ' ' H ' ' A' ' 173' ' ' VAL . 81.9 m95 -72.48 -27.36 62.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -50.93 -9.1 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.0 110.93 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.8 t -78.25 -21.16 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.539 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.494 HG11 HD13 ' A' ' 185' ' ' ILE . 1.2 m -116.18 -3.65 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.745 0.783 . . . . 0.0 109.85 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -80.64 151.76 28.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.15 -1.387 . . . . 0.0 112.157 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.87 126.5 27.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.674 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -107.17 -43.8 4.52 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.317 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 150.34 23.3 0.06 OUTLIER Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.3 173.7 15.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.157 0.503 . . . . 0.0 111.156 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.4 m-20 -95.75 88.38 4.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -124.22 127.72 48.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.403 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -81.71 146.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.524 ' C ' HD12 ' A' ' 184' ' ' LEU . 7.2 m -136.29 122.09 19.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.772 0.32 . . . . 0.0 111.06 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -107.57 126.12 52.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.317 0.58 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.494 HD13 HG11 ' A' ' 174' ' ' VAL . 9.7 pt -137.55 178.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.663 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 -178.794 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 121.028 0.442 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.404 ' CE1' ' OE2' ' A' ' 165' ' ' GLU . 4.5 m-85 -80.37 132.9 35.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.85 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.1 133.92 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.041 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.519 HG22 HG13 ' A' ' 163' ' ' VAL . 82.0 t -117.2 128.62 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.446 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.491 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.45 135.62 53.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.6 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.77 142.53 14.04 Favored Glycine 0 N--CA 1.465 0.596 0 CA-C-O 121.773 0.652 . . . . 0.0 111.642 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 52.3 p-10 -100.32 141.56 32.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.294 -0.953 . . . . 0.0 111.409 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.18 126.16 28.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 157' ' ' GLU . 6.2 m -109.46 -22.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.421 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.04 158.14 13.44 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.802 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.455 HG21 ' CE2' ' A' ' 156' ' ' TYR . 25.1 m -134.85 156.18 49.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.382 0.61 . . . . 0.0 109.778 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.477 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 ptpp? -149.66 178.81 8.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.278 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.69 147.1 23.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.509 . . . . 0.0 110.549 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.32 80.02 3.07 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.814 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 51.7 tttm . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.189 178.649 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 120.797 0.249 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.3 m-20 -68.86 163.93 23.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.177 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.425 ' O ' HD23 ' A' ' 66' ' ' LEU . 6.6 tt -76.43 -14.16 60.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.307 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.44 80.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.482 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 13.7 pt-20 -74.69 -19.05 60.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.396 . . . . 0.0 110.704 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 65' ' ' ASP . 96.9 t -77.56 -53.78 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.526 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.02 88.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.125 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -73.0 -27.94 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.523 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.89 137.02 58.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.84 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.7 p -89.78 159.27 17.12 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.182 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 105' ' ' SER . 50.1 tp -122.41 129.71 52.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.994 0.426 . . . . 0.0 111.008 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.3 m-20 -97.5 90.64 5.11 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.594 ' O ' HG12 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -50.48 -13.53 0.13 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' N ' ' C ' ' A' ' 75' ' ' ASP . 71.3 mmtt -71.27 -8.95 57.03 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -106.53 13.45 28.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 76' ' ' LYS . 6.4 p -87.43 123.17 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.822 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.0 pt -120.44 -7.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.13 -169.26 40.47 Favored Glycine 0 C--N 1.317 -0.527 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -146.54 155.72 42.71 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.178 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.4 tp -125.79 128.94 72.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -126.93 131.39 51.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.79 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 24.7 mt -130.63 122.04 19.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.04 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -81.67 -37.16 0.28 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 122.304 2.002 . . . . 0.0 112.422 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -49.12 -37.92 23.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.25 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -118.25 -3.47 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.531 -178.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.51 51.48 1.51 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -109.32 128.93 55.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.132 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.59 113.54 11.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.594 HD22 ' HA2' ' A' ' 106' ' ' GLY . 15.7 mt -146.49 111.79 4.29 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.5 Cg_endo -42.17 143.0 1.45 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.508 1.472 . . . . 0.0 110.583 176.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.28 119.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -102.09 121.44 42.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.076 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 66.0 tttm -64.75 -47.11 79.42 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.3 p -60.6 97.86 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.993 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.93 97.94 7.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.19 0.519 . . . . 0.0 109.803 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.5 p -139.49 158.45 44.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.53 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -60.59 -25.01 65.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.352 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -83.79 -45.2 13.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 111.348 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' HA ' HD21 ' A' ' 102' ' ' ASN . 10.7 m120 -66.86 -35.07 79.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.444 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 108' ' ' ALA . 22.6 mt -63.5 -16.99 62.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.73 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.07 -27.22 62.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.698 ' HB3' HD22 ' A' ' 74' ' ' LEU . 3.5 m -98.75 -7.48 27.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.594 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 173.8 -170.07 43.17 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.729 -1.225 . . . . 0.0 112.146 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.14 124.35 31.7 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.69 149.81 25.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.779 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 109' ' ' THR . 6.1 p -75.28 152.03 38.27 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 122' ' ' ALA . 1.1 p -88.1 -35.45 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -89.24 143.95 26.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.316 0.579 . . . . 0.0 111.096 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.509 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.1 pt-20 -70.09 -17.14 63.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.916 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.45 52.22 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.792 0.33 . . . . 0.0 111.186 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -88.75 157.98 18.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.78 134.07 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.753 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 5.2 mtp -77.87 123.82 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.23 5.07 65.96 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -140.78 120.18 13.11 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.43 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.91 -173.44 53.64 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 173' ' ' VAL . 39.7 t-20 -78.25 107.58 10.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -85.51 103.42 14.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -90.34 122.5 33.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.306 0.574 . . . . 0.0 111.679 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.09 128.9 56.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.74 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.01 138.54 46.25 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 110.551 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.52 17.69 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.778 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' LEU . 49.9 m-70 -87.32 142.99 27.47 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.998 0.428 . . . . 0.0 110.708 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 129' ' ' SER . 66.8 t30 -109.26 28.65 8.3 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.874 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.56 -18.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.717 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 61.8 37.39 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.941 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -133.98 106.91 7.49 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -50.18 125.61 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.88 -22.9 11.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.0 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.837 HG12 ' H ' ' A' ' 134' ' ' LEU . 33.7 t -90.09 179.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 117.659 0.729 . . . . 0.0 109.352 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.837 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -71.13 135.22 47.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.878 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.04 36.07 2.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.381 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 26.3 p -81.45 -8.94 59.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 85.9 m-20 -145.9 37.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.5 pt -68.64 -32.27 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.472 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.9 5.75 2.45 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.139 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -95.27 -15.7 22.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.79 124.31 22.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.701 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.33 152.25 19.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -54.29 127.26 26.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.616 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.71 22.0 32.37 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 34.6 m-20 -85.41 134.57 34.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -79.35 131.48 36.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 111.88 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.6 mt -127.24 125.96 67.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.532 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.63 119.93 39.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.055 0.455 . . . . 0.0 110.079 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 tp -115.66 143.39 45.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -108.07 124.82 50.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.086 0.47 . . . . 0.0 111.418 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -97.7 -173.03 2.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 152' ' ' ASN . 5.5 p30 -30.35 -69.56 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 70.8 mm-40 -135.03 27.0 3.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.757 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 158.34 38.46 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.465 0.65 . . . . 0.0 112.463 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -116.52 122.18 43.94 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.338 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -105.91 131.92 52.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 111.25 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 204' ' ' VAL . 96.6 mt-10 -96.37 115.26 27.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.984 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -113.93 141.92 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.422 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.16 131.18 54.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.488 0.661 . . . . 0.0 111.198 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 47.8 t -65.37 134.33 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.08 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -100.94 -30.42 11.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 124.708 1.255 . . . . 0.0 110.299 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.46 156.69 11.04 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.207 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.54 154.74 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.916 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.9 t -167.65 178.03 5.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.578 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.44 ' O ' HG13 ' A' ' 166' ' ' VAL . 75.3 mt-10 -113.12 127.64 56.26 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 165' ' ' GLU . 6.1 m -155.52 174.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.361 . . . . 0.0 111.483 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 169' ' ' ASP . 8.9 p -90.56 136.55 28.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.651 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -54.13 -0.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.191 1.927 . . . . 0.0 112.263 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 167' ' ' THR . 48.5 p-10 -74.23 -18.99 60.67 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HZ1' ' NH2' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -85.68 72.21 10.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.521 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 59.8 m95 -74.38 -4.17 34.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.185 0.516 . . . . 0.0 112.001 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.562 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.6 mt-10 -60.55 -18.2 50.92 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.45 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 4.4 m -92.86 -0.29 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.471 HG21 ' CE3' ' A' ' 171' ' ' TRP . 0.5 OUTLIER -123.68 -6.6 7.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.38 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.513 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 69.4 mm-40 -87.56 152.22 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.206 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.4 ' HA ' ' H ' ' A' ' 120' ' ' ASN . 97.8 m-20 -59.42 127.33 31.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.714 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.562 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.1 m170 -119.94 27.94 8.39 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.55 76.87 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -148.84 164.91 33.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.073 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -91.91 91.37 7.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.55 0.691 . . . . 0.0 109.826 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -117.41 164.55 14.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.522 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.96 140.75 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.547 ' C ' HD12 ' A' ' 184' ' ' LEU . 56.7 m -135.75 126.47 27.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.624 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 183' ' ' THR . 9.8 mp -108.25 120.8 43.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.376 0.608 . . . . 0.0 109.684 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.2 pt -130.32 -178.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.513 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.466 0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.26 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.61 ' NH2' ' HZ1' ' A' ' 170' ' ' LYS . 20.6 ptt180 . . . . . 0 N--CA 1.458 -0.046 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.11 137.52 37.51 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.1 p -131.71 135.87 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.19 137.87 52.7 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.142 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.58 151.97 21.42 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 54.4 p-10 -110.18 147.17 34.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.923 -0.639 . . . . 0.0 111.902 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 205' ' ' GLY . 45.4 tp -67.71 126.24 28.76 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.774 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 157' ' ' GLU . 6.9 m -109.59 -23.54 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.03 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -177.78 172.71 45.38 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.213 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.8 m -152.67 151.43 30.57 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.087 0.47 . . . . 0.0 110.686 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -148.14 175.8 10.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.116 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.82 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.062 0.458 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -73.61 79.75 1.5 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.886 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.768 178.59 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.487 1.141 0 CA-C-O 120.894 0.289 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -77.14 170.76 15.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.3 -14.54 63.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.729 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.36 88.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mm-40 -75.85 -22.48 56.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.449 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.09 -50.35 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.638 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.16 87.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.196 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.66 -31.41 69.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.17 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.63 109.04 1.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -96.69 113.09 24.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.113 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.494 HD21 HD22 ' A' ' 95' ' ' LEU . 38.0 tp -110.24 124.15 51.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.91 140.21 49.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.234 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -64.84 -5.4 5.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.561 . . . . 0.0 109.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -74.45 -9.33 58.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 10.4 mp0 -94.83 3.73 54.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -89.22 126.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.537 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -123.66 -7.9 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.014 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.63 -172.63 39.2 Favored Glycine 0 C--N 1.312 -0.763 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -147.82 154.32 40.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 117.457 0.628 . . . . 0.0 111.852 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.3 tt -123.35 123.7 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.393 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -125.9 129.67 49.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.517 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 15.7 mt -133.89 124.11 17.46 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.424 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.5 Cg_endo -81.97 -36.02 0.34 Allowed 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.194 1.929 . . . . 0.0 112.576 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.516 ' OG ' HD23 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -50.86 -38.78 51.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.806 -177.655 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 90' ' ' LEU . 14.3 m -118.94 -3.36 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 110.535 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.97 49.54 1.6 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -106.77 126.79 52.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 -179.121 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.634 ' N ' HD13 ' A' ' 90' ' ' LEU . 82.8 tt0 -133.96 115.31 14.23 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.2 tp -149.95 113.5 3.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.6 Cg_endo -41.87 158.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.261 1.307 . . . . 0.0 110.427 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.32 124.84 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.494 HD22 HD21 ' A' ' 74' ' ' LEU . 33.6 mt -104.82 123.82 48.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 63.0 tttp -66.15 -46.89 75.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.097 0.475 . . . . 0.0 110.85 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.43 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 3.6 m -71.75 102.83 2.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.52 97.29 9.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 5.2 p -136.33 155.17 50.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.908 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -54.19 -26.19 26.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.485 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -85.12 -47.45 10.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.475 0.655 . . . . 0.0 111.71 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 97' ' ' SER . 2.4 m120 -65.63 -36.43 83.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.267 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.13 -19.33 61.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -70.79 -32.04 69.01 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 m -92.62 -9.73 39.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.81 176.54 43.21 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.606 -1.283 . . . . 0.0 112.407 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.74 128.01 34.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.17 28.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.001 0.429 . . . . 0.0 111.265 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.0 p -75.56 153.08 37.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.22 -46.38 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -90.54 140.91 29.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.859 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.506 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.0 pt-20 -66.81 -6.12 14.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.694 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -145.73 45.76 1.28 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.78 0.324 . . . . 0.0 110.925 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.534 ' OE1' ' CG ' ' A' ' 121' ' ' TYR . 6.0 tt0 -72.04 161.18 31.28 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.5 t -136.92 124.53 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.8 mtt -75.1 127.82 34.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.494 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.83 71.83 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -140.85 121.61 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.097 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 75.68 -172.26 54.0 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -85.66 111.66 20.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.534 ' CG ' ' OE1' ' A' ' 114' ' ' GLN . 6.0 t80 -83.67 103.25 12.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.435 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.72 128.11 36.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 111.891 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.81 131.26 53.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.764 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.13 140.18 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.407 0.622 . . . . 0.0 110.95 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.8 -177.53 17.03 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.774 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -85.84 149.32 25.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.628 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' SER . 50.4 p30 -114.57 27.36 9.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.945 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.5 mmm -47.94 -10.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.93 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 m 55.87 42.12 29.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.327 0.584 . . . . 0.0 109.598 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.426 ' N ' ' OG ' ' A' ' 136' ' ' SER . 31.7 mmtm -132.56 110.55 10.55 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.927 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -53.92 125.25 17.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.726 0.774 . . . . 0.0 110.544 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.3 9.4 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.611 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.777 HG12 ' H ' ' A' ' 134' ' ' LEU . 52.3 t -77.84 178.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 CA-C-N 117.466 0.633 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.777 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.56 135.58 47.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.974 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 46.07 30.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.539 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.28 -11.44 59.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.68 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.16 20.61 2.09 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.5 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.0 pt -68.06 -25.01 31.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.622 0.249 . . . . 0.0 111.419 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.25 6.09 2.46 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.0 t -98.88 -16.09 18.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.516 HD23 ' OG ' ' A' ' 87' ' ' SER . 15.7 mt -64.91 125.02 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.075 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.444 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 22.6 ttpt -99.83 173.87 6.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.409 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 12.4 ttpt -68.57 125.25 25.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.729 0.776 . . . . 0.0 111.617 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.91 26.92 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 85.7 m-20 -85.29 133.31 34.16 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -79.49 127.18 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.302 0.572 . . . . 0.0 111.829 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.99 121.59 63.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.912 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -102.69 121.49 42.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.1 tp -118.52 144.12 46.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -113.04 130.78 56.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.297 0.57 . . . . 0.0 111.193 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.0 t0 -108.87 -172.17 2.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.516 -1.22 . . . . 0.0 107.913 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.506 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.8 m-20 -27.05 -67.7 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.163 0.506 . . . . 0.0 111.799 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.97 22.02 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.8 152.76 36.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.365 0.602 . . . . 0.0 112.461 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.17 120.79 40.93 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CE2' HG21 ' A' ' 206' ' ' THR . 63.2 m-85 -106.85 130.73 54.49 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 111.075 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.7 mt-10 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.297 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -113.33 141.91 46.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.31 131.57 54.28 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.532 0.682 . . . . 0.0 110.42 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.6 135.81 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.146 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -100.92 -23.09 14.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.461 1.1 . . . . 0.0 110.339 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 153.16 155.93 7.36 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.497 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.39 138.56 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.331 -0.934 . . . . 0.0 109.905 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.0 m -135.04 149.57 50.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.129 0.49 . . . . 0.0 111.601 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.49 111.54 24.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.308 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.03 158.59 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.184 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 p -67.06 168.47 10.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.535 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.3 Cg_endo -81.52 -11.09 11.85 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 122.033 1.822 . . . . 0.0 111.47 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -86.69 -14.49 42.37 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.168 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -87.37 72.26 9.81 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.143 0.496 . . . . 0.0 110.442 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 89.4 m95 -76.21 -1.72 27.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.464 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.505 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -53.56 -31.26 45.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 0.0 110.739 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.713 ' O ' HG21 ' A' ' 183' ' ' THR . 17.7 m -83.68 4.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.66 -16.23 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.616 0.722 . . . . 0.0 109.456 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.9 159.9 19.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.878 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.26 129.34 39.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 39.5 m80 -102.25 -38.87 7.47 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.49 29.33 0.28 Allowed Glycine 0 N--CA 1.472 1.076 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.427 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.0 ptpt -156.18 176.91 12.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.381 0.61 . . . . 0.0 111.595 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 23.9 p30 -90.69 88.62 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.893 0.854 . . . . 0.0 109.84 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.44 166.88 13.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.169 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.25 140.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.713 HG21 ' O ' ' A' ' 173' ' ' VAL . 19.5 m -135.28 126.33 27.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.77 118.29 33.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.339 0.59 . . . . 0.0 109.782 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.51 HG22 HG13 ' A' ' 198' ' ' VAL . 29.3 pt -129.35 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.54 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.529 ' OG1' ' NH1' ' A' ' 196' ' ' ARG . 44.3 p . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.113 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.529 ' NH1' ' OG1' ' A' ' 186' ' ' THR . 61.0 ttm-85 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.92 0.39 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.98 127.39 42.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.51 HG13 HG22 ' A' ' 185' ' ' ILE . 47.9 t -133.54 136.92 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 126.39 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.579 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.09 136.79 52.7 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.28 0.562 . . . . 0.0 110.3 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.6 155.48 23.63 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.632 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -112.32 146.16 38.75 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.813 0.34 . . . . 0.0 111.865 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.41 128.34 36.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 121.368 0.604 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.7 p -107.31 -24.14 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.752 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.47 175.15 46.11 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.445 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.428 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.2 m -152.7 151.6 30.74 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 110.83 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -149.17 176.27 10.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.04 146.02 24.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.337 0.589 . . . . 0.0 111.17 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.53 79.63 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.566 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp . . . . . 0 C--N 1.318 -0.795 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.76 178.615 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.486 1.035 0 CA-C-O 120.818 0.258 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 57.8 t0 -71.64 152.89 42.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.439 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.7 mt -59.6 -24.3 63.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.715 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.78 90.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -73.41 -34.57 65.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.3 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.61 -44.17 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.606 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.81 89.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.92 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.47 -24.74 36.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.91 109.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.892 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -95.6 121.84 37.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.039 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.4 tp -115.79 127.94 55.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.986 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.42 138.38 55.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.587 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -71.19 -6.86 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.5 . . . . 0.0 110.274 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.09 -36.68 85.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.174 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -76.69 13.01 1.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.316 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.43 126.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.75 -4.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.87 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.22 -171.23 40.54 Favored Glycine 0 C--N 1.318 -0.468 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.793 ' O ' HD23 ' A' ' 149' ' ' LEU . 53.5 mtt180 -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.1 tt -119.28 124.71 73.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 m -127.1 128.68 46.6 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 56.6 mt -131.78 129.36 21.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.355 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -82.31 -35.4 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.22 1.947 . . . . 0.0 112.377 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -49.71 -39.67 37.8 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.669 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.9 p -118.44 -2.31 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 123.027 0.204 . . . . 0.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.89 53.08 3.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.7 tp -113.34 131.84 55.81 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.037 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.89 115.7 15.57 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 83' ' ' ILE . 39.5 mt -143.97 111.64 5.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.7 Cg_endo -40.65 138.64 1.42 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.57 1.513 . . . . 0.0 110.811 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 68.1 t -90.96 122.93 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -100.03 136.96 39.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.338 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.79 -34.48 60.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.6 m -93.83 115.84 28.27 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.465 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.8 p -82.79 66.44 8.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.211 0.529 . . . . 0.0 110.183 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.415 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -94.65 150.73 19.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.377 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -54.16 -52.01 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.634 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.83 -41.88 95.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.368 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.758 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -66.17 -33.47 75.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.37 -178.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.87 -15.08 62.6 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.413 HD23 ' NE2' ' A' ' 126' ' ' HIS . 24.3 mt -72.35 -23.44 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -94.08 -9.65 35.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.413 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 169.25 -162.94 36.63 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.853 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.453 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -89.08 127.84 35.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.249 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.82 26.02 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.6 p -71.45 149.75 45.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.3 t -82.92 -46.13 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -92.8 -171.55 2.75 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.297 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -106.79 -55.19 2.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.505 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -90.8 46.61 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.575 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.9 147.01 23.83 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.17 131.83 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.535 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.5 mtt -64.71 128.1 34.33 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.42 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.52 5.85 71.44 Favored Glycine 0 CA--C 1.508 -0.364 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -140.62 118.5 11.79 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.809 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.0 -168.45 54.21 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 61.1 t30 -85.99 109.11 18.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.63 103.54 13.03 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.7 126.73 36.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.806 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.486 HD13 HD12 ' A' ' 83' ' ' ILE . 11.5 mt -122.63 132.62 54.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.689 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.09 140.0 48.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.114 0.483 . . . . 0.0 110.587 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.99 -178.12 17.77 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.413 ' NE2' HD23 ' A' ' 104' ' ' LEU . 44.6 m-70 -80.9 156.62 25.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 0.0 110.622 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 129' ' ' SER . 2.2 p-10 -120.95 27.47 8.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 35.0 mtt -46.24 -12.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.615 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 57.5 40.35 27.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.616 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -134.0 112.07 10.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.032 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -52.84 124.51 14.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.059 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.65 -29.73 7.66 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.779 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.703 HG12 ' N ' ' A' ' 134' ' ' LEU . 95.6 t -75.22 176.68 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 117.914 0.857 . . . . 0.0 109.247 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.703 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.61 134.76 46.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.117 -178.466 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.3 m-85 46.13 32.87 1.54 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.958 0.408 . . . . 0.0 110.708 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -82.24 -9.85 59.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -146.58 28.28 1.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.431 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.5 pt -69.74 -27.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.496 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.83 0.13 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.846 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.8 m -91.27 -15.5 29.08 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.69 116.76 6.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.054 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.447 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.5 mttp -103.53 154.74 19.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -50.76 113.29 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.395 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.29 4.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.8 m-20 -101.06 128.47 47.1 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -82.99 134.61 35.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.247 0.546 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 158' ' ' TYR . 90.0 mt -123.95 124.24 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.946 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -105.08 122.01 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 110.82 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.7 mt -116.12 150.42 37.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.397 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.465 ' O ' ' SD ' ' A' ' 116' ' ' MET . 60.2 m-85 -118.36 130.19 55.86 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.087 0.47 . . . . 0.0 110.991 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.5 t0 -109.93 -170.15 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 7.5 p30 -27.03 -71.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.1 0.476 . . . . 0.0 111.602 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.7 mt-10 -137.49 31.41 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.081 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.16 138.95 48.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.324 0.583 . . . . 0.0 112.401 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -103.94 121.62 43.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -104.42 133.46 49.27 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.294 0.568 . . . . 0.0 111.55 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.412 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.7 mt-10 -98.38 119.86 37.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.016 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 147' ' ' ILE . 31.6 m-85 -120.0 139.7 52.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.93 135.14 54.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.492 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.4 t -70.7 135.9 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.981 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 11.4 p -102.68 -23.98 13.79 Favored 'General case' 0 C--N 1.341 0.235 0 O-C-N 124.814 1.321 . . . . 0.0 110.972 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.81 154.79 7.26 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.31 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.56 146.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.551 -0.824 . . . . 0.0 109.789 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.9 t -146.19 156.15 43.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.86 0.362 . . . . 0.0 111.178 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -109.18 118.23 36.2 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.18 156.69 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.968 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 169' ' ' ASP . 20.4 p -66.15 136.31 95.33 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.602 ' CB ' HH21 ' A' ' 196' ' ' ARG . 1.6 Cg_endo -47.77 -12.99 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.97 1.78 . . . . 0.0 111.816 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 167' ' ' THR . 55.0 t0 -86.0 -11.15 53.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.642 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -86.78 75.35 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.774 0.321 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -78.11 -5.64 52.22 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.049 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -53.43 -35.03 60.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.944 0.402 . . . . 0.0 111.191 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.709 ' O ' HG21 ' A' ' 183' ' ' THR . 16.8 m -81.45 3.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.828 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.0 t -119.53 -15.04 8.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.567 0.699 . . . . 0.0 109.773 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -85.31 163.19 18.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.047 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.35 129.62 39.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.0 -42.62 6.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.135 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.69 30.12 0.26 Allowed Glycine 0 N--CA 1.469 0.89 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -155.81 177.37 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.071 0.462 . . . . 0.0 111.236 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 61.9 m-20 -88.88 89.34 7.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.266 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -124.21 166.17 16.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.971 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.68 143.18 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 173' ' ' VAL . 8.2 m -136.21 125.33 24.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.711 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.566 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -112.85 125.59 54.53 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.505 HG22 HG12 ' A' ' 198' ' ' VAL . 5.6 pt -140.6 -177.86 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.7 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 32.1 p . . . . . 0 N--CA 1.467 0.404 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.771 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.602 HH21 ' CB ' ' A' ' 168' ' ' PRO . 29.6 ttm180 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.737 0.304 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -84.92 129.76 34.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 185' ' ' ILE . 34.6 m -137.57 140.07 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.165 0.507 . . . . 0.0 111.626 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.5 t -118.06 130.9 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.419 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.92 136.98 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.643 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.44 160.95 24.62 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.377 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 53.2 p-10 -112.53 146.03 39.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.175 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 157' ' ' GLU . 37.2 tp -68.95 127.74 34.22 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.24 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.2 176.58 44.51 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.386 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 36.1 m -153.56 153.44 32.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.077 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -149.78 179.21 8.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.578 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.64 148.97 21.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.618 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 209' ' ' LYS . 15.0 ptmt -64.42 79.59 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.455 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.314 -0.938 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.661 178.059 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.483 0.866 0 N-CA-C 110.982 -0.43 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.01 166.21 23.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.692 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.9 mm? -69.61 -16.29 63.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 111.152 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.91 94.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.381 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.9 mm-40 -72.52 -33.57 66.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.91 -46.52 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.911 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.016 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 59.9 t-20 -82.9 -28.32 30.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.59 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.83 106.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.851 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 m -97.3 114.81 26.63 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.58 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.441 HD13 ' OD1' ' A' ' 102' ' ' ASN . 53.2 tp -107.24 125.67 51.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.934 0.397 . . . . 0.0 111.106 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -68.23 138.48 55.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.321 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -63.92 -8.5 11.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.286 0.565 . . . . 0.0 110.207 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -70.76 -14.82 62.58 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.389 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -91.94 1.02 57.45 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.496 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.76 122.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 tt -104.31 -36.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.407 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.37 -158.47 8.78 Favored Glycine 0 C--N 1.321 -0.303 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.451 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 25.7 mtp85 -146.9 150.6 35.53 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.52 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.8 tt -122.34 127.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -126.84 129.15 47.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.849 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 12.6 mt -133.62 117.18 14.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.2 -177.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 3.4 Cg_exo -80.92 -37.75 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.486 2.124 . . . . 0.0 112.653 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 t -49.26 -36.79 21.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.491 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 90' ' ' LEU . 6.9 m -119.87 -7.07 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.381 0.134 . . . . 0.0 111.057 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 73.33 46.02 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.663 0.744 . . . . 0.0 109.952 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -106.0 125.59 51.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.512 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -137.0 110.75 8.11 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' O ' HG22 ' A' ' 83' ' ' ILE . 18.3 mt -146.61 116.88 4.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -41.14 140.41 1.33 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.795 1.663 . . . . 0.0 109.931 176.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.35 126.82 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.423 HD22 HD21 ' A' ' 74' ' ' LEU . 28.1 mt -103.11 124.97 49.56 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -70.37 -34.36 72.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.1 m -86.45 108.85 18.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.987 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -82.0 69.35 8.69 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 110.221 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.574 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.08 151.58 22.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.484 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.74 -50.14 66.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.593 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.01 -40.63 95.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.075 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.574 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 43.0 m-20 -65.64 -37.03 85.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.58 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.25 -18.09 46.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.627 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.31 -17.71 61.28 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -100.56 -12.14 19.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.52 -174.72 43.86 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 127.46 32.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.29 146.61 29.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 110.771 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.9 p -75.5 151.5 37.99 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.11 -50.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -90.65 139.22 30.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.72 -48.09 83.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.826 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -98.51 47.36 0.99 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.01 159.71 30.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -140.86 124.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 -178.738 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.0 mtt -75.36 127.97 34.34 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.32 -1.14 72.56 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 115' ' ' VAL . 29.5 tptp -142.81 127.34 17.9 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.986 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 72.93 -172.98 48.71 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -86.6 110.29 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -85.63 100.79 12.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.37 125.32 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.531 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.492 HD13 HD12 ' A' ' 83' ' ' ILE . 7.1 mt -119.32 130.28 55.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.36 138.98 47.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 110.754 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.76 -178.57 18.8 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.323 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 42.5 m-70 -85.69 141.05 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.569 0.223 . . . . 0.0 110.581 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 129' ' ' SER . 65.3 t30 -110.44 27.68 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.124 0.488 . . . . 0.0 110.567 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -44.81 -16.18 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.854 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.56 40.88 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.069 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 136' ' ' SER . 98.4 mttt -131.25 109.46 10.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.358 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 132' ' ' GLY . 7.7 tmtt? -53.31 123.87 13.1 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.511 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.404 ' N ' ' HD3' ' A' ' 131' ' ' LYS . . . 114.91 -29.2 7.58 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 134' ' ' LEU . 57.2 t -77.84 178.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.752 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.88 136.67 47.03 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.768 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 44.87 32.0 0.76 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.108 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.2 p -82.4 -11.92 58.24 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.96 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.403 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 35.2 t0 -141.71 25.91 1.95 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 pt -70.3 -22.33 23.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.918 0.389 . . . . 0.0 111.846 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.9 3.91 7.41 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.661 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.403 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.7 m -99.57 -11.45 20.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.111 0.481 . . . . 0.0 110.298 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.474 ' O ' HG21 ' A' ' 163' ' ' VAL . 14.6 mt -62.95 124.95 22.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.463 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.462 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -96.97 163.04 13.12 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.846 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -60.77 136.1 57.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.528 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.14 57.73 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 40.5 m-20 -87.61 131.62 34.35 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.948 ' HZ1' HG11 ' A' ' 204' ' ' VAL . 3.4 mmpt? -78.2 129.2 34.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.932 0.396 . . . . 0.0 111.726 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.1 mt -124.8 123.15 65.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -104.12 120.26 40.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.194 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.607 HD22 ' SD ' ' A' ' 116' ' ' MET . 0.4 OUTLIER -115.38 136.44 53.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.404 -178.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.451 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 87.7 m-85 -108.27 130.61 55.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 111.285 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.6 t0 -113.46 -165.46 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.524 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.3 m-20 -24.11 -75.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.174 0.512 . . . . 0.0 111.328 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -137.03 26.02 2.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -126.22 143.13 51.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -108.39 120.46 42.45 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -103.35 131.19 50.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.547 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.494 ' OE2' ' NZ ' ' A' ' 146' ' ' LYS . 70.3 tt0 -95.96 121.04 37.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -120.25 137.27 54.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.246 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.11 132.56 56.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 110.547 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.24 134.84 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.155 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.3 t -104.74 -24.29 12.94 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.468 1.105 . . . . 0.0 111.516 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.18 147.37 5.11 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.397 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 199' ' ' VAL . 13.5 t -111.08 155.51 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.6 t -161.34 169.64 21.66 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.936 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -121.22 123.88 43.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -135.69 157.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 111.326 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 169' ' ' ASP . 16.9 p -59.16 131.3 87.28 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.563 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.1 Cg_endo -45.57 -14.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.968 1.779 . . . . 0.0 112.122 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 167' ' ' THR . 53.6 t0 -84.83 -8.58 58.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.275 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.455 ' O ' HG22 ' A' ' 173' ' ' VAL . 1.3 tppp? -87.82 62.74 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.563 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 26.9 m95 -72.24 -18.21 61.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.804 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.09 -9.64 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.166 0.508 . . . . 0.0 111.195 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 171' ' ' TRP . 24.6 m -83.39 -25.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.817 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.459 HG11 HD13 ' A' ' 185' ' ' ILE . 0.8 OUTLIER -109.67 -2.33 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.622 0.725 . . . . 0.0 109.865 -178.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 176' ' ' ASP . 95.3 mt-10 -82.18 119.9 24.65 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.78 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 175' ' ' GLU . 97.9 m-20 -28.96 119.81 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.957 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -98.86 -43.43 6.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.051 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.17 33.47 0.32 Allowed Glycine 0 N--CA 1.47 0.963 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.1 ptpt -153.6 176.29 12.24 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.235 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 50.6 p-10 -97.44 88.62 4.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.904 0.859 . . . . 0.0 110.46 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -131.0 177.11 7.69 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.282 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.48 HD12 HD12 ' A' ' 149' ' ' LEU . 20.3 tt -130.63 143.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.538 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.615 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.5 m -138.22 123.88 19.77 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.563 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.615 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -110.86 128.82 55.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.459 HD13 HG11 ' A' ' 174' ' ' VAL . 7.1 pt -138.61 -166.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.626 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.656 -179.005 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' A' ' 168' ' ' PRO . 7.8 tmm_? . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.602 0.239 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -100.27 134.48 43.15 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.7 138.95 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.898 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.544 HG22 HG13 ' A' ' 163' ' ' VAL . 77.7 t -116.97 128.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.528 ' O ' HG22 ' A' ' 161' ' ' THR . . . -112.52 133.01 54.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.453 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.06 152.99 20.74 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 64.5 t0 -111.04 149.41 30.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.783 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.543 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.54 127.73 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.207 0.527 . . . . 0.0 110.795 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.948 HG11 ' HZ1' ' A' ' 146' ' ' LYS . 6.1 p -111.32 -21.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.699 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.43 176.05 47.46 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.678 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.0 m -156.86 154.51 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.824 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -150.76 178.99 8.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -90.96 148.19 22.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.285 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.411 ' O ' ' OXT' ' A' ' 210' ' ' LYS . 64.4 tttm -74.49 79.24 1.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.561 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.411 ' OXT' ' O ' ' A' ' 209' ' ' LYS . 26.7 ttpt . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.461 178.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.485 1.008 0 CA-C-O 120.988 0.328 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -77.42 171.36 15.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.71 -16.07 63.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.89 92.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.459 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -74.33 -31.97 62.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.507 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.7 t -75.01 -45.48 42.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.575 -178.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.7 89.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.853 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -77.06 -28.49 54.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.282 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.79 107.25 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.977 -179.236 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.9 t -96.67 119.63 35.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.159 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.8 tp -119.05 129.48 55.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.481 -179.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.45 138.87 49.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.835 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -68.78 -7.82 37.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.297 0.57 . . . . 0.0 110.246 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -73.5 -10.34 59.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.864 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.8 mp0 -91.87 1.61 57.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.02 131.27 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.882 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.1 pt -123.22 -5.5 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -178.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.0 -170.08 35.51 Favored Glycine 0 C--N 1.316 -0.573 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -146.32 150.89 36.59 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.704 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -123.02 124.8 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.616 ' N ' HD13 ' A' ' 83' ' ' ILE . 26.3 t -130.32 131.11 45.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.621 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.5 mt -133.46 131.15 21.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.461 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.36 -35.43 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.315 2.01 . . . . 0.0 111.854 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -48.41 -39.86 23.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.519 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.6 p -119.48 -2.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.901 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 2.6 p 62.67 52.22 2.89 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -112.28 132.44 54.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.101 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -134.85 115.49 13.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.458 ' O ' HG22 ' A' ' 83' ' ' ILE . 64.3 mt -144.09 113.65 5.32 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -177.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.3 Cg_endo -41.76 147.62 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.767 1.645 . . . . 0.0 110.58 176.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.55 123.0 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.465 ' CB ' HD22 ' A' ' 102' ' ' ASN . 22.3 mt -104.25 123.75 47.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.044 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 65.8 tttm -67.38 -47.13 71.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.192 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.59 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -74.06 105.99 5.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.366 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -81.84 101.98 10.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.494 0.664 . . . . 0.0 110.199 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.528 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.8 p -135.54 164.15 28.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.33 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.969 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -83.0 -42.4 17.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.788 -179.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -66.65 -35.24 79.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.231 -178.821 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -63.72 -16.34 60.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.863 -178.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.65 -16.47 60.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.8 p -106.29 -9.3 16.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.2 -172.54 44.49 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.403 -178.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.85 128.45 33.37 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.114 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.559 ' CB ' HD21 ' A' ' 102' ' ' ASN . . . -105.27 146.77 28.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.79 149.91 39.53 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.19 -41.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 112' ' ' GLU . 24.3 tttp -88.74 -173.35 4.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.78 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 35.4 tp10 -120.95 -11.33 8.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.296 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 112' ' ' GLU . 97.9 m-20 -141.57 42.09 1.73 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.234 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -89.74 160.53 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.6 t -132.02 132.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.741 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.416 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.7 mtt -68.38 128.67 37.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.209 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.31 3.02 72.88 Favored Glycine 0 N--CA 1.461 0.323 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -140.4 120.91 14.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.96 53.13 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.492 HD21 ' CB ' ' A' ' 183' ' ' THR . 2.0 t30 -95.39 110.9 22.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -84.4 103.73 13.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 128.54 36.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.281 0.563 . . . . 0.0 111.969 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.45 129.48 51.31 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.716 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 139.16 46.65 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.469 0.652 . . . . 0.0 110.888 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.56 -178.64 17.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.746 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -81.98 155.42 25.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.3 p-10 -121.82 27.04 8.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.428 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 39.0 mtt -44.08 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.004 -178.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 59.65 40.04 20.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.398 0.618 . . . . 0.0 109.613 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 136' ' ' SER . 65.4 tttm -135.59 118.55 16.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.823 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.0 124.99 21.2 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.637 0.732 . . . . 0.0 110.47 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.5 -26.1 10.53 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.816 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 134' ' ' LEU . 98.4 t -78.97 175.69 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.774 0.787 . . . . 0.0 109.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.713 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.28 135.07 45.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.191 -178.401 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 46.26 32.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.458 . . . . 0.0 110.542 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.27 -7.59 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.512 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.6 m-20 -147.09 31.46 0.93 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -177.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.5 pt -70.73 -23.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.463 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB2' ' CG ' ' A' ' 197' ' ' TYR . . . -74.48 3.2 7.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.668 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -97.02 -11.6 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.4 ' O ' HG21 ' A' ' 163' ' ' VAL . 16.9 mt -64.79 122.45 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.608 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 60.4 mttp -96.82 151.4 19.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.489 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -54.74 123.77 14.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.606 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.73 19.64 19.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.5 m-20 -88.23 132.29 34.43 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -82.15 135.19 35.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.386 0.612 . . . . 0.0 111.978 -177.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 158' ' ' TYR . 96.0 mt -127.47 125.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.718 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.41 118.36 36.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.147 0.498 . . . . 0.0 109.986 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.39 144.82 43.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.314 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.416 ' O ' ' SD ' ' A' ' 116' ' ' MET . 19.2 m-85 -114.78 131.75 56.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.216 0.531 . . . . 0.0 111.271 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.8 t0 -112.41 -168.73 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 151' ' ' ASP . 86.3 m-20 -24.22 -74.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.04 0.448 . . . . 0.0 112.066 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -137.47 28.22 2.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.86 148.77 50.48 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -175.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.31 122.26 47.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.433 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.8 m-85 -105.65 132.01 52.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 111.412 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -95.92 114.16 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.163 178.373 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 147' ' ' ILE . 46.9 m-85 -115.38 139.96 49.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -120.58 134.79 55.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.491 0.662 . . . . 0.0 111.561 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.95 133.29 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.96 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 p -102.89 -28.44 12.04 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 124.959 1.412 . . . . 0.0 110.697 -178.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.22 152.56 7.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.82 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 199' ' ' VAL . 12.2 t -116.29 150.15 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.742 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -152.27 161.95 41.86 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.277 0.56 . . . . 0.0 111.543 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -111.51 126.47 55.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.478 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.59 162.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.01 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.1 p -71.17 141.31 86.13 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -46.54 -17.24 0.33 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.862 1.708 . . . . 0.0 111.842 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.6 m-20 -82.77 -3.6 56.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.1 tptt -80.98 148.07 29.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 81.7 m95 -158.33 -26.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.963 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.13 -8.67 0.08 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.236 0.541 . . . . 0.0 110.531 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.794 HG23 HG13 ' A' ' 174' ' ' VAL . 4.8 m -74.8 -30.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.923 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.794 HG13 HG23 ' A' ' 173' ' ' VAL . 2.5 m -105.59 -5.13 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.756 0.789 . . . . 0.0 109.763 -178.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 176' ' ' ASP . 77.6 mm-40 -80.02 118.38 21.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.9 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 175' ' ' GLU . 68.2 t0 -29.01 124.08 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.491 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -99.08 -40.72 7.87 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.917 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.5 29.21 0.28 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' A' ' 181' ' ' GLU . 21.9 pttp -156.03 179.52 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 111.296 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -94.12 100.11 12.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.714 0.769 . . . . 0.0 109.79 179.215 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' A' ' 179' ' ' LYS . 17.1 pt-20 -138.92 174.58 10.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.922 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.1 tt -131.12 143.88 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.548 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.588 ' C ' HD12 ' A' ' 184' ' ' LEU . 12.4 m -135.9 126.01 26.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.677 0.275 . . . . 0.0 111.239 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -113.14 126.89 55.94 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.384 0.612 . . . . 0.0 110.643 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 174' ' ' VAL . 8.1 pt -141.13 -172.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.184 -178.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.017 -179.751 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.227 0 CA-C-O 121.144 0.497 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.419 ' CG ' ' HB2' ' A' ' 139' ' ' ALA . 8.6 m-85 -121.22 131.53 54.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.003 178.603 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.36 127.74 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.894 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.49 HG22 HG13 ' A' ' 163' ' ' VAL . 70.1 t -117.63 129.11 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.509 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.04 54.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.415 0.626 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.42 159.06 24.31 Favored Glycine 0 N--CA 1.461 0.322 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.849 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -110.17 153.35 24.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.709 -0.746 . . . . 0.0 111.873 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.9 tp -74.94 127.7 33.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.255 0.55 . . . . 0.0 110.878 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.403 HG21 ' HB2' ' A' ' 159' ' ' ALA . 93.1 t -107.56 -25.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.912 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 174.29 176.7 42.88 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.47 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 156' ' ' TYR . 15.1 m -153.49 153.2 31.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 111.052 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.33 176.91 10.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.463 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.56 142.08 27.86 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.898 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.99 79.87 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.847 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.2 tttm . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.552 178.64 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.484 0.968 0 CA-C-O 120.818 0.258 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 171.58 14.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.92 -14.3 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.683 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.92 91.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mt-10 -74.85 -26.09 59.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.18 -47.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.671 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -42.24 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -70.83 -31.04 67.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.82 145.46 55.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.44 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -139.26 108.13 5.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.059 0.456 . . . . 0.0 110.998 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.427 HD11 HD22 ' A' ' 95' ' ' LEU . 3.9 tt -105.13 127.05 52.72 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.056 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -74.0 137.1 43.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' O ' HG12 ' A' ' 79' ' ' VAL . 4.5 mptp? -67.33 -9.41 40.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 110.165 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -80.29 -11.94 59.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.497 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.71 6.92 36.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 76' ' ' LYS . 8.6 p -88.18 138.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.1 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 pt -120.79 -5.96 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.561 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.64 -165.29 30.84 Favored Glycine 0 C--N 1.32 -0.361 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.408 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 11.8 ttp180 -152.57 155.0 36.54 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.042 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 83' ' ' ILE . 20.6 tt -128.61 130.17 68.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.675 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.04 130.83 51.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.553 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 mt -134.76 100.86 11.97 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.136 -178.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -67.82 -34.2 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.244 1.963 . . . . 0.0 112.404 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.5 t -52.1 -38.73 58.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 -177.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 137' ' ' ASP . 25.3 t -110.31 -9.6 11.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 120.58 0.229 . . . . 0.0 110.665 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.82 43.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.413 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -115.8 130.48 56.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.819 -178.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -134.45 118.91 17.9 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.3 mt -145.31 163.13 33.92 Favored Pre-proline 0 N--CA 1.465 0.275 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.547 -177.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.78 150.27 7.3 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.052 2.501 . . . . 0.0 109.428 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.9 t -95.77 116.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.427 HD22 HD11 ' A' ' 74' ' ' LEU . 39.7 mt -101.83 122.55 44.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.057 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -65.76 -46.19 79.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.084 0.468 . . . . 0.0 111.046 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 p -75.3 103.91 5.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.376 -179.003 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 99.8 11.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.333 0.587 . . . . 0.0 110.316 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 5.4 p -132.11 160.41 36.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.685 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -56.74 -28.96 62.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.781 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.485 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 18.8 ptmt -84.25 -41.88 16.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.342 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 101' ' ' LYS . 5.4 m120 -65.76 -36.47 83.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.396 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.89 -20.58 62.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.4 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -75.58 -15.51 60.35 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.6 m -103.32 -11.49 17.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.09 -166.59 39.79 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.226 -178.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.14 125.01 28.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.61 143.28 33.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.058 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.3 p -69.19 144.06 53.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.334 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.49 -44.69 18.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -89.33 -175.08 4.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.95 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -115.42 -11.57 11.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.623 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -137.6 43.19 2.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -178.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.653 ' NE2' ' CZ ' ' A' ' 121' ' ' TYR . 18.1 pt20 -92.17 155.28 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.362 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.05 132.37 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.507 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.0 mtt -68.3 128.15 35.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.413 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 89.34 4.61 73.7 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.86 121.17 12.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.638 -179.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.76 -168.88 54.6 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.47 ' CG ' ' HG1' ' A' ' 183' ' ' THR . 6.7 t-20 -89.33 110.48 21.26 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.653 ' CZ ' ' NE2' ' A' ' 114' ' ' GLN . 1.7 t80 -84.74 105.22 15.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.476 ' O ' HD22 ' A' ' 123' ' ' LEU . . . -95.01 120.13 34.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.998 -178.398 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 122' ' ' ALA . 1.9 mm? -117.09 132.42 56.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.862 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 142.54 43.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.752 -179.175 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.02 -178.6 19.88 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.545 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -85.16 152.07 23.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.922 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' SER . 41.7 t30 -116.01 28.34 8.68 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -50.14 -8.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.66 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 127' ' ' ASN . 3.0 t 52.51 44.18 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 109.716 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' SER . 29.3 tptp -134.15 113.53 12.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.643 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -56.01 125.17 20.39 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.415 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.45 -29.22 8.84 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.827 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.3 t -76.82 178.37 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 117.847 0.824 . . . . 0.0 109.384 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.743 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.38 136.51 49.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.715 0.293 . . . . 0.0 110.933 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 138' ' ' ILE . 4.1 m-30 43.17 31.76 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.928 178.312 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.41 -11.66 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.108 -178.803 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.492 ' O ' HG21 ' A' ' 88' ' ' VAL . 7.1 m-20 -142.24 22.1 2.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.097 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 140' ' ' SER . 4.5 pt -67.52 -29.41 45.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.61 2.43 1.33 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.793 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 138' ' ' ILE . 49.9 m -97.03 -11.46 24.45 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.19 121.15 12.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.51 172.69 7.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.766 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.35 122.1 22.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.543 0.687 . . . . 0.0 112.035 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.83 14.61 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -93.35 134.79 35.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -83.37 137.25 34.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.454 0.645 . . . . 0.0 112.074 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.65 122.85 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.001 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 73.9 m-85 -101.09 117.08 34.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.8 tp -115.1 144.96 42.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.675 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.408 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 31.1 m-85 -117.05 130.69 56.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.998 0.427 . . . . 0.0 111.676 -178.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.8 t0 -107.02 -167.66 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.497 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 61.6 t-20 -29.39 -68.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -138.41 21.7 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.766 179.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.44 146.33 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -176.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.37 118.87 37.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 206' ' ' THR . 60.5 m-85 -104.21 130.69 51.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.144 0.497 . . . . 0.0 111.085 -178.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 41.5 tp10 -94.41 117.18 29.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.15 137.81 51.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.31 133.36 56.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.274 0.559 . . . . 0.0 110.566 179.186 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 133.39 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -104.72 -25.15 12.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.537 1.148 . . . . 0.0 110.751 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.03 153.86 7.08 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.917 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.73 155.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.576 -0.812 . . . . 0.0 109.28 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.9 p -151.7 162.3 41.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.077 0.465 . . . . 0.0 111.198 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -114.22 113.67 24.95 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 159.66 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.139 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.3 p -60.3 168.46 2.29 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.5 -11.52 11.71 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.905 1.736 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.58 -6.64 59.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.997 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 173' ' ' VAL . 15.5 mmtp -85.06 66.71 9.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 173' ' ' VAL . 63.1 m95 -72.29 -24.57 61.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.98 -17.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.247 0.546 . . . . 0.0 110.365 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 170' ' ' LYS . 24.3 m -69.87 -27.23 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.206 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.52 HG11 HD13 ' A' ' 185' ' ' ILE . 1.6 m -109.73 1.0 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.554 0.692 . . . . 0.0 110.052 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.83 125.86 32.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.317 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -34.95 122.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.445 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -103.07 -44.22 5.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.777 0.323 . . . . 0.0 111.309 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.69 28.06 0.17 Allowed Glycine 0 N--CA 1.47 0.932 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -153.49 173.36 15.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 22.3 m-20 -94.25 88.86 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.462 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 75.1 tt0 -133.34 127.07 32.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.099 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.1 tt -81.16 148.26 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.54 ' C ' HD12 ' A' ' 184' ' ' LEU . 17.5 m -135.93 125.75 25.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.843 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.54 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -111.29 127.08 55.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 111.204 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.52 HD13 HG11 ' A' ' 174' ' ' VAL . 5.7 pt -132.35 153.61 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.248 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 -179.198 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -93.04 128.49 38.94 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.527 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.01 132.47 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 111.142 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.96 129.46 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.215 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.512 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.18 137.35 51.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.516 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.97 135.3 8.59 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.4 t0 -95.63 133.5 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.069 -0.566 . . . . 0.0 111.546 -178.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.401 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 44.8 tp -62.18 124.06 19.84 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.214 0.53 . . . . 0.0 110.385 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.1 -21.7 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.054 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.01 175.14 47.11 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.159 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 156' ' ' TYR . 22.4 m -154.57 152.71 30.36 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.023 0.44 . . . . 0.0 110.628 178.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -150.98 177.45 10.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.116 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.18 148.77 21.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.201 0.524 . . . . 0.0 110.845 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -70.79 80.27 0.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.535 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.669 178.424 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.483 0.899 0 N-CA-C 110.8 -0.5 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.78 147.77 48.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.808 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.8 mt -55.25 -25.9 36.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.053 -178.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.9 95.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.618 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 70.3 mm-40 -72.58 -33.38 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.923 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.3 t -75.36 -45.68 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.056 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -38.02 88.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.98 -25.97 34.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.639 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.63 131.84 51.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.388 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.8 t -95.92 158.92 15.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.024 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.689 HD22 ' HB3' ' A' ' 105' ' ' SER . 44.6 tp -123.24 134.13 54.13 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -179.002 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.28 105.54 15.84 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.027 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.587 ' O ' HG12 ' A' ' 79' ' ' VAL . 6.0 mptp? -63.81 -8.73 11.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.269 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -63.73 -39.47 94.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.605 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 8.0 pt20 -89.11 19.97 3.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.768 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.3 p -84.72 126.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.568 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.5 -9.26 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.43 -166.35 37.27 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.504 ' O ' HD12 ' A' ' 149' ' ' LEU . 34.6 mtp180 -146.88 150.57 35.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.622 -178.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 92' ' ' LEU . 7.8 tp -113.18 122.56 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 t -126.87 128.05 45.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.508 HG21 HD21 ' A' ' 141' ' ' LEU . 10.5 mt -135.62 122.31 14.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.969 -177.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.79 -34.73 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.577 2.184 . . . . 0.0 112.37 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.556 ' CB ' HD23 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -51.08 -39.75 56.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.488 -177.24 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 90' ' ' LEU . 20.7 m -118.62 -9.01 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 122.314 0.246 . . . . 0.0 111.096 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.505 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 74.37 48.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.407 0.622 . . . . 0.0 109.833 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.66 HD11 HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -107.18 123.49 48.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 -178.808 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.658 ' N ' HD13 ' A' ' 90' ' ' LEU . 84.7 tt0 -135.46 110.44 8.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 90' ' ' LEU . 10.6 mt -149.8 115.86 3.53 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.9 Cg_endo -39.91 143.11 0.46 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 121.832 1.688 . . . . 0.0 110.132 176.38 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.72 123.54 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.438 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.427 HD21 HD11 ' A' ' 74' ' ' LEU . 9.2 mt -105.21 138.37 41.52 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.088 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -78.71 -25.27 44.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.387 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -89.27 104.24 16.81 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -81.4 62.71 5.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.292 0.568 . . . . 0.0 110.37 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -93.84 162.83 13.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.708 179.59 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.64 -48.0 79.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.1 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 19.6 ptmt -67.27 -40.52 86.2 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.602 0.564 . . . . 0.0 111.74 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.605 ' OD1' ' NE2' ' A' ' 78' ' ' GLN . 8.7 m-80 -64.74 -37.56 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.243 -178.507 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.68 -20.76 61.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.63 -18.95 62.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.689 ' HB3' HD22 ' A' ' 74' ' ' LEU . 1.8 m -102.05 -13.83 17.37 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.58 ' HA2' HD13 ' A' ' 92' ' ' LEU . . . 176.25 -162.17 30.86 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.234 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.77 126.09 36.72 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.095 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -72.86 152.81 41.32 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.15 -47.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -93.19 145.36 24.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.54 -51.13 68.59 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.623 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.06 46.42 1.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.29 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.523 ' NE2' ' CE1' ' A' ' 121' ' ' TYR . 3.7 tt0 -80.89 153.71 27.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.59 117.77 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.147 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.453 ' N ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.14 129.95 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.795 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.25 -8.76 57.37 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -143.99 130.9 20.4 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.439 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.29 -167.95 52.8 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 25.2 t-20 -86.77 107.22 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.587 0.232 . . . . 0.0 110.659 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.523 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 4.7 t80 -86.56 100.51 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.88 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.21 123.8 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.837 -179.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.497 ' CD1' HD13 ' A' ' 83' ' ' ILE . 11.2 mt -118.18 132.64 56.31 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.373 178.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.34 140.17 48.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.923 -178.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.75 -178.09 16.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.661 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -85.17 146.17 27.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.621 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.9 p30 -112.79 26.23 10.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 0.0 110.869 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -42.76 -19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.816 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.11 39.43 12.96 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.139 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.86 109.49 10.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.04 124.88 16.87 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.829 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.85 -25.03 10.43 Favored Glycine 0 N--CA 1.473 1.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.533 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.785 HG12 ' H ' ' A' ' 134' ' ' LEU . 39.2 t -83.24 179.0 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -73.17 136.12 44.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.031 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.63 31.51 0.64 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 110.751 178.427 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -80.22 -7.47 58.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.719 -178.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.434 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.1 t0 -146.55 40.26 1.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.2 pt -70.65 -26.73 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.13 1.29 13.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.022 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.434 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.5 m -91.22 -17.96 25.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.087 -179.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.573 HD22 ' OD2' ' A' ' 145' ' ' ASP . 15.7 mt -65.21 125.3 24.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.324 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -95.93 170.91 8.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.72 130.03 40.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.923 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.03 21.18 36.65 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD2' HD22 ' A' ' 141' ' ' LEU . 1.7 t70 -87.49 132.28 34.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -79.56 134.9 36.49 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.391 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' TYR . 96.5 mt -126.55 125.83 67.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.16 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.31 113.62 26.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.578 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 82' ' ' ARG . 42.1 tp -113.32 134.47 54.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.389 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -105.83 133.98 49.69 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -178.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 152' ' ' ASN . 43.9 t0 -108.7 -169.28 1.47 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 151' ' ' ASP . 13.1 t-20 -32.93 -67.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.992 0.425 . . . . 0.0 110.65 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -135.98 21.89 3.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.065 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.53 150.37 40.96 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.103 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -114.81 119.47 36.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.341 178.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -105.23 130.19 53.44 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.372 0.606 . . . . 0.0 112.016 -178.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.45 117.34 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.498 ' O ' ' N ' ' A' ' 147' ' ' ILE . 20.0 m-85 -119.58 139.37 52.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.285 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.9 137.85 52.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.874 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.79 134.18 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.862 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.3 -27.26 12.95 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.84 1.338 . . . . 0.0 111.242 -178.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.81 158.76 9.89 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.54 152.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 165.56 35.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.098 -178.146 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -109.55 116.53 31.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.38 157.19 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.076 0.465 . . . . 0.0 111.285 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 169' ' ' ASP . 30.9 p -73.38 136.33 78.53 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -47.47 -15.45 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.113 1.875 . . . . 0.0 111.903 -178.62 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 167' ' ' THR . 95.9 m-20 -84.03 -11.54 56.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.518 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -88.04 67.69 8.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.9 m95 -74.13 -3.93 32.6 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.608 0.568 . . . . 0.0 112.193 -178.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.1 mt-10 -53.01 -39.89 63.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.961 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.3 m -77.84 2.7 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.199 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.1 -14.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.793 0.806 . . . . 0.0 110.597 -178.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.2 mt-10 -86.47 -179.14 6.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.878 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.6 p-10 -86.51 124.76 33.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.157 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.4 m80 -103.08 -43.91 5.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.206 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 25.33 0.07 OUTLIER Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -157.26 178.36 10.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.766 0.317 . . . . 0.0 111.07 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.67 ' OD2' HD22 ' A' ' 203' ' ' LEU . 31.3 t0 -96.68 89.83 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.613 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -126.69 127.62 45.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.369 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -85.43 149.42 4.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.57 ' C ' HD12 ' A' ' 184' ' ' LEU . 52.1 m -137.44 124.67 21.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.436 -179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -109.85 121.39 45.12 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.108 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 12.4 pt -140.4 -173.28 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.844 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 16.2 p . . . . . 0 N--CA 1.462 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.582 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.566 ' NH1' ' O ' ' A' ' 186' ' ' THR . 57.7 ttm-85 . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.69 139.28 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.282 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.94 129.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.38 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.14 135.9 53.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.28 143.6 14.88 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 51.8 p-10 -102.7 142.64 33.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.435 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.67 HD22 ' OD2' ' A' ' 180' ' ' ASP . 38.5 tp -65.31 126.88 29.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.4 -24.77 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.528 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.74 175.58 46.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.734 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.6 m -155.04 151.4 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.179 0.514 . . . . 0.0 111.244 -179.344 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -151.63 178.52 9.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.32 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.79 144.92 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.307 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.27 78.99 0.36 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.853 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 78.3 tttt . . . . . 0 C--N 1.322 -0.602 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.332 178.618 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.487 1.091 0 N-CA-C 111.122 -0.376 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.8 163.48 26.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.42 -19.96 65.45 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 123.163 0.289 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.74 93.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.6 mt-10 -72.2 -37.13 69.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.63 -45.81 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.886 -178.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.12 85.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -85.15 -26.64 26.71 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.86 137.76 57.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.127 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -92.09 158.13 16.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.912 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.456 HD13 ' CB ' ' A' ' 105' ' ' SER . 50.9 tp -127.13 127.32 44.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 111.288 -178.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -100.52 103.88 15.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.973 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.61 ' O ' HG12 ' A' ' 79' ' ' VAL . 44.5 mmtm -62.36 -7.09 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.572 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -75.08 -13.08 60.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.322 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -102.54 12.08 36.95 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.736 -178.465 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 76' ' ' LYS . 7.0 p -88.16 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.254 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 109' ' ' THR . 7.0 pt -121.4 -7.55 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.46 -171.28 39.28 Favored Glycine 0 C--N 1.32 -0.318 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.579 HH11 ' NZ ' ' A' ' 209' ' ' LYS . 42.0 mtm180 -146.46 152.03 38.37 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.72 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.5 tt -121.04 122.31 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -124.15 127.75 48.24 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.437 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 73.3 mt -131.29 130.81 22.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.801 -178.052 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.61 -38.28 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.56 2.173 . . . . 0.0 112.417 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.3 p -46.14 -37.88 7.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.424 -177.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.4 p -120.91 -0.45 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.942 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m 59.94 54.52 4.2 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.12 136.76 52.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.03 -177.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -137.0 116.39 12.72 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 83' ' ' ILE . 82.7 mt -141.03 101.58 6.32 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.349 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.6 127.92 1.74 Allowed 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 121.897 1.731 . . . . 0.0 110.211 176.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.95 121.84 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.2 mt -103.19 123.27 46.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.53 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' HB2' HD13 ' A' ' 80' ' ' ILE . 88.4 tttt -64.73 -49.5 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.065 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.2 m -65.74 98.7 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.134 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -80.24 98.13 7.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.258 0.551 . . . . 0.0 109.86 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.9 p -134.31 161.13 35.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.606 -178.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.79 -27.78 66.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.918 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.81 -41.77 18.69 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.837 0.711 . . . . 0.0 112.139 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -67.06 -35.12 79.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.412 -179.227 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.1 mt -65.03 -18.86 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -72.7 -14.92 61.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.339 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.456 ' CB ' HD13 ' A' ' 74' ' ' LEU . 58.7 m -110.53 -9.26 14.57 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.453 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 174.39 -153.55 16.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.304 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.554 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -100.49 127.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.263 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 149.97 24.97 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.674 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.455 HG21 HD11 ' A' ' 80' ' ' ILE . 9.7 p -75.81 148.38 38.47 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.9 -47.28 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.253 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -92.66 139.84 30.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.317 0.58 . . . . 0.0 110.989 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -75.48 -3.18 32.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.272 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.88 37.63 2.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 111.164 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 156.26 16.52 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.5 t -124.55 135.58 63.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.4 mtp -75.93 125.7 29.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.27 66.93 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -144.77 121.38 11.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.544 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.36 178.5 32.51 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 40.9 t-20 -68.93 105.06 2.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.444 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -85.33 105.45 15.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 124.89 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.31 0.576 . . . . 0.0 111.439 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 83' ' ' ILE . 10.0 mt -122.31 130.24 52.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.509 179.012 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.6 140.16 45.19 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.305 0.574 . . . . 0.0 110.759 -178.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.45 -176.95 18.92 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.614 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -84.48 147.07 27.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.696 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.7 p30 -115.48 25.48 10.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.146 0.498 . . . . 0.0 110.984 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -41.94 -18.19 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.646 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 57.57 39.96 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.191 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 136' ' ' SER . 65.2 tttm -134.2 119.45 18.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.511 -178.665 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.04 124.46 21.18 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.332 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.38 -21.46 8.66 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.447 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 134' ' ' LEU . 2.6 t -91.97 172.46 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.797 ' H ' HD23 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -74.93 139.34 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.882 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.554 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.5 m-85 50.49 27.34 2.79 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.008 0.433 . . . . 0.0 110.969 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.444 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -84.66 -8.99 58.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.643 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.6 m-20 -145.31 30.85 1.12 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.041 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.9 pt -70.07 -25.88 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.58 3.78 4.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.707 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.5 m -97.19 -11.65 23.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.283 -178.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.488 ' O ' HG21 ' A' ' 163' ' ' VAL . 17.7 mt -65.42 124.72 23.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.66 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.431 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 98.6 mttt -97.04 161.48 13.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.676 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.48 127.6 32.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.959 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 91.88 20.98 34.89 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 31.9 m-20 -83.73 136.86 34.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.08 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -80.76 122.76 27.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.5 mt -122.26 122.57 66.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -103.5 118.24 36.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.451 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -112.79 132.72 55.13 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.946 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.696 ' N ' HD13 ' A' ' 149' ' ' LEU . 67.9 m-85 -99.12 125.68 44.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.151 -179.121 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 152' ' ' ASN . 45.9 t0 -98.07 -169.05 1.75 Allowed 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 151' ' ' ASP . 51.9 t30 -36.19 -67.03 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.124 0.488 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -135.07 25.07 3.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.208 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.85 153.05 44.7 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.605 ' CD ' ' HZ1' ' A' ' 207' ' ' LYS . 67.1 tt0 -114.6 119.0 35.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.265 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -103.84 131.55 50.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.5 mt-10 -97.17 119.35 35.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.129 178.234 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -116.69 142.08 47.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.19 129.79 53.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.461 0.648 . . . . 0.0 110.769 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' GLY . 56.2 t -68.23 134.7 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.1 t -105.15 -26.61 12.01 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 124.583 1.177 . . . . 0.0 111.256 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.99 147.87 5.57 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.304 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 199' ' ' VAL . 17.2 t -110.56 149.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.239 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.0 p -156.92 165.87 34.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.133 -178.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -113.6 102.6 10.43 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.017 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.8 m -117.49 153.34 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 p -59.57 167.87 2.19 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.546 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.6 Cg_endo -81.77 -10.46 11.77 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.027 1.818 . . . . 0.0 112.007 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.81 -14.16 48.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.202 -178.437 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.64 71.21 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.028 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.546 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 90.4 m95 -75.31 -2.23 27.28 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.285 -178.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.42 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 71.5 mm-40 -54.03 -37.24 63.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.69 ' O ' HG21 ' A' ' 183' ' ' THR . 16.3 m -80.82 3.7 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.03 -179.03 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -119.71 -15.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.581 0.705 . . . . 0.0 110.251 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 74.4 mm-40 -86.75 175.94 7.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.027 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.5 p-10 -80.78 128.6 33.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.251 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.42 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.8 m170 -102.57 -43.28 5.67 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.043 -179.448 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.07 27.61 0.12 Allowed Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -157.65 -179.75 8.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.855 0.36 . . . . 0.0 111.094 179.36 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -93.01 88.46 6.14 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -117.82 167.7 11.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.922 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.37 142.94 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.002 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.69 HG21 ' O ' ' A' ' 173' ' ' VAL . 10.7 m -136.65 125.24 23.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.596 -178.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -110.52 120.77 43.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 13.5 pt -134.91 -167.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.767 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.586 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 14.1 t . . . . . 0 N--CA 1.464 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.366 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.586 ' NH1' ' O ' ' A' ' 186' ' ' THR . 11.8 ptp180 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -105.94 139.53 40.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.07 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.7 134.22 58.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 121.023 0.439 . . . . 0.0 110.623 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.54 HG22 HG13 ' A' ' 163' ' ' VAL . 73.2 t -119.46 129.46 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.653 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.09 136.29 53.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.349 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.16 147.38 19.06 Favored Glycine 0 N--CA 1.466 0.653 0 CA-C-O 121.773 0.652 . . . . 0.0 112.006 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 55.4 p-10 -106.81 148.28 28.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.207 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 205' ' ' GLY . 44.4 tp -69.03 126.99 31.56 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.84 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -109.38 -24.38 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.037 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.02 175.26 47.18 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.627 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 m -155.5 150.99 27.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.605 ' HZ1' ' CD ' ' A' ' 155' ' ' GLU . 25.8 pttm -150.81 178.16 9.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.09 146.61 23.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.579 ' NZ ' HH11 ' A' ' 82' ' ' ARG . 88.0 tttt -73.77 80.23 1.58 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.604 -179.19 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.281 178.799 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.477 0.52 0 N-CA-C 111.097 -0.386 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.84 152.05 46.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.804 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -68.39 -15.0 63.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.799 0.333 . . . . 0.0 111.393 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.5 -45.16 84.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.821 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 6.0 pt-20 -74.63 -22.44 58.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.3 t -76.97 -51.98 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.481 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.64 92.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.774 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.32 -31.17 68.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.54 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.3 138.42 57.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.004 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -141.09 85.1 1.96 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.71 -178.647 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.4 pt? -75.04 172.12 12.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.523 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.1 m-20 -103.13 121.16 42.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.59 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.573 ' O ' HG12 ' A' ' 79' ' ' VAL . 14.1 mptt -56.44 -9.4 0.7 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.14 0.495 . . . . 0.0 109.853 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -62.49 -35.39 79.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.76 16.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.572 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 76' ' ' LYS . 10.0 p -86.94 124.57 40.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 pt -120.64 -6.53 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.47 -168.34 39.92 Favored Glycine 0 C--N 1.318 -0.467 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.406 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 38.0 mtm180 -147.68 156.09 42.42 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.538 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.2 tt -121.32 125.92 74.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -126.26 127.07 45.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.482 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 79.3 mt -127.44 128.01 24.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.646 -178.222 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.8 Cg_endo -83.29 -39.33 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 122.371 2.047 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 t -48.75 -37.03 17.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.579 -177.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -120.73 -2.83 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.783 -178.926 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t 62.81 55.18 2.13 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.286 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.16 133.64 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.607 -178.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -135.99 114.22 11.52 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.524 ' O ' HG22 ' A' ' 83' ' ' ILE . 69.9 mt -143.45 109.36 5.28 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.1 Cg_endo -39.6 142.64 0.44 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.865 1.71 . . . . 0.0 110.144 176.388 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.8 118.65 43.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -106.68 122.94 47.36 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.41 -48.47 75.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.6 p -61.67 100.02 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.928 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.0 p -82.97 101.29 10.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 110.006 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.0 p -137.29 160.49 38.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.417 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.85 -28.38 67.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.75 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -83.33 -45.47 13.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.457 0.646 . . . . 0.0 112.116 -178.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -65.78 -32.72 74.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.316 -179.107 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.61 -13.96 61.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.3 p -103.79 -13.46 16.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -177.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.402 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 172.96 -156.86 25.57 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.64 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.46 125.89 35.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.997 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.63 144.38 31.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -75.33 152.27 38.16 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 185' ' ' ILE . 40.0 t -86.02 -40.22 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.47 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.67 -172.68 3.66 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.13 -178.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -126.2 -9.64 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 111.289 -177.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -138.89 37.35 2.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.108 0.48 . . . . 0.0 111.304 -177.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.411 ' NE2' ' CE1' ' A' ' 121' ' ' TYR . 16.5 pt20 -93.44 161.14 14.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.855 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -131.72 132.04 62.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.773 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.7 mtt -63.69 129.04 38.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.16 75.04 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -138.54 118.92 13.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.116 0.484 . . . . 0.0 110.504 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -160.12 52.71 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -94.04 111.19 22.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.411 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 4.6 t80 -84.72 103.4 13.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.43 126.64 35.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 111.785 -179.056 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD12 ' A' ' 83' ' ' ILE . 5.9 mt -122.46 130.53 53.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.477 178.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.99 139.19 46.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.774 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.61 -178.2 16.42 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.5 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -88.83 143.08 27.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.567 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 67.0 t30 -108.28 28.22 8.53 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.126 0.489 . . . . 0.0 110.676 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.17 -17.24 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.683 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.6 OUTLIER 60.98 37.73 17.92 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.283 178.805 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 136' ' ' SER . 55.2 mtmt -135.46 106.48 6.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.685 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.43 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -48.74 130.11 17.33 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.545 179.344 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.22 -26.33 12.38 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.784 HG12 ' H ' ' A' ' 134' ' ' LEU . 27.7 t -84.97 179.14 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.784 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.63 133.08 46.36 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.178 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.42 31.91 1.43 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 110.822 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.64 -9.91 59.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.04 -178.825 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -146.95 29.36 0.99 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.091 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 138' ' ' ILE . 5.5 pt -69.58 -27.83 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.805 0.336 . . . . 0.0 111.856 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.76 0.34 3.39 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.638 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.1 t -91.75 -14.66 29.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.156 0.503 . . . . 0.0 110.18 -179.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 mt -65.63 126.9 29.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.246 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.28 172.16 8.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.973 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.2 132.65 44.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.47 21.12 57.25 Favored Glycine 0 N--CA 1.462 0.396 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 146' ' ' LYS . 15.0 t70 -78.78 -158.89 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 7.9 tptm -146.81 129.15 15.8 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.076 -178.286 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.75 122.97 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.452 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -102.04 122.08 43.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.04 141.92 48.29 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.449 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.536 ' CE2' ' OE2' ' A' ' 155' ' ' GLU . 68.6 m-85 -107.81 131.23 54.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.208 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.8 t0 -105.47 -171.26 1.88 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.0 m-20 -35.64 -62.8 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.203 0.525 . . . . 0.0 111.273 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.49 20.87 2.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 145.03 48.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.782 -175.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.536 ' OE2' ' CE2' ' A' ' 150' ' ' TYR . 4.5 mm-40 -106.89 121.14 43.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.43 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -107.25 129.54 54.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.487 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.83 120.94 39.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.386 177.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -117.65 138.79 51.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.49 131.81 56.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.599 0.714 . . . . 0.0 110.144 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.38 134.56 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.613 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.1 p -101.63 -26.36 13.55 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 124.368 1.043 . . . . 0.0 111.16 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.06 150.93 5.84 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 163' ' ' VAL . 2.7 p -98.26 146.38 8.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -0.63 . . . . 0.0 109.323 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.7 t -145.79 154.22 41.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.055 0.455 . . . . 0.0 110.989 -178.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.28 119.27 38.94 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.708 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.633 ' CG2' HH21 ' A' ' 196' ' ' ARG . 29.1 m -134.88 158.78 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 111.269 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 169' ' ' ASP . 25.5 p -76.71 136.16 67.47 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.336 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.97 -15.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.077 1.851 . . . . 0.0 112.064 -178.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 167' ' ' THR . 51.3 t0 -81.81 -13.03 58.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 -178.254 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -85.88 77.15 9.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.358 0.599 . . . . 0.0 110.198 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.544 ' C ' ' H ' ' A' ' 173' ' ' VAL . 84.1 m95 -75.79 -20.32 58.31 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.092 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.67 -6.94 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.01 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' TRP . 53.6 t -85.81 -24.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.669 -178.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.453 HG11 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -108.41 -10.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.808 0.813 . . . . 0.0 109.72 -178.473 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.58 139.81 38.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.744 -176.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.43 130.59 45.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.297 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -102.05 -40.41 6.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.462 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.68 29.26 0.27 Allowed Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -156.05 179.24 9.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.244 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -90.89 92.54 8.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.371 0.605 . . . . 0.0 109.917 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -127.9 169.41 13.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.251 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.888 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.597 ' C ' HD12 ' A' ' 184' ' ' LEU . 19.2 m -137.31 124.98 22.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.484 -178.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.597 HD12 ' C ' ' A' ' 183' ' ' THR . 10.8 mp -111.34 120.95 43.92 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.342 0.592 . . . . 0.0 110.774 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 110' ' ' VAL . 16.4 pt -135.12 -167.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -178.795 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.77 -178.979 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.633 HH21 ' CG2' ' A' ' 166' ' ' VAL . 16.0 ttp180 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 120.868 0.366 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.01 129.97 46.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.952 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.438 HG11 HG11 ' A' ' 173' ' ' VAL . 46.2 t -135.23 136.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.52 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.24 126.37 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.425 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.72 135.54 53.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.228 0.537 . . . . 0.0 110.419 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.15 163.16 25.11 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -116.21 150.72 37.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.233 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.5 tp -71.8 126.96 31.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.025 0.44 . . . . 0.0 110.71 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.39 -24.57 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.188 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.72 44.42 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.847 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.3 m -154.15 154.07 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.226 0.536 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.49 ' HZ2' ' HB2' ' A' ' 155' ' ' GLU . 20.7 pttp -149.76 177.03 10.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.335 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.34 150.87 23.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.98 78.99 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.115 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.3 mptt . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 117.804 -1.093 . . . . 0.0 109.989 178.625 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.487 1.09 0 CA-C-O 121.057 0.357 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -79.16 173.34 12.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.67 -13.67 62.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.853 -179.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.0 92.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.266 0.555 . . . . 0.0 110.268 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -75.87 -23.62 55.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.582 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.31 -49.88 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.41 89.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.43 -31.98 70.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.972 -179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.09 132.73 52.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.222 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.8 t -140.85 88.35 2.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.824 0.345 . . . . 0.0 111.656 -179.379 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.557 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 1.5 pt? -79.93 170.28 16.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.489 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -102.48 139.78 37.63 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.055 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.57 -7.2 6.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.497 0.665 . . . . 0.0 110.131 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -64.61 -31.86 73.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.848 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.11 10.42 2.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.168 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.547 HG11 HH12 ' A' ' 82' ' ' ARG . 99.2 t -86.31 120.96 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.5 pt -120.35 -7.46 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 111.9 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.7 -170.85 41.96 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.547 HH12 HG11 ' A' ' 79' ' ' VAL . 33.6 mtt-85 -146.8 158.05 43.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.897 -178.681 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 tt -128.75 130.15 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.662 0.744 . . . . 0.0 109.322 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -130.16 131.64 45.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.071 -178.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.29 127.82 19.07 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.11 -178.65 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.08 -34.65 0.32 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.304 2.002 . . . . 0.0 112.031 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -48.16 -38.61 18.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.423 -177.234 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.5 p -118.61 -2.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.879 -178.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.57 50.77 2.08 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.595 ' CD2' HD23 ' A' ' 92' ' ' LEU . 2.0 tt -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -178.158 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.756 ' O ' HD22 ' A' ' 92' ' ' LEU . 83.0 tt0 -129.42 105.3 8.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.301 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 91' ' ' GLU . 3.8 mm? -128.5 148.95 70.32 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.502 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HD3' HD13 ' A' ' 92' ' ' LEU . 4.1 Cg_exo -84.65 145.2 10.29 Favored 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 122.617 2.211 . . . . 0.0 109.26 177.496 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -94.89 112.65 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 mt -101.53 121.68 42.43 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.568 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -63.8 -46.33 85.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.329 0.585 . . . . 0.0 110.805 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m -60.03 95.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.457 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.7 p -81.87 95.0 7.2 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 110.1 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.7 p -135.97 159.66 41.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.124 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.25 -28.67 66.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.29 -43.52 15.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.93 -36.14 82.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.565 -179.18 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.07 -21.11 63.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.52 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.27 -33.24 69.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.164 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.455 ' OG ' HD22 ' A' ' 74' ' ' LEU . 62.2 m -89.54 -10.22 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.8 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 92' ' ' LEU . . . 174.05 -178.92 45.72 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.314 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.94 126.42 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.43 145.73 30.45 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.979 0.419 . . . . 0.0 110.968 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.8 p -73.12 150.22 42.41 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.24 -45.32 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.281 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.86 -172.32 3.32 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.962 -0.461 . . . . 0.0 110.966 -178.568 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 1.2 pm0 -112.58 -56.47 2.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.859 -178.371 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -90.61 44.63 1.21 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.268 -177.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -99.58 154.69 18.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.187 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.3 135.37 52.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 67.2 mtt -67.99 130.62 43.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.323 178.827 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.51 5.87 81.45 Favored Glycine 0 C--O 1.229 -0.18 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -142.72 120.36 11.82 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.037 -179.342 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.02 -168.35 54.26 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -85.52 106.82 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -84.66 102.45 12.95 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.76 128.44 36.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.289 0.566 . . . . 0.0 111.824 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -124.59 132.56 53.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.88 178.532 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.35 44.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 110.606 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.19 -177.66 19.26 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.455 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.529 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -92.12 143.48 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 5.9 m-20 -109.53 29.23 7.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.326 0.584 . . . . 0.0 109.71 179.515 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 9.2 mmm -42.94 -14.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.693 -179.223 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 62.13 40.67 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -132.32 105.66 7.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.586 -179.471 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -50.1 125.68 12.81 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.831 0.824 . . . . 0.0 110.094 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.82 -28.84 8.56 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.699 -177.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 134' ' ' LEU . 49.0 t -79.89 178.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.995 -0.709 . . . . 0.0 109.294 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.778 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -70.97 139.54 50.62 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.954 -178.568 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.6 m-85 43.7 35.01 0.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.072 0.463 . . . . 0.0 111.076 177.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.5 p -81.64 -14.56 56.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -147.45 31.97 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.419 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 3.6 pt -70.46 -26.65 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.703 0.287 . . . . 0.0 111.613 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.14 2.19 4.91 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.284 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 t -93.66 -13.85 27.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 109.573 -179.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.34 120.86 13.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.653 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.529 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.4 mttt -97.86 150.05 21.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.426 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.7 121.05 5.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.371 0.605 . . . . 0.0 111.463 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.67 10.48 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 3.8 m-20 -90.64 134.55 34.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.471 ' HZ2' ' HB3' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -83.63 132.61 34.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.311 0.577 . . . . 0.0 111.967 -178.41 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.59 126.27 71.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.278 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -103.17 119.95 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.173 0.511 . . . . 0.0 110.754 -178.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.482 HD12 ' SD ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -109.42 139.48 44.33 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.638 -179.879 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' SD ' ' A' ' 116' ' ' MET . 86.6 m-85 -114.81 127.26 55.62 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.194 0.521 . . . . 0.0 111.343 179.409 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.1 t0 -112.45 -166.24 1.06 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.2 p30 -22.57 -76.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.409 0.624 . . . . 0.0 111.816 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.508 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.5 mt-10 -137.53 29.37 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.749 178.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -127.66 144.5 51.07 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -109.99 120.96 44.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.096 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.14 132.7 49.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.682 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -96.05 118.03 31.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -118.32 141.39 48.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.34 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.13 55.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 110.804 178.367 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 60.2 t -66.34 133.09 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.032 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.3 p -100.76 -28.63 12.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.861 -178.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.37 150.2 5.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.842 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.74 149.1 8.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.704 -0.748 . . . . 0.0 109.462 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.6 p -150.76 160.4 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.453 . . . . 0.0 111.234 -178.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -107.19 117.36 33.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.554 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.38 159.12 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.229 -178.703 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 p -66.87 168.41 10.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.461 ' HA ' HH11 ' A' ' 196' ' ' ARG . 2.4 Cg_endo -81.7 -11.19 11.6 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.941 1.761 . . . . 0.0 111.761 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -87.77 -5.3 58.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -85.92 71.88 10.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 0.0 110.2 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.477 ' C ' ' N ' ' A' ' 173' ' ' VAL . 92.6 m95 -70.62 -29.89 66.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.047 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.557 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 55.4 mp0 -48.53 -14.28 0.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.485 0.66 . . . . 0.0 110.523 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.477 ' N ' ' C ' ' A' ' 171' ' ' TRP . 90.7 t -73.11 -25.85 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.923 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.522 HG11 HD13 ' A' ' 185' ' ' ILE . 27.0 m -115.29 -0.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.535 0.683 . . . . 0.0 110.513 -178.219 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.57 122.78 28.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.959 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -31.8 127.62 0.21 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.75 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -103.08 -42.75 5.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.017 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.29 29.24 0.15 Allowed Glycine 0 N--CA 1.471 1.029 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.39 176.78 12.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.942 0.401 . . . . 0.0 111.531 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.58 89.11 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.72 0.771 . . . . 0.0 109.404 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -122.48 167.84 12.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.028 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.7 142.57 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.233 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.523 ' C ' HD12 ' A' ' 184' ' ' LEU . 4.9 m -135.99 120.35 17.99 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.114 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -106.06 128.63 53.99 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.164 0.507 . . . . 0.0 110.321 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.522 HD13 HG11 ' A' ' 174' ' ' VAL . 4.3 pt -137.47 -175.24 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.729 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.527 HG21 ' ND2' ' A' ' 127' ' ' ASN . 3.3 t . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.001 -179.535 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 168' ' ' PRO . 57.7 ttp180 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.79 131.25 37.52 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 142.13 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.79 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.11 130.29 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.338 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.44 134.33 54.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.29 150.04 19.93 Favored Glycine 0 N--CA 1.467 0.763 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.446 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.0 t0 -108.49 145.87 34.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.517 -0.341 . . . . 0.0 111.361 -179.169 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.8 tp -70.32 129.51 39.51 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.443 0.639 . . . . 0.0 110.709 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.81 -21.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.605 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.43 175.9 45.91 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.132 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.3 m -155.54 155.84 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.237 0.542 . . . . 0.0 110.85 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -148.15 178.35 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.421 178.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -100.35 142.89 31.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.296 0.57 . . . . 0.0 111.086 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -61.86 80.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.61 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 208' ' ' ALA . 80.8 tttt . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.075 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 CA-C-O 121.187 0.411 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.04 151.71 44.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.85 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.2 mp -55.75 -26.1 43.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -178.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -39.6 93.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.322 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.1 mm-40 -74.1 -32.03 63.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.701 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.31 -45.32 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.919 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -75.84 -28.47 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.113 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.3 141.8 58.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.38 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.6 p -139.79 122.18 16.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.484 HD21 HD22 ' A' ' 95' ' ' LEU . 33.8 tp -114.6 129.24 56.65 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.343 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 68.0 t0 -68.47 134.45 50.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.274 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 4.5 mptp? -64.3 -8.84 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.52 . . . . 0.0 109.923 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -64.38 -33.96 77.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.048 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.586 ' OE1' ' ND2' ' A' ' 102' ' ' ASN . 75.7 mt-30 -77.68 14.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.201 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.83 127.37 47.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.78 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.686 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.11 2.61 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.694 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.26 -178.84 42.0 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -146.89 151.23 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.74 -179.498 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -120.47 124.33 72.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.61 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.1 t -128.88 129.02 45.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 64.8 mt -133.67 130.12 20.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.67 -178.331 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.22 -34.71 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.349 2.033 . . . . 0.0 111.561 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 m -47.74 -39.4 17.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.43 -176.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -121.19 -0.84 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.933 -179.288 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 61.33 54.25 3.24 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.76 133.42 56.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.419 -178.254 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.724 ' O ' HD12 ' A' ' 92' ' ' LEU . 12.6 tm-20 -130.07 114.38 15.69 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.641 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.3 mp -136.73 103.72 9.18 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.053 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.38 130.95 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.777 1.652 . . . . 0.0 110.264 175.527 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.7 t -82.36 127.89 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.484 HD22 HD21 ' A' ' 74' ' ' LEU . 13.1 mt -111.78 123.1 49.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.893 0.378 . . . . 0.0 110.068 -179.091 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -65.64 -45.9 81.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.741 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.455 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 44.9 m -66.84 100.07 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.376 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.66 97.69 10.26 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.437 0.637 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 4.8 p -137.37 155.57 49.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -51.53 -36.44 44.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -75.43 -45.75 36.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.99 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' A' ' 78' ' ' GLN . 2.4 m-20 -65.23 -36.56 84.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.57 -178.215 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 mt -59.24 -21.87 60.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.439 -179.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.13 -31.19 68.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.078 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -89.19 -11.44 43.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.56 42.21 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.59 127.93 34.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.885 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 146.72 29.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.013 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.62 152.22 39.25 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.28 -51.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 113' ' ' ASN . 82.8 tttt -93.78 139.26 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 -178.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -74.12 -0.18 15.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.225 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 90.6 m-20 -138.01 38.29 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.151 0.5 . . . . 0.0 110.983 -177.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.74 21.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.718 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -129.98 128.75 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.1 mtt -69.36 128.14 35.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 110.202 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.59 0.18 69.93 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -140.5 121.96 15.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.877 0.37 . . . . 0.0 110.974 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.11 -169.95 53.54 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -86.34 110.77 19.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.19 102.77 12.86 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.016 0.436 . . . . 0.0 109.91 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 129.04 36.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.589 0.709 . . . . 0.0 112.114 -178.813 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.87 130.44 52.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.565 178.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.87 139.35 46.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.567 0.698 . . . . 0.0 110.496 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.15 -178.8 19.31 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.669 -179.453 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 134' ' ' LEU . 74.7 m-70 -91.33 140.87 29.36 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.152 0.501 . . . . 0.0 110.654 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 129' ' ' SER . 26.9 t-20 -108.68 29.62 7.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.517 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mmm -43.28 -15.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.792 -179.123 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.88 38.62 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.239 0.542 . . . . 0.0 110.165 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.5 tttt -133.0 106.15 7.49 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.178 -179.107 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -51.9 125.2 14.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.807 0.813 . . . . 0.0 110.137 -179.243 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.96 -29.42 7.13 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.62 -178.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.831 HG12 ' H ' ' A' ' 134' ' ' LEU . 41.3 t -81.06 -179.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.058 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.831 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.88 135.31 47.94 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.418 -178.277 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.46 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 47.66 35.81 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.155 0.502 . . . . 0.0 111.076 178.393 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 2.4 p -81.93 -16.88 49.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.45 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 21.3 t0 -142.85 30.57 1.46 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.7 pt -70.44 -25.91 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.825 0.345 . . . . 0.0 111.458 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.04 4.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.45 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.1 m -95.38 -11.97 26.81 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.238 0.542 . . . . 0.0 109.637 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.7 mt -63.92 124.96 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.402 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.12 155.8 16.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.589 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.03 129.32 41.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.594 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.53 38.73 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 40.6 m-20 -86.0 137.46 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.214 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -81.64 126.99 32.42 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.68 125.19 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.261 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -104.71 115.59 30.58 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.372 0.606 . . . . 0.0 109.874 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.7 tp -116.1 144.62 43.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.307 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.511 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 50.0 m-85 -116.13 133.45 56.01 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.314 0.578 . . . . 0.0 111.49 -179.34 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.0 t0 -109.98 -168.32 1.31 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.977 178.138 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 65.4 t30 -29.13 -71.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.342 0.591 . . . . 0.0 111.283 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.66 25.33 3.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.95 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.93 142.9 51.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.481 0.658 . . . . 0.0 112.486 -175.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.511 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 33.6 tp10 -107.14 120.16 41.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.29 130.77 52.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.202 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -94.91 117.12 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.647 177.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -117.39 138.98 51.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.232 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.79 135.34 54.12 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.789 178.622 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 46.7 t -68.45 132.96 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.03 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -27.74 11.46 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 124.463 1.102 . . . . 0.0 110.683 -178.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.63 154.57 8.7 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.687 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.28 144.03 19.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.786 -0.707 . . . . 0.0 109.735 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -155.26 166.1 34.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.271 0.558 . . . . 0.0 111.47 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -123.67 128.16 49.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.678 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.4 154.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 169' ' ' ASP . 10.7 p -58.39 129.79 83.97 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.91 -13.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.781 1.654 . . . . 0.0 111.963 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.3 m-20 -81.0 -11.31 59.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.995 -177.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.13 74.06 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -73.25 -15.33 61.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.527 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 3.0 pt-20 -53.24 -36.18 60.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.234 0.54 . . . . 0.0 109.873 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.882 ' O ' HG21 ' A' ' 183' ' ' THR . 2.9 t -69.71 -1.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.973 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.99 -13.74 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.854 0.835 . . . . 0.0 109.919 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -86.92 172.78 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.106 -1.407 . . . . 0.0 112.279 -178.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 67.4 t0 -82.3 131.4 35.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.735 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.527 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 40.5 m80 -111.07 -42.02 4.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.552 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.52 25.67 0.09 OUTLIER Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 181' ' ' GLU . 0.0 OUTLIER -151.42 166.33 31.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.22 89.13 5.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.528 0.68 . . . . 0.0 110.454 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.517 ' OE1' ' NZ ' ' A' ' 179' ' ' LYS . 53.2 tt0 -130.23 129.22 43.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.271 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.64 148.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.882 HG21 ' O ' ' A' ' 173' ' ' VAL . 21.6 m -136.73 122.41 19.8 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.189 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 183' ' ' THR . 10.8 mp -109.11 125.9 52.63 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.273 0.558 . . . . 0.0 110.545 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 35.4 pt -136.25 163.03 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.119 -178.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.504 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 59.1 p . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.29 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 186' ' ' THR . 11.3 ptp180 . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 121.257 0.551 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -106.16 133.99 49.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.152 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.91 132.38 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 43.9 t -117.95 127.73 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.52 134.33 54.11 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.353 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.45 139.92 11.34 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -98.28 140.67 32.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.622 -0.789 . . . . 0.0 111.642 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 205' ' ' GLY . 43.5 tp -65.22 125.31 24.62 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.17 -21.4 5.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.421 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.411 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.39 174.69 46.49 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.199 -179.713 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.5 m -154.35 151.77 29.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.824 179.582 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -150.45 177.6 9.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.56 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -94.43 147.31 23.37 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.342 0.591 . . . . 0.0 110.575 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -61.66 80.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.708 -179.927 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 208' ' ' ALA . 73.8 tttt . . . . . 0 C--N 1.314 -0.965 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.075 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.49 1.287 0 CA-C-O 120.766 0.236 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.05 161.6 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.46 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 66' ' ' LEU . 9.7 mp -65.37 -19.99 66.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.634 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.8 88.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 110.036 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.3 mt-10 -74.19 -33.15 63.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.641 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.28 -44.68 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.542 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.41 86.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.923 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -83.36 -22.57 32.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.047 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.34 104.32 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -179.475 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -95.54 112.22 23.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.189 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tt -115.84 133.02 56.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.323 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -80.41 148.82 30.4 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.453 179.105 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -67.98 0.93 3.03 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.375 0.607 . . . . 0.0 109.588 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 75' ' ' ASP . 38.8 ttmt -62.96 -42.86 99.95 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.723 179.37 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -79.41 0.16 30.41 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.14 0.495 . . . . 0.0 110.439 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.7 t -99.56 129.71 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.576 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.617 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.57 7.09 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.731 -178.162 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.73 -172.54 35.66 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.418 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 13.3 ttm180 -153.31 153.18 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 111.262 -179.422 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 83' ' ' ILE . 17.0 tt -127.7 130.77 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.706 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.8 m -127.77 130.98 49.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.031 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.58 117.12 16.38 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.222 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.28 -36.39 0.99 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.097 1.864 . . . . 0.0 111.534 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -52.33 -38.73 59.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.711 -177.847 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 137' ' ' ASP . 42.5 t -112.05 -6.94 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.75 0.31 . . . . 0.0 110.67 -178.788 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.59 47.47 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.3 tp -114.15 131.46 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.784 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -133.02 116.61 16.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -146.46 165.1 21.09 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.423 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.38 161.01 8.24 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 123.206 2.604 . . . . 0.0 108.923 177.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -112.78 122.95 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.2 mt -103.32 123.97 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.33 -47.99 74.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.199 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.6 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 7.7 p -85.19 119.98 26.18 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.791 -179.583 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p -86.76 118.8 26.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.337 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.2 p -140.69 168.83 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.413 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 4.0 tm-20 -69.87 -34.44 73.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.87 -42.24 21.81 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 97' ' ' SER . 3.6 p-10 -68.75 -20.18 64.36 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.37 -17.77 63.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.218 -179.068 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.1 mp -75.29 -15.98 60.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.544 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.8 m -96.69 -13.6 22.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.476 ' N ' HD13 ' A' ' 134' ' ' LEU . . . 165.6 -149.6 16.13 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.59 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -93.65 126.3 38.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.401 0.619 . . . . 0.0 110.0 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.08 147.82 26.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 41.9 p -72.22 149.56 44.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 t -83.95 -46.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -88.69 -170.91 3.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.85 -178.081 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -124.31 -5.44 7.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.654 -178.475 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -138.87 36.09 2.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.694 0.283 . . . . 0.0 110.764 -178.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -92.55 158.92 15.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.119 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.37 132.1 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 -179.736 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -65.73 127.14 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 178.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.47 1.82 68.43 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -142.55 126.76 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 110.227 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 179' ' ' LYS . . . 72.55 -176.85 41.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.05 108.81 13.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.536 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.68 99.47 10.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.007 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.47 128.61 37.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.232 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.21 133.02 54.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.978 178.086 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.09 140.34 45.71 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.453 0.644 . . . . 0.0 110.916 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.16 -178.13 20.49 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.962 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -84.58 150.45 25.19 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 111.28 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 129' ' ' SER . 44.7 t30 -114.71 27.48 9.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.588 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.4 mmm -45.47 -12.72 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.532 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.8 m 51.7 42.41 29.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -136.06 119.58 17.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.868 -178.462 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -61.9 124.47 20.85 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.855 0.836 . . . . 0.0 110.686 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.26 5.78 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.033 -177.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 134' ' ' LEU . 22.1 t -138.53 175.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.062 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.89 130.7 43.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 111.371 -178.105 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.5 m-30 46.71 32.96 1.89 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.636 178.693 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -11.14 58.59 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.853 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.522 ' O ' HG21 ' A' ' 88' ' ' VAL . 4.1 m-20 -144.68 21.83 1.64 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -177.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.538 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.6 pt -69.0 -27.44 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.719 0.295 . . . . 0.0 111.527 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.58 1.49 2.36 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.549 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.7 m -95.54 -10.44 29.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.91 118.6 7.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.524 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -98.19 170.98 8.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -67.25 137.4 56.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.134 0.968 . . . . 0.0 112.409 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.53 20.3 64.37 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.781 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -90.94 134.05 34.78 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -83.46 138.23 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.548 0.689 . . . . 0.0 112.16 -178.371 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 158' ' ' TYR . 76.9 mt -130.82 119.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.504 179.103 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -100.47 122.72 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.239 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.3 tp -117.32 147.03 42.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.726 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.418 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 15.5 m-85 -113.49 128.81 56.58 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.17 0.509 . . . . 0.0 111.134 -179.04 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -109.3 -168.44 1.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.52 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 151' ' ' ASP . 92.3 m-20 -25.73 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.381 0.61 . . . . 0.0 112.312 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -138.85 23.4 2.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -124.95 144.63 50.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.131 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.66 121.74 44.19 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -105.94 130.05 53.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.307 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.84 119.2 34.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' A' ' 147' ' ' ILE . 52.0 m-85 -116.64 138.74 51.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.167 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -114.9 132.14 56.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.35 0.595 . . . . 0.0 110.56 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.27 134.18 30.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -107.57 -25.11 11.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.357 1.036 . . . . 0.0 110.714 -179.512 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.37 164.21 23.68 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.89 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.76 152.27 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.2 t -156.88 169.11 25.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.378 0.609 . . . . 0.0 111.369 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.99 126.98 52.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.399 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -139.55 159.0 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.113 -178.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 169' ' ' ASP . 17.6 p -68.5 135.62 90.73 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.573 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.9 Cg_endo -47.17 -12.62 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.604 1.536 . . . . 0.0 111.727 -179.263 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 167' ' ' THR . 66.5 t0 -78.15 -17.7 56.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.44 -178.628 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.603 ' O ' HG22 ' A' ' 173' ' ' VAL . 13.6 mptt -84.7 68.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.573 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 63.0 m95 -73.72 -24.04 59.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.379 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.36 -7.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 170' ' ' LYS . 17.3 m -85.9 -9.12 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.128 -178.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.544 HG11 HD13 ' A' ' 185' ' ' ILE . 1.4 m -131.27 8.3 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 109.158 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 72.4 mm-40 -83.6 143.71 29.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.443 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -55.81 120.14 6.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.801 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 41.7 m80 -111.3 -40.1 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.71 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 122.85 34.67 0.78 Allowed Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 119' ' ' GLY . 19.8 mmmt -139.03 157.08 46.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.664 -179.262 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.2 m-20 -87.96 88.57 7.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.906 0.86 . . . . 0.0 108.891 177.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -135.12 170.09 16.44 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.133 -178.368 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.1 tt -131.29 143.3 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.845 178.527 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.602 ' C ' HD12 ' A' ' 184' ' ' LEU . 13.5 m -137.25 128.07 27.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.098 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 183' ' ' THR . 10.4 mp -112.77 125.62 54.53 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.216 0.532 . . . . 0.0 110.325 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.544 HD13 HG11 ' A' ' 174' ' ' VAL . 11.9 pt -133.91 164.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.427 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.116 -179.585 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.483 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.21 142.66 45.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.77 139.05 46.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.72 129.93 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.302 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 161' ' ' THR . . . -115.21 135.74 53.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.999 0.428 . . . . 0.0 110.402 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.52 145.73 17.0 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.843 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -100.69 139.02 36.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.773 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.48 126.16 27.41 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.212 0.529 . . . . 0.0 110.711 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.63 -25.93 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.376 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.64 161.26 20.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.434 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 207' ' ' LYS . 40.5 m -137.73 157.4 46.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.446 0.641 . . . . 0.0 110.07 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 206' ' ' THR . 16.2 ptpt -148.93 179.32 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.306 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.17 144.42 25.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.467 0.651 . . . . 0.0 110.901 179.352 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -67.98 80.15 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.644 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 77.3 tttt . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.59 179.068 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.484 0.916 0 N-CA-C 110.846 -0.482 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.24 154.35 42.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.877 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.6 mt -56.13 -26.37 49.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 110.869 -179.153 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.92 96.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.651 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.62 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.9 mt-10 -72.63 -36.09 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.679 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.5 t -74.47 -44.63 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.083 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.76 92.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -80.76 -25.79 37.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.447 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.62 140.92 58.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.112 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 p -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.519 HD11 ' OE1' ' A' ' 78' ' ' GLN . 12.9 tp -140.83 140.0 34.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.316 -178.483 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.72 140.84 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.383 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 79' ' ' VAL . 14.1 mptt -70.07 -6.0 30.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.302 0.572 . . . . 0.0 110.009 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.21 -35.74 81.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.358 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.519 ' OE1' HD11 ' A' ' 74' ' ' LEU . 80.9 mt-30 -75.59 11.93 1.17 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.653 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 76' ' ' LYS . 96.2 t -87.8 126.09 41.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.573 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 96' ' ' LYS . 9.1 pt -119.9 -9.07 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 112.058 -178.286 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 -170.26 38.03 Favored Glycine 0 C--N 1.321 -0.264 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.09 152.42 38.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.507 -178.099 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 HD13 ' A' ' 123' ' ' LEU . 10.1 tt -122.58 125.8 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -125.79 127.86 46.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.172 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 67.1 mt -131.61 126.71 21.18 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.258 -177.961 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -82.66 -35.9 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.162 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.9 t -46.64 -37.73 8.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.403 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -120.6 -0.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 t 61.49 55.63 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.47 136.07 54.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.184 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.676 ' O ' HD12 ' A' ' 92' ' ' LEU . 81.8 tt0 -135.24 119.89 18.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.442 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -146.09 107.67 4.24 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -176.108 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.73 159.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.841 1.694 . . . . 0.0 109.898 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.6 t -110.04 124.68 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 74' ' ' LEU . 26.4 mt -108.09 123.87 49.35 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HB2' HD13 ' A' ' 80' ' ' ILE . 65.9 tttm -66.81 -49.64 65.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.196 0.522 . . . . 0.0 111.435 -179.649 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.8 m -62.05 99.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.496 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 p -82.99 102.16 11.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.918 0.389 . . . . 0.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.493 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 80.4 p -141.86 155.17 45.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.307 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -57.86 -23.03 51.02 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -81.82 -50.11 9.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.278 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.2 p-10 -66.29 -31.56 72.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.588 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.97 -22.49 62.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.422 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -72.9 -16.53 61.56 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.6 m -106.96 -14.94 14.83 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.601 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.93 48.1 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.296 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -107.57 145.49 33.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.188 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.8 p -70.14 149.18 47.84 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.54 -45.12 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.471 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.32 -170.84 2.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.027 -178.813 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.98 -10.12 8.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 113' ' ' ASN . 54.3 p30 -135.45 36.35 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.929 0.395 . . . . 0.0 111.026 -177.342 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -93.82 158.74 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.927 179.256 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.43 131.16 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.794 -178.708 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.435 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 67.0 mtt -65.41 129.47 39.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.58 -2.75 74.09 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -138.49 121.26 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.867 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 74.93 -173.96 51.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' A' ' 181' ' ' GLU . 2.6 t-20 -82.65 111.98 19.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -84.77 104.84 15.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.17 130.12 36.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.608 -179.074 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.554 HD13 HD12 ' A' ' 83' ' ' ILE . 6.3 mt -128.74 134.31 48.4 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.069 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.42 43.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.256 0.55 . . . . 0.0 111.005 -178.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.75 -177.58 17.89 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 64.3 m-70 -87.69 140.68 29.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.675 0.274 . . . . 0.0 110.58 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 49.1 p30 -107.16 28.27 8.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.155 0.502 . . . . 0.0 110.735 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -43.31 -15.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.887 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.2 40.01 18.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.256 178.867 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.58 107.1 7.78 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.07 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.35 128.15 16.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.857 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.71 -26.44 11.74 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.603 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.796 HG12 ' H ' ' A' ' 134' ' ' LEU . 47.7 t -83.6 179.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.796 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 137.51 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 -178.103 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 138' ' ' ILE . 4.0 m-85 44.39 35.47 1.32 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 111.184 177.701 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 16.8 p -82.41 -13.46 56.77 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 136' ' ' SER . 78.4 m-20 -146.97 31.57 0.94 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.33 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.514 HD13 ' CD2' ' A' ' 135' ' ' PHE . 4.0 pt -70.84 -25.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.819 0.343 . . . . 0.0 111.825 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.43 0.92 7.15 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.53 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -93.68 -11.68 31.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.304 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 163' ' ' VAL . 18.9 mt -65.64 120.69 13.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.537 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.508 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.05 151.9 19.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.628 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -52.07 122.82 9.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.302 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.93 21.29 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.7 m-20 -87.25 139.55 30.45 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -81.66 127.26 32.72 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.496 -178.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 158' ' ' TYR . 32.9 mm -115.02 124.25 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -105.64 115.81 30.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.634 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.95 150.86 39.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.148 -178.536 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -123.77 136.9 54.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.185 0.516 . . . . 0.0 111.65 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 156' ' ' TYR . 2.5 m-20 -113.7 -163.53 0.87 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.613 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.6 p30 -26.03 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.07 0.462 . . . . 0.0 111.438 178.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.52 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.6 mt-10 -132.94 29.86 4.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.065 178.765 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.412 ' OD1' ' OD1' ' A' ' 152' ' ' ASN . 28.3 m120 -127.82 145.34 50.96 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -106.29 121.78 44.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.724 179.404 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.588 ' CE1' ' OD2' ' A' ' 151' ' ' ASP . 19.7 m-85 -104.35 129.12 52.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.629 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.58 117.27 30.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' O ' ' N ' ' A' ' 147' ' ' ILE . 8.2 m-85 -120.53 137.85 54.16 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.859 -178.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.1 134.96 53.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.76 178.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.26 134.43 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.158 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 12.2 p -99.07 -26.96 14.05 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.486 1.116 . . . . 0.0 111.316 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.99 145.25 4.17 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.342 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 141' ' ' LEU . 58.1 t -91.8 141.46 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -139.9 151.41 45.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.756 0.312 . . . . 0.0 111.05 -177.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -106.47 115.94 31.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.86 159.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.232 -177.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.0 p -66.94 170.03 6.99 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.555 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.7 Cg_endo -81.68 -13.19 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.888 1.725 . . . . 0.0 111.901 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -87.87 -14.21 40.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -178.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -85.69 69.13 10.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.555 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.4 m95 -74.83 -2.44 26.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.09 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -53.37 -35.38 60.24 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.162 0.506 . . . . 0.0 111.024 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.827 ' O ' HG21 ' A' ' 183' ' ' THR . 17.0 m -80.88 3.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.925 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.38 -15.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.833 0.825 . . . . 0.0 109.971 -178.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.06 162.22 17.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.838 -179.145 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -66.76 128.16 35.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.637 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -99.29 -39.53 8.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.083 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.2 29.42 0.5 Allowed Glycine 0 N--CA 1.473 1.103 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.439 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 58.5 pttt -156.05 -179.11 7.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 43.8 m-20 -92.21 90.26 7.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.145 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.5 ' HB3' HD21 ' A' ' 120' ' ' ASN . 49.9 tt0 -128.2 169.28 14.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.861 -178.214 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.9 tt -132.94 143.33 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.827 HG21 ' O ' ' A' ' 173' ' ' VAL . 11.3 m -138.29 120.61 15.89 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.872 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -108.77 126.03 52.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.958 0.409 . . . . 0.0 111.179 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.416 HG22 HG12 ' A' ' 198' ' ' VAL . 5.1 pt -133.89 -166.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.518 -178.594 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.587 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 23.4 p . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.572 -179.423 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.587 ' NH1' ' O ' ' A' ' 186' ' ' THR . 15.4 ttm180 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.509 0.195 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -89.19 132.91 34.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.308 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.416 HG12 HG22 ' A' ' 185' ' ' ILE . 27.7 m -139.46 142.09 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 111.514 -179.126 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 40.1 t -116.29 129.16 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.178 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.01 134.62 54.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.646 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.08 157.28 22.78 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -112.15 148.8 33.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.972 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.29 127.23 32.06 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.858 0.361 . . . . 0.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.03 -25.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.346 -178.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.6 163.18 22.15 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.616 178.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.521 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 93.6 m -139.49 159.05 43.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.058 0.456 . . . . 0.0 110.109 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 206' ' ' THR . 15.9 ptpt -147.27 178.79 8.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.655 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -97.35 142.99 28.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.545 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.94 80.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.556 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.388 178.524 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.498 1.749 0 CA-C-O 121.015 0.34 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 58.5 t0 -76.43 152.94 36.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.1 mt -55.04 -25.0 27.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.565 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.71 -39.11 87.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 98.0 mt-10 -74.14 -32.12 63.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.6 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.18 -44.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.83 85.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.81 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -81.6 -28.46 33.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.455 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.17 111.73 1.45 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 111.218 -178.44 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.8 m -97.37 85.97 3.78 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.7 tp -74.4 146.74 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.335 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -94.88 111.61 23.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 179.311 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' O ' HG12 ' A' ' 79' ' ' VAL . 17.2 tptp -52.61 -10.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.434 . . . . 0.0 110.198 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -70.93 -12.19 61.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.925 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -95.54 15.86 18.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.475 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.9 p -91.22 126.24 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.07 179.637 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.34 -3.71 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.946 0.403 . . . . 0.0 111.66 -178.401 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.34 -162.01 32.19 Favored Glycine 0 C--N 1.317 -0.524 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.685 ' NH1' ' HZ3' ' A' ' 209' ' ' LYS . 36.8 ptt180 -156.31 162.64 40.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.426 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -133.26 139.67 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 t -130.03 135.57 48.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.529 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 70.5 mt -131.89 125.55 20.31 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.734 -178.89 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.66 -36.29 0.34 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.46 2.107 . . . . 0.0 112.864 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 p -48.21 -36.49 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.706 -176.369 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.8 p -119.81 -0.21 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.576 0.227 . . . . 0.0 110.65 -179.067 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.0 p 61.53 52.12 3.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 88' ' ' VAL . 4.7 tp -115.57 134.11 55.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.714 -178.694 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.56 128.69 22.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.636 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 1.0 OUTLIER -161.55 130.21 3.0 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.128 -178.857 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -47.59 156.89 1.0 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.583 1.522 . . . . 0.0 110.873 177.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.5 t -107.88 125.55 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -106.48 125.38 50.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.845 0.355 . . . . 0.0 110.592 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.57 -45.35 72.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.095 0.474 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.2 m -67.68 104.83 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.577 -178.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.1 p -81.74 96.63 7.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.096 0.475 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.419 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 4.8 p -135.96 157.65 46.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.947 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -58.11 -27.33 63.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.884 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.53 -45.28 13.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.24 0.543 . . . . 0.0 111.197 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 4.5 m120 -65.67 -36.68 84.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.405 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 108' ' ' ALA . 14.5 mt -63.46 -17.94 63.24 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.651 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.0 mt -71.21 -28.96 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.1 p -97.71 -8.23 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.35 -164.66 32.92 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.691 -1.242 . . . . 0.0 112.584 -178.504 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.636 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -92.36 127.95 38.03 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.06 146.71 28.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.0 p -74.27 153.16 39.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 185' ' ' ILE . 6.3 t -85.52 -47.04 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.081 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.42 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 14.7 mptt -92.49 -170.29 2.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.633 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 11.5 pt-20 -106.97 -52.83 2.7 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.72 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 91.1 m-20 -89.24 43.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.479 -178.118 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.42 ' CD ' ' H ' ' A' ' 111' ' ' LYS . 67.9 mt-30 -79.6 146.33 32.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.034 0.445 . . . . 0.0 110.859 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 122.8 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.34 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.99 125.12 25.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.538 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.3 0.68 70.17 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -140.72 126.17 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.508 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.57 -172.13 48.77 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -84.34 108.34 17.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.82 101.91 12.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 124.83 35.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.0 112.132 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -119.67 131.4 55.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.446 177.849 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.77 141.11 45.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.176 0.512 . . . . 0.0 110.594 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.68 -178.22 18.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.412 -179.761 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.1 m-70 -87.08 144.86 26.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.985 0.421 . . . . 0.0 110.873 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.0 t-20 -108.88 28.9 7.98 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.869 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -44.15 -13.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.742 -178.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 m 57.44 39.78 27.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.146 0.498 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -135.02 108.21 7.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.531 -178.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -51.15 127.83 20.26 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.642 -179.093 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.53 -26.71 11.47 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.448 -178.369 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.821 HG12 ' H ' ' A' ' 134' ' ' LEU . 46.3 t -82.72 178.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 117.52 0.66 . . . . 0.0 109.772 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.821 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.22 136.94 48.28 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.628 -177.996 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.86 33.57 1.02 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.898 178.508 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.8 p -81.78 -12.01 58.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 23.4 t70 -149.12 32.84 0.74 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.094 -178.378 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.9 pt -69.58 -27.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.442 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.15 2.07 4.06 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 63.5 m -91.77 -14.85 29.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 23.1 mt -62.76 126.48 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.165 -179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -96.46 171.41 8.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -76.8 129.59 36.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.505 0.669 . . . . 0.0 111.937 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.51 21.11 49.37 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.25 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.17 -158.51 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -147.26 129.84 15.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.686 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.3 mt -126.92 124.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.814 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -102.99 120.23 40.26 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 tp -117.03 148.4 41.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 -179.408 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.13 131.19 53.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.12 0.486 . . . . 0.0 112.028 -178.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 152' ' ' ASN . 36.8 t0 -109.18 -167.42 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.168 177.611 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 151' ' ' ASP . 89.5 m-20 -19.99 -76.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.56 0.538 . . . . 0.0 111.981 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -138.16 27.23 2.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.58 144.2 49.26 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -176.387 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -107.68 121.52 44.86 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.452 ' CE2' HG21 ' A' ' 206' ' ' THR . 63.6 m-85 -105.35 128.92 53.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -178.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.461 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 98.0 mt-10 -95.83 119.44 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.236 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -116.36 143.94 44.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.67 131.77 56.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.038 0.447 . . . . 0.0 110.13 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.69 132.6 32.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.527 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -28.67 12.06 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.344 1.028 . . . . 0.0 109.906 -178.522 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 169.96 25.53 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.279 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.07 153.86 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.439 -0.881 . . . . 0.0 109.918 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.3 t -153.89 166.12 33.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 111.523 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 63.2 mm-40 -109.9 126.94 54.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.58 161.37 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.769 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.6 p -76.89 145.23 73.82 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.336 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.35 -21.81 7.72 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.867 1.711 . . . . 0.0 111.662 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.37 -2.73 53.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.805 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.596 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 21.6 tptt -80.71 150.18 29.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 83.6 m95 -157.62 -24.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.536 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.3 mt-10 -51.9 -8.56 0.07 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.111 0.482 . . . . 0.0 110.298 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' TRP . 7.0 m -78.41 -32.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 185' ' ' ILE . 28.5 m -110.03 -1.35 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.451 0.643 . . . . 0.0 110.468 -178.57 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 176' ' ' ASP . 94.0 mt-10 -80.37 119.81 23.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.7 -179.016 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' GLU . 98.1 m-20 -30.41 120.04 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.655 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 49.9 m80 -102.85 -43.23 5.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.969 -179.278 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.16 29.41 0.22 Allowed Glycine 0 N--CA 1.467 0.738 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -152.57 172.7 16.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -93.86 89.47 6.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.386 178.856 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.26 127.5 30.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.762 -179.142 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -82.56 148.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.562 ' CG2' HG12 ' A' ' 174' ' ' VAL . 3.4 m -136.1 124.84 23.87 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.513 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -108.47 129.93 55.27 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.924 0.392 . . . . 0.0 110.512 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 174' ' ' VAL . 7.1 pt -141.5 -168.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.924 -179.649 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.827 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.531 0.205 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.7 m-85 -102.96 123.38 46.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.635 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.11 133.22 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.394 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 76.4 t -120.31 130.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.184 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.26 135.24 53.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.295 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.14 137.39 10.11 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.323 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.6 t0 -95.54 132.47 40.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.23 -0.485 . . . . 0.0 112.077 -178.729 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 47.1 tp -62.15 125.84 25.27 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.168 0.508 . . . . 0.0 110.597 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.95 -24.91 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.678 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.11 159.86 17.03 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.064 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.452 HG21 ' CE2' ' A' ' 156' ' ' TYR . 20.5 m -134.15 156.17 48.79 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.105 0.479 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.461 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.5 ptpp? -148.14 179.21 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.129 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.84 146.82 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.232 0.539 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.685 ' HZ3' ' NH1' ' A' ' 82' ' ' ARG . 63.7 tttp -70.36 80.8 0.55 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.655 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.766 178.562 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.486 1.038 0 N-CA-C 110.973 -0.433 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.35 146.16 48.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.634 179.471 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -49.26 -28.13 4.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.73 -179.711 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.58 93.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.353 -179.428 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.9 mt-10 -73.1 -33.92 65.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.748 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t -75.06 -45.89 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.052 -178.957 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.81 86.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.88 -25.33 32.61 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.372 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.76 130.62 47.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.4 t -95.64 158.88 15.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -138.63 123.69 19.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.014 0.435 . . . . 0.0 110.951 -178.845 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.682 ' N ' HD13 ' A' ' 74' ' ' LEU . 98.0 m-20 -81.45 104.14 11.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.058 178.648 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -49.4 -35.84 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.242 -179.645 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -58.77 -11.49 3.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.498 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -90.41 -3.31 57.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.915 -178.724 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.34 133.27 30.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.983 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 pt -117.37 -5.73 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.933 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.72 33.77 Favored Glycine 0 C--N 1.317 -0.522 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.573 HH22 ' HZ1' ' A' ' 209' ' ' LYS . 29.5 ptt-85 -154.94 166.01 34.9 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.545 -179.775 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.77 134.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.824 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 t -123.85 130.27 52.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.242 -178.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 17.3 mt -133.15 111.05 12.95 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.402 -177.739 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 4.2 Cg_exo -78.69 -36.66 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.757 2.305 . . . . 0.0 113.013 -178.899 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 t -47.81 -35.83 10.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.48 -177.249 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 90' ' ' LEU . 4.2 m -118.96 -5.92 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 123.361 0.413 . . . . 0.0 111.432 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.15 45.69 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.737 -179.916 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 88' ' ' VAL . 1.1 mt -112.2 129.0 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.233 -178.84 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -135.86 115.65 13.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.361 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.1 mt -143.79 161.99 43.48 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.341 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -86.56 152.83 8.98 Favored 'Trans proline' 0 C--N 1.326 -0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 108.882 177.676 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.75 115.52 44.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.0 mt -100.18 128.26 46.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.045 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -66.22 -49.51 67.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.154 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -78.74 108.98 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 -179.092 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 98.72 11.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 109.927 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -133.06 154.8 50.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.33 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -51.55 -27.79 11.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.538 -179.607 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -83.57 -47.17 11.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.745 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.05 -33.36 75.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.593 -178.868 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.84 -19.35 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.807 -178.928 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.469 ' O ' HD11 ' A' ' 134' ' ' LEU . 22.7 mt -69.94 -25.13 63.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.42 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.667 ' OG ' HD23 ' A' ' 74' ' ' LEU . 21.6 m -91.82 -9.61 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.138 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.447 ' N ' HD13 ' A' ' 134' ' ' LEU . . . 165.09 -154.04 24.58 Favored Glycine 0 N--CA 1.46 0.238 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.646 -179.387 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.42 125.26 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.634 -0.783 . . . . 0.0 110.061 179.591 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.23 148.03 26.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.576 -179.678 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.2 p -75.77 150.53 37.75 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.216 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 t -86.78 -56.51 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.67 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -96.74 138.65 33.99 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.301 0.572 . . . . 0.0 111.015 -179.178 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -80.55 9.09 6.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.656 -178.337 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.407 ' C ' ' OD1' ' A' ' 113' ' ' ASN . 54.8 p30 -132.88 22.78 4.21 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.139 -0.351 . . . . 0.0 111.352 -177.87 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -91.05 156.12 18.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.955 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -134.26 133.5 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.547 ' SD ' HD22 ' A' ' 149' ' ' LEU . 67.8 mtt -67.14 127.35 32.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 179.091 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.507 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.36 0.23 76.92 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.56 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -142.39 127.58 18.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.037 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.85 -171.2 45.47 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.254 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -86.77 107.84 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.773 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -84.91 99.32 10.88 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 122.76 34.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mt -117.7 131.14 56.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.296 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.95 137.91 48.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.627 0.727 . . . . 0.0 110.789 -178.413 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.25 -178.68 17.76 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.607 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -85.95 141.75 29.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.479 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.5 p30 -109.98 26.56 10.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -42.96 -15.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.876 -179.51 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 59.39 39.13 22.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.142 178.959 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.9 tttt -133.27 114.95 14.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.468 -179.184 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.35 125.19 21.71 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.173 -179.652 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.93 -24.68 11.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.292 -178.379 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.724 HG12 ' H ' ' A' ' 134' ' ' LEU . 61.5 t -82.37 178.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.724 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -71.89 135.74 46.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.245 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 43.67 32.81 0.6 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.166 0.508 . . . . 0.0 110.892 178.381 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -81.45 -6.37 58.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.784 -178.355 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 136' ' ' SER . 94.2 m-20 -143.25 34.37 1.33 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.625 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.6 pt -68.3 -30.5 47.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.788 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.49 5.83 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.029 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -97.57 -14.65 20.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.023 -179.359 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.11 124.67 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.288 179.621 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.401 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.41 154.38 17.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.664 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.19 126.44 27.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.307 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.73 25.16 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.771 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.401 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -91.28 133.47 35.38 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -80.59 142.03 34.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.166 0.508 . . . . 0.0 111.592 -178.904 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 158' ' ' TYR . 85.7 mt -132.74 124.41 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.352 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.03 121.9 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.076 0.465 . . . . 0.0 109.994 -178.781 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.547 HD22 ' SD ' ' A' ' 116' ' ' MET . 1.1 mt -114.18 156.53 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.445 -179.489 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 26.3 m-85 -134.55 123.37 23.77 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 152' ' ' ASN . 11.3 t0 -114.35 -165.6 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.795 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.558 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.9 m-20 -11.31 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.737 0.648 . . . . 0.0 111.504 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -139.1 28.04 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.19 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.15 148.04 41.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.191 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 74.3 mt-10 -110.29 119.75 40.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.865 178.38 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -106.04 125.03 50.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.893 -178.764 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.522 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.2 mt-10 -96.12 118.98 33.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.108 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.507 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.8 m-85 -118.38 144.9 45.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.014 -178.843 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' ASP . . . -120.42 131.69 54.9 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.338 0.589 . . . . 0.0 110.368 178.825 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.31 133.84 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.962 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.2 p -102.19 -27.07 13.1 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 124.701 1.251 . . . . 0.0 110.986 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 179.94 36.53 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.259 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.98 147.48 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.776 -179.531 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -151.28 159.94 44.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.083 0.468 . . . . 0.0 110.976 -178.42 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -107.23 118.87 37.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 173' ' ' VAL . 17.8 m -132.21 154.07 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.107 0.479 . . . . 0.0 111.034 -178.498 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 169' ' ' ASP . 35.8 p -75.94 135.86 70.34 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.691 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.59 -15.61 0.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.104 1.869 . . . . 0.0 111.659 -178.653 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.7 m-20 -81.35 -22.75 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 -177.906 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 173' ' ' VAL . 32.6 ttmt -85.65 75.84 10.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.229 179.307 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.575 ' C ' ' H ' ' A' ' 173' ' ' VAL . 86.0 m95 -71.39 -18.67 62.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.306 -178.665 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 81.0 mm-40 -51.97 -5.72 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.974 0.416 . . . . 0.0 111.15 179.208 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.726 ' O ' HG21 ' A' ' 183' ' ' THR . 34.0 m -90.38 -2.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.173 -178.466 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.564 HG13 HG23 ' A' ' 173' ' ' VAL . 1.2 m -132.99 -6.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.63 0.729 . . . . 0.0 109.563 -179.681 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.35 159.56 24.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.093 -176.623 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -66.28 124.5 22.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.517 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.1 m170 -113.94 24.47 12.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.656 -179.13 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.31 19.16 74.88 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.117 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.16 165.74 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 28.9 p30 -97.5 87.62 4.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.71 0.767 . . . . 0.0 110.561 179.751 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -123.24 130.0 52.14 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.053 -179.389 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.9 tt -81.5 146.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.334 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.726 HG21 ' O ' ' A' ' 173' ' ' VAL . 17.3 m -136.71 120.7 17.63 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.279 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -106.0 123.31 47.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.528 0.68 . . . . 0.0 110.786 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.5 pt -137.03 -169.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.645 -178.793 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.512 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.046 -178.907 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.8 ttm180 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -86.39 133.27 33.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.888 179.121 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 134.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 111.201 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.37 130.15 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.682 -179.548 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -119.12 137.83 53.32 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.643 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.0 145.24 17.32 Favored Glycine 0 N--CA 1.466 0.641 0 CA-C-O 121.828 0.682 . . . . 0.0 111.668 -179.213 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.9 t0 -100.57 140.24 35.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.51 -0.845 . . . . 0.0 111.414 -178.796 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 31.8 tp -65.36 128.14 34.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.7 p -107.26 -25.9 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.213 -178.875 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.81 161.79 22.05 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.728 179.133 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 207' ' ' LYS . 89.9 m -142.22 157.06 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.185 0.517 . . . . 0.0 109.967 -179.263 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.52 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.6 pttm -150.82 178.97 8.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.109 179.617 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.77 144.23 26.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.777 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.573 ' HZ1' HH22 ' A' ' 82' ' ' ARG . 88.5 tttt -69.54 78.47 0.41 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.905 -179.247 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.699 178.266 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.487 1.108 0 N-CA-C 111.253 -0.326 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 56.4 t0 -76.38 159.14 30.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 84.6 mt -60.27 -24.39 64.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.765 -179.105 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.15 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.343 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.9 mt-10 -72.62 -34.44 67.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.654 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -75.07 -44.78 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.897 -178.937 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.97 87.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.955 179.853 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.0 -21.49 33.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.336 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.52 132.97 55.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -141.94 81.49 1.76 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.001 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.7 pt? -73.35 154.87 39.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.924 179.074 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -70.31 136.7 50.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -66.39 -7.77 21.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.379 0.609 . . . . 0.0 110.364 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.95 -29.63 70.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.05 5.1 8.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.551 -178.794 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.37 127.62 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.74 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.704 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -135.47 8.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.269 -177.416 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.49 -174.31 39.7 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -178.888 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -153.16 155.16 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.346 -179.221 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 83' ' ' ILE . 18.4 tt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 179.59 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -129.27 130.14 45.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.828 -178.886 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.471 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 26.5 mt -135.36 120.97 13.96 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.475 -178.353 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -82.32 -34.49 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.601 2.201 . . . . 0.0 112.472 -179.597 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -49.97 -39.24 40.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.749 -176.699 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.433 ' O ' ' CB ' ' A' ' 89' ' ' SER . 3.4 m -118.88 -7.32 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 123.309 0.381 . . . . 0.0 111.039 -178.902 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 75.77 48.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.56 0.695 . . . . 0.0 110.42 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 92' ' ' LEU . 2.4 mt -107.24 122.56 46.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.429 -179.424 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.17 109.27 10.31 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.977 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.528 HD12 HD22 ' A' ' 90' ' ' LEU . 36.1 mt -144.37 165.56 22.87 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.333 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.01 156.09 7.15 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.916 2.411 . . . . 0.0 108.628 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.413 ' O ' HD13 ' A' ' 80' ' ' ILE . 69.0 t -107.24 120.01 57.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.958 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.03 119.57 39.08 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.55 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.07 -47.52 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.5 p -81.47 117.94 22.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -82.9 75.55 9.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.068 0.461 . . . . 0.0 110.163 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.406 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -90.65 142.96 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.424 179.909 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.459 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 84.0 tt0 -50.46 -56.96 9.21 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.568 -179.597 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -66.28 -32.09 73.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.318 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.597 HD21 ' N ' ' A' ' 102' ' ' ASN . 1.2 m120 -68.1 -27.06 66.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 108' ' ' ALA . 13.0 mt -73.2 -9.57 58.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.444 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.3 mp -76.44 -14.45 60.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.01 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.43 ' OG ' HD22 ' A' ' 74' ' ' LEU . 35.5 m -112.13 -5.6 14.22 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.48 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.96 -167.68 39.14 Favored Glycine 0 C--N 1.323 -0.19 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.555 -179.761 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.04 128.01 38.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.686 179.413 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.433 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.95 152.55 22.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.465 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -78.19 156.07 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.279 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.6 t -84.69 -55.54 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.22 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -94.36 137.92 32.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.111 0.481 . . . . 0.0 111.091 -179.359 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.27 6.25 17.42 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.028 -178.511 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -130.19 24.53 5.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.834 0.35 . . . . 0.0 111.408 -177.432 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -94.28 162.9 13.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.02 135.83 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.4 mtp -70.56 124.57 24.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.819 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.71 7.37 64.79 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.646 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -143.62 124.69 14.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.389 -178.887 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.0 -170.43 51.92 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.315 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.58 107.4 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.643 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.75 101.99 12.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.241 -179.566 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.94 128.06 36.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.362 0.601 . . . . 0.0 111.692 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.92 131.24 53.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.429 178.497 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.28 140.32 45.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.476 0.655 . . . . 0.0 111.101 -178.567 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.86 -179.94 19.99 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.4 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.27 156.88 27.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 129' ' ' SER . 7.6 t30 -122.78 27.1 7.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.968 0.413 . . . . 0.0 110.844 -179.163 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.0 mtt -45.9 -13.01 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.797 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 m 54.97 40.35 31.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.006 178.705 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 136' ' ' SER . 83.4 tttt -134.04 120.67 20.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.049 -179.168 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.97 124.23 19.2 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.209 0.528 . . . . 0.0 109.973 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.37 -29.66 7.17 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.203 -177.913 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.71 HG12 ' N ' ' A' ' 134' ' ' LEU . 99.5 t -76.03 177.21 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.359 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.71 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -73.27 139.21 45.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.514 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.4 m-30 45.0 27.57 0.29 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.149 0.499 . . . . 0.0 111.22 178.029 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -83.42 -15.65 48.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.554 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -132.47 12.98 4.55 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.511 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.417 HD13 ' CD2' ' A' ' 135' ' ' PHE . 9.7 pt -68.81 -25.83 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.927 0.394 . . . . 0.0 111.789 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.06 1.53 1.94 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.569 -179.6 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 138' ' ' ILE . 15.8 t -98.76 -11.29 22.02 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.226 0.536 . . . . 0.0 110.226 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.08 120.37 11.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.365 179.757 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -99.81 166.06 11.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.676 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.404 ' HB3' ' HZ2' ' A' ' 143' ' ' LYS . 10.4 ttpp -65.04 118.9 9.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.308 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.39 14.92 12.06 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.198 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -95.28 133.51 39.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.354 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.785 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 158' ' ' TYR . 69.2 mt -125.86 124.99 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.975 178.662 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.4 ' CD2' ' OE2' ' A' ' 157' ' ' GLU . 63.2 m-85 -99.39 114.69 27.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.979 -178.801 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 tp -113.93 142.91 45.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.94 -179.38 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -110.25 137.36 48.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.053 0.454 . . . . 0.0 111.653 -178.434 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 37.3 t70 -110.72 -172.77 2.1 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.271 178.189 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.1 m-20 -37.45 -62.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -179.478 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -137.6 23.86 2.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.865 179.349 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.85 152.2 48.11 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.641 0.734 . . . . 0.0 112.65 -175.702 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -114.81 122.02 45.08 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.299 178.887 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -105.11 130.99 53.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.319 0.58 . . . . 0.0 111.427 -179.015 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 204' ' ' VAL . 80.5 mm-40 -96.4 117.76 31.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.155 178.474 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 147' ' ' ILE . 29.6 m-85 -115.92 141.49 48.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.79 130.29 55.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.552 0.691 . . . . 0.0 110.11 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.42 134.13 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.067 -179.37 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.8 p -102.0 -25.72 13.66 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 124.705 1.253 . . . . 0.0 111.132 -178.972 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 163.81 166.45 22.7 Favored Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.243 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.56 153.16 37.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.741 -179.618 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.3 t -153.38 161.44 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -178.164 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -116.48 117.1 28.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.807 -179.349 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.22 160.36 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 111.245 -178.497 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 p -57.22 168.91 0.81 Allowed Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.028 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.77 -9.11 12.2 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.094 1.863 . . . . 0.0 111.957 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.76 1.52 42.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -178.402 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.602 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 13.5 mptt -83.59 149.57 26.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.358 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 87.8 m95 -157.6 -28.99 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.173 -178.648 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.88 -8.26 0.09 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.099 0.475 . . . . 0.0 110.665 178.655 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 171' ' ' TRP . 8.9 m -79.16 -25.67 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.607 -178.807 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 171' ' ' TRP . 16.6 m -110.69 -2.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 0.0 110.402 -178.806 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 176' ' ' ASP . 75.4 mm-40 -81.09 119.37 23.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.977 -178.04 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.0 p-10 -30.27 122.21 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.867 179.002 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -104.43 -44.35 4.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.253 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.29 26.36 0.1 Allowed Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -154.05 173.97 15.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.186 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.37 87.02 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.248 0.547 . . . . 0.0 109.901 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -128.05 125.14 38.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -179.002 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -81.2 148.3 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.9 m -137.56 122.98 19.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.184 -179.141 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -109.14 125.54 52.29 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.239 0.542 . . . . 0.0 111.394 -179.546 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.405 HD13 HG11 ' A' ' 174' ' ' VAL . 9.2 pt -134.21 161.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.583 -179.47 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.465 0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.443 -178.876 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.3 134.01 46.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.947 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.71 135.63 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.247 -179.393 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -119.35 130.44 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.416 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.23 134.83 54.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.42 141.13 12.4 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 50.9 p-10 -100.18 141.33 33.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.636 -0.782 . . . . 0.0 111.503 -179.111 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.62 125.1 24.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 110.66 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.5 p -107.16 -24.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.135 -179.034 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.12 177.16 44.92 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.947 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 35.1 m -154.99 154.64 32.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.278 0.561 . . . . 0.0 110.993 -179.858 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.87 178.17 8.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.81 146.27 24.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.508 179.931 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.67 78.31 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.75 -179.118 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.419 178.279 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.486 1.077 0 CA-C-O 121.027 0.345 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.18 157.3 37.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.788 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.41 -28.96 70.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -178.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.17 90.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 -179.571 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.9 mt-10 -73.13 -40.97 64.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.303 0.573 . . . . 0.0 110.836 -179.572 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -73.49 -41.89 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.483 -179.0 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.64 84.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.85 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -91.57 -14.58 30.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.396 -178.665 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.12 110.77 1.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.747 -179.685 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.2 t -106.65 135.64 47.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.76 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.729 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.2 pt? -128.02 174.14 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.057 -179.59 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.9 m-20 -83.65 98.63 9.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.677 178.527 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 79' ' ' VAL . 34.5 mtmm -58.5 -4.23 0.38 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.377 0.608 . . . . 0.0 110.438 -179.669 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.7 mmtp -67.51 -11.18 57.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.549 -179.898 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.88 18.84 12.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.782 -179.481 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 76' ' ' LYS . 53.9 t -80.03 124.29 37.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.135 178.897 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 tt -106.5 -35.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.074 -179.044 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.41 -155.43 8.16 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.569 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -146.38 155.9 42.93 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.48 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -125.37 129.08 73.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.652 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.604 ' N ' HD13 ' A' ' 83' ' ' ILE . 50.2 m -130.5 130.97 44.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.049 -179.276 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.7 mt -132.73 118.59 15.65 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.34 -178.269 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.82 -37.47 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.361 2.041 . . . . 0.0 112.263 -179.503 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 t -48.9 -37.75 20.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.909 -177.146 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 89' ' ' SER . 2.0 m -121.23 -6.59 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.998 -179.026 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.44 50.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.49 124.23 49.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.966 -179.556 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.77 ' O ' HD22 ' A' ' 92' ' ' LEU . 83.0 tt0 -132.59 107.14 8.24 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.395 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.77 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -144.15 116.17 5.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.088 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HD2' HD13 ' A' ' 92' ' ' LEU . 2.3 Cg_endo -41.16 146.49 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 121.817 1.678 . . . . 0.0 110.2 175.446 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.3 t -97.84 121.69 48.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.463 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 mt -103.16 117.48 34.64 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.802 0.334 . . . . 0.0 110.469 -178.993 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -63.62 -48.54 76.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.272 0.558 . . . . 0.0 110.483 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 90.5 p -60.95 102.66 0.21 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.415 -179.637 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 98' ' ' SER . 53.1 p -83.89 91.51 7.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.11 144.37 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.939 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.516 ' HA ' HD12 ' A' ' 103' ' ' LEU . 1.4 tt0 -53.42 -42.94 67.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.951 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -63.57 -46.39 86.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.087 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.644 HD21 HD12 ' A' ' 74' ' ' LEU . 10.2 m120 -68.11 -35.58 78.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 111.779 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 100' ' ' GLU . 4.6 mt -49.46 -22.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.134 -179.47 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.99 -13.25 61.19 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.717 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.538 ' OG ' HD22 ' A' ' 74' ' ' LEU . 3.2 m -105.03 -11.12 16.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.298 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 167.3 -179.06 41.12 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.275 -179.309 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.43 126.06 29.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.785 -0.707 . . . . 0.0 109.941 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.41 150.18 25.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -76.28 153.8 35.66 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.77 -45.94 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.742 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 113' ' ' ASN . 85.6 tttt -89.2 136.24 33.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.165 0.507 . . . . 0.0 110.486 -178.366 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -62.22 -8.27 5.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.109 -178.848 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.468 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 66.1 t30 -146.4 50.31 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 -177.94 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -79.9 161.87 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.784 179.655 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.0 127.04 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 -179.314 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.4 mtt -74.19 127.29 32.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.189 179.013 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.496 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.37 1.71 74.62 Favored Glycine 0 N--CA 1.461 0.326 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -141.58 123.91 15.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.213 0.53 . . . . 0.0 110.974 -179.502 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.59 -170.65 50.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -85.6 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.23 99.91 10.26 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 121.18 32.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.289 0.566 . . . . 0.0 111.323 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -116.58 130.56 56.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.699 178.713 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.29 137.63 47.77 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.459 0.647 . . . . 0.0 110.433 -179.322 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.39 -177.15 17.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.713 -178.902 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 134' ' ' LEU . 54.8 m-70 -90.37 137.06 32.65 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 -179.504 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 129' ' ' SER . 29.2 t-20 -105.91 28.24 7.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 109.891 -179.986 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.7 mmm -44.6 -13.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.859 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.71 40.91 15.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.684 179.481 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 19.1 mmmt -132.03 107.59 8.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.092 -179.131 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -52.36 124.18 12.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.596 0.713 . . . . 0.0 110.297 179.984 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.74 -28.05 9.27 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.946 -178.34 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.734 HG12 ' H ' ' A' ' 134' ' ' LEU . 60.4 t -78.37 178.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-N 117.879 0.839 . . . . 0.0 109.047 179.415 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.734 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -70.44 134.2 47.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.239 -178.224 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.411 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.9 m-30 44.59 32.81 0.81 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.258 0.552 . . . . 0.0 110.585 178.529 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.7 -7.02 59.67 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.464 -178.501 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -145.79 24.02 1.37 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.577 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.411 HD13 ' CD2' ' A' ' 135' ' ' PHE . 7.1 pt -70.46 -21.5 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.699 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.24 2.97 7.96 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.6 t -99.21 -10.85 21.91 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.361 0.6 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.513 ' O ' HG21 ' A' ' 163' ' ' VAL . 15.6 mt -64.24 124.12 20.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.662 -179.888 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 17.9 ptpt -97.42 166.31 11.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.69 123.6 19.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 179.638 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.62 26.74 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.633 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 71.4 m-20 -82.51 130.94 35.21 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.985 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -78.3 129.3 34.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 0.0 111.675 -179.118 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.3 mt -127.28 127.44 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -109.66 123.83 50.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.146 0.498 . . . . 0.0 110.682 -179.087 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.65 148.74 37.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.222 179.6 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.2 t70 -114.01 -166.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.943 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.1 m-20 -24.37 -75.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.108 0.48 . . . . 0.0 111.848 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -138.15 29.76 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.054 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -129.87 145.73 51.6 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.249 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -110.09 123.0 48.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.823 179.334 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.62 132.71 50.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 111.57 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -96.31 116.75 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.62 178.394 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 44.6 m-85 -117.17 141.59 48.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.55 -179.52 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.76 133.72 54.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.31 0.576 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.33 134.38 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.232 179.446 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.2 p -102.37 -28.57 12.16 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 124.826 1.329 . . . . 0.0 111.048 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.31 144.04 3.91 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.113 -1.041 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 141' ' ' LEU . 12.4 t -103.74 149.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.523 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 t -153.68 164.25 38.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.137 0.494 . . . . 0.0 111.352 -178.683 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -110.96 117.28 32.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.777 179.728 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.37 160.14 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 169' ' ' ASP . 29.5 p -71.99 134.44 83.3 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.67 -11.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.093 1.862 . . . . 0.0 111.794 -179.093 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 167' ' ' THR . 51.5 t0 -83.4 -10.02 58.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.18 -178.841 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -88.39 70.54 9.06 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.573 0.349 . . . . 0.0 110.435 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -75.43 -6.29 49.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.082 0.467 . . . . 0.0 110.97 -179.642 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.56 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.5 mt-10 -52.77 -50.13 64.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.705 ' O ' HG21 ' A' ' 183' ' ' THR . 18.3 m -69.88 6.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.0 -179.704 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.04 28.76 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.909 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.27 131.32 18.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.783 0.801 . . . . 0.0 111.779 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -27.77 121.66 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.962 179.642 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.56 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 53.2 m80 -107.05 -40.23 5.51 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.6 24.59 0.13 Allowed Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.859 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.38 172.9 16.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.974 0.416 . . . . 0.0 111.214 179.582 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -96.21 89.58 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 0.0 110.05 178.476 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -125.3 175.87 7.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.2 tt -129.48 142.4 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.394 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.705 HG21 ' O ' ' A' ' 173' ' ' VAL . 13.0 m -136.34 124.9 23.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.136 -179.95 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -114.02 126.3 54.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.436 0.636 . . . . 0.0 110.463 179.242 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.468 HG22 HG13 ' A' ' 198' ' ' VAL . 28.1 pt -134.61 -169.9 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.738 -179.11 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.422 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 5.1 t . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.309 -179.461 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.422 ' NH2' ' O ' ' A' ' 186' ' ' THR . 60.7 ttt180 . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.864 0.364 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.44 129.47 50.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.037 179.023 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.468 HG13 HG22 ' A' ' 185' ' ' ILE . 42.7 t -130.14 131.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.422 -179.182 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 93.5 t -115.1 127.1 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.358 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.38 135.21 54.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.282 0.563 . . . . 0.0 110.373 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.94 159.1 25.42 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.765 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -112.12 150.66 30.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.676 -0.762 . . . . 0.0 111.456 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.408 HD13 ' CZ ' ' A' ' 158' ' ' TYR . 11.9 tp -73.74 129.78 38.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.251 0.548 . . . . 0.0 110.62 179.721 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.97 -22.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.086 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.32 177.84 44.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.202 -179.157 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.3 m -151.65 151.17 31.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -148.96 177.83 9.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.672 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.41 146.99 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.312 0.577 . . . . 0.0 110.735 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.93 79.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.899 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 tptp . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.694 178.63 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.483 0.859 0 CA-C-O 121.052 0.355 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.1 m-20 -79.03 172.93 13.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.543 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.4 mp -60.01 -24.84 64.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.66 -178.414 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.34 97.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.499 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.0 mt-10 -74.11 -30.66 62.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.083 179.665 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.868 HG22 HD22 ' A' ' 104' ' ' LEU . 59.9 t -75.47 -47.64 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.831 -178.641 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.83 88.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.064 179.379 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -75.73 -31.08 59.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.476 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.98 132.97 53.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.949 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -140.2 152.52 46.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 -179.283 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.755 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.3 pt? -138.01 171.91 13.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.231 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -97.93 114.8 27.0 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.359 179.001 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 76' ' ' LYS . 1.1 mptm? -46.62 -16.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 110.258 -179.992 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 75' ' ' ASP . 54.6 mtmt -66.99 -10.06 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -92.78 6.62 46.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.247 -178.922 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.04 125.2 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.657 179.544 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.37 -10.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.385 -178.136 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.07 -173.07 44.03 Favored Glycine 0 C--N 1.316 -0.577 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.705 HH22 ' NZ ' ' A' ' 209' ' ' LYS . 38.1 mtm-85 -144.82 156.9 44.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 111.567 -179.046 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.8 tt -128.56 130.69 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 122.034 0.921 . . . . 0.0 109.225 179.751 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.2 t -132.42 133.8 44.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.543 -178.867 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.54 HG21 HD21 ' A' ' 141' ' ' LEU . 23.9 mt -134.8 126.45 17.91 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.872 -178.543 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -82.46 -35.82 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.48 2.12 . . . . 0.0 112.421 -179.16 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.461 ' CB ' HD23 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -50.52 -39.62 49.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -177.129 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.9 -1.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.237 0.215 . . . . 0.0 111.132 -178.842 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 t 61.51 49.73 4.99 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.659 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.81 131.09 55.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.792 -178.544 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 92' ' ' LEU . 44.8 tt0 -137.74 120.26 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.802 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.2 tp -153.01 112.66 2.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 113.334 -177.413 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -40.71 160.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.849 1.699 . . . . 0.0 110.205 175.83 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.81 122.75 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.065 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -105.68 120.88 42.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.255 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.7 -46.94 80.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.004 0.431 . . . . 0.0 111.104 -179.745 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.6 p -65.94 100.21 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.376 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p -81.09 94.64 6.65 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.218 0.532 . . . . 0.0 109.871 179.957 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.3 p -136.66 160.44 38.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.312 -179.272 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -55.32 -42.71 74.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.047 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.88 -46.27 72.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.294 -179.453 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 102' ' ' ASN . 10.5 m120 -65.76 -38.39 88.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.2 -179.427 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.2 mt -64.88 -27.88 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.631 -179.042 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.868 HD22 HG22 ' A' ' 69' ' ' VAL . 50.9 mt -72.98 -17.18 61.49 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.606 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -105.33 -10.51 16.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.755 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.87 -165.49 34.54 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.568 -179.23 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.61 124.21 33.84 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.22 144.14 32.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.167 -179.356 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.5 p -74.24 152.25 39.76 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.84 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.89 -43.35 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.767 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -91.11 -173.17 3.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.823 0.344 . . . . 0.0 111.25 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -111.32 -58.81 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.14 -177.831 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -91.33 43.61 1.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.461 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -98.5 154.34 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 179.621 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.42 132.95 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.1 mtt -61.48 130.35 45.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.841 178.635 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.33 82.81 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -141.23 120.22 12.79 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.012 -178.76 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.29 -170.72 52.01 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.858 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -83.12 107.93 16.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.269 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -84.39 101.5 12.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.154 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.61 119.52 30.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.43 0.634 . . . . 0.0 111.643 -179.215 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 mt -115.94 130.0 56.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.242 178.411 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.93 138.28 50.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.643 0.735 . . . . 0.0 110.984 -178.566 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.09 -179.8 18.69 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.769 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -80.26 146.14 31.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.812 0.339 . . . . 0.0 110.204 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 129' ' ' SER . 41.6 p30 -112.59 27.53 9.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.07 0.462 . . . . 0.0 110.998 -179.183 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.0 mtt -43.42 -15.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.457 -179.339 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 58.42 39.34 25.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.256 179.127 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -135.57 113.83 11.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -52.73 125.92 18.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.669 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -30.28 6.91 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.195 -178.468 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.702 HG12 ' N ' ' A' ' 134' ' ' LEU . 85.7 t -77.98 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.264 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.702 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -72.94 138.85 46.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.516 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 45.26 30.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 178.303 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -83.85 -14.2 51.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.543 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -133.71 18.34 3.89 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.769 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.487 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.9 pt -70.28 -20.89 23.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.869 0.366 . . . . 0.0 111.934 -179.668 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.78 3.42 11.89 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 t -98.76 -13.59 20.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.29 0.567 . . . . 0.0 109.987 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 85' ' ' ILE . 16.4 mt -64.62 124.8 22.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.302 179.814 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 143' ' ' LYS . 65.7 tttt -96.5 172.0 8.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.507 -179.814 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 77.7 tttt -66.62 128.4 36.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.43 22.02 30.41 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.138 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 49.1 m-20 -86.59 130.8 34.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.242 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -77.7 132.58 38.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.257 0.551 . . . . 0.0 111.641 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.6 mt -127.85 125.97 65.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.1 179.458 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -102.8 122.84 45.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.177 0.513 . . . . 0.0 110.621 -178.589 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.42 136.56 52.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.699 -179.391 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.581 ' CB ' HH11 ' A' ' 82' ' ' ARG . 93.8 m-85 -111.37 119.7 39.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.396 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.7 t0 -104.8 -165.42 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.836 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.508 ' C ' ' O ' ' A' ' 151' ' ' ASP . 91.2 m-20 -24.01 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.498 0.499 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.6 30.25 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.696 178.716 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -128.13 146.77 50.6 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.984 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.96 123.49 49.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.854 179.118 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 206' ' ' THR . 64.6 m-85 -107.46 131.38 54.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.382 0.61 . . . . 0.0 111.3 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.3 mt-10 -97.34 118.29 33.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.828 177.909 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -115.96 140.65 49.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.82 -178.659 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.2 129.31 54.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.563 0.697 . . . . 0.0 111.155 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.21 135.81 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.82 -179.58 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.7 OUTLIER -105.61 -25.13 12.39 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.48 1.112 . . . . 0.0 111.084 -179.094 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.63 165.21 22.58 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.413 -179.539 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.8 p -125.88 151.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.671 -0.765 . . . . 0.0 109.669 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.6 p -155.6 164.38 38.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.458 . . . . 0.0 111.228 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.457 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 96.2 mt-10 -112.26 113.93 26.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.491 -179.735 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.99 157.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.457 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 p -65.77 168.63 8.22 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.052 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.27 -7.0 12.0 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.193 1.929 . . . . 0.0 112.105 -179.351 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.9 p-10 -82.95 -12.43 57.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.028 -178.762 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -89.44 69.85 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.784 0.434 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.77 -5.88 43.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.683 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.546 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.9 mt-10 -53.48 -40.04 65.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.351 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.734 ' O ' HG21 ' A' ' 183' ' ' THR . 74.4 t -72.71 1.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.812 -179.679 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.36 28.92 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.925 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.78 129.42 19.19 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.729 0.776 . . . . 0.0 111.854 -177.021 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -29.22 123.07 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.894 179.442 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.546 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.2 m80 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.626 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.24 24.3 0.32 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.058 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -156.72 178.74 10.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.132 0.491 . . . . 0.0 111.377 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -89.68 89.2 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.521 0.677 . . . . 0.0 110.093 178.949 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 202' ' ' ASP . 23.5 tp10 -121.08 163.3 18.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.308 -179.197 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.6 tt -130.68 142.12 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.644 179.487 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.734 HG21 ' O ' ' A' ' 173' ' ' VAL . 15.7 m -136.36 126.17 25.69 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.383 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -112.36 120.32 41.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.562 0.696 . . . . 0.0 110.814 179.77 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 198' ' ' VAL . 42.1 pt -139.83 -176.66 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.81 -178.9 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.342 -179.471 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.439 HH11 HG22 ' A' ' 198' ' ' VAL . 9.2 tmm_? . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.857 0.36 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.457 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.9 m-85 -80.03 135.72 36.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.976 179.571 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.567 HG11 HG11 ' A' ' 173' ' ' VAL . 75.8 t -129.67 130.98 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.087 0.47 . . . . 0.0 110.821 -179.588 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -119.53 130.56 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.748 -179.423 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.548 ' O ' HG22 ' A' ' 161' ' ' THR . . . -120.36 138.89 53.48 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.621 -179.87 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.82 152.0 19.98 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.215 -179.387 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 181' ' ' GLU . 16.2 m-20 -109.49 139.1 44.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.553 -0.823 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 157' ' ' GLU . 48.0 tp -63.69 125.38 24.1 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.027 0.442 . . . . 0.0 110.928 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -107.41 -25.02 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.152 -178.937 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.33 176.32 45.31 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.953 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.447 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.2 m -153.92 153.13 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.432 0.634 . . . . 0.0 111.038 179.842 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -147.23 177.34 9.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.382 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.35 146.61 24.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.043 0.449 . . . . 0.0 110.679 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.705 ' NZ ' HH22 ' A' ' 82' ' ' ARG . 63.8 tttp -72.12 78.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.586 -179.234 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.747 178.424 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.485 1.017 0 N-CA-C 111.027 -0.413 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.79 171.9 11.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -48.92 -31.22 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.654 -179.141 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.52 -38.82 90.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 -179.973 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -73.97 -27.21 60.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.663 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -82.15 -46.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.243 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.54 74.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.767 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 25.9 p-10 -69.57 -28.56 66.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -179.218 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.87 138.3 58.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.986 -179.734 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -140.22 133.57 29.87 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 tp -140.9 135.1 30.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.655 -179.037 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 67.8 t0 -67.52 137.66 55.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.092 179.136 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.512 ' O ' HG22 ' A' ' 79' ' ' VAL . 70.3 mmtt -65.01 -7.89 13.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.159 0.504 . . . . 0.0 110.22 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -79.96 -10.11 59.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.956 -179.763 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -78.34 -3.21 41.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.639 -179.268 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 76' ' ' LYS . 6.2 m -85.15 138.6 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 -179.627 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -122.74 -4.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.329 -179.183 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.11 -174.04 39.26 Favored Glycine 0 C--N 1.318 -0.469 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -147.19 151.91 37.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.524 -179.027 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 83' ' ' ILE . 20.6 tt -124.31 120.67 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -118.86 128.09 54.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.665 -179.629 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.584 HG21 HD21 ' A' ' 141' ' ' LEU . 22.5 mt -134.62 122.12 15.46 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.579 -177.965 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.56 -34.17 0.57 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.404 2.069 . . . . 0.0 112.423 -179.492 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.553 ' OG ' HD23 ' A' ' 141' ' ' LEU . 2.0 t -49.81 -39.32 38.09 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.539 -177.496 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.77 -1.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.458 0.17 . . . . 0.0 111.072 -179.219 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 63.64 49.99 2.86 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.214 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.6 tp -115.71 132.3 56.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.315 -178.661 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.714 ' O ' HD22 ' A' ' 92' ' ' LEU . 82.9 tt0 -139.33 118.0 12.28 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.586 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -148.35 116.72 4.02 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.878 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.528 ' HD2' HD13 ' A' ' 92' ' ' LEU . 2.2 Cg_endo -39.88 161.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.894 1.729 . . . . 0.0 110.307 175.227 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.92 126.98 72.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' CB ' HD22 ' A' ' 102' ' ' ASN . 22.2 mt -102.32 127.63 49.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.982 -179.192 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -71.38 -48.69 48.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.618 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -69.5 107.44 3.37 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.348 -179.225 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -81.93 99.54 9.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.192 0.52 . . . . 0.0 110.115 179.938 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.513 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.9 p -139.74 164.35 30.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 -179.264 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.96 -36.59 84.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -71.74 -47.54 53.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.567 -179.57 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.1 p-10 -65.97 -36.99 84.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.412 -178.766 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.402 ' O ' HD12 ' A' ' 134' ' ' LEU . 18.7 mt -53.16 -24.37 10.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.431 -179.112 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.428 ' O ' HD11 ' A' ' 134' ' ' LEU . 50.0 mt -68.92 -29.37 67.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.319 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.2 t -85.33 -14.31 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.365 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.56 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 162.8 -172.03 38.75 Favored Glycine 0 N--CA 1.465 0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.679 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -71.94 127.94 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.921 -179.806 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -104.78 148.68 26.35 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.51 -179.726 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.45 ' O ' ' OG ' ' A' ' 98' ' ' SER . 44.7 p -75.57 154.23 36.9 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.65 -52.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -91.81 138.5 31.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 -178.93 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -72.84 1.41 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.023 -178.69 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -142.96 36.37 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 0.0 111.047 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.29 159.13 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.03 130.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.532 -179.672 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.7 mtt -73.15 127.86 33.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.935 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.48 67.95 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.715 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -138.73 123.95 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.089 -179.133 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.89 -173.39 44.93 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -83.51 109.72 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.122 179.84 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -83.96 101.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.02 129.14 37.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.336 0.589 . . . . 0.0 112.062 -178.935 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -123.57 132.28 53.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.472 178.544 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.73 138.41 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.324 0.583 . . . . 0.0 110.601 -178.973 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.0 -178.54 17.43 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.439 -179.328 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.414 ' HD2' HD12 ' A' ' 134' ' ' LEU . 58.2 m-70 -89.64 145.55 25.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.836 0.351 . . . . 0.0 110.624 -179.691 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 129' ' ' SER . 60.5 t-20 -110.08 28.35 8.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 110.411 -179.754 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -46.19 -12.26 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.789 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 m 56.67 40.38 29.28 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.997 179.069 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -130.74 108.73 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.194 -179.146 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -51.61 124.81 13.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.03 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.31 -29.35 8.39 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.137 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 134' ' ' LEU . 59.6 t -77.05 179.13 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 117.69 0.745 . . . . 0.0 109.044 179.45 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.754 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -70.32 136.61 49.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.089 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.0 m-30 42.55 32.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.165 0.507 . . . . 0.0 111.009 178.339 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 p -82.07 -10.7 59.12 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.36 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.23 26.86 1.62 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.537 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.92 -20.52 20.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.779 0.323 . . . . 0.0 111.838 179.917 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.84 -1.28 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.815 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t -94.09 -13.17 27.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 109.923 -179.625 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.584 HD21 HG21 ' A' ' 85' ' ' ILE . 20.3 mt -64.37 123.32 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.432 -179.75 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.494 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.3 mttt -96.54 173.13 7.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.734 -179.774 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -70.1 136.36 50.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.661 -179.669 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.82 22.07 56.34 Favored Glycine 0 N--CA 1.463 0.449 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.708 179.663 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.494 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.8 m-20 -88.96 130.16 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.37 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -77.48 134.04 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 158' ' ' TYR . 77.3 mt -128.87 121.55 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.272 179.296 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -102.21 122.03 43.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.099 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.0 tp -118.97 143.83 46.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 -178.993 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.97 133.03 56.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.318 0.58 . . . . 0.0 111.498 -178.946 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.52 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.0 t0 -113.98 -166.42 1.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.282 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 151' ' ' ASP . 92.9 m-20 -22.99 -74.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.064 0.459 . . . . 0.0 111.632 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -138.09 24.45 2.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.64 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -123.37 143.91 49.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.863 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -109.71 121.04 44.32 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.688 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' A' ' 206' ' ' THR . 77.6 m-85 -105.48 131.1 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.521 -178.763 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 204' ' ' VAL . 97.4 mt-10 -94.7 118.04 31.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.399 178.53 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 147' ' ' ILE . 53.0 m-85 -117.88 139.97 50.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 -179.424 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.17 135.58 54.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.089 0.471 . . . . 0.0 110.563 178.725 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.66 133.91 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.096 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -108.92 -24.81 11.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 124.464 1.102 . . . . 0.0 111.184 -179.185 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.13 157.19 11.99 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.495 -179.648 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.43 HG23 HG22 ' A' ' 199' ' ' VAL . 12.1 p -123.39 151.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.548 -179.797 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -161.25 171.76 17.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 111.297 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -115.81 110.92 19.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.757 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.14 145.43 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.019 -178.6 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.6 p -60.18 132.85 90.24 Favored Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.569 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.4 Cg_endo -47.28 -17.88 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.873 1.715 . . . . 0.0 111.826 -179.035 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.1 -17.78 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.193 -178.494 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.434 ' O ' HG22 ' A' ' 173' ' ' VAL . 30.0 ttmt -87.29 72.24 9.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.847 0.459 . . . . 0.0 110.946 179.817 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.569 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 47.1 m95 -73.53 -18.52 61.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.004 -179.176 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.7 mt-10 -50.27 -7.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.062 0.458 . . . . 0.0 111.009 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 171' ' ' TRP . 27.9 m -83.79 -21.84 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.671 -178.565 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.587 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -114.44 -1.27 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.618 0.723 . . . . 0.0 109.955 -178.744 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.511 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.8 mt-10 -83.96 125.11 31.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.065 -178.442 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 41.6 p-10 -30.92 122.32 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.703 178.882 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.0 m80 -112.36 24.25 12.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.735 -179.186 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.42 76.46 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.898 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -149.44 166.46 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 0.0 111.237 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 29.7 p30 -96.08 87.78 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.561 0.696 . . . . 0.0 110.477 179.469 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.458 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 79.8 tt0 -127.24 128.31 45.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.33 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.94 147.3 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.238 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.52 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.2 m -138.15 122.37 18.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.179 -179.907 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.52 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -104.82 128.26 52.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.379 0.609 . . . . 0.0 110.987 -179.756 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.587 HD13 HG11 ' A' ' 174' ' ' VAL . 3.1 pt -139.1 175.54 7.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.811 -178.81 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.507 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.3 p . . . . . 0 N--CA 1.464 0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.819 -179.335 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 186' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 . . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -126.06 132.65 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.505 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.49 137.86 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.159 0.504 . . . . 0.0 110.969 -179.428 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.43 HG22 HG23 ' A' ' 163' ' ' VAL . 73.2 t -120.01 131.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.356 -179.535 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.63 135.86 53.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.61 -179.551 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.02 135.18 8.09 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 121.596 0.553 . . . . 0.0 111.762 -179.476 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -90.88 139.46 30.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.293 -179.235 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 11.7 tp -67.21 127.5 32.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.192 0.52 . . . . 0.0 110.632 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 157' ' ' GLU . 4.6 m -109.01 -21.51 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.514 -178.674 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.96 175.89 46.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.031 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.423 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.6 m -155.02 153.43 30.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 110.811 179.503 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -149.39 177.98 9.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.176 179.04 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.18 142.14 30.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.859 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -58.27 80.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 208' ' ' ALA . 49.6 tttp . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.482 0.812 0 N-CA-C 110.864 -0.476 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.28 167.67 21.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.82 -19.95 65.12 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.403 0.439 . . . . 0.0 111.108 -179.377 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.11 97.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.627 -179.569 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 93.2 mt-10 -72.12 -36.69 69.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.785 179.52 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.9 -45.43 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.873 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.38 86.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.19 -27.09 28.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.895 -179.037 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.13 136.77 58.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.331 179.594 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' NZ ' ' A' ' 101' ' ' LYS . 29.3 t -91.08 156.73 17.69 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 105' ' ' SER . 46.2 tp -120.29 125.51 48.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 -178.823 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -95.21 87.81 4.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 79' ' ' VAL . 1.2 mppt? -48.94 -33.07 10.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.029 -179.486 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -51.6 -14.78 0.36 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.243 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -100.77 14.34 31.96 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.853 -178.74 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 79' ' ' VAL . 5.4 p -89.8 126.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.299 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.8 pt -118.5 -6.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.319 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.04 -165.08 34.33 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.03 157.34 43.58 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.273 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 92' ' ' LEU . 5.9 tt -128.63 132.3 67.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.808 0.814 . . . . 0.0 109.249 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -132.75 133.42 43.44 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.609 -178.167 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 21.5 mt -134.73 126.73 18.14 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.808 -178.465 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.09 -34.71 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.54 2.16 . . . . 0.0 112.5 -179.694 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.3 t -49.27 -41.43 37.83 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.655 -177.487 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.4 p -119.91 -3.59 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 123.245 0.34 . . . . 0.0 111.094 -179.27 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 68.33 50.99 0.7 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.672 -179.585 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -109.27 125.02 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.789 -178.003 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.666 ' N ' HD13 ' A' ' 90' ' ' LEU . 80.1 tt0 -134.88 114.39 12.52 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.408 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.733 HD12 HD11 ' A' ' 90' ' ' LEU . 10.1 mt -148.59 117.39 4.01 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.736 -177.672 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.6 Cg_endo -41.25 151.59 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.971 1.781 . . . . 0.0 110.121 176.41 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.12 121.65 52.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.1 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.9 mt -104.53 128.5 52.49 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -72.55 -39.92 67.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.942 0.401 . . . . 0.0 111.389 -179.457 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.9 m -72.69 102.0 3.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.073 -179.375 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.8 p -82.34 93.34 7.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 109.913 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.0 p -132.01 158.25 42.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.186 -178.909 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.471 ' O ' HD21 ' A' ' 104' ' ' LEU . 10.0 tm-20 -60.62 -24.6 65.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.719 -179.261 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 65.3 tttm -83.87 -44.17 14.57 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.815 0.697 . . . . 0.0 112.158 -178.865 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HA ' HD21 ' A' ' 102' ' ' ASN . 10.6 m120 -67.26 -34.89 78.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.844 -179.706 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 108' ' ' ALA . 20.1 mt -68.31 -11.48 59.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.621 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.471 HD21 ' O ' ' A' ' 100' ' ' GLU . 17.2 mt -74.63 -14.26 60.74 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.991 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.455 ' HB3' HD13 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -125.7 -3.86 7.15 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.417 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.534 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . -175.63 172.95 45.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.385 -179.522 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.93 127.44 32.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.531 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.4 150.02 25.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.048 0.451 . . . . 0.0 110.803 -179.153 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 p -75.35 151.23 38.24 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.933 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 122' ' ' ALA . 1.3 p -87.17 -32.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.468 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 21.2 tptt -90.05 179.99 5.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.964 0.412 . . . . 0.0 110.837 -177.955 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 22.4 pt-20 -105.7 -16.5 14.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.058 -178.447 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -144.11 53.19 1.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -177.186 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -91.61 153.64 19.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.59 131.6 72.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.617 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.6 mtp -70.19 125.34 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.913 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.32 4.95 65.87 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.474 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -143.32 123.72 13.9 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.55 -178.339 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.59 51.84 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -178.838 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -83.29 108.19 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.91 102.68 13.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.477 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.469 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -91.53 126.11 36.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.062 0.458 . . . . 0.0 112.186 -179.4 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.82 130.41 53.96 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.468 178.85 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.39 140.02 46.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -178.035 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.94 -177.92 17.53 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.229 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -81.63 155.83 25.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 129' ' ' SER . 9.3 p30 -123.9 28.05 7.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.029 0.442 . . . . 0.0 111.171 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.2 mtt -44.05 -15.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.107 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.19 38.08 13.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.843 178.889 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.52 120.53 19.8 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.601 -179.123 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.2 124.76 21.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.0 -30.75 6.4 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -177.87 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 134' ' ' LEU . 94.1 t -72.42 176.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.381 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.701 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -74.1 133.07 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.781 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 48.11 39.2 11.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.796 177.774 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 20.8 p -77.55 -68.03 0.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.287 -179.266 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.519 ' N ' ' OG ' ' A' ' 136' ' ' SER . 94.1 m-20 -88.3 41.88 1.03 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.1 pt -69.99 -26.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.293 -179.758 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.24 3.92 9.8 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.9 m -92.98 -15.1 26.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.328 -179.237 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 mt -66.4 121.28 14.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.526 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -95.84 153.14 17.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -53.67 121.91 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 -179.968 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 101.04 16.94 24.22 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.803 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 73.7 m-20 -85.09 135.89 33.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.13 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -82.33 131.4 35.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 0.0 111.796 -178.321 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.77 124.44 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.552 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -104.5 120.21 40.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.299 -178.554 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.92 158.47 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.956 -178.854 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.56 136.13 53.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 111.708 -178.878 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.4 t0 -112.81 -166.49 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.656 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.2 m-20 -34.73 -67.96 0.13 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.491 0.662 . . . . 0.0 111.042 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.03 29.65 2.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.074 179.643 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.82 147.72 52.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.822 0.82 . . . . 0.0 112.8 -175.495 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.74 123.45 50.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.814 178.958 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -104.44 133.43 49.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.582 -178.765 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -97.57 116.29 29.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.59 177.8 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -116.16 141.07 48.62 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 -178.962 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.63 131.64 54.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 178.879 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.417 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 61.3 t -65.67 134.23 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.968 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -30.61 11.21 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.201 1.563 . . . . 0.0 110.916 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.79 157.78 11.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.965 -178.693 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.3 150.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.526 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.9 p -156.51 164.46 38.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.783 -177.704 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.438 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 94.9 mt-10 -114.19 115.63 27.78 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.232 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 158.3 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.622 0.249 . . . . 0.0 111.154 -178.074 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 p -60.49 167.61 3.07 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.301 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.38 -6.97 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.079 1.853 . . . . 0.0 112.192 -179.815 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -85.39 -6.97 59.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.909 -178.088 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -86.49 68.97 10.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.459 ' C ' ' N ' ' A' ' 173' ' ' VAL . 78.4 m95 -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.985 -179.299 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 98.3 mt-10 -47.17 -16.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 O-C-N 123.432 0.457 . . . . 0.0 110.666 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.459 ' N ' ' C ' ' A' ' 171' ' ' TRP . 54.4 t -74.46 -24.93 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.685 -179.055 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.58 -8.61 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.715 0.769 . . . . 0.0 110.041 -177.998 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.9 mt-10 -80.4 157.79 26.18 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.58 -176.716 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.8 p-10 -66.22 128.59 36.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.339 179.834 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 34.4 m80 -108.07 -44.47 4.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.718 -179.561 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.22 24.54 0.1 OUTLIER Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 178.926 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -153.39 172.5 16.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.955 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 6.7 p30 -95.05 86.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 110.211 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -128.22 125.55 39.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.735 -179.077 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.2 tt -80.82 148.43 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.464 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.7 m -136.8 118.63 15.14 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.385 -178.231 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 184' ' ' LEU . 10.2 mp -100.32 127.26 46.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 111.185 -179.64 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 pt -139.95 -171.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -178.6 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.529 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.473 -178.77 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.438 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 3.8 m-85 -104.51 132.66 50.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.61 139.37 45.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.183 0.515 . . . . 0.0 110.997 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 80.9 t -125.2 135.81 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 -179.256 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.74 134.95 54.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.89 134.55 8.26 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -96.53 137.57 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.934 -179.082 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.41 HD23 ' OD2' ' A' ' 180' ' ' ASP . 40.3 tp -64.7 127.2 30.52 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.902 179.92 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.26 -23.81 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.684 -179.41 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.409 ' O ' HD11 ' A' ' 203' ' ' LEU . . . 177.01 178.26 46.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.511 -179.519 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 152.41 30.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.955 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -147.94 178.16 8.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.868 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.45 144.71 25.33 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.467 -179.438 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -73.02 79.75 1.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 -179.049 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.388 178.563 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 N-CA-C 111.027 -0.413 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -76.76 170.83 15.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.883 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.39 -15.35 63.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.826 0.346 . . . . 0.0 111.309 -179.199 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.566 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -64.03 -41.27 97.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.146 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.7 mm-40 -76.35 -19.65 58.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.518 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.01 -55.42 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.273 -178.613 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.77 94.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.566 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 51.7 m-20 -68.78 -32.74 72.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.605 -179.258 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.8 129.74 41.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.519 179.579 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -92.91 159.82 15.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.152 179.858 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.648 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -139.4 120.68 14.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.924 0.392 . . . . 0.0 111.105 -178.903 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.648 ' N ' HD13 ' A' ' 74' ' ' LEU . 97.5 m-20 -86.56 106.5 17.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.166 178.846 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -46.64 -16.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.289 0.566 . . . . 0.0 110.69 -179.781 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.481 ' N ' ' C ' ' A' ' 75' ' ' ASP . 63.7 mttp -65.4 -12.02 48.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -97.84 8.73 44.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.463 -178.872 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.8 t -91.27 125.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.763 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.2 pt -122.38 -3.55 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.328 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.33 -162.03 34.61 Favored Glycine 0 C--N 1.321 -0.288 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.627 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.576 HH12 ' HZ1' ' A' ' 209' ' ' LYS . 10.8 ptp85 -157.53 164.76 37.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.943 -179.724 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 92' ' ' LEU . 8.6 tt -133.08 144.51 36.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.223 179.738 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 t -134.18 135.2 42.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.82 -178.828 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 mt -129.47 76.33 78.84 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.571 -177.404 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.26 -42.05 3.48 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.996 2.464 . . . . 0.0 112.565 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -55.18 -42.68 73.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.719 -177.436 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 88' ' ' VAL . 67.8 t -107.97 5.26 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.753 0.311 . . . . 0.0 110.799 -179.075 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 t 56.1 46.23 22.0 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.139 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -109.96 124.56 51.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.874 -178.273 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.636 ' O ' HD12 ' A' ' 92' ' ' LEU . 83.1 tt0 -128.04 113.09 15.36 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.934 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -145.09 111.01 4.72 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.7 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.7 Cg_endo -41.71 157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.888 1.725 . . . . 0.0 109.767 175.697 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.09 117.0 51.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.996 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.1 mt -100.47 120.83 40.58 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.843 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -66.65 -48.26 69.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 111.171 -179.709 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.9 p -60.13 100.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 179.874 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.449 ' O ' ' OG ' ' A' ' 98' ' ' SER . 18.6 p -82.73 97.17 8.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.349 0.595 . . . . 0.0 110.32 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 p -140.01 158.22 44.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.094 -179.275 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.2 -33.26 70.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.469 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.03 -44.47 47.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.105 -179.495 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.429 ' HA ' HD21 ' A' ' 102' ' ' ASN . 9.5 m120 -65.08 -38.6 91.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.711 -178.903 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.6 mt -57.18 -22.32 39.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.492 -179.385 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.34 -32.88 72.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.655 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.516 ' OG ' HD23 ' A' ' 74' ' ' LEU . 10.4 m -91.33 -9.65 44.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.924 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.86 -176.87 45.6 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.401 -179.401 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.38 124.4 27.47 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.056 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.75 150.48 25.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.061 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.7 p -68.65 148.37 50.54 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.839 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.512 HG21 HD11 ' A' ' 185' ' ' ILE . 84.5 t -88.72 -33.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -177.097 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 170.24 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.388 . . . . 0.0 110.946 -178.851 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.17 -47.12 81.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.193 -178.026 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 113' ' ' ASN . 50.4 p30 -158.0 69.76 0.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.154 -178.336 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 121' ' ' TYR . 4.4 pt20 -76.38 175.06 9.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.246 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -132.47 125.13 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.856 0.36 . . . . 0.0 110.649 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.488 ' SD ' ' OH ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.8 127.44 32.64 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.403 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.85 -5.59 59.85 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -140.37 123.18 16.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.15 -170.24 50.17 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.074 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 27.7 t-20 -83.71 107.74 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.921 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 114' ' ' GLN . 5.8 t80 -84.42 102.67 12.95 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.567 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.45 122.26 33.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.203 0.525 . . . . 0.0 111.827 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -117.67 131.11 56.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.902 178.656 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.83 139.14 46.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.262 0.553 . . . . 0.0 110.768 -178.211 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.47 -178.34 16.5 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.486 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.9 m-70 -93.74 138.59 31.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.574 -179.424 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -98.59 28.78 4.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 110.658 -179.481 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.454 ' HB2' HG11 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -40.67 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.199 -179.335 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 m 59.21 36.87 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.456 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.56 ' HB3' ' HZ3' ' A' ' 130' ' ' LYS . 10.4 mtpm? -131.94 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.471 -178.898 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -48.95 124.09 8.12 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.56 -31.01 7.14 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.314 -177.915 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 134' ' ' LEU . 61.0 t -74.67 179.35 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.761 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -71.51 136.78 47.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.958 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.6 m-30 43.63 35.1 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.816 178.069 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 p -82.92 -14.15 54.7 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.45 ' O ' HG21 ' A' ' 88' ' ' VAL . 65.7 m-20 -141.17 26.48 2.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.409 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.499 HD13 ' CD2' ' A' ' 135' ' ' PHE . 7.2 pt -75.67 -18.08 15.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.479 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.4 18.19 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.644 -179.598 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 t -92.26 -14.05 29.48 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.357 0.598 . . . . 0.0 110.037 -179.319 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.415 ' CD2' ' OD2' ' A' ' 145' ' ' ASP . 23.8 mt -63.77 128.55 36.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.359 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -101.85 174.54 5.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.876 -179.83 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.89 124.29 23.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.6 16.0 47.67 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.603 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.415 ' OD2' ' CD2' ' A' ' 141' ' ' LEU . 10.4 t70 -78.83 136.42 37.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.035 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.8 132.55 35.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.979 0.419 . . . . 0.0 111.626 -178.163 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 93.7 mt -129.01 127.5 66.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.686 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -104.26 120.68 41.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.027 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.63 145.31 45.54 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.975 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -119.34 135.12 54.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -178.089 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.8 t0 -110.66 -164.22 0.9 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.542 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 3.5 p-10 -26.37 -77.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.354 0.409 . . . . 0.0 111.29 179.202 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.542 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 78.6 mm-40 -134.02 30.0 3.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.096 178.949 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.479 ' OD1' ' ND2' ' A' ' 152' ' ' ASN . 33.8 m120 -128.85 148.2 50.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.956 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -109.21 123.32 49.05 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.068 179.819 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.4 ' CZ ' HG21 ' A' ' 206' ' ' THR . 48.6 m-85 -106.3 129.72 54.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.655 -178.847 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -94.75 113.59 25.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.338 178.935 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -113.48 143.36 44.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.454 -178.901 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.01 132.23 54.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.262 0.553 . . . . 0.0 110.707 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.6 135.71 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.52 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.1 p -100.24 -27.27 13.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 124.593 1.183 . . . . 0.0 111.013 -178.497 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.0 156.45 8.15 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.426 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.34 139.6 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.389 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 198' ' ' VAL . 73.9 m -136.82 151.27 48.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.786 0.326 . . . . 0.0 111.091 -178.083 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 54.9 mp0 -111.07 102.52 10.97 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.4 m -134.09 156.59 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -178.212 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.2 p -63.02 168.8 4.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.211 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.41 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -82.31 -4.04 11.64 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.179 1.919 . . . . 0.0 112.119 -179.596 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.02 -19.38 44.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.806 -178.569 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -85.96 74.37 10.15 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.817 0.447 . . . . 0.0 110.307 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.41 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 96.6 m95 -74.68 -6.16 47.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.023 -179.279 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.579 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 9.8 pt-20 -52.47 -43.63 65.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.984 0.421 . . . . 0.0 110.919 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.77 ' O ' HG21 ' A' ' 183' ' ' THR . 16.8 m -71.33 4.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.976 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.81 -14.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.779 0.799 . . . . 0.0 110.215 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.7 mt-10 -87.32 172.6 9.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.018 -178.869 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -74.29 125.72 29.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.579 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 48.3 m80 -110.82 22.49 15.3 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.641 -179.37 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.78 20.98 79.27 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.356 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -151.17 168.08 25.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.137 -179.477 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -94.39 87.57 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.174 0.511 . . . . 0.0 110.236 -179.841 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -123.91 124.94 43.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.626 -178.98 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.4 tt -81.51 146.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.455 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.77 HG21 ' O ' ' A' ' 173' ' ' VAL . 14.5 m -137.28 121.74 18.32 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.395 -179.123 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -105.95 123.45 48.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 111.024 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 110' ' ' VAL . 12.6 pt -139.01 169.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.992 -178.531 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.631 -179.21 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.47 ' NH1' ' CG2' ' A' ' 185' ' ' ILE . 7.9 tmm_? . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.2 133.0 43.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 164' ' ' SER . 3.7 p -138.15 141.26 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.335 0.588 . . . . 0.0 111.332 -179.398 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.7 t -121.16 131.85 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.185 -179.261 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -117.22 136.46 53.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.485 -179.838 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.25 140.69 11.99 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.445 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 53.5 p-10 -97.52 144.95 26.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.566 -0.817 . . . . 0.0 111.473 -178.972 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.12 126.49 29.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.062 0.458 . . . . 0.0 111.166 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.7 -25.35 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.413 -178.755 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.87 177.43 44.89 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.74 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.4 HG21 ' CZ ' ' A' ' 156' ' ' TYR . 17.7 m -152.89 152.67 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.274 0.559 . . . . 0.0 111.108 -179.78 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -149.36 178.79 8.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.345 179.594 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.78 146.03 24.09 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.403 -179.773 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.576 ' HZ1' HH12 ' A' ' 82' ' ' ARG . 88.4 tttt -77.04 79.02 3.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.748 -179.1 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.562 178.057 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.253 0 CA-C-O 121.121 0.384 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -69.18 152.07 45.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.679 179.636 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.1 mm? -56.61 -27.18 57.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.64 -179.099 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.87 91.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.898 0.38 . . . . 0.0 110.411 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mm-40 -74.38 -35.1 63.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.33 -44.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.41 88.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.766 179.661 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.25 -27.55 42.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.24 140.78 55.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.374 -179.505 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -139.45 147.09 40.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.756 -179.463 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.748 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.4 pt? -137.17 173.8 11.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 -179.515 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.12 128.5 45.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 178.489 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.572 ' O ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -67.91 -10.17 51.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.346 179.996 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 79' ' ' VAL . 1.3 mppt? -63.54 -30.62 71.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.172 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.19 13.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.826 -178.964 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.3 p -85.86 123.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.597 179.672 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.99 -5.48 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.86 -178.197 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.24 -160.26 27.04 Favored Glycine 0 C--N 1.318 -0.432 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 9.3 ttm180 -151.38 157.32 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.129 0.49 . . . . 0.0 110.924 -179.812 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.43 ' N ' ' HG3' ' A' ' 82' ' ' ARG . 3.3 tp -125.9 127.21 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.191 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -129.03 130.15 46.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.77 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 44.9 mt -136.68 123.2 13.78 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.817 -178.731 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.8 Cg_endo -82.33 -30.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.462 2.108 . . . . 0.0 112.473 -179.867 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -48.39 -39.99 24.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.052 -176.475 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.582 HG11 HD12 ' A' ' 90' ' ' LEU . 3.3 p -120.53 -4.17 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.578 0.228 . . . . 0.0 111.12 -179.13 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.09 50.72 0.11 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.021 0.439 . . . . 0.0 109.967 179.895 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.582 HD12 HG11 ' A' ' 88' ' ' VAL . 18.6 mt -111.37 127.42 55.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 179.762 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.49 113.14 11.51 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.947 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 mt -146.09 166.48 16.92 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.395 -177.719 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.82 150.61 8.54 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 109.516 178.105 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.73 108.22 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.84 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HB2' HD21 ' A' ' 102' ' ' ASN . 12.9 mt -101.93 121.61 42.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.03 -48.95 72.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.985 0.421 . . . . 0.0 111.176 -179.653 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.41 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 48.4 m -56.68 98.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.777 -179.411 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 85.3 p -80.6 100.56 8.69 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.393 0.616 . . . . 0.0 110.626 179.675 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -135.42 157.73 46.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.352 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -54.97 -39.17 68.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.923 179.524 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.93 -39.08 72.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.091 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 108' ' ' ALA . 6.8 t-20 -62.77 -39.55 94.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 -179.406 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.97 -27.45 63.47 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.288 -178.688 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.68 -14.54 62.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.37 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.494 ' OG ' HD13 ' A' ' 74' ' ' LEU . 5.9 m -104.98 -13.96 15.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.768 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.83 -149.98 14.91 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.013 -178.326 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.34 125.2 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -105.84 144.34 32.71 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.719 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 p -76.84 153.32 34.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 185' ' ' ILE . 74.6 t -85.81 -45.03 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.171 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -88.47 -170.97 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.222 -178.402 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -124.67 -5.28 7.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.826 -177.739 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.42 41.8 1.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.078 0.466 . . . . 0.0 110.675 -177.931 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -95.29 161.94 13.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.388 179.679 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.66 132.83 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.543 ' SD ' HD12 ' A' ' 149' ' ' LEU . 67.8 mtt -69.62 129.81 40.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.51 179.13 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.97 75.96 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -146.46 128.17 15.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.579 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.6 -169.7 47.23 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -85.52 103.48 14.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.506 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.94 101.3 11.6 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.8 124.31 35.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 0.0 112.042 -178.846 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -120.13 130.14 54.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.693 178.224 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.47 139.97 43.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 110.256 -178.996 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.24 -178.22 18.88 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.939 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -83.62 152.26 24.9 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.112 0.482 . . . . 0.0 110.767 -179.85 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 129' ' ' SER . 48.6 p30 -122.09 28.23 7.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.29 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.6 mtt -44.78 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.944 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 61.24 36.33 17.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.535 ' H ' ' HG ' ' A' ' 136' ' ' SER . 68.1 mttm -135.64 114.75 12.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.944 -179.213 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -56.21 126.65 27.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.687 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -30.64 6.67 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 -178.136 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.737 HG12 ' N ' ' A' ' 134' ' ' LEU . 97.0 t -72.36 175.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.737 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.45 128.77 36.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.392 -178.409 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 48.45 42.61 18.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 178.202 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.535 ' HG ' ' H ' ' A' ' 130' ' ' LYS . 2.4 t -75.23 -67.26 0.67 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.36 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -90.27 43.98 1.18 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.183 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.8 pt -68.1 -26.74 35.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.675 179.525 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.16 7.47 4.16 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.246 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -96.25 -14.47 22.64 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.46 122.24 15.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.136 -179.357 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 26.6 mtpp -96.3 157.14 16.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.758 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.43 122.13 13.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.622 -179.627 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.63 18.45 23.18 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.1 m-20 -83.79 134.98 34.7 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.923 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -81.78 126.09 31.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.178 -177.335 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.89 126.78 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.295 178.668 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -101.94 118.1 36.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.271 -179.101 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.58 HD21 ' CD1' ' A' ' 182' ' ' ILE . 0.7 OUTLIER -106.24 135.92 46.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.973 179.907 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.509 ' O ' ' SD ' ' A' ' 116' ' ' MET . 56.3 m-85 -114.69 127.79 55.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.325 0.583 . . . . 0.0 111.324 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 152' ' ' ASN . 42.8 t0 -113.82 -166.6 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.348 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.1 m-20 -23.04 -75.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.062 0.458 . . . . 0.0 111.994 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -139.22 30.64 2.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.276 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -127.7 144.13 51.1 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.046 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -110.94 121.83 46.35 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.898 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -103.65 132.71 49.66 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.323 -178.874 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.79 115.08 27.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.166 178.785 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -114.77 146.67 40.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.574 -179.844 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.1 132.43 53.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.341 0.591 . . . . 0.0 111.022 178.073 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.425 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 62.0 t -67.11 133.41 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.631 179.56 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.82 -29.01 11.72 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 124.739 1.274 . . . . 0.0 110.395 -178.856 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.83 164.07 23.9 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.031 -179.355 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.92 147.45 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.911 -0.644 . . . . 0.0 109.765 -179.661 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.0 p -151.69 162.15 41.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.195 0.521 . . . . 0.0 111.289 -179.115 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -117.91 111.31 18.83 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.696 179.89 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.8 160.14 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.096 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -62.18 166.98 5.66 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.532 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.1 Cg_endo -82.21 -5.87 12.0 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.256 1.97 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -17.03 52.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.725 -178.78 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.568 ' O ' HG22 ' A' ' 173' ' ' VAL . 1.8 mptm? -87.37 73.57 9.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.508 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 70.1 m95 -73.52 -21.51 60.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.362 -179.847 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.545 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.3 mt-10 -51.06 -8.82 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.001 0.429 . . . . 0.0 110.825 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 170' ' ' LYS . 19.5 m -83.29 -21.86 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.747 -178.792 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.634 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -112.89 -0.71 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.591 0.71 . . . . 0.0 109.677 -179.051 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.533 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 97.0 mt-10 -83.55 139.65 32.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.19 -178.253 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -44.51 123.57 3.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.063 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.545 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 45.7 m80 -114.25 22.84 13.4 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.056 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.06 19.73 79.72 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.237 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -147.59 164.27 33.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.065 0.459 . . . . 0.0 111.28 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.15 89.08 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.852 179.512 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.487 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 79.3 tt0 -129.23 125.53 37.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.595 -179.118 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.58 ' CD1' HD21 ' A' ' 149' ' ' LEU . 17.7 tt -79.46 148.09 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.269 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.518 ' C ' HD12 ' A' ' 184' ' ' LEU . 10.2 m -135.95 125.44 25.1 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -106.94 127.42 53.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.499 179.866 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 110' ' ' VAL . 11.9 pt -136.79 176.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.622 -179.233 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.584 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.9 p . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.163 -179.178 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.584 ' NH1' ' O ' ' A' ' 186' ' ' THR . 8.6 ptp180 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.135 0.493 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.58 141.68 47.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.06 178.7 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.2 t -132.09 133.99 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.151 0.5 . . . . 0.0 110.99 -179.504 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.24 133.28 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.337 -179.415 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.487 ' HB1' ' OE2' ' A' ' 181' ' ' GLU . . . -116.51 135.89 53.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.707 -179.751 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.07 135.64 8.75 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -179.757 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -92.13 138.65 31.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.555 -179.24 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.26 127.11 30.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.112 0.482 . . . . 0.0 110.543 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 -23.01 4.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.341 -179.036 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 173.43 178.11 43.16 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.289 -178.513 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.6 m -151.95 152.29 32.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 111.285 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -148.74 177.53 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.549 179.655 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.06 146.6 24.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.344 0.592 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -76.02 79.8 2.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.693 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.317 -0.824 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.718 178.443 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.485 1.029 0 CA-C-O 120.923 0.301 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 55.4 t0 -72.6 158.65 35.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.458 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 3.9 mm? -64.03 -20.53 65.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.766 -179.359 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.0 92.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.289 -179.727 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 72.3 mm-40 -73.8 -32.64 63.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.68 -45.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.854 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.91 90.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.026 179.839 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -79.03 -23.53 44.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.253 -179.392 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.82 105.1 0.51 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.868 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.6 m -96.58 80.74 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.463 ' CD1' HE22 ' A' ' 78' ' ' GLN . 44.7 tp -74.88 148.02 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.182 179.334 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 77' ' ' LYS . 42.4 t0 -81.31 91.13 6.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.48 ' O ' HG13 ' A' ' 79' ' ' VAL . 63.7 mttp -52.74 -9.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.132 0.491 . . . . 0.0 110.364 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 75' ' ' ASP . 17.5 tptm -79.65 -10.89 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.538 -179.803 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.582 ' OE1' ' ND2' ' A' ' 102' ' ' ASN . 4.2 pt20 -93.6 19.36 8.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.563 -178.785 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 76' ' ' LYS . 33.6 m -83.0 146.26 7.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.855 -179.433 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.68 -6.04 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.83 -165.54 32.94 Favored Glycine 0 C--N 1.317 -0.473 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.461 ' NH1' ' C ' ' A' ' 92' ' ' LEU . 8.5 ttm-85 -151.52 154.47 36.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.303 0.573 . . . . 0.0 111.326 -179.258 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 83' ' ' ILE . 18.0 tt -127.88 130.01 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.72 179.444 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -127.76 129.68 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.022 -179.155 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 37.3 mt -134.78 118.36 13.32 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -177.946 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 3.3 Cg_exo -81.25 -33.67 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.736 2.29 . . . . 0.0 112.388 179.869 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.4 t -49.54 -39.41 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.696 -177.052 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 90' ' ' LEU . 3.9 m -119.14 -6.23 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -178.777 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 75.28 49.9 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.305 0.574 . . . . 0.0 110.209 179.904 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.503 HD12 HG21 ' A' ' 88' ' ' VAL . 2.5 mt -111.0 125.45 53.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.251 -179.365 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -133.25 112.41 11.66 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.461 ' C ' ' NH1' ' A' ' 82' ' ' ARG . 76.6 mt -145.58 162.5 36.21 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.908 -177.03 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -88.06 152.05 6.99 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 123.118 2.545 . . . . 0.0 109.119 177.41 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.1 t -98.15 115.63 38.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.757 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 mt -101.66 122.96 44.86 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.066 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -67.23 -45.06 77.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.428 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 3.4 m -69.62 99.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.453 -179.51 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.3 p -81.69 96.27 7.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.516 0.674 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.9 p -136.99 157.3 47.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.924 -179.584 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.15 -31.97 65.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.648 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -78.27 -45.28 23.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.617 0.722 . . . . 0.0 111.295 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.582 ' ND2' ' OE1' ' A' ' 78' ' ' GLN . 2.4 m120 -66.25 -35.17 79.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.494 -178.171 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.83 -15.4 58.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.933 -178.797 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 mt -71.37 -27.22 63.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.894 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.6 m -94.31 -8.78 37.99 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.753 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.2 -158.16 28.48 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.814 -178.591 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.09 126.58 37.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.875 -0.662 . . . . 0.0 109.941 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.02 147.46 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 -179.779 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 44.5 p -71.02 147.7 48.34 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.35 -43.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.979 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -89.82 -171.32 3.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.028 -178.721 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -121.58 -9.27 8.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.982 0.42 . . . . 0.0 111.535 -178.212 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -139.36 39.86 2.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.017 0.437 . . . . 0.0 111.393 -177.66 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -91.33 157.45 17.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.098 179.713 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.4 t -132.61 131.66 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.639 179.943 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.6 mtt -66.93 129.3 39.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.006 178.75 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.27 3.37 75.69 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -141.77 120.98 13.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.71 -165.75 54.75 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -178.867 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -90.23 109.98 21.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.614 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.69 102.26 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.922 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.22 129.83 37.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.474 0.654 . . . . 0.0 111.966 -179.177 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -127.04 132.35 50.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.526 178.637 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.24 141.66 45.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.556 0.693 . . . . 0.0 110.76 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.1 -179.04 20.31 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.588 -179.531 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 31.0 m-70 -81.84 145.08 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 129' ' ' SER . 22.9 t-20 -116.87 28.1 8.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmm -46.49 -12.15 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.911 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.59 40.98 16.07 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.078 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 88.4 tttt -134.42 115.15 13.67 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.768 -179.087 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -57.46 126.39 27.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.668 0.747 . . . . 0.0 110.156 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.49 -22.61 17.05 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.734 HG12 ' H ' ' A' ' 134' ' ' LEU . 55.6 t -84.3 177.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.073 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.734 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -72.19 133.19 44.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.607 0.241 . . . . 0.0 110.4 -178.247 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 46.16 33.0 1.59 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.297 0.57 . . . . 0.0 110.551 178.343 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 0.9 OUTLIER -81.86 -4.37 56.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.817 -178.571 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.455 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 22.8 t70 -147.09 39.76 1.02 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.605 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.69 -27.29 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.927 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.38 3.53 10.87 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.719 -179.604 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.455 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.2 m -95.35 -12.98 25.15 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.406 0.622 . . . . 0.0 109.694 -179.55 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.44 ' O ' HG21 ' A' ' 163' ' ' VAL . 13.8 mt -65.87 125.15 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.983 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -96.81 158.43 15.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.607 -179.837 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -61.46 128.03 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.874 -179.615 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 90.67 20.22 41.33 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.784 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 37.5 m-20 -85.82 132.33 34.13 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.406 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -79.79 135.69 36.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.812 -178.548 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 158' ' ' TYR . 84.5 mt -127.66 122.3 58.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.542 179.302 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.443 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.0 m-85 -100.18 117.66 34.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.975 -179.071 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.48 142.37 46.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.967 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.421 ' O ' ' SD ' ' A' ' 116' ' ' MET . 34.5 m-85 -116.06 132.95 56.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 111.471 -178.842 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.0 t0 -113.94 -166.38 1.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.6 m-20 -22.54 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.539 0.524 . . . . 0.0 111.676 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -137.81 28.28 2.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.289 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -126.93 143.77 51.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.899 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -109.18 121.62 45.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.844 179.067 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -104.65 132.01 51.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.418 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.443 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 70.2 mm-40 -94.62 112.65 24.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.992 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.5 m-85 -114.39 137.38 51.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.436 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.89 54.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 111.382 178.785 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 144' ' ' GLY . 44.3 t -67.38 132.64 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.959 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -112.26 -29.39 7.57 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 124.619 1.199 . . . . 0.0 111.13 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.19 145.18 8.45 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.498 -179.765 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 141' ' ' LEU . 97.8 t -121.86 138.24 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.784 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.5 m -159.34 171.88 18.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.693 -178.341 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.04 133.27 54.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.718 179.964 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 m -138.78 159.66 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.3 -178.691 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 169' ' ' ASP . 3.6 p -69.11 133.59 89.72 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.146 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.07 -13.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.046 1.831 . . . . 0.0 111.794 -178.95 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.1 m-20 -78.84 -22.36 46.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.903 -177.963 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.699 ' O ' HG22 ' A' ' 173' ' ' VAL . 14.4 mptt -85.67 75.91 10.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.847 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.545 ' C ' ' H ' ' A' ' 173' ' ' VAL . 83.3 m95 -74.05 -20.03 60.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.992 -179.18 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 57.1 mp0 -52.24 -6.79 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.821 179.575 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.712 ' O ' HG21 ' A' ' 183' ' ' THR . 24.4 m -89.81 -3.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.101 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 173' ' ' VAL . 1.0 OUTLIER -128.9 -7.24 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.745 0.783 . . . . 0.0 109.012 179.794 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.18 157.03 25.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.239 -176.749 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.89 127.52 32.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.092 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -102.11 -41.44 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.075 -179.78 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 140.84 28.03 0.19 Allowed Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.498 ' NZ ' ' CD ' ' A' ' 181' ' ' GLU . 19.7 pttp -156.37 178.49 10.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 4.6 m-20 -92.19 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.72 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.498 ' CD ' ' NZ ' ' A' ' 179' ' ' LYS . 22.4 tt0 -123.18 169.39 11.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.148 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.93 143.01 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.873 179.354 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.712 HG21 ' O ' ' A' ' 173' ' ' VAL . 16.0 m -136.02 123.56 22.18 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 111.489 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -111.11 123.72 50.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.405 0.621 . . . . 0.0 110.556 179.334 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 198' ' ' VAL . 8.5 pt -139.77 -171.45 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.932 -178.62 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.467 0.418 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.717 -179.159 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.936 0.398 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -108.27 137.65 45.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.209 179.341 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.475 HG22 HG22 ' A' ' 185' ' ' ILE . 78.9 t -129.49 131.27 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.268 0.556 . . . . 0.0 110.824 -179.155 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.2 130.38 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.328 -179.755 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.47 135.86 54.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.574 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.43 147.97 18.45 Favored Glycine 0 N--CA 1.465 0.619 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.772 -179.791 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -103.32 140.22 37.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.933 -0.633 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.1 tp -66.11 125.76 26.5 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.204 0.526 . . . . 0.0 110.802 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.11 -24.21 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.042 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.88 176.63 46.04 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 119.93 -1.128 . . . . 0.0 112.102 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.7 m -153.51 151.48 29.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 110.94 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -150.09 178.39 9.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.677 179.439 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.34 144.85 24.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.157 0.503 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.45 79.55 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.763 -179.529 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.601 178.479 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.484 0.921 0 N-CA-C 111.137 -0.37 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.09 146.58 52.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.823 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.81 -28.84 66.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.77 91.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.459 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.9 mm-40 -73.09 -35.39 66.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.805 179.469 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.87 -43.7 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.743 -179.181 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.35 83.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -87.89 -15.5 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.563 -178.801 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.39 133.05 53.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.521 179.658 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.1 p -90.9 159.4 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.054 179.598 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 105' ' ' SER . 51.0 tp -125.89 135.55 52.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.956 0.407 . . . . 0.0 111.112 -179.16 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.482 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.3 m-20 -89.91 89.31 7.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.763 179.756 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 4.6 mptp? -46.8 -16.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.18 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.482 ' N ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -65.64 -35.91 82.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.285 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 18.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.563 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.2 123.01 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.888 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.94 -7.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.016 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.15 38.54 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.514 ' O ' HD23 ' A' ' 149' ' ' LEU . 18.6 mtp85 -147.31 153.51 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.068 -178.64 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.8 tt -126.97 131.05 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.206 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.6 m -130.9 132.36 45.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.211 -178.765 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.15 129.85 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 -178.461 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.48 -35.05 0.26 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.397 2.064 . . . . 0.0 112.102 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -47.21 -38.73 12.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.491 -176.859 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -120.58 -0.54 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.845 -178.936 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 53.74 3.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.168 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.1 tp -116.06 133.84 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.34 116.37 13.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.522 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 83' ' ' ILE . 60.2 mt -144.53 110.87 4.94 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.079 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.1 Cg_endo -41.29 141.01 1.31 Allowed 'Trans proline' 0 N--CA 1.486 1.041 0 C-N-CA 121.79 1.66 . . . . 0.0 110.326 176.206 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.4 t -89.65 125.5 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.036 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.7 mt -108.95 122.45 47.25 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.28 -48.58 72.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.974 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 m -71.59 103.78 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.042 -179.613 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 109' ' ' THR . 3.2 m -84.32 101.48 11.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.273 0.558 . . . . 0.0 110.078 179.537 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.4 p -132.75 156.19 47.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.099 -179.75 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.449 ' O ' HD21 ' A' ' 104' ' ' LEU . 9.6 tm-20 -55.83 -26.94 49.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.545 -179.505 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.32 -43.73 14.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.374 0.607 . . . . 0.0 111.947 -179.507 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.412 ' HA ' HD21 ' A' ' 102' ' ' ASN . 10.1 m120 -66.44 -34.31 77.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.621 -179.138 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.4 mt -68.94 -12.67 61.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.03 -178.593 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 100' ' ' GLU . 14.6 mt -76.14 -13.14 60.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.121 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB3' HD22 ' A' ' 74' ' ' LEU . 57.8 m -121.35 -7.52 9.26 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.52 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.6 47.58 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.832 -179.742 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.17 129.07 36.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.955 179.375 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.456 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -106.63 146.65 30.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.986 -179.64 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.522 ' O ' ' OG ' ' A' ' 98' ' ' SER . 32.9 p -75.41 149.92 38.47 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.791 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.46 -40.52 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.845 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -87.82 145.07 26.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 111.044 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.16 -16.9 64.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.077 -179.141 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -144.86 52.02 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.295 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.415 ' CD ' ' H ' ' A' ' 122' ' ' ALA . 1.1 tt0 -80.73 155.55 26.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.656 179.557 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -133.08 127.7 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.0 mtt -71.49 126.65 30.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.256 179.482 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.91 70.94 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.521 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -139.2 119.71 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.259 -179.161 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -164.35 54.57 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.25 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -90.02 109.82 20.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.732 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -84.96 101.1 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.415 ' H ' ' CD ' ' A' ' 114' ' ' GLN . . . -90.39 126.29 35.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 112.135 -178.919 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.4 130.92 53.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.454 178.146 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.2 139.49 45.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.46 0.647 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.89 -178.78 19.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 134' ' ' LEU . 36.0 m-70 -85.16 140.65 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 110.66 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 28.6 t-20 -108.22 28.2 8.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.388 0.614 . . . . 0.0 110.265 -179.91 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -44.28 -13.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.873 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 55.45 39.56 31.14 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.942 179.264 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.477 ' O ' ' OG ' ' A' ' 136' ' ' SER . 79.8 tttt -134.7 123.05 23.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.607 -178.782 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -64.08 123.64 19.55 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.132 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.59 25.05 5.62 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.546 -177.905 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 134' ' ' LEU . 3.0 t -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.952 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -70.26 131.72 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.43 -177.838 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 47.14 32.74 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.077 0.465 . . . . 0.0 110.893 178.251 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.45 -10.31 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.022 -178.948 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.5 m-20 -144.5 38.08 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.26 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -68.12 -35.24 70.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.943 0.401 . . . . 0.0 111.657 179.75 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.58 3.3 1.9 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.88 -179.381 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 138' ' ' ILE . 19.0 m -95.61 -12.61 25.35 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.127 0.489 . . . . 0.0 109.861 -179.447 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -67.42 125.28 25.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.98 159.68 14.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.708 -179.806 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 144' ' ' GLY . 10.1 tmtt? -60.22 128.0 34.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -179.829 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 143' ' ' LYS . . . 91.14 22.32 32.88 Favored Glycine 0 N--CA 1.463 0.444 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.935 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.86 132.4 34.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.221 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -79.93 130.19 35.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.275 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 89.5 mt -125.3 124.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.31 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -106.7 122.45 46.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.484 -178.651 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.607 HD22 ' SD ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -115.91 148.49 39.96 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.369 -179.584 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.92 131.76 53.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.364 0.602 . . . . 0.0 111.438 -179.834 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 152' ' ' ASN . 26.2 t70 -114.64 -165.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.011 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 151' ' ' ASP . 2.3 t-20 -23.78 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.178 0.514 . . . . 0.0 111.733 179.463 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -139.61 25.6 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.911 178.853 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -124.05 141.62 51.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.689 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.537 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 75.5 tt0 -106.49 121.06 43.51 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.059 179.321 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.408 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.5 m-85 -104.29 128.32 52.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -95.01 117.55 30.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.571 178.652 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.52 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 21.5 m-85 -117.78 141.09 48.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.186 -179.346 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.03 136.49 54.86 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.172 0.51 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.13 132.25 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.756 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.5 t -111.8 -26.78 8.78 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 124.799 1.312 . . . . 0.0 111.37 -179.067 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.27 149.66 9.61 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.418 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.575 HG13 HG22 ' A' ' 199' ' ' VAL . 21.8 t -125.74 148.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.904 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.6 p -160.3 168.76 24.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.157 0.503 . . . . 0.0 111.365 -177.987 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.453 ' OE1' ' CE1' ' A' ' 197' ' ' TYR . 1.6 pm0 -117.95 124.28 47.85 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.456 179.722 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.71 160.32 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.249 -178.412 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 169' ' ' ASP . 15.0 p -71.62 138.23 83.25 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.455 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.94 -14.9 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.012 1.808 . . . . 0.0 111.993 -178.7 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 65.4 t0 -78.96 -11.5 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.552 -177.86 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.414 ' O ' HG23 ' A' ' 173' ' ' VAL . 31.1 mmtt -84.77 64.53 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.182 0.515 . . . . 0.0 110.357 179.476 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.464 ' C ' ' N ' ' A' ' 173' ' ' VAL . 86.3 m95 -70.1 -30.87 68.2 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.218 -179.716 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 41.4 mp0 -47.3 -15.97 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.212 0.53 . . . . 0.0 110.672 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 198' ' ' VAL . 87.4 t -66.13 -43.07 92.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.284 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.477 HG11 HD13 ' A' ' 185' ' ' ILE . 13.4 m -98.94 2.16 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.624 0.725 . . . . 0.0 110.506 -178.221 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.57 120.28 25.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.417 -1.265 . . . . 0.0 112.08 -178.569 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -31.79 122.81 0.28 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.506 178.846 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -105.41 -41.73 5.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.47 27.1 0.14 Allowed Glycine 0 N--CA 1.471 1.013 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -154.09 173.75 15.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.654 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -96.07 86.94 4.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.292 179.016 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -128.07 128.53 45.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.271 -179.286 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 149' ' ' LEU . 20.3 tt -81.43 147.26 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.527 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.479 ' C ' HD12 ' A' ' 184' ' ' LEU . 7.8 m -136.87 118.1 14.52 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 111.025 -179.608 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -103.44 126.18 50.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.381 0.61 . . . . 0.0 110.999 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.477 HD13 HG11 ' A' ' 174' ' ' VAL . 11.8 pt -138.45 -177.13 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.592 -179.06 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.655 HG23 ' HE ' ' A' ' 196' ' ' ARG . 15.2 t . . . . . 0 N--CA 1.465 0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.655 ' HE ' HG23 ' A' ' 186' ' ' THR . 5.6 ptp85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.917 0.389 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.453 ' CE1' ' OE1' ' A' ' 165' ' ' GLU . 4.3 m-85 -92.58 140.54 29.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.938 179.158 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 173' ' ' VAL . 45.4 t -132.2 134.54 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 -179.437 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.575 HG22 HG13 ' A' ' 163' ' ' VAL . 61.1 t -119.4 130.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.809 -179.39 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.23 136.14 53.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.141 179.505 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.63 140.19 11.6 Favored Glycine 0 N--CA 1.468 0.813 0 CA-C-O 121.648 0.582 . . . . 0.0 111.709 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.3 t0 -96.61 140.18 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.966 -179.09 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.52 HD13 ' CZ ' ' A' ' 158' ' ' TYR . 12.1 tp -67.45 129.15 39.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 111.004 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 79.6 t -106.93 -23.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.25 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.49 162.53 21.92 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.687 178.774 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.408 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 48.0 m -138.79 157.49 45.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.246 0.546 . . . . 0.0 109.934 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.8 pttp -150.33 178.5 8.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.097 179.864 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -96.11 140.27 31.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.768 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -61.97 79.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.482 -179.44 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 208' ' ' ALA . 99.2 mttt . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.518 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m 51.67 -147.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.702 0.287 . . . . 0.0 110.325 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.575 ' C ' ' H ' ' A' ' 57' ' ' ASP . 99.1 m-70 -80.7 12.38 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.758 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.0 mtt 55.34 -0.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.988 0.423 . . . . 0.0 111.099 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.575 ' H ' ' C ' ' A' ' 55' ' ' HIS . 73.9 m-20 -92.37 4.45 53.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.984 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.61 -37.77 70.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.648 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 61' ' ' ILE . 80.2 p -86.73 18.65 3.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.719 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -68.24 40.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.094 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' A' ' 59' ' ' SER . 32.6 mm -66.28 -44.67 91.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 0.0 110.355 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 64' ' ' PRO . 15.9 t0 61.24 123.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -38.06 93.0 0.06 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 123.157 0.285 . . . . 0.0 110.489 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.46 ' N ' ' O ' ' A' ' 62' ' ' ASP . 5.4 Cg_exo -73.81 157.72 47.42 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.372 1.381 . . . . 0.0 112.39 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.66 149.2 45.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.551 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.18 -24.47 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.094 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.5 86.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.44 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -73.4 -35.96 65.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.177 179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.98 -43.23 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.509 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.05 88.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -84.26 -19.81 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.53 131.95 51.78 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.582 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 m -92.3 152.42 19.8 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.378 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.2 tp -116.38 130.3 56.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.907 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -94.13 88.97 5.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 79' ' ' VAL . 45.0 mmtm -50.43 -11.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 75' ' ' ASP . 69.2 mmtt -74.52 -9.28 58.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.513 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.632 ' NE2' ' OG ' ' A' ' 97' ' ' SER . 30.6 mt-30 -106.51 16.51 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.37 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.9 p -90.6 126.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.774 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.33 -4.62 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.761 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.7 -167.54 36.55 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.483 ' HE ' ' NZ ' ' A' ' 209' ' ' LYS . 44.4 mtt-85 -146.92 155.24 42.13 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.973 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.617 HD12 HD13 ' A' ' 123' ' ' LEU . 8.8 tt -127.55 126.44 67.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.329 0.585 . . . . 0.0 109.821 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -125.14 130.55 52.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.006 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.48 79.57 59.79 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.252 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -43.6 -35.89 6.7 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.909 2.406 . . . . 0.0 112.972 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 m -49.11 -37.39 21.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -115.59 0.59 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.622 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.59 47.83 2.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.3 tp -115.04 129.32 56.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.737 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -134.34 120.66 20.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -146.72 162.47 33.59 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.241 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.64 151.68 8.83 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.826 2.35 . . . . 0.0 109.646 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -99.35 113.98 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.43 122.31 42.96 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.45 -45.73 82.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.797 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.632 ' OG ' ' NE2' ' A' ' 78' ' ' GLN . 91.5 p -70.79 104.57 2.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.152 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.0 p -82.79 99.81 9.91 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.254 0.55 . . . . 0.0 110.098 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.2 p -131.29 158.17 41.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.855 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.1 -26.42 68.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -83.23 -41.23 18.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.299 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -66.46 -36.21 82.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.503 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.0 mt -66.32 -14.7 62.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -75.49 -13.93 60.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -121.09 -4.49 9.54 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.38 -176.54 44.65 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.633 -1.27 . . . . 0.0 112.286 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.15 125.29 32.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.29 -0.455 . . . . 0.0 109.812 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.0 145.4 30.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.0 p -71.68 149.1 45.81 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.22 -44.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.94 -171.18 2.77 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.03 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -108.01 -56.78 2.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.809 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -91.17 46.54 1.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.59 150.27 24.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.133 0.492 . . . . 0.0 109.931 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.29 132.16 52.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.403 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.5 mtt -73.78 127.33 32.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 0.0 110.263 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.37 -0.9 68.87 Favored Glycine 0 C--O 1.23 -0.14 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -137.72 119.48 15.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.508 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -171.71 54.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.5 t30 -86.15 111.52 20.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -83.84 106.79 15.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.74 128.53 36.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.048 0.451 . . . . 0.0 112.081 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.617 HD13 HD12 ' A' ' 83' ' ' ILE . 10.1 mt -126.0 130.55 51.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.027 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.98 141.68 47.11 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.342 0.591 . . . . 0.0 110.768 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.48 -177.41 18.39 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.283 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.0 m-70 -82.69 150.0 27.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.1 0.476 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 129' ' ' SER . 4.5 t-20 -117.59 27.96 8.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.715 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.4 mmm -45.43 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.7 p 62.82 41.03 9.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.19 0.519 . . . . 0.0 110.201 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.83 109.66 9.24 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.884 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -51.66 127.87 21.74 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.44 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.7 -25.5 14.76 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.782 HG12 ' H ' ' A' ' 134' ' ' LEU . 45.9 t -82.51 177.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 117.54 0.67 . . . . 0.0 109.499 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.782 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.22 136.91 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.315 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 44.57 32.73 0.8 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.045 0.45 . . . . 0.0 110.656 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -81.89 -8.11 59.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.207 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -149.96 41.91 0.85 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.731 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.2 pt -68.08 -33.85 63.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.371 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.21 5.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.104 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -94.57 -16.79 22.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.2 124.95 23.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.835 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.65 156.13 16.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.566 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 144' ' ' GLY . 5.6 tmtt? -56.85 127.35 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.675 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.436 ' N ' ' HD3' ' A' ' 143' ' ' LYS . . . 90.9 21.72 35.38 Favored Glycine 0 CA--C 1.516 0.139 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -82.75 134.66 35.12 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.542 ' NZ ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 mmmm -80.96 121.78 26.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.565 0.698 . . . . 0.0 112.312 -178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 94.4 mt -117.69 117.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.11 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.548 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.1 m-85 -100.32 119.02 37.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.43 144.68 44.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.73 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -116.41 136.75 52.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.411 0.624 . . . . 0.0 111.565 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' A' ' 152' ' ' ASN . 32.2 t70 -114.74 -171.07 1.86 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.9 p30 -21.17 -73.53 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.072 0.463 . . . . 0.0 111.658 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.496 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.2 mt-10 -138.38 26.0 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.82 147.89 45.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.369 0.604 . . . . 0.0 112.254 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -113.08 120.43 41.31 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CE2' HG21 ' A' ' 206' ' ' THR . 65.9 m-85 -104.29 131.18 51.89 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.073 0.463 . . . . 0.0 111.36 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.548 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 42.4 tp10 -94.52 114.77 26.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -114.5 141.92 47.07 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.63 135.7 54.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.538 0.685 . . . . 0.0 111.428 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.3 132.27 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.875 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -105.97 -27.74 10.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 124.917 1.386 . . . . 0.0 110.709 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.84 141.12 3.68 Favored Glycine 0 C--N 1.32 -0.328 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.405 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.2 p -106.08 139.8 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.058 -0.571 . . . . 0.0 109.564 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.9 t -154.09 166.72 32.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.345 0.593 . . . . 0.0 111.557 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.03 125.95 53.14 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.665 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.07 153.97 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.805 0.336 . . . . 0.0 110.995 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 p -60.0 167.2 2.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.75 -13.69 11.68 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.949 1.766 . . . . 0.0 111.446 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 36.9 p30 -82.91 -18.49 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.881 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.445 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.2 ttmt -86.72 74.75 9.76 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.073 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.401 ' CE3' HG21 ' A' ' 174' ' ' VAL . 94.0 m95 -75.54 -7.54 54.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.868 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -52.57 -25.42 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.039 0.447 . . . . 0.0 110.557 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.662 ' O ' HG21 ' A' ' 183' ' ' THR . 74.4 t -75.71 -16.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.228 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.401 HG21 ' CE3' ' A' ' 171' ' ' TRP . 2.6 t -108.71 -13.78 10.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.665 0.745 . . . . 0.0 109.676 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.01 152.66 24.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.919 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.54 133.93 53.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -101.18 -39.07 7.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.45 30.33 0.35 Allowed Glycine 0 N--CA 1.469 0.843 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -156.23 179.31 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.262 0.553 . . . . 0.0 111.369 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.23 89.71 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -125.06 166.13 16.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.193 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.29 142.45 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.662 HG21 ' O ' ' A' ' 173' ' ' VAL . 18.0 m -134.37 127.01 30.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.573 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.56 126.86 55.76 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.106 0.479 . . . . 0.0 109.722 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.48 HG22 HG22 ' A' ' 198' ' ' VAL . 28.6 pt -140.32 -169.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.519 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 33.3 p -138.23 152.23 48.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.732 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 19.4 m -66.32 -46.79 75.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.52 145.4 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.193 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 191' ' ' LYS . 37.9 t -144.28 133.26 22.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.127 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 98.5 t 48.61 -85.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.931 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 189' ' ' SER . 66.0 tttm -145.67 158.85 43.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.729 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.82 -47.03 81.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 110.162 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -63.51 -39.83 95.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.058 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.8 m -60.04 171.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.4 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -97.08 -173.16 2.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.395 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -140.42 162.05 36.25 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.214 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.5 133.58 42.67 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 173' ' ' VAL . 93.4 t -133.59 137.02 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.2 t -116.01 128.15 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.465 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.16 136.87 52.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.212 0.529 . . . . 0.0 110.074 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.46 25.85 Favored Glycine 0 N--CA 1.462 0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.451 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -115.61 150.1 37.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.043 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 41.8 tp -69.9 127.12 31.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.506 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.13 -24.43 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.759 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 175.01 45.81 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.532 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.412 HG21 ' CE2' ' A' ' 156' ' ' TYR . 16.5 m -153.3 151.66 30.26 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 121.375 0.607 . . . . 0.0 111.015 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -149.84 179.03 8.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.395 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.26 145.7 24.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.168 0.508 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.483 ' NZ ' ' HE ' ' A' ' 82' ' ' ARG . 88.5 tttt -74.14 80.0 1.76 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.321 -0.63 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.872 178.758 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.8 p -75.72 162.09 28.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.745 0.307 . . . . 0.0 110.318 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -76.36 158.48 31.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 110.123 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 55.5 ttp -59.38 -43.08 92.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.14 0.495 . . . . 0.0 110.422 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 7.7 p30 -95.84 102.77 14.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.395 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.69 -8.05 55.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.855 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 t -84.22 -92.86 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.514 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp 50.46 39.97 22.03 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.009 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mm -63.66 -44.21 98.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.929 0.395 . . . . 0.0 110.196 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.7 t0 58.88 -111.48 0.56 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.35 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -142.06 80.13 15.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -42.13 148.3 0.4 Allowed 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.063 1.842 . . . . 0.0 111.533 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 162.78 29.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.063 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 66' ' ' LEU . 1.2 tt -60.22 -25.18 65.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.978 0.418 . . . . 0.0 110.247 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.13 89.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.004 0.43 . . . . 0.0 110.447 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 71.0 mm-40 -73.67 -33.71 64.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 110.788 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.28 -45.54 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.754 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.19 88.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.183 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -80.85 -24.11 38.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.209 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.45 141.5 58.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.712 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.6 m -139.22 119.28 13.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.578 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD13 HD21 ' A' ' 102' ' ' ASN . 35.2 tp -120.31 140.41 51.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.825 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.08 138.55 57.22 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 79' ' ' VAL . 14.4 mptt -82.16 -10.51 59.14 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.169 0.509 . . . . 0.0 109.995 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -81.12 -8.96 59.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -90.99 11.84 21.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.529 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 76' ' ' LYS . 14.7 m -88.63 146.36 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.121 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.8 -6.98 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 111.393 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.16 -170.76 36.41 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -146.26 148.75 32.78 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.569 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -122.81 121.74 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -123.49 129.31 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.429 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 50.5 mt -129.73 125.54 22.28 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.322 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.5 Cg_endo -82.75 -39.23 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 t -49.92 -39.31 39.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.414 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -116.95 -2.18 9.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.464 0.173 . . . . 0.0 110.777 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m 63.18 50.88 2.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.484 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -108.31 130.6 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.137 -178.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -137.1 114.68 11.12 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.628 HD22 ' HA2' ' A' ' 106' ' ' GLY . 16.6 mt -145.92 111.17 4.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.4 Cg_endo -41.24 142.9 0.86 Allowed 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 121.643 1.562 . . . . 0.0 110.328 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.41 122.95 44.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.84 132.71 47.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.157 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.78 -27.96 68.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.416 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 93.2 p -69.34 -179.52 1.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.543 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -159.15 49.92 0.35 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.085 0.469 . . . . 0.0 110.272 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.5 p -108.03 155.1 20.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.73 -31.31 64.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -72.01 -48.11 47.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.466 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.45 HD21 HD13 ' A' ' 74' ' ' LEU . 12.5 m120 -66.86 -38.56 86.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.183 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 134' ' ' LEU . 12.7 mt -56.35 -16.14 5.14 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.6 mt -70.24 -31.7 69.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.0 m -90.63 -12.22 37.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.628 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 170.87 -175.06 44.72 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.911 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.14 130.66 41.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 97' ' ' SER . . . -104.64 143.25 33.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.838 0.352 . . . . 0.0 110.158 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.8 p -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.445 HG21 HD11 ' A' ' 185' ' ' ILE . 84.1 t -81.31 -50.22 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -94.5 147.64 23.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.997 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -87.45 -6.3 58.47 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -126.78 31.84 5.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.107 0.48 . . . . 0.0 111.329 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -97.59 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.568 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.23 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.987 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.9 125.1 31.67 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.697 0.284 . . . . 0.0 110.395 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.55 72.92 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.87 121.44 13.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.104 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.55 55.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -83.83 110.17 18.14 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -87.48 104.26 16.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.486 ' O ' HD22 ' A' ' 123' ' ' LEU . . . -92.88 121.0 33.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.681 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 122' ' ' ALA . 2.4 mm? -117.31 131.66 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.022 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.07 141.04 43.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.466 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.2 -177.76 15.81 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.536 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.473 ' O ' ' O ' ' A' ' 134' ' ' LEU . 62.1 m-70 -92.99 130.25 38.63 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.083 0.468 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -91.99 28.47 1.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -35.84 -26.2 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.368 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 64.95 34.84 8.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.403 0.62 . . . . 0.0 109.596 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.43 106.91 6.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.39 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -49.11 128.62 16.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.064 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.46 -23.03 14.2 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.809 HG12 ' H ' ' A' ' 134' ' ' LEU . 49.0 t -89.69 178.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.809 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.13 135.5 49.22 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.36 -177.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 44.88 39.41 3.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.193 0.521 . . . . 0.0 110.63 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 60.6 p -81.36 -8.56 59.76 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 136' ' ' SER . 77.8 m-20 -147.6 37.99 0.92 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.8 -29.85 42.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.824 0.345 . . . . 0.0 111.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.02 6.41 4.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.815 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -97.67 -13.75 21.32 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.02 123.31 19.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.896 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 23.2 tptt -96.34 169.46 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.161 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 142' ' ' LYS . 48.9 tttm -68.0 125.8 27.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 97.06 18.73 28.34 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.0 m-20 -84.32 131.76 34.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -79.52 129.99 34.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.894 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.9 mt -125.23 126.12 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.529 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 58.0 m-85 -103.06 118.94 37.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.563 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.702 HD13 ' N ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -115.53 133.67 55.8 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.702 ' N ' HD13 ' A' ' 149' ' ' LEU . 20.6 m-85 -103.08 132.48 49.31 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 111.084 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 50.0 t0 -110.0 -167.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.679 -1.146 . . . . 0.0 107.952 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.519 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -29.66 -72.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.978 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -136.78 29.05 2.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -131.7 150.26 52.21 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -108.75 123.74 49.48 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.378 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 40.1 m-85 -104.99 129.91 53.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.391 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.529 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 73.9 mm-40 -96.65 114.92 26.61 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.15 142.93 45.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.76 132.11 54.08 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.395 0.617 . . . . 0.0 111.238 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 144' ' ' GLY . 53.7 t -66.63 134.37 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.981 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.5 OUTLIER -106.84 -29.18 9.66 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 124.36 1.037 . . . . 0.0 110.437 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.73 157.81 17.15 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.638 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 150.74 33.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.824 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.9 m -156.48 168.2 28.1 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.259 0.552 . . . . 0.0 111.366 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -106.06 132.0 52.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.439 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.02 159.07 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 110.931 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.545 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 71.2 p -77.79 142.44 65.46 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -47.32 -18.81 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.089 1.859 . . . . 0.0 111.604 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -81.24 -2.87 50.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.974 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.6 tptt -82.03 140.59 33.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 94.4 m95 -157.78 -22.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.849 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -56.74 -17.67 9.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.397 0.617 . . . . 0.0 110.429 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.09 -6.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.321 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 185' ' ' ILE . 2.9 m -136.23 43.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 70.5 mm-40 -144.6 84.53 1.74 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.027 -176.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 175' ' ' GLU . 92.3 m-20 27.18 108.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.231 0.957 . . . . 0.0 112.805 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -96.84 -40.34 8.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.313 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.2 29.59 0.72 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.48 178.45 10.22 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -92.83 88.84 6.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.976 0.893 . . . . 0.0 109.511 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -131.63 167.29 19.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.91 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 15.7 tt -131.67 143.42 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.585 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.5 m -136.22 129.71 32.01 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.301 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -112.4 127.58 56.06 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.24 0.543 . . . . 0.0 110.867 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.607 HD13 HG11 ' A' ' 174' ' ' VAL . 3.4 pt -141.17 -167.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.876 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.0 t -139.92 153.92 47.08 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.567 ' C ' ' H ' ' A' ' 189' ' ' SER . 72.8 m -78.52 -97.77 0.03 OUTLIER 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.213 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.8 t 56.39 -1.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.236 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.567 ' H ' ' C ' ' A' ' 187' ' ' CYS . 24.0 m 45.29 -114.43 0.44 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.414 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.55 128.33 69.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -92.54 -131.2 0.12 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.796 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -93.39 -3.26 53.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.886 0.374 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 194' ' ' SER . 16.7 t-20 -163.03 -125.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.768 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.499 ' N ' ' OD1' ' A' ' 193' ' ' ASN . 19.2 p -139.14 119.92 14.26 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -165.66 101.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.322 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 167' ' ' THR . 8.3 ttm180 -150.42 144.52 25.48 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.616 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.0 139.66 48.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 110.091 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -134.45 136.9 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 111.229 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.77 134.2 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.049 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.93 138.1 51.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.542 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.6 139.98 11.39 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.8 t0 -99.05 137.05 38.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.253 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.0 tp -63.75 126.2 26.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.287 0.565 . . . . 0.0 110.881 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.24 -25.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.825 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.7 159.91 16.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.008 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.412 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 59.5 m -135.71 157.18 47.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 206' ' ' THR . 20.2 ptmt -148.64 178.9 8.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.237 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.8 144.88 24.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.289 0.566 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.85 80.69 2.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.472 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.633 178.107 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 t -60.04 -45.17 93.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.005 0.431 . . . . 0.0 110.668 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -84.29 133.03 34.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.304 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.5 ttt -73.25 -121.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 65.9 t0 -76.98 148.23 36.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.534 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -68.51 -40.07 80.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.474 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 t 57.06 3.12 0.13 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.523 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 58' ' ' ALA . 88.3 tttt -99.08 93.77 6.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.552 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -142.54 -80.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.065 -178.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 54.43 -80.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.922 0.391 . . . . 0.0 111.051 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 61' ' ' ILE . 5.1 pt20 -139.95 70.45 35.74 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.093 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -43.55 147.48 1.02 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.617 2.211 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.13 151.34 43.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.975 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.5 mp -55.48 -26.76 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 110.68 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.51 93.99 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.4 mt-10 -73.39 -32.1 64.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.674 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.58 -46.32 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.972 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.76 91.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.157 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.95 -30.12 55.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.395 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.95 158.34 11.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.869 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 p -138.56 158.84 43.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 110.62 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.647 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -139.21 121.48 15.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 111.172 -178.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.647 ' N ' HD13 ' A' ' 74' ' ' LEU . 99.2 m-20 -81.89 110.73 17.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.796 178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -47.13 -16.13 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.226 0.536 . . . . 0.0 110.318 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 75' ' ' ASP . 87.4 tttt -67.44 -33.52 75.32 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.977 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -78.41 9.45 3.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.584 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.5 t -92.91 129.11 43.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.753 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 pt -118.29 -3.43 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.81 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.95 34.41 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -157.06 164.94 37.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.714 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.9 tt -131.07 140.23 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.712 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 m -132.87 133.17 42.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.36 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' CG2' ' OG ' ' A' ' 87' ' ' SER . 67.9 mt -133.17 129.26 20.82 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.546 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.88 -36.18 0.19 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.429 2.086 . . . . 0.0 112.147 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.418 ' OG ' ' CG2' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -47.15 -38.98 12.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.409 -177.188 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.3 p -120.55 0.23 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.828 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 60.71 54.29 3.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 tp -117.74 134.83 54.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.346 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.96 117.38 14.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 83' ' ' ILE . 58.9 mt -143.65 114.02 5.55 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.9 Cg_endo -42.38 146.67 0.67 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 121.892 1.728 . . . . 0.0 109.99 176.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -95.3 123.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.87 123.18 47.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.87 -46.79 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.974 0.416 . . . . 0.0 111.079 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.9 p -69.79 102.87 2.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 98' ' ' SER . 5.6 p -82.77 103.85 12.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.421 0.629 . . . . 0.0 110.329 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 p -142.94 157.12 44.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.944 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -54.71 -32.44 59.58 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.722 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -79.13 -45.08 20.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.687 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HA ' HD21 ' A' ' 102' ' ' ASN . 9.3 m120 -65.19 -34.72 79.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.242 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 134' ' ' LEU . 17.0 mt -61.68 -21.36 64.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.375 0.607 . . . . 0.0 111.808 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.89 -32.93 73.76 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.477 ' OG ' HD23 ' A' ' 74' ' ' LEU . 3.8 p -87.83 -13.58 41.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.57 -171.69 44.18 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.492 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.01 127.55 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.482 . . . . 0.0 110.057 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.73 146.46 29.77 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.844 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 109' ' ' THR . 5.5 p -74.42 151.55 39.62 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.92 -42.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.464 ' N ' HE22 ' A' ' 114' ' ' GLN . 99.2 mttt -88.29 -171.99 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.027 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -116.7 -9.81 11.23 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -145.87 43.41 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.464 HE22 ' N ' ' A' ' 111' ' ' LYS . 1.7 pm0 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.888 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.54 131.36 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.681 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.3 mtt -71.49 128.37 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.075 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 91.17 1.97 71.71 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -141.32 123.7 15.77 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.66 -164.47 54.81 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.43 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 22.1 t-20 -92.28 108.91 20.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -85.37 103.24 14.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.038 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 128.59 36.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.384 0.611 . . . . 0.0 112.15 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.56 130.47 52.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.127 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.71 140.94 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.055 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.49 -178.34 17.59 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 134' ' ' LEU . 56.8 m-70 -93.42 140.92 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.721 ' C ' HD21 ' A' ' 127' ' ' ASN . 0.1 OUTLIER -106.44 29.44 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 110.549 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.0 mmm -42.22 -15.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.837 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 61.56 38.0 15.9 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.076 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -133.62 107.65 8.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.984 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -52.92 126.74 21.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.8 -24.61 11.77 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 134' ' ' LEU . 42.4 t -86.66 -179.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.816 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.79 133.03 46.19 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.194 -178.228 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 47.26 40.82 11.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 111.149 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.8 p -81.6 -11.88 58.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.903 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 73.7 m-20 -149.82 42.8 0.88 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.7 pt -68.57 -35.56 70.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 0.0 112.013 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.7 1.58 2.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.2 m -92.66 -13.71 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.161 0.505 . . . . 0.0 110.18 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.4 122.78 18.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.213 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.69 157.91 15.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.792 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.48 127.87 33.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.258 0.551 . . . . 0.0 111.147 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.23 16.51 40.43 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.72 133.84 34.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -81.52 134.56 35.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 111.852 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -127.82 121.04 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -101.76 120.24 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.8 tp -117.72 147.93 42.49 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -122.03 131.86 54.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.153 0.501 . . . . 0.0 111.584 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.9 t0 -112.08 -164.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 151' ' ' ASP . 28.4 m120 -21.95 -78.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.205 0.526 . . . . 0.0 111.406 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -136.31 26.07 3.2 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -123.48 142.22 51.22 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -108.15 120.52 42.58 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 206' ' ' THR . 75.0 m-85 -104.14 130.32 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.152 0.501 . . . . 0.0 111.582 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -93.66 115.27 27.72 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 51.5 m-85 -116.78 138.61 51.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.631 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -118.59 136.79 53.67 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.247 0.546 . . . . 0.0 110.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.78 134.8 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.297 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.5 OUTLIER -107.83 -24.12 11.79 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.357 1.036 . . . . 0.0 111.278 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 166.17 165.9 24.31 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.115 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.29 151.64 31.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.3 p -152.28 161.54 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.04 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -114.15 117.44 31.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.87 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.85 159.25 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.989 0.424 . . . . 0.0 111.28 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 169' ' ' ASP . 33.9 p -69.48 134.27 88.78 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.459 ' HB3' HH21 ' A' ' 196' ' ' ARG . 1.2 Cg_endo -46.25 -12.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.081 1.854 . . . . 0.0 111.749 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 167' ' ' THR . 96.0 m-20 -81.11 -8.73 59.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -85.97 70.1 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.133 0.492 . . . . 0.0 110.259 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.467 ' C ' ' N ' ' A' ' 173' ' ' VAL . 80.8 m95 -70.48 -30.47 67.28 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.441 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -48.81 -14.81 0.07 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.543 . . . . 0.0 110.464 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.467 ' N ' ' C ' ' A' ' 171' ' ' TRP . 86.1 t -75.08 -24.32 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.809 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.91 -6.64 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.703 0.763 . . . . 0.0 109.561 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -80.46 152.8 28.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.861 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p-10 -64.64 128.32 35.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.288 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.441 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.8 m80 -108.69 -42.69 4.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.62 0.248 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.47 23.99 0.09 OUTLIER Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -152.92 171.73 17.88 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -94.75 87.91 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -126.88 126.61 43.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.365 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.5 tt -81.04 148.23 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 184' ' ' LEU . 7.2 m -136.68 121.19 18.26 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.375 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.516 HD12 ' C ' ' A' ' 183' ' ' THR . 10.4 mp -105.35 126.64 52.34 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.28 0.562 . . . . 0.0 111.149 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 29.7 pt -135.2 169.92 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.491 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.569 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 35.5 p -116.44 141.83 47.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.362 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.473 ' HB2' HH22 ' A' ' 196' ' ' ARG . 3.2 m 56.7 162.22 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.766 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.9 m -114.91 2.47 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.822 0.344 . . . . 0.0 111.488 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 55.4 m -145.07 172.98 12.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.1 m -71.12 135.26 28.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -112.55 -165.35 0.98 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.8 0.333 . . . . 0.0 110.825 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 192' ' ' ASP . 29.5 p-10 -60.32 -42.35 95.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.897 0.379 . . . . 0.0 110.739 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 192' ' ' ASP . 98.5 m-20 -103.17 132.55 49.35 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.424 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 84.8 p -79.55 -15.11 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 111.303 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -70.69 128.83 37.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.103 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 186' ' ' THR . 59.9 ttm-85 -145.64 145.06 30.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.886 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.48 133.29 49.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 81.8 t -135.16 136.82 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.65 131.65 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.615 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.526 ' O ' HG22 ' A' ' 161' ' ' THR . . . -115.22 136.69 52.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.48 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.45 11.73 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 47.9 p-10 -96.4 141.3 29.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.915 -0.643 . . . . 0.0 111.247 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.12 125.42 25.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.098 0.475 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 72.4 t -107.59 -23.21 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.535 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.83 177.9 45.22 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.883 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 156' ' ' TYR . 15.9 m -154.1 152.63 30.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.159 0.504 . . . . 0.0 111.018 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -151.14 178.8 8.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.371 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.67 145.6 24.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.948 0.404 . . . . 0.0 110.534 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.19 79.04 0.96 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.32 -0.705 0 CA-C-O 117.854 -1.069 . . . . 0.0 110.724 178.59 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 t -65.06 137.69 57.85 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -142.16 106.51 4.8 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.923 0.392 . . . . 0.0 111.093 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.3 mmm -85.99 144.47 27.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.716 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.63 136.03 56.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.044 0.45 . . . . 0.0 110.194 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.12 -39.87 71.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.575 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 61' ' ' ILE . 58.2 m -88.75 31.93 0.82 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.369 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -72.59 10.57 0.8 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.317 0.579 . . . . 0.0 111.326 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 59' ' ' SER . 57.4 mt -65.37 -45.15 94.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.206 0.527 . . . . 0.0 110.676 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 188' ' ' VAL . 99.8 m-20 55.6 -98.62 0.09 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.942 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -151.16 78.25 7.25 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -42.96 147.44 0.66 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.095 1.863 . . . . 0.0 111.594 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.59 154.79 41.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.1 mm? -57.1 -27.16 61.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.707 0.289 . . . . 0.0 110.601 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.85 91.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.924 0.392 . . . . 0.0 110.041 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.2 mt-10 -74.29 -36.11 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.797 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -74.34 -43.9 49.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.627 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.13 86.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.27 -22.75 30.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.217 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.29 138.35 58.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.397 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -139.97 149.56 43.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.795 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.764 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.3 pt? -139.92 166.76 23.77 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.432 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.31 140.86 43.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.763 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 79' ' ' VAL . 70.2 mmtt -79.57 -2.08 40.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.196 0.522 . . . . 0.0 110.155 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -89.47 -7.25 55.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -85.84 0.33 53.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 76' ' ' LYS . 7.8 p -88.26 135.12 26.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.73 0.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.686 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -177.95 39.83 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -147.53 151.54 36.5 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.194 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 83' ' ' ILE . 14.7 tt -126.21 123.46 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 m -123.18 128.03 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.608 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.72 116.69 13.82 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.71 -33.17 1.31 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.286 1.991 . . . . 0.0 112.376 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.449 ' CB ' HD23 ' A' ' 141' ' ' LEU . 3.0 m -50.73 -37.22 40.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.36 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -117.23 -6.79 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.252 -0.28 . . . . 0.0 110.512 -179.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.8 p 71.76 47.82 0.32 Allowed 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.64 127.51 54.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.479 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -132.82 113.9 13.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -145.0 165.43 22.21 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.001 -0.679 . . . . 0.0 112.554 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -89.01 156.38 5.82 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 123.252 2.635 . . . . 0.0 109.264 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.58 114.38 46.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.9 120.9 41.44 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.81 -45.19 83.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.985 0.421 . . . . 0.0 110.776 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 4.2 m -67.05 103.93 1.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.936 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -82.03 109.0 15.96 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 110.318 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.512 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -143.35 155.77 44.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.24 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -61.19 -28.03 68.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -80.22 -46.64 15.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.898 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.4 p-10 -68.78 -31.16 69.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.585 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -61.89 -20.39 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.84 -14.41 61.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.613 ' OG ' HD22 ' A' ' 74' ' ' LEU . 19.9 m -103.22 -10.22 18.94 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.82 -153.04 18.91 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.247 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.81 127.86 44.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.115 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -108.34 148.85 29.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 p -73.53 149.61 42.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.574 HG21 HD11 ' A' ' 185' ' ' ILE . 4.3 t -84.8 -42.22 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 9.5 tptp -90.28 -172.65 3.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.788 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 46.6 tp10 -107.04 -57.9 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.343 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.93 45.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.296 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.45 154.17 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.085 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.19 135.19 63.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 mtp -78.05 122.55 25.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.61 2.43 60.0 Favored Glycine 0 N--CA 1.461 0.314 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -140.59 128.28 21.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.076 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.68 -169.65 49.96 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.5 107.17 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -85.39 103.21 14.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.62 126.27 35.9 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.485 0.66 . . . . 0.0 112.208 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.441 HD13 HD12 ' A' ' 83' ' ' ILE . 11.6 mt -120.49 131.22 54.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.512 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.69 138.49 45.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.582 0.706 . . . . 0.0 110.921 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.69 -178.39 16.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.556 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 80.7 m-70 -90.79 139.69 30.49 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' SER . 64.2 t30 -102.52 28.53 5.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 109.91 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.49 -24.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.184 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 64.44 36.71 8.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.416 0.627 . . . . 0.0 109.61 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.458 ' N ' ' OG ' ' A' ' 136' ' ' SER . 26.1 mtpp -134.34 111.67 10.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.917 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.41 126.12 18.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.625 0.726 . . . . 0.0 110.226 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.6 9.7 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.564 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.76 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.6 t -79.09 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 117.749 0.775 . . . . 0.0 109.484 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.76 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.57 134.37 46.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.24 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 45.17 33.78 1.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.159 0.504 . . . . 0.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.458 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.2 -8.51 59.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -146.68 39.74 1.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.29 -30.02 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.863 0.363 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.06 3.36 5.55 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.135 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -95.81 -13.9 23.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.449 HD23 ' CB ' ' A' ' 87' ' ' SER . 15.2 mt -66.21 126.4 28.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.704 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -97.2 158.84 15.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.415 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.16 138.64 58.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.434 0.635 . . . . 0.0 111.317 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.61 65.09 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -81.11 136.83 35.96 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.2 122.64 25.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.635 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mm -115.39 119.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.73 118.23 36.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 tp -119.94 154.96 33.69 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.02 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -127.32 135.68 50.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.505 0.669 . . . . 0.0 112.118 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.0 t0 -115.52 -167.04 1.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.29 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.224 0.535 . . . . 0.0 111.798 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -138.09 28.66 2.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -127.8 140.58 51.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.522 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 78.7 tt0 -103.35 122.17 44.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.572 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.445 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 55.0 m-85 -104.25 127.05 51.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.394 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 157' ' ' GLU . 39.7 mp0 -94.64 115.45 27.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.071 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -119.14 134.08 55.41 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.342 0.591 . . . . 0.0 110.718 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.04 133.42 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.736 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.4 p -103.79 -26.81 12.57 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 124.524 1.14 . . . . 0.0 110.794 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.36 165.6 19.65 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.995 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.7 p -121.79 149.21 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 198' ' ' VAL . 19.5 m -153.22 164.28 38.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.088 0.47 . . . . 0.0 111.196 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -107.82 102.83 12.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.437 HG22 HG11 ' A' ' 198' ' ' VAL . 11.3 m -117.05 144.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.102 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.8 p -61.32 167.02 4.42 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.54 -14.48 11.56 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.958 1.772 . . . . 0.0 111.982 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 65.9 t0 -84.54 -20.28 31.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -85.82 81.27 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.538 . . . . 0.0 110.214 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.547 ' C ' ' H ' ' A' ' 173' ' ' VAL . 95.4 m95 -75.77 -15.16 60.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.898 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.624 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 40.7 mp0 -51.99 -6.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.146 0.498 . . . . 0.0 110.968 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 171' ' ' TRP . 73.2 t -88.65 -19.06 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.163 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.68 -6.29 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.488 0.661 . . . . 0.0 109.383 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -82.07 150.9 27.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.18 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -60.72 127.29 30.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 25.9 m170 -116.44 24.3 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.77 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 15.62 68.05 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -149.64 167.89 25.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 111.183 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.65 97.84 8.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.717 0.77 . . . . 0.0 110.734 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.73 135.09 45.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.36 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.4 tt -82.62 147.96 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 173' ' ' VAL . 7.3 m -136.5 117.54 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.931 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 184' ' ' LEU . 10.4 mp -101.73 124.19 46.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.071 0.462 . . . . 0.0 110.174 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 110' ' ' VAL . 13.8 pt -137.38 -176.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.06 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.551 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 43.0 p -137.27 147.7 45.9 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 187' ' ' CYS . 54.1 t -98.45 34.62 1.96 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.113 0.482 . . . . 0.0 110.718 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 62' ' ' ASP . 52.2 t -95.42 127.54 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.6 t -66.44 144.73 56.33 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.997 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 190' ' ' VAL . 11.7 p -123.15 132.92 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.808 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -147.28 -62.57 0.28 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.803 0.335 . . . . 0.0 111.614 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -92.32 108.39 19.92 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.791 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.471 ' CG ' ' H ' ' A' ' 194' ' ' SER . 64.3 t30 46.44 -164.67 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.471 ' H ' ' CG ' ' A' ' 193' ' ' ASN . 2.1 p 62.2 140.71 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.435 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -136.57 143.85 43.86 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 111.362 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.1 ttm180 -69.07 135.8 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.009 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -108.66 139.12 43.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.395 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 164' ' ' SER . 3.4 p -135.35 139.04 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.394 0.616 . . . . 0.0 111.467 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.53 130.63 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.79 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.81 135.65 53.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.263 0.554 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.52 153.71 20.56 Favored Glycine 0 N--CA 1.46 0.292 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 50.5 p-10 -108.18 142.27 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.728 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.08 127.87 34.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.413 0.625 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 159' ' ' ALA . 91.7 t -107.84 -26.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.186 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.16 162.17 20.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 25.5 m -136.88 156.17 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.245 0.545 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.522 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.1 pttp -150.9 179.13 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.08 142.87 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.401 0.62 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -61.97 81.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.561 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttp . . . . . 0 C--N 1.313 -0.983 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.57 178.427 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.3 m -59.35 -43.05 92.86 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.511 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 43.86 82.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.438 . . . . 0.0 110.748 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 92.8 mtp -65.11 -40.1 94.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.592 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -86.72 114.01 23.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.5 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.95 -14.15 61.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.568 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.544 ' C ' ' H ' ' A' ' 61' ' ' ILE . 83.5 p -88.14 0.1 56.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.809 0.338 . . . . 0.0 111.21 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -66.45 14.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.463 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.544 ' H ' ' C ' ' A' ' 59' ' ' SER . 29.6 mm -63.82 -45.47 97.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.101 0.476 . . . . 0.0 110.169 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 54.41 -94.39 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.188 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -150.87 78.99 7.2 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.595 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -43.51 147.96 0.89 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.017 1.811 . . . . 0.0 111.971 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -73.42 158.36 35.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.227 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -54.71 -25.85 30.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.893 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.32 91.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.5 mt-10 -75.08 -26.08 59.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.235 0.541 . . . . 0.0 110.474 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.8 t -79.4 -49.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.942 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.95 81.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.173 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -68.78 -32.1 71.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.334 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.24 113.3 2.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.938 0.399 . . . . 0.0 111.219 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -92.21 133.59 35.67 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.97 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.521 HD13 ' ND2' ' A' ' 102' ' ' ASN . 61.2 tp -129.57 134.85 47.96 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.757 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -94.02 132.26 38.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.568 ' O ' HG12 ' A' ' 79' ' ' VAL . 69.5 mmtt -66.34 -9.5 33.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.474 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 79' ' ' VAL . 63.7 mttp -65.44 -34.37 78.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.835 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.23 17.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.8 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.8 p -92.31 127.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pt -122.45 -2.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.03 38.49 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.479 ' O ' HD23 ' A' ' 149' ' ' LEU . 32.4 mtm180 -147.88 153.28 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.854 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 83' ' ' ILE . 16.1 tt -124.69 122.27 63.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m -121.35 127.96 51.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.584 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.4 mt -133.75 120.42 15.47 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.81 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.84 -32.33 1.55 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.829 1.686 . . . . 0.0 112.331 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.1 p -47.87 -37.39 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.975 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.7 p -118.32 0.12 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.476 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t 63.49 52.79 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -119.54 133.07 55.84 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -135.31 119.74 17.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 mt -145.46 167.32 14.68 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.023 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.94 150.09 7.09 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.886 2.391 . . . . 0.0 109.652 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.6 t -102.18 113.91 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.45 -45.05 85.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.972 0.415 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.5 p -71.33 106.91 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.232 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.7 p -83.79 107.14 16.02 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.094 0.473 . . . . 0.0 110.234 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.8 p -137.43 156.59 48.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.113 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -57.86 -36.45 72.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -74.72 -43.65 53.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.387 0.613 . . . . 0.0 112.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.521 ' ND2' HD13 ' A' ' 74' ' ' LEU . 8.3 m120 -66.43 -35.45 80.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.441 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 126' ' ' HIS . 36.4 mt -65.56 -15.93 63.19 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.65 -14.18 60.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.8 m -116.53 -7.41 11.63 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.0 -163.83 28.74 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.117 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -101.49 130.33 47.74 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.083 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.25 147.91 34.02 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.3 p -76.47 153.79 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.06 -46.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -92.18 142.16 27.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.123 0.487 . . . . 0.0 111.179 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.4 pt-20 -62.58 -51.41 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.662 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 88.1 m-20 -96.75 47.88 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.379 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -83.59 154.22 23.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.79 130.25 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.595 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.43 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.1 mtt -72.61 128.39 35.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.762 0.315 . . . . 0.0 110.948 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.522 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.19 4.91 73.7 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -140.93 120.65 13.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.257 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.64 -166.9 54.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -85.07 106.29 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.57 101.18 11.91 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.93 130.82 36.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.991 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.92 132.21 53.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.09 137.72 46.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.351 0.596 . . . . 0.0 110.596 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.404 ' HA3' ' CD2' ' A' ' 135' ' ' PHE . . . -145.19 -176.5 19.22 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.517 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 103' ' ' LEU . 76.3 m-70 -93.28 157.51 16.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.826 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.0 p-10 -122.05 29.04 7.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.585 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.2 mmt -38.15 -20.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.636 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 59.93 37.44 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.275 0.56 . . . . 0.0 109.836 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 136' ' ' SER . 58.3 tttp -136.49 107.73 6.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.767 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.469 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -58.4 130.24 45.81 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.59 0.71 . . . . 0.0 111.249 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.02 15.61 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.176 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 134' ' ' LEU . 2.0 t -96.97 177.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.616 ' H ' HG12 ' A' ' 133' ' ' VAL . 1.3 pt? -71.62 136.38 47.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.754 0.788 . . . . 0.0 112.355 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.4 m-85 46.45 31.92 1.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.429 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.0 p -81.75 -6.03 58.68 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.7 m-20 -146.97 43.1 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.091 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.9 pt -69.97 -30.69 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.261 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.06 7.28 2.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 t -95.56 -14.71 23.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.14 123.72 18.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.81 154.21 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.62 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.93 130.61 47.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.64 21.99 41.55 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 37.7 m-20 -87.0 134.77 33.45 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -81.5 129.64 34.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.529 0.68 . . . . 0.0 112.147 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 90.1 mt -123.39 123.92 68.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.817 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -105.05 121.84 44.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.344 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 82' ' ' ARG . 2.3 mt -113.0 153.17 28.49 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.167 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -127.2 131.23 50.71 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.344 0.592 . . . . 0.0 111.756 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 42.0 t0 -115.04 -168.06 1.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 89.5 m-20 -20.87 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.082 0.468 . . . . 0.0 112.137 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -140.17 25.32 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -122.83 142.3 50.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -106.33 122.08 45.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.87 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.47 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.3 m-85 -104.01 126.62 51.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.987 0.422 . . . . 0.0 111.667 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.66 117.12 29.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 19.6 m-85 -116.55 147.11 42.13 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.381 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.57 134.83 53.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 110.489 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 55.7 t -70.15 133.61 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.706 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.7 p -101.1 -25.4 14.05 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 124.51 1.131 . . . . 0.0 110.349 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.08 156.3 7.99 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.356 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.34 147.82 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.639 -0.781 . . . . 0.0 109.871 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.2 p -148.64 159.59 43.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.173 0.511 . . . . 0.0 111.334 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.81 119.6 39.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.437 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.09 159.84 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.1 p -76.72 142.92 70.68 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.42 -18.55 3.76 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.89 1.727 . . . . 0.0 111.836 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -83.44 -6.67 59.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -83.36 70.63 10.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.263 0.554 . . . . 0.0 110.331 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.498 ' C ' ' H ' ' A' ' 173' ' ' VAL . 85.0 m95 -71.46 -28.53 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.57 -11.36 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.058 0.456 . . . . 0.0 110.475 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 171' ' ' TRP . 43.9 t -80.48 -22.68 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.72 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -110.08 -6.86 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.756 0.788 . . . . 0.0 109.282 -178.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.01 137.08 37.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.981 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 39.9 p-10 -51.97 127.28 20.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.962 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -104.86 -43.39 5.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.46 26.33 0.1 Allowed Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -152.85 173.37 15.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.244 0.545 . . . . 0.0 111.157 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 11.5 m-20 -94.23 89.39 5.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.049 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -128.89 127.28 41.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.678 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.0 tt -82.42 146.81 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.453 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.1 m -135.91 119.31 16.83 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.547 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -105.75 124.73 50.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.012 0.434 . . . . 0.0 109.912 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.538 HD13 HG11 ' A' ' 174' ' ' VAL . 8.9 pt -135.88 173.2 14.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.79 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.2 p -133.12 154.13 50.88 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 2.5 p -85.59 130.43 34.57 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.992 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.526 ' CG2' HD21 ' A' ' 193' ' ' ASN . 14.3 p -145.02 151.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.061 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.2 t -62.58 143.9 56.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.806 0.336 . . . . 0.0 110.6 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.16 -23.65 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.594 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -46.13 162.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.677 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -80.68 112.2 17.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.889 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.526 HD21 ' CG2' ' A' ' 188' ' ' VAL . 52.2 p30 -151.24 -149.34 0.3 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 36.8 t -63.46 146.34 53.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.564 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.52 140.43 51.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.485 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -71.34 141.33 50.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.466 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -102.92 131.25 49.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.6 p -133.79 137.47 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.02 130.35 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.44 136.92 52.48 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.593 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.73 147.99 19.36 Favored Glycine 0 N--CA 1.466 0.671 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -100.84 140.87 34.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.02 -0.59 . . . . 0.0 112.163 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 49.5 tp -64.46 129.44 39.89 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.212 0.529 . . . . 0.0 110.291 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 159' ' ' ALA . 64.5 t -107.72 -27.07 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.125 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.35 20.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.202 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.47 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 34.6 m -135.04 156.06 49.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.201 0.524 . . . . 0.0 109.814 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 206' ' ' THR . 20.6 ptmt -149.53 180.0 7.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.903 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.66 145.48 24.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.225 0.536 . . . . 0.0 110.787 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -74.51 81.17 1.95 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.647 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.642 178.845 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 55' ' ' HIS . 59.9 p 47.3 -124.28 1.55 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.437 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.476 ' N ' ' OG ' ' A' ' 54' ' ' SER . 76.6 t60 -100.29 45.08 0.99 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.394 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.3 ttt -61.27 -43.24 99.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.88 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -94.13 108.02 19.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.411 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.67 -9.17 58.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.039 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 m -84.55 -95.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.224 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt 45.61 27.92 0.47 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.093 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.4 mt -64.22 -48.21 86.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.384 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.3 t0 60.73 -101.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.75 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -150.05 77.45 8.38 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -42.64 147.9 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.353 2.035 . . . . 0.0 111.548 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.5 m-20 -75.51 158.67 32.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.23 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.05 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.198 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.05 -52.46 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.76 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 5.2 pt-20 -74.08 -17.84 60.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 65' ' ' ASP . 49.3 t -77.69 -54.73 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.903 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.38 84.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.272 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.55 110.77 1.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.793 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.6 m -94.35 120.48 34.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.1 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.514 HD11 ' OE1' ' A' ' 78' ' ' GLN . 41.7 tp -113.84 129.08 56.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.61 139.82 55.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -73.31 -8.72 57.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.24 0.543 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.48 -32.77 74.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.514 ' OE1' HD11 ' A' ' 74' ' ' LEU . 85.7 mt-30 -77.17 11.48 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.1 t -91.34 123.72 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -122.42 -5.21 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.984 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.25 -169.61 38.62 Favored Glycine 0 C--N 1.316 -0.54 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -146.48 154.01 41.08 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.251 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.9 tt -121.89 124.54 71.6 Favored 'Isoleucine or valine' 0 C--O 1.23 0.056 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -127.53 130.86 49.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -133.63 129.13 20.31 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.569 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -35.89 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.392 2.061 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -49.41 -40.19 35.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.529 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -119.57 -0.94 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.241 0.216 . . . . 0.0 110.819 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.33 52.14 3.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.2 tp -110.61 130.7 55.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.045 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -133.21 114.83 14.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 83' ' ' ILE . 50.4 mt -143.92 110.51 5.17 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.73 136.7 1.88 Allowed 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.6 1.533 . . . . 0.0 110.764 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.71 123.07 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.9 mt -103.4 131.0 50.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.34 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 97' ' ' SER . 20.1 pttp -72.44 -42.84 64.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.464 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 55.5 m -74.68 103.13 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.245 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.5 p -82.36 94.41 7.37 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.281 0.562 . . . . 0.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.416 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 2.4 p -134.31 154.38 51.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.903 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -56.46 -37.35 70.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -71.86 -46.28 58.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.501 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.502 ' ND2' HD13 ' A' ' 74' ' ' LEU . 6.9 m120 -66.2 -36.3 82.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.561 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.69 -16.18 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.721 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.0 mt -70.13 -27.61 64.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -93.36 -10.27 35.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 167.51 -174.43 42.61 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.983 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.46 130.17 38.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.294 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 147.46 29.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.865 0.364 . . . . 0.0 110.876 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.0 p -73.14 149.45 43.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.88 -43.24 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.74 141.36 28.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.18 0.514 . . . . 0.0 111.183 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.21 -16.09 41.37 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.56 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -144.27 56.51 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.31 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.45 ' NE2' ' CG ' ' A' ' 121' ' ' TYR . 3.0 tt0 -77.9 159.84 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.0 121.81 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.016 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -72.77 128.02 34.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.443 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.86 73.45 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -142.13 121.53 13.19 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 76.17 -174.71 53.13 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.491 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.9 t30 -83.79 110.43 18.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.45 ' CG ' ' NE2' ' A' ' 114' ' ' GLN . 6.8 t80 -83.52 103.59 12.98 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 130.4 36.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.109 0.48 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 HD12 ' A' ' 83' ' ' ILE . 7.9 mt -127.42 130.65 49.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.89 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.31 140.19 46.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 110.578 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.2 179.65 20.56 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.615 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -84.81 154.78 22.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.792 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 129' ' ' SER . 14.8 p30 -121.97 29.18 7.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.655 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.3 mtt -43.46 -13.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.776 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 61.78 38.35 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.935 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -135.11 107.7 7.4 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.89 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.29 125.61 12.93 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.634 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.73 8.97 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.927 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.5 t -83.48 179.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.584 0.692 . . . . 0.0 109.183 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.778 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.42 132.45 43.93 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.436 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 49.13 38.08 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.219 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.17 -12.31 58.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.8 m-20 -147.98 34.06 0.83 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 140' ' ' SER . 7.3 pt -68.87 -32.19 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.425 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.63 2.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.706 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 138' ' ' ILE . 8.5 t -93.5 -14.86 26.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.48 120.29 12.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.069 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mmtt -104.93 155.72 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -53.68 114.81 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.214 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.22 21.58 5.17 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 96.9 m-20 -99.16 128.02 45.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.94 133.14 35.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.792 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 93.1 mt -126.39 125.72 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.927 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.9 123.13 48.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.725 0.298 . . . . 0.0 110.759 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -112.48 146.36 38.59 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.067 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -116.05 131.16 57.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 152' ' ' ASN . 46.9 t0 -114.27 -166.52 1.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.6 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 111.852 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -138.41 29.86 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -128.96 145.23 51.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -111.52 121.78 46.08 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -102.73 133.51 47.64 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 111.513 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.1 118.08 31.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.765 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.416 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 41.3 m-85 -119.06 140.25 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.155 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.46 134.82 55.22 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.51 0.672 . . . . 0.0 110.449 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.29 135.64 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.733 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -101.46 -24.54 14.15 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 124.888 1.367 . . . . 0.0 110.764 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.58 154.08 7.32 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.294 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 163' ' ' VAL . 9.9 p -98.45 129.41 48.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.832 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.4 m -132.01 149.53 52.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.296 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -109.18 116.64 32.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.343 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -133.95 153.17 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.9 p -64.56 169.09 5.51 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 -13.87 11.81 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.884 1.723 . . . . 0.0 111.71 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.58 -19.66 41.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.639 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -85.79 75.34 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 109.944 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -74.74 -9.63 58.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.041 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -53.4 -22.47 7.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.78 ' O ' HG21 ' A' ' 183' ' ' THR . 79.9 t -81.03 -10.82 12.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.049 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.13 -12.08 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.739 0.78 . . . . 0.0 110.178 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.11 157.81 20.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.376 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 66.2 t0 -66.54 131.17 45.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.42 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 31.3 m80 -101.26 -41.63 6.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.35 29.9 0.24 Allowed Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.448 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 48.5 pttt -157.44 179.25 9.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.547 . . . . 0.0 111.515 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 26.7 p30 -90.81 88.81 7.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.866 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -123.63 166.56 15.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.128 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.85 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.78 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.78 HG21 ' O ' ' A' ' 173' ' ' VAL . 19.0 m -135.7 123.85 23.02 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.059 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 183' ' ' THR . 10.2 mp -111.79 125.09 53.63 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.129 0.49 . . . . 0.0 110.078 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.477 HG22 HG13 ' A' ' 198' ' ' VAL . 36.2 pt -134.32 162.1 39.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.001 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 64.6 p -89.36 167.93 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.413 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 98.4 m -76.19 131.94 39.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.519 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.97 151.52 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 190' ' ' VAL . 36.7 t -142.09 -149.95 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.806 0.336 . . . . 0.0 110.854 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 191' ' ' LYS . 58.1 t -58.74 166.36 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.612 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.587 ' N ' HG12 ' A' ' 190' ' ' VAL . 29.3 tptp -71.58 139.22 49.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.364 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 42.24 35.02 0.55 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.533 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -62.46 -51.15 68.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.757 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.7 p -169.13 164.13 11.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.719 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.61 130.15 42.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -97.77 147.09 24.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.868 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -110.63 138.72 46.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.303 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.503 HG11 HG11 ' A' ' 173' ' ' VAL . 50.1 t -133.33 136.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.23 128.43 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.562 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.63 136.52 52.9 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.331 0.586 . . . . 0.0 110.314 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.09 158.01 24.08 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.598 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 63.1 t0 -113.77 146.3 40.11 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.568 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.0 tp -68.04 130.82 44.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.062 0.458 . . . . 0.0 110.716 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.77 -22.85 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.5 175.89 45.96 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.329 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 207' ' ' LYS . 60.9 m -154.23 154.13 32.94 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.344 0.592 . . . . 0.0 111.014 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 206' ' ' THR . 63.8 pttt -148.33 177.58 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.524 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.69 142.78 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.061 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.23 80.81 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.272 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 208' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.55 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.1 m -70.55 145.37 50.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 78.4 m80 48.57 -163.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.409 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.452 ' HG2' ' H ' ' A' ' 57' ' ' ASP . 12.6 ttt 54.45 176.93 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.164 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' H ' ' HG2' ' A' ' 56' ' ' MET . 42.9 p-10 -140.89 113.33 8.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.76 0.314 . . . . 0.0 110.818 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.44 -13.43 61.44 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.706 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 61' ' ' ILE . 88.3 p -87.0 24.3 1.56 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.38 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.21 32.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.464 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.498 ' H ' ' C ' ' A' ' 59' ' ' SER . 64.6 mt -62.19 -49.28 84.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.212 0.529 . . . . 0.0 110.675 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' OD1' ' OG ' ' A' ' 189' ' ' SER . 99.3 m-20 51.28 -90.8 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.092 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.481 ' CG ' ' SD ' ' A' ' 128' ' ' MET . 9.1 tt0 -151.33 79.55 6.7 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.47 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.83 144.43 1.4 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.282 1.988 . . . . 0.0 111.526 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -75.68 158.05 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 66' ' ' LEU . 1.7 tt -57.09 -28.77 62.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.069 0.461 . . . . 0.0 110.095 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.52 97.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.647 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 97.7 mt-10 -73.63 -31.46 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.327 0.584 . . . . 0.0 110.789 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.8 t -75.48 -46.38 37.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.783 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.25 87.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.926 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.4 -30.37 64.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.342 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.56 119.68 9.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.811 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 m -93.21 156.51 16.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -138.29 122.1 17.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.918 0.389 . . . . 0.0 110.81 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.634 ' N ' HD13 ' A' ' 74' ' ' LEU . 99.2 m-20 -83.55 108.74 16.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 11.7 mptt -47.71 -15.39 0.06 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.082 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.479 ' N ' ' C ' ' A' ' 75' ' ' ASP . 99.2 mttt -69.51 -8.26 45.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.77 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.61 6.45 48.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.923 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.1 t -91.06 128.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.942 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.2 -6.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.728 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.61 -167.47 35.28 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 83' ' ' ILE . 19.4 ttm180 -150.96 157.0 42.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.402 0.62 . . . . 0.0 111.07 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.4 ' N ' ' CG ' ' A' ' 82' ' ' ARG . 15.8 tt -129.88 134.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.979 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.1 t -131.53 133.3 44.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.951 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.6 mt -136.0 127.92 17.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.329 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.21 -33.08 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.41 2.073 . . . . 0.0 112.02 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -49.12 -41.93 37.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.586 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -116.09 -1.69 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.8 -0.182 . . . . 0.0 110.878 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 64.38 50.04 2.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.8 tp -113.47 130.9 56.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.259 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -134.77 116.06 14.43 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.9 mt -143.7 163.28 37.06 Favored Pre-proline 0 N--CA 1.463 0.183 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.737 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.5 157.5 6.53 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.981 2.454 . . . . 0.0 109.235 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.0 t -107.01 117.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.0 mt -101.21 129.99 47.24 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -71.06 -36.99 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.986 0.422 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.0 m -75.54 100.12 4.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 98' ' ' SER . 53.5 p -82.85 92.93 7.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.2 p -133.81 155.87 49.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.016 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -55.36 -32.67 62.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.402 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -76.57 -46.5 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.003 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -66.25 -34.45 78.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.832 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.92 -18.88 59.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.63 -18.24 61.6 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.8 m -99.9 -11.25 20.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.53 -155.88 25.77 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.973 -1.108 . . . . 0.0 111.658 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.29 126.17 36.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.889 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.95 144.26 32.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -75.55 152.96 37.68 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.44 -47.96 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -92.44 137.64 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 110.853 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 14.2 pt-20 -62.89 -47.11 84.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.869 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 61.6 t-20 -96.74 47.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.404 ' NE2' ' CE1' ' A' ' 121' ' ' TYR . 3.2 tt0 -91.55 155.38 18.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.4 t -130.27 133.79 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.202 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.6 mtp -73.51 126.24 29.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.704 0.288 . . . . 0.0 110.474 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.31 67.43 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.26 120.08 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.092 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.21 -178.31 41.32 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -73.82 107.43 6.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.404 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 10.6 t80 -84.26 103.51 13.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.97 126.55 35.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.122 0.486 . . . . 0.0 111.495 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -121.4 131.31 54.1 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.69 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 139.17 45.01 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.311 0.577 . . . . 0.0 110.662 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.78 15.17 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.701 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -92.44 146.09 23.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.726 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.8 p30 -108.01 27.53 9.16 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.293 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.481 ' SD ' ' CG ' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -42.18 -16.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.701 -179.175 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 127' ' ' ASN . 2.6 t 55.06 37.14 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.812 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -133.87 111.96 10.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.458 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.67 123.66 14.83 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.152 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.43 5.93 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 134' ' ' LEU . 41.8 t -137.37 177.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.761 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -69.76 128.0 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.758 0.313 . . . . 0.0 110.644 -178.164 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 47.41 38.5 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 110.468 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.39 -6.02 59.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.723 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.6 t0 -151.16 39.97 0.69 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.071 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.0 pt -69.02 -30.18 45.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.49 4.14 3.28 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 49.6 m -95.69 -14.48 23.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 109.749 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.01 124.81 23.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.529 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -96.73 156.57 16.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.755 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.21 128.8 38.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.415 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.5 20.81 43.1 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.403 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 30.0 m-20 -82.36 136.36 35.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.495 ' NZ ' HG11 ' A' ' 204' ' ' VAL . 27.9 mmtt -80.35 126.63 31.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 112.1 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.68 118.01 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 121.3 41.26 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.2 tp -114.28 142.84 45.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.984 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.17 136.42 44.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.242 0.544 . . . . 0.0 111.468 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 154' ' ' ASN . 40.9 t0 -113.0 177.0 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.347 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' A' ' 153' ' ' GLU . 19.4 p-10 -35.79 -54.46 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.409 0.623 . . . . 0.0 111.338 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 97.7 mt-10 -141.69 16.56 2.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -128.63 142.42 51.04 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -109.35 124.02 50.28 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CE2' HG21 ' A' ' 206' ' ' THR . 56.7 m-85 -106.55 134.99 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.388 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.73 118.49 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.408 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -115.88 138.0 51.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.246 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.78 132.58 55.11 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.429 0.633 . . . . 0.0 110.822 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 48.6 t -66.98 134.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.7 p -101.75 -28.33 12.52 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 124.443 1.089 . . . . 0.0 110.799 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.44 143.73 4.39 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.775 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.43 137.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 18.8 t -159.56 171.11 20.24 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.136 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -122.53 130.27 52.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.426 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.12 157.37 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.492 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 169' ' ' ASP . 6.8 p -68.56 130.18 92.16 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.452 ' HG3' HH21 ' A' ' 196' ' ' ARG . 1.5 Cg_endo -46.38 -11.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.921 1.747 . . . . 0.0 111.648 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 167' ' ' THR . 43.1 t0 -75.69 -22.2 56.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -84.82 73.15 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.009 0.433 . . . . 0.0 110.134 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -71.69 -14.66 62.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.513 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.479 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.5 mt-10 -52.97 -34.38 55.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.216 0.531 . . . . 0.0 110.074 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.714 ' O ' HG21 ' A' ' 183' ' ' THR . 97.2 t -70.94 -5.22 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.024 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.77 -14.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.678 0.751 . . . . 0.0 109.969 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -86.2 177.16 7.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.835 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.3 p-10 -81.74 131.66 35.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.479 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 42.9 m80 -103.21 -41.76 5.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.9 27.13 0.13 Allowed Glycine 0 N--CA 1.471 0.98 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -157.47 179.56 9.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 111.411 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -89.98 90.25 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -121.01 166.93 13.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.081 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.9 tt -132.32 144.07 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.714 HG21 ' O ' ' A' ' 173' ' ' VAL . 18.8 m -135.72 126.37 27.15 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.196 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -112.55 118.23 34.52 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.409 HG22 HG13 ' A' ' 198' ' ' VAL . 12.0 pt -134.3 171.67 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.643 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.57 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.3 p -125.92 131.29 52.34 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.716 0.293 . . . . 0.0 110.892 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 6.8 t -82.74 128.46 34.39 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.332 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 59' ' ' SER . 56.9 t -127.31 -94.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.439 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.404 ' OG ' ' OD1' ' A' ' 62' ' ' ASP . 42.5 m -158.55 155.4 28.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.818 0.342 . . . . 0.0 110.467 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.4 -25.88 34.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.271 0.558 . . . . 0.0 110.487 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -53.1 -26.75 17.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.053 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 52.39 37.97 23.96 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.68 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -72.36 -3.61 25.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.072 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.8 p -151.91 161.35 42.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.0 110.623 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -94.38 145.28 24.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.113 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.57 ' NH1' ' O ' ' A' ' 186' ' ' THR . 16.7 ptp180 -115.59 166.51 11.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.028 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.34 140.66 44.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.409 HG13 HG22 ' A' ' 185' ' ' ILE . 47.4 t -129.61 132.17 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.132 0.492 . . . . 0.0 111.14 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.7 t -116.22 127.31 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.512 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.19 135.56 53.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.92 157.5 25.37 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 60.6 t0 -115.11 152.49 32.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.446 -0.377 . . . . 0.0 111.161 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.562 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.95 129.24 38.09 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.085 0.469 . . . . 0.0 110.767 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.495 HG11 ' NZ ' ' A' ' 146' ' ' LYS . 5.1 p -107.81 -25.97 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.011 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.68 175.29 47.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.219 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.428 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.5 m -152.67 150.26 29.28 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.194 0.521 . . . . 0.0 110.883 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -148.62 178.0 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.538 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.97 21.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.151 0.5 . . . . 0.0 110.817 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -77.08 79.82 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.744 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.561 178.422 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.409 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 56' ' ' MET . 8.4 m 46.24 -165.05 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 55' ' ' HIS . 51.9 t-80 47.87 15.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.372 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 54' ' ' SER . 65.5 mtt 48.99 -173.94 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.895 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 62.7 t0 -153.9 152.23 30.38 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.879 0.371 . . . . 0.0 110.85 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.558 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -71.79 -14.13 61.9 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.78 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 61' ' ' ILE . 69.1 p -87.61 12.31 12.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.982 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -67.86 39.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.931 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 59' ' ' SER . 55.3 mt -60.68 -49.66 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.716 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.2 t0 50.67 -95.75 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.012 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -151.0 86.58 4.84 Favored Pre-proline 0 C--O 1.234 0.289 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.22 155.57 41.93 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.855 2.37 . . . . 0.0 110.984 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -74.58 160.29 31.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.1 mp -64.66 -21.31 66.7 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.251 0.344 . . . . 0.0 110.862 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.73 -40.28 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.49 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.3 mt-10 -72.29 -34.91 68.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.623 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.8 t -75.07 -45.2 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.074 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.5 87.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.02 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -84.04 -23.31 30.96 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.621 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.23 118.98 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.336 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -94.78 140.75 29.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.198 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 ' CB ' ' A' ' 105' ' ' SER . 57.4 tp -115.42 140.71 48.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.452 ' C ' ' N ' ' A' ' 77' ' ' LYS . 39.2 m-20 -95.11 100.92 12.65 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -46.89 -18.06 0.06 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.452 ' N ' ' C ' ' A' ' 75' ' ' ASP . 3.2 ttmp? -65.95 -33.8 76.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.312 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 0.9 OUTLIER -80.08 13.94 2.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.817 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.467 HG11 ' NH1' ' A' ' 82' ' ' ARG . 89.1 t -91.49 127.48 43.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.633 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.15 -6.31 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.106 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.83 -173.19 43.94 Favored Glycine 0 C--N 1.321 -0.284 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.497 ' O ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -141.87 153.94 44.79 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.841 -177.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.8 tt -125.75 131.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 t -134.01 132.02 39.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.692 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.17 128.74 19.6 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.17 -36.67 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.412 2.075 . . . . 0.0 112.376 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -48.4 -39.98 24.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.51 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.3 p -119.31 -1.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.372 0.42 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.75 50.24 4.46 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.11 131.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.574 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.79 114.66 12.09 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 83' ' ' ILE . 76.2 mt -142.53 112.35 5.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -40.05 140.61 0.79 Allowed 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.661 1.574 . . . . 0.0 110.302 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.6 t -93.15 122.02 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.66 123.47 48.55 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.484 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.06 -47.8 76.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.184 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -71.7 105.88 3.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.878 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -85.8 100.95 12.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.5 p -131.75 156.96 45.05 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.104 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.66 -28.99 61.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -82.87 -42.39 17.82 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.882 0.739 . . . . 0.0 111.936 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.63 -38.09 88.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.136 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.62 -19.76 62.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.061 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.49 -33.17 70.93 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.45 ' CB ' HD22 ' A' ' 74' ' ' LEU . 16.2 m -95.58 -9.47 32.19 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 177.43 179.57 47.73 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.254 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.89 127.82 33.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.948 -0.626 . . . . 0.0 109.84 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.63 146.14 31.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.4 p -76.4 153.87 35.34 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.0 t -85.43 -48.18 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -92.26 137.72 32.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.41 0.624 . . . . 0.0 110.698 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.9 pt-20 -60.32 -47.6 85.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.161 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 98.8 m-20 -98.8 47.41 0.98 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.39 155.45 21.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.964 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.9 131.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.409 ' SD ' HD22 ' A' ' 149' ' ' LEU . 65.3 mtt -74.98 128.0 34.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.11 0.54 70.94 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -139.36 118.15 12.38 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.017 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -171.86 53.65 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -83.66 110.81 18.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.1 102.9 13.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 128.99 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.597 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.5 HD13 HD12 ' A' ' 83' ' ' ILE . 6.5 mt -123.96 130.45 52.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.331 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.92 138.21 47.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.318 0.58 . . . . 0.0 110.806 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.36 -179.05 17.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.259 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 134' ' ' LEU . 37.5 m-70 -86.46 144.44 27.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.455 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 129' ' ' SER . 8.1 t-20 -110.99 28.19 8.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.061 0.458 . . . . 0.0 110.652 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -47.37 -11.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.11 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 127' ' ' ASN . 2.3 t 56.1 40.67 30.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.024 -0.671 . . . . 0.0 109.928 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.31 105.93 7.6 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -50.42 124.94 11.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.614 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -26.4 9.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.374 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.803 HG12 ' H ' ' A' ' 134' ' ' LEU . 39.7 t -82.82 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.803 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -72.88 132.33 43.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 48.85 37.79 10.68 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.93 0.395 . . . . 0.0 111.345 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -82.12 -11.4 58.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 136' ' ' SER . 83.7 m-20 -145.51 38.13 1.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -66.09 -36.13 76.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB2' ' CG ' ' A' ' 197' ' ' TYR . . . -68.48 3.08 1.95 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.815 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 138' ' ' ILE . 6.3 t -96.49 -11.19 25.88 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.279 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.39 122.26 18.03 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.538 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 64.4 mttp -95.57 161.46 14.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.391 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -61.12 135.12 57.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.46 19.08 57.61 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 2.6 m-20 -85.1 130.05 34.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.88 131.09 35.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.2 mt -122.57 123.09 67.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -100.63 118.67 37.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.5 mt -113.53 149.15 34.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.194 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -124.64 130.26 52.09 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.433 0.635 . . . . 0.0 111.416 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.7 t0 -113.52 -168.52 1.35 Allowed 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 90.9 m-20 -24.86 -71.69 0.03 OUTLIER 'General case' 0 C--O 1.232 0.154 0 O-C-N 123.475 0.485 . . . . 0.0 111.579 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.62 26.6 2.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.25 146.87 44.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -111.74 118.7 36.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.735 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.492 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.7 m-85 -105.44 127.99 53.29 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.571 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -98.82 122.75 42.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.926 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -122.08 142.32 50.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 135.02 55.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.335 0.588 . . . . 0.0 110.703 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.7 133.35 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.51 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.1 t -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.64 1.212 . . . . 0.0 111.515 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.32 149.95 6.51 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.3 t -104.8 134.38 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -135.66 151.31 50.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.444 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.72 116.87 32.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.634 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.77 154.84 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 169' ' ' ASP . 23.4 p -78.16 140.46 61.5 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.59 -18.26 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.975 1.783 . . . . 0.0 111.867 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.7 m-20 -77.4 -21.19 53.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.025 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -83.03 70.54 10.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.119 0.568 . . . . 0.0 110.176 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.528 ' C ' ' H ' ' A' ' 173' ' ' VAL . 82.0 m95 -70.48 -27.04 63.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.944 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.4 -10.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.631 0.582 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.5 t -80.95 -23.69 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.501 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.01 -5.33 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.588 0.708 . . . . 0.0 110.015 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.35 142.06 36.38 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.925 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -54.84 128.98 35.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -102.4 -42.72 5.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.49 28.52 0.15 Allowed Glycine 0 N--CA 1.471 0.985 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -157.15 179.76 8.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.999 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 8.1 m-20 -93.87 94.12 8.32 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 182' ' ' ILE . 46.1 tt0 -127.54 170.87 12.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.906 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.409 ' H ' ' HG2' ' A' ' 181' ' ' GLU . 20.6 tt -131.63 143.19 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.709 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.496 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.7 m -138.29 116.89 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -102.38 119.59 39.08 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.605 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -130.97 -169.97 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.379 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 31.0 p -134.9 151.84 51.22 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.376 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.8 p -98.29 133.2 43.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.971 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 190' ' ' VAL . 8.2 m -141.97 -40.42 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.484 ' N ' HG23 ' A' ' 188' ' ' VAL . 11.8 m 48.55 -91.74 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.442 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 188' ' ' VAL . 69.1 t -63.71 135.41 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.514 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 tttp 51.13 87.89 0.03 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.612 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.76 141.13 58.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.474 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -86.55 113.36 22.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.561 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 79.8 p -57.58 -34.81 69.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.043 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -90.17 56.51 3.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.035 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -78.11 127.93 33.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.689 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' A' ' 139' ' ' ALA . 4.9 m-85 -117.3 132.44 56.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.528 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 185' ' ' ILE . 48.3 t -135.6 136.57 50.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.091 0.472 . . . . 0.0 111.046 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.96 129.65 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.673 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.66 133.39 55.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.144 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.77 146.62 17.1 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 121.807 0.671 . . . . 0.0 111.706 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -105.32 139.12 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.714 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.18 129.16 38.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.937 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 p -106.41 -25.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.073 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.27 159.6 16.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.453 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.492 HG21 ' CE2' ' A' ' 156' ' ' TYR . 29.9 m -135.7 155.02 51.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.86 177.78 9.51 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.3 144.34 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.551 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.07 79.09 0.67 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.023 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.548 178.813 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.1 t -133.84 -13.73 2.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.539 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -105.71 127.99 53.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 20.6 ptp -69.01 163.95 23.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.884 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 40.2 p-10 -65.31 119.11 10.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 110.346 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.63 76.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.9 m -150.88 -84.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.414 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm 55.28 31.29 16.32 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.432 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 62' ' ' ASP . 35.8 mm -65.86 -44.58 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.778 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 64' ' ' PRO . 10.4 t0 61.22 119.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.519 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 62' ' ' ASP . 2.5 pt20 -38.15 93.69 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' N ' ' O ' ' A' ' 62' ' ' ASP . 6.1 Cg_exo -75.44 154.28 40.34 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.566 2.177 . . . . 0.0 111.262 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.99 152.51 41.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.691 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.2 pt? -59.0 -23.98 62.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.402 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.6 mt-10 -73.07 -33.07 65.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.606 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.3 -42.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.1 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.09 92.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.405 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.1 p-10 -86.31 -15.14 41.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.669 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.08 120.27 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.107 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.2 p -91.39 159.55 15.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.11 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.11 142.57 44.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -94.12 100.51 12.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -57.23 -14.93 4.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.049 0.452 . . . . 0.0 110.347 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -76.44 -14.55 60.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.146 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.47 13.17 34.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.529 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.13 135.99 24.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.988 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.408 HD13 ' HB3' ' A' ' 96' ' ' LYS . 4.4 pt -117.5 -3.55 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.035 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.63 34.86 Favored Glycine 0 C--N 1.317 -0.518 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -154.05 165.26 36.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.808 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 tt -134.3 140.96 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.891 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 t -133.52 135.79 44.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.362 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 14.0 mt -134.58 127.77 18.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.802 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.55 -38.34 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.357 2.038 . . . . 0.0 112.584 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -47.37 -41.01 18.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.599 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.4 p -116.69 -3.31 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.828 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.83 49.46 1.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -107.49 127.3 53.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.865 -178.37 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.649 ' N ' HD13 ' A' ' 90' ' ' LEU . 83.2 tt0 -138.16 116.14 11.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.645 HD23 ' HD2' ' A' ' 93' ' ' PRO . 2.7 mt -157.71 127.52 3.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.471 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.645 ' HD2' HD23 ' A' ' 92' ' ' LEU . 1.3 Cg_endo -42.96 159.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.929 0 C-N-CA 121.928 1.752 . . . . 0.0 109.703 176.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 t -113.61 124.66 70.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.11 128.89 49.86 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.217 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HB3' HD13 ' A' ' 80' ' ' ILE . 62.8 pttt -65.05 -35.3 80.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.717 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -176.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.632 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 p -162.51 55.48 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.699 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.0 p -105.68 160.03 15.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.151 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.48 -32.33 71.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.603 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.4 -41.85 55.2 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.85 0.719 . . . . 0.0 112.26 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 102' ' ' ASN . 9.4 m120 -65.82 -39.92 91.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.553 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.9 mt -59.78 -19.82 52.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.87 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.467 HD23 ' NE2' ' A' ' 126' ' ' HIS . 15.8 mt -69.25 -34.85 75.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.0 m -97.16 -7.71 31.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -179.0 -174.6 45.33 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . . . -83.58 127.95 34.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.12 -0.54 . . . . 0.0 109.882 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.422 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.38 141.61 36.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.768 0.318 . . . . 0.0 110.715 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.4 p -71.87 147.54 47.02 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.77 -47.68 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -92.03 -170.47 2.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.657 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 113' ' ' ASN . 1.6 pt-20 -113.19 -53.86 2.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.951 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.456 ' H ' ' HG3' ' A' ' 112' ' ' GLU . 89.0 m-20 -94.42 44.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.37 154.54 17.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.71 133.9 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.816 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.458 ' SD ' HD22 ' A' ' 149' ' ' LEU . 68.5 mtt -69.66 128.39 36.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.989 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.481 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.68 1.33 77.49 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.6 123.44 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.974 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.19 -164.36 54.34 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -94.64 108.68 20.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -84.91 100.87 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.043 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 124.63 35.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.511 . . . . 0.0 111.722 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.94 132.02 54.33 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.322 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.6 138.9 45.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.375 0.607 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.69 -176.26 16.63 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.43 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 135' ' ' PHE . 15.3 m-70 -86.11 141.79 29.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.815 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 129' ' ' SER . 5.3 t-20 -109.86 26.88 10.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.214 0.531 . . . . 0.0 110.481 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -46.34 -14.29 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.778 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 129' ' ' SER . 1.4 p 55.2 41.15 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.822 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 136' ' ' SER . 30.5 mmtm -133.91 129.25 36.06 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.653 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -74.24 124.52 26.56 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.41 -28.24 6.61 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 134' ' ' LEU . 4.2 t -78.04 170.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.22 133.16 40.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.685 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 126' ' ' HIS . 3.6 m-85 49.27 38.74 14.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 1.1 p -80.33 -61.26 2.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.282 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 136' ' ' SER . 97.9 m-20 -89.35 39.7 0.95 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.7 pt -69.78 -26.72 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.241 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.42 6.81 5.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.0 t -95.33 -13.64 24.59 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.26 118.74 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -98.4 161.57 13.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.741 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -58.38 118.54 5.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.133 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.95 21.06 7.63 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 90.9 m-20 -96.65 127.99 43.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -80.58 138.31 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.956 0.408 . . . . 0.0 111.332 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 158' ' ' TYR . 97.5 mt -129.4 123.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -101.76 119.22 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.996 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.458 HD22 ' SD ' ' A' ' 116' ' ' MET . 2.7 mt -110.0 158.15 18.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.346 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 149' ' ' LEU . 66.6 m-85 -141.63 121.22 13.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.092 0.472 . . . . 0.0 111.859 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 152' ' ' ASN . 13.3 t0 -114.64 -166.11 1.08 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.579 ' C ' ' O ' ' A' ' 151' ' ' ASP . 95.1 m-20 -4.4 -88.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.857 0.723 . . . . 0.0 111.32 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -138.99 30.83 2.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -121.73 140.96 51.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -102.89 120.78 41.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.196 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.457 ' CE2' HG21 ' A' ' 206' ' ' THR . 90.7 m-85 -105.07 125.21 50.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.725 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -94.19 115.27 27.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.481 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.6 m-85 -117.18 142.82 46.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.224 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.06 132.13 53.98 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.439 0.637 . . . . 0.0 110.501 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.7 135.87 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.269 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 14.2 p -101.75 -25.56 13.79 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.783 1.302 . . . . 0.0 110.99 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.49 177.18 34.35 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.146 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.09 149.1 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.743 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.42 ' O ' HG12 ' A' ' 198' ' ' VAL . 38.9 m -152.59 161.6 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 0.0 111.099 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -99.36 120.93 40.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 196' ' ' ARG . 18.4 m -132.45 157.45 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 169' ' ' ASP . 32.1 p -82.42 135.93 46.41 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.584 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -46.37 -15.1 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.004 1.803 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 67.3 t0 -84.52 -22.61 30.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -83.95 72.42 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.062 0.458 . . . . 0.0 110.928 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 94.1 m95 -74.94 -2.22 26.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.969 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.467 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 72.4 mm-40 -54.19 -39.0 66.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.743 ' O ' HG21 ' A' ' 183' ' ' THR . 17.9 m -75.19 4.57 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.944 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.07 -15.99 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.904 0.859 . . . . 0.0 110.042 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.403 ' O ' ' CD2' ' A' ' 177' ' ' HIS . 63.4 mm-40 -89.21 166.45 13.8 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.972 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -68.18 129.42 39.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.083 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.467 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.0 m170 -103.32 -40.54 6.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.143 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.83 25.23 0.12 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -156.41 179.23 9.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.863 0.363 . . . . 0.0 110.815 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -97.36 93.36 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.802 0.81 . . . . 0.0 110.408 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -127.02 175.16 8.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.407 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -130.38 143.47 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.216 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.743 HG21 ' O ' ' A' ' 173' ' ' VAL . 13.1 m -135.99 123.67 22.38 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.557 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 183' ' ' THR . 10.5 mp -112.19 121.96 46.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.455 0.645 . . . . 0.0 110.982 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.27 -174.84 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.829 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.546 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 15.4 p -138.53 158.46 44.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.368 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 99.6 m -62.75 -39.14 93.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.22 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 189' ' ' SER . 2.1 t -130.61 -140.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.314 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.536 ' H ' HG12 ' A' ' 188' ' ' VAL . 34.8 p -157.52 165.66 35.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.764 0.316 . . . . 0.0 110.437 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 190' ' ' VAL . 9.7 p -63.6 130.24 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? 45.59 -141.14 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.952 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -65.65 -80.19 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 45.88 86.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.976 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.7 t -58.84 -45.11 90.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 111.098 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -85.39 137.92 32.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.26 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 186' ' ' THR . 39.1 ttm180 -95.88 137.01 35.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.003 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.57 140.96 35.52 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 164' ' ' SER . 2.9 p -140.71 144.54 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.72 0.295 . . . . 0.0 111.425 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.63 129.91 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.204 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -121.21 138.93 53.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.256 0.551 . . . . 0.0 110.507 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.66 160.96 24.98 Favored Glycine 0 N--CA 1.461 0.337 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.8 t0 -113.55 149.69 34.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.954 -0.623 . . . . 0.0 111.135 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.536 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 21.7 tp -73.42 132.39 42.92 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 159' ' ' ALA . 59.3 t -107.96 -27.1 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.512 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.93 160.37 16.82 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.388 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.457 HG21 ' CE2' ' A' ' 156' ' ' TYR . 28.4 m -136.42 155.6 49.78 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -151.62 179.84 8.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.08 143.19 26.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.461 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.5 81.22 1.95 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.528 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.379 178.693 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.1 t -153.82 151.56 29.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.911 0.386 . . . . 0.0 110.627 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -109.98 152.29 26.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.503 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 12.7 ptp -75.76 145.78 40.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.702 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.98 138.14 54.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.336 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.06 -41.66 73.88 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.023 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 96.1 p -150.5 -96.25 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.482 ' N ' ' OG ' ' A' ' 59' ' ' SER . 99.4 mttt 48.88 40.77 17.3 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.692 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.2 mm -63.05 -45.11 99.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.331 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.8 t0 68.42 -123.51 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.268 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -140.78 72.17 29.42 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -43.26 145.53 1.38 Allowed 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.485 2.123 . . . . 0.0 111.391 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -77.57 163.3 26.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.163 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.631 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.0 pt? -60.16 -21.75 62.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.234 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.23 -39.62 94.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.1 mm-40 -73.76 -30.33 62.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.317 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -77.31 -44.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.799 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.98 85.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 61.3 t-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.75 139.72 57.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.696 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -140.82 84.21 1.93 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 111.361 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.6 tp -82.15 134.64 35.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.21 138.81 55.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.439 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -64.02 -8.73 12.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 109.78 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -64.02 -30.12 71.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.863 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -76.75 9.87 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.109 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.69 124.41 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -129.8 -3.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.64 -170.55 32.58 Favored Glycine 0 C--N 1.315 -0.607 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' HD2' ' H ' ' A' ' 83' ' ' ILE . 5.3 tpt180 -153.02 151.14 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.837 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 92' ' ' LEU . 5.7 tt -123.39 127.4 74.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -128.3 129.57 46.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.462 HG21 HD21 ' A' ' 141' ' ' LEU . 45.2 mt -135.02 122.26 15.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.284 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -82.28 -33.89 0.49 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.372 2.048 . . . . 0.0 112.877 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.464 ' CB ' HD23 ' A' ' 141' ' ' LEU . 1.6 m -50.38 -36.37 32.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.45 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.628 HG23 HD23 ' A' ' 90' ' ' LEU . 18.7 m -120.17 -6.34 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.634 0.254 . . . . 0.0 110.982 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.84 48.22 0.41 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.628 HD23 HG23 ' A' ' 88' ' ' VAL . 3.7 mm? -109.92 129.69 55.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.839 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.617 ' O ' HD12 ' A' ' 92' ' ' LEU . 97.2 mt-10 -135.34 115.85 13.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.617 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.1 tp -146.35 111.15 4.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.4 Cg_endo -41.02 147.89 0.25 Allowed 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 121.636 1.558 . . . . 0.0 110.529 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.4 t -96.16 124.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.9 145.33 30.55 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -90.41 -35.33 15.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.279 0.561 . . . . 0.0 110.961 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.631 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 2.1 p -76.22 97.95 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.117 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -82.66 89.98 6.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.059 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 p -133.14 157.75 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.901 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.89 -29.76 60.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.765 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 11.4 ptpt -83.29 -43.84 15.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.631 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 3.1 m-20 -66.63 -34.21 77.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.635 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.99 -20.93 63.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.433 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.46 -18.79 61.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.6 p -102.42 -13.11 17.41 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.21 -179.43 47.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.165 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.55 125.84 28.43 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.6 143.16 34.14 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.866 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 46.7 p -75.1 154.15 37.96 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.68 -56.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -96.4 141.22 29.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.993 0.425 . . . . 0.0 110.689 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.2 pm0 -82.47 6.65 16.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -131.27 24.89 4.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -93.75 156.16 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.195 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.2 t -133.28 133.89 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.851 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.4 mtt -67.24 127.6 33.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.995 0.426 . . . . 0.0 110.237 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 90.96 2.41 71.68 Favored Glycine 0 C--O 1.23 -0.101 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -141.06 121.87 14.4 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.067 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.18 -168.88 53.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -87.86 110.03 20.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.52 103.67 13.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.88 127.79 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 112.105 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 HD12 ' A' ' 83' ' ' ILE . 6.1 mt -123.54 132.41 53.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.933 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.57 139.08 45.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.402 0.62 . . . . 0.0 110.656 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.74 -176.58 15.01 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.72 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -97.46 141.5 30.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.951 0.405 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' SER . 43.5 p-10 -102.3 27.76 6.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -21.8 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.159 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 62.09 37.29 14.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.477 ' N ' ' OG ' ' A' ' 136' ' ' SER . 63.7 mmtt -133.32 108.02 8.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.769 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -50.66 125.98 14.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.809 0.814 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.02 -30.26 7.83 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.631 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 134' ' ' LEU . 59.4 t -76.02 178.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.355 0 CA-C-N 117.681 0.74 . . . . 0.0 109.437 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.756 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -71.15 136.39 48.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.778 0.323 . . . . 0.0 110.437 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.3 m-85 44.11 32.03 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.324 0.583 . . . . 0.0 110.561 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -81.26 -12.26 59.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 29.4 t0 -142.62 26.45 1.76 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.2 pt -70.16 -25.76 28.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.797 0.332 . . . . 0.0 111.581 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.11 1.11 6.27 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.1 m -95.41 -11.7 27.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.464 HD23 ' CB ' ' A' ' 87' ' ' SER . 18.3 mt -63.9 124.22 20.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.008 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 145' ' ' ASP . 99.2 mttt -96.4 158.17 15.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -56.58 134.87 54.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.185 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.36 19.49 62.24 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 142' ' ' LYS . 28.7 m-20 -81.43 132.73 35.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -79.51 130.33 35.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.274 0.559 . . . . 0.0 111.515 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.6 mt -122.92 121.68 63.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.583 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.4 120.57 40.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.118 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.0 OUTLIER -110.73 158.83 18.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -132.96 128.11 35.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.635 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.517 ' O ' ' C ' ' A' ' 152' ' ' ASN . 44.4 t0 -113.89 -166.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.517 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.3 t-20 -21.95 -74.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.152 0.501 . . . . 0.0 111.929 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.22 27.95 1.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -122.54 144.93 48.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -108.13 122.73 47.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.032 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.469 ' CE2' HG21 ' A' ' 206' ' ' THR . 71.8 m-85 -106.32 127.37 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.822 0.344 . . . . 0.0 111.489 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.62 115.88 28.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.503 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.517 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 22.4 m-85 -117.07 142.24 47.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.308 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.7 134.51 55.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.629 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.5 133.97 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.915 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -102.14 -25.86 13.56 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 124.544 1.153 . . . . 0.0 110.787 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.98 142.34 3.37 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.857 -1.163 . . . . 0.0 111.768 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 141' ' ' LEU . 10.0 t -104.77 152.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.5 t -168.42 178.32 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.4 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.79 115.13 26.52 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.36 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 12.5 m -117.0 139.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.543 ' C ' HH12 ' A' ' 196' ' ' ARG . 66.8 p -54.23 162.6 1.5 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.57 -19.76 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.194 1.929 . . . . 0.0 111.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 34.3 p30 -81.91 -19.31 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 35.1 ttpt -88.13 74.68 8.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 110.503 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -75.27 -6.1 48.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.851 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.7 -24.55 14.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.745 ' O ' HG21 ' A' ' 183' ' ' THR . 94.2 t -78.21 -3.25 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.815 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.65 -12.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.665 0.745 . . . . 0.0 109.814 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -85.6 155.63 21.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.934 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.33 132.14 47.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.62 -39.33 6.41 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.44 28.56 0.17 Allowed Glycine 0 N--CA 1.471 1.012 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -155.1 174.92 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.126 0.489 . . . . 0.0 111.284 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -90.13 89.34 7.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.692 0.758 . . . . 0.0 109.557 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -119.59 168.36 11.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.826 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.7 tt -129.95 141.32 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.226 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.745 HG21 ' O ' ' A' ' 173' ' ' VAL . 11.9 m -137.11 123.4 20.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.178 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.598 HD12 ' C ' ' A' ' 183' ' ' THR . 11.0 mp -112.59 122.75 48.6 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.194 0.521 . . . . 0.0 110.091 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 pt -132.91 168.08 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.689 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 187' ' ' CYS . 74.3 p -138.99 158.42 44.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.633 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' A' ' 186' ' ' THR . 98.2 m 46.33 94.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.291 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 71.3 t -61.32 -47.56 92.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.999 0.428 . . . . 0.0 110.607 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.2 p -80.92 165.79 21.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.281 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 190' ' ' VAL . 11.2 p -122.85 130.9 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -158.71 -80.01 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.747 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.48 -41.22 96.6 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.482 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -106.88 117.68 34.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.154 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 45.6 t -61.61 -44.04 97.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 110.903 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -124.34 149.62 46.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.774 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 166' ' ' VAL . 35.2 ptt-85 -117.91 169.08 9.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -97.57 131.41 44.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.465 HG21 HG22 ' A' ' 166' ' ' VAL . 42.3 t -131.48 133.57 61.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 111.253 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.0 t -111.28 124.06 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.02 134.16 55.04 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.06 160.88 25.49 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.5 t0 -114.56 151.43 33.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.974 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.65 129.86 38.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.443 0.639 . . . . 0.0 110.755 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 98.7 t -106.34 -24.48 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.161 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.74 163.33 23.59 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.036 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.469 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.7 m -136.6 154.46 50.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.278 0.561 . . . . 0.0 109.975 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -148.99 179.43 7.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.176 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.65 24.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.279 0.562 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.68 80.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.612 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.574 178.644 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.8 t -144.03 110.76 5.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.887 0.375 . . . . 0.0 110.354 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -147.19 137.98 23.64 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.933 0.397 . . . . 0.0 110.906 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.2 mtt -65.18 -41.48 94.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.615 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -132.22 111.13 11.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.283 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.01 -59.96 2.48 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.258 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 61' ' ' ILE . 69.6 p -154.83 44.43 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.155 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -71.28 19.67 0.06 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.038 0.447 . . . . 0.0 111.325 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.498 ' H ' ' C ' ' A' ' 59' ' ' SER . 40.2 mt -63.74 -46.85 93.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.116 0.484 . . . . 0.0 110.596 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.6 t0 56.84 -100.58 0.11 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.802 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -150.26 78.92 7.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.94 136.75 4.72 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.386 2.057 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.18 166.93 20.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.906 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.6 mp -52.02 -28.44 17.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.607 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 71' ' ' ASN . . . -65.43 -39.73 92.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.542 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 71.5 mm-40 -73.81 -31.28 63.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.741 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.83 -45.88 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.821 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.51 78.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.07 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 67' ' ' ALA . 9.3 m120 -69.06 -29.25 67.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.997 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.41 100.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -96.93 111.39 23.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.395 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -111.36 128.6 56.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.8 m-20 -71.97 138.71 48.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.267 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 79' ' ' VAL . 1.3 mppt? -64.43 0.45 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 109.877 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 75' ' ' ASP . 13.2 mptt -92.06 -8.86 44.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.585 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -83.17 -6.62 59.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 76' ' ' LYS . 5.4 m -86.96 138.03 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.68 -3.32 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.487 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.07 -160.3 24.24 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -153.59 155.98 37.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.384 0.612 . . . . 0.0 111.258 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.26 136.86 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.073 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -128.99 134.07 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.986 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.598 ' CG2' HD21 ' A' ' 141' ' ' LEU . 2.5 mt -133.01 74.17 74.18 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.541 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -44.76 -39.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 123.151 2.567 . . . . 0.0 112.943 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.752 ' OG ' HD23 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -48.67 -32.17 7.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.623 -177.406 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 89' ' ' SER . 15.7 m -117.13 -7.01 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.637 0.256 . . . . 0.0 111.158 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER 75.22 39.49 0.37 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.197 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.64 130.02 56.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.48 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -144.79 129.97 18.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.763 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -164.44 152.54 10.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.072 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 162.99 4.51 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.064 1.843 . . . . 0.0 109.739 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.29 125.0 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 102' ' ' ASN . 10.2 mt -101.43 136.11 41.83 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.81 -48.54 24.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.11 0.481 . . . . 0.0 111.485 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 123.4 28.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.177 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.4 p -81.7 64.83 6.58 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.45 0.643 . . . . 0.0 110.46 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.552 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -91.81 143.21 26.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.077 179.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 101' ' ' LYS . 15.3 pt-20 -56.33 -44.22 79.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.403 0.621 . . . . 0.0 110.742 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.493 ' N ' ' CG ' ' A' ' 100' ' ' GLU . 54.5 tttp -66.03 -46.38 78.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.808 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.552 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 2.9 m-20 -67.18 -36.97 82.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.844 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -55.04 -16.82 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.451 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.447 ' O ' HD11 ' A' ' 134' ' ' LEU . 55.0 mt -70.63 -29.9 66.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -89.74 -10.56 45.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 178.52 41.27 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.763 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -72.37 132.16 43.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.97 150.13 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.125 0.488 . . . . 0.0 111.031 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.5 p -73.6 153.93 39.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.34 -52.2 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -91.76 141.44 28.67 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.994 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -71.39 -2.58 16.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.538 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.34 41.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.251 0.548 . . . . 0.0 111.115 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -84.86 158.1 20.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -134.49 129.7 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.628 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -73.7 127.88 34.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.43 -0.15 70.86 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -139.71 121.61 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.967 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.32 -171.86 52.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -84.03 110.13 18.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.24 99.38 10.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.78 130.44 36.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.363 0.601 . . . . 0.0 111.425 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -125.9 133.83 51.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.826 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.18 141.56 47.37 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.378 0.609 . . . . 0.0 110.71 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.9 -178.85 18.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.656 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -81.83 149.27 28.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.972 0.415 . . . . 0.0 110.748 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 129' ' ' SER . 45.1 t30 -112.48 28.44 8.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.169 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.1 mmm -47.43 -11.74 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.638 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 127' ' ' ASN . 3.1 t 54.72 41.11 32.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.982 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.4 tttt -134.52 116.2 14.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.565 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -57.33 125.61 23.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.764 0.792 . . . . 0.0 110.53 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.25 -25.87 11.96 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.871 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.798 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.3 t -79.9 179.07 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.798 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.28 133.31 45.97 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.768 -178.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.5 m-30 44.47 33.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.148 0.499 . . . . 0.0 111.06 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -82.29 -7.79 59.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.5 m-20 -147.47 38.14 0.94 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.6 pt -74.24 -25.49 19.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.84 0.352 . . . . 0.0 111.881 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.83 0.52 8.86 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.749 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.0 m -93.39 -12.24 30.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.27 0.557 . . . . 0.0 109.628 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.752 HD23 ' OG ' ' A' ' 87' ' ' SER . 21.0 mt -65.58 125.0 23.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.204 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -96.34 158.46 15.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.677 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.05 133.06 54.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.514 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.5 59.18 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.421 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 38.4 m-20 -83.52 136.91 34.1 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -81.0 130.23 34.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 111.345 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -127.13 126.64 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 148' ' ' TYR . 42.4 m-85 -107.87 120.24 41.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.191 0.519 . . . . 0.0 109.776 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.6 tp -113.59 143.93 43.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.346 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -114.82 127.88 55.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.314 0.578 . . . . 0.0 111.541 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.4 t0 -106.0 -166.12 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.6 m-20 -27.94 -71.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.695 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -137.42 22.8 2.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.754 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.27 147.83 44.49 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -113.42 118.28 34.08 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.416 ' CE2' HG21 ' A' ' 206' ' ' THR . 68.4 m-85 -103.45 131.51 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.407 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -93.4 117.85 30.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.347 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.2 133.18 55.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 45.2 t -67.73 133.03 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.107 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -101.0 -27.19 13.42 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 124.609 1.193 . . . . 0.0 110.63 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.53 144.35 3.98 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.86 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.47 141.32 15.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.41 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.9 p -150.06 161.93 41.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.372 0.606 . . . . 0.0 111.548 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 95.3 mt-10 -114.81 123.18 48.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.749 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.68 149.63 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.344 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.4 p -53.66 166.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.571 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -81.58 -15.59 9.68 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.854 1.703 . . . . 0.0 111.812 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 60.0 t0 -88.64 -11.09 46.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.502 ' O ' HG22 ' A' ' 173' ' ' VAL . 13.6 ttmm -86.95 67.81 9.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.979 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.571 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 57.3 m95 -76.53 -8.39 57.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.449 . . . . 0.0 111.856 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.9 mt-10 -53.19 -23.47 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.203 0.525 . . . . 0.0 110.937 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 170' ' ' LYS . 33.3 m -77.63 -13.06 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.922 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 185' ' ' ILE . 4.4 m -132.34 43.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.521 ' O ' ' O ' ' A' ' 176' ' ' ASP . 95.4 mt-10 -146.23 83.17 1.62 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.895 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' GLU . 66.5 t0 23.82 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.346 1.028 . . . . 0.0 113.022 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.455 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 13.2 m170 -102.13 -43.97 5.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 0.0 111.289 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.84 23.78 0.16 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -154.11 173.91 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.954 0.407 . . . . 0.0 111.237 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -96.3 88.65 4.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.242 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -131.58 130.63 42.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.037 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.6 tt -83.17 145.57 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.483 ' C ' HD12 ' A' ' 184' ' ' LEU . 3.6 m -138.57 115.94 11.18 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.576 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -104.48 134.34 47.84 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.18 0.514 . . . . 0.0 110.711 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.724 HG22 HG22 ' A' ' 198' ' ' VAL . 34.6 pt -135.1 154.67 36.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.093 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -139.32 101.69 4.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.447 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 188' ' ' VAL . 3.7 t -174.55 -71.74 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 187' ' ' CYS . 3.5 t 57.61 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.577 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 188' ' ' VAL . 2.0 p 61.77 128.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.437 HG22 ' H ' ' A' ' 190' ' ' VAL . 16.0 m -85.69 -14.31 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.982 0.42 . . . . 0.0 111.231 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -62.28 -42.28 99.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.401 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -88.01 100.57 13.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.391 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 194' ' ' SER . 61.4 t-20 -67.31 -108.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.996 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 193' ' ' ASN . 1.5 p 60.05 148.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.727 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -66.53 130.17 42.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.125 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.404 HH21 HG21 ' A' ' 198' ' ' VAL . 56.0 ttp180 -97.77 137.3 36.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.225 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.6 m-85 -95.95 129.02 43.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.505 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.724 HG22 HG22 ' A' ' 185' ' ' ILE . 71.2 t -131.08 133.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.193 0.521 . . . . 0.0 111.366 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.73 126.96 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.593 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -112.77 132.93 55.02 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 110.721 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.66 14.13 Favored Glycine 0 N--CA 1.464 0.525 0 CA-C-O 121.727 0.626 . . . . 0.0 111.685 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -98.91 142.3 30.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.891 -0.655 . . . . 0.0 111.405 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.1 tp -67.09 128.54 36.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.315 0.578 . . . . 0.0 110.288 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.97 -21.7 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.216 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.5 176.12 46.87 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.009 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.416 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.0 m -154.74 153.18 30.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.161 0.505 . . . . 0.0 110.534 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -150.27 178.65 8.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.264 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -99.98 142.26 31.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -57.18 80.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.248 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ALA . 77.5 tttt . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.557 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.7 m -129.54 124.63 34.37 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.617 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -64.44 -43.37 94.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.452 ' HG2' ' H ' ' A' ' 57' ' ' ASP . 28.6 ttm 54.19 175.13 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.038 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' H ' ' HG2' ' A' ' 56' ' ' MET . 98.4 m-20 -63.07 140.32 58.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.921 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.17 77.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.936 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 189' ' ' SER . 7.0 m -153.18 72.27 0.94 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.718 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -71.35 41.49 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.238 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 59' ' ' SER . 34.5 mt -62.42 -46.78 95.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.032 0.444 . . . . 0.0 110.75 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.7 t0 49.99 -97.25 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.197 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -150.71 85.36 5.25 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.491 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.71 151.46 41.07 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.495 2.13 . . . . 0.0 111.362 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' O ' HG23 ' A' ' 69' ' ' VAL . 53.8 t0 -62.46 163.15 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.8 mm? -77.65 -13.63 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.921 -0.487 . . . . 0.0 111.069 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.35 -48.38 70.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.405 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.17 -21.83 59.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.889 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 65' ' ' ASP . 85.7 t -78.07 -53.25 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.756 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.47 84.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.512 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.471 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 52.4 t-20 -76.13 -11.21 59.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.927 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 145.27 38.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.429 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -139.51 80.45 1.78 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.674 HD13 ' ND2' ' A' ' 102' ' ' ASN . 51.9 tp -80.16 147.4 31.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.52 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.54 133.69 49.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.922 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 79' ' ' VAL . 15.7 tptm -79.89 -6.44 57.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.249 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -80.74 -10.63 59.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.98 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -94.24 5.77 50.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 76' ' ' LYS . 8.3 p -80.62 136.47 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.97 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.411 HD13 ' HB2' ' A' ' 96' ' ' LYS . 7.5 pt -119.2 -10.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.72 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.44 -170.09 37.94 Favored Glycine 0 C--N 1.316 -0.545 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -147.15 152.34 38.29 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.416 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.2 tt -123.99 121.1 61.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 t -124.63 130.75 53.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.909 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 141' ' ' LEU . 16.5 mt -135.15 126.77 17.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -82.26 -35.49 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.358 2.039 . . . . 0.0 112.5 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.506 ' OG ' HD23 ' A' ' 141' ' ' LEU . 2.3 t -51.14 -40.09 57.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.844 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.4 m -115.49 -4.24 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.18 49.9 1.9 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.4 tp -111.32 129.74 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.656 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -136.72 113.7 10.5 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 83' ' ' ILE . 54.3 mt -145.69 107.71 4.36 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.2 Cg_endo -41.66 135.46 3.33 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.77 1.647 . . . . 0.0 110.659 176.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.17 125.1 39.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 74' ' ' LEU . 20.5 mt -108.86 120.83 43.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.193 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 80' ' ' ILE . 88.4 tttt -66.72 -47.43 72.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.708 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.6 p -69.8 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.1 p -84.43 107.68 16.83 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.283 0.564 . . . . 0.0 110.214 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 p -137.08 166.32 23.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.026 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.442 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 16.9 pt-20 -61.9 -35.43 78.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.681 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -82.92 -37.62 23.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.559 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.674 ' ND2' HD13 ' A' ' 74' ' ' LEU . 6.5 m120 -67.22 -22.88 65.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.637 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.88 -13.41 61.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.482 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.9 mp -76.92 -14.35 59.88 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -106.19 -15.63 14.81 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 172.98 -176.05 45.83 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.71 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.22 129.58 38.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.248 -0.476 . . . . 0.0 109.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.48 144.53 31.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.752 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.7 p -73.84 146.94 43.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.65 -46.69 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -91.02 144.28 25.83 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.806 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.71 -5.07 35.21 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.859 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 113' ' ' ASN . 61.2 t-20 -142.15 41.47 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.688 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -84.03 155.54 22.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.29 128.19 51.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.72 126.23 30.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 98.05 -6.12 61.77 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -137.21 118.99 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.668 0.271 . . . . 0.0 110.78 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.98 -172.85 54.07 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.476 HD21 ' HB3' ' A' ' 181' ' ' GLU . 2.4 t-20 -82.54 111.72 18.8 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -85.18 103.07 13.83 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.36 121.52 32.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 111.412 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.1 mt -117.76 131.86 56.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.85 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.62 46.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.02 -178.07 20.33 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.814 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 30.2 m-70 -83.5 131.23 35.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.231 0.539 . . . . 0.0 110.863 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.9 p30 -101.52 27.02 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.4 mmm -46.05 -14.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.957 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 41.67 17.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.875 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -133.8 106.85 7.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.081 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -50.69 125.93 14.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.547 0.689 . . . . 0.0 109.985 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.25 -26.1 10.69 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.946 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.788 HG12 ' H ' ' A' ' 134' ' ' LEU . 35.4 t -83.4 178.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 CA-C-N 117.736 0.768 . . . . 0.0 109.13 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.788 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.17 138.56 47.72 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.178 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 45.64 31.99 1.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.057 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.2 p -80.58 -12.31 59.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -138.56 35.94 2.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 140' ' ' SER . 8.8 pt -67.67 -41.51 85.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.09 2.09 1.69 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.961 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 138' ' ' ILE . 13.3 t -89.23 -21.65 23.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.506 HD23 ' OG ' ' A' ' 87' ' ' SER . 12.2 mt -65.58 121.7 15.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.143 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.441 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.7 mtmt -96.99 157.71 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.555 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -57.62 125.89 24.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.321 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.83 19.04 23.35 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 89.6 m-20 -89.86 133.24 34.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.75 134.74 37.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 111.723 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 73.0 mt -127.66 124.25 62.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.379 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -105.26 122.09 45.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.024 0.44 . . . . 0.0 110.218 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.68 153.21 32.73 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.093 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -121.12 130.87 53.94 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.316 0.579 . . . . 0.0 111.334 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 23.9 t0 -112.8 -167.07 1.14 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -24.48 -74.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.449 0.468 . . . . 0.0 111.705 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -137.97 28.58 2.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -125.59 151.38 46.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -112.03 122.04 46.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.741 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' A' ' 117' ' ' GLY . 47.2 m-85 -105.52 127.9 53.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.108 0.48 . . . . 0.0 111.791 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.6 mt-10 -97.64 118.74 34.85 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -115.86 145.11 43.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.219 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.3 128.69 54.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.24 0.543 . . . . 0.0 110.374 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.1 t -68.46 135.59 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.066 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 8.5 p -100.33 -22.86 14.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 124.378 1.049 . . . . 0.0 110.16 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 152.97 -178.51 30.03 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.833 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.8 p -124.2 143.01 39.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.318 -0.941 . . . . 0.0 109.893 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.8 t -136.77 148.08 47.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 111.107 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.13 113.01 26.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.239 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.33 159.44 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.1 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.0 p -71.22 142.59 87.32 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.568 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.5 Cg_endo -48.42 -16.24 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.862 1.708 . . . . 0.0 111.772 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 61.6 t0 -83.32 -11.55 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.91 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.521 ' O ' HG22 ' A' ' 173' ' ' VAL . 19.9 tptt -83.47 62.47 6.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.468 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.568 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 45.7 m95 -73.06 -21.13 60.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.675 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -51.12 -9.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.102 0.477 . . . . 0.0 110.947 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 170' ' ' LYS . 27.4 m -77.15 -29.26 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.917 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.457 HG11 HD13 ' A' ' 185' ' ' ILE . 1.7 m -107.2 -0.65 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.618 0.723 . . . . 0.0 109.938 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 176' ' ' ASP . 76.3 mm-40 -82.28 117.44 22.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.785 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.0 p-10 -27.71 123.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.872 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -99.62 -37.63 9.06 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.62 33.2 0.62 Allowed Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -154.72 177.14 11.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.129 0.49 . . . . 0.0 111.68 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.06 88.96 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.37 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.476 ' HB3' HD21 ' A' ' 120' ' ' ASN . 56.4 tt0 -128.74 167.42 17.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.831 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.603 ' C ' HD12 ' A' ' 184' ' ' LEU . 3.2 m -136.74 127.34 27.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.603 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.18 128.95 56.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.404 0.621 . . . . 0.0 110.778 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.457 HD13 HG11 ' A' ' 174' ' ' VAL . 8.7 pt -139.93 -167.68 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.923 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.552 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 3.3 t -139.94 157.12 46.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.414 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 18.7 t -78.04 155.3 30.74 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.017 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.629 HG11 HH22 ' A' ' 196' ' ' ARG . 3.1 p -135.31 152.33 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.394 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 59' ' ' SER . 55.1 m -147.57 -134.5 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.22 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.79 -23.42 32.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.491 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.73 -47.39 84.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.942 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 47.0 t0 47.71 72.95 0.22 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.061 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 195' ' ' LYS . 66.0 t30 -64.21 153.28 38.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.301 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 t -59.06 -43.69 91.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 110.55 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.542 ' O ' ' ND2' ' A' ' 193' ' ' ASN . 60.9 pttt -145.54 149.16 34.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.496 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.629 HH22 HG11 ' A' ' 188' ' ' VAL . 43.7 ttm180 -111.87 128.62 56.19 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.275 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -77.12 132.61 38.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.701 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.63 135.04 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.01 128.41 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.537 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.91 139.3 51.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.272 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.36 152.25 21.1 Favored Glycine 0 C--O 1.226 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -107.45 147.2 30.75 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.635 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.5 tp -69.83 126.28 29.25 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 121.097 0.475 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -106.65 -26.65 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.745 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.32 161.88 21.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.05 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 207' ' ' LYS . 88.0 m -139.17 157.69 45.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.363 0.602 . . . . 0.0 110.11 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.436 ' N ' HG22 ' A' ' 206' ' ' THR . 20.1 ptmt -149.08 178.79 8.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.384 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.33 147.25 23.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.78 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -76.9 78.95 3.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.714 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.716 178.678 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 p -75.29 158.7 32.46 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -82.0 -17.75 45.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 0.0 110.78 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.9 mtm -83.08 144.86 29.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.72 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -66.89 138.58 57.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 110.199 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.17 73.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.075 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.9 m -86.37 -91.09 0.1 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.437 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 53.3 27.96 6.75 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.058 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 63' ' ' GLN . 36.6 mt -63.07 -48.64 86.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.15 0.5 . . . . 0.0 110.966 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 43.65 -92.5 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.33 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' ILE . 5.3 pt20 -150.89 86.41 4.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.332 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.43 150.95 47.25 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.323 2.016 . . . . 0.0 111.648 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.73 159.15 31.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.864 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.68 -23.63 66.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.7 92.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.715 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 97.0 mt-10 -73.46 -35.31 65.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.477 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.7 t -76.92 -42.96 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.755 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.83 91.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.698 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.4 p-10 -84.95 -17.87 36.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.44 111.62 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.961 0.41 . . . . 0.0 110.875 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -95.46 118.46 32.23 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.228 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.505 HD11 ' OE1' ' A' ' 78' ' ' GLN . 47.9 tp -116.14 131.16 57.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.061 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.54 134.82 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 79' ' ' VAL . 70.4 mmtt -75.83 -9.29 58.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 110.254 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.4 -12.66 61.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.037 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.535 ' OE1' ' ND2' ' A' ' 102' ' ' ASN . 94.0 mt-30 -95.51 12.72 28.48 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.221 0.534 . . . . 0.0 111.028 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 76' ' ' LYS . 5.4 p -90.45 128.83 42.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.741 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -120.9 -5.39 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 120.896 0.379 . . . . 0.0 111.88 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.87 41.74 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.918 HH12 ' HZ3' ' A' ' 209' ' ' LYS . 30.0 mtt85 -147.34 156.6 43.05 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.477 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.581 HD12 HD13 ' A' ' 123' ' ' LEU . 8.2 tt -123.63 128.28 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.427 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.1 t -128.24 130.2 47.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.47 128.88 19.36 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.399 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 -34.61 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.291 1.994 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -47.36 -39.51 15.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.457 -177.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -119.86 -1.72 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.781 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.7 p 63.6 50.4 2.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.081 0.943 . . . . 0.0 108.562 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.418 HD11 HD23 ' A' ' 92' ' ' LEU . 33.7 tp -113.51 133.63 55.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.397 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.822 ' O ' HD22 ' A' ' 92' ' ' LEU . 80.9 tt0 -135.81 111.4 9.26 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.8 OUTLIER -138.29 113.46 8.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.114 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.2 Cg_endo -41.6 147.46 0.39 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 110.419 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.9 124.57 53.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -105.0 125.47 51.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.004 0.431 . . . . 0.0 110.631 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 61.2 tttp -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 110.752 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.617 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 84.7 p -71.45 103.48 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 96.31 9.57 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 2.5 p -134.31 160.89 36.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.947 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -57.53 -33.49 68.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.6 -45.65 21.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 0.0 111.487 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.617 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 3.4 m120 -67.2 -35.38 79.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.696 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.69 -17.42 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.814 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.07 -16.79 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 t -107.93 -9.73 15.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' CA ' HD12 ' A' ' 92' ' ' LEU . . . 171.63 175.46 39.96 Favored Glycine 0 N--CA 1.461 0.327 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.446 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -72.18 127.57 32.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.008 -0.596 . . . . 0.0 109.785 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.52 24.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.893 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -72.84 150.24 42.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.1 t -84.49 -49.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -91.81 143.15 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 110.778 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 tt0 -61.92 -49.95 74.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.798 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -95.89 49.52 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.168 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 3.9 tt0 -89.15 151.47 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.2 127.6 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.966 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 129.39 36.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.812 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.03 -6.83 62.22 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -143.59 126.89 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.961 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 77.24 -162.41 51.26 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.536 HD22 ' CE1' ' A' ' 177' ' ' HIS . 41.0 t-20 -93.53 108.9 20.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -86.05 100.23 12.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.425 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.54 126.02 35.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.252 0.549 . . . . 0.0 111.043 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 83' ' ' ILE . 9.3 mt -119.79 131.2 55.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.819 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.37 140.03 47.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 187' ' ' CYS . . . -143.78 -178.49 19.58 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.405 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.42 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -84.04 141.84 30.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.736 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 61.7 t30 -109.1 28.39 8.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.185 0.517 . . . . 0.0 110.078 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.7 mmm -43.53 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.775 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.3 m 57.74 38.48 27.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.03 107.49 8.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.007 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -51.63 122.29 7.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.36 0.6 . . . . 0.0 110.045 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.12 21.82 6.48 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.316 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.737 HG12 ' H ' ' A' ' 134' ' ' LEU . 24.0 t -136.57 176.61 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.737 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -69.62 130.67 43.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 0.0 110.362 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.2 m-85 48.44 36.39 7.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.172 0.51 . . . . 0.0 110.585 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -82.35 -10.37 59.1 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 136' ' ' SER . 72.3 m-20 -150.33 31.91 0.66 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.6 pt -70.63 -21.02 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.803 0.335 . . . . 0.0 111.567 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.6 5.1 8.0 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.481 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -99.51 -10.3 22.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.25 0.548 . . . . 0.0 109.679 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.429 ' O ' HG21 ' A' ' 163' ' ' VAL . 17.8 mt -64.27 126.37 27.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.618 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.3 mttp -96.76 159.66 14.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.531 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -58.15 132.33 53.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.105 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.9 21.65 57.07 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 19.2 m-20 -79.35 135.23 36.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -78.96 121.74 25.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 111.979 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.32 120.82 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.132 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -103.24 117.7 35.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.198 0.523 . . . . 0.0 109.806 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.2 tp -112.35 144.33 41.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.132 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.42 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 60.8 m-85 -108.21 131.68 54.43 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.273 0.559 . . . . 0.0 111.672 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -104.77 -172.51 2.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.5 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -36.39 -63.26 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.161 0.505 . . . . 0.0 111.121 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -137.55 24.34 2.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.77 152.91 47.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -115.38 121.77 43.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.781 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -104.06 132.37 50.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.29 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -95.5 114.74 26.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -114.6 141.37 47.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.2 132.02 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.606 0.717 . . . . 0.0 111.309 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.01 134.06 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.898 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -102.86 -28.11 12.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 124.625 1.203 . . . . 0.0 110.818 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.24 141.08 3.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.877 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 199' ' ' VAL . 13.1 t -106.28 147.73 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.487 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.3 p -157.26 167.5 30.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.286 0.565 . . . . 0.0 111.638 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -118.15 120.6 38.21 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.55 158.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 111.3 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.4 p -57.21 165.47 1.95 Allowed Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.2 Cg_endo -82.03 -9.43 11.79 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.967 1.778 . . . . 0.0 111.913 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 63.2 t0 -83.38 -10.53 58.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.388 . . . . 0.0 110.449 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.581 ' O ' HG22 ' A' ' 173' ' ' VAL . 38.1 mmtt -85.93 64.33 8.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.798 0.332 . . . . 0.0 110.69 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.552 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 86.8 m95 -73.33 -10.11 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.457 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 80.9 mm-40 -59.93 -35.41 74.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.188 0.518 . . . . 0.0 110.975 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.849 HG23 HG13 ' A' ' 174' ' ' VAL . 4.7 m -65.68 -8.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.243 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.849 HG13 HG23 ' A' ' 173' ' ' VAL . 17.5 m -136.0 43.04 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 176' ' ' ASP . 48.8 mm-40 -144.8 107.24 4.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.733 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 175' ' ' GLU . 41.0 p-10 4.27 112.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.65 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.536 ' CE1' HD22 ' A' ' 120' ' ' ASN . 40.4 m80 -102.91 -42.49 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.883 0.373 . . . . 0.0 111.028 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 136.32 29.82 0.32 Allowed Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 17.9 ptpt -153.83 173.12 16.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 8.7 p30 -95.19 88.34 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.836 0.827 . . . . 0.0 110.181 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -130.12 174.72 9.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.552 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.8 tt -130.89 143.12 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.174 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.601 ' C ' HD12 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -137.79 124.08 20.56 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.313 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -111.57 131.13 55.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.235 0.54 . . . . 0.0 110.695 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.669 HG21 HG11 ' A' ' 174' ' ' VAL . 7.5 pt -138.53 171.53 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.952 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 60.5 p -76.55 169.32 18.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.129 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.492 ' N ' ' O ' ' A' ' 125' ' ' GLY . 16.7 m -39.24 -87.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.105 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.422 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 11.3 p -168.21 -24.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.215 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 188' ' ' VAL . 0.7 OUTLIER 60.88 119.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.047 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.1 -45.53 98.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.791 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -136.21 -179.23 5.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.691 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.27 138.14 58.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -159.42 -125.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.9 0.381 . . . . 0.0 110.827 -178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.2 p -69.77 156.79 38.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.06 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -65.38 126.86 29.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.422 ' NH2' ' O ' ' A' ' 188' ' ' VAL . 42.1 ttm180 -80.1 138.31 36.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.067 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.69 138.47 43.86 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.532 HG12 HG22 ' A' ' 185' ' ' ILE . 31.4 m -135.38 138.18 48.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.439 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 163' ' ' VAL . 76.1 t -117.18 128.8 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.342 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.95 135.22 54.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.087 0.47 . . . . 0.0 110.346 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.77 156.96 24.52 Favored Glycine 0 N--CA 1.461 0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.574 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.19 153.82 26.48 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.049 -0.576 . . . . 0.0 111.396 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.433 HD11 ' O ' ' A' ' 205' ' ' GLY . 39.4 tp -73.87 128.06 34.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.256 0.551 . . . . 0.0 110.574 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 38.1 t -109.06 -25.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.931 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.433 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.52 175.03 46.7 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.972 -1.108 . . . . 0.0 112.155 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.0 m -153.78 152.31 30.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.143 0.496 . . . . 0.0 110.826 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.14 177.14 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.19 145.19 24.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.099 0.476 . . . . 0.0 110.718 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.918 ' HZ3' HH12 ' A' ' 82' ' ' ARG . 88.3 tttt -74.44 79.69 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.904 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--N 1.314 -0.94 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.561 178.528 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' C ' ' N ' ' A' ' 55' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p 47.91 14.95 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.148 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.448 ' N ' ' C ' ' A' ' 53' ' ' GLY . 80.3 m80 47.31 88.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.516 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.423 ' HG2' ' H ' ' A' ' 57' ' ' ASP . 29.9 ttp -88.58 173.15 8.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.261 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' H ' ' HG2' ' A' ' 56' ' ' MET . 98.1 m-20 -63.43 140.36 58.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.024 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.76 -12.18 61.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.948 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 61' ' ' ILE . 24.0 p -87.44 32.56 0.71 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.876 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' C ' ' CD ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -70.41 31.31 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.613 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 63' ' ' GLN . 61.1 mt -59.83 -51.13 76.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.018 0.437 . . . . 0.0 110.833 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.1 t0 45.28 -91.4 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.185 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 61' ' ' ILE . 2.4 pt20 -148.37 90.56 4.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.824 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.5 158.46 47.77 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.583 2.189 . . . . 0.0 111.213 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.17 165.21 24.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.659 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -69.51 -16.19 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.04 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.62 95.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.283 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 89.7 mt-10 -73.14 -33.46 65.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.665 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.37 -45.76 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.075 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.45 89.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.025 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.02 -28.46 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.589 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.79 107.42 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.804 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.3 m -95.98 115.31 27.24 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.289 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.0 tp -115.23 126.49 54.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.277 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -69.01 139.01 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.555 ' O ' HG12 ' A' ' 79' ' ' VAL . 13.9 mptt -76.13 -0.11 20.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 110.211 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -85.29 -8.99 58.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.143 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.533 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.0 mp0 -90.92 2.84 55.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.757 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 76' ' ' LYS . 11.1 p -87.64 138.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.821 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.6 pt -120.82 -5.27 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.781 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.89 33.14 Favored Glycine 0 C--N 1.321 -0.285 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -152.75 152.69 31.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.264 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 83' ' ' ILE . 17.9 tt -126.1 130.85 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.845 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -128.2 129.17 46.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.002 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 67.5 mt -133.59 127.83 19.77 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.543 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.65 -34.18 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.452 2.102 . . . . 0.0 112.285 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.1 p -46.98 -38.73 11.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.7 p -119.93 -0.34 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.852 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 63.81 52.68 2.11 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.7 tp -116.97 132.81 56.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.372 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -134.67 117.65 16.3 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -143.85 161.73 44.58 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.12 155.6 7.0 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.851 2.367 . . . . 0.0 108.901 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 118.24 52.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.416 ' CB ' HD22 ' A' ' 102' ' ' ASN . 10.1 mt -100.21 124.14 45.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -65.35 -48.56 72.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.807 0.337 . . . . 0.0 111.32 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.585 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 99.9 p -78.91 112.87 16.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.014 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.6 p -84.53 110.63 18.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.201 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.517 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -139.61 166.56 24.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.447 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.51 -31.07 70.94 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -81.39 -44.09 18.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.972 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.3 p-10 -66.38 -31.67 72.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.201 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.39 -21.02 66.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.43 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.21 -18.45 61.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -97.54 -13.15 21.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 170.06 -147.98 11.29 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.658 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.27 129.56 45.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.972 -0.614 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 102' ' ' ASN . . . -107.91 148.1 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.4 p -70.39 148.25 48.6 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 185' ' ' ILE . 26.0 t -82.86 -40.26 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -90.29 149.53 22.31 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.011 0.434 . . . . 0.0 111.077 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.43 -18.61 64.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.908 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -144.77 55.95 1.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.012 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.565 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 2.4 tt0 -80.67 156.36 26.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.938 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.9 t -136.0 124.35 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.83 127.24 32.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 99.12 -8.38 60.86 Favored Glycine 0 N--CA 1.46 0.237 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -135.27 117.77 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.69 -167.53 54.75 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.48 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 63.8 t30 -86.65 112.54 21.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -85.03 103.47 14.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.03 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.565 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.42 122.92 33.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.362 0.601 . . . . 0.0 111.511 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.406 HD13 HD12 ' A' ' 83' ' ' ILE . 15.3 mt -118.34 132.05 56.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.287 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.36 48.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.381 0.61 . . . . 0.0 111.015 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.64 -178.23 16.93 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.541 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.4 ' HD2' HD12 ' A' ' 134' ' ' LEU . 78.8 m-70 -84.24 145.79 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.649 0.261 . . . . 0.0 110.845 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 54.4 t-20 -110.8 28.45 8.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.9 mmt -43.98 -15.51 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.0 OUTLIER 58.87 39.14 24.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.303 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -133.82 107.65 8.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.611 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -50.28 126.9 15.97 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.745 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.8 12.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.818 HG12 ' H ' ' A' ' 134' ' ' LEU . 17.4 t -87.94 179.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.818 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.21 136.69 48.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.258 -177.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.414 ' HA ' HG23 ' A' ' 138' ' ' ILE . 3.4 m-85 44.18 34.02 0.92 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.231 0.538 . . . . 0.0 110.989 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 p -82.38 -9.78 59.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -149.1 34.99 0.74 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.414 HG23 ' HA ' ' A' ' 135' ' ' PHE . 6.8 pt -69.89 -28.12 35.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.869 0.366 . . . . 0.0 111.771 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.61 0.86 4.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.606 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -92.93 -13.82 28.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.027 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -64.83 122.92 18.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.397 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mttm -95.63 157.77 15.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.574 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -55.64 133.0 50.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.796 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.6 18.29 62.24 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 16.8 m-20 -79.58 135.06 36.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -81.47 128.01 33.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.511 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.0 mt -123.38 121.7 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.06 119.33 38.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.978 0.418 . . . . 0.0 110.043 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.2 tp -118.07 138.26 52.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -106.01 135.65 47.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.07 0.462 . . . . 0.0 111.48 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 46.7 t0 -109.89 -169.83 1.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 64.8 t30 -33.67 -67.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.26 0.552 . . . . 0.0 111.099 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.89 23.78 3.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.107 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.05 147.06 49.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.575 0.702 . . . . 0.0 112.712 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.543 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 90.7 mt-10 -108.57 122.25 46.69 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.823 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.494 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 34.5 m-85 -105.02 128.29 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.114 0.483 . . . . 0.0 111.773 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -95.5 115.87 28.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -116.02 140.94 48.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.461 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.26 134.35 55.17 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.484 0.659 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 133.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -101.81 -25.84 13.68 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 124.76 1.287 . . . . 0.0 111.088 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.31 145.61 4.39 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.663 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 163' ' ' VAL . 3.7 p -104.56 151.56 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -154.02 162.64 41.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.129 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.532 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 70.3 mt-10 -111.98 117.81 33.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.08 158.52 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 111.335 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.5 p -59.67 168.72 1.74 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.445 ' HA ' HH11 ' A' ' 196' ' ' ARG . 2.8 Cg_endo -81.47 -10.69 12.05 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.948 1.765 . . . . 0.0 111.944 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.22 -3.06 58.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.202 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.6 68.32 9.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 110.865 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.425 ' C ' ' N ' ' A' ' 173' ' ' VAL . 70.7 m95 -70.48 -29.86 66.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.765 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 56.0 mp0 -49.23 -17.71 0.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.204 0.526 . . . . 0.0 110.537 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.425 ' N ' ' C ' ' A' ' 171' ' ' TRP . 90.4 t -71.48 -23.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.577 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.421 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -107.86 -7.37 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.608 0.718 . . . . 0.0 109.679 -178.169 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -79.77 139.0 37.43 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.823 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -51.24 128.59 22.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.174 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -99.15 -39.59 8.4 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.035 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.89 29.0 0.37 Allowed Glycine 0 N--CA 1.473 1.156 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -156.63 -179.33 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.351 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -91.1 88.85 7.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.368 0.604 . . . . 0.0 109.833 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -124.33 168.31 13.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.077 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.72 142.75 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.951 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 184' ' ' LEU . 9.4 m -136.84 123.35 20.87 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.388 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -109.04 122.81 48.04 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.32 0.581 . . . . 0.0 110.92 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.513 HD11 HG21 ' A' ' 110' ' ' VAL . 27.9 pt -134.92 -167.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.953 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 34.1 p -134.77 159.57 40.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.781 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.402 ' SG ' HD12 ' A' ' 61' ' ' ILE . 7.5 t -79.53 125.97 30.27 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.914 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.2 157.33 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.69 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.0 p -162.16 10.08 0.07 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.957 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.2 t -117.96 128.99 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.779 0.324 . . . . 0.0 110.254 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -80.15 126.88 31.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.908 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -168.1 179.36 4.62 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.961 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -92.81 12.71 22.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.956 0.408 . . . . 0.0 111.103 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.9 p -68.89 156.78 37.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.287 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -106.92 136.46 46.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.485 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.445 HH11 ' HA ' ' A' ' 168' ' ' PRO . 55.5 ttp180 -98.12 133.08 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.891 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.532 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.6 m-85 -91.03 129.12 37.06 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.679 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 138.71 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.258 0.551 . . . . 0.0 111.48 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.74 127.71 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.556 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.11 135.32 54.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.167 0.508 . . . . 0.0 110.457 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.44 158.92 24.26 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 55.4 p-10 -113.74 150.24 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.387 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 40.0 tp -72.07 127.62 33.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.086 0.469 . . . . 0.0 111.017 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.6 t -106.34 -25.6 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.329 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.29 162.12 20.92 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.421 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.494 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 81.1 m -139.51 157.63 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.189 0.518 . . . . 0.0 110.032 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.543 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 19.4 pttp -149.91 178.54 8.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.6 143.63 26.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -71.28 79.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.702 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.691 178.461 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.974 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.9 m -58.6 -42.86 89.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.802 0.334 . . . . 0.0 110.556 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -80.21 139.59 36.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.145 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.9 mtm -138.2 150.36 46.68 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.231 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -80.9 107.01 13.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.349 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.4 -12.73 60.91 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.277 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 61' ' ' ILE . 3.2 t -86.83 10.67 15.32 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.933 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -65.71 26.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.63 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 59' ' ' SER . 45.7 mt -90.88 -67.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.433 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.6 t0 59.5 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.072 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' ILE . 4.9 pt20 -151.82 72.47 8.02 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.019 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.09 146.53 0.62 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.501 2.134 . . . . 0.0 110.895 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.76 154.81 41.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.717 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.4 mp -59.4 -27.61 66.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.689 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.46 94.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.279 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.8 mt-10 -72.58 -37.49 68.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.732 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.5 t -72.0 -44.29 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.574 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.96 89.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.33 -26.69 30.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.44 136.8 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.9 t -92.36 158.55 16.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.529 HD13 ' CB ' ' A' ' 105' ' ' SER . 55.6 tp -122.7 127.22 48.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.0 0.428 . . . . 0.0 111.06 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -96.1 98.26 10.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.564 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.419 ' C ' ' N ' ' A' ' 78' ' ' GLN . 29.0 mmtp -55.84 -35.51 66.49 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.119 0.485 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -51.56 -13.06 0.2 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.035 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.419 ' N ' ' C ' ' A' ' 76' ' ' LYS . 94.7 mm-40 -102.55 11.09 38.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.476 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.77 124.95 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -119.39 -4.57 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.171 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.03 -162.29 35.59 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -155.97 165.36 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.574 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.8 tt -131.35 139.65 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.796 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -131.66 132.84 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.053 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -131.03 127.0 21.91 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.95 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.84 -38.13 0.17 Allowed 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.256 1.971 . . . . 0.0 112.314 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.2 t -46.97 -39.55 12.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.586 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 90' ' ' LEU . 1.3 p -117.9 -2.5 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.68 55.38 2.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -120.77 138.49 53.99 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.559 -177.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 91' ' ' GLU . 55.8 mp0 -138.98 120.1 14.6 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.593 HD22 ' HA2' ' A' ' 106' ' ' GLY . 35.4 mt -143.37 109.55 5.33 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -40.74 139.48 1.28 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 121.887 1.724 . . . . 0.0 109.924 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.3 t -90.39 118.2 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.1 mt -102.37 121.73 42.87 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.058 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -64.83 -47.54 77.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.121 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.3 m -69.7 102.13 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.311 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 98' ' ' SER . 25.2 p -81.15 98.6 8.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.457 0.646 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.6 p -136.59 157.79 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.499 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -56.38 -29.19 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -81.98 -43.58 17.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.226 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.34 -34.45 78.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -63.21 -21.31 66.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.806 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 mt -69.66 -26.51 64.43 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.529 ' CB ' HD13 ' A' ' 74' ' ' LEU . 23.4 m -93.85 -10.99 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.593 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 165.62 -170.81 40.63 Favored Glycine 0 N--CA 1.458 0.149 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.658 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.32 129.2 37.34 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.116 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.12 148.13 28.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.424 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 p -70.32 143.41 52.01 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 185' ' ' ILE . 7.6 t -83.76 -44.64 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -89.43 -172.86 3.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.6 pm0 -119.48 -9.15 9.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.055 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -139.63 39.21 2.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.39 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -91.09 157.25 17.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.48 131.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.896 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -67.58 128.83 37.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.58 2.46 76.08 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -141.83 121.84 13.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.729 0.299 . . . . 0.0 111.107 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.83 -165.73 54.76 Favored Glycine 0 CA--C 1.517 0.218 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -89.86 109.05 20.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.59 101.77 12.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.918 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.57 128.69 36.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.423 0.63 . . . . 0.0 111.739 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -126.0 131.95 52.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.553 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.81 140.85 46.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.58 0.705 . . . . 0.0 111.096 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.1 -179.36 18.31 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -81.93 153.35 26.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 129' ' ' SER . 57.6 t30 -122.36 28.02 7.64 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.007 0.432 . . . . 0.0 111.208 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 31.9 mtt -43.82 -15.0 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.616 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 38.07 21.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.067 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 136' ' ' SER . 1.6 tppp? -134.13 121.07 20.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.835 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.18 125.66 24.51 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.98 -25.07 11.08 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.347 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 134' ' ' LEU . 95.1 t -80.39 176.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.721 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -74.55 136.6 42.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.391 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 46.52 30.66 1.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.095 0.474 . . . . 0.0 110.953 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.16 -8.23 59.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.213 -178.738 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.9 m-20 -143.99 36.3 1.26 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 pt -69.46 -30.05 44.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 111.971 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.08 1.69 7.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.807 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 t -92.18 -15.82 27.08 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.998 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.99 119.51 11.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 53.3 mtmt -96.33 156.28 16.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -56.46 121.77 10.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.61 19.0 14.38 Favored Glycine 0 N--CA 1.466 0.694 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 86.5 m-20 -90.28 131.31 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -79.64 135.22 36.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.08 0.467 . . . . 0.0 111.574 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -129.31 121.78 54.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.28 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.39 120.48 40.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.1 tp -116.71 142.86 46.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.181 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.226 0.536 . . . . 0.0 111.499 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 34.7 t0 -112.09 -165.38 0.99 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.0 m-20 -22.4 -75.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.729 0.643 . . . . 0.0 111.479 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -138.26 27.23 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.002 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -125.62 142.34 51.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -108.43 121.41 44.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.903 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.433 ' CE2' HG21 ' A' ' 206' ' ' THR . 79.6 m-85 -105.2 131.25 52.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.55 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -94.43 115.91 28.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.2 m-85 -117.39 136.65 53.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.589 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.34 133.87 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.482 0.658 . . . . 0.0 111.0 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.22 135.33 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.887 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.3 t -106.14 -24.83 12.24 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.995 1.434 . . . . 0.0 111.178 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.56 155.01 7.5 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.623 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.9 144.28 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.2 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.8 m -138.64 151.36 47.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.102 0.477 . . . . 0.0 111.298 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -106.02 110.26 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.314 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.2 m -130.74 153.03 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.2 p -64.11 168.48 6.09 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.8 Cg_endo -80.97 -12.63 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.923 1.748 . . . . 0.0 111.926 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -85.47 -21.53 28.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.096 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -86.64 76.5 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.501 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.543 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 27.1 m95 -75.35 -12.69 60.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.244 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -51.05 -8.1 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' A' ' 171' ' ' TRP . 32.8 m -90.21 -15.54 8.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.683 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.646 HG11 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER -120.62 -0.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.724 0.773 . . . . 0.0 109.709 -178.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -83.43 143.66 30.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.844 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.12 128.18 35.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.599 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -104.54 -41.88 5.59 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.757 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.73 31.08 0.21 Allowed Glycine 0 N--CA 1.473 1.114 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -154.03 174.72 14.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 3.8 m-20 -91.55 89.62 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.736 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -123.17 169.79 10.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.851 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -131.61 142.72 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.794 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.571 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.9 m -137.32 124.26 21.41 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -109.56 125.06 52.13 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.611 0.719 . . . . 0.0 110.902 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.646 HD13 HG11 ' A' ' 174' ' ' VAL . 8.4 pt -135.53 -170.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.608 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.594 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.1 p -138.35 144.55 40.39 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.724 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 186' ' ' THR . 5.1 t 54.72 107.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.36 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.558 HG23 ' N ' ' A' ' 189' ' ' SER . 17.2 m -61.17 -43.32 96.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.06 0.457 . . . . 0.0 110.782 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.558 ' N ' HG23 ' A' ' 188' ' ' VAL . 25.9 p -76.32 165.3 25.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.104 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 190' ' ' VAL . 15.8 m -80.44 130.69 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.065 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -94.84 160.89 14.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.566 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -61.34 -37.61 83.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.0 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -77.84 123.7 27.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.817 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 34.5 p -100.64 62.4 1.04 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.92 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -163.92 60.09 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.731 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.594 ' NH1' ' O ' ' A' ' 186' ' ' THR . 12.0 ptp180 -92.94 167.73 11.62 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.925 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -106.68 139.85 40.47 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.011 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 24.6 t -133.46 135.43 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.265 0.555 . . . . 0.0 110.937 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.5 t -118.42 130.28 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.692 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 161' ' ' THR . . . -118.77 136.54 53.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.425 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.61 150.44 19.51 Favored Glycine 0 N--CA 1.466 0.679 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.023 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -105.47 143.78 33.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.15 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.504 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.27 127.83 33.86 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 110.698 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.2 t -108.4 -23.54 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.529 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.42 177.03 46.81 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.745 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 156' ' ' TYR . 21.8 m -154.03 151.63 29.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -150.31 179.27 8.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.603 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.83 144.42 25.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.023 0.439 . . . . 0.0 110.57 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.54 78.87 1.06 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.638 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt . . . . . 0 C--N 1.319 -0.739 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.329 178.167 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 m -69.98 145.57 51.74 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -152.82 160.97 43.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.031 0.443 . . . . 0.0 110.97 -178.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 50.4 mtt -64.18 -39.87 94.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.78 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 55' ' ' HIS . 31.3 t0 -140.68 164.58 29.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.335 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.481 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -68.35 -37.09 80.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.417 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.3 p -84.64 -85.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.385 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.3 tttt 46.95 29.91 1.14 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.029 0.442 . . . . 0.0 111.032 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.02 -49.77 82.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.084 0.469 . . . . 0.0 110.781 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.0 t0 49.58 -94.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.313 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -150.76 86.63 4.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.619 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.79 150.41 44.45 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.43 2.086 . . . . 0.0 111.628 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 69' ' ' VAL . 48.0 t0 -76.33 172.48 12.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -61.08 -21.59 63.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.786 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.87 95.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.31 -20.49 57.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 65' ' ' ASP . 66.3 t -81.14 -51.67 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.686 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.9 90.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.967 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.45 -32.79 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.857 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 146.72 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.847 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.7 t -138.58 141.41 39.21 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.995 0.426 . . . . 0.0 110.794 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -138.43 121.64 16.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.289 -179.226 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.704 ' N ' HD13 ' A' ' 74' ' ' LEU . 96.2 m-20 -70.31 112.1 6.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.36 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.523 ' O ' HG22 ' A' ' 79' ' ' VAL . 28.4 mmtp -52.81 -9.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.511 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 75' ' ' ASP . 99.4 mttt -83.19 -4.38 58.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.771 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -95.12 10.41 35.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.706 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 76' ' ' LYS . 14.7 m -94.28 147.39 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -134.11 4.85 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.921 0.391 . . . . 0.0 111.695 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.5 38.25 Favored Glycine 0 C--N 1.322 -0.247 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -152.43 153.26 33.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.231 0.539 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 83' ' ' ILE . 16.0 tt -128.66 130.29 68.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 m -128.61 129.46 45.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.11 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 19.0 mt -135.33 116.06 11.94 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.162 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 4.7 Cg_exo -78.35 -32.94 2.08 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 122.745 2.297 . . . . 0.0 112.843 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 t -50.36 -40.08 48.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.012 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.34 -6.68 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.819 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.23 47.64 0.28 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.09 129.93 56.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.761 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.79 119.1 14.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.1 mt -146.59 166.29 17.11 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.72 153.86 8.81 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.072 2.514 . . . . 0.0 108.767 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 73.6 t -104.43 121.09 55.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.25 132.47 53.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -80.15 -29.9 38.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.991 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 m -79.03 102.42 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.128 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -80.9 97.93 7.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.332 0.587 . . . . 0.0 109.882 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.0 p -141.01 158.56 43.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.104 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.83 -37.77 77.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.821 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -69.94 -46.29 65.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.83 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.51 -38.34 89.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.777 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.3 mt -59.73 -26.46 65.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.84 -14.14 61.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -105.74 -13.13 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 175.24 -170.07 43.06 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.486 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.17 123.29 27.78 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.32 142.82 34.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.114 0.483 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.401 ' O ' ' OG ' ' A' ' 98' ' ' SER . 43.8 p -73.95 152.03 40.21 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.455 HG21 HD11 ' A' ' 185' ' ' ILE . 4.2 t -86.07 -42.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -89.51 -172.06 3.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.846 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -123.64 -8.62 7.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.977 0.418 . . . . 0.0 111.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -139.7 39.94 2.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -93.46 159.86 15.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.007 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.87 133.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.009 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.63 127.75 33.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.172 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.52 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.35 5.75 72.04 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -143.56 124.13 14.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 0.0 110.992 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.98 -164.45 54.28 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.83 107.86 19.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.27 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.81 100.01 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.8 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 127.36 36.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 0.0 112.071 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.4 mt -122.88 130.4 52.82 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.29 47.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.13 -178.49 19.01 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.601 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.533 ' O ' ' O ' ' A' ' 134' ' ' LEU . 44.6 m-70 -88.74 139.05 30.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 34.0 p30 -108.2 27.26 9.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.215 0.531 . . . . 0.0 110.323 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.8 mmm -43.87 -14.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.987 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.62 40.91 9.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.009 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -131.7 108.41 9.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.744 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 44.0 pttt -51.07 125.65 14.35 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.319 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.4 -29.76 8.44 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.725 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.0 t -75.54 178.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.725 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.33 137.65 46.79 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.281 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.508 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.3 m-85 44.37 31.81 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 110.989 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -81.97 -12.94 58.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.293 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 136' ' ' SER . 95.9 m-20 -143.19 24.96 1.76 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.508 HD13 ' CD2' ' A' ' 135' ' ' PHE . 4.1 pt -69.02 -23.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.85 0.357 . . . . 0.0 111.687 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.78 4.83 3.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.648 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.2 m -96.91 -14.63 21.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.2 0.524 . . . . 0.0 109.638 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.484 ' O ' HG21 ' A' ' 163' ' ' VAL . 15.0 mt -62.43 132.27 51.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.352 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -106.97 175.18 5.59 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.946 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -69.51 135.47 50.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.68 71.51 Favored Glycine 0 N--CA 1.461 0.312 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.28 136.03 36.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -82.95 127.38 33.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.695 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.6 mt -122.72 123.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -103.82 115.63 30.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.838 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.18 148.86 38.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.931 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -123.44 133.61 54.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.399 0.619 . . . . 0.0 111.629 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -112.14 -165.5 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 16.4 t-20 -23.99 -75.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 111.617 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -137.04 26.7 2.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -124.07 145.94 48.91 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -108.52 119.56 39.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.76 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.455 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.0 m-85 -104.42 129.33 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.61 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.477 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 97.7 mt-10 -95.73 117.73 31.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.021 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.52 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 50.6 m-85 -117.47 138.88 51.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.292 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -115.69 132.08 56.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.501 0.667 . . . . 0.0 111.145 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.66 134.88 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.166 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -105.75 -25.49 12.18 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 124.431 1.082 . . . . 0.0 111.081 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.4 161.55 19.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.395 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.519 HG13 HG22 ' A' ' 199' ' ' VAL . 10.5 t -128.78 155.5 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.823 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -164.16 174.46 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 0.0 111.666 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.535 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 40.1 mp0 -121.88 117.13 25.74 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.8 159.06 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 p -62.82 167.12 6.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.22 -9.95 11.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.343 2.028 . . . . 0.0 111.922 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -81.34 -11.61 59.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.808 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -86.4 73.21 10.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.369 0.605 . . . . 0.0 109.72 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.527 ' C ' ' H ' ' A' ' 173' ' ' VAL . 81.9 m95 -72.48 -27.36 62.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -50.93 -9.1 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.0 110.93 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.8 t -78.25 -21.16 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.539 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.494 HG11 HD13 ' A' ' 185' ' ' ILE . 1.2 m -116.18 -3.65 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.745 0.783 . . . . 0.0 109.85 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -80.64 151.76 28.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.15 -1.387 . . . . 0.0 112.157 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.87 126.5 27.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.674 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -107.17 -43.8 4.52 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.317 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 150.34 23.3 0.06 OUTLIER Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.3 173.7 15.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.157 0.503 . . . . 0.0 111.156 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.4 m-20 -95.75 88.38 4.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -124.22 127.72 48.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.403 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -81.71 146.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.524 ' C ' HD12 ' A' ' 184' ' ' LEU . 7.2 m -136.29 122.09 19.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.772 0.32 . . . . 0.0 111.06 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -107.57 126.12 52.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.317 0.58 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.494 HD13 HG11 ' A' ' 174' ' ' VAL . 9.7 pt -137.55 178.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.663 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t -139.08 161.29 37.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.3 t 57.88 -170.69 0.11 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.738 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.41 -118.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.52 0.2 . . . . 0.0 111.003 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.1 m -82.95 -9.03 59.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.937 0.398 . . . . 0.0 110.874 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 89.3 t -68.77 132.07 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.183 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.01 -45.91 92.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.979 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.4 t0 48.1 -101.04 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.429 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -95.37 162.2 13.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.856 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.9 m -59.21 -44.92 92.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.002 0.43 . . . . 0.0 110.828 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -139.84 147.09 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.087 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -111.27 149.45 31.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.241 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.404 ' CE1' ' OE2' ' A' ' 165' ' ' GLU . 4.5 m-85 -80.37 132.9 35.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.85 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.1 133.92 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.041 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.519 HG22 HG13 ' A' ' 163' ' ' VAL . 82.0 t -117.2 128.62 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.446 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.491 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.45 135.62 53.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.6 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.77 142.53 14.04 Favored Glycine 0 N--CA 1.465 0.596 0 CA-C-O 121.773 0.652 . . . . 0.0 111.642 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 52.3 p-10 -100.32 141.56 32.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.294 -0.953 . . . . 0.0 111.409 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.18 126.16 28.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 157' ' ' GLU . 6.2 m -109.46 -22.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.421 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.04 158.14 13.44 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.802 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.455 HG21 ' CE2' ' A' ' 156' ' ' TYR . 25.1 m -134.85 156.18 49.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.382 0.61 . . . . 0.0 109.778 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.477 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 ptpp? -149.66 178.81 8.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.278 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.69 147.1 23.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.509 . . . . 0.0 110.549 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.32 80.02 3.07 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.814 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 51.7 tttm . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.189 178.649 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -68.68 145.49 53.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 110.651 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -84.47 132.2 34.58 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.173 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 20.5 ptm -151.06 171.45 17.3 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.605 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.435 ' CG ' ' HG ' ' A' ' 59' ' ' SER . 35.0 t0 -88.72 110.3 20.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.388 0.613 . . . . 0.0 110.152 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.2 -4.21 34.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.742 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 61' ' ' ILE . 89.0 p -83.22 1.05 42.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.773 0.321 . . . . 0.0 111.478 -178.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.78 14.2 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.805 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.534 ' H ' ' C ' ' A' ' 59' ' ' SER . 40.9 mt -62.25 -49.06 85.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.161 0.505 . . . . 0.0 110.609 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.6 t0 48.49 -92.81 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.508 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 61' ' ' ILE . 45.8 tt0 -150.65 86.17 5.08 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.484 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.28 155.49 41.64 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.384 2.056 . . . . 0.0 111.606 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.3 m-20 -68.86 163.93 23.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.177 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.425 ' O ' HD23 ' A' ' 66' ' ' LEU . 6.6 tt -76.43 -14.16 60.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.307 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.44 80.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.482 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 13.7 pt-20 -74.69 -19.05 60.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.396 . . . . 0.0 110.704 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 65' ' ' ASP . 96.9 t -77.56 -53.78 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.526 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.02 88.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.125 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -73.0 -27.94 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.523 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.89 137.02 58.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.84 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.7 p -89.78 159.27 17.12 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.182 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 105' ' ' SER . 50.1 tp -122.41 129.71 52.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.994 0.426 . . . . 0.0 111.008 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.3 m-20 -97.5 90.64 5.11 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.594 ' O ' HG12 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -50.48 -13.53 0.13 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' N ' ' C ' ' A' ' 75' ' ' ASP . 71.3 mmtt -71.27 -8.95 57.03 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -106.53 13.45 28.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 76' ' ' LYS . 6.4 p -87.43 123.17 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.822 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.0 pt -120.44 -7.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.13 -169.26 40.47 Favored Glycine 0 C--N 1.317 -0.527 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -146.54 155.72 42.71 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.178 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.4 tp -125.79 128.94 72.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -126.93 131.39 51.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.79 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 24.7 mt -130.63 122.04 19.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.04 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -81.67 -37.16 0.28 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 122.304 2.002 . . . . 0.0 112.422 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -49.12 -37.92 23.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.25 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -118.25 -3.47 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.531 -178.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.51 51.48 1.51 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -109.32 128.93 55.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.132 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.59 113.54 11.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.594 HD22 ' HA2' ' A' ' 106' ' ' GLY . 15.7 mt -146.49 111.79 4.29 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.5 Cg_endo -42.17 143.0 1.45 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.508 1.472 . . . . 0.0 110.583 176.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.28 119.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -102.09 121.44 42.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.076 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 66.0 tttm -64.75 -47.11 79.42 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.3 p -60.6 97.86 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.993 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.93 97.94 7.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.19 0.519 . . . . 0.0 109.803 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.5 p -139.49 158.45 44.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.53 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -60.59 -25.01 65.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.352 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -83.79 -45.2 13.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 111.348 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' HA ' HD21 ' A' ' 102' ' ' ASN . 10.7 m120 -66.86 -35.07 79.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.444 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 108' ' ' ALA . 22.6 mt -63.5 -16.99 62.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.73 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.07 -27.22 62.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.698 ' HB3' HD22 ' A' ' 74' ' ' LEU . 3.5 m -98.75 -7.48 27.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.594 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 173.8 -170.07 43.17 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.729 -1.225 . . . . 0.0 112.146 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.14 124.35 31.7 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.69 149.81 25.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.779 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 109' ' ' THR . 6.1 p -75.28 152.03 38.27 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 122' ' ' ALA . 1.1 p -88.1 -35.45 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -89.24 143.95 26.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.316 0.579 . . . . 0.0 111.096 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.509 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.1 pt-20 -70.09 -17.14 63.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.916 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.45 52.22 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.792 0.33 . . . . 0.0 111.186 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -88.75 157.98 18.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.78 134.07 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.753 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 5.2 mtp -77.87 123.82 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.23 5.07 65.96 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -140.78 120.18 13.11 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.43 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.91 -173.44 53.64 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 173' ' ' VAL . 39.7 t-20 -78.25 107.58 10.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -85.51 103.42 14.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -90.34 122.5 33.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.306 0.574 . . . . 0.0 111.679 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.09 128.9 56.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.74 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.01 138.54 46.25 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 110.551 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.52 17.69 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.778 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' LEU . 49.9 m-70 -87.32 142.99 27.47 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.998 0.428 . . . . 0.0 110.708 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 129' ' ' SER . 66.8 t30 -109.26 28.65 8.3 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.874 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.56 -18.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.717 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 61.8 37.39 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.941 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -133.98 106.91 7.49 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -50.18 125.61 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.88 -22.9 11.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.0 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.837 HG12 ' H ' ' A' ' 134' ' ' LEU . 33.7 t -90.09 179.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 117.659 0.729 . . . . 0.0 109.352 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.837 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -71.13 135.22 47.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.878 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.04 36.07 2.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.381 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 26.3 p -81.45 -8.94 59.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 85.9 m-20 -145.9 37.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.5 pt -68.64 -32.27 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.472 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.9 5.75 2.45 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.139 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -95.27 -15.7 22.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.79 124.31 22.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.701 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.33 152.25 19.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -54.29 127.26 26.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.616 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.71 22.0 32.37 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 34.6 m-20 -85.41 134.57 34.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -79.35 131.48 36.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 111.88 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.6 mt -127.24 125.96 67.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.532 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.63 119.93 39.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.055 0.455 . . . . 0.0 110.079 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 tp -115.66 143.39 45.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -108.07 124.82 50.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.086 0.47 . . . . 0.0 111.418 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -97.7 -173.03 2.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 152' ' ' ASN . 5.5 p30 -30.35 -69.56 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 70.8 mm-40 -135.03 27.0 3.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.757 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 158.34 38.46 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.465 0.65 . . . . 0.0 112.463 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -116.52 122.18 43.94 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.338 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -105.91 131.92 52.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 111.25 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 204' ' ' VAL . 96.6 mt-10 -96.37 115.26 27.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.984 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -113.93 141.92 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.422 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.16 131.18 54.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.488 0.661 . . . . 0.0 111.198 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 47.8 t -65.37 134.33 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.08 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -100.94 -30.42 11.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 124.708 1.255 . . . . 0.0 110.299 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.46 156.69 11.04 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.207 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.54 154.74 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.916 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.9 t -167.65 178.03 5.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.578 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.44 ' O ' HG13 ' A' ' 166' ' ' VAL . 75.3 mt-10 -113.12 127.64 56.26 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 165' ' ' GLU . 6.1 m -155.52 174.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.361 . . . . 0.0 111.483 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 169' ' ' ASP . 8.9 p -90.56 136.55 28.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.651 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -54.13 -0.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.191 1.927 . . . . 0.0 112.263 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 167' ' ' THR . 48.5 p-10 -74.23 -18.99 60.67 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HZ1' ' NH2' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -85.68 72.21 10.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.521 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 59.8 m95 -74.38 -4.17 34.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.185 0.516 . . . . 0.0 112.001 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.562 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.6 mt-10 -60.55 -18.2 50.92 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.45 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 4.4 m -92.86 -0.29 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.471 HG21 ' CE3' ' A' ' 171' ' ' TRP . 0.5 OUTLIER -123.68 -6.6 7.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.38 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.513 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 69.4 mm-40 -87.56 152.22 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.206 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.4 ' HA ' ' H ' ' A' ' 120' ' ' ASN . 97.8 m-20 -59.42 127.33 31.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.714 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.562 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.1 m170 -119.94 27.94 8.39 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.55 76.87 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -148.84 164.91 33.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.073 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -91.91 91.37 7.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.55 0.691 . . . . 0.0 109.826 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -117.41 164.55 14.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.522 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.96 140.75 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.547 ' C ' HD12 ' A' ' 184' ' ' LEU . 56.7 m -135.75 126.47 27.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.624 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 183' ' ' THR . 9.8 mp -108.25 120.8 43.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.376 0.608 . . . . 0.0 109.684 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.2 pt -130.32 -178.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.513 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t -138.67 156.9 47.02 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 34.0 m -85.71 113.74 22.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.039 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.95 138.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.178 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.4 p -158.17 30.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.684 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.7 m -76.38 -154.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -85.0 37.46 0.67 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.58 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 50.54 42.16 26.34 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.049 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.77 -40.37 97.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.225 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.8 p -154.94 161.41 41.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.562 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.11 145.16 29.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.151 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.61 ' NH2' ' HZ1' ' A' ' 170' ' ' LYS . 20.6 ptt180 -86.45 169.52 12.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.082 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.11 137.52 37.51 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.1 p -131.71 135.87 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.19 137.87 52.7 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.142 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.58 151.97 21.42 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 54.4 p-10 -110.18 147.17 34.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.923 -0.639 . . . . 0.0 111.902 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 205' ' ' GLY . 45.4 tp -67.71 126.24 28.76 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.774 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 157' ' ' GLU . 6.9 m -109.59 -23.54 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.03 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -177.78 172.71 45.38 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.213 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.8 m -152.67 151.43 30.57 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.087 0.47 . . . . 0.0 110.686 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -148.14 175.8 10.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.116 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.82 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.062 0.458 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -73.61 79.75 1.5 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.886 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.768 178.59 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -70.19 142.05 52.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 0.0 110.114 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -56.44 -78.79 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.051 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.481 ' O ' ' CD ' ' A' ' 60' ' ' LYS . 28.2 ttt -154.5 -93.2 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.744 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -79.13 24.49 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.155 0.502 . . . . 0.0 110.24 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 56' ' ' MET . . . -68.99 -39.49 79.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.275 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.2 m -152.76 15.45 0.57 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.993 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' CD ' ' O ' ' A' ' 56' ' ' MET . 27.0 mtpp -81.87 35.8 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' O ' ' N ' ' A' ' 63' ' ' GLN . 60.1 mt -62.38 -49.78 82.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.375 0.607 . . . . 0.0 110.539 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 100.0 m-20 45.74 -93.35 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.399 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 61' ' ' ILE . 7.1 pt20 -150.84 81.78 6.25 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.525 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.77 146.94 38.92 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.153 1.902 . . . . 0.0 112.02 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -77.14 170.76 15.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.3 -14.54 63.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.729 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.36 88.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mm-40 -75.85 -22.48 56.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.449 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.09 -50.35 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.638 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.16 87.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.196 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.66 -31.41 69.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.17 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.63 109.04 1.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -96.69 113.09 24.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.113 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.494 HD21 HD22 ' A' ' 95' ' ' LEU . 38.0 tp -110.24 124.15 51.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.91 140.21 49.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.234 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -64.84 -5.4 5.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.561 . . . . 0.0 109.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -74.45 -9.33 58.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 10.4 mp0 -94.83 3.73 54.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -89.22 126.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.537 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -123.66 -7.9 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.014 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.63 -172.63 39.2 Favored Glycine 0 C--N 1.312 -0.763 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -147.82 154.32 40.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 117.457 0.628 . . . . 0.0 111.852 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.3 tt -123.35 123.7 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.393 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -125.9 129.67 49.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.517 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 15.7 mt -133.89 124.11 17.46 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.424 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.5 Cg_endo -81.97 -36.02 0.34 Allowed 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.194 1.929 . . . . 0.0 112.576 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.516 ' OG ' HD23 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -50.86 -38.78 51.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.806 -177.655 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 90' ' ' LEU . 14.3 m -118.94 -3.36 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 110.535 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.97 49.54 1.6 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -106.77 126.79 52.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 -179.121 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.634 ' N ' HD13 ' A' ' 90' ' ' LEU . 82.8 tt0 -133.96 115.31 14.23 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.2 tp -149.95 113.5 3.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.6 Cg_endo -41.87 158.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.261 1.307 . . . . 0.0 110.427 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.32 124.84 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.494 HD22 HD21 ' A' ' 74' ' ' LEU . 33.6 mt -104.82 123.82 48.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 63.0 tttp -66.15 -46.89 75.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.097 0.475 . . . . 0.0 110.85 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.43 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 3.6 m -71.75 102.83 2.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.52 97.29 9.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 5.2 p -136.33 155.17 50.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.908 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -54.19 -26.19 26.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.485 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -85.12 -47.45 10.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.475 0.655 . . . . 0.0 111.71 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 97' ' ' SER . 2.4 m120 -65.63 -36.43 83.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.267 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.13 -19.33 61.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -70.79 -32.04 69.01 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 m -92.62 -9.73 39.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.81 176.54 43.21 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.606 -1.283 . . . . 0.0 112.407 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.74 128.01 34.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.17 28.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.001 0.429 . . . . 0.0 111.265 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.0 p -75.56 153.08 37.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.22 -46.38 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -90.54 140.91 29.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.859 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.0 pt-20 -66.81 -6.12 14.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.694 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -145.73 45.76 1.28 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.78 0.324 . . . . 0.0 110.925 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.534 ' OE1' ' CG ' ' A' ' 121' ' ' TYR . 6.0 tt0 -72.04 161.18 31.28 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.5 t -136.92 124.53 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.8 mtt -75.1 127.82 34.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.494 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.83 71.83 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -140.85 121.61 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.097 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 75.68 -172.26 54.0 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -85.66 111.66 20.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.534 ' CG ' ' OE1' ' A' ' 114' ' ' GLN . 6.0 t80 -83.67 103.25 12.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.435 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.72 128.11 36.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 111.891 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.81 131.26 53.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.764 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.13 140.18 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.407 0.622 . . . . 0.0 110.95 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.8 -177.53 17.03 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.774 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -85.84 149.32 25.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.628 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' SER . 50.4 p30 -114.57 27.36 9.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.945 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.5 mmm -47.94 -10.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.93 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 m 55.87 42.12 29.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.327 0.584 . . . . 0.0 109.598 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.426 ' N ' ' OG ' ' A' ' 136' ' ' SER . 31.7 mmtm -132.56 110.55 10.55 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.927 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -53.92 125.25 17.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.726 0.774 . . . . 0.0 110.544 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.3 9.4 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.611 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.777 HG12 ' H ' ' A' ' 134' ' ' LEU . 52.3 t -77.84 178.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 CA-C-N 117.466 0.633 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.777 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.56 135.58 47.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.974 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 46.07 30.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.539 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.28 -11.44 59.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.68 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.16 20.61 2.09 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.5 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.0 pt -68.06 -25.01 31.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.622 0.249 . . . . 0.0 111.419 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.25 6.09 2.46 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.0 t -98.88 -16.09 18.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.516 HD23 ' OG ' ' A' ' 87' ' ' SER . 15.7 mt -64.91 125.02 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.075 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.444 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 22.6 ttpt -99.83 173.87 6.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.409 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 12.4 ttpt -68.57 125.25 25.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.729 0.776 . . . . 0.0 111.617 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.91 26.92 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 85.7 m-20 -85.29 133.31 34.16 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -79.49 127.18 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.302 0.572 . . . . 0.0 111.829 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.99 121.59 63.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.912 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -102.69 121.49 42.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.1 tp -118.52 144.12 46.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -113.04 130.78 56.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.297 0.57 . . . . 0.0 111.193 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.0 t0 -108.87 -172.17 2.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.516 -1.22 . . . . 0.0 107.913 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.506 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.8 m-20 -27.05 -67.7 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.163 0.506 . . . . 0.0 111.799 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.97 22.02 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.8 152.76 36.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.365 0.602 . . . . 0.0 112.461 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.17 120.79 40.93 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CE2' HG21 ' A' ' 206' ' ' THR . 63.2 m-85 -106.85 130.73 54.49 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 111.075 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.7 mt-10 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.297 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -113.33 141.91 46.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.31 131.57 54.28 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.532 0.682 . . . . 0.0 110.42 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.6 135.81 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.146 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -100.92 -23.09 14.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.461 1.1 . . . . 0.0 110.339 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 153.16 155.93 7.36 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.497 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.39 138.56 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.331 -0.934 . . . . 0.0 109.905 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.0 m -135.04 149.57 50.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.129 0.49 . . . . 0.0 111.601 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.49 111.54 24.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.308 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.03 158.59 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.184 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 p -67.06 168.47 10.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.535 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.3 Cg_endo -81.52 -11.09 11.85 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 122.033 1.822 . . . . 0.0 111.47 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -86.69 -14.49 42.37 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.168 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -87.37 72.26 9.81 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.143 0.496 . . . . 0.0 110.442 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 89.4 m95 -76.21 -1.72 27.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.464 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.505 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -53.56 -31.26 45.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 0.0 110.739 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.713 ' O ' HG21 ' A' ' 183' ' ' THR . 17.7 m -83.68 4.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.66 -16.23 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.616 0.722 . . . . 0.0 109.456 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.9 159.9 19.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.878 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.26 129.34 39.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 39.5 m80 -102.25 -38.87 7.47 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.49 29.33 0.28 Allowed Glycine 0 N--CA 1.472 1.076 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.427 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.0 ptpt -156.18 176.91 12.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.381 0.61 . . . . 0.0 111.595 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 23.9 p30 -90.69 88.62 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.893 0.854 . . . . 0.0 109.84 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.44 166.88 13.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.169 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.25 140.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.713 HG21 ' O ' ' A' ' 173' ' ' VAL . 19.5 m -135.28 126.33 27.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.77 118.29 33.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.339 0.59 . . . . 0.0 109.782 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.51 HG22 HG13 ' A' ' 198' ' ' VAL . 29.3 pt -129.35 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.54 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.529 ' OG1' ' NH1' ' A' ' 196' ' ' ARG . 44.3 p -132.19 163.09 29.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.113 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.7 p -42.88 163.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.23 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 188' ' ' VAL . 10.7 p -93.09 128.05 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.967 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.3 p -155.23 162.94 40.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 111.045 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.28 141.01 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.793 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -143.43 -78.82 0.22 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -149.61 63.44 1.0 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 63.2 t30 56.52 35.91 26.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.0 109.823 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.3 m -75.52 147.02 40.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.945 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -88.14 138.37 31.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.194 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.529 ' NH1' ' OG1' ' A' ' 186' ' ' THR . 61.0 ttm-85 -101.8 145.86 28.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.268 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.98 127.39 42.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.51 HG13 HG22 ' A' ' 185' ' ' ILE . 47.9 t -133.54 136.92 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 126.39 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.579 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.09 136.79 52.7 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.28 0.562 . . . . 0.0 110.3 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.6 155.48 23.63 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.632 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -112.32 146.16 38.75 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.813 0.34 . . . . 0.0 111.865 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.41 128.34 36.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 121.368 0.604 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.7 p -107.31 -24.14 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.752 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.47 175.15 46.11 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.445 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.428 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.2 m -152.7 151.6 30.74 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 110.83 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -149.17 176.27 10.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.04 146.02 24.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.337 0.589 . . . . 0.0 111.17 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.53 79.63 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.566 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp . . . . . 0 C--N 1.318 -0.795 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.76 178.615 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.8 m -60.37 -43.61 96.41 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.799 0.333 . . . . 0.0 110.655 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.414 ' O ' ' O ' ' A' ' 56' ' ' MET . 59.0 t-80 -69.34 -64.3 0.9 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.473 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 55' ' ' HIS . 13.2 ttt 52.45 172.94 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.237 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' H ' ' HG2' ' A' ' 56' ' ' MET . 96.3 m-20 -111.44 110.57 21.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.366 . . . . 0.0 110.41 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.55 -51.92 20.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.946 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -153.48 62.05 0.75 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.474 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.46 28.16 4.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.438 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.57 -47.31 92.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.233 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.5 t0 49.7 -93.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.377 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 64' ' ' PRO . 5.1 tm0? -150.8 90.5 4.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.6 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 6.2 Cg_exo -73.47 153.14 49.78 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.074 1.849 . . . . 0.0 111.622 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 57.8 t0 -71.64 152.89 42.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.439 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.7 mt -59.6 -24.3 63.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.715 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.78 90.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -73.41 -34.57 65.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.3 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.61 -44.17 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.606 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.81 89.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.92 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.47 -24.74 36.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.91 109.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.892 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -95.6 121.84 37.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.039 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.4 tp -115.79 127.94 55.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.986 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.42 138.38 55.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.587 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -71.19 -6.86 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.5 . . . . 0.0 110.274 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.09 -36.68 85.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.174 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -76.69 13.01 1.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.316 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.43 126.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.75 -4.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.87 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.22 -171.23 40.54 Favored Glycine 0 C--N 1.318 -0.468 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.793 ' O ' HD23 ' A' ' 149' ' ' LEU . 53.5 mtt180 -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.1 tt -119.28 124.71 73.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 m -127.1 128.68 46.6 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 56.6 mt -131.78 129.36 21.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.355 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -82.31 -35.4 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.22 1.947 . . . . 0.0 112.377 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -49.71 -39.67 37.8 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.669 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.9 p -118.44 -2.31 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 123.027 0.204 . . . . 0.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.89 53.08 3.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.7 tp -113.34 131.84 55.81 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.037 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.89 115.7 15.57 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 83' ' ' ILE . 39.5 mt -143.97 111.64 5.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.7 Cg_endo -40.65 138.64 1.42 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.57 1.513 . . . . 0.0 110.811 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 68.1 t -90.96 122.93 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -100.03 136.96 39.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.338 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.79 -34.48 60.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.6 m -93.83 115.84 28.27 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.465 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.8 p -82.79 66.44 8.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.211 0.529 . . . . 0.0 110.183 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.415 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -94.65 150.73 19.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.377 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -54.16 -52.01 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.634 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.83 -41.88 95.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.368 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.758 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -66.17 -33.47 75.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.37 -178.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.87 -15.08 62.6 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.413 HD23 ' NE2' ' A' ' 126' ' ' HIS . 24.3 mt -72.35 -23.44 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -94.08 -9.65 35.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.413 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 169.25 -162.94 36.63 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.853 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.453 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -89.08 127.84 35.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.249 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.82 26.02 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.6 p -71.45 149.75 45.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.3 t -82.92 -46.13 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -92.8 -171.55 2.75 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.297 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -106.79 -55.19 2.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.505 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -90.8 46.61 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.575 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.9 147.01 23.83 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.17 131.83 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.535 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.5 mtt -64.71 128.1 34.33 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.42 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.52 5.85 71.44 Favored Glycine 0 CA--C 1.508 -0.364 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -140.62 118.5 11.79 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.809 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.0 -168.45 54.21 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 61.1 t30 -85.99 109.11 18.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.63 103.54 13.03 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.7 126.73 36.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.806 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.486 HD13 HD12 ' A' ' 83' ' ' ILE . 11.5 mt -122.63 132.62 54.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.689 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.09 140.0 48.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.114 0.483 . . . . 0.0 110.587 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.99 -178.12 17.77 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.413 ' NE2' HD23 ' A' ' 104' ' ' LEU . 44.6 m-70 -80.9 156.62 25.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 0.0 110.622 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 129' ' ' SER . 2.2 p-10 -120.95 27.47 8.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 35.0 mtt -46.24 -12.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.615 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 57.5 40.35 27.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.616 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -134.0 112.07 10.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.032 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -52.84 124.51 14.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.059 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.65 -29.73 7.66 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.779 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.703 HG12 ' N ' ' A' ' 134' ' ' LEU . 95.6 t -75.22 176.68 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 117.914 0.857 . . . . 0.0 109.247 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.703 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.61 134.76 46.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.117 -178.466 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.3 m-85 46.13 32.87 1.54 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.958 0.408 . . . . 0.0 110.708 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -82.24 -9.85 59.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -146.58 28.28 1.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.431 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.5 pt -69.74 -27.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.496 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.83 0.13 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.846 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.8 m -91.27 -15.5 29.08 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.69 116.76 6.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.054 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.447 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.5 mttp -103.53 154.74 19.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -50.76 113.29 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.395 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.29 4.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.8 m-20 -101.06 128.47 47.1 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -82.99 134.61 35.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.247 0.546 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 158' ' ' TYR . 90.0 mt -123.95 124.24 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.946 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -105.08 122.01 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 110.82 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.7 mt -116.12 150.42 37.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.397 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.465 ' O ' ' SD ' ' A' ' 116' ' ' MET . 60.2 m-85 -118.36 130.19 55.86 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.087 0.47 . . . . 0.0 110.991 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.5 t0 -109.93 -170.15 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 7.5 p30 -27.03 -71.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.1 0.476 . . . . 0.0 111.602 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.7 mt-10 -137.49 31.41 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.081 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.16 138.95 48.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.324 0.583 . . . . 0.0 112.401 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -103.94 121.62 43.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -104.42 133.46 49.27 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.294 0.568 . . . . 0.0 111.55 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.412 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.7 mt-10 -98.38 119.86 37.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.016 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 147' ' ' ILE . 31.6 m-85 -120.0 139.7 52.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.93 135.14 54.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.492 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.4 t -70.7 135.9 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.981 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 11.4 p -102.68 -23.98 13.79 Favored 'General case' 0 C--N 1.341 0.235 0 O-C-N 124.814 1.321 . . . . 0.0 110.972 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.81 154.79 7.26 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.31 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.56 146.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.551 -0.824 . . . . 0.0 109.789 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.9 t -146.19 156.15 43.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.86 0.362 . . . . 0.0 111.178 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -109.18 118.23 36.2 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.18 156.69 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.968 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 169' ' ' ASP . 20.4 p -66.15 136.31 95.33 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.602 ' CB ' HH21 ' A' ' 196' ' ' ARG . 1.6 Cg_endo -47.77 -12.99 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.97 1.78 . . . . 0.0 111.816 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 167' ' ' THR . 55.0 t0 -86.0 -11.15 53.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.642 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -86.78 75.35 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.774 0.321 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -78.11 -5.64 52.22 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.049 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -53.43 -35.03 60.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.944 0.402 . . . . 0.0 111.191 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.709 ' O ' HG21 ' A' ' 183' ' ' THR . 16.8 m -81.45 3.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.828 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.0 t -119.53 -15.04 8.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.567 0.699 . . . . 0.0 109.773 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -85.31 163.19 18.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.047 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.35 129.62 39.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.0 -42.62 6.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.135 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.69 30.12 0.26 Allowed Glycine 0 N--CA 1.469 0.89 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -155.81 177.37 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.071 0.462 . . . . 0.0 111.236 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 61.9 m-20 -88.88 89.34 7.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.266 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -124.21 166.17 16.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.971 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.68 143.18 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 173' ' ' VAL . 8.2 m -136.21 125.33 24.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.711 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.566 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -112.85 125.59 54.53 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.505 HG22 HG12 ' A' ' 198' ' ' VAL . 5.6 pt -140.6 -177.86 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.7 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 32.1 p -138.03 153.31 49.37 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.771 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 187' ' ' CYS . 27.1 p -100.29 76.25 1.87 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.433 HG12 ' ND2' ' A' ' 127' ' ' ASN . 3.0 m -64.86 -41.99 93.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.934 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m 49.98 60.98 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.873 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 79.0 t -125.99 133.58 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.82 0.343 . . . . 0.0 110.138 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.05 -44.64 96.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.36 -178.75 5.96 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 195' ' ' LYS . 91.5 m-20 48.97 58.14 5.68 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.865 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 87.2 p -66.73 61.8 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.901 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 193' ' ' ASN . 61.6 pttt -145.49 146.67 31.55 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.615 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.602 HH21 ' CB ' ' A' ' 168' ' ' PRO . 29.6 ttm180 -142.73 135.29 27.8 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.151 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -84.92 129.76 34.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 185' ' ' ILE . 34.6 m -137.57 140.07 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.165 0.507 . . . . 0.0 111.626 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.5 t -118.06 130.9 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.419 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.92 136.98 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.643 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.44 160.95 24.62 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.377 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 53.2 p-10 -112.53 146.03 39.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.175 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 157' ' ' GLU . 37.2 tp -68.95 127.74 34.22 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.24 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.2 176.58 44.51 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.386 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 36.1 m -153.56 153.44 32.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.077 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -149.78 179.21 8.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.578 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.64 148.97 21.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.618 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 209' ' ' LYS . 15.0 ptmt -64.42 79.59 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.455 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.314 -0.938 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.661 178.059 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.52 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m -59.05 -42.9 91.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 110.886 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.563 ' C ' ' H ' ' A' ' 57' ' ' ASP . 75.9 m80 -68.25 -168.36 0.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.673 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 57' ' ' ASP . 8.0 ttt 65.58 -19.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.622 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' A' ' 55' ' ' HIS . 97.4 m-20 48.96 94.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.577 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.1 -13.35 61.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.204 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.5 p -87.36 0.32 55.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.701 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -71.22 49.05 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.007 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 63' ' ' GLN . 46.6 mt -62.97 -46.82 95.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 46.65 -95.27 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.301 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ILE . 2.5 pt20 -149.19 88.01 5.18 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.652 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.79 154.42 43.54 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.725 2.284 . . . . 0.0 110.982 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.01 166.21 23.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.692 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.9 mm? -69.61 -16.29 63.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 111.152 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.91 94.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.381 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.9 mm-40 -72.52 -33.57 66.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.91 -46.52 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.911 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.016 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 59.9 t-20 -82.9 -28.32 30.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.59 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.83 106.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.851 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 m -97.3 114.81 26.63 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.58 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.441 HD13 ' OD1' ' A' ' 102' ' ' ASN . 53.2 tp -107.24 125.67 51.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.934 0.397 . . . . 0.0 111.106 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -68.23 138.48 55.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.321 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -63.92 -8.5 11.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.286 0.565 . . . . 0.0 110.207 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -70.76 -14.82 62.58 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.389 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -91.94 1.02 57.45 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.496 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.76 122.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 tt -104.31 -36.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.407 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.37 -158.47 8.78 Favored Glycine 0 C--N 1.321 -0.303 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.451 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 25.7 mtp85 -146.9 150.6 35.53 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.52 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.8 tt -122.34 127.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -126.84 129.15 47.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.849 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 12.6 mt -133.62 117.18 14.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.2 -177.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 3.4 Cg_exo -80.92 -37.75 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.486 2.124 . . . . 0.0 112.653 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 t -49.26 -36.79 21.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.491 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 90' ' ' LEU . 6.9 m -119.87 -7.07 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.381 0.134 . . . . 0.0 111.057 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 73.33 46.02 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.663 0.744 . . . . 0.0 109.952 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -106.0 125.59 51.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.512 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -137.0 110.75 8.11 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' O ' HG22 ' A' ' 83' ' ' ILE . 18.3 mt -146.61 116.88 4.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -41.14 140.41 1.33 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.795 1.663 . . . . 0.0 109.931 176.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.35 126.82 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.423 HD22 HD21 ' A' ' 74' ' ' LEU . 28.1 mt -103.11 124.97 49.56 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -70.37 -34.36 72.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.1 m -86.45 108.85 18.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.987 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -82.0 69.35 8.69 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 110.221 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.574 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.08 151.58 22.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.484 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.74 -50.14 66.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.593 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.01 -40.63 95.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.075 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.574 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 43.0 m-20 -65.64 -37.03 85.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.58 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.25 -18.09 46.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.627 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.31 -17.71 61.28 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -100.56 -12.14 19.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.52 -174.72 43.86 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 127.46 32.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.29 146.61 29.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 110.771 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.9 p -75.5 151.5 37.99 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.11 -50.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -90.65 139.22 30.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.72 -48.09 83.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.826 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -98.51 47.36 0.99 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.01 159.71 30.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -140.86 124.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 -178.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.0 mtt -75.36 127.97 34.34 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.32 -1.14 72.56 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 115' ' ' VAL . 29.5 tptp -142.81 127.34 17.9 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.986 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 72.93 -172.98 48.71 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -86.6 110.29 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -85.63 100.79 12.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.37 125.32 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.531 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.492 HD13 HD12 ' A' ' 83' ' ' ILE . 7.1 mt -119.32 130.28 55.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.36 138.98 47.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 110.754 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.76 -178.57 18.8 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.323 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 42.5 m-70 -85.69 141.05 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.569 0.223 . . . . 0.0 110.581 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 129' ' ' SER . 65.3 t30 -110.44 27.68 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.124 0.488 . . . . 0.0 110.567 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -44.81 -16.18 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.854 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.56 40.88 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.069 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 136' ' ' SER . 98.4 mttt -131.25 109.46 10.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.358 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 132' ' ' GLY . 7.7 tmtt? -53.31 123.87 13.1 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.511 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.404 ' N ' ' HD3' ' A' ' 131' ' ' LYS . . . 114.91 -29.2 7.58 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 134' ' ' LEU . 57.2 t -77.84 178.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.752 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.88 136.67 47.03 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.768 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 44.87 32.0 0.76 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.108 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.2 p -82.4 -11.92 58.24 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.96 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.403 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 35.2 t0 -141.71 25.91 1.95 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 pt -70.3 -22.33 23.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.918 0.389 . . . . 0.0 111.846 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.9 3.91 7.41 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.661 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.403 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.7 m -99.57 -11.45 20.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.111 0.481 . . . . 0.0 110.298 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.474 ' O ' HG21 ' A' ' 163' ' ' VAL . 14.6 mt -62.95 124.95 22.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.463 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.462 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -96.97 163.04 13.12 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.846 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -60.77 136.1 57.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.528 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.14 57.73 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 40.5 m-20 -87.61 131.62 34.35 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.948 ' HZ1' HG11 ' A' ' 204' ' ' VAL . 3.4 mmpt? -78.2 129.2 34.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.932 0.396 . . . . 0.0 111.726 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.1 mt -124.8 123.15 65.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -104.12 120.26 40.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.194 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.607 HD22 ' SD ' ' A' ' 116' ' ' MET . 0.4 OUTLIER -115.38 136.44 53.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.404 -178.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.451 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 87.7 m-85 -108.27 130.61 55.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 111.285 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.6 t0 -113.46 -165.46 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.524 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.3 m-20 -24.11 -75.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.174 0.512 . . . . 0.0 111.328 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -137.03 26.02 2.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -126.22 143.13 51.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -108.39 120.46 42.45 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -103.35 131.19 50.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.547 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.494 ' OE2' ' NZ ' ' A' ' 146' ' ' LYS . 70.3 tt0 -95.96 121.04 37.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -120.25 137.27 54.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.246 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.11 132.56 56.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 110.547 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.24 134.84 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.155 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.3 t -104.74 -24.29 12.94 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.468 1.105 . . . . 0.0 111.516 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.18 147.37 5.11 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.397 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 199' ' ' VAL . 13.5 t -111.08 155.51 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.6 t -161.34 169.64 21.66 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.936 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -121.22 123.88 43.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -135.69 157.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 111.326 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 169' ' ' ASP . 16.9 p -59.16 131.3 87.28 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.563 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.1 Cg_endo -45.57 -14.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.968 1.779 . . . . 0.0 112.122 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 167' ' ' THR . 53.6 t0 -84.83 -8.58 58.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.275 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.455 ' O ' HG22 ' A' ' 173' ' ' VAL . 1.3 tppp? -87.82 62.74 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.563 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 26.9 m95 -72.24 -18.21 61.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.804 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.09 -9.64 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.166 0.508 . . . . 0.0 111.195 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 171' ' ' TRP . 24.6 m -83.39 -25.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.817 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.459 HG11 HD13 ' A' ' 185' ' ' ILE . 0.8 OUTLIER -109.67 -2.33 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.622 0.725 . . . . 0.0 109.865 -178.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 176' ' ' ASP . 95.3 mt-10 -82.18 119.9 24.65 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.78 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 175' ' ' GLU . 97.9 m-20 -28.96 119.81 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.957 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -98.86 -43.43 6.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.051 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.17 33.47 0.32 Allowed Glycine 0 N--CA 1.47 0.963 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.1 ptpt -153.6 176.29 12.24 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.235 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 50.6 p-10 -97.44 88.62 4.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.904 0.859 . . . . 0.0 110.46 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -131.0 177.11 7.69 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.282 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.48 HD12 HD12 ' A' ' 149' ' ' LEU . 20.3 tt -130.63 143.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.538 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.615 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.5 m -138.22 123.88 19.77 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.563 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.615 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -110.86 128.82 55.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.459 HD13 HG11 ' A' ' 174' ' ' VAL . 7.1 pt -138.61 -166.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.626 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 188' ' ' VAL . 3.7 t -131.55 164.34 26.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.656 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.417 ' O ' ' O ' ' A' ' 188' ' ' VAL . 84.5 m -64.51 8.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.405 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 186' ' ' THR . 60.2 t 47.94 94.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.469 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.3 p -82.99 146.55 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.525 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.42 -45.37 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.059 0.457 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -86.76 45.3 1.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.444 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -91.05 94.53 9.66 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.135 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -63.15 -42.97 99.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.218 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 40.2 t -85.69 164.09 17.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.208 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.04 147.17 38.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' A' ' 168' ' ' PRO . 7.8 tmm_? -63.44 136.7 57.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.431 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -100.27 134.48 43.15 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.7 138.95 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.898 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.544 HG22 HG13 ' A' ' 163' ' ' VAL . 77.7 t -116.97 128.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.528 ' O ' HG22 ' A' ' 161' ' ' THR . . . -112.52 133.01 54.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.453 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.06 152.99 20.74 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 64.5 t0 -111.04 149.41 30.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.783 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.543 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.54 127.73 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.207 0.527 . . . . 0.0 110.795 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.948 HG11 ' HZ1' ' A' ' 146' ' ' LYS . 6.1 p -111.32 -21.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.699 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.43 176.05 47.46 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.678 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.0 m -156.86 154.51 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.824 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -150.76 178.99 8.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -90.96 148.19 22.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.285 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.411 ' O ' ' OXT' ' A' ' 210' ' ' LYS . 64.4 tttm -74.49 79.24 1.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.561 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.411 ' OXT' ' O ' ' A' ' 209' ' ' LYS . 26.7 ttpt . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.461 178.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -63.4 141.19 58.86 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -150.93 145.69 25.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 56' ' ' MET . 0.0 OUTLIER -97.63 161.07 13.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.378 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -148.75 158.05 43.88 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.094 0.473 . . . . 0.0 111.577 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.63 -8.99 58.17 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.275 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.4 p -86.47 37.34 0.73 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.558 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -79.08 33.83 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.027 0.441 . . . . 0.0 111.034 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.45 -46.5 95.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.26 0.553 . . . . 0.0 110.621 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 49.45 -96.27 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.341 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.9 82.43 6.0 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.713 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.54 151.24 41.73 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.455 2.103 . . . . 0.0 111.715 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -77.42 171.36 15.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.71 -16.07 63.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.89 92.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.459 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -74.33 -31.97 62.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.507 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.7 t -75.01 -45.48 42.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.575 -178.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.7 89.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.853 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -77.06 -28.49 54.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.282 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.79 107.25 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.977 -179.236 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.9 t -96.67 119.63 35.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.159 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.8 tp -119.05 129.48 55.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.481 -179.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.45 138.87 49.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.835 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -68.78 -7.82 37.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.297 0.57 . . . . 0.0 110.246 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -73.5 -10.34 59.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.864 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.8 mp0 -91.87 1.61 57.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.02 131.27 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.882 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.1 pt -123.22 -5.5 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -178.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.0 -170.08 35.51 Favored Glycine 0 C--N 1.316 -0.573 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -146.32 150.89 36.59 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.704 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -123.02 124.8 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.616 ' N ' HD13 ' A' ' 83' ' ' ILE . 26.3 t -130.32 131.11 45.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.621 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.5 mt -133.46 131.15 21.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.461 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.36 -35.43 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.315 2.01 . . . . 0.0 111.854 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -48.41 -39.86 23.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.519 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.6 p -119.48 -2.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.901 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 2.6 p 62.67 52.22 2.89 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -112.28 132.44 54.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.101 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -134.85 115.49 13.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.458 ' O ' HG22 ' A' ' 83' ' ' ILE . 64.3 mt -144.09 113.65 5.32 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -177.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.3 Cg_endo -41.76 147.62 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.767 1.645 . . . . 0.0 110.58 176.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.55 123.0 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.465 ' CB ' HD22 ' A' ' 102' ' ' ASN . 22.3 mt -104.25 123.75 47.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.044 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 65.8 tttm -67.38 -47.13 71.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.192 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.59 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -74.06 105.99 5.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.366 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -81.84 101.98 10.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.494 0.664 . . . . 0.0 110.199 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.528 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.8 p -135.54 164.15 28.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.33 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.969 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -83.0 -42.4 17.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.788 -179.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -66.65 -35.24 79.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.231 -178.821 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -63.72 -16.34 60.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.863 -178.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.65 -16.47 60.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.8 p -106.29 -9.3 16.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.2 -172.54 44.49 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.403 -178.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.85 128.45 33.37 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.114 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.559 ' CB ' HD21 ' A' ' 102' ' ' ASN . . . -105.27 146.77 28.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.79 149.91 39.53 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.19 -41.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 112' ' ' GLU . 24.3 tttp -88.74 -173.35 4.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.78 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 35.4 tp10 -120.95 -11.33 8.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.296 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 112' ' ' GLU . 97.9 m-20 -141.57 42.09 1.73 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.234 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -89.74 160.53 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.6 t -132.02 132.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.741 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.416 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.7 mtt -68.38 128.67 37.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.209 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.31 3.02 72.88 Favored Glycine 0 N--CA 1.461 0.323 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -140.4 120.91 14.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.96 53.13 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.492 HD21 ' CB ' ' A' ' 183' ' ' THR . 2.0 t30 -95.39 110.9 22.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -84.4 103.73 13.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 128.54 36.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.281 0.563 . . . . 0.0 111.969 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.45 129.48 51.31 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.716 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 139.16 46.65 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.469 0.652 . . . . 0.0 110.888 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.56 -178.64 17.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.746 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -81.98 155.42 25.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.3 p-10 -121.82 27.04 8.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.428 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 39.0 mtt -44.08 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.004 -178.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 59.65 40.04 20.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.398 0.618 . . . . 0.0 109.613 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 136' ' ' SER . 65.4 tttm -135.59 118.55 16.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.823 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.0 124.99 21.2 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.637 0.732 . . . . 0.0 110.47 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.5 -26.1 10.53 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.816 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 134' ' ' LEU . 98.4 t -78.97 175.69 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.774 0.787 . . . . 0.0 109.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.713 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.28 135.07 45.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.191 -178.401 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 46.26 32.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.458 . . . . 0.0 110.542 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.27 -7.59 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.512 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.6 m-20 -147.09 31.46 0.93 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -177.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.5 pt -70.73 -23.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.463 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB2' ' CG ' ' A' ' 197' ' ' TYR . . . -74.48 3.2 7.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.668 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -97.02 -11.6 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.4 ' O ' HG21 ' A' ' 163' ' ' VAL . 16.9 mt -64.79 122.45 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.608 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 60.4 mttp -96.82 151.4 19.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.489 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -54.74 123.77 14.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.606 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.73 19.64 19.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.5 m-20 -88.23 132.29 34.43 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -82.15 135.19 35.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.386 0.612 . . . . 0.0 111.978 -177.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 158' ' ' TYR . 96.0 mt -127.47 125.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.718 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.41 118.36 36.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.147 0.498 . . . . 0.0 109.986 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.39 144.82 43.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.314 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.416 ' O ' ' SD ' ' A' ' 116' ' ' MET . 19.2 m-85 -114.78 131.75 56.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.216 0.531 . . . . 0.0 111.271 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.8 t0 -112.41 -168.73 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 151' ' ' ASP . 86.3 m-20 -24.22 -74.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.04 0.448 . . . . 0.0 112.066 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -137.47 28.22 2.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.86 148.77 50.48 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -175.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.31 122.26 47.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.433 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.8 m-85 -105.65 132.01 52.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 111.412 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -95.92 114.16 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.163 178.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 147' ' ' ILE . 46.9 m-85 -115.38 139.96 49.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -120.58 134.79 55.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.491 0.662 . . . . 0.0 111.561 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.95 133.29 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.96 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 p -102.89 -28.44 12.04 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 124.959 1.412 . . . . 0.0 110.697 -178.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.22 152.56 7.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.82 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 199' ' ' VAL . 12.2 t -116.29 150.15 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.742 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -152.27 161.95 41.86 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.277 0.56 . . . . 0.0 111.543 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -111.51 126.47 55.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.478 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.59 162.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.01 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.1 p -71.17 141.31 86.13 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -46.54 -17.24 0.33 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.862 1.708 . . . . 0.0 111.842 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.448 ' OD1' ' NZ ' ' A' ' 191' ' ' LYS . 91.6 m-20 -82.77 -3.6 56.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.1 tptt -80.98 148.07 29.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 81.7 m95 -158.33 -26.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.963 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.13 -8.67 0.08 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.236 0.541 . . . . 0.0 110.531 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.794 HG23 HG13 ' A' ' 174' ' ' VAL . 4.8 m -74.8 -30.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.923 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.794 HG13 HG23 ' A' ' 173' ' ' VAL . 2.5 m -105.59 -5.13 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.756 0.789 . . . . 0.0 109.763 -178.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 176' ' ' ASP . 77.6 mm-40 -80.02 118.38 21.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.9 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 175' ' ' GLU . 68.2 t0 -29.01 124.08 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.491 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -99.08 -40.72 7.87 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.917 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.5 29.21 0.28 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' A' ' 181' ' ' GLU . 21.9 pttp -156.03 179.52 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 111.296 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -94.12 100.11 12.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.714 0.769 . . . . 0.0 109.79 179.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' A' ' 179' ' ' LYS . 17.1 pt-20 -138.92 174.58 10.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.922 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.1 tt -131.12 143.88 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.548 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.588 ' C ' HD12 ' A' ' 184' ' ' LEU . 12.4 m -135.9 126.01 26.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.677 0.275 . . . . 0.0 111.239 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -113.14 126.89 55.94 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.384 0.612 . . . . 0.0 110.643 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 174' ' ' VAL . 8.1 pt -141.13 -172.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.184 -178.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t -139.44 147.39 41.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.017 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 6.0 t -101.17 104.19 15.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.129 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.487 HG21 HD21 ' A' ' 127' ' ' ASN . 7.4 p -146.59 139.34 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.012 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 190' ' ' VAL . 1.9 m -89.44 -138.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 189' ' ' SER . 4.4 t 52.84 99.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.094 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.448 ' NZ ' ' OD1' ' A' ' 169' ' ' ASP . 71.8 mmtt -84.93 -16.08 42.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.624 -178.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.36 -47.3 84.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.858 0.361 . . . . 0.0 110.987 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -64.47 -42.67 95.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.049 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.7 p 59.19 21.21 9.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -82.4 108.37 15.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.095 0.474 . . . . 0.0 110.56 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.02 125.3 13.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.174 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.419 ' CG ' ' HB2' ' A' ' 139' ' ' ALA . 8.6 m-85 -121.22 131.53 54.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.003 178.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.36 127.74 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.894 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.49 HG22 HG13 ' A' ' 163' ' ' VAL . 70.1 t -117.63 129.11 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.509 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.04 54.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.415 0.626 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.42 159.06 24.31 Favored Glycine 0 N--CA 1.461 0.322 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.849 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -110.17 153.35 24.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.709 -0.746 . . . . 0.0 111.873 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.9 tp -74.94 127.7 33.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.255 0.55 . . . . 0.0 110.878 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.403 HG21 ' HB2' ' A' ' 159' ' ' ALA . 93.1 t -107.56 -25.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.912 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 174.29 176.7 42.88 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.47 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 156' ' ' TYR . 15.1 m -153.49 153.2 31.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 111.052 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.33 176.91 10.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.463 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.56 142.08 27.86 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.898 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.99 79.87 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.847 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.2 tttm . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.552 178.64 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -64.55 141.59 58.72 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 57' ' ' ASP . 95.8 m-70 -84.04 -18.34 37.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.746 0.307 . . . . 0.0 111.18 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.0 mtt 46.34 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.14 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 55' ' ' HIS . 48.2 t0 -142.7 145.85 33.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.525 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.85 -17.65 62.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.65 -179.201 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.4 m -87.46 -103.8 0.07 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.877 0.37 . . . . 0.0 110.075 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp 48.25 32.02 2.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.218 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.4 -45.14 96.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.817 0.342 . . . . 0.0 110.601 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.519 ' H ' ' CB ' ' A' ' 189' ' ' SER . 68.1 t0 52.91 -104.75 0.21 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -151.08 81.85 6.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.336 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.73 144.78 35.76 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.305 2.003 . . . . 0.0 111.731 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 171.58 14.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.92 -14.3 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.683 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.92 91.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mt-10 -74.85 -26.09 59.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.18 -47.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.671 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -42.24 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -70.83 -31.04 67.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.82 145.46 55.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.44 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -139.26 108.13 5.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.059 0.456 . . . . 0.0 110.998 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.427 HD11 HD22 ' A' ' 95' ' ' LEU . 3.9 tt -105.13 127.05 52.72 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.056 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -74.0 137.1 43.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' O ' HG12 ' A' ' 79' ' ' VAL . 4.5 mptp? -67.33 -9.41 40.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 110.165 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -80.29 -11.94 59.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.497 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.71 6.92 36.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 76' ' ' LYS . 8.6 p -88.18 138.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.1 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 pt -120.79 -5.96 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.561 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.64 -165.29 30.84 Favored Glycine 0 C--N 1.32 -0.361 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.408 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 11.8 ttp180 -152.57 155.0 36.54 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.042 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 83' ' ' ILE . 20.6 tt -128.61 130.17 68.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.675 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.04 130.83 51.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.553 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 mt -134.76 100.86 11.97 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.136 -178.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -67.82 -34.2 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.244 1.963 . . . . 0.0 112.404 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.5 t -52.1 -38.73 58.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 -177.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 137' ' ' ASP . 25.3 t -110.31 -9.6 11.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 120.58 0.229 . . . . 0.0 110.665 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.82 43.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.413 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -115.8 130.48 56.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.819 -178.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -134.45 118.91 17.9 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.3 mt -145.31 163.13 33.92 Favored Pre-proline 0 N--CA 1.465 0.275 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.547 -177.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.78 150.27 7.3 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.052 2.501 . . . . 0.0 109.428 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.9 t -95.77 116.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.427 HD22 HD11 ' A' ' 74' ' ' LEU . 39.7 mt -101.83 122.55 44.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.057 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -65.76 -46.19 79.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.084 0.468 . . . . 0.0 111.046 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 p -75.3 103.91 5.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.376 -179.003 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 99.8 11.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.333 0.587 . . . . 0.0 110.316 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 5.4 p -132.11 160.41 36.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.685 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -56.74 -28.96 62.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.781 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.485 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 18.8 ptmt -84.25 -41.88 16.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.342 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 101' ' ' LYS . 5.4 m120 -65.76 -36.47 83.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.396 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.89 -20.58 62.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.4 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -75.58 -15.51 60.35 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.6 m -103.32 -11.49 17.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.09 -166.59 39.79 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.226 -178.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.14 125.01 28.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.61 143.28 33.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.058 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.3 p -69.19 144.06 53.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.49 -44.69 18.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -89.33 -175.08 4.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.95 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -115.42 -11.57 11.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.623 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -137.6 43.19 2.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -178.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.653 ' NE2' ' CZ ' ' A' ' 121' ' ' TYR . 18.1 pt20 -92.17 155.28 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.362 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.05 132.37 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.507 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.0 mtt -68.3 128.15 35.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.413 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 89.34 4.61 73.7 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.86 121.17 12.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.638 -179.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.76 -168.88 54.6 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.47 ' CG ' ' HG1' ' A' ' 183' ' ' THR . 6.7 t-20 -89.33 110.48 21.26 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.653 ' CZ ' ' NE2' ' A' ' 114' ' ' GLN . 1.7 t80 -84.74 105.22 15.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.476 ' O ' HD22 ' A' ' 123' ' ' LEU . . . -95.01 120.13 34.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.998 -178.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 122' ' ' ALA . 1.9 mm? -117.09 132.42 56.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.862 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 142.54 43.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.752 -179.175 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.02 -178.6 19.88 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.545 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -85.16 152.07 23.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.922 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' SER . 41.7 t30 -116.01 28.34 8.68 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -50.14 -8.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.66 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 127' ' ' ASN . 3.0 t 52.51 44.18 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 109.716 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' SER . 29.3 tptp -134.15 113.53 12.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.643 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -56.01 125.17 20.39 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.415 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.45 -29.22 8.84 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.827 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.3 t -76.82 178.37 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 117.847 0.824 . . . . 0.0 109.384 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.743 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.38 136.51 49.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.715 0.293 . . . . 0.0 110.933 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 138' ' ' ILE . 4.1 m-30 43.17 31.76 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.928 178.312 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.41 -11.66 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.108 -178.803 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.492 ' O ' HG21 ' A' ' 88' ' ' VAL . 7.1 m-20 -142.24 22.1 2.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.097 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 140' ' ' SER . 4.5 pt -67.52 -29.41 45.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.61 2.43 1.33 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.793 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 138' ' ' ILE . 49.9 m -97.03 -11.46 24.45 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.19 121.15 12.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.51 172.69 7.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.766 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.35 122.1 22.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.543 0.687 . . . . 0.0 112.035 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.83 14.61 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -93.35 134.79 35.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -83.37 137.25 34.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.454 0.645 . . . . 0.0 112.074 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.65 122.85 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.001 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 73.9 m-85 -101.09 117.08 34.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.8 tp -115.1 144.96 42.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.675 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.408 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 31.1 m-85 -117.05 130.69 56.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.998 0.427 . . . . 0.0 111.676 -178.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.8 t0 -107.02 -167.66 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.497 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 61.6 t-20 -29.39 -68.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -138.41 21.7 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.766 179.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.44 146.33 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -176.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.37 118.87 37.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 206' ' ' THR . 60.5 m-85 -104.21 130.69 51.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.144 0.497 . . . . 0.0 111.085 -178.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 41.5 tp10 -94.41 117.18 29.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.15 137.81 51.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.31 133.36 56.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.274 0.559 . . . . 0.0 110.566 179.186 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 133.39 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -104.72 -25.15 12.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.537 1.148 . . . . 0.0 110.751 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.03 153.86 7.08 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.917 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.73 155.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.576 -0.812 . . . . 0.0 109.28 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.9 p -151.7 162.3 41.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.077 0.465 . . . . 0.0 111.198 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -114.22 113.67 24.95 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 159.66 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.139 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.3 p -60.3 168.46 2.29 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.5 -11.52 11.71 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.905 1.736 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.58 -6.64 59.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.997 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 173' ' ' VAL . 15.5 mmtp -85.06 66.71 9.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 173' ' ' VAL . 63.1 m95 -72.29 -24.57 61.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.98 -17.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.247 0.546 . . . . 0.0 110.365 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 170' ' ' LYS . 24.3 m -69.87 -27.23 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.206 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.52 HG11 HD13 ' A' ' 185' ' ' ILE . 1.6 m -109.73 1.0 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.554 0.692 . . . . 0.0 110.052 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.83 125.86 32.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.317 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -34.95 122.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.445 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -103.07 -44.22 5.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.777 0.323 . . . . 0.0 111.309 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.69 28.06 0.17 Allowed Glycine 0 N--CA 1.47 0.932 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -153.49 173.36 15.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 22.3 m-20 -94.25 88.86 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.462 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 75.1 tt0 -133.34 127.07 32.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.099 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.1 tt -81.16 148.26 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.54 ' C ' HD12 ' A' ' 184' ' ' LEU . 17.5 m -135.93 125.75 25.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.843 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.54 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -111.29 127.08 55.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 111.204 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.52 HD13 HG11 ' A' ' 174' ' ' VAL . 5.7 pt -132.35 153.61 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.248 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 6.9 t -140.76 162.95 34.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.49 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 3.4 t 59.78 59.02 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.851 178.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 189' ' ' SER . 14.5 m -63.21 -42.19 95.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.098 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.528 ' N ' HG23 ' A' ' 188' ' ' VAL . 11.3 t -74.67 166.49 23.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.86 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 87.8 t -70.36 132.12 33.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -142.1 162.8 34.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.949 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.47 -20.27 62.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.251 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 195' ' ' LYS . 51.7 t-20 -63.71 -40.52 96.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.636 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.19 -68.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.372 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 193' ' ' ASN . 27.3 tptt -66.87 130.95 44.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.877 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.49 ' NH2' ' O ' ' A' ' 187' ' ' CYS . 42.4 ttm180 -112.47 138.41 49.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.169 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -93.04 128.49 38.94 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.527 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.01 132.47 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 111.142 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.96 129.46 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.215 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.512 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.18 137.35 51.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.516 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.97 135.3 8.59 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.4 t0 -95.63 133.5 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.069 -0.566 . . . . 0.0 111.546 -178.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.401 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 44.8 tp -62.18 124.06 19.84 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.214 0.53 . . . . 0.0 110.385 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.1 -21.7 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.054 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.01 175.14 47.11 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.159 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 156' ' ' TYR . 22.4 m -154.57 152.71 30.36 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.023 0.44 . . . . 0.0 110.628 178.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -150.98 177.45 10.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.116 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.18 148.77 21.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.201 0.524 . . . . 0.0 110.845 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -70.79 80.27 0.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.535 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.669 178.424 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.567 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.1 p -61.09 -38.16 85.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.851 -0.174 . . . . 0.0 110.789 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 60.9 m170 48.27 -173.56 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.048 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.415 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 45.6 tpp -74.28 -72.51 0.28 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.141 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 48.19 29.43 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.111 0.481 . . . . 0.0 111.389 177.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 56' ' ' MET . . . -71.92 -15.07 62.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.318 -178.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.6 t -149.19 -93.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.2 tttm 52.11 21.63 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 111.42 178.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.33 -46.49 90.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.871 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 54.14 -98.53 0.08 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -151.49 78.23 7.04 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.385 -179.151 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.34 146.93 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.5 2.134 . . . . 0.0 110.8 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.78 147.77 48.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.808 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.8 mt -55.25 -25.9 36.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.053 -178.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.9 95.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.618 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 70.3 mm-40 -72.58 -33.38 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.923 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.3 t -75.36 -45.68 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.056 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -38.02 88.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.98 -25.97 34.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.639 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.63 131.84 51.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.388 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.8 t -95.92 158.92 15.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.024 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.689 HD22 ' HB3' ' A' ' 105' ' ' SER . 44.6 tp -123.24 134.13 54.13 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -179.002 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.28 105.54 15.84 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.027 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.587 ' O ' HG12 ' A' ' 79' ' ' VAL . 6.0 mptp? -63.81 -8.73 11.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.269 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -63.73 -39.47 94.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.605 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 8.0 pt20 -89.11 19.97 3.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.768 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.3 p -84.72 126.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.568 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.5 -9.26 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.43 -166.35 37.27 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.504 ' O ' HD12 ' A' ' 149' ' ' LEU . 34.6 mtp180 -146.88 150.57 35.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.622 -178.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 92' ' ' LEU . 7.8 tp -113.18 122.56 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 t -126.87 128.05 45.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.508 HG21 HD21 ' A' ' 141' ' ' LEU . 10.5 mt -135.62 122.31 14.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.969 -177.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.79 -34.73 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.577 2.184 . . . . 0.0 112.37 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.556 ' CB ' HD23 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -51.08 -39.75 56.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.488 -177.24 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 90' ' ' LEU . 20.7 m -118.62 -9.01 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 122.314 0.246 . . . . 0.0 111.096 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.505 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 74.37 48.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.407 0.622 . . . . 0.0 109.833 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.66 HD11 HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -107.18 123.49 48.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 -178.808 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.658 ' N ' HD13 ' A' ' 90' ' ' LEU . 84.7 tt0 -135.46 110.44 8.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 90' ' ' LEU . 10.6 mt -149.8 115.86 3.53 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.9 Cg_endo -39.91 143.11 0.46 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 121.832 1.688 . . . . 0.0 110.132 176.38 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.72 123.54 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.427 HD21 HD11 ' A' ' 74' ' ' LEU . 9.2 mt -105.21 138.37 41.52 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.088 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -78.71 -25.27 44.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.387 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -89.27 104.24 16.81 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -81.4 62.71 5.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.292 0.568 . . . . 0.0 110.37 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -93.84 162.83 13.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.708 179.59 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.64 -48.0 79.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.1 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 19.6 ptmt -67.27 -40.52 86.2 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.602 0.564 . . . . 0.0 111.74 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.605 ' OD1' ' NE2' ' A' ' 78' ' ' GLN . 8.7 m-80 -64.74 -37.56 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.243 -178.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.68 -20.76 61.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.63 -18.95 62.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.689 ' HB3' HD22 ' A' ' 74' ' ' LEU . 1.8 m -102.05 -13.83 17.37 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.58 ' HA2' HD13 ' A' ' 92' ' ' LEU . . . 176.25 -162.17 30.86 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.234 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.77 126.09 36.72 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.095 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -72.86 152.81 41.32 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.15 -47.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -93.19 145.36 24.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.54 -51.13 68.59 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.623 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.06 46.42 1.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.29 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.523 ' NE2' ' CE1' ' A' ' 121' ' ' TYR . 3.7 tt0 -80.89 153.71 27.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.59 117.77 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.147 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.453 ' N ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.14 129.95 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.795 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.25 -8.76 57.37 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -143.99 130.9 20.4 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.439 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.29 -167.95 52.8 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 25.2 t-20 -86.77 107.22 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.587 0.232 . . . . 0.0 110.659 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.523 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 4.7 t80 -86.56 100.51 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.88 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.21 123.8 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.837 -179.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.497 ' CD1' HD13 ' A' ' 83' ' ' ILE . 11.2 mt -118.18 132.64 56.31 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.373 178.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.34 140.17 48.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.923 -178.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.75 -178.09 16.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.661 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -85.17 146.17 27.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.621 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 129' ' ' SER . 0.9 OUTLIER -112.79 26.23 10.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 0.0 110.869 -179.592 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -42.76 -19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.816 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.11 39.43 12.96 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.139 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.86 109.49 10.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.04 124.88 16.87 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.829 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.85 -25.03 10.43 Favored Glycine 0 N--CA 1.473 1.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.533 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.785 HG12 ' H ' ' A' ' 134' ' ' LEU . 39.2 t -83.24 179.0 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -73.17 136.12 44.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.031 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.63 31.51 0.64 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 110.751 178.427 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -80.22 -7.47 58.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.719 -178.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.434 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.1 t0 -146.55 40.26 1.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.2 pt -70.65 -26.73 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.13 1.29 13.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.022 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.434 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.5 m -91.22 -17.96 25.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.087 -179.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.573 HD22 ' OD2' ' A' ' 145' ' ' ASP . 15.7 mt -65.21 125.3 24.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.324 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -95.93 170.91 8.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.72 130.03 40.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.923 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.03 21.18 36.65 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD2' HD22 ' A' ' 141' ' ' LEU . 1.7 t70 -87.49 132.28 34.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -79.56 134.9 36.49 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.391 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' TYR . 96.5 mt -126.55 125.83 67.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.16 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.31 113.62 26.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.578 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 82' ' ' ARG . 42.1 tp -113.32 134.47 54.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.389 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -105.83 133.98 49.69 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -178.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 152' ' ' ASN . 43.9 t0 -108.7 -169.28 1.47 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 151' ' ' ASP . 13.1 t-20 -32.93 -67.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.992 0.425 . . . . 0.0 110.65 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -135.98 21.89 3.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.065 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.53 150.37 40.96 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.103 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -114.81 119.47 36.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.341 178.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -105.23 130.19 53.44 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.372 0.606 . . . . 0.0 112.016 -178.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.45 117.34 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.498 ' O ' ' N ' ' A' ' 147' ' ' ILE . 20.0 m-85 -119.58 139.37 52.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.285 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.9 137.85 52.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.874 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.79 134.18 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.862 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.3 -27.26 12.95 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.84 1.338 . . . . 0.0 111.242 -178.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.81 158.76 9.89 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.54 152.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 165.56 35.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.098 -178.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -109.55 116.53 31.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.38 157.19 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.076 0.465 . . . . 0.0 111.285 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 169' ' ' ASP . 30.9 p -73.38 136.33 78.53 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -47.47 -15.45 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.113 1.875 . . . . 0.0 111.903 -178.62 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 167' ' ' THR . 95.9 m-20 -84.03 -11.54 56.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.518 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -88.04 67.69 8.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.9 m95 -74.13 -3.93 32.6 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.608 0.568 . . . . 0.0 112.193 -178.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.1 mt-10 -53.01 -39.89 63.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.961 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.3 m -77.84 2.7 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.199 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.1 -14.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.793 0.806 . . . . 0.0 110.597 -178.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.2 mt-10 -86.47 -179.14 6.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.878 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.6 p-10 -86.51 124.76 33.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.157 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.4 m80 -103.08 -43.91 5.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.206 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 25.33 0.07 OUTLIER Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -157.26 178.36 10.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.766 0.317 . . . . 0.0 111.07 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.67 ' OD2' HD22 ' A' ' 203' ' ' LEU . 31.3 t0 -96.68 89.83 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.613 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -126.69 127.62 45.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.369 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -85.43 149.42 4.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.57 ' C ' HD12 ' A' ' 184' ' ' LEU . 52.1 m -137.44 124.67 21.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.436 -179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -109.85 121.39 45.12 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.108 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 12.4 pt -140.4 -173.28 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.844 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 16.2 p -138.08 166.14 24.87 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.582 -179.136 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 33.3 m -96.66 120.31 36.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.612 ' H ' HH22 ' A' ' 196' ' ' ARG . 70.5 t -144.8 -24.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.525 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 188' ' ' VAL . 82.6 p 46.78 -170.89 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.846 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 192' ' ' ASP . 3.0 m -58.89 -108.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.42 ' H ' HG23 ' A' ' 190' ' ' VAL . 28.6 tptp 47.75 -93.86 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.584 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 190' ' ' VAL . 97.9 m-20 -62.41 -42.38 99.39 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 60.8 t30 55.92 36.93 28.23 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.174 178.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.1 t -93.9 169.22 10.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.91 130.16 42.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.612 HH22 ' H ' ' A' ' 188' ' ' VAL . 57.7 ttm-85 -104.2 137.88 41.48 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.69 139.28 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.282 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.94 129.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.38 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.14 135.9 53.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.28 143.6 14.88 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 51.8 p-10 -102.7 142.64 33.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.435 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.67 HD22 ' OD2' ' A' ' 180' ' ' ASP . 38.5 tp -65.31 126.88 29.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.4 -24.77 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.528 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.74 175.58 46.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.734 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.6 m -155.04 151.4 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.179 0.514 . . . . 0.0 111.244 -179.344 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -151.63 178.52 9.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.32 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.79 144.92 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.307 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.27 78.99 0.36 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.853 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 78.3 tttt . . . . . 0 C--N 1.322 -0.602 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.332 178.618 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.093 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 55' ' ' HIS . 14.3 t 47.84 92.37 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.479 178.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 54' ' ' SER . 97.7 m-70 48.58 -172.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.639 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.0 mtm -83.58 146.51 28.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.215 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 66.8 t0 -64.76 144.67 57.09 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.534 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -68.4 -35.63 77.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.799 -178.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.6 m -83.08 -83.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.423 -178.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.6 tttm 54.54 35.22 22.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.386 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 62' ' ' ASP . 29.7 mm -64.79 -44.15 96.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.286 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 64' ' ' PRO . 9.5 t0 62.03 118.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.462 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.457 ' CD ' ' O ' ' A' ' 63' ' ' GLN . 1.6 tm0? -38.32 93.96 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.302 0 O-C-N 123.48 0.487 . . . . 0.0 110.326 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' N ' ' O ' ' A' ' 62' ' ' ASP . 6.2 Cg_exo -76.23 152.71 35.46 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.684 2.256 . . . . 0.0 111.122 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.8 163.48 26.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.42 -19.96 65.45 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 123.163 0.289 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.74 93.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.6 mt-10 -72.2 -37.13 69.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.63 -45.81 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.886 -178.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.12 85.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -85.15 -26.64 26.71 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.86 137.76 57.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.127 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -92.09 158.13 16.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.912 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.456 HD13 ' CB ' ' A' ' 105' ' ' SER . 50.9 tp -127.13 127.32 44.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 111.288 -178.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -100.52 103.88 15.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.973 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.61 ' O ' HG12 ' A' ' 79' ' ' VAL . 44.5 mmtm -62.36 -7.09 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.572 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -75.08 -13.08 60.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.322 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -102.54 12.08 36.95 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.736 -178.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 76' ' ' LYS . 7.0 p -88.16 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.254 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 109' ' ' THR . 7.0 pt -121.4 -7.55 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.46 -171.28 39.28 Favored Glycine 0 C--N 1.32 -0.318 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.579 HH11 ' NZ ' ' A' ' 209' ' ' LYS . 42.0 mtm180 -146.46 152.03 38.37 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.72 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.5 tt -121.04 122.31 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -124.15 127.75 48.24 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.437 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 73.3 mt -131.29 130.81 22.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.801 -178.052 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.61 -38.28 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.56 2.173 . . . . 0.0 112.417 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.3 p -46.14 -37.88 7.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.424 -177.014 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.4 p -120.91 -0.45 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.942 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m 59.94 54.52 4.2 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.12 136.76 52.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.03 -177.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -137.0 116.39 12.72 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 83' ' ' ILE . 82.7 mt -141.03 101.58 6.32 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.349 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.6 127.92 1.74 Allowed 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 121.897 1.731 . . . . 0.0 110.211 176.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.95 121.84 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.2 mt -103.19 123.27 46.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.53 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' HB2' HD13 ' A' ' 80' ' ' ILE . 88.4 tttt -64.73 -49.5 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.065 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.2 m -65.74 98.7 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.134 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -80.24 98.13 7.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.258 0.551 . . . . 0.0 109.86 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.9 p -134.31 161.13 35.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.606 -178.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.79 -27.78 66.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.918 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.81 -41.77 18.69 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.837 0.711 . . . . 0.0 112.139 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -67.06 -35.12 79.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.412 -179.227 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.501 HD13 ' SG ' ' A' ' 187' ' ' CYS . 43.1 mt -65.03 -18.86 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -72.7 -14.92 61.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.339 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.456 ' CB ' HD13 ' A' ' 74' ' ' LEU . 58.7 m -110.53 -9.26 14.57 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.453 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 174.39 -153.55 16.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.304 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.554 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -100.49 127.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.263 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 149.97 24.97 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.674 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.455 HG21 HD11 ' A' ' 80' ' ' ILE . 9.7 p -75.81 148.38 38.47 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.9 -47.28 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.253 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -92.66 139.84 30.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.317 0.58 . . . . 0.0 110.989 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -75.48 -3.18 32.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.272 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.88 37.63 2.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 111.164 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 156.26 16.52 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.5 t -124.55 135.58 63.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.4 mtp -75.93 125.7 29.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.27 66.93 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -144.77 121.38 11.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.544 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.36 178.5 32.51 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 40.9 t-20 -68.93 105.06 2.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.444 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -85.33 105.45 15.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 124.89 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.31 0.576 . . . . 0.0 111.439 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 83' ' ' ILE . 10.0 mt -122.31 130.24 52.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.509 179.012 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.6 140.16 45.19 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.305 0.574 . . . . 0.0 110.759 -178.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.45 -176.95 18.92 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.614 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -84.48 147.07 27.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.696 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.7 p30 -115.48 25.48 10.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.146 0.498 . . . . 0.0 110.984 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -41.94 -18.19 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.646 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 57.57 39.96 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.191 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 136' ' ' SER . 65.2 tttm -134.2 119.45 18.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.511 -178.665 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.04 124.46 21.18 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.332 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.38 -21.46 8.66 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.447 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 134' ' ' LEU . 2.6 t -91.97 172.46 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.797 ' H ' HD23 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -74.93 139.34 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.882 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.554 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.5 m-85 50.49 27.34 2.79 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.008 0.433 . . . . 0.0 110.969 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.444 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -84.66 -8.99 58.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.643 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.6 m-20 -145.31 30.85 1.12 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.041 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.9 pt -70.07 -25.88 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.58 3.78 4.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.707 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.5 m -97.19 -11.65 23.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.283 -178.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.488 ' O ' HG21 ' A' ' 163' ' ' VAL . 17.7 mt -65.42 124.72 23.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.66 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.431 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 98.6 mttt -97.04 161.48 13.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.676 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.48 127.6 32.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.959 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 91.88 20.98 34.89 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 31.9 m-20 -83.73 136.86 34.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.08 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -80.76 122.76 27.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.5 mt -122.26 122.57 66.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -103.5 118.24 36.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.451 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -112.79 132.72 55.13 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.946 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.696 ' N ' HD13 ' A' ' 149' ' ' LEU . 67.9 m-85 -99.12 125.68 44.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.151 -179.121 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 152' ' ' ASN . 45.9 t0 -98.07 -169.05 1.75 Allowed 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 151' ' ' ASP . 51.9 t30 -36.19 -67.03 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.124 0.488 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -135.07 25.07 3.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.208 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.85 153.05 44.7 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.605 ' CD ' ' HZ1' ' A' ' 207' ' ' LYS . 67.1 tt0 -114.6 119.0 35.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.265 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -103.84 131.55 50.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.5 mt-10 -97.17 119.35 35.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.129 178.234 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -116.69 142.08 47.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.19 129.79 53.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.461 0.648 . . . . 0.0 110.769 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' GLY . 56.2 t -68.23 134.7 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.1 t -105.15 -26.61 12.01 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 124.583 1.177 . . . . 0.0 111.256 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.99 147.87 5.57 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.304 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 199' ' ' VAL . 17.2 t -110.56 149.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.239 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.0 p -156.92 165.87 34.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.133 -178.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -113.6 102.6 10.43 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.017 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.8 m -117.49 153.34 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 p -59.57 167.87 2.19 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.546 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.6 Cg_endo -81.77 -10.46 11.77 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.027 1.818 . . . . 0.0 112.007 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.81 -14.16 48.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.202 -178.437 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.64 71.21 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.028 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.546 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 90.4 m95 -75.31 -2.23 27.28 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.285 -178.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.42 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 71.5 mm-40 -54.03 -37.24 63.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.69 ' O ' HG21 ' A' ' 183' ' ' THR . 16.3 m -80.82 3.7 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.03 -179.03 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -119.71 -15.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.581 0.705 . . . . 0.0 110.251 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 74.4 mm-40 -86.75 175.94 7.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.027 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.5 p-10 -80.78 128.6 33.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.251 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.42 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.8 m170 -102.57 -43.28 5.67 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.043 -179.448 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.07 27.61 0.12 Allowed Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -157.65 -179.75 8.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.855 0.36 . . . . 0.0 111.094 179.36 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -93.01 88.46 6.14 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -117.82 167.7 11.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.922 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.37 142.94 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.002 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.69 HG21 ' O ' ' A' ' 173' ' ' VAL . 10.7 m -136.65 125.24 23.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.596 -178.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -110.52 120.77 43.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 13.5 pt -134.91 -167.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.767 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.586 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 14.1 t -134.08 151.28 51.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.366 -178.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.501 ' SG ' HD13 ' A' ' 103' ' ' LEU . 1.2 p -96.8 -36.39 10.64 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.678 0.275 . . . . 0.0 111.387 -178.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.66 154.44 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.773 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 83.5 p -153.0 164.19 38.44 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.75 0.31 . . . . 0.0 110.665 -178.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 191' ' ' LYS . 62.3 t -116.41 130.2 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.079 -179.265 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 190' ' ' VAL . 61.5 pttt -53.01 -170.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.629 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 48.9 -173.06 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.866 179.049 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -64.03 126.51 27.91 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 45.0 t -153.42 163.59 39.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.763 0.316 . . . . 0.0 110.934 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -144.57 153.83 42.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.577 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.586 ' NH1' ' O ' ' A' ' 186' ' ' THR . 11.8 ptp180 -127.97 166.65 17.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.672 -179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -105.94 139.53 40.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.07 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.7 134.22 58.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 121.023 0.439 . . . . 0.0 110.623 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.54 HG22 HG13 ' A' ' 163' ' ' VAL . 73.2 t -119.46 129.46 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.653 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.09 136.29 53.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.349 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.16 147.38 19.06 Favored Glycine 0 N--CA 1.466 0.653 0 CA-C-O 121.773 0.652 . . . . 0.0 112.006 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 55.4 p-10 -106.81 148.28 28.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.207 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 205' ' ' GLY . 44.4 tp -69.03 126.99 31.56 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.84 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -109.38 -24.38 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.037 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.02 175.26 47.18 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.627 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 m -155.5 150.99 27.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.605 ' HZ1' ' CD ' ' A' ' 155' ' ' GLU . 25.8 pttm -150.81 178.16 9.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.09 146.61 23.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.579 ' NZ ' HH11 ' A' ' 82' ' ' ARG . 88.0 tttt -73.77 80.23 1.58 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.604 -179.19 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.281 178.799 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.5 m -155.38 157.36 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 0.0 110.507 -179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -99.8 105.29 17.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.201 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 95.4 mtp -134.88 144.83 47.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -178.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 66.7 t0 -75.69 137.4 40.63 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -69.01 -40.06 78.91 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.712 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p 70.39 -42.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.675 0.274 . . . . 0.0 110.979 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 58' ' ' ALA . 99.1 mttt 42.73 32.33 0.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.41 . . . . 0.0 111.438 178.702 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -67.2 -25.28 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.42 0.628 . . . . 0.0 111.311 -178.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -52.49 -43.27 64.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.608 -179.326 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -138.91 76.9 33.18 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.987 -178.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.06 155.82 26.19 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.564 2.176 . . . . 0.0 111.097 -178.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.84 152.05 46.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.804 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -68.39 -15.0 63.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.799 0.333 . . . . 0.0 111.393 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.5 -45.16 84.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.821 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 6.0 pt-20 -74.63 -22.44 58.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.3 t -76.97 -51.98 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.481 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.64 92.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.774 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.32 -31.17 68.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.54 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.3 138.42 57.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.004 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -141.09 85.1 1.96 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.71 -178.647 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.4 pt? -75.04 172.12 12.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.523 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.1 m-20 -103.13 121.16 42.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.59 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.573 ' O ' HG12 ' A' ' 79' ' ' VAL . 14.1 mptt -56.44 -9.4 0.7 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.14 0.495 . . . . 0.0 109.853 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -62.49 -35.39 79.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.76 16.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.572 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 76' ' ' LYS . 10.0 p -86.94 124.57 40.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 pt -120.64 -6.53 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.47 -168.34 39.92 Favored Glycine 0 C--N 1.318 -0.467 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.406 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 38.0 mtm180 -147.68 156.09 42.42 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.538 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.2 tt -121.32 125.92 74.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -126.26 127.07 45.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.482 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 79.3 mt -127.44 128.01 24.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.646 -178.222 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.8 Cg_endo -83.29 -39.33 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 122.371 2.047 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 t -48.75 -37.03 17.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.579 -177.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -120.73 -2.83 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.783 -178.926 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t 62.81 55.18 2.13 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.286 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.16 133.64 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.607 -178.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -135.99 114.22 11.52 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.524 ' O ' HG22 ' A' ' 83' ' ' ILE . 69.9 mt -143.45 109.36 5.28 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.1 Cg_endo -39.6 142.64 0.44 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.865 1.71 . . . . 0.0 110.144 176.388 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.8 118.65 43.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -106.68 122.94 47.36 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.41 -48.47 75.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.6 p -61.67 100.02 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.928 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.0 p -82.97 101.29 10.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 110.006 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.0 p -137.29 160.49 38.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.417 -179.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.85 -28.38 67.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.75 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -83.33 -45.47 13.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.457 0.646 . . . . 0.0 112.116 -178.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -65.78 -32.72 74.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.316 -179.107 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.61 -13.96 61.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.3 p -103.79 -13.46 16.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -177.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.402 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 172.96 -156.86 25.57 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.64 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.46 125.89 35.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.997 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.63 144.38 31.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -75.33 152.27 38.16 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 185' ' ' ILE . 40.0 t -86.02 -40.22 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.47 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.67 -172.68 3.66 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.13 -178.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -126.2 -9.64 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 111.289 -177.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -138.89 37.35 2.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.108 0.48 . . . . 0.0 111.304 -177.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.411 ' NE2' ' CE1' ' A' ' 121' ' ' TYR . 16.5 pt20 -93.44 161.14 14.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.855 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -131.72 132.04 62.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.773 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.7 mtt -63.69 129.04 38.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.16 75.04 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -138.54 118.92 13.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.116 0.484 . . . . 0.0 110.504 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -160.12 52.71 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -94.04 111.19 22.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.411 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 4.6 t80 -84.72 103.4 13.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.43 126.64 35.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 111.785 -179.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD12 ' A' ' 83' ' ' ILE . 5.9 mt -122.46 130.53 53.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.477 178.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.99 139.19 46.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.774 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.61 -178.2 16.42 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.5 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -88.83 143.08 27.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.567 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 67.0 t30 -108.28 28.22 8.53 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.126 0.489 . . . . 0.0 110.676 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.17 -17.24 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.683 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.6 OUTLIER 60.98 37.73 17.92 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.283 178.805 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 136' ' ' SER . 55.2 mtmt -135.46 106.48 6.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.685 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.43 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -48.74 130.11 17.33 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.545 179.344 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.22 -26.33 12.38 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.784 HG12 ' H ' ' A' ' 134' ' ' LEU . 27.7 t -84.97 179.14 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.784 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.63 133.08 46.36 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.178 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.42 31.91 1.43 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 110.822 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.64 -9.91 59.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.04 -178.825 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -146.95 29.36 0.99 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.091 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 138' ' ' ILE . 5.5 pt -69.58 -27.83 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.805 0.336 . . . . 0.0 111.856 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.76 0.34 3.39 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.638 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.1 t -91.75 -14.66 29.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.156 0.503 . . . . 0.0 110.18 -179.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 mt -65.63 126.9 29.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.246 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.28 172.16 8.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.973 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.2 132.65 44.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.47 21.12 57.25 Favored Glycine 0 N--CA 1.462 0.396 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 146' ' ' LYS . 15.0 t70 -78.78 -158.89 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 7.9 tptm -146.81 129.15 15.8 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.076 -178.286 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.75 122.97 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.452 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -102.04 122.08 43.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.04 141.92 48.29 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.449 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.536 ' CE2' ' OE2' ' A' ' 155' ' ' GLU . 68.6 m-85 -107.81 131.23 54.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.208 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.8 t0 -105.47 -171.26 1.88 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.0 m-20 -35.64 -62.8 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.203 0.525 . . . . 0.0 111.273 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.49 20.87 2.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 145.03 48.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.782 -175.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.536 ' OE2' ' CE2' ' A' ' 150' ' ' TYR . 4.5 mm-40 -106.89 121.14 43.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.43 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -107.25 129.54 54.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.487 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.83 120.94 39.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.386 177.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -117.65 138.79 51.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.49 131.81 56.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.599 0.714 . . . . 0.0 110.144 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.38 134.56 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.613 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.1 p -101.63 -26.36 13.55 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 124.368 1.043 . . . . 0.0 111.16 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.06 150.93 5.84 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 163' ' ' VAL . 2.7 p -98.26 146.38 8.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -0.63 . . . . 0.0 109.323 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.7 t -145.79 154.22 41.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.055 0.455 . . . . 0.0 110.989 -178.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.28 119.27 38.94 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.708 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.633 ' CG2' HH21 ' A' ' 196' ' ' ARG . 29.1 m -134.88 158.78 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 111.269 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 169' ' ' ASP . 25.5 p -76.71 136.16 67.47 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.336 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.97 -15.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.077 1.851 . . . . 0.0 112.064 -178.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 167' ' ' THR . 51.3 t0 -81.81 -13.03 58.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 -178.254 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -85.88 77.15 9.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.358 0.599 . . . . 0.0 110.198 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.544 ' C ' ' H ' ' A' ' 173' ' ' VAL . 84.1 m95 -75.79 -20.32 58.31 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.092 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.67 -6.94 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.01 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' TRP . 53.6 t -85.81 -24.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.669 -178.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.453 HG11 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -108.41 -10.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.808 0.813 . . . . 0.0 109.72 -178.473 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.58 139.81 38.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.744 -176.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.43 130.59 45.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.297 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -102.05 -40.41 6.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.462 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.68 29.26 0.27 Allowed Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -156.05 179.24 9.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.244 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -90.89 92.54 8.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.371 0.605 . . . . 0.0 109.917 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -127.9 169.41 13.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.251 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.888 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.597 ' C ' HD12 ' A' ' 184' ' ' LEU . 19.2 m -137.31 124.98 22.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.484 -178.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.597 HD12 ' C ' ' A' ' 183' ' ' THR . 10.8 mp -111.34 120.95 43.92 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.342 0.592 . . . . 0.0 110.774 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 110' ' ' VAL . 16.4 pt -135.12 -167.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -178.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t -138.6 152.4 48.1 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.77 -178.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 6.5 t -83.65 125.73 32.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.909 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.8 t -139.88 -112.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.63 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.9 t -157.47 166.4 33.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -178.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p -90.13 157.47 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt 47.72 34.26 3.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.058 178.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -156.37 166.51 33.2 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.365 -178.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 33.0 m120 48.94 66.24 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.78 178.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 78.3 p -62.32 -19.98 63.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.618 -179.02 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -99.2 117.35 33.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.408 -179.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.633 HH21 ' CG2' ' A' ' 166' ' ' VAL . 16.0 ttp180 -146.29 137.94 24.76 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.318 -178.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.01 129.97 46.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.952 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.438 HG11 HG11 ' A' ' 173' ' ' VAL . 46.2 t -135.23 136.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.52 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.24 126.37 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.425 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.72 135.54 53.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.228 0.537 . . . . 0.0 110.419 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.15 163.16 25.11 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -116.21 150.72 37.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.233 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.5 tp -71.8 126.96 31.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.025 0.44 . . . . 0.0 110.71 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.39 -24.57 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.188 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.72 44.42 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.847 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.3 m -154.15 154.07 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.226 0.536 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.49 ' HZ2' ' HB2' ' A' ' 155' ' ' GLU . 20.7 pttp -149.76 177.03 10.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.335 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.34 150.87 23.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.98 78.99 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.115 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.3 mptt . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 117.804 -1.093 . . . . 0.0 109.989 178.625 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.4 p -155.64 162.41 40.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.945 0.402 . . . . 0.0 110.786 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -64.6 -7.93 12.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.387 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 96.1 mmm -67.17 154.36 41.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.341 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -144.95 168.0 21.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.465 -178.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.99 -45.7 66.74 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.032 -179.368 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.2 m -150.92 -88.22 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.187 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.8 tttt 54.41 32.86 17.39 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.787 178.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 63' ' ' GLN . 53.7 mt -61.73 -48.76 87.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.33 0.586 . . . . 0.0 110.591 -179.138 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.5 t0 48.34 -93.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.214 179.002 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 61' ' ' ILE . 1.1 tp-100 -151.16 84.43 5.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.622 -179.293 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.0 151.47 39.57 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.634 2.223 . . . . 0.0 111.322 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -79.16 173.34 12.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.67 -13.67 62.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.853 -179.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.0 92.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.266 0.555 . . . . 0.0 110.268 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -75.87 -23.62 55.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.582 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.31 -49.88 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.41 89.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.43 -31.98 70.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.972 -179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.09 132.73 52.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.222 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.8 t -140.85 88.35 2.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.824 0.345 . . . . 0.0 111.656 -179.379 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.557 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 1.5 pt? -79.93 170.28 16.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.489 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -102.48 139.78 37.63 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.055 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.57 -7.2 6.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.497 0.665 . . . . 0.0 110.131 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -64.61 -31.86 73.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.848 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.11 10.42 2.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.168 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.547 HG11 HH12 ' A' ' 82' ' ' ARG . 99.2 t -86.31 120.96 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.5 pt -120.35 -7.46 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 111.9 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.7 -170.85 41.96 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.547 HH12 HG11 ' A' ' 79' ' ' VAL . 33.6 mtt-85 -146.8 158.05 43.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.897 -178.681 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 tt -128.75 130.15 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.662 0.744 . . . . 0.0 109.322 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -130.16 131.64 45.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.071 -178.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.29 127.82 19.07 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.11 -178.65 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.08 -34.65 0.32 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.304 2.002 . . . . 0.0 112.031 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -48.16 -38.61 18.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.423 -177.234 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.5 p -118.61 -2.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.879 -178.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.57 50.77 2.08 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.595 ' CD2' HD23 ' A' ' 92' ' ' LEU . 2.0 tt -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -178.158 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.756 ' O ' HD22 ' A' ' 92' ' ' LEU . 83.0 tt0 -129.42 105.3 8.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.301 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 91' ' ' GLU . 3.8 mm? -128.5 148.95 70.32 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.502 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HD3' HD13 ' A' ' 92' ' ' LEU . 4.1 Cg_exo -84.65 145.2 10.29 Favored 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 122.617 2.211 . . . . 0.0 109.26 177.496 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -94.89 112.65 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 mt -101.53 121.68 42.43 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -63.8 -46.33 85.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.329 0.585 . . . . 0.0 110.805 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m -60.03 95.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.457 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.7 p -81.87 95.0 7.2 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 110.1 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.7 p -135.97 159.66 41.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.124 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.25 -28.67 66.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.29 -43.52 15.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -65.93 -36.14 82.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.565 -179.18 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.07 -21.11 63.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.52 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.27 -33.24 69.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.164 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.455 ' OG ' HD22 ' A' ' 74' ' ' LEU . 62.2 m -89.54 -10.22 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 92' ' ' LEU . . . 174.05 -178.92 45.72 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.314 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.94 126.42 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.43 145.73 30.45 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.979 0.419 . . . . 0.0 110.968 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.8 p -73.12 150.22 42.41 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.24 -45.32 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.281 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.86 -172.32 3.32 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.962 -0.461 . . . . 0.0 110.966 -178.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 1.2 pm0 -112.58 -56.47 2.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.859 -178.371 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -90.61 44.63 1.21 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.268 -177.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -99.58 154.69 18.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.187 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.3 135.37 52.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 67.2 mtt -67.99 130.62 43.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.323 178.827 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.51 5.87 81.45 Favored Glycine 0 C--O 1.229 -0.18 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -142.72 120.36 11.82 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.037 -179.342 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.02 -168.35 54.26 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -85.52 106.82 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -84.66 102.45 12.95 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.76 128.44 36.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.289 0.566 . . . . 0.0 111.824 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -124.59 132.56 53.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.88 178.532 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.35 44.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 110.606 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.19 -177.66 19.26 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.455 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.529 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -92.12 143.48 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 5.9 m-20 -109.53 29.23 7.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.326 0.584 . . . . 0.0 109.71 179.515 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.4 ' SD ' ' OE1' ' A' ' 63' ' ' GLN . 9.2 mmm -42.94 -14.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.693 -179.223 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 62.13 40.67 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -132.32 105.66 7.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.586 -179.471 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -50.1 125.68 12.81 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.831 0.824 . . . . 0.0 110.094 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.82 -28.84 8.56 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.699 -177.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 134' ' ' LEU . 49.0 t -79.89 178.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.995 -0.709 . . . . 0.0 109.294 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.778 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -70.97 139.54 50.62 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.954 -178.568 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.6 m-85 43.7 35.01 0.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.072 0.463 . . . . 0.0 111.076 177.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.5 p -81.64 -14.56 56.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -147.45 31.97 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.419 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 3.6 pt -70.46 -26.65 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.703 0.287 . . . . 0.0 111.613 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.14 2.19 4.91 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.284 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 t -93.66 -13.85 27.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 109.573 -179.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.34 120.86 13.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.653 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.529 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.4 mttt -97.86 150.05 21.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.426 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.7 121.05 5.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.371 0.605 . . . . 0.0 111.463 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.67 10.48 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 3.8 m-20 -90.64 134.55 34.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.471 ' HZ2' ' HB3' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -83.63 132.61 34.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.311 0.577 . . . . 0.0 111.967 -178.41 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.59 126.27 71.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.278 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -103.17 119.95 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.173 0.511 . . . . 0.0 110.754 -178.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.482 HD12 ' SD ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -109.42 139.48 44.33 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.638 -179.879 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' SD ' ' A' ' 116' ' ' MET . 86.6 m-85 -114.81 127.26 55.62 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.194 0.521 . . . . 0.0 111.343 179.409 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.1 t0 -112.45 -166.24 1.06 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.2 p30 -22.57 -76.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.409 0.624 . . . . 0.0 111.816 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.508 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.5 mt-10 -137.53 29.37 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.749 178.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -127.66 144.5 51.07 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -109.99 120.96 44.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.096 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.14 132.7 49.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.682 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -96.05 118.03 31.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -118.32 141.39 48.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.34 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.13 55.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 110.804 178.367 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 60.2 t -66.34 133.09 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.032 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.3 p -100.76 -28.63 12.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.861 -178.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.37 150.2 5.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.842 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.74 149.1 8.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.704 -0.748 . . . . 0.0 109.462 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.6 p -150.76 160.4 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.453 . . . . 0.0 111.234 -178.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -107.19 117.36 33.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.554 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.38 159.12 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.229 -178.703 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 p -66.87 168.41 10.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.461 ' HA ' HH11 ' A' ' 196' ' ' ARG . 2.4 Cg_endo -81.7 -11.19 11.6 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.941 1.761 . . . . 0.0 111.761 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -87.77 -5.3 58.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -85.92 71.88 10.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 0.0 110.2 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.477 ' C ' ' N ' ' A' ' 173' ' ' VAL . 92.6 m95 -70.62 -29.89 66.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.047 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.557 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 55.4 mp0 -48.53 -14.28 0.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.485 0.66 . . . . 0.0 110.523 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.477 ' N ' ' C ' ' A' ' 171' ' ' TRP . 90.7 t -73.11 -25.85 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.923 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.522 HG11 HD13 ' A' ' 185' ' ' ILE . 27.0 m -115.29 -0.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.535 0.683 . . . . 0.0 110.513 -178.219 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.57 122.78 28.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.959 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -31.8 127.62 0.21 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.75 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -103.08 -42.75 5.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.017 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.29 29.24 0.15 Allowed Glycine 0 N--CA 1.471 1.029 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.39 176.78 12.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.942 0.401 . . . . 0.0 111.531 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.58 89.11 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.72 0.771 . . . . 0.0 109.404 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -122.48 167.84 12.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.028 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.7 142.57 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.233 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.523 ' C ' HD12 ' A' ' 184' ' ' LEU . 4.9 m -135.99 120.35 17.99 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.114 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -106.06 128.63 53.99 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.164 0.507 . . . . 0.0 110.321 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.522 HD13 HG11 ' A' ' 174' ' ' VAL . 4.3 pt -137.47 -175.24 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.729 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.527 HG21 ' ND2' ' A' ' 127' ' ' ASN . 3.3 t -139.67 155.86 47.15 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.001 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 20.1 m -100.14 100.45 11.29 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.012 0.434 . . . . 0.0 110.346 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.28 160.29 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 -179.207 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.1 t -154.13 98.75 2.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.954 0.407 . . . . 0.0 111.166 -179.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 70.8 t -125.58 130.66 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.508 -179.75 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.95 -161.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.857 179.476 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 49.31 -131.26 1.84 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.049 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 193' ' ' ASN . 45.5 p-10 -96.62 135.46 38.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 28.8 m -153.42 155.02 35.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.974 -179.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -143.22 147.28 34.6 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 168' ' ' PRO . 57.7 ttp180 -113.18 119.99 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.228 -179.439 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.79 131.25 37.52 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 142.13 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.79 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.11 130.29 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.338 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.44 134.33 54.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.29 150.04 19.93 Favored Glycine 0 N--CA 1.467 0.763 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.446 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.0 t0 -108.49 145.87 34.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.517 -0.341 . . . . 0.0 111.361 -179.169 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.8 tp -70.32 129.51 39.51 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.443 0.639 . . . . 0.0 110.709 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.81 -21.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.605 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.43 175.9 45.91 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.132 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.3 m -155.54 155.84 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.237 0.542 . . . . 0.0 110.85 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -148.15 178.35 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.421 178.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -100.35 142.89 31.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.296 0.57 . . . . 0.0 111.086 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -61.86 80.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.61 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 208' ' ' ALA . 80.8 tttt . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.075 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -67.58 139.24 56.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.6 t60 47.68 80.66 0.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.452 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.3 ptm -87.38 -167.16 1.79 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.904 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.77 137.77 57.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.037 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.67 -51.46 27.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.176 -178.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.439 ' HG ' HG11 ' A' ' 190' ' ' VAL . 1.9 t -151.73 -89.75 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.845 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 48.64 38.48 11.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.89 178.539 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 63' ' ' GLN . 47.9 mt -67.45 -76.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 -179.419 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.5 t0 57.41 -81.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.049 178.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 61' ' ' ILE . 6.7 pt20 -150.51 72.56 9.05 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.007 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.28 141.51 2.05 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.264 1.976 . . . . 0.0 111.674 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.04 151.71 44.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.85 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.2 mp -55.75 -26.1 43.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -178.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -39.6 93.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.322 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.1 mm-40 -74.1 -32.03 63.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.701 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.31 -45.32 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.919 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -75.84 -28.47 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.113 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.3 141.8 58.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.38 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.6 p -139.79 122.18 16.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.484 HD21 HD22 ' A' ' 95' ' ' LEU . 33.8 tp -114.6 129.24 56.65 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.343 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 68.0 t0 -68.47 134.45 50.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.274 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 4.5 mptp? -64.3 -8.84 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.52 . . . . 0.0 109.923 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -64.38 -33.96 77.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.048 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.586 ' OE1' ' ND2' ' A' ' 102' ' ' ASN . 75.7 mt-30 -77.68 14.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.201 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.83 127.37 47.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.78 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.686 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.11 2.61 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.694 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.26 -178.84 42.0 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -146.89 151.23 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.74 -179.498 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -120.47 124.33 72.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.61 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.1 t -128.88 129.02 45.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 64.8 mt -133.67 130.12 20.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.67 -178.331 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.22 -34.71 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.349 2.033 . . . . 0.0 111.561 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 m -47.74 -39.4 17.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.43 -176.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -121.19 -0.84 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.933 -179.288 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 61.33 54.25 3.24 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.76 133.42 56.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.419 -178.254 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.724 ' O ' HD12 ' A' ' 92' ' ' LEU . 12.6 tm-20 -130.07 114.38 15.69 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.3 mp -136.73 103.72 9.18 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.053 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.38 130.95 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.777 1.652 . . . . 0.0 110.264 175.527 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.7 t -82.36 127.89 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.484 HD22 HD21 ' A' ' 74' ' ' LEU . 13.1 mt -111.78 123.1 49.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.893 0.378 . . . . 0.0 110.068 -179.091 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -65.64 -45.9 81.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.741 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.455 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 44.9 m -66.84 100.07 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.376 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.66 97.69 10.26 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.437 0.637 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 4.8 p -137.37 155.57 49.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -51.53 -36.44 44.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -75.43 -45.75 36.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.99 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.586 ' ND2' ' OE1' ' A' ' 78' ' ' GLN . 2.4 m-20 -65.23 -36.56 84.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.57 -178.215 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.402 HD13 ' SG ' ' A' ' 187' ' ' CYS . 11.5 mt -59.24 -21.87 60.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.439 -179.079 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.13 -31.19 68.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.078 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -89.19 -11.44 43.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.56 42.21 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.59 127.93 34.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.885 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 146.72 29.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.013 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.62 152.22 39.25 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.28 -51.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 113' ' ' ASN . 82.8 tttt -93.78 139.26 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 -178.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -74.12 -0.18 15.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.225 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 90.6 m-20 -138.01 38.29 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.151 0.5 . . . . 0.0 110.983 -177.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.74 21.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.718 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -129.98 128.75 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.1 mtt -69.36 128.14 35.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 110.202 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.59 0.18 69.93 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -140.5 121.96 15.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.877 0.37 . . . . 0.0 110.974 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.11 -169.95 53.54 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -86.34 110.77 19.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.19 102.77 12.86 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.016 0.436 . . . . 0.0 109.91 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 129.04 36.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.589 0.709 . . . . 0.0 112.114 -178.813 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.87 130.44 52.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.565 178.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.87 139.35 46.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.567 0.698 . . . . 0.0 110.496 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.15 -178.8 19.31 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.669 -179.453 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 134' ' ' LEU . 74.7 m-70 -91.33 140.87 29.36 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.152 0.501 . . . . 0.0 110.654 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 129' ' ' SER . 26.9 t-20 -108.68 29.62 7.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.517 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mmm -43.28 -15.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.792 -179.123 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.88 38.62 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.239 0.542 . . . . 0.0 110.165 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.5 tttt -133.0 106.15 7.49 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.178 -179.107 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -51.9 125.2 14.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.807 0.813 . . . . 0.0 110.137 -179.243 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.96 -29.42 7.13 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.62 -178.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.831 HG12 ' H ' ' A' ' 134' ' ' LEU . 41.3 t -81.06 -179.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.058 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.831 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.88 135.31 47.94 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.418 -178.277 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.46 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 47.66 35.81 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.155 0.502 . . . . 0.0 111.076 178.393 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 2.4 p -81.93 -16.88 49.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.45 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 21.3 t0 -142.85 30.57 1.46 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.7 pt -70.44 -25.91 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.825 0.345 . . . . 0.0 111.458 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.04 4.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.45 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.1 m -95.38 -11.97 26.81 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.238 0.542 . . . . 0.0 109.637 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.7 mt -63.92 124.96 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.402 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.12 155.8 16.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.589 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.03 129.32 41.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.594 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.53 38.73 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 40.6 m-20 -86.0 137.46 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.214 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -81.64 126.99 32.42 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.68 125.19 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.261 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -104.71 115.59 30.58 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.372 0.606 . . . . 0.0 109.874 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.7 tp -116.1 144.62 43.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.307 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.511 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 50.0 m-85 -116.13 133.45 56.01 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.314 0.578 . . . . 0.0 111.49 -179.34 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.0 t0 -109.98 -168.32 1.31 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.977 178.138 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 65.4 t30 -29.13 -71.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.342 0.591 . . . . 0.0 111.283 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.66 25.33 3.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.95 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.93 142.9 51.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.481 0.658 . . . . 0.0 112.486 -175.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.511 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 33.6 tp10 -107.14 120.16 41.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.29 130.77 52.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.202 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -94.91 117.12 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.647 177.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -117.39 138.98 51.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.232 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.79 135.34 54.12 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.789 178.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 46.7 t -68.45 132.96 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.03 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -27.74 11.46 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 124.463 1.102 . . . . 0.0 110.683 -178.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.63 154.57 8.7 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.687 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.28 144.03 19.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.786 -0.707 . . . . 0.0 109.735 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -155.26 166.1 34.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.271 0.558 . . . . 0.0 111.47 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -123.67 128.16 49.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.678 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.4 154.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 169' ' ' ASP . 10.7 p -58.39 129.79 83.97 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.91 -13.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.781 1.654 . . . . 0.0 111.963 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.3 m-20 -81.0 -11.31 59.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.995 -177.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.13 74.06 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -73.25 -15.33 61.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.527 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 3.0 pt-20 -53.24 -36.18 60.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.234 0.54 . . . . 0.0 109.873 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.882 ' O ' HG21 ' A' ' 183' ' ' THR . 2.9 t -69.71 -1.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.973 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.99 -13.74 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.854 0.835 . . . . 0.0 109.919 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -86.92 172.78 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.106 -1.407 . . . . 0.0 112.279 -178.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 67.4 t0 -82.3 131.4 35.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.735 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.527 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 40.5 m80 -111.07 -42.02 4.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.552 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.52 25.67 0.09 OUTLIER Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 181' ' ' GLU . 0.0 OUTLIER -151.42 166.33 31.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.22 89.13 5.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.528 0.68 . . . . 0.0 110.454 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.517 ' OE1' ' NZ ' ' A' ' 179' ' ' LYS . 53.2 tt0 -130.23 129.22 43.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.271 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.64 148.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.882 HG21 ' O ' ' A' ' 173' ' ' VAL . 21.6 m -136.73 122.41 19.8 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.189 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 183' ' ' THR . 10.8 mp -109.11 125.9 52.63 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.273 0.558 . . . . 0.0 110.545 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 35.4 pt -136.25 163.03 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.119 -178.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.504 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 59.1 p -82.26 164.11 21.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.29 179.28 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 187' ' ' CYS . 33.9 t -98.35 27.58 4.63 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.801 0.334 . . . . 0.0 111.52 -179.17 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.576 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 53.6 t -102.31 99.01 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.384 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.7 t -170.66 19.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.664 -179.06 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.439 HG11 ' HG ' ' A' ' 59' ' ' SER . 35.0 m -97.86 -3.09 9.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.016 0.436 . . . . 0.0 111.554 -179.033 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -143.43 -131.68 0.09 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.372 -178.567 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.26 141.48 58.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.211 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -59.39 151.24 24.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.794 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.5 t -151.28 148.05 27.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.138 0.494 . . . . 0.0 111.653 -179.213 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.55 134.31 53.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.868 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.576 ' NH2' ' O ' ' A' ' 188' ' ' VAL . 11.3 ptp180 -142.42 163.83 31.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.778 -178.748 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -106.16 133.99 49.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.152 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.91 132.38 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 43.9 t -117.95 127.73 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.52 134.33 54.11 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.353 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.45 139.92 11.34 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -98.28 140.67 32.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.622 -0.789 . . . . 0.0 111.642 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 205' ' ' GLY . 43.5 tp -65.22 125.31 24.62 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.17 -21.4 5.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.421 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.411 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.39 174.69 46.49 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.199 -179.713 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.5 m -154.35 151.77 29.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.824 179.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -150.45 177.6 9.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.56 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -94.43 147.31 23.37 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.342 0.591 . . . . 0.0 110.575 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -61.66 80.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.708 -179.927 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 208' ' ' ALA . 73.8 tttt . . . . . 0 C--N 1.314 -0.965 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.075 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 p 62.69 134.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -66.38 -40.39 89.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.433 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.43 ' H ' ' H ' ' A' ' 57' ' ' ASP . 28.0 ttt -166.34 -18.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.138 0.494 . . . . 0.0 110.335 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.43 ' H ' ' H ' ' A' ' 56' ' ' MET . 65.9 t0 -52.26 137.7 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.719 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -73.44 -8.88 57.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.418 -179.46 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.5 m -85.82 33.47 0.59 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.832 0.349 . . . . 0.0 111.406 -178.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -88.46 28.2 1.15 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.209 -179.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mm -64.76 -44.68 96.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.352 0.596 . . . . 0.0 110.672 -178.455 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 49.69 -97.49 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.288 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -151.66 87.77 4.38 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.784 -179.348 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.03 151.76 50.43 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.937 1.758 . . . . 0.0 111.7 179.633 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.05 161.6 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.46 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 66' ' ' LEU . 9.7 mp -65.37 -19.99 66.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.634 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.8 88.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 110.036 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.3 mt-10 -74.19 -33.15 63.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.641 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.28 -44.68 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.542 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.41 86.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.923 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -83.36 -22.57 32.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.047 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.34 104.32 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -179.475 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -95.54 112.22 23.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.189 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tt -115.84 133.02 56.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.323 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -80.41 148.82 30.4 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.453 179.105 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -67.98 0.93 3.03 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.375 0.607 . . . . 0.0 109.588 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 75' ' ' ASP . 38.8 ttmt -62.96 -42.86 99.95 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.723 179.37 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -79.41 0.16 30.41 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.14 0.495 . . . . 0.0 110.439 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.7 t -99.56 129.71 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.576 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.617 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.57 7.09 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.731 -178.162 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.73 -172.54 35.66 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.418 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 13.3 ttm180 -153.31 153.18 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 111.262 -179.422 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 83' ' ' ILE . 17.0 tt -127.7 130.77 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.706 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.8 m -127.77 130.98 49.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.031 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.58 117.12 16.38 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.222 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.28 -36.39 0.99 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.097 1.864 . . . . 0.0 111.534 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -52.33 -38.73 59.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.711 -177.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 137' ' ' ASP . 42.5 t -112.05 -6.94 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.75 0.31 . . . . 0.0 110.67 -178.788 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.59 47.47 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.3 tp -114.15 131.46 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.784 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -133.02 116.61 16.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -146.46 165.1 21.09 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.423 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.38 161.01 8.24 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 123.206 2.604 . . . . 0.0 108.923 177.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -112.78 122.95 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.2 mt -103.32 123.97 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.33 -47.99 74.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.199 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.6 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 7.7 p -85.19 119.98 26.18 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.791 -179.583 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p -86.76 118.8 26.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.337 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.2 p -140.69 168.83 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.413 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 4.0 tm-20 -69.87 -34.44 73.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.87 -42.24 21.81 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 97' ' ' SER . 3.6 p-10 -68.75 -20.18 64.36 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.37 -17.77 63.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.218 -179.068 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.1 mp -75.29 -15.98 60.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.544 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.8 m -96.69 -13.6 22.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.476 ' N ' HD13 ' A' ' 134' ' ' LEU . . . 165.6 -149.6 16.13 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.59 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -93.65 126.3 38.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.401 0.619 . . . . 0.0 110.0 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.08 147.82 26.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 41.9 p -72.22 149.56 44.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 t -83.95 -46.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -88.69 -170.91 3.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.85 -178.081 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -124.31 -5.44 7.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.654 -178.475 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -138.87 36.09 2.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.694 0.283 . . . . 0.0 110.764 -178.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -92.55 158.92 15.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.119 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.37 132.1 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 -179.736 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -65.73 127.14 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 178.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.47 1.82 68.43 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -142.55 126.76 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 110.227 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 179' ' ' LYS . . . 72.55 -176.85 41.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.05 108.81 13.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.536 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.68 99.47 10.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.007 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.47 128.61 37.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.232 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.21 133.02 54.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.978 178.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.09 140.34 45.71 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.453 0.644 . . . . 0.0 110.916 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.16 -178.13 20.49 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.962 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -84.58 150.45 25.19 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 111.28 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 129' ' ' SER . 44.7 t30 -114.71 27.48 9.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.588 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.4 mmm -45.47 -12.72 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.532 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.8 m 51.7 42.41 29.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -136.06 119.58 17.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.868 -178.462 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -61.9 124.47 20.85 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.855 0.836 . . . . 0.0 110.686 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.26 5.78 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.033 -177.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 134' ' ' LEU . 22.1 t -138.53 175.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.062 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.89 130.7 43.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 111.371 -178.105 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.5 m-30 46.71 32.96 1.89 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.636 178.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -11.14 58.59 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.853 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.522 ' O ' HG21 ' A' ' 88' ' ' VAL . 4.1 m-20 -144.68 21.83 1.64 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -177.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.538 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.6 pt -69.0 -27.44 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.719 0.295 . . . . 0.0 111.527 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.58 1.49 2.36 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.549 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.7 m -95.54 -10.44 29.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.91 118.6 7.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.524 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -98.19 170.98 8.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -67.25 137.4 56.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.134 0.968 . . . . 0.0 112.409 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.53 20.3 64.37 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.781 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -90.94 134.05 34.78 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -83.46 138.23 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.548 0.689 . . . . 0.0 112.16 -178.371 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 158' ' ' TYR . 76.9 mt -130.82 119.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.504 179.103 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -100.47 122.72 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.239 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.3 tp -117.32 147.03 42.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.726 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.418 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 15.5 m-85 -113.49 128.81 56.58 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.17 0.509 . . . . 0.0 111.134 -179.04 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -109.3 -168.44 1.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.52 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 151' ' ' ASP . 92.3 m-20 -25.73 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.381 0.61 . . . . 0.0 112.312 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -138.85 23.4 2.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -124.95 144.63 50.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.131 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.66 121.74 44.19 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -105.94 130.05 53.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.307 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.84 119.2 34.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' A' ' 147' ' ' ILE . 52.0 m-85 -116.64 138.74 51.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.167 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -114.9 132.14 56.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.35 0.595 . . . . 0.0 110.56 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.27 134.18 30.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -107.57 -25.11 11.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.357 1.036 . . . . 0.0 110.714 -179.512 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.37 164.21 23.68 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.89 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.76 152.27 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.2 t -156.88 169.11 25.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.378 0.609 . . . . 0.0 111.369 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.99 126.98 52.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.399 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -139.55 159.0 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.113 -178.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 169' ' ' ASP . 17.6 p -68.5 135.62 90.73 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.573 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.9 Cg_endo -47.17 -12.62 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.604 1.536 . . . . 0.0 111.727 -179.263 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 167' ' ' THR . 66.5 t0 -78.15 -17.7 56.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.44 -178.628 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.603 ' O ' HG22 ' A' ' 173' ' ' VAL . 13.6 mptt -84.7 68.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.573 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 63.0 m95 -73.72 -24.04 59.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.379 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.36 -7.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 170' ' ' LYS . 17.3 m -85.9 -9.12 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.128 -178.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.544 HG11 HD13 ' A' ' 185' ' ' ILE . 1.4 m -131.27 8.3 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 109.158 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 72.4 mm-40 -83.6 143.71 29.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.443 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -55.81 120.14 6.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.801 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 41.7 m80 -111.3 -40.1 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.71 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 122.85 34.67 0.78 Allowed Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 119' ' ' GLY . 19.8 mmmt -139.03 157.08 46.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.664 -179.262 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.2 m-20 -87.96 88.57 7.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.906 0.86 . . . . 0.0 108.891 177.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -135.12 170.09 16.44 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.133 -178.368 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.1 tt -131.29 143.3 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.845 178.527 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.602 ' C ' HD12 ' A' ' 184' ' ' LEU . 13.5 m -137.25 128.07 27.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.098 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 183' ' ' THR . 10.4 mp -112.77 125.62 54.53 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.216 0.532 . . . . 0.0 110.325 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.544 HD13 HG11 ' A' ' 174' ' ' VAL . 11.9 pt -133.91 164.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.427 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.0 p -139.43 163.54 32.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.116 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 53.4 t 47.18 94.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 110.052 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 18.5 m -87.12 16.98 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.214 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.4 m -68.25 140.84 56.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.918 0.389 . . . . 0.0 110.783 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.15 -45.97 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.237 0.541 . . . . 0.0 110.273 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -58.86 144.58 43.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.625 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 192' ' ' ASP . 46.8 t0 -63.63 -23.58 67.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.14 0.495 . . . . 0.0 110.318 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.425 ' CG ' ' H ' ' A' ' 194' ' ' SER . 24.6 t-20 52.17 -121.04 1.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.132 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 195' ' ' LYS . 80.6 p -92.87 -80.52 0.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.3 0.572 . . . . 0.0 110.745 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.462 ' N ' ' OG ' ' A' ' 194' ' ' SER . 21.9 pttp -146.96 153.18 39.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.222 -179.497 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.75 120.35 24.94 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.483 . . . . 0.0 110.786 -179.3 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.21 142.66 45.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.77 139.05 46.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.72 129.93 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.302 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 161' ' ' THR . . . -115.21 135.74 53.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.999 0.428 . . . . 0.0 110.402 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.52 145.73 17.0 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.843 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -100.69 139.02 36.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.773 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.48 126.16 27.41 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.212 0.529 . . . . 0.0 110.711 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.63 -25.93 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.376 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.64 161.26 20.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.434 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 207' ' ' LYS . 40.5 m -137.73 157.4 46.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.446 0.641 . . . . 0.0 110.07 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 206' ' ' THR . 16.2 ptpt -148.93 179.32 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.306 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.17 144.42 25.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.467 0.651 . . . . 0.0 110.901 179.352 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -67.98 80.15 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.644 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 77.3 tttt . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.59 179.068 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.0 p -74.99 162.54 28.49 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -97.83 25.36 5.99 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.857 0.36 . . . . 0.0 111.325 -179.031 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 82.2 mmm -61.97 -43.85 97.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.239 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.7 t0 52.55 28.03 5.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.073 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.37 -36.93 79.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.201 -178.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 61' ' ' ILE . 15.0 m -85.87 27.08 0.91 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 -178.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -71.64 35.57 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.726 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 59' ' ' SER . 59.3 mt -62.06 -47.54 92.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.093 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 51.12 -93.2 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.958 178.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' ILE . 4.2 pt20 -150.76 80.36 6.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.088 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.33 146.37 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.266 1.977 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.24 154.35 42.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.877 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.6 mt -56.13 -26.37 49.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 110.869 -179.153 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.92 96.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.651 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.62 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.9 mt-10 -72.63 -36.09 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.679 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.5 t -74.47 -44.63 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.083 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.76 92.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -80.76 -25.79 37.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.447 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.62 140.92 58.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.112 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 p -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.519 HD11 ' OE1' ' A' ' 78' ' ' GLN . 12.9 tp -140.83 140.0 34.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.316 -178.483 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.72 140.84 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.383 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 79' ' ' VAL . 14.1 mptt -70.07 -6.0 30.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.302 0.572 . . . . 0.0 110.009 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.21 -35.74 81.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.358 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.519 ' OE1' HD11 ' A' ' 74' ' ' LEU . 80.9 mt-30 -75.59 11.93 1.17 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.653 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 76' ' ' LYS . 96.2 t -87.8 126.09 41.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.573 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 96' ' ' LYS . 9.1 pt -119.9 -9.07 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 112.058 -178.286 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 -170.26 38.03 Favored Glycine 0 C--N 1.321 -0.264 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.09 152.42 38.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.507 -178.099 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 HD13 ' A' ' 123' ' ' LEU . 10.1 tt -122.58 125.8 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -125.79 127.86 46.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.172 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 67.1 mt -131.61 126.71 21.18 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.258 -177.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -82.66 -35.9 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.162 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.9 t -46.64 -37.73 8.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.403 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -120.6 -0.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 t 61.49 55.63 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.47 136.07 54.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.184 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.676 ' O ' HD12 ' A' ' 92' ' ' LEU . 81.8 tt0 -135.24 119.89 18.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.442 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -146.09 107.67 4.24 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -176.108 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.73 159.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.841 1.694 . . . . 0.0 109.898 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.6 t -110.04 124.68 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 74' ' ' LEU . 26.4 mt -108.09 123.87 49.35 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HB2' HD13 ' A' ' 80' ' ' ILE . 65.9 tttm -66.81 -49.64 65.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.196 0.522 . . . . 0.0 111.435 -179.649 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.8 m -62.05 99.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.496 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 p -82.99 102.16 11.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.918 0.389 . . . . 0.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.493 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 80.4 p -141.86 155.17 45.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.307 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -57.86 -23.03 51.02 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -81.82 -50.11 9.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.278 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.2 p-10 -66.29 -31.56 72.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.588 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.97 -22.49 62.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.422 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -72.9 -16.53 61.56 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.6 m -106.96 -14.94 14.83 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.601 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.93 48.1 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.296 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -107.57 145.49 33.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.188 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.8 p -70.14 149.18 47.84 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.54 -45.12 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.32 -170.84 2.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.027 -178.813 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.98 -10.12 8.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 113' ' ' ASN . 54.3 p30 -135.45 36.35 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.929 0.395 . . . . 0.0 111.026 -177.342 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -93.82 158.74 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.927 179.256 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.43 131.16 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.794 -178.708 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.435 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 67.0 mtt -65.41 129.47 39.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.58 -2.75 74.09 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -138.49 121.26 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.867 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 74.93 -173.96 51.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' A' ' 181' ' ' GLU . 2.6 t-20 -82.65 111.98 19.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -84.77 104.84 15.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.17 130.12 36.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.608 -179.074 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.554 HD13 HD12 ' A' ' 83' ' ' ILE . 6.3 mt -128.74 134.31 48.4 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.069 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.42 43.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.256 0.55 . . . . 0.0 111.005 -178.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.75 -177.58 17.89 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 64.3 m-70 -87.69 140.68 29.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.675 0.274 . . . . 0.0 110.58 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 49.1 p30 -107.16 28.27 8.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.155 0.502 . . . . 0.0 110.735 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -43.31 -15.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.887 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.2 40.01 18.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.256 178.867 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.58 107.1 7.78 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.07 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.35 128.15 16.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.857 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.71 -26.44 11.74 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.603 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.796 HG12 ' H ' ' A' ' 134' ' ' LEU . 47.7 t -83.6 179.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.796 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 137.51 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 -178.103 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 138' ' ' ILE . 4.0 m-85 44.39 35.47 1.32 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 111.184 177.701 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 16.8 p -82.41 -13.46 56.77 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 136' ' ' SER . 78.4 m-20 -146.97 31.57 0.94 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.33 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.514 HD13 ' CD2' ' A' ' 135' ' ' PHE . 4.0 pt -70.84 -25.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.819 0.343 . . . . 0.0 111.825 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.43 0.92 7.15 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.53 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -93.68 -11.68 31.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.304 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 163' ' ' VAL . 18.9 mt -65.64 120.69 13.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.537 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.508 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.05 151.9 19.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.628 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -52.07 122.82 9.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.302 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.93 21.29 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.7 m-20 -87.25 139.55 30.45 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -81.66 127.26 32.72 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.496 -178.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 158' ' ' TYR . 32.9 mm -115.02 124.25 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -105.64 115.81 30.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.634 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.95 150.86 39.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.148 -178.536 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -123.77 136.9 54.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.185 0.516 . . . . 0.0 111.65 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 156' ' ' TYR . 2.5 m-20 -113.7 -163.53 0.87 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.613 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.6 p30 -26.03 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.07 0.462 . . . . 0.0 111.438 178.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.52 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.6 mt-10 -132.94 29.86 4.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.065 178.765 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.412 ' OD1' ' OD1' ' A' ' 152' ' ' ASN . 28.3 m120 -127.82 145.34 50.96 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -106.29 121.78 44.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.724 179.404 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.588 ' CE1' ' OD2' ' A' ' 151' ' ' ASP . 19.7 m-85 -104.35 129.12 52.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.629 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.58 117.27 30.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' O ' ' N ' ' A' ' 147' ' ' ILE . 8.2 m-85 -120.53 137.85 54.16 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.859 -178.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.1 134.96 53.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.76 178.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.26 134.43 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.158 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 12.2 p -99.07 -26.96 14.05 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.486 1.116 . . . . 0.0 111.316 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.99 145.25 4.17 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.342 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 141' ' ' LEU . 58.1 t -91.8 141.46 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -139.9 151.41 45.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.756 0.312 . . . . 0.0 111.05 -177.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -106.47 115.94 31.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.86 159.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.232 -177.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.0 p -66.94 170.03 6.99 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.555 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.7 Cg_endo -81.68 -13.19 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.888 1.725 . . . . 0.0 111.901 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -87.87 -14.21 40.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -178.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -85.69 69.13 10.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.555 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.4 m95 -74.83 -2.44 26.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.09 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -53.37 -35.38 60.24 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.162 0.506 . . . . 0.0 111.024 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.827 ' O ' HG21 ' A' ' 183' ' ' THR . 17.0 m -80.88 3.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.925 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.38 -15.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.833 0.825 . . . . 0.0 109.971 -178.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.06 162.22 17.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.838 -179.145 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -66.76 128.16 35.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.637 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -99.29 -39.53 8.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.083 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.2 29.42 0.5 Allowed Glycine 0 N--CA 1.473 1.103 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.439 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 58.5 pttt -156.05 -179.11 7.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 43.8 m-20 -92.21 90.26 7.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.145 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.5 ' HB3' HD21 ' A' ' 120' ' ' ASN . 49.9 tt0 -128.2 169.28 14.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.861 -178.214 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.9 tt -132.94 143.33 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.827 HG21 ' O ' ' A' ' 173' ' ' VAL . 11.3 m -138.29 120.61 15.89 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.872 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -108.77 126.03 52.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.958 0.409 . . . . 0.0 111.179 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.416 HG22 HG12 ' A' ' 198' ' ' VAL . 5.1 pt -133.89 -166.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.518 -178.594 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.587 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 23.4 p -137.24 167.21 22.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.572 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 186' ' ' THR . 91.8 m -49.15 178.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.248 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.6 p -64.91 139.35 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 190' ' ' VAL . 20.2 p -73.42 171.4 13.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 189' ' ' SER . 16.0 m -53.36 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.223 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -59.78 -47.58 85.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.642 0.258 . . . . 0.0 111.239 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 193' ' ' ASN . 39.7 t0 -166.77 -158.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.503 ' H ' ' CG ' ' A' ' 192' ' ' ASP . 99.1 m-20 50.01 34.09 7.69 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.78 178.196 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.8 m -155.05 155.49 34.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.559 -178.227 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.99 134.48 50.35 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.592 -179.346 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.587 ' NH1' ' O ' ' A' ' 186' ' ' THR . 15.4 ttm180 -78.15 126.59 31.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.727 -179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -89.19 132.91 34.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.308 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.416 HG12 HG22 ' A' ' 185' ' ' ILE . 27.7 m -139.46 142.09 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 111.514 -179.126 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 40.1 t -116.29 129.16 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.178 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.01 134.62 54.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.646 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.08 157.28 22.78 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -112.15 148.8 33.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.972 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.29 127.23 32.06 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.858 0.361 . . . . 0.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.03 -25.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.346 -178.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.6 163.18 22.15 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.616 178.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.521 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 93.6 m -139.49 159.05 43.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.058 0.456 . . . . 0.0 110.109 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 206' ' ' THR . 15.9 ptpt -147.27 178.79 8.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.655 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -97.35 142.99 28.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.545 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.94 80.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.556 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.388 178.524 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.455 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 54' ' ' SER . 27.1 p 49.59 95.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.18 -45.44 93.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 -179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' ASP . 33.2 tpp 49.54 -126.3 2.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' MET . 96.7 m-20 48.44 98.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.455 179.307 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.58 75.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.113 -178.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 1.4 t -150.08 -95.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.337 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.553 ' N ' ' OG ' ' A' ' 59' ' ' SER . 68.1 mttm 45.73 33.7 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.736 179.188 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.2 mt -67.23 -30.97 51.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.79 -179.219 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 1.8 p30 48.14 -162.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.912 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.516 ' CG ' ' SD ' ' A' ' 128' ' ' MET . 15.9 tt0 -96.53 87.06 0.41 Allowed Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -44.22 141.44 4.86 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.032 1.822 . . . . 0.0 112.534 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 58.5 t0 -76.43 152.94 36.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.1 mt -55.04 -25.0 27.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.565 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.71 -39.11 87.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 98.0 mt-10 -74.14 -32.12 63.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.6 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.18 -44.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.83 85.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.81 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -81.6 -28.46 33.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.455 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.17 111.73 1.45 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 111.218 -178.44 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.8 m -97.37 85.97 3.78 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.7 tp -74.4 146.74 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.335 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -94.88 111.61 23.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 179.311 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' O ' HG12 ' A' ' 79' ' ' VAL . 17.2 tptp -52.61 -10.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.434 . . . . 0.0 110.198 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -70.93 -12.19 61.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.925 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -95.54 15.86 18.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.475 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.9 p -91.22 126.24 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.07 179.637 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.34 -3.71 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.946 0.403 . . . . 0.0 111.66 -178.401 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.34 -162.01 32.19 Favored Glycine 0 C--N 1.317 -0.524 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.685 ' NH1' ' HZ3' ' A' ' 209' ' ' LYS . 36.8 ptt180 -156.31 162.64 40.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.426 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -133.26 139.67 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 t -130.03 135.57 48.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.529 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 70.5 mt -131.89 125.55 20.31 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.734 -178.89 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.66 -36.29 0.34 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.46 2.107 . . . . 0.0 112.864 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 p -48.21 -36.49 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.706 -176.369 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.8 p -119.81 -0.21 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.576 0.227 . . . . 0.0 110.65 -179.067 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.0 p 61.53 52.12 3.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 88' ' ' VAL . 4.7 tp -115.57 134.11 55.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.714 -178.694 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.56 128.69 22.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.636 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 1.0 OUTLIER -161.55 130.21 3.0 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.128 -178.857 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -47.59 156.89 1.0 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.583 1.522 . . . . 0.0 110.873 177.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.5 t -107.88 125.55 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -106.48 125.38 50.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.845 0.355 . . . . 0.0 110.592 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.57 -45.35 72.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.095 0.474 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.2 m -67.68 104.83 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.577 -178.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.1 p -81.74 96.63 7.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.096 0.475 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.419 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 4.8 p -135.96 157.65 46.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.947 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -58.11 -27.33 63.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.884 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.53 -45.28 13.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.24 0.543 . . . . 0.0 111.197 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 4.5 m120 -65.67 -36.68 84.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.405 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 108' ' ' ALA . 14.5 mt -63.46 -17.94 63.24 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.651 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.0 mt -71.21 -28.96 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.1 p -97.71 -8.23 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.35 -164.66 32.92 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.691 -1.242 . . . . 0.0 112.584 -178.504 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.636 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -92.36 127.95 38.03 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.06 146.71 28.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.0 p -74.27 153.16 39.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 185' ' ' ILE . 6.3 t -85.52 -47.04 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.081 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.42 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 14.7 mptt -92.49 -170.29 2.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.633 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 11.5 pt-20 -106.97 -52.83 2.7 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.72 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 91.1 m-20 -89.24 43.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.479 -178.118 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.42 ' CD ' ' H ' ' A' ' 111' ' ' LYS . 67.9 mt-30 -79.6 146.33 32.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.034 0.445 . . . . 0.0 110.859 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 122.8 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.34 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.99 125.12 25.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.538 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.3 0.68 70.17 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -140.72 126.17 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.508 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.57 -172.13 48.77 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -84.34 108.34 17.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.82 101.91 12.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 124.83 35.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.0 112.132 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -119.67 131.4 55.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.446 177.849 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.77 141.11 45.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.176 0.512 . . . . 0.0 110.594 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.68 -178.22 18.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.412 -179.761 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.1 m-70 -87.08 144.86 26.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.985 0.421 . . . . 0.0 110.873 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.0 t-20 -108.88 28.9 7.98 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.869 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.516 ' SD ' ' CG ' ' A' ' 63' ' ' GLN . 0.9 OUTLIER -44.15 -13.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.742 -178.872 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 m 57.44 39.78 27.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.146 0.498 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -135.02 108.21 7.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.531 -178.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -51.15 127.83 20.26 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.642 -179.093 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.53 -26.71 11.47 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.448 -178.369 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.821 HG12 ' H ' ' A' ' 134' ' ' LEU . 46.3 t -82.72 178.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 117.52 0.66 . . . . 0.0 109.772 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.821 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.22 136.94 48.28 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.628 -177.996 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.86 33.57 1.02 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.898 178.508 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.8 p -81.78 -12.01 58.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 23.4 t70 -149.12 32.84 0.74 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.094 -178.378 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.9 pt -69.58 -27.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.442 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.15 2.07 4.06 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 63.5 m -91.77 -14.85 29.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 23.1 mt -62.76 126.48 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.165 -179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -96.46 171.41 8.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -76.8 129.59 36.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.505 0.669 . . . . 0.0 111.937 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.51 21.11 49.37 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.25 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.17 -158.51 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -147.26 129.84 15.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.686 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.3 mt -126.92 124.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.814 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -102.99 120.23 40.26 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 tp -117.03 148.4 41.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 -179.408 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.13 131.19 53.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.12 0.486 . . . . 0.0 112.028 -178.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 152' ' ' ASN . 36.8 t0 -109.18 -167.42 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.168 177.611 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 151' ' ' ASP . 89.5 m-20 -19.99 -76.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.56 0.538 . . . . 0.0 111.981 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -138.16 27.23 2.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.58 144.2 49.26 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -176.387 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -107.68 121.52 44.86 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.452 ' CE2' HG21 ' A' ' 206' ' ' THR . 63.6 m-85 -105.35 128.92 53.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -178.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.461 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 98.0 mt-10 -95.83 119.44 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.236 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -116.36 143.94 44.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.67 131.77 56.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.038 0.447 . . . . 0.0 110.13 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.69 132.6 32.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.527 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -28.67 12.06 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.344 1.028 . . . . 0.0 109.906 -178.522 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 169.96 25.53 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.279 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.07 153.86 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.439 -0.881 . . . . 0.0 109.918 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.3 t -153.89 166.12 33.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 111.523 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 63.2 mm-40 -109.9 126.94 54.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.58 161.37 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.769 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.6 p -76.89 145.23 73.82 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.336 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.35 -21.81 7.72 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.867 1.711 . . . . 0.0 111.662 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.37 -2.73 53.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.805 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.596 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 21.6 tptt -80.71 150.18 29.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 83.6 m95 -157.62 -24.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.536 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.3 mt-10 -51.9 -8.56 0.07 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.111 0.482 . . . . 0.0 110.298 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' TRP . 7.0 m -78.41 -32.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 185' ' ' ILE . 28.5 m -110.03 -1.35 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.451 0.643 . . . . 0.0 110.468 -178.57 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 176' ' ' ASP . 94.0 mt-10 -80.37 119.81 23.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.7 -179.016 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' GLU . 98.1 m-20 -30.41 120.04 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.655 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 49.9 m80 -102.85 -43.23 5.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.969 -179.278 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.16 29.41 0.22 Allowed Glycine 0 N--CA 1.467 0.738 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -152.57 172.7 16.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -93.86 89.47 6.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.386 178.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.26 127.5 30.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.762 -179.142 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -82.56 148.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.562 ' CG2' HG12 ' A' ' 174' ' ' VAL . 3.4 m -136.1 124.84 23.87 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.513 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -108.47 129.93 55.27 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.924 0.392 . . . . 0.0 110.512 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 174' ' ' VAL . 7.1 pt -141.5 -168.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.924 -179.649 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.8 t -138.0 147.47 44.24 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.1 p -98.35 -7.84 28.11 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.692 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.5 t -76.24 64.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.731 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.5 p -78.91 156.1 28.74 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.551 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.559 HG22 ' H ' ' A' ' 192' ' ' ASP . 5.1 p -143.64 142.55 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.428 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -85.46 -11.89 53.22 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.963 0.411 . . . . 0.0 110.969 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.559 ' H ' HG22 ' A' ' 190' ' ' VAL . 64.9 t0 -63.86 -37.22 86.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.686 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.469 ' OD1' ' CG1' ' A' ' 190' ' ' VAL . 42.4 p30 -146.82 169.27 19.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.765 -179.326 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.1 m -121.61 85.2 2.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.219 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -148.93 129.7 14.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.972 -179.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -145.36 142.93 29.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.994 -179.012 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.7 m-85 -102.96 123.38 46.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.635 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.11 133.22 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.394 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 76.4 t -120.31 130.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.184 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.26 135.24 53.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.295 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.14 137.39 10.11 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.323 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.6 t0 -95.54 132.47 40.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.23 -0.485 . . . . 0.0 112.077 -178.729 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 47.1 tp -62.15 125.84 25.27 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.168 0.508 . . . . 0.0 110.597 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.95 -24.91 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.678 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.11 159.86 17.03 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.064 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.452 HG21 ' CE2' ' A' ' 156' ' ' TYR . 20.5 m -134.15 156.17 48.79 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.105 0.479 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.461 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.5 ptpp? -148.14 179.21 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.129 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.84 146.82 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.232 0.539 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.685 ' HZ3' ' NH1' ' A' ' 82' ' ' ARG . 63.7 tttp -70.36 80.8 0.55 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.655 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.766 178.562 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.3 t -60.13 -44.83 94.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.965 0.412 . . . . 0.0 110.522 -179.654 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -77.82 138.18 38.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.149 179.522 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 56' ' ' MET . 0.0 OUTLIER -96.35 142.43 28.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.665 -179.653 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -74.85 141.41 44.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.475 179.8 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.53 -17.88 62.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.87 -178.777 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 61' ' ' ILE . 52.8 m -86.92 -1.24 57.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.683 -178.596 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -68.91 37.72 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.199 -179.152 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.497 ' H ' ' C ' ' A' ' 59' ' ' SER . 67.3 mt -61.14 -50.15 81.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.052 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.1 t0 57.45 -98.5 0.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.906 179.047 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.441 ' CG ' ' SD ' ' A' ' 128' ' ' MET . 21.4 tt0 -151.66 77.74 7.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -43.46 138.86 4.91 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 122.404 2.069 . . . . 0.0 110.973 -179.446 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.35 146.16 48.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.634 179.471 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -49.26 -28.13 4.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.73 -179.711 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.58 93.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.353 -179.428 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.9 mt-10 -73.1 -33.92 65.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.748 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t -75.06 -45.89 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.052 -178.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.81 86.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.88 -25.33 32.61 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.372 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.76 130.62 47.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.4 t -95.64 158.88 15.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -138.63 123.69 19.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.014 0.435 . . . . 0.0 110.951 -178.845 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.682 ' N ' HD13 ' A' ' 74' ' ' LEU . 98.0 m-20 -81.45 104.14 11.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.058 178.648 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -49.4 -35.84 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.242 -179.645 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -58.77 -11.49 3.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.498 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -90.41 -3.31 57.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.915 -178.724 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.34 133.27 30.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.983 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 pt -117.37 -5.73 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.933 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.72 33.77 Favored Glycine 0 C--N 1.317 -0.522 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.573 HH22 ' HZ1' ' A' ' 209' ' ' LYS . 29.5 ptt-85 -154.94 166.01 34.9 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.545 -179.775 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.77 134.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.824 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 t -123.85 130.27 52.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.242 -178.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 17.3 mt -133.15 111.05 12.95 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.402 -177.739 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 4.2 Cg_exo -78.69 -36.66 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.757 2.305 . . . . 0.0 113.013 -178.899 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 t -47.81 -35.83 10.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.48 -177.249 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 90' ' ' LEU . 4.2 m -118.96 -5.92 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 123.361 0.413 . . . . 0.0 111.432 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.15 45.69 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.737 -179.916 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 88' ' ' VAL . 1.1 mt -112.2 129.0 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.233 -178.84 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -135.86 115.65 13.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.361 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.1 mt -143.79 161.99 43.48 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.341 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -86.56 152.83 8.98 Favored 'Trans proline' 0 C--N 1.326 -0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 108.882 177.676 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.75 115.52 44.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.0 mt -100.18 128.26 46.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.045 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -66.22 -49.51 67.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.154 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -78.74 108.98 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 -179.092 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 98.72 11.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 109.927 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -133.06 154.8 50.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.33 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -51.55 -27.79 11.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.538 -179.607 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -83.57 -47.17 11.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.745 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.05 -33.36 75.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.593 -178.868 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.84 -19.35 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.807 -178.928 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.469 ' O ' HD11 ' A' ' 134' ' ' LEU . 22.7 mt -69.94 -25.13 63.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.42 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.667 ' OG ' HD23 ' A' ' 74' ' ' LEU . 21.6 m -91.82 -9.61 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.138 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.447 ' N ' HD13 ' A' ' 134' ' ' LEU . . . 165.09 -154.04 24.58 Favored Glycine 0 N--CA 1.46 0.238 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.646 -179.387 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.42 125.26 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.634 -0.783 . . . . 0.0 110.061 179.591 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.23 148.03 26.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.576 -179.678 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.2 p -75.77 150.53 37.75 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.216 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 t -86.78 -56.51 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.67 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -96.74 138.65 33.99 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.301 0.572 . . . . 0.0 111.015 -179.178 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -80.55 9.09 6.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.656 -178.337 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.407 ' C ' ' OD1' ' A' ' 113' ' ' ASN . 54.8 p30 -132.88 22.78 4.21 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.139 -0.351 . . . . 0.0 111.352 -177.87 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -91.05 156.12 18.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.955 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -134.26 133.5 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.547 ' SD ' HD22 ' A' ' 149' ' ' LEU . 67.8 mtt -67.14 127.35 32.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 179.091 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.507 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.36 0.23 76.92 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.56 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -142.39 127.58 18.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.037 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.85 -171.2 45.47 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.254 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -86.77 107.84 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.773 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -84.91 99.32 10.88 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 122.76 34.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mt -117.7 131.14 56.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.296 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.95 137.91 48.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.627 0.727 . . . . 0.0 110.789 -178.413 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.25 -178.68 17.76 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.607 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -85.95 141.75 29.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.479 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.5 p30 -109.98 26.56 10.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.441 ' SD ' ' CG ' ' A' ' 63' ' ' GLN . 0.9 OUTLIER -42.96 -15.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.876 -179.51 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 59.39 39.13 22.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.142 178.959 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.9 tttt -133.27 114.95 14.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.468 -179.184 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.35 125.19 21.71 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.173 -179.652 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.93 -24.68 11.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.292 -178.379 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.724 HG12 ' H ' ' A' ' 134' ' ' LEU . 61.5 t -82.37 178.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.724 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -71.89 135.74 46.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.245 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 43.67 32.81 0.6 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.166 0.508 . . . . 0.0 110.892 178.381 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -81.45 -6.37 58.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.784 -178.355 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 136' ' ' SER . 94.2 m-20 -143.25 34.37 1.33 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.625 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.6 pt -68.3 -30.5 47.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.788 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.49 5.83 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.029 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -97.57 -14.65 20.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.023 -179.359 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.11 124.67 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.288 179.621 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.401 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.41 154.38 17.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.664 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.19 126.44 27.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.307 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.73 25.16 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.771 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.401 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -91.28 133.47 35.38 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -80.59 142.03 34.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.166 0.508 . . . . 0.0 111.592 -178.904 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 158' ' ' TYR . 85.7 mt -132.74 124.41 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.352 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.03 121.9 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.076 0.465 . . . . 0.0 109.994 -178.781 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.547 HD22 ' SD ' ' A' ' 116' ' ' MET . 1.1 mt -114.18 156.53 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.445 -179.489 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 26.3 m-85 -134.55 123.37 23.77 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 152' ' ' ASN . 11.3 t0 -114.35 -165.6 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.795 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.558 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.9 m-20 -11.31 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.737 0.648 . . . . 0.0 111.504 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -139.1 28.04 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.19 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.15 148.04 41.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.191 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 74.3 mt-10 -110.29 119.75 40.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.865 178.38 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -106.04 125.03 50.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.893 -178.764 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.522 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.2 mt-10 -96.12 118.98 33.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.108 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.507 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.8 m-85 -118.38 144.9 45.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.014 -178.843 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' ASP . . . -120.42 131.69 54.9 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.338 0.589 . . . . 0.0 110.368 178.825 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.31 133.84 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.962 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.2 p -102.19 -27.07 13.1 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 124.701 1.251 . . . . 0.0 110.986 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 179.94 36.53 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.259 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.98 147.48 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.776 -179.531 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -151.28 159.94 44.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.083 0.468 . . . . 0.0 110.976 -178.42 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -107.23 118.87 37.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 173' ' ' VAL . 17.8 m -132.21 154.07 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.107 0.479 . . . . 0.0 111.034 -178.498 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 169' ' ' ASP . 35.8 p -75.94 135.86 70.34 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.691 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.59 -15.61 0.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.104 1.869 . . . . 0.0 111.659 -178.653 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.7 m-20 -81.35 -22.75 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 -177.906 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 173' ' ' VAL . 32.6 ttmt -85.65 75.84 10.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.229 179.307 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.575 ' C ' ' H ' ' A' ' 173' ' ' VAL . 86.0 m95 -71.39 -18.67 62.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.306 -178.665 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 81.0 mm-40 -51.97 -5.72 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.974 0.416 . . . . 0.0 111.15 179.208 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.726 ' O ' HG21 ' A' ' 183' ' ' THR . 34.0 m -90.38 -2.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.173 -178.466 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.564 HG13 HG23 ' A' ' 173' ' ' VAL . 1.2 m -132.99 -6.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.63 0.729 . . . . 0.0 109.563 -179.681 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.35 159.56 24.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.093 -176.623 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -66.28 124.5 22.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.517 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.1 m170 -113.94 24.47 12.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.656 -179.13 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.31 19.16 74.88 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.117 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.16 165.74 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 28.9 p30 -97.5 87.62 4.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.71 0.767 . . . . 0.0 110.561 179.751 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -123.24 130.0 52.14 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.053 -179.389 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.9 tt -81.5 146.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.334 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.726 HG21 ' O ' ' A' ' 173' ' ' VAL . 17.3 m -136.71 120.7 17.63 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.279 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -106.0 123.31 47.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.528 0.68 . . . . 0.0 110.786 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.5 pt -137.03 -169.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.645 -178.793 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.512 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 0.6 OUTLIER -134.35 130.59 37.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.046 -178.907 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.402 ' SG ' HD12 ' A' ' 61' ' ' ILE . 11.1 t -88.36 110.61 20.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.085 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.405 ' CG2' ' NH2' ' A' ' 196' ' ' ARG . 35.6 m -140.06 165.96 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.225 -178.904 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.3 t -54.36 147.59 13.32 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.742 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 191' ' ' LYS . 64.5 t -59.51 -49.02 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.397 -178.84 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 190' ' ' VAL . 44.2 tttp 52.42 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.159 178.398 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 193' ' ' ASN . 53.1 p-10 -66.93 -117.36 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.972 179.515 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.522 ' H ' ' CG ' ' A' ' 192' ' ' ASP . 98.4 m-20 -96.56 131.89 42.72 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.357 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.4 m -153.81 155.58 36.08 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 111.22 -178.576 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -99.79 142.76 30.85 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.179 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.8 ttm180 -139.56 134.76 32.61 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.513 -178.695 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -86.39 133.27 33.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.888 179.121 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 134.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 111.201 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.37 130.15 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.682 -179.548 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -119.12 137.83 53.32 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.643 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.0 145.24 17.32 Favored Glycine 0 N--CA 1.466 0.641 0 CA-C-O 121.828 0.682 . . . . 0.0 111.668 -179.213 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.9 t0 -100.57 140.24 35.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.51 -0.845 . . . . 0.0 111.414 -178.796 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 31.8 tp -65.36 128.14 34.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.7 p -107.26 -25.9 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.213 -178.875 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.81 161.79 22.05 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.728 179.133 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 207' ' ' LYS . 89.9 m -142.22 157.06 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.185 0.517 . . . . 0.0 109.967 -179.263 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.52 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.6 pttm -150.82 178.97 8.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.109 179.617 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.77 144.23 26.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.777 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.573 ' HZ1' HH22 ' A' ' 82' ' ' ARG . 88.5 tttt -69.54 78.47 0.41 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.905 -179.247 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.699 178.266 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 54' ' ' SER . 7.1 t 48.1 20.34 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.803 178.823 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.2 m80 47.28 -161.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.989 179.857 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.446 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 20.1 tpp -86.15 169.92 12.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.564 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 66.4 t0 -137.69 146.02 43.3 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.131 0.491 . . . . 0.0 110.858 -179.013 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -69.48 -44.39 71.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.854 -179.091 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 t -155.77 71.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.651 0.262 . . . . 0.0 111.049 -178.463 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -69.01 -5.92 24.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.559 0.695 . . . . 0.0 111.572 -179.142 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' ASP . 15.6 mm -66.3 -31.51 53.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.0 -179.096 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 64' ' ' PRO . 37.5 t0 57.17 110.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.704 179.528 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 62' ' ' ASP . 2.5 tp-100 -38.1 93.0 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 123.158 0.286 . . . . 0.0 110.459 -179.361 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.486 ' N ' ' O ' ' A' ' 62' ' ' ASP . 6.2 Cg_exo -76.5 150.94 32.49 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 122.585 2.19 . . . . 0.0 111.253 -178.903 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 56.4 t0 -76.38 159.14 30.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 84.6 mt -60.27 -24.39 64.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.765 -179.105 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.15 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.343 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.9 mt-10 -72.62 -34.44 67.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.654 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -75.07 -44.78 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.897 -178.937 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.97 87.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.955 179.853 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.0 -21.49 33.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.336 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.52 132.97 55.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -141.94 81.49 1.76 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.001 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.7 pt? -73.35 154.87 39.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.924 179.074 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -70.31 136.7 50.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -66.39 -7.77 21.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.379 0.609 . . . . 0.0 110.364 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.95 -29.63 70.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.05 5.1 8.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.551 -178.794 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.37 127.62 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.74 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.704 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -135.47 8.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.269 -177.416 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.49 -174.31 39.7 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -178.888 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -153.16 155.16 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.346 -179.221 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 83' ' ' ILE . 18.4 tt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 179.59 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -129.27 130.14 45.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.828 -178.886 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.471 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 26.5 mt -135.36 120.97 13.96 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.475 -178.353 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -82.32 -34.49 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.601 2.201 . . . . 0.0 112.472 -179.597 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -49.97 -39.24 40.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.749 -176.699 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.433 ' O ' ' CB ' ' A' ' 89' ' ' SER . 3.4 m -118.88 -7.32 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 123.309 0.381 . . . . 0.0 111.039 -178.902 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 75.77 48.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.56 0.695 . . . . 0.0 110.42 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 92' ' ' LEU . 2.4 mt -107.24 122.56 46.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.429 -179.424 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.17 109.27 10.31 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.528 HD12 HD22 ' A' ' 90' ' ' LEU . 36.1 mt -144.37 165.56 22.87 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.333 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.01 156.09 7.15 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.916 2.411 . . . . 0.0 108.628 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.413 ' O ' HD13 ' A' ' 80' ' ' ILE . 69.0 t -107.24 120.01 57.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.958 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.03 119.57 39.08 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.55 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.07 -47.52 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.5 p -81.47 117.94 22.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -82.9 75.55 9.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.068 0.461 . . . . 0.0 110.163 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.406 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -90.65 142.96 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.424 179.909 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.459 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 84.0 tt0 -50.46 -56.96 9.21 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.568 -179.597 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -66.28 -32.09 73.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.318 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.597 HD21 ' N ' ' A' ' 102' ' ' ASN . 1.2 m120 -68.1 -27.06 66.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 108' ' ' ALA . 13.0 mt -73.2 -9.57 58.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.444 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.3 mp -76.44 -14.45 60.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.01 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.43 ' OG ' HD22 ' A' ' 74' ' ' LEU . 35.5 m -112.13 -5.6 14.22 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.48 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.96 -167.68 39.14 Favored Glycine 0 C--N 1.323 -0.19 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.555 -179.761 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.04 128.01 38.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.686 179.413 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.433 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.95 152.55 22.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.465 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -78.19 156.07 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.279 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.6 t -84.69 -55.54 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.22 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -94.36 137.92 32.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.111 0.481 . . . . 0.0 111.091 -179.359 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.27 6.25 17.42 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.028 -178.511 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -130.19 24.53 5.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.834 0.35 . . . . 0.0 111.408 -177.432 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -94.28 162.9 13.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.02 135.83 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.4 mtp -70.56 124.57 24.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.819 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.71 7.37 64.79 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.646 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -143.62 124.69 14.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.389 -178.887 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.0 -170.43 51.92 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.315 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.58 107.4 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.643 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.75 101.99 12.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.241 -179.566 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.94 128.06 36.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.362 0.601 . . . . 0.0 111.692 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.92 131.24 53.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.429 178.497 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.28 140.32 45.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.476 0.655 . . . . 0.0 111.101 -178.567 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.86 -179.94 19.99 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.4 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -79.27 156.88 27.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 129' ' ' SER . 7.6 t30 -122.78 27.1 7.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.968 0.413 . . . . 0.0 110.844 -179.163 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.0 mtt -45.9 -13.01 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.797 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 m 54.97 40.35 31.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.006 178.705 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 136' ' ' SER . 83.4 tttt -134.04 120.67 20.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.049 -179.168 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.97 124.23 19.2 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.209 0.528 . . . . 0.0 109.973 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.37 -29.66 7.17 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.203 -177.913 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.71 HG12 ' N ' ' A' ' 134' ' ' LEU . 99.5 t -76.03 177.21 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.359 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.71 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -73.27 139.21 45.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.514 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.4 m-30 45.0 27.57 0.29 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.149 0.499 . . . . 0.0 111.22 178.029 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -83.42 -15.65 48.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.554 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -132.47 12.98 4.55 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.511 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.417 HD13 ' CD2' ' A' ' 135' ' ' PHE . 9.7 pt -68.81 -25.83 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.927 0.394 . . . . 0.0 111.789 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.06 1.53 1.94 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.569 -179.6 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 138' ' ' ILE . 15.8 t -98.76 -11.29 22.02 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.226 0.536 . . . . 0.0 110.226 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.08 120.37 11.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.365 179.757 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -99.81 166.06 11.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.676 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.404 ' HB3' ' HZ2' ' A' ' 143' ' ' LYS . 10.4 ttpp -65.04 118.9 9.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.308 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.39 14.92 12.06 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.198 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -95.28 133.51 39.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.354 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.785 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 158' ' ' TYR . 69.2 mt -125.86 124.99 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.975 178.662 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.4 ' CD2' ' OE2' ' A' ' 157' ' ' GLU . 63.2 m-85 -99.39 114.69 27.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.979 -178.801 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 tp -113.93 142.91 45.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.94 -179.38 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -110.25 137.36 48.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.053 0.454 . . . . 0.0 111.653 -178.434 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 37.3 t70 -110.72 -172.77 2.1 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.271 178.189 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.1 m-20 -37.45 -62.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -179.478 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -137.6 23.86 2.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.865 179.349 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.85 152.2 48.11 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.641 0.734 . . . . 0.0 112.65 -175.702 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -114.81 122.02 45.08 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.299 178.887 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -105.11 130.99 53.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.319 0.58 . . . . 0.0 111.427 -179.015 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 204' ' ' VAL . 80.5 mm-40 -96.4 117.76 31.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.155 178.474 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 147' ' ' ILE . 29.6 m-85 -115.92 141.49 48.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.79 130.29 55.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.552 0.691 . . . . 0.0 110.11 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.42 134.13 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.067 -179.37 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.8 p -102.0 -25.72 13.66 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 124.705 1.253 . . . . 0.0 111.132 -178.972 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 163.81 166.45 22.7 Favored Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.243 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.56 153.16 37.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.741 -179.618 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.3 t -153.38 161.44 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -178.164 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -116.48 117.1 28.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.807 -179.349 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.22 160.36 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 111.245 -178.497 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 p -57.22 168.91 0.81 Allowed Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.028 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.77 -9.11 12.2 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.094 1.863 . . . . 0.0 111.957 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.76 1.52 42.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -178.402 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.602 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 13.5 mptt -83.59 149.57 26.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.358 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 87.8 m95 -157.6 -28.99 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.173 -178.648 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.88 -8.26 0.09 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.099 0.475 . . . . 0.0 110.665 178.655 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 171' ' ' TRP . 8.9 m -79.16 -25.67 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.607 -178.807 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 171' ' ' TRP . 16.6 m -110.69 -2.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 0.0 110.402 -178.806 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 176' ' ' ASP . 75.4 mm-40 -81.09 119.37 23.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.977 -178.04 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.0 p-10 -30.27 122.21 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.867 179.002 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -104.43 -44.35 4.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.253 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.29 26.36 0.1 Allowed Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -154.05 173.97 15.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.186 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.37 87.02 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.248 0.547 . . . . 0.0 109.901 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -128.05 125.14 38.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -179.002 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -81.2 148.3 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.9 m -137.56 122.98 19.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.184 -179.141 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -109.14 125.54 52.29 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.239 0.542 . . . . 0.0 111.394 -179.546 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.405 HD13 HG11 ' A' ' 174' ' ' VAL . 9.2 pt -134.21 161.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.583 -179.47 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 p -133.53 152.88 51.97 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.443 -178.876 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 14.2 p -93.5 138.57 31.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.195 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.9 p -142.3 140.06 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.842 0.353 . . . . 0.0 110.999 -178.613 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.4 m -65.99 147.32 53.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.201 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 190' ' ' VAL . 16.0 m -71.58 132.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -165.43 -169.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.107 -178.348 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 192' ' ' ASP . 49.3 p-10 -71.08 142.06 50.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.062 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 49.61 33.14 5.58 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.9 178.773 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 87.0 p -64.22 135.21 56.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.344 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -150.66 155.11 38.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.919 0.39 . . . . 0.0 110.84 -179.151 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -129.8 143.15 50.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.429 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.3 134.01 46.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.947 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.71 135.63 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.247 -179.393 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -119.35 130.44 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.416 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.23 134.83 54.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.42 141.13 12.4 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 50.9 p-10 -100.18 141.33 33.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.636 -0.782 . . . . 0.0 111.503 -179.111 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.62 125.1 24.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 110.66 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.5 p -107.16 -24.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.135 -179.034 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.12 177.16 44.92 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.947 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 35.1 m -154.99 154.64 32.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.278 0.561 . . . . 0.0 110.993 -179.858 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.87 178.17 8.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.81 146.27 24.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.508 179.931 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.67 78.31 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.75 -179.118 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.419 178.279 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.096 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 p -157.88 161.84 38.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.853 0.358 . . . . 0.0 110.873 -179.622 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -87.02 -11.47 50.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.4 mtm 48.55 -163.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.554 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 50.48 31.13 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.505 178.834 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.31 -12.81 61.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.942 -178.942 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 61' ' ' ILE . 98.7 p -87.61 11.32 15.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.909 0.385 . . . . 0.0 111.26 -178.896 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -60.16 71.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.002 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 59' ' ' SER . 2.6 mt -68.41 -75.16 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-O 121.366 0.603 . . . . 0.0 110.207 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 50.95 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.029 179.781 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 61' ' ' ILE . 4.4 pt20 -132.36 78.84 67.15 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.466 -179.5 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' CG ' HG23 ' A' ' 61' ' ' ILE . 4.6 Cg_exo -79.05 170.56 17.65 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.021 2.48 . . . . 0.0 111.668 179.85 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.18 157.3 37.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.788 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.41 -28.96 70.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -178.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.17 90.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 -179.571 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.9 mt-10 -73.13 -40.97 64.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.303 0.573 . . . . 0.0 110.836 -179.572 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -73.49 -41.89 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.483 -179.0 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.64 84.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.85 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -91.57 -14.58 30.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.396 -178.665 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.12 110.77 1.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.747 -179.685 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.2 t -106.65 135.64 47.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.76 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.729 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.2 pt? -128.02 174.14 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.057 -179.59 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.9 m-20 -83.65 98.63 9.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.677 178.527 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 79' ' ' VAL . 34.5 mtmm -58.5 -4.23 0.38 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.377 0.608 . . . . 0.0 110.438 -179.669 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.7 mmtp -67.51 -11.18 57.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.549 -179.898 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.88 18.84 12.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.782 -179.481 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 76' ' ' LYS . 53.9 t -80.03 124.29 37.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.135 178.897 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 tt -106.5 -35.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.074 -179.044 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.41 -155.43 8.16 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.569 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -146.38 155.9 42.93 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.48 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -125.37 129.08 73.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.652 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.604 ' N ' HD13 ' A' ' 83' ' ' ILE . 50.2 m -130.5 130.97 44.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.049 -179.276 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.7 mt -132.73 118.59 15.65 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.34 -178.269 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.82 -37.47 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.361 2.041 . . . . 0.0 112.263 -179.503 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 t -48.9 -37.75 20.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.909 -177.146 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 89' ' ' SER . 2.0 m -121.23 -6.59 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.998 -179.026 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.44 50.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.49 124.23 49.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.966 -179.556 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.77 ' O ' HD22 ' A' ' 92' ' ' LEU . 83.0 tt0 -132.59 107.14 8.24 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.395 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.77 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -144.15 116.17 5.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.088 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HD2' HD13 ' A' ' 92' ' ' LEU . 2.3 Cg_endo -41.16 146.49 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 121.817 1.678 . . . . 0.0 110.2 175.446 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.3 t -97.84 121.69 48.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.463 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 mt -103.16 117.48 34.64 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.802 0.334 . . . . 0.0 110.469 -178.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -63.62 -48.54 76.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.272 0.558 . . . . 0.0 110.483 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 90.5 p -60.95 102.66 0.21 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.415 -179.637 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 98' ' ' SER . 53.1 p -83.89 91.51 7.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.11 144.37 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.939 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.516 ' HA ' HD12 ' A' ' 103' ' ' LEU . 1.4 tt0 -53.42 -42.94 67.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.951 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -63.57 -46.39 86.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.087 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.644 HD21 HD12 ' A' ' 74' ' ' LEU . 10.2 m120 -68.11 -35.58 78.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 111.779 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 100' ' ' GLU . 4.6 mt -49.46 -22.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.134 -179.47 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.99 -13.25 61.19 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.717 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.538 ' OG ' HD22 ' A' ' 74' ' ' LEU . 3.2 m -105.03 -11.12 16.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.298 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 167.3 -179.06 41.12 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.275 -179.309 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.43 126.06 29.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.785 -0.707 . . . . 0.0 109.941 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.41 150.18 25.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -76.28 153.8 35.66 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.77 -45.94 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.742 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 113' ' ' ASN . 85.6 tttt -89.2 136.24 33.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.165 0.507 . . . . 0.0 110.486 -178.366 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -62.22 -8.27 5.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.109 -178.848 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.468 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 66.1 t30 -146.4 50.31 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 -177.94 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -79.9 161.87 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.784 179.655 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.0 127.04 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 -179.314 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.4 mtt -74.19 127.29 32.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.189 179.013 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.496 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.37 1.71 74.62 Favored Glycine 0 N--CA 1.461 0.326 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -141.58 123.91 15.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.213 0.53 . . . . 0.0 110.974 -179.502 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.59 -170.65 50.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -85.6 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.23 99.91 10.26 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 121.18 32.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.289 0.566 . . . . 0.0 111.323 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -116.58 130.56 56.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.699 178.713 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.29 137.63 47.77 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.459 0.647 . . . . 0.0 110.433 -179.322 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.39 -177.15 17.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.713 -178.902 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 134' ' ' LEU . 54.8 m-70 -90.37 137.06 32.65 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 -179.504 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 129' ' ' SER . 29.2 t-20 -105.91 28.24 7.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 109.891 -179.986 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.7 mmm -44.6 -13.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.859 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.71 40.91 15.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.684 179.481 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 19.1 mmmt -132.03 107.59 8.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.092 -179.131 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -52.36 124.18 12.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.596 0.713 . . . . 0.0 110.297 179.984 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.74 -28.05 9.27 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.946 -178.34 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.734 HG12 ' H ' ' A' ' 134' ' ' LEU . 60.4 t -78.37 178.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-N 117.879 0.839 . . . . 0.0 109.047 179.415 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.734 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -70.44 134.2 47.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.239 -178.224 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.411 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.9 m-30 44.59 32.81 0.81 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.258 0.552 . . . . 0.0 110.585 178.529 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.7 -7.02 59.67 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.464 -178.501 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -145.79 24.02 1.37 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.577 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.411 HD13 ' CD2' ' A' ' 135' ' ' PHE . 7.1 pt -70.46 -21.5 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.699 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.24 2.97 7.96 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.6 t -99.21 -10.85 21.91 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.361 0.6 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.513 ' O ' HG21 ' A' ' 163' ' ' VAL . 15.6 mt -64.24 124.12 20.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.662 -179.888 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 17.9 ptpt -97.42 166.31 11.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.69 123.6 19.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 179.638 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.62 26.74 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.633 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 71.4 m-20 -82.51 130.94 35.21 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.985 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -78.3 129.3 34.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 0.0 111.675 -179.118 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.3 mt -127.28 127.44 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -109.66 123.83 50.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.146 0.498 . . . . 0.0 110.682 -179.087 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.65 148.74 37.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.222 179.6 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.2 t70 -114.01 -166.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.943 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.1 m-20 -24.37 -75.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.108 0.48 . . . . 0.0 111.848 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -138.15 29.76 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.054 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -129.87 145.73 51.6 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.249 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -110.09 123.0 48.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.823 179.334 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.62 132.71 50.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 111.57 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -96.31 116.75 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.62 178.394 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 44.6 m-85 -117.17 141.59 48.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.55 -179.52 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.76 133.72 54.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.31 0.576 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.33 134.38 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.232 179.446 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.2 p -102.37 -28.57 12.16 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 124.826 1.329 . . . . 0.0 111.048 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.31 144.04 3.91 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.113 -1.041 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 141' ' ' LEU . 12.4 t -103.74 149.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.523 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 t -153.68 164.25 38.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.137 0.494 . . . . 0.0 111.352 -178.683 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -110.96 117.28 32.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.777 179.728 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.37 160.14 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 169' ' ' ASP . 29.5 p -71.99 134.44 83.3 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.67 -11.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.093 1.862 . . . . 0.0 111.794 -179.093 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 167' ' ' THR . 51.5 t0 -83.4 -10.02 58.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.18 -178.841 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -88.39 70.54 9.06 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.573 0.349 . . . . 0.0 110.435 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -75.43 -6.29 49.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.082 0.467 . . . . 0.0 110.97 -179.642 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.56 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.5 mt-10 -52.77 -50.13 64.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.705 ' O ' HG21 ' A' ' 183' ' ' THR . 18.3 m -69.88 6.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.0 -179.704 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.04 28.76 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.909 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.27 131.32 18.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.783 0.801 . . . . 0.0 111.779 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -27.77 121.66 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.962 179.642 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.56 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 53.2 m80 -107.05 -40.23 5.51 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.6 24.59 0.13 Allowed Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.859 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.38 172.9 16.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.974 0.416 . . . . 0.0 111.214 179.582 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -96.21 89.58 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 0.0 110.05 178.476 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -125.3 175.87 7.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.2 tt -129.48 142.4 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.394 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.705 HG21 ' O ' ' A' ' 173' ' ' VAL . 13.0 m -136.34 124.9 23.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.136 -179.95 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -114.02 126.3 54.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.436 0.636 . . . . 0.0 110.463 179.242 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.468 HG22 HG13 ' A' ' 198' ' ' VAL . 28.1 pt -134.61 -169.9 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.738 -179.11 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.422 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 5.1 t -139.39 158.15 44.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.309 -179.461 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.5 m -62.08 162.31 9.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.002 179.151 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 188' ' ' VAL . 10.4 p -120.03 129.6 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.04 -178.751 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.6 p -77.91 165.75 23.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.333 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.0 m -61.86 -25.11 36.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.475 -179.65 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -56.62 142.57 39.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.371 179.695 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -88.33 8.14 28.95 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.301 -179.048 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -62.17 140.87 58.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.272 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.9 t -97.53 106.58 18.92 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.155 -179.499 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -171.24 96.36 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.804 -179.089 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.422 ' NH2' ' O ' ' A' ' 186' ' ' THR . 60.7 ttt180 -146.06 136.8 24.28 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.389 -179.355 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.44 129.47 50.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.037 179.023 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.468 HG13 HG22 ' A' ' 185' ' ' ILE . 42.7 t -130.14 131.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.422 -179.182 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 93.5 t -115.1 127.1 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.358 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.38 135.21 54.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.282 0.563 . . . . 0.0 110.373 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.94 159.1 25.42 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.765 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -112.12 150.66 30.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.676 -0.762 . . . . 0.0 111.456 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.408 HD13 ' CZ ' ' A' ' 158' ' ' TYR . 11.9 tp -73.74 129.78 38.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.251 0.548 . . . . 0.0 110.62 179.721 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.97 -22.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.086 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.32 177.84 44.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.202 -179.157 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.3 m -151.65 151.17 31.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -148.96 177.83 9.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.672 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.41 146.99 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.312 0.577 . . . . 0.0 110.735 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.93 79.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.899 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 tptp . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.694 178.63 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.528 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.0 t -60.66 -44.77 96.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.865 -179.466 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.654 ' CD2' ' H ' ' A' ' 56' ' ' MET . 23.5 p-80 -62.31 -114.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.837 179.402 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.654 ' H ' ' CD2' ' A' ' 55' ' ' HIS . 37.3 tpp 50.47 -115.38 0.84 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.355 178.626 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.7 113.41 23.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.978 0.418 . . . . 0.0 110.118 179.657 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.64 -52.28 27.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.252 -178.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 m -154.98 57.88 0.66 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.671 0.272 . . . . 0.0 110.766 -178.505 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -99.3 39.69 1.27 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.641 -178.705 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.3 mt -61.83 -49.83 82.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.692 -179.494 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.8 t0 52.23 -99.05 0.08 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.61 85.77 5.2 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.326 -179.544 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.25 149.5 40.58 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.754 2.303 . . . . 0.0 111.226 179.669 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.1 m-20 -79.03 172.93 13.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.543 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.4 mp -60.01 -24.84 64.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.66 -178.414 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.34 97.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.499 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.0 mt-10 -74.11 -30.66 62.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.083 179.665 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.868 HG22 HD22 ' A' ' 104' ' ' LEU . 59.9 t -75.47 -47.64 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.831 -178.641 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.83 88.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.064 179.379 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -75.73 -31.08 59.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.476 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.98 132.97 53.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.949 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -140.2 152.52 46.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 -179.283 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.755 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.3 pt? -138.01 171.91 13.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.231 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -97.93 114.8 27.0 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.359 179.001 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 76' ' ' LYS . 1.1 mptm? -46.62 -16.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 110.258 -179.992 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 75' ' ' ASP . 54.6 mtmt -66.99 -10.06 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -92.78 6.62 46.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.247 -178.922 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.04 125.2 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.657 179.544 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.37 -10.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.385 -178.136 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.07 -173.07 44.03 Favored Glycine 0 C--N 1.316 -0.577 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.705 HH22 ' NZ ' ' A' ' 209' ' ' LYS . 38.1 mtm-85 -144.82 156.9 44.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 111.567 -179.046 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.8 tt -128.56 130.69 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 122.034 0.921 . . . . 0.0 109.225 179.751 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.2 t -132.42 133.8 44.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.543 -178.867 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.54 HG21 HD21 ' A' ' 141' ' ' LEU . 23.9 mt -134.8 126.45 17.91 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.872 -178.543 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -82.46 -35.82 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.48 2.12 . . . . 0.0 112.421 -179.16 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.461 ' CB ' HD23 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -50.52 -39.62 49.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -177.129 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.9 -1.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.237 0.215 . . . . 0.0 111.132 -178.842 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 t 61.51 49.73 4.99 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.659 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.81 131.09 55.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.792 -178.544 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 92' ' ' LEU . 44.8 tt0 -137.74 120.26 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.802 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.2 tp -153.01 112.66 2.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 113.334 -177.413 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -40.71 160.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.849 1.699 . . . . 0.0 110.205 175.83 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.81 122.75 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.065 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -105.68 120.88 42.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.255 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.7 -46.94 80.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.004 0.431 . . . . 0.0 111.104 -179.745 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.6 p -65.94 100.21 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.376 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p -81.09 94.64 6.65 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.218 0.532 . . . . 0.0 109.871 179.957 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.3 p -136.66 160.44 38.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.312 -179.272 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -55.32 -42.71 74.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.047 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.88 -46.27 72.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.294 -179.453 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 102' ' ' ASN . 10.5 m120 -65.76 -38.39 88.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.2 -179.427 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.2 mt -64.88 -27.88 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.631 -179.042 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.868 HD22 HG22 ' A' ' 69' ' ' VAL . 50.9 mt -72.98 -17.18 61.49 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.606 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -105.33 -10.51 16.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.755 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.87 -165.49 34.54 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.568 -179.23 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.61 124.21 33.84 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.22 144.14 32.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.167 -179.356 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.5 p -74.24 152.25 39.76 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.84 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.89 -43.35 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.767 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -91.11 -173.17 3.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.823 0.344 . . . . 0.0 111.25 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -111.32 -58.81 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.14 -177.831 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -91.33 43.61 1.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.461 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -98.5 154.34 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 179.621 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.42 132.95 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.1 mtt -61.48 130.35 45.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.841 178.635 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.33 82.81 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -141.23 120.22 12.79 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.012 -178.76 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.29 -170.72 52.01 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.858 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -83.12 107.93 16.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.269 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -84.39 101.5 12.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.154 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.61 119.52 30.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.43 0.634 . . . . 0.0 111.643 -179.215 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 mt -115.94 130.0 56.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.242 178.411 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.93 138.28 50.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.643 0.735 . . . . 0.0 110.984 -178.566 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.09 -179.8 18.69 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.769 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -80.26 146.14 31.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.812 0.339 . . . . 0.0 110.204 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 129' ' ' SER . 41.6 p30 -112.59 27.53 9.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.07 0.462 . . . . 0.0 110.998 -179.183 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.0 mtt -43.42 -15.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.457 -179.339 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 58.42 39.34 25.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.256 179.127 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -135.57 113.83 11.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -52.73 125.92 18.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.669 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -30.28 6.91 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.195 -178.468 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.702 HG12 ' N ' ' A' ' 134' ' ' LEU . 85.7 t -77.98 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.264 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.702 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -72.94 138.85 46.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.516 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 45.26 30.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 178.303 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -83.85 -14.2 51.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.543 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -133.71 18.34 3.89 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.769 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.487 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.9 pt -70.28 -20.89 23.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.869 0.366 . . . . 0.0 111.934 -179.668 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.78 3.42 11.89 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 t -98.76 -13.59 20.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.29 0.567 . . . . 0.0 109.987 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 85' ' ' ILE . 16.4 mt -64.62 124.8 22.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.302 179.814 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 143' ' ' LYS . 65.7 tttt -96.5 172.0 8.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.507 -179.814 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 77.7 tttt -66.62 128.4 36.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.43 22.02 30.41 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.138 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 49.1 m-20 -86.59 130.8 34.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.242 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -77.7 132.58 38.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.257 0.551 . . . . 0.0 111.641 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.6 mt -127.85 125.97 65.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.1 179.458 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -102.8 122.84 45.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.177 0.513 . . . . 0.0 110.621 -178.589 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.42 136.56 52.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.699 -179.391 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.581 ' CB ' HH11 ' A' ' 82' ' ' ARG . 93.8 m-85 -111.37 119.7 39.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.396 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.7 t0 -104.8 -165.42 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.836 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.508 ' C ' ' O ' ' A' ' 151' ' ' ASP . 91.2 m-20 -24.01 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.498 0.499 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.6 30.25 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.696 178.716 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -128.13 146.77 50.6 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.984 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.96 123.49 49.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.854 179.118 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 206' ' ' THR . 64.6 m-85 -107.46 131.38 54.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.382 0.61 . . . . 0.0 111.3 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.3 mt-10 -97.34 118.29 33.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.828 177.909 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -115.96 140.65 49.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.82 -178.659 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.2 129.31 54.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.563 0.697 . . . . 0.0 111.155 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.21 135.81 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.82 -179.58 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.7 OUTLIER -105.61 -25.13 12.39 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.48 1.112 . . . . 0.0 111.084 -179.094 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.63 165.21 22.58 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.413 -179.539 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.8 p -125.88 151.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.671 -0.765 . . . . 0.0 109.669 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.6 p -155.6 164.38 38.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.458 . . . . 0.0 111.228 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.457 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 96.2 mt-10 -112.26 113.93 26.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.491 -179.735 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.99 157.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.457 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 p -65.77 168.63 8.22 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.052 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.27 -7.0 12.0 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.193 1.929 . . . . 0.0 112.105 -179.351 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.9 p-10 -82.95 -12.43 57.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.028 -178.762 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -89.44 69.85 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.784 0.434 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.77 -5.88 43.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.683 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.546 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.9 mt-10 -53.48 -40.04 65.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.351 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.734 ' O ' HG21 ' A' ' 183' ' ' THR . 74.4 t -72.71 1.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.812 -179.679 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.36 28.92 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.925 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.78 129.42 19.19 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.729 0.776 . . . . 0.0 111.854 -177.021 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -29.22 123.07 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.894 179.442 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.546 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.2 m80 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.626 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.24 24.3 0.32 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.058 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -156.72 178.74 10.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.132 0.491 . . . . 0.0 111.377 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -89.68 89.2 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.521 0.677 . . . . 0.0 110.093 178.949 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 202' ' ' ASP . 23.5 tp10 -121.08 163.3 18.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.308 -179.197 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.6 tt -130.68 142.12 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.644 179.487 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.734 HG21 ' O ' ' A' ' 173' ' ' VAL . 15.7 m -136.36 126.17 25.69 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.383 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -112.36 120.32 41.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.562 0.696 . . . . 0.0 110.814 179.77 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 198' ' ' VAL . 42.1 pt -139.83 -176.66 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.81 -178.9 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.3 p -139.88 166.69 23.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.342 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 52.0 t 48.73 90.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.597 178.871 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.68 -45.68 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.921 -179.45 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 t -58.64 168.82 1.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.882 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 74.2 t -107.17 120.79 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.696 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.43 144.61 38.14 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 -178.619 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -88.44 87.12 7.18 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.207 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 194' ' ' SER . 54.9 t-20 -155.95 101.51 2.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.444 -178.821 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 193' ' ' ASN . 13.9 p 52.22 178.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.337 179.43 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.95 136.23 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.342 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.439 HH11 HG22 ' A' ' 198' ' ' VAL . 9.2 tmm_? -87.74 142.78 27.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.953 -179.572 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.457 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.9 m-85 -80.03 135.72 36.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.976 179.571 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.567 HG11 HG11 ' A' ' 173' ' ' VAL . 75.8 t -129.67 130.98 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.087 0.47 . . . . 0.0 110.821 -179.588 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -119.53 130.56 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.748 -179.423 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.548 ' O ' HG22 ' A' ' 161' ' ' THR . . . -120.36 138.89 53.48 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.621 -179.87 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.82 152.0 19.98 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.215 -179.387 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 181' ' ' GLU . 16.2 m-20 -109.49 139.1 44.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.553 -0.823 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 157' ' ' GLU . 48.0 tp -63.69 125.38 24.1 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.027 0.442 . . . . 0.0 110.928 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -107.41 -25.02 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.152 -178.937 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.33 176.32 45.31 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.953 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.447 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.2 m -153.92 153.13 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.432 0.634 . . . . 0.0 111.038 179.842 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -147.23 177.34 9.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.382 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.35 146.61 24.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.043 0.449 . . . . 0.0 110.679 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.705 ' NZ ' HH22 ' A' ' 82' ' ' ARG . 63.8 tttp -72.12 78.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.586 -179.234 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.747 178.424 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.6 p -75.1 161.28 29.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.711 0.291 . . . . 0.0 110.342 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -74.02 143.56 45.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.035 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.5 mtp -115.07 146.47 41.26 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.803 0.335 . . . . 0.0 110.641 -179.188 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 55.7 t0 -94.13 18.26 11.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.321 0.581 . . . . 0.0 110.89 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.62 -19.1 62.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.075 -179.127 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 1.8 t -150.01 -94.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.704 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' N ' ' OG ' ' A' ' 59' ' ' SER . 29.4 ttpt 47.57 27.27 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.097 178.234 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.53 -44.37 96.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.827 -178.965 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.2 t0 71.72 -126.56 0.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.852 179.896 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -140.62 70.7 31.29 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -42.68 129.57 5.21 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.507 2.138 . . . . 0.0 111.027 -179.538 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.79 171.9 11.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -48.92 -31.22 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.654 -179.141 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.52 -38.82 90.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 -179.973 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -73.97 -27.21 60.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.663 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -82.15 -46.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.243 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.54 74.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.767 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 25.9 p-10 -69.57 -28.56 66.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -179.218 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.87 138.3 58.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.986 -179.734 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -140.22 133.57 29.87 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 tp -140.9 135.1 30.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.655 -179.037 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 67.8 t0 -67.52 137.66 55.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.092 179.136 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.512 ' O ' HG22 ' A' ' 79' ' ' VAL . 70.3 mmtt -65.01 -7.89 13.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.159 0.504 . . . . 0.0 110.22 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -79.96 -10.11 59.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.956 -179.763 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -78.34 -3.21 41.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.639 -179.268 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 76' ' ' LYS . 6.2 m -85.15 138.6 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 -179.627 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -122.74 -4.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.329 -179.183 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.11 -174.04 39.26 Favored Glycine 0 C--N 1.318 -0.469 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -147.19 151.91 37.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.524 -179.027 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 83' ' ' ILE . 20.6 tt -124.31 120.67 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -118.86 128.09 54.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.665 -179.629 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.584 HG21 HD21 ' A' ' 141' ' ' LEU . 22.5 mt -134.62 122.12 15.46 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.579 -177.965 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.56 -34.17 0.57 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.404 2.069 . . . . 0.0 112.423 -179.492 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.553 ' OG ' HD23 ' A' ' 141' ' ' LEU . 2.0 t -49.81 -39.32 38.09 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.539 -177.496 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.77 -1.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.458 0.17 . . . . 0.0 111.072 -179.219 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 63.64 49.99 2.86 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.214 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.6 tp -115.71 132.3 56.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.315 -178.661 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.714 ' O ' HD22 ' A' ' 92' ' ' LEU . 82.9 tt0 -139.33 118.0 12.28 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.586 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -148.35 116.72 4.02 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.878 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.528 ' HD2' HD13 ' A' ' 92' ' ' LEU . 2.2 Cg_endo -39.88 161.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.894 1.729 . . . . 0.0 110.307 175.227 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.92 126.98 72.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' CB ' HD22 ' A' ' 102' ' ' ASN . 22.2 mt -102.32 127.63 49.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.982 -179.192 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -71.38 -48.69 48.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.618 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -69.5 107.44 3.37 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.348 -179.225 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -81.93 99.54 9.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.192 0.52 . . . . 0.0 110.115 179.938 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.513 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.9 p -139.74 164.35 30.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 -179.264 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.96 -36.59 84.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -71.74 -47.54 53.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.567 -179.57 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.1 p-10 -65.97 -36.99 84.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.412 -178.766 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.402 ' O ' HD12 ' A' ' 134' ' ' LEU . 18.7 mt -53.16 -24.37 10.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.431 -179.112 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.428 ' O ' HD11 ' A' ' 134' ' ' LEU . 50.0 mt -68.92 -29.37 67.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.319 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.2 t -85.33 -14.31 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.365 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.56 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 162.8 -172.03 38.75 Favored Glycine 0 N--CA 1.465 0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.679 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -71.94 127.94 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.921 -179.806 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -104.78 148.68 26.35 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.51 -179.726 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.45 ' O ' ' OG ' ' A' ' 98' ' ' SER . 44.7 p -75.57 154.23 36.9 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.65 -52.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -91.81 138.5 31.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 -178.93 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -72.84 1.41 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.023 -178.69 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -142.96 36.37 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 0.0 111.047 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.29 159.13 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.03 130.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.532 -179.672 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.7 mtt -73.15 127.86 33.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.935 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.48 67.95 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.715 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -138.73 123.95 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.089 -179.133 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.89 -173.39 44.93 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -83.51 109.72 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.122 179.84 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -83.96 101.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.02 129.14 37.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.336 0.589 . . . . 0.0 112.062 -178.935 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -123.57 132.28 53.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.472 178.544 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.73 138.41 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.324 0.583 . . . . 0.0 110.601 -178.973 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.0 -178.54 17.43 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.439 -179.328 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.414 ' HD2' HD12 ' A' ' 134' ' ' LEU . 58.2 m-70 -89.64 145.55 25.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.836 0.351 . . . . 0.0 110.624 -179.691 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 129' ' ' SER . 60.5 t-20 -110.08 28.35 8.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 110.411 -179.754 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -46.19 -12.26 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.789 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 m 56.67 40.38 29.28 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.997 179.069 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -130.74 108.73 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.194 -179.146 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -51.61 124.81 13.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.03 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.31 -29.35 8.39 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.137 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 134' ' ' LEU . 59.6 t -77.05 179.13 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 117.69 0.745 . . . . 0.0 109.044 179.45 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.754 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -70.32 136.61 49.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.089 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.0 m-30 42.55 32.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.165 0.507 . . . . 0.0 111.009 178.339 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 p -82.07 -10.7 59.12 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.36 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.23 26.86 1.62 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.537 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.92 -20.52 20.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.779 0.323 . . . . 0.0 111.838 179.917 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.84 -1.28 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.815 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t -94.09 -13.17 27.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 109.923 -179.625 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.584 HD21 HG21 ' A' ' 85' ' ' ILE . 20.3 mt -64.37 123.32 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.432 -179.75 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.494 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.3 mttt -96.54 173.13 7.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.734 -179.774 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -70.1 136.36 50.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.661 -179.669 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.82 22.07 56.34 Favored Glycine 0 N--CA 1.463 0.449 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.708 179.663 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.494 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.8 m-20 -88.96 130.16 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.37 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -77.48 134.04 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 158' ' ' TYR . 77.3 mt -128.87 121.55 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.272 179.296 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -102.21 122.03 43.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.099 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.0 tp -118.97 143.83 46.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 -178.993 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.97 133.03 56.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.318 0.58 . . . . 0.0 111.498 -178.946 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.52 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.0 t0 -113.98 -166.42 1.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.282 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 151' ' ' ASP . 92.9 m-20 -22.99 -74.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.064 0.459 . . . . 0.0 111.632 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -138.09 24.45 2.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.64 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -123.37 143.91 49.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.863 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -109.71 121.04 44.32 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.688 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' A' ' 206' ' ' THR . 77.6 m-85 -105.48 131.1 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.521 -178.763 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 204' ' ' VAL . 97.4 mt-10 -94.7 118.04 31.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.399 178.53 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 147' ' ' ILE . 53.0 m-85 -117.88 139.97 50.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 -179.424 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.17 135.58 54.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.089 0.471 . . . . 0.0 110.563 178.725 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.66 133.91 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.096 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -108.92 -24.81 11.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 124.464 1.102 . . . . 0.0 111.184 -179.185 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.13 157.19 11.99 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.495 -179.648 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.43 HG23 HG22 ' A' ' 199' ' ' VAL . 12.1 p -123.39 151.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.548 -179.797 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -161.25 171.76 17.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 111.297 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -115.81 110.92 19.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.757 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.14 145.43 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.019 -178.6 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.6 p -60.18 132.85 90.24 Favored Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.569 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.4 Cg_endo -47.28 -17.88 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.873 1.715 . . . . 0.0 111.826 -179.035 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.1 -17.78 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.193 -178.494 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.434 ' O ' HG22 ' A' ' 173' ' ' VAL . 30.0 ttmt -87.29 72.24 9.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.847 0.459 . . . . 0.0 110.946 179.817 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.569 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 47.1 m95 -73.53 -18.52 61.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.004 -179.176 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.7 mt-10 -50.27 -7.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.062 0.458 . . . . 0.0 111.009 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 171' ' ' TRP . 27.9 m -83.79 -21.84 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.671 -178.565 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.587 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -114.44 -1.27 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.618 0.723 . . . . 0.0 109.955 -178.744 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.511 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.8 mt-10 -83.96 125.11 31.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.065 -178.442 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 41.6 p-10 -30.92 122.32 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.703 178.882 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.0 m80 -112.36 24.25 12.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.735 -179.186 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.42 76.46 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.898 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -149.44 166.46 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 0.0 111.237 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 29.7 p30 -96.08 87.78 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.561 0.696 . . . . 0.0 110.477 179.469 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.458 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 79.8 tt0 -127.24 128.31 45.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.33 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.94 147.3 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.238 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.52 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.2 m -138.15 122.37 18.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.179 -179.907 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.52 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -104.82 128.26 52.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.379 0.609 . . . . 0.0 110.987 -179.756 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.587 HD13 HG11 ' A' ' 174' ' ' VAL . 3.1 pt -139.1 175.54 7.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.811 -178.81 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.507 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.3 p -133.4 160.15 38.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.819 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.555 ' C ' HH12 ' A' ' 196' ' ' ARG . 1.7 p -66.79 150.54 48.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.014 179.738 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.563 HG13 ' N ' ' A' ' 189' ' ' SER . 14.7 p -58.64 -45.54 90.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.296 -179.49 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.563 ' N ' HG13 ' A' ' 188' ' ' VAL . 90.9 p 45.16 -168.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.424 179.177 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 65.6 t -126.66 127.2 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.432 ' NZ ' ' O ' ' A' ' 195' ' ' LYS . 59.5 pttt -161.89 160.7 28.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.462 -178.598 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.561 ' C ' ' H ' ' A' ' 194' ' ' SER . 96.9 m-20 -78.8 173.01 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.39 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 1.9 m120 67.56 -25.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.139 179.289 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.561 ' H ' ' C ' ' A' ' 192' ' ' ASP . 13.4 m 43.64 89.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.501 179.196 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.432 ' O ' ' NZ ' ' A' ' 191' ' ' LYS . 25.3 pttm -143.17 149.57 38.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.81 -178.938 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.555 HH12 ' C ' ' A' ' 187' ' ' CYS . 0.8 OUTLIER -133.63 140.82 47.32 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.317 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -126.06 132.65 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.505 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.49 137.86 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.159 0.504 . . . . 0.0 110.969 -179.428 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.43 HG22 HG23 ' A' ' 163' ' ' VAL . 73.2 t -120.01 131.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.356 -179.535 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.63 135.86 53.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.61 -179.551 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.02 135.18 8.09 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 121.596 0.553 . . . . 0.0 111.762 -179.476 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -90.88 139.46 30.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.293 -179.235 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 11.7 tp -67.21 127.5 32.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.192 0.52 . . . . 0.0 110.632 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 157' ' ' GLU . 4.6 m -109.01 -21.51 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.514 -178.674 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.96 175.89 46.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.031 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.423 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.6 m -155.02 153.43 30.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 110.811 179.503 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -149.39 177.98 9.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.176 179.04 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.18 142.14 30.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.859 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -58.27 80.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 208' ' ' ALA . 49.6 tttp . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.593 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -58.55 -41.95 86.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.835 0.35 . . . . 0.0 110.956 -179.544 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.572 ' H ' ' CD2' ' A' ' 55' ' ' HIS . 10.2 p80 -88.16 118.04 27.46 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.483 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtt -96.4 159.41 14.96 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.449 -179.69 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -63.54 140.84 58.91 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.31 -5.26 38.46 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.706 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 94.5 p -84.67 42.9 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.194 -178.046 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -82.55 26.7 0.55 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.107 -179.288 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mt -63.55 -45.77 96.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.126 -178.892 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 46.89 -97.39 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.3 178.827 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -150.74 85.56 5.19 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.653 -179.053 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.32 150.44 36.83 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.908 2.406 . . . . 0.0 110.864 179.442 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.28 167.67 21.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.82 -19.95 65.12 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.403 0.439 . . . . 0.0 111.108 -179.377 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.11 97.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.627 -179.569 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 93.2 mt-10 -72.12 -36.69 69.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.785 179.52 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.9 -45.43 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.873 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.38 86.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.19 -27.09 28.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.895 -179.037 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.13 136.77 58.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.331 179.594 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' NZ ' ' A' ' 101' ' ' LYS . 29.3 t -91.08 156.73 17.69 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 105' ' ' SER . 46.2 tp -120.29 125.51 48.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 -178.823 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -95.21 87.81 4.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 79' ' ' VAL . 1.2 mppt? -48.94 -33.07 10.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.029 -179.486 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -51.6 -14.78 0.36 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.243 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -100.77 14.34 31.96 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.853 -178.74 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 79' ' ' VAL . 5.4 p -89.8 126.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.299 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.8 pt -118.5 -6.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.319 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.04 -165.08 34.33 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.03 157.34 43.58 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.273 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 92' ' ' LEU . 5.9 tt -128.63 132.3 67.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.808 0.814 . . . . 0.0 109.249 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -132.75 133.42 43.44 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.609 -178.167 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 21.5 mt -134.73 126.73 18.14 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.808 -178.465 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.09 -34.71 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.54 2.16 . . . . 0.0 112.5 -179.694 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.3 t -49.27 -41.43 37.83 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.655 -177.487 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.4 p -119.91 -3.59 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 123.245 0.34 . . . . 0.0 111.094 -179.27 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 68.33 50.99 0.7 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.672 -179.585 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -109.27 125.02 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.789 -178.003 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.666 ' N ' HD13 ' A' ' 90' ' ' LEU . 80.1 tt0 -134.88 114.39 12.52 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.408 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.733 HD12 HD11 ' A' ' 90' ' ' LEU . 10.1 mt -148.59 117.39 4.01 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.736 -177.672 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.6 Cg_endo -41.25 151.59 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.971 1.781 . . . . 0.0 110.121 176.41 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.12 121.65 52.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.1 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.9 mt -104.53 128.5 52.49 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -72.55 -39.92 67.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.942 0.401 . . . . 0.0 111.389 -179.457 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.9 m -72.69 102.0 3.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.073 -179.375 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.8 p -82.34 93.34 7.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 109.913 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.0 p -132.01 158.25 42.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.186 -178.909 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.471 ' O ' HD21 ' A' ' 104' ' ' LEU . 10.0 tm-20 -60.62 -24.6 65.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.719 -179.261 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 65.3 tttm -83.87 -44.17 14.57 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.815 0.697 . . . . 0.0 112.158 -178.865 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HA ' HD21 ' A' ' 102' ' ' ASN . 10.6 m120 -67.26 -34.89 78.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.844 -179.706 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 108' ' ' ALA . 20.1 mt -68.31 -11.48 59.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.621 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.471 HD21 ' O ' ' A' ' 100' ' ' GLU . 17.2 mt -74.63 -14.26 60.74 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.991 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.455 ' HB3' HD13 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -125.7 -3.86 7.15 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.417 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.534 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . -175.63 172.95 45.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.385 -179.522 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.93 127.44 32.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.531 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.4 150.02 25.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.048 0.451 . . . . 0.0 110.803 -179.153 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 p -75.35 151.23 38.24 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 122' ' ' ALA . 1.3 p -87.17 -32.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.468 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 21.2 tptt -90.05 179.99 5.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.964 0.412 . . . . 0.0 110.837 -177.955 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 22.4 pt-20 -105.7 -16.5 14.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.058 -178.447 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -144.11 53.19 1.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -177.186 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -91.61 153.64 19.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.59 131.6 72.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.617 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.6 mtp -70.19 125.34 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.913 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.32 4.95 65.87 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.474 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -143.32 123.72 13.9 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.55 -178.339 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.59 51.84 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -178.838 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -83.29 108.19 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.91 102.68 13.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.477 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.469 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -91.53 126.11 36.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.062 0.458 . . . . 0.0 112.186 -179.4 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.82 130.41 53.96 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.468 178.85 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.39 140.02 46.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -178.035 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.94 -177.92 17.53 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.229 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -81.63 155.83 25.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 129' ' ' SER . 3.0 p-10 -123.9 28.05 7.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.029 0.442 . . . . 0.0 111.171 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.2 mtt -44.05 -15.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.107 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.19 38.08 13.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.843 178.889 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.52 120.53 19.8 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.601 -179.123 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.2 124.76 21.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.0 -30.75 6.4 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -177.87 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 134' ' ' LEU . 94.1 t -72.42 176.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.381 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.701 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -74.1 133.07 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.781 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 48.11 39.2 11.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.796 177.774 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 20.8 p -77.55 -68.03 0.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.287 -179.266 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.519 ' N ' ' OG ' ' A' ' 136' ' ' SER . 94.1 m-20 -88.3 41.88 1.03 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.1 pt -69.99 -26.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.293 -179.758 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.24 3.92 9.8 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.9 m -92.98 -15.1 26.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.328 -179.237 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 mt -66.4 121.28 14.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.526 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -95.84 153.14 17.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -53.67 121.91 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 -179.968 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 101.04 16.94 24.22 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.803 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 73.7 m-20 -85.09 135.89 33.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.13 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -82.33 131.4 35.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 0.0 111.796 -178.321 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.77 124.44 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.552 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -104.5 120.21 40.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.299 -178.554 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.92 158.47 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.956 -178.854 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.56 136.13 53.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 111.708 -178.878 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.4 t0 -112.81 -166.49 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.656 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.2 m-20 -34.73 -67.96 0.13 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.491 0.662 . . . . 0.0 111.042 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.03 29.65 2.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.074 179.643 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.82 147.72 52.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.822 0.82 . . . . 0.0 112.8 -175.495 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.74 123.45 50.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.814 178.958 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -104.44 133.43 49.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.582 -178.765 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -97.57 116.29 29.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.59 177.8 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -116.16 141.07 48.62 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 -178.962 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.63 131.64 54.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 178.879 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 61.3 t -65.67 134.23 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.968 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -30.61 11.21 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.201 1.563 . . . . 0.0 110.916 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.79 157.78 11.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.965 -178.693 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.3 150.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.526 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.9 p -156.51 164.46 38.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.783 -177.704 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.438 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 94.9 mt-10 -114.19 115.63 27.78 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.232 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 158.3 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.622 0.249 . . . . 0.0 111.154 -178.074 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 p -60.49 167.61 3.07 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.301 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.38 -6.97 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.079 1.853 . . . . 0.0 112.192 -179.815 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -85.39 -6.97 59.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.909 -178.088 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -86.49 68.97 10.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.459 ' C ' ' N ' ' A' ' 173' ' ' VAL . 78.4 m95 -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.985 -179.299 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 98.3 mt-10 -47.17 -16.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 O-C-N 123.432 0.457 . . . . 0.0 110.666 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.459 ' N ' ' C ' ' A' ' 171' ' ' TRP . 54.4 t -74.46 -24.93 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.685 -179.055 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.58 -8.61 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.715 0.769 . . . . 0.0 110.041 -177.998 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.9 mt-10 -80.4 157.79 26.18 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.58 -176.716 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.8 p-10 -66.22 128.59 36.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.339 179.834 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 34.4 m80 -108.07 -44.47 4.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.718 -179.561 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.22 24.54 0.1 OUTLIER Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 178.926 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -153.39 172.5 16.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.955 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 6.7 p30 -95.05 86.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 110.211 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -128.22 125.55 39.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.735 -179.077 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.2 tt -80.82 148.43 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.464 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.7 m -136.8 118.63 15.14 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.385 -178.231 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 184' ' ' LEU . 10.2 mp -100.32 127.26 46.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 111.185 -179.64 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 pt -139.95 -171.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -178.6 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 27.9 p -137.13 156.64 48.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.473 -178.77 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 13.7 t -93.41 80.93 4.38 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.65 -179.347 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.407 ' CG2' ' OD1' ' A' ' 127' ' ' ASN . 67.9 t -127.87 130.27 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.821 -178.881 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.9 t -160.33 85.3 0.72 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.399 -178.664 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 76.4 t -146.55 85.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.183 -178.891 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.9 tttm 45.27 -125.9 1.16 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.726 179.16 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -99.43 133.94 43.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.531 ' CG ' ' H ' ' A' ' 194' ' ' SER . 40.2 t-20 -154.82 -148.15 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.562 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.531 ' H ' ' CG ' ' A' ' 193' ' ' ASN . 90.4 p -72.74 158.01 36.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -71.86 131.98 43.77 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -75.85 136.28 40.17 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.198 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.438 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 3.8 m-85 -104.51 132.66 50.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.61 139.37 45.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.183 0.515 . . . . 0.0 110.997 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 80.9 t -125.2 135.81 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 -179.256 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.74 134.95 54.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.89 134.55 8.26 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -96.53 137.57 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.934 -179.082 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.41 HD23 ' OD2' ' A' ' 180' ' ' ASP . 40.3 tp -64.7 127.2 30.52 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.902 179.92 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.26 -23.81 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.684 -179.41 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.409 ' O ' HD11 ' A' ' 203' ' ' LEU . . . 177.01 178.26 46.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.511 -179.519 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 152.41 30.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.955 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -147.94 178.16 8.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.868 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.45 144.71 25.33 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.467 -179.438 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -73.02 79.75 1.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 -179.049 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.388 178.563 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.2 p -74.16 158.2 34.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.823 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.711 ' CG ' ' H ' ' A' ' 56' ' ' MET . 29.6 t-80 47.66 -170.7 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.712 179.427 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.711 ' H ' ' CG ' ' A' ' 55' ' ' HIS . 64.8 mtt -130.14 164.21 24.94 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.751 0.31 . . . . 0.0 110.286 -179.377 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 50.1 p-10 -61.47 146.75 47.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.654 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.85 -38.17 82.79 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.617 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.479 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 99.0 p -148.39 -95.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.179 -178.565 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' N ' ' OG ' ' A' ' 59' ' ' SER . 76.5 tttt 50.85 40.32 24.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.225 178.231 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 63' ' ' GLN . 42.2 mt -61.73 -48.21 89.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.825 -178.841 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 47.02 -94.3 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.274 178.835 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 2.3 pt20 -150.83 85.29 5.22 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.902 -179.106 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.36 153.81 40.37 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.817 2.344 . . . . 0.0 111.027 179.602 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -76.76 170.83 15.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.883 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.39 -15.35 63.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.826 0.346 . . . . 0.0 111.309 -179.199 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.566 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -64.03 -41.27 97.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.146 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.7 mm-40 -76.35 -19.65 58.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.518 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.01 -55.42 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.273 -178.613 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.77 94.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.566 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 51.7 m-20 -68.78 -32.74 72.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.605 -179.258 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.8 129.74 41.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.519 179.579 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -92.91 159.82 15.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.152 179.858 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.648 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -139.4 120.68 14.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.924 0.392 . . . . 0.0 111.105 -178.903 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.648 ' N ' HD13 ' A' ' 74' ' ' LEU . 97.5 m-20 -86.56 106.5 17.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.166 178.846 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -46.64 -16.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.289 0.566 . . . . 0.0 110.69 -179.781 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.481 ' N ' ' C ' ' A' ' 75' ' ' ASP . 63.7 mttp -65.4 -12.02 48.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -97.84 8.73 44.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.463 -178.872 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.8 t -91.27 125.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.763 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.2 pt -122.38 -3.55 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.328 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.33 -162.03 34.61 Favored Glycine 0 C--N 1.321 -0.288 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.627 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.576 HH12 ' HZ1' ' A' ' 209' ' ' LYS . 10.8 ptp85 -157.53 164.76 37.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.943 -179.724 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 92' ' ' LEU . 8.6 tt -133.08 144.51 36.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.223 179.738 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 t -134.18 135.2 42.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.82 -178.828 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 mt -129.47 76.33 78.84 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.571 -177.404 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.26 -42.05 3.48 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.996 2.464 . . . . 0.0 112.565 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -55.18 -42.68 73.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.719 -177.436 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 88' ' ' VAL . 67.8 t -107.97 5.26 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.753 0.311 . . . . 0.0 110.799 -179.075 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 t 56.1 46.23 22.0 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.139 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -109.96 124.56 51.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.874 -178.273 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.636 ' O ' HD12 ' A' ' 92' ' ' LEU . 83.1 tt0 -128.04 113.09 15.36 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.934 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -145.09 111.01 4.72 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.7 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.7 Cg_endo -41.71 157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.888 1.725 . . . . 0.0 109.767 175.697 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.09 117.0 51.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.996 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.1 mt -100.47 120.83 40.58 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.843 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -66.65 -48.26 69.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 111.171 -179.709 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.9 p -60.13 100.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 179.874 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.449 ' O ' ' OG ' ' A' ' 98' ' ' SER . 18.6 p -82.73 97.17 8.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.349 0.595 . . . . 0.0 110.32 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 p -140.01 158.22 44.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.094 -179.275 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.2 -33.26 70.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.469 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.03 -44.47 47.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.105 -179.495 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.429 ' HA ' HD21 ' A' ' 102' ' ' ASN . 9.5 m120 -65.08 -38.6 91.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.711 -178.903 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.6 mt -57.18 -22.32 39.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.492 -179.385 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.34 -32.88 72.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.655 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.516 ' OG ' HD23 ' A' ' 74' ' ' LEU . 10.4 m -91.33 -9.65 44.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.924 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.86 -176.87 45.6 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.401 -179.401 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.38 124.4 27.47 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.056 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.75 150.48 25.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.061 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.7 p -68.65 148.37 50.54 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.839 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.512 HG21 HD11 ' A' ' 185' ' ' ILE . 84.5 t -88.72 -33.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -177.097 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 170.24 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.388 . . . . 0.0 110.946 -178.851 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.17 -47.12 81.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.193 -178.026 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 113' ' ' ASN . 50.4 p30 -158.0 69.76 0.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.154 -178.336 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 121' ' ' TYR . 4.4 pt20 -76.38 175.06 9.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.246 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -132.47 125.13 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.856 0.36 . . . . 0.0 110.649 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.488 ' SD ' ' OH ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.8 127.44 32.64 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.403 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.85 -5.59 59.85 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -140.37 123.18 16.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.15 -170.24 50.17 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.074 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 27.7 t-20 -83.71 107.74 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.921 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 114' ' ' GLN . 5.8 t80 -84.42 102.67 12.95 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.567 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.45 122.26 33.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.203 0.525 . . . . 0.0 111.827 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -117.67 131.11 56.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.902 178.656 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.83 139.14 46.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.262 0.553 . . . . 0.0 110.768 -178.211 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.47 -178.34 16.5 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.486 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.9 m-70 -93.74 138.59 31.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.574 -179.424 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -98.59 28.78 4.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 110.658 -179.481 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.454 ' HB2' HG11 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -40.67 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.199 -179.335 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 m 59.21 36.87 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.456 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.56 ' HB3' ' HZ3' ' A' ' 130' ' ' LYS . 10.4 mtpm? -131.94 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.471 -178.898 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -48.95 124.09 8.12 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.56 -31.01 7.14 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.314 -177.915 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 134' ' ' LEU . 61.0 t -74.67 179.35 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.761 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -71.51 136.78 47.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.958 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.6 m-30 43.63 35.1 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.816 178.069 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 p -82.92 -14.15 54.7 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.45 ' O ' HG21 ' A' ' 88' ' ' VAL . 65.7 m-20 -141.17 26.48 2.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.409 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.499 HD13 ' CD2' ' A' ' 135' ' ' PHE . 7.2 pt -75.67 -18.08 15.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.479 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.4 18.19 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.644 -179.598 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 t -92.26 -14.05 29.48 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.357 0.598 . . . . 0.0 110.037 -179.319 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.415 ' CD2' ' OD2' ' A' ' 145' ' ' ASP . 23.8 mt -63.77 128.55 36.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.359 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -101.85 174.54 5.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.876 -179.83 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.89 124.29 23.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.6 16.0 47.67 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.603 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.415 ' OD2' ' CD2' ' A' ' 141' ' ' LEU . 10.4 t70 -78.83 136.42 37.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.035 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.8 132.55 35.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.979 0.419 . . . . 0.0 111.626 -178.163 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 93.7 mt -129.01 127.5 66.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.686 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -104.26 120.68 41.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.027 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.63 145.31 45.54 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.975 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -119.34 135.12 54.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -178.089 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.8 t0 -110.66 -164.22 0.9 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.542 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 3.5 p-10 -26.37 -77.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.354 0.409 . . . . 0.0 111.29 179.202 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.542 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 78.6 mm-40 -134.02 30.0 3.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.096 178.949 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.479 ' OD1' ' ND2' ' A' ' 152' ' ' ASN . 33.8 m120 -128.85 148.2 50.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.956 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -109.21 123.32 49.05 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.068 179.819 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.4 ' CZ ' HG21 ' A' ' 206' ' ' THR . 48.6 m-85 -106.3 129.72 54.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.655 -178.847 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -94.75 113.59 25.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.338 178.935 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -113.48 143.36 44.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.454 -178.901 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.01 132.23 54.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.262 0.553 . . . . 0.0 110.707 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.6 135.71 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.52 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.1 p -100.24 -27.27 13.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 124.593 1.183 . . . . 0.0 111.013 -178.497 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.0 156.45 8.15 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.426 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.34 139.6 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.389 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 198' ' ' VAL . 73.9 m -136.82 151.27 48.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.786 0.326 . . . . 0.0 111.091 -178.083 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 54.9 mp0 -111.07 102.52 10.97 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.4 m -134.09 156.59 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -178.212 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.2 p -63.02 168.8 4.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.211 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.41 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -82.31 -4.04 11.64 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.179 1.919 . . . . 0.0 112.119 -179.596 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.02 -19.38 44.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.806 -178.569 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -85.96 74.37 10.15 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.817 0.447 . . . . 0.0 110.307 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.41 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 96.6 m95 -74.68 -6.16 47.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.023 -179.279 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.579 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 9.8 pt-20 -52.47 -43.63 65.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.984 0.421 . . . . 0.0 110.919 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.77 ' O ' HG21 ' A' ' 183' ' ' THR . 16.8 m -71.33 4.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.976 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.81 -14.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.779 0.799 . . . . 0.0 110.215 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.7 mt-10 -87.32 172.6 9.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.018 -178.869 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -74.29 125.72 29.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.579 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 48.3 m80 -110.82 22.49 15.3 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.641 -179.37 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.78 20.98 79.27 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.356 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -151.17 168.08 25.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.137 -179.477 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -94.39 87.57 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.174 0.511 . . . . 0.0 110.236 -179.841 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -123.91 124.94 43.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.626 -178.98 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.4 tt -81.51 146.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.455 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.77 HG21 ' O ' ' A' ' 173' ' ' VAL . 14.5 m -137.28 121.74 18.32 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.395 -179.123 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -105.95 123.45 48.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 111.024 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 110' ' ' VAL . 12.6 pt -139.01 169.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.992 -178.531 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.5 p -135.45 158.65 43.83 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.631 -179.21 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.6 m -84.28 131.53 34.72 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.55 153.23 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.746 0.307 . . . . 0.0 110.973 -178.511 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 89.8 p -77.61 -130.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.976 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.8 -120.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.528 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -108.32 18.37 21.12 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.775 0.321 . . . . 0.0 111.504 -179.603 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.36 -41.85 94.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.332 -179.134 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -95.71 31.6 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.261 -179.5 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.27 -166.35 0.21 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.426 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -68.87 139.75 55.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.379 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.47 ' NH1' ' CG2' ' A' ' 185' ' ' ILE . 7.9 tmm_? -69.9 142.09 53.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.452 -179.847 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.2 133.0 43.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 164' ' ' SER . 3.7 p -138.15 141.26 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.335 0.588 . . . . 0.0 111.332 -179.398 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.7 t -121.16 131.85 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.185 -179.261 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -117.22 136.46 53.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.485 -179.838 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.25 140.69 11.99 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.445 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 53.5 p-10 -97.52 144.95 26.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.566 -0.817 . . . . 0.0 111.473 -178.972 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.12 126.49 29.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.062 0.458 . . . . 0.0 111.166 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.7 -25.35 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.413 -178.755 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.87 177.43 44.89 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.74 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.4 HG21 ' CZ ' ' A' ' 156' ' ' TYR . 17.7 m -152.89 152.67 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.274 0.559 . . . . 0.0 111.108 -179.78 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -149.36 178.79 8.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.345 179.594 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.78 146.03 24.09 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.403 -179.773 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.576 ' HZ1' HH12 ' A' ' 82' ' ' ARG . 88.4 tttt -77.04 79.02 3.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.748 -179.1 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.562 178.057 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.1 p -63.33 -27.73 69.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.956 0.408 . . . . 0.0 110.474 179.865 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -78.12 127.57 32.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.135 -179.94 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.4 mtt -138.18 154.21 49.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 111.185 -179.052 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -47.14 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.073 179.747 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.48 -61.92 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.46 -178.742 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.0 m -94.44 -101.48 0.15 Allowed 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 120.928 0.394 . . . . 0.0 110.008 -179.404 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 44.24 25.81 0.13 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.285 178.877 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -65.25 -46.35 90.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.692 -179.141 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 56.24 -98.87 0.09 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -151.15 77.8 7.41 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.419 -179.641 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -43.32 140.84 3.57 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.145 1.897 . . . . 0.0 111.71 -179.553 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -69.18 152.07 45.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.679 179.636 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.1 mm? -56.61 -27.18 57.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.64 -179.099 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.87 91.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.898 0.38 . . . . 0.0 110.411 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mm-40 -74.38 -35.1 63.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.33 -44.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.41 88.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.766 179.661 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.25 -27.55 42.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.24 140.78 55.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.374 -179.505 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -139.45 147.09 40.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.756 -179.463 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.748 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.4 pt? -137.17 173.8 11.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 -179.515 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.12 128.5 45.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 178.489 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.572 ' O ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -67.91 -10.17 51.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.346 179.996 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 79' ' ' VAL . 1.3 mppt? -63.54 -30.62 71.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.172 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.19 13.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.826 -178.964 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.3 p -85.86 123.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.597 179.672 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.99 -5.48 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.86 -178.197 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.24 -160.26 27.04 Favored Glycine 0 C--N 1.318 -0.432 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 9.3 ttm180 -151.38 157.32 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.129 0.49 . . . . 0.0 110.924 -179.812 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.43 ' N ' ' HG3' ' A' ' 82' ' ' ARG . 3.3 tp -125.9 127.21 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.191 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -129.03 130.15 46.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.77 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 44.9 mt -136.68 123.2 13.78 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.817 -178.731 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.8 Cg_endo -82.33 -30.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.462 2.108 . . . . 0.0 112.473 -179.867 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -48.39 -39.99 24.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.052 -176.475 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.582 HG11 HD12 ' A' ' 90' ' ' LEU . 3.3 p -120.53 -4.17 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.578 0.228 . . . . 0.0 111.12 -179.13 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.09 50.72 0.11 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.021 0.439 . . . . 0.0 109.967 179.895 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.582 HD12 HG11 ' A' ' 88' ' ' VAL . 18.6 mt -111.37 127.42 55.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 179.762 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.49 113.14 11.51 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.947 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 mt -146.09 166.48 16.92 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.395 -177.719 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.82 150.61 8.54 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 109.516 178.105 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.73 108.22 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.84 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HB2' HD21 ' A' ' 102' ' ' ASN . 12.9 mt -101.93 121.61 42.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.03 -48.95 72.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.985 0.421 . . . . 0.0 111.176 -179.653 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.41 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 48.4 m -56.68 98.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.777 -179.411 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 85.3 p -80.6 100.56 8.69 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.393 0.616 . . . . 0.0 110.626 179.675 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -135.42 157.73 46.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.352 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -54.97 -39.17 68.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.923 179.524 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.93 -39.08 72.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.091 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 108' ' ' ALA . 6.8 t-20 -62.77 -39.55 94.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 -179.406 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.97 -27.45 63.47 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.288 -178.688 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.68 -14.54 62.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.37 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.494 ' OG ' HD13 ' A' ' 74' ' ' LEU . 5.9 m -104.98 -13.96 15.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.768 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.83 -149.98 14.91 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.013 -178.326 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.34 125.2 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -105.84 144.34 32.71 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.719 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 p -76.84 153.32 34.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 185' ' ' ILE . 74.6 t -85.81 -45.03 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.171 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -88.47 -170.97 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.222 -178.402 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -124.67 -5.28 7.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.826 -177.739 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.42 41.8 1.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.078 0.466 . . . . 0.0 110.675 -177.931 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -95.29 161.94 13.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.388 179.679 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.66 132.83 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.543 ' SD ' HD12 ' A' ' 149' ' ' LEU . 67.8 mtt -69.62 129.81 40.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.51 179.13 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.97 75.96 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -146.46 128.17 15.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.579 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.6 -169.7 47.23 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -85.52 103.48 14.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.506 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.94 101.3 11.6 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.8 124.31 35.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 0.0 112.042 -178.846 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -120.13 130.14 54.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.693 178.224 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.47 139.97 43.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 110.256 -178.996 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.24 -178.22 18.88 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.939 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -83.62 152.26 24.9 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.112 0.482 . . . . 0.0 110.767 -179.85 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 129' ' ' SER . 48.6 p30 -122.09 28.23 7.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.29 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.6 mtt -44.78 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.944 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 61.24 36.33 17.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.535 ' H ' ' HG ' ' A' ' 136' ' ' SER . 68.1 mttm -135.64 114.75 12.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.944 -179.213 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -56.21 126.65 27.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.687 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -30.64 6.67 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 -178.136 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.737 HG12 ' N ' ' A' ' 134' ' ' LEU . 97.0 t -72.36 175.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.737 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.45 128.77 36.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.392 -178.409 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 48.45 42.61 18.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 178.202 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.535 ' HG ' ' H ' ' A' ' 130' ' ' LYS . 2.4 t -75.23 -67.26 0.67 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.36 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -90.27 43.98 1.18 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.183 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.8 pt -68.1 -26.74 35.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.675 179.525 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.16 7.47 4.16 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.246 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -96.25 -14.47 22.64 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.46 122.24 15.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.136 -179.357 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 26.6 mtpp -96.3 157.14 16.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.758 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.43 122.13 13.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.622 -179.627 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.63 18.45 23.18 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.1 m-20 -83.79 134.98 34.7 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.923 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -81.78 126.09 31.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.178 -177.335 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.89 126.78 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.295 178.668 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -101.94 118.1 36.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.271 -179.101 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.58 HD21 ' CD1' ' A' ' 182' ' ' ILE . 0.7 OUTLIER -106.24 135.92 46.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.973 179.907 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.509 ' O ' ' SD ' ' A' ' 116' ' ' MET . 56.3 m-85 -114.69 127.79 55.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.325 0.583 . . . . 0.0 111.324 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 152' ' ' ASN . 42.8 t0 -113.82 -166.6 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.348 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.1 m-20 -23.04 -75.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.062 0.458 . . . . 0.0 111.994 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -139.22 30.64 2.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.276 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -127.7 144.13 51.1 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.046 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -110.94 121.83 46.35 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.898 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -103.65 132.71 49.66 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.323 -178.874 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.79 115.08 27.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.166 178.785 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -114.77 146.67 40.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.574 -179.844 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.1 132.43 53.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.341 0.591 . . . . 0.0 111.022 178.073 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.425 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 62.0 t -67.11 133.41 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.631 179.56 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.82 -29.01 11.72 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 124.739 1.274 . . . . 0.0 110.395 -178.856 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.83 164.07 23.9 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.031 -179.355 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.92 147.45 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.911 -0.644 . . . . 0.0 109.765 -179.661 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.0 p -151.69 162.15 41.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.195 0.521 . . . . 0.0 111.289 -179.115 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -117.91 111.31 18.83 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.696 179.89 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.8 160.14 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.096 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -62.18 166.98 5.66 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.532 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.1 Cg_endo -82.21 -5.87 12.0 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.256 1.97 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -17.03 52.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.725 -178.78 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.568 ' O ' HG22 ' A' ' 173' ' ' VAL . 1.8 mptm? -87.37 73.57 9.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.508 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 70.1 m95 -73.52 -21.51 60.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.362 -179.847 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.545 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.3 mt-10 -51.06 -8.82 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.001 0.429 . . . . 0.0 110.825 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 170' ' ' LYS . 19.5 m -83.29 -21.86 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.747 -178.792 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.634 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -112.89 -0.71 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.591 0.71 . . . . 0.0 109.677 -179.051 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.533 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 97.0 mt-10 -83.55 139.65 32.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.19 -178.253 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -44.51 123.57 3.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.063 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.545 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 45.7 m80 -114.25 22.84 13.4 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.056 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.06 19.73 79.72 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.237 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -147.59 164.27 33.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.065 0.459 . . . . 0.0 111.28 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.15 89.08 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.852 179.512 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.487 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 79.3 tt0 -129.23 125.53 37.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.595 -179.118 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.58 ' CD1' HD21 ' A' ' 149' ' ' LEU . 17.7 tt -79.46 148.09 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.269 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.518 ' C ' HD12 ' A' ' 184' ' ' LEU . 10.2 m -135.95 125.44 25.1 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -106.94 127.42 53.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.499 179.866 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 110' ' ' VAL . 11.9 pt -136.79 176.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.622 -179.233 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.584 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.9 p -134.67 166.13 23.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.163 -179.178 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 15.1 p -53.7 -177.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.202 179.747 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.04 124.18 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.86 0.362 . . . . 0.0 110.679 -179.785 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 48.4 t -81.65 134.36 35.47 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.249 179.798 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 190' ' ' VAL . 8.8 p -105.41 2.43 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.019 0.438 . . . . 0.0 110.952 -179.277 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -72.17 100.75 2.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.347 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 68.0 t0 48.23 -107.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.993 179.202 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -85.08 114.16 22.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.168 179.295 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 27.3 m -59.23 134.16 56.75 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.686 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -152.17 147.16 26.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 -178.976 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.584 ' NH1' ' O ' ' A' ' 186' ' ' THR . 8.6 ptp180 -159.14 168.01 27.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.58 141.68 47.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.06 178.7 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.2 t -132.09 133.99 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.151 0.5 . . . . 0.0 110.99 -179.504 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.24 133.28 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.337 -179.415 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.487 ' HB1' ' OE2' ' A' ' 181' ' ' GLU . . . -116.51 135.89 53.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.707 -179.751 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.07 135.64 8.75 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -179.757 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -92.13 138.65 31.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.555 -179.24 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.26 127.11 30.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.112 0.482 . . . . 0.0 110.543 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 -23.01 4.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.341 -179.036 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 173.43 178.11 43.16 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.289 -178.513 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.6 m -151.95 152.29 32.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 111.285 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -148.74 177.53 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.549 179.655 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.06 146.6 24.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.344 0.592 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -76.02 79.8 2.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.693 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.317 -0.824 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.718 178.443 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.473 ' O ' ' ND1' ' A' ' 55' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 t 47.57 19.83 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.463 . . . . 0.0 110.731 179.49 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 53' ' ' GLY . 76.9 m80 -80.0 163.19 24.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.86 -179.672 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.5 mtm -72.68 146.87 46.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.272 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.38 137.47 57.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.87 -40.48 79.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.471 -178.871 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 61' ' ' ILE . 1.9 p 60.11 15.34 5.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.352 179.276 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -76.66 32.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.41 -179.381 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 59' ' ' SER . 43.9 mt -62.3 -47.78 91.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.19 0.519 . . . . 0.0 110.861 -178.905 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 47.66 -94.76 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.281 179.206 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -149.99 86.2 5.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.872 -179.177 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.86 151.55 40.38 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.578 2.185 . . . . 0.0 111.326 179.722 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 55.4 t0 -72.6 158.65 35.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.458 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 3.9 mm? -64.03 -20.53 65.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.766 -179.359 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.0 92.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.289 -179.727 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 72.3 mm-40 -73.8 -32.64 63.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.68 -45.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.854 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.91 90.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.026 179.839 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -79.03 -23.53 44.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.253 -179.392 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.82 105.1 0.51 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.868 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.6 m -96.58 80.74 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.463 ' CD1' HE22 ' A' ' 78' ' ' GLN . 44.7 tp -74.88 148.02 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.182 179.334 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 77' ' ' LYS . 42.4 t0 -81.31 91.13 6.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.48 ' O ' HG13 ' A' ' 79' ' ' VAL . 63.7 mttp -52.74 -9.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.132 0.491 . . . . 0.0 110.364 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 75' ' ' ASP . 17.5 tptm -79.65 -10.89 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.538 -179.803 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.582 ' OE1' ' ND2' ' A' ' 102' ' ' ASN . 4.2 pt20 -93.6 19.36 8.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.563 -178.785 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 76' ' ' LYS . 33.6 m -83.0 146.26 7.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.855 -179.433 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.68 -6.04 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.83 -165.54 32.94 Favored Glycine 0 C--N 1.317 -0.473 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.461 ' NH1' ' C ' ' A' ' 92' ' ' LEU . 8.5 ttm-85 -151.52 154.47 36.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.303 0.573 . . . . 0.0 111.326 -179.258 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 83' ' ' ILE . 18.0 tt -127.88 130.01 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.72 179.444 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -127.76 129.68 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.022 -179.155 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 37.3 mt -134.78 118.36 13.32 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -177.946 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 3.3 Cg_exo -81.25 -33.67 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.736 2.29 . . . . 0.0 112.388 179.869 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.4 t -49.54 -39.41 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.696 -177.052 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 90' ' ' LEU . 3.9 m -119.14 -6.23 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -178.777 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 75.28 49.9 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.305 0.574 . . . . 0.0 110.209 179.904 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.503 HD12 HG21 ' A' ' 88' ' ' VAL . 2.5 mt -111.0 125.45 53.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.251 -179.365 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -133.25 112.41 11.66 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.461 ' C ' ' NH1' ' A' ' 82' ' ' ARG . 76.6 mt -145.58 162.5 36.21 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.908 -177.03 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -88.06 152.05 6.99 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 123.118 2.545 . . . . 0.0 109.119 177.41 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.1 t -98.15 115.63 38.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.757 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 mt -101.66 122.96 44.86 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.066 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -67.23 -45.06 77.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.428 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . 3.4 m -69.62 99.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.453 -179.51 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.3 p -81.69 96.27 7.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.516 0.674 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.9 p -136.99 157.3 47.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.924 -179.584 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.15 -31.97 65.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.648 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -78.27 -45.28 23.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.617 0.722 . . . . 0.0 111.295 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.582 ' ND2' ' OE1' ' A' ' 78' ' ' GLN . 2.4 m120 -66.25 -35.17 79.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.494 -178.171 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.83 -15.4 58.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.933 -178.797 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 mt -71.37 -27.22 63.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.894 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.6 m -94.31 -8.78 37.99 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.753 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.2 -158.16 28.48 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.814 -178.591 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.09 126.58 37.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.875 -0.662 . . . . 0.0 109.941 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.02 147.46 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 -179.779 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 44.5 p -71.02 147.7 48.34 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.35 -43.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.979 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -89.82 -171.32 3.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.028 -178.721 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -121.58 -9.27 8.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.982 0.42 . . . . 0.0 111.535 -178.212 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -139.36 39.86 2.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.017 0.437 . . . . 0.0 111.393 -177.66 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -91.33 157.45 17.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.098 179.713 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.4 t -132.61 131.66 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.639 179.943 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.6 mtt -66.93 129.3 39.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.006 178.75 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.27 3.37 75.69 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -141.77 120.98 13.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.71 -165.75 54.75 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -178.867 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -90.23 109.98 21.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.614 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.69 102.26 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.922 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.22 129.83 37.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.474 0.654 . . . . 0.0 111.966 -179.177 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -127.04 132.35 50.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.526 178.637 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.24 141.66 45.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.556 0.693 . . . . 0.0 110.76 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.1 -179.04 20.31 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.588 -179.531 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 31.0 m-70 -81.84 145.08 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 129' ' ' SER . 22.9 t-20 -116.87 28.1 8.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmm -46.49 -12.15 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.911 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.59 40.98 16.07 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.078 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 88.4 tttt -134.42 115.15 13.67 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.768 -179.087 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -57.46 126.39 27.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.668 0.747 . . . . 0.0 110.156 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.49 -22.61 17.05 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.734 HG12 ' H ' ' A' ' 134' ' ' LEU . 55.6 t -84.3 177.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.073 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.734 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -72.19 133.19 44.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.607 0.241 . . . . 0.0 110.4 -178.247 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 46.16 33.0 1.59 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.297 0.57 . . . . 0.0 110.551 178.343 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 0.9 OUTLIER -81.86 -4.37 56.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.817 -178.571 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.455 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 22.8 t70 -147.09 39.76 1.02 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.605 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.69 -27.29 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.927 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.38 3.53 10.87 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.719 -179.604 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.455 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.2 m -95.35 -12.98 25.15 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.406 0.622 . . . . 0.0 109.694 -179.55 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.44 ' O ' HG21 ' A' ' 163' ' ' VAL . 13.8 mt -65.87 125.15 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.983 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -96.81 158.43 15.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.607 -179.837 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -61.46 128.03 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.874 -179.615 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 90.67 20.22 41.33 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.784 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 37.5 m-20 -85.82 132.33 34.13 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.406 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -79.79 135.69 36.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.812 -178.548 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 158' ' ' TYR . 84.5 mt -127.66 122.3 58.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.542 179.302 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.443 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.0 m-85 -100.18 117.66 34.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.975 -179.071 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.48 142.37 46.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.967 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.421 ' O ' ' SD ' ' A' ' 116' ' ' MET . 34.5 m-85 -116.06 132.95 56.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 111.471 -178.842 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.0 t0 -113.94 -166.38 1.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.6 m-20 -22.54 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.539 0.524 . . . . 0.0 111.676 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -137.81 28.28 2.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.289 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -126.93 143.77 51.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.899 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -109.18 121.62 45.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.844 179.067 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -104.65 132.01 51.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.418 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.443 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 70.2 mm-40 -94.62 112.65 24.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.992 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.5 m-85 -114.39 137.38 51.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.436 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.89 54.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 111.382 178.785 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 144' ' ' GLY . 44.3 t -67.38 132.64 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.959 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -112.26 -29.39 7.57 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 124.619 1.199 . . . . 0.0 111.13 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.19 145.18 8.45 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.498 -179.765 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 141' ' ' LEU . 97.8 t -121.86 138.24 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.784 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.5 m -159.34 171.88 18.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.693 -178.341 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.04 133.27 54.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.718 179.964 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 m -138.78 159.66 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.3 -178.691 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 169' ' ' ASP . 3.6 p -69.11 133.59 89.72 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.146 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.07 -13.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.046 1.831 . . . . 0.0 111.794 -178.95 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.1 m-20 -78.84 -22.36 46.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.903 -177.963 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.699 ' O ' HG22 ' A' ' 173' ' ' VAL . 14.4 mptt -85.67 75.91 10.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.847 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.545 ' C ' ' H ' ' A' ' 173' ' ' VAL . 83.3 m95 -74.05 -20.03 60.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.992 -179.18 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 57.1 mp0 -52.24 -6.79 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.821 179.575 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.712 ' O ' HG21 ' A' ' 183' ' ' THR . 24.4 m -89.81 -3.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.101 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 173' ' ' VAL . 1.0 OUTLIER -128.9 -7.24 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.745 0.783 . . . . 0.0 109.012 179.794 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.18 157.03 25.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.239 -176.749 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.89 127.52 32.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.092 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -102.11 -41.44 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.075 -179.78 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 140.84 28.03 0.19 Allowed Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.498 ' NZ ' ' CD ' ' A' ' 181' ' ' GLU . 19.7 pttp -156.37 178.49 10.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 4.6 m-20 -92.19 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.72 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.498 ' CD ' ' NZ ' ' A' ' 179' ' ' LYS . 22.4 tt0 -123.18 169.39 11.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.148 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.93 143.01 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.873 179.354 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.712 HG21 ' O ' ' A' ' 173' ' ' VAL . 16.0 m -136.02 123.56 22.18 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 111.489 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -111.11 123.72 50.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.405 0.621 . . . . 0.0 110.556 179.334 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 198' ' ' VAL . 8.5 pt -139.77 -171.45 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.932 -178.62 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t -138.81 155.02 48.49 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.717 -179.159 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 10.9 t -105.75 77.98 1.3 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 188' ' ' VAL . 11.4 p -143.43 131.99 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.216 -179.43 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 m 174.25 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.875 -179.428 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.599 HG13 ' N ' ' A' ' 191' ' ' LYS . 7.3 p -149.4 -45.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 111.842 -179.185 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.599 ' N ' HG13 ' A' ' 190' ' ' VAL . 63.3 tttp -93.83 -81.92 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.829 -178.89 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -69.16 140.76 54.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.019 179.399 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 193' ' ' ASN . 53.4 p-10 -94.71 148.99 21.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.465 -179.742 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.4 t 48.28 82.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.708 179.248 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -159.54 70.7 0.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.977 -178.185 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -146.51 144.6 29.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.574 -178.83 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -108.27 137.65 45.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.209 179.341 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.475 HG22 HG22 ' A' ' 185' ' ' ILE . 78.9 t -129.49 131.27 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.268 0.556 . . . . 0.0 110.824 -179.155 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.2 130.38 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.328 -179.755 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.47 135.86 54.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.574 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.43 147.97 18.45 Favored Glycine 0 N--CA 1.465 0.619 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.772 -179.791 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -103.32 140.22 37.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.933 -0.633 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.1 tp -66.11 125.76 26.5 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.204 0.526 . . . . 0.0 110.802 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.11 -24.21 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.042 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.88 176.63 46.04 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 119.93 -1.128 . . . . 0.0 112.102 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.7 m -153.51 151.48 29.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 110.94 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -150.09 178.39 9.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.677 179.439 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.34 144.85 24.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.157 0.503 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.45 79.55 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.763 -179.529 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.601 178.479 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 55' ' ' HIS . 50.8 m -58.41 -44.69 89.12 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.3 -0.16 . . . . 0.0 110.619 -179.471 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 56' ' ' MET . 36.9 t-80 51.57 102.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.631 178.816 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.488 ' O ' ' O ' ' A' ' 55' ' ' HIS . 95.5 mmm -56.41 -118.86 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.999 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 58.8 t0 46.1 19.72 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.286 0.565 . . . . 0.0 111.086 178.324 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 56' ' ' MET . . . -73.27 -11.85 60.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.276 -179.005 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 t -149.41 -73.52 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.64 -178.383 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 55.38 17.79 2.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.24 0.543 . . . . 0.0 111.231 178.538 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.4 mt -66.38 -45.27 89.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.726 -179.105 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.442 ' O ' HG13 ' A' ' 188' ' ' VAL . 68.1 t0 53.42 -100.05 0.1 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.109 179.122 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -149.81 88.67 4.82 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.808 -179.119 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.38 153.21 39.84 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 122.454 2.103 . . . . 0.0 111.137 179.476 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.09 146.58 52.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.823 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.81 -28.84 66.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.77 91.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.459 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.9 mm-40 -73.09 -35.39 66.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.805 179.469 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.87 -43.7 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.743 -179.181 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.35 83.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -87.89 -15.5 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.563 -178.801 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.39 133.05 53.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.521 179.658 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.1 p -90.9 159.4 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.054 179.598 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 105' ' ' SER . 51.0 tp -125.89 135.55 52.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.956 0.407 . . . . 0.0 111.112 -179.16 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.482 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.3 m-20 -89.91 89.31 7.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.763 179.756 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 4.6 mptp? -46.8 -16.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.18 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.482 ' N ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -65.64 -35.91 82.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.285 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 18.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.563 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.2 123.01 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.888 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.94 -7.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.016 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.15 38.54 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.514 ' O ' HD23 ' A' ' 149' ' ' LEU . 18.6 mtp85 -147.31 153.51 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.068 -178.64 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.8 tt -126.97 131.05 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.206 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.6 m -130.9 132.36 45.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.211 -178.765 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.15 129.85 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 -178.461 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.48 -35.05 0.26 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.397 2.064 . . . . 0.0 112.102 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -47.21 -38.73 12.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.491 -176.859 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -120.58 -0.54 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.845 -178.936 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 53.74 3.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.168 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.1 tp -116.06 133.84 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.34 116.37 13.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.522 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 83' ' ' ILE . 60.2 mt -144.53 110.87 4.94 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.079 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.1 Cg_endo -41.29 141.01 1.31 Allowed 'Trans proline' 0 N--CA 1.486 1.041 0 C-N-CA 121.79 1.66 . . . . 0.0 110.326 176.206 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.4 t -89.65 125.5 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.036 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.7 mt -108.95 122.45 47.25 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.28 -48.58 72.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.974 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 m -71.59 103.78 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.042 -179.613 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 109' ' ' THR . 3.2 m -84.32 101.48 11.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.273 0.558 . . . . 0.0 110.078 179.537 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.4 p -132.75 156.19 47.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.099 -179.75 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.449 ' O ' HD21 ' A' ' 104' ' ' LEU . 9.6 tm-20 -55.83 -26.94 49.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.545 -179.505 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.32 -43.73 14.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.374 0.607 . . . . 0.0 111.947 -179.507 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.412 ' HA ' HD21 ' A' ' 102' ' ' ASN . 10.1 m120 -66.44 -34.31 77.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.621 -179.138 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.4 mt -68.94 -12.67 61.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.03 -178.593 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 100' ' ' GLU . 14.6 mt -76.14 -13.14 60.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.121 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB3' HD22 ' A' ' 74' ' ' LEU . 57.8 m -121.35 -7.52 9.26 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.52 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.6 47.58 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.832 -179.742 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.17 129.07 36.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.955 179.375 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.456 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -106.63 146.65 30.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.986 -179.64 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.522 ' O ' ' OG ' ' A' ' 98' ' ' SER . 32.9 p -75.41 149.92 38.47 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.791 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.46 -40.52 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.845 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -87.82 145.07 26.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 111.044 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.16 -16.9 64.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.077 -179.141 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -144.86 52.02 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.295 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.415 ' CD ' ' H ' ' A' ' 122' ' ' ALA . 1.1 tt0 -80.73 155.55 26.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.656 179.557 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -133.08 127.7 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.0 mtt -71.49 126.65 30.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.256 179.482 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.91 70.94 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.521 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -139.2 119.71 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.259 -179.161 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -164.35 54.57 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.25 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -90.02 109.82 20.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.732 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -84.96 101.1 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.415 ' H ' ' CD ' ' A' ' 114' ' ' GLN . . . -90.39 126.29 35.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 112.135 -178.919 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.4 130.92 53.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.454 178.146 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.2 139.49 45.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.46 0.647 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.89 -178.78 19.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 134' ' ' LEU . 36.0 m-70 -85.16 140.65 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 110.66 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 28.6 t-20 -108.22 28.2 8.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.388 0.614 . . . . 0.0 110.265 -179.91 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -44.28 -13.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.873 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 55.45 39.56 31.14 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.942 179.264 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.477 ' O ' ' OG ' ' A' ' 136' ' ' SER . 79.8 tttt -134.7 123.05 23.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.607 -178.782 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -64.08 123.64 19.55 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.132 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.59 25.05 5.62 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.546 -177.905 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 134' ' ' LEU . 3.0 t -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.952 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -70.26 131.72 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.43 -177.838 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 47.14 32.74 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.077 0.465 . . . . 0.0 110.893 178.251 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.45 -10.31 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.022 -178.948 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.5 m-20 -144.5 38.08 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.26 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -68.12 -35.24 70.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.943 0.401 . . . . 0.0 111.657 179.75 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.58 3.3 1.9 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.88 -179.381 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 138' ' ' ILE . 19.0 m -95.61 -12.61 25.35 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.127 0.489 . . . . 0.0 109.861 -179.447 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -67.42 125.28 25.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.98 159.68 14.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.708 -179.806 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 144' ' ' GLY . 10.1 tmtt? -60.22 128.0 34.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -179.829 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 143' ' ' LYS . . . 91.14 22.32 32.88 Favored Glycine 0 N--CA 1.463 0.444 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.935 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.86 132.4 34.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.221 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -79.93 130.19 35.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.275 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 89.5 mt -125.3 124.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.31 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -106.7 122.45 46.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.484 -178.651 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.607 HD22 ' SD ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -115.91 148.49 39.96 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.369 -179.584 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.92 131.76 53.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.364 0.602 . . . . 0.0 111.438 -179.834 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 152' ' ' ASN . 26.2 t70 -114.64 -165.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.011 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 151' ' ' ASP . 2.3 t-20 -23.78 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.178 0.514 . . . . 0.0 111.733 179.463 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -139.61 25.6 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.911 178.853 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -124.05 141.62 51.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.689 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.537 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 75.5 tt0 -106.49 121.06 43.51 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.059 179.321 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.408 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.5 m-85 -104.29 128.32 52.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -95.01 117.55 30.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.571 178.652 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.52 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 21.5 m-85 -117.78 141.09 48.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.186 -179.346 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.03 136.49 54.86 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.172 0.51 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.13 132.25 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.756 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.5 t -111.8 -26.78 8.78 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 124.799 1.312 . . . . 0.0 111.37 -179.067 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.27 149.66 9.61 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.418 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.575 HG13 HG22 ' A' ' 199' ' ' VAL . 21.8 t -125.74 148.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.904 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.6 p -160.3 168.76 24.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.157 0.503 . . . . 0.0 111.365 -177.987 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.453 ' OE1' ' CE1' ' A' ' 197' ' ' TYR . 1.6 pm0 -117.95 124.28 47.85 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.456 179.722 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.71 160.32 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.249 -178.412 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 169' ' ' ASP . 15.0 p -71.62 138.23 83.25 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.455 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.94 -14.9 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.012 1.808 . . . . 0.0 111.993 -178.7 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 65.4 t0 -78.96 -11.5 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.552 -177.86 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.414 ' O ' HG23 ' A' ' 173' ' ' VAL . 31.1 mmtt -84.77 64.53 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.182 0.515 . . . . 0.0 110.357 179.476 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.464 ' C ' ' N ' ' A' ' 173' ' ' VAL . 86.3 m95 -70.1 -30.87 68.2 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.218 -179.716 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 41.4 mp0 -47.3 -15.97 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.212 0.53 . . . . 0.0 110.672 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 198' ' ' VAL . 87.4 t -66.13 -43.07 92.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.284 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.477 HG11 HD13 ' A' ' 185' ' ' ILE . 13.4 m -98.94 2.16 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.624 0.725 . . . . 0.0 110.506 -178.221 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.57 120.28 25.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.417 -1.265 . . . . 0.0 112.08 -178.569 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -31.79 122.81 0.28 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.506 178.846 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -105.41 -41.73 5.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.47 27.1 0.14 Allowed Glycine 0 N--CA 1.471 1.013 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -154.09 173.75 15.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.654 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -96.07 86.94 4.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.292 179.016 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -128.07 128.53 45.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.271 -179.286 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 149' ' ' LEU . 20.3 tt -81.43 147.26 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.527 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.479 ' C ' HD12 ' A' ' 184' ' ' LEU . 7.8 m -136.87 118.1 14.52 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 111.025 -179.608 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -103.44 126.18 50.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.381 0.61 . . . . 0.0 110.999 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.477 HD13 HG11 ' A' ' 174' ' ' VAL . 11.8 pt -138.45 -177.13 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.592 -179.06 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.655 HG23 ' HE ' ' A' ' 196' ' ' ARG . 15.2 t -138.45 147.57 43.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 -179.459 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 72.8 m -104.47 42.16 1.23 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.306 -179.514 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 62' ' ' ASP . 62.5 t -119.27 130.88 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.288 -179.47 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -133.56 107.47 8.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.144 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 193' ' ' ASN . 9.1 t -133.38 161.43 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 -179.551 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.94 -41.19 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.928 -179.039 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -59.08 -49.24 78.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 193' ' ' ASN . 42.9 p30 -99.32 79.95 2.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.824 -179.575 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.9 t -59.04 -43.99 91.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.041 -179.354 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -122.21 139.74 53.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.99 -179.704 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.655 ' HE ' HG23 ' A' ' 186' ' ' THR . 5.6 ptp85 -95.16 160.78 14.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.876 -179.572 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.453 ' CE1' ' OE1' ' A' ' 165' ' ' GLU . 4.3 m-85 -92.58 140.54 29.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.938 179.158 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 173' ' ' VAL . 45.4 t -132.2 134.54 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 -179.437 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.575 HG22 HG13 ' A' ' 163' ' ' VAL . 61.1 t -119.4 130.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.809 -179.39 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.23 136.14 53.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.141 179.505 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.63 140.19 11.6 Favored Glycine 0 N--CA 1.468 0.813 0 CA-C-O 121.648 0.582 . . . . 0.0 111.709 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.3 t0 -96.61 140.18 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.966 -179.09 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.52 HD13 ' CZ ' ' A' ' 158' ' ' TYR . 12.1 tp -67.45 129.15 39.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 111.004 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 79.6 t -106.93 -23.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.25 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.49 162.53 21.92 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.687 178.774 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.408 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 48.0 m -138.79 157.49 45.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.246 0.546 . . . . 0.0 109.934 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.8 pttp -150.33 178.5 8.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.097 179.864 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -96.11 140.27 31.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.768 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -61.97 79.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.482 -179.44 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 208' ' ' ALA . 99.2 mttt . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.518 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo . . . . . 0 N--CA 1.49 1.286 0 CA-C-O 121.09 0.371 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.66 149.2 45.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.551 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.18 -24.47 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.094 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.5 86.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.44 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -73.4 -35.96 65.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.177 179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.98 -43.23 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.509 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.05 88.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -84.26 -19.81 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.53 131.95 51.78 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.582 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 m -92.3 152.42 19.8 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.378 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.2 tp -116.38 130.3 56.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.907 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -94.13 88.97 5.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 79' ' ' VAL . 45.0 mmtm -50.43 -11.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 75' ' ' ASP . 69.2 mmtt -74.52 -9.28 58.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.513 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -106.51 16.51 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.37 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.9 p -90.6 126.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.774 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.33 -4.62 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.761 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.7 -167.54 36.55 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.483 ' HE ' ' NZ ' ' A' ' 209' ' ' LYS . 44.4 mtt-85 -146.92 155.24 42.13 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.973 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.617 HD12 HD13 ' A' ' 123' ' ' LEU . 8.8 tt -127.55 126.44 67.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.329 0.585 . . . . 0.0 109.821 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -125.14 130.55 52.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.006 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.48 79.57 59.79 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.252 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -43.6 -35.89 6.7 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.909 2.406 . . . . 0.0 112.972 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 m -49.11 -37.39 21.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -115.59 0.59 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.622 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.59 47.83 2.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.3 tp -115.04 129.32 56.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.737 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -134.34 120.66 20.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -146.72 162.47 33.59 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.241 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.64 151.68 8.83 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.826 2.35 . . . . 0.0 109.646 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -99.35 113.98 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.43 122.31 42.96 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.45 -45.73 82.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.797 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.549 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 91.5 p -70.79 104.57 2.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.152 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.0 p -82.79 99.81 9.91 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.254 0.55 . . . . 0.0 110.098 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.2 p -131.29 158.17 41.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.855 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.1 -26.42 68.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -83.23 -41.23 18.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.299 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.549 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 98.5 m-20 -66.46 -36.21 82.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.503 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.0 mt -66.32 -14.7 62.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -75.49 -13.93 60.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -121.09 -4.49 9.54 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.38 -176.54 44.65 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.633 -1.27 . . . . 0.0 112.286 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.15 125.29 32.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.29 -0.455 . . . . 0.0 109.812 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.0 145.4 30.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.0 p -71.68 149.1 45.81 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.22 -44.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.94 -171.18 2.77 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.03 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -108.01 -56.78 2.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.809 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -91.17 46.54 1.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.59 150.27 24.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.133 0.492 . . . . 0.0 109.931 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.29 132.16 52.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.403 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.5 mtt -73.78 127.33 32.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 0.0 110.263 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.37 -0.9 68.87 Favored Glycine 0 C--O 1.23 -0.14 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -137.72 119.48 15.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.508 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -171.71 54.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.5 t30 -86.15 111.52 20.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -83.84 106.79 15.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.74 128.53 36.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.048 0.451 . . . . 0.0 112.081 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.617 HD13 HD12 ' A' ' 83' ' ' ILE . 10.1 mt -126.0 130.55 51.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.027 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.98 141.68 47.11 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.342 0.591 . . . . 0.0 110.768 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.48 -177.41 18.39 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.283 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.0 m-70 -82.69 150.0 27.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.1 0.476 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 129' ' ' SER . 61.2 t30 -117.59 27.96 8.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.715 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.4 mmm -45.43 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.7 p 62.82 41.03 9.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.19 0.519 . . . . 0.0 110.201 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.83 109.66 9.24 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.884 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -51.66 127.87 21.74 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.44 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.7 -25.5 14.76 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.782 HG12 ' H ' ' A' ' 134' ' ' LEU . 45.9 t -82.51 177.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 117.54 0.67 . . . . 0.0 109.499 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.782 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.22 136.91 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.315 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 44.57 32.73 0.8 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.045 0.45 . . . . 0.0 110.656 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -81.89 -8.11 59.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.207 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -149.96 41.91 0.85 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.731 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.2 pt -68.08 -33.85 63.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.371 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.21 5.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.104 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -94.57 -16.79 22.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.2 124.95 23.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.835 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.65 156.13 16.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.566 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 144' ' ' GLY . 5.6 tmtt? -56.85 127.35 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.675 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.436 ' N ' ' HD3' ' A' ' 143' ' ' LYS . . . 90.9 21.72 35.38 Favored Glycine 0 CA--C 1.516 0.139 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -82.75 134.66 35.12 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.542 ' NZ ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 mmmm -80.96 121.78 26.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.565 0.698 . . . . 0.0 112.312 -178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 94.4 mt -117.69 117.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.11 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.548 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.1 m-85 -100.32 119.02 37.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.43 144.68 44.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.73 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -116.41 136.75 52.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.411 0.624 . . . . 0.0 111.565 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' A' ' 152' ' ' ASN . 32.2 t70 -114.74 -171.07 1.86 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.9 p30 -21.17 -73.53 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.072 0.463 . . . . 0.0 111.658 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.496 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.2 mt-10 -138.38 26.0 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.82 147.89 45.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.369 0.604 . . . . 0.0 112.254 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -113.08 120.43 41.31 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CE2' HG21 ' A' ' 206' ' ' THR . 65.9 m-85 -104.29 131.18 51.89 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.073 0.463 . . . . 0.0 111.36 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.548 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 42.4 tp10 -94.52 114.77 26.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -114.5 141.92 47.07 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.63 135.7 54.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.538 0.685 . . . . 0.0 111.428 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.3 132.27 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.875 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -105.97 -27.74 10.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 124.917 1.386 . . . . 0.0 110.709 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.84 141.12 3.68 Favored Glycine 0 C--N 1.32 -0.328 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.405 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.2 p -106.08 139.8 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.058 -0.571 . . . . 0.0 109.564 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.9 t -154.09 166.72 32.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.345 0.593 . . . . 0.0 111.557 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.03 125.95 53.14 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.665 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.07 153.97 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.805 0.336 . . . . 0.0 110.995 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 p -60.0 167.2 2.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.75 -13.69 11.68 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.949 1.766 . . . . 0.0 111.446 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 36.9 p30 -82.91 -18.49 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.881 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.445 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.2 ttmt -86.72 74.75 9.76 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.073 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.401 ' CE3' HG21 ' A' ' 174' ' ' VAL . 94.0 m95 -75.54 -7.54 54.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.868 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -52.57 -25.42 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.039 0.447 . . . . 0.0 110.557 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.662 ' O ' HG21 ' A' ' 183' ' ' THR . 74.4 t -75.71 -16.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.228 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.401 HG21 ' CE3' ' A' ' 171' ' ' TRP . 2.6 t -108.71 -13.78 10.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.665 0.745 . . . . 0.0 109.676 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.01 152.66 24.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.919 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.54 133.93 53.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -101.18 -39.07 7.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.45 30.33 0.35 Allowed Glycine 0 N--CA 1.469 0.843 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -156.23 179.31 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.262 0.553 . . . . 0.0 111.369 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.23 89.71 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -125.06 166.13 16.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.193 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.29 142.45 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.662 HG21 ' O ' ' A' ' 173' ' ' VAL . 18.0 m -134.37 127.01 30.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.573 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.56 126.86 55.76 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.106 0.479 . . . . 0.0 109.722 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.48 HG22 HG22 ' A' ' 198' ' ' VAL . 28.6 pt -140.32 -169.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.519 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.732 179.481 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 120.93 0.395 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.5 133.58 42.67 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 173' ' ' VAL . 93.4 t -133.59 137.02 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.2 t -116.01 128.15 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.465 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.16 136.87 52.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.212 0.529 . . . . 0.0 110.074 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.46 25.85 Favored Glycine 0 N--CA 1.462 0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.451 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -115.61 150.1 37.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.043 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 41.8 tp -69.9 127.12 31.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.506 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.13 -24.43 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.759 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 175.01 45.81 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.532 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.412 HG21 ' CE2' ' A' ' 156' ' ' TYR . 16.5 m -153.3 151.66 30.26 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 121.375 0.607 . . . . 0.0 111.015 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -149.84 179.03 8.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.395 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.26 145.7 24.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.168 0.508 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.483 ' NZ ' ' HE ' ' A' ' 82' ' ' ARG . 88.5 tttt -74.14 80.0 1.76 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.321 -0.63 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.872 178.758 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 CA-C-O 121.221 0.425 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 162.78 29.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.063 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 66' ' ' LEU . 1.2 tt -60.22 -25.18 65.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.978 0.418 . . . . 0.0 110.247 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.13 89.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.004 0.43 . . . . 0.0 110.447 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 71.0 mm-40 -73.67 -33.71 64.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 110.788 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.28 -45.54 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.754 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.19 88.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.183 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -80.85 -24.11 38.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.209 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.45 141.5 58.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.712 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.6 m -139.22 119.28 13.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.578 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.2 tp -120.31 140.41 51.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.825 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.08 138.55 57.22 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 79' ' ' VAL . 14.4 mptt -82.16 -10.51 59.14 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.169 0.509 . . . . 0.0 109.995 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -81.12 -8.96 59.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -90.99 11.84 21.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.529 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 76' ' ' LYS . 14.7 m -88.63 146.36 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.121 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.8 -6.98 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 111.393 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.16 -170.76 36.41 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -146.26 148.75 32.78 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.569 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -122.81 121.74 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -123.49 129.31 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.429 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 50.5 mt -129.73 125.54 22.28 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.322 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.5 Cg_endo -82.75 -39.23 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 t -49.92 -39.31 39.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.414 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -116.95 -2.18 9.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.464 0.173 . . . . 0.0 110.777 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m 63.18 50.88 2.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.484 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -108.31 130.6 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.137 -178.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -137.1 114.68 11.12 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.628 HD22 ' HA2' ' A' ' 106' ' ' GLY . 16.6 mt -145.92 111.17 4.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.4 Cg_endo -41.24 142.9 0.86 Allowed 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 121.643 1.562 . . . . 0.0 110.328 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.41 122.95 44.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.84 132.71 47.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.157 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.78 -27.96 68.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.416 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 93.2 p -69.34 -179.52 1.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.543 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -159.15 49.92 0.35 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.085 0.469 . . . . 0.0 110.272 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.493 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 67.5 p -108.03 155.1 20.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.73 -31.31 64.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -72.01 -48.11 47.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.466 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.493 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 72.2 m-20 -66.86 -38.56 86.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.183 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 134' ' ' LEU . 12.7 mt -56.35 -16.14 5.14 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.6 mt -70.24 -31.7 69.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.0 m -90.63 -12.22 37.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.628 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 170.87 -175.06 44.72 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.911 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.14 130.66 41.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 97' ' ' SER . . . -104.64 143.25 33.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.838 0.352 . . . . 0.0 110.158 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.8 p -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.445 HG21 HD11 ' A' ' 185' ' ' ILE . 84.1 t -81.31 -50.22 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -94.5 147.64 23.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.997 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -87.45 -6.3 58.47 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -126.78 31.84 5.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.107 0.48 . . . . 0.0 111.329 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -97.59 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.568 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.23 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.987 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.9 125.1 31.67 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.697 0.284 . . . . 0.0 110.395 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.55 72.92 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.87 121.44 13.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.104 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.55 55.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -83.83 110.17 18.14 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -87.48 104.26 16.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.486 ' O ' HD22 ' A' ' 123' ' ' LEU . . . -92.88 121.0 33.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.681 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 122' ' ' ALA . 2.4 mm? -117.31 131.66 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.022 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.07 141.04 43.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.466 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.2 -177.76 15.81 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.536 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.473 ' O ' ' O ' ' A' ' 134' ' ' LEU . 62.1 m-70 -92.99 130.25 38.63 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.083 0.468 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -91.99 28.47 1.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -35.84 -26.2 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.368 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 64.95 34.84 8.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.403 0.62 . . . . 0.0 109.596 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.43 106.91 6.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.39 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -49.11 128.62 16.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.064 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.46 -23.03 14.2 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.809 HG12 ' H ' ' A' ' 134' ' ' LEU . 49.0 t -89.69 178.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.809 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.13 135.5 49.22 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.36 -177.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 44.88 39.41 3.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.193 0.521 . . . . 0.0 110.63 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 60.6 p -81.36 -8.56 59.76 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 136' ' ' SER . 77.8 m-20 -147.6 37.99 0.92 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.8 -29.85 42.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.824 0.345 . . . . 0.0 111.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.02 6.41 4.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.815 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -97.67 -13.75 21.32 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.02 123.31 19.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.896 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 23.2 tptt -96.34 169.46 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.161 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 142' ' ' LYS . 48.9 tttm -68.0 125.8 27.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 97.06 18.73 28.34 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.0 m-20 -84.32 131.76 34.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -79.52 129.99 34.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.894 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.9 mt -125.23 126.12 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.529 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 58.0 m-85 -103.06 118.94 37.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.563 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.702 HD13 ' N ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -115.53 133.67 55.8 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.702 ' N ' HD13 ' A' ' 149' ' ' LEU . 20.6 m-85 -103.08 132.48 49.31 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 111.084 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 50.0 t0 -110.0 -167.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.679 -1.146 . . . . 0.0 107.952 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.519 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -29.66 -72.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.978 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -136.78 29.05 2.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -131.7 150.26 52.21 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -108.75 123.74 49.48 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.378 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 40.1 m-85 -104.99 129.91 53.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.391 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.529 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 73.9 mm-40 -96.65 114.92 26.61 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.15 142.93 45.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.76 132.11 54.08 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.395 0.617 . . . . 0.0 111.238 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 144' ' ' GLY . 53.7 t -66.63 134.37 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.981 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.5 OUTLIER -106.84 -29.18 9.66 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 124.36 1.037 . . . . 0.0 110.437 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.73 157.81 17.15 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.638 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 150.74 33.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.824 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.9 m -156.48 168.2 28.1 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.259 0.552 . . . . 0.0 111.366 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -106.06 132.0 52.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.439 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.02 159.07 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 110.931 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.545 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 71.2 p -77.79 142.44 65.46 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -47.32 -18.81 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.089 1.859 . . . . 0.0 111.604 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -81.24 -2.87 50.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.974 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.6 tptt -82.03 140.59 33.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 94.4 m95 -157.78 -22.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.849 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -56.74 -17.67 9.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.397 0.617 . . . . 0.0 110.429 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.09 -6.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.321 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 185' ' ' ILE . 2.9 m -136.23 43.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 70.5 mm-40 -144.6 84.53 1.74 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.027 -176.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 175' ' ' GLU . 92.3 m-20 27.18 108.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.231 0.957 . . . . 0.0 112.805 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -96.84 -40.34 8.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.313 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.2 29.59 0.72 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.48 178.45 10.22 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -92.83 88.84 6.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.976 0.893 . . . . 0.0 109.511 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -131.63 167.29 19.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.91 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 15.7 tt -131.67 143.42 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.585 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.5 m -136.22 129.71 32.01 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.301 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -112.4 127.58 56.06 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.24 0.543 . . . . 0.0 110.867 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.607 HD13 HG11 ' A' ' 174' ' ' VAL . 3.4 pt -141.17 -167.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.876 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.53 0.206 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -179.858 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 167' ' ' THR . 8.3 ttm180 . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.616 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.0 139.66 48.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 110.091 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -134.45 136.9 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 111.229 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.77 134.2 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.049 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.93 138.1 51.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.542 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.6 139.98 11.39 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.8 t0 -99.05 137.05 38.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.253 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.0 tp -63.75 126.2 26.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.287 0.565 . . . . 0.0 110.881 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.24 -25.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.825 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.7 159.91 16.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.008 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.412 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 59.5 m -135.71 157.18 47.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 206' ' ' THR . 20.2 ptmt -148.64 178.9 8.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.237 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.8 144.88 24.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.289 0.566 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.85 80.69 2.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.472 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.633 178.107 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.485 1.001 0 N-CA-C 110.847 -0.482 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.13 151.34 43.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.975 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.5 mp -55.48 -26.76 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 110.68 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.51 93.99 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.4 mt-10 -73.39 -32.1 64.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.674 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.58 -46.32 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.972 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.76 91.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.157 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.95 -30.12 55.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.395 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.95 158.34 11.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.869 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 p -138.56 158.84 43.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 110.62 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.647 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -139.21 121.48 15.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 111.172 -178.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.647 ' N ' HD13 ' A' ' 74' ' ' LEU . 99.2 m-20 -81.89 110.73 17.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.796 178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -47.13 -16.13 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.226 0.536 . . . . 0.0 110.318 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 75' ' ' ASP . 87.4 tttt -67.44 -33.52 75.32 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.977 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -78.41 9.45 3.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.584 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.5 t -92.91 129.11 43.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.753 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 pt -118.29 -3.43 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.81 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.95 34.41 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -157.06 164.94 37.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.714 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.9 tt -131.07 140.23 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.712 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 m -132.87 133.17 42.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.36 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' CG2' ' OG ' ' A' ' 87' ' ' SER . 67.9 mt -133.17 129.26 20.82 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.546 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.88 -36.18 0.19 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.429 2.086 . . . . 0.0 112.147 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.418 ' OG ' ' CG2' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -47.15 -38.98 12.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.409 -177.188 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.3 p -120.55 0.23 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.828 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 60.71 54.29 3.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 tp -117.74 134.83 54.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.346 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.96 117.38 14.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 83' ' ' ILE . 58.9 mt -143.65 114.02 5.55 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.9 Cg_endo -42.38 146.67 0.67 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 121.892 1.728 . . . . 0.0 109.99 176.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -95.3 123.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.87 123.18 47.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.87 -46.79 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.974 0.416 . . . . 0.0 111.079 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.544 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 34.9 p -69.79 102.87 2.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 98' ' ' SER . 5.6 p -82.77 103.85 12.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.421 0.629 . . . . 0.0 110.329 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.534 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 3.0 p -142.94 157.12 44.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.944 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -54.71 -32.44 59.58 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.722 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -79.13 -45.08 20.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.687 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.544 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.8 m-20 -65.19 -34.72 79.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.242 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 134' ' ' LEU . 17.0 mt -61.68 -21.36 64.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.375 0.607 . . . . 0.0 111.808 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.89 -32.93 73.76 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.477 ' OG ' HD23 ' A' ' 74' ' ' LEU . 3.8 p -87.83 -13.58 41.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.57 -171.69 44.18 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.492 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.01 127.55 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.482 . . . . 0.0 110.057 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.73 146.46 29.77 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.844 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 109' ' ' THR . 5.5 p -74.42 151.55 39.62 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.92 -42.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.464 ' N ' HE22 ' A' ' 114' ' ' GLN . 99.2 mttt -88.29 -171.99 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.027 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 21.6 pt-20 -116.7 -9.81 11.23 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 112' ' ' GLU . 17.7 m120 -145.87 43.41 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.464 HE22 ' N ' ' A' ' 111' ' ' LYS . 1.7 pm0 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.888 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.54 131.36 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.681 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.3 mtt -71.49 128.37 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.075 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 91.17 1.97 71.71 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -141.32 123.7 15.77 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.66 -164.47 54.81 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.43 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 22.1 t-20 -92.28 108.91 20.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -85.37 103.24 14.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.038 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 128.59 36.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.384 0.611 . . . . 0.0 112.15 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.56 130.47 52.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.127 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.71 140.94 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.055 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.49 -178.34 17.59 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 134' ' ' LEU . 56.8 m-70 -93.42 140.92 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.3 p30 -106.44 29.44 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 110.549 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.0 mmm -42.22 -15.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.837 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 61.56 38.0 15.9 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.076 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -133.62 107.65 8.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.984 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -52.92 126.74 21.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.8 -24.61 11.77 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 134' ' ' LEU . 42.4 t -86.66 -179.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.816 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.79 133.03 46.19 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.194 -178.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 47.26 40.82 11.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 111.149 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.8 p -81.6 -11.88 58.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.903 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 73.7 m-20 -149.82 42.8 0.88 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.7 pt -68.57 -35.56 70.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 0.0 112.013 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.7 1.58 2.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.2 m -92.66 -13.71 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.161 0.505 . . . . 0.0 110.18 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.4 122.78 18.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.213 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.69 157.91 15.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.792 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.48 127.87 33.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.258 0.551 . . . . 0.0 111.147 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.23 16.51 40.43 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.72 133.84 34.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -81.52 134.56 35.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 111.852 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -127.82 121.04 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -101.76 120.24 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.8 tp -117.72 147.93 42.49 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -122.03 131.86 54.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.153 0.501 . . . . 0.0 111.584 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.9 t0 -112.08 -164.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 151' ' ' ASP . 28.4 m120 -21.95 -78.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.205 0.526 . . . . 0.0 111.406 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -136.31 26.07 3.2 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -123.48 142.22 51.22 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -108.15 120.52 42.58 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 206' ' ' THR . 75.0 m-85 -104.14 130.32 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.152 0.501 . . . . 0.0 111.582 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -93.66 115.27 27.72 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 51.5 m-85 -116.78 138.61 51.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.631 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -118.59 136.79 53.67 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.247 0.546 . . . . 0.0 110.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.78 134.8 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.297 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.5 OUTLIER -107.83 -24.12 11.79 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.357 1.036 . . . . 0.0 111.278 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 166.17 165.9 24.31 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.115 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.29 151.64 31.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.3 p -152.28 161.54 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.04 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -114.15 117.44 31.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.87 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.85 159.25 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.989 0.424 . . . . 0.0 111.28 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 169' ' ' ASP . 33.9 p -69.48 134.27 88.78 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.459 ' HB3' HH21 ' A' ' 196' ' ' ARG . 1.2 Cg_endo -46.25 -12.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.081 1.854 . . . . 0.0 111.749 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 167' ' ' THR . 96.0 m-20 -81.11 -8.73 59.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -85.97 70.1 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.133 0.492 . . . . 0.0 110.259 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.467 ' C ' ' N ' ' A' ' 173' ' ' VAL . 80.8 m95 -70.48 -30.47 67.28 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.441 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -48.81 -14.81 0.07 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.543 . . . . 0.0 110.464 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.467 ' N ' ' C ' ' A' ' 171' ' ' TRP . 86.1 t -75.08 -24.32 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.809 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.91 -6.64 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.703 0.763 . . . . 0.0 109.561 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -80.46 152.8 28.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.861 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p-10 -64.64 128.32 35.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.288 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.441 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.8 m80 -108.69 -42.69 4.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.62 0.248 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.47 23.99 0.09 OUTLIER Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -152.92 171.73 17.88 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -94.75 87.91 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -126.88 126.61 43.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.365 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.5 tt -81.04 148.23 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 184' ' ' LEU . 7.2 m -136.68 121.19 18.26 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.375 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.516 HD12 ' C ' ' A' ' 183' ' ' THR . 10.4 mp -105.35 126.64 52.34 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.28 0.562 . . . . 0.0 111.149 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 29.7 pt -135.2 169.92 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.491 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.569 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 35.5 p . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.362 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 186' ' ' THR . 59.9 ttm-85 . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.48 133.29 49.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 81.8 t -135.16 136.82 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.65 131.65 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.615 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.526 ' O ' HG22 ' A' ' 161' ' ' THR . . . -115.22 136.69 52.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.48 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.45 11.73 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 47.9 p-10 -96.4 141.3 29.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.915 -0.643 . . . . 0.0 111.247 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.12 125.42 25.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.098 0.475 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 72.4 t -107.59 -23.21 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.535 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.83 177.9 45.22 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.883 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 156' ' ' TYR . 15.9 m -154.1 152.63 30.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.159 0.504 . . . . 0.0 111.018 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -151.14 178.8 8.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.371 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.67 145.6 24.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.948 0.404 . . . . 0.0 110.534 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.19 79.04 0.96 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.32 -0.705 0 CA-C-O 117.854 -1.069 . . . . 0.0 110.724 178.59 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.49 1.318 0 CA-C-O 121.153 0.397 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.59 154.79 41.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.1 mm? -57.1 -27.16 61.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.707 0.289 . . . . 0.0 110.601 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.85 91.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.924 0.392 . . . . 0.0 110.041 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.2 mt-10 -74.29 -36.11 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.797 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -74.34 -43.9 49.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.627 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.13 86.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.27 -22.75 30.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.217 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.29 138.35 58.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.397 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -139.97 149.56 43.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.795 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.764 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.3 pt? -139.92 166.76 23.77 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.432 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.31 140.86 43.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.763 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 79' ' ' VAL . 70.2 mmtt -79.57 -2.08 40.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.196 0.522 . . . . 0.0 110.155 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -89.47 -7.25 55.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -85.84 0.33 53.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 76' ' ' LYS . 7.8 p -88.26 135.12 26.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.73 0.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.686 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -177.95 39.83 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -147.53 151.54 36.5 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.194 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 83' ' ' ILE . 14.7 tt -126.21 123.46 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 m -123.18 128.03 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.608 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.72 116.69 13.82 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.71 -33.17 1.31 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.286 1.991 . . . . 0.0 112.376 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.449 ' CB ' HD23 ' A' ' 141' ' ' LEU . 3.0 m -50.73 -37.22 40.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.36 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -117.23 -6.79 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.252 -0.28 . . . . 0.0 110.512 -179.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.8 p 71.76 47.82 0.32 Allowed 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.64 127.51 54.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.479 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -132.82 113.9 13.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -145.0 165.43 22.21 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.001 -0.679 . . . . 0.0 112.554 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -89.01 156.38 5.82 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 123.252 2.635 . . . . 0.0 109.264 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.58 114.38 46.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.9 120.9 41.44 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.81 -45.19 83.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.985 0.421 . . . . 0.0 110.776 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 4.2 m -67.05 103.93 1.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.936 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -82.03 109.0 15.96 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 110.318 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.512 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -143.35 155.77 44.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.24 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -61.19 -28.03 68.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -80.22 -46.64 15.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.898 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.4 p-10 -68.78 -31.16 69.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.585 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -61.89 -20.39 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.84 -14.41 61.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.613 ' OG ' HD22 ' A' ' 74' ' ' LEU . 19.9 m -103.22 -10.22 18.94 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.82 -153.04 18.91 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.247 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.81 127.86 44.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.115 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -108.34 148.85 29.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 p -73.53 149.61 42.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.574 HG21 HD11 ' A' ' 185' ' ' ILE . 4.3 t -84.8 -42.22 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 9.5 tptp -90.28 -172.65 3.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.788 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 46.6 tp10 -107.04 -57.9 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.343 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.93 45.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.296 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.45 154.17 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.085 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.19 135.19 63.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 mtp -78.05 122.55 25.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.61 2.43 60.0 Favored Glycine 0 N--CA 1.461 0.314 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -140.59 128.28 21.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.076 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.68 -169.65 49.96 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.5 107.17 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -85.39 103.21 14.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.62 126.27 35.9 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.485 0.66 . . . . 0.0 112.208 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.441 HD13 HD12 ' A' ' 83' ' ' ILE . 11.6 mt -120.49 131.22 54.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.512 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.69 138.49 45.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.582 0.706 . . . . 0.0 110.921 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.69 -178.39 16.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.556 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 80.7 m-70 -90.79 139.69 30.49 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' SER . 64.2 t30 -102.52 28.53 5.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 109.91 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.49 -24.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.184 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 64.44 36.71 8.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.416 0.627 . . . . 0.0 109.61 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.458 ' N ' ' OG ' ' A' ' 136' ' ' SER . 26.1 mtpp -134.34 111.67 10.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.917 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.41 126.12 18.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.625 0.726 . . . . 0.0 110.226 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.6 9.7 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.564 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.76 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.6 t -79.09 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 117.749 0.775 . . . . 0.0 109.484 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.76 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.57 134.37 46.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.24 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 45.17 33.78 1.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.159 0.504 . . . . 0.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.458 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.2 -8.51 59.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -146.68 39.74 1.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.29 -30.02 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.863 0.363 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.06 3.36 5.55 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.135 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -95.81 -13.9 23.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.449 HD23 ' CB ' ' A' ' 87' ' ' SER . 15.2 mt -66.21 126.4 28.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.704 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -97.2 158.84 15.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.415 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.16 138.64 58.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.434 0.635 . . . . 0.0 111.317 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.61 65.09 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -81.11 136.83 35.96 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.2 122.64 25.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.635 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mm -115.39 119.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.73 118.23 36.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 tp -119.94 154.96 33.69 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.02 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -127.32 135.68 50.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.505 0.669 . . . . 0.0 112.118 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.0 t0 -115.52 -167.04 1.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.29 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.224 0.535 . . . . 0.0 111.798 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -138.09 28.66 2.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -127.8 140.58 51.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.522 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 78.7 tt0 -103.35 122.17 44.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.572 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.445 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 55.0 m-85 -104.25 127.05 51.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.394 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 157' ' ' GLU . 39.7 mp0 -94.64 115.45 27.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.071 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -119.14 134.08 55.41 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.342 0.591 . . . . 0.0 110.718 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.04 133.42 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.736 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.4 p -103.79 -26.81 12.57 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 124.524 1.14 . . . . 0.0 110.794 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.36 165.6 19.65 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.995 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.7 p -121.79 149.21 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 198' ' ' VAL . 19.5 m -153.22 164.28 38.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.088 0.47 . . . . 0.0 111.196 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -107.82 102.83 12.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.437 HG22 HG11 ' A' ' 198' ' ' VAL . 11.3 m -117.05 144.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.102 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.8 p -61.32 167.02 4.42 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.54 -14.48 11.56 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.958 1.772 . . . . 0.0 111.982 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 65.9 t0 -84.54 -20.28 31.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -85.82 81.27 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.538 . . . . 0.0 110.214 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.547 ' C ' ' H ' ' A' ' 173' ' ' VAL . 95.4 m95 -75.77 -15.16 60.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.898 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.624 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 40.7 mp0 -51.99 -6.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.146 0.498 . . . . 0.0 110.968 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 171' ' ' TRP . 73.2 t -88.65 -19.06 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.163 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.68 -6.29 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.488 0.661 . . . . 0.0 109.383 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -82.07 150.9 27.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.18 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -60.72 127.29 30.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 25.9 m170 -116.44 24.3 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.77 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 15.62 68.05 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -149.64 167.89 25.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 111.183 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.65 97.84 8.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.717 0.77 . . . . 0.0 110.734 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.73 135.09 45.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.36 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.4 tt -82.62 147.96 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 173' ' ' VAL . 7.3 m -136.5 117.54 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.931 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 184' ' ' LEU . 10.4 mp -101.73 124.19 46.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.071 0.462 . . . . 0.0 110.174 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 110' ' ' VAL . 13.8 pt -137.38 -176.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.06 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.551 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 43.0 p . . . . . 0 CA--C 1.534 0.362 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.1 ttm180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.177 0.513 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -108.66 139.12 43.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.395 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 164' ' ' SER . 3.4 p -135.35 139.04 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.394 0.616 . . . . 0.0 111.467 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.53 130.63 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.79 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.81 135.65 53.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.263 0.554 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.52 153.71 20.56 Favored Glycine 0 N--CA 1.46 0.292 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 50.5 p-10 -108.18 142.27 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.728 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.08 127.87 34.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.413 0.625 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 159' ' ' ALA . 91.7 t -107.84 -26.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.186 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.16 162.17 20.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 25.5 m -136.88 156.17 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.245 0.545 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.522 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.1 pttp -150.9 179.13 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.08 142.87 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.401 0.62 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -61.97 81.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.561 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttp . . . . . 0 C--N 1.313 -0.983 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.57 178.427 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.493 1.479 0 CA-C-O 120.988 0.328 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -73.42 158.36 35.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.227 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -54.71 -25.85 30.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.893 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.32 91.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.5 mt-10 -75.08 -26.08 59.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.235 0.541 . . . . 0.0 110.474 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.8 t -79.4 -49.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.942 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.95 81.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.173 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -68.78 -32.1 71.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.334 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.24 113.3 2.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.938 0.399 . . . . 0.0 111.219 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -92.21 133.59 35.67 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.97 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.2 tp -129.57 134.85 47.96 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.757 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -94.02 132.26 38.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.568 ' O ' HG12 ' A' ' 79' ' ' VAL . 69.5 mmtt -66.34 -9.5 33.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.474 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 79' ' ' VAL . 63.7 mttp -65.44 -34.37 78.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.835 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.23 17.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.8 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.8 p -92.31 127.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pt -122.45 -2.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.03 38.49 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.479 ' O ' HD23 ' A' ' 149' ' ' LEU . 32.4 mtm180 -147.88 153.28 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.854 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 83' ' ' ILE . 16.1 tt -124.69 122.27 63.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m -121.35 127.96 51.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.584 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.4 mt -133.75 120.42 15.47 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.81 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.84 -32.33 1.55 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.829 1.686 . . . . 0.0 112.331 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.1 p -47.87 -37.39 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.975 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.7 p -118.32 0.12 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.476 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t 63.49 52.79 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -119.54 133.07 55.84 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -135.31 119.74 17.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 mt -145.46 167.32 14.68 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.023 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.94 150.09 7.09 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.886 2.391 . . . . 0.0 109.652 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.6 t -102.18 113.91 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.45 -45.05 85.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.972 0.415 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.5 p -71.33 106.91 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.232 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.7 p -83.79 107.14 16.02 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.094 0.473 . . . . 0.0 110.234 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.481 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 3.8 p -137.43 156.59 48.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.113 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -57.86 -36.45 72.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -74.72 -43.65 53.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.387 0.613 . . . . 0.0 112.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.481 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 92.3 m-20 -66.43 -35.45 80.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.441 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 126' ' ' HIS . 36.4 mt -65.56 -15.93 63.19 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.65 -14.18 60.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.8 m -116.53 -7.41 11.63 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.0 -163.83 28.74 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.117 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -101.49 130.33 47.74 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.083 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.25 147.91 34.02 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.3 p -76.47 153.79 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.06 -46.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -92.18 142.16 27.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.123 0.487 . . . . 0.0 111.179 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.4 pt-20 -62.58 -51.41 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.662 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 8.4 m120 -96.75 47.88 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.379 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -83.59 154.22 23.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.79 130.25 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.595 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.43 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.1 mtt -72.61 128.39 35.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.762 0.315 . . . . 0.0 110.948 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.522 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.19 4.91 73.7 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -140.93 120.65 13.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.257 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.64 -166.9 54.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -85.07 106.29 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.57 101.18 11.91 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.93 130.82 36.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.991 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.92 132.21 53.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.09 137.72 46.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.351 0.596 . . . . 0.0 110.596 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.404 ' HA3' ' CD2' ' A' ' 135' ' ' PHE . . . -145.19 -176.5 19.22 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.517 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 103' ' ' LEU . 76.3 m-70 -93.28 157.51 16.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.826 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.0 p-10 -122.05 29.04 7.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.585 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.2 mmt -38.15 -20.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.636 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 59.93 37.44 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.275 0.56 . . . . 0.0 109.836 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 136' ' ' SER . 58.3 tttp -136.49 107.73 6.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.767 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.469 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -58.4 130.24 45.81 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.59 0.71 . . . . 0.0 111.249 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.02 15.61 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.176 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 134' ' ' LEU . 2.0 t -96.97 177.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.616 ' H ' HG12 ' A' ' 133' ' ' VAL . 1.3 pt? -71.62 136.38 47.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.754 0.788 . . . . 0.0 112.355 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.4 m-85 46.45 31.92 1.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.429 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.0 p -81.75 -6.03 58.68 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.7 m-20 -146.97 43.1 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.091 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.9 pt -69.97 -30.69 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.261 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.06 7.28 2.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 t -95.56 -14.71 23.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.14 123.72 18.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.81 154.21 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.62 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.93 130.61 47.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.64 21.99 41.55 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 37.7 m-20 -87.0 134.77 33.45 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -81.5 129.64 34.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.529 0.68 . . . . 0.0 112.147 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 90.1 mt -123.39 123.92 68.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.817 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -105.05 121.84 44.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.344 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 82' ' ' ARG . 2.3 mt -113.0 153.17 28.49 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.167 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -127.2 131.23 50.71 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.344 0.592 . . . . 0.0 111.756 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 42.0 t0 -115.04 -168.06 1.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.7 m120 -20.87 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.082 0.468 . . . . 0.0 112.137 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -140.17 25.32 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -122.83 142.3 50.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -106.33 122.08 45.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.87 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.47 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.3 m-85 -104.01 126.62 51.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.987 0.422 . . . . 0.0 111.667 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.66 117.12 29.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 19.6 m-85 -116.55 147.11 42.13 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.381 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.57 134.83 53.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 110.489 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 55.7 t -70.15 133.61 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.706 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.7 p -101.1 -25.4 14.05 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 124.51 1.131 . . . . 0.0 110.349 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.08 156.3 7.99 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.356 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.34 147.82 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.639 -0.781 . . . . 0.0 109.871 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.2 p -148.64 159.59 43.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.173 0.511 . . . . 0.0 111.334 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.81 119.6 39.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.437 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.09 159.84 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.1 p -76.72 142.92 70.68 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.42 -18.55 3.76 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.89 1.727 . . . . 0.0 111.836 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -83.44 -6.67 59.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -83.36 70.63 10.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.263 0.554 . . . . 0.0 110.331 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.498 ' C ' ' H ' ' A' ' 173' ' ' VAL . 85.0 m95 -71.46 -28.53 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.57 -11.36 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.058 0.456 . . . . 0.0 110.475 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 171' ' ' TRP . 43.9 t -80.48 -22.68 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.72 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -110.08 -6.86 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.756 0.788 . . . . 0.0 109.282 -178.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.01 137.08 37.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.981 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 39.9 p-10 -51.97 127.28 20.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.962 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -104.86 -43.39 5.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.46 26.33 0.1 Allowed Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -152.85 173.37 15.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.244 0.545 . . . . 0.0 111.157 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 11.5 m-20 -94.23 89.39 5.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.049 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -128.89 127.28 41.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.678 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.0 tt -82.42 146.81 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.453 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.1 m -135.91 119.31 16.83 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.547 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -105.75 124.73 50.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.012 0.434 . . . . 0.0 109.912 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.538 HD13 HG11 ' A' ' 174' ' ' VAL . 8.9 pt -135.88 173.2 14.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.79 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.176 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.689 0.28 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -102.92 131.25 49.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.6 p -133.79 137.47 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.02 130.35 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.44 136.92 52.48 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.593 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.73 147.99 19.36 Favored Glycine 0 N--CA 1.466 0.671 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -100.84 140.87 34.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.02 -0.59 . . . . 0.0 112.163 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 49.5 tp -64.46 129.44 39.89 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.212 0.529 . . . . 0.0 110.291 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 159' ' ' ALA . 64.5 t -107.72 -27.07 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.125 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.35 20.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.202 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.47 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 34.6 m -135.04 156.06 49.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.201 0.524 . . . . 0.0 109.814 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 206' ' ' THR . 20.6 ptmt -149.53 180.0 7.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.903 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.66 145.48 24.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.225 0.536 . . . . 0.0 110.787 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -74.51 81.17 1.95 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.647 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.642 178.845 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.49 1.321 0 CA-C-O 121.023 0.343 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.5 m-20 -75.51 158.67 32.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.23 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.05 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.198 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.05 -52.46 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.76 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 5.2 pt-20 -74.08 -17.84 60.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 65' ' ' ASP . 49.3 t -77.69 -54.73 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.903 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.38 84.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.272 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.55 110.77 1.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.793 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.6 m -94.35 120.48 34.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.1 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.514 HD11 ' OE1' ' A' ' 78' ' ' GLN . 41.7 tp -113.84 129.08 56.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.61 139.82 55.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -73.31 -8.72 57.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.24 0.543 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.48 -32.77 74.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.514 ' OE1' HD11 ' A' ' 74' ' ' LEU . 85.7 mt-30 -77.17 11.48 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.1 t -91.34 123.72 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -122.42 -5.21 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.984 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.25 -169.61 38.62 Favored Glycine 0 C--N 1.316 -0.54 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -146.48 154.01 41.08 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.251 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.9 tt -121.89 124.54 71.6 Favored 'Isoleucine or valine' 0 C--O 1.23 0.056 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -127.53 130.86 49.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -133.63 129.13 20.31 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.569 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -35.89 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.392 2.061 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -49.41 -40.19 35.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.529 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -119.57 -0.94 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.241 0.216 . . . . 0.0 110.819 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.33 52.14 3.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.2 tp -110.61 130.7 55.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.045 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -133.21 114.83 14.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 83' ' ' ILE . 50.4 mt -143.92 110.51 5.17 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.73 136.7 1.88 Allowed 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.6 1.533 . . . . 0.0 110.764 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.71 123.07 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.9 mt -103.4 131.0 50.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.34 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 97' ' ' SER . 20.1 pttp -72.44 -42.84 64.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.464 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 55.5 m -74.68 103.13 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.245 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.5 p -82.36 94.41 7.37 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.281 0.562 . . . . 0.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.4 p -134.31 154.38 51.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.903 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -56.46 -37.35 70.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -71.86 -46.28 58.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.501 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.51 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 75.2 m-20 -66.2 -36.3 82.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.561 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.69 -16.18 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.721 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.0 mt -70.13 -27.61 64.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -93.36 -10.27 35.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 167.51 -174.43 42.61 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.983 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.46 130.17 38.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.294 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 147.46 29.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.865 0.364 . . . . 0.0 110.876 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.0 p -73.14 149.45 43.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.88 -43.24 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.74 141.36 28.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.18 0.514 . . . . 0.0 111.183 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.21 -16.09 41.37 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.56 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -144.27 56.51 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.31 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.45 ' NE2' ' CG ' ' A' ' 121' ' ' TYR . 3.0 tt0 -77.9 159.84 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.0 121.81 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.016 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -72.77 128.02 34.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.443 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.86 73.45 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -142.13 121.53 13.19 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 76.17 -174.71 53.13 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.491 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.9 t30 -83.79 110.43 18.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.45 ' CG ' ' NE2' ' A' ' 114' ' ' GLN . 6.8 t80 -83.52 103.59 12.98 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 130.4 36.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.109 0.48 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 HD12 ' A' ' 83' ' ' ILE . 7.9 mt -127.42 130.65 49.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.89 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.31 140.19 46.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 110.578 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.2 179.65 20.56 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.615 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -84.81 154.78 22.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.792 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 129' ' ' SER . 14.8 p30 -121.97 29.18 7.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.655 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.3 mtt -43.46 -13.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.776 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 61.78 38.35 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.935 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -135.11 107.7 7.4 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.89 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.29 125.61 12.93 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.634 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.73 8.97 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.927 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.5 t -83.48 179.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.584 0.692 . . . . 0.0 109.183 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.778 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.42 132.45 43.93 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.436 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 49.13 38.08 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.219 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.17 -12.31 58.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.8 m-20 -147.98 34.06 0.83 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 140' ' ' SER . 7.3 pt -68.87 -32.19 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.425 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.63 2.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.706 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 138' ' ' ILE . 8.5 t -93.5 -14.86 26.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.48 120.29 12.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.069 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mmtt -104.93 155.72 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -53.68 114.81 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.214 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.22 21.58 5.17 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 96.9 m-20 -99.16 128.02 45.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.94 133.14 35.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.792 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 93.1 mt -126.39 125.72 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.927 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.9 123.13 48.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.725 0.298 . . . . 0.0 110.759 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -112.48 146.36 38.59 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.067 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -116.05 131.16 57.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 152' ' ' ASN . 46.9 t0 -114.27 -166.52 1.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.6 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 111.852 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -138.41 29.86 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -128.96 145.23 51.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -111.52 121.78 46.08 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -102.73 133.51 47.64 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 111.513 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.1 118.08 31.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.765 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.416 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 41.3 m-85 -119.06 140.25 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.155 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.46 134.82 55.22 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.51 0.672 . . . . 0.0 110.449 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.29 135.64 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.733 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -101.46 -24.54 14.15 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 124.888 1.367 . . . . 0.0 110.764 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.58 154.08 7.32 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.294 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 163' ' ' VAL . 9.9 p -98.45 129.41 48.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.832 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.4 m -132.01 149.53 52.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.296 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -109.18 116.64 32.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.343 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -133.95 153.17 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.9 p -64.56 169.09 5.51 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 -13.87 11.81 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.884 1.723 . . . . 0.0 111.71 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.58 -19.66 41.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.639 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -85.79 75.34 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 109.944 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -74.74 -9.63 58.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.041 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -53.4 -22.47 7.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.78 ' O ' HG21 ' A' ' 183' ' ' THR . 79.9 t -81.03 -10.82 12.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.049 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.13 -12.08 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.739 0.78 . . . . 0.0 110.178 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.11 157.81 20.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.376 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 66.2 t0 -66.54 131.17 45.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.42 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 31.3 m80 -101.26 -41.63 6.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.35 29.9 0.24 Allowed Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.448 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 48.5 pttt -157.44 179.25 9.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.547 . . . . 0.0 111.515 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 26.7 p30 -90.81 88.81 7.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.866 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -123.63 166.56 15.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.128 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.85 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.78 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.78 HG21 ' O ' ' A' ' 173' ' ' VAL . 19.0 m -135.7 123.85 23.02 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.059 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 183' ' ' THR . 10.2 mp -111.79 125.09 53.63 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.129 0.49 . . . . 0.0 110.078 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.477 HG22 HG13 ' A' ' 198' ' ' VAL . 36.2 pt -134.32 162.1 39.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.001 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 64.6 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.413 179.225 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -110.63 138.72 46.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.303 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.503 HG11 HG11 ' A' ' 173' ' ' VAL . 50.1 t -133.33 136.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.23 128.43 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.562 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.63 136.52 52.9 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.331 0.586 . . . . 0.0 110.314 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.09 158.01 24.08 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.598 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 63.1 t0 -113.77 146.3 40.11 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.568 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.0 tp -68.04 130.82 44.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.062 0.458 . . . . 0.0 110.716 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.77 -22.85 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.5 175.89 45.96 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.329 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 207' ' ' LYS . 60.9 m -154.23 154.13 32.94 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.344 0.592 . . . . 0.0 111.014 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 206' ' ' THR . 63.8 pttt -148.33 177.58 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.524 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.69 142.78 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.061 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.23 80.81 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.272 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 208' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.55 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.251 0 CA-C-O 121.068 0.362 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -75.68 158.05 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 66' ' ' LEU . 1.7 tt -57.09 -28.77 62.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.069 0.461 . . . . 0.0 110.095 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.52 97.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.647 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 97.7 mt-10 -73.63 -31.46 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.327 0.584 . . . . 0.0 110.789 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.8 t -75.48 -46.38 37.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.783 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.25 87.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.926 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.4 -30.37 64.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.342 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.56 119.68 9.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.811 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 m -93.21 156.51 16.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -138.29 122.1 17.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.918 0.389 . . . . 0.0 110.81 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.634 ' N ' HD13 ' A' ' 74' ' ' LEU . 99.2 m-20 -83.55 108.74 16.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 11.7 mptt -47.71 -15.39 0.06 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.082 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.479 ' N ' ' C ' ' A' ' 75' ' ' ASP . 99.2 mttt -69.51 -8.26 45.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.77 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.61 6.45 48.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.923 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.1 t -91.06 128.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.942 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.2 -6.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.728 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.61 -167.47 35.28 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 83' ' ' ILE . 19.4 ttm180 -150.96 157.0 42.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.402 0.62 . . . . 0.0 111.07 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.4 ' N ' ' CG ' ' A' ' 82' ' ' ARG . 15.8 tt -129.88 134.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.979 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.1 t -131.53 133.3 44.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.951 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.6 mt -136.0 127.92 17.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.329 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.21 -33.08 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.41 2.073 . . . . 0.0 112.02 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -49.12 -41.93 37.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.586 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -116.09 -1.69 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.8 -0.182 . . . . 0.0 110.878 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 64.38 50.04 2.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.8 tp -113.47 130.9 56.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.259 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -134.77 116.06 14.43 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.9 mt -143.7 163.28 37.06 Favored Pre-proline 0 N--CA 1.463 0.183 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.737 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.5 157.5 6.53 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.981 2.454 . . . . 0.0 109.235 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.0 t -107.01 117.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.0 mt -101.21 129.99 47.24 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -71.06 -36.99 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.986 0.422 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.0 m -75.54 100.12 4.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 98' ' ' SER . 53.5 p -82.85 92.93 7.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.531 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 5.2 p -133.81 155.87 49.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.016 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -55.36 -32.67 62.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.402 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -76.57 -46.5 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.003 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.531 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 97.4 m-20 -66.25 -34.45 78.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.832 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.92 -18.88 59.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.63 -18.24 61.6 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.8 m -99.9 -11.25 20.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.53 -155.88 25.77 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.973 -1.108 . . . . 0.0 111.658 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.29 126.17 36.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.889 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.95 144.26 32.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -75.55 152.96 37.68 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.44 -47.96 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -92.44 137.64 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 110.853 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 14.2 pt-20 -62.89 -47.11 84.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.869 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 61.6 t-20 -96.74 47.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.404 ' NE2' ' CE1' ' A' ' 121' ' ' TYR . 3.2 tt0 -91.55 155.38 18.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.4 t -130.27 133.79 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.202 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.6 mtp -73.51 126.24 29.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.704 0.288 . . . . 0.0 110.474 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.31 67.43 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.26 120.08 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.092 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.21 -178.31 41.32 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -73.82 107.43 6.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.404 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 10.6 t80 -84.26 103.51 13.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.97 126.55 35.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.122 0.486 . . . . 0.0 111.495 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -121.4 131.31 54.1 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.69 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 139.17 45.01 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.311 0.577 . . . . 0.0 110.662 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.78 15.17 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.701 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -92.44 146.09 23.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.726 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.8 p30 -108.01 27.53 9.16 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.293 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -42.18 -16.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.701 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 127' ' ' ASN . 2.6 t 55.06 37.14 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.812 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -133.87 111.96 10.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.458 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.67 123.66 14.83 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.152 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.43 5.93 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 134' ' ' LEU . 41.8 t -137.37 177.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.761 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -69.76 128.0 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.758 0.313 . . . . 0.0 110.644 -178.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 47.41 38.5 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 110.468 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.39 -6.02 59.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.723 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.6 t0 -151.16 39.97 0.69 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.071 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.0 pt -69.02 -30.18 45.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.49 4.14 3.28 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 49.6 m -95.69 -14.48 23.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 109.749 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.01 124.81 23.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.529 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -96.73 156.57 16.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.755 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.21 128.8 38.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.415 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.5 20.81 43.1 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.403 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 30.0 m-20 -82.36 136.36 35.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.495 ' NZ ' HG11 ' A' ' 204' ' ' VAL . 27.9 mmtt -80.35 126.63 31.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 112.1 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.68 118.01 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 121.3 41.26 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.2 tp -114.28 142.84 45.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.984 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.17 136.42 44.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.242 0.544 . . . . 0.0 111.468 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 154' ' ' ASN . 40.9 t0 -113.0 177.0 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.347 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' A' ' 153' ' ' GLU . 19.4 p-10 -35.79 -54.46 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.409 0.623 . . . . 0.0 111.338 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 97.7 mt-10 -141.69 16.56 2.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -128.63 142.42 51.04 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -109.35 124.02 50.28 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CE2' HG21 ' A' ' 206' ' ' THR . 56.7 m-85 -106.55 134.99 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.388 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.73 118.49 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.408 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -115.88 138.0 51.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.246 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.78 132.58 55.11 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.429 0.633 . . . . 0.0 110.822 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 48.6 t -66.98 134.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.7 p -101.75 -28.33 12.52 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 124.443 1.089 . . . . 0.0 110.799 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.44 143.73 4.39 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.775 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.43 137.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 18.8 t -159.56 171.11 20.24 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.136 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -122.53 130.27 52.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.426 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.12 157.37 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.492 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 169' ' ' ASP . 6.8 p -68.56 130.18 92.16 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.452 ' HG3' HH21 ' A' ' 196' ' ' ARG . 1.5 Cg_endo -46.38 -11.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.921 1.747 . . . . 0.0 111.648 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 167' ' ' THR . 43.1 t0 -75.69 -22.2 56.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -84.82 73.15 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.009 0.433 . . . . 0.0 110.134 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -71.69 -14.66 62.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.513 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.479 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.5 mt-10 -52.97 -34.38 55.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.216 0.531 . . . . 0.0 110.074 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.714 ' O ' HG21 ' A' ' 183' ' ' THR . 97.2 t -70.94 -5.22 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.024 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.77 -14.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.678 0.751 . . . . 0.0 109.969 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -86.2 177.16 7.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.835 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.3 p-10 -81.74 131.66 35.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.479 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 42.9 m80 -103.21 -41.76 5.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.9 27.13 0.13 Allowed Glycine 0 N--CA 1.471 0.98 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -157.47 179.56 9.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 111.411 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -89.98 90.25 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -121.01 166.93 13.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.081 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.9 tt -132.32 144.07 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.714 HG21 ' O ' ' A' ' 173' ' ' VAL . 18.8 m -135.72 126.37 27.15 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.196 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -112.55 118.23 34.52 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.409 HG22 HG13 ' A' ' 198' ' ' VAL . 12.0 pt -134.3 171.67 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.643 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.57 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.3 p . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.716 0.293 . . . . 0.0 110.892 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.57 ' NH1' ' O ' ' A' ' 186' ' ' THR . 16.7 ptp180 . . . . . 0 N--CA 1.463 0.211 0 CA-C-O 120.961 0.41 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.34 140.66 44.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.409 HG13 HG22 ' A' ' 185' ' ' ILE . 47.4 t -129.61 132.17 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.132 0.492 . . . . 0.0 111.14 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.7 t -116.22 127.31 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.512 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.19 135.56 53.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.92 157.5 25.37 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 60.6 t0 -115.11 152.49 32.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.446 -0.377 . . . . 0.0 111.161 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.562 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.95 129.24 38.09 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.085 0.469 . . . . 0.0 110.767 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.495 HG11 ' NZ ' ' A' ' 146' ' ' LYS . 5.1 p -107.81 -25.97 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.011 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.68 175.29 47.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.219 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.428 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.5 m -152.67 150.26 29.28 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.194 0.521 . . . . 0.0 110.883 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -148.62 178.0 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.538 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.97 21.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.151 0.5 . . . . 0.0 110.817 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -77.08 79.82 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.744 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.561 178.422 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.483 0.863 0 N-CA-C 110.984 -0.429 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -74.58 160.29 31.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.1 mp -64.66 -21.31 66.7 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.251 0.344 . . . . 0.0 110.862 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.73 -40.28 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.49 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.3 mt-10 -72.29 -34.91 68.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.623 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.8 t -75.07 -45.2 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.074 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.5 87.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.02 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -84.04 -23.31 30.96 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.621 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.23 118.98 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.336 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -94.78 140.75 29.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.198 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 ' CB ' ' A' ' 105' ' ' SER . 57.4 tp -115.42 140.71 48.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.452 ' C ' ' N ' ' A' ' 77' ' ' LYS . 39.2 m-20 -95.11 100.92 12.65 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -46.89 -18.06 0.06 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.452 ' N ' ' C ' ' A' ' 75' ' ' ASP . 3.2 ttmp? -65.95 -33.8 76.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.312 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 0.9 OUTLIER -80.08 13.94 2.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.817 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.467 HG11 ' NH1' ' A' ' 82' ' ' ARG . 89.1 t -91.49 127.48 43.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.633 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.15 -6.31 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.106 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.83 -173.19 43.94 Favored Glycine 0 C--N 1.321 -0.284 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.497 ' O ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -141.87 153.94 44.79 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.841 -177.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.8 tt -125.75 131.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 t -134.01 132.02 39.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.692 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.17 128.74 19.6 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.17 -36.67 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.412 2.075 . . . . 0.0 112.376 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -48.4 -39.98 24.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.51 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.3 p -119.31 -1.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.372 0.42 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.75 50.24 4.46 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.11 131.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.574 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.79 114.66 12.09 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 83' ' ' ILE . 76.2 mt -142.53 112.35 5.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -40.05 140.61 0.79 Allowed 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.661 1.574 . . . . 0.0 110.302 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.6 t -93.15 122.02 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.66 123.47 48.55 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.484 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.06 -47.8 76.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.184 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -71.7 105.88 3.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.878 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -85.8 100.95 12.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.5 p -131.75 156.96 45.05 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.104 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.66 -28.99 61.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -82.87 -42.39 17.82 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.882 0.739 . . . . 0.0 111.936 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.63 -38.09 88.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.136 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.62 -19.76 62.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.061 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.49 -33.17 70.93 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.45 ' CB ' HD22 ' A' ' 74' ' ' LEU . 16.2 m -95.58 -9.47 32.19 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 177.43 179.57 47.73 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.254 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.89 127.82 33.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.948 -0.626 . . . . 0.0 109.84 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.63 146.14 31.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.4 p -76.4 153.87 35.34 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.0 t -85.43 -48.18 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -92.26 137.72 32.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.41 0.624 . . . . 0.0 110.698 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.9 pt-20 -60.32 -47.6 85.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.161 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 98.8 m-20 -98.8 47.41 0.98 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.39 155.45 21.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.964 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.9 131.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.409 ' SD ' HD22 ' A' ' 149' ' ' LEU . 65.3 mtt -74.98 128.0 34.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.11 0.54 70.94 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -139.36 118.15 12.38 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.017 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -171.86 53.65 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -83.66 110.81 18.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.1 102.9 13.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 128.99 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.597 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.5 HD13 HD12 ' A' ' 83' ' ' ILE . 6.5 mt -123.96 130.45 52.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.331 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.92 138.21 47.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.318 0.58 . . . . 0.0 110.806 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.36 -179.05 17.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.259 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 134' ' ' LEU . 37.5 m-70 -86.46 144.44 27.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.455 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 129' ' ' SER . 8.1 t-20 -110.99 28.19 8.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.061 0.458 . . . . 0.0 110.652 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -47.37 -11.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.11 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 127' ' ' ASN . 2.3 t 56.1 40.67 30.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.024 -0.671 . . . . 0.0 109.928 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.31 105.93 7.6 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -50.42 124.94 11.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.614 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -26.4 9.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.374 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.803 HG12 ' H ' ' A' ' 134' ' ' LEU . 39.7 t -82.82 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.803 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -72.88 132.33 43.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 48.85 37.79 10.68 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.93 0.395 . . . . 0.0 111.345 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -82.12 -11.4 58.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 136' ' ' SER . 83.7 m-20 -145.51 38.13 1.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -66.09 -36.13 76.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB2' ' CG ' ' A' ' 197' ' ' TYR . . . -68.48 3.08 1.95 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.815 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 138' ' ' ILE . 6.3 t -96.49 -11.19 25.88 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.279 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.39 122.26 18.03 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.538 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 64.4 mttp -95.57 161.46 14.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.391 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -61.12 135.12 57.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.46 19.08 57.61 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 2.6 m-20 -85.1 130.05 34.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.88 131.09 35.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.2 mt -122.57 123.09 67.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -100.63 118.67 37.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.5 mt -113.53 149.15 34.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.194 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -124.64 130.26 52.09 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.433 0.635 . . . . 0.0 111.416 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.7 t0 -113.52 -168.52 1.35 Allowed 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 16.9 m120 -24.86 -71.69 0.03 OUTLIER 'General case' 0 C--O 1.232 0.154 0 O-C-N 123.475 0.485 . . . . 0.0 111.579 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.62 26.6 2.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.25 146.87 44.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -111.74 118.7 36.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.735 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.492 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.7 m-85 -105.44 127.99 53.29 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.571 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -98.82 122.75 42.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.926 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -122.08 142.32 50.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 135.02 55.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.335 0.588 . . . . 0.0 110.703 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.7 133.35 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.51 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.1 t -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.64 1.212 . . . . 0.0 111.515 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.32 149.95 6.51 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.3 t -104.8 134.38 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -135.66 151.31 50.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.444 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.72 116.87 32.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.634 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.77 154.84 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 169' ' ' ASP . 23.4 p -78.16 140.46 61.5 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.59 -18.26 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.975 1.783 . . . . 0.0 111.867 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.7 m-20 -77.4 -21.19 53.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.025 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -83.03 70.54 10.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.119 0.568 . . . . 0.0 110.176 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.528 ' C ' ' H ' ' A' ' 173' ' ' VAL . 82.0 m95 -70.48 -27.04 63.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.944 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.4 -10.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.631 0.582 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.5 t -80.95 -23.69 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.501 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.01 -5.33 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.588 0.708 . . . . 0.0 110.015 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.35 142.06 36.38 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.925 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -54.84 128.98 35.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -102.4 -42.72 5.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.49 28.52 0.15 Allowed Glycine 0 N--CA 1.471 0.985 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -157.15 179.76 8.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.999 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 8.1 m-20 -93.87 94.12 8.32 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 182' ' ' ILE . 46.1 tt0 -127.54 170.87 12.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.906 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.409 ' H ' ' HG2' ' A' ' 181' ' ' GLU . 20.6 tt -131.63 143.19 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.709 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.496 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.7 m -138.29 116.89 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -102.38 119.59 39.08 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.605 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -130.97 -169.97 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.379 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 31.0 p . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.376 -178.857 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.45 0.167 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' A' ' 139' ' ' ALA . 4.9 m-85 -117.3 132.44 56.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.528 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 185' ' ' ILE . 48.3 t -135.6 136.57 50.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.091 0.472 . . . . 0.0 111.046 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.96 129.65 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.673 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.66 133.39 55.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.144 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.77 146.62 17.1 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 121.807 0.671 . . . . 0.0 111.706 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -105.32 139.12 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.714 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.18 129.16 38.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.937 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 p -106.41 -25.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.073 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.27 159.6 16.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.453 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.492 HG21 ' CE2' ' A' ' 156' ' ' TYR . 29.9 m -135.7 155.02 51.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.86 177.78 9.51 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.3 144.34 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.551 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.07 79.09 0.67 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.023 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.548 178.813 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.486 1.057 0 N-CA-C 111.262 -0.322 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.99 152.51 41.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.691 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.2 pt? -59.0 -23.98 62.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.402 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.6 mt-10 -73.07 -33.07 65.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.606 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.3 -42.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.1 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.09 92.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.405 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.1 p-10 -86.31 -15.14 41.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.669 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.08 120.27 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.107 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.2 p -91.39 159.55 15.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.11 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.11 142.57 44.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -94.12 100.51 12.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -57.23 -14.93 4.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.049 0.452 . . . . 0.0 110.347 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -76.44 -14.55 60.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.146 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.47 13.17 34.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.529 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.13 135.99 24.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.988 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.408 HD13 ' HB3' ' A' ' 96' ' ' LYS . 4.4 pt -117.5 -3.55 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.035 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.63 34.86 Favored Glycine 0 C--N 1.317 -0.518 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -154.05 165.26 36.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.808 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 tt -134.3 140.96 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.891 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 t -133.52 135.79 44.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.362 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 14.0 mt -134.58 127.77 18.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.802 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.55 -38.34 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.357 2.038 . . . . 0.0 112.584 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -47.37 -41.01 18.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.599 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.4 p -116.69 -3.31 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.828 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.83 49.46 1.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -107.49 127.3 53.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.865 -178.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.649 ' N ' HD13 ' A' ' 90' ' ' LEU . 83.2 tt0 -138.16 116.14 11.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.645 HD23 ' HD2' ' A' ' 93' ' ' PRO . 2.7 mt -157.71 127.52 3.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.471 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.645 ' HD2' HD23 ' A' ' 92' ' ' LEU . 1.3 Cg_endo -42.96 159.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.929 0 C-N-CA 121.928 1.752 . . . . 0.0 109.703 176.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 t -113.61 124.66 70.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.11 128.89 49.86 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.217 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HB3' HD13 ' A' ' 80' ' ' ILE . 62.8 pttt -65.05 -35.3 80.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.717 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -176.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.632 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 p -162.51 55.48 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.699 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 7.0 p -105.68 160.03 15.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.151 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.48 -32.33 71.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.603 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.4 -41.85 55.2 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.85 0.719 . . . . 0.0 112.26 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 98.3 m-20 -65.82 -39.92 91.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.553 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.9 mt -59.78 -19.82 52.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.87 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.467 HD23 ' NE2' ' A' ' 126' ' ' HIS . 15.8 mt -69.25 -34.85 75.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.0 m -97.16 -7.71 31.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -179.0 -174.6 45.33 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . . . -83.58 127.95 34.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.12 -0.54 . . . . 0.0 109.882 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.422 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.38 141.61 36.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.768 0.318 . . . . 0.0 110.715 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.4 p -71.87 147.54 47.02 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.77 -47.68 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -92.03 -170.47 2.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.657 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 113' ' ' ASN . 1.6 pt-20 -113.19 -53.86 2.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.951 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.456 ' H ' ' HG3' ' A' ' 112' ' ' GLU . 89.0 m-20 -94.42 44.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -93.37 154.54 17.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.71 133.9 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.816 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.458 ' SD ' HD22 ' A' ' 149' ' ' LEU . 68.5 mtt -69.66 128.39 36.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.989 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.481 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.68 1.33 77.49 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.6 123.44 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.974 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.19 -164.36 54.34 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -94.64 108.68 20.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -84.91 100.87 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.043 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 124.63 35.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.511 . . . . 0.0 111.722 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.94 132.02 54.33 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.322 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.6 138.9 45.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.375 0.607 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.69 -176.26 16.63 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.43 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 135' ' ' PHE . 15.3 m-70 -86.11 141.79 29.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.815 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 129' ' ' SER . 32.1 t30 -109.86 26.88 10.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.214 0.531 . . . . 0.0 110.481 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -46.34 -14.29 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.778 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 129' ' ' SER . 1.4 p 55.2 41.15 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.822 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 136' ' ' SER . 30.5 mmtm -133.91 129.25 36.06 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.653 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -74.24 124.52 26.56 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.41 -28.24 6.61 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 134' ' ' LEU . 4.2 t -78.04 170.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.22 133.16 40.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.685 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 126' ' ' HIS . 3.6 m-85 49.27 38.74 14.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 1.1 p -80.33 -61.26 2.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.282 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 136' ' ' SER . 97.9 m-20 -89.35 39.7 0.95 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.7 pt -69.78 -26.72 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.241 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.42 6.81 5.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.0 t -95.33 -13.64 24.59 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.26 118.74 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -98.4 161.57 13.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.741 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -58.38 118.54 5.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.133 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.95 21.06 7.63 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 90.9 m-20 -96.65 127.99 43.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -80.58 138.31 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.956 0.408 . . . . 0.0 111.332 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 158' ' ' TYR . 97.5 mt -129.4 123.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -101.76 119.22 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.996 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.458 HD22 ' SD ' ' A' ' 116' ' ' MET . 2.7 mt -110.0 158.15 18.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.346 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 149' ' ' LEU . 66.6 m-85 -141.63 121.22 13.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.092 0.472 . . . . 0.0 111.859 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 152' ' ' ASN . 13.3 t0 -114.64 -166.11 1.08 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.579 ' C ' ' O ' ' A' ' 151' ' ' ASP . 95.1 m-20 -4.4 -88.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.857 0.723 . . . . 0.0 111.32 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -138.99 30.83 2.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -121.73 140.96 51.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -102.89 120.78 41.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.196 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.457 ' CE2' HG21 ' A' ' 206' ' ' THR . 90.7 m-85 -105.07 125.21 50.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.725 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -94.19 115.27 27.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.481 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.6 m-85 -117.18 142.82 46.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.224 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.06 132.13 53.98 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.439 0.637 . . . . 0.0 110.501 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.7 135.87 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.269 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 14.2 p -101.75 -25.56 13.79 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.783 1.302 . . . . 0.0 110.99 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.49 177.18 34.35 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.146 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.09 149.1 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.743 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.42 ' O ' HG12 ' A' ' 198' ' ' VAL . 38.9 m -152.59 161.6 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 0.0 111.099 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -99.36 120.93 40.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 196' ' ' ARG . 18.4 m -132.45 157.45 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 169' ' ' ASP . 32.1 p -82.42 135.93 46.41 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.584 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -46.37 -15.1 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.004 1.803 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 67.3 t0 -84.52 -22.61 30.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -83.95 72.42 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.062 0.458 . . . . 0.0 110.928 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 94.1 m95 -74.94 -2.22 26.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.969 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.467 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 72.4 mm-40 -54.19 -39.0 66.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.743 ' O ' HG21 ' A' ' 183' ' ' THR . 17.9 m -75.19 4.57 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.944 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.07 -15.99 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.904 0.859 . . . . 0.0 110.042 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.403 ' O ' ' CD2' ' A' ' 177' ' ' HIS . 63.4 mm-40 -89.21 166.45 13.8 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.972 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -68.18 129.42 39.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.083 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.467 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.0 m170 -103.32 -40.54 6.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.143 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.83 25.23 0.12 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -156.41 179.23 9.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.863 0.363 . . . . 0.0 110.815 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -97.36 93.36 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.802 0.81 . . . . 0.0 110.408 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -127.02 175.16 8.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.407 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -130.38 143.47 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.216 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.743 HG21 ' O ' ' A' ' 173' ' ' VAL . 13.1 m -135.99 123.67 22.38 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.557 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 183' ' ' THR . 10.5 mp -112.19 121.96 46.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.455 0.645 . . . . 0.0 110.982 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.27 -174.84 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.829 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.546 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 15.4 p . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.368 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 186' ' ' THR . 39.1 ttm180 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.57 140.96 35.52 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 164' ' ' SER . 2.9 p -140.71 144.54 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.72 0.295 . . . . 0.0 111.425 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.63 129.91 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.204 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -121.21 138.93 53.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.256 0.551 . . . . 0.0 110.507 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.66 160.96 24.98 Favored Glycine 0 N--CA 1.461 0.337 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.8 t0 -113.55 149.69 34.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.954 -0.623 . . . . 0.0 111.135 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.536 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 21.7 tp -73.42 132.39 42.92 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 159' ' ' ALA . 59.3 t -107.96 -27.1 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.512 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.93 160.37 16.82 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.388 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.457 HG21 ' CE2' ' A' ' 156' ' ' TYR . 28.4 m -136.42 155.6 49.78 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -151.62 179.84 8.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.08 143.19 26.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.461 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.5 81.22 1.95 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.528 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.379 178.693 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.487 1.124 0 CA-C-O 121.166 0.403 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -77.57 163.3 26.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.163 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.631 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.0 pt? -60.16 -21.75 62.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.234 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.23 -39.62 94.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.1 mm-40 -73.76 -30.33 62.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.317 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -77.31 -44.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.799 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.98 85.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 61.3 t-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.75 139.72 57.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.696 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -140.82 84.21 1.93 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 111.361 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.6 tp -82.15 134.64 35.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.21 138.81 55.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.439 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -64.02 -8.73 12.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 109.78 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -64.02 -30.12 71.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.863 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.429 HE22 ' NZ ' ' A' ' 96' ' ' LYS . 22.6 mm100 -76.75 9.87 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.109 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.69 124.41 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -129.8 -3.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.64 -170.55 32.58 Favored Glycine 0 C--N 1.315 -0.607 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' HD2' ' H ' ' A' ' 83' ' ' ILE . 5.3 tpt180 -153.02 151.14 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.837 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 92' ' ' LEU . 5.7 tt -123.39 127.4 74.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -128.3 129.57 46.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.462 HG21 HD21 ' A' ' 141' ' ' LEU . 45.2 mt -135.02 122.26 15.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.284 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -82.28 -33.89 0.49 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.372 2.048 . . . . 0.0 112.877 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.464 ' CB ' HD23 ' A' ' 141' ' ' LEU . 1.6 m -50.38 -36.37 32.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.45 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.628 HG23 HD23 ' A' ' 90' ' ' LEU . 18.7 m -120.17 -6.34 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.634 0.254 . . . . 0.0 110.982 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.84 48.22 0.41 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.628 HD23 HG23 ' A' ' 88' ' ' VAL . 3.7 mm? -109.92 129.69 55.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.839 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.617 ' O ' HD12 ' A' ' 92' ' ' LEU . 97.2 mt-10 -135.34 115.85 13.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.617 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.1 tp -146.35 111.15 4.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.4 Cg_endo -41.02 147.89 0.25 Allowed 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 121.636 1.558 . . . . 0.0 110.529 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.4 t -96.16 124.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.9 145.33 30.55 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' NZ ' HE22 ' A' ' 78' ' ' GLN . 21.8 pttp -90.41 -35.33 15.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.279 0.561 . . . . 0.0 110.961 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.1 p -76.22 97.95 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.117 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -82.66 89.98 6.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.059 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 p -133.14 157.75 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.901 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.89 -29.76 60.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.765 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 11.4 ptpt -83.29 -43.84 15.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.699 HD22 ' N ' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -66.63 -34.21 77.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.635 -178.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.99 -20.93 63.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.433 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.46 -18.79 61.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.6 p -102.42 -13.11 17.41 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.21 -179.43 47.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.165 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.55 125.84 28.43 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.6 143.16 34.14 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.866 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 46.7 p -75.1 154.15 37.96 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.68 -56.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -96.4 141.22 29.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.993 0.425 . . . . 0.0 110.689 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.2 pm0 -82.47 6.65 16.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -131.27 24.89 4.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -93.75 156.16 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.195 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.2 t -133.28 133.89 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.851 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.4 mtt -67.24 127.6 33.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.995 0.426 . . . . 0.0 110.237 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 90.96 2.41 71.68 Favored Glycine 0 C--O 1.23 -0.101 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -141.06 121.87 14.4 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.067 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.18 -168.88 53.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -87.86 110.03 20.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.52 103.67 13.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.88 127.79 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 112.105 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 HD12 ' A' ' 83' ' ' ILE . 6.1 mt -123.54 132.41 53.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.933 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.57 139.08 45.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.402 0.62 . . . . 0.0 110.656 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.74 -176.58 15.01 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.72 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -97.46 141.5 30.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.951 0.405 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' SER . 43.5 p-10 -102.3 27.76 6.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -21.8 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.159 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 62.09 37.29 14.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.477 ' N ' ' OG ' ' A' ' 136' ' ' SER . 63.7 mmtt -133.32 108.02 8.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.769 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -50.66 125.98 14.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.809 0.814 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.02 -30.26 7.83 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.631 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 134' ' ' LEU . 59.4 t -76.02 178.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.355 0 CA-C-N 117.681 0.74 . . . . 0.0 109.437 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.756 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -71.15 136.39 48.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.778 0.323 . . . . 0.0 110.437 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.3 m-85 44.11 32.03 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.324 0.583 . . . . 0.0 110.561 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -81.26 -12.26 59.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 29.4 t0 -142.62 26.45 1.76 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.2 pt -70.16 -25.76 28.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.797 0.332 . . . . 0.0 111.581 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.11 1.11 6.27 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.1 m -95.41 -11.7 27.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.464 HD23 ' CB ' ' A' ' 87' ' ' SER . 18.3 mt -63.9 124.22 20.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.008 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 145' ' ' ASP . 99.2 mttt -96.4 158.17 15.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -56.58 134.87 54.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.185 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.36 19.49 62.24 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 142' ' ' LYS . 28.7 m-20 -81.43 132.73 35.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -79.51 130.33 35.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.274 0.559 . . . . 0.0 111.515 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.6 mt -122.92 121.68 63.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.583 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.4 120.57 40.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.118 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.0 OUTLIER -110.73 158.83 18.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -132.96 128.11 35.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.635 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.517 ' O ' ' C ' ' A' ' 152' ' ' ASN . 44.4 t0 -113.89 -166.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.517 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.3 t-20 -21.95 -74.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.152 0.501 . . . . 0.0 111.929 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.22 27.95 1.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -122.54 144.93 48.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -108.13 122.73 47.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.032 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.469 ' CE2' HG21 ' A' ' 206' ' ' THR . 71.8 m-85 -106.32 127.37 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.822 0.344 . . . . 0.0 111.489 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.62 115.88 28.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.503 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.517 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 22.4 m-85 -117.07 142.24 47.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.308 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.7 134.51 55.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.629 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.5 133.97 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.915 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -102.14 -25.86 13.56 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 124.544 1.153 . . . . 0.0 110.787 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.98 142.34 3.37 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.857 -1.163 . . . . 0.0 111.768 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 141' ' ' LEU . 10.0 t -104.77 152.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.5 t -168.42 178.32 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.4 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.79 115.13 26.52 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.36 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 12.5 m -117.0 139.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.543 ' C ' HH12 ' A' ' 196' ' ' ARG . 66.8 p -54.23 162.6 1.5 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.57 -19.76 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.194 1.929 . . . . 0.0 111.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 34.3 p30 -81.91 -19.31 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 35.1 ttpt -88.13 74.68 8.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 110.503 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -75.27 -6.1 48.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.851 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.7 -24.55 14.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.745 ' O ' HG21 ' A' ' 183' ' ' THR . 94.2 t -78.21 -3.25 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.815 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.65 -12.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.665 0.745 . . . . 0.0 109.814 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -85.6 155.63 21.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.934 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.33 132.14 47.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.62 -39.33 6.41 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.44 28.56 0.17 Allowed Glycine 0 N--CA 1.471 1.012 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -155.1 174.92 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.126 0.489 . . . . 0.0 111.284 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -90.13 89.34 7.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.692 0.758 . . . . 0.0 109.557 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -119.59 168.36 11.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.826 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.7 tt -129.95 141.32 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.226 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.745 HG21 ' O ' ' A' ' 173' ' ' VAL . 11.9 m -137.11 123.4 20.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.178 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.598 HD12 ' C ' ' A' ' 183' ' ' THR . 11.0 mp -112.59 122.75 48.6 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.194 0.521 . . . . 0.0 110.091 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 pt -132.91 168.08 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.689 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.633 -179.995 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 166' ' ' VAL . 35.2 ptt-85 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.895 0.379 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -97.57 131.41 44.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.465 HG21 HG22 ' A' ' 166' ' ' VAL . 42.3 t -131.48 133.57 61.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 111.253 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.0 t -111.28 124.06 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.02 134.16 55.04 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.06 160.88 25.49 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.5 t0 -114.56 151.43 33.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.974 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.65 129.86 38.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.443 0.639 . . . . 0.0 110.755 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 98.7 t -106.34 -24.48 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.161 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.74 163.33 23.59 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.036 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.469 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.7 m -136.6 154.46 50.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.278 0.561 . . . . 0.0 109.975 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -148.99 179.43 7.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.176 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.65 24.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.279 0.562 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.68 80.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.612 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.574 178.644 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 CA-C-O 121.299 0.458 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.18 166.93 20.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.906 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.6 mp -52.02 -28.44 17.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.607 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 71' ' ' ASN . . . -65.43 -39.73 92.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.542 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 71.5 mm-40 -73.81 -31.28 63.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.741 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.83 -45.88 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.821 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.51 78.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.07 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 67' ' ' ALA . 9.3 m120 -69.06 -29.25 67.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.997 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.41 100.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -96.93 111.39 23.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.395 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -111.36 128.6 56.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.567 ' H ' ' NE2' ' A' ' 78' ' ' GLN . 97.8 m-20 -71.97 138.71 48.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.267 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 79' ' ' VAL . 1.3 mppt? -64.43 0.45 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 109.877 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 75' ' ' ASP . 13.2 mptt -92.06 -8.86 44.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.585 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.567 ' NE2' ' H ' ' A' ' 75' ' ' ASP . 76.1 mt-30 -83.17 -6.62 59.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 76' ' ' LYS . 5.4 m -86.96 138.03 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.68 -3.32 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.487 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.07 -160.3 24.24 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -153.59 155.98 37.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.384 0.612 . . . . 0.0 111.258 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.26 136.86 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.073 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -128.99 134.07 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.986 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.598 ' CG2' HD21 ' A' ' 141' ' ' LEU . 2.5 mt -133.01 74.17 74.18 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.541 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -44.76 -39.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 123.151 2.567 . . . . 0.0 112.943 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.752 ' OG ' HD23 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -48.67 -32.17 7.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.623 -177.406 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 89' ' ' SER . 15.7 m -117.13 -7.01 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.637 0.256 . . . . 0.0 111.158 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER 75.22 39.49 0.37 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.197 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.64 130.02 56.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.48 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -144.79 129.97 18.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.763 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -164.44 152.54 10.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.072 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 162.99 4.51 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.064 1.843 . . . . 0.0 109.739 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.29 125.0 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 102' ' ' ASN . 10.2 mt -101.43 136.11 41.83 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.81 -48.54 24.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.11 0.481 . . . . 0.0 111.485 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 123.4 28.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.177 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.4 p -81.7 64.83 6.58 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.45 0.643 . . . . 0.0 110.46 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.552 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -91.81 143.21 26.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.077 179.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 101' ' ' LYS . 15.3 pt-20 -56.33 -44.22 79.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.403 0.621 . . . . 0.0 110.742 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.493 ' N ' ' CG ' ' A' ' 100' ' ' GLU . 54.5 tttp -66.03 -46.38 78.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.808 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.552 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 2.9 m-20 -67.18 -36.97 82.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.844 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -55.04 -16.82 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.451 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.447 ' O ' HD11 ' A' ' 134' ' ' LEU . 55.0 mt -70.63 -29.9 66.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -89.74 -10.56 45.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 178.52 41.27 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.763 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -72.37 132.16 43.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.97 150.13 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.125 0.488 . . . . 0.0 111.031 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.5 p -73.6 153.93 39.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.34 -52.2 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -91.76 141.44 28.67 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.994 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -71.39 -2.58 16.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.538 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.34 41.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.251 0.548 . . . . 0.0 111.115 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -84.86 158.1 20.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -134.49 129.7 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.628 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -73.7 127.88 34.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.43 -0.15 70.86 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -139.71 121.61 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.967 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.32 -171.86 52.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.515 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 10.2 t30 -84.03 110.13 18.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.24 99.38 10.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.78 130.44 36.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.363 0.601 . . . . 0.0 111.425 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -125.9 133.83 51.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.826 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.18 141.56 47.37 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.378 0.609 . . . . 0.0 110.71 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.9 -178.85 18.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.656 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -81.83 149.27 28.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.972 0.415 . . . . 0.0 110.748 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 129' ' ' SER . 45.1 t30 -112.48 28.44 8.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.169 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.1 mmm -47.43 -11.74 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.638 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 127' ' ' ASN . 3.1 t 54.72 41.11 32.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.982 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.4 tttt -134.52 116.2 14.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.565 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -57.33 125.61 23.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.764 0.792 . . . . 0.0 110.53 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.25 -25.87 11.96 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.871 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.798 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.3 t -79.9 179.07 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.798 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.28 133.31 45.97 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.768 -178.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.5 m-30 44.47 33.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.148 0.499 . . . . 0.0 111.06 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -82.29 -7.79 59.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.5 m-20 -147.47 38.14 0.94 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.6 pt -74.24 -25.49 19.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.84 0.352 . . . . 0.0 111.881 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.83 0.52 8.86 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.749 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.0 m -93.39 -12.24 30.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.27 0.557 . . . . 0.0 109.628 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.752 HD23 ' OG ' ' A' ' 87' ' ' SER . 21.0 mt -65.58 125.0 23.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.204 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -96.34 158.46 15.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.677 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.05 133.06 54.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.514 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.5 59.18 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.421 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 38.4 m-20 -83.52 136.91 34.1 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -81.0 130.23 34.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 111.345 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -127.13 126.64 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 148' ' ' TYR . 42.4 m-85 -107.87 120.24 41.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.191 0.519 . . . . 0.0 109.776 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.6 tp -113.59 143.93 43.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.346 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -114.82 127.88 55.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.314 0.578 . . . . 0.0 111.541 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.4 t0 -106.0 -166.12 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.6 m-20 -27.94 -71.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.695 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -137.42 22.8 2.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.754 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.27 147.83 44.49 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -113.42 118.28 34.08 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.416 ' CE2' HG21 ' A' ' 206' ' ' THR . 68.4 m-85 -103.45 131.51 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.407 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -93.4 117.85 30.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.347 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.2 133.18 55.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 45.2 t -67.73 133.03 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.107 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -101.0 -27.19 13.42 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 124.609 1.193 . . . . 0.0 110.63 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.53 144.35 3.98 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.86 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.47 141.32 15.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.41 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.9 p -150.06 161.93 41.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.372 0.606 . . . . 0.0 111.548 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 95.3 mt-10 -114.81 123.18 48.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.749 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.68 149.63 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.344 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.4 p -53.66 166.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.571 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -81.58 -15.59 9.68 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.854 1.703 . . . . 0.0 111.812 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 60.0 t0 -88.64 -11.09 46.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.502 ' O ' HG22 ' A' ' 173' ' ' VAL . 13.6 ttmm -86.95 67.81 9.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.979 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.571 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 57.3 m95 -76.53 -8.39 57.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.449 . . . . 0.0 111.856 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.9 mt-10 -53.19 -23.47 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.203 0.525 . . . . 0.0 110.937 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 170' ' ' LYS . 33.3 m -77.63 -13.06 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.922 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 185' ' ' ILE . 4.4 m -132.34 43.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.521 ' O ' ' O ' ' A' ' 176' ' ' ASP . 95.4 mt-10 -146.23 83.17 1.62 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.895 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' GLU . 66.5 t0 23.82 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.346 1.028 . . . . 0.0 113.022 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.455 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 13.2 m170 -102.13 -43.97 5.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 0.0 111.289 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.84 23.78 0.16 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -154.11 173.91 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.954 0.407 . . . . 0.0 111.237 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -96.3 88.65 4.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.242 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -131.58 130.63 42.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.037 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.6 tt -83.17 145.57 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.515 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 3.6 m -138.57 115.94 11.18 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.576 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -104.48 134.34 47.84 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.18 0.514 . . . . 0.0 110.711 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.724 HG22 HG22 ' A' ' 198' ' ' VAL . 34.6 pt -135.1 154.67 36.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.093 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.447 -179.661 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.404 HH21 HG21 ' A' ' 198' ' ' VAL . 56.0 ttp180 . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.929 0.395 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.6 m-85 -95.95 129.02 43.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.505 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.724 HG22 HG22 ' A' ' 185' ' ' ILE . 71.2 t -131.08 133.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.193 0.521 . . . . 0.0 111.366 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.73 126.96 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.593 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -112.77 132.93 55.02 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 110.721 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.66 14.13 Favored Glycine 0 N--CA 1.464 0.525 0 CA-C-O 121.727 0.626 . . . . 0.0 111.685 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -98.91 142.3 30.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.891 -0.655 . . . . 0.0 111.405 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.1 tp -67.09 128.54 36.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.315 0.578 . . . . 0.0 110.288 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.97 -21.7 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.216 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.5 176.12 46.87 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.009 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.416 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.0 m -154.74 153.18 30.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.161 0.505 . . . . 0.0 110.534 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -150.27 178.65 8.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.264 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -99.98 142.26 31.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -57.18 80.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.248 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ALA . 77.5 tttt . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.557 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.488 1.182 0 N-CA-C 111.362 -0.284 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' O ' HG23 ' A' ' 69' ' ' VAL . 53.8 t0 -62.46 163.15 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.8 mm? -77.65 -13.63 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.921 -0.487 . . . . 0.0 111.069 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.35 -48.38 70.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.405 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.17 -21.83 59.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.889 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 65' ' ' ASP . 85.7 t -78.07 -53.25 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.756 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.47 84.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.512 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.471 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 52.4 t-20 -76.13 -11.21 59.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.927 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 145.27 38.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.429 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -139.51 80.45 1.78 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.524 HD13 ' OD1' ' A' ' 102' ' ' ASN . 51.9 tp -80.16 147.4 31.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.52 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.54 133.69 49.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.922 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 79' ' ' VAL . 15.7 tptm -79.89 -6.44 57.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.249 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -80.74 -10.63 59.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.98 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -94.24 5.77 50.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 76' ' ' LYS . 8.3 p -80.62 136.47 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.97 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.411 HD13 ' HB2' ' A' ' 96' ' ' LYS . 7.5 pt -119.2 -10.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.72 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.44 -170.09 37.94 Favored Glycine 0 C--N 1.316 -0.545 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -147.15 152.34 38.29 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.416 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.2 tt -123.99 121.1 61.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 t -124.63 130.75 53.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.909 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 141' ' ' LEU . 16.5 mt -135.15 126.77 17.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -82.26 -35.49 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.358 2.039 . . . . 0.0 112.5 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.506 ' OG ' HD23 ' A' ' 141' ' ' LEU . 2.3 t -51.14 -40.09 57.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.844 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.4 m -115.49 -4.24 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.18 49.9 1.9 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.4 tp -111.32 129.74 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.656 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -136.72 113.7 10.5 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 83' ' ' ILE . 54.3 mt -145.69 107.71 4.36 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.2 Cg_endo -41.66 135.46 3.33 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.77 1.647 . . . . 0.0 110.659 176.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.17 125.1 39.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 74' ' ' LEU . 20.5 mt -108.86 120.83 43.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.193 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 80' ' ' ILE . 88.4 tttt -66.72 -47.43 72.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.708 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.439 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 54.6 p -69.8 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.1 p -84.43 107.68 16.83 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.283 0.564 . . . . 0.0 110.214 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 p -137.08 166.32 23.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.026 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.442 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 16.9 pt-20 -61.9 -35.43 78.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.681 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -82.92 -37.62 23.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.559 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.524 ' OD1' HD13 ' A' ' 74' ' ' LEU . 76.7 m-20 -67.22 -22.88 65.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.637 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.88 -13.41 61.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.482 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.9 mp -76.92 -14.35 59.88 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -106.19 -15.63 14.81 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 172.98 -176.05 45.83 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.71 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.22 129.58 38.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.248 -0.476 . . . . 0.0 109.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.48 144.53 31.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.752 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.7 p -73.84 146.94 43.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.65 -46.69 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -91.02 144.28 25.83 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.806 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.71 -5.07 35.21 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.859 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 113' ' ' ASN . 61.2 t-20 -142.15 41.47 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.688 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -84.03 155.54 22.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.29 128.19 51.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.72 126.23 30.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 98.05 -6.12 61.77 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -137.21 118.99 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.668 0.271 . . . . 0.0 110.78 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.98 -172.85 54.07 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.506 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 55.8 t30 -82.54 111.72 18.8 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -85.18 103.07 13.83 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.36 121.52 32.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 111.412 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.1 mt -117.76 131.86 56.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.85 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.62 46.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.02 -178.07 20.33 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.814 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 30.2 m-70 -83.5 131.23 35.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.231 0.539 . . . . 0.0 110.863 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.9 p30 -101.52 27.02 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.4 mmm -46.05 -14.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.957 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 41.67 17.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.875 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -133.8 106.85 7.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.081 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -50.69 125.93 14.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.547 0.689 . . . . 0.0 109.985 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.25 -26.1 10.69 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.946 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.788 HG12 ' H ' ' A' ' 134' ' ' LEU . 35.4 t -83.4 178.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 CA-C-N 117.736 0.768 . . . . 0.0 109.13 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.788 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.17 138.56 47.72 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.178 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 45.64 31.99 1.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.057 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.2 p -80.58 -12.31 59.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -138.56 35.94 2.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 140' ' ' SER . 8.8 pt -67.67 -41.51 85.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.09 2.09 1.69 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.961 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 138' ' ' ILE . 13.3 t -89.23 -21.65 23.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.506 HD23 ' OG ' ' A' ' 87' ' ' SER . 12.2 mt -65.58 121.7 15.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.143 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.441 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.7 mtmt -96.99 157.71 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.555 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -57.62 125.89 24.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.321 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.83 19.04 23.35 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 89.6 m-20 -89.86 133.24 34.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.75 134.74 37.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 111.723 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 73.0 mt -127.66 124.25 62.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.379 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -105.26 122.09 45.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.024 0.44 . . . . 0.0 110.218 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.68 153.21 32.73 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.093 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -121.12 130.87 53.94 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.316 0.579 . . . . 0.0 111.334 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 23.9 t0 -112.8 -167.07 1.14 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -24.48 -74.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.449 0.468 . . . . 0.0 111.705 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -137.97 28.58 2.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -125.59 151.38 46.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -112.03 122.04 46.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.741 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' A' ' 117' ' ' GLY . 47.2 m-85 -105.52 127.9 53.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.108 0.48 . . . . 0.0 111.791 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.6 mt-10 -97.64 118.74 34.85 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -115.86 145.11 43.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.219 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.3 128.69 54.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.24 0.543 . . . . 0.0 110.374 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.1 t -68.46 135.59 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.066 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 8.5 p -100.33 -22.86 14.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 124.378 1.049 . . . . 0.0 110.16 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 152.97 -178.51 30.03 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.833 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.8 p -124.2 143.01 39.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.318 -0.941 . . . . 0.0 109.893 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.8 t -136.77 148.08 47.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 111.107 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.13 113.01 26.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.239 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.33 159.44 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.1 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.0 p -71.22 142.59 87.32 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.568 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.5 Cg_endo -48.42 -16.24 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.862 1.708 . . . . 0.0 111.772 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 61.6 t0 -83.32 -11.55 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.91 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.521 ' O ' HG22 ' A' ' 173' ' ' VAL . 19.9 tptt -83.47 62.47 6.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.468 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.568 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 45.7 m95 -73.06 -21.13 60.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.675 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -51.12 -9.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.102 0.477 . . . . 0.0 110.947 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 170' ' ' LYS . 27.4 m -77.15 -29.26 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.917 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.457 HG11 HD13 ' A' ' 185' ' ' ILE . 1.7 m -107.2 -0.65 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.618 0.723 . . . . 0.0 109.938 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 176' ' ' ASP . 76.3 mm-40 -82.28 117.44 22.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.785 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.0 p-10 -27.71 123.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.872 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -99.62 -37.63 9.06 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.62 33.2 0.62 Allowed Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -154.72 177.14 11.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.129 0.49 . . . . 0.0 111.68 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.06 88.96 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.37 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -128.74 167.42 17.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.831 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.603 ' C ' HD12 ' A' ' 184' ' ' LEU . 3.2 m -136.74 127.34 27.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.603 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.18 128.95 56.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.404 0.621 . . . . 0.0 110.778 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.457 HD13 HG11 ' A' ' 174' ' ' VAL . 8.7 pt -139.93 -167.68 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.923 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.552 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 3.3 t . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.414 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.7 ttm180 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -77.12 132.61 38.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.701 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.63 135.04 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.01 128.41 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.537 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.91 139.3 51.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.272 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.36 152.25 21.1 Favored Glycine 0 C--O 1.226 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -107.45 147.2 30.75 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.635 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.5 tp -69.83 126.28 29.25 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 121.097 0.475 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -106.65 -26.65 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.745 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.32 161.88 21.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.05 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 207' ' ' LYS . 88.0 m -139.17 157.69 45.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.363 0.602 . . . . 0.0 110.11 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.436 ' N ' HG22 ' A' ' 206' ' ' THR . 20.1 ptmt -149.08 178.79 8.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.384 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.33 147.25 23.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.78 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -76.9 78.95 3.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.714 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.716 178.678 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.485 1.008 0 CA-C-O 120.872 0.28 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.73 159.15 31.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.864 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.68 -23.63 66.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.7 92.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.715 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 97.0 mt-10 -73.46 -35.31 65.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.477 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.7 t -76.92 -42.96 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.755 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.83 91.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.698 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.4 p-10 -84.95 -17.87 36.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.44 111.62 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.961 0.41 . . . . 0.0 110.875 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -95.46 118.46 32.23 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.228 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.66 HD11 ' NE2' ' A' ' 78' ' ' GLN . 47.9 tp -116.14 131.16 57.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.061 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.54 134.82 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 79' ' ' VAL . 70.4 mmtt -75.83 -9.29 58.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 110.254 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.4 -12.66 61.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.037 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.66 ' NE2' HD11 ' A' ' 74' ' ' LEU . 25.2 mt-30 -95.51 12.72 28.48 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.221 0.534 . . . . 0.0 111.028 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 76' ' ' LYS . 5.4 p -90.45 128.83 42.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.741 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -120.9 -5.39 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 120.896 0.379 . . . . 0.0 111.88 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.87 41.74 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.918 HH12 ' HZ3' ' A' ' 209' ' ' LYS . 30.0 mtt85 -147.34 156.6 43.05 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.477 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.581 HD12 HD13 ' A' ' 123' ' ' LEU . 8.2 tt -123.63 128.28 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.427 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.1 t -128.24 130.2 47.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.47 128.88 19.36 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.399 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 -34.61 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.291 1.994 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -47.36 -39.51 15.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.457 -177.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -119.86 -1.72 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.781 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.7 p 63.6 50.4 2.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.081 0.943 . . . . 0.0 108.562 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.418 HD11 HD23 ' A' ' 92' ' ' LEU . 33.7 tp -113.51 133.63 55.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.397 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.822 ' O ' HD22 ' A' ' 92' ' ' LEU . 80.9 tt0 -135.81 111.4 9.26 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.8 OUTLIER -138.29 113.46 8.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.2 Cg_endo -41.6 147.46 0.39 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 110.419 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.9 124.57 53.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -105.0 125.47 51.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.004 0.431 . . . . 0.0 110.631 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 61.2 tttp -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 110.752 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.465 ' OG ' ' OD1' ' A' ' 102' ' ' ASN . 84.7 p -71.45 103.48 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 96.31 9.57 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.608 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.5 p -134.31 160.89 36.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.947 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -57.53 -33.49 68.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.6 -45.65 21.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 0.0 111.487 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.608 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.2 m-80 -67.2 -35.38 79.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.696 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.69 -17.42 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.814 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.07 -16.79 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 t -107.93 -9.73 15.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' CA ' HD12 ' A' ' 92' ' ' LEU . . . 171.63 175.46 39.96 Favored Glycine 0 N--CA 1.461 0.327 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.446 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -72.18 127.57 32.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.008 -0.596 . . . . 0.0 109.785 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.52 24.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.893 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -72.84 150.24 42.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.1 t -84.49 -49.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -91.81 143.15 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 110.778 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 tt0 -61.92 -49.95 74.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.798 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -95.89 49.52 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.168 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 3.9 tt0 -89.15 151.47 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.2 127.6 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.966 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 129.39 36.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.812 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.03 -6.83 62.22 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -143.59 126.89 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.961 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 77.24 -162.41 51.26 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.536 HD22 ' CE1' ' A' ' 177' ' ' HIS . 41.0 t-20 -93.53 108.9 20.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -86.05 100.23 12.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.425 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.54 126.02 35.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.252 0.549 . . . . 0.0 111.043 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 83' ' ' ILE . 9.3 mt -119.79 131.2 55.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.819 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.37 140.03 47.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.78 -178.49 19.58 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.405 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.42 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -84.04 141.84 30.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.736 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 61.7 t30 -109.1 28.39 8.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.185 0.517 . . . . 0.0 110.078 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.7 mmm -43.53 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.775 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.3 m 57.74 38.48 27.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.03 107.49 8.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.007 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -51.63 122.29 7.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.36 0.6 . . . . 0.0 110.045 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.12 21.82 6.48 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.316 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.737 HG12 ' H ' ' A' ' 134' ' ' LEU . 24.0 t -136.57 176.61 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.737 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -69.62 130.67 43.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 0.0 110.362 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.2 m-85 48.44 36.39 7.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.172 0.51 . . . . 0.0 110.585 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -82.35 -10.37 59.1 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 136' ' ' SER . 72.3 m-20 -150.33 31.91 0.66 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.6 pt -70.63 -21.02 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.803 0.335 . . . . 0.0 111.567 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.6 5.1 8.0 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.481 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -99.51 -10.3 22.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.25 0.548 . . . . 0.0 109.679 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.429 ' O ' HG21 ' A' ' 163' ' ' VAL . 17.8 mt -64.27 126.37 27.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.618 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.3 mttp -96.76 159.66 14.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.531 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -58.15 132.33 53.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.105 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.9 21.65 57.07 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 19.2 m-20 -79.35 135.23 36.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -78.96 121.74 25.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 111.979 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.32 120.82 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.132 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -103.24 117.7 35.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.198 0.523 . . . . 0.0 109.806 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.2 tp -112.35 144.33 41.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.132 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.42 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 60.8 m-85 -108.21 131.68 54.43 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.273 0.559 . . . . 0.0 111.672 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -104.77 -172.51 2.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.5 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -36.39 -63.26 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.161 0.505 . . . . 0.0 111.121 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -137.55 24.34 2.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.77 152.91 47.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -115.38 121.77 43.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.781 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -104.06 132.37 50.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.29 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -95.5 114.74 26.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -114.6 141.37 47.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.2 132.02 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.606 0.717 . . . . 0.0 111.309 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.01 134.06 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.898 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -102.86 -28.11 12.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 124.625 1.203 . . . . 0.0 110.818 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.24 141.08 3.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.877 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 199' ' ' VAL . 13.1 t -106.28 147.73 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.487 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.3 p -157.26 167.5 30.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.286 0.565 . . . . 0.0 111.638 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -118.15 120.6 38.21 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.55 158.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 111.3 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.4 p -57.21 165.47 1.95 Allowed Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.2 Cg_endo -82.03 -9.43 11.79 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.967 1.778 . . . . 0.0 111.913 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 63.2 t0 -83.38 -10.53 58.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.388 . . . . 0.0 110.449 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.581 ' O ' HG22 ' A' ' 173' ' ' VAL . 38.1 mmtt -85.93 64.33 8.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.798 0.332 . . . . 0.0 110.69 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.552 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 86.8 m95 -73.33 -10.11 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.457 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 80.9 mm-40 -59.93 -35.41 74.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.188 0.518 . . . . 0.0 110.975 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.849 HG23 HG13 ' A' ' 174' ' ' VAL . 4.7 m -65.68 -8.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.243 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.849 HG13 HG23 ' A' ' 173' ' ' VAL . 17.5 m -136.0 43.04 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 176' ' ' ASP . 48.8 mm-40 -144.8 107.24 4.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.733 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 175' ' ' GLU . 41.0 p-10 4.27 112.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.65 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.536 ' CE1' HD22 ' A' ' 120' ' ' ASN . 40.4 m80 -102.91 -42.49 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.883 0.373 . . . . 0.0 111.028 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 136.32 29.82 0.32 Allowed Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 17.9 ptpt -153.83 173.12 16.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 8.7 p30 -95.19 88.34 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.836 0.827 . . . . 0.0 110.181 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -130.12 174.72 9.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.552 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.8 tt -130.89 143.12 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.174 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.601 ' C ' HD12 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -137.79 124.08 20.56 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.313 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -111.57 131.13 55.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.235 0.54 . . . . 0.0 110.695 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.669 HG21 HG11 ' A' ' 174' ' ' VAL . 7.5 pt -138.53 171.53 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.952 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 60.5 p . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.129 179.097 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.183 0.516 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.69 138.47 43.86 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.532 HG12 HG22 ' A' ' 185' ' ' ILE . 31.4 m -135.38 138.18 48.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.439 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 163' ' ' VAL . 76.1 t -117.18 128.8 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.342 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.95 135.22 54.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.087 0.47 . . . . 0.0 110.346 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.77 156.96 24.52 Favored Glycine 0 N--CA 1.461 0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.574 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.19 153.82 26.48 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.049 -0.576 . . . . 0.0 111.396 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.433 HD11 ' O ' ' A' ' 205' ' ' GLY . 39.4 tp -73.87 128.06 34.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.256 0.551 . . . . 0.0 110.574 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 38.1 t -109.06 -25.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.931 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.433 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.52 175.03 46.7 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.972 -1.108 . . . . 0.0 112.155 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.0 m -153.78 152.31 30.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.143 0.496 . . . . 0.0 110.826 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.14 177.14 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.19 145.19 24.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.099 0.476 . . . . 0.0 110.718 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.918 ' HZ3' HH12 ' A' ' 82' ' ' ARG . 88.3 tttt -74.44 79.69 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.904 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--N 1.314 -0.94 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.561 178.528 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.486 1.053 0 N-CA-C 111.213 -0.341 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.17 165.21 24.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.659 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -69.51 -16.19 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.04 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.62 95.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.283 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 89.7 mt-10 -73.14 -33.46 65.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.665 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.37 -45.76 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.075 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.45 89.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.025 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.02 -28.46 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.589 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.79 107.42 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.804 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.3 m -95.98 115.31 27.24 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.289 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.0 tp -115.23 126.49 54.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.277 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -69.01 139.01 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.555 ' O ' HG12 ' A' ' 79' ' ' VAL . 13.9 mptt -76.13 -0.11 20.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 110.211 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -85.29 -8.99 58.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.143 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.533 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.0 mp0 -90.92 2.84 55.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.757 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 76' ' ' LYS . 11.1 p -87.64 138.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.821 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.6 pt -120.82 -5.27 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.781 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.89 33.14 Favored Glycine 0 C--N 1.321 -0.285 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -152.75 152.69 31.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.264 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 83' ' ' ILE . 17.9 tt -126.1 130.85 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.845 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -128.2 129.17 46.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.002 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 67.5 mt -133.59 127.83 19.77 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.543 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.65 -34.18 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.452 2.102 . . . . 0.0 112.285 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.1 p -46.98 -38.73 11.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.7 p -119.93 -0.34 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.852 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 63.81 52.68 2.11 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.7 tp -116.97 132.81 56.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.372 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -134.67 117.65 16.3 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -143.85 161.73 44.58 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.12 155.6 7.0 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.851 2.367 . . . . 0.0 108.901 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 118.24 52.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.416 ' CB ' HD22 ' A' ' 102' ' ' ASN . 10.1 mt -100.21 124.14 45.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -65.35 -48.56 72.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.807 0.337 . . . . 0.0 111.32 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.585 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 99.9 p -78.91 112.87 16.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.014 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.6 p -84.53 110.63 18.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.201 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.517 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -139.61 166.56 24.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.447 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.51 -31.07 70.94 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -81.39 -44.09 18.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.972 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.3 p-10 -66.38 -31.67 72.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.201 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.39 -21.02 66.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.43 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.21 -18.45 61.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -97.54 -13.15 21.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 170.06 -147.98 11.29 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.658 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.27 129.56 45.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.972 -0.614 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 102' ' ' ASN . . . -107.91 148.1 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.4 p -70.39 148.25 48.6 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 185' ' ' ILE . 26.0 t -82.86 -40.26 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -90.29 149.53 22.31 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.011 0.434 . . . . 0.0 111.077 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.43 -18.61 64.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.908 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -144.77 55.95 1.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.012 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.565 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 2.4 tt0 -80.67 156.36 26.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.938 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.9 t -136.0 124.35 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.83 127.24 32.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 99.12 -8.38 60.86 Favored Glycine 0 N--CA 1.46 0.237 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -135.27 117.77 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.69 -167.53 54.75 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.48 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 63.8 t30 -86.65 112.54 21.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -85.03 103.47 14.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.03 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.565 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.42 122.92 33.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.362 0.601 . . . . 0.0 111.511 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.406 HD13 HD12 ' A' ' 83' ' ' ILE . 15.3 mt -118.34 132.05 56.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.287 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.36 48.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.381 0.61 . . . . 0.0 111.015 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.64 -178.23 16.93 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.541 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.4 ' HD2' HD12 ' A' ' 134' ' ' LEU . 78.8 m-70 -84.24 145.79 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.649 0.261 . . . . 0.0 110.845 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 54.4 t-20 -110.8 28.45 8.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.9 mmt -43.98 -15.51 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.0 OUTLIER 58.87 39.14 24.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.303 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -133.82 107.65 8.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.611 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -50.28 126.9 15.97 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.745 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.8 12.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.818 HG12 ' H ' ' A' ' 134' ' ' LEU . 17.4 t -87.94 179.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.818 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.21 136.69 48.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.258 -177.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.414 ' HA ' HG23 ' A' ' 138' ' ' ILE . 3.4 m-85 44.18 34.02 0.92 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.231 0.538 . . . . 0.0 110.989 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 p -82.38 -9.78 59.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -149.1 34.99 0.74 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.414 HG23 ' HA ' ' A' ' 135' ' ' PHE . 6.8 pt -69.89 -28.12 35.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.869 0.366 . . . . 0.0 111.771 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.61 0.86 4.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.606 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -92.93 -13.82 28.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.027 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -64.83 122.92 18.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.397 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mttm -95.63 157.77 15.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.574 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -55.64 133.0 50.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.796 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.6 18.29 62.24 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 16.8 m-20 -79.58 135.06 36.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -81.47 128.01 33.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.511 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.0 mt -123.38 121.7 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.06 119.33 38.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.978 0.418 . . . . 0.0 110.043 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.2 tp -118.07 138.26 52.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -106.01 135.65 47.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.07 0.462 . . . . 0.0 111.48 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 46.7 t0 -109.89 -169.83 1.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 64.8 t30 -33.67 -67.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.26 0.552 . . . . 0.0 111.099 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.89 23.78 3.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.107 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.05 147.06 49.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.575 0.702 . . . . 0.0 112.712 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.543 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 90.7 mt-10 -108.57 122.25 46.69 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.823 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.494 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 34.5 m-85 -105.02 128.29 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.114 0.483 . . . . 0.0 111.773 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -95.5 115.87 28.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -116.02 140.94 48.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.461 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.26 134.35 55.17 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.484 0.659 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 133.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -101.81 -25.84 13.68 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 124.76 1.287 . . . . 0.0 111.088 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.31 145.61 4.39 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.663 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 163' ' ' VAL . 3.7 p -104.56 151.56 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -154.02 162.64 41.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.129 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.532 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 70.3 mt-10 -111.98 117.81 33.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.08 158.52 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 111.335 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.5 p -59.67 168.72 1.74 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.445 ' HA ' HH11 ' A' ' 196' ' ' ARG . 2.8 Cg_endo -81.47 -10.69 12.05 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.948 1.765 . . . . 0.0 111.944 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.22 -3.06 58.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.202 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.6 68.32 9.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 110.865 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.425 ' C ' ' N ' ' A' ' 173' ' ' VAL . 70.7 m95 -70.48 -29.86 66.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.765 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 56.0 mp0 -49.23 -17.71 0.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.204 0.526 . . . . 0.0 110.537 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.425 ' N ' ' C ' ' A' ' 171' ' ' TRP . 90.4 t -71.48 -23.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.577 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.421 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -107.86 -7.37 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.608 0.718 . . . . 0.0 109.679 -178.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -79.77 139.0 37.43 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.823 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -51.24 128.59 22.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.174 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -99.15 -39.59 8.4 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.035 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.89 29.0 0.37 Allowed Glycine 0 N--CA 1.473 1.156 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -156.63 -179.33 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.351 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -91.1 88.85 7.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.368 0.604 . . . . 0.0 109.833 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -124.33 168.31 13.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.077 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.72 142.75 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.951 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 184' ' ' LEU . 9.4 m -136.84 123.35 20.87 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.388 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -109.04 122.81 48.04 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.32 0.581 . . . . 0.0 110.92 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.513 HD11 HG21 ' A' ' 110' ' ' VAL . 27.9 pt -134.92 -167.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.953 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.781 -179.159 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.445 HH11 ' HA ' ' A' ' 168' ' ' PRO . 55.5 ttp180 . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 120.923 0.392 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.532 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.6 m-85 -91.03 129.12 37.06 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.679 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 138.71 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.258 0.551 . . . . 0.0 111.48 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.74 127.71 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.556 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.11 135.32 54.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.167 0.508 . . . . 0.0 110.457 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.44 158.92 24.26 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 55.4 p-10 -113.74 150.24 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.387 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 40.0 tp -72.07 127.62 33.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.086 0.469 . . . . 0.0 111.017 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.6 t -106.34 -25.6 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.329 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.29 162.12 20.92 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.421 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.494 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 81.1 m -139.51 157.63 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.189 0.518 . . . . 0.0 110.032 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.543 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 19.4 pttp -149.91 178.54 8.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.6 143.63 26.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -71.28 79.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.702 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.691 178.461 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.486 1.083 0 N-CA-C 110.895 -0.463 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.76 154.81 41.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.717 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.4 mp -59.4 -27.61 66.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.689 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.46 94.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.279 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.8 mt-10 -72.58 -37.49 68.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.732 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.5 t -72.0 -44.29 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.574 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.96 89.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.33 -26.69 30.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.44 136.8 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.9 t -92.36 158.55 16.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.529 HD13 ' CB ' ' A' ' 105' ' ' SER . 55.6 tp -122.7 127.22 48.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.0 0.428 . . . . 0.0 111.06 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -96.1 98.26 10.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.564 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.419 ' C ' ' N ' ' A' ' 78' ' ' GLN . 29.0 mmtp -55.84 -35.51 66.49 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.119 0.485 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -51.56 -13.06 0.2 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.035 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 97' ' ' SER . 23.8 mm100 -102.55 11.09 38.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.476 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.77 124.95 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -119.39 -4.57 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.171 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.03 -162.29 35.59 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -155.97 165.36 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.574 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.8 tt -131.35 139.65 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.796 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -131.66 132.84 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.053 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -131.03 127.0 21.91 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.95 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.84 -38.13 0.17 Allowed 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.256 1.971 . . . . 0.0 112.314 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.2 t -46.97 -39.55 12.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.586 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 90' ' ' LEU . 1.3 p -117.9 -2.5 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.68 55.38 2.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -120.77 138.49 53.99 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.559 -177.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 91' ' ' GLU . 55.8 mp0 -138.98 120.1 14.6 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.593 HD22 ' HA2' ' A' ' 106' ' ' GLY . 35.4 mt -143.37 109.55 5.33 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -40.74 139.48 1.28 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 121.887 1.724 . . . . 0.0 109.924 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.3 t -90.39 118.2 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.1 mt -102.37 121.73 42.87 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.058 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -64.83 -47.54 77.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.121 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 78' ' ' GLN . 70.3 m -69.7 102.13 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.311 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 98' ' ' SER . 25.2 p -81.15 98.6 8.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.457 0.646 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.6 p -136.59 157.79 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.499 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -56.38 -29.19 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -81.98 -43.58 17.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.226 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.34 -34.45 78.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -63.21 -21.31 66.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.806 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 mt -69.66 -26.51 64.43 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.529 ' CB ' HD13 ' A' ' 74' ' ' LEU . 23.4 m -93.85 -10.99 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.593 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 165.62 -170.81 40.63 Favored Glycine 0 N--CA 1.458 0.149 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.658 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.32 129.2 37.34 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.116 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.12 148.13 28.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.424 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 p -70.32 143.41 52.01 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 185' ' ' ILE . 7.6 t -83.76 -44.64 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.414 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 55.3 mtpt -89.43 -172.86 3.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.6 pm0 -119.48 -9.15 9.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.055 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -139.63 39.21 2.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.39 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.414 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 7.4 pt20 -91.09 157.25 17.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.48 131.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.896 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -67.58 128.83 37.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.58 2.46 76.08 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -141.83 121.84 13.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.729 0.299 . . . . 0.0 111.107 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.83 -165.73 54.76 Favored Glycine 0 CA--C 1.517 0.218 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -89.86 109.05 20.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.59 101.77 12.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.918 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.57 128.69 36.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.423 0.63 . . . . 0.0 111.739 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -126.0 131.95 52.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.553 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.81 140.85 46.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.58 0.705 . . . . 0.0 111.096 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.1 -179.36 18.31 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -81.93 153.35 26.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 129' ' ' SER . 57.6 t30 -122.36 28.02 7.64 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.007 0.432 . . . . 0.0 111.208 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 31.9 mtt -43.82 -15.0 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.616 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 38.07 21.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.067 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 136' ' ' SER . 1.6 tppp? -134.13 121.07 20.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.835 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.18 125.66 24.51 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.98 -25.07 11.08 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.347 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 134' ' ' LEU . 95.1 t -80.39 176.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.721 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -74.55 136.6 42.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 46.52 30.66 1.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.095 0.474 . . . . 0.0 110.953 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.16 -8.23 59.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.213 -178.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.9 m-20 -143.99 36.3 1.26 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 pt -69.46 -30.05 44.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 111.971 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.08 1.69 7.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.807 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 t -92.18 -15.82 27.08 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.998 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.99 119.51 11.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 53.3 mtmt -96.33 156.28 16.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -56.46 121.77 10.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.61 19.0 14.38 Favored Glycine 0 N--CA 1.466 0.694 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 86.5 m-20 -90.28 131.31 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -79.64 135.22 36.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.08 0.467 . . . . 0.0 111.574 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -129.31 121.78 54.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.28 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.39 120.48 40.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.1 tp -116.71 142.86 46.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.181 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.226 0.536 . . . . 0.0 111.499 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 34.7 t0 -112.09 -165.38 0.99 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.0 m-20 -22.4 -75.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.729 0.643 . . . . 0.0 111.479 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -138.26 27.23 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.002 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -125.62 142.34 51.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -108.43 121.41 44.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.903 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.433 ' CE2' HG21 ' A' ' 206' ' ' THR . 79.6 m-85 -105.2 131.25 52.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.55 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -94.43 115.91 28.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.2 m-85 -117.39 136.65 53.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.589 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.34 133.87 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.482 0.658 . . . . 0.0 111.0 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.22 135.33 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.887 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.3 t -106.14 -24.83 12.24 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.995 1.434 . . . . 0.0 111.178 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.56 155.01 7.5 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.623 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.9 144.28 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.2 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.8 m -138.64 151.36 47.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.102 0.477 . . . . 0.0 111.298 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -106.02 110.26 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.314 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.2 m -130.74 153.03 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.2 p -64.11 168.48 6.09 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.8 Cg_endo -80.97 -12.63 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.923 1.748 . . . . 0.0 111.926 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -85.47 -21.53 28.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.096 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -86.64 76.5 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.501 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.543 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 27.1 m95 -75.35 -12.69 60.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.244 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -51.05 -8.1 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' A' ' 171' ' ' TRP . 32.8 m -90.21 -15.54 8.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.683 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.646 HG11 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER -120.62 -0.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.724 0.773 . . . . 0.0 109.709 -178.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -83.43 143.66 30.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.844 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.12 128.18 35.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.599 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -104.54 -41.88 5.59 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.757 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.73 31.08 0.21 Allowed Glycine 0 N--CA 1.473 1.114 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -154.03 174.72 14.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 3.8 m-20 -91.55 89.62 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.736 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -123.17 169.79 10.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.851 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -131.61 142.72 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.794 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.571 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.9 m -137.32 124.26 21.41 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -109.56 125.06 52.13 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.611 0.719 . . . . 0.0 110.902 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.646 HD13 HG11 ' A' ' 174' ' ' VAL . 8.4 pt -135.53 -170.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.608 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.594 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.1 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.724 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.594 ' NH1' ' O ' ' A' ' 186' ' ' THR . 12.0 ptp180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.952 0.406 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -106.68 139.85 40.47 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.011 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 24.6 t -133.46 135.43 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.265 0.555 . . . . 0.0 110.937 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.5 t -118.42 130.28 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.692 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 161' ' ' THR . . . -118.77 136.54 53.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.425 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.61 150.44 19.51 Favored Glycine 0 N--CA 1.466 0.679 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.023 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -105.47 143.78 33.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.15 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.504 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.27 127.83 33.86 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 110.698 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.2 t -108.4 -23.54 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.529 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.42 177.03 46.81 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.745 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 156' ' ' TYR . 21.8 m -154.03 151.63 29.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -150.31 179.27 8.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.603 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.83 144.42 25.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.023 0.439 . . . . 0.0 110.57 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.54 78.87 1.06 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.638 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt . . . . . 0 C--N 1.319 -0.739 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.329 178.167 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.485 0.981 0 CA-C-O 121.144 0.393 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 69' ' ' VAL . 48.0 t0 -76.33 172.48 12.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -61.08 -21.59 63.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.786 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.87 95.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.31 -20.49 57.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 65' ' ' ASP . 66.3 t -81.14 -51.67 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.686 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.9 90.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.967 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.45 -32.79 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.857 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 146.72 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.847 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.7 t -138.58 141.41 39.21 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.995 0.426 . . . . 0.0 110.794 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -138.43 121.64 16.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.289 -179.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.704 ' N ' HD13 ' A' ' 74' ' ' LEU . 96.2 m-20 -70.31 112.1 6.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.36 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.523 ' O ' HG22 ' A' ' 79' ' ' VAL . 28.4 mmtp -52.81 -9.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.511 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 75' ' ' ASP . 99.4 mttt -83.19 -4.38 58.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.771 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -95.12 10.41 35.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.706 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 76' ' ' LYS . 14.7 m -94.28 147.39 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -134.11 4.85 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.921 0.391 . . . . 0.0 111.695 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.5 38.25 Favored Glycine 0 C--N 1.322 -0.247 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -152.43 153.26 33.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.231 0.539 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 83' ' ' ILE . 16.0 tt -128.66 130.29 68.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 m -128.61 129.46 45.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.11 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 19.0 mt -135.33 116.06 11.94 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.162 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 4.7 Cg_exo -78.35 -32.94 2.08 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 122.745 2.297 . . . . 0.0 112.843 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 t -50.36 -40.08 48.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.012 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.34 -6.68 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.819 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.23 47.64 0.28 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.09 129.93 56.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.761 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.79 119.1 14.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.1 mt -146.59 166.29 17.11 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.72 153.86 8.81 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.072 2.514 . . . . 0.0 108.767 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 73.6 t -104.43 121.09 55.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.25 132.47 53.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -80.15 -29.9 38.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.991 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 m -79.03 102.42 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.128 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -80.9 97.93 7.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.332 0.587 . . . . 0.0 109.882 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.567 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.0 p -141.01 158.56 43.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.104 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.83 -37.77 77.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.821 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -69.94 -46.29 65.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.83 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.567 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.5 m-80 -65.51 -38.34 89.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.777 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.3 mt -59.73 -26.46 65.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.84 -14.14 61.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -105.74 -13.13 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 175.24 -170.07 43.06 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.486 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.17 123.29 27.78 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.32 142.82 34.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.114 0.483 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.401 ' O ' ' OG ' ' A' ' 98' ' ' SER . 43.8 p -73.95 152.03 40.21 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.455 HG21 HD11 ' A' ' 185' ' ' ILE . 4.2 t -86.07 -42.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -89.51 -172.06 3.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.846 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -123.64 -8.62 7.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.977 0.418 . . . . 0.0 111.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -139.7 39.94 2.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -93.46 159.86 15.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.007 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.87 133.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.009 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.63 127.75 33.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.172 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.52 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.35 5.75 72.04 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -143.56 124.13 14.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 0.0 110.992 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.98 -164.45 54.28 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.83 107.86 19.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.27 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.81 100.01 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.8 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 127.36 36.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 0.0 112.071 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.4 mt -122.88 130.4 52.82 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.29 47.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.13 -178.49 19.01 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.601 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.533 ' O ' ' O ' ' A' ' 134' ' ' LEU . 44.6 m-70 -88.74 139.05 30.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 34.0 p30 -108.2 27.26 9.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.215 0.531 . . . . 0.0 110.323 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.8 mmm -43.87 -14.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.987 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.62 40.91 9.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.009 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -131.7 108.41 9.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.744 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 44.0 pttt -51.07 125.65 14.35 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.319 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.4 -29.76 8.44 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.725 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.0 t -75.54 178.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.725 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.33 137.65 46.79 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.508 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.3 m-85 44.37 31.81 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 110.989 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -81.97 -12.94 58.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.293 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 136' ' ' SER . 95.9 m-20 -143.19 24.96 1.76 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.508 HD13 ' CD2' ' A' ' 135' ' ' PHE . 4.1 pt -69.02 -23.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.85 0.357 . . . . 0.0 111.687 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.78 4.83 3.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.648 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.2 m -96.91 -14.63 21.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.2 0.524 . . . . 0.0 109.638 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.484 ' O ' HG21 ' A' ' 163' ' ' VAL . 15.0 mt -62.43 132.27 51.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.352 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -106.97 175.18 5.59 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.946 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -69.51 135.47 50.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.68 71.51 Favored Glycine 0 N--CA 1.461 0.312 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.28 136.03 36.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -82.95 127.38 33.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.695 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.6 mt -122.72 123.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -103.82 115.63 30.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.838 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.18 148.86 38.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.931 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -123.44 133.61 54.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.399 0.619 . . . . 0.0 111.629 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -112.14 -165.5 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 16.4 t-20 -23.99 -75.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 111.617 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -137.04 26.7 2.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -124.07 145.94 48.91 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -108.52 119.56 39.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.76 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.455 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.0 m-85 -104.42 129.33 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.61 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.477 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 97.7 mt-10 -95.73 117.73 31.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.021 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.52 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 50.6 m-85 -117.47 138.88 51.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.292 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -115.69 132.08 56.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.501 0.667 . . . . 0.0 111.145 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.66 134.88 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.166 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -105.75 -25.49 12.18 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 124.431 1.082 . . . . 0.0 111.081 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.4 161.55 19.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.395 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.519 HG13 HG22 ' A' ' 199' ' ' VAL . 10.5 t -128.78 155.5 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.823 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -164.16 174.46 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 0.0 111.666 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.535 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 40.1 mp0 -121.88 117.13 25.74 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.8 159.06 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 p -62.82 167.12 6.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.22 -9.95 11.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.343 2.028 . . . . 0.0 111.922 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -81.34 -11.61 59.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.808 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -86.4 73.21 10.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.369 0.605 . . . . 0.0 109.72 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.527 ' C ' ' H ' ' A' ' 173' ' ' VAL . 81.9 m95 -72.48 -27.36 62.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -50.93 -9.1 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.0 110.93 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.8 t -78.25 -21.16 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.539 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.494 HG11 HD13 ' A' ' 185' ' ' ILE . 1.2 m -116.18 -3.65 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.745 0.783 . . . . 0.0 109.85 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -80.64 151.76 28.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.15 -1.387 . . . . 0.0 112.157 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.87 126.5 27.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.674 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -107.17 -43.8 4.52 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.317 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 150.34 23.3 0.06 OUTLIER Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.3 173.7 15.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.157 0.503 . . . . 0.0 111.156 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.4 m-20 -95.75 88.38 4.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -124.22 127.72 48.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.403 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -81.71 146.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.524 ' C ' HD12 ' A' ' 184' ' ' LEU . 7.2 m -136.29 122.09 19.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.772 0.32 . . . . 0.0 111.06 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -107.57 126.12 52.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.317 0.58 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.494 HD13 HG11 ' A' ' 174' ' ' VAL . 9.7 pt -137.55 178.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.663 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 -178.794 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 121.028 0.442 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.404 ' CE1' ' OE2' ' A' ' 165' ' ' GLU . 4.5 m-85 -80.37 132.9 35.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.85 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.1 133.92 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.041 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.519 HG22 HG13 ' A' ' 163' ' ' VAL . 82.0 t -117.2 128.62 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.446 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.491 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.45 135.62 53.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.6 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.77 142.53 14.04 Favored Glycine 0 N--CA 1.465 0.596 0 CA-C-O 121.773 0.652 . . . . 0.0 111.642 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 52.3 p-10 -100.32 141.56 32.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.294 -0.953 . . . . 0.0 111.409 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.18 126.16 28.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 157' ' ' GLU . 6.2 m -109.46 -22.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.421 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.04 158.14 13.44 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.802 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.455 HG21 ' CE2' ' A' ' 156' ' ' TYR . 25.1 m -134.85 156.18 49.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.382 0.61 . . . . 0.0 109.778 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.477 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 ptpp? -149.66 178.81 8.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.278 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.69 147.1 23.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.509 . . . . 0.0 110.549 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.32 80.02 3.07 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.814 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 51.7 tttm . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.189 178.649 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 120.797 0.249 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.3 m-20 -68.86 163.93 23.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.177 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.425 ' O ' HD23 ' A' ' 66' ' ' LEU . 6.6 tt -76.43 -14.16 60.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.307 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.44 80.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.482 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 13.7 pt-20 -74.69 -19.05 60.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.396 . . . . 0.0 110.704 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 65' ' ' ASP . 96.9 t -77.56 -53.78 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.526 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.02 88.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.125 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -73.0 -27.94 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.523 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.89 137.02 58.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.84 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.7 p -89.78 159.27 17.12 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.182 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 105' ' ' SER . 50.1 tp -122.41 129.71 52.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.994 0.426 . . . . 0.0 111.008 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.3 m-20 -97.5 90.64 5.11 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.594 ' O ' HG12 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -50.48 -13.53 0.13 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' N ' ' C ' ' A' ' 75' ' ' ASP . 71.3 mmtt -71.27 -8.95 57.03 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -106.53 13.45 28.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 76' ' ' LYS . 6.4 p -87.43 123.17 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.822 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.0 pt -120.44 -7.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.13 -169.26 40.47 Favored Glycine 0 C--N 1.317 -0.527 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -146.54 155.72 42.71 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.178 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.4 tp -125.79 128.94 72.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -126.93 131.39 51.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.79 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 24.7 mt -130.63 122.04 19.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.04 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -81.67 -37.16 0.28 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 122.304 2.002 . . . . 0.0 112.422 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -49.12 -37.92 23.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.25 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -118.25 -3.47 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.531 -178.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.51 51.48 1.51 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -109.32 128.93 55.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.132 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.59 113.54 11.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.594 HD22 ' HA2' ' A' ' 106' ' ' GLY . 15.7 mt -146.49 111.79 4.29 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.5 Cg_endo -42.17 143.0 1.45 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.508 1.472 . . . . 0.0 110.583 176.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.28 119.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -102.09 121.44 42.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.076 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 66.0 tttm -64.75 -47.11 79.42 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.558 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 18.3 p -60.6 97.86 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.993 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.93 97.94 7.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.19 0.519 . . . . 0.0 109.803 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.5 p -139.49 158.45 44.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.53 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -60.59 -25.01 65.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.352 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -83.79 -45.2 13.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 111.348 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.558 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.5 m-20 -66.86 -35.07 79.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.444 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 108' ' ' ALA . 22.6 mt -63.5 -16.99 62.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.73 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.07 -27.22 62.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.698 ' HB3' HD22 ' A' ' 74' ' ' LEU . 3.5 m -98.75 -7.48 27.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.594 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 173.8 -170.07 43.17 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.729 -1.225 . . . . 0.0 112.146 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.14 124.35 31.7 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.69 149.81 25.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.779 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 109' ' ' THR . 6.1 p -75.28 152.03 38.27 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 122' ' ' ALA . 1.1 p -88.1 -35.45 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -89.24 143.95 26.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.316 0.579 . . . . 0.0 111.096 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.509 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.1 pt-20 -70.09 -17.14 63.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.916 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.45 52.22 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.792 0.33 . . . . 0.0 111.186 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -88.75 157.98 18.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.78 134.07 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.753 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 5.2 mtp -77.87 123.82 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.23 5.07 65.96 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -140.78 120.18 13.11 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.43 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.91 -173.44 53.64 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 173' ' ' VAL . 39.7 t-20 -78.25 107.58 10.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -85.51 103.42 14.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -90.34 122.5 33.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.306 0.574 . . . . 0.0 111.679 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.09 128.9 56.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.74 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.01 138.54 46.25 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 110.551 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.52 17.69 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.778 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' LEU . 49.9 m-70 -87.32 142.99 27.47 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.998 0.428 . . . . 0.0 110.708 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 129' ' ' SER . 66.8 t30 -109.26 28.65 8.3 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.874 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.56 -18.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.717 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 61.8 37.39 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.941 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -133.98 106.91 7.49 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -50.18 125.61 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.88 -22.9 11.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.0 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.837 HG12 ' H ' ' A' ' 134' ' ' LEU . 33.7 t -90.09 179.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 117.659 0.729 . . . . 0.0 109.352 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.837 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -71.13 135.22 47.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.878 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.04 36.07 2.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.381 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 26.3 p -81.45 -8.94 59.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 85.9 m-20 -145.9 37.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.5 pt -68.64 -32.27 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.472 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.9 5.75 2.45 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.139 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -95.27 -15.7 22.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.79 124.31 22.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.701 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.33 152.25 19.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -54.29 127.26 26.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.616 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.71 22.0 32.37 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 34.6 m-20 -85.41 134.57 34.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -79.35 131.48 36.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 111.88 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.6 mt -127.24 125.96 67.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.532 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.63 119.93 39.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.055 0.455 . . . . 0.0 110.079 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 tp -115.66 143.39 45.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -108.07 124.82 50.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.086 0.47 . . . . 0.0 111.418 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -97.7 -173.03 2.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 152' ' ' ASN . 5.5 p30 -30.35 -69.56 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 70.8 mm-40 -135.03 27.0 3.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.757 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 158.34 38.46 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.465 0.65 . . . . 0.0 112.463 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -116.52 122.18 43.94 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.338 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -105.91 131.92 52.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 111.25 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 204' ' ' VAL . 96.6 mt-10 -96.37 115.26 27.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.984 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -113.93 141.92 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.422 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.16 131.18 54.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.488 0.661 . . . . 0.0 111.198 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 47.8 t -65.37 134.33 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.08 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -100.94 -30.42 11.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 124.708 1.255 . . . . 0.0 110.299 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.46 156.69 11.04 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.207 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.54 154.74 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.916 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.9 t -167.65 178.03 5.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.578 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.44 ' O ' HG13 ' A' ' 166' ' ' VAL . 75.3 mt-10 -113.12 127.64 56.26 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 165' ' ' GLU . 6.1 m -155.52 174.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.361 . . . . 0.0 111.483 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 169' ' ' ASP . 8.9 p -90.56 136.55 28.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.651 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -54.13 -0.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.191 1.927 . . . . 0.0 112.263 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 167' ' ' THR . 48.5 p-10 -74.23 -18.99 60.67 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HZ1' ' NH2' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -85.68 72.21 10.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.521 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 59.8 m95 -74.38 -4.17 34.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.185 0.516 . . . . 0.0 112.001 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.562 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.6 mt-10 -60.55 -18.2 50.92 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.45 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 4.4 m -92.86 -0.29 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.471 HG21 ' CE3' ' A' ' 171' ' ' TRP . 0.5 OUTLIER -123.68 -6.6 7.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.513 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 69.4 mm-40 -87.56 152.22 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.206 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.4 ' HA ' ' H ' ' A' ' 120' ' ' ASN . 97.8 m-20 -59.42 127.33 31.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.714 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.562 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.1 m170 -119.94 27.94 8.39 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.55 76.87 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -148.84 164.91 33.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.073 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -91.91 91.37 7.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.55 0.691 . . . . 0.0 109.826 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -117.41 164.55 14.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.522 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.96 140.75 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.547 ' C ' HD12 ' A' ' 184' ' ' LEU . 56.7 m -135.75 126.47 27.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.624 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 183' ' ' THR . 9.8 mp -108.25 120.8 43.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.376 0.608 . . . . 0.0 109.684 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.2 pt -130.32 -178.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.513 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.466 0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.26 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.61 ' NH2' ' HZ1' ' A' ' 170' ' ' LYS . 20.6 ptt180 . . . . . 0 N--CA 1.458 -0.046 0 CA-C-O 120.809 0.338 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.11 137.52 37.51 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.1 p -131.71 135.87 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.19 137.87 52.7 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.142 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.58 151.97 21.42 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 54.4 p-10 -110.18 147.17 34.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.923 -0.639 . . . . 0.0 111.902 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 205' ' ' GLY . 45.4 tp -67.71 126.24 28.76 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.774 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 157' ' ' GLU . 6.9 m -109.59 -23.54 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.03 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -177.78 172.71 45.38 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.213 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.8 m -152.67 151.43 30.57 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.087 0.47 . . . . 0.0 110.686 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -148.14 175.8 10.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.116 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.82 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.062 0.458 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -73.61 79.75 1.5 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.886 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.768 178.59 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.487 1.141 0 CA-C-O 120.894 0.289 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -77.14 170.76 15.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.3 -14.54 63.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.729 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.36 88.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mm-40 -75.85 -22.48 56.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.449 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.09 -50.35 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.638 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.16 87.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.196 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.66 -31.41 69.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.17 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.63 109.04 1.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -96.69 113.09 24.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.113 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.494 HD21 HD22 ' A' ' 95' ' ' LEU . 38.0 tp -110.24 124.15 51.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.91 140.21 49.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.234 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -64.84 -5.4 5.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.561 . . . . 0.0 109.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -74.45 -9.33 58.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 10.4 mp0 -94.83 3.73 54.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -89.22 126.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.537 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -123.66 -7.9 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.014 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.63 -172.63 39.2 Favored Glycine 0 C--N 1.312 -0.763 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -147.82 154.32 40.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 117.457 0.628 . . . . 0.0 111.852 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.3 tt -123.35 123.7 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.393 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -125.9 129.67 49.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.517 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 15.7 mt -133.89 124.11 17.46 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.424 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.5 Cg_endo -81.97 -36.02 0.34 Allowed 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.194 1.929 . . . . 0.0 112.576 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.516 ' OG ' HD23 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -50.86 -38.78 51.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.806 -177.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 90' ' ' LEU . 14.3 m -118.94 -3.36 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 110.535 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.97 49.54 1.6 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -106.77 126.79 52.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 -179.121 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.634 ' N ' HD13 ' A' ' 90' ' ' LEU . 82.8 tt0 -133.96 115.31 14.23 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.2 tp -149.95 113.5 3.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.6 Cg_endo -41.87 158.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.261 1.307 . . . . 0.0 110.427 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.32 124.84 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.494 HD22 HD21 ' A' ' 74' ' ' LEU . 33.6 mt -104.82 123.82 48.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 63.0 tttp -66.15 -46.89 75.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.097 0.475 . . . . 0.0 110.85 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -71.75 102.83 2.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.52 97.29 9.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.581 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 5.2 p -136.33 155.17 50.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.908 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -54.19 -26.19 26.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.485 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -85.12 -47.45 10.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.475 0.655 . . . . 0.0 111.71 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -65.63 -36.43 83.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.267 -179.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.13 -19.33 61.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -70.79 -32.04 69.01 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 m -92.62 -9.73 39.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.81 176.54 43.21 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.606 -1.283 . . . . 0.0 112.407 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.74 128.01 34.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.17 28.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.001 0.429 . . . . 0.0 111.265 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.0 p -75.56 153.08 37.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.22 -46.38 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -90.54 140.91 29.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.859 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.506 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.0 pt-20 -66.81 -6.12 14.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.694 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -145.73 45.76 1.28 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.78 0.324 . . . . 0.0 110.925 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.534 ' OE1' ' CG ' ' A' ' 121' ' ' TYR . 6.0 tt0 -72.04 161.18 31.28 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.5 t -136.92 124.53 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.8 mtt -75.1 127.82 34.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.494 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.83 71.83 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -140.85 121.61 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.097 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 75.68 -172.26 54.0 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -85.66 111.66 20.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.534 ' CG ' ' OE1' ' A' ' 114' ' ' GLN . 6.0 t80 -83.67 103.25 12.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.435 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.72 128.11 36.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 111.891 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.81 131.26 53.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.764 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.13 140.18 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.407 0.622 . . . . 0.0 110.95 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.8 -177.53 17.03 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.774 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -85.84 149.32 25.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.628 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' SER . 50.4 p30 -114.57 27.36 9.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.945 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.5 mmm -47.94 -10.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.93 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 m 55.87 42.12 29.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.327 0.584 . . . . 0.0 109.598 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.426 ' N ' ' OG ' ' A' ' 136' ' ' SER . 31.7 mmtm -132.56 110.55 10.55 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.927 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -53.92 125.25 17.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.726 0.774 . . . . 0.0 110.544 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.3 9.4 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.611 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.777 HG12 ' H ' ' A' ' 134' ' ' LEU . 52.3 t -77.84 178.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 CA-C-N 117.466 0.633 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.777 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.56 135.58 47.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.974 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 46.07 30.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.539 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.28 -11.44 59.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.16 20.61 2.09 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.5 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.0 pt -68.06 -25.01 31.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.622 0.249 . . . . 0.0 111.419 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.25 6.09 2.46 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.0 t -98.88 -16.09 18.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.516 HD23 ' OG ' ' A' ' 87' ' ' SER . 15.7 mt -64.91 125.02 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.075 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.444 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 22.6 ttpt -99.83 173.87 6.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.409 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 12.4 ttpt -68.57 125.25 25.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.729 0.776 . . . . 0.0 111.617 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.91 26.92 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 85.7 m-20 -85.29 133.31 34.16 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -79.49 127.18 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.302 0.572 . . . . 0.0 111.829 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.99 121.59 63.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.912 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -102.69 121.49 42.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.1 tp -118.52 144.12 46.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -113.04 130.78 56.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.297 0.57 . . . . 0.0 111.193 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.0 t0 -108.87 -172.17 2.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.516 -1.22 . . . . 0.0 107.913 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.506 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.8 m-20 -27.05 -67.7 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.163 0.506 . . . . 0.0 111.799 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.97 22.02 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.8 152.76 36.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.365 0.602 . . . . 0.0 112.461 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.17 120.79 40.93 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CE2' HG21 ' A' ' 206' ' ' THR . 63.2 m-85 -106.85 130.73 54.49 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 111.075 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.7 mt-10 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.297 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -113.33 141.91 46.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.31 131.57 54.28 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.532 0.682 . . . . 0.0 110.42 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.6 135.81 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.146 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -100.92 -23.09 14.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.461 1.1 . . . . 0.0 110.339 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 153.16 155.93 7.36 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.497 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.39 138.56 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.331 -0.934 . . . . 0.0 109.905 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.0 m -135.04 149.57 50.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.129 0.49 . . . . 0.0 111.601 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.49 111.54 24.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.308 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.03 158.59 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.184 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 p -67.06 168.47 10.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.535 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.3 Cg_endo -81.52 -11.09 11.85 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 122.033 1.822 . . . . 0.0 111.47 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -86.69 -14.49 42.37 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.168 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -87.37 72.26 9.81 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.143 0.496 . . . . 0.0 110.442 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 89.4 m95 -76.21 -1.72 27.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.464 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.505 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -53.56 -31.26 45.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 0.0 110.739 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.713 ' O ' HG21 ' A' ' 183' ' ' THR . 17.7 m -83.68 4.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.66 -16.23 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.616 0.722 . . . . 0.0 109.456 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.9 159.9 19.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.878 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.26 129.34 39.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 39.5 m80 -102.25 -38.87 7.47 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.49 29.33 0.28 Allowed Glycine 0 N--CA 1.472 1.076 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.427 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.0 ptpt -156.18 176.91 12.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.381 0.61 . . . . 0.0 111.595 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 23.9 p30 -90.69 88.62 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.893 0.854 . . . . 0.0 109.84 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.44 166.88 13.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.169 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.25 140.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.713 HG21 ' O ' ' A' ' 173' ' ' VAL . 19.5 m -135.28 126.33 27.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.77 118.29 33.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.339 0.59 . . . . 0.0 109.782 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.51 HG22 HG13 ' A' ' 198' ' ' VAL . 29.3 pt -129.35 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.54 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.529 ' OG1' ' NH1' ' A' ' 196' ' ' ARG . 44.3 p . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.113 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.529 ' NH1' ' OG1' ' A' ' 186' ' ' THR . 61.0 ttm-85 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.92 0.39 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.98 127.39 42.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.51 HG13 HG22 ' A' ' 185' ' ' ILE . 47.9 t -133.54 136.92 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 126.39 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.579 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.09 136.79 52.7 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.28 0.562 . . . . 0.0 110.3 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.6 155.48 23.63 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.632 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -112.32 146.16 38.75 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.813 0.34 . . . . 0.0 111.865 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.41 128.34 36.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 121.368 0.604 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.7 p -107.31 -24.14 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.752 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.47 175.15 46.11 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.445 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.428 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.2 m -152.7 151.6 30.74 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 110.83 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -149.17 176.27 10.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.04 146.02 24.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.337 0.589 . . . . 0.0 111.17 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.53 79.63 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.566 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp . . . . . 0 C--N 1.318 -0.795 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.76 178.615 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.486 1.035 0 CA-C-O 120.818 0.258 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 57.8 t0 -71.64 152.89 42.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.439 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.7 mt -59.6 -24.3 63.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.715 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.78 90.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -73.41 -34.57 65.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.3 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.61 -44.17 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.606 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.81 89.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.92 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.47 -24.74 36.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.91 109.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.892 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -95.6 121.84 37.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.039 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.4 tp -115.79 127.94 55.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.986 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.42 138.38 55.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.587 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -71.19 -6.86 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.5 . . . . 0.0 110.274 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.09 -36.68 85.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.174 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.461 HE22 HD21 ' A' ' 102' ' ' ASN . 83.7 mt-30 -76.69 13.01 1.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.316 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.43 126.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.75 -4.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.87 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.22 -171.23 40.54 Favored Glycine 0 C--N 1.318 -0.468 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.793 ' O ' HD23 ' A' ' 149' ' ' LEU . 53.5 mtt180 -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.1 tt -119.28 124.71 73.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 m -127.1 128.68 46.6 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 56.6 mt -131.78 129.36 21.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.355 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -82.31 -35.4 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.22 1.947 . . . . 0.0 112.377 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -49.71 -39.67 37.8 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.669 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.9 p -118.44 -2.31 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 123.027 0.204 . . . . 0.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.89 53.08 3.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.7 tp -113.34 131.84 55.81 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.037 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.89 115.7 15.57 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 83' ' ' ILE . 39.5 mt -143.97 111.64 5.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.7 Cg_endo -40.65 138.64 1.42 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.57 1.513 . . . . 0.0 110.811 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 68.1 t -90.96 122.93 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -100.03 136.96 39.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.338 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.79 -34.48 60.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.6 m -93.83 115.84 28.27 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.465 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.8 p -82.79 66.44 8.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.211 0.529 . . . . 0.0 110.183 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.547 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -94.65 150.73 19.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.377 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -54.16 -52.01 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.634 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.83 -41.88 95.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.368 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.547 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 3.7 m-20 -66.17 -33.47 75.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.37 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.87 -15.08 62.6 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.413 HD23 ' NE2' ' A' ' 126' ' ' HIS . 24.3 mt -72.35 -23.44 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -94.08 -9.65 35.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.413 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 169.25 -162.94 36.63 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.853 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.453 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -89.08 127.84 35.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.249 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.82 26.02 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.6 p -71.45 149.75 45.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.3 t -82.92 -46.13 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -92.8 -171.55 2.75 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.297 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -106.79 -55.19 2.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.505 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -90.8 46.61 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.575 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.9 147.01 23.83 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.17 131.83 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.535 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.5 mtt -64.71 128.1 34.33 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.42 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.52 5.85 71.44 Favored Glycine 0 CA--C 1.508 -0.364 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -140.62 118.5 11.79 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.809 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.0 -168.45 54.21 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 61.1 t30 -85.99 109.11 18.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.63 103.54 13.03 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.7 126.73 36.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.806 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.486 HD13 HD12 ' A' ' 83' ' ' ILE . 11.5 mt -122.63 132.62 54.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.689 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.09 140.0 48.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.114 0.483 . . . . 0.0 110.587 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.99 -178.12 17.77 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.413 ' NE2' HD23 ' A' ' 104' ' ' LEU . 44.6 m-70 -80.9 156.62 25.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 0.0 110.622 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 129' ' ' SER . 2.2 p-10 -120.95 27.47 8.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 35.0 mtt -46.24 -12.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.615 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 57.5 40.35 27.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.616 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -134.0 112.07 10.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.032 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -52.84 124.51 14.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.059 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.65 -29.73 7.66 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.779 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.703 HG12 ' N ' ' A' ' 134' ' ' LEU . 95.6 t -75.22 176.68 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 117.914 0.857 . . . . 0.0 109.247 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.703 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.61 134.76 46.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.117 -178.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.3 m-85 46.13 32.87 1.54 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.958 0.408 . . . . 0.0 110.708 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -82.24 -9.85 59.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -146.58 28.28 1.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.431 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.5 pt -69.74 -27.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.496 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.83 0.13 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.846 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.8 m -91.27 -15.5 29.08 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.69 116.76 6.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.054 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.447 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.5 mttp -103.53 154.74 19.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -50.76 113.29 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.395 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.29 4.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.8 m-20 -101.06 128.47 47.1 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -82.99 134.61 35.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.247 0.546 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 158' ' ' TYR . 90.0 mt -123.95 124.24 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.946 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -105.08 122.01 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 110.82 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.7 mt -116.12 150.42 37.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.397 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.465 ' O ' ' SD ' ' A' ' 116' ' ' MET . 60.2 m-85 -118.36 130.19 55.86 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.087 0.47 . . . . 0.0 110.991 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.5 t0 -109.93 -170.15 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 7.5 p30 -27.03 -71.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.1 0.476 . . . . 0.0 111.602 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.7 mt-10 -137.49 31.41 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.081 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.16 138.95 48.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.324 0.583 . . . . 0.0 112.401 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -103.94 121.62 43.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -104.42 133.46 49.27 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.294 0.568 . . . . 0.0 111.55 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.412 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.7 mt-10 -98.38 119.86 37.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.016 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 147' ' ' ILE . 31.6 m-85 -120.0 139.7 52.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.93 135.14 54.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.492 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.4 t -70.7 135.9 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.981 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 11.4 p -102.68 -23.98 13.79 Favored 'General case' 0 C--N 1.341 0.235 0 O-C-N 124.814 1.321 . . . . 0.0 110.972 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.81 154.79 7.26 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.31 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.56 146.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.551 -0.824 . . . . 0.0 109.789 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.9 t -146.19 156.15 43.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.86 0.362 . . . . 0.0 111.178 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -109.18 118.23 36.2 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.18 156.69 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.968 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 169' ' ' ASP . 20.4 p -66.15 136.31 95.33 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.602 ' CB ' HH21 ' A' ' 196' ' ' ARG . 1.6 Cg_endo -47.77 -12.99 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.97 1.78 . . . . 0.0 111.816 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 167' ' ' THR . 55.0 t0 -86.0 -11.15 53.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.642 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -86.78 75.35 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.774 0.321 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -78.11 -5.64 52.22 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.049 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -53.43 -35.03 60.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.944 0.402 . . . . 0.0 111.191 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.709 ' O ' HG21 ' A' ' 183' ' ' THR . 16.8 m -81.45 3.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.828 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.0 t -119.53 -15.04 8.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.567 0.699 . . . . 0.0 109.773 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -85.31 163.19 18.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.047 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.35 129.62 39.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.0 -42.62 6.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.135 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.69 30.12 0.26 Allowed Glycine 0 N--CA 1.469 0.89 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -155.81 177.37 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.071 0.462 . . . . 0.0 111.236 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 61.9 m-20 -88.88 89.34 7.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.266 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -124.21 166.17 16.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.971 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.68 143.18 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 173' ' ' VAL . 8.2 m -136.21 125.33 24.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.711 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.566 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -112.85 125.59 54.53 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.505 HG22 HG12 ' A' ' 198' ' ' VAL . 5.6 pt -140.6 -177.86 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.7 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 32.1 p . . . . . 0 N--CA 1.467 0.404 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.771 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.602 HH21 ' CB ' ' A' ' 168' ' ' PRO . 29.6 ttm180 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.737 0.304 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -84.92 129.76 34.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 185' ' ' ILE . 34.6 m -137.57 140.07 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.165 0.507 . . . . 0.0 111.626 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.5 t -118.06 130.9 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.419 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.92 136.98 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.643 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.44 160.95 24.62 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.377 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 53.2 p-10 -112.53 146.03 39.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.175 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 157' ' ' GLU . 37.2 tp -68.95 127.74 34.22 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.24 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.2 176.58 44.51 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.386 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 36.1 m -153.56 153.44 32.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.077 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -149.78 179.21 8.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.578 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.64 148.97 21.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.618 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 209' ' ' LYS . 15.0 ptmt -64.42 79.59 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.455 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.314 -0.938 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.661 178.059 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.483 0.866 0 N-CA-C 110.982 -0.43 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.01 166.21 23.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.692 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.9 mm? -69.61 -16.29 63.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 111.152 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.91 94.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.381 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.9 mm-40 -72.52 -33.57 66.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.91 -46.52 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.911 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.016 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 59.9 t-20 -82.9 -28.32 30.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.59 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.83 106.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.851 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 m -97.3 114.81 26.63 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.58 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.441 HD13 ' OD1' ' A' ' 102' ' ' ASN . 53.2 tp -107.24 125.67 51.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.934 0.397 . . . . 0.0 111.106 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -68.23 138.48 55.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.321 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -63.92 -8.5 11.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.286 0.565 . . . . 0.0 110.207 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -70.76 -14.82 62.58 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.389 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -91.94 1.02 57.45 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.496 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.76 122.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 tt -104.31 -36.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.407 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.37 -158.47 8.78 Favored Glycine 0 C--N 1.321 -0.303 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.451 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 25.7 mtp85 -146.9 150.6 35.53 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.52 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.8 tt -122.34 127.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -126.84 129.15 47.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.849 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 12.6 mt -133.62 117.18 14.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.2 -177.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 3.4 Cg_exo -80.92 -37.75 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.486 2.124 . . . . 0.0 112.653 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 t -49.26 -36.79 21.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.491 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 90' ' ' LEU . 6.9 m -119.87 -7.07 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.381 0.134 . . . . 0.0 111.057 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 73.33 46.02 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.663 0.744 . . . . 0.0 109.952 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -106.0 125.59 51.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.512 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -137.0 110.75 8.11 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' O ' HG22 ' A' ' 83' ' ' ILE . 18.3 mt -146.61 116.88 4.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -41.14 140.41 1.33 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.795 1.663 . . . . 0.0 109.931 176.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.35 126.82 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.423 HD22 HD21 ' A' ' 74' ' ' LEU . 28.1 mt -103.11 124.97 49.56 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -70.37 -34.36 72.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.1 m -86.45 108.85 18.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.987 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -82.0 69.35 8.69 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 110.221 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.574 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.08 151.58 22.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.484 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.74 -50.14 66.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.593 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.01 -40.63 95.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.075 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.574 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 43.0 m-20 -65.64 -37.03 85.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.58 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.25 -18.09 46.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.627 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.31 -17.71 61.28 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -100.56 -12.14 19.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.52 -174.72 43.86 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 127.46 32.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.29 146.61 29.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 110.771 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.9 p -75.5 151.5 37.99 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.11 -50.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -90.65 139.22 30.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.72 -48.09 83.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.826 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -98.51 47.36 0.99 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.01 159.71 30.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -140.86 124.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 -178.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.0 mtt -75.36 127.97 34.34 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.32 -1.14 72.56 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 115' ' ' VAL . 29.5 tptp -142.81 127.34 17.9 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.986 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 72.93 -172.98 48.71 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -86.6 110.29 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -85.63 100.79 12.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.37 125.32 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.531 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.492 HD13 HD12 ' A' ' 83' ' ' ILE . 7.1 mt -119.32 130.28 55.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.36 138.98 47.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 110.754 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.76 -178.57 18.8 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.323 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 42.5 m-70 -85.69 141.05 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.569 0.223 . . . . 0.0 110.581 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 129' ' ' SER . 65.3 t30 -110.44 27.68 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.124 0.488 . . . . 0.0 110.567 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -44.81 -16.18 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.854 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.56 40.88 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.069 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 136' ' ' SER . 98.4 mttt -131.25 109.46 10.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.358 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 132' ' ' GLY . 7.7 tmtt? -53.31 123.87 13.1 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.511 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.404 ' N ' ' HD3' ' A' ' 131' ' ' LYS . . . 114.91 -29.2 7.58 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 134' ' ' LEU . 57.2 t -77.84 178.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.752 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.88 136.67 47.03 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 44.87 32.0 0.76 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.108 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.2 p -82.4 -11.92 58.24 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.96 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.403 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 35.2 t0 -141.71 25.91 1.95 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 pt -70.3 -22.33 23.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.918 0.389 . . . . 0.0 111.846 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.9 3.91 7.41 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.661 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.403 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.7 m -99.57 -11.45 20.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.111 0.481 . . . . 0.0 110.298 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.474 ' O ' HG21 ' A' ' 163' ' ' VAL . 14.6 mt -62.95 124.95 22.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.463 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.462 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -96.97 163.04 13.12 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.846 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -60.77 136.1 57.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.528 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.14 57.73 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 40.5 m-20 -87.61 131.62 34.35 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.948 ' HZ1' HG11 ' A' ' 204' ' ' VAL . 3.4 mmpt? -78.2 129.2 34.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.932 0.396 . . . . 0.0 111.726 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.1 mt -124.8 123.15 65.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -104.12 120.26 40.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.194 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.607 HD22 ' SD ' ' A' ' 116' ' ' MET . 0.4 OUTLIER -115.38 136.44 53.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.404 -178.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.451 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 87.7 m-85 -108.27 130.61 55.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 111.285 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.6 t0 -113.46 -165.46 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.524 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.3 m-20 -24.11 -75.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.174 0.512 . . . . 0.0 111.328 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -137.03 26.02 2.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -126.22 143.13 51.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -108.39 120.46 42.45 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -103.35 131.19 50.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.547 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.494 ' OE2' ' NZ ' ' A' ' 146' ' ' LYS . 70.3 tt0 -95.96 121.04 37.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -120.25 137.27 54.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.246 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.11 132.56 56.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 110.547 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.24 134.84 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.155 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.3 t -104.74 -24.29 12.94 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.468 1.105 . . . . 0.0 111.516 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.18 147.37 5.11 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.397 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 199' ' ' VAL . 13.5 t -111.08 155.51 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.6 t -161.34 169.64 21.66 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.936 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -121.22 123.88 43.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -135.69 157.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 111.326 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 169' ' ' ASP . 16.9 p -59.16 131.3 87.28 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.563 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.1 Cg_endo -45.57 -14.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.968 1.779 . . . . 0.0 112.122 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 167' ' ' THR . 53.6 t0 -84.83 -8.58 58.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.275 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.455 ' O ' HG22 ' A' ' 173' ' ' VAL . 1.3 tppp? -87.82 62.74 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.563 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 26.9 m95 -72.24 -18.21 61.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.804 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.09 -9.64 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.166 0.508 . . . . 0.0 111.195 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 171' ' ' TRP . 24.6 m -83.39 -25.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.817 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.459 HG11 HD13 ' A' ' 185' ' ' ILE . 0.8 OUTLIER -109.67 -2.33 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.622 0.725 . . . . 0.0 109.865 -178.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 176' ' ' ASP . 95.3 mt-10 -82.18 119.9 24.65 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.78 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 175' ' ' GLU . 97.9 m-20 -28.96 119.81 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.957 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -98.86 -43.43 6.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.051 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.17 33.47 0.32 Allowed Glycine 0 N--CA 1.47 0.963 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.1 ptpt -153.6 176.29 12.24 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.235 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 50.6 p-10 -97.44 88.62 4.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.904 0.859 . . . . 0.0 110.46 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -131.0 177.11 7.69 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.282 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.48 HD12 HD12 ' A' ' 149' ' ' LEU . 20.3 tt -130.63 143.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.538 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.615 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.5 m -138.22 123.88 19.77 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.563 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.615 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -110.86 128.82 55.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.459 HD13 HG11 ' A' ' 174' ' ' VAL . 7.1 pt -138.61 -166.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.626 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.464 0.229 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.656 -179.005 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' A' ' 168' ' ' PRO . 7.8 tmm_? . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.602 0.239 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -100.27 134.48 43.15 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.7 138.95 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.898 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.544 HG22 HG13 ' A' ' 163' ' ' VAL . 77.7 t -116.97 128.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.528 ' O ' HG22 ' A' ' 161' ' ' THR . . . -112.52 133.01 54.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.453 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.06 152.99 20.74 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 64.5 t0 -111.04 149.41 30.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.783 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.543 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.54 127.73 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.207 0.527 . . . . 0.0 110.795 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.948 HG11 ' HZ1' ' A' ' 146' ' ' LYS . 6.1 p -111.32 -21.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.699 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.43 176.05 47.46 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.678 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.0 m -156.86 154.51 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.824 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -150.76 178.99 8.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -90.96 148.19 22.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.285 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.411 ' O ' ' OXT' ' A' ' 210' ' ' LYS . 64.4 tttm -74.49 79.24 1.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.561 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.411 ' OXT' ' O ' ' A' ' 209' ' ' LYS . 26.7 ttpt . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.461 178.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.485 1.008 0 CA-C-O 120.988 0.328 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -77.42 171.36 15.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.71 -16.07 63.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.89 92.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.459 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -74.33 -31.97 62.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.507 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.7 t -75.01 -45.48 42.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.575 -178.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.7 89.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.853 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -77.06 -28.49 54.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.282 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.79 107.25 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.977 -179.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.9 t -96.67 119.63 35.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.159 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.8 tp -119.05 129.48 55.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.481 -179.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.45 138.87 49.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.835 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -68.78 -7.82 37.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.297 0.57 . . . . 0.0 110.246 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -73.5 -10.34 59.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.864 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.8 mp0 -91.87 1.61 57.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.02 131.27 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.882 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.1 pt -123.22 -5.5 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -178.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.0 -170.08 35.51 Favored Glycine 0 C--N 1.316 -0.573 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -146.32 150.89 36.59 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.704 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -123.02 124.8 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.616 ' N ' HD13 ' A' ' 83' ' ' ILE . 26.3 t -130.32 131.11 45.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.621 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.5 mt -133.46 131.15 21.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.461 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.36 -35.43 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.315 2.01 . . . . 0.0 111.854 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -48.41 -39.86 23.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.519 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.6 p -119.48 -2.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.901 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 2.6 p 62.67 52.22 2.89 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -112.28 132.44 54.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.101 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -134.85 115.49 13.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.458 ' O ' HG22 ' A' ' 83' ' ' ILE . 64.3 mt -144.09 113.65 5.32 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -177.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.3 Cg_endo -41.76 147.62 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.767 1.645 . . . . 0.0 110.58 176.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.55 123.0 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.465 ' CB ' HD22 ' A' ' 102' ' ' ASN . 22.3 mt -104.25 123.75 47.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.044 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 65.8 tttm -67.38 -47.13 71.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.192 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.59 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -74.06 105.99 5.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.366 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -81.84 101.98 10.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.494 0.664 . . . . 0.0 110.199 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.528 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.8 p -135.54 164.15 28.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.33 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.969 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -83.0 -42.4 17.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.788 -179.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -66.65 -35.24 79.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.231 -178.821 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -63.72 -16.34 60.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.863 -178.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.65 -16.47 60.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.8 p -106.29 -9.3 16.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.2 -172.54 44.49 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.403 -178.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.85 128.45 33.37 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.114 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.559 ' CB ' HD21 ' A' ' 102' ' ' ASN . . . -105.27 146.77 28.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.79 149.91 39.53 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.19 -41.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 112' ' ' GLU . 24.3 tttp -88.74 -173.35 4.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.78 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 35.4 tp10 -120.95 -11.33 8.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.296 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 112' ' ' GLU . 97.9 m-20 -141.57 42.09 1.73 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.234 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -89.74 160.53 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.6 t -132.02 132.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.741 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.416 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.7 mtt -68.38 128.67 37.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.209 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.31 3.02 72.88 Favored Glycine 0 N--CA 1.461 0.323 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -140.4 120.91 14.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.96 53.13 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.492 HD21 ' CB ' ' A' ' 183' ' ' THR . 2.0 t30 -95.39 110.9 22.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -84.4 103.73 13.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 128.54 36.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.281 0.563 . . . . 0.0 111.969 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.45 129.48 51.31 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.716 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 139.16 46.65 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.469 0.652 . . . . 0.0 110.888 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.56 -178.64 17.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.746 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -81.98 155.42 25.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.3 p-10 -121.82 27.04 8.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.428 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 39.0 mtt -44.08 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.004 -178.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 59.65 40.04 20.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.398 0.618 . . . . 0.0 109.613 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 136' ' ' SER . 65.4 tttm -135.59 118.55 16.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.823 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.0 124.99 21.2 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.637 0.732 . . . . 0.0 110.47 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.5 -26.1 10.53 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.816 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 134' ' ' LEU . 98.4 t -78.97 175.69 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.774 0.787 . . . . 0.0 109.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.713 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.28 135.07 45.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.191 -178.401 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 46.26 32.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.458 . . . . 0.0 110.542 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.27 -7.59 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.512 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.6 m-20 -147.09 31.46 0.93 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -177.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.5 pt -70.73 -23.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.463 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB2' ' CG ' ' A' ' 197' ' ' TYR . . . -74.48 3.2 7.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.668 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -97.02 -11.6 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.4 ' O ' HG21 ' A' ' 163' ' ' VAL . 16.9 mt -64.79 122.45 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.608 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 60.4 mttp -96.82 151.4 19.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.489 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -54.74 123.77 14.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.606 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.73 19.64 19.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.5 m-20 -88.23 132.29 34.43 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -82.15 135.19 35.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.386 0.612 . . . . 0.0 111.978 -177.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 158' ' ' TYR . 96.0 mt -127.47 125.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.718 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.41 118.36 36.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.147 0.498 . . . . 0.0 109.986 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.39 144.82 43.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.314 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.416 ' O ' ' SD ' ' A' ' 116' ' ' MET . 19.2 m-85 -114.78 131.75 56.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.216 0.531 . . . . 0.0 111.271 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.8 t0 -112.41 -168.73 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.9 m120 -24.22 -74.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.04 0.448 . . . . 0.0 112.066 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -137.47 28.22 2.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.86 148.77 50.48 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -175.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.31 122.26 47.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.433 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.8 m-85 -105.65 132.01 52.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 111.412 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -95.92 114.16 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.163 178.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 147' ' ' ILE . 46.9 m-85 -115.38 139.96 49.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -120.58 134.79 55.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.491 0.662 . . . . 0.0 111.561 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.95 133.29 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.96 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 p -102.89 -28.44 12.04 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 124.959 1.412 . . . . 0.0 110.697 -178.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.22 152.56 7.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.82 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 199' ' ' VAL . 12.2 t -116.29 150.15 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.742 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -152.27 161.95 41.86 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.277 0.56 . . . . 0.0 111.543 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -111.51 126.47 55.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.478 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.59 162.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.01 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.1 p -71.17 141.31 86.13 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -46.54 -17.24 0.33 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.862 1.708 . . . . 0.0 111.842 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.6 m-20 -82.77 -3.6 56.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.1 tptt -80.98 148.07 29.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 81.7 m95 -158.33 -26.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.963 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.13 -8.67 0.08 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.236 0.541 . . . . 0.0 110.531 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.794 HG23 HG13 ' A' ' 174' ' ' VAL . 4.8 m -74.8 -30.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.923 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.794 HG13 HG23 ' A' ' 173' ' ' VAL . 2.5 m -105.59 -5.13 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.756 0.789 . . . . 0.0 109.763 -178.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 176' ' ' ASP . 77.6 mm-40 -80.02 118.38 21.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.9 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 175' ' ' GLU . 68.2 t0 -29.01 124.08 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.491 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -99.08 -40.72 7.87 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.917 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.5 29.21 0.28 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' A' ' 181' ' ' GLU . 21.9 pttp -156.03 179.52 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 111.296 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -94.12 100.11 12.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.714 0.769 . . . . 0.0 109.79 179.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' A' ' 179' ' ' LYS . 17.1 pt-20 -138.92 174.58 10.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.922 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.1 tt -131.12 143.88 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.548 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.588 ' C ' HD12 ' A' ' 184' ' ' LEU . 12.4 m -135.9 126.01 26.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.677 0.275 . . . . 0.0 111.239 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -113.14 126.89 55.94 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.384 0.612 . . . . 0.0 110.643 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 174' ' ' VAL . 8.1 pt -141.13 -172.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.184 -178.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.017 -179.751 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.227 0 CA-C-O 121.144 0.497 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.419 ' CG ' ' HB2' ' A' ' 139' ' ' ALA . 8.6 m-85 -121.22 131.53 54.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.003 178.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.36 127.74 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.894 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.49 HG22 HG13 ' A' ' 163' ' ' VAL . 70.1 t -117.63 129.11 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.509 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.04 54.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.415 0.626 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.42 159.06 24.31 Favored Glycine 0 N--CA 1.461 0.322 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.849 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -110.17 153.35 24.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.709 -0.746 . . . . 0.0 111.873 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.9 tp -74.94 127.7 33.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.255 0.55 . . . . 0.0 110.878 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.403 HG21 ' HB2' ' A' ' 159' ' ' ALA . 93.1 t -107.56 -25.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.912 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 174.29 176.7 42.88 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.47 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 156' ' ' TYR . 15.1 m -153.49 153.2 31.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 111.052 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.33 176.91 10.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.463 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.56 142.08 27.86 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.898 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.99 79.87 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.847 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.2 tttm . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.552 178.64 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.484 0.968 0 CA-C-O 120.818 0.258 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 171.58 14.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.92 -14.3 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.683 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.92 91.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mt-10 -74.85 -26.09 59.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.18 -47.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.671 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -42.24 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -70.83 -31.04 67.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.82 145.46 55.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.44 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -139.26 108.13 5.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.059 0.456 . . . . 0.0 110.998 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.427 HD11 HD22 ' A' ' 95' ' ' LEU . 3.9 tt -105.13 127.05 52.72 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.056 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -74.0 137.1 43.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' O ' HG12 ' A' ' 79' ' ' VAL . 4.5 mptp? -67.33 -9.41 40.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 110.165 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -80.29 -11.94 59.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.497 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.71 6.92 36.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 76' ' ' LYS . 8.6 p -88.18 138.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.1 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 pt -120.79 -5.96 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.561 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.64 -165.29 30.84 Favored Glycine 0 C--N 1.32 -0.361 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.408 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 11.8 ttp180 -152.57 155.0 36.54 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.042 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 83' ' ' ILE . 20.6 tt -128.61 130.17 68.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.675 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.04 130.83 51.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.553 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 mt -134.76 100.86 11.97 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.136 -178.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -67.82 -34.2 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.244 1.963 . . . . 0.0 112.404 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.5 t -52.1 -38.73 58.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 -177.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 137' ' ' ASP . 25.3 t -110.31 -9.6 11.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 120.58 0.229 . . . . 0.0 110.665 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.82 43.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.413 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -115.8 130.48 56.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.819 -178.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -134.45 118.91 17.9 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.3 mt -145.31 163.13 33.92 Favored Pre-proline 0 N--CA 1.465 0.275 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.547 -177.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.78 150.27 7.3 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.052 2.501 . . . . 0.0 109.428 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.9 t -95.77 116.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.427 HD22 HD11 ' A' ' 74' ' ' LEU . 39.7 mt -101.83 122.55 44.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -65.76 -46.19 79.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.084 0.468 . . . . 0.0 111.046 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 p -75.3 103.91 5.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.376 -179.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 99.8 11.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.333 0.587 . . . . 0.0 110.316 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 5.4 p -132.11 160.41 36.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.685 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -56.74 -28.96 62.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.781 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.485 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 18.8 ptmt -84.25 -41.88 16.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.342 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 101' ' ' LYS . 5.4 m120 -65.76 -36.47 83.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.396 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.89 -20.58 62.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.4 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -75.58 -15.51 60.35 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.6 m -103.32 -11.49 17.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.09 -166.59 39.79 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.226 -178.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.14 125.01 28.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.61 143.28 33.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.058 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.3 p -69.19 144.06 53.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.49 -44.69 18.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -89.33 -175.08 4.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.95 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -115.42 -11.57 11.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.623 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -137.6 43.19 2.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -178.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.518 ' OE1' ' CZ ' ' A' ' 121' ' ' TYR . 5.7 pt20 -92.17 155.28 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.362 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.05 132.37 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.507 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.0 mtt -68.3 128.15 35.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.413 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 89.34 4.61 73.7 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.86 121.17 12.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.638 -179.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.76 -168.88 54.6 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.565 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 8.1 t30 -89.33 110.48 21.26 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.518 ' CZ ' ' OE1' ' A' ' 114' ' ' GLN . 1.7 t80 -84.74 105.22 15.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.476 ' O ' HD22 ' A' ' 123' ' ' LEU . . . -95.01 120.13 34.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.998 -178.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 122' ' ' ALA . 1.9 mm? -117.09 132.42 56.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.862 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 142.54 43.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.752 -179.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.02 -178.6 19.88 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.545 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -85.16 152.07 23.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.922 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' SER . 41.7 t30 -116.01 28.34 8.68 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -50.14 -8.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.66 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 127' ' ' ASN . 3.0 t 52.51 44.18 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 109.716 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' SER . 29.3 tptp -134.15 113.53 12.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.643 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -56.01 125.17 20.39 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.415 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.45 -29.22 8.84 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.827 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.3 t -76.82 178.37 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 117.847 0.824 . . . . 0.0 109.384 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.743 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.38 136.51 49.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.715 0.293 . . . . 0.0 110.933 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 138' ' ' ILE . 4.1 m-30 43.17 31.76 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.928 178.312 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.41 -11.66 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.108 -178.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.492 ' O ' HG21 ' A' ' 88' ' ' VAL . 7.1 m-20 -142.24 22.1 2.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 140' ' ' SER . 4.5 pt -67.52 -29.41 45.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.61 2.43 1.33 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.793 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 138' ' ' ILE . 49.9 m -97.03 -11.46 24.45 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.19 121.15 12.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.51 172.69 7.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.766 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.35 122.1 22.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.543 0.687 . . . . 0.0 112.035 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.83 14.61 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -93.35 134.79 35.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -83.37 137.25 34.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.454 0.645 . . . . 0.0 112.074 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.65 122.85 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.001 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 73.9 m-85 -101.09 117.08 34.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.8 tp -115.1 144.96 42.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.675 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.408 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 31.1 m-85 -117.05 130.69 56.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.998 0.427 . . . . 0.0 111.676 -178.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.8 t0 -107.02 -167.66 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.497 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 61.6 t-20 -29.39 -68.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -138.41 21.7 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.766 179.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.44 146.33 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -176.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.37 118.87 37.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 206' ' ' THR . 60.5 m-85 -104.21 130.69 51.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.144 0.497 . . . . 0.0 111.085 -178.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 41.5 tp10 -94.41 117.18 29.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.15 137.81 51.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.31 133.36 56.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.274 0.559 . . . . 0.0 110.566 179.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 133.39 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -104.72 -25.15 12.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.537 1.148 . . . . 0.0 110.751 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.03 153.86 7.08 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.917 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.73 155.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.576 -0.812 . . . . 0.0 109.28 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.9 p -151.7 162.3 41.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.077 0.465 . . . . 0.0 111.198 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -114.22 113.67 24.95 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 159.66 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.139 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.3 p -60.3 168.46 2.29 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.5 -11.52 11.71 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.905 1.736 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.58 -6.64 59.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.997 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 173' ' ' VAL . 15.5 mmtp -85.06 66.71 9.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 173' ' ' VAL . 63.1 m95 -72.29 -24.57 61.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.98 -17.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.247 0.546 . . . . 0.0 110.365 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 170' ' ' LYS . 24.3 m -69.87 -27.23 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.206 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.52 HG11 HD13 ' A' ' 185' ' ' ILE . 1.6 m -109.73 1.0 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.554 0.692 . . . . 0.0 110.052 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.83 125.86 32.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.317 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -34.95 122.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.445 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -103.07 -44.22 5.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.777 0.323 . . . . 0.0 111.309 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.69 28.06 0.17 Allowed Glycine 0 N--CA 1.47 0.932 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -153.49 173.36 15.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 22.3 m-20 -94.25 88.86 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.462 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 75.1 tt0 -133.34 127.07 32.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.099 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.1 tt -81.16 148.26 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.565 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 17.5 m -135.93 125.75 25.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.843 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.54 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -111.29 127.08 55.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 111.204 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.52 HD13 HG11 ' A' ' 174' ' ' VAL . 5.7 pt -132.35 153.61 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.248 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 -179.198 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -93.04 128.49 38.94 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.527 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.01 132.47 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 111.142 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.96 129.46 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.215 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.512 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.18 137.35 51.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.516 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.97 135.3 8.59 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.4 t0 -95.63 133.5 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.069 -0.566 . . . . 0.0 111.546 -178.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.401 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 44.8 tp -62.18 124.06 19.84 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.214 0.53 . . . . 0.0 110.385 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.1 -21.7 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.054 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.01 175.14 47.11 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.159 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 156' ' ' TYR . 22.4 m -154.57 152.71 30.36 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.023 0.44 . . . . 0.0 110.628 178.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -150.98 177.45 10.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.116 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.18 148.77 21.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.201 0.524 . . . . 0.0 110.845 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -70.79 80.27 0.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.535 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.669 178.424 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.483 0.899 0 N-CA-C 110.8 -0.5 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.78 147.77 48.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.808 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.8 mt -55.25 -25.9 36.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.053 -178.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.9 95.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.618 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 70.3 mm-40 -72.58 -33.38 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.923 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.3 t -75.36 -45.68 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.056 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -38.02 88.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.98 -25.97 34.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.639 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.63 131.84 51.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.388 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.8 t -95.92 158.92 15.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.024 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.689 HD22 ' HB3' ' A' ' 105' ' ' SER . 44.6 tp -123.24 134.13 54.13 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -179.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.28 105.54 15.84 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.027 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.587 ' O ' HG12 ' A' ' 79' ' ' VAL . 6.0 mptp? -63.81 -8.73 11.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.269 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -63.73 -39.47 94.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.545 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 3.6 pt20 -89.11 19.97 3.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.768 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.3 p -84.72 126.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.568 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.5 -9.26 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.43 -166.35 37.27 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.504 ' O ' HD12 ' A' ' 149' ' ' LEU . 34.6 mtp180 -146.88 150.57 35.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.622 -178.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 92' ' ' LEU . 7.8 tp -113.18 122.56 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 t -126.87 128.05 45.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.508 HG21 HD21 ' A' ' 141' ' ' LEU . 10.5 mt -135.62 122.31 14.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.969 -177.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.79 -34.73 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.577 2.184 . . . . 0.0 112.37 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.556 ' CB ' HD23 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -51.08 -39.75 56.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.488 -177.24 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 90' ' ' LEU . 20.7 m -118.62 -9.01 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 122.314 0.246 . . . . 0.0 111.096 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.505 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 74.37 48.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.407 0.622 . . . . 0.0 109.833 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.66 HD11 HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -107.18 123.49 48.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 -178.808 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.658 ' N ' HD13 ' A' ' 90' ' ' LEU . 84.7 tt0 -135.46 110.44 8.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 90' ' ' LEU . 10.6 mt -149.8 115.86 3.53 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.9 Cg_endo -39.91 143.11 0.46 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 121.832 1.688 . . . . 0.0 110.132 176.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.72 123.54 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.497 HD22 ' NE2' ' A' ' 78' ' ' GLN . 9.2 mt -105.21 138.37 41.52 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.088 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -78.71 -25.27 44.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.387 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -89.27 104.24 16.81 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -81.4 62.71 5.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.292 0.568 . . . . 0.0 110.37 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -93.84 162.83 13.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.708 179.59 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.64 -48.0 79.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.1 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 19.6 ptmt -67.27 -40.52 86.2 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.602 0.564 . . . . 0.0 111.74 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.593 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 8.7 m-80 -64.74 -37.56 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.243 -178.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.68 -20.76 61.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.63 -18.95 62.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.689 ' HB3' HD22 ' A' ' 74' ' ' LEU . 1.8 m -102.05 -13.83 17.37 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.58 ' HA2' HD13 ' A' ' 92' ' ' LEU . . . 176.25 -162.17 30.86 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.234 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.77 126.09 36.72 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.095 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -72.86 152.81 41.32 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.15 -47.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -93.19 145.36 24.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.54 -51.13 68.59 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.623 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.06 46.42 1.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.29 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.593 ' NE2' ' H ' ' A' ' 122' ' ' ALA . 10.6 tt0 -80.89 153.71 27.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.59 117.77 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.147 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.453 ' N ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.14 129.95 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.795 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.25 -8.76 57.37 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -143.99 130.9 20.4 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.439 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.29 -167.95 52.8 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 25.2 t-20 -86.77 107.22 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.587 0.232 . . . . 0.0 110.659 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.453 ' CE1' ' N ' ' A' ' 116' ' ' MET . 4.7 t80 -86.56 100.51 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.88 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.593 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.21 123.8 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.837 -179.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.497 ' CD1' HD13 ' A' ' 83' ' ' ILE . 11.2 mt -118.18 132.64 56.31 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.373 178.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.34 140.17 48.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.923 -178.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.75 -178.09 16.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.661 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -85.17 146.17 27.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.621 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.9 p30 -112.79 26.23 10.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 0.0 110.869 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -42.76 -19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.816 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.11 39.43 12.96 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.139 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.86 109.49 10.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.04 124.88 16.87 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.829 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.85 -25.03 10.43 Favored Glycine 0 N--CA 1.473 1.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.533 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.785 HG12 ' H ' ' A' ' 134' ' ' LEU . 39.2 t -83.24 179.0 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -73.17 136.12 44.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.031 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.63 31.51 0.64 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 110.751 178.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -80.22 -7.47 58.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.719 -178.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.434 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.1 t0 -146.55 40.26 1.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.2 pt -70.65 -26.73 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.13 1.29 13.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.022 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.434 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.5 m -91.22 -17.96 25.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.087 -179.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.573 HD22 ' OD2' ' A' ' 145' ' ' ASP . 15.7 mt -65.21 125.3 24.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.324 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -95.93 170.91 8.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.72 130.03 40.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.923 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.03 21.18 36.65 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD2' HD22 ' A' ' 141' ' ' LEU . 1.7 t70 -87.49 132.28 34.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -79.56 134.9 36.49 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.391 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' TYR . 96.5 mt -126.55 125.83 67.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.16 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.31 113.62 26.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.578 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 82' ' ' ARG . 42.1 tp -113.32 134.47 54.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.389 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -105.83 133.98 49.69 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -178.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 152' ' ' ASN . 43.9 t0 -108.7 -169.28 1.47 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 151' ' ' ASP . 13.1 t-20 -32.93 -67.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.992 0.425 . . . . 0.0 110.65 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -135.98 21.89 3.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.065 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.53 150.37 40.96 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -114.81 119.47 36.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.341 178.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -105.23 130.19 53.44 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.372 0.606 . . . . 0.0 112.016 -178.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.45 117.34 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.498 ' O ' ' N ' ' A' ' 147' ' ' ILE . 20.0 m-85 -119.58 139.37 52.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.285 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.9 137.85 52.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.874 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.79 134.18 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.862 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.3 -27.26 12.95 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.84 1.338 . . . . 0.0 111.242 -178.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.81 158.76 9.89 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.54 152.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 165.56 35.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.098 -178.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -109.55 116.53 31.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.38 157.19 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.076 0.465 . . . . 0.0 111.285 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 169' ' ' ASP . 30.9 p -73.38 136.33 78.53 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -47.47 -15.45 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.113 1.875 . . . . 0.0 111.903 -178.62 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 167' ' ' THR . 95.9 m-20 -84.03 -11.54 56.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.518 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -88.04 67.69 8.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.9 m95 -74.13 -3.93 32.6 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.608 0.568 . . . . 0.0 112.193 -178.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.1 mt-10 -53.01 -39.89 63.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.961 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.3 m -77.84 2.7 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.199 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.1 -14.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.793 0.806 . . . . 0.0 110.597 -178.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.2 mt-10 -86.47 -179.14 6.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.878 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.6 p-10 -86.51 124.76 33.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.157 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.4 m80 -103.08 -43.91 5.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.206 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 25.33 0.07 OUTLIER Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -157.26 178.36 10.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.766 0.317 . . . . 0.0 111.07 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.67 ' OD2' HD22 ' A' ' 203' ' ' LEU . 31.3 t0 -96.68 89.83 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.613 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -126.69 127.62 45.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.369 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -85.43 149.42 4.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.57 ' C ' HD12 ' A' ' 184' ' ' LEU . 52.1 m -137.44 124.67 21.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.436 -179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -109.85 121.39 45.12 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.108 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 12.4 pt -140.4 -173.28 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.844 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 16.2 p . . . . . 0 N--CA 1.462 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.582 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.566 ' NH1' ' O ' ' A' ' 186' ' ' THR . 57.7 ttm-85 . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.69 139.28 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.282 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.94 129.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.38 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.14 135.9 53.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.28 143.6 14.88 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 51.8 p-10 -102.7 142.64 33.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.435 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.67 HD22 ' OD2' ' A' ' 180' ' ' ASP . 38.5 tp -65.31 126.88 29.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.4 -24.77 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.528 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.74 175.58 46.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.734 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.6 m -155.04 151.4 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.179 0.514 . . . . 0.0 111.244 -179.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -151.63 178.52 9.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.32 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.79 144.92 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.307 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.27 78.99 0.36 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.853 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 78.3 tttt . . . . . 0 C--N 1.322 -0.602 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.332 178.618 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.487 1.091 0 N-CA-C 111.122 -0.376 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.8 163.48 26.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.42 -19.96 65.45 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 123.163 0.289 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.74 93.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.6 mt-10 -72.2 -37.13 69.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.63 -45.81 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.886 -178.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.12 85.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -85.15 -26.64 26.71 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.86 137.76 57.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.127 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -92.09 158.13 16.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.912 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.456 HD13 ' CB ' ' A' ' 105' ' ' SER . 50.9 tp -127.13 127.32 44.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 111.288 -178.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -100.52 103.88 15.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.973 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.61 ' O ' HG12 ' A' ' 79' ' ' VAL . 44.5 mmtm -62.36 -7.09 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.572 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -75.08 -13.08 60.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.322 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -102.54 12.08 36.95 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.736 -178.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 76' ' ' LYS . 7.0 p -88.16 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.254 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 109' ' ' THR . 7.0 pt -121.4 -7.55 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.46 -171.28 39.28 Favored Glycine 0 C--N 1.32 -0.318 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.579 HH11 ' NZ ' ' A' ' 209' ' ' LYS . 42.0 mtm180 -146.46 152.03 38.37 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.72 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.5 tt -121.04 122.31 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -124.15 127.75 48.24 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.437 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 73.3 mt -131.29 130.81 22.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.801 -178.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.61 -38.28 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.56 2.173 . . . . 0.0 112.417 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.3 p -46.14 -37.88 7.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.424 -177.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.4 p -120.91 -0.45 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.942 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m 59.94 54.52 4.2 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.12 136.76 52.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.03 -177.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -137.0 116.39 12.72 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 83' ' ' ILE . 82.7 mt -141.03 101.58 6.32 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.6 127.92 1.74 Allowed 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 121.897 1.731 . . . . 0.0 110.211 176.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.95 121.84 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.2 mt -103.19 123.27 46.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.53 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' HB2' HD13 ' A' ' 80' ' ' ILE . 88.4 tttt -64.73 -49.5 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.065 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.2 m -65.74 98.7 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.134 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -80.24 98.13 7.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.258 0.551 . . . . 0.0 109.86 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.9 p -134.31 161.13 35.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.606 -178.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.79 -27.78 66.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.918 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.81 -41.77 18.69 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.837 0.711 . . . . 0.0 112.139 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -67.06 -35.12 79.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.412 -179.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.1 mt -65.03 -18.86 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -72.7 -14.92 61.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.456 ' CB ' HD13 ' A' ' 74' ' ' LEU . 58.7 m -110.53 -9.26 14.57 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.453 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 174.39 -153.55 16.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.304 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.554 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -100.49 127.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.263 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 149.97 24.97 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.674 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.455 HG21 HD11 ' A' ' 80' ' ' ILE . 9.7 p -75.81 148.38 38.47 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.9 -47.28 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -92.66 139.84 30.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.317 0.58 . . . . 0.0 110.989 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.414 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 18.1 pt-20 -75.48 -3.18 32.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.272 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 112' ' ' GLU . 11.5 m120 -135.88 37.63 2.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 111.164 -177.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 156.26 16.52 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.5 t -124.55 135.58 63.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.4 mtp -75.93 125.7 29.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.27 66.93 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -144.77 121.38 11.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.544 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.36 178.5 32.51 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 40.9 t-20 -68.93 105.06 2.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -85.33 105.45 15.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 124.89 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.31 0.576 . . . . 0.0 111.439 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 83' ' ' ILE . 10.0 mt -122.31 130.24 52.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.509 179.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.6 140.16 45.19 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.305 0.574 . . . . 0.0 110.759 -178.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.45 -176.95 18.92 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.614 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -84.48 147.07 27.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.696 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.7 p30 -115.48 25.48 10.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.146 0.498 . . . . 0.0 110.984 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -41.94 -18.19 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.646 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 57.57 39.96 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.191 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 136' ' ' SER . 65.2 tttm -134.2 119.45 18.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.511 -178.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.04 124.46 21.18 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.332 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.38 -21.46 8.66 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.447 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 134' ' ' LEU . 2.6 t -91.97 172.46 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.797 ' H ' HD23 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -74.93 139.34 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.882 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.554 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.5 m-85 50.49 27.34 2.79 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.008 0.433 . . . . 0.0 110.969 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.444 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -84.66 -8.99 58.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.6 m-20 -145.31 30.85 1.12 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.9 pt -70.07 -25.88 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.58 3.78 4.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.707 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.5 m -97.19 -11.65 23.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.283 -178.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.488 ' O ' HG21 ' A' ' 163' ' ' VAL . 17.7 mt -65.42 124.72 23.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.66 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.431 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 98.6 mttt -97.04 161.48 13.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.676 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.48 127.6 32.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.959 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 91.88 20.98 34.89 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 31.9 m-20 -83.73 136.86 34.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.08 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -80.76 122.76 27.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.5 mt -122.26 122.57 66.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -103.5 118.24 36.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.451 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -112.79 132.72 55.13 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.946 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.696 ' N ' HD13 ' A' ' 149' ' ' LEU . 67.9 m-85 -99.12 125.68 44.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.151 -179.121 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 152' ' ' ASN . 45.9 t0 -98.07 -169.05 1.75 Allowed 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 151' ' ' ASP . 51.9 t30 -36.19 -67.03 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.124 0.488 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -135.07 25.07 3.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.208 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.85 153.05 44.7 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.605 ' CD ' ' HZ1' ' A' ' 207' ' ' LYS . 67.1 tt0 -114.6 119.0 35.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.265 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -103.84 131.55 50.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.5 mt-10 -97.17 119.35 35.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.129 178.234 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -116.69 142.08 47.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.19 129.79 53.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.461 0.648 . . . . 0.0 110.769 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' GLY . 56.2 t -68.23 134.7 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.1 t -105.15 -26.61 12.01 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 124.583 1.177 . . . . 0.0 111.256 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.99 147.87 5.57 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.304 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 199' ' ' VAL . 17.2 t -110.56 149.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.239 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.0 p -156.92 165.87 34.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.133 -178.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -113.6 102.6 10.43 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.017 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.8 m -117.49 153.34 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 p -59.57 167.87 2.19 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.546 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.6 Cg_endo -81.77 -10.46 11.77 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.027 1.818 . . . . 0.0 112.007 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.81 -14.16 48.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.202 -178.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.64 71.21 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.028 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.546 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 90.4 m95 -75.31 -2.23 27.28 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.285 -178.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.42 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 71.5 mm-40 -54.03 -37.24 63.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.69 ' O ' HG21 ' A' ' 183' ' ' THR . 16.3 m -80.82 3.7 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.03 -179.03 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -119.71 -15.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.581 0.705 . . . . 0.0 110.251 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 74.4 mm-40 -86.75 175.94 7.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.027 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.5 p-10 -80.78 128.6 33.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.251 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.42 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.8 m170 -102.57 -43.28 5.67 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.043 -179.448 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.07 27.61 0.12 Allowed Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -157.65 -179.75 8.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.855 0.36 . . . . 0.0 111.094 179.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -93.01 88.46 6.14 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -117.82 167.7 11.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.922 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.37 142.94 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.002 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.69 HG21 ' O ' ' A' ' 173' ' ' VAL . 10.7 m -136.65 125.24 23.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.596 -178.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -110.52 120.77 43.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 13.5 pt -134.91 -167.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.767 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.586 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 14.1 t . . . . . 0 N--CA 1.464 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.366 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.586 ' NH1' ' O ' ' A' ' 186' ' ' THR . 11.8 ptp180 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -105.94 139.53 40.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.07 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.7 134.22 58.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 121.023 0.439 . . . . 0.0 110.623 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.54 HG22 HG13 ' A' ' 163' ' ' VAL . 73.2 t -119.46 129.46 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.653 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.09 136.29 53.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.349 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.16 147.38 19.06 Favored Glycine 0 N--CA 1.466 0.653 0 CA-C-O 121.773 0.652 . . . . 0.0 112.006 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 55.4 p-10 -106.81 148.28 28.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.207 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 205' ' ' GLY . 44.4 tp -69.03 126.99 31.56 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.84 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -109.38 -24.38 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.037 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.02 175.26 47.18 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.627 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 m -155.5 150.99 27.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.605 ' HZ1' ' CD ' ' A' ' 155' ' ' GLU . 25.8 pttm -150.81 178.16 9.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.09 146.61 23.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.579 ' NZ ' HH11 ' A' ' 82' ' ' ARG . 88.0 tttt -73.77 80.23 1.58 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.604 -179.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.281 178.799 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.477 0.52 0 N-CA-C 111.097 -0.386 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.84 152.05 46.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.804 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -68.39 -15.0 63.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.799 0.333 . . . . 0.0 111.393 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.5 -45.16 84.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.821 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 6.0 pt-20 -74.63 -22.44 58.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.3 t -76.97 -51.98 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.481 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.64 92.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.774 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.32 -31.17 68.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.54 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.3 138.42 57.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.004 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -141.09 85.1 1.96 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.71 -178.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.4 pt? -75.04 172.12 12.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.523 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.1 m-20 -103.13 121.16 42.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.59 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.573 ' O ' HG12 ' A' ' 79' ' ' VAL . 14.1 mptt -56.44 -9.4 0.7 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.14 0.495 . . . . 0.0 109.853 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -62.49 -35.39 79.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.76 16.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.572 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 76' ' ' LYS . 10.0 p -86.94 124.57 40.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 pt -120.64 -6.53 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.47 -168.34 39.92 Favored Glycine 0 C--N 1.318 -0.467 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.406 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 38.0 mtm180 -147.68 156.09 42.42 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.538 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.2 tt -121.32 125.92 74.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -126.26 127.07 45.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.482 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 79.3 mt -127.44 128.01 24.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.646 -178.222 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.8 Cg_endo -83.29 -39.33 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 122.371 2.047 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 t -48.75 -37.03 17.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.579 -177.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -120.73 -2.83 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.783 -178.926 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t 62.81 55.18 2.13 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.286 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.16 133.64 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.607 -178.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -135.99 114.22 11.52 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.524 ' O ' HG22 ' A' ' 83' ' ' ILE . 69.9 mt -143.45 109.36 5.28 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.1 Cg_endo -39.6 142.64 0.44 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.865 1.71 . . . . 0.0 110.144 176.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.8 118.65 43.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -106.68 122.94 47.36 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.41 -48.47 75.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.408 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 86.6 p -61.67 100.02 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.928 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.0 p -82.97 101.29 10.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 110.006 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.474 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 70.0 p -137.29 160.49 38.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.417 -179.067 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.85 -28.38 67.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.75 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -83.33 -45.47 13.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.457 0.646 . . . . 0.0 112.116 -178.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.474 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 91.0 m-20 -65.78 -32.72 74.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.316 -179.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.61 -13.96 61.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.3 p -103.79 -13.46 16.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -177.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.402 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 172.96 -156.86 25.57 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.64 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.46 125.89 35.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.997 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.63 144.38 31.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -75.33 152.27 38.16 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 185' ' ' ILE . 40.0 t -86.02 -40.22 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.443 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 99.5 mttt -89.67 -172.68 3.66 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.13 -178.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -126.2 -9.64 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 111.289 -177.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -138.89 37.35 2.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.108 0.48 . . . . 0.0 111.304 -177.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 16.4 pt20 -93.44 161.14 14.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.855 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -131.72 132.04 62.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.773 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.7 mtt -63.69 129.04 38.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.16 75.04 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -138.54 118.92 13.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.116 0.484 . . . . 0.0 110.504 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -160.12 52.71 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -94.04 111.19 22.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -84.72 103.4 13.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.43 126.64 35.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 111.785 -179.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD12 ' A' ' 83' ' ' ILE . 5.9 mt -122.46 130.53 53.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.477 178.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.99 139.19 46.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.774 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.61 -178.2 16.42 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.5 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -88.83 143.08 27.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.567 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 67.0 t30 -108.28 28.22 8.53 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.126 0.489 . . . . 0.0 110.676 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.17 -17.24 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.683 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.6 OUTLIER 60.98 37.73 17.92 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.283 178.805 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 136' ' ' SER . 55.2 mtmt -135.46 106.48 6.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.685 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.43 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -48.74 130.11 17.33 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.545 179.344 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.22 -26.33 12.38 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.784 HG12 ' H ' ' A' ' 134' ' ' LEU . 27.7 t -84.97 179.14 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.784 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.63 133.08 46.36 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.178 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.42 31.91 1.43 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 110.822 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.64 -9.91 59.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.04 -178.825 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -146.95 29.36 0.99 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 138' ' ' ILE . 5.5 pt -69.58 -27.83 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.805 0.336 . . . . 0.0 111.856 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.76 0.34 3.39 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.638 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.1 t -91.75 -14.66 29.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.156 0.503 . . . . 0.0 110.18 -179.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 mt -65.63 126.9 29.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.246 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.28 172.16 8.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.973 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.2 132.65 44.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.47 21.12 57.25 Favored Glycine 0 N--CA 1.462 0.396 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 146' ' ' LYS . 15.0 t70 -78.78 -158.89 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 7.9 tptm -146.81 129.15 15.8 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.076 -178.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.75 122.97 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.452 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -102.04 122.08 43.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.04 141.92 48.29 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.449 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.536 ' CE2' ' OE2' ' A' ' 155' ' ' GLU . 68.6 m-85 -107.81 131.23 54.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.208 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.8 t0 -105.47 -171.26 1.88 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.0 m-20 -35.64 -62.8 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.203 0.525 . . . . 0.0 111.273 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.49 20.87 2.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 145.03 48.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.782 -175.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.536 ' OE2' ' CE2' ' A' ' 150' ' ' TYR . 4.5 mm-40 -106.89 121.14 43.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.43 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -107.25 129.54 54.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.487 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.83 120.94 39.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.386 177.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -117.65 138.79 51.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.49 131.81 56.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.599 0.714 . . . . 0.0 110.144 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.38 134.56 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.613 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.1 p -101.63 -26.36 13.55 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 124.368 1.043 . . . . 0.0 111.16 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.06 150.93 5.84 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 163' ' ' VAL . 2.7 p -98.26 146.38 8.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -0.63 . . . . 0.0 109.323 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.7 t -145.79 154.22 41.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.055 0.455 . . . . 0.0 110.989 -178.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.28 119.27 38.94 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.708 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.633 ' CG2' HH21 ' A' ' 196' ' ' ARG . 29.1 m -134.88 158.78 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 111.269 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 169' ' ' ASP . 25.5 p -76.71 136.16 67.47 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.97 -15.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.077 1.851 . . . . 0.0 112.064 -178.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 167' ' ' THR . 51.3 t0 -81.81 -13.03 58.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 -178.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -85.88 77.15 9.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.358 0.599 . . . . 0.0 110.198 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.544 ' C ' ' H ' ' A' ' 173' ' ' VAL . 84.1 m95 -75.79 -20.32 58.31 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.092 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.67 -6.94 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.01 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' TRP . 53.6 t -85.81 -24.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.669 -178.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.453 HG11 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -108.41 -10.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.808 0.813 . . . . 0.0 109.72 -178.473 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.58 139.81 38.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.744 -176.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.43 130.59 45.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.297 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -102.05 -40.41 6.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.462 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.68 29.26 0.27 Allowed Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -156.05 179.24 9.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.244 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -90.89 92.54 8.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.371 0.605 . . . . 0.0 109.917 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -127.9 169.41 13.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.251 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.888 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.597 ' C ' HD12 ' A' ' 184' ' ' LEU . 19.2 m -137.31 124.98 22.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.484 -178.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.597 HD12 ' C ' ' A' ' 183' ' ' THR . 10.8 mp -111.34 120.95 43.92 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.342 0.592 . . . . 0.0 110.774 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 110' ' ' VAL . 16.4 pt -135.12 -167.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -178.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.77 -178.979 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.633 HH21 ' CG2' ' A' ' 166' ' ' VAL . 16.0 ttp180 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 120.868 0.366 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.01 129.97 46.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.952 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.438 HG11 HG11 ' A' ' 173' ' ' VAL . 46.2 t -135.23 136.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.52 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.24 126.37 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.425 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.72 135.54 53.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.228 0.537 . . . . 0.0 110.419 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.15 163.16 25.11 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -116.21 150.72 37.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.233 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.5 tp -71.8 126.96 31.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.025 0.44 . . . . 0.0 110.71 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.39 -24.57 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.188 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.72 44.42 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.847 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.3 m -154.15 154.07 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.226 0.536 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.49 ' HZ2' ' HB2' ' A' ' 155' ' ' GLU . 20.7 pttp -149.76 177.03 10.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.335 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.34 150.87 23.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.98 78.99 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.3 mptt . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 117.804 -1.093 . . . . 0.0 109.989 178.625 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.487 1.09 0 CA-C-O 121.057 0.357 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -79.16 173.34 12.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.67 -13.67 62.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.853 -179.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.0 92.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.266 0.555 . . . . 0.0 110.268 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -75.87 -23.62 55.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.582 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.31 -49.88 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.41 89.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.43 -31.98 70.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.972 -179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.09 132.73 52.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.222 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.8 t -140.85 88.35 2.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.824 0.345 . . . . 0.0 111.656 -179.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.557 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 1.5 pt? -79.93 170.28 16.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.489 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -102.48 139.78 37.63 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.055 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.57 -7.2 6.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.497 0.665 . . . . 0.0 110.131 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -64.61 -31.86 73.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.848 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.11 10.42 2.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.168 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.547 HG11 HH12 ' A' ' 82' ' ' ARG . 99.2 t -86.31 120.96 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.5 pt -120.35 -7.46 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 111.9 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.7 -170.85 41.96 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.547 HH12 HG11 ' A' ' 79' ' ' VAL . 33.6 mtt-85 -146.8 158.05 43.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.897 -178.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 tt -128.75 130.15 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.662 0.744 . . . . 0.0 109.322 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -130.16 131.64 45.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.071 -178.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.29 127.82 19.07 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.11 -178.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.08 -34.65 0.32 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.304 2.002 . . . . 0.0 112.031 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -48.16 -38.61 18.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.423 -177.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.5 p -118.61 -2.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.879 -178.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.57 50.77 2.08 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.595 ' CD2' HD23 ' A' ' 92' ' ' LEU . 2.0 tt -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -178.158 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.756 ' O ' HD22 ' A' ' 92' ' ' LEU . 83.0 tt0 -129.42 105.3 8.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 91' ' ' GLU . 3.8 mm? -128.5 148.95 70.32 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HD3' HD13 ' A' ' 92' ' ' LEU . 4.1 Cg_exo -84.65 145.2 10.29 Favored 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 122.617 2.211 . . . . 0.0 109.26 177.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -94.89 112.65 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 mt -101.53 121.68 42.43 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -63.8 -46.33 85.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.329 0.585 . . . . 0.0 110.805 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m -60.03 95.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.457 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.7 p -81.87 95.0 7.2 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 110.1 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.405 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 81.7 p -135.97 159.66 41.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.124 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.25 -28.67 66.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.29 -43.52 15.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 94.2 m-20 -65.93 -36.14 82.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.565 -179.18 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.07 -21.11 63.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.52 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.27 -33.24 69.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.455 ' OG ' HD22 ' A' ' 74' ' ' LEU . 62.2 m -89.54 -10.22 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 92' ' ' LEU . . . 174.05 -178.92 45.72 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.314 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.94 126.42 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.43 145.73 30.45 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.979 0.419 . . . . 0.0 110.968 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.8 p -73.12 150.22 42.41 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.24 -45.32 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.281 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.86 -172.32 3.32 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.962 -0.461 . . . . 0.0 110.966 -178.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 1.2 pm0 -112.58 -56.47 2.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.859 -178.371 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -90.61 44.63 1.21 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.268 -177.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -99.58 154.69 18.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.187 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.3 135.37 52.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 67.2 mtt -67.99 130.62 43.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.323 178.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.51 5.87 81.45 Favored Glycine 0 C--O 1.229 -0.18 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -142.72 120.36 11.82 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.037 -179.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.02 -168.35 54.26 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -85.52 106.82 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -84.66 102.45 12.95 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.76 128.44 36.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.289 0.566 . . . . 0.0 111.824 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -124.59 132.56 53.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.88 178.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.35 44.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 110.606 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.19 -177.66 19.26 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.455 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.529 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -92.12 143.48 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 0.7 OUTLIER -109.53 29.23 7.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.326 0.584 . . . . 0.0 109.71 179.515 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 9.2 mmm -42.94 -14.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.693 -179.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 62.13 40.67 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -132.32 105.66 7.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.586 -179.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -50.1 125.68 12.81 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.831 0.824 . . . . 0.0 110.094 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.82 -28.84 8.56 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.699 -177.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 134' ' ' LEU . 49.0 t -79.89 178.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.995 -0.709 . . . . 0.0 109.294 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.778 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -70.97 139.54 50.62 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.954 -178.568 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.6 m-85 43.7 35.01 0.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.072 0.463 . . . . 0.0 111.076 177.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.5 p -81.64 -14.56 56.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -147.45 31.97 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 3.6 pt -70.46 -26.65 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.703 0.287 . . . . 0.0 111.613 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.14 2.19 4.91 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.284 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 t -93.66 -13.85 27.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 109.573 -179.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.34 120.86 13.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.653 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.529 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.4 mttt -97.86 150.05 21.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.426 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.7 121.05 5.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.371 0.605 . . . . 0.0 111.463 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.67 10.48 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 3.8 m-20 -90.64 134.55 34.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.471 ' HZ2' ' HB3' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -83.63 132.61 34.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.311 0.577 . . . . 0.0 111.967 -178.41 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.59 126.27 71.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.278 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -103.17 119.95 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.173 0.511 . . . . 0.0 110.754 -178.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.482 HD12 ' SD ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -109.42 139.48 44.33 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.638 -179.879 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' SD ' ' A' ' 116' ' ' MET . 86.6 m-85 -114.81 127.26 55.62 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.194 0.521 . . . . 0.0 111.343 179.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.1 t0 -112.45 -166.24 1.06 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.2 p30 -22.57 -76.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.409 0.624 . . . . 0.0 111.816 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.508 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.5 mt-10 -137.53 29.37 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.749 178.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -127.66 144.5 51.07 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -109.99 120.96 44.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.14 132.7 49.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.682 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -96.05 118.03 31.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -118.32 141.39 48.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.34 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.13 55.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 110.804 178.367 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 60.2 t -66.34 133.09 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.032 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.3 p -100.76 -28.63 12.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.861 -178.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.37 150.2 5.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.842 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.74 149.1 8.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.704 -0.748 . . . . 0.0 109.462 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.6 p -150.76 160.4 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.453 . . . . 0.0 111.234 -178.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -107.19 117.36 33.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.554 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.38 159.12 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.229 -178.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 p -66.87 168.41 10.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.461 ' HA ' HH11 ' A' ' 196' ' ' ARG . 2.4 Cg_endo -81.7 -11.19 11.6 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.941 1.761 . . . . 0.0 111.761 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -87.77 -5.3 58.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -85.92 71.88 10.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 0.0 110.2 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.477 ' C ' ' N ' ' A' ' 173' ' ' VAL . 92.6 m95 -70.62 -29.89 66.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.047 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.557 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 55.4 mp0 -48.53 -14.28 0.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.485 0.66 . . . . 0.0 110.523 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.477 ' N ' ' C ' ' A' ' 171' ' ' TRP . 90.7 t -73.11 -25.85 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.923 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.522 HG11 HD13 ' A' ' 185' ' ' ILE . 27.0 m -115.29 -0.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.535 0.683 . . . . 0.0 110.513 -178.219 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.57 122.78 28.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.959 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -31.8 127.62 0.21 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.75 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -103.08 -42.75 5.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.017 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.29 29.24 0.15 Allowed Glycine 0 N--CA 1.471 1.029 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.39 176.78 12.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.942 0.401 . . . . 0.0 111.531 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.58 89.11 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.72 0.771 . . . . 0.0 109.404 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -122.48 167.84 12.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.028 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.7 142.57 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.233 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.523 ' C ' HD12 ' A' ' 184' ' ' LEU . 4.9 m -135.99 120.35 17.99 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.114 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -106.06 128.63 53.99 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.164 0.507 . . . . 0.0 110.321 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.522 HD13 HG11 ' A' ' 174' ' ' VAL . 4.3 pt -137.47 -175.24 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.729 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.001 -179.535 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 168' ' ' PRO . 57.7 ttp180 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.79 131.25 37.52 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 142.13 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.79 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.11 130.29 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.338 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.44 134.33 54.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.29 150.04 19.93 Favored Glycine 0 N--CA 1.467 0.763 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.0 t0 -108.49 145.87 34.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.517 -0.341 . . . . 0.0 111.361 -179.169 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.8 tp -70.32 129.51 39.51 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.443 0.639 . . . . 0.0 110.709 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.81 -21.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.605 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.43 175.9 45.91 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.132 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.3 m -155.54 155.84 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.237 0.542 . . . . 0.0 110.85 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -148.15 178.35 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.421 178.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -100.35 142.89 31.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.296 0.57 . . . . 0.0 111.086 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -61.86 80.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.61 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 208' ' ' ALA . 80.8 tttt . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.075 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 CA-C-O 121.187 0.411 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.04 151.71 44.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.85 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.2 mp -55.75 -26.1 43.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -178.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -39.6 93.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.322 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.1 mm-40 -74.1 -32.03 63.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.701 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.31 -45.32 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.919 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -75.84 -28.47 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.113 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.3 141.8 58.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.38 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.6 p -139.79 122.18 16.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.484 HD21 HD22 ' A' ' 95' ' ' LEU . 33.8 tp -114.6 129.24 56.65 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.343 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 68.0 t0 -68.47 134.45 50.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.274 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 4.5 mptp? -64.3 -8.84 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.52 . . . . 0.0 109.923 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -64.38 -33.96 77.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.048 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.436 ' OE1' ' OD1' ' A' ' 102' ' ' ASN . 75.7 mt-30 -77.68 14.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.201 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.83 127.37 47.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.78 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.686 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.11 2.61 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.694 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.26 -178.84 42.0 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -146.89 151.23 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.74 -179.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -120.47 124.33 72.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.61 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.1 t -128.88 129.02 45.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 64.8 mt -133.67 130.12 20.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.67 -178.331 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.22 -34.71 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.349 2.033 . . . . 0.0 111.561 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 m -47.74 -39.4 17.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.43 -176.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -121.19 -0.84 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.933 -179.288 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 61.33 54.25 3.24 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.76 133.42 56.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.419 -178.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.724 ' O ' HD12 ' A' ' 92' ' ' LEU . 12.6 tm-20 -130.07 114.38 15.69 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.3 mp -136.73 103.72 9.18 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.053 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.38 130.95 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.777 1.652 . . . . 0.0 110.264 175.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.7 t -82.36 127.89 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.484 HD22 HD21 ' A' ' 74' ' ' LEU . 13.1 mt -111.78 123.1 49.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.893 0.378 . . . . 0.0 110.068 -179.091 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -65.64 -45.9 81.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.741 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.9 m -66.84 100.07 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.376 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.66 97.69 10.26 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.437 0.637 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.56 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 4.8 p -137.37 155.57 49.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -51.53 -36.44 44.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -75.43 -45.75 36.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.99 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.693 HD22 ' N ' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -65.23 -36.56 84.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.57 -178.215 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.5 mt -59.24 -21.87 60.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.439 -179.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.13 -31.19 68.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -89.19 -11.44 43.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.56 42.21 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.59 127.93 34.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.885 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 146.72 29.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.013 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.62 152.22 39.25 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.28 -51.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 113' ' ' ASN . 82.8 tttt -93.78 139.26 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 -178.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -74.12 -0.18 15.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.225 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 16.9 m120 -138.01 38.29 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.151 0.5 . . . . 0.0 110.983 -177.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.74 21.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.718 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -129.98 128.75 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.1 mtt -69.36 128.14 35.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 110.202 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.59 0.18 69.93 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -140.5 121.96 15.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.877 0.37 . . . . 0.0 110.974 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.11 -169.95 53.54 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.551 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 12.4 t30 -86.34 110.77 19.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.19 102.77 12.86 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.016 0.436 . . . . 0.0 109.91 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 129.04 36.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.589 0.709 . . . . 0.0 112.114 -178.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.87 130.44 52.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.565 178.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.87 139.35 46.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.567 0.698 . . . . 0.0 110.496 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.15 -178.8 19.31 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.669 -179.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 134' ' ' LEU . 74.7 m-70 -91.33 140.87 29.36 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.152 0.501 . . . . 0.0 110.654 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 129' ' ' SER . 26.9 t-20 -108.68 29.62 7.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.517 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mmm -43.28 -15.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.792 -179.123 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.88 38.62 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.239 0.542 . . . . 0.0 110.165 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.5 tttt -133.0 106.15 7.49 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.178 -179.107 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -51.9 125.2 14.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.807 0.813 . . . . 0.0 110.137 -179.243 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.96 -29.42 7.13 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.62 -178.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.831 HG12 ' H ' ' A' ' 134' ' ' LEU . 41.3 t -81.06 -179.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.058 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.831 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.88 135.31 47.94 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.418 -178.277 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.46 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 47.66 35.81 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.155 0.502 . . . . 0.0 111.076 178.393 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 2.4 p -81.93 -16.88 49.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.45 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 21.3 t0 -142.85 30.57 1.46 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.7 pt -70.44 -25.91 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.825 0.345 . . . . 0.0 111.458 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.04 4.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.45 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.1 m -95.38 -11.97 26.81 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.238 0.542 . . . . 0.0 109.637 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.7 mt -63.92 124.96 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.402 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.12 155.8 16.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.589 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.03 129.32 41.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.594 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.53 38.73 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 40.6 m-20 -86.0 137.46 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.214 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -81.64 126.99 32.42 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.68 125.19 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.261 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -104.71 115.59 30.58 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.372 0.606 . . . . 0.0 109.874 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.7 tp -116.1 144.62 43.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.307 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.511 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 50.0 m-85 -116.13 133.45 56.01 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.314 0.578 . . . . 0.0 111.49 -179.34 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.0 t0 -109.98 -168.32 1.31 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.977 178.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 65.4 t30 -29.13 -71.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.342 0.591 . . . . 0.0 111.283 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.66 25.33 3.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.95 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.93 142.9 51.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.481 0.658 . . . . 0.0 112.486 -175.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.511 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 33.6 tp10 -107.14 120.16 41.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.29 130.77 52.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.202 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -94.91 117.12 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.647 177.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -117.39 138.98 51.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.232 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.79 135.34 54.12 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.789 178.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 46.7 t -68.45 132.96 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.03 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -27.74 11.46 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 124.463 1.102 . . . . 0.0 110.683 -178.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.63 154.57 8.7 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.687 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.28 144.03 19.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.786 -0.707 . . . . 0.0 109.735 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -155.26 166.1 34.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.271 0.558 . . . . 0.0 111.47 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -123.67 128.16 49.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.678 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.4 154.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 169' ' ' ASP . 10.7 p -58.39 129.79 83.97 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.91 -13.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.781 1.654 . . . . 0.0 111.963 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.3 m-20 -81.0 -11.31 59.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.995 -177.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.13 74.06 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -73.25 -15.33 61.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.527 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 3.0 pt-20 -53.24 -36.18 60.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.234 0.54 . . . . 0.0 109.873 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.882 ' O ' HG21 ' A' ' 183' ' ' THR . 2.9 t -69.71 -1.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.973 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.99 -13.74 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.854 0.835 . . . . 0.0 109.919 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -86.92 172.78 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.106 -1.407 . . . . 0.0 112.279 -178.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 67.4 t0 -82.3 131.4 35.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.735 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.527 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 40.5 m80 -111.07 -42.02 4.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.552 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.52 25.67 0.09 OUTLIER Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 181' ' ' GLU . 0.0 OUTLIER -151.42 166.33 31.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.22 89.13 5.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.528 0.68 . . . . 0.0 110.454 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.517 ' OE1' ' NZ ' ' A' ' 179' ' ' LYS . 53.2 tt0 -130.23 129.22 43.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.271 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.64 148.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.882 HG21 ' O ' ' A' ' 173' ' ' VAL . 21.6 m -136.73 122.41 19.8 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.189 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 183' ' ' THR . 10.8 mp -109.11 125.9 52.63 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.273 0.558 . . . . 0.0 110.545 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 35.4 pt -136.25 163.03 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.119 -178.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.504 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 59.1 p . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.29 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 186' ' ' THR . 11.3 ptp180 . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 121.257 0.551 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -106.16 133.99 49.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.152 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.91 132.38 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 43.9 t -117.95 127.73 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.52 134.33 54.11 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.353 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.45 139.92 11.34 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -98.28 140.67 32.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.622 -0.789 . . . . 0.0 111.642 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 205' ' ' GLY . 43.5 tp -65.22 125.31 24.62 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.17 -21.4 5.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.421 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.411 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.39 174.69 46.49 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.199 -179.713 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.5 m -154.35 151.77 29.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.824 179.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -150.45 177.6 9.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.56 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -94.43 147.31 23.37 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.342 0.591 . . . . 0.0 110.575 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -61.66 80.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.708 -179.927 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 208' ' ' ALA . 73.8 tttt . . . . . 0 C--N 1.314 -0.965 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.075 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.49 1.287 0 CA-C-O 120.766 0.236 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.05 161.6 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.46 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 66' ' ' LEU . 9.7 mp -65.37 -19.99 66.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.634 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.8 88.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 110.036 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.3 mt-10 -74.19 -33.15 63.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.641 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.28 -44.68 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.542 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.41 86.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.923 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -83.36 -22.57 32.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.047 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.34 104.32 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -179.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -95.54 112.22 23.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.189 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tt -115.84 133.02 56.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.323 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -80.41 148.82 30.4 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.453 179.105 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -67.98 0.93 3.03 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.375 0.607 . . . . 0.0 109.588 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 75' ' ' ASP . 38.8 ttmt -62.96 -42.86 99.95 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.723 179.37 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -79.41 0.16 30.41 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.14 0.495 . . . . 0.0 110.439 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.7 t -99.56 129.71 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.576 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.617 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.57 7.09 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.731 -178.162 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.73 -172.54 35.66 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.418 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 13.3 ttm180 -153.31 153.18 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 111.262 -179.422 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 83' ' ' ILE . 17.0 tt -127.7 130.77 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.706 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.8 m -127.77 130.98 49.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.031 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.58 117.12 16.38 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.222 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.28 -36.39 0.99 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.097 1.864 . . . . 0.0 111.534 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -52.33 -38.73 59.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.711 -177.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 137' ' ' ASP . 42.5 t -112.05 -6.94 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.75 0.31 . . . . 0.0 110.67 -178.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.59 47.47 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.3 tp -114.15 131.46 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.784 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -133.02 116.61 16.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -146.46 165.1 21.09 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.423 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.38 161.01 8.24 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 123.206 2.604 . . . . 0.0 108.923 177.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -112.78 122.95 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.2 mt -103.32 123.97 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.33 -47.99 74.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.199 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.6 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 7.7 p -85.19 119.98 26.18 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.791 -179.583 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p -86.76 118.8 26.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.337 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.2 p -140.69 168.83 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.413 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 4.0 tm-20 -69.87 -34.44 73.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.87 -42.24 21.81 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 97' ' ' SER . 3.6 p-10 -68.75 -20.18 64.36 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.37 -17.77 63.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.218 -179.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.1 mp -75.29 -15.98 60.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.8 m -96.69 -13.6 22.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.476 ' N ' HD13 ' A' ' 134' ' ' LEU . . . 165.6 -149.6 16.13 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.59 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -93.65 126.3 38.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.401 0.619 . . . . 0.0 110.0 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.08 147.82 26.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 41.9 p -72.22 149.56 44.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 t -83.95 -46.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -88.69 -170.91 3.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.85 -178.081 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -124.31 -5.44 7.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.654 -178.475 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -138.87 36.09 2.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.694 0.283 . . . . 0.0 110.764 -178.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -92.55 158.92 15.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.119 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.37 132.1 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 -179.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -65.73 127.14 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 178.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.47 1.82 68.43 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -142.55 126.76 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 110.227 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 179' ' ' LYS . . . 72.55 -176.85 41.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -80.05 108.81 13.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.536 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.68 99.47 10.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.007 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.47 128.61 37.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.232 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.21 133.02 54.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.978 178.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.09 140.34 45.71 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.453 0.644 . . . . 0.0 110.916 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.16 -178.13 20.49 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.962 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -84.58 150.45 25.19 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 111.28 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 129' ' ' SER . 44.7 t30 -114.71 27.48 9.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.588 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.4 mmm -45.47 -12.72 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.532 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.8 m 51.7 42.41 29.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -136.06 119.58 17.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.868 -178.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -61.9 124.47 20.85 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.855 0.836 . . . . 0.0 110.686 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.26 5.78 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.033 -177.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 134' ' ' LEU . 22.1 t -138.53 175.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.062 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.89 130.7 43.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 111.371 -178.105 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.5 m-30 46.71 32.96 1.89 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.636 178.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -11.14 58.59 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.522 ' O ' HG21 ' A' ' 88' ' ' VAL . 4.1 m-20 -144.68 21.83 1.64 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -177.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.538 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.6 pt -69.0 -27.44 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.719 0.295 . . . . 0.0 111.527 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.58 1.49 2.36 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.549 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.7 m -95.54 -10.44 29.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.91 118.6 7.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.524 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -98.19 170.98 8.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -67.25 137.4 56.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.134 0.968 . . . . 0.0 112.409 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.53 20.3 64.37 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.781 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -90.94 134.05 34.78 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -83.46 138.23 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.548 0.689 . . . . 0.0 112.16 -178.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 158' ' ' TYR . 76.9 mt -130.82 119.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.504 179.103 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -100.47 122.72 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.3 tp -117.32 147.03 42.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.726 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.418 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 15.5 m-85 -113.49 128.81 56.58 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.17 0.509 . . . . 0.0 111.134 -179.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -109.3 -168.44 1.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 151' ' ' ASP . 92.3 m-20 -25.73 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.381 0.61 . . . . 0.0 112.312 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -138.85 23.4 2.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -124.95 144.63 50.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.131 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.66 121.74 44.19 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -105.94 130.05 53.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.307 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.84 119.2 34.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' A' ' 147' ' ' ILE . 52.0 m-85 -116.64 138.74 51.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.167 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -114.9 132.14 56.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.35 0.595 . . . . 0.0 110.56 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.27 134.18 30.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -107.57 -25.11 11.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.357 1.036 . . . . 0.0 110.714 -179.512 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.37 164.21 23.68 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.89 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.76 152.27 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.2 t -156.88 169.11 25.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.378 0.609 . . . . 0.0 111.369 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.99 126.98 52.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.399 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -139.55 159.0 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.113 -178.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 169' ' ' ASP . 17.6 p -68.5 135.62 90.73 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.573 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.9 Cg_endo -47.17 -12.62 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.604 1.536 . . . . 0.0 111.727 -179.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 167' ' ' THR . 66.5 t0 -78.15 -17.7 56.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.44 -178.628 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.603 ' O ' HG22 ' A' ' 173' ' ' VAL . 13.6 mptt -84.7 68.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.573 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 63.0 m95 -73.72 -24.04 59.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.379 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.36 -7.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 170' ' ' LYS . 17.3 m -85.9 -9.12 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.128 -178.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.544 HG11 HD13 ' A' ' 185' ' ' ILE . 1.4 m -131.27 8.3 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 109.158 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 72.4 mm-40 -83.6 143.71 29.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.443 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -55.81 120.14 6.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.801 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 41.7 m80 -111.3 -40.1 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.71 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 122.85 34.67 0.78 Allowed Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 119' ' ' GLY . 19.8 mmmt -139.03 157.08 46.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.664 -179.262 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.2 m-20 -87.96 88.57 7.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.906 0.86 . . . . 0.0 108.891 177.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -135.12 170.09 16.44 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.133 -178.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.1 tt -131.29 143.3 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.845 178.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.602 ' C ' HD12 ' A' ' 184' ' ' LEU . 13.5 m -137.25 128.07 27.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.098 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 183' ' ' THR . 10.4 mp -112.77 125.62 54.53 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.216 0.532 . . . . 0.0 110.325 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.544 HD13 HG11 ' A' ' 174' ' ' VAL . 11.9 pt -133.91 164.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.427 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.116 -179.585 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.483 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.21 142.66 45.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.77 139.05 46.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.72 129.93 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.302 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 161' ' ' THR . . . -115.21 135.74 53.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.999 0.428 . . . . 0.0 110.402 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.52 145.73 17.0 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.843 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -100.69 139.02 36.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.773 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.48 126.16 27.41 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.212 0.529 . . . . 0.0 110.711 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.63 -25.93 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.376 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.64 161.26 20.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.434 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 207' ' ' LYS . 40.5 m -137.73 157.4 46.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.446 0.641 . . . . 0.0 110.07 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 206' ' ' THR . 16.2 ptpt -148.93 179.32 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.306 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.17 144.42 25.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.467 0.651 . . . . 0.0 110.901 179.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -67.98 80.15 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.644 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 77.3 tttt . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.59 179.068 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.484 0.916 0 N-CA-C 110.846 -0.482 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.24 154.35 42.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.877 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.6 mt -56.13 -26.37 49.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 110.869 -179.153 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.92 96.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.651 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.62 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.9 mt-10 -72.63 -36.09 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.679 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.5 t -74.47 -44.63 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.083 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.76 92.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -80.76 -25.79 37.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.447 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.62 140.92 58.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.112 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 p -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.519 HD11 ' OE1' ' A' ' 78' ' ' GLN . 12.9 tp -140.83 140.0 34.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.316 -178.483 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.72 140.84 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.383 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 79' ' ' VAL . 14.1 mptt -70.07 -6.0 30.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.302 0.572 . . . . 0.0 110.009 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.21 -35.74 81.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.358 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.519 ' OE1' HD11 ' A' ' 74' ' ' LEU . 80.9 mt-30 -75.59 11.93 1.17 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.653 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 76' ' ' LYS . 96.2 t -87.8 126.09 41.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.573 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 96' ' ' LYS . 9.1 pt -119.9 -9.07 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 112.058 -178.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 -170.26 38.03 Favored Glycine 0 C--N 1.321 -0.264 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.09 152.42 38.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.507 -178.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 HD13 ' A' ' 123' ' ' LEU . 10.1 tt -122.58 125.8 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -125.79 127.86 46.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.172 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 67.1 mt -131.61 126.71 21.18 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.258 -177.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -82.66 -35.9 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.162 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.9 t -46.64 -37.73 8.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.403 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -120.6 -0.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 t 61.49 55.63 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.47 136.07 54.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.184 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.676 ' O ' HD12 ' A' ' 92' ' ' LEU . 81.8 tt0 -135.24 119.89 18.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -146.09 107.67 4.24 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -176.108 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.73 159.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.841 1.694 . . . . 0.0 109.898 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.6 t -110.04 124.68 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 74' ' ' LEU . 26.4 mt -108.09 123.87 49.35 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HB2' HD13 ' A' ' 80' ' ' ILE . 65.9 tttm -66.81 -49.64 65.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.196 0.522 . . . . 0.0 111.435 -179.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.8 m -62.05 99.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.496 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 p -82.99 102.16 11.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.918 0.389 . . . . 0.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.493 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 80.4 p -141.86 155.17 45.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.307 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -57.86 -23.03 51.02 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -81.82 -50.11 9.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.278 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.2 p-10 -66.29 -31.56 72.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.588 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.97 -22.49 62.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.422 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -72.9 -16.53 61.56 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.6 m -106.96 -14.94 14.83 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.93 48.1 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.296 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -107.57 145.49 33.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.188 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.8 p -70.14 149.18 47.84 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.54 -45.12 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.32 -170.84 2.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.027 -178.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.98 -10.12 8.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 113' ' ' ASN . 54.3 p30 -135.45 36.35 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.929 0.395 . . . . 0.0 111.026 -177.342 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -93.82 158.74 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.927 179.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.43 131.16 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.794 -178.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.435 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 67.0 mtt -65.41 129.47 39.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.58 -2.75 74.09 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -138.49 121.26 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.867 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 74.93 -173.96 51.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.442 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 56.7 t30 -82.65 111.98 19.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -84.77 104.84 15.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.17 130.12 36.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.608 -179.074 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.554 HD13 HD12 ' A' ' 83' ' ' ILE . 6.3 mt -128.74 134.31 48.4 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.069 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.42 43.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.256 0.55 . . . . 0.0 111.005 -178.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.75 -177.58 17.89 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 64.3 m-70 -87.69 140.68 29.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.675 0.274 . . . . 0.0 110.58 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 49.1 p30 -107.16 28.27 8.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.155 0.502 . . . . 0.0 110.735 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -43.31 -15.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.887 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.2 40.01 18.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.256 178.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.58 107.1 7.78 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.35 128.15 16.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.857 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.71 -26.44 11.74 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.796 HG12 ' H ' ' A' ' 134' ' ' LEU . 47.7 t -83.6 179.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.796 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 137.51 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 -178.103 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 138' ' ' ILE . 4.0 m-85 44.39 35.47 1.32 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 111.184 177.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 16.8 p -82.41 -13.46 56.77 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 136' ' ' SER . 78.4 m-20 -146.97 31.57 0.94 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.33 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.514 HD13 ' CD2' ' A' ' 135' ' ' PHE . 4.0 pt -70.84 -25.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.819 0.343 . . . . 0.0 111.825 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.43 0.92 7.15 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.53 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -93.68 -11.68 31.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.304 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 163' ' ' VAL . 18.9 mt -65.64 120.69 13.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.537 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.508 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.05 151.9 19.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.628 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -52.07 122.82 9.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.302 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.93 21.29 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.7 m-20 -87.25 139.55 30.45 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -81.66 127.26 32.72 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.496 -178.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 158' ' ' TYR . 32.9 mm -115.02 124.25 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -105.64 115.81 30.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.95 150.86 39.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.148 -178.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -123.77 136.9 54.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.185 0.516 . . . . 0.0 111.65 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 156' ' ' TYR . 2.5 m-20 -113.7 -163.53 0.87 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.613 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.6 p30 -26.03 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.07 0.462 . . . . 0.0 111.438 178.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.52 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.6 mt-10 -132.94 29.86 4.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.065 178.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.412 ' OD1' ' OD1' ' A' ' 152' ' ' ASN . 28.3 m120 -127.82 145.34 50.96 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -106.29 121.78 44.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.724 179.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.588 ' CE1' ' OD2' ' A' ' 151' ' ' ASP . 19.7 m-85 -104.35 129.12 52.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.629 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.58 117.27 30.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' O ' ' N ' ' A' ' 147' ' ' ILE . 8.2 m-85 -120.53 137.85 54.16 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.859 -178.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.1 134.96 53.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.76 178.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.26 134.43 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.158 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 12.2 p -99.07 -26.96 14.05 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.486 1.116 . . . . 0.0 111.316 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.99 145.25 4.17 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.342 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 141' ' ' LEU . 58.1 t -91.8 141.46 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -139.9 151.41 45.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.756 0.312 . . . . 0.0 111.05 -177.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -106.47 115.94 31.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.86 159.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.232 -177.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.0 p -66.94 170.03 6.99 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.555 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.7 Cg_endo -81.68 -13.19 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.888 1.725 . . . . 0.0 111.901 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -87.87 -14.21 40.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -178.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -85.69 69.13 10.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.555 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.4 m95 -74.83 -2.44 26.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.09 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -53.37 -35.38 60.24 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.162 0.506 . . . . 0.0 111.024 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.827 ' O ' HG21 ' A' ' 183' ' ' THR . 17.0 m -80.88 3.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.925 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.38 -15.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.833 0.825 . . . . 0.0 109.971 -178.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.06 162.22 17.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.838 -179.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -66.76 128.16 35.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.637 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -99.29 -39.53 8.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.083 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.2 29.42 0.5 Allowed Glycine 0 N--CA 1.473 1.103 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.439 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 58.5 pttt -156.05 -179.11 7.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 43.8 m-20 -92.21 90.26 7.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.145 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -128.2 169.28 14.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.861 -178.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.9 tt -132.94 143.33 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.827 HG21 ' O ' ' A' ' 173' ' ' VAL . 11.3 m -138.29 120.61 15.89 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.872 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -108.77 126.03 52.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.958 0.409 . . . . 0.0 111.179 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.416 HG22 HG12 ' A' ' 198' ' ' VAL . 5.1 pt -133.89 -166.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.518 -178.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.587 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 23.4 p . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.572 -179.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.587 ' NH1' ' O ' ' A' ' 186' ' ' THR . 15.4 ttm180 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.509 0.195 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -89.19 132.91 34.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.416 HG12 HG22 ' A' ' 185' ' ' ILE . 27.7 m -139.46 142.09 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 111.514 -179.126 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 40.1 t -116.29 129.16 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.178 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.01 134.62 54.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.646 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.08 157.28 22.78 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -112.15 148.8 33.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.972 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.29 127.23 32.06 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.858 0.361 . . . . 0.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.03 -25.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.346 -178.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.6 163.18 22.15 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.616 178.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.521 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 93.6 m -139.49 159.05 43.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.058 0.456 . . . . 0.0 110.109 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 206' ' ' THR . 15.9 ptpt -147.27 178.79 8.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.655 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -97.35 142.99 28.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.545 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.94 80.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.556 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.388 178.524 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.498 1.749 0 CA-C-O 121.015 0.34 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 58.5 t0 -76.43 152.94 36.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.1 mt -55.04 -25.0 27.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.565 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.71 -39.11 87.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 98.0 mt-10 -74.14 -32.12 63.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.6 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.18 -44.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.83 85.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.81 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -81.6 -28.46 33.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.455 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.17 111.73 1.45 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 111.218 -178.44 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.8 m -97.37 85.97 3.78 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.7 tp -74.4 146.74 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.335 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -94.88 111.61 23.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 179.311 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' O ' HG12 ' A' ' 79' ' ' VAL . 17.2 tptp -52.61 -10.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.434 . . . . 0.0 110.198 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -70.93 -12.19 61.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.925 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -95.54 15.86 18.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.475 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.9 p -91.22 126.24 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.07 179.637 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.34 -3.71 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.946 0.403 . . . . 0.0 111.66 -178.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.34 -162.01 32.19 Favored Glycine 0 C--N 1.317 -0.524 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.685 ' NH1' ' HZ3' ' A' ' 209' ' ' LYS . 36.8 ptt180 -156.31 162.64 40.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.426 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -133.26 139.67 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 t -130.03 135.57 48.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.529 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 70.5 mt -131.89 125.55 20.31 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.734 -178.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.66 -36.29 0.34 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.46 2.107 . . . . 0.0 112.864 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 p -48.21 -36.49 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.706 -176.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.8 p -119.81 -0.21 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.576 0.227 . . . . 0.0 110.65 -179.067 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.0 p 61.53 52.12 3.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 88' ' ' VAL . 4.7 tp -115.57 134.11 55.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.714 -178.694 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.56 128.69 22.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.636 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 1.0 OUTLIER -161.55 130.21 3.0 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.128 -178.857 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -47.59 156.89 1.0 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.583 1.522 . . . . 0.0 110.873 177.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.5 t -107.88 125.55 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -106.48 125.38 50.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.845 0.355 . . . . 0.0 110.592 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.57 -45.35 72.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.095 0.474 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.2 m -67.68 104.83 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.577 -178.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.1 p -81.74 96.63 7.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.096 0.475 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.58 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 4.8 p -135.96 157.65 46.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.947 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -58.11 -27.33 63.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.884 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.53 -45.28 13.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.24 0.543 . . . . 0.0 111.197 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.58 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.9 m-80 -65.67 -36.68 84.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.405 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 108' ' ' ALA . 14.5 mt -63.46 -17.94 63.24 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.651 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.0 mt -71.21 -28.96 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.1 p -97.71 -8.23 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.35 -164.66 32.92 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.691 -1.242 . . . . 0.0 112.584 -178.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.636 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -92.36 127.95 38.03 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.06 146.71 28.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.0 p -74.27 153.16 39.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 185' ' ' ILE . 6.3 t -85.52 -47.04 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.081 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.42 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 14.7 mptt -92.49 -170.29 2.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.633 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 11.5 pt-20 -106.97 -52.83 2.7 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.72 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 17.9 m120 -89.24 43.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.479 -178.118 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.42 ' CD ' ' H ' ' A' ' 111' ' ' LYS . 67.9 mt-30 -79.6 146.33 32.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.034 0.445 . . . . 0.0 110.859 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 122.8 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.34 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.99 125.12 25.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.538 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.3 0.68 70.17 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -140.72 126.17 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.508 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.57 -172.13 48.77 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.532 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 0.4 OUTLIER -84.34 108.34 17.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.626 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.82 101.91 12.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 124.83 35.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.0 112.132 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -119.67 131.4 55.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.446 177.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.77 141.11 45.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.176 0.512 . . . . 0.0 110.594 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.68 -178.22 18.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.412 -179.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.1 m-70 -87.08 144.86 26.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.985 0.421 . . . . 0.0 110.873 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.0 t-20 -108.88 28.9 7.98 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.869 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -44.15 -13.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.742 -178.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 m 57.44 39.78 27.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.146 0.498 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -135.02 108.21 7.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.531 -178.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -51.15 127.83 20.26 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.642 -179.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.53 -26.71 11.47 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.448 -178.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.821 HG12 ' H ' ' A' ' 134' ' ' LEU . 46.3 t -82.72 178.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 117.52 0.66 . . . . 0.0 109.772 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.821 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.22 136.94 48.28 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.628 -177.996 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.86 33.57 1.02 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.898 178.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.8 p -81.78 -12.01 58.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 23.4 t70 -149.12 32.84 0.74 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.094 -178.378 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.9 pt -69.58 -27.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.442 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.15 2.07 4.06 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 63.5 m -91.77 -14.85 29.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 23.1 mt -62.76 126.48 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.165 -179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -96.46 171.41 8.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -76.8 129.59 36.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.505 0.669 . . . . 0.0 111.937 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.51 21.11 49.37 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.25 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.17 -158.51 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -147.26 129.84 15.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.686 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.3 mt -126.92 124.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.814 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -102.99 120.23 40.26 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 tp -117.03 148.4 41.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 -179.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.13 131.19 53.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.12 0.486 . . . . 0.0 112.028 -178.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 152' ' ' ASN . 36.8 t0 -109.18 -167.42 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.168 177.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 151' ' ' ASP . 16.2 m120 -19.99 -76.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.56 0.538 . . . . 0.0 111.981 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -138.16 27.23 2.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.58 144.2 49.26 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -176.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -107.68 121.52 44.86 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.452 ' CE2' HG21 ' A' ' 206' ' ' THR . 63.6 m-85 -105.35 128.92 53.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -178.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.461 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 98.0 mt-10 -95.83 119.44 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.236 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -116.36 143.94 44.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.67 131.77 56.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.038 0.447 . . . . 0.0 110.13 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.69 132.6 32.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.527 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -28.67 12.06 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.344 1.028 . . . . 0.0 109.906 -178.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 169.96 25.53 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.279 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.07 153.86 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.439 -0.881 . . . . 0.0 109.918 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.3 t -153.89 166.12 33.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 111.523 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 63.2 mm-40 -109.9 126.94 54.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.58 161.37 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.769 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.6 p -76.89 145.23 73.82 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.336 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.35 -21.81 7.72 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.867 1.711 . . . . 0.0 111.662 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.37 -2.73 53.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.805 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.596 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 21.6 tptt -80.71 150.18 29.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 83.6 m95 -157.62 -24.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.536 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.3 mt-10 -51.9 -8.56 0.07 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.111 0.482 . . . . 0.0 110.298 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' TRP . 7.0 m -78.41 -32.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 185' ' ' ILE . 28.5 m -110.03 -1.35 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.451 0.643 . . . . 0.0 110.468 -178.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 176' ' ' ASP . 94.0 mt-10 -80.37 119.81 23.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.7 -179.016 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' GLU . 98.1 m-20 -30.41 120.04 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.655 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 49.9 m80 -102.85 -43.23 5.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.969 -179.278 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.16 29.41 0.22 Allowed Glycine 0 N--CA 1.467 0.738 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -152.57 172.7 16.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -93.86 89.47 6.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.386 178.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.26 127.5 30.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.762 -179.142 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -82.56 148.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.562 ' CG2' HG12 ' A' ' 174' ' ' VAL . 3.4 m -136.1 124.84 23.87 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.513 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -108.47 129.93 55.27 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.924 0.392 . . . . 0.0 110.512 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 174' ' ' VAL . 7.1 pt -141.5 -168.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.924 -179.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.827 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.531 0.205 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.7 m-85 -102.96 123.38 46.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.11 133.22 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.394 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 76.4 t -120.31 130.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.184 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.26 135.24 53.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.295 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.14 137.39 10.11 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.6 t0 -95.54 132.47 40.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.23 -0.485 . . . . 0.0 112.077 -178.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 47.1 tp -62.15 125.84 25.27 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.168 0.508 . . . . 0.0 110.597 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.95 -24.91 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.678 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.11 159.86 17.03 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.064 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.452 HG21 ' CE2' ' A' ' 156' ' ' TYR . 20.5 m -134.15 156.17 48.79 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.105 0.479 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.461 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.5 ptpp? -148.14 179.21 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.129 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.84 146.82 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.232 0.539 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.685 ' HZ3' ' NH1' ' A' ' 82' ' ' ARG . 63.7 tttp -70.36 80.8 0.55 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.655 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.766 178.562 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.486 1.038 0 N-CA-C 110.973 -0.433 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.35 146.16 48.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.634 179.471 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -49.26 -28.13 4.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.73 -179.711 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.58 93.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.353 -179.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.9 mt-10 -73.1 -33.92 65.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.748 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t -75.06 -45.89 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.052 -178.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.81 86.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.88 -25.33 32.61 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.372 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.76 130.62 47.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.4 t -95.64 158.88 15.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -138.63 123.69 19.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.014 0.435 . . . . 0.0 110.951 -178.845 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.682 ' N ' HD13 ' A' ' 74' ' ' LEU . 98.0 m-20 -81.45 104.14 11.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.058 178.648 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -49.4 -35.84 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.242 -179.645 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -58.77 -11.49 3.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.498 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -90.41 -3.31 57.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.915 -178.724 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.34 133.27 30.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.983 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 pt -117.37 -5.73 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.933 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.72 33.77 Favored Glycine 0 C--N 1.317 -0.522 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.573 HH22 ' HZ1' ' A' ' 209' ' ' LYS . 29.5 ptt-85 -154.94 166.01 34.9 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.545 -179.775 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.77 134.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.824 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 t -123.85 130.27 52.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.242 -178.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 17.3 mt -133.15 111.05 12.95 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.402 -177.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 4.2 Cg_exo -78.69 -36.66 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.757 2.305 . . . . 0.0 113.013 -178.899 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 t -47.81 -35.83 10.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.48 -177.249 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 90' ' ' LEU . 4.2 m -118.96 -5.92 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 123.361 0.413 . . . . 0.0 111.432 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.15 45.69 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.737 -179.916 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 88' ' ' VAL . 1.1 mt -112.2 129.0 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.233 -178.84 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -135.86 115.65 13.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.361 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.1 mt -143.79 161.99 43.48 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -86.56 152.83 8.98 Favored 'Trans proline' 0 C--N 1.326 -0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 108.882 177.676 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.75 115.52 44.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.0 mt -100.18 128.26 46.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.045 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -66.22 -49.51 67.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.154 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -78.74 108.98 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 -179.092 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 98.72 11.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 109.927 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -133.06 154.8 50.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.33 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -51.55 -27.79 11.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.538 -179.607 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -83.57 -47.17 11.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.745 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.05 -33.36 75.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.593 -178.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.84 -19.35 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.807 -178.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.469 ' O ' HD11 ' A' ' 134' ' ' LEU . 22.7 mt -69.94 -25.13 63.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.42 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.667 ' OG ' HD23 ' A' ' 74' ' ' LEU . 21.6 m -91.82 -9.61 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.138 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.447 ' N ' HD13 ' A' ' 134' ' ' LEU . . . 165.09 -154.04 24.58 Favored Glycine 0 N--CA 1.46 0.238 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.646 -179.387 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.42 125.26 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.634 -0.783 . . . . 0.0 110.061 179.591 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.23 148.03 26.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.576 -179.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.2 p -75.77 150.53 37.75 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.216 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 t -86.78 -56.51 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.67 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -96.74 138.65 33.99 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.301 0.572 . . . . 0.0 111.015 -179.178 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -80.55 9.09 6.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.656 -178.337 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.407 ' C ' ' OD1' ' A' ' 113' ' ' ASN . 54.8 p30 -132.88 22.78 4.21 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.139 -0.351 . . . . 0.0 111.352 -177.87 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -91.05 156.12 18.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.955 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -134.26 133.5 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.547 ' SD ' HD22 ' A' ' 149' ' ' LEU . 67.8 mtt -67.14 127.35 32.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 179.091 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.507 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.36 0.23 76.92 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.56 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -142.39 127.58 18.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.037 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.85 -171.2 45.47 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.254 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -86.77 107.84 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -84.91 99.32 10.88 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 122.76 34.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mt -117.7 131.14 56.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.296 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.95 137.91 48.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.627 0.727 . . . . 0.0 110.789 -178.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.25 -178.68 17.76 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.607 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -85.95 141.75 29.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.479 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.5 p30 -109.98 26.56 10.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -42.96 -15.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.876 -179.51 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 59.39 39.13 22.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.142 178.959 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.9 tttt -133.27 114.95 14.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.468 -179.184 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.35 125.19 21.71 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.173 -179.652 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.93 -24.68 11.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.292 -178.379 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.724 HG12 ' H ' ' A' ' 134' ' ' LEU . 61.5 t -82.37 178.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.724 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -71.89 135.74 46.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.245 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 43.67 32.81 0.6 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.166 0.508 . . . . 0.0 110.892 178.381 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -81.45 -6.37 58.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.784 -178.355 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 136' ' ' SER . 94.2 m-20 -143.25 34.37 1.33 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.625 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.6 pt -68.3 -30.5 47.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.788 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.49 5.83 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.029 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -97.57 -14.65 20.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.023 -179.359 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.11 124.67 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.288 179.621 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.401 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.41 154.38 17.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.664 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.19 126.44 27.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.307 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.73 25.16 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.771 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.401 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -91.28 133.47 35.38 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -80.59 142.03 34.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.166 0.508 . . . . 0.0 111.592 -178.904 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 158' ' ' TYR . 85.7 mt -132.74 124.41 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.352 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.03 121.9 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.076 0.465 . . . . 0.0 109.994 -178.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.547 HD22 ' SD ' ' A' ' 116' ' ' MET . 1.1 mt -114.18 156.53 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.445 -179.489 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 26.3 m-85 -134.55 123.37 23.77 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 152' ' ' ASN . 11.3 t0 -114.35 -165.6 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.795 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.558 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.9 m-20 -11.31 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.737 0.648 . . . . 0.0 111.504 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -139.1 28.04 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.19 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.15 148.04 41.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.191 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 74.3 mt-10 -110.29 119.75 40.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.865 178.38 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -106.04 125.03 50.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.893 -178.764 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.522 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.2 mt-10 -96.12 118.98 33.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.108 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.507 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.8 m-85 -118.38 144.9 45.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.014 -178.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' ASP . . . -120.42 131.69 54.9 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.338 0.589 . . . . 0.0 110.368 178.825 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.31 133.84 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.962 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.2 p -102.19 -27.07 13.1 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 124.701 1.251 . . . . 0.0 110.986 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 179.94 36.53 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.259 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.98 147.48 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.776 -179.531 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -151.28 159.94 44.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.083 0.468 . . . . 0.0 110.976 -178.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -107.23 118.87 37.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 173' ' ' VAL . 17.8 m -132.21 154.07 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.107 0.479 . . . . 0.0 111.034 -178.498 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 169' ' ' ASP . 35.8 p -75.94 135.86 70.34 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.691 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.59 -15.61 0.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.104 1.869 . . . . 0.0 111.659 -178.653 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.7 m-20 -81.35 -22.75 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 -177.906 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 173' ' ' VAL . 32.6 ttmt -85.65 75.84 10.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.229 179.307 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.575 ' C ' ' H ' ' A' ' 173' ' ' VAL . 86.0 m95 -71.39 -18.67 62.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.306 -178.665 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 81.0 mm-40 -51.97 -5.72 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.974 0.416 . . . . 0.0 111.15 179.208 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.726 ' O ' HG21 ' A' ' 183' ' ' THR . 34.0 m -90.38 -2.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.173 -178.466 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.564 HG13 HG23 ' A' ' 173' ' ' VAL . 1.2 m -132.99 -6.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.63 0.729 . . . . 0.0 109.563 -179.681 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.35 159.56 24.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.093 -176.623 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -66.28 124.5 22.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.517 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.1 m170 -113.94 24.47 12.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.656 -179.13 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.31 19.16 74.88 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.117 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.16 165.74 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 28.9 p30 -97.5 87.62 4.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.71 0.767 . . . . 0.0 110.561 179.751 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -123.24 130.0 52.14 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.053 -179.389 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.9 tt -81.5 146.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.334 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.726 HG21 ' O ' ' A' ' 173' ' ' VAL . 17.3 m -136.71 120.7 17.63 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.279 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -106.0 123.31 47.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.528 0.68 . . . . 0.0 110.786 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.5 pt -137.03 -169.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.645 -178.793 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.512 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.046 -178.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.8 ttm180 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -86.39 133.27 33.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.888 179.121 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 134.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 111.201 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.37 130.15 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.682 -179.548 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -119.12 137.83 53.32 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.643 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.0 145.24 17.32 Favored Glycine 0 N--CA 1.466 0.641 0 CA-C-O 121.828 0.682 . . . . 0.0 111.668 -179.213 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.9 t0 -100.57 140.24 35.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.51 -0.845 . . . . 0.0 111.414 -178.796 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 31.8 tp -65.36 128.14 34.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.7 p -107.26 -25.9 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.213 -178.875 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.81 161.79 22.05 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.728 179.133 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 207' ' ' LYS . 89.9 m -142.22 157.06 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.185 0.517 . . . . 0.0 109.967 -179.263 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.52 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.6 pttm -150.82 178.97 8.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.109 179.617 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.77 144.23 26.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.777 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.573 ' HZ1' HH22 ' A' ' 82' ' ' ARG . 88.5 tttt -69.54 78.47 0.41 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.905 -179.247 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.699 178.266 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.487 1.108 0 N-CA-C 111.253 -0.326 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 56.4 t0 -76.38 159.14 30.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 84.6 mt -60.27 -24.39 64.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.765 -179.105 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.15 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.343 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.9 mt-10 -72.62 -34.44 67.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.654 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -75.07 -44.78 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.897 -178.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.97 87.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.955 179.853 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.0 -21.49 33.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.336 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.52 132.97 55.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -141.94 81.49 1.76 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.001 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.7 pt? -73.35 154.87 39.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.924 179.074 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -70.31 136.7 50.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -66.39 -7.77 21.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.379 0.609 . . . . 0.0 110.364 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.95 -29.63 70.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.05 5.1 8.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.551 -178.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.37 127.62 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.74 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.704 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -135.47 8.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.269 -177.416 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.49 -174.31 39.7 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -178.888 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -153.16 155.16 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.346 -179.221 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 83' ' ' ILE . 18.4 tt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 179.59 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -129.27 130.14 45.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.828 -178.886 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.471 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 26.5 mt -135.36 120.97 13.96 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.475 -178.353 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -82.32 -34.49 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.601 2.201 . . . . 0.0 112.472 -179.597 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -49.97 -39.24 40.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.749 -176.699 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.433 ' O ' ' CB ' ' A' ' 89' ' ' SER . 3.4 m -118.88 -7.32 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 123.309 0.381 . . . . 0.0 111.039 -178.902 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 75.77 48.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.56 0.695 . . . . 0.0 110.42 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 92' ' ' LEU . 2.4 mt -107.24 122.56 46.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.429 -179.424 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.17 109.27 10.31 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.528 HD12 HD22 ' A' ' 90' ' ' LEU . 36.1 mt -144.37 165.56 22.87 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.333 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.01 156.09 7.15 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.916 2.411 . . . . 0.0 108.628 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.413 ' O ' HD13 ' A' ' 80' ' ' ILE . 69.0 t -107.24 120.01 57.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.03 119.57 39.08 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.55 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.07 -47.52 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.5 p -81.47 117.94 22.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -82.9 75.55 9.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.068 0.461 . . . . 0.0 110.163 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.562 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -90.65 142.96 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.424 179.909 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.459 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 84.0 tt0 -50.46 -56.96 9.21 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.568 -179.597 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -66.28 -32.09 73.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.318 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.562 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 10.6 m-20 -68.1 -27.06 66.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 108' ' ' ALA . 13.0 mt -73.2 -9.57 58.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.444 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.3 mp -76.44 -14.45 60.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.01 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.43 ' OG ' HD22 ' A' ' 74' ' ' LEU . 35.5 m -112.13 -5.6 14.22 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.48 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.96 -167.68 39.14 Favored Glycine 0 C--N 1.323 -0.19 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.555 -179.761 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.04 128.01 38.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.686 179.413 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.433 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.95 152.55 22.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.465 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -78.19 156.07 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.279 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.6 t -84.69 -55.54 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.22 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.469 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 68.8 mmtt -94.36 137.92 32.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.111 0.481 . . . . 0.0 111.091 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.27 6.25 17.42 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.028 -178.511 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -130.19 24.53 5.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.834 0.35 . . . . 0.0 111.408 -177.432 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.469 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 11.2 pt20 -94.28 162.9 13.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.02 135.83 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.4 mtp -70.56 124.57 24.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.819 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.71 7.37 64.79 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.646 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -143.62 124.69 14.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.389 -178.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.0 -170.43 51.92 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.58 107.4 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.643 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.75 101.99 12.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.241 -179.566 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.94 128.06 36.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.362 0.601 . . . . 0.0 111.692 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.92 131.24 53.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.429 178.497 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.28 140.32 45.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.476 0.655 . . . . 0.0 111.101 -178.567 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.86 -179.94 19.99 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.4 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.27 156.88 27.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 129' ' ' SER . 2.6 t-20 -122.78 27.1 7.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.968 0.413 . . . . 0.0 110.844 -179.163 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.0 mtt -45.9 -13.01 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.797 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 m 54.97 40.35 31.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.006 178.705 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 136' ' ' SER . 83.4 tttt -134.04 120.67 20.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.049 -179.168 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.97 124.23 19.2 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.209 0.528 . . . . 0.0 109.973 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.37 -29.66 7.17 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.203 -177.913 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.71 HG12 ' N ' ' A' ' 134' ' ' LEU . 99.5 t -76.03 177.21 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.71 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -73.27 139.21 45.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.514 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.4 m-30 45.0 27.57 0.29 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.149 0.499 . . . . 0.0 111.22 178.029 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -83.42 -15.65 48.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.554 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -132.47 12.98 4.55 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.511 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.417 HD13 ' CD2' ' A' ' 135' ' ' PHE . 9.7 pt -68.81 -25.83 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.927 0.394 . . . . 0.0 111.789 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.06 1.53 1.94 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.569 -179.6 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 138' ' ' ILE . 15.8 t -98.76 -11.29 22.02 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.226 0.536 . . . . 0.0 110.226 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.08 120.37 11.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.365 179.757 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -99.81 166.06 11.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.676 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.404 ' HB3' ' HZ2' ' A' ' 143' ' ' LYS . 10.4 ttpp -65.04 118.9 9.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.308 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.39 14.92 12.06 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.198 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -95.28 133.51 39.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.354 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.785 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 158' ' ' TYR . 69.2 mt -125.86 124.99 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.975 178.662 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.4 ' CD2' ' OE2' ' A' ' 157' ' ' GLU . 63.2 m-85 -99.39 114.69 27.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.979 -178.801 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 tp -113.93 142.91 45.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.94 -179.38 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -110.25 137.36 48.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.053 0.454 . . . . 0.0 111.653 -178.434 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 37.3 t70 -110.72 -172.77 2.1 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.271 178.189 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.1 m-20 -37.45 -62.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -179.478 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -137.6 23.86 2.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.865 179.349 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.85 152.2 48.11 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.641 0.734 . . . . 0.0 112.65 -175.702 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -114.81 122.02 45.08 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.299 178.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -105.11 130.99 53.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.319 0.58 . . . . 0.0 111.427 -179.015 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 204' ' ' VAL . 80.5 mm-40 -96.4 117.76 31.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.155 178.474 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 147' ' ' ILE . 29.6 m-85 -115.92 141.49 48.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.79 130.29 55.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.552 0.691 . . . . 0.0 110.11 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.42 134.13 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.067 -179.37 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.8 p -102.0 -25.72 13.66 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 124.705 1.253 . . . . 0.0 111.132 -178.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 163.81 166.45 22.7 Favored Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.243 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.56 153.16 37.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.741 -179.618 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.3 t -153.38 161.44 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -178.164 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -116.48 117.1 28.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.807 -179.349 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.22 160.36 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 111.245 -178.497 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 p -57.22 168.91 0.81 Allowed Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.028 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.77 -9.11 12.2 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.094 1.863 . . . . 0.0 111.957 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.76 1.52 42.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -178.402 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.602 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 13.5 mptt -83.59 149.57 26.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.358 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 87.8 m95 -157.6 -28.99 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.173 -178.648 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.88 -8.26 0.09 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.099 0.475 . . . . 0.0 110.665 178.655 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 171' ' ' TRP . 8.9 m -79.16 -25.67 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.607 -178.807 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 171' ' ' TRP . 16.6 m -110.69 -2.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 0.0 110.402 -178.806 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 176' ' ' ASP . 75.4 mm-40 -81.09 119.37 23.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.977 -178.04 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.0 p-10 -30.27 122.21 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.867 179.002 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -104.43 -44.35 4.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.253 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.29 26.36 0.1 Allowed Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -154.05 173.97 15.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.186 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.37 87.02 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.248 0.547 . . . . 0.0 109.901 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -128.05 125.14 38.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -179.002 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -81.2 148.3 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.9 m -137.56 122.98 19.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.184 -179.141 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -109.14 125.54 52.29 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.239 0.542 . . . . 0.0 111.394 -179.546 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.405 HD13 HG11 ' A' ' 174' ' ' VAL . 9.2 pt -134.21 161.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.583 -179.47 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.415 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 1.3 p . . . . . 0 N--CA 1.465 0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.443 -178.876 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.3 134.01 46.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.947 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.71 135.63 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.247 -179.393 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -119.35 130.44 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.416 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.23 134.83 54.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.42 141.13 12.4 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 50.9 p-10 -100.18 141.33 33.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.636 -0.782 . . . . 0.0 111.503 -179.111 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.62 125.1 24.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 110.66 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.5 p -107.16 -24.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.135 -179.034 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.12 177.16 44.92 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.947 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 35.1 m -154.99 154.64 32.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.278 0.561 . . . . 0.0 110.993 -179.858 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.87 178.17 8.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.81 146.27 24.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.508 179.931 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.67 78.31 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.75 -179.118 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.419 178.279 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.486 1.077 0 CA-C-O 121.027 0.345 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.18 157.3 37.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.788 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.41 -28.96 70.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -178.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.17 90.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 -179.571 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.9 mt-10 -73.13 -40.97 64.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.303 0.573 . . . . 0.0 110.836 -179.572 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -73.49 -41.89 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.483 -179.0 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.64 84.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.85 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -91.57 -14.58 30.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.396 -178.665 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.12 110.77 1.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.747 -179.685 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.2 t -106.65 135.64 47.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.76 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.729 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.2 pt? -128.02 174.14 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.057 -179.59 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.9 m-20 -83.65 98.63 9.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.677 178.527 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 79' ' ' VAL . 34.5 mtmm -58.5 -4.23 0.38 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.377 0.608 . . . . 0.0 110.438 -179.669 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.7 mmtp -67.51 -11.18 57.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.549 -179.898 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.88 18.84 12.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.782 -179.481 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 76' ' ' LYS . 53.9 t -80.03 124.29 37.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.135 178.897 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 tt -106.5 -35.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.074 -179.044 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.41 -155.43 8.16 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.569 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -146.38 155.9 42.93 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.48 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -125.37 129.08 73.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.652 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.604 ' N ' HD13 ' A' ' 83' ' ' ILE . 50.2 m -130.5 130.97 44.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.049 -179.276 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.7 mt -132.73 118.59 15.65 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.34 -178.269 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.82 -37.47 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.361 2.041 . . . . 0.0 112.263 -179.503 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 t -48.9 -37.75 20.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.909 -177.146 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 89' ' ' SER . 2.0 m -121.23 -6.59 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.998 -179.026 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.44 50.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.49 124.23 49.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.966 -179.556 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.77 ' O ' HD22 ' A' ' 92' ' ' LEU . 83.0 tt0 -132.59 107.14 8.24 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.395 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.77 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -144.15 116.17 5.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.088 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HD2' HD13 ' A' ' 92' ' ' LEU . 2.3 Cg_endo -41.16 146.49 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 121.817 1.678 . . . . 0.0 110.2 175.446 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.3 t -97.84 121.69 48.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 mt -103.16 117.48 34.64 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.802 0.334 . . . . 0.0 110.469 -178.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -63.62 -48.54 76.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.272 0.558 . . . . 0.0 110.483 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 90.5 p -60.95 102.66 0.21 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.415 -179.637 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 98' ' ' SER . 53.1 p -83.89 91.51 7.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.627 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -130.11 144.37 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.939 179.793 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.516 ' HA ' HD12 ' A' ' 103' ' ' LEU . 1.4 tt0 -53.42 -42.94 67.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.951 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -63.57 -46.39 86.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.087 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.627 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 8.8 m-80 -68.11 -35.58 78.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 111.779 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 100' ' ' GLU . 4.6 mt -49.46 -22.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.134 -179.47 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.99 -13.25 61.19 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.717 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.538 ' OG ' HD22 ' A' ' 74' ' ' LEU . 3.2 m -105.03 -11.12 16.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.298 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.401 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 167.3 -179.06 41.12 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.275 -179.309 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.43 126.06 29.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.785 -0.707 . . . . 0.0 109.941 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.41 150.18 25.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -76.28 153.8 35.66 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.77 -45.94 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.742 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 113' ' ' ASN . 85.6 tttt -89.2 136.24 33.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.165 0.507 . . . . 0.0 110.486 -178.366 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -62.22 -8.27 5.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.109 -178.848 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.468 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 66.1 t30 -146.4 50.31 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 -177.94 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -79.9 161.87 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.784 179.655 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.0 127.04 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 -179.314 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.4 mtt -74.19 127.29 32.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.189 179.013 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.496 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.37 1.71 74.62 Favored Glycine 0 N--CA 1.461 0.326 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -141.58 123.91 15.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.213 0.53 . . . . 0.0 110.974 -179.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.59 -170.65 50.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -85.6 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.23 99.91 10.26 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 121.18 32.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.289 0.566 . . . . 0.0 111.323 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -116.58 130.56 56.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.699 178.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.29 137.63 47.77 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.459 0.647 . . . . 0.0 110.433 -179.322 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.39 -177.15 17.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.713 -178.902 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 134' ' ' LEU . 54.8 m-70 -90.37 137.06 32.65 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 -179.504 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 129' ' ' SER . 29.2 t-20 -105.91 28.24 7.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 109.891 -179.986 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.7 mmm -44.6 -13.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.859 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.71 40.91 15.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.684 179.481 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 19.1 mmmt -132.03 107.59 8.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.092 -179.131 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -52.36 124.18 12.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.596 0.713 . . . . 0.0 110.297 179.984 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.74 -28.05 9.27 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.946 -178.34 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.734 HG12 ' H ' ' A' ' 134' ' ' LEU . 60.4 t -78.37 178.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-N 117.879 0.839 . . . . 0.0 109.047 179.415 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.734 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -70.44 134.2 47.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.239 -178.224 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.411 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.9 m-30 44.59 32.81 0.81 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.258 0.552 . . . . 0.0 110.585 178.529 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.7 -7.02 59.67 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.464 -178.501 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -145.79 24.02 1.37 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.577 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.411 HD13 ' CD2' ' A' ' 135' ' ' PHE . 7.1 pt -70.46 -21.5 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.699 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.24 2.97 7.96 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.6 t -99.21 -10.85 21.91 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.361 0.6 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.513 ' O ' HG21 ' A' ' 163' ' ' VAL . 15.6 mt -64.24 124.12 20.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.662 -179.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 17.9 ptpt -97.42 166.31 11.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.69 123.6 19.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 179.638 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.62 26.74 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.633 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 71.4 m-20 -82.51 130.94 35.21 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.985 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -78.3 129.3 34.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 0.0 111.675 -179.118 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.3 mt -127.28 127.44 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -109.66 123.83 50.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.146 0.498 . . . . 0.0 110.682 -179.087 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.65 148.74 37.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.222 179.6 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.2 t70 -114.01 -166.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.1 m-20 -24.37 -75.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.108 0.48 . . . . 0.0 111.848 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -138.15 29.76 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -129.87 145.73 51.6 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.249 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -110.09 123.0 48.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.823 179.334 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.62 132.71 50.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 111.57 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -96.31 116.75 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.62 178.394 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 44.6 m-85 -117.17 141.59 48.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.55 -179.52 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.76 133.72 54.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.31 0.576 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.33 134.38 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.232 179.446 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.2 p -102.37 -28.57 12.16 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 124.826 1.329 . . . . 0.0 111.048 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.31 144.04 3.91 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.113 -1.041 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 141' ' ' LEU . 12.4 t -103.74 149.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.523 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 t -153.68 164.25 38.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.137 0.494 . . . . 0.0 111.352 -178.683 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -110.96 117.28 32.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.777 179.728 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.37 160.14 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 169' ' ' ASP . 29.5 p -71.99 134.44 83.3 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.67 -11.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.093 1.862 . . . . 0.0 111.794 -179.093 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 167' ' ' THR . 51.5 t0 -83.4 -10.02 58.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.18 -178.841 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -88.39 70.54 9.06 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.573 0.349 . . . . 0.0 110.435 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -75.43 -6.29 49.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.082 0.467 . . . . 0.0 110.97 -179.642 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.56 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.5 mt-10 -52.77 -50.13 64.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.705 ' O ' HG21 ' A' ' 183' ' ' THR . 18.3 m -69.88 6.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.0 -179.704 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.04 28.76 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.27 131.32 18.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.783 0.801 . . . . 0.0 111.779 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -27.77 121.66 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.962 179.642 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.56 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 53.2 m80 -107.05 -40.23 5.51 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.6 24.59 0.13 Allowed Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.38 172.9 16.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.974 0.416 . . . . 0.0 111.214 179.582 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -96.21 89.58 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 0.0 110.05 178.476 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -125.3 175.87 7.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.2 tt -129.48 142.4 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.394 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.705 HG21 ' O ' ' A' ' 173' ' ' VAL . 13.0 m -136.34 124.9 23.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.136 -179.95 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -114.02 126.3 54.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.436 0.636 . . . . 0.0 110.463 179.242 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.468 HG22 HG13 ' A' ' 198' ' ' VAL . 28.1 pt -134.61 -169.9 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.738 -179.11 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.422 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 5.1 t . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.309 -179.461 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.422 ' NH2' ' O ' ' A' ' 186' ' ' THR . 60.7 ttt180 . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.864 0.364 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.44 129.47 50.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.037 179.023 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.468 HG13 HG22 ' A' ' 185' ' ' ILE . 42.7 t -130.14 131.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.422 -179.182 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 93.5 t -115.1 127.1 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.358 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.38 135.21 54.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.282 0.563 . . . . 0.0 110.373 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.94 159.1 25.42 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.765 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -112.12 150.66 30.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.676 -0.762 . . . . 0.0 111.456 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.408 HD13 ' CZ ' ' A' ' 158' ' ' TYR . 11.9 tp -73.74 129.78 38.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.251 0.548 . . . . 0.0 110.62 179.721 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.97 -22.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.086 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.32 177.84 44.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.202 -179.157 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.3 m -151.65 151.17 31.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -148.96 177.83 9.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.672 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.41 146.99 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.312 0.577 . . . . 0.0 110.735 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.93 79.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.899 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 tptp . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.694 178.63 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.483 0.859 0 CA-C-O 121.052 0.355 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.1 m-20 -79.03 172.93 13.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.543 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.4 mp -60.01 -24.84 64.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.66 -178.414 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.34 97.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.499 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.0 mt-10 -74.11 -30.66 62.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.083 179.665 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.868 HG22 HD22 ' A' ' 104' ' ' LEU . 59.9 t -75.47 -47.64 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.831 -178.641 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.83 88.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.064 179.379 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -75.73 -31.08 59.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.476 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.98 132.97 53.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.949 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -140.2 152.52 46.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 -179.283 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.755 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.3 pt? -138.01 171.91 13.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.231 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -97.93 114.8 27.0 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.359 179.001 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 76' ' ' LYS . 1.1 mptm? -46.62 -16.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 110.258 -179.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 75' ' ' ASP . 54.6 mtmt -66.99 -10.06 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -92.78 6.62 46.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.247 -178.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.04 125.2 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.657 179.544 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.37 -10.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.385 -178.136 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.07 -173.07 44.03 Favored Glycine 0 C--N 1.316 -0.577 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.705 HH22 ' NZ ' ' A' ' 209' ' ' LYS . 38.1 mtm-85 -144.82 156.9 44.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 111.567 -179.046 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.8 tt -128.56 130.69 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 122.034 0.921 . . . . 0.0 109.225 179.751 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.2 t -132.42 133.8 44.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.543 -178.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.54 HG21 HD21 ' A' ' 141' ' ' LEU . 23.9 mt -134.8 126.45 17.91 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.872 -178.543 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -82.46 -35.82 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.48 2.12 . . . . 0.0 112.421 -179.16 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.461 ' CB ' HD23 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -50.52 -39.62 49.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -177.129 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.9 -1.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.237 0.215 . . . . 0.0 111.132 -178.842 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 t 61.51 49.73 4.99 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.81 131.09 55.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.792 -178.544 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 92' ' ' LEU . 44.8 tt0 -137.74 120.26 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.802 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.2 tp -153.01 112.66 2.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 113.334 -177.413 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -40.71 160.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.849 1.699 . . . . 0.0 110.205 175.83 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.81 122.75 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.065 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -105.68 120.88 42.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.255 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.7 -46.94 80.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.004 0.431 . . . . 0.0 111.104 -179.745 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.569 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 13.6 p -65.94 100.21 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.376 -179.709 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p -81.09 94.64 6.65 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.218 0.532 . . . . 0.0 109.871 179.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.3 p -136.66 160.44 38.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.312 -179.272 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -55.32 -42.71 74.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.047 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.88 -46.27 72.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.294 -179.453 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.569 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.9 m-20 -65.76 -38.39 88.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.2 -179.427 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.2 mt -64.88 -27.88 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.631 -179.042 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.868 HD22 HG22 ' A' ' 69' ' ' VAL . 50.9 mt -72.98 -17.18 61.49 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.606 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -105.33 -10.51 16.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.755 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.87 -165.49 34.54 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.568 -179.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.61 124.21 33.84 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.22 144.14 32.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.167 -179.356 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.5 p -74.24 152.25 39.76 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.84 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.89 -43.35 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.767 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -91.11 -173.17 3.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.823 0.344 . . . . 0.0 111.25 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -111.32 -58.81 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.14 -177.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -91.33 43.61 1.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.461 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -98.5 154.34 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 179.621 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.42 132.95 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.1 mtt -61.48 130.35 45.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.841 178.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.33 82.81 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -141.23 120.22 12.79 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.012 -178.76 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.29 -170.72 52.01 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.858 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -83.12 107.93 16.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.269 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -84.39 101.5 12.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.154 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.61 119.52 30.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.43 0.634 . . . . 0.0 111.643 -179.215 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 mt -115.94 130.0 56.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.242 178.411 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.93 138.28 50.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.643 0.735 . . . . 0.0 110.984 -178.566 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.09 -179.8 18.69 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.769 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -80.26 146.14 31.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.812 0.339 . . . . 0.0 110.204 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 129' ' ' SER . 41.6 p30 -112.59 27.53 9.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.07 0.462 . . . . 0.0 110.998 -179.183 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.0 mtt -43.42 -15.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.457 -179.339 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 58.42 39.34 25.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.256 179.127 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -135.57 113.83 11.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -52.73 125.92 18.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.669 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -30.28 6.91 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.195 -178.468 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.702 HG12 ' N ' ' A' ' 134' ' ' LEU . 85.7 t -77.98 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.264 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.702 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -72.94 138.85 46.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.516 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 45.26 30.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 178.303 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -83.85 -14.2 51.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -133.71 18.34 3.89 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.487 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.9 pt -70.28 -20.89 23.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.869 0.366 . . . . 0.0 111.934 -179.668 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.78 3.42 11.89 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 t -98.76 -13.59 20.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.29 0.567 . . . . 0.0 109.987 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 85' ' ' ILE . 16.4 mt -64.62 124.8 22.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.302 179.814 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 143' ' ' LYS . 65.7 tttt -96.5 172.0 8.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.507 -179.814 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 77.7 tttt -66.62 128.4 36.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.43 22.02 30.41 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.138 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 49.1 m-20 -86.59 130.8 34.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.242 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -77.7 132.58 38.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.257 0.551 . . . . 0.0 111.641 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.6 mt -127.85 125.97 65.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.1 179.458 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -102.8 122.84 45.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.177 0.513 . . . . 0.0 110.621 -178.589 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.42 136.56 52.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.699 -179.391 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.581 ' CB ' HH11 ' A' ' 82' ' ' ARG . 93.8 m-85 -111.37 119.7 39.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.396 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.7 t0 -104.8 -165.42 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.508 ' C ' ' O ' ' A' ' 151' ' ' ASP . 91.2 m-20 -24.01 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.498 0.499 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.6 30.25 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.696 178.716 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -128.13 146.77 50.6 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.984 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.96 123.49 49.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.854 179.118 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 206' ' ' THR . 64.6 m-85 -107.46 131.38 54.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.382 0.61 . . . . 0.0 111.3 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.3 mt-10 -97.34 118.29 33.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.828 177.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -115.96 140.65 49.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.82 -178.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.2 129.31 54.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.563 0.697 . . . . 0.0 111.155 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.21 135.81 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.82 -179.58 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.7 OUTLIER -105.61 -25.13 12.39 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.48 1.112 . . . . 0.0 111.084 -179.094 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.63 165.21 22.58 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.413 -179.539 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.8 p -125.88 151.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.671 -0.765 . . . . 0.0 109.669 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.6 p -155.6 164.38 38.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.458 . . . . 0.0 111.228 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.457 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 96.2 mt-10 -112.26 113.93 26.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.491 -179.735 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.99 157.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.457 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 p -65.77 168.63 8.22 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.052 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.27 -7.0 12.0 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.193 1.929 . . . . 0.0 112.105 -179.351 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.9 p-10 -82.95 -12.43 57.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.028 -178.762 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -89.44 69.85 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.784 0.434 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.77 -5.88 43.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.683 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.546 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.9 mt-10 -53.48 -40.04 65.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.351 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.734 ' O ' HG21 ' A' ' 183' ' ' THR . 74.4 t -72.71 1.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.812 -179.679 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.36 28.92 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.78 129.42 19.19 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.729 0.776 . . . . 0.0 111.854 -177.021 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -29.22 123.07 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.894 179.442 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.546 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.2 m80 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.626 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.24 24.3 0.32 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.058 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -156.72 178.74 10.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.132 0.491 . . . . 0.0 111.377 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -89.68 89.2 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.521 0.677 . . . . 0.0 110.093 178.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 202' ' ' ASP . 23.5 tp10 -121.08 163.3 18.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.308 -179.197 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.6 tt -130.68 142.12 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.644 179.487 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.734 HG21 ' O ' ' A' ' 173' ' ' VAL . 15.7 m -136.36 126.17 25.69 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.383 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -112.36 120.32 41.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.562 0.696 . . . . 0.0 110.814 179.77 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 198' ' ' VAL . 42.1 pt -139.83 -176.66 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.81 -178.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.342 -179.471 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.439 HH11 HG22 ' A' ' 198' ' ' VAL . 9.2 tmm_? . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.857 0.36 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.457 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.9 m-85 -80.03 135.72 36.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.976 179.571 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.567 HG11 HG11 ' A' ' 173' ' ' VAL . 75.8 t -129.67 130.98 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.087 0.47 . . . . 0.0 110.821 -179.588 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -119.53 130.56 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.748 -179.423 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.548 ' O ' HG22 ' A' ' 161' ' ' THR . . . -120.36 138.89 53.48 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.621 -179.87 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.82 152.0 19.98 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.215 -179.387 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 181' ' ' GLU . 16.2 m-20 -109.49 139.1 44.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.553 -0.823 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 157' ' ' GLU . 48.0 tp -63.69 125.38 24.1 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.027 0.442 . . . . 0.0 110.928 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -107.41 -25.02 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.152 -178.937 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.33 176.32 45.31 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.953 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.447 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.2 m -153.92 153.13 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.432 0.634 . . . . 0.0 111.038 179.842 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -147.23 177.34 9.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.382 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.35 146.61 24.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.043 0.449 . . . . 0.0 110.679 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.705 ' NZ ' HH22 ' A' ' 82' ' ' ARG . 63.8 tttp -72.12 78.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.586 -179.234 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.747 178.424 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.485 1.017 0 N-CA-C 111.027 -0.413 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.79 171.9 11.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -48.92 -31.22 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.654 -179.141 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.475 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -65.52 -38.82 90.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -73.97 -27.21 60.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.663 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -82.15 -46.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.243 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.54 74.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.767 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.625 ' ND2' ' N ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -69.57 -28.56 66.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -179.218 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.625 ' N ' ' ND2' ' A' ' 71' ' ' ASN . . . -61.87 138.3 58.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.986 -179.734 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -140.22 133.57 29.87 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 tp -140.9 135.1 30.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.655 -179.037 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 67.8 t0 -67.52 137.66 55.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.092 179.136 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.512 ' O ' HG22 ' A' ' 79' ' ' VAL . 70.3 mmtt -65.01 -7.89 13.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.159 0.504 . . . . 0.0 110.22 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -79.96 -10.11 59.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.956 -179.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -78.34 -3.21 41.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.639 -179.268 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 76' ' ' LYS . 6.2 m -85.15 138.6 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 -179.627 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -122.74 -4.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.329 -179.183 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.11 -174.04 39.26 Favored Glycine 0 C--N 1.318 -0.469 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -147.19 151.91 37.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.524 -179.027 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 83' ' ' ILE . 20.6 tt -124.31 120.67 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -118.86 128.09 54.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.665 -179.629 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.584 HG21 HD21 ' A' ' 141' ' ' LEU . 22.5 mt -134.62 122.12 15.46 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.579 -177.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.56 -34.17 0.57 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.404 2.069 . . . . 0.0 112.423 -179.492 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.553 ' OG ' HD23 ' A' ' 141' ' ' LEU . 2.0 t -49.81 -39.32 38.09 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.539 -177.496 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.77 -1.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.458 0.17 . . . . 0.0 111.072 -179.219 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 63.64 49.99 2.86 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.214 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.6 tp -115.71 132.3 56.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.315 -178.661 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.714 ' O ' HD22 ' A' ' 92' ' ' LEU . 82.9 tt0 -139.33 118.0 12.28 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.586 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -148.35 116.72 4.02 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.878 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.528 ' HD2' HD13 ' A' ' 92' ' ' LEU . 2.2 Cg_endo -39.88 161.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.894 1.729 . . . . 0.0 110.307 175.227 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.92 126.98 72.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' CB ' HD22 ' A' ' 102' ' ' ASN . 22.2 mt -102.32 127.63 49.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.982 -179.192 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -71.38 -48.69 48.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.618 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -69.5 107.44 3.37 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.348 -179.225 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -81.93 99.54 9.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.192 0.52 . . . . 0.0 110.115 179.938 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.513 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.9 p -139.74 164.35 30.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 -179.264 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.96 -36.59 84.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -71.74 -47.54 53.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.567 -179.57 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.1 p-10 -65.97 -36.99 84.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.412 -178.766 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.402 ' O ' HD12 ' A' ' 134' ' ' LEU . 18.7 mt -53.16 -24.37 10.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.431 -179.112 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.428 ' O ' HD11 ' A' ' 134' ' ' LEU . 50.0 mt -68.92 -29.37 67.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.319 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.2 t -85.33 -14.31 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.365 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.56 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 162.8 -172.03 38.75 Favored Glycine 0 N--CA 1.465 0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.679 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -71.94 127.94 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.921 -179.806 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -104.78 148.68 26.35 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.51 -179.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.45 ' O ' ' OG ' ' A' ' 98' ' ' SER . 44.7 p -75.57 154.23 36.9 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.65 -52.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -91.81 138.5 31.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 -178.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -72.84 1.41 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.023 -178.69 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -142.96 36.37 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 0.0 111.047 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.29 159.13 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.03 130.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.532 -179.672 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.7 mtt -73.15 127.86 33.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.48 67.95 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.715 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -138.73 123.95 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.089 -179.133 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.89 -173.39 44.93 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -83.51 109.72 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.122 179.84 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -83.96 101.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.02 129.14 37.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.336 0.589 . . . . 0.0 112.062 -178.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -123.57 132.28 53.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.472 178.544 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.73 138.41 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.324 0.583 . . . . 0.0 110.601 -178.973 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.0 -178.54 17.43 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.439 -179.328 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.414 ' HD2' HD12 ' A' ' 134' ' ' LEU . 58.2 m-70 -89.64 145.55 25.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.836 0.351 . . . . 0.0 110.624 -179.691 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 129' ' ' SER . 60.5 t-20 -110.08 28.35 8.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 110.411 -179.754 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -46.19 -12.26 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.789 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 m 56.67 40.38 29.28 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.997 179.069 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -130.74 108.73 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.194 -179.146 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -51.61 124.81 13.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.03 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.31 -29.35 8.39 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.137 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 134' ' ' LEU . 59.6 t -77.05 179.13 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 117.69 0.745 . . . . 0.0 109.044 179.45 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.754 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -70.32 136.61 49.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.089 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.0 m-30 42.55 32.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.165 0.507 . . . . 0.0 111.009 178.339 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 p -82.07 -10.7 59.12 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.36 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.23 26.86 1.62 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.537 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.92 -20.52 20.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.779 0.323 . . . . 0.0 111.838 179.917 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.84 -1.28 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.815 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t -94.09 -13.17 27.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 109.923 -179.625 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.584 HD21 HG21 ' A' ' 85' ' ' ILE . 20.3 mt -64.37 123.32 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.432 -179.75 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.494 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.3 mttt -96.54 173.13 7.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.734 -179.774 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -70.1 136.36 50.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.661 -179.669 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.82 22.07 56.34 Favored Glycine 0 N--CA 1.463 0.449 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.708 179.663 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.494 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.8 m-20 -88.96 130.16 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.37 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -77.48 134.04 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 158' ' ' TYR . 77.3 mt -128.87 121.55 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.272 179.296 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -102.21 122.03 43.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.099 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.0 tp -118.97 143.83 46.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 -178.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.97 133.03 56.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.318 0.58 . . . . 0.0 111.498 -178.946 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.52 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.0 t0 -113.98 -166.42 1.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.282 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 151' ' ' ASP . 15.9 m120 -22.99 -74.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.064 0.459 . . . . 0.0 111.632 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -138.09 24.45 2.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -123.37 143.91 49.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.863 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -109.71 121.04 44.32 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.688 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' A' ' 206' ' ' THR . 77.6 m-85 -105.48 131.1 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.521 -178.763 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 204' ' ' VAL . 97.4 mt-10 -94.7 118.04 31.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.399 178.53 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 147' ' ' ILE . 53.0 m-85 -117.88 139.97 50.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 -179.424 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.17 135.58 54.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.089 0.471 . . . . 0.0 110.563 178.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.66 133.91 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.096 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -108.92 -24.81 11.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 124.464 1.102 . . . . 0.0 111.184 -179.185 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.13 157.19 11.99 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.495 -179.648 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.43 HG23 HG22 ' A' ' 199' ' ' VAL . 12.1 p -123.39 151.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.548 -179.797 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -161.25 171.76 17.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 111.297 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -115.81 110.92 19.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.757 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.14 145.43 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.019 -178.6 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.6 p -60.18 132.85 90.24 Favored Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.569 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.4 Cg_endo -47.28 -17.88 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.873 1.715 . . . . 0.0 111.826 -179.035 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.1 -17.78 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.193 -178.494 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.434 ' O ' HG22 ' A' ' 173' ' ' VAL . 30.0 ttmt -87.29 72.24 9.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.847 0.459 . . . . 0.0 110.946 179.817 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.569 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 47.1 m95 -73.53 -18.52 61.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.004 -179.176 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.7 mt-10 -50.27 -7.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.062 0.458 . . . . 0.0 111.009 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 171' ' ' TRP . 27.9 m -83.79 -21.84 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.671 -178.565 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.587 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -114.44 -1.27 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.618 0.723 . . . . 0.0 109.955 -178.744 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.511 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.8 mt-10 -83.96 125.11 31.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.065 -178.442 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 41.6 p-10 -30.92 122.32 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.703 178.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.0 m80 -112.36 24.25 12.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.735 -179.186 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.42 76.46 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.898 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -149.44 166.46 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 0.0 111.237 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 29.7 p30 -96.08 87.78 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.561 0.696 . . . . 0.0 110.477 179.469 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.458 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 79.8 tt0 -127.24 128.31 45.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.33 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.94 147.3 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.238 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.52 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.2 m -138.15 122.37 18.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.179 -179.907 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.52 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -104.82 128.26 52.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.379 0.609 . . . . 0.0 110.987 -179.756 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.587 HD13 HG11 ' A' ' 174' ' ' VAL . 3.1 pt -139.1 175.54 7.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.811 -178.81 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.507 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.3 p . . . . . 0 N--CA 1.464 0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.819 -179.335 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 186' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -126.06 132.65 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.505 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.49 137.86 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.159 0.504 . . . . 0.0 110.969 -179.428 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.43 HG22 HG23 ' A' ' 163' ' ' VAL . 73.2 t -120.01 131.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.356 -179.535 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.63 135.86 53.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.61 -179.551 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.02 135.18 8.09 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 121.596 0.553 . . . . 0.0 111.762 -179.476 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -90.88 139.46 30.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.293 -179.235 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 11.7 tp -67.21 127.5 32.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.192 0.52 . . . . 0.0 110.632 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 157' ' ' GLU . 4.6 m -109.01 -21.51 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.514 -178.674 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.96 175.89 46.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.031 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.423 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.6 m -155.02 153.43 30.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 110.811 179.503 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -149.39 177.98 9.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.176 179.04 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.18 142.14 30.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.859 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -58.27 80.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 208' ' ' ALA . 49.6 tttp . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.482 0.812 0 N-CA-C 110.864 -0.476 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.28 167.67 21.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.82 -19.95 65.12 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.403 0.439 . . . . 0.0 111.108 -179.377 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.11 97.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.627 -179.569 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 93.2 mt-10 -72.12 -36.69 69.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.785 179.52 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.9 -45.43 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.873 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.38 86.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.19 -27.09 28.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.895 -179.037 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.13 136.77 58.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.331 179.594 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' NZ ' ' A' ' 101' ' ' LYS . 29.3 t -91.08 156.73 17.69 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 105' ' ' SER . 46.2 tp -120.29 125.51 48.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 -178.823 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -95.21 87.81 4.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 79' ' ' VAL . 1.2 mppt? -48.94 -33.07 10.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.029 -179.486 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -51.6 -14.78 0.36 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.243 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -100.77 14.34 31.96 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.853 -178.74 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 79' ' ' VAL . 5.4 p -89.8 126.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.299 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.8 pt -118.5 -6.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.319 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.04 -165.08 34.33 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.03 157.34 43.58 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.273 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 92' ' ' LEU . 5.9 tt -128.63 132.3 67.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.808 0.814 . . . . 0.0 109.249 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -132.75 133.42 43.44 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.609 -178.167 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 21.5 mt -134.73 126.73 18.14 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.808 -178.465 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.09 -34.71 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.54 2.16 . . . . 0.0 112.5 -179.694 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.3 t -49.27 -41.43 37.83 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.655 -177.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.4 p -119.91 -3.59 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 123.245 0.34 . . . . 0.0 111.094 -179.27 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 68.33 50.99 0.7 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.672 -179.585 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -109.27 125.02 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.789 -178.003 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.666 ' N ' HD13 ' A' ' 90' ' ' LEU . 80.1 tt0 -134.88 114.39 12.52 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.408 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.733 HD12 HD11 ' A' ' 90' ' ' LEU . 10.1 mt -148.59 117.39 4.01 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.736 -177.672 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.6 Cg_endo -41.25 151.59 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.971 1.781 . . . . 0.0 110.121 176.41 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.12 121.65 52.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.1 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.9 mt -104.53 128.5 52.49 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -72.55 -39.92 67.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.942 0.401 . . . . 0.0 111.389 -179.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.9 m -72.69 102.0 3.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.073 -179.375 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.8 p -82.34 93.34 7.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 109.913 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.0 p -132.01 158.25 42.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.186 -178.909 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.471 ' O ' HD21 ' A' ' 104' ' ' LEU . 10.0 tm-20 -60.62 -24.6 65.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.719 -179.261 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 65.3 tttm -83.87 -44.17 14.57 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.815 0.697 . . . . 0.0 112.158 -178.865 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -67.26 -34.89 78.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.844 -179.706 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 108' ' ' ALA . 20.1 mt -68.31 -11.48 59.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.621 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.471 HD21 ' O ' ' A' ' 100' ' ' GLU . 17.2 mt -74.63 -14.26 60.74 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.991 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.455 ' HB3' HD13 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -125.7 -3.86 7.15 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.417 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.534 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . -175.63 172.95 45.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.385 -179.522 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.93 127.44 32.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.531 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.4 150.02 25.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.048 0.451 . . . . 0.0 110.803 -179.153 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 p -75.35 151.23 38.24 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 122' ' ' ALA . 1.3 p -87.17 -32.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.468 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 21.2 tptt -90.05 179.99 5.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.964 0.412 . . . . 0.0 110.837 -177.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 22.4 pt-20 -105.7 -16.5 14.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.058 -178.447 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -144.11 53.19 1.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -177.186 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -91.61 153.64 19.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.59 131.6 72.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.617 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.6 mtp -70.19 125.34 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.913 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.32 4.95 65.87 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.474 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -143.32 123.72 13.9 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.55 -178.339 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.59 51.84 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -178.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 6.8 t30 -83.29 108.19 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.903 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.91 102.68 13.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.477 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.469 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -91.53 126.11 36.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.062 0.458 . . . . 0.0 112.186 -179.4 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.82 130.41 53.96 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.468 178.85 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.39 140.02 46.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -178.035 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.94 -177.92 17.53 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.229 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -81.63 155.83 25.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 129' ' ' SER . 9.3 p30 -123.9 28.05 7.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.029 0.442 . . . . 0.0 111.171 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.2 mtt -44.05 -15.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.107 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.19 38.08 13.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.843 178.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.52 120.53 19.8 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.601 -179.123 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.2 124.76 21.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.0 -30.75 6.4 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -177.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 134' ' ' LEU . 94.1 t -72.42 176.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.381 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.701 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -74.1 133.07 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.781 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 48.11 39.2 11.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.796 177.774 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 20.8 p -77.55 -68.03 0.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.287 -179.266 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.519 ' N ' ' OG ' ' A' ' 136' ' ' SER . 94.1 m-20 -88.3 41.88 1.03 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.1 pt -69.99 -26.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.293 -179.758 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.24 3.92 9.8 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.9 m -92.98 -15.1 26.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.328 -179.237 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 mt -66.4 121.28 14.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.526 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -95.84 153.14 17.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -53.67 121.91 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 -179.968 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 101.04 16.94 24.22 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.803 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 73.7 m-20 -85.09 135.89 33.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.13 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -82.33 131.4 35.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 0.0 111.796 -178.321 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.77 124.44 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.552 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -104.5 120.21 40.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.299 -178.554 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.92 158.47 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.956 -178.854 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.56 136.13 53.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 111.708 -178.878 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.4 t0 -112.81 -166.49 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.656 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.2 m-20 -34.73 -67.96 0.13 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.491 0.662 . . . . 0.0 111.042 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.03 29.65 2.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.074 179.643 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.82 147.72 52.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.822 0.82 . . . . 0.0 112.8 -175.495 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.74 123.45 50.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.814 178.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -104.44 133.43 49.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.582 -178.765 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -97.57 116.29 29.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.59 177.8 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -116.16 141.07 48.62 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 -178.962 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.63 131.64 54.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 178.879 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.417 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 61.3 t -65.67 134.23 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.968 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -30.61 11.21 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.201 1.563 . . . . 0.0 110.916 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.79 157.78 11.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.965 -178.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.3 150.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.526 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.9 p -156.51 164.46 38.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.783 -177.704 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.438 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 94.9 mt-10 -114.19 115.63 27.78 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.232 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 158.3 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.622 0.249 . . . . 0.0 111.154 -178.074 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 p -60.49 167.61 3.07 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.301 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.38 -6.97 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.079 1.853 . . . . 0.0 112.192 -179.815 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -85.39 -6.97 59.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.909 -178.088 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -86.49 68.97 10.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.459 ' C ' ' N ' ' A' ' 173' ' ' VAL . 78.4 m95 -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.985 -179.299 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 98.3 mt-10 -47.17 -16.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 O-C-N 123.432 0.457 . . . . 0.0 110.666 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.459 ' N ' ' C ' ' A' ' 171' ' ' TRP . 54.4 t -74.46 -24.93 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.685 -179.055 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.58 -8.61 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.715 0.769 . . . . 0.0 110.041 -177.998 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.9 mt-10 -80.4 157.79 26.18 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.58 -176.716 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.8 p-10 -66.22 128.59 36.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.339 179.834 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 34.4 m80 -108.07 -44.47 4.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.718 -179.561 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.22 24.54 0.1 OUTLIER Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 178.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -153.39 172.5 16.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.955 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 6.7 p30 -95.05 86.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 110.211 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -128.22 125.55 39.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.735 -179.077 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.2 tt -80.82 148.43 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 8.7 m -136.8 118.63 15.14 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.385 -178.231 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 184' ' ' LEU . 10.2 mp -100.32 127.26 46.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 111.185 -179.64 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 pt -139.95 -171.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -178.6 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.529 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.473 -178.77 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.438 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 3.8 m-85 -104.51 132.66 50.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.61 139.37 45.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.183 0.515 . . . . 0.0 110.997 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 80.9 t -125.2 135.81 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 -179.256 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.74 134.95 54.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.89 134.55 8.26 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -96.53 137.57 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.934 -179.082 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.41 HD23 ' OD2' ' A' ' 180' ' ' ASP . 40.3 tp -64.7 127.2 30.52 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.902 179.92 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.26 -23.81 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.684 -179.41 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.409 ' O ' HD11 ' A' ' 203' ' ' LEU . . . 177.01 178.26 46.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.511 -179.519 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 152.41 30.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.955 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -147.94 178.16 8.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.868 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.45 144.71 25.33 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.467 -179.438 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -73.02 79.75 1.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 -179.049 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.388 178.563 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 N-CA-C 111.027 -0.413 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -76.76 170.83 15.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.883 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.39 -15.35 63.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.826 0.346 . . . . 0.0 111.309 -179.199 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 71' ' ' ASN . . . -64.03 -41.27 97.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.146 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.7 mm-40 -76.35 -19.65 58.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.518 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.01 -55.42 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.273 -178.613 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.77 94.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 67' ' ' ALA . 8.1 m120 -68.78 -32.74 72.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.605 -179.258 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.8 129.74 41.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.519 179.579 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -92.91 159.82 15.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.152 179.858 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.648 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -139.4 120.68 14.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.924 0.392 . . . . 0.0 111.105 -178.903 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.648 ' N ' HD13 ' A' ' 74' ' ' LEU . 97.5 m-20 -86.56 106.5 17.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.166 178.846 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -46.64 -16.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.289 0.566 . . . . 0.0 110.69 -179.781 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.481 ' N ' ' C ' ' A' ' 75' ' ' ASP . 63.7 mttp -65.4 -12.02 48.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -97.84 8.73 44.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.463 -178.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.8 t -91.27 125.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.763 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.2 pt -122.38 -3.55 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.328 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.33 -162.03 34.61 Favored Glycine 0 C--N 1.321 -0.288 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.627 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.576 HH12 ' HZ1' ' A' ' 209' ' ' LYS . 10.8 ptp85 -157.53 164.76 37.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.943 -179.724 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 92' ' ' LEU . 8.6 tt -133.08 144.51 36.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.223 179.738 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 t -134.18 135.2 42.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.82 -178.828 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 mt -129.47 76.33 78.84 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.571 -177.404 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.26 -42.05 3.48 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.996 2.464 . . . . 0.0 112.565 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -55.18 -42.68 73.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.719 -177.436 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 88' ' ' VAL . 67.8 t -107.97 5.26 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.753 0.311 . . . . 0.0 110.799 -179.075 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 t 56.1 46.23 22.0 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.139 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -109.96 124.56 51.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.874 -178.273 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.636 ' O ' HD12 ' A' ' 92' ' ' LEU . 83.1 tt0 -128.04 113.09 15.36 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.934 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -145.09 111.01 4.72 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.7 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.7 Cg_endo -41.71 157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.888 1.725 . . . . 0.0 109.767 175.697 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.09 117.0 51.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.1 mt -100.47 120.83 40.58 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.843 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -66.65 -48.26 69.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 111.171 -179.709 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.561 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 23.9 p -60.13 100.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 179.874 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.449 ' O ' ' OG ' ' A' ' 98' ' ' SER . 18.6 p -82.73 97.17 8.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.349 0.595 . . . . 0.0 110.32 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.524 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 3.6 p -140.01 158.22 44.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.094 -179.275 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.2 -33.26 70.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.469 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.03 -44.47 47.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.105 -179.495 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.561 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 98.2 m-20 -65.08 -38.6 91.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.711 -178.903 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.6 mt -57.18 -22.32 39.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.492 -179.385 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.34 -32.88 72.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.655 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.516 ' OG ' HD23 ' A' ' 74' ' ' LEU . 10.4 m -91.33 -9.65 44.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.924 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.86 -176.87 45.6 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.401 -179.401 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.38 124.4 27.47 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.056 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.75 150.48 25.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.061 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.7 p -68.65 148.37 50.54 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.839 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.512 HG21 HD11 ' A' ' 185' ' ' ILE . 84.5 t -88.72 -33.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -177.097 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 170.24 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.388 . . . . 0.0 110.946 -178.851 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.17 -47.12 81.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.193 -178.026 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 113' ' ' ASN . 50.4 p30 -158.0 69.76 0.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.154 -178.336 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 121' ' ' TYR . 4.4 pt20 -76.38 175.06 9.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.246 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -132.47 125.13 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.856 0.36 . . . . 0.0 110.649 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.488 ' SD ' ' OH ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.8 127.44 32.64 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.403 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.85 -5.59 59.85 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -140.37 123.18 16.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.15 -170.24 50.17 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.074 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -83.71 107.74 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.921 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 114' ' ' GLN . 5.8 t80 -84.42 102.67 12.95 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.567 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.45 122.26 33.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.203 0.525 . . . . 0.0 111.827 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -117.67 131.11 56.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.902 178.656 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.83 139.14 46.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.262 0.553 . . . . 0.0 110.768 -178.211 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.47 -178.34 16.5 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.486 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.9 m-70 -93.74 138.59 31.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.574 -179.424 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -98.59 28.78 4.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 110.658 -179.481 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.454 ' HB2' HG11 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -40.67 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.199 -179.335 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 m 59.21 36.87 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.456 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.56 ' HB3' ' HZ3' ' A' ' 130' ' ' LYS . 10.4 mtpm? -131.94 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.471 -178.898 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -48.95 124.09 8.12 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.56 -31.01 7.14 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.314 -177.915 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 134' ' ' LEU . 61.0 t -74.67 179.35 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.761 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -71.51 136.78 47.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.958 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.6 m-30 43.63 35.1 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.816 178.069 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 p -82.92 -14.15 54.7 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.45 ' O ' HG21 ' A' ' 88' ' ' VAL . 65.7 m-20 -141.17 26.48 2.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.409 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.499 HD13 ' CD2' ' A' ' 135' ' ' PHE . 7.2 pt -75.67 -18.08 15.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.479 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.4 18.19 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.644 -179.598 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 t -92.26 -14.05 29.48 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.357 0.598 . . . . 0.0 110.037 -179.319 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.415 ' CD2' ' OD2' ' A' ' 145' ' ' ASP . 23.8 mt -63.77 128.55 36.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.359 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -101.85 174.54 5.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.876 -179.83 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.89 124.29 23.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.6 16.0 47.67 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.603 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.415 ' OD2' ' CD2' ' A' ' 141' ' ' LEU . 10.4 t70 -78.83 136.42 37.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.035 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.8 132.55 35.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.979 0.419 . . . . 0.0 111.626 -178.163 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 93.7 mt -129.01 127.5 66.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.686 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -104.26 120.68 41.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.027 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.63 145.31 45.54 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -119.34 135.12 54.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -178.089 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.8 t0 -110.66 -164.22 0.9 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.542 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 3.5 p-10 -26.37 -77.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.354 0.409 . . . . 0.0 111.29 179.202 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.542 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 78.6 mm-40 -134.02 30.0 3.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.096 178.949 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.479 ' OD1' ' ND2' ' A' ' 152' ' ' ASN . 33.8 m120 -128.85 148.2 50.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.956 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -109.21 123.32 49.05 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.068 179.819 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.4 ' CZ ' HG21 ' A' ' 206' ' ' THR . 48.6 m-85 -106.3 129.72 54.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.655 -178.847 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -94.75 113.59 25.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.338 178.935 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -113.48 143.36 44.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.454 -178.901 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.01 132.23 54.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.262 0.553 . . . . 0.0 110.707 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.6 135.71 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.52 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.1 p -100.24 -27.27 13.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 124.593 1.183 . . . . 0.0 111.013 -178.497 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.0 156.45 8.15 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.426 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.34 139.6 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.389 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 198' ' ' VAL . 73.9 m -136.82 151.27 48.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.786 0.326 . . . . 0.0 111.091 -178.083 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 54.9 mp0 -111.07 102.52 10.97 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.4 m -134.09 156.59 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -178.212 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.2 p -63.02 168.8 4.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.211 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.41 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -82.31 -4.04 11.64 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.179 1.919 . . . . 0.0 112.119 -179.596 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.02 -19.38 44.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.806 -178.569 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -85.96 74.37 10.15 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.817 0.447 . . . . 0.0 110.307 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.41 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 96.6 m95 -74.68 -6.16 47.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.023 -179.279 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.579 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 9.8 pt-20 -52.47 -43.63 65.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.984 0.421 . . . . 0.0 110.919 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.77 ' O ' HG21 ' A' ' 183' ' ' THR . 16.8 m -71.33 4.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.976 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.81 -14.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.779 0.799 . . . . 0.0 110.215 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.7 mt-10 -87.32 172.6 9.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.018 -178.869 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -74.29 125.72 29.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.579 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 48.3 m80 -110.82 22.49 15.3 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.641 -179.37 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.78 20.98 79.27 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.356 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -151.17 168.08 25.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.137 -179.477 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -94.39 87.57 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.174 0.511 . . . . 0.0 110.236 -179.841 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -123.91 124.94 43.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.626 -178.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.4 tt -81.51 146.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.455 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.77 HG21 ' O ' ' A' ' 173' ' ' VAL . 14.5 m -137.28 121.74 18.32 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.395 -179.123 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -105.95 123.45 48.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 111.024 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 110' ' ' VAL . 12.6 pt -139.01 169.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.992 -178.531 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.631 -179.21 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.47 ' NH1' ' CG2' ' A' ' 185' ' ' ILE . 7.9 tmm_? . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.2 133.0 43.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 164' ' ' SER . 3.7 p -138.15 141.26 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.335 0.588 . . . . 0.0 111.332 -179.398 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.7 t -121.16 131.85 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.185 -179.261 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -117.22 136.46 53.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.485 -179.838 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.25 140.69 11.99 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.445 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 53.5 p-10 -97.52 144.95 26.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.566 -0.817 . . . . 0.0 111.473 -178.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.12 126.49 29.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.062 0.458 . . . . 0.0 111.166 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.7 -25.35 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.413 -178.755 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.87 177.43 44.89 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.74 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.4 HG21 ' CZ ' ' A' ' 156' ' ' TYR . 17.7 m -152.89 152.67 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.274 0.559 . . . . 0.0 111.108 -179.78 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -149.36 178.79 8.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.345 179.594 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.78 146.03 24.09 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.403 -179.773 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.576 ' HZ1' HH12 ' A' ' 82' ' ' ARG . 88.4 tttt -77.04 79.02 3.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.748 -179.1 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.562 178.057 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.253 0 CA-C-O 121.121 0.384 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -69.18 152.07 45.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.679 179.636 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.1 mm? -56.61 -27.18 57.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.64 -179.099 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.87 91.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.898 0.38 . . . . 0.0 110.411 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mm-40 -74.38 -35.1 63.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.33 -44.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.41 88.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.766 179.661 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.25 -27.55 42.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.24 140.78 55.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.374 -179.505 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -139.45 147.09 40.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.756 -179.463 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.748 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.4 pt? -137.17 173.8 11.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 -179.515 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.12 128.5 45.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 178.489 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.572 ' O ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -67.91 -10.17 51.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.346 179.996 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 79' ' ' VAL . 1.3 mppt? -63.54 -30.62 71.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.172 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.19 13.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.826 -178.964 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.3 p -85.86 123.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.597 179.672 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.99 -5.48 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.86 -178.197 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.24 -160.26 27.04 Favored Glycine 0 C--N 1.318 -0.432 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 9.3 ttm180 -151.38 157.32 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.129 0.49 . . . . 0.0 110.924 -179.812 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.43 ' N ' ' HG3' ' A' ' 82' ' ' ARG . 3.3 tp -125.9 127.21 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.191 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -129.03 130.15 46.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.77 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 44.9 mt -136.68 123.2 13.78 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.817 -178.731 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.8 Cg_endo -82.33 -30.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.462 2.108 . . . . 0.0 112.473 -179.867 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -48.39 -39.99 24.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.052 -176.475 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.582 HG11 HD12 ' A' ' 90' ' ' LEU . 3.3 p -120.53 -4.17 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.578 0.228 . . . . 0.0 111.12 -179.13 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.09 50.72 0.11 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.021 0.439 . . . . 0.0 109.967 179.895 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.582 HD12 HG11 ' A' ' 88' ' ' VAL . 18.6 mt -111.37 127.42 55.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 179.762 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.49 113.14 11.51 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.947 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 mt -146.09 166.48 16.92 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.395 -177.719 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.82 150.61 8.54 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 109.516 178.105 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.73 108.22 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HB2' HD21 ' A' ' 102' ' ' ASN . 12.9 mt -101.93 121.61 42.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.03 -48.95 72.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.985 0.421 . . . . 0.0 111.176 -179.653 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.41 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 48.4 m -56.68 98.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.777 -179.411 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 85.3 p -80.6 100.56 8.69 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.393 0.616 . . . . 0.0 110.626 179.675 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -135.42 157.73 46.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.352 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -54.97 -39.17 68.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.923 179.524 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.93 -39.08 72.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.091 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 108' ' ' ALA . 6.8 t-20 -62.77 -39.55 94.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 -179.406 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.97 -27.45 63.47 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.288 -178.688 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.68 -14.54 62.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.37 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.494 ' OG ' HD13 ' A' ' 74' ' ' LEU . 5.9 m -104.98 -13.96 15.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.768 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.83 -149.98 14.91 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.013 -178.326 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.34 125.2 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -105.84 144.34 32.71 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.719 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 p -76.84 153.32 34.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 185' ' ' ILE . 74.6 t -85.81 -45.03 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.171 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -88.47 -170.97 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.222 -178.402 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -124.67 -5.28 7.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.826 -177.739 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.42 41.8 1.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.078 0.466 . . . . 0.0 110.675 -177.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.29 161.94 13.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.388 179.679 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.66 132.83 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.543 ' SD ' HD12 ' A' ' 149' ' ' LEU . 67.8 mtt -69.62 129.81 40.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.51 179.13 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.97 75.96 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -146.46 128.17 15.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.579 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.6 -169.7 47.23 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -85.52 103.48 14.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.506 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.94 101.3 11.6 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.8 124.31 35.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 0.0 112.042 -178.846 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -120.13 130.14 54.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.693 178.224 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.47 139.97 43.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 110.256 -178.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.24 -178.22 18.88 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.939 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -83.62 152.26 24.9 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.112 0.482 . . . . 0.0 110.767 -179.85 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 129' ' ' SER . 48.6 p30 -122.09 28.23 7.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.29 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.6 mtt -44.78 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.944 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 61.24 36.33 17.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.535 ' H ' ' HG ' ' A' ' 136' ' ' SER . 68.1 mttm -135.64 114.75 12.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.944 -179.213 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -56.21 126.65 27.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.687 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -30.64 6.67 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 -178.136 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.737 HG12 ' N ' ' A' ' 134' ' ' LEU . 97.0 t -72.36 175.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.737 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.45 128.77 36.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.392 -178.409 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 48.45 42.61 18.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 178.202 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.535 ' HG ' ' H ' ' A' ' 130' ' ' LYS . 2.4 t -75.23 -67.26 0.67 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.36 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -90.27 43.98 1.18 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.183 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.8 pt -68.1 -26.74 35.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.675 179.525 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.16 7.47 4.16 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.246 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -96.25 -14.47 22.64 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.46 122.24 15.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.136 -179.357 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 26.6 mtpp -96.3 157.14 16.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.758 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.43 122.13 13.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.622 -179.627 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.63 18.45 23.18 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.1 m-20 -83.79 134.98 34.7 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.923 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -81.78 126.09 31.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.178 -177.335 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.89 126.78 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.295 178.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -101.94 118.1 36.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.271 -179.101 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.58 HD21 ' CD1' ' A' ' 182' ' ' ILE . 0.7 OUTLIER -106.24 135.92 46.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.973 179.907 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.509 ' O ' ' SD ' ' A' ' 116' ' ' MET . 56.3 m-85 -114.69 127.79 55.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.325 0.583 . . . . 0.0 111.324 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 152' ' ' ASN . 42.8 t0 -113.82 -166.6 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.348 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.1 m-20 -23.04 -75.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.062 0.458 . . . . 0.0 111.994 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -139.22 30.64 2.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.276 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -127.7 144.13 51.1 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.046 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -110.94 121.83 46.35 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.898 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -103.65 132.71 49.66 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.323 -178.874 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.79 115.08 27.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.166 178.785 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -114.77 146.67 40.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.574 -179.844 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.1 132.43 53.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.341 0.591 . . . . 0.0 111.022 178.073 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.425 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 62.0 t -67.11 133.41 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.631 179.56 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.82 -29.01 11.72 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 124.739 1.274 . . . . 0.0 110.395 -178.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.83 164.07 23.9 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.031 -179.355 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.92 147.45 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.911 -0.644 . . . . 0.0 109.765 -179.661 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.0 p -151.69 162.15 41.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.195 0.521 . . . . 0.0 111.289 -179.115 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -117.91 111.31 18.83 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.696 179.89 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.8 160.14 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.096 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -62.18 166.98 5.66 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.532 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.1 Cg_endo -82.21 -5.87 12.0 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.256 1.97 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -17.03 52.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.725 -178.78 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.568 ' O ' HG22 ' A' ' 173' ' ' VAL . 1.8 mptm? -87.37 73.57 9.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.508 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 70.1 m95 -73.52 -21.51 60.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.362 -179.847 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.545 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.3 mt-10 -51.06 -8.82 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.001 0.429 . . . . 0.0 110.825 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 170' ' ' LYS . 19.5 m -83.29 -21.86 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.747 -178.792 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.634 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -112.89 -0.71 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.591 0.71 . . . . 0.0 109.677 -179.051 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.533 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 97.0 mt-10 -83.55 139.65 32.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.19 -178.253 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -44.51 123.57 3.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.063 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.545 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 45.7 m80 -114.25 22.84 13.4 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.056 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.06 19.73 79.72 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.237 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -147.59 164.27 33.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.065 0.459 . . . . 0.0 111.28 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.15 89.08 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.852 179.512 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.487 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 79.3 tt0 -129.23 125.53 37.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.595 -179.118 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.58 ' CD1' HD21 ' A' ' 149' ' ' LEU . 17.7 tt -79.46 148.09 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.269 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.518 ' C ' HD12 ' A' ' 184' ' ' LEU . 10.2 m -135.95 125.44 25.1 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -106.94 127.42 53.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.499 179.866 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 110' ' ' VAL . 11.9 pt -136.79 176.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.622 -179.233 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.584 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.9 p . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.163 -179.178 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.584 ' NH1' ' O ' ' A' ' 186' ' ' THR . 8.6 ptp180 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.135 0.493 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.58 141.68 47.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.06 178.7 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.2 t -132.09 133.99 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.151 0.5 . . . . 0.0 110.99 -179.504 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.24 133.28 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.337 -179.415 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.487 ' HB1' ' OE2' ' A' ' 181' ' ' GLU . . . -116.51 135.89 53.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.707 -179.751 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.07 135.64 8.75 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -179.757 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -92.13 138.65 31.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.555 -179.24 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.26 127.11 30.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.112 0.482 . . . . 0.0 110.543 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 -23.01 4.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.341 -179.036 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 173.43 178.11 43.16 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.289 -178.513 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.6 m -151.95 152.29 32.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 111.285 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -148.74 177.53 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.549 179.655 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.06 146.6 24.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.344 0.592 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -76.02 79.8 2.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.693 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.317 -0.824 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.718 178.443 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.485 1.029 0 CA-C-O 120.923 0.301 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 55.4 t0 -72.6 158.65 35.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.458 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 3.9 mm? -64.03 -20.53 65.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.766 -179.359 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.0 92.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.289 -179.727 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 72.3 mm-40 -73.8 -32.64 63.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.68 -45.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.854 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.91 90.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.026 179.839 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -79.03 -23.53 44.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.253 -179.392 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.82 105.1 0.51 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.868 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.6 m -96.58 80.74 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.548 HD11 ' NE2' ' A' ' 78' ' ' GLN . 44.7 tp -74.88 148.02 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.182 179.334 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 77' ' ' LYS . 42.4 t0 -81.31 91.13 6.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.48 ' O ' HG13 ' A' ' 79' ' ' VAL . 63.7 mttp -52.74 -9.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.132 0.491 . . . . 0.0 110.364 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 75' ' ' ASP . 17.5 tptm -79.65 -10.89 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.538 -179.803 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.572 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 9.0 pt20 -93.6 19.36 8.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.563 -178.785 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 76' ' ' LYS . 33.6 m -83.0 146.26 7.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.855 -179.433 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.68 -6.04 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.83 -165.54 32.94 Favored Glycine 0 C--N 1.317 -0.473 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.461 ' NH1' ' C ' ' A' ' 92' ' ' LEU . 8.5 ttm-85 -151.52 154.47 36.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.303 0.573 . . . . 0.0 111.326 -179.258 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 83' ' ' ILE . 18.0 tt -127.88 130.01 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.72 179.444 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -127.76 129.68 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.022 -179.155 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 37.3 mt -134.78 118.36 13.32 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -177.946 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 3.3 Cg_exo -81.25 -33.67 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.736 2.29 . . . . 0.0 112.388 179.869 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.4 t -49.54 -39.41 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.696 -177.052 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 90' ' ' LEU . 3.9 m -119.14 -6.23 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -178.777 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 75.28 49.9 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.305 0.574 . . . . 0.0 110.209 179.904 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.503 HD12 HG21 ' A' ' 88' ' ' VAL . 2.5 mt -111.0 125.45 53.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.251 -179.365 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -133.25 112.41 11.66 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.461 ' C ' ' NH1' ' A' ' 82' ' ' ARG . 76.6 mt -145.58 162.5 36.21 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.908 -177.03 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -88.06 152.05 6.99 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 123.118 2.545 . . . . 0.0 109.119 177.41 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.1 t -98.15 115.63 38.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.757 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 mt -101.66 122.96 44.86 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.066 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -67.23 -45.06 77.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 m -69.62 99.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.453 -179.51 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.3 p -81.69 96.27 7.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.516 0.674 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.586 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.9 p -136.99 157.3 47.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.924 -179.584 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.15 -31.97 65.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.648 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -78.27 -45.28 23.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.617 0.722 . . . . 0.0 111.295 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.662 HD22 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -66.25 -35.17 79.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.494 -178.171 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.83 -15.4 58.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.933 -178.797 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 mt -71.37 -27.22 63.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.894 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.6 m -94.31 -8.78 37.99 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.753 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.2 -158.16 28.48 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.814 -178.591 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.09 126.58 37.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.875 -0.662 . . . . 0.0 109.941 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.02 147.46 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 -179.779 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 44.5 p -71.02 147.7 48.34 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.35 -43.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -89.82 -171.32 3.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.028 -178.721 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -121.58 -9.27 8.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.982 0.42 . . . . 0.0 111.535 -178.212 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -139.36 39.86 2.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.017 0.437 . . . . 0.0 111.393 -177.66 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -91.33 157.45 17.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.098 179.713 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.4 t -132.61 131.66 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.639 179.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.6 mtt -66.93 129.3 39.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.006 178.75 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.27 3.37 75.69 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -141.77 120.98 13.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.71 -165.75 54.75 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -178.867 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -90.23 109.98 21.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.614 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.69 102.26 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.922 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.22 129.83 37.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.474 0.654 . . . . 0.0 111.966 -179.177 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -127.04 132.35 50.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.526 178.637 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.24 141.66 45.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.556 0.693 . . . . 0.0 110.76 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.1 -179.04 20.31 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.588 -179.531 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 31.0 m-70 -81.84 145.08 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 129' ' ' SER . 22.9 t-20 -116.87 28.1 8.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmm -46.49 -12.15 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.911 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.59 40.98 16.07 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.078 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 88.4 tttt -134.42 115.15 13.67 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.768 -179.087 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -57.46 126.39 27.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.668 0.747 . . . . 0.0 110.156 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.49 -22.61 17.05 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.734 HG12 ' H ' ' A' ' 134' ' ' LEU . 55.6 t -84.3 177.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.073 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.734 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -72.19 133.19 44.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.607 0.241 . . . . 0.0 110.4 -178.247 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 46.16 33.0 1.59 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.297 0.57 . . . . 0.0 110.551 178.343 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 0.9 OUTLIER -81.86 -4.37 56.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.817 -178.571 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.455 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 22.8 t70 -147.09 39.76 1.02 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.605 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.69 -27.29 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.927 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.38 3.53 10.87 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.719 -179.604 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.455 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.2 m -95.35 -12.98 25.15 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.406 0.622 . . . . 0.0 109.694 -179.55 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.44 ' O ' HG21 ' A' ' 163' ' ' VAL . 13.8 mt -65.87 125.15 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.983 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -96.81 158.43 15.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.607 -179.837 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -61.46 128.03 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.874 -179.615 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 90.67 20.22 41.33 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.784 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 37.5 m-20 -85.82 132.33 34.13 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.406 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -79.79 135.69 36.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.812 -178.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 158' ' ' TYR . 84.5 mt -127.66 122.3 58.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.542 179.302 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.443 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.0 m-85 -100.18 117.66 34.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.975 -179.071 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.48 142.37 46.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.967 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.421 ' O ' ' SD ' ' A' ' 116' ' ' MET . 34.5 m-85 -116.06 132.95 56.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 111.471 -178.842 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.0 t0 -113.94 -166.38 1.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.6 m-20 -22.54 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.539 0.524 . . . . 0.0 111.676 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -137.81 28.28 2.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.289 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -126.93 143.77 51.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.899 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -109.18 121.62 45.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.844 179.067 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -104.65 132.01 51.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.418 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.443 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 70.2 mm-40 -94.62 112.65 24.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.992 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.5 m-85 -114.39 137.38 51.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.436 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.89 54.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 111.382 178.785 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 144' ' ' GLY . 44.3 t -67.38 132.64 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.959 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -112.26 -29.39 7.57 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 124.619 1.199 . . . . 0.0 111.13 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.19 145.18 8.45 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.498 -179.765 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 141' ' ' LEU . 97.8 t -121.86 138.24 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.784 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.5 m -159.34 171.88 18.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.693 -178.341 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.04 133.27 54.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.718 179.964 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 m -138.78 159.66 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.3 -178.691 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 169' ' ' ASP . 3.6 p -69.11 133.59 89.72 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.146 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.07 -13.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.046 1.831 . . . . 0.0 111.794 -178.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.1 m-20 -78.84 -22.36 46.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.903 -177.963 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.699 ' O ' HG22 ' A' ' 173' ' ' VAL . 14.4 mptt -85.67 75.91 10.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.545 ' C ' ' H ' ' A' ' 173' ' ' VAL . 83.3 m95 -74.05 -20.03 60.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.992 -179.18 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 57.1 mp0 -52.24 -6.79 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.821 179.575 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.712 ' O ' HG21 ' A' ' 183' ' ' THR . 24.4 m -89.81 -3.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.101 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 173' ' ' VAL . 1.0 OUTLIER -128.9 -7.24 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.745 0.783 . . . . 0.0 109.012 179.794 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.18 157.03 25.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.239 -176.749 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.89 127.52 32.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.092 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -102.11 -41.44 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.075 -179.78 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 140.84 28.03 0.19 Allowed Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.498 ' NZ ' ' CD ' ' A' ' 181' ' ' GLU . 19.7 pttp -156.37 178.49 10.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 4.6 m-20 -92.19 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.72 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.498 ' CD ' ' NZ ' ' A' ' 179' ' ' LYS . 22.4 tt0 -123.18 169.39 11.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.148 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.93 143.01 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.873 179.354 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.712 HG21 ' O ' ' A' ' 173' ' ' VAL . 16.0 m -136.02 123.56 22.18 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 111.489 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -111.11 123.72 50.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.405 0.621 . . . . 0.0 110.556 179.334 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 198' ' ' VAL . 8.5 pt -139.77 -171.45 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.932 -178.62 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.467 0.418 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.717 -179.159 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.936 0.398 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -108.27 137.65 45.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.209 179.341 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.475 HG22 HG22 ' A' ' 185' ' ' ILE . 78.9 t -129.49 131.27 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.268 0.556 . . . . 0.0 110.824 -179.155 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.2 130.38 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.328 -179.755 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.47 135.86 54.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.574 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.43 147.97 18.45 Favored Glycine 0 N--CA 1.465 0.619 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.772 -179.791 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -103.32 140.22 37.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.933 -0.633 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.1 tp -66.11 125.76 26.5 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.204 0.526 . . . . 0.0 110.802 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.11 -24.21 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.042 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.88 176.63 46.04 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 119.93 -1.128 . . . . 0.0 112.102 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.7 m -153.51 151.48 29.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 110.94 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -150.09 178.39 9.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.677 179.439 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.34 144.85 24.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.157 0.503 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.45 79.55 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.763 -179.529 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.601 178.479 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.484 0.921 0 N-CA-C 111.137 -0.37 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.09 146.58 52.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.823 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.81 -28.84 66.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.77 91.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.459 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.9 mm-40 -73.09 -35.39 66.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.805 179.469 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.87 -43.7 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.743 -179.181 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.35 83.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -87.89 -15.5 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.563 -178.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.39 133.05 53.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.521 179.658 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.1 p -90.9 159.4 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.054 179.598 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 105' ' ' SER . 51.0 tp -125.89 135.55 52.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.956 0.407 . . . . 0.0 111.112 -179.16 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.482 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.3 m-20 -89.91 89.31 7.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.763 179.756 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 4.6 mptp? -46.8 -16.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.18 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.482 ' N ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -65.64 -35.91 82.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.285 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 18.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.563 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.2 123.01 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.888 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.94 -7.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.016 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.15 38.54 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.514 ' O ' HD23 ' A' ' 149' ' ' LEU . 18.6 mtp85 -147.31 153.51 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.068 -178.64 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.8 tt -126.97 131.05 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.206 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.6 m -130.9 132.36 45.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.211 -178.765 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.15 129.85 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 -178.461 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.48 -35.05 0.26 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.397 2.064 . . . . 0.0 112.102 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -47.21 -38.73 12.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.491 -176.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -120.58 -0.54 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.845 -178.936 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 53.74 3.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.168 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.1 tp -116.06 133.84 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.34 116.37 13.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.522 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 83' ' ' ILE . 60.2 mt -144.53 110.87 4.94 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.079 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.1 Cg_endo -41.29 141.01 1.31 Allowed 'Trans proline' 0 N--CA 1.486 1.041 0 C-N-CA 121.79 1.66 . . . . 0.0 110.326 176.206 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.4 t -89.65 125.5 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.036 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.7 mt -108.95 122.45 47.25 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.28 -48.58 72.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.974 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 m -71.59 103.78 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.042 -179.613 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 109' ' ' THR . 3.2 m -84.32 101.48 11.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.273 0.558 . . . . 0.0 110.078 179.537 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.515 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 6.4 p -132.75 156.19 47.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.099 -179.75 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.449 ' O ' HD21 ' A' ' 104' ' ' LEU . 9.6 tm-20 -55.83 -26.94 49.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.545 -179.505 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.32 -43.73 14.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.374 0.607 . . . . 0.0 111.947 -179.507 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.515 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 98.3 m-20 -66.44 -34.31 77.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.621 -179.138 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.4 mt -68.94 -12.67 61.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.03 -178.593 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 100' ' ' GLU . 14.6 mt -76.14 -13.14 60.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.121 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB3' HD22 ' A' ' 74' ' ' LEU . 57.8 m -121.35 -7.52 9.26 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.52 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.6 47.58 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.832 -179.742 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.17 129.07 36.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.955 179.375 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.456 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -106.63 146.65 30.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.986 -179.64 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.522 ' O ' ' OG ' ' A' ' 98' ' ' SER . 32.9 p -75.41 149.92 38.47 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.791 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.46 -40.52 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.845 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -87.82 145.07 26.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 111.044 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.16 -16.9 64.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.077 -179.141 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -144.86 52.02 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.295 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.415 ' CD ' ' H ' ' A' ' 122' ' ' ALA . 1.1 tt0 -80.73 155.55 26.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.656 179.557 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -133.08 127.7 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.0 mtt -71.49 126.65 30.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.256 179.482 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.91 70.94 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.521 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -139.2 119.71 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.259 -179.161 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -164.35 54.57 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.25 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.621 HD21 ' CB ' ' A' ' 183' ' ' THR . 1.3 t30 -90.02 109.82 20.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.732 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -84.96 101.1 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.415 ' H ' ' CD ' ' A' ' 114' ' ' GLN . . . -90.39 126.29 35.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 112.135 -178.919 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.4 130.92 53.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.454 178.146 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.2 139.49 45.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.46 0.647 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.89 -178.78 19.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 134' ' ' LEU . 36.0 m-70 -85.16 140.65 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 110.66 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 28.6 t-20 -108.22 28.2 8.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.388 0.614 . . . . 0.0 110.265 -179.91 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -44.28 -13.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.873 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 55.45 39.56 31.14 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.942 179.264 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.477 ' O ' ' OG ' ' A' ' 136' ' ' SER . 79.8 tttt -134.7 123.05 23.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.607 -178.782 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -64.08 123.64 19.55 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.132 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.59 25.05 5.62 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.546 -177.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 134' ' ' LEU . 3.0 t -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.952 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -70.26 131.72 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.43 -177.838 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 47.14 32.74 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.077 0.465 . . . . 0.0 110.893 178.251 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.45 -10.31 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.022 -178.948 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.5 m-20 -144.5 38.08 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.26 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -68.12 -35.24 70.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.943 0.401 . . . . 0.0 111.657 179.75 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.58 3.3 1.9 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.88 -179.381 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 138' ' ' ILE . 19.0 m -95.61 -12.61 25.35 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.127 0.489 . . . . 0.0 109.861 -179.447 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -67.42 125.28 25.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.98 159.68 14.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.708 -179.806 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 144' ' ' GLY . 10.1 tmtt? -60.22 128.0 34.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -179.829 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 143' ' ' LYS . . . 91.14 22.32 32.88 Favored Glycine 0 N--CA 1.463 0.444 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.935 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.86 132.4 34.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.221 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -79.93 130.19 35.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.275 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 89.5 mt -125.3 124.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.31 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -106.7 122.45 46.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.484 -178.651 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.607 HD22 ' SD ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -115.91 148.49 39.96 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.369 -179.584 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.92 131.76 53.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.364 0.602 . . . . 0.0 111.438 -179.834 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 152' ' ' ASN . 26.2 t70 -114.64 -165.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.011 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 151' ' ' ASP . 2.3 t-20 -23.78 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.178 0.514 . . . . 0.0 111.733 179.463 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -139.61 25.6 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.911 178.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -124.05 141.62 51.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.689 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.537 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 75.5 tt0 -106.49 121.06 43.51 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.059 179.321 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.408 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.5 m-85 -104.29 128.32 52.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -95.01 117.55 30.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.571 178.652 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.52 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 21.5 m-85 -117.78 141.09 48.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.186 -179.346 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.03 136.49 54.86 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.172 0.51 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.13 132.25 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.756 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.5 t -111.8 -26.78 8.78 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 124.799 1.312 . . . . 0.0 111.37 -179.067 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.27 149.66 9.61 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.418 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.575 HG13 HG22 ' A' ' 199' ' ' VAL . 21.8 t -125.74 148.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.904 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.6 p -160.3 168.76 24.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.157 0.503 . . . . 0.0 111.365 -177.987 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.453 ' OE1' ' CE1' ' A' ' 197' ' ' TYR . 1.6 pm0 -117.95 124.28 47.85 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.456 179.722 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.71 160.32 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.249 -178.412 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 169' ' ' ASP . 15.0 p -71.62 138.23 83.25 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.455 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.94 -14.9 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.012 1.808 . . . . 0.0 111.993 -178.7 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 65.4 t0 -78.96 -11.5 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.552 -177.86 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.414 ' O ' HG23 ' A' ' 173' ' ' VAL . 31.1 mmtt -84.77 64.53 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.182 0.515 . . . . 0.0 110.357 179.476 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.464 ' C ' ' N ' ' A' ' 173' ' ' VAL . 86.3 m95 -70.1 -30.87 68.2 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.218 -179.716 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 41.4 mp0 -47.3 -15.97 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.212 0.53 . . . . 0.0 110.672 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 198' ' ' VAL . 87.4 t -66.13 -43.07 92.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.284 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.477 HG11 HD13 ' A' ' 185' ' ' ILE . 13.4 m -98.94 2.16 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.624 0.725 . . . . 0.0 110.506 -178.221 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.57 120.28 25.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.417 -1.265 . . . . 0.0 112.08 -178.569 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -31.79 122.81 0.28 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.506 178.846 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -105.41 -41.73 5.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.47 27.1 0.14 Allowed Glycine 0 N--CA 1.471 1.013 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -154.09 173.75 15.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.654 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -96.07 86.94 4.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.292 179.016 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -128.07 128.53 45.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.271 -179.286 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 149' ' ' LEU . 20.3 tt -81.43 147.26 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.527 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.621 ' CB ' HD21 ' A' ' 120' ' ' ASN . 7.8 m -136.87 118.1 14.52 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 111.025 -179.608 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -103.44 126.18 50.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.381 0.61 . . . . 0.0 110.999 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.477 HD13 HG11 ' A' ' 174' ' ' VAL . 11.8 pt -138.45 -177.13 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.592 -179.06 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.655 HG23 ' HE ' ' A' ' 196' ' ' ARG . 15.2 t . . . . . 0 N--CA 1.465 0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.655 ' HE ' HG23 ' A' ' 186' ' ' THR . 5.6 ptp85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.917 0.389 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.453 ' CE1' ' OE1' ' A' ' 165' ' ' GLU . 4.3 m-85 -92.58 140.54 29.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.938 179.158 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 173' ' ' VAL . 45.4 t -132.2 134.54 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 -179.437 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.575 HG22 HG13 ' A' ' 163' ' ' VAL . 61.1 t -119.4 130.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.809 -179.39 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.23 136.14 53.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.141 179.505 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.63 140.19 11.6 Favored Glycine 0 N--CA 1.468 0.813 0 CA-C-O 121.648 0.582 . . . . 0.0 111.709 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.3 t0 -96.61 140.18 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.966 -179.09 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.52 HD13 ' CZ ' ' A' ' 158' ' ' TYR . 12.1 tp -67.45 129.15 39.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 111.004 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 79.6 t -106.93 -23.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.25 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.49 162.53 21.92 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.687 178.774 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.408 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 48.0 m -138.79 157.49 45.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.246 0.546 . . . . 0.0 109.934 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.8 pttp -150.33 178.5 8.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.097 179.864 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -96.11 140.27 31.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.768 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -61.97 79.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.482 -179.44 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 208' ' ' ALA . 99.2 mttt . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.518 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m 51.67 -147.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.702 0.287 . . . . 0.0 110.325 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.575 ' C ' ' H ' ' A' ' 57' ' ' ASP . 99.1 m-70 -80.7 12.38 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.758 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.0 mtt 55.34 -0.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.988 0.423 . . . . 0.0 111.099 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.575 ' H ' ' C ' ' A' ' 55' ' ' HIS . 73.9 m-20 -92.37 4.45 53.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.984 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.61 -37.77 70.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.648 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 61' ' ' ILE . 80.2 p -86.73 18.65 3.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.719 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -68.24 40.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.094 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' A' ' 59' ' ' SER . 32.6 mm -66.28 -44.67 91.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.852 0.358 . . . . 0.0 110.355 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 64' ' ' PRO . 15.9 t0 61.24 123.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -38.06 93.0 0.06 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 123.157 0.285 . . . . 0.0 110.489 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.46 ' N ' ' O ' ' A' ' 62' ' ' ASP . 5.4 Cg_exo -73.81 157.72 47.42 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.372 1.381 . . . . 0.0 112.39 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.66 149.2 45.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.551 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.18 -24.47 59.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.094 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.5 86.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.44 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -73.4 -35.96 65.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.177 179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.98 -43.23 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.509 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.05 88.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -84.26 -19.81 33.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.53 131.95 51.78 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.582 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 m -92.3 152.42 19.8 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.378 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.2 tp -116.38 130.3 56.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.907 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -94.13 88.97 5.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 79' ' ' VAL . 45.0 mmtm -50.43 -11.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 75' ' ' ASP . 69.2 mmtt -74.52 -9.28 58.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.513 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -106.51 16.51 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.37 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.9 p -90.6 126.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.774 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.33 -4.62 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.761 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.7 -167.54 36.55 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.483 ' HE ' ' NZ ' ' A' ' 209' ' ' LYS . 44.4 mtt-85 -146.92 155.24 42.13 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.973 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.617 HD12 HD13 ' A' ' 123' ' ' LEU . 8.8 tt -127.55 126.44 67.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.329 0.585 . . . . 0.0 109.821 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -125.14 130.55 52.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.006 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.48 79.57 59.79 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.252 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -43.6 -35.89 6.7 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.909 2.406 . . . . 0.0 112.972 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 m -49.11 -37.39 21.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -115.59 0.59 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.732 0.301 . . . . 0.0 110.622 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.59 47.83 2.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.3 tp -115.04 129.32 56.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.737 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -134.34 120.66 20.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.6 mt -146.72 162.47 33.59 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 120.093 -0.643 . . . . 0.0 112.241 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.64 151.68 8.83 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.826 2.35 . . . . 0.0 109.646 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -99.35 113.98 36.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.43 122.31 42.96 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.45 -45.73 82.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.797 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.549 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 91.5 p -70.79 104.57 2.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.152 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.0 p -82.79 99.81 9.91 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.254 0.55 . . . . 0.0 110.098 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.2 p -131.29 158.17 41.36 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.855 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -62.1 -26.42 68.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.885 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -83.23 -41.23 18.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.299 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.549 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 98.5 m-20 -66.46 -36.21 82.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.503 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.0 mt -66.32 -14.7 62.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.2 mt -75.49 -13.93 60.4 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -121.09 -4.49 9.54 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -176.38 -176.54 44.65 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 119.633 -1.27 . . . . 0.0 112.286 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.15 125.29 32.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.29 -0.455 . . . . 0.0 109.812 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.0 145.4 30.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.0 p -71.68 149.1 45.81 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.6 t -83.22 -44.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.94 -171.18 2.77 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.03 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -108.01 -56.78 2.19 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.809 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -91.17 46.54 1.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.032 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -85.59 150.27 24.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.133 0.492 . . . . 0.0 109.931 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.29 132.16 52.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.403 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.5 mtt -73.78 127.33 32.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 0.0 110.263 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.37 -0.9 68.87 Favored Glycine 0 C--O 1.23 -0.14 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -137.72 119.48 15.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.508 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -171.71 54.48 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.5 t30 -86.15 111.52 20.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -83.84 106.79 15.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.74 128.53 36.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.048 0.451 . . . . 0.0 112.081 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.617 HD13 HD12 ' A' ' 83' ' ' ILE . 10.1 mt -126.0 130.55 51.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.027 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.98 141.68 47.11 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.342 0.591 . . . . 0.0 110.768 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.48 -177.41 18.39 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.283 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.0 m-70 -82.69 150.0 27.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.1 0.476 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.55 ' ND2' ' OG ' ' A' ' 189' ' ' SER . 61.2 t30 -117.59 27.96 8.74 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.715 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.4 mmm -45.43 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.7 p 62.82 41.03 9.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.19 0.519 . . . . 0.0 110.201 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -133.83 109.66 9.24 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.884 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -51.66 127.87 21.74 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.44 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.7 -25.5 14.76 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.782 HG12 ' H ' ' A' ' 134' ' ' LEU . 45.9 t -82.51 177.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 117.54 0.67 . . . . 0.0 109.499 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.782 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.22 136.91 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.315 -177.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 44.57 32.73 0.8 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.045 0.45 . . . . 0.0 110.656 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -81.89 -8.11 59.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.207 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -149.96 41.91 0.85 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.731 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.2 pt -68.08 -33.85 63.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.371 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.21 5.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.104 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -94.57 -16.79 22.94 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.2 124.95 23.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.835 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.65 156.13 16.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.566 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 144' ' ' GLY . 5.6 tmtt? -56.85 127.35 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.675 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.436 ' N ' ' HD3' ' A' ' 143' ' ' LYS . . . 90.9 21.72 35.38 Favored Glycine 0 CA--C 1.516 0.139 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -82.75 134.66 35.12 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.542 ' NZ ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 mmmm -80.96 121.78 26.45 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.565 0.698 . . . . 0.0 112.312 -178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 94.4 mt -117.69 117.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.11 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.548 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.1 m-85 -100.32 119.02 37.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -117.43 144.68 44.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.73 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -116.41 136.75 52.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.411 0.624 . . . . 0.0 111.565 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' A' ' 152' ' ' ASN . 32.2 t70 -114.74 -171.07 1.86 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.9 p30 -21.17 -73.53 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.072 0.463 . . . . 0.0 111.658 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.496 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.2 mt-10 -138.38 26.0 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.82 147.89 45.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.369 0.604 . . . . 0.0 112.254 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -113.08 120.43 41.31 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CE2' HG21 ' A' ' 206' ' ' THR . 65.9 m-85 -104.29 131.18 51.89 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.073 0.463 . . . . 0.0 111.36 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.548 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 42.4 tp10 -94.52 114.77 26.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -114.5 141.92 47.07 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.63 135.7 54.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.538 0.685 . . . . 0.0 111.428 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.3 132.27 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.875 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -105.97 -27.74 10.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 124.917 1.386 . . . . 0.0 110.709 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 175.84 141.12 3.68 Favored Glycine 0 C--N 1.32 -0.328 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.405 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.2 p -106.08 139.8 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.058 -0.571 . . . . 0.0 109.564 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.9 t -154.09 166.72 32.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.345 0.593 . . . . 0.0 111.557 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -116.03 125.95 53.14 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.665 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.07 153.97 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.805 0.336 . . . . 0.0 110.995 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 p -60.0 167.2 2.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.75 -13.69 11.68 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.949 1.766 . . . . 0.0 111.446 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 36.9 p30 -82.91 -18.49 39.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.881 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.445 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.2 ttmt -86.72 74.75 9.76 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.03 0.443 . . . . 0.0 110.073 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.401 ' CE3' HG21 ' A' ' 174' ' ' VAL . 94.0 m95 -75.54 -7.54 54.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.868 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -52.57 -25.42 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.039 0.447 . . . . 0.0 110.557 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.662 ' O ' HG21 ' A' ' 183' ' ' THR . 74.4 t -75.71 -16.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.228 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.401 HG21 ' CE3' ' A' ' 171' ' ' TRP . 2.6 t -108.71 -13.78 10.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.665 0.745 . . . . 0.0 109.676 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.01 152.66 24.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.919 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -64.54 133.93 53.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.824 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -101.18 -39.07 7.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.45 30.33 0.35 Allowed Glycine 0 N--CA 1.469 0.843 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -156.23 179.31 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.262 0.553 . . . . 0.0 111.369 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -89.23 89.71 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -125.06 166.13 16.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.193 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.3 tt -130.29 142.45 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.662 HG21 ' O ' ' A' ' 173' ' ' VAL . 18.0 m -134.37 127.01 30.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.573 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.56 126.86 55.76 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.106 0.479 . . . . 0.0 109.722 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.48 HG22 HG22 ' A' ' 198' ' ' VAL . 28.6 pt -140.32 -169.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.519 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 33.3 p -138.23 152.23 48.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.732 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 19.4 m -66.32 -46.79 75.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.52 145.4 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.193 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.55 ' OG ' ' ND2' ' A' ' 127' ' ' ASN . 37.9 t -144.28 133.26 22.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.127 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 98.5 t 48.61 -85.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.931 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 189' ' ' SER . 66.0 tttm -145.67 158.85 43.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.729 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.82 -47.03 81.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 110.162 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -63.51 -39.83 95.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.058 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.8 m -60.04 171.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.4 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -97.08 -173.16 2.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.395 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -140.42 162.05 36.25 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.214 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.5 133.58 42.67 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.553 HG11 HG11 ' A' ' 173' ' ' VAL . 93.4 t -133.59 137.02 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.2 t -116.01 128.15 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.465 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.16 136.87 52.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.212 0.529 . . . . 0.0 110.074 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.46 25.85 Favored Glycine 0 N--CA 1.462 0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.451 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -115.61 150.1 37.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.043 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 41.8 tp -69.9 127.12 31.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.506 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 53.8 t -109.13 -24.43 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.759 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 175.01 45.81 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.532 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.412 HG21 ' CE2' ' A' ' 156' ' ' TYR . 16.5 m -153.3 151.66 30.26 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-O 121.375 0.607 . . . . 0.0 111.015 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -149.84 179.03 8.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.395 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.26 145.7 24.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.168 0.508 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.483 ' NZ ' ' HE ' ' A' ' 82' ' ' ARG . 88.5 tttt -74.14 80.0 1.76 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.321 -0.63 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.872 178.758 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.8 p -75.72 162.09 28.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.745 0.307 . . . . 0.0 110.318 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -76.36 158.48 31.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 110.123 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 55.5 ttp -59.38 -43.08 92.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.14 0.495 . . . . 0.0 110.422 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 7.7 p30 -95.84 102.77 14.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.395 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.69 -8.05 55.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.855 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 t -84.22 -92.86 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.514 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp 50.46 39.97 22.03 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.009 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mm -63.66 -44.21 98.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.929 0.395 . . . . 0.0 110.196 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.7 t0 58.88 -111.48 0.56 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.35 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -142.06 80.13 15.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -42.13 148.3 0.4 Allowed 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.063 1.842 . . . . 0.0 111.533 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 162.78 29.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.063 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 66' ' ' LEU . 1.2 tt -60.22 -25.18 65.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.978 0.418 . . . . 0.0 110.247 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.73 -38.13 89.3 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.004 0.43 . . . . 0.0 110.447 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 71.0 mm-40 -73.67 -33.71 64.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.217 0.532 . . . . 0.0 110.788 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.28 -45.54 40.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.754 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.43 -39.19 88.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.183 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -80.85 -24.11 38.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.209 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.45 141.5 58.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.712 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.6 m -139.22 119.28 13.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.821 0.343 . . . . 0.0 110.578 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.2 tp -120.31 140.41 51.3 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.825 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.08 138.55 57.22 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.215 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 79' ' ' VAL . 14.4 mptt -82.16 -10.51 59.14 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.169 0.509 . . . . 0.0 109.995 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -81.12 -8.96 59.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -90.99 11.84 21.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.529 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 76' ' ' LYS . 14.7 m -88.63 146.36 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.121 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 pt -121.8 -6.98 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 111.393 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.16 -170.76 36.41 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -146.26 148.75 32.78 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.569 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -122.81 121.74 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.5 m -123.49 129.31 51.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.429 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 50.5 mt -129.73 125.54 22.28 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.322 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.5 Cg_endo -82.75 -39.23 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.325 2.016 . . . . 0.0 112.454 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 t -49.92 -39.31 39.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.414 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -116.95 -2.18 9.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.464 0.173 . . . . 0.0 110.777 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.3 m 63.18 50.88 2.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.484 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -108.31 130.6 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.137 -178.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -137.1 114.68 11.12 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.628 HD22 ' HA2' ' A' ' 106' ' ' GLY . 16.6 mt -145.92 111.17 4.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.4 Cg_endo -41.24 142.9 0.86 Allowed 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 121.643 1.562 . . . . 0.0 110.328 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.41 122.95 44.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.84 132.71 47.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.157 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -66.78 -27.96 68.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.416 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 93.2 p -69.34 -179.52 1.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.543 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -159.15 49.92 0.35 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.085 0.469 . . . . 0.0 110.272 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.493 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 67.5 p -108.03 155.1 20.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.73 -31.31 64.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -72.01 -48.11 47.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.466 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.493 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 72.2 m-20 -66.86 -38.56 86.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.183 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 134' ' ' LEU . 12.7 mt -56.35 -16.14 5.14 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.6 mt -70.24 -31.7 69.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.0 m -90.63 -12.22 37.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.628 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 170.87 -175.06 44.72 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.911 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.14 130.66 41.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 97' ' ' SER . . . -104.64 143.25 33.33 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.838 0.352 . . . . 0.0 110.158 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.8 p -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.445 HG21 HD11 ' A' ' 185' ' ' ILE . 84.1 t -81.31 -50.22 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -94.5 147.64 23.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.997 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -87.45 -6.3 58.47 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.239 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -126.78 31.84 5.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.107 0.48 . . . . 0.0 111.329 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -97.59 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.568 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.23 149.84 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.987 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 2.5 mtp -83.9 125.1 31.67 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.697 0.284 . . . . 0.0 110.395 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.13 5.55 72.92 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.87 121.44 13.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.104 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.55 55.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -83.83 110.17 18.14 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -87.48 104.26 16.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.486 ' O ' HD22 ' A' ' 123' ' ' LEU . . . -92.88 121.0 33.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.681 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 122' ' ' ALA . 2.4 mm? -117.31 131.66 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.022 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.07 141.04 43.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.466 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.2 -177.76 15.81 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.536 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.473 ' O ' ' O ' ' A' ' 134' ' ' LEU . 62.1 m-70 -92.99 130.25 38.63 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.083 0.468 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -91.99 28.47 1.84 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -35.84 -26.2 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.368 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 64.95 34.84 8.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.403 0.62 . . . . 0.0 109.596 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.43 106.91 6.48 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.39 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -49.11 128.62 16.68 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.064 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.46 -23.03 14.2 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.809 HG12 ' H ' ' A' ' 134' ' ' LEU . 49.0 t -89.69 178.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.252 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.809 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.13 135.5 49.22 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.36 -177.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 44.88 39.41 3.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.193 0.521 . . . . 0.0 110.63 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 60.6 p -81.36 -8.56 59.76 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 136' ' ' SER . 77.8 m-20 -147.6 37.99 0.92 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.8 -29.85 42.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.824 0.345 . . . . 0.0 111.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.02 6.41 4.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.815 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -97.67 -13.75 21.32 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.02 123.31 19.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.896 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 23.2 tptt -96.34 169.46 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.161 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 142' ' ' LYS . 48.9 tttm -68.0 125.8 27.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.222 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 97.06 18.73 28.34 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.0 m-20 -84.32 131.76 34.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -79.52 129.99 34.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.894 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.9 mt -125.23 126.12 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.529 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 58.0 m-85 -103.06 118.94 37.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.563 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.702 HD13 ' N ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -115.53 133.67 55.8 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.702 ' N ' HD13 ' A' ' 149' ' ' LEU . 20.6 m-85 -103.08 132.48 49.31 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.016 0.436 . . . . 0.0 111.084 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 50.0 t0 -110.0 -167.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.679 -1.146 . . . . 0.0 107.952 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.519 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -29.66 -72.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.186 0.517 . . . . 0.0 111.978 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -136.78 29.05 2.9 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -131.7 150.26 52.21 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -108.75 123.74 49.48 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.378 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.412 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 40.1 m-85 -104.99 129.91 53.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.391 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.529 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 73.9 mm-40 -96.65 114.92 26.61 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.15 142.93 45.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.76 132.11 54.08 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.395 0.617 . . . . 0.0 111.238 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 144' ' ' GLY . 53.7 t -66.63 134.37 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.981 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.5 OUTLIER -106.84 -29.18 9.66 Favored 'General case' 0 C--O 1.226 -0.158 0 O-C-N 124.36 1.037 . . . . 0.0 110.437 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 174.73 157.81 17.15 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.638 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 150.74 33.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.824 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 41.9 m -156.48 168.2 28.1 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.259 0.552 . . . . 0.0 111.366 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -106.06 132.0 52.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.439 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.02 159.07 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.751 0.31 . . . . 0.0 110.931 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.545 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 71.2 p -77.79 142.44 65.46 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -47.32 -18.81 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.089 1.859 . . . . 0.0 111.604 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -81.24 -2.87 50.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.974 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.6 tptt -82.03 140.59 33.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 94.4 m95 -157.78 -22.1 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.849 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -56.74 -17.67 9.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.397 0.617 . . . . 0.0 110.429 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.7 m -84.09 -6.81 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.321 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 185' ' ' ILE . 2.9 m -136.23 43.17 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 70.5 mm-40 -144.6 84.53 1.74 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.027 -176.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 175' ' ' GLU . 92.3 m-20 27.18 108.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 O-C-N 124.231 0.957 . . . . 0.0 112.805 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -96.84 -40.34 8.98 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.313 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.2 29.59 0.72 Allowed Glycine 0 N--CA 1.473 1.102 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.48 178.45 10.22 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.552 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -92.83 88.84 6.36 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.976 0.893 . . . . 0.0 109.511 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -131.63 167.29 19.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.91 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 15.7 tt -131.67 143.42 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.585 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.5 m -136.22 129.71 32.01 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.301 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -112.4 127.58 56.06 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.24 0.543 . . . . 0.0 110.867 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.607 HD13 HG11 ' A' ' 174' ' ' VAL . 3.4 pt -141.17 -167.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.876 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.0 t -139.92 153.92 47.08 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.725 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.567 ' C ' ' H ' ' A' ' 189' ' ' SER . 72.8 m -78.52 -97.77 0.03 OUTLIER 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.213 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.8 t 56.39 -1.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.236 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.567 ' H ' ' C ' ' A' ' 187' ' ' CYS . 24.0 m 45.29 -114.43 0.44 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.414 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.55 128.33 69.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -92.54 -131.2 0.12 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.796 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -93.39 -3.26 53.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.886 0.374 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 194' ' ' SER . 16.7 t-20 -163.03 -125.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.768 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.499 ' N ' ' OD1' ' A' ' 193' ' ' ASN . 19.2 p -139.14 119.92 14.26 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -165.66 101.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.322 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 167' ' ' THR . 8.3 ttm180 -150.42 144.52 25.48 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.908 0.385 . . . . 0.0 111.616 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.0 139.66 48.47 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.948 0.404 . . . . 0.0 110.091 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.6 p -134.45 136.9 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 111.229 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -122.77 134.2 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.049 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.93 138.1 51.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.542 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.6 139.98 11.39 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.8 t0 -99.05 137.05 38.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.253 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.0 tp -63.75 126.2 26.81 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.287 0.565 . . . . 0.0 110.881 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.24 -25.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.825 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.7 159.91 16.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.935 -1.126 . . . . 0.0 112.008 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.412 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 59.5 m -135.71 157.18 47.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 206' ' ' THR . 20.2 ptmt -148.64 178.9 8.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.237 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.8 144.88 24.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.289 0.566 . . . . 0.0 110.995 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -74.85 80.69 2.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.472 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.633 178.107 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 t -60.04 -45.17 93.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.005 0.431 . . . . 0.0 110.668 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -84.29 133.03 34.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.304 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.5 ttt -73.25 -121.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 65.9 t0 -76.98 148.23 36.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.534 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -68.51 -40.07 80.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.474 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 t 57.06 3.12 0.13 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.523 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 58' ' ' ALA . 88.3 tttt -99.08 93.77 6.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.552 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -142.54 -80.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.065 -178.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 54.43 -80.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.922 0.391 . . . . 0.0 111.051 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' A' ' 61' ' ' ILE . 5.1 pt20 -139.95 70.45 35.74 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.093 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -43.55 147.48 1.02 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.617 2.211 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.13 151.34 43.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.975 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.5 mp -55.48 -26.76 44.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 110.68 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.51 93.99 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.4 mt-10 -73.39 -32.1 64.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.674 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.58 -46.32 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.972 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.76 91.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.157 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.95 -30.12 55.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.395 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.95 158.34 11.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.869 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 p -138.56 158.84 43.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.808 0.337 . . . . 0.0 110.62 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.647 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -139.21 121.48 15.93 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 111.172 -178.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.647 ' N ' HD13 ' A' ' 74' ' ' LEU . 99.2 m-20 -81.89 110.73 17.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.796 178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -47.13 -16.13 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.226 0.536 . . . . 0.0 110.318 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 75' ' ' ASP . 87.4 tttt -67.44 -33.52 75.32 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.977 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -78.41 9.45 3.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.584 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.5 t -92.91 129.11 43.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.753 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 pt -118.29 -3.43 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.81 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.48 -161.95 34.41 Favored Glycine 0 C--N 1.317 -0.521 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -157.06 164.94 37.38 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.714 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.9 tt -131.07 140.23 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.712 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 m -132.87 133.17 42.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.36 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' CG2' ' OG ' ' A' ' 87' ' ' SER . 67.9 mt -133.17 129.26 20.82 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.546 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.88 -36.18 0.19 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.429 2.086 . . . . 0.0 112.147 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.418 ' OG ' ' CG2' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -47.15 -38.98 12.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.409 -177.188 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.3 p -120.55 0.23 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.828 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 60.71 54.29 3.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.4 tp -117.74 134.83 54.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.346 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -135.96 117.38 14.71 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 83' ' ' ILE . 58.9 mt -143.65 114.02 5.55 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.9 Cg_endo -42.38 146.67 0.67 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 121.892 1.728 . . . . 0.0 109.99 176.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -95.3 123.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.87 123.18 47.78 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.87 -46.79 77.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.974 0.416 . . . . 0.0 111.079 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.544 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 34.9 p -69.79 102.87 2.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.36 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 98' ' ' SER . 5.6 p -82.77 103.85 12.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.421 0.629 . . . . 0.0 110.329 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.534 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 3.0 p -142.94 157.12 44.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.944 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER -54.71 -32.44 59.58 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.722 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -79.13 -45.08 20.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.687 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.544 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.8 m-20 -65.19 -34.72 79.05 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.242 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 134' ' ' LEU . 17.0 mt -61.68 -21.36 64.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.375 0.607 . . . . 0.0 111.808 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.89 -32.93 73.76 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.477 ' OG ' HD23 ' A' ' 74' ' ' LEU . 3.8 p -87.83 -13.58 41.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.57 -171.69 44.18 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.492 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.01 127.55 32.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.482 . . . . 0.0 110.057 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.73 146.46 29.77 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.844 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 109' ' ' THR . 5.5 p -74.42 151.55 39.62 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 t -82.92 -42.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.464 ' N ' HE22 ' A' ' 114' ' ' GLN . 99.2 mttt -88.29 -171.99 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.027 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 21.6 pt-20 -116.7 -9.81 11.23 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 112' ' ' GLU . 17.7 m120 -145.87 43.41 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 111.384 -177.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.464 HE22 ' N ' ' A' ' 111' ' ' LYS . 1.7 pm0 -84.91 165.02 18.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.888 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -135.54 131.36 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.681 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.3 mtt -71.49 128.37 35.62 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.075 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 91.17 1.97 71.71 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -141.32 123.7 15.77 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.082 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.66 -164.47 54.81 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.43 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 22.1 t-20 -92.28 108.91 20.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -85.37 103.24 14.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.038 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 128.59 36.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.384 0.611 . . . . 0.0 112.15 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -123.56 130.47 52.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.127 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.71 140.94 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.374 0.607 . . . . 0.0 111.055 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.49 -178.34 17.59 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 134' ' ' LEU . 56.8 m-70 -93.42 140.92 29.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 110.78 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.3 p30 -106.44 29.44 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 110.549 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.0 mmm -42.22 -15.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.837 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 61.56 38.0 15.9 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.076 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -133.62 107.65 8.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 108.984 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -52.92 126.74 21.33 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.8 -24.61 11.77 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 134' ' ' LEU . 42.4 t -86.66 -179.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.816 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.79 133.03 46.19 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.194 -178.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 47.26 40.82 11.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 111.149 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.8 p -81.6 -11.88 58.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.903 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 73.7 m-20 -149.82 42.8 0.88 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.7 pt -68.57 -35.56 70.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.015 0.436 . . . . 0.0 112.013 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.7 1.58 2.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.2 m -92.66 -13.71 29.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.161 0.505 . . . . 0.0 110.18 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.4 122.78 18.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.213 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.69 157.91 15.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.792 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -60.48 127.87 33.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.258 0.551 . . . . 0.0 111.147 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.23 16.51 40.43 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -84.72 133.84 34.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -81.52 134.56 35.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 111.852 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -127.82 121.04 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -101.76 120.24 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.8 tp -117.72 147.93 42.49 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -122.03 131.86 54.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.153 0.501 . . . . 0.0 111.584 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.527 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.9 t0 -112.08 -164.88 0.94 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 151' ' ' ASP . 28.4 m120 -21.95 -78.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.205 0.526 . . . . 0.0 111.406 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -136.31 26.07 3.2 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -123.48 142.22 51.22 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -108.15 120.52 42.58 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 206' ' ' THR . 75.0 m-85 -104.14 130.32 51.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.152 0.501 . . . . 0.0 111.582 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -93.66 115.27 27.72 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 51.5 m-85 -116.78 138.61 51.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.631 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -118.59 136.79 53.67 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.247 0.546 . . . . 0.0 110.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.78 134.8 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.297 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.5 OUTLIER -107.83 -24.12 11.79 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.357 1.036 . . . . 0.0 111.278 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 166.17 165.9 24.31 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.115 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.1 p -125.29 151.64 31.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.3 p -152.28 161.54 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 111.04 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -114.15 117.44 31.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.87 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.85 159.25 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.989 0.424 . . . . 0.0 111.28 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 169' ' ' ASP . 33.9 p -69.48 134.27 88.78 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.459 ' HB3' HH21 ' A' ' 196' ' ' ARG . 1.2 Cg_endo -46.25 -12.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.081 1.854 . . . . 0.0 111.749 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 167' ' ' THR . 96.0 m-20 -81.11 -8.73 59.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -85.97 70.1 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.133 0.492 . . . . 0.0 110.259 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.467 ' C ' ' N ' ' A' ' 173' ' ' VAL . 80.8 m95 -70.48 -30.47 67.28 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.441 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -48.81 -14.81 0.07 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.543 . . . . 0.0 110.464 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.467 ' N ' ' C ' ' A' ' 171' ' ' TRP . 86.1 t -75.08 -24.32 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.809 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.91 -6.64 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.703 0.763 . . . . 0.0 109.561 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -80.46 152.8 28.58 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.861 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p-10 -64.64 128.32 35.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.288 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.441 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.8 m80 -108.69 -42.69 4.45 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.62 0.248 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.47 23.99 0.09 OUTLIER Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -152.92 171.73 17.88 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -94.75 87.91 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.224 0.535 . . . . 0.0 110.02 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -126.88 126.61 43.6 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.365 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.5 tt -81.04 148.23 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 184' ' ' LEU . 7.2 m -136.68 121.19 18.26 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.375 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.516 HD12 ' C ' ' A' ' 183' ' ' THR . 10.4 mp -105.35 126.64 52.34 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.28 0.562 . . . . 0.0 111.149 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 29.7 pt -135.2 169.92 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.491 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.569 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 35.5 p -116.44 141.83 47.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.362 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.473 ' HB2' HH22 ' A' ' 196' ' ' ARG . 3.2 m 56.7 162.22 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.766 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.9 m -114.91 2.47 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.822 0.344 . . . . 0.0 111.488 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 55.4 m -145.07 172.98 12.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.1 m -71.12 135.26 28.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.417 ' NZ ' ' ND2' ' A' ' 127' ' ' ASN . 60.4 pttt -112.55 -165.35 0.98 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.8 0.333 . . . . 0.0 110.825 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 192' ' ' ASP . 29.5 p-10 -60.32 -42.35 95.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.897 0.379 . . . . 0.0 110.739 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 192' ' ' ASP . 98.5 m-20 -103.17 132.55 49.35 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.424 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 84.8 p -79.55 -15.11 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 111.303 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -70.69 128.83 37.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.103 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.569 ' NH1' ' O ' ' A' ' 186' ' ' THR . 59.9 ttm-85 -145.64 145.06 30.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.886 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -104.48 133.29 49.6 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 81.8 t -135.16 136.82 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.65 131.65 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.615 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.526 ' O ' HG22 ' A' ' 161' ' ' THR . . . -115.22 136.69 52.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.48 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.45 11.73 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 47.9 p-10 -96.4 141.3 29.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.915 -0.643 . . . . 0.0 111.247 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.12 125.42 25.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.098 0.475 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 72.4 t -107.59 -23.21 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.535 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.83 177.9 45.22 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.883 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 156' ' ' TYR . 15.9 m -154.1 152.63 30.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.159 0.504 . . . . 0.0 111.018 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -151.14 178.8 8.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.371 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.67 145.6 24.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.948 0.404 . . . . 0.0 110.534 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.19 79.04 0.96 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.778 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.32 -0.705 0 CA-C-O 117.854 -1.069 . . . . 0.0 110.724 178.59 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 t -65.06 137.69 57.85 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -142.16 106.51 4.8 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.923 0.392 . . . . 0.0 111.093 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.3 mmm -85.99 144.47 27.59 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.716 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.63 136.03 56.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.044 0.45 . . . . 0.0 110.194 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.12 -39.87 71.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.575 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 61' ' ' ILE . 58.2 m -88.75 31.93 0.82 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.369 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -72.59 10.57 0.8 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.317 0.579 . . . . 0.0 111.326 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 59' ' ' SER . 57.4 mt -65.37 -45.15 94.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.206 0.527 . . . . 0.0 110.676 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 188' ' ' VAL . 99.8 m-20 55.6 -98.62 0.09 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.942 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -151.16 78.25 7.25 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -42.96 147.44 0.66 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.095 1.863 . . . . 0.0 111.594 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.59 154.79 41.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.1 mm? -57.1 -27.16 61.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.707 0.289 . . . . 0.0 110.601 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.42 -38.85 91.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.924 0.392 . . . . 0.0 110.041 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.2 mt-10 -74.29 -36.11 63.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.797 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.8 t -74.34 -43.9 49.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.627 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.74 -38.13 86.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.27 -22.75 30.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.217 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.29 138.35 58.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.397 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -139.97 149.56 43.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.795 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.764 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.3 pt? -139.92 166.76 23.77 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.432 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -75.31 140.86 43.37 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.763 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 79' ' ' VAL . 70.2 mmtt -79.57 -2.08 40.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.196 0.522 . . . . 0.0 110.155 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -89.47 -7.25 55.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.778 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -85.84 0.33 53.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.178 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 76' ' ' LYS . 7.8 p -88.26 135.12 26.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.874 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.73 0.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.686 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.45 -177.95 39.83 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -147.53 151.54 36.5 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.194 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 83' ' ' ILE . 14.7 tt -126.21 123.46 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 m -123.18 128.03 49.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.608 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.72 116.69 13.82 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.71 -33.17 1.31 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.286 1.991 . . . . 0.0 112.376 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.449 ' CB ' HD23 ' A' ' 141' ' ' LEU . 3.0 m -50.73 -37.22 40.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.36 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -117.23 -6.79 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 122.252 -0.28 . . . . 0.0 110.512 -179.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.8 p 71.76 47.82 0.32 Allowed 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mt -109.64 127.51 54.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.479 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -132.82 113.9 13.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -145.0 165.43 22.21 Favored Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.001 -0.679 . . . . 0.0 112.554 -177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -89.01 156.38 5.82 Favored 'Trans proline' 0 C--N 1.32 -0.962 0 C-N-CA 123.252 2.635 . . . . 0.0 109.264 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.9 t -107.58 114.38 46.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mt -102.9 120.9 41.44 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -65.81 -45.19 83.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.985 0.421 . . . . 0.0 110.776 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 4.2 m -67.05 103.93 1.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.936 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -82.03 109.0 15.96 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.277 0.56 . . . . 0.0 110.318 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.512 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -143.35 155.77 44.52 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.24 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -61.19 -28.03 68.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -80.22 -46.64 15.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.898 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.4 p-10 -68.78 -31.16 69.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.585 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -61.89 -20.39 63.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -73.84 -14.41 61.08 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.613 ' OG ' HD22 ' A' ' 74' ' ' LEU . 19.9 m -103.22 -10.22 18.94 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.82 -153.04 18.91 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.247 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.81 127.86 44.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.115 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -108.34 148.85 29.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.8 p -73.53 149.61 42.11 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.574 HG21 HD11 ' A' ' 185' ' ' ILE . 4.3 t -84.8 -42.22 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 9.5 tptp -90.28 -172.65 3.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.788 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 46.6 tp10 -107.04 -57.9 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.343 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.93 45.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.296 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.45 154.17 22.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.085 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.19 135.19 63.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 mtp -78.05 122.55 25.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.61 2.43 60.0 Favored Glycine 0 N--CA 1.461 0.314 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -140.59 128.28 21.63 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.076 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.68 -169.65 49.96 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -84.5 107.17 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -85.39 103.21 14.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.62 126.27 35.9 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.485 0.66 . . . . 0.0 112.208 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.441 HD13 HD12 ' A' ' 83' ' ' ILE . 11.6 mt -120.49 131.22 54.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.512 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.69 138.49 45.98 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.582 0.706 . . . . 0.0 110.921 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -138.69 -178.39 16.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.556 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 80.7 m-70 -90.79 139.69 30.49 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' SER . 64.2 t30 -102.52 28.53 5.93 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 109.91 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.49 -24.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.184 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 64.44 36.71 8.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.416 0.627 . . . . 0.0 109.61 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.458 ' N ' ' OG ' ' A' ' 136' ' ' SER . 26.1 mtpp -134.34 111.67 10.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.917 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -52.41 126.12 18.3 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.625 0.726 . . . . 0.0 110.226 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.65 -27.6 9.7 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.564 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.76 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.6 t -79.09 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 117.749 0.775 . . . . 0.0 109.484 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.76 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.57 134.37 46.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.24 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 45.17 33.78 1.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.159 0.504 . . . . 0.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.458 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.2 -8.51 59.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -146.68 39.74 1.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.29 -30.02 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.863 0.363 . . . . 0.0 111.574 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.06 3.36 5.55 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.135 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -95.81 -13.9 23.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.449 HD23 ' CB ' ' A' ' 87' ' ' SER . 15.2 mt -66.21 126.4 28.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.704 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -97.2 158.84 15.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.415 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -61.16 138.64 58.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.434 0.635 . . . . 0.0 111.317 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.88 19.61 65.09 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -81.11 136.83 35.96 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.2 122.64 25.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.457 0.646 . . . . 0.0 111.635 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mm -115.39 119.52 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.73 118.23 36.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 tp -119.94 154.96 33.69 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.02 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -127.32 135.68 50.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.505 0.669 . . . . 0.0 112.118 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.498 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.0 t0 -115.52 -167.04 1.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.29 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.224 0.535 . . . . 0.0 111.798 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -138.09 28.66 2.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -127.8 140.58 51.96 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.522 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 78.7 tt0 -103.35 122.17 44.27 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.572 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.445 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 55.0 m-85 -104.25 127.05 51.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.394 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 157' ' ' GLU . 39.7 mp0 -94.64 115.45 27.57 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.08 144.4 44.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.071 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -119.14 134.08 55.41 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.342 0.591 . . . . 0.0 110.718 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.04 133.42 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.736 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.4 p -103.79 -26.81 12.57 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 124.524 1.14 . . . . 0.0 110.794 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.36 165.6 19.65 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.008 -1.091 . . . . 0.0 111.995 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.7 p -121.79 149.21 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.539 -0.83 . . . . 0.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 198' ' ' VAL . 19.5 m -153.22 164.28 38.36 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.088 0.47 . . . . 0.0 111.196 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -107.82 102.83 12.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.626 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.437 HG22 HG11 ' A' ' 198' ' ' VAL . 11.3 m -117.05 144.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.102 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.8 p -61.32 167.02 4.42 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.54 -14.48 11.56 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.958 1.772 . . . . 0.0 111.982 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 65.9 t0 -84.54 -20.28 31.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -85.82 81.27 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.229 0.538 . . . . 0.0 110.214 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.547 ' C ' ' H ' ' A' ' 173' ' ' VAL . 95.4 m95 -75.77 -15.16 60.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.898 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.624 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 40.7 mp0 -51.99 -6.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.146 0.498 . . . . 0.0 110.968 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 171' ' ' TRP . 73.2 t -88.65 -19.06 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.163 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.68 -6.29 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.488 0.661 . . . . 0.0 109.383 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -82.07 150.9 27.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.18 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -60.72 127.29 30.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 25.9 m170 -116.44 24.3 11.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.77 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.55 15.62 68.05 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -149.64 167.89 25.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 111.183 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.65 97.84 8.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.717 0.77 . . . . 0.0 110.734 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.73 135.09 45.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.36 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.4 tt -82.62 147.96 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 173' ' ' VAL . 7.3 m -136.5 117.54 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.931 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 184' ' ' LEU . 10.4 mp -101.73 124.19 46.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.071 0.462 . . . . 0.0 110.174 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 110' ' ' VAL . 13.8 pt -137.38 -176.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.06 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.551 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 43.0 p -137.27 147.7 45.9 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 187' ' ' CYS . 54.1 t -98.45 34.62 1.96 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.113 0.482 . . . . 0.0 110.718 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 62' ' ' ASP . 52.2 t -95.42 127.54 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.6 t -66.44 144.73 56.33 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.997 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 190' ' ' VAL . 11.7 p -123.15 132.92 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.808 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -147.28 -62.57 0.28 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.803 0.335 . . . . 0.0 111.614 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -92.32 108.39 19.92 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.791 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.471 ' CG ' ' H ' ' A' ' 194' ' ' SER . 64.3 t30 46.44 -164.67 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.471 ' H ' ' CG ' ' A' ' 193' ' ' ASN . 2.1 p 62.2 140.71 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.435 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -136.57 143.85 43.86 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 111.362 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.1 ttm180 -69.07 135.8 51.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.009 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -108.66 139.12 43.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.395 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 164' ' ' SER . 3.4 p -135.35 139.04 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.394 0.616 . . . . 0.0 111.467 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.53 130.63 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.79 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.81 135.65 53.95 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.263 0.554 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.52 153.71 20.56 Favored Glycine 0 N--CA 1.46 0.292 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 50.5 p-10 -108.18 142.27 38.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.91 -0.645 . . . . 0.0 111.728 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.08 127.87 34.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.413 0.625 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 159' ' ' ALA . 91.7 t -107.84 -26.44 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.186 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.16 162.17 20.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 119.816 -1.183 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 25.5 m -136.88 156.17 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.245 0.545 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.522 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.1 pttp -150.9 179.13 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.08 142.87 26.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.401 0.62 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -61.97 81.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.561 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 62.2 mttp . . . . . 0 C--N 1.313 -0.983 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.57 178.427 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.3 m -59.35 -43.05 92.86 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.511 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 43.86 82.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.438 . . . . 0.0 110.748 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 92.8 mtp -65.11 -40.1 94.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.592 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -86.72 114.01 23.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.5 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.95 -14.15 61.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.568 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.544 ' C ' ' H ' ' A' ' 61' ' ' ILE . 83.5 p -88.14 0.1 56.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.809 0.338 . . . . 0.0 111.21 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -66.45 14.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.463 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.544 ' H ' ' C ' ' A' ' 59' ' ' SER . 29.6 mm -63.82 -45.47 97.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.101 0.476 . . . . 0.0 110.169 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 54.41 -94.39 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.188 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.87 78.99 7.2 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.595 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -43.51 147.96 0.89 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.017 1.811 . . . . 0.0 111.971 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -73.42 158.36 35.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.227 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -54.71 -25.85 30.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.893 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.32 91.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.547 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.5 mt-10 -75.08 -26.08 59.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.235 0.541 . . . . 0.0 110.474 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.8 t -79.4 -49.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.942 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.95 81.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.173 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -68.78 -32.1 71.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.334 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.24 113.3 2.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.938 0.399 . . . . 0.0 111.219 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -92.21 133.59 35.67 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.97 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.2 tp -129.57 134.85 47.96 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.757 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -94.02 132.26 38.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.904 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.568 ' O ' HG12 ' A' ' 79' ' ' VAL . 69.5 mmtt -66.34 -9.5 33.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.474 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 79' ' ' VAL . 63.7 mttp -65.44 -34.37 78.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.835 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.23 17.71 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.8 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.568 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.8 p -92.31 127.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.7 pt -122.45 -2.86 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.459 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.67 -171.03 38.49 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.479 ' O ' HD23 ' A' ' 149' ' ' LEU . 32.4 mtm180 -147.88 153.28 38.91 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.854 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 83' ' ' ILE . 16.1 tt -124.69 122.27 63.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.6 m -121.35 127.96 51.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.584 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.4 mt -133.75 120.42 15.47 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.81 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.84 -32.33 1.55 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.829 1.686 . . . . 0.0 112.331 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.1 p -47.87 -37.39 13.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.975 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.7 p -118.32 0.12 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.476 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t 63.49 52.79 2.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -119.54 133.07 55.84 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -135.31 119.74 17.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 mt -145.46 167.32 14.68 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.023 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.94 150.09 7.09 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 122.886 2.391 . . . . 0.0 109.652 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.6 t -102.18 113.91 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.45 -45.05 85.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.972 0.415 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 97.5 p -71.33 106.91 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.232 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.7 p -83.79 107.14 16.02 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.094 0.473 . . . . 0.0 110.234 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.481 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 3.8 p -137.43 156.59 48.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.113 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -57.86 -36.45 72.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.391 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -74.72 -43.65 53.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.387 0.613 . . . . 0.0 112.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.481 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 92.3 m-20 -66.43 -35.45 80.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.441 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 126' ' ' HIS . 36.4 mt -65.56 -15.93 63.19 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.65 -14.18 60.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.8 m -116.53 -7.41 11.63 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.0 -163.83 28.74 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.117 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -101.49 130.33 47.74 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.083 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.25 147.91 34.02 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.3 p -76.47 153.79 35.26 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.06 -46.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -92.18 142.16 27.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.123 0.487 . . . . 0.0 111.179 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.4 pt-20 -62.58 -51.41 67.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.662 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.452 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 8.4 m120 -96.75 47.88 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.379 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -83.59 154.22 23.9 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.79 130.25 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.595 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.43 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.1 mtt -72.61 128.39 35.42 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.762 0.315 . . . . 0.0 110.948 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.522 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.19 4.91 73.7 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -140.93 120.65 13.4 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.257 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.64 -166.9 54.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -85.07 106.29 16.44 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.57 101.18 11.91 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.93 130.82 36.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.991 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.92 132.21 53.7 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.09 137.72 46.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.351 0.596 . . . . 0.0 110.596 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.404 ' HA3' ' CD2' ' A' ' 135' ' ' PHE . . . -145.19 -176.5 19.22 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.517 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 103' ' ' LEU . 76.3 m-70 -93.28 157.51 16.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.093 0.473 . . . . 0.0 111.826 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.0 p-10 -122.05 29.04 7.23 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.585 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.2 mmt -38.15 -20.39 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.636 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 59.93 37.44 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.275 0.56 . . . . 0.0 109.836 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 136' ' ' SER . 58.3 tttp -136.49 107.73 6.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.767 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.469 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -58.4 130.24 45.81 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.59 0.71 . . . . 0.0 111.249 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.02 15.61 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.176 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 134' ' ' LEU . 2.0 t -96.97 177.84 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.616 ' H ' HG12 ' A' ' 133' ' ' VAL . 1.3 pt? -71.62 136.38 47.34 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.754 0.788 . . . . 0.0 112.355 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.4 m-85 46.45 31.92 1.44 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.429 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 2.0 p -81.75 -6.03 58.68 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.7 m-20 -146.97 43.1 1.14 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.091 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.9 pt -69.97 -30.69 45.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.261 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.06 7.28 2.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 t -95.56 -14.71 23.36 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.14 123.72 18.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.81 154.21 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.62 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.93 130.61 47.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 88.64 21.99 41.55 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 37.7 m-20 -87.0 134.77 33.45 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -81.5 129.64 34.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.529 0.68 . . . . 0.0 112.147 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 90.1 mt -123.39 123.92 68.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.817 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -105.05 121.84 44.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 110.344 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 82' ' ' ARG . 2.3 mt -113.0 153.17 28.49 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.167 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -127.2 131.23 50.71 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.344 0.592 . . . . 0.0 111.756 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 42.0 t0 -115.04 -168.06 1.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.7 m120 -20.87 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.082 0.468 . . . . 0.0 112.137 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -140.17 25.32 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -122.83 142.3 50.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -106.33 122.08 45.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.87 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.47 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.3 m-85 -104.01 126.62 51.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.987 0.422 . . . . 0.0 111.667 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -94.66 117.12 29.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.522 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 19.6 m-85 -116.55 147.11 42.13 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.381 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.57 134.83 53.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 110.489 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 55.7 t -70.15 133.61 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.706 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.7 p -101.1 -25.4 14.05 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 124.51 1.131 . . . . 0.0 110.349 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.08 156.3 7.99 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.356 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 p -106.34 147.82 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.639 -0.781 . . . . 0.0 109.871 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.2 p -148.64 159.59 43.96 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.173 0.511 . . . . 0.0 111.334 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.81 119.6 39.77 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.437 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.09 159.84 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.445 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 20.1 p -76.72 142.92 70.68 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.42 -18.55 3.76 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.89 1.727 . . . . 0.0 111.836 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -83.44 -6.67 59.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.937 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -83.36 70.63 10.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.263 0.554 . . . . 0.0 110.331 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.498 ' C ' ' H ' ' A' ' 173' ' ' VAL . 85.0 m95 -71.46 -28.53 64.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.696 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.57 -11.36 0.05 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.058 0.456 . . . . 0.0 110.475 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 171' ' ' TRP . 43.9 t -80.48 -22.68 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.72 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -110.08 -6.86 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.756 0.788 . . . . 0.0 109.282 -178.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.01 137.08 37.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.981 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 39.9 p-10 -51.97 127.28 20.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.962 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -104.86 -43.39 5.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.964 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.46 26.33 0.1 Allowed Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -152.85 173.37 15.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.244 0.545 . . . . 0.0 111.157 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 11.5 m-20 -94.23 89.39 5.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.049 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -128.89 127.28 41.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.678 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.0 tt -82.42 146.81 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.453 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.1 m -135.91 119.31 16.83 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.547 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -105.75 124.73 50.03 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.012 0.434 . . . . 0.0 109.912 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.538 HD13 HG11 ' A' ' 174' ' ' VAL . 8.9 pt -135.88 173.2 14.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.79 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.2 p -133.12 154.13 50.88 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 2.5 p -85.59 130.43 34.57 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.992 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.526 ' CG2' HD21 ' A' ' 193' ' ' ASN . 14.3 p -145.02 151.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.061 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.2 t -62.58 143.9 56.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.806 0.336 . . . . 0.0 110.6 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.16 -23.65 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.594 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -46.13 162.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.677 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -80.68 112.2 17.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.889 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.526 HD21 ' CG2' ' A' ' 188' ' ' VAL . 52.2 p30 -151.24 -149.34 0.3 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 36.8 t -63.46 146.34 53.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.564 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.52 140.43 51.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.485 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -71.34 141.33 50.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.466 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -102.92 131.25 49.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.6 p -133.79 137.47 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.02 130.35 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.44 136.92 52.48 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.593 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.73 147.99 19.36 Favored Glycine 0 N--CA 1.466 0.671 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -100.84 140.87 34.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.02 -0.59 . . . . 0.0 112.163 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 49.5 tp -64.46 129.44 39.89 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.212 0.529 . . . . 0.0 110.291 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 159' ' ' ALA . 64.5 t -107.72 -27.07 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.125 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.56 162.35 20.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.202 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.47 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 34.6 m -135.04 156.06 49.68 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.201 0.524 . . . . 0.0 109.814 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.415 ' N ' HG22 ' A' ' 206' ' ' THR . 20.6 ptmt -149.53 180.0 7.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.261 -0.882 . . . . 0.0 108.903 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.66 145.48 24.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.225 0.536 . . . . 0.0 110.787 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -74.51 81.17 1.95 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.647 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.642 178.845 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.476 ' OG ' ' N ' ' A' ' 55' ' ' HIS . 59.9 p 47.3 -124.28 1.55 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.437 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.476 ' N ' ' OG ' ' A' ' 54' ' ' SER . 76.6 t60 -100.29 45.08 0.99 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.394 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 7.3 ttt -61.27 -43.24 99.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.88 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -94.13 108.02 19.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.411 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.67 -9.17 58.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.039 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 m -84.55 -95.82 0.07 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.224 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt 45.61 27.92 0.47 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.093 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.4 mt -64.22 -48.21 86.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.384 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.3 t0 60.73 -101.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.75 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -150.05 77.45 8.38 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -42.64 147.9 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.353 2.035 . . . . 0.0 111.548 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.5 m-20 -75.51 158.67 32.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.23 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.05 -18.99 60.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.198 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.05 -52.46 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.76 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 5.2 pt-20 -74.08 -17.84 60.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.932 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 65' ' ' ASP . 49.3 t -77.69 -54.73 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.903 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -39.38 84.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.272 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.55 110.77 1.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.793 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.6 m -94.35 120.48 34.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.1 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.514 HD11 ' OE1' ' A' ' 78' ' ' GLN . 41.7 tp -113.84 129.08 56.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.61 139.82 55.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.294 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -73.31 -8.72 57.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.24 0.543 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.48 -32.77 74.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.514 ' OE1' HD11 ' A' ' 74' ' ' LEU . 85.7 mt-30 -77.17 11.48 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.1 t -91.34 123.72 43.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -122.42 -5.21 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.984 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.25 -169.61 38.62 Favored Glycine 0 C--N 1.316 -0.54 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -146.48 154.01 41.08 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.251 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.9 tt -121.89 124.54 71.6 Favored 'Isoleucine or valine' 0 C--O 1.23 0.056 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -127.53 130.86 49.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mt -133.63 129.13 20.31 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.569 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -35.89 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.392 2.061 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -49.41 -40.19 35.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.529 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -119.57 -0.94 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.241 0.216 . . . . 0.0 110.819 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.33 52.14 3.96 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.2 tp -110.61 130.7 55.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.045 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -133.21 114.83 14.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 83' ' ' ILE . 50.4 mt -143.92 110.51 5.17 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.73 136.7 1.88 Allowed 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.6 1.533 . . . . 0.0 110.764 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.9 t -85.71 123.07 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.9 mt -103.4 131.0 50.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.34 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 97' ' ' SER . 20.1 pttp -72.44 -42.84 64.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.464 ' N ' ' CG ' ' A' ' 96' ' ' LYS . 55.5 m -74.68 103.13 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.245 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.5 p -82.36 94.41 7.37 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.281 0.562 . . . . 0.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.51 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.4 p -134.31 154.38 51.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.903 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -56.46 -37.35 70.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -71.86 -46.28 58.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.501 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.51 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 75.2 m-20 -66.2 -36.3 82.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.561 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.69 -16.18 24.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.721 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.0 mt -70.13 -27.61 64.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -93.36 -10.27 35.86 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 167.51 -174.43 42.61 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.983 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.46 130.17 38.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.294 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 147.46 29.09 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.865 0.364 . . . . 0.0 110.876 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.0 p -73.14 149.45 43.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.88 -43.24 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.74 141.36 28.88 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.18 0.514 . . . . 0.0 111.183 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.21 -16.09 41.37 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.56 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -144.27 56.51 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.31 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.45 ' NE2' ' CG ' ' A' ' 121' ' ' TYR . 3.0 tt0 -77.9 159.84 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.0 121.81 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.016 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -72.77 128.02 34.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.443 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.86 73.45 Favored Glycine 0 C--O 1.23 -0.103 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -142.13 121.53 13.19 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 76.17 -174.71 53.13 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.491 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 62.9 t30 -83.79 110.43 18.33 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.45 ' CG ' ' NE2' ' A' ' 114' ' ' GLN . 6.8 t80 -83.52 103.59 12.98 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 130.4 36.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.109 0.48 . . . . 0.0 111.734 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.499 HD13 HD12 ' A' ' 83' ' ' ILE . 7.9 mt -127.42 130.65 49.71 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.89 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.31 140.19 46.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 110.578 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.2 179.65 20.56 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.615 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -84.81 154.78 22.12 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.975 0.417 . . . . 0.0 110.792 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 129' ' ' SER . 14.8 p30 -121.97 29.18 7.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.655 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.3 mtt -43.46 -13.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.776 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.3 OUTLIER 61.78 38.35 14.94 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.935 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -135.11 107.7 7.4 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.89 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -50.29 125.61 12.93 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.634 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.73 8.97 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.927 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.5 t -83.48 179.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 117.584 0.692 . . . . 0.0 109.183 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.778 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.42 132.45 43.93 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.436 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 49.13 38.08 12.24 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.219 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.447 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.17 -12.31 58.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 136' ' ' SER . 76.8 m-20 -147.98 34.06 0.83 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 140' ' ' SER . 7.3 pt -68.87 -32.19 53.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.425 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.63 2.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.706 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 138' ' ' ILE . 8.5 t -93.5 -14.86 26.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.48 120.29 12.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.069 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mmtt -104.93 155.72 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -53.68 114.81 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.214 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.22 21.58 5.17 Favored Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 96.9 m-20 -99.16 128.02 45.22 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.94 133.14 35.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.792 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 93.1 mt -126.39 125.72 67.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.927 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -107.9 123.13 48.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.725 0.298 . . . . 0.0 110.759 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -112.48 146.36 38.59 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.067 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -116.05 131.16 57.02 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 152' ' ' ASN . 46.9 t0 -114.27 -166.52 1.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -23.6 -74.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.175 0.512 . . . . 0.0 111.852 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -138.41 29.86 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -128.96 145.23 51.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -176.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -111.52 121.78 46.08 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -102.73 133.51 47.64 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.087 0.47 . . . . 0.0 111.513 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.1 118.08 31.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.765 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.416 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 41.3 m-85 -119.06 140.25 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.155 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.46 134.82 55.22 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.51 0.672 . . . . 0.0 110.449 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.29 135.64 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.733 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -101.46 -24.54 14.15 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 124.888 1.367 . . . . 0.0 110.764 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.58 154.08 7.32 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.294 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 163' ' ' VAL . 9.9 p -98.45 129.41 48.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.832 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 49.4 m -132.01 149.53 52.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.188 0.518 . . . . 0.0 111.296 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -109.18 116.64 32.31 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.343 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -133.95 153.17 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 111.068 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.9 p -64.56 169.09 5.51 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 -13.87 11.81 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.884 1.723 . . . . 0.0 111.71 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.58 -19.66 41.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.639 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -85.79 75.34 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 109.944 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -74.74 -9.63 58.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.041 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -53.4 -22.47 7.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.78 ' O ' HG21 ' A' ' 183' ' ' THR . 79.9 t -81.03 -10.82 12.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.049 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.13 -12.08 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.739 0.78 . . . . 0.0 110.178 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -85.11 157.81 20.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.295 -1.321 . . . . 0.0 112.376 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 66.2 t0 -66.54 131.17 45.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.42 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 31.3 m80 -101.26 -41.63 6.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.35 29.9 0.24 Allowed Glycine 0 N--CA 1.471 0.993 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.448 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 48.5 pttt -157.44 179.25 9.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.547 . . . . 0.0 111.515 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 26.7 p30 -90.81 88.81 7.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.866 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -123.63 166.56 15.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.128 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.85 141.4 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.78 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.78 HG21 ' O ' ' A' ' 173' ' ' VAL . 19.0 m -135.7 123.85 23.02 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.059 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 183' ' ' THR . 10.2 mp -111.79 125.09 53.63 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.129 0.49 . . . . 0.0 110.078 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.477 HG22 HG13 ' A' ' 198' ' ' VAL . 36.2 pt -134.32 162.1 39.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.001 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 64.6 p -89.36 167.93 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.413 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 98.4 m -76.19 131.94 39.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.519 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.5 p -54.97 151.52 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 190' ' ' VAL . 36.7 t -142.09 -149.95 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.806 0.336 . . . . 0.0 110.854 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 191' ' ' LYS . 58.1 t -58.74 166.36 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.612 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.587 ' N ' HG12 ' A' ' 190' ' ' VAL . 29.3 tptp -71.58 139.22 49.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.364 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 42.24 35.02 0.55 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.533 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -62.46 -51.15 68.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.757 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.7 p -169.13 164.13 11.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.719 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.61 130.15 42.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -97.77 147.09 24.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.868 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -110.63 138.72 46.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.303 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.503 HG11 HG11 ' A' ' 173' ' ' VAL . 50.1 t -133.33 136.51 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.205 0.526 . . . . 0.0 111.326 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.23 128.43 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.562 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.63 136.52 52.9 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.331 0.586 . . . . 0.0 110.314 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.09 158.01 24.08 Favored Glycine 0 N--CA 1.463 0.469 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.598 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 63.1 t0 -113.77 146.3 40.11 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.568 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.0 tp -68.04 130.82 44.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.062 0.458 . . . . 0.0 110.716 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.77 -22.85 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.328 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.5 175.89 45.96 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.329 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 207' ' ' LYS . 60.9 m -154.23 154.13 32.94 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.344 0.592 . . . . 0.0 111.014 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 206' ' ' THR . 63.8 pttt -148.33 177.58 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.524 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.69 142.78 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.306 0.574 . . . . 0.0 111.061 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.23 80.81 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.272 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 208' ' ' ALA . 87.3 tttt . . . . . 0 C--N 1.318 -0.786 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.55 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.1 m -70.55 145.37 50.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 78.4 m80 48.57 -163.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.409 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.452 ' HG2' ' H ' ' A' ' 57' ' ' ASP . 12.6 ttt 54.45 176.93 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.164 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' H ' ' HG2' ' A' ' 56' ' ' MET . 42.9 p-10 -140.89 113.33 8.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.76 0.314 . . . . 0.0 110.818 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.44 -13.43 61.44 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.706 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 61' ' ' ILE . 88.3 p -87.0 24.3 1.56 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.38 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.21 32.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.464 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.498 ' H ' ' C ' ' A' ' 59' ' ' SER . 64.6 mt -62.19 -49.28 84.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.212 0.529 . . . . 0.0 110.675 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' OD1' ' OG ' ' A' ' 189' ' ' SER . 99.3 m-20 51.28 -90.8 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.092 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.481 ' CG ' ' SD ' ' A' ' 128' ' ' MET . 9.1 tt0 -151.33 79.55 6.7 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.47 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.83 144.43 1.4 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.282 1.988 . . . . 0.0 111.526 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -75.68 158.05 32.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 66' ' ' LEU . 1.7 tt -57.09 -28.77 62.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.069 0.461 . . . . 0.0 110.095 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.52 97.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.647 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.557 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 97.7 mt-10 -73.63 -31.46 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.327 0.584 . . . . 0.0 110.789 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.8 t -75.48 -46.38 37.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.783 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.25 87.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.926 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.4 -30.37 64.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.342 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.56 119.68 9.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.811 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.2 m -93.21 156.51 16.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.258 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -138.29 122.1 17.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.918 0.389 . . . . 0.0 110.81 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.634 ' N ' HD13 ' A' ' 74' ' ' LEU . 99.2 m-20 -83.55 108.74 16.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 11.7 mptt -47.71 -15.39 0.06 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.082 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.479 ' N ' ' C ' ' A' ' 75' ' ' ASP . 99.2 mttt -69.51 -8.26 45.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.77 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.61 6.45 48.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.923 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.1 t -91.06 128.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.942 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.1 pt -119.2 -6.39 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.728 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.61 -167.47 35.28 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.4 ' CG ' ' N ' ' A' ' 83' ' ' ILE . 19.4 ttm180 -150.96 157.0 42.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.402 0.62 . . . . 0.0 111.07 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.4 ' N ' ' CG ' ' A' ' 82' ' ' ARG . 15.8 tt -129.88 134.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.979 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.1 t -131.53 133.3 44.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.951 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.6 mt -136.0 127.92 17.37 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.329 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.21 -33.08 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.41 2.073 . . . . 0.0 112.02 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -49.12 -41.93 37.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.586 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -116.09 -1.69 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.8 -0.182 . . . . 0.0 110.878 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 64.38 50.04 2.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.8 tp -113.47 130.9 56.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.259 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -134.77 116.06 14.43 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.9 mt -143.7 163.28 37.06 Favored Pre-proline 0 N--CA 1.463 0.183 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.737 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.5 157.5 6.53 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.981 2.454 . . . . 0.0 109.235 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.0 t -107.01 117.56 53.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.0 mt -101.21 129.99 47.24 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -71.06 -36.99 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.986 0.422 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.0 m -75.54 100.12 4.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.375 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 98' ' ' SER . 53.5 p -82.85 92.93 7.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.264 0.554 . . . . 0.0 110.264 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.531 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 5.2 p -133.81 155.87 49.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.016 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -55.36 -32.67 62.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.402 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -76.57 -46.5 26.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.003 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.531 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 97.4 m-20 -66.25 -34.45 78.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.832 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.92 -18.88 59.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -72.63 -18.24 61.6 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.8 m -99.9 -11.25 20.86 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.53 -155.88 25.77 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.973 -1.108 . . . . 0.0 111.658 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.29 126.17 36.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.889 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.95 144.26 32.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -75.55 152.96 37.68 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.44 -47.96 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -92.44 137.64 32.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.224 0.535 . . . . 0.0 110.853 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 14.2 pt-20 -62.89 -47.11 84.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.869 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 61.6 t-20 -96.74 47.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.404 ' NE2' ' CE1' ' A' ' 121' ' ' TYR . 3.2 tt0 -91.55 155.38 18.43 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.4 t -130.27 133.79 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.202 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.6 mtp -73.51 126.24 29.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.704 0.288 . . . . 0.0 110.474 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.86 8.31 67.43 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.26 120.08 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.092 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.21 -178.31 41.32 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.926 -1.269 . . . . 0.0 109.926 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -73.82 107.43 6.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.404 ' CE1' ' NE2' ' A' ' 114' ' ' GLN . 10.6 t80 -84.26 103.51 13.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.97 126.55 35.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.122 0.486 . . . . 0.0 111.495 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -121.4 131.31 54.1 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.69 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 139.17 45.01 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.311 0.577 . . . . 0.0 110.662 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.8 -176.78 15.17 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.701 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -92.44 146.09 23.95 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.726 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 129' ' ' SER . 52.8 p30 -108.01 27.53 9.16 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.293 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.481 ' SD ' ' CG ' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -42.18 -16.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.701 -179.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 127' ' ' ASN . 2.6 t 55.06 37.14 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.812 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -133.87 111.96 10.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.458 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -55.67 123.66 14.83 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.152 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.43 5.93 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 134' ' ' LEU . 41.8 t -137.37 177.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.761 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -69.76 128.0 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.758 0.313 . . . . 0.0 110.644 -178.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 47.41 38.5 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 110.468 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.39 -6.02 59.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.723 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.6 t0 -151.16 39.97 0.69 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.632 -0.427 . . . . 0.0 112.071 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 11.0 pt -69.02 -30.18 45.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.49 4.14 3.28 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 49.6 m -95.69 -14.48 23.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 109.749 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.01 124.81 23.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.529 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -96.73 156.57 16.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.755 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.21 128.8 38.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.415 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 89.5 20.81 43.1 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.403 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 30.0 m-20 -82.36 136.36 35.0 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.495 ' NZ ' HG11 ' A' ' 204' ' ' VAL . 27.9 mmtt -80.35 126.63 31.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 112.1 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 86.7 mt -123.68 118.01 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 121.3 41.26 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.2 tp -114.28 142.84 45.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.984 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.17 136.42 44.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.242 0.544 . . . . 0.0 111.468 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 154' ' ' ASN . 40.9 t0 -113.0 177.0 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.347 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' A' ' 153' ' ' GLU . 19.4 p-10 -35.79 -54.46 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.409 0.623 . . . . 0.0 111.338 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 97.7 mt-10 -141.69 16.56 2.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.259 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -128.63 142.42 51.04 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -109.35 124.02 50.28 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CE2' HG21 ' A' ' 206' ' ' THR . 56.7 m-85 -106.55 134.99 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.388 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.73 118.49 32.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.408 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -115.88 138.0 51.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.246 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.78 132.58 55.11 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.429 0.633 . . . . 0.0 110.822 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 48.6 t -66.98 134.11 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.95 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.7 p -101.75 -28.33 12.52 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 124.443 1.089 . . . . 0.0 110.799 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 173.44 143.73 4.39 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.775 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.43 137.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 18.8 t -159.56 171.11 20.24 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.136 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -122.53 130.27 52.85 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.426 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.12 157.37 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.492 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 169' ' ' ASP . 6.8 p -68.56 130.18 92.16 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.452 ' HG3' HH21 ' A' ' 196' ' ' ARG . 1.5 Cg_endo -46.38 -11.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.921 1.747 . . . . 0.0 111.648 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 167' ' ' THR . 43.1 t0 -75.69 -22.2 56.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.63 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -84.82 73.15 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.009 0.433 . . . . 0.0 110.134 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -71.69 -14.66 62.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.513 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.479 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.5 mt-10 -52.97 -34.38 55.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.216 0.531 . . . . 0.0 110.074 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.714 ' O ' HG21 ' A' ' 183' ' ' THR . 97.2 t -70.94 -5.22 5.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.024 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.77 -14.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.678 0.751 . . . . 0.0 109.969 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -86.2 177.16 7.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.835 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.3 p-10 -81.74 131.66 35.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.479 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 42.9 m80 -103.21 -41.76 5.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.9 27.13 0.13 Allowed Glycine 0 N--CA 1.471 0.98 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -157.47 179.56 9.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.912 0.387 . . . . 0.0 111.411 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -89.98 90.25 8.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -121.01 166.93 13.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.081 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.9 tt -132.32 144.07 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.714 HG21 ' O ' ' A' ' 173' ' ' VAL . 18.8 m -135.72 126.37 27.15 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.196 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -112.55 118.23 34.52 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.409 HG22 HG13 ' A' ' 198' ' ' VAL . 12.0 pt -134.3 171.67 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.643 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.57 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.3 p -125.92 131.29 52.34 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.716 0.293 . . . . 0.0 110.892 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 6.8 t -82.74 128.46 34.39 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.332 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 59' ' ' SER . 56.9 t -127.31 -94.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.439 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.404 ' OG ' ' OD1' ' A' ' 62' ' ' ASP . 42.5 m -158.55 155.4 28.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.818 0.342 . . . . 0.0 110.467 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.4 -25.88 34.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.271 0.558 . . . . 0.0 110.487 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -53.1 -26.75 17.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.053 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 52.39 37.97 23.96 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.68 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -72.36 -3.61 25.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.072 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.8 p -151.91 161.35 42.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.0 110.623 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -94.38 145.28 24.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.113 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.57 ' NH1' ' O ' ' A' ' 186' ' ' THR . 16.7 ptp180 -115.59 166.51 11.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.028 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.34 140.66 44.31 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.158 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.409 HG13 HG22 ' A' ' 185' ' ' ILE . 47.4 t -129.61 132.17 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.132 0.492 . . . . 0.0 111.14 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.7 t -116.22 127.31 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.512 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.19 135.56 53.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.92 157.5 25.37 Favored Glycine 0 N--CA 1.465 0.618 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.562 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 60.6 t0 -115.11 152.49 32.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.446 -0.377 . . . . 0.0 111.161 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.562 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.95 129.24 38.09 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.085 0.469 . . . . 0.0 110.767 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.495 HG11 ' NZ ' ' A' ' 146' ' ' LYS . 5.1 p -107.81 -25.97 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.011 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.68 175.29 47.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.219 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.428 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.5 m -152.67 150.26 29.28 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.194 0.521 . . . . 0.0 110.883 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -148.62 178.0 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.538 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.97 21.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.151 0.5 . . . . 0.0 110.817 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -77.08 79.82 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.744 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.561 178.422 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.409 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 56' ' ' MET . 8.4 m 46.24 -165.05 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 55' ' ' HIS . 83.8 t60 47.87 15.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.372 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 54' ' ' SER . 65.5 mtt 48.99 -173.94 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.895 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 62.7 t0 -153.9 152.23 30.38 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.879 0.371 . . . . 0.0 110.85 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.558 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -71.79 -14.13 61.9 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.78 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 61' ' ' ILE . 69.1 p -87.61 12.31 12.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.982 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -67.86 39.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.931 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 59' ' ' SER . 55.3 mt -60.68 -49.66 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.716 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.2 t0 50.67 -95.75 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.012 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -151.0 86.58 4.84 Favored Pre-proline 0 C--O 1.234 0.289 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.22 155.57 41.93 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.855 2.37 . . . . 0.0 110.984 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -74.58 160.29 31.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.665 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.1 mp -64.66 -21.31 66.7 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.251 0.344 . . . . 0.0 110.862 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.73 -40.28 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.49 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.3 mt-10 -72.29 -34.91 68.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.623 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.8 t -75.07 -45.2 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.074 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.13 -37.5 87.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.02 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -84.04 -23.31 30.96 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.621 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.23 118.98 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.336 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -94.78 140.75 29.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.198 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 ' CB ' ' A' ' 105' ' ' SER . 57.4 tp -115.42 140.71 48.9 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.452 ' C ' ' N ' ' A' ' 77' ' ' LYS . 39.2 m-20 -95.11 100.92 12.65 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.574 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -46.89 -18.06 0.06 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.452 ' N ' ' C ' ' A' ' 75' ' ' ASP . 3.2 ttmp? -65.95 -33.8 76.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.312 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 0.9 OUTLIER -80.08 13.94 2.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.817 -178.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.467 HG11 ' NH1' ' A' ' 82' ' ' ARG . 89.1 t -91.49 127.48 43.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.633 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.15 -6.31 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.106 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.83 -173.19 43.94 Favored Glycine 0 C--N 1.321 -0.284 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.497 ' O ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -141.87 153.94 44.79 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.841 -177.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.8 tt -125.75 131.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 t -134.01 132.02 39.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.692 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.17 128.74 19.6 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.17 -36.67 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.412 2.075 . . . . 0.0 112.376 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -48.4 -39.98 24.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.51 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.3 p -119.31 -1.48 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.372 0.42 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.75 50.24 4.46 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.11 131.96 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.574 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -135.79 114.66 12.09 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 83' ' ' ILE . 76.2 mt -142.53 112.35 5.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -40.05 140.61 0.79 Allowed 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.661 1.574 . . . . 0.0 110.302 176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.6 t -93.15 122.02 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.66 123.47 48.55 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.484 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -65.06 -47.8 76.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.184 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -71.7 105.88 3.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.878 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -85.8 100.95 12.4 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.5 p -131.75 156.96 45.05 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.104 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.66 -28.99 61.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -82.87 -42.39 17.82 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.882 0.739 . . . . 0.0 111.936 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.63 -38.09 88.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.136 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -61.62 -19.76 62.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.061 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.49 -33.17 70.93 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.45 ' CB ' HD22 ' A' ' 74' ' ' LEU . 16.2 m -95.58 -9.47 32.19 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 177.43 179.57 47.73 Favored Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.254 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.89 127.82 33.81 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.948 -0.626 . . . . 0.0 109.84 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.63 146.14 31.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.853 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.4 p -76.4 153.87 35.34 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.0 t -85.43 -48.18 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -92.26 137.72 32.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.41 0.624 . . . . 0.0 110.698 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 12.9 pt-20 -60.32 -47.6 85.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.161 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 98.8 m-20 -98.8 47.41 0.98 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -85.39 155.45 21.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.964 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.9 131.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.409 ' SD ' HD22 ' A' ' 149' ' ' LEU . 65.3 mtt -74.98 128.0 34.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.417 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.11 0.54 70.94 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -139.36 118.15 12.38 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.017 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.0 -171.86 53.65 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -83.66 110.81 18.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.1 102.9 13.63 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 128.99 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.597 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.5 HD13 HD12 ' A' ' 83' ' ' ILE . 6.5 mt -123.96 130.45 52.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.331 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.92 138.21 47.6 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.318 0.58 . . . . 0.0 110.806 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.36 -179.05 17.64 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.259 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 134' ' ' LEU . 37.5 m-70 -86.46 144.44 27.28 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.455 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 129' ' ' SER . 8.1 t-20 -110.99 28.19 8.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.061 0.458 . . . . 0.0 110.652 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -47.37 -11.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.11 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 127' ' ' ASN . 2.3 t 56.1 40.67 30.16 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.024 -0.671 . . . . 0.0 109.928 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -132.31 105.93 7.6 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.659 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -50.42 124.94 11.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.614 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -26.4 9.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.374 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.803 HG12 ' H ' ' A' ' 134' ' ' LEU . 39.7 t -82.82 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.803 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -72.88 132.33 43.37 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -178.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 48.85 37.79 10.68 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.93 0.395 . . . . 0.0 111.345 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.459 ' OG ' ' C ' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -82.12 -11.4 58.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 136' ' ' SER . 83.7 m-20 -145.51 38.13 1.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -66.09 -36.13 76.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB2' ' CG ' ' A' ' 197' ' ' TYR . . . -68.48 3.08 1.95 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.815 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 138' ' ' ILE . 6.3 t -96.49 -11.19 25.88 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.279 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.39 122.26 18.03 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.538 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 64.4 mttp -95.57 161.46 14.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.391 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -61.12 135.12 57.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.46 19.08 57.61 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 2.6 m-20 -85.1 130.05 34.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.88 131.09 35.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 82.2 mt -122.57 123.09 67.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -100.63 118.67 37.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.693 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.5 mt -113.53 149.15 34.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.194 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -124.64 130.26 52.09 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.433 0.635 . . . . 0.0 111.416 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.7 t0 -113.52 -168.52 1.35 Allowed 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 16.9 m120 -24.86 -71.69 0.03 OUTLIER 'General case' 0 C--O 1.232 0.154 0 O-C-N 123.475 0.485 . . . . 0.0 111.579 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.62 26.6 2.31 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.25 146.87 44.86 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -111.74 118.7 36.34 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.735 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.492 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.7 m-85 -105.44 127.99 53.29 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.571 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -98.82 122.75 42.46 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.926 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -122.08 142.32 50.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 135.02 55.21 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.335 0.588 . . . . 0.0 110.703 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.5 t -69.7 133.35 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.51 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.1 t -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 124.64 1.212 . . . . 0.0 111.515 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.32 149.95 6.51 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.3 t -104.8 134.38 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.7 t -135.66 151.31 50.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.444 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.72 116.87 32.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.634 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.77 154.84 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 169' ' ' ASP . 23.4 p -78.16 140.46 61.5 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -45.59 -18.26 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.975 1.783 . . . . 0.0 111.867 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.7 m-20 -77.4 -21.19 53.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.025 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -83.03 70.54 10.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.119 0.568 . . . . 0.0 110.176 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.528 ' C ' ' H ' ' A' ' 173' ' ' VAL . 82.0 m95 -70.48 -27.04 63.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.944 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.4 -10.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.631 0.582 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.5 t -80.95 -23.69 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.501 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.01 -5.33 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.588 0.708 . . . . 0.0 110.015 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.35 142.06 36.38 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.925 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -54.84 128.98 35.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -102.4 -42.72 5.89 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.49 28.52 0.15 Allowed Glycine 0 N--CA 1.471 0.985 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -157.15 179.76 8.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.999 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 8.1 m-20 -93.87 94.12 8.32 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 182' ' ' ILE . 46.1 tt0 -127.54 170.87 12.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.906 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.409 ' H ' ' HG2' ' A' ' 181' ' ' GLU . 20.6 tt -131.63 143.19 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.709 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.496 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.7 m -138.29 116.89 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -102.38 119.59 39.08 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.605 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -130.97 -169.97 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.379 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 31.0 p -134.9 151.84 51.22 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.376 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.8 p -98.29 133.2 43.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.971 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 190' ' ' VAL . 8.2 m -141.97 -40.42 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.484 ' N ' HG23 ' A' ' 188' ' ' VAL . 11.8 m 48.55 -91.74 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.442 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 188' ' ' VAL . 69.1 t -63.71 135.41 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.514 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 tttp 51.13 87.89 0.03 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.612 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.76 141.13 58.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.474 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -86.55 113.36 22.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.561 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 79.8 p -57.58 -34.81 69.6 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.043 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -90.17 56.51 3.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.035 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -78.11 127.93 33.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.689 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.467 ' CG ' ' HB2' ' A' ' 139' ' ' ALA . 4.9 m-85 -117.3 132.44 56.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.528 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 185' ' ' ILE . 48.3 t -135.6 136.57 50.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.091 0.472 . . . . 0.0 111.046 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.96 129.65 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.673 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.66 133.39 55.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.144 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.77 146.62 17.1 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-O 121.807 0.671 . . . . 0.0 111.706 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -105.32 139.12 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.89 -0.655 . . . . 0.0 110.714 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 tp -66.18 129.16 38.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.937 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.7 p -106.41 -25.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.073 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.27 159.6 16.59 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.453 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.492 HG21 ' CE2' ' A' ' 156' ' ' TYR . 29.9 m -135.7 155.02 51.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -149.86 177.78 9.51 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.3 144.34 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 0.0 110.551 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -71.07 79.09 0.67 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.023 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 117.86 -1.067 . . . . 0.0 110.548 178.813 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.1 t -133.84 -13.73 2.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.539 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -105.71 127.99 53.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 20.6 ptp -69.01 163.95 23.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.884 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 40.2 p-10 -65.31 119.11 10.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 110.346 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.63 76.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.9 m -150.88 -84.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.414 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm 55.28 31.29 16.32 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.432 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 62' ' ' ASP . 35.8 mm -65.86 -44.58 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.778 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 64' ' ' PRO . 10.4 t0 61.22 119.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.519 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 62' ' ' ASP . 2.5 pt20 -38.15 93.69 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' N ' ' O ' ' A' ' 62' ' ' ASP . 6.1 Cg_exo -75.44 154.28 40.34 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.566 2.177 . . . . 0.0 111.262 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.99 152.51 41.32 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.623 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.691 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.2 pt? -59.0 -23.98 62.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.402 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.6 mt-10 -73.07 -33.07 65.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.606 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.3 -42.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.1 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.09 92.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.405 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.1 p-10 -86.31 -15.14 41.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.669 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.08 120.27 9.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.107 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.2 p -91.39 159.55 15.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.11 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -136.11 142.57 44.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -94.12 100.51 12.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -57.23 -14.93 4.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.049 0.452 . . . . 0.0 110.347 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -76.44 -14.55 60.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.146 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.47 13.17 34.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.529 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 71.9 t -90.13 135.99 24.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.988 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.408 HD13 ' HB3' ' A' ' 96' ' ' LYS . 4.4 pt -117.5 -3.55 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.035 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.63 34.86 Favored Glycine 0 C--N 1.317 -0.518 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -154.05 165.26 36.72 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.808 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 tt -134.3 140.96 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.891 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 t -133.52 135.79 44.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.362 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 14.0 mt -134.58 127.77 18.77 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.802 -178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.55 -38.34 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.357 2.038 . . . . 0.0 112.584 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -47.37 -41.01 18.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.599 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.4 p -116.69 -3.31 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.828 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.83 49.46 1.21 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -107.49 127.3 53.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.865 -178.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.649 ' N ' HD13 ' A' ' 90' ' ' LEU . 83.2 tt0 -138.16 116.14 11.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.645 HD23 ' HD2' ' A' ' 93' ' ' PRO . 2.7 mt -157.71 127.52 3.29 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 118.97 -1.092 . . . . 0.0 113.471 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.645 ' HD2' HD23 ' A' ' 92' ' ' LEU . 1.3 Cg_endo -42.96 159.04 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.929 0 C-N-CA 121.928 1.752 . . . . 0.0 109.703 176.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 t -113.61 124.66 70.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.4 mt -103.11 128.89 49.86 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.217 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HB3' HD13 ' A' ' 80' ' ' ILE . 62.8 pttt -65.05 -35.3 80.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.717 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.9 m -56.53 -176.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.632 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 p -162.51 55.48 0.22 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.699 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 7.0 p -105.68 160.03 15.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.151 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.48 -32.33 71.32 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.603 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -75.4 -41.85 55.2 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.85 0.719 . . . . 0.0 112.26 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 98.3 m-20 -65.82 -39.92 91.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.553 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.9 mt -59.78 -19.82 52.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.87 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.467 HD23 ' NE2' ' A' ' 126' ' ' HIS . 15.8 mt -69.25 -34.85 75.43 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.0 m -97.16 -7.71 31.84 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -179.0 -174.6 45.33 Favored Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . . . -83.58 127.95 34.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.12 -0.54 . . . . 0.0 109.882 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.422 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.38 141.61 36.03 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.768 0.318 . . . . 0.0 110.715 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.4 p -71.87 147.54 47.02 Favored 'General case' 0 C--N 1.335 -0.057 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.77 -47.68 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -92.03 -170.47 2.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.975 0.417 . . . . 0.0 110.657 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 113' ' ' ASN . 1.6 pt-20 -113.19 -53.86 2.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.951 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.456 ' H ' ' HG3' ' A' ' 112' ' ' GLU . 89.0 m-20 -94.42 44.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -93.37 154.54 17.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.984 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.71 133.9 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.816 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.458 ' SD ' HD22 ' A' ' 149' ' ' LEU . 68.5 mtt -69.66 128.39 36.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.989 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.481 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.68 1.33 77.49 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -142.6 123.44 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.974 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.19 -164.36 54.34 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -94.64 108.68 20.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -84.91 100.87 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.043 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 124.63 35.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.511 . . . . 0.0 111.722 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt -121.94 132.02 54.33 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.322 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.6 138.9 45.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.375 0.607 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.69 -176.26 16.63 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.43 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 135' ' ' PHE . 15.3 m-70 -86.11 141.79 29.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.815 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.643 HD22 ' N ' ' A' ' 190' ' ' VAL . 32.1 t30 -109.86 26.88 10.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.214 0.531 . . . . 0.0 110.481 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -46.34 -14.29 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.778 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 129' ' ' SER . 1.4 p 55.2 41.15 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.822 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 136' ' ' SER . 30.5 mmtm -133.91 129.25 36.06 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.653 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -74.24 124.52 26.56 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.089 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.41 -28.24 6.61 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 134' ' ' LEU . 4.2 t -78.04 170.58 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.22 133.16 40.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.685 -179.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 126' ' ' HIS . 3.6 m-85 49.27 38.74 14.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 1.1 p -80.33 -61.26 2.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.282 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 136' ' ' SER . 97.9 m-20 -89.35 39.7 0.95 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 42.7 pt -69.78 -26.72 31.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.241 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.42 6.81 5.11 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.0 t -95.33 -13.64 24.59 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.105 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.26 118.74 9.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.49 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -98.4 161.57 13.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.741 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -58.38 118.54 5.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.133 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.95 21.06 7.63 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 90.9 m-20 -96.65 127.99 43.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -80.58 138.31 36.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.956 0.408 . . . . 0.0 111.332 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 158' ' ' TYR . 97.5 mt -129.4 123.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -101.76 119.22 38.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.996 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.458 HD22 ' SD ' ' A' ' 116' ' ' MET . 2.7 mt -110.0 158.15 18.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.346 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.405 ' CD1' ' C ' ' A' ' 149' ' ' LEU . 66.6 m-85 -141.63 121.22 13.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.092 0.472 . . . . 0.0 111.859 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 152' ' ' ASN . 13.3 t0 -114.64 -166.11 1.08 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.579 ' C ' ' O ' ' A' ' 151' ' ' ASP . 95.1 m-20 -4.4 -88.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.857 0.723 . . . . 0.0 111.32 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -138.99 30.83 2.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -121.73 140.96 51.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -102.89 120.78 41.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.196 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.457 ' CE2' HG21 ' A' ' 206' ' ' THR . 90.7 m-85 -105.07 125.21 50.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.725 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -94.19 115.27 27.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.481 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.6 m-85 -117.18 142.82 46.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.224 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.06 132.13 53.98 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.439 0.637 . . . . 0.0 110.501 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.0 t -67.7 135.87 27.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.269 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 14.2 p -101.75 -25.56 13.79 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 124.783 1.302 . . . . 0.0 110.99 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.49 177.18 34.35 Favored Glycine 0 C--N 1.32 -0.345 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.146 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.09 149.1 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.743 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.42 ' O ' HG12 ' A' ' 198' ' ' VAL . 38.9 m -152.59 161.6 42.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.382 . . . . 0.0 111.099 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -99.36 120.93 40.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 196' ' ' ARG . 18.4 m -132.45 157.45 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 169' ' ' ASP . 32.1 p -82.42 135.93 46.41 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.584 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -46.37 -15.1 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.004 1.803 . . . . 0.0 112.041 -178.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 67.3 t0 -84.52 -22.61 30.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -83.95 72.42 10.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.062 0.458 . . . . 0.0 110.928 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 94.1 m95 -74.94 -2.22 26.07 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.969 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.467 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 72.4 mm-40 -54.19 -39.0 66.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.743 ' O ' HG21 ' A' ' 183' ' ' THR . 17.9 m -75.19 4.57 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.944 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -122.07 -15.99 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.904 0.859 . . . . 0.0 110.042 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.403 ' O ' ' CD2' ' A' ' 177' ' ' HIS . 63.4 mm-40 -89.21 166.45 13.8 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.972 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -68.18 129.42 39.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.083 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.467 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.0 m170 -103.32 -40.54 6.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.143 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.83 25.23 0.12 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -156.41 179.23 9.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.863 0.363 . . . . 0.0 110.815 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -97.36 93.36 6.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.802 0.81 . . . . 0.0 110.408 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -127.02 175.16 8.31 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.407 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -130.38 143.47 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.216 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.743 HG21 ' O ' ' A' ' 173' ' ' VAL . 13.1 m -135.99 123.67 22.38 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.557 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 183' ' ' THR . 10.5 mp -112.19 121.96 46.39 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.455 0.645 . . . . 0.0 110.982 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.27 -174.84 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.829 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.546 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 15.4 p -138.53 158.46 44.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.368 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 99.6 m -62.75 -39.14 93.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.22 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 189' ' ' SER . 2.1 t -130.61 -140.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.314 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.536 ' H ' HG12 ' A' ' 188' ' ' VAL . 34.8 p -157.52 165.66 35.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.764 0.316 . . . . 0.0 110.437 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.643 ' N ' HD22 ' A' ' 127' ' ' ASN . 9.7 p -63.6 130.24 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? 45.59 -141.14 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.952 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -65.65 -80.19 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 45.88 86.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.976 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.7 t -58.84 -45.11 90.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 111.098 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -85.39 137.92 32.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.26 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.546 ' NH1' ' O ' ' A' ' 186' ' ' THR . 39.1 ttm180 -95.88 137.01 35.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.003 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.57 140.96 35.52 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 164' ' ' SER . 2.9 p -140.71 144.54 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.72 0.295 . . . . 0.0 111.425 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.63 129.91 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.204 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.415 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -121.21 138.93 53.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.256 0.551 . . . . 0.0 110.507 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.66 160.96 24.98 Favored Glycine 0 N--CA 1.461 0.337 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.8 t0 -113.55 149.69 34.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.954 -0.623 . . . . 0.0 111.135 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.536 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 21.7 tp -73.42 132.39 42.92 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 159' ' ' ALA . 59.3 t -107.96 -27.1 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.512 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.93 160.37 16.82 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.388 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.457 HG21 ' CE2' ' A' ' 156' ' ' TYR . 28.4 m -136.42 155.6 49.78 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -151.62 179.84 8.04 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.08 143.19 26.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.461 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.5 81.22 1.95 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.528 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.379 178.693 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.1 t -153.82 151.56 29.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.911 0.386 . . . . 0.0 110.627 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -109.98 152.29 26.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.503 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 12.7 ptp -75.76 145.78 40.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.702 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -68.98 138.14 54.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.336 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.06 -41.66 73.88 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.023 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 96.1 p -150.5 -96.25 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.482 ' N ' ' OG ' ' A' ' 59' ' ' SER . 99.4 mttt 48.88 40.77 17.3 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.692 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.2 mm -63.05 -45.11 99.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.331 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.8 t0 68.42 -123.51 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.268 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -140.78 72.17 29.42 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -43.26 145.53 1.38 Allowed 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.485 2.123 . . . . 0.0 111.391 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -77.57 163.3 26.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.163 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.631 ' N ' HD23 ' A' ' 66' ' ' LEU . 2.0 pt? -60.16 -21.75 62.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.234 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.23 -39.62 94.34 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.1 mm-40 -73.76 -30.33 62.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.317 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -77.31 -44.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.799 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.98 85.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.919 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 61.3 t-20 -83.31 -27.03 30.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.054 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.75 139.72 57.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.696 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -140.82 84.21 1.93 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.822 0.344 . . . . 0.0 111.361 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.6 tp -82.15 134.64 35.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.569 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -68.21 138.81 55.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.3 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.439 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -64.02 -8.73 12.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 109.78 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -64.02 -30.12 71.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.863 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.429 HE22 ' NZ ' ' A' ' 96' ' ' LYS . 22.6 mm100 -76.75 9.87 2.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.109 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.1 t -92.69 124.41 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -129.8 -3.86 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.64 -170.55 32.58 Favored Glycine 0 C--N 1.315 -0.607 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' HD2' ' H ' ' A' ' 83' ' ' ILE . 5.3 tpt180 -153.02 151.14 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.837 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 92' ' ' LEU . 5.7 tt -123.39 127.4 74.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 t -128.3 129.57 46.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.462 HG21 HD21 ' A' ' 141' ' ' LEU . 45.2 mt -135.02 122.26 15.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.284 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -82.28 -33.89 0.49 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.372 2.048 . . . . 0.0 112.877 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.464 ' CB ' HD23 ' A' ' 141' ' ' LEU . 1.6 m -50.38 -36.37 32.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.45 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.628 HG23 HD23 ' A' ' 90' ' ' LEU . 18.7 m -120.17 -6.34 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.634 0.254 . . . . 0.0 110.982 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.84 48.22 0.41 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.628 HD23 HG23 ' A' ' 88' ' ' VAL . 3.7 mm? -109.92 129.69 55.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.839 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.617 ' O ' HD12 ' A' ' 92' ' ' LEU . 97.2 mt-10 -135.34 115.85 13.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.617 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.1 tp -146.35 111.15 4.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.4 Cg_endo -41.02 147.89 0.25 Allowed 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 121.636 1.558 . . . . 0.0 110.529 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.4 t -96.16 124.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.0 mt -104.9 145.33 30.55 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' NZ ' HE22 ' A' ' 78' ' ' GLN . 21.8 pttp -90.41 -35.33 15.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.279 0.561 . . . . 0.0 110.961 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.1 p -76.22 97.95 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.117 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -82.66 89.98 6.79 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.373 0.606 . . . . 0.0 110.059 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 p -133.14 157.75 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.901 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -55.89 -29.76 60.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.765 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 11.4 ptpt -83.29 -43.84 15.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.699 HD22 ' N ' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -66.63 -34.21 77.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.635 -178.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 mt -60.99 -20.93 63.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.433 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -73.46 -18.79 61.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.6 p -102.42 -13.11 17.41 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.21 -179.43 47.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.165 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.55 125.84 28.43 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.6 143.16 34.14 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.936 0.398 . . . . 0.0 110.866 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 46.7 p -75.1 154.15 37.96 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.68 -56.24 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -96.4 141.22 29.96 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.993 0.425 . . . . 0.0 110.689 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.2 pm0 -82.47 6.65 16.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.588 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -131.27 24.89 4.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.942 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -93.75 156.16 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.195 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.2 t -133.28 133.89 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.851 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.4 mtt -67.24 127.6 33.26 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.995 0.426 . . . . 0.0 110.237 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.402 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 90.96 2.41 71.68 Favored Glycine 0 C--O 1.23 -0.101 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -141.06 121.87 14.4 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.067 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.18 -168.88 53.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -87.86 110.03 20.21 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.52 103.67 13.05 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.88 127.79 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 112.105 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD13 HD12 ' A' ' 83' ' ' ILE . 6.1 mt -123.54 132.41 53.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.933 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.57 139.08 45.01 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.402 0.62 . . . . 0.0 110.656 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.74 -176.58 15.01 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.72 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -97.46 141.5 30.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.951 0.405 . . . . 0.0 110.732 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 129' ' ' SER . 43.5 p-10 -102.3 27.76 6.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -38.82 -21.8 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.159 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 62.09 37.29 14.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.477 ' N ' ' OG ' ' A' ' 136' ' ' SER . 63.7 mmtt -133.32 108.02 8.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.769 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -50.66 125.98 14.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.809 0.814 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.02 -30.26 7.83 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.631 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.753 HG12 ' H ' ' A' ' 134' ' ' LEU . 59.4 t -76.02 178.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.355 0 CA-C-N 117.681 0.74 . . . . 0.0 109.437 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.756 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -71.15 136.39 48.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.778 0.323 . . . . 0.0 110.437 -178.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.3 m-85 44.11 32.03 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.324 0.583 . . . . 0.0 110.561 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -81.26 -12.26 59.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 29.4 t0 -142.62 26.45 1.76 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.2 pt -70.16 -25.76 28.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.797 0.332 . . . . 0.0 111.581 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.11 1.11 6.27 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.701 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.1 m -95.41 -11.7 27.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.464 HD23 ' CB ' ' A' ' 87' ' ' SER . 18.3 mt -63.9 124.22 20.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.008 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 145' ' ' ASP . 99.2 mttt -96.4 158.17 15.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -56.58 134.87 54.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.185 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.36 19.49 62.24 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 142' ' ' LYS . 28.7 m-20 -81.43 132.73 35.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -79.51 130.33 35.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.274 0.559 . . . . 0.0 111.515 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.6 mt -122.92 121.68 63.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.583 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -102.4 120.57 40.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.012 0.434 . . . . 0.0 110.118 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.0 OUTLIER -110.73 158.83 18.21 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.973 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -132.96 128.11 35.7 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.635 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.517 ' O ' ' C ' ' A' ' 152' ' ' ASN . 44.4 t0 -113.89 -166.01 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.517 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.3 t-20 -21.95 -74.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.152 0.501 . . . . 0.0 111.929 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.22 27.95 1.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -122.54 144.93 48.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -108.13 122.73 47.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.032 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.469 ' CE2' HG21 ' A' ' 206' ' ' THR . 71.8 m-85 -106.32 127.37 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.822 0.344 . . . . 0.0 111.489 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -94.62 115.88 28.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.503 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.517 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 22.4 m-85 -117.07 142.24 47.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.308 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.7 134.51 55.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.629 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.5 133.97 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.915 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -102.14 -25.86 13.56 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 124.544 1.153 . . . . 0.0 110.787 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.98 142.34 3.37 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 119.857 -1.163 . . . . 0.0 111.768 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 141' ' ' LEU . 10.0 t -104.77 152.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.5 t -168.42 178.32 4.91 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.4 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.79 115.13 26.52 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.36 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 12.5 m -117.0 139.78 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.543 ' C ' HH12 ' A' ' 196' ' ' ARG . 66.8 p -54.23 162.6 1.5 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.57 -19.76 8.55 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.194 1.929 . . . . 0.0 111.828 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 170' ' ' LYS . 34.3 p30 -81.91 -19.31 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 35.1 ttpt -88.13 74.68 8.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.143 0.497 . . . . 0.0 110.503 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -75.27 -6.1 48.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.851 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.7 -24.55 14.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.745 ' O ' HG21 ' A' ' 183' ' ' THR . 94.2 t -78.21 -3.25 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.815 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.5 t -124.65 -12.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.665 0.745 . . . . 0.0 109.814 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -85.6 155.63 21.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.618 -1.173 . . . . 0.0 111.934 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.33 132.14 47.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.109 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.62 -39.33 6.41 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.334 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.44 28.56 0.17 Allowed Glycine 0 N--CA 1.471 1.012 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -155.1 174.92 14.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.126 0.489 . . . . 0.0 111.284 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 2.8 m-20 -90.13 89.34 7.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.692 0.758 . . . . 0.0 109.557 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -119.59 168.36 11.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.826 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.7 tt -129.95 141.32 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.226 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.745 HG21 ' O ' ' A' ' 173' ' ' VAL . 11.9 m -137.11 123.4 20.61 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.178 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.598 HD12 ' C ' ' A' ' 183' ' ' THR . 11.0 mp -112.59 122.75 48.6 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.194 0.521 . . . . 0.0 110.091 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 pt -132.91 168.08 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.689 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 187' ' ' CYS . 74.3 p -138.99 158.42 44.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.633 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' A' ' 186' ' ' THR . 98.2 m 46.33 94.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.601 -0.439 . . . . 0.0 110.291 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 71.3 t -61.32 -47.56 92.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.999 0.428 . . . . 0.0 110.607 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.2 p -80.92 165.79 21.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.281 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 190' ' ' VAL . 11.2 p -122.85 130.9 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -158.71 -80.01 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.747 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.48 -41.22 96.6 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.482 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -106.88 117.68 34.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.154 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 45.6 t -61.61 -44.04 97.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 110.903 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -124.34 149.62 46.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.774 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 166' ' ' VAL . 35.2 ptt-85 -117.91 169.08 9.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -97.57 131.41 44.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.465 HG21 HG22 ' A' ' 166' ' ' VAL . 42.3 t -131.48 133.57 61.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 111.253 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.0 t -111.28 124.06 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.276 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.02 134.16 55.04 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.079 0.466 . . . . 0.0 110.289 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.06 160.88 25.49 Favored Glycine 0 N--CA 1.463 0.452 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 62.5 t0 -114.56 151.43 33.42 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.974 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.65 129.86 38.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.443 0.639 . . . . 0.0 110.755 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 98.7 t -106.34 -24.48 4.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.161 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.74 163.33 23.59 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.036 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.469 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.7 m -136.6 154.46 50.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.278 0.561 . . . . 0.0 109.975 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -148.99 179.43 7.88 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.176 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.65 24.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.279 0.562 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.68 80.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.612 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.574 178.644 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.8 t -144.03 110.76 5.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.887 0.375 . . . . 0.0 110.354 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -147.19 137.98 23.64 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.933 0.397 . . . . 0.0 110.906 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.2 mtt -65.18 -41.48 94.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.615 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -132.22 111.13 11.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.283 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.01 -59.96 2.48 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.258 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 61' ' ' ILE . 69.6 p -154.83 44.43 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.155 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -71.28 19.67 0.06 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.038 0.447 . . . . 0.0 111.325 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.498 ' H ' ' C ' ' A' ' 59' ' ' SER . 40.2 mt -63.74 -46.85 93.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.116 0.484 . . . . 0.0 110.596 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.6 t0 56.84 -100.58 0.11 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.802 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -150.26 78.92 7.69 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.94 136.75 4.72 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.386 2.057 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -81.18 166.93 20.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.906 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.6 mp -52.02 -28.44 17.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.607 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 71' ' ' ASN . . . -65.43 -39.73 92.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.239 0.542 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 71.5 mm-40 -73.81 -31.28 63.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.741 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.83 -45.88 30.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.821 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.51 78.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.07 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 67' ' ' ALA . 9.3 m120 -69.06 -29.25 67.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.997 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.41 100.91 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.848 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -96.93 111.39 23.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.395 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -111.36 128.6 56.02 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.567 ' H ' ' NE2' ' A' ' 78' ' ' GLN . 97.8 m-20 -71.97 138.71 48.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.267 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 79' ' ' VAL . 1.3 mppt? -64.43 0.45 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.441 . . . . 0.0 109.877 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 75' ' ' ASP . 13.2 mptt -92.06 -8.86 44.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.585 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.567 ' NE2' ' H ' ' A' ' 75' ' ' ASP . 76.1 mt-30 -83.17 -6.62 59.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 76' ' ' LYS . 5.4 m -86.96 138.03 19.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.68 -3.32 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.487 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.07 -160.3 24.24 Favored Glycine 0 C--N 1.319 -0.364 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -153.59 155.98 37.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.384 0.612 . . . . 0.0 111.258 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.26 136.86 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.073 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -128.99 134.07 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.986 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.598 ' CG2' HD21 ' A' ' 141' ' ' LEU . 2.5 mt -133.01 74.17 74.18 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.541 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -44.76 -39.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 123.151 2.567 . . . . 0.0 112.943 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.752 ' OG ' HD23 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -48.67 -32.17 7.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.623 -177.406 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 89' ' ' SER . 15.7 m -117.13 -7.01 11.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.637 0.256 . . . . 0.0 111.158 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER 75.22 39.49 0.37 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.197 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.64 130.02 56.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.48 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -144.79 129.97 18.59 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.763 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -164.44 152.54 10.8 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.072 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 162.99 4.51 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.064 1.843 . . . . 0.0 109.739 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.29 125.0 73.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 102' ' ' ASN . 10.2 mt -101.43 136.11 41.83 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.81 -48.54 24.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.11 0.481 . . . . 0.0 111.485 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.3 m -81.61 123.4 28.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.177 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.4 p -81.7 64.83 6.58 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.45 0.643 . . . . 0.0 110.46 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.552 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -91.81 143.21 26.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.077 179.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 101' ' ' LYS . 15.3 pt-20 -56.33 -44.22 79.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.403 0.621 . . . . 0.0 110.742 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.493 ' N ' ' CG ' ' A' ' 100' ' ' GLU . 54.5 tttp -66.03 -46.38 78.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.808 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.552 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 2.9 m-20 -67.18 -36.97 82.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.844 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -55.04 -16.82 3.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.451 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.447 ' O ' HD11 ' A' ' 134' ' ' LEU . 55.0 mt -70.63 -29.9 66.4 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -89.74 -10.56 45.18 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.42 178.52 41.27 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.984 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.763 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -72.37 132.16 43.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.97 150.13 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.125 0.488 . . . . 0.0 111.031 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 42.5 p -73.6 153.93 39.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.34 -52.2 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -91.76 141.44 28.67 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.994 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 -71.39 -2.58 16.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.538 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.34 41.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.251 0.548 . . . . 0.0 111.115 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -84.86 158.1 20.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.88 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -134.49 129.7 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.628 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -73.7 127.88 34.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.43 -0.15 70.86 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -139.71 121.61 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.967 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.32 -171.86 52.51 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.515 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 10.2 t30 -84.03 110.13 18.21 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.24 99.38 10.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.78 130.44 36.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.363 0.601 . . . . 0.0 111.425 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -125.9 133.83 51.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.826 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.18 141.56 47.37 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.378 0.609 . . . . 0.0 110.71 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.9 -178.85 18.42 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.656 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -81.83 149.27 28.42 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.972 0.415 . . . . 0.0 110.748 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 129' ' ' SER . 45.1 t30 -112.48 28.44 8.77 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.169 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.1 mmm -47.43 -11.74 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.638 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 127' ' ' ASN . 3.1 t 54.72 41.11 32.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.982 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.4 tttt -134.52 116.2 14.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.565 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -57.33 125.61 23.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.764 0.792 . . . . 0.0 110.53 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.25 -25.87 11.96 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.871 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.798 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.3 t -79.9 179.07 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.798 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.28 133.31 45.97 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.768 -178.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.5 m-30 44.47 33.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.148 0.499 . . . . 0.0 111.06 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -82.29 -7.79 59.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.5 m-20 -147.47 38.14 0.94 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.6 pt -74.24 -25.49 19.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.84 0.352 . . . . 0.0 111.881 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.83 0.52 8.86 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.749 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.0 m -93.39 -12.24 30.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.27 0.557 . . . . 0.0 109.628 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.752 HD23 ' OG ' ' A' ' 87' ' ' SER . 21.0 mt -65.58 125.0 23.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.204 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -96.34 158.46 15.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.677 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.05 133.06 54.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.514 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.5 59.18 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.421 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 38.4 m-20 -83.52 136.91 34.1 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -81.0 130.23 34.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.232 0.539 . . . . 0.0 111.345 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 72.8 mt -127.13 126.64 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 148' ' ' TYR . 42.4 m-85 -107.87 120.24 41.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.191 0.519 . . . . 0.0 109.776 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.6 tp -113.59 143.93 43.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.346 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -114.82 127.88 55.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.314 0.578 . . . . 0.0 111.541 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.4 t0 -106.0 -166.12 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.6 m-20 -27.94 -71.6 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.695 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -137.42 22.8 2.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.754 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.27 147.83 44.49 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -113.42 118.28 34.08 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.416 ' CE2' HG21 ' A' ' 206' ' ' THR . 68.4 m-85 -103.45 131.51 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.407 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -93.4 117.85 30.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.312 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.347 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.2 133.18 55.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 45.2 t -67.73 133.03 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.107 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -101.0 -27.19 13.42 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 124.609 1.193 . . . . 0.0 110.63 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.53 144.35 3.98 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.86 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 91.4 t -95.47 141.32 15.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.41 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 88.9 p -150.06 161.93 41.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.372 0.606 . . . . 0.0 111.548 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.535 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 95.3 mt-10 -114.81 123.18 48.56 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.749 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.68 149.63 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.344 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.4 p -53.66 166.78 0.55 Allowed Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.571 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -81.58 -15.59 9.68 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.854 1.703 . . . . 0.0 111.812 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 60.0 t0 -88.64 -11.09 46.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.905 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.502 ' O ' HG22 ' A' ' 173' ' ' VAL . 13.6 ttmm -86.95 67.81 9.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.028 0.442 . . . . 0.0 110.979 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.571 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 57.3 m95 -76.53 -8.39 57.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.044 0.449 . . . . 0.0 111.856 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.9 mt-10 -53.19 -23.47 8.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.203 0.525 . . . . 0.0 110.937 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 170' ' ' LYS . 33.3 m -77.63 -13.06 14.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.922 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 185' ' ' ILE . 4.4 m -132.34 43.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.521 ' O ' ' O ' ' A' ' 176' ' ' ASP . 95.4 mt-10 -146.23 83.17 1.62 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.895 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 175' ' ' GLU . 66.5 t0 23.82 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.346 1.028 . . . . 0.0 113.022 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.455 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 13.2 m170 -102.13 -43.97 5.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.866 0.365 . . . . 0.0 111.289 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.84 23.78 0.16 Allowed Glycine 0 N--CA 1.47 0.906 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -154.11 173.91 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.954 0.407 . . . . 0.0 111.237 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -96.3 88.65 4.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.242 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -131.58 130.63 42.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.037 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.6 tt -83.17 145.57 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.515 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 3.6 m -138.57 115.94 11.18 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.576 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -104.48 134.34 47.84 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.18 0.514 . . . . 0.0 110.711 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.724 HG22 HG22 ' A' ' 198' ' ' VAL . 34.6 pt -135.1 154.67 36.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.093 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -139.32 101.69 4.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.447 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 188' ' ' VAL . 3.7 t -174.55 -71.74 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 187' ' ' CYS . 3.5 t 57.61 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.577 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 188' ' ' VAL . 2.0 p 61.77 128.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.245 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.437 HG22 ' H ' ' A' ' 190' ' ' VAL . 16.0 m -85.69 -14.31 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.982 0.42 . . . . 0.0 111.231 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -62.28 -42.28 99.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.401 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -88.01 100.57 13.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.391 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 194' ' ' SER . 61.4 t-20 -67.31 -108.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.996 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 193' ' ' ASN . 1.5 p 60.05 148.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.727 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -66.53 130.17 42.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.125 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.404 HH21 HG21 ' A' ' 198' ' ' VAL . 56.0 ttp180 -97.77 137.3 36.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.225 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.535 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.6 m-85 -95.95 129.02 43.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.505 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.724 HG22 HG22 ' A' ' 185' ' ' ILE . 71.2 t -131.08 133.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.193 0.521 . . . . 0.0 111.366 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.73 126.96 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.593 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -112.77 132.93 55.02 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 110.721 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.66 14.13 Favored Glycine 0 N--CA 1.464 0.525 0 CA-C-O 121.727 0.626 . . . . 0.0 111.685 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.8 t0 -98.91 142.3 30.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.891 -0.655 . . . . 0.0 111.405 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.1 tp -67.09 128.54 36.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.315 0.578 . . . . 0.0 110.288 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.97 -21.7 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.216 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.5 176.12 46.87 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.009 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.416 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.0 m -154.74 153.18 30.85 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.161 0.505 . . . . 0.0 110.534 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -150.27 178.65 8.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.264 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -99.98 142.26 31.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 111.103 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -57.18 80.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.248 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 208' ' ' ALA . 77.5 tttt . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.557 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.7 m -129.54 124.63 34.37 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 110.617 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -64.44 -43.37 94.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.452 ' HG2' ' H ' ' A' ' 57' ' ' ASP . 28.6 ttm 54.19 175.13 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.038 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' H ' ' HG2' ' A' ' 56' ' ' MET . 98.4 m-20 -63.07 140.32 58.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.921 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.47 -39.17 77.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.936 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 189' ' ' SER . 7.0 m -153.18 72.27 0.94 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.718 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -71.35 41.49 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.238 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 59' ' ' SER . 34.5 mt -62.42 -46.78 95.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.032 0.444 . . . . 0.0 110.75 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.7 t0 49.99 -97.25 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.197 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -150.71 85.36 5.25 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.491 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.71 151.46 41.07 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.495 2.13 . . . . 0.0 111.362 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' O ' HG23 ' A' ' 69' ' ' VAL . 53.8 t0 -62.46 163.15 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.8 mm? -77.65 -13.63 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 121.921 -0.487 . . . . 0.0 111.069 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.35 -48.38 70.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.405 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -74.17 -21.83 59.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.889 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 65' ' ' ASP . 85.7 t -78.07 -53.25 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.756 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.47 84.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.512 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.471 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 52.4 t-20 -76.13 -11.21 59.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.927 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 145.27 38.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.429 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.4 m -139.51 80.45 1.78 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.015 0.436 . . . . 0.0 111.261 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.524 HD13 ' OD1' ' A' ' 102' ' ' ASN . 51.9 tp -80.16 147.4 31.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.52 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.54 133.69 49.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.922 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 79' ' ' VAL . 15.7 tptm -79.89 -6.44 57.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.249 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -80.74 -10.63 59.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.98 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -94.24 5.77 50.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 76' ' ' LYS . 8.3 p -80.62 136.47 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.97 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.411 HD13 ' HB2' ' A' ' 96' ' ' LYS . 7.5 pt -119.2 -10.49 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.72 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.44 -170.09 37.94 Favored Glycine 0 C--N 1.316 -0.545 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -147.15 152.34 38.29 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.416 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.2 tt -123.99 121.1 61.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 t -124.63 130.75 53.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.909 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 141' ' ' LEU . 16.5 mt -135.15 126.77 17.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.819 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -82.26 -35.49 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.358 2.039 . . . . 0.0 112.5 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.506 ' OG ' HD23 ' A' ' 141' ' ' LEU . 2.3 t -51.14 -40.09 57.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.844 -177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.4 m -115.49 -4.24 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-O 120.637 0.256 . . . . 0.0 110.903 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.18 49.9 1.9 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.4 tp -111.32 129.74 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.656 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -136.72 113.7 10.5 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 83' ' ' ILE . 54.3 mt -145.69 107.71 4.36 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.2 Cg_endo -41.66 135.46 3.33 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 121.77 1.647 . . . . 0.0 110.659 176.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.17 125.1 39.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 74' ' ' LEU . 20.5 mt -108.86 120.83 43.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.193 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 80' ' ' ILE . 88.4 tttt -66.72 -47.43 72.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.708 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.439 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 54.6 p -69.8 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.1 p -84.43 107.68 16.83 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.283 0.564 . . . . 0.0 110.214 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 p -137.08 166.32 23.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.026 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.442 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 16.9 pt-20 -61.9 -35.43 78.33 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.681 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -82.92 -37.62 23.94 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.559 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.524 ' OD1' HD13 ' A' ' 74' ' ' LEU . 76.7 m-20 -67.22 -22.88 65.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.637 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.88 -13.41 61.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.482 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.9 mp -76.92 -14.35 59.88 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.9 m -106.19 -15.63 14.81 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 172.98 -176.05 45.83 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 119.88 -1.153 . . . . 0.0 111.71 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.22 129.58 38.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.248 -0.476 . . . . 0.0 109.862 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.48 144.53 31.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.752 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.7 p -73.84 146.94 43.76 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.65 -46.69 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -91.02 144.28 25.83 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.806 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.71 -5.07 35.21 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.859 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 113' ' ' ASN . 61.2 t-20 -142.15 41.47 1.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.688 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -84.03 155.54 22.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -134.29 128.19 51.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.873 0.368 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.72 126.23 30.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 98.05 -6.12 61.77 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -137.21 118.99 15.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.668 0.271 . . . . 0.0 110.78 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.98 -172.85 54.07 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.506 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 55.8 t30 -82.54 111.72 18.8 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -85.18 103.07 13.83 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.36 121.52 32.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.367 0.604 . . . . 0.0 111.412 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.1 mt -117.76 131.86 56.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.85 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.62 140.62 46.08 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.482 0.658 . . . . 0.0 110.712 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.02 -178.07 20.33 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.814 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 30.2 m-70 -83.5 131.23 35.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.231 0.539 . . . . 0.0 110.863 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.9 p30 -101.52 27.02 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.4 mmm -46.05 -14.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.957 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 41.67 17.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.875 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -133.8 106.85 7.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.081 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -50.69 125.93 14.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.547 0.689 . . . . 0.0 109.985 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.25 -26.1 10.69 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.946 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.788 HG12 ' H ' ' A' ' 134' ' ' LEU . 35.4 t -83.4 178.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.39 0 CA-C-N 117.736 0.768 . . . . 0.0 109.13 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.788 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.17 138.56 47.72 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.178 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 45.64 31.99 1.08 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.057 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.2 p -80.58 -12.31 59.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -138.56 35.94 2.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 140' ' ' SER . 8.8 pt -67.67 -41.51 85.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.668 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.09 2.09 1.69 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.961 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 138' ' ' ILE . 13.3 t -89.23 -21.65 23.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.506 HD23 ' OG ' ' A' ' 87' ' ' SER . 12.2 mt -65.58 121.7 15.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.143 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.441 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.7 mtmt -96.99 157.71 15.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.555 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -57.62 125.89 24.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.321 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.83 19.04 23.35 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 89.6 m-20 -89.86 133.24 34.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.75 134.74 37.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.337 0.589 . . . . 0.0 111.723 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 73.0 mt -127.66 124.25 62.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.379 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -105.26 122.09 45.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.024 0.44 . . . . 0.0 110.218 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.68 153.21 32.73 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.093 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -121.12 130.87 53.94 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.316 0.579 . . . . 0.0 111.334 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 23.9 t0 -112.8 -167.07 1.14 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.7 m-20 -24.48 -74.77 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.449 0.468 . . . . 0.0 111.705 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -137.97 28.58 2.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -125.59 151.38 46.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -112.03 122.04 46.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.741 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' A' ' 117' ' ' GLY . 47.2 m-85 -105.52 127.9 53.27 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.108 0.48 . . . . 0.0 111.791 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.6 mt-10 -97.64 118.74 34.85 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -115.86 145.11 43.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.219 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.3 128.69 54.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.24 0.543 . . . . 0.0 110.374 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.1 t -68.46 135.59 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.066 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 8.5 p -100.33 -22.86 14.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 124.378 1.049 . . . . 0.0 110.16 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 152.97 -178.51 30.03 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.833 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.8 p -124.2 143.01 39.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.318 -0.941 . . . . 0.0 109.893 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.8 t -136.77 148.08 47.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 111.107 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -105.13 113.01 26.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.239 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -131.33 159.44 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.1 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.0 p -71.22 142.59 87.32 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.568 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.5 Cg_endo -48.42 -16.24 0.65 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.862 1.708 . . . . 0.0 111.772 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 61.6 t0 -83.32 -11.55 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.91 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.521 ' O ' HG22 ' A' ' 173' ' ' VAL . 19.9 tptt -83.47 62.47 6.8 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 110.468 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.568 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 45.7 m95 -73.06 -21.13 60.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.675 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -51.12 -9.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.102 0.477 . . . . 0.0 110.947 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 170' ' ' LYS . 27.4 m -77.15 -29.26 17.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.917 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.457 HG11 HD13 ' A' ' 185' ' ' ILE . 1.7 m -107.2 -0.65 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.618 0.723 . . . . 0.0 109.938 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 176' ' ' ASP . 76.3 mm-40 -82.28 117.44 22.38 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.785 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.0 p-10 -27.71 123.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.872 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -99.62 -37.63 9.06 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.62 33.2 0.62 Allowed Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -154.72 177.14 11.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.129 0.49 . . . . 0.0 111.68 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.06 88.96 7.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.37 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -128.74 167.42 17.3 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.831 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.6 tt -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.603 ' C ' HD12 ' A' ' 184' ' ' LEU . 3.2 m -136.74 127.34 27.0 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.603 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.18 128.95 56.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.404 0.621 . . . . 0.0 110.778 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.457 HD13 HG11 ' A' ' 174' ' ' VAL . 8.7 pt -139.93 -167.68 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.923 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.552 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 3.3 t -139.94 157.12 46.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.414 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 18.7 t -78.04 155.3 30.74 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.017 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.629 HG11 HH22 ' A' ' 196' ' ' ARG . 3.1 p -135.31 152.33 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.394 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 59' ' ' SER . 55.1 m -147.57 -134.5 0.07 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.22 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.79 -23.42 32.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.491 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.73 -47.39 84.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.942 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 47.0 t0 47.71 72.95 0.22 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.061 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 195' ' ' LYS . 66.0 t30 -64.21 153.28 38.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.301 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 t -59.06 -43.69 91.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 110.55 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.542 ' O ' ' ND2' ' A' ' 193' ' ' ASN . 60.9 pttt -145.54 149.16 34.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.496 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.629 HH22 HG11 ' A' ' 188' ' ' VAL . 43.7 ttm180 -111.87 128.62 56.19 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.275 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -77.12 132.61 38.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.701 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.63 135.04 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.01 128.41 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.537 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.91 139.3 51.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.272 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.36 152.25 21.1 Favored Glycine 0 C--O 1.226 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.772 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -107.45 147.2 30.75 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.2 -0.5 . . . . 0.0 111.635 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 43.5 tp -69.83 126.28 29.25 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 121.097 0.475 . . . . 0.0 110.622 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -106.65 -26.65 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.745 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.32 161.88 21.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.05 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 207' ' ' LYS . 88.0 m -139.17 157.69 45.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.363 0.602 . . . . 0.0 110.11 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.436 ' N ' HG22 ' A' ' 206' ' ' THR . 20.1 ptmt -149.08 178.79 8.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.384 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.33 147.25 23.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.78 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -76.9 78.95 3.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.714 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.716 178.678 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.8 p -75.29 158.7 32.46 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -82.0 -17.75 45.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 0.0 110.78 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.9 mtm -83.08 144.86 29.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.72 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -66.89 138.58 57.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.881 0.372 . . . . 0.0 110.199 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.31 -41.17 73.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.075 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.9 m -86.37 -91.09 0.1 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.437 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 53.3 27.96 6.75 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.058 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 63' ' ' GLN . 36.6 mt -63.07 -48.64 86.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.15 0.5 . . . . 0.0 110.966 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 43.65 -92.5 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.33 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' ILE . 5.3 pt20 -150.89 86.41 4.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.332 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.43 150.95 47.25 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.323 2.016 . . . . 0.0 111.648 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -75.73 159.15 31.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.864 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.68 -23.63 66.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.26 -39.7 92.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.715 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 97.0 mt-10 -73.46 -35.31 65.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.477 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.7 t -76.92 -42.96 32.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.755 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.83 91.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.698 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.4 p-10 -84.95 -17.87 36.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.44 111.62 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.961 0.41 . . . . 0.0 110.875 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.1 m -95.46 118.46 32.23 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.228 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.66 HD11 ' NE2' ' A' ' 78' ' ' GLN . 47.9 tp -116.14 131.16 57.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.061 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.54 134.82 51.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.126 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 79' ' ' VAL . 70.4 mmtt -75.83 -9.29 58.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 110.254 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.4 -12.66 61.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.037 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.66 ' NE2' HD11 ' A' ' 74' ' ' LEU . 25.2 mt-30 -95.51 12.72 28.48 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.221 0.534 . . . . 0.0 111.028 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 76' ' ' LYS . 5.4 p -90.45 128.83 42.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.741 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -120.9 -5.39 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 120.896 0.379 . . . . 0.0 111.88 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.32 -170.87 41.74 Favored Glycine 0 C--N 1.315 -0.633 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.918 HH12 ' HZ3' ' A' ' 209' ' ' LYS . 30.0 mtt85 -147.34 156.6 43.05 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.477 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.581 HD12 HD13 ' A' ' 123' ' ' LEU . 8.2 tt -123.63 128.28 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.427 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.1 t -128.24 130.2 47.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.47 128.88 19.36 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.399 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.17 -34.61 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.291 1.994 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.3 m -47.36 -39.51 15.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.457 -177.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -119.86 -1.72 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.781 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.7 p 63.6 50.4 2.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.081 0.943 . . . . 0.0 108.562 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.418 HD11 HD23 ' A' ' 92' ' ' LEU . 33.7 tp -113.51 133.63 55.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.397 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.822 ' O ' HD22 ' A' ' 92' ' ' LEU . 80.9 tt0 -135.81 111.4 9.26 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.8 OUTLIER -138.29 113.46 8.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.2 Cg_endo -41.6 147.46 0.39 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.835 1.69 . . . . 0.0 110.419 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.9 124.57 53.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -105.0 125.47 51.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.004 0.431 . . . . 0.0 110.631 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.46 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 61.2 tttp -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 110.752 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.465 ' OG ' ' OD1' ' A' ' 102' ' ' ASN . 84.7 p -71.45 103.48 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 96.31 9.57 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.608 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.5 p -134.31 160.89 36.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.947 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -57.53 -33.49 68.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.6 -45.65 21.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 0.0 111.487 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.608 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.2 m-80 -67.2 -35.38 79.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.696 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.5 mt -61.69 -17.42 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.814 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.07 -16.79 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.4 t -107.93 -9.73 15.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' CA ' HD12 ' A' ' 92' ' ' LEU . . . 171.63 175.46 39.96 Favored Glycine 0 N--CA 1.461 0.327 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.446 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -72.18 127.57 32.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.008 -0.596 . . . . 0.0 109.785 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.27 150.52 24.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.893 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -72.84 150.24 42.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.1 t -84.49 -49.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -91.81 143.15 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 110.778 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.46 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 tt0 -61.92 -49.95 74.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.798 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -95.89 49.52 1.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.168 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 3.9 tt0 -89.15 151.47 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.2 127.6 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.966 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 129.39 36.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.812 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.03 -6.83 62.22 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -143.59 126.89 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.961 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 77.24 -162.41 51.26 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.536 HD22 ' CE1' ' A' ' 177' ' ' HIS . 41.0 t-20 -93.53 108.9 20.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -86.05 100.23 12.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.425 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.54 126.02 35.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.252 0.549 . . . . 0.0 111.043 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.581 HD13 HD12 ' A' ' 83' ' ' ILE . 9.3 mt -119.79 131.2 55.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.819 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.37 140.03 47.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.365 0.602 . . . . 0.0 110.553 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 187' ' ' CYS . . . -143.78 -178.49 19.58 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.405 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.42 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -84.04 141.84 30.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.999 0.428 . . . . 0.0 110.736 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 61.7 t30 -109.1 28.39 8.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.185 0.517 . . . . 0.0 110.078 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.7 mmm -43.53 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.775 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.3 m 57.74 38.48 27.44 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.821 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.03 107.49 8.28 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.007 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -51.63 122.29 7.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.36 0.6 . . . . 0.0 110.045 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.12 21.82 6.48 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.316 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.737 HG12 ' H ' ' A' ' 134' ' ' LEU . 24.0 t -136.57 176.61 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.737 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -69.62 130.67 43.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.896 0.379 . . . . 0.0 110.362 -178.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.2 m-85 48.44 36.39 7.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.172 0.51 . . . . 0.0 110.585 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -82.35 -10.37 59.1 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 136' ' ' SER . 72.3 m-20 -150.33 31.91 0.66 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.6 pt -70.63 -21.02 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.803 0.335 . . . . 0.0 111.567 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.6 5.1 8.0 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.481 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -99.51 -10.3 22.28 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.25 0.548 . . . . 0.0 109.679 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.429 ' O ' HG21 ' A' ' 163' ' ' VAL . 17.8 mt -64.27 126.37 27.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.618 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.3 mttp -96.76 159.66 14.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.531 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -58.15 132.33 53.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.105 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.9 21.65 57.07 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 19.2 m-20 -79.35 135.23 36.66 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -78.96 121.74 25.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 111.979 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.32 120.82 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.132 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -103.24 117.7 35.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.198 0.523 . . . . 0.0 109.806 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.2 tp -112.35 144.33 41.96 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.132 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.42 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 60.8 m-85 -108.21 131.68 54.43 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.273 0.559 . . . . 0.0 111.672 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -104.77 -172.51 2.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.027 177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.5 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.1 m-20 -36.39 -63.26 0.4 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.161 0.505 . . . . 0.0 111.121 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -137.55 24.34 2.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.77 152.91 47.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -115.38 121.77 43.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.781 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -104.06 132.37 50.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.29 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -95.5 114.74 26.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -114.6 141.37 47.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.2 132.02 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.606 0.717 . . . . 0.0 111.309 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.01 134.06 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.898 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -102.86 -28.11 12.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 124.625 1.203 . . . . 0.0 110.818 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.24 141.08 3.12 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.94 -1.124 . . . . 0.0 111.877 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 199' ' ' VAL . 13.1 t -106.28 147.73 11.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.487 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 84.3 p -157.26 167.5 30.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.286 0.565 . . . . 0.0 111.638 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -118.15 120.6 38.21 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.55 158.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 111.3 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.4 p -57.21 165.47 1.95 Allowed Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.2 Cg_endo -82.03 -9.43 11.79 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 121.967 1.778 . . . . 0.0 111.913 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 63.2 t0 -83.38 -10.53 58.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.388 . . . . 0.0 110.449 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.581 ' O ' HG22 ' A' ' 173' ' ' VAL . 38.1 mmtt -85.93 64.33 8.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.798 0.332 . . . . 0.0 110.69 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.552 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 86.8 m95 -73.33 -10.11 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.457 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 80.9 mm-40 -59.93 -35.41 74.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.188 0.518 . . . . 0.0 110.975 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.849 HG23 HG13 ' A' ' 174' ' ' VAL . 4.7 m -65.68 -8.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.243 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.849 HG13 HG23 ' A' ' 173' ' ' VAL . 17.5 m -136.0 43.04 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 176' ' ' ASP . 48.8 mm-40 -144.8 107.24 4.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.733 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.484 ' C ' ' O ' ' A' ' 175' ' ' GLU . 41.0 p-10 4.27 112.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.65 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.536 ' CE1' HD22 ' A' ' 120' ' ' ASN . 40.4 m80 -102.91 -42.49 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.883 0.373 . . . . 0.0 111.028 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 136.32 29.82 0.32 Allowed Glycine 0 N--CA 1.47 0.92 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 17.9 ptpt -153.83 173.12 16.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 8.7 p30 -95.19 88.34 5.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.836 0.827 . . . . 0.0 110.181 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -130.12 174.72 9.53 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.552 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.8 tt -130.89 143.12 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.174 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.601 ' C ' HD12 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -137.79 124.08 20.56 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.313 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -111.57 131.13 55.47 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.235 0.54 . . . . 0.0 110.695 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.669 HG21 HG11 ' A' ' 174' ' ' VAL . 7.5 pt -138.53 171.53 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.952 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 60.5 p -76.55 169.32 18.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.129 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.492 ' N ' ' O ' ' A' ' 125' ' ' GLY . 16.7 m -39.24 -87.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.105 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.422 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 11.3 p -168.21 -24.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.215 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 188' ' ' VAL . 0.7 OUTLIER 60.88 119.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.047 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.1 -45.53 98.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.791 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -136.21 -179.23 5.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.691 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -63.27 138.14 58.43 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -159.42 -125.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.9 0.381 . . . . 0.0 110.827 -178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.2 p -69.77 156.79 38.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.06 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -65.38 126.86 29.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.576 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.422 ' NH2' ' O ' ' A' ' 188' ' ' VAL . 42.1 ttm180 -80.1 138.31 36.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.067 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.69 138.47 43.86 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.532 HG12 HG22 ' A' ' 185' ' ' ILE . 31.4 m -135.38 138.18 48.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.439 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.494 HG22 HG13 ' A' ' 163' ' ' VAL . 76.1 t -117.18 128.8 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.342 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.95 135.22 54.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.087 0.47 . . . . 0.0 110.346 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.77 156.96 24.52 Favored Glycine 0 N--CA 1.461 0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.574 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -112.19 153.82 26.48 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.049 -0.576 . . . . 0.0 111.396 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.433 HD11 ' O ' ' A' ' 205' ' ' GLY . 39.4 tp -73.87 128.06 34.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.256 0.551 . . . . 0.0 110.574 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 38.1 t -109.06 -25.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.931 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.433 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.52 175.03 46.7 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 119.972 -1.108 . . . . 0.0 112.155 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.0 m -153.78 152.31 30.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.143 0.496 . . . . 0.0 110.826 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -150.14 177.14 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.492 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.19 145.19 24.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.099 0.476 . . . . 0.0 110.718 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.918 ' HZ3' HH12 ' A' ' 82' ' ' ARG . 88.3 tttt -74.44 79.69 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.904 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt . . . . . 0 C--N 1.314 -0.94 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.561 178.528 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' C ' ' N ' ' A' ' 55' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p 47.91 14.95 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.148 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.448 ' N ' ' C ' ' A' ' 53' ' ' GLY . 80.3 m80 47.31 88.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.516 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.423 ' HG2' ' H ' ' A' ' 57' ' ' ASP . 29.9 ttp -88.58 173.15 8.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.261 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' H ' ' HG2' ' A' ' 56' ' ' MET . 98.1 m-20 -63.43 140.36 58.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.024 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.76 -12.18 61.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.948 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 61' ' ' ILE . 24.0 p -87.44 32.56 0.71 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.876 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' C ' ' CD ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -70.41 31.31 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.613 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 63' ' ' GLN . 61.1 mt -59.83 -51.13 76.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.018 0.437 . . . . 0.0 110.833 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' OD2' ' NE2' ' A' ' 63' ' ' GLN . 66.1 t0 45.28 -91.4 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.185 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 61' ' ' ILE . 2.7 pt20 -148.37 90.56 4.92 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.824 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.5 158.46 47.77 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.583 2.189 . . . . 0.0 111.213 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.17 165.21 24.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.659 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -69.51 -16.19 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.04 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.62 95.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.283 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 89.7 mt-10 -73.14 -33.46 65.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.665 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.1 t -74.37 -45.76 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.075 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.45 89.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.025 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.02 -28.46 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.589 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.79 107.42 0.83 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.804 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.3 m -95.98 115.31 27.24 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.289 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.0 tp -115.23 126.49 54.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.277 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -69.01 139.01 54.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.109 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.555 ' O ' HG12 ' A' ' 79' ' ' VAL . 13.9 mptt -76.13 -0.11 20.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 110.211 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -85.29 -8.99 58.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.143 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.533 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.0 mp0 -90.92 2.84 55.9 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.757 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 76' ' ' LYS . 11.1 p -87.64 138.66 18.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.821 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.6 pt -120.82 -5.27 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.781 -178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.89 33.14 Favored Glycine 0 C--N 1.321 -0.285 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -152.75 152.69 31.96 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.264 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 83' ' ' ILE . 17.9 tt -126.1 130.85 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.845 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 m -128.2 129.17 46.05 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.002 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 67.5 mt -133.59 127.83 19.77 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.543 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.65 -34.18 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.452 2.102 . . . . 0.0 112.285 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.1 p -46.98 -38.73 11.18 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.534 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.7 p -119.93 -0.34 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.852 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 63.81 52.68 2.11 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.7 tp -116.97 132.81 56.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.372 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -134.67 117.65 16.3 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -143.85 161.73 44.58 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.12 155.6 7.0 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.851 2.367 . . . . 0.0 108.901 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 118.24 52.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.416 ' CB ' HD22 ' A' ' 102' ' ' ASN . 10.1 mt -100.21 124.14 45.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -65.35 -48.56 72.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.807 0.337 . . . . 0.0 111.32 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.585 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 99.9 p -78.91 112.87 16.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.014 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.6 p -84.53 110.63 18.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.201 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.517 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 2.8 p -139.61 166.56 24.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.447 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.51 -31.07 70.94 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.121 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -81.39 -44.09 18.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.972 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.3 p-10 -66.38 -31.67 72.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.201 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.39 -21.02 66.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.43 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.21 -18.45 61.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -97.54 -13.15 21.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 170.06 -147.98 11.29 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.658 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.27 129.56 45.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.972 -0.614 . . . . 0.0 110.25 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 102' ' ' ASN . . . -107.91 148.1 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.4 p -70.39 148.25 48.6 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 185' ' ' ILE . 26.0 t -82.86 -40.26 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -90.29 149.53 22.31 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.011 0.434 . . . . 0.0 111.077 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.43 -18.61 64.9 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.908 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -144.77 55.95 1.26 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.012 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.565 ' NE2' ' N ' ' A' ' 122' ' ' ALA . 2.4 tt0 -80.67 156.36 26.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.938 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.9 t -136.0 124.35 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.722 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.83 127.24 32.31 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 99.12 -8.38 60.86 Favored Glycine 0 N--CA 1.46 0.237 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -135.27 117.77 15.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.69 -167.53 54.75 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.48 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 63.8 t30 -86.65 112.54 21.71 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -85.03 103.47 14.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.03 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.565 ' N ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.42 122.92 33.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.362 0.601 . . . . 0.0 111.511 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.406 HD13 HD12 ' A' ' 83' ' ' ILE . 15.3 mt -118.34 132.05 56.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.287 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.36 48.7 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.381 0.61 . . . . 0.0 111.015 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.64 -178.23 16.93 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.541 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.4 ' HD2' HD12 ' A' ' 134' ' ' LEU . 78.8 m-70 -84.24 145.79 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.649 0.261 . . . . 0.0 110.845 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 129' ' ' SER . 54.4 t-20 -110.8 28.45 8.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.9 mmt -43.98 -15.51 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.959 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.0 OUTLIER 58.87 39.14 24.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.303 178.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -133.82 107.65 8.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.611 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.9 tttp -50.28 126.9 15.97 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.745 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.72 -23.8 12.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.818 HG12 ' H ' ' A' ' 134' ' ' LEU . 17.4 t -87.94 179.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.818 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.21 136.69 48.17 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.258 -177.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.414 ' HA ' HG23 ' A' ' 138' ' ' ILE . 3.4 m-85 44.18 34.02 0.92 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.231 0.538 . . . . 0.0 110.989 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 p -82.38 -9.78 59.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.199 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -149.1 34.99 0.74 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.414 HG23 ' HA ' ' A' ' 135' ' ' PHE . 6.8 pt -69.89 -28.12 35.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.869 0.366 . . . . 0.0 111.771 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.61 0.86 4.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.606 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -92.93 -13.82 28.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.027 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.7 mt -64.83 122.92 18.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.397 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 68.3 mttm -95.63 157.77 15.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.574 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -55.64 133.0 50.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.796 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.6 18.29 62.24 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 16.8 m-20 -79.58 135.06 36.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -81.47 128.01 33.42 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.511 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.0 mt -123.38 121.7 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -101.06 119.33 38.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.978 0.418 . . . . 0.0 110.043 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.2 tp -118.07 138.26 52.36 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -106.01 135.65 47.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.07 0.462 . . . . 0.0 111.48 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 46.7 t0 -109.89 -169.83 1.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 64.8 t30 -33.67 -67.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.26 0.552 . . . . 0.0 111.099 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.89 23.78 3.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.107 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.05 147.06 49.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.575 0.702 . . . . 0.0 112.712 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.543 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 90.7 mt-10 -108.57 122.25 46.69 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.823 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.494 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 34.5 m-85 -105.02 128.29 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.114 0.483 . . . . 0.0 111.773 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -95.5 115.87 28.03 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -116.02 140.94 48.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.461 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.26 134.35 55.17 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.484 0.659 . . . . 0.0 110.846 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.62 133.97 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -101.81 -25.84 13.68 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 124.76 1.287 . . . . 0.0 111.088 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.31 145.61 4.39 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.663 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 163' ' ' VAL . 3.7 p -104.56 151.56 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -154.02 162.64 41.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.129 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.532 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 70.3 mt-10 -111.98 117.81 33.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.08 158.52 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 111.335 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 54.5 p -59.67 168.72 1.74 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.445 ' HA ' HH11 ' A' ' 196' ' ' ARG . 2.8 Cg_endo -81.47 -10.69 12.05 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.948 1.765 . . . . 0.0 111.944 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.22 -3.06 58.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.202 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.6 68.32 9.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 110.865 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.425 ' C ' ' N ' ' A' ' 173' ' ' VAL . 70.7 m95 -70.48 -29.86 66.5 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.765 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 56.0 mp0 -49.23 -17.71 0.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.204 0.526 . . . . 0.0 110.537 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.425 ' N ' ' C ' ' A' ' 171' ' ' TRP . 90.4 t -71.48 -23.76 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.577 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.421 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -107.86 -7.37 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.608 0.718 . . . . 0.0 109.679 -178.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -79.77 139.0 37.43 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.823 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -51.24 128.59 22.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.174 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -99.15 -39.59 8.4 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.035 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.89 29.0 0.37 Allowed Glycine 0 N--CA 1.473 1.156 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -156.63 -179.33 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.351 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -91.1 88.85 7.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.368 0.604 . . . . 0.0 109.833 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -124.33 168.31 13.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.077 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.8 tt -131.72 142.75 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.951 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 184' ' ' LEU . 9.4 m -136.84 123.35 20.87 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.388 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -109.04 122.81 48.04 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.32 0.581 . . . . 0.0 110.92 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.513 HD11 HG21 ' A' ' 110' ' ' VAL . 27.9 pt -134.92 -167.46 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.953 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 34.1 p -134.77 159.57 40.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.781 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.402 ' SG ' HD12 ' A' ' 61' ' ' ILE . 7.5 t -79.53 125.97 30.27 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.914 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.2 157.33 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.69 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.0 p -162.16 10.08 0.07 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.957 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.2 t -117.96 128.99 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.779 0.324 . . . . 0.0 110.254 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -80.15 126.88 31.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.908 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -168.1 179.36 4.62 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.961 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.81 12.71 22.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.956 0.408 . . . . 0.0 111.103 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.9 p -68.89 156.78 37.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.287 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -106.92 136.46 46.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.485 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.445 HH11 ' HA ' ' A' ' 168' ' ' PRO . 55.5 ttp180 -98.12 133.08 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.891 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.532 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.6 m-85 -91.03 129.12 37.06 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.679 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 138.71 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.258 0.551 . . . . 0.0 111.48 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.74 127.71 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.556 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.11 135.32 54.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.167 0.508 . . . . 0.0 110.457 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.44 158.92 24.26 Favored Glycine 0 N--CA 1.465 0.594 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 55.4 p-10 -113.74 150.24 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.387 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 40.0 tp -72.07 127.62 33.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.086 0.469 . . . . 0.0 111.017 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.6 t -106.34 -25.6 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.329 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.29 162.12 20.92 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.421 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.494 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 81.1 m -139.51 157.63 45.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.189 0.518 . . . . 0.0 110.032 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.543 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 19.4 pttp -149.91 178.54 8.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.098 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.6 143.63 26.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -71.28 79.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.702 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.691 178.461 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.974 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.9 m -58.6 -42.86 89.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.802 0.334 . . . . 0.0 110.556 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -80.21 139.59 36.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.145 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.9 mtm -138.2 150.36 46.68 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.231 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -80.9 107.01 13.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.349 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.4 -12.73 60.91 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.277 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 61' ' ' ILE . 3.2 t -86.83 10.67 15.32 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.933 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -65.71 26.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.63 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 59' ' ' SER . 45.7 mt -90.88 -67.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.433 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.6 t0 59.5 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.072 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 61' ' ' ILE . 4.9 pt20 -151.82 72.47 8.02 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.019 -179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.09 146.53 0.62 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.501 2.134 . . . . 0.0 110.895 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.76 154.81 41.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.717 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.4 mp -59.4 -27.61 66.16 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.689 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.46 94.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.279 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.8 mt-10 -72.58 -37.49 68.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.732 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.5 t -72.0 -44.29 66.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.574 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.96 89.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.024 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.33 -26.69 30.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.674 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.44 136.8 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.9 t -92.36 158.55 16.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.529 HD13 ' CB ' ' A' ' 105' ' ' SER . 55.6 tp -122.7 127.22 48.98 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.0 0.428 . . . . 0.0 111.06 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -96.1 98.26 10.21 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.564 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.419 ' C ' ' N ' ' A' ' 78' ' ' GLN . 29.0 mmtp -55.84 -35.51 66.49 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.119 0.485 . . . . 0.0 110.364 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -51.56 -13.06 0.2 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.035 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 97' ' ' SER . 23.8 mm100 -102.55 11.09 38.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.476 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.77 124.95 44.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.943 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.5 pt -119.39 -4.57 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.171 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.03 -162.29 35.59 Favored Glycine 0 C--N 1.315 -0.595 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -155.97 165.36 36.68 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.574 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.8 tt -131.35 139.65 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.796 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.2 m -131.66 132.84 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.053 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.1 mt -131.03 127.0 21.91 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.95 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.84 -38.13 0.17 Allowed 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.256 1.971 . . . . 0.0 112.314 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.2 t -46.97 -39.55 12.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.586 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 90' ' ' LEU . 1.3 p -117.9 -2.5 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.422 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.68 55.38 2.73 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -120.77 138.49 53.99 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.559 -177.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.553 ' N ' ' OE1' ' A' ' 91' ' ' GLU . 55.8 mp0 -138.98 120.1 14.6 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.593 HD22 ' HA2' ' A' ' 106' ' ' GLY . 35.4 mt -143.37 109.55 5.33 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -177.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -40.74 139.48 1.28 Allowed 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 121.887 1.724 . . . . 0.0 109.924 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.3 t -90.39 118.2 35.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.1 mt -102.37 121.73 42.87 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.058 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -64.83 -47.54 77.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.121 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 78' ' ' GLN . 70.3 m -69.7 102.13 1.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.311 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 98' ' ' SER . 25.2 p -81.15 98.6 8.12 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.457 0.646 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.6 p -136.59 157.79 45.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.499 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -56.38 -29.19 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -81.98 -43.58 17.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.226 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.34 -34.45 78.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 15.0 mt -63.21 -21.31 66.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.806 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 mt -69.66 -26.51 64.43 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.529 ' CB ' HD13 ' A' ' 74' ' ' LEU . 23.4 m -93.85 -10.99 32.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.593 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 165.62 -170.81 40.63 Favored Glycine 0 N--CA 1.458 0.149 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.658 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.32 129.2 37.34 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.79 -0.705 . . . . 0.0 110.116 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.12 148.13 28.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.424 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.8 p -70.32 143.41 52.01 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.52 HG21 HD11 ' A' ' 185' ' ' ILE . 7.6 t -83.76 -44.64 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.414 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 55.3 mtpt -89.43 -172.86 3.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.824 0.345 . . . . 0.0 110.897 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.6 pm0 -119.48 -9.15 9.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.055 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -139.63 39.21 2.03 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.39 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.414 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 7.4 pt20 -91.09 157.25 17.34 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.861 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.48 131.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.896 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.9 mtt -67.58 128.83 37.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.58 2.46 76.08 Favored Glycine 0 N--CA 1.463 0.466 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -141.83 121.84 13.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.729 0.299 . . . . 0.0 111.107 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.83 -165.73 54.76 Favored Glycine 0 CA--C 1.517 0.218 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -89.86 109.05 20.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.59 101.77 12.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.918 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.57 128.69 36.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.423 0.63 . . . . 0.0 111.739 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -126.0 131.95 52.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.553 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.81 140.85 46.11 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.58 0.705 . . . . 0.0 111.096 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.1 -179.36 18.31 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.738 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -81.93 153.35 26.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 129' ' ' SER . 57.6 t30 -122.36 28.02 7.64 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.007 0.432 . . . . 0.0 111.208 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 31.9 mtt -43.82 -15.0 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.616 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.8 OUTLIER 59.95 38.07 21.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.067 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 136' ' ' SER . 1.6 tppp? -134.13 121.07 20.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.835 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.18 125.66 24.51 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.981 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.98 -25.07 11.08 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.347 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 134' ' ' LEU . 95.1 t -80.39 176.43 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.721 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -74.55 136.6 42.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 46.52 30.66 1.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.095 0.474 . . . . 0.0 110.953 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.16 -8.23 59.72 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.213 -178.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.9 m-20 -143.99 36.3 1.26 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.9 pt -69.46 -30.05 44.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 120.919 0.39 . . . . 0.0 111.971 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.08 1.69 7.0 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.807 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 t -92.18 -15.82 27.08 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.998 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.3 mt -65.99 119.51 11.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.556 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 53.3 mtmt -96.33 156.28 16.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.657 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -56.46 121.77 10.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.61 19.0 14.38 Favored Glycine 0 N--CA 1.466 0.694 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 86.5 m-20 -90.28 131.31 36.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.0 mmtm -79.64 135.22 36.51 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.08 0.467 . . . . 0.0 111.574 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 158' ' ' TYR . 89.3 mt -129.31 121.78 54.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.28 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.39 120.48 40.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.1 tp -116.71 142.86 46.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.181 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.226 0.536 . . . . 0.0 111.499 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.503 ' O ' ' C ' ' A' ' 152' ' ' ASN . 34.7 t0 -112.09 -165.38 0.99 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.0 m-20 -22.4 -75.74 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.729 0.643 . . . . 0.0 111.479 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -138.26 27.23 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.002 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -125.62 142.34 51.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -108.43 121.41 44.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.903 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.433 ' CE2' HG21 ' A' ' 206' ' ' THR . 79.6 m-85 -105.2 131.25 52.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.55 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -94.43 115.91 28.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.433 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.2 m-85 -117.39 136.65 53.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.589 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.34 133.87 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.482 0.658 . . . . 0.0 111.0 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.22 135.33 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.887 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.3 t -106.14 -24.83 12.24 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 124.995 1.434 . . . . 0.0 111.178 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.56 155.01 7.5 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.623 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.9 144.28 14.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.2 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.8 m -138.64 151.36 47.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.102 0.477 . . . . 0.0 111.298 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -106.02 110.26 22.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.314 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.2 m -130.74 153.03 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.382 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.2 p -64.11 168.48 6.09 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.8 Cg_endo -80.97 -12.63 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.923 1.748 . . . . 0.0 111.926 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -85.47 -21.53 28.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.096 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -86.64 76.5 9.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.501 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.543 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 27.1 m95 -75.35 -12.69 60.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.244 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -51.05 -8.1 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' A' ' 171' ' ' TRP . 32.8 m -90.21 -15.54 8.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.683 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.646 HG11 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER -120.62 -0.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.724 0.773 . . . . 0.0 109.709 -178.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -83.43 143.66 30.12 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.844 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.12 128.18 35.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.599 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -104.54 -41.88 5.59 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.757 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 138.73 31.08 0.21 Allowed Glycine 0 N--CA 1.473 1.114 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -154.03 174.72 14.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.879 0.371 . . . . 0.0 111.411 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 3.8 m-20 -91.55 89.62 7.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.736 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -123.17 169.79 10.89 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.851 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -131.61 142.72 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.794 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.571 ' C ' HD12 ' A' ' 184' ' ' LEU . 8.9 m -137.32 124.26 21.41 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.408 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -109.56 125.06 52.13 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.611 0.719 . . . . 0.0 110.902 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.646 HD13 HG11 ' A' ' 174' ' ' VAL . 8.4 pt -135.53 -170.98 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.608 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.594 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 52.1 p -138.35 144.55 40.39 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.724 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 186' ' ' THR . 5.1 t 54.72 107.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.36 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.558 HG23 ' N ' ' A' ' 189' ' ' SER . 17.2 m -61.17 -43.32 96.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.06 0.457 . . . . 0.0 110.782 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.558 ' N ' HG23 ' A' ' 188' ' ' VAL . 25.9 p -76.32 165.3 25.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.104 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 190' ' ' VAL . 15.8 m -80.44 130.69 35.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.065 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -94.84 160.89 14.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.566 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -61.34 -37.61 83.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.0 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -77.84 123.7 27.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.817 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 34.5 p -100.64 62.4 1.04 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.92 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -163.92 60.09 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.047 0.451 . . . . 0.0 111.731 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.594 ' NH1' ' O ' ' A' ' 186' ' ' THR . 12.0 ptp180 -92.94 167.73 11.62 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.925 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -106.68 139.85 40.47 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.011 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 24.6 t -133.46 135.43 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.265 0.555 . . . . 0.0 110.937 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.5 t -118.42 130.28 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.692 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 161' ' ' THR . . . -118.77 136.54 53.92 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.425 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.61 150.44 19.51 Favored Glycine 0 N--CA 1.466 0.679 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.023 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -105.47 143.78 33.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.15 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.504 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.6 tp -71.27 127.83 33.86 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.168 0.508 . . . . 0.0 110.698 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.2 t -108.4 -23.54 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.529 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.42 177.03 46.81 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.745 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 156' ' ' TYR . 21.8 m -154.03 151.63 29.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -150.31 179.27 8.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.603 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.83 144.42 25.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.023 0.439 . . . . 0.0 110.57 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.54 78.87 1.06 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.638 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt . . . . . 0 C--N 1.319 -0.739 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.329 178.167 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 m -69.98 145.57 51.74 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -152.82 160.97 43.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.031 0.443 . . . . 0.0 110.97 -178.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 50.4 mtt -64.18 -39.87 94.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.78 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' O ' ' CD2' ' A' ' 55' ' ' HIS . 31.3 t0 -140.68 164.58 29.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.335 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.481 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -68.35 -37.09 80.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.417 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.3 p -84.64 -85.78 0.13 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.385 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.3 tttt 46.95 29.91 1.14 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.029 0.442 . . . . 0.0 111.032 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.8 mt -62.02 -49.77 82.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.084 0.469 . . . . 0.0 110.781 -178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.0 t0 49.58 -94.26 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.313 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -150.76 86.63 4.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.619 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.79 150.41 44.45 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.43 2.086 . . . . 0.0 111.628 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 69' ' ' VAL . 48.0 t0 -76.33 172.48 12.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.452 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -61.08 -21.59 63.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.786 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.87 95.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.572 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.31 -20.49 57.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 65' ' ' ASP . 66.3 t -81.14 -51.67 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.686 -179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.9 90.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.967 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.45 -32.79 73.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.857 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 146.72 50.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.847 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.7 t -138.58 141.41 39.21 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.995 0.426 . . . . 0.0 110.794 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -138.43 121.64 16.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.289 -179.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.704 ' N ' HD13 ' A' ' 74' ' ' LEU . 96.2 m-20 -70.31 112.1 6.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.36 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.523 ' O ' HG22 ' A' ' 79' ' ' VAL . 28.4 mmtp -52.81 -9.11 0.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.511 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 75' ' ' ASP . 99.4 mttt -83.19 -4.38 58.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.771 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -95.12 10.41 35.94 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.706 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 76' ' ' LYS . 14.7 m -94.28 147.39 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.725 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.666 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -134.11 4.85 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.921 0.391 . . . . 0.0 111.695 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.5 38.25 Favored Glycine 0 C--N 1.322 -0.247 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -152.43 153.26 33.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.231 0.539 . . . . 0.0 111.582 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 83' ' ' ILE . 16.0 tt -128.66 130.29 68.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.617 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 m -128.61 129.46 45.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.11 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 19.0 mt -135.33 116.06 11.94 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.162 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 4.7 Cg_exo -78.35 -32.94 2.08 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 122.745 2.297 . . . . 0.0 112.843 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 t -50.36 -40.08 48.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.012 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.34 -6.68 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.819 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.23 47.64 0.28 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.4 tt -117.09 129.93 56.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.761 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.79 119.1 14.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.1 mt -146.59 166.29 17.11 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.72 153.86 8.81 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.072 2.514 . . . . 0.0 108.767 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 73.6 t -104.43 121.09 55.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.25 132.47 53.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -80.15 -29.9 38.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.991 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 m -79.03 102.42 8.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.128 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -80.9 97.93 7.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.332 0.587 . . . . 0.0 109.882 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.567 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.0 p -141.01 158.56 43.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.104 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.83 -37.77 77.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.821 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -69.94 -46.29 65.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.83 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.567 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.5 m-80 -65.51 -38.34 89.42 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.777 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.3 mt -59.73 -26.46 65.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.84 -14.14 61.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t -105.74 -13.13 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 175.24 -170.07 43.06 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.486 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.17 123.29 27.78 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.32 142.82 34.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.114 0.483 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.401 ' O ' ' OG ' ' A' ' 98' ' ' SER . 43.8 p -73.95 152.03 40.21 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.455 HG21 HD11 ' A' ' 185' ' ' ILE . 4.2 t -86.07 -42.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -89.51 -172.06 3.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.846 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -123.64 -8.62 7.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.977 0.418 . . . . 0.0 111.427 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -139.7 39.94 2.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.054 0.454 . . . . 0.0 111.286 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -93.46 159.86 15.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.007 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.1 t -132.87 133.49 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.009 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -67.63 127.75 33.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.172 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.52 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.35 5.75 72.04 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -143.56 124.13 14.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 0.0 110.992 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.98 -164.45 54.28 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.83 107.86 19.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 0.0 110.27 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.81 100.01 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.8 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.69 127.36 36.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 0.0 112.071 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.4 mt -122.88 130.4 52.82 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.77 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.12 139.29 47.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.623 0.725 . . . . 0.0 111.069 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.13 -178.49 19.01 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.601 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.533 ' O ' ' O ' ' A' ' 134' ' ' LEU . 44.6 m-70 -88.74 139.05 30.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.27 0.557 . . . . 0.0 110.843 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 34.0 p30 -108.2 27.26 9.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.215 0.531 . . . . 0.0 110.323 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.8 mmm -43.87 -14.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.987 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.62 40.91 9.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.009 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -131.7 108.41 9.46 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.744 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 44.0 pttt -51.07 125.65 14.35 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.319 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.4 -29.76 8.44 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.725 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.0 t -75.54 178.09 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.725 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -72.33 137.65 46.79 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.508 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.3 m-85 44.37 31.81 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 110.989 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.46 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 1.3 p -81.97 -12.94 58.1 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.293 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 136' ' ' SER . 95.9 m-20 -143.19 24.96 1.76 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.508 HD13 ' CD2' ' A' ' 135' ' ' PHE . 4.1 pt -69.02 -23.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.85 0.357 . . . . 0.0 111.687 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.78 4.83 3.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.648 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.2 m -96.91 -14.63 21.65 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.2 0.524 . . . . 0.0 109.638 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.484 ' O ' HG21 ' A' ' 163' ' ' VAL . 15.0 mt -62.43 132.27 51.97 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.352 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -106.97 175.18 5.59 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.946 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -69.51 135.47 50.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.07 17.68 71.51 Favored Glycine 0 N--CA 1.461 0.312 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.28 136.03 36.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -82.95 127.38 33.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.695 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.6 mt -122.72 123.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -103.82 115.63 30.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.838 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.18 148.86 38.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.931 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -123.44 133.61 54.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.399 0.619 . . . . 0.0 111.629 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -112.14 -165.5 1.0 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 151' ' ' ASP . 16.4 t-20 -23.99 -75.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 111.617 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -137.04 26.7 2.96 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -124.07 145.94 48.91 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -108.52 119.56 39.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.76 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.455 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.0 m-85 -104.42 129.33 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.61 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.477 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 97.7 mt-10 -95.73 117.73 31.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.021 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.52 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 50.6 m-85 -117.47 138.88 51.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.292 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' O ' ' OD1' ' A' ' 202' ' ' ASP . . . -115.69 132.08 56.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.501 0.667 . . . . 0.0 111.145 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.66 134.88 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.166 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -105.75 -25.49 12.18 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 124.431 1.082 . . . . 0.0 111.081 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.4 161.55 19.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.395 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.519 HG13 HG22 ' A' ' 199' ' ' VAL . 10.5 t -128.78 155.5 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.851 -0.674 . . . . 0.0 109.823 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.6 t -164.16 174.46 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 0.0 111.666 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.535 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 40.1 mp0 -121.88 117.13 25.74 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.8 159.06 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 p -62.82 167.12 6.32 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.22 -9.95 11.41 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.343 2.028 . . . . 0.0 111.922 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -81.34 -11.61 59.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.808 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -86.4 73.21 10.18 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.369 0.605 . . . . 0.0 109.72 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.527 ' C ' ' H ' ' A' ' 173' ' ' VAL . 81.9 m95 -72.48 -27.36 62.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.557 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -50.93 -9.1 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.122 0.487 . . . . 0.0 110.93 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 171' ' ' TRP . 59.8 t -78.25 -21.16 13.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.539 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.494 HG11 HD13 ' A' ' 185' ' ' ILE . 1.2 m -116.18 -3.65 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.745 0.783 . . . . 0.0 109.85 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -80.64 151.76 28.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.15 -1.387 . . . . 0.0 112.157 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -63.87 126.5 27.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.674 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -107.17 -43.8 4.52 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.317 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 150.34 23.3 0.06 OUTLIER Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -154.3 173.7 15.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.157 0.503 . . . . 0.0 111.156 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.4 m-20 -95.75 88.38 4.96 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.196 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -124.22 127.72 48.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.403 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -81.71 146.95 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.524 ' C ' HD12 ' A' ' 184' ' ' LEU . 7.2 m -136.29 122.09 19.88 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.772 0.32 . . . . 0.0 111.06 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -107.57 126.12 52.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.317 0.58 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.494 HD13 HG11 ' A' ' 174' ' ' VAL . 9.7 pt -137.55 178.19 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.663 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t -139.08 161.29 37.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.3 t 57.88 -170.69 0.11 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.738 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.9 t -136.41 -118.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.52 0.2 . . . . 0.0 111.003 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.1 m -82.95 -9.03 59.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.937 0.398 . . . . 0.0 110.874 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 89.3 t -68.77 132.07 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.183 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.01 -45.91 92.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.979 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.4 t0 48.1 -101.04 0.07 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.429 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -95.37 162.2 13.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.856 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 64.9 m -59.21 -44.92 92.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.002 0.43 . . . . 0.0 110.828 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -139.84 147.09 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.087 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -111.27 149.45 31.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.241 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.404 ' CE1' ' OE2' ' A' ' 165' ' ' GLU . 4.5 m-85 -80.37 132.9 35.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.85 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.1 133.92 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.041 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.519 HG22 HG13 ' A' ' 163' ' ' VAL . 82.0 t -117.2 128.62 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.446 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.491 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.45 135.62 53.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.6 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.77 142.53 14.04 Favored Glycine 0 N--CA 1.465 0.596 0 CA-C-O 121.773 0.652 . . . . 0.0 111.642 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 52.3 p-10 -100.32 141.56 32.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.294 -0.953 . . . . 0.0 111.409 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.18 126.16 28.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.19 0.519 . . . . 0.0 110.863 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 157' ' ' GLU . 6.2 m -109.46 -22.38 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.421 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.04 158.14 13.44 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.802 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.455 HG21 ' CE2' ' A' ' 156' ' ' TYR . 25.1 m -134.85 156.18 49.36 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.382 0.61 . . . . 0.0 109.778 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.477 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.8 ptpp? -149.66 178.81 8.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.278 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.69 147.1 23.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.509 . . . . 0.0 110.549 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -76.32 80.02 3.07 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.814 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 51.7 tttm . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.189 178.649 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -68.68 145.49 53.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.778 0.323 . . . . 0.0 110.651 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -84.47 132.2 34.58 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.173 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 20.5 ptm -151.06 171.45 17.3 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.605 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.435 ' CG ' ' HG ' ' A' ' 59' ' ' SER . 35.0 t0 -88.72 110.3 20.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.388 0.613 . . . . 0.0 110.152 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.2 -4.21 34.52 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.742 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 61' ' ' ILE . 89.0 p -83.22 1.05 42.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.773 0.321 . . . . 0.0 111.478 -178.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.78 14.2 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.805 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.534 ' H ' ' C ' ' A' ' 59' ' ' SER . 40.9 mt -62.25 -49.06 85.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.161 0.505 . . . . 0.0 110.609 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.6 t0 48.49 -92.81 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.508 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 61' ' ' ILE . 45.8 tt0 -150.65 86.17 5.08 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.484 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.28 155.49 41.64 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.384 2.056 . . . . 0.0 111.606 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.3 m-20 -68.86 163.93 23.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.177 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.425 ' O ' HD23 ' A' ' 66' ' ' LEU . 6.6 tt -76.43 -14.16 60.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.307 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.44 80.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.482 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 13.7 pt-20 -74.69 -19.05 60.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.931 0.396 . . . . 0.0 110.704 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 65' ' ' ASP . 96.9 t -77.56 -53.78 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.526 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.02 88.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.125 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -73.0 -27.94 62.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.523 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.89 137.02 58.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.84 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.7 p -89.78 159.27 17.12 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.182 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD22 ' HB3' ' A' ' 105' ' ' SER . 50.1 tp -122.41 129.71 52.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.994 0.426 . . . . 0.0 111.008 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.3 m-20 -97.5 90.64 5.11 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.594 ' O ' HG12 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -50.48 -13.53 0.13 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' N ' ' C ' ' A' ' 75' ' ' ASP . 71.3 mmtt -71.27 -8.95 57.03 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.858 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -106.53 13.45 28.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.818 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 76' ' ' LYS . 6.4 p -87.43 123.17 39.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.822 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.0 pt -120.44 -7.32 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.13 -169.26 40.47 Favored Glycine 0 C--N 1.317 -0.527 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -146.54 155.72 42.71 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.178 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 92' ' ' LEU . 2.4 tp -125.79 128.94 72.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 t -126.93 131.39 51.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.79 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 24.7 mt -130.63 122.04 19.5 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.04 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -81.67 -37.16 0.28 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 122.304 2.002 . . . . 0.0 112.422 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -49.12 -37.92 23.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.25 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -118.25 -3.47 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.531 -178.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.51 51.48 1.51 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HB2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -109.32 128.93 55.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.132 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -135.59 113.54 11.16 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.594 HD22 ' HA2' ' A' ' 106' ' ' GLY . 15.7 mt -146.49 111.79 4.29 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.5 Cg_endo -42.17 143.0 1.45 Allowed 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.508 1.472 . . . . 0.0 110.583 176.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.28 119.07 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -102.09 121.44 42.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.076 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 66.0 tttm -64.75 -47.11 79.42 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.771 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.558 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 18.3 p -60.6 97.86 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.993 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.93 97.94 7.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.19 0.519 . . . . 0.0 109.803 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.5 p -139.49 158.45 44.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.53 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -60.59 -25.01 65.92 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.352 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -83.79 -45.2 13.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.411 0.624 . . . . 0.0 111.348 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.558 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.5 m-20 -66.86 -35.07 79.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.444 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 108' ' ' ALA . 22.6 mt -63.5 -16.99 62.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.73 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.07 -27.22 62.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.698 ' HB3' HD22 ' A' ' 74' ' ' LEU . 3.5 m -98.75 -7.48 27.58 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.594 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 173.8 -170.07 43.17 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 119.729 -1.225 . . . . 0.0 112.146 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.14 124.35 31.7 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.69 149.81 25.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.779 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 109' ' ' THR . 6.1 p -75.28 152.03 38.27 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 122' ' ' ALA . 1.1 p -88.1 -35.45 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -89.24 143.95 26.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.316 0.579 . . . . 0.0 111.096 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.509 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.1 pt-20 -70.09 -17.14 63.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.916 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -140.45 52.22 1.65 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.792 0.33 . . . . 0.0 111.186 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -88.75 157.98 18.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.78 134.07 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.753 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 5.2 mtp -77.87 123.82 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.23 5.07 65.96 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -140.78 120.18 13.11 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.43 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.91 -173.44 53.64 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 173' ' ' VAL . 39.7 t-20 -78.25 107.58 10.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -85.51 103.42 14.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -90.34 122.5 33.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.306 0.574 . . . . 0.0 111.679 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.09 128.9 56.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.74 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.01 138.54 46.25 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 110.551 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.37 -178.52 17.69 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.778 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 134' ' ' LEU . 49.9 m-70 -87.32 142.99 27.47 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.998 0.428 . . . . 0.0 110.708 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 129' ' ' SER . 66.8 t30 -109.26 28.65 8.3 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.874 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.56 -18.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.717 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 61.8 37.39 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.941 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -133.98 106.91 7.49 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -50.18 125.61 12.75 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.88 -22.9 11.22 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.0 -178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.837 HG12 ' H ' ' A' ' 134' ' ' LEU . 33.7 t -90.09 179.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 117.659 0.729 . . . . 0.0 109.352 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.837 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -71.13 135.22 47.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.878 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.04 36.07 2.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.381 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.442 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 26.3 p -81.45 -8.94 59.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 136' ' ' SER . 85.9 m-20 -145.9 37.65 1.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 9.5 pt -68.64 -32.27 54.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.472 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.9 5.75 2.45 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.139 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -95.27 -15.7 22.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.79 124.31 22.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.701 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.33 152.25 19.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -54.29 127.26 26.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.616 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.71 22.0 32.37 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 34.6 m-20 -85.41 134.57 34.07 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -79.35 131.48 36.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 111.88 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.6 mt -127.24 125.96 67.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.532 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.63 119.93 39.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.055 0.455 . . . . 0.0 110.079 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.5 tp -115.66 143.39 45.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.873 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -108.07 124.82 50.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.086 0.47 . . . . 0.0 111.418 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.9 t0 -97.7 -173.03 2.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 152' ' ' ASN . 5.5 p30 -30.35 -69.56 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.356 0.598 . . . . 0.0 111.359 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 70.8 mm-40 -135.03 27.0 3.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.757 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 158.34 38.46 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.465 0.65 . . . . 0.0 112.463 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -116.52 122.18 43.94 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.338 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -105.91 131.92 52.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 111.25 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 204' ' ' VAL . 96.6 mt-10 -96.37 115.26 27.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.984 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -113.93 141.92 46.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.422 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.16 131.18 54.92 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.488 0.661 . . . . 0.0 111.198 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 47.8 t -65.37 134.33 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.08 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.8 p -100.94 -30.42 11.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 124.708 1.255 . . . . 0.0 110.299 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 169.46 156.69 11.04 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.207 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.6 p -126.54 154.74 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.916 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.9 t -167.65 178.03 5.55 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.578 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.44 ' O ' HG13 ' A' ' 166' ' ' VAL . 75.3 mt-10 -113.12 127.64 56.26 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 165' ' ' GLU . 6.1 m -155.52 174.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.361 . . . . 0.0 111.483 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 169' ' ' ASP . 8.9 p -90.56 136.55 28.01 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.651 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -54.13 -0.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.191 1.927 . . . . 0.0 112.263 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 167' ' ' THR . 48.5 p-10 -74.23 -18.99 60.67 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -176.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HZ1' ' NH2' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -85.68 72.21 10.6 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.521 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 59.8 m95 -74.38 -4.17 34.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.185 0.516 . . . . 0.0 112.001 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.562 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.6 mt-10 -60.55 -18.2 50.92 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.45 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 4.4 m -92.86 -0.29 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.471 HG21 ' CE3' ' A' ' 171' ' ' TRP . 0.5 OUTLIER -123.68 -6.6 7.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.513 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 69.4 mm-40 -87.56 152.22 22.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.206 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.4 ' HA ' ' H ' ' A' ' 120' ' ' ASN . 97.8 m-20 -59.42 127.33 31.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.714 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.562 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 21.1 m170 -119.94 27.94 8.39 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.8 19.55 76.87 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -148.84 164.91 33.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.054 0.454 . . . . 0.0 111.073 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -91.91 91.37 7.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.55 0.691 . . . . 0.0 109.826 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -117.41 164.55 14.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.522 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.1 tt -128.96 140.75 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.547 ' C ' HD12 ' A' ' 184' ' ' LEU . 56.7 m -135.75 126.47 27.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.624 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 183' ' ' THR . 9.8 mp -108.25 120.8 43.41 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.376 0.608 . . . . 0.0 109.684 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.2 pt -130.32 -178.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.513 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t -138.67 156.9 47.02 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.933 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 34.0 m -85.71 113.74 22.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.039 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.95 138.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.178 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.4 p -158.17 30.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.684 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.7 m -76.38 -154.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -85.0 37.46 0.67 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.58 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 50.54 42.16 26.34 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.049 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.77 -40.37 97.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.225 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 31.8 p -154.94 161.41 41.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.562 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.11 145.16 29.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.151 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.61 ' NH2' ' HZ1' ' A' ' 170' ' ' LYS . 20.6 ptt180 -86.45 169.52 12.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.082 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.11 137.52 37.51 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.1 p -131.71 135.87 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.56 130.01 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -118.19 137.87 52.7 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.142 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.58 151.97 21.42 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 54.4 p-10 -110.18 147.17 34.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.923 -0.639 . . . . 0.0 111.902 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 205' ' ' GLY . 45.4 tp -67.71 126.24 28.76 Favored 'General case' 0 C--N 1.34 0.152 0 CA-C-O 121.118 0.485 . . . . 0.0 110.774 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 157' ' ' GLU . 6.9 m -109.59 -23.54 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.03 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -177.78 172.71 45.38 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.213 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.8 m -152.67 151.43 30.57 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.087 0.47 . . . . 0.0 110.686 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -148.14 175.8 10.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.116 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.2 145.82 24.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.062 0.458 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -73.61 79.75 1.5 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.886 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.768 178.59 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.1 m -70.19 142.05 52.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 0.0 110.114 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -56.44 -78.79 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.051 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.481 ' O ' ' CD ' ' A' ' 60' ' ' LYS . 28.2 ttt -154.5 -93.2 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.744 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -79.13 24.49 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.155 0.502 . . . . 0.0 110.24 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 56' ' ' MET . . . -68.99 -39.49 79.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.275 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.2 m -152.76 15.45 0.57 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.993 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' CD ' ' O ' ' A' ' 56' ' ' MET . 27.0 mtpp -81.87 35.8 0.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' O ' ' N ' ' A' ' 63' ' ' GLN . 60.1 mt -62.38 -49.78 82.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.375 0.607 . . . . 0.0 110.539 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 100.0 m-20 45.74 -93.35 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.399 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 61' ' ' ILE . 7.1 pt20 -150.84 81.78 6.25 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.525 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.77 146.94 38.92 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.153 1.902 . . . . 0.0 112.02 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -77.14 170.76 15.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.3 -14.54 63.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.729 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.63 -40.36 88.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.986 0.422 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mm-40 -75.85 -22.48 56.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.449 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.09 -50.35 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.638 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.16 87.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.196 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.66 -31.41 69.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.17 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.63 109.04 1.55 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.9 m -96.69 113.09 24.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.113 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.494 HD21 HD22 ' A' ' 95' ' ' LEU . 38.0 tp -110.24 124.15 51.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -71.91 140.21 49.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.234 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -64.84 -5.4 5.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.277 0.561 . . . . 0.0 109.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -74.45 -9.33 58.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 10.4 mp0 -94.83 3.73 54.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 110.207 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -89.22 126.74 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.537 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 pt -123.66 -7.9 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.014 -178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.63 -172.63 39.2 Favored Glycine 0 C--N 1.312 -0.763 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -147.82 154.32 40.31 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 117.457 0.628 . . . . 0.0 111.852 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.3 tt -123.35 123.7 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.393 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -125.9 129.67 49.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.517 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 15.7 mt -133.89 124.11 17.46 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 119.204 -0.427 . . . . 0.0 111.424 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.5 Cg_endo -81.97 -36.02 0.34 Allowed 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.194 1.929 . . . . 0.0 112.576 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.516 ' OG ' HD23 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -50.86 -38.78 51.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.806 -177.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 90' ' ' LEU . 14.3 m -118.94 -3.36 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.587 0.232 . . . . 0.0 110.535 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.97 49.54 1.6 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -106.77 126.79 52.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.56 -179.121 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.634 ' N ' HD13 ' A' ' 90' ' ' LEU . 82.8 tt0 -133.96 115.31 14.23 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.2 tp -149.95 113.5 3.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' LEU . 2.6 Cg_endo -41.87 158.25 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.261 1.307 . . . . 0.0 110.427 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.32 124.84 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.494 HD22 HD21 ' A' ' 74' ' ' LEU . 33.6 mt -104.82 123.82 48.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 112' ' ' GLU . 63.0 tttp -66.15 -46.89 75.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.097 0.475 . . . . 0.0 110.85 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.6 m -71.75 102.83 2.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.52 97.29 9.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.648 0.737 . . . . 0.0 109.848 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.581 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 5.2 p -136.33 155.17 50.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.908 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -54.19 -26.19 26.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.485 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -85.12 -47.45 10.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.475 0.655 . . . . 0.0 111.71 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -65.63 -36.43 83.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.267 -179.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.13 -19.33 61.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -70.79 -32.04 69.01 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 m -92.62 -9.73 39.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.81 176.54 43.21 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.606 -1.283 . . . . 0.0 112.407 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.74 128.01 34.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.17 28.95 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.001 0.429 . . . . 0.0 111.265 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 38.0 p -75.56 153.08 37.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.22 -46.38 18.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -90.54 140.91 29.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.859 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' O ' ' NZ ' ' A' ' 96' ' ' LYS . 17.0 pt-20 -66.81 -6.12 14.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.694 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.7 p30 -145.73 45.76 1.28 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.78 0.324 . . . . 0.0 110.925 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.534 ' OE1' ' CG ' ' A' ' 121' ' ' TYR . 6.0 tt0 -72.04 161.18 31.28 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.5 t -136.92 124.53 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.728 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.8 mtt -75.1 127.82 34.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.494 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.67 0.83 71.83 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -140.85 121.61 14.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.097 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 75.68 -172.26 54.0 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -85.66 111.66 20.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.534 ' CG ' ' OE1' ' A' ' 114' ' ' GLN . 6.0 t80 -83.67 103.25 12.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.435 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.72 128.11 36.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.311 0.576 . . . . 0.0 111.891 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.81 131.26 53.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.764 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.13 140.18 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.407 0.622 . . . . 0.0 110.95 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.8 -177.53 17.03 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.774 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -85.84 149.32 25.33 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.628 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' SER . 50.4 p30 -114.57 27.36 9.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.945 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.5 mmm -47.94 -10.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.93 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 m 55.87 42.12 29.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.327 0.584 . . . . 0.0 109.598 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.426 ' N ' ' OG ' ' A' ' 136' ' ' SER . 31.7 mmtm -132.56 110.55 10.55 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.927 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -53.92 125.25 17.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.726 0.774 . . . . 0.0 110.544 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.3 9.4 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.611 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.777 HG12 ' H ' ' A' ' 134' ' ' LEU . 52.3 t -77.84 178.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 CA-C-N 117.466 0.633 . . . . 0.0 109.678 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.777 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.56 135.58 47.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.974 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 46.07 30.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.539 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.28 -11.44 59.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.16 20.61 2.09 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.5 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.0 pt -68.06 -25.01 31.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.622 0.249 . . . . 0.0 111.419 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.25 6.09 2.46 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.927 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.0 t -98.88 -16.09 18.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.516 HD23 ' OG ' ' A' ' 87' ' ' SER . 15.7 mt -64.91 125.02 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.075 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.444 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 22.6 ttpt -99.83 173.87 6.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.409 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 12.4 ttpt -68.57 125.25 25.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.729 0.776 . . . . 0.0 111.617 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.91 26.92 Favored Glycine 0 N--CA 1.461 0.317 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 85.7 m-20 -85.29 133.31 34.16 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -79.49 127.18 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.302 0.572 . . . . 0.0 111.829 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.5 mt -122.99 121.59 63.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.912 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -102.69 121.49 42.53 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.07 0.462 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.1 tp -118.52 144.12 46.27 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -113.04 130.78 56.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.297 0.57 . . . . 0.0 111.193 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.0 t0 -108.87 -172.17 2.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.516 -1.22 . . . . 0.0 107.913 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.506 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 98.8 m-20 -27.05 -67.7 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.163 0.506 . . . . 0.0 111.799 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.97 22.02 2.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.8 152.76 36.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.365 0.602 . . . . 0.0 112.461 -176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.17 120.79 40.93 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.428 ' CE2' HG21 ' A' ' 206' ' ' THR . 63.2 m-85 -106.85 130.73 54.49 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 111.075 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.7 mt-10 -94.83 115.73 27.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.297 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -113.33 141.91 46.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.562 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.31 131.57 54.28 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.532 0.682 . . . . 0.0 110.42 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.6 135.81 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.146 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -100.92 -23.09 14.62 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.461 1.1 . . . . 0.0 110.339 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 153.16 155.93 7.36 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.497 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.39 138.56 21.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.331 -0.934 . . . . 0.0 109.905 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.0 m -135.04 149.57 50.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.129 0.49 . . . . 0.0 111.601 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.49 111.54 24.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.308 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.03 158.59 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.184 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 p -67.06 168.47 10.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.535 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.3 Cg_endo -81.52 -11.09 11.85 Favored 'Trans proline' 0 N--CA 1.488 1.166 0 C-N-CA 122.033 1.822 . . . . 0.0 111.47 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -86.69 -14.49 42.37 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.168 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -87.37 72.26 9.81 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.143 0.496 . . . . 0.0 110.442 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 89.4 m95 -76.21 -1.72 27.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.464 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.505 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.8 mt-10 -53.56 -31.26 45.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.199 0.523 . . . . 0.0 110.739 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.713 ' O ' HG21 ' A' ' 183' ' ' THR . 17.7 m -83.68 4.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.66 -16.23 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.616 0.722 . . . . 0.0 109.456 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -85.9 159.9 19.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.878 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -66.26 129.34 39.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 39.5 m80 -102.25 -38.87 7.47 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.125 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.49 29.33 0.28 Allowed Glycine 0 N--CA 1.472 1.076 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.427 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.0 ptpt -156.18 176.91 12.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.381 0.61 . . . . 0.0 111.595 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 23.9 p30 -90.69 88.62 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.893 0.854 . . . . 0.0 109.84 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -121.44 166.88 13.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.169 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.25 140.99 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.713 HG21 ' O ' ' A' ' 173' ' ' VAL . 19.5 m -135.28 126.33 27.84 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -113.77 118.29 33.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.339 0.59 . . . . 0.0 109.782 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.51 HG22 HG13 ' A' ' 198' ' ' VAL . 29.3 pt -129.35 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.54 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.529 ' OG1' ' NH1' ' A' ' 196' ' ' ARG . 44.3 p -132.19 163.09 29.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.113 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.7 p -42.88 163.34 0.01 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.23 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 188' ' ' VAL . 10.7 p -93.09 128.05 44.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.967 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.3 p -155.23 162.94 40.79 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.076 0.465 . . . . 0.0 111.045 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.28 141.01 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.793 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -143.43 -78.82 0.22 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -149.61 63.44 1.0 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 63.2 t30 56.52 35.91 26.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.161 0.505 . . . . 0.0 109.823 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.3 m -75.52 147.02 40.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.945 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -88.14 138.37 31.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.194 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.529 ' NH1' ' OG1' ' A' ' 186' ' ' THR . 61.0 ttm-85 -101.8 145.86 28.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.268 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.98 127.39 42.9 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.51 HG13 HG22 ' A' ' 185' ' ' ILE . 47.9 t -133.54 136.92 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.449 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.69 126.39 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.579 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.09 136.79 52.7 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.28 0.562 . . . . 0.0 110.3 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.6 155.48 23.63 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.632 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -112.32 146.16 38.75 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.813 0.34 . . . . 0.0 111.865 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.41 128.34 36.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 121.368 0.604 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.7 p -107.31 -24.14 4.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.752 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.47 175.15 46.11 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.445 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.428 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.2 m -152.7 151.6 30.74 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.141 0.496 . . . . 0.0 110.83 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -149.17 176.27 10.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.04 146.02 24.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.337 0.589 . . . . 0.0 111.17 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.53 79.63 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.566 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp . . . . . 0 C--N 1.318 -0.795 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.76 178.615 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.8 m -60.37 -43.61 96.41 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.799 0.333 . . . . 0.0 110.655 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.414 ' O ' ' O ' ' A' ' 56' ' ' MET . 59.0 t-80 -69.34 -64.3 0.9 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.473 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 55' ' ' HIS . 13.2 ttt 52.45 172.94 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.237 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' H ' ' HG2' ' A' ' 56' ' ' MET . 96.3 m-20 -111.44 110.57 21.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.366 . . . . 0.0 110.41 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.55 -51.92 20.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.946 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 m -153.48 62.05 0.75 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.474 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -98.46 28.16 4.33 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.438 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.57 -47.31 92.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.233 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.5 t0 49.7 -93.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.377 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 64' ' ' PRO . 5.1 tm0? -150.8 90.5 4.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.6 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 6.2 Cg_exo -73.47 153.14 49.78 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.074 1.849 . . . . 0.0 111.622 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 57.8 t0 -71.64 152.89 42.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.439 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.7 mt -59.6 -24.3 63.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.715 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.72 -38.78 90.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.219 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -73.41 -34.57 65.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.3 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.61 -44.17 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.606 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.81 89.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.92 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.47 -24.74 36.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.91 109.1 0.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.892 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -95.6 121.84 37.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.039 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.4 tp -115.79 127.94 55.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.986 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -68.42 138.38 55.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.587 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -71.19 -6.86 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.151 0.5 . . . . 0.0 110.274 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.09 -36.68 85.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.174 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.461 HE22 HD21 ' A' ' 102' ' ' ASN . 83.7 mt-30 -76.69 13.01 1.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.316 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.43 126.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.75 -4.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.87 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.22 -171.23 40.54 Favored Glycine 0 C--N 1.318 -0.468 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.793 ' O ' HD23 ' A' ' 149' ' ' LEU . 53.5 mtt180 -146.58 153.03 39.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.27 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.1 tt -119.28 124.71 73.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.8 m -127.1 128.68 46.6 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 56.6 mt -131.78 129.36 21.95 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.355 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -82.31 -35.4 0.35 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.22 1.947 . . . . 0.0 112.377 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.5 m -49.71 -39.67 37.8 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.669 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.9 p -118.44 -2.31 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 123.027 0.204 . . . . 0.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.89 53.08 3.19 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.7 tp -113.34 131.84 55.81 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.037 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.89 115.7 15.57 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 83' ' ' ILE . 39.5 mt -143.97 111.64 5.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.7 Cg_endo -40.65 138.64 1.42 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.57 1.513 . . . . 0.0 110.811 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 68.1 t -90.96 122.93 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.9 mt -100.03 136.96 39.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.338 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.79 -34.48 60.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.6 m -93.83 115.84 28.27 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.465 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.8 p -82.79 66.44 8.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.211 0.529 . . . . 0.0 110.183 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.547 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -94.65 150.73 19.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.377 179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -54.16 -52.01 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.634 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.83 -41.88 95.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.368 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.547 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 3.7 m-20 -66.17 -33.47 75.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.37 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.87 -15.08 62.6 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.413 HD23 ' NE2' ' A' ' 126' ' ' HIS . 24.3 mt -72.35 -23.44 61.14 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -94.08 -9.65 35.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.413 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 169.25 -162.94 36.63 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.853 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.453 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -89.08 127.84 35.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.249 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 148.82 26.02 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.852 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.6 p -71.45 149.75 45.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.3 t -82.92 -46.13 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -92.8 -171.55 2.75 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.297 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -106.79 -55.19 2.36 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.505 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -90.8 46.61 1.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.575 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -94.9 147.01 23.83 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.17 131.83 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.535 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.5 mtt -64.71 128.1 34.33 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.42 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 89.52 5.85 71.44 Favored Glycine 0 CA--C 1.508 -0.364 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -140.62 118.5 11.79 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.809 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.0 -168.45 54.21 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.473 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 61.1 t30 -85.99 109.11 18.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -83.63 103.54 13.03 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.7 126.73 36.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.806 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.486 HD13 HD12 ' A' ' 83' ' ' ILE . 11.5 mt -122.63 132.62 54.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.689 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.09 140.0 48.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.114 0.483 . . . . 0.0 110.587 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.99 -178.12 17.77 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.188 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.413 ' NE2' HD23 ' A' ' 104' ' ' LEU . 44.6 m-70 -80.9 156.62 25.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 0.0 110.622 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 129' ' ' SER . 2.2 p-10 -120.95 27.47 8.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.648 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 35.0 mtt -46.24 -12.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.615 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 57.5 40.35 27.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.616 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -134.0 112.07 10.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.032 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -52.84 124.51 14.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.059 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.65 -29.73 7.66 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.779 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.703 HG12 ' N ' ' A' ' 134' ' ' LEU . 95.6 t -75.22 176.68 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 117.914 0.857 . . . . 0.0 109.247 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.703 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.61 134.76 46.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.117 -178.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.3 m-85 46.13 32.87 1.54 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.958 0.408 . . . . 0.0 110.708 178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -82.24 -9.85 59.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -146.58 28.28 1.07 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.431 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.5 pt -69.74 -27.18 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.496 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.83 0.13 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.846 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.8 m -91.27 -15.5 29.08 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.69 116.76 6.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.054 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.447 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 63.5 mttp -103.53 154.74 19.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.89 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -50.76 113.29 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.395 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.19 20.29 4.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.8 m-20 -101.06 128.47 47.1 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -82.99 134.61 35.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.247 0.546 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 158' ' ' TYR . 90.0 mt -123.95 124.24 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.946 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -105.08 122.01 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 110.82 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 82' ' ' ARG . 1.7 mt -116.12 150.42 37.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.397 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.465 ' O ' ' SD ' ' A' ' 116' ' ' MET . 60.2 m-85 -118.36 130.19 55.86 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.087 0.47 . . . . 0.0 110.991 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 51.5 t0 -109.93 -170.15 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 7.5 p30 -27.03 -71.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.1 0.476 . . . . 0.0 111.602 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.528 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 95.7 mt-10 -137.49 31.41 2.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.081 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.16 138.95 48.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.324 0.583 . . . . 0.0 112.401 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -103.94 121.62 43.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -104.42 133.46 49.27 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.294 0.568 . . . . 0.0 111.55 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.412 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.7 mt-10 -98.38 119.86 37.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.016 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 147' ' ' ILE . 31.6 m-85 -120.0 139.7 52.09 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.93 135.14 54.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.492 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.4 t -70.7 135.9 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.981 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 11.4 p -102.68 -23.98 13.79 Favored 'General case' 0 C--N 1.341 0.235 0 O-C-N 124.814 1.321 . . . . 0.0 110.972 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.81 154.79 7.26 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.31 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.56 146.52 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.551 -0.824 . . . . 0.0 109.789 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.9 t -146.19 156.15 43.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.86 0.362 . . . . 0.0 111.178 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -109.18 118.23 36.2 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.18 156.69 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.968 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 169' ' ' ASP . 20.4 p -66.15 136.31 95.33 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.602 ' CB ' HH21 ' A' ' 196' ' ' ARG . 1.6 Cg_endo -47.77 -12.99 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.97 1.78 . . . . 0.0 111.816 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 167' ' ' THR . 55.0 t0 -86.0 -11.15 53.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.642 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -86.78 75.35 9.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.774 0.321 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -78.11 -5.64 52.22 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.049 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -53.43 -35.03 60.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.944 0.402 . . . . 0.0 111.191 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.709 ' O ' HG21 ' A' ' 183' ' ' THR . 16.8 m -81.45 3.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.828 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.0 t -119.53 -15.04 8.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.567 0.699 . . . . 0.0 109.773 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -85.31 163.19 18.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.047 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.35 129.62 39.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.035 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.0 -42.62 6.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.135 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.69 30.12 0.26 Allowed Glycine 0 N--CA 1.469 0.89 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -155.81 177.37 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.071 0.462 . . . . 0.0 111.236 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 61.9 m-20 -88.88 89.34 7.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.266 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -124.21 166.17 16.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.971 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.68 143.18 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 173' ' ' VAL . 8.2 m -136.21 125.33 24.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.711 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.566 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -112.85 125.59 54.53 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.505 HG22 HG12 ' A' ' 198' ' ' VAL . 5.6 pt -140.6 -177.86 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.7 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 32.1 p -138.03 153.31 49.37 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.771 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 187' ' ' CYS . 27.1 p -100.29 76.25 1.87 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.952 0.406 . . . . 0.0 110.932 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.433 HG12 ' ND2' ' A' ' 127' ' ' ASN . 3.0 m -64.86 -41.99 93.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.934 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m 49.98 60.98 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.873 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 79.0 t -125.99 133.58 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.82 0.343 . . . . 0.0 110.138 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.05 -44.64 96.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.36 -178.75 5.96 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 195' ' ' LYS . 18.1 m120 48.97 58.14 5.68 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.865 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 87.2 p -66.73 61.8 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.901 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 193' ' ' ASN . 61.6 pttt -145.49 146.67 31.55 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.615 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.602 HH21 ' CB ' ' A' ' 168' ' ' PRO . 29.6 ttm180 -142.73 135.29 27.8 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.151 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -84.92 129.76 34.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.505 HG12 HG22 ' A' ' 185' ' ' ILE . 34.6 m -137.57 140.07 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.165 0.507 . . . . 0.0 111.626 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.5 t -118.06 130.9 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.419 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.92 136.98 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.643 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.44 160.95 24.62 Favored Glycine 0 N--CA 1.462 0.387 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.377 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 53.2 p-10 -112.53 146.03 39.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.088 -0.556 . . . . 0.0 112.175 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 157' ' ' GLU . 37.2 tp -68.95 127.74 34.22 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.376 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.24 -23.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.323 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.2 176.58 44.51 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.863 -1.16 . . . . 0.0 112.386 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 36.1 m -153.56 153.44 32.38 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.077 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -149.78 179.21 8.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.578 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.64 148.97 21.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.618 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 209' ' ' LYS . 15.0 ptmt -64.42 79.59 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.455 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.314 -0.938 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.661 178.059 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.52 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m -59.05 -42.9 91.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 110.886 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.563 ' C ' ' H ' ' A' ' 57' ' ' ASP . 75.9 m80 -68.25 -168.36 0.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.673 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 57' ' ' ASP . 8.0 ttt 65.58 -19.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.622 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' A' ' 55' ' ' HIS . 97.4 m-20 48.96 94.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.577 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.1 -13.35 61.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.204 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.5 p -87.36 0.32 55.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.701 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -71.22 49.05 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.007 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 63' ' ' GLN . 46.6 mt -62.97 -46.82 95.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 46.65 -95.27 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.301 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ILE . 2.5 pt20 -149.19 88.01 5.18 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.652 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.79 154.42 43.54 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.725 2.284 . . . . 0.0 110.982 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.01 166.21 23.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.692 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.9 mm? -69.61 -16.29 63.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 0.0 111.152 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.91 94.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.381 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.9 mm-40 -72.52 -33.57 66.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.609 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.91 -46.52 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.911 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.79 84.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.016 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 71' ' ' ASN . 59.9 t-20 -82.9 -28.32 30.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.59 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.83 106.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.851 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 m -97.3 114.81 26.63 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.58 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.441 HD13 ' OD1' ' A' ' 102' ' ' ASN . 53.2 tp -107.24 125.67 51.43 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.934 0.397 . . . . 0.0 111.106 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -68.23 138.48 55.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.321 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -63.92 -8.5 11.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.286 0.565 . . . . 0.0 110.207 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -70.76 -14.82 62.58 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.389 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -91.94 1.02 57.45 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.496 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.76 122.51 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.804 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.9 tt -104.31 -36.41 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.407 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.37 -158.47 8.78 Favored Glycine 0 C--N 1.321 -0.303 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.451 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 25.7 mtp85 -146.9 150.6 35.53 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.52 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.8 tt -122.34 127.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -126.84 129.15 47.72 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.849 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 12.6 mt -133.62 117.18 14.1 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.2 -177.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 3.4 Cg_exo -80.92 -37.75 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.486 2.124 . . . . 0.0 112.653 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 t -49.26 -36.79 21.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.491 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.545 HG23 ' HB2' ' A' ' 90' ' ' LEU . 6.9 m -119.87 -7.07 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.381 0.134 . . . . 0.0 111.057 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 73.33 46.02 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.663 0.744 . . . . 0.0 109.952 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -106.0 125.59 51.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.512 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -137.0 110.75 8.11 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' O ' HG22 ' A' ' 83' ' ' ILE . 18.3 mt -146.61 116.88 4.64 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -41.14 140.41 1.33 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.795 1.663 . . . . 0.0 109.931 176.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -91.35 126.82 43.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.423 HD22 HD21 ' A' ' 74' ' ' LEU . 28.1 mt -103.11 124.97 49.56 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -70.37 -34.36 72.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.1 m -86.45 108.85 18.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.987 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 p -82.0 69.35 8.69 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 110.221 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.574 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.08 151.58 22.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.484 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -53.74 -50.14 66.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.593 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.01 -40.63 95.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.075 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.574 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 43.0 m-20 -65.64 -37.03 85.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.58 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.25 -18.09 46.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.627 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.31 -17.71 61.28 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -100.56 -12.14 19.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.52 -174.72 43.86 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.363 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.89 127.46 32.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.29 146.61 29.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.361 . . . . 0.0 110.771 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.9 p -75.5 151.5 37.99 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.11 -50.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -90.65 139.22 30.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.077 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.72 -48.09 83.04 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.826 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -98.51 47.36 0.99 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.01 159.71 30.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 118' ' ' LYS . 0.7 OUTLIER -140.86 124.29 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 -178.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.0 mtt -75.36 127.97 34.34 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.32 -1.14 72.56 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 115' ' ' VAL . 29.5 tptp -142.81 127.34 17.9 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.986 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 72.93 -172.98 48.71 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -86.6 110.29 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -85.63 100.79 12.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.37 125.32 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.531 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.492 HD13 HD12 ' A' ' 83' ' ' ILE . 7.1 mt -119.32 130.28 55.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.436 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.36 138.98 47.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 110.754 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.76 -178.57 18.8 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.323 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 42.5 m-70 -85.69 141.05 30.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.569 0.223 . . . . 0.0 110.581 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 129' ' ' SER . 65.3 t30 -110.44 27.68 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.124 0.488 . . . . 0.0 110.567 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -44.81 -16.18 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.854 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.56 40.88 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.069 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 136' ' ' SER . 98.4 mttt -131.25 109.46 10.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.358 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 132' ' ' GLY . 7.7 tmtt? -53.31 123.87 13.1 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.511 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.404 ' N ' ' HD3' ' A' ' 131' ' ' LYS . . . 114.91 -29.2 7.58 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 134' ' ' LEU . 57.2 t -77.84 178.58 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.752 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -71.88 136.67 47.03 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 44.87 32.0 0.76 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.239 0.542 . . . . 0.0 111.108 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.2 p -82.4 -11.92 58.24 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.96 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.403 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 35.2 t0 -141.71 25.91 1.95 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.2 pt -70.3 -22.33 23.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.918 0.389 . . . . 0.0 111.846 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.9 3.91 7.41 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.661 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.403 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 66.7 m -99.57 -11.45 20.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.111 0.481 . . . . 0.0 110.298 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.474 ' O ' HG21 ' A' ' 163' ' ' VAL . 14.6 mt -62.95 124.95 22.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.463 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.462 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -96.97 163.04 13.12 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.846 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -60.77 136.1 57.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.528 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.14 22.14 57.73 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 40.5 m-20 -87.61 131.62 34.35 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.948 ' HZ1' HG11 ' A' ' 204' ' ' VAL . 3.4 mmpt? -78.2 129.2 34.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.932 0.396 . . . . 0.0 111.726 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 81.1 mt -124.8 123.15 65.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -104.12 120.26 40.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.194 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.607 HD22 ' SD ' ' A' ' 116' ' ' MET . 0.4 OUTLIER -115.38 136.44 53.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.404 -178.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.451 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 87.7 m-85 -108.27 130.61 55.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 111.285 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.524 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.6 t0 -113.46 -165.46 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.524 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.3 m-20 -24.11 -75.81 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.174 0.512 . . . . 0.0 111.328 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -137.03 26.02 2.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -126.22 143.13 51.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -108.39 120.46 42.45 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -103.35 131.19 50.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.547 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.494 ' OE2' ' NZ ' ' A' ' 146' ' ' LYS . 70.3 tt0 -95.96 121.04 37.29 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -120.25 137.27 54.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.246 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.11 132.56 56.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.137 0.494 . . . . 0.0 110.547 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.24 134.84 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.155 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.3 t -104.74 -24.29 12.94 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.468 1.105 . . . . 0.0 111.516 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.18 147.37 5.11 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.397 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 199' ' ' VAL . 13.5 t -111.08 155.51 12.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.6 t -161.34 169.64 21.66 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.936 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -121.22 123.88 43.3 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -135.69 157.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 111.326 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 169' ' ' ASP . 16.9 p -59.16 131.3 87.28 Favored Pre-proline 0 N--CA 1.447 -0.619 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.563 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.1 Cg_endo -45.57 -14.03 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.968 1.779 . . . . 0.0 112.122 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 167' ' ' THR . 53.6 t0 -84.83 -8.58 58.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.275 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.455 ' O ' HG22 ' A' ' 173' ' ' VAL . 1.3 tppp? -87.82 62.74 7.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.563 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 26.9 m95 -72.24 -18.21 61.84 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.804 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.09 -9.64 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.166 0.508 . . . . 0.0 111.195 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 171' ' ' TRP . 24.6 m -83.39 -25.71 7.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.817 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.459 HG11 HD13 ' A' ' 185' ' ' ILE . 0.8 OUTLIER -109.67 -2.33 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.622 0.725 . . . . 0.0 109.865 -178.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 176' ' ' ASP . 95.3 mt-10 -82.18 119.9 24.65 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.78 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 175' ' ' GLU . 97.9 m-20 -28.96 119.81 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.957 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -98.86 -43.43 6.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.051 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.17 33.47 0.32 Allowed Glycine 0 N--CA 1.47 0.963 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.471 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 18.1 ptpt -153.6 176.29 12.24 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.235 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 50.6 p-10 -97.44 88.62 4.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.904 0.859 . . . . 0.0 110.46 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -131.0 177.11 7.69 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.282 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.48 HD12 HD12 ' A' ' 149' ' ' LEU . 20.3 tt -130.63 143.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.538 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.615 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.5 m -138.22 123.88 19.77 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.634 -0.427 . . . . 0.0 111.563 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.615 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -110.86 128.82 55.92 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.262 0.553 . . . . 0.0 111.393 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.459 HD13 HG11 ' A' ' 174' ' ' VAL . 7.1 pt -138.61 -166.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.626 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 188' ' ' VAL . 3.7 t -131.55 164.34 26.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.656 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.417 ' O ' ' O ' ' A' ' 188' ' ' VAL . 84.5 m -64.51 8.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.405 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 186' ' ' THR . 60.2 t 47.94 94.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.469 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.3 p -82.99 146.55 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.525 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.42 -45.37 96.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.059 0.457 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -86.76 45.3 1.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.444 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -91.05 94.53 9.66 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.135 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -63.15 -42.97 99.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.218 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 40.2 t -85.69 164.09 17.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.208 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.04 147.17 38.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' A' ' 168' ' ' PRO . 7.8 tmm_? -63.44 136.7 57.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.431 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -100.27 134.48 43.15 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.7 138.95 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 110.898 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.544 HG22 HG13 ' A' ' 163' ' ' VAL . 77.7 t -116.97 128.76 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.528 ' O ' HG22 ' A' ' 161' ' ' THR . . . -112.52 133.01 54.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.453 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.06 152.99 20.74 Favored Glycine 0 N--CA 1.464 0.539 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 64.5 t0 -111.04 149.41 30.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.783 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.543 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 11.5 tp -74.54 127.73 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.207 0.527 . . . . 0.0 110.795 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.948 HG11 ' HZ1' ' A' ' 146' ' ' LYS . 6.1 p -111.32 -21.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.699 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.43 176.05 47.46 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.678 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.0 m -156.86 154.51 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.511 . . . . 0.0 110.824 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -150.76 178.99 8.58 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -90.96 148.19 22.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.285 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.411 ' O ' ' OXT' ' A' ' 210' ' ' LYS . 64.4 tttm -74.49 79.24 1.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.561 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.411 ' OXT' ' O ' ' A' ' 209' ' ' LYS . 26.7 ttpt . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.461 178.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -63.4 141.19 58.86 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.439 ' CD2' ' O ' ' A' ' 56' ' ' MET . 80.4 t60 -150.93 145.69 25.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 -178.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 56' ' ' MET . 0.0 OUTLIER -97.63 161.07 13.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.378 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -148.75 158.05 43.88 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.094 0.473 . . . . 0.0 111.577 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.63 -8.99 58.17 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.275 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.4 p -86.47 37.34 0.73 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.558 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -79.08 33.83 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.027 0.441 . . . . 0.0 111.034 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.45 -46.5 95.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.26 0.553 . . . . 0.0 110.621 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 49.45 -96.27 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.341 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.9 82.43 6.0 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.713 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.54 151.24 41.73 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.455 2.103 . . . . 0.0 111.715 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -77.42 171.36 15.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.595 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.71 -16.07 63.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.89 92.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.459 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -74.33 -31.97 62.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.507 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.7 t -75.01 -45.48 42.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.575 -178.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.7 89.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.853 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -77.06 -28.49 54.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.282 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.79 107.25 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.977 -179.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.9 t -96.67 119.63 35.5 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.159 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.8 tp -119.05 129.48 55.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.481 -179.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.45 138.87 49.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.835 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -68.78 -7.82 37.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.297 0.57 . . . . 0.0 110.246 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -73.5 -10.34 59.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.864 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 78' ' ' GLN . 8.8 mp0 -91.87 1.61 57.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.616 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.02 131.27 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.882 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.1 pt -123.22 -5.5 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.752 -178.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.0 -170.08 35.51 Favored Glycine 0 C--N 1.316 -0.573 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -146.32 150.89 36.59 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.704 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -123.02 124.8 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.234 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.616 ' N ' HD13 ' A' ' 83' ' ' ILE . 26.3 t -130.32 131.11 45.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.621 -179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.5 mt -133.46 131.15 21.3 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.461 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.36 -35.43 0.25 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.315 2.01 . . . . 0.0 111.854 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.1 m -48.41 -39.86 23.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.519 -176.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.6 p -119.48 -2.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.901 -179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 89' ' ' SER . 2.6 p 62.67 52.22 2.89 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.3 tp -112.28 132.44 54.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.101 -179.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -134.85 115.49 13.71 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.878 -1.526 . . . . 0.0 106.878 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.458 ' O ' HG22 ' A' ' 83' ' ' ILE . 64.3 mt -144.09 113.65 5.32 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -177.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.3 Cg_endo -41.76 147.62 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.767 1.645 . . . . 0.0 110.58 176.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.55 123.0 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.465 ' CB ' HD22 ' A' ' 102' ' ' ASN . 22.3 mt -104.25 123.75 47.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 110.044 -179.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 65.8 tttm -67.38 -47.13 71.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.192 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.59 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -74.06 105.99 5.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.366 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -81.84 101.98 10.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.494 0.664 . . . . 0.0 110.199 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.528 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.8 p -135.54 164.15 28.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.33 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.969 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -83.0 -42.4 17.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.788 -179.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -66.65 -35.24 79.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.231 -178.821 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 mt -63.72 -16.34 60.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.863 -178.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.9 mt -74.65 -16.47 60.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -177.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.8 p -106.29 -9.3 16.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 171.2 -172.54 44.49 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.403 -178.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.85 128.45 33.37 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.114 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.559 ' CB ' HD21 ' A' ' 102' ' ' ASN . . . -105.27 146.77 28.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.79 149.91 39.53 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.19 -41.3 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 112' ' ' GLU . 24.3 tttp -88.74 -173.35 4.09 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.78 -178.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 35.4 tp10 -120.95 -11.33 8.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.296 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 112' ' ' GLU . 97.9 m-20 -141.57 42.09 1.73 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.234 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -89.74 160.53 16.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 50.6 t -132.02 132.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.741 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.416 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.7 mtt -68.38 128.67 37.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.209 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.31 3.02 72.88 Favored Glycine 0 N--CA 1.461 0.323 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -140.4 120.91 14.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.003 0.43 . . . . 0.0 110.398 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.96 53.13 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.492 HD21 ' CB ' ' A' ' 183' ' ' THR . 2.0 t30 -95.39 110.9 22.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -84.4 103.73 13.81 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 128.54 36.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.281 0.563 . . . . 0.0 111.969 -178.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.45 129.48 51.31 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.716 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 139.16 46.65 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.469 0.652 . . . . 0.0 110.888 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.56 -178.64 17.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.746 -179.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -81.98 155.42 25.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.903 0.382 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.3 p-10 -121.82 27.04 8.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.428 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 39.0 mtt -44.08 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.004 -178.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 59.65 40.04 20.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.398 0.618 . . . . 0.0 109.613 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 136' ' ' SER . 65.4 tttm -135.59 118.55 16.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.823 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.0 124.99 21.2 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.637 0.732 . . . . 0.0 110.47 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.5 -26.1 10.53 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.816 -178.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 134' ' ' LEU . 98.4 t -78.97 175.69 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.774 0.787 . . . . 0.0 109.149 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.713 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -72.28 135.07 45.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.191 -178.401 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 46.26 32.57 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.458 . . . . 0.0 110.542 178.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -82.27 -7.59 59.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.512 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 136' ' ' SER . 81.6 m-20 -147.09 31.46 0.93 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -177.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 8.5 pt -70.73 -23.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.463 179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB2' ' CG ' ' A' ' 197' ' ' TYR . . . -74.48 3.2 7.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.668 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -97.02 -11.6 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.4 ' O ' HG21 ' A' ' 163' ' ' VAL . 16.9 mt -64.79 122.45 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.608 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 60.4 mttp -96.82 151.4 19.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.489 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -54.74 123.77 14.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.606 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.73 19.64 19.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 82.5 m-20 -88.23 132.29 34.43 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -82.15 135.19 35.32 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.386 0.612 . . . . 0.0 111.978 -177.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 158' ' ' TYR . 96.0 mt -127.47 125.02 64.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.718 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -102.41 118.36 36.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.147 0.498 . . . . 0.0 109.986 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.39 144.82 43.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.314 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.416 ' O ' ' SD ' ' A' ' 116' ' ' MET . 19.2 m-85 -114.78 131.75 56.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.216 0.531 . . . . 0.0 111.271 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.8 t0 -112.41 -168.73 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 151' ' ' ASP . 14.9 m120 -24.22 -74.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.04 0.448 . . . . 0.0 112.066 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -137.47 28.22 2.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.86 148.77 50.48 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -175.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -110.31 122.26 47.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.855 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.433 ' CE2' HG21 ' A' ' 206' ' ' THR . 61.8 m-85 -105.65 132.01 52.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.171 0.51 . . . . 0.0 111.412 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -95.92 114.16 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.163 178.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 147' ' ' ILE . 46.9 m-85 -115.38 139.96 49.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -120.58 134.79 55.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.491 0.662 . . . . 0.0 111.561 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.95 133.29 31.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.96 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 p -102.89 -28.44 12.04 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 124.959 1.412 . . . . 0.0 110.697 -178.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.22 152.56 7.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.82 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 199' ' ' VAL . 12.2 t -116.29 150.15 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.742 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -152.27 161.95 41.86 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.277 0.56 . . . . 0.0 111.543 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -111.51 126.47 55.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.478 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.59 162.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.01 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.1 p -71.17 141.31 86.13 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -46.54 -17.24 0.33 Allowed 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.862 1.708 . . . . 0.0 111.842 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.448 ' OD1' ' NZ ' ' A' ' 191' ' ' LYS . 91.6 m-20 -82.77 -3.6 56.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 -178.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.592 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 23.1 tptt -80.98 148.07 29.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 81.7 m95 -158.33 -26.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.963 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.13 -8.67 0.08 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.236 0.541 . . . . 0.0 110.531 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.794 HG23 HG13 ' A' ' 174' ' ' VAL . 4.8 m -74.8 -30.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.923 -179.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.794 HG13 HG23 ' A' ' 173' ' ' VAL . 2.5 m -105.59 -5.13 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.756 0.789 . . . . 0.0 109.763 -178.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 176' ' ' ASP . 77.6 mm-40 -80.02 118.38 21.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.9 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 175' ' ' GLU . 68.2 t0 -29.01 124.08 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.491 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -99.08 -40.72 7.87 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.917 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.5 29.21 0.28 Allowed Glycine 0 N--CA 1.472 1.04 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' A' ' 181' ' ' GLU . 21.9 pttp -156.03 179.52 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 111.296 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -94.12 100.11 12.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.714 0.769 . . . . 0.0 109.79 179.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' A' ' 179' ' ' LYS . 17.1 pt-20 -138.92 174.58 10.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.922 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.1 tt -131.12 143.88 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.548 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.588 ' C ' HD12 ' A' ' 184' ' ' LEU . 12.4 m -135.9 126.01 26.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.677 0.275 . . . . 0.0 111.239 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -113.14 126.89 55.94 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.384 0.612 . . . . 0.0 110.643 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.79 HD13 HG11 ' A' ' 174' ' ' VAL . 8.1 pt -141.13 -172.85 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.184 -178.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t -139.44 147.39 41.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.017 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 6.0 t -101.17 104.19 15.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.129 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.487 HG21 HD21 ' A' ' 127' ' ' ASN . 7.4 p -146.59 139.34 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.012 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 190' ' ' VAL . 1.9 m -89.44 -138.01 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 189' ' ' SER . 4.4 t 52.84 99.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.094 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.448 ' NZ ' ' OD1' ' A' ' 169' ' ' ASP . 71.8 mmtt -84.93 -16.08 42.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.624 -178.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.36 -47.3 84.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.858 0.361 . . . . 0.0 110.987 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -64.47 -42.67 95.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.049 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.7 p 59.19 21.21 9.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.792 0.33 . . . . 0.0 111.124 179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -82.4 108.37 15.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.095 0.474 . . . . 0.0 110.56 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.02 125.3 13.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.174 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.419 ' CG ' ' HB2' ' A' ' 139' ' ' ALA . 8.6 m-85 -121.22 131.53 54.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.003 178.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.36 127.74 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.894 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.49 HG22 HG13 ' A' ' 163' ' ' VAL . 70.1 t -117.63 129.11 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.509 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.69 138.04 54.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.415 0.626 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.42 159.06 24.31 Favored Glycine 0 N--CA 1.461 0.322 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.849 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -110.17 153.35 24.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.709 -0.746 . . . . 0.0 111.873 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.9 tp -74.94 127.7 33.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.255 0.55 . . . . 0.0 110.878 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.403 HG21 ' HB2' ' A' ' 159' ' ' ALA . 93.1 t -107.56 -25.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.912 -178.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 174.29 176.7 42.88 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.47 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.433 HG21 ' CE2' ' A' ' 156' ' ' TYR . 15.1 m -153.49 153.2 31.99 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 111.052 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -150.33 176.91 10.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.463 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.56 142.08 27.86 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.898 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -67.99 79.87 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.847 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 56.2 tttm . . . . . 0 C--N 1.318 -0.762 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.552 178.64 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -64.55 141.59 58.72 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.486 ' O ' ' N ' ' A' ' 57' ' ' ASP . 95.8 m-70 -84.04 -18.34 37.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.746 0.307 . . . . 0.0 111.18 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.0 mtt 46.34 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.14 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 55' ' ' HIS . 48.2 t0 -142.7 145.85 33.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.525 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.85 -17.65 62.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.65 -179.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.4 m -87.46 -103.8 0.07 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.877 0.37 . . . . 0.0 110.075 -179.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp 48.25 32.02 2.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.218 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.0 mm -64.4 -45.14 96.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.817 0.342 . . . . 0.0 110.601 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.519 ' H ' ' CB ' ' A' ' 189' ' ' SER . 68.1 t0 52.91 -104.75 0.21 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -151.08 81.85 6.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.336 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.73 144.78 35.76 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.305 2.003 . . . . 0.0 111.731 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.73 171.58 14.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.92 -14.3 61.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.683 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.92 91.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mt-10 -74.85 -26.09 59.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.559 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.18 -47.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.671 -179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -42.24 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.694 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -70.83 -31.04 67.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.82 145.46 55.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.44 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -139.26 108.13 5.97 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.059 0.456 . . . . 0.0 110.998 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.427 HD11 HD22 ' A' ' 95' ' ' LEU . 3.9 tt -105.13 127.05 52.72 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.056 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -74.0 137.1 43.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.341 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' O ' HG12 ' A' ' 79' ' ' VAL . 4.5 mptp? -67.33 -9.41 40.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 110.165 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -80.29 -11.94 59.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.497 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.71 6.92 36.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 76' ' ' LYS . 8.6 p -88.18 138.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.1 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.8 pt -120.79 -5.96 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.561 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.64 -165.29 30.84 Favored Glycine 0 C--N 1.32 -0.361 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.408 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 11.8 ttp180 -152.57 155.0 36.54 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.042 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 83' ' ' ILE . 20.6 tt -128.61 130.17 68.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.675 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.04 130.83 51.93 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.553 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 mt -134.76 100.86 11.97 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.136 -178.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -67.82 -34.2 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.244 1.963 . . . . 0.0 112.404 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.5 t -52.1 -38.73 58.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.467 -177.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 137' ' ' ASP . 25.3 t -110.31 -9.6 11.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 120.58 0.229 . . . . 0.0 110.665 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.82 43.14 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.413 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.6 tp -115.8 130.48 56.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.819 -178.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -134.45 118.91 17.9 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.3 mt -145.31 163.13 33.92 Favored Pre-proline 0 N--CA 1.465 0.275 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.547 -177.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -87.78 150.27 7.3 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 123.052 2.501 . . . . 0.0 109.428 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.9 t -95.77 116.58 37.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.427 HD22 HD11 ' A' ' 74' ' ' LEU . 39.7 mt -101.83 122.55 44.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -179.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -65.76 -46.19 79.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.084 0.468 . . . . 0.0 111.046 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 p -75.3 103.91 5.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.376 -179.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t -85.48 99.8 11.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.333 0.587 . . . . 0.0 110.316 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 102' ' ' ASN . 5.4 p -132.11 160.41 36.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.685 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -56.74 -28.96 62.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.781 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.485 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 18.8 ptmt -84.25 -41.88 16.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.342 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 101' ' ' LYS . 5.4 m120 -65.76 -36.47 83.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.396 -179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.89 -20.58 62.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.4 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -75.58 -15.51 60.35 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.6 m -103.32 -11.49 17.88 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.09 -166.59 39.79 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.226 -178.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.14 125.01 28.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.61 143.28 33.29 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.058 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.3 p -69.19 144.06 53.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.49 -44.69 18.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -89.33 -175.08 4.63 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.95 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -115.42 -11.57 11.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.623 -178.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -137.6 43.19 2.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 111.461 -178.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.518 ' OE1' ' CZ ' ' A' ' 121' ' ' TYR . 5.7 pt20 -92.17 155.28 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.362 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.05 132.37 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.507 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.0 mtt -68.3 128.15 35.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.413 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 89.34 4.61 73.7 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -142.86 121.17 12.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.638 -179.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.76 -168.88 54.6 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.565 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 8.1 t30 -89.33 110.48 21.26 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.518 ' CZ ' ' OE1' ' A' ' 114' ' ' GLN . 1.7 t80 -84.74 105.22 15.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.476 ' O ' HD22 ' A' ' 123' ' ' LEU . . . -95.01 120.13 34.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.998 -178.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 122' ' ' ALA . 1.9 mm? -117.09 132.42 56.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.862 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.06 142.54 43.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.752 -179.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.02 -178.6 19.88 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.545 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -85.16 152.07 23.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.94 0.4 . . . . 0.0 110.922 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' SER . 41.7 t30 -116.01 28.34 8.68 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.799 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.0 mmm -50.14 -8.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.66 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 127' ' ' ASN . 3.0 t 52.51 44.18 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 109.716 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 136' ' ' SER . 29.3 tptp -134.15 113.53 12.14 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.643 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -56.01 125.17 20.39 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.415 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.45 -29.22 8.84 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.827 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.743 HG12 ' H ' ' A' ' 134' ' ' LEU . 58.3 t -76.82 178.37 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 117.847 0.824 . . . . 0.0 109.384 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.743 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.38 136.51 49.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.715 0.293 . . . . 0.0 110.933 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 138' ' ' ILE . 4.1 m-30 43.17 31.76 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.167 0.508 . . . . 0.0 110.928 178.312 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.41 -11.66 58.4 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.108 -178.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.492 ' O ' HG21 ' A' ' 88' ' ' VAL . 7.1 m-20 -142.24 22.1 2.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 140' ' ' SER . 4.5 pt -67.52 -29.41 45.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.61 2.43 1.33 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.793 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 138' ' ' ILE . 49.9 m -97.03 -11.46 24.45 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.19 121.15 12.39 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.51 172.69 7.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.766 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.35 122.1 22.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.543 0.687 . . . . 0.0 112.035 -179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.7 19.83 14.61 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -93.35 134.79 35.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -83.37 137.25 34.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.454 0.645 . . . . 0.0 112.074 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.65 122.85 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.001 179.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 73.9 m-85 -101.09 117.08 34.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.8 tp -115.1 144.96 42.85 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.675 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.408 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 31.1 m-85 -117.05 130.69 56.83 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.998 0.427 . . . . 0.0 111.676 -178.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.8 t0 -107.02 -167.66 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.497 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 61.6 t-20 -29.39 -68.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -138.41 21.7 2.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.766 179.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.44 146.33 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -176.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -111.37 118.87 37.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.402 ' CE2' HG21 ' A' ' 206' ' ' THR . 60.5 m-85 -104.21 130.69 51.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.144 0.497 . . . . 0.0 111.085 -178.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 41.5 tp10 -94.41 117.18 29.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.15 137.81 51.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.31 133.36 56.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.274 0.559 . . . . 0.0 110.566 179.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.66 133.39 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -104.72 -25.15 12.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 124.537 1.148 . . . . 0.0 110.751 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.03 153.86 7.08 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.917 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 13.0 p -111.73 155.71 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.576 -0.812 . . . . 0.0 109.28 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.9 p -151.7 162.3 41.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.077 0.465 . . . . 0.0 111.198 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -114.22 113.67 24.95 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 159.66 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.139 -178.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 79.3 p -60.3 168.46 2.29 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.5 -11.52 11.71 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.905 1.736 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.58 -6.64 59.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.997 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 173' ' ' VAL . 15.5 mmtp -85.06 66.71 9.89 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.442 ' C ' ' N ' ' A' ' 173' ' ' VAL . 63.1 m95 -72.29 -24.57 61.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.338 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.98 -17.12 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.247 0.546 . . . . 0.0 110.365 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 170' ' ' LYS . 24.3 m -69.87 -27.23 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.206 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.52 HG11 HD13 ' A' ' 185' ' ' ILE . 1.6 m -109.73 1.0 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.554 0.692 . . . . 0.0 110.052 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -83.83 125.86 32.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.317 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -34.95 122.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.445 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -103.07 -44.22 5.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.777 0.323 . . . . 0.0 111.309 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 141.69 28.06 0.17 Allowed Glycine 0 N--CA 1.47 0.932 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -153.49 173.36 15.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 22.3 m-20 -94.25 88.86 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.462 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 75.1 tt0 -133.34 127.07 32.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.099 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.1 tt -81.16 148.26 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.565 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 17.5 m -135.93 125.75 25.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.843 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.54 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -111.29 127.08 55.52 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 111.204 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.52 HD13 HG11 ' A' ' 174' ' ' VAL . 5.7 pt -132.35 153.61 38.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.248 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 6.9 t -140.76 162.95 34.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.285 -179.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.49 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 3.4 t 59.78 59.02 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.851 178.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 189' ' ' SER . 14.5 m -63.21 -42.19 95.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.098 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.528 ' N ' HG23 ' A' ' 188' ' ' VAL . 11.3 t -74.67 166.49 23.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.86 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 87.8 t -70.36 132.12 33.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -142.1 162.8 34.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 110.949 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.47 -20.27 62.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.251 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 195' ' ' LYS . 51.7 t-20 -63.71 -40.52 96.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.636 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.19 -68.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.372 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 193' ' ' ASN . 27.3 tptt -66.87 130.95 44.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.877 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.49 ' NH2' ' O ' ' A' ' 187' ' ' CYS . 42.4 ttm180 -112.47 138.41 49.27 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.169 -179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -93.04 128.49 38.94 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.527 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.01 132.47 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.98 0.419 . . . . 0.0 111.142 -179.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.96 129.46 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.215 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.512 ' O ' HG22 ' A' ' 161' ' ' THR . . . -113.18 137.35 51.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.516 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.97 135.3 8.59 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.4 t0 -95.63 133.5 39.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.069 -0.566 . . . . 0.0 111.546 -178.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.401 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 44.8 tp -62.18 124.06 19.84 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.214 0.53 . . . . 0.0 110.385 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.1 -21.7 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.054 -179.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.01 175.14 47.11 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.159 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 156' ' ' TYR . 22.4 m -154.57 152.71 30.36 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.023 0.44 . . . . 0.0 110.628 178.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -150.98 177.45 10.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.116 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.18 148.77 21.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.201 0.524 . . . . 0.0 110.845 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -70.79 80.27 0.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.535 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.669 178.424 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.567 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.1 p -61.09 -38.16 85.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.851 -0.174 . . . . 0.0 110.789 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 60.9 m170 48.27 -173.56 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.048 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.415 ' HG3' ' H ' ' A' ' 58' ' ' ALA . 45.6 tpp -74.28 -72.51 0.28 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.141 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 48.19 29.43 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.111 0.481 . . . . 0.0 111.389 177.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 56' ' ' MET . . . -71.92 -15.07 62.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.318 -178.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.6 t -149.19 -93.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.2 tttm 52.11 21.63 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 111.42 178.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.33 -46.49 90.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.871 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 54.14 -98.53 0.08 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 179.27 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -151.49 78.23 7.04 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.385 -179.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.34 146.93 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.5 2.134 . . . . 0.0 110.8 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -70.78 147.77 48.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.808 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.8 mt -55.25 -25.9 36.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.053 -178.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.9 95.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.618 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 70.3 mm-40 -72.58 -33.38 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.923 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.3 t -75.36 -45.68 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.056 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.54 -38.02 88.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -81.98 -25.97 34.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.639 -179.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.63 131.84 51.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.388 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.8 t -95.92 158.92 15.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.024 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.689 HD22 ' HB3' ' A' ' 105' ' ' SER . 44.6 tp -123.24 134.13 54.13 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.013 -179.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.28 105.54 15.84 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.027 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.587 ' O ' HG12 ' A' ' 79' ' ' VAL . 6.0 mptp? -63.81 -8.73 11.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.269 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -63.73 -39.47 94.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.537 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.545 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 3.6 pt20 -89.11 19.97 3.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.768 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 76' ' ' LYS . 4.3 p -84.72 126.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.568 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.5 -9.26 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.43 -166.35 37.27 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.504 ' O ' HD12 ' A' ' 149' ' ' LEU . 34.6 mtp180 -146.88 150.57 35.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.622 -178.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 92' ' ' LEU . 7.8 tp -113.18 122.56 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 t -126.87 128.05 45.89 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.508 HG21 HD21 ' A' ' 141' ' ' LEU . 10.5 mt -135.62 122.31 14.46 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.969 -177.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.79 -34.73 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.577 2.184 . . . . 0.0 112.37 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.556 ' CB ' HD23 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -51.08 -39.75 56.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.488 -177.24 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 90' ' ' LEU . 20.7 m -118.62 -9.01 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 122.314 0.246 . . . . 0.0 111.096 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.505 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.5 p 74.37 48.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.407 0.622 . . . . 0.0 109.833 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.66 HD11 HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -107.18 123.49 48.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.617 -178.808 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.658 ' N ' HD13 ' A' ' 90' ' ' LEU . 84.7 tt0 -135.46 110.44 8.82 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 90' ' ' LEU . 10.6 mt -149.8 115.86 3.53 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.9 Cg_endo -39.91 143.11 0.46 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 121.832 1.688 . . . . 0.0 110.132 176.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.72 123.54 49.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.497 HD22 ' NE2' ' A' ' 78' ' ' GLN . 9.2 mt -105.21 138.37 41.52 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.088 -179.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -78.71 -25.27 44.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.387 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -89.27 104.24 16.81 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.339 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.5 p -81.4 62.71 5.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.292 0.568 . . . . 0.0 110.37 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -93.84 162.83 13.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.708 179.59 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.64 -48.0 79.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.1 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.42 ' CG ' ' N ' ' A' ' 102' ' ' ASN . 19.6 ptmt -67.27 -40.52 86.2 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.602 0.564 . . . . 0.0 111.74 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.593 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 8.7 m-80 -64.74 -37.56 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.243 -178.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.68 -20.76 61.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.63 -18.95 62.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.689 ' HB3' HD22 ' A' ' 74' ' ' LEU . 1.8 m -102.05 -13.83 17.37 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.58 ' HA2' HD13 ' A' ' 92' ' ' LEU . . . 176.25 -162.17 30.86 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.234 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.77 126.09 36.72 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.095 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.47 146.19 29.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.784 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 p -72.86 152.81 41.32 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.15 -47.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -93.19 145.36 24.48 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.028 0.442 . . . . 0.0 111.15 -178.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.54 -51.13 68.59 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.623 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -96.06 46.42 1.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.29 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.593 ' NE2' ' H ' ' A' ' 122' ' ' ALA . 10.6 tt0 -80.89 153.71 27.45 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.59 117.77 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.147 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.453 ' N ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -74.14 129.95 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.795 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.25 -8.76 57.37 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -143.99 130.9 20.4 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.439 -178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.29 -167.95 52.8 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 25.2 t-20 -86.77 107.22 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.587 0.232 . . . . 0.0 110.659 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.453 ' CE1' ' N ' ' A' ' 116' ' ' MET . 4.7 t80 -86.56 100.51 12.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.88 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.593 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -90.21 123.8 34.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.837 -179.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.497 ' CD1' HD13 ' A' ' 83' ' ' ILE . 11.2 mt -118.18 132.64 56.31 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.373 178.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -114.34 140.17 48.86 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.923 -178.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -140.75 -178.09 16.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.661 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -85.17 146.17 27.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.621 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.9 p30 -112.79 26.23 10.7 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 0.0 110.869 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -42.76 -19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.816 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.7 OUTLIER 62.11 39.43 12.96 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.139 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.86 109.49 10.14 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.793 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.04 124.88 16.87 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.829 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.85 -25.03 10.43 Favored Glycine 0 N--CA 1.473 1.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.533 -177.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.785 HG12 ' H ' ' A' ' 134' ' ' LEU . 39.2 t -83.24 179.0 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.812 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -73.17 136.12 44.72 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.031 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.63 31.51 0.64 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 110.751 178.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 p -80.22 -7.47 58.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.719 -178.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.434 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 15.1 t0 -146.55 40.26 1.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.2 pt -70.65 -26.73 28.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.13 1.29 13.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.022 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.434 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.5 m -91.22 -17.96 25.19 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.087 -179.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.573 HD22 ' OD2' ' A' ' 145' ' ' ASP . 15.7 mt -65.21 125.3 24.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.324 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -95.93 170.91 8.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.447 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.72 130.03 40.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.923 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.03 21.18 36.65 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' OD2' HD22 ' A' ' 141' ' ' LEU . 1.7 t70 -87.49 132.28 34.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -79.56 134.9 36.49 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.391 -178.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' TYR . 96.5 mt -126.55 125.83 67.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.16 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.31 113.62 26.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.578 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 82' ' ' ARG . 42.1 tp -113.32 134.47 54.6 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.389 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -105.83 133.98 49.69 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.133 -178.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 152' ' ' ASN . 43.9 t0 -108.7 -169.28 1.47 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 151' ' ' ASP . 13.1 t-20 -32.93 -67.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.992 0.425 . . . . 0.0 110.65 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -135.98 21.89 3.28 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.065 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.53 150.37 40.96 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -176.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -114.81 119.47 36.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.341 178.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -105.23 130.19 53.44 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.372 0.606 . . . . 0.0 112.016 -178.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -95.45 117.34 30.2 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.498 ' O ' ' N ' ' A' ' 147' ' ' ILE . 20.0 m-85 -119.58 139.37 52.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.285 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.9 137.85 52.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.874 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.79 134.18 30.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.862 179.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.3 -27.26 12.95 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.84 1.338 . . . . 0.0 111.242 -178.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.81 158.76 9.89 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.54 152.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.2 t -156.34 165.56 35.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.098 -178.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -109.55 116.53 31.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.38 157.19 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-O 121.076 0.465 . . . . 0.0 111.285 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 169' ' ' ASP . 30.9 p -73.38 136.33 78.53 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.0 OUTLIER -47.47 -15.45 0.3 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.113 1.875 . . . . 0.0 111.903 -178.62 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 167' ' ' THR . 95.9 m-20 -84.03 -11.54 56.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.518 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -88.04 67.69 8.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.9 m95 -74.13 -3.93 32.6 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 123.608 0.568 . . . . 0.0 112.193 -178.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.1 mt-10 -53.01 -39.89 63.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.961 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 15.3 m -77.84 2.7 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.199 -179.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.1 -14.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.793 0.806 . . . . 0.0 110.597 -178.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.2 mt-10 -86.47 -179.14 6.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.878 -179.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.6 p-10 -86.51 124.76 33.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.157 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.4 m80 -103.08 -43.91 5.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.206 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 25.33 0.07 OUTLIER Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -157.26 178.36 10.42 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.766 0.317 . . . . 0.0 111.07 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.67 ' OD2' HD22 ' A' ' 203' ' ' LEU . 31.3 t0 -96.68 89.83 5.09 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.613 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -126.69 127.62 45.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.369 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.2 tt -85.43 149.42 4.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.57 ' C ' HD12 ' A' ' 184' ' ' LEU . 52.1 m -137.44 124.67 21.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.436 -179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 183' ' ' THR . 10.3 mp -109.85 121.39 45.12 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.452 0.644 . . . . 0.0 111.108 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 12.4 pt -140.4 -173.28 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.844 -179.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.566 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 16.2 p -138.08 166.14 24.87 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.582 -179.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 33.3 m -96.66 120.31 36.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.612 ' H ' HH22 ' A' ' 196' ' ' ARG . 70.5 t -144.8 -24.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 188' ' ' VAL . 82.6 p 46.78 -170.89 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.846 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 192' ' ' ASP . 3.0 m -58.89 -108.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.42 ' H ' HG23 ' A' ' 190' ' ' VAL . 28.6 tptp 47.75 -93.86 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.584 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 190' ' ' VAL . 97.9 m-20 -62.41 -42.38 99.39 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 60.8 t30 55.92 36.93 28.23 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.174 178.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.1 t -93.9 169.22 10.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.91 130.16 42.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.612 HH22 ' H ' ' A' ' 188' ' ' VAL . 57.7 ttm-85 -104.2 137.88 41.48 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.28 132.35 41.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.69 139.28 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.282 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.94 129.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.38 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.14 135.9 53.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.279 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.28 143.6 14.88 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 51.8 p-10 -102.7 142.64 33.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.328 -0.936 . . . . 0.0 111.435 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.67 HD22 ' OD2' ' A' ' 180' ' ' ASP . 38.5 tp -65.31 126.88 29.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.4 -24.77 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.528 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.74 175.58 46.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.734 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.6 m -155.04 151.4 28.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.179 0.514 . . . . 0.0 111.244 -179.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -151.63 178.52 9.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.32 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.79 144.92 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.307 179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.27 78.99 0.36 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.853 -179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 78.3 tttt . . . . . 0 C--N 1.322 -0.602 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.332 178.618 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.093 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 55' ' ' HIS . 14.3 t 47.84 92.37 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.479 178.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 54' ' ' SER . 97.7 m-70 48.58 -172.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.639 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.0 mtm -83.58 146.51 28.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.215 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 66.8 t0 -64.76 144.67 57.09 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.534 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -68.4 -35.63 77.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.799 -178.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.6 m -83.08 -83.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.423 -178.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.6 tttm 54.54 35.22 22.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.386 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 62' ' ' ASP . 29.7 mm -64.79 -44.15 96.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.286 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 64' ' ' PRO . 9.5 t0 62.03 118.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.462 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.457 ' CD ' ' O ' ' A' ' 63' ' ' GLN . 1.6 tm0? -38.32 93.96 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.302 0 O-C-N 123.48 0.487 . . . . 0.0 110.326 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' N ' ' O ' ' A' ' 62' ' ' ASP . 6.2 Cg_exo -76.23 152.71 35.46 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.684 2.256 . . . . 0.0 111.122 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.8 163.48 26.75 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.4 mt -67.42 -19.96 65.45 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 123.163 0.289 . . . . 0.0 111.044 -178.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.74 93.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.615 -179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.6 mt-10 -72.2 -37.13 69.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.63 -45.81 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.886 -178.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.12 85.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -85.15 -26.64 26.71 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.726 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -58.86 137.76 57.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.127 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.1 m -92.09 158.13 16.37 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.912 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.456 HD13 ' CB ' ' A' ' 105' ' ' SER . 50.9 tp -127.13 127.32 44.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 111.288 -178.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -100.52 103.88 15.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.973 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.61 ' O ' HG12 ' A' ' 79' ' ' VAL . 44.5 mmtm -62.36 -7.09 3.84 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.572 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -75.08 -13.08 60.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.322 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -102.54 12.08 36.95 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.736 -178.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 76' ' ' LYS . 7.0 p -88.16 123.93 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.254 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.455 HD11 HG21 ' A' ' 109' ' ' THR . 7.0 pt -121.4 -7.55 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.46 -171.28 39.28 Favored Glycine 0 C--N 1.32 -0.318 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.579 HH11 ' NZ ' ' A' ' 209' ' ' LYS . 42.0 mtm180 -146.46 152.03 38.37 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.72 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.5 tt -121.04 122.31 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -124.15 127.75 48.24 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.437 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 73.3 mt -131.29 130.81 22.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.801 -178.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.4 Cg_endo -83.61 -38.28 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.56 2.173 . . . . 0.0 112.417 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.3 p -46.14 -37.88 7.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.424 -177.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.4 p -120.91 -0.45 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.942 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m 59.94 54.52 4.2 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.12 136.76 52.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.03 -177.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -137.0 116.39 12.72 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 83' ' ' ILE . 82.7 mt -141.03 101.58 6.32 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.6 127.92 1.74 Allowed 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 121.897 1.731 . . . . 0.0 110.211 176.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.95 121.84 34.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.2 mt -103.19 123.27 46.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.53 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' HB2' HD13 ' A' ' 80' ' ' ILE . 88.4 tttt -64.73 -49.5 70.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.065 -179.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.2 m -65.74 98.7 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.134 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -80.24 98.13 7.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.258 0.551 . . . . 0.0 109.86 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.9 p -134.31 161.13 35.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.606 -178.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.79 -27.78 66.86 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.918 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.81 -41.77 18.69 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.837 0.711 . . . . 0.0 112.139 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -67.06 -35.12 79.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.412 -179.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.501 HD13 ' SG ' ' A' ' 187' ' ' CYS . 43.1 mt -65.03 -18.86 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -72.7 -14.92 61.68 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.456 ' CB ' HD13 ' A' ' 74' ' ' LEU . 58.7 m -110.53 -9.26 14.57 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -177.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.453 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 174.39 -153.55 16.77 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.304 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.554 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -100.49 127.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.965 -0.617 . . . . 0.0 110.263 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.46 149.97 24.97 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.674 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.455 HG21 HD11 ' A' ' 80' ' ' ILE . 9.7 p -75.81 148.38 38.47 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.9 -47.28 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -92.66 139.84 30.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.317 0.58 . . . . 0.0 110.989 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.414 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 18.1 pt-20 -75.48 -3.18 32.48 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.272 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 112' ' ' GLU . 11.5 m120 -135.88 37.63 2.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 111.164 -177.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 156.26 16.52 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.5 t -124.55 135.58 63.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.4 mtp -75.93 125.7 29.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.91 10.27 66.93 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -144.77 121.38 11.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.544 -178.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.36 178.5 32.51 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 40.9 t-20 -68.93 105.06 2.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -85.33 105.45 15.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 124.89 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.31 0.576 . . . . 0.0 111.439 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 83' ' ' ILE . 10.0 mt -122.31 130.24 52.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.509 179.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.6 140.16 45.19 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.305 0.574 . . . . 0.0 110.759 -178.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.45 -176.95 18.92 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.614 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -84.48 147.07 27.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.696 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.7 p30 -115.48 25.48 10.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.146 0.498 . . . . 0.0 110.984 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.1 mmm -41.94 -18.19 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.646 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 57.57 39.96 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.191 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 136' ' ' SER . 65.2 tttm -134.2 119.45 18.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.511 -178.665 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.04 124.46 21.18 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.332 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 120.38 -21.46 8.66 Favored Glycine 0 N--CA 1.471 1.001 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.447 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 134' ' ' LEU . 2.6 t -91.97 172.46 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.797 ' H ' HD23 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -74.93 139.34 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.882 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.554 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 3.5 m-85 50.49 27.34 2.79 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.008 0.433 . . . . 0.0 110.969 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.444 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -84.66 -8.99 58.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.6 m-20 -145.31 30.85 1.12 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -177.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 7.9 pt -70.07 -25.88 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.58 3.78 4.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.707 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.5 m -97.19 -11.65 23.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.283 -178.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.488 ' O ' HG21 ' A' ' 163' ' ' VAL . 17.7 mt -65.42 124.72 23.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.66 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.431 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 98.6 mttt -97.04 161.48 13.81 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.676 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.48 127.6 32.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.959 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 91.88 20.98 34.89 Favored Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 31.9 m-20 -83.73 136.86 34.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.08 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -80.76 122.76 27.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.5 mt -122.26 122.57 66.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -103.5 118.24 36.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.451 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -112.79 132.72 55.13 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -178.946 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.696 ' N ' HD13 ' A' ' 149' ' ' LEU . 67.9 m-85 -99.12 125.68 44.71 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.151 -179.121 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 152' ' ' ASN . 45.9 t0 -98.07 -169.05 1.75 Allowed 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 151' ' ' ASP . 51.9 t30 -36.19 -67.03 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.124 0.488 . . . . 0.0 110.851 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -135.07 25.07 3.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.208 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.85 153.05 44.7 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.605 ' CD ' ' HZ1' ' A' ' 207' ' ' LYS . 67.1 tt0 -114.6 119.0 35.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.265 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -103.84 131.55 50.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.5 mt-10 -97.17 119.35 35.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.129 178.234 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -116.69 142.08 47.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.19 129.79 53.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.461 0.648 . . . . 0.0 110.769 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' GLY . 56.2 t -68.23 134.7 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.099 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 200' ' ' ALA . 1.1 t -105.15 -26.61 12.01 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 124.583 1.177 . . . . 0.0 111.256 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.99 147.87 5.57 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.304 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 199' ' ' VAL . 17.2 t -110.56 149.08 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.239 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 51.0 p -156.92 165.87 34.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 111.133 -178.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -113.6 102.6 10.43 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.017 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.8 m -117.49 153.34 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -178.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 p -59.57 167.87 2.19 Favored Pre-proline 0 N--CA 1.449 -0.5 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.546 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.6 Cg_endo -81.77 -10.46 11.77 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.027 1.818 . . . . 0.0 112.007 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -84.81 -14.16 48.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.202 -178.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -87.64 71.21 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.028 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.546 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 90.4 m95 -75.31 -2.23 27.28 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.285 -178.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.42 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 71.5 mm-40 -54.03 -37.24 63.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.69 ' O ' HG21 ' A' ' 183' ' ' THR . 16.3 m -80.82 3.7 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.03 -179.03 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -119.71 -15.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.581 0.705 . . . . 0.0 110.251 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 74.4 mm-40 -86.75 175.94 7.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.027 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.5 p-10 -80.78 128.6 33.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.251 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.42 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.8 m170 -102.57 -43.28 5.67 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.043 -179.448 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.07 27.61 0.12 Allowed Glycine 0 N--CA 1.471 1.024 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -157.65 -179.75 8.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.855 0.36 . . . . 0.0 111.094 179.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -93.01 88.46 6.14 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -117.82 167.7 11.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.922 -179.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.37 142.94 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.002 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.69 HG21 ' O ' ' A' ' 173' ' ' VAL . 10.7 m -136.65 125.24 23.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.596 -178.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -110.52 120.77 43.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.489 0.661 . . . . 0.0 110.965 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 13.5 pt -134.91 -167.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.767 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.586 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 14.1 t -134.08 151.28 51.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.366 -178.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.501 ' SG ' HD13 ' A' ' 103' ' ' LEU . 1.2 p -96.8 -36.39 10.64 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.678 0.275 . . . . 0.0 111.387 -178.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.66 154.44 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.773 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 83.5 p -153.0 164.19 38.44 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.75 0.31 . . . . 0.0 110.665 -178.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 191' ' ' LYS . 62.3 t -116.41 130.2 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.079 -179.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 190' ' ' VAL . 61.5 pttt -53.01 -170.52 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.629 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 48.9 -173.06 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.866 179.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -64.03 126.51 27.91 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 45.0 t -153.42 163.59 39.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.763 0.316 . . . . 0.0 110.934 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -144.57 153.83 42.22 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.577 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.586 ' NH1' ' O ' ' A' ' 186' ' ' THR . 11.8 ptp180 -127.97 166.65 17.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.672 -179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -105.94 139.53 40.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.07 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.7 134.22 58.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 121.023 0.439 . . . . 0.0 110.623 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.54 HG22 HG13 ' A' ' 163' ' ' VAL . 73.2 t -119.46 129.46 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.653 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.09 136.29 53.15 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.349 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.16 147.38 19.06 Favored Glycine 0 N--CA 1.466 0.653 0 CA-C-O 121.773 0.652 . . . . 0.0 112.006 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 55.4 p-10 -106.81 148.28 28.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.207 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 205' ' ' GLY . 44.4 tp -69.03 126.99 31.56 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.84 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -109.38 -24.38 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.037 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.02 175.26 47.18 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.627 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 m -155.5 150.99 27.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.135 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.605 ' HZ1' ' CD ' ' A' ' 155' ' ' GLU . 25.8 pttm -150.81 178.16 9.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.09 146.61 23.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.579 ' NZ ' HH11 ' A' ' 82' ' ' ARG . 88.0 tttt -73.77 80.23 1.58 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.604 -179.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 117.821 -1.085 . . . . 0.0 110.281 178.799 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.5 m -155.38 157.36 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.777 0.322 . . . . 0.0 110.507 -179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -99.8 105.29 17.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.201 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 95.4 mtp -134.88 144.83 47.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -178.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 66.7 t0 -75.69 137.4 40.63 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -69.01 -40.06 78.91 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.712 -179.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 p 70.39 -42.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.675 0.274 . . . . 0.0 110.979 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 58' ' ' ALA . 99.1 mttt 42.73 32.33 0.38 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.41 . . . . 0.0 111.438 178.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -67.2 -25.28 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.42 0.628 . . . . 0.0 111.311 -178.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -52.49 -43.27 64.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.608 -179.326 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -138.91 76.9 33.18 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.987 -178.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.06 155.82 26.19 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.564 2.176 . . . . 0.0 111.097 -178.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.84 152.05 46.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.804 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -68.39 -15.0 63.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.799 0.333 . . . . 0.0 111.393 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.5 -45.16 84.67 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.821 -179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 6.0 pt-20 -74.63 -22.44 58.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.3 t -76.97 -51.98 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.481 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.58 -41.64 92.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.774 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.32 -31.17 68.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.54 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.3 138.42 57.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.004 -179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -141.09 85.1 1.96 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 111.71 -178.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.533 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.4 pt? -75.04 172.12 12.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.523 179.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.1 m-20 -103.13 121.16 42.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.59 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.573 ' O ' HG12 ' A' ' 79' ' ' VAL . 14.1 mptt -56.44 -9.4 0.7 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.14 0.495 . . . . 0.0 109.853 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -62.49 -35.39 79.2 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.76 16.17 0.55 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.572 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 76' ' ' LYS . 10.0 p -86.94 124.57 40.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.768 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.9 pt -120.64 -6.53 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.47 -168.34 39.92 Favored Glycine 0 C--N 1.318 -0.467 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.406 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 38.0 mtm180 -147.68 156.09 42.42 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.538 -178.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 92' ' ' LEU . 6.2 tt -121.32 125.92 74.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -126.26 127.07 45.03 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.801 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.482 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 79.3 mt -127.44 128.01 24.07 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.646 -178.222 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.8 Cg_endo -83.29 -39.33 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 122.371 2.047 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 t -48.75 -37.03 17.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.579 -177.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -120.73 -2.83 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.783 -178.926 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t 62.81 55.18 2.13 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.286 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.16 133.64 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.607 -178.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -135.99 114.22 11.52 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.524 ' O ' HG22 ' A' ' 83' ' ' ILE . 69.9 mt -143.45 109.36 5.28 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -176.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.1 Cg_endo -39.6 142.64 0.44 Allowed 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 121.865 1.71 . . . . 0.0 110.144 176.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.8 118.65 43.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.6 mt -106.68 122.94 47.36 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -64.41 -48.47 75.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.408 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 86.6 p -61.67 100.02 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.928 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.0 p -82.97 101.29 10.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.168 0.509 . . . . 0.0 110.006 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.474 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 70.0 p -137.29 160.49 38.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.417 -179.067 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -59.85 -28.38 67.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.75 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -83.33 -45.47 13.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.457 0.646 . . . . 0.0 112.116 -178.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.474 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 91.0 m-20 -65.78 -32.72 74.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.316 -179.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.6 mt -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.757 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.61 -13.96 61.1 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.3 p -103.79 -13.46 16.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -177.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.402 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . 172.96 -156.86 25.57 Favored Glycine 0 N--CA 1.46 0.255 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.64 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.46 125.89 35.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.997 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.63 144.38 31.79 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 p -75.33 152.27 38.16 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 185' ' ' ILE . 40.0 t -86.02 -40.22 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.443 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 99.5 mttt -89.67 -172.68 3.66 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.13 -178.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -126.2 -9.64 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 111.289 -177.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -138.89 37.35 2.16 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.108 0.48 . . . . 0.0 111.304 -177.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 16.4 pt20 -93.44 161.14 14.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.855 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -131.72 132.04 62.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.773 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.7 mtt -63.69 129.04 38.5 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.16 75.04 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -138.54 118.92 13.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.116 0.484 . . . . 0.0 110.504 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -160.12 52.71 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -94.04 111.19 22.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -84.72 103.4 13.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.43 126.64 35.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 111.785 -179.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD12 ' A' ' 83' ' ' ILE . 5.9 mt -122.46 130.53 53.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.477 178.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.99 139.19 46.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.774 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.61 -178.2 16.42 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.5 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -88.83 143.08 27.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.567 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' SER . 67.0 t30 -108.28 28.22 8.53 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.126 0.489 . . . . 0.0 110.676 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mmt -42.17 -17.24 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.683 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.6 OUTLIER 60.98 37.73 17.92 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.283 178.805 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.475 ' O ' ' OG ' ' A' ' 136' ' ' SER . 55.2 mtmt -135.46 106.48 6.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.685 -179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.43 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -48.74 130.11 17.33 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.545 179.344 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.22 -26.33 12.38 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.784 HG12 ' H ' ' A' ' 134' ' ' LEU . 27.7 t -84.97 179.14 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.784 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -70.63 133.08 46.36 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 -178.178 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 46.42 31.91 1.43 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 110.822 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.64 -9.91 59.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.04 -178.825 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -146.95 29.36 0.99 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 138' ' ' ILE . 5.5 pt -69.58 -27.83 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 120.805 0.336 . . . . 0.0 111.856 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.76 0.34 3.39 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.638 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.1 t -91.75 -14.66 29.56 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.156 0.503 . . . . 0.0 110.18 -179.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.6 mt -65.63 126.9 29.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.246 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.28 172.16 8.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.973 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -72.2 132.65 44.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.47 21.12 57.25 Favored Glycine 0 N--CA 1.462 0.396 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 146' ' ' LYS . 15.0 t70 -78.78 -158.89 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 7.9 tptm -146.81 129.15 15.8 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.076 -178.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.75 122.97 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.452 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -102.04 122.08 43.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.896 -178.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.8 tp -119.04 141.92 48.29 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.449 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.536 ' CE2' ' OE2' ' A' ' 155' ' ' GLU . 68.6 m-85 -107.81 131.23 54.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.208 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 52.8 t0 -105.47 -171.26 1.88 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 99.0 m-20 -35.64 -62.8 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.203 0.525 . . . . 0.0 111.273 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.49 20.87 2.55 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.931 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.14 145.03 48.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.686 0.755 . . . . 0.0 112.782 -175.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.536 ' OE2' ' CE2' ' A' ' 150' ' ' TYR . 4.5 mm-40 -106.89 121.14 43.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.43 178.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -107.25 129.54 54.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.487 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.83 120.94 39.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.386 177.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -117.65 138.79 51.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.49 131.81 56.82 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.599 0.714 . . . . 0.0 110.144 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.38 134.56 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.613 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.1 p -101.63 -26.36 13.55 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 124.368 1.043 . . . . 0.0 111.16 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.06 150.93 5.84 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 163' ' ' VAL . 2.7 p -98.26 146.38 8.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.94 -0.63 . . . . 0.0 109.323 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.7 t -145.79 154.22 41.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.055 0.455 . . . . 0.0 110.989 -178.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.28 119.27 38.94 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.708 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.633 ' CG2' HH21 ' A' ' 196' ' ' ARG . 29.1 m -134.88 158.78 41.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 111.269 -178.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 169' ' ' ASP . 25.5 p -76.71 136.16 67.47 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.97 -15.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.077 1.851 . . . . 0.0 112.064 -178.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 167' ' ' THR . 51.3 t0 -81.81 -13.03 58.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.922 -178.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -85.88 77.15 9.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.358 0.599 . . . . 0.0 110.198 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.544 ' C ' ' H ' ' A' ' 173' ' ' VAL . 84.1 m95 -75.79 -20.32 58.31 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.092 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -52.67 -6.94 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.01 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' TRP . 53.6 t -85.81 -24.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.669 -178.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.453 HG11 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -108.41 -10.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.808 0.813 . . . . 0.0 109.72 -178.473 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.58 139.81 38.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.744 -176.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.43 130.59 45.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.297 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -102.05 -40.41 6.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.462 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 137.68 29.26 0.27 Allowed Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -156.05 179.24 9.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.244 179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -90.89 92.54 8.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.371 0.605 . . . . 0.0 109.917 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -127.9 169.41 13.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.251 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.888 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.597 ' C ' HD12 ' A' ' 184' ' ' LEU . 19.2 m -137.31 124.98 22.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.729 0.299 . . . . 0.0 111.484 -178.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.597 HD12 ' C ' ' A' ' 183' ' ' THR . 10.8 mp -111.34 120.95 43.92 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.342 0.592 . . . . 0.0 110.774 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 110' ' ' VAL . 16.4 pt -135.12 -167.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -178.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t -138.6 152.4 48.1 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.77 -178.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 6.5 t -83.65 125.73 32.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.909 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.8 t -139.88 -112.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.63 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 40.9 t -157.47 166.4 33.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -178.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p -90.13 157.47 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt 47.72 34.26 3.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.058 178.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -156.37 166.51 33.2 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.365 -178.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 33.0 m120 48.94 66.24 1.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.78 178.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 78.3 p -62.32 -19.98 63.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.618 -179.02 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -99.2 117.35 33.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.408 -179.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.633 HH21 ' CG2' ' A' ' 166' ' ' VAL . 16.0 ttp180 -146.29 137.94 24.76 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.318 -178.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.01 129.97 46.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.952 179.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.438 HG11 HG11 ' A' ' 173' ' ' VAL . 46.2 t -135.23 136.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.52 -179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -114.24 126.37 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.425 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -116.72 135.54 53.69 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.228 0.537 . . . . 0.0 110.419 -179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.15 163.16 25.11 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -116.21 150.72 37.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.233 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.5 tp -71.8 126.96 31.07 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.025 0.44 . . . . 0.0 110.71 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.39 -24.57 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.188 -178.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.12 177.72 44.42 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.847 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.3 m -154.15 154.07 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.226 0.536 . . . . 0.0 111.016 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.49 ' HZ2' ' HB2' ' A' ' 155' ' ' GLU . 20.7 pttp -149.76 177.03 10.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.335 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -87.34 150.87 23.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -78.98 78.99 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.3 mptt . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 117.804 -1.093 . . . . 0.0 109.989 178.625 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.4 p -155.64 162.41 40.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.945 0.402 . . . . 0.0 110.786 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -64.6 -7.93 12.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.387 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 96.1 mmm -67.17 154.36 41.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.341 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -144.95 168.0 21.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.968 0.413 . . . . 0.0 111.465 -178.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.99 -45.7 66.74 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.032 -179.368 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.2 m -150.92 -88.22 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.8 tttt 54.41 32.86 17.39 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.787 178.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 63' ' ' GLN . 53.7 mt -61.73 -48.76 87.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.33 0.586 . . . . 0.0 110.591 -179.138 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.5 t0 48.34 -93.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.214 179.002 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 61' ' ' ILE . 1.1 tp-100 -151.16 84.43 5.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.622 -179.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.0 151.47 39.57 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.634 2.223 . . . . 0.0 111.322 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -79.16 173.34 12.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.115 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.67 -13.67 62.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.853 -179.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.0 92.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.266 0.555 . . . . 0.0 110.268 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -75.87 -23.62 55.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.582 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.3 t -80.31 -49.88 18.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.113 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.41 89.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.43 -31.98 70.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.972 -179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.09 132.73 52.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.222 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.8 t -140.85 88.35 2.18 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.824 0.345 . . . . 0.0 111.656 -179.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.557 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 1.5 pt? -79.93 170.28 16.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.489 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -102.48 139.78 37.63 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.055 178.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.57 -7.2 6.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.497 0.665 . . . . 0.0 110.131 179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -64.61 -31.86 73.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.848 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.11 10.42 2.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.168 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.547 HG11 HH12 ' A' ' 82' ' ' ARG . 99.2 t -86.31 120.96 36.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.5 pt -120.35 -7.46 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 111.9 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.7 -170.85 41.96 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.547 HH12 HG11 ' A' ' 79' ' ' VAL . 33.6 mtt-85 -146.8 158.05 43.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.318 0.58 . . . . 0.0 110.897 -178.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 tt -128.75 130.15 68.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.662 0.744 . . . . 0.0 109.322 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.5 m -130.16 131.64 45.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.071 -178.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.29 127.82 19.07 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.11 -178.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -83.08 -34.65 0.32 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.304 2.002 . . . . 0.0 112.031 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -48.16 -38.61 18.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.423 -177.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.5 p -118.61 -2.7 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.879 -178.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 64.57 50.77 2.08 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.595 ' CD2' HD23 ' A' ' 92' ' ' LEU . 2.0 tt -111.84 129.45 56.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -178.158 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.756 ' O ' HD22 ' A' ' 92' ' ' LEU . 83.0 tt0 -129.42 105.3 8.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 91' ' ' GLU . 3.8 mm? -128.5 148.95 70.32 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HD3' HD13 ' A' ' 92' ' ' LEU . 4.1 Cg_exo -84.65 145.2 10.29 Favored 'Trans proline' 0 N--CA 1.483 0.869 0 C-N-CA 122.617 2.211 . . . . 0.0 109.26 177.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -94.89 112.65 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 mt -101.53 121.68 42.43 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -63.8 -46.33 85.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.329 0.585 . . . . 0.0 110.805 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m -60.03 95.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.457 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.7 p -81.87 95.0 7.2 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 110.1 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.405 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 81.7 p -135.97 159.66 41.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.124 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.25 -28.67 66.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -83.29 -43.52 15.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.365 0.602 . . . . 0.0 112.075 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 94.2 m-20 -65.93 -36.14 82.54 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.565 -179.18 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 mt -61.07 -21.11 63.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.52 -179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.27 -33.24 69.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.455 ' OG ' HD22 ' A' ' 74' ' ' LEU . 62.2 m -89.54 -10.22 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 92' ' ' LEU . . . 174.05 -178.92 45.72 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.822 -1.18 . . . . 0.0 112.314 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.94 126.42 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.43 145.73 30.45 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.979 0.419 . . . . 0.0 110.968 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.8 p -73.12 150.22 42.41 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.24 -45.32 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.281 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.86 -172.32 3.32 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.962 -0.461 . . . . 0.0 110.966 -178.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 1.2 pm0 -112.58 -56.47 2.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.859 -178.371 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -90.61 44.63 1.21 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.268 -177.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -99.58 154.69 18.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.187 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.2 t -135.3 135.37 52.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 67.2 mtt -67.99 130.62 43.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.323 178.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.51 5.87 81.45 Favored Glycine 0 C--O 1.229 -0.18 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -142.72 120.36 11.82 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.037 -179.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.02 -168.35 54.26 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -85.52 106.82 17.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -84.66 102.45 12.95 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.76 128.44 36.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.289 0.566 . . . . 0.0 111.824 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -124.59 132.56 53.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.88 178.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.35 44.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 110.606 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.19 -177.66 19.26 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.455 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.529 ' O ' ' O ' ' A' ' 134' ' ' LEU . 39.0 m-70 -92.12 143.48 26.4 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.016 0.436 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 129' ' ' SER . 0.7 OUTLIER -109.53 29.23 7.77 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.326 0.584 . . . . 0.0 109.71 179.515 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.4 ' SD ' ' OE1' ' A' ' 63' ' ' GLN . 9.2 mmm -42.94 -14.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.693 -179.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 p 62.13 40.67 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -132.32 105.66 7.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.586 -179.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -50.1 125.68 12.81 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.831 0.824 . . . . 0.0 110.094 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.82 -28.84 8.56 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.699 -177.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.778 HG12 ' H ' ' A' ' 134' ' ' LEU . 49.0 t -79.89 178.97 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.995 -0.709 . . . . 0.0 109.294 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.778 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -70.97 139.54 50.62 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.954 -178.568 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.6 m-85 43.7 35.01 0.93 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.072 0.463 . . . . 0.0 111.076 177.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.5 p -81.64 -14.56 56.53 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -147.45 31.97 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 135' ' ' PHE . 3.6 pt -70.46 -26.65 29.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.703 0.287 . . . . 0.0 111.613 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.14 2.19 4.91 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.284 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 t -93.66 -13.85 27.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 109.573 -179.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.34 120.86 13.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.653 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.529 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.4 mttt -97.86 150.05 21.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.426 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.7 121.05 5.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.371 0.605 . . . . 0.0 111.463 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.16 19.67 10.48 Favored Glycine 0 N--CA 1.465 0.583 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 3.8 m-20 -90.64 134.55 34.32 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.471 ' HZ2' ' HB3' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -83.63 132.61 34.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.311 0.577 . . . . 0.0 111.967 -178.41 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.59 126.27 71.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.278 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -103.17 119.95 39.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.173 0.511 . . . . 0.0 110.754 -178.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.482 HD12 ' SD ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -109.42 139.48 44.33 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.638 -179.879 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' SD ' ' A' ' 116' ' ' MET . 86.6 m-85 -114.81 127.26 55.62 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.194 0.521 . . . . 0.0 111.343 179.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 152' ' ' ASN . 41.1 t0 -112.45 -166.24 1.06 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.526 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.2 p30 -22.57 -76.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.409 0.624 . . . . 0.0 111.816 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.508 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.5 mt-10 -137.53 29.37 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.749 178.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -127.66 144.5 51.07 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -109.99 120.96 44.12 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.14 132.7 49.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.682 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -96.05 118.03 31.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -118.32 141.39 48.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.34 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.78 133.13 55.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.282 0.563 . . . . 0.0 110.804 178.367 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 60.2 t -66.34 133.09 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.032 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 4.3 p -100.76 -28.63 12.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.861 -178.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.37 150.2 5.85 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.842 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.74 149.1 8.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.704 -0.748 . . . . 0.0 109.462 179.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.6 p -150.76 160.4 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.05 0.453 . . . . 0.0 111.234 -178.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -107.19 117.36 33.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.554 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.38 159.12 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.229 -178.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.6 p -66.87 168.41 10.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.461 ' HA ' HH11 ' A' ' 196' ' ' ARG . 2.4 Cg_endo -81.7 -11.19 11.6 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.941 1.761 . . . . 0.0 111.761 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -87.77 -5.3 58.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.101 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -85.92 71.88 10.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.073 0.463 . . . . 0.0 110.2 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.477 ' C ' ' N ' ' A' ' 173' ' ' VAL . 92.6 m95 -70.62 -29.89 66.39 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.047 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.557 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 55.4 mp0 -48.53 -14.28 0.06 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.485 0.66 . . . . 0.0 110.523 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.477 ' N ' ' C ' ' A' ' 171' ' ' TRP . 90.7 t -73.11 -25.85 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.923 -179.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.522 HG11 HD13 ' A' ' 185' ' ' ILE . 27.0 m -115.29 -0.4 9.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.535 0.683 . . . . 0.0 110.513 -178.219 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.57 122.78 28.01 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.959 -177.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -31.8 127.62 0.21 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.75 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -103.08 -42.75 5.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.017 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 142.29 29.24 0.15 Allowed Glycine 0 N--CA 1.471 1.029 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.39 176.78 12.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.942 0.401 . . . . 0.0 111.531 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.58 89.11 7.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.72 0.771 . . . . 0.0 109.404 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -122.48 167.84 12.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.028 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.7 142.57 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.233 179.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.523 ' C ' HD12 ' A' ' 184' ' ' LEU . 4.9 m -135.99 120.35 17.99 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.114 -179.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -106.06 128.63 53.99 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.164 0.507 . . . . 0.0 110.321 179.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.522 HD13 HG11 ' A' ' 174' ' ' VAL . 4.3 pt -137.47 -175.24 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.729 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.3 t -139.67 155.86 47.15 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.001 -179.535 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 20.1 m -100.14 100.45 11.29 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.012 0.434 . . . . 0.0 110.346 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 30.0 m -137.28 160.29 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 -179.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.1 t -154.13 98.75 2.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.954 0.407 . . . . 0.0 111.166 -179.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 70.8 t -125.58 130.66 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.508 -179.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.95 -161.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.857 179.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 49.31 -131.26 1.84 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.049 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 193' ' ' ASN . 45.5 p-10 -96.62 135.46 38.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 28.8 m -153.42 155.02 35.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.974 -179.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -143.22 147.28 34.6 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 168' ' ' PRO . 57.7 ttp180 -113.18 119.99 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.228 -179.439 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.79 131.25 37.52 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.96 142.13 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.79 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.11 130.29 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.338 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.44 134.33 54.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.391 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.29 150.04 19.93 Favored Glycine 0 N--CA 1.467 0.763 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.0 t0 -108.49 145.87 34.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.517 -0.341 . . . . 0.0 111.361 -179.169 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.548 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 10.8 tp -70.32 129.51 39.51 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.443 0.639 . . . . 0.0 110.709 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.81 -21.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.605 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.43 175.9 45.91 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.888 -1.149 . . . . 0.0 112.132 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.3 m -155.54 155.84 34.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.237 0.542 . . . . 0.0 110.85 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -148.15 178.35 8.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.421 178.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -100.35 142.89 31.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.296 0.57 . . . . 0.0 111.086 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -61.86 80.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.61 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 208' ' ' ALA . 80.8 tttt . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.075 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.2 t -67.58 139.24 56.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.6 t60 47.68 80.66 0.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.452 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.3 ptm -87.38 -167.16 1.79 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.904 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.77 137.77 57.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.037 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.67 -51.46 27.63 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.176 -178.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.439 ' HG ' HG11 ' A' ' 190' ' ' VAL . 1.9 t -151.73 -89.75 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 48.64 38.48 11.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.89 178.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 63' ' ' GLN . 47.9 mt -67.45 -76.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 -179.419 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.5 t0 57.41 -81.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.049 178.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 61' ' ' ILE . 6.7 pt20 -150.51 72.56 9.05 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.007 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -42.28 141.51 2.05 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.264 1.976 . . . . 0.0 111.674 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -71.04 151.71 44.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.85 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.2 mp -55.75 -26.1 43.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -178.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -39.6 93.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.322 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.1 mm-40 -74.1 -32.03 63.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.701 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.31 -45.32 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.919 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -41.43 90.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.773 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -75.84 -28.47 58.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.113 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.3 141.8 58.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.38 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.6 p -139.79 122.18 16.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.484 HD21 HD22 ' A' ' 95' ' ' LEU . 33.8 tp -114.6 129.24 56.65 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.343 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 68.0 t0 -68.47 134.45 50.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.274 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 4.5 mptp? -64.3 -8.84 14.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.191 0.52 . . . . 0.0 109.923 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -64.38 -33.96 77.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.048 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.436 ' OE1' ' OD1' ' A' ' 102' ' ' ASN . 75.7 mt-30 -77.68 14.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.201 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.83 127.37 47.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.78 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.686 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.11 2.61 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -177.694 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.26 -178.84 42.0 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -146.89 151.23 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.149 -0.621 . . . . 0.0 111.74 -179.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -120.47 124.33 72.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.61 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.1 t -128.88 129.02 45.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 64.8 mt -133.67 130.12 20.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.67 -178.331 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.22 -34.71 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.349 2.033 . . . . 0.0 111.561 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 m -47.74 -39.4 17.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.43 -176.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -121.19 -0.84 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.933 -179.288 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 61.33 54.25 3.24 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 36.3 tp -115.76 133.42 56.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.419 -178.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.724 ' O ' HD12 ' A' ' 92' ' ' LEU . 12.6 tm-20 -130.07 114.38 15.69 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.3 mp -136.73 103.72 9.18 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.053 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.38 130.95 3.52 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.777 1.652 . . . . 0.0 110.264 175.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 84.7 t -82.36 127.89 39.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.484 HD22 HD21 ' A' ' 74' ' ' LEU . 13.1 mt -111.78 123.1 49.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.893 0.378 . . . . 0.0 110.068 -179.091 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -65.64 -45.9 81.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.741 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.9 m -66.84 100.07 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.376 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.66 97.69 10.26 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.437 0.637 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.56 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 4.8 p -137.37 155.57 49.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -51.53 -36.44 44.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.24 179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -75.43 -45.75 36.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.99 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.693 HD22 ' N ' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -65.23 -36.56 84.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.57 -178.215 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.402 HD13 ' SG ' ' A' ' 187' ' ' CYS . 11.5 mt -59.24 -21.87 60.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.439 -179.079 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.3 mt -70.13 -31.19 68.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -89.19 -11.44 43.74 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.56 42.21 Favored Glycine 0 N--CA 1.464 0.54 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.052 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.59 127.93 34.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.308 -0.446 . . . . 0.0 109.885 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -106.24 146.72 29.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.013 -179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.6 p -74.62 152.22 39.25 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.28 -51.67 13.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 113' ' ' ASN . 82.8 tttt -93.78 139.26 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 -178.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -74.12 -0.18 15.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.225 -179.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 16.9 m120 -138.01 38.29 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.151 0.5 . . . . 0.0 110.983 -177.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.74 21.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.718 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.5 t -129.98 128.75 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.4 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 66.1 mtt -69.36 128.14 35.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.786 0.327 . . . . 0.0 110.202 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.59 0.18 69.93 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -140.5 121.96 15.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.877 0.37 . . . . 0.0 110.974 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.11 -169.95 53.54 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.551 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 12.4 t30 -86.34 110.77 19.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.19 102.77 12.86 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.016 0.436 . . . . 0.0 109.91 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 129.04 36.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.589 0.709 . . . . 0.0 112.114 -178.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.87 130.44 52.61 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.565 178.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.87 139.35 46.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.567 0.698 . . . . 0.0 110.496 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.15 -178.8 19.31 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.669 -179.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 134' ' ' LEU . 74.7 m-70 -91.33 140.87 29.36 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.152 0.501 . . . . 0.0 110.654 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 129' ' ' SER . 26.9 t-20 -108.68 29.62 7.25 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.517 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mmm -43.28 -15.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.792 -179.123 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.88 38.62 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.239 0.542 . . . . 0.0 110.165 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.5 tttt -133.0 106.15 7.49 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.178 -179.107 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -51.9 125.2 14.57 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.807 0.813 . . . . 0.0 110.137 -179.243 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.96 -29.42 7.13 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.62 -178.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.831 HG12 ' H ' ' A' ' 134' ' ' LEU . 41.3 t -81.06 -179.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.058 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.831 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -70.88 135.31 47.94 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.418 -178.277 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.46 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 47.66 35.81 4.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.155 0.502 . . . . 0.0 111.076 178.393 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 2.4 p -81.93 -16.88 49.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.45 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 21.3 t0 -142.85 30.57 1.46 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 135' ' ' PHE . 5.7 pt -70.44 -25.91 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.825 0.345 . . . . 0.0 111.458 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.04 4.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.385 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.45 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.1 m -95.38 -11.97 26.81 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.238 0.542 . . . . 0.0 109.637 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.7 mt -63.92 124.96 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.402 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -97.12 155.8 16.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.589 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.03 129.32 41.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.594 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 90.03 21.53 38.73 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 40.6 m-20 -86.0 137.46 32.7 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.214 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -81.64 126.99 32.42 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.68 125.19 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.261 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -104.71 115.59 30.58 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.372 0.606 . . . . 0.0 109.874 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.7 tp -116.1 144.62 43.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.307 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.511 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 50.0 m-85 -116.13 133.45 56.01 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.314 0.578 . . . . 0.0 111.49 -179.34 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 49.0 t0 -109.98 -168.32 1.31 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.977 178.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 65.4 t30 -29.13 -71.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.342 0.591 . . . . 0.0 111.283 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.66 25.33 3.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.95 178.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.93 142.9 51.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.481 0.658 . . . . 0.0 112.486 -175.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.511 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 33.6 tp10 -107.14 120.16 41.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -104.29 130.77 52.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.202 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -94.91 117.12 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.647 177.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -117.39 138.98 51.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.232 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.79 135.34 54.12 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.127 0.489 . . . . 0.0 110.789 178.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 46.7 t -68.45 132.96 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.03 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.04 -27.74 11.46 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 124.463 1.102 . . . . 0.0 110.683 -178.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.63 154.57 8.7 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.687 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.28 144.03 19.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.786 -0.707 . . . . 0.0 109.735 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.9 m -155.26 166.1 34.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.271 0.558 . . . . 0.0 111.47 -178.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -123.67 128.16 49.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.678 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -137.4 154.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 111.285 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 169' ' ' ASP . 10.7 p -58.39 129.79 83.97 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.91 -13.56 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.781 1.654 . . . . 0.0 111.963 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.3 m-20 -81.0 -11.31 59.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.995 -177.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -86.13 74.06 10.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -73.25 -15.33 61.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.521 -179.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.527 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 3.0 pt-20 -53.24 -36.18 60.77 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.234 0.54 . . . . 0.0 109.873 178.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.882 ' O ' HG21 ' A' ' 183' ' ' THR . 2.9 t -69.71 -1.97 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.973 -179.006 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.99 -13.74 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.854 0.835 . . . . 0.0 109.919 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -86.92 172.78 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.106 -1.407 . . . . 0.0 112.279 -178.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 177' ' ' HIS . 67.4 t0 -82.3 131.4 35.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.735 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.527 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 40.5 m80 -111.07 -42.02 4.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.552 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.52 25.67 0.09 OUTLIER Glycine 0 N--CA 1.472 1.078 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 181' ' ' GLU . 0.0 OUTLIER -151.42 166.33 31.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.808 0.337 . . . . 0.0 110.725 -179.796 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.22 89.13 5.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.528 0.68 . . . . 0.0 110.454 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.517 ' OE1' ' NZ ' ' A' ' 179' ' ' LYS . 53.2 tt0 -130.23 129.22 43.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.271 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.7 tt -80.64 148.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.882 HG21 ' O ' ' A' ' 173' ' ' VAL . 21.6 m -136.73 122.41 19.8 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.189 -179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 183' ' ' THR . 10.8 mp -109.11 125.9 52.63 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.273 0.558 . . . . 0.0 110.545 179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 35.4 pt -136.25 163.03 34.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.119 -178.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.504 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 59.1 p -82.26 164.11 21.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.29 179.28 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 187' ' ' CYS . 33.9 t -98.35 27.58 4.63 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.801 0.334 . . . . 0.0 111.52 -179.17 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.576 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 53.6 t -102.31 99.01 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.384 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.7 t -170.66 19.69 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.664 -179.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.439 HG11 ' HG ' ' A' ' 59' ' ' SER . 35.0 m -97.86 -3.09 9.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.016 0.436 . . . . 0.0 111.554 -179.033 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -143.43 -131.68 0.09 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.372 -178.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -66.26 141.48 58.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.211 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -59.39 151.24 24.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.794 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.5 t -151.28 148.05 27.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.138 0.494 . . . . 0.0 111.653 -179.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.55 134.31 53.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.868 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.576 ' NH2' ' O ' ' A' ' 188' ' ' VAL . 11.3 ptp180 -142.42 163.83 31.77 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.778 -178.748 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -106.16 133.99 49.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.152 178.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.91 132.38 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 43.9 t -117.95 127.73 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.947 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.52 134.33 54.11 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.353 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.45 139.92 11.34 Favored Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -98.28 140.67 32.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.622 -0.789 . . . . 0.0 111.642 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 205' ' ' GLY . 43.5 tp -65.22 125.31 24.62 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.17 -21.4 5.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.421 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.411 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -179.39 174.69 46.49 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.199 -179.713 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.5 m -154.35 151.77 29.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.295 0.569 . . . . 0.0 110.824 179.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -150.45 177.6 9.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.56 179.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -94.43 147.31 23.37 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.342 0.591 . . . . 0.0 110.575 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -61.66 80.27 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.708 -179.927 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 208' ' ' ALA . 73.8 tttt . . . . . 0 C--N 1.314 -0.965 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.075 178.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 p 62.69 134.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -66.38 -40.39 89.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.433 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.43 ' H ' ' H ' ' A' ' 57' ' ' ASP . 28.0 ttt -166.34 -18.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.138 0.494 . . . . 0.0 110.335 -178.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.43 ' H ' ' H ' ' A' ' 56' ' ' MET . 65.9 t0 -52.26 137.7 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.719 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -73.44 -8.88 57.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.418 -179.46 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.5 m -85.82 33.47 0.59 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.832 0.349 . . . . 0.0 111.406 -178.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -88.46 28.2 1.15 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.209 -179.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mm -64.76 -44.68 96.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.352 0.596 . . . . 0.0 110.672 -178.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 49.69 -97.49 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.288 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -151.66 87.77 4.38 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.784 -179.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.03 151.76 50.43 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.937 1.758 . . . . 0.0 111.7 179.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.05 161.6 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.46 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 66' ' ' LEU . 9.7 mp -65.37 -19.99 66.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.634 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.36 -37.8 88.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 110.036 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.3 mt-10 -74.19 -33.15 63.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.641 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.28 -44.68 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.542 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.41 86.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.923 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -83.36 -22.57 32.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.047 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -60.34 104.32 0.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -179.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -95.54 112.22 23.98 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.189 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tt -115.84 133.02 56.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.323 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -80.41 148.82 30.4 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.453 179.105 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -67.98 0.93 3.03 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.375 0.607 . . . . 0.0 109.588 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 75' ' ' ASP . 38.8 ttmt -62.96 -42.86 99.95 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.723 179.37 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -79.41 0.16 30.41 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.14 0.495 . . . . 0.0 110.439 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.7 t -99.56 129.71 49.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.576 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.617 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -133.57 7.09 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.731 -178.162 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.73 -172.54 35.66 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.418 ' H ' ' HB2' ' A' ' 150' ' ' TYR . 13.3 ttm180 -153.31 153.18 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 111.262 -179.422 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 83' ' ' ILE . 17.0 tt -127.7 130.77 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.706 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.8 m -127.77 130.98 49.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.031 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.0 mt -131.58 117.12 16.38 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.222 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.28 -36.39 0.99 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.097 1.864 . . . . 0.0 111.534 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.0 m -52.33 -38.73 59.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.711 -177.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 137' ' ' ASP . 42.5 t -112.05 -6.94 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.75 0.31 . . . . 0.0 110.67 -178.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.59 47.47 1.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.3 tp -114.15 131.46 56.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.784 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -133.02 116.61 16.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 179.218 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -146.46 165.1 21.09 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.423 -177.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.38 161.01 8.24 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 123.206 2.604 . . . . 0.0 108.923 177.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -112.78 122.95 67.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.2 mt -103.32 123.97 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.33 -47.99 74.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.199 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.6 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 7.7 p -85.19 119.98 26.18 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.791 -179.583 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 p -86.76 118.8 26.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.219 0.533 . . . . 0.0 110.337 178.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.499 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.2 p -140.69 168.83 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.413 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 4.0 tm-20 -69.87 -34.44 73.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.67 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.87 -42.24 21.81 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 97' ' ' SER . 3.6 p-10 -68.75 -20.18 64.36 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.37 -17.77 63.72 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.218 -179.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.1 mp -75.29 -15.98 60.47 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.8 m -96.69 -13.6 22.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.476 ' N ' HD13 ' A' ' 134' ' ' LEU . . . 165.6 -149.6 16.13 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.59 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -93.65 126.3 38.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.401 0.619 . . . . 0.0 110.0 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.08 147.82 26.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.699 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 41.9 p -72.22 149.56 44.48 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 t -83.95 -46.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -88.69 -170.91 3.11 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.85 -178.081 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -124.31 -5.44 7.76 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.654 -178.475 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -138.87 36.09 2.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.694 0.283 . . . . 0.0 110.764 -178.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -92.55 158.92 15.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.119 179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.37 132.1 57.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.874 -179.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.5 mtt -65.73 127.14 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 178.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.47 1.82 68.43 Favored Glycine 0 CA--C 1.518 0.256 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -142.55 126.76 17.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.005 0.431 . . . . 0.0 110.227 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 179' ' ' LYS . . . 72.55 -176.85 41.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -80.05 108.81 13.94 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.536 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.68 99.47 10.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.007 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.47 128.61 37.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.232 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt -123.21 133.02 54.25 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.978 178.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.09 140.34 45.71 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.453 0.644 . . . . 0.0 110.916 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -145.16 -178.13 20.49 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.962 -179.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -84.58 150.45 25.19 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 111.28 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 129' ' ' SER . 44.7 t30 -114.71 27.48 9.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.588 179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.4 mmm -45.47 -12.72 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.532 -178.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.8 m 51.7 42.41 29.76 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -136.06 119.58 17.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.868 -178.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -61.9 124.47 20.85 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.855 0.836 . . . . 0.0 110.686 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.26 5.78 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.033 -177.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 134' ' ' LEU . 22.1 t -138.53 175.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.062 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.89 130.7 43.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 111.371 -178.105 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.5 m-30 46.71 32.96 1.89 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.636 178.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -11.14 58.59 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.522 ' O ' HG21 ' A' ' 88' ' ' VAL . 4.1 m-20 -144.68 21.83 1.64 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.449 -177.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.538 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.6 pt -69.0 -27.44 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.719 0.295 . . . . 0.0 111.527 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.58 1.49 2.36 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.549 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.7 m -95.54 -10.44 29.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.91 118.6 7.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.524 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -98.19 170.98 8.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -67.25 137.4 56.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.134 0.968 . . . . 0.0 112.409 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.53 20.3 64.37 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.781 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -90.94 134.05 34.78 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.036 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -83.46 138.23 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.548 0.689 . . . . 0.0 112.16 -178.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 158' ' ' TYR . 76.9 mt -130.82 119.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.504 179.103 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -100.47 122.72 43.66 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.3 tp -117.32 147.03 42.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.726 -179.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.418 ' HB2' ' H ' ' A' ' 82' ' ' ARG . 15.5 m-85 -113.49 128.81 56.58 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.17 0.509 . . . . 0.0 111.134 -179.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 152' ' ' ASN . 38.4 t0 -109.3 -168.44 1.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 151' ' ' ASP . 92.3 m-20 -25.73 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.381 0.61 . . . . 0.0 112.312 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -138.85 23.4 2.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -124.95 144.63 50.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.131 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -104.66 121.74 44.19 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -105.94 130.05 53.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.307 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -96.84 119.2 34.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' A' ' 147' ' ' ILE . 52.0 m-85 -116.64 138.74 51.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.167 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -114.9 132.14 56.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.35 0.595 . . . . 0.0 110.56 179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.27 134.18 30.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -107.57 -25.11 11.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.357 1.036 . . . . 0.0 110.714 -179.512 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.37 164.21 23.68 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.89 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.76 152.27 35.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 34.2 t -156.88 169.11 25.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.378 0.609 . . . . 0.0 111.369 -179.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -119.99 126.98 52.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.399 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -139.55 159.0 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.113 -178.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 169' ' ' ASP . 17.6 p -68.5 135.62 90.73 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.573 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.9 Cg_endo -47.17 -12.62 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.604 1.536 . . . . 0.0 111.727 -179.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 167' ' ' THR . 66.5 t0 -78.15 -17.7 56.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.44 -178.628 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.603 ' O ' HG22 ' A' ' 173' ' ' VAL . 13.6 mptt -84.7 68.79 10.53 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.573 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 63.0 m95 -73.72 -24.04 59.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.379 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.36 -7.32 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 170' ' ' LYS . 17.3 m -85.9 -9.12 11.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.128 -178.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.544 HG11 HD13 ' A' ' 185' ' ' ILE . 1.4 m -131.27 8.3 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.689 0.757 . . . . 0.0 109.158 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 72.4 mm-40 -83.6 143.71 29.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.443 -178.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -55.81 120.14 6.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.801 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.447 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 41.7 m80 -111.3 -40.1 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.71 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 122.85 34.67 0.78 Allowed Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.199 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.466 ' O ' ' C ' ' A' ' 119' ' ' GLY . 19.8 mmmt -139.03 157.08 46.62 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.664 -179.262 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 180' ' ' ASP . 1.2 m-20 -87.96 88.57 7.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.906 0.86 . . . . 0.0 108.891 177.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -135.12 170.09 16.44 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.133 -178.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.1 tt -131.29 143.3 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.845 178.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.602 ' C ' HD12 ' A' ' 184' ' ' LEU . 13.5 m -137.25 128.07 27.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.098 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 183' ' ' THR . 10.4 mp -112.77 125.62 54.53 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.216 0.532 . . . . 0.0 110.325 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.544 HD13 HG11 ' A' ' 174' ' ' VAL . 11.9 pt -133.91 164.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.427 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.0 p -139.43 163.54 32.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.116 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 53.4 t 47.18 94.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 110.052 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 18.5 m -87.12 16.98 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.214 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.4 m -68.25 140.84 56.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.918 0.389 . . . . 0.0 110.783 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.15 -45.97 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.237 0.541 . . . . 0.0 110.273 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -58.86 144.58 43.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.625 179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 192' ' ' ASP . 46.8 t0 -63.63 -23.58 67.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.14 0.495 . . . . 0.0 110.318 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.425 ' CG ' ' H ' ' A' ' 194' ' ' SER . 24.6 t-20 52.17 -121.04 1.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.132 179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 195' ' ' LYS . 80.6 p -92.87 -80.52 0.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.3 0.572 . . . . 0.0 110.745 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.462 ' N ' ' OG ' ' A' ' 194' ' ' SER . 21.9 pttp -146.96 153.18 39.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.222 -179.497 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.75 120.35 24.94 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.483 . . . . 0.0 110.786 -179.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.21 142.66 45.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.77 139.05 46.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.027 -179.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.72 129.93 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.302 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 161' ' ' THR . . . -115.21 135.74 53.85 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.999 0.428 . . . . 0.0 110.402 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.52 145.73 17.0 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.843 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -100.69 139.02 36.96 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.773 -178.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.48 126.16 27.41 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.212 0.529 . . . . 0.0 110.711 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.63 -25.93 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.376 -179.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.64 161.26 20.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.434 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 207' ' ' LYS . 40.5 m -137.73 157.4 46.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.446 0.641 . . . . 0.0 110.07 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 206' ' ' THR . 16.2 ptpt -148.93 179.32 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.306 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.17 144.42 25.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.467 0.651 . . . . 0.0 110.901 179.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -67.98 80.15 0.21 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.644 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 77.3 tttt . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.59 179.068 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.0 p -74.99 162.54 28.49 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -97.83 25.36 5.99 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.857 0.36 . . . . 0.0 111.325 -179.031 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 82.2 mmm -61.97 -43.85 97.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.239 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.7 t0 52.55 28.03 5.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.073 178.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.37 -36.93 79.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.201 -178.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 61' ' ' ILE . 15.0 m -85.87 27.08 0.91 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 -178.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -71.64 35.57 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.726 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 59' ' ' SER . 59.3 mt -62.06 -47.54 92.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 51.12 -93.2 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.958 178.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' ILE . 4.2 pt20 -150.76 80.36 6.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.088 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.33 146.37 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.266 1.977 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.24 154.35 42.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.877 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.6 mt -56.13 -26.37 49.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 110.869 -179.153 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.92 96.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.651 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.62 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.9 mt-10 -72.63 -36.09 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.679 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.5 t -74.47 -44.63 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.083 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.76 92.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.273 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -80.76 -25.79 37.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.447 -179.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.62 140.92 58.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.112 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.0 p -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 -179.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.519 HD11 ' OE1' ' A' ' 78' ' ' GLN . 12.9 tp -140.83 140.0 34.58 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.316 -178.483 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -75.72 140.84 42.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.383 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 79' ' ' VAL . 14.1 mptt -70.07 -6.0 30.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.302 0.572 . . . . 0.0 110.009 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.21 -35.74 81.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.358 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.519 ' OE1' HD11 ' A' ' 74' ' ' LEU . 80.9 mt-30 -75.59 11.93 1.17 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.653 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 76' ' ' LYS . 96.2 t -87.8 126.09 41.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.573 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 96' ' ' LYS . 9.1 pt -119.9 -9.07 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 112.058 -178.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 -170.26 38.03 Favored Glycine 0 C--N 1.321 -0.264 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.09 152.42 38.47 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.507 -178.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.554 HD12 HD13 ' A' ' 123' ' ' LEU . 10.1 tt -122.58 125.8 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -125.79 127.86 46.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.172 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 67.1 mt -131.61 126.71 21.18 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.258 -177.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.7 Cg_endo -82.66 -35.9 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.162 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.9 t -46.64 -37.73 8.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.403 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.1 p -120.6 -0.37 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 t 61.49 55.63 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.47 136.07 54.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.184 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.676 ' O ' HD12 ' A' ' 92' ' ' LEU . 81.8 tt0 -135.24 119.89 18.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 179.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -146.09 107.67 4.24 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -176.108 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.0 Cg_endo -39.73 159.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.841 1.694 . . . . 0.0 109.898 175.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.6 t -110.04 124.68 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 74' ' ' LEU . 26.4 mt -108.09 123.87 49.35 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HB2' HD13 ' A' ' 80' ' ' ILE . 65.9 tttm -66.81 -49.64 65.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.196 0.522 . . . . 0.0 111.435 -179.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.8 m -62.05 99.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.496 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 p -82.99 102.16 11.56 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.918 0.389 . . . . 0.0 110.348 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.493 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 80.4 p -141.86 155.17 45.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.307 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -57.86 -23.03 51.02 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -81.82 -50.11 9.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.278 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.2 p-10 -66.29 -31.56 72.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.588 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.97 -22.49 62.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.422 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -72.9 -16.53 61.56 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.6 m -106.96 -14.94 14.83 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.93 48.1 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.296 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -107.57 145.49 33.15 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.188 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.8 p -70.14 149.18 47.84 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.54 -45.12 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.32 -170.84 2.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.027 -178.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.98 -10.12 8.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 113' ' ' ASN . 54.3 p30 -135.45 36.35 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.929 0.395 . . . . 0.0 111.026 -177.342 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -93.82 158.74 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.927 179.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.43 131.16 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.794 -178.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.435 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 67.0 mtt -65.41 129.47 39.86 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 92.58 -2.75 74.09 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -138.49 121.26 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.867 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 179' ' ' LYS . . . 74.93 -173.96 51.95 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.442 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 56.7 t30 -82.65 111.98 19.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -84.77 104.84 15.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.17 130.12 36.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.608 -179.074 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.554 HD13 HD12 ' A' ' 83' ' ' ILE . 6.3 mt -128.74 134.31 48.4 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.069 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.42 43.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.256 0.55 . . . . 0.0 111.005 -178.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.75 -177.58 17.89 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 134' ' ' LEU . 64.3 m-70 -87.69 140.68 29.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.675 0.274 . . . . 0.0 110.58 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 49.1 p30 -107.16 28.27 8.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.155 0.502 . . . . 0.0 110.735 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -43.31 -15.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.887 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.2 40.01 18.59 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.256 178.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.58 107.1 7.78 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.35 128.15 16.44 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.857 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.71 -26.44 11.74 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.796 HG12 ' H ' ' A' ' 134' ' ' LEU . 47.7 t -83.6 179.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.205 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.796 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 137.51 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.245 -0.279 . . . . 0.0 110.245 -178.103 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 138' ' ' ILE . 4.0 m-85 44.39 35.47 1.32 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.1 0.476 . . . . 0.0 111.184 177.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 16.8 p -82.41 -13.46 56.77 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 136' ' ' SER . 78.4 m-20 -146.97 31.57 0.94 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.33 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.514 HD13 ' CD2' ' A' ' 135' ' ' PHE . 4.0 pt -70.84 -25.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.819 0.343 . . . . 0.0 111.825 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.43 0.92 7.15 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.53 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -93.68 -11.68 31.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.304 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 163' ' ' VAL . 18.9 mt -65.64 120.69 13.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.537 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.508 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.05 151.9 19.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.628 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -52.07 122.82 9.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.302 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.93 21.29 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.7 m-20 -87.25 139.55 30.45 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.078 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -81.66 127.26 32.72 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.496 -178.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 158' ' ' TYR . 32.9 mm -115.02 124.25 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -105.64 115.81 30.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.95 150.86 39.2 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.148 -178.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -123.77 136.9 54.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.185 0.516 . . . . 0.0 111.65 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 156' ' ' TYR . 2.5 m-20 -113.7 -163.53 0.87 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.613 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 151' ' ' ASP . 4.6 p30 -26.03 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.07 0.462 . . . . 0.0 111.438 178.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.52 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 94.6 mt-10 -132.94 29.86 4.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.065 178.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.412 ' OD1' ' OD1' ' A' ' 152' ' ' ASN . 28.3 m120 -127.82 145.34 50.96 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -106.29 121.78 44.89 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.724 179.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.588 ' CE1' ' OD2' ' A' ' 151' ' ' ASP . 19.7 m-85 -104.35 129.12 52.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.629 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.58 117.27 30.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' O ' ' N ' ' A' ' 147' ' ' ILE . 8.2 m-85 -120.53 137.85 54.16 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.859 -178.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.1 134.96 53.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.76 178.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.26 134.43 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.158 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 12.2 p -99.07 -26.96 14.05 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.486 1.116 . . . . 0.0 111.316 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.99 145.25 4.17 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.342 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 141' ' ' LEU . 58.1 t -91.8 141.46 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -139.9 151.41 45.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.756 0.312 . . . . 0.0 111.05 -177.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -106.47 115.94 31.08 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.86 159.06 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.232 -177.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.0 p -66.94 170.03 6.99 Favored Pre-proline 0 N--CA 1.451 -0.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.555 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.7 Cg_endo -81.68 -13.19 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.888 1.725 . . . . 0.0 111.901 -179.437 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -87.87 -14.21 40.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -178.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -85.69 69.13 10.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.555 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 91.4 m95 -74.83 -2.44 26.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.09 -178.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -53.37 -35.38 60.24 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.162 0.506 . . . . 0.0 111.024 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.827 ' O ' HG21 ' A' ' 183' ' ' THR . 17.0 m -80.88 3.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.925 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.38 -15.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.833 0.825 . . . . 0.0 109.971 -178.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -87.06 162.22 17.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.838 -179.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -66.76 128.16 35.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.637 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -99.29 -39.53 8.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.083 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 133.2 29.42 0.5 Allowed Glycine 0 N--CA 1.473 1.103 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.439 ' O ' ' CA ' ' A' ' 119' ' ' GLY . 58.5 pttt -156.05 -179.11 7.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 43.8 m-20 -92.21 90.26 7.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.151 0.5 . . . . 0.0 110.145 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -128.2 169.28 14.33 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.861 -178.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.9 tt -132.94 143.33 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.827 HG21 ' O ' ' A' ' 173' ' ' VAL . 11.3 m -138.29 120.61 15.89 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.872 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 183' ' ' THR . 10.6 mp -108.77 126.03 52.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.958 0.409 . . . . 0.0 111.179 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.416 HG22 HG12 ' A' ' 198' ' ' VAL . 5.1 pt -133.89 -166.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.518 -178.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.587 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 23.4 p -137.24 167.21 22.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.572 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 186' ' ' THR . 91.8 m -49.15 178.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.248 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 11.6 p -64.91 139.35 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 190' ' ' VAL . 20.2 p -73.42 171.4 13.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 189' ' ' SER . 16.0 m -53.36 -168.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.223 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -59.78 -47.58 85.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.642 0.258 . . . . 0.0 111.239 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 193' ' ' ASN . 39.7 t0 -166.77 -158.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.503 ' H ' ' CG ' ' A' ' 192' ' ' ASP . 99.1 m-20 50.01 34.09 7.69 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.78 178.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 68.8 m -155.05 155.49 34.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.559 -178.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.99 134.48 50.35 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.592 -179.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.587 ' NH1' ' O ' ' A' ' 186' ' ' THR . 15.4 ttm180 -78.15 126.59 31.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.727 -179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -89.19 132.91 34.63 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.416 HG12 HG22 ' A' ' 185' ' ' ILE . 27.7 m -139.46 142.09 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 111.514 -179.126 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 40.1 t -116.29 129.16 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.178 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -113.01 134.62 54.43 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.646 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.08 157.28 22.78 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -112.15 148.8 33.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.972 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.29 127.23 32.06 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.858 0.361 . . . . 0.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 81.3 t -108.03 -25.46 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.346 -178.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 168.6 163.18 22.15 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.616 178.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.521 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 93.6 m -139.49 159.05 43.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.058 0.456 . . . . 0.0 110.109 -179.28 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 206' ' ' THR . 15.9 ptpt -147.27 178.79 8.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.655 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -97.35 142.99 28.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.545 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -63.94 80.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.556 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.388 178.524 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.455 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 54' ' ' SER . 27.1 p 49.59 95.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -60.18 -45.44 93.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 -179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' ASP . 33.2 tpp 49.54 -126.3 2.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' MET . 96.7 m-20 48.44 98.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 110.455 179.307 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.58 75.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.113 -178.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 1.4 t -150.08 -95.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.337 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.553 ' N ' ' OG ' ' A' ' 59' ' ' SER . 68.1 mttm 45.73 33.7 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.736 179.188 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.2 mt -67.23 -30.97 51.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.79 -179.219 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 1.8 p30 48.14 -162.91 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.912 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.516 ' CG ' ' SD ' ' A' ' 128' ' ' MET . 15.9 tt0 -96.53 87.06 0.41 Allowed Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -44.22 141.44 4.86 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.032 1.822 . . . . 0.0 112.534 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 58.5 t0 -76.43 152.94 36.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.556 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.1 mt -55.04 -25.0 27.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.565 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.71 -39.11 87.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.212 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 98.0 mt-10 -74.14 -32.12 63.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.6 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.18 -44.96 36.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 -179.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.83 85.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.81 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -81.6 -28.46 33.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.455 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.17 111.73 1.45 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 111.218 -178.44 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.8 m -97.37 85.97 3.78 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 67.7 tp -74.4 146.74 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.335 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' LYS . 96.0 m-20 -94.88 111.61 23.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 179.311 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' O ' HG12 ' A' ' 79' ' ' VAL . 17.2 tptp -52.61 -10.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.01 0.434 . . . . 0.0 110.198 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -70.93 -12.19 61.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.925 -179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -95.54 15.86 18.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.475 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.9 p -91.22 126.24 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.07 179.637 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -117.34 -3.71 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.946 0.403 . . . . 0.0 111.66 -178.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.34 -162.01 32.19 Favored Glycine 0 C--N 1.317 -0.524 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.685 ' NH1' ' HZ3' ' A' ' 209' ' ' LYS . 36.8 ptt180 -156.31 162.64 40.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.426 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -133.26 139.67 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 t -130.03 135.57 48.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.529 -179.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 70.5 mt -131.89 125.55 20.31 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.734 -178.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.66 -36.29 0.34 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.46 2.107 . . . . 0.0 112.864 -179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.1 p -48.21 -36.49 13.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.706 -176.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.8 p -119.81 -0.21 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.576 0.227 . . . . 0.0 110.65 -179.067 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.0 p 61.53 52.12 3.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 88' ' ' VAL . 4.7 tp -115.57 134.11 55.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.714 -178.694 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.56 128.69 22.22 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.636 ' CD1' ' H ' ' A' ' 107' ' ' ALA . 1.0 OUTLIER -161.55 130.21 3.0 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.128 -178.857 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -47.59 156.89 1.0 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.583 1.522 . . . . 0.0 110.873 177.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.5 t -107.88 125.55 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -106.48 125.38 50.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.845 0.355 . . . . 0.0 110.592 -178.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.57 -45.35 72.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.095 0.474 . . . . 0.0 110.843 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.2 m -67.68 104.83 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.577 -178.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.1 p -81.74 96.63 7.62 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.096 0.475 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.58 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 4.8 p -135.96 157.65 46.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.947 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -58.11 -27.33 63.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.884 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.53 -45.28 13.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.24 0.543 . . . . 0.0 111.197 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.58 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 1.9 m-80 -65.67 -36.68 84.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.405 -178.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 108' ' ' ALA . 14.5 mt -63.46 -17.94 63.24 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.651 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.0 mt -71.21 -28.96 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.1 p -97.71 -8.23 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.35 -164.66 32.92 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.691 -1.242 . . . . 0.0 112.584 -178.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.636 ' H ' ' CD1' ' A' ' 92' ' ' LEU . . . -92.36 127.95 38.03 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.06 146.71 28.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.012 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.0 p -74.27 153.16 39.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 185' ' ' ILE . 6.3 t -85.52 -47.04 16.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.081 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.42 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 14.7 mptt -92.49 -170.29 2.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.633 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 113' ' ' ASN . 11.5 pt-20 -106.97 -52.83 2.7 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.72 -178.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 112' ' ' GLU . 17.9 m120 -89.24 43.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.479 -178.118 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.42 ' CD ' ' H ' ' A' ' 111' ' ' LYS . 67.9 mt-30 -79.6 146.33 32.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.034 0.445 . . . . 0.0 110.859 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.72 122.8 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.34 -179.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.99 125.12 25.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.538 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.3 0.68 70.17 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -140.72 126.17 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.508 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.57 -172.13 48.77 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.532 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 0.4 OUTLIER -84.34 108.34 17.12 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.626 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -84.82 101.91 12.64 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 124.83 35.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.0 112.132 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.0 mt -119.67 131.4 55.42 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.446 177.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.77 141.11 45.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.176 0.512 . . . . 0.0 110.594 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.68 -178.22 18.42 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.412 -179.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.1 m-70 -87.08 144.86 26.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.985 0.421 . . . . 0.0 110.873 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 129' ' ' SER . 17.0 t-20 -108.88 28.9 7.98 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.869 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.516 ' SD ' ' CG ' ' A' ' 63' ' ' GLN . 0.9 OUTLIER -44.15 -13.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.742 -178.872 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 m 57.44 39.78 27.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.146 0.498 . . . . 0.0 109.998 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -135.02 108.21 7.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.531 -178.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -51.15 127.83 20.26 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.642 -179.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.53 -26.71 11.47 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.448 -178.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.821 HG12 ' H ' ' A' ' 134' ' ' LEU . 46.3 t -82.72 178.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 117.52 0.66 . . . . 0.0 109.772 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.821 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -71.22 136.94 48.28 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.628 -177.996 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 44.86 33.57 1.02 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.898 178.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.8 p -81.78 -12.01 58.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 23.4 t70 -149.12 32.84 0.74 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.677 -0.409 . . . . 0.0 112.094 -178.378 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.9 pt -69.58 -27.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.442 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.15 2.07 4.06 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 63.5 m -91.77 -14.85 29.2 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 23.1 mt -62.76 126.48 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.165 -179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -96.46 171.41 8.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -76.8 129.59 36.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.505 0.669 . . . . 0.0 111.937 -179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.51 21.11 49.37 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.25 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.17 -158.51 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -147.26 129.84 15.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.686 -178.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 84.3 mt -126.92 124.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.814 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -102.99 120.23 40.26 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.8 tp -117.03 148.4 41.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 -179.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.13 131.19 53.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.12 0.486 . . . . 0.0 112.028 -178.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 152' ' ' ASN . 36.8 t0 -109.18 -167.42 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.168 177.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 151' ' ' ASP . 16.2 m120 -19.99 -76.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.56 0.538 . . . . 0.0 111.981 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -138.16 27.23 2.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -122.58 144.2 49.26 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.509 -176.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -107.68 121.52 44.86 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.452 ' CE2' HG21 ' A' ' 206' ' ' THR . 63.6 m-85 -105.35 128.92 53.74 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.13 -178.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.461 ' OE2' ' CE ' ' A' ' 207' ' ' LYS . 98.0 mt-10 -95.83 119.44 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.236 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -116.36 143.94 44.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.67 131.77 56.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.038 0.447 . . . . 0.0 110.13 179.14 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.69 132.6 32.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.527 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -28.67 12.06 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.344 1.028 . . . . 0.0 109.906 -178.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 169.96 25.53 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.279 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.2 p -127.07 153.86 36.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.439 -0.881 . . . . 0.0 109.918 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.3 t -153.89 166.12 33.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 111.523 -179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 63.2 mm-40 -109.9 126.94 54.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.58 161.37 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.769 -178.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.6 p -76.89 145.23 73.82 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.336 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.35 -21.81 7.72 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.867 1.711 . . . . 0.0 111.662 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -82.37 -2.73 53.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.805 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.596 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 21.6 tptt -80.71 150.18 29.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.266 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.596 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 83.6 m95 -157.62 -24.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.536 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 97.3 mt-10 -51.9 -8.56 0.07 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.111 0.482 . . . . 0.0 110.298 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 171' ' ' TRP . 7.0 m -78.41 -32.47 16.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.022 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 185' ' ' ILE . 28.5 m -110.03 -1.35 9.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.451 0.643 . . . . 0.0 110.468 -178.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 176' ' ' ASP . 94.0 mt-10 -80.37 119.81 23.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.7 -179.016 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' GLU . 98.1 m-20 -30.41 120.04 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.655 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 49.9 m80 -102.85 -43.23 5.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.969 -179.278 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.16 29.41 0.22 Allowed Glycine 0 N--CA 1.467 0.738 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -152.57 172.7 16.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -93.86 89.47 6.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.386 178.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.26 127.5 30.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.762 -179.142 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.1 tt -82.56 148.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.562 ' CG2' HG12 ' A' ' 174' ' ' VAL . 3.4 m -136.1 124.84 23.87 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.513 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -108.47 129.93 55.27 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.924 0.392 . . . . 0.0 110.512 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 174' ' ' VAL . 7.1 pt -141.5 -168.46 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.924 -179.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.8 t -138.0 147.47 44.24 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.1 p -98.35 -7.84 28.11 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.692 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.5 t -76.24 64.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.731 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.5 p -78.91 156.1 28.74 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.551 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.559 HG22 ' H ' ' A' ' 192' ' ' ASP . 5.1 p -143.64 142.55 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.428 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -85.46 -11.89 53.22 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.963 0.411 . . . . 0.0 110.969 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.559 ' H ' HG22 ' A' ' 190' ' ' VAL . 64.9 t0 -63.86 -37.22 86.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.686 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.469 ' OD1' ' CG1' ' A' ' 190' ' ' VAL . 42.4 p30 -146.82 169.27 19.45 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.765 -179.326 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.1 m -121.61 85.2 2.37 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.219 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -148.93 129.7 14.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.972 -179.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -145.36 142.93 29.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.994 -179.012 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 2.7 m-85 -102.96 123.38 46.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.11 133.22 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.394 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 76.4 t -120.31 130.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.184 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -112.26 135.24 53.18 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.295 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -126.14 137.39 10.11 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.6 t0 -95.54 132.47 40.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.23 -0.485 . . . . 0.0 112.077 -178.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.415 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 47.1 tp -62.15 125.84 25.27 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.168 0.508 . . . . 0.0 110.597 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.95 -24.91 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.678 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.11 159.86 17.03 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.064 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.452 HG21 ' CE2' ' A' ' 156' ' ' TYR . 20.5 m -134.15 156.17 48.79 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.105 0.479 . . . . 0.0 110.092 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.461 ' CE ' ' OE2' ' A' ' 157' ' ' GLU . 9.5 ptpp? -148.14 179.21 7.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.129 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.84 146.82 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.232 0.539 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.685 ' HZ3' ' NH1' ' A' ' 82' ' ' ARG . 63.7 tttp -70.36 80.8 0.55 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.655 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.766 178.562 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.3 t -60.13 -44.83 94.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.965 0.412 . . . . 0.0 110.522 -179.654 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -77.82 138.18 38.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.149 179.522 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 56' ' ' MET . 0.0 OUTLIER -96.35 142.43 28.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.665 -179.653 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -74.85 141.41 44.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.475 179.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.53 -17.88 62.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.87 -178.777 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 61' ' ' ILE . 52.8 m -86.92 -1.24 57.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.683 -178.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -68.91 37.72 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.199 -179.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.497 ' H ' ' C ' ' A' ' 59' ' ' SER . 67.3 mt -61.14 -50.15 81.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.052 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.1 t0 57.45 -98.5 0.09 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.906 179.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.441 ' CG ' ' SD ' ' A' ' 128' ' ' MET . 21.4 tt0 -151.66 77.74 7.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -43.46 138.86 4.91 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 122.404 2.069 . . . . 0.0 110.973 -179.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.35 146.16 48.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.634 179.471 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -49.26 -28.13 4.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.73 -179.711 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -40.58 93.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.353 -179.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 96.9 mt-10 -73.1 -33.92 65.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.748 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t -75.06 -45.89 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.052 -178.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.81 86.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.88 -25.33 32.61 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.372 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.76 130.62 47.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.132 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.4 t -95.64 158.88 15.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -138.63 123.69 19.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.014 0.435 . . . . 0.0 110.951 -178.845 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.682 ' N ' HD13 ' A' ' 74' ' ' LEU . 98.0 m-20 -81.45 104.14 11.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.058 178.648 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -49.4 -35.84 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.242 -179.645 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -58.77 -11.49 3.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.498 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -90.41 -3.31 57.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.915 -178.724 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.34 133.27 30.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.983 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 pt -117.37 -5.73 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.933 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.58 -162.72 33.77 Favored Glycine 0 C--N 1.317 -0.522 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.573 HH22 ' HZ1' ' A' ' 209' ' ' LYS . 29.5 ptt-85 -154.94 166.01 34.9 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.545 -179.775 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.8 tt -132.77 134.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.824 -179.755 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 t -123.85 130.27 52.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.242 -178.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 17.3 mt -133.15 111.05 12.95 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.402 -177.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 4.2 Cg_exo -78.69 -36.66 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.757 2.305 . . . . 0.0 113.013 -178.899 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 t -47.81 -35.83 10.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.48 -177.249 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 90' ' ' LEU . 4.2 m -118.96 -5.92 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 O-C-N 123.361 0.413 . . . . 0.0 111.432 -179.242 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 73.15 45.69 0.27 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.737 -179.916 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 88' ' ' VAL . 1.1 mt -112.2 129.0 56.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.233 -178.84 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -135.86 115.65 13.03 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.361 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.1 mt -143.79 161.99 43.48 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -86.56 152.83 8.98 Favored 'Trans proline' 0 C--N 1.326 -0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 108.882 177.676 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.75 115.52 44.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.0 mt -100.18 128.26 46.29 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.045 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -66.22 -49.51 67.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.154 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t -78.74 108.98 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 -179.092 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.47 98.72 11.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.211 0.529 . . . . 0.0 109.927 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.6 p -133.06 154.8 50.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.33 -179.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -51.55 -27.79 11.91 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.538 -179.607 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -83.57 -47.17 11.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.745 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.05 -33.36 75.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.593 -178.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.84 -19.35 64.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.807 -178.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.469 ' O ' HD11 ' A' ' 134' ' ' LEU . 22.7 mt -69.94 -25.13 63.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.42 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.667 ' OG ' HD23 ' A' ' 74' ' ' LEU . 21.6 m -91.82 -9.61 42.83 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.138 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.447 ' N ' HD13 ' A' ' 134' ' ' LEU . . . 165.09 -154.04 24.58 Favored Glycine 0 N--CA 1.46 0.238 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.646 -179.387 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.42 125.26 35.09 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 114.634 -0.783 . . . . 0.0 110.061 179.591 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.23 148.03 26.79 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.576 -179.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 29.2 p -75.77 150.53 37.75 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.216 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 t -86.78 -56.51 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.67 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -96.74 138.65 33.99 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.301 0.572 . . . . 0.0 111.015 -179.178 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -80.55 9.09 6.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.656 -178.337 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.407 ' C ' ' OD1' ' A' ' 113' ' ' ASN . 54.8 p30 -132.88 22.78 4.21 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.139 -0.351 . . . . 0.0 111.352 -177.87 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -91.05 156.12 18.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.955 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -134.26 133.5 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.386 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.547 ' SD ' HD22 ' A' ' 149' ' ' LEU . 67.8 mtt -67.14 127.35 32.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.165 179.091 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.507 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.36 0.23 76.92 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 179.56 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -142.39 127.58 18.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.037 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.85 -171.2 45.47 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.254 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -86.77 107.84 18.44 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -84.91 99.32 10.88 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.09 122.76 34.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.138 -179.039 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mt -117.7 131.14 56.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.296 178.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.95 137.91 48.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.627 0.727 . . . . 0.0 110.789 -178.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.25 -178.68 17.76 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.607 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -85.95 141.75 29.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.479 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 129' ' ' SER . 56.5 p30 -109.98 26.56 10.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.441 ' SD ' ' CG ' ' A' ' 63' ' ' GLN . 0.9 OUTLIER -42.96 -15.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.876 -179.51 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 59.39 39.13 22.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.142 178.959 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 136' ' ' SER . 87.9 tttt -133.27 114.95 14.37 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.468 -179.184 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.35 125.19 21.71 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.173 -179.652 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.93 -24.68 11.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.292 -178.379 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.724 HG12 ' H ' ' A' ' 134' ' ' LEU . 61.5 t -82.37 178.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.724 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -71.89 135.74 46.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.245 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 43.67 32.81 0.6 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.166 0.508 . . . . 0.0 110.892 178.381 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -81.45 -6.37 58.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.784 -178.355 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 136' ' ' SER . 94.2 m-20 -143.25 34.37 1.33 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.625 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 10.6 pt -68.3 -30.5 47.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.788 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.49 5.83 2.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.029 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -97.57 -14.65 20.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.077 0.465 . . . . 0.0 110.023 -179.359 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -64.11 124.67 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.288 179.621 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.401 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 55.4 mtpt -96.41 154.38 17.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.664 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.19 126.44 27.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.307 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 95.99 20.73 25.16 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.771 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.401 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 87.6 m-20 -91.28 133.47 35.38 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -80.59 142.03 34.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.166 0.508 . . . . 0.0 111.592 -178.904 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.478 ' N ' ' O ' ' A' ' 158' ' ' TYR . 85.7 mt -132.74 124.41 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.352 179.73 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -103.03 121.9 43.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.076 0.465 . . . . 0.0 109.994 -178.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.547 HD22 ' SD ' ' A' ' 116' ' ' MET . 1.1 mt -114.18 156.53 24.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.445 -179.489 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 26.3 m-85 -134.55 123.37 23.77 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.747 -179.187 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.558 ' O ' ' C ' ' A' ' 152' ' ' ASN . 11.3 t0 -114.35 -165.6 1.03 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.795 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.558 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.9 m-20 -11.31 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.737 0.648 . . . . 0.0 111.504 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -139.1 28.04 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.19 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.15 148.04 41.92 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -176.191 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 74.3 mt-10 -110.29 119.75 40.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.865 178.38 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -106.04 125.03 50.51 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.893 -178.764 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.522 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.2 mt-10 -96.12 118.98 33.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.108 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.507 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 15.8 m-85 -118.38 144.9 45.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.014 -178.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' ASP . . . -120.42 131.69 54.9 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.338 0.589 . . . . 0.0 110.368 178.825 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.31 133.84 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.962 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 2.2 p -102.19 -27.07 13.1 Favored 'General case' 0 C--N 1.342 0.265 0 O-C-N 124.701 1.251 . . . . 0.0 110.986 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.52 179.94 36.53 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.259 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.98 147.48 33.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.776 -179.531 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -151.28 159.94 44.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.083 0.468 . . . . 0.0 110.976 -178.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -107.23 118.87 37.85 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.575 -179.803 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 173' ' ' VAL . 17.8 m -132.21 154.07 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.107 0.479 . . . . 0.0 111.034 -178.498 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 169' ' ' ASP . 35.8 p -75.94 135.86 70.34 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.691 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.59 -15.61 0.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.104 1.869 . . . . 0.0 111.659 -178.653 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 167' ' ' THR . 91.7 m-20 -81.35 -22.75 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.02 -177.906 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 173' ' ' VAL . 32.6 ttmt -85.65 75.84 10.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.229 179.307 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.575 ' C ' ' H ' ' A' ' 173' ' ' VAL . 86.0 m95 -71.39 -18.67 62.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.306 -178.665 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.517 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 81.0 mm-40 -51.97 -5.72 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.974 0.416 . . . . 0.0 111.15 179.208 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.726 ' O ' HG21 ' A' ' 183' ' ' THR . 34.0 m -90.38 -2.13 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.173 -178.466 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.564 HG13 HG23 ' A' ' 173' ' ' VAL . 1.2 m -132.99 -6.65 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.63 0.729 . . . . 0.0 109.563 -179.681 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.35 159.56 24.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.189 -1.368 . . . . 0.0 112.093 -176.623 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -66.28 124.5 22.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.517 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 33.1 m170 -113.94 24.47 12.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.656 -179.13 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.31 19.16 74.88 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.117 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.16 165.74 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.291 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 28.9 p30 -97.5 87.62 4.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.71 0.767 . . . . 0.0 110.561 179.751 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -123.24 130.0 52.14 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.053 -179.389 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.9 tt -81.5 146.65 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.334 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.726 HG21 ' O ' ' A' ' 173' ' ' VAL . 17.3 m -136.71 120.7 17.63 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.875 0.369 . . . . 0.0 111.206 -179.279 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -106.0 123.31 47.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.528 0.68 . . . . 0.0 110.786 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.5 pt -137.03 -169.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.645 -178.793 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.512 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 0.6 OUTLIER -134.35 130.59 37.17 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.046 -178.907 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.402 ' SG ' HD12 ' A' ' 61' ' ' ILE . 11.1 t -88.36 110.61 20.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.085 179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.405 ' CG2' ' NH2' ' A' ' 196' ' ' ARG . 35.6 m -140.06 165.96 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.225 -178.904 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.3 t -54.36 147.59 13.32 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.742 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 191' ' ' LYS . 64.5 t -59.51 -49.02 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.397 -178.84 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 190' ' ' VAL . 44.2 tttp 52.42 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.159 178.398 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 193' ' ' ASN . 53.1 p-10 -66.93 -117.36 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.972 179.515 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.522 ' H ' ' CG ' ' A' ' 192' ' ' ASP . 98.4 m-20 -96.56 131.89 42.72 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.357 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.4 m -153.81 155.58 36.08 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 111.22 -178.576 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -99.79 142.76 30.85 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.179 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 186' ' ' THR . 43.8 ttm180 -139.56 134.76 32.61 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.513 -178.695 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -86.39 133.27 33.8 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.888 179.121 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.03 134.57 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.06 0.457 . . . . 0.0 111.201 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.37 130.15 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.682 -179.548 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -119.12 137.83 53.32 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.643 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.0 145.24 17.32 Favored Glycine 0 N--CA 1.466 0.641 0 CA-C-O 121.828 0.682 . . . . 0.0 111.668 -179.213 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.9 t0 -100.57 140.24 35.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.51 -0.845 . . . . 0.0 111.414 -178.796 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.494 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 31.8 tp -65.36 128.14 34.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.7 p -107.26 -25.9 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.213 -178.875 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 170.81 161.79 22.05 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.728 179.133 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 207' ' ' LYS . 89.9 m -142.22 157.06 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.185 0.517 . . . . 0.0 109.967 -179.263 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.52 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 26.6 pttm -150.82 178.97 8.62 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.109 179.617 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.77 144.23 26.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.777 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.573 ' HZ1' HH22 ' A' ' 82' ' ' ARG . 88.5 tttt -69.54 78.47 0.41 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.905 -179.247 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.699 178.266 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 54' ' ' SER . 7.1 t 48.1 20.34 0.25 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.803 178.823 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.2 m80 47.28 -161.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.989 179.857 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.446 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 20.1 tpp -86.15 169.92 12.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.564 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 66.4 t0 -137.69 146.02 43.3 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.131 0.491 . . . . 0.0 110.858 -179.013 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -69.48 -44.39 71.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.854 -179.091 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 t -155.77 71.81 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.651 0.262 . . . . 0.0 111.049 -178.463 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -69.01 -5.92 24.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.559 0.695 . . . . 0.0 111.572 -179.142 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' ASP . 15.6 mm -66.3 -31.51 53.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.0 -179.096 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 64' ' ' PRO . 37.5 t0 57.17 110.85 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.704 179.528 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 62' ' ' ASP . 5.2 tp60 -38.1 93.0 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 123.158 0.286 . . . . 0.0 110.459 -179.361 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.486 ' N ' ' O ' ' A' ' 62' ' ' ASP . 6.2 Cg_exo -76.5 150.94 32.49 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 122.585 2.19 . . . . 0.0 111.253 -178.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 56.4 t0 -76.38 159.14 30.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 84.6 mt -60.27 -24.39 64.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.765 -179.105 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.15 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.343 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.9 mt-10 -72.62 -34.44 67.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.654 179.765 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.7 t -75.07 -44.78 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.897 -178.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.97 87.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.955 179.853 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -83.0 -21.49 33.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.336 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.52 132.97 55.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 m -141.94 81.49 1.76 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.001 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 74' ' ' LEU . 1.7 pt? -73.35 154.87 39.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.924 179.074 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -70.31 136.7 50.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.55 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -66.39 -7.77 21.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.379 0.609 . . . . 0.0 110.364 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.95 -29.63 70.07 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.05 5.1 8.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.551 -178.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.1 t -101.37 127.62 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.74 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.704 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -135.47 8.5 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.269 -177.416 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.49 -174.31 39.7 Favored Glycine 0 C--N 1.321 -0.254 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -178.888 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -153.16 155.16 36.18 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.346 -179.221 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 83' ' ' ILE . 18.4 tt -128.78 131.51 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.721 179.59 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -129.27 130.14 45.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.828 -178.886 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.471 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 26.5 mt -135.36 120.97 13.96 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.475 -178.353 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -82.32 -34.49 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.601 2.201 . . . . 0.0 112.472 -179.597 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -49.97 -39.24 40.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.749 -176.699 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.433 ' O ' ' CB ' ' A' ' 89' ' ' SER . 3.4 m -118.88 -7.32 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 123.309 0.381 . . . . 0.0 111.039 -178.902 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.486 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 75.77 48.37 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.56 0.695 . . . . 0.0 110.42 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 92' ' ' LEU . 2.4 mt -107.24 122.56 46.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.429 -179.424 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.17 109.27 10.31 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.528 HD12 HD22 ' A' ' 90' ' ' LEU . 36.1 mt -144.37 165.56 22.87 Favored Pre-proline 0 C--O 1.233 0.221 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.333 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -88.01 156.09 7.15 Favored 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 122.916 2.411 . . . . 0.0 108.628 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.413 ' O ' HD13 ' A' ' 80' ' ' ILE . 69.0 t -107.24 120.01 57.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -103.03 119.57 39.08 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.55 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.07 -47.52 84.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.095 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.5 p -81.47 117.94 22.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -82.9 75.55 9.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.068 0.461 . . . . 0.0 110.163 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.562 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -90.65 142.96 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.424 179.909 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.459 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 84.0 tt0 -50.46 -56.96 9.21 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.568 -179.597 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -66.28 -32.09 73.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.318 -179.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.562 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 10.6 m-20 -68.1 -27.06 66.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 108' ' ' ALA . 13.0 mt -73.2 -9.57 58.86 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.444 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 104' ' ' LEU . 8.3 mp -76.44 -14.45 60.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.01 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.43 ' OG ' HD22 ' A' ' 74' ' ' LEU . 35.5 m -112.13 -5.6 14.22 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -177.48 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 176.96 -167.68 39.14 Favored Glycine 0 C--N 1.323 -0.19 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.555 -179.761 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.04 128.01 38.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.686 179.413 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.433 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -104.95 152.55 22.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 -179.465 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -78.19 156.07 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.279 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.6 t -84.69 -55.54 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -177.22 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.469 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 68.8 mmtt -94.36 137.92 32.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.111 0.481 . . . . 0.0 111.091 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.27 6.25 17.42 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.028 -178.511 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -130.19 24.53 5.22 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.834 0.35 . . . . 0.0 111.408 -177.432 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.469 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 11.2 pt20 -94.28 162.9 13.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.004 179.815 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -130.02 135.83 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.4 mtp -70.56 124.57 24.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.819 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.71 7.37 64.79 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 179.646 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -143.62 124.69 14.44 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.389 -178.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.0 -170.43 51.92 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.58 107.4 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.643 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -84.75 101.99 12.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.241 -179.566 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.94 128.06 36.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.362 0.601 . . . . 0.0 111.692 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.92 131.24 53.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.429 178.497 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.28 140.32 45.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.476 0.655 . . . . 0.0 111.101 -178.567 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.86 -179.94 19.99 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.4 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.27 156.88 27.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.543 -0.328 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 129' ' ' SER . 2.6 t-20 -122.78 27.1 7.91 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.968 0.413 . . . . 0.0 110.844 -179.163 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.0 mtt -45.9 -13.01 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.797 -179.579 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.5 m 54.97 40.35 31.98 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.006 178.705 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 136' ' ' SER . 83.4 tttt -134.04 120.67 20.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.049 -179.168 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -58.97 124.23 19.2 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.209 0.528 . . . . 0.0 109.973 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.37 -29.66 7.17 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.203 -177.913 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.71 HG12 ' N ' ' A' ' 134' ' ' LEU . 99.5 t -76.03 177.21 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.71 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -73.27 139.21 45.99 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.514 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.4 m-30 45.0 27.57 0.29 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.149 0.499 . . . . 0.0 111.22 178.029 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 1.1 p -83.42 -15.65 48.89 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.554 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 p30 -132.47 12.98 4.55 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.511 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.417 HD13 ' CD2' ' A' ' 135' ' ' PHE . 9.7 pt -68.81 -25.83 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 120.927 0.394 . . . . 0.0 111.789 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.06 1.53 1.94 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.569 -179.6 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 138' ' ' ILE . 15.8 t -98.76 -11.29 22.02 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.226 0.536 . . . . 0.0 110.226 -179.282 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.08 120.37 11.92 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.365 179.757 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -99.81 166.06 11.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.676 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.404 ' HB3' ' HZ2' ' A' ' 143' ' ' LYS . 10.4 ttpp -65.04 118.9 9.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.308 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.39 14.92 12.06 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.198 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -95.28 133.51 39.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.354 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -83.29 139.11 33.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.785 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 158' ' ' TYR . 69.2 mt -125.86 124.99 67.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.975 178.662 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.4 ' CD2' ' OE2' ' A' ' 157' ' ' GLU . 63.2 m-85 -99.39 114.69 27.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.979 -178.801 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.4 tp -113.93 142.91 45.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.94 -179.38 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -110.25 137.36 48.1 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.053 0.454 . . . . 0.0 111.653 -178.434 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 37.3 t70 -110.72 -172.77 2.1 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.271 178.189 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.514 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.1 m-20 -37.45 -62.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -179.478 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -137.6 23.86 2.9 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.865 179.349 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -127.85 152.2 48.11 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.641 0.734 . . . . 0.0 112.65 -175.702 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -114.81 122.02 45.08 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.299 178.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -105.11 130.99 53.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.319 0.58 . . . . 0.0 111.427 -179.015 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 204' ' ' VAL . 80.5 mm-40 -96.4 117.76 31.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.155 178.474 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 147' ' ' ILE . 29.6 m-85 -115.92 141.49 48.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 -179.239 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.79 130.29 55.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.552 0.691 . . . . 0.0 110.11 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.42 134.13 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.067 -179.37 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.8 p -102.0 -25.72 13.66 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 124.705 1.253 . . . . 0.0 111.132 -178.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 163.81 166.45 22.7 Favored Glycine 0 C--N 1.319 -0.414 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.243 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.56 153.16 37.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.741 -179.618 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.3 t -153.38 161.44 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.048 0.452 . . . . 0.0 110.982 -178.164 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -116.48 117.1 28.96 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.807 -179.349 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.22 160.36 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.399 . . . . 0.0 111.245 -178.497 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 p -57.22 168.91 0.81 Allowed Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.028 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.77 -9.11 12.2 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.094 1.863 . . . . 0.0 111.957 -179.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.76 1.52 42.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -178.402 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.602 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 13.5 mptt -83.59 149.57 26.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.358 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.602 ' CD1' ' O ' ' A' ' 170' ' ' LYS . 87.8 m95 -157.6 -28.99 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.173 -178.648 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.88 -8.26 0.09 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.099 0.475 . . . . 0.0 110.665 178.655 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 171' ' ' TRP . 8.9 m -79.16 -25.67 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.607 -178.807 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 171' ' ' TRP . 16.6 m -110.69 -2.02 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 0.0 110.402 -178.806 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 176' ' ' ASP . 75.4 mm-40 -81.09 119.37 23.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.977 -178.04 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 42.0 p-10 -30.27 122.21 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.867 179.002 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -104.43 -44.35 4.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.253 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 145.29 26.36 0.1 Allowed Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.302 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -154.05 173.97 15.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.186 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.37 87.02 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.248 0.547 . . . . 0.0 109.901 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -128.05 125.14 38.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.59 -179.002 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 17.8 tt -81.2 148.3 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.9 m -137.56 122.98 19.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.184 -179.141 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 183' ' ' THR . 10.1 mp -109.14 125.54 52.29 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.239 0.542 . . . . 0.0 111.394 -179.546 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.405 HD13 HG11 ' A' ' 174' ' ' VAL . 9.2 pt -134.21 161.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.583 -179.47 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.415 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 1.3 p -133.53 152.88 51.97 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.443 -178.876 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 14.2 p -93.5 138.57 31.66 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.195 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 12.9 p -142.3 140.06 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 120.842 0.353 . . . . 0.0 110.999 -178.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.4 m -65.99 147.32 53.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.201 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 190' ' ' VAL . 16.0 m -71.58 132.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -165.43 -169.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.107 -178.348 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 192' ' ' ASP . 49.3 p-10 -71.08 142.06 50.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.062 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 49.61 33.14 5.58 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.9 178.773 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 87.0 p -64.22 135.21 56.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.344 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -150.66 155.11 38.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.919 0.39 . . . . 0.0 110.84 -179.151 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -129.8 143.15 50.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.429 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -102.3 134.01 46.29 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.947 -179.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.71 135.63 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.247 -179.393 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -119.35 130.44 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.416 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -114.23 134.83 54.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.42 141.13 12.4 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 50.9 p-10 -100.18 141.33 33.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.636 -0.782 . . . . 0.0 111.503 -179.111 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.62 125.1 24.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.959 0.409 . . . . 0.0 110.66 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.5 p -107.16 -24.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.135 -179.034 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 176.12 177.16 44.92 Favored Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.947 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 35.1 m -154.99 154.64 32.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.278 0.561 . . . . 0.0 110.993 -179.858 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.87 178.17 8.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.81 146.27 24.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.508 179.931 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.67 78.31 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.75 -179.118 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.419 178.279 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.096 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 p -157.88 161.84 38.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.853 0.358 . . . . 0.0 110.873 -179.622 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -87.02 -11.47 50.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.4 mtm 48.55 -163.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.554 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 50.48 31.13 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.505 178.834 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.31 -12.81 61.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.942 -178.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 61' ' ' ILE . 98.7 p -87.61 11.32 15.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.909 0.385 . . . . 0.0 111.26 -178.896 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -60.16 71.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.002 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.513 ' N ' ' O ' ' A' ' 59' ' ' SER . 2.6 mt -68.41 -75.16 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-O 121.366 0.603 . . . . 0.0 110.207 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 50.95 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.029 179.781 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 61' ' ' ILE . 4.4 pt20 -132.36 78.84 67.15 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.466 -179.5 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' CG ' HG23 ' A' ' 61' ' ' ILE . 4.6 Cg_exo -79.05 170.56 17.65 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.021 2.48 . . . . 0.0 111.668 179.85 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.18 157.3 37.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.788 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.41 -28.96 70.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.662 -178.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.17 90.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 -179.571 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 95.9 mt-10 -73.13 -40.97 64.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.303 0.573 . . . . 0.0 110.836 -179.572 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.8 t -73.49 -41.89 56.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.483 -179.0 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.64 84.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.85 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -91.57 -14.58 30.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.396 -178.665 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.12 110.77 1.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.033 0.444 . . . . 0.0 110.747 -179.685 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.2 t -106.65 135.64 47.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.76 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.729 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.2 pt? -128.02 174.14 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.057 -179.59 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.9 m-20 -83.65 98.63 9.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.677 178.527 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 79' ' ' VAL . 34.5 mtmm -58.5 -4.23 0.38 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.377 0.608 . . . . 0.0 110.438 -179.669 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.7 mmtp -67.51 -11.18 57.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.549 -179.898 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.88 18.84 12.42 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.782 -179.481 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 76' ' ' LYS . 53.9 t -80.03 124.29 37.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.135 178.897 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.4 tt -106.5 -35.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.074 -179.044 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.41 -155.43 8.16 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.569 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -146.38 155.9 42.93 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.48 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -125.37 129.08 73.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.652 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.604 ' N ' HD13 ' A' ' 83' ' ' ILE . 50.2 m -130.5 130.97 44.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.049 -179.276 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.7 mt -132.73 118.59 15.65 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.34 -178.269 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.82 -37.47 0.33 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.361 2.041 . . . . 0.0 112.263 -179.503 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.7 t -48.9 -37.75 20.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.909 -177.146 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 89' ' ' SER . 2.0 m -121.23 -6.59 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 110.998 -179.026 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.44 50.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.022 0.439 . . . . 0.0 110.273 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.49 124.23 49.28 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.966 -179.556 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.77 ' O ' HD22 ' A' ' 92' ' ' LEU . 83.0 tt0 -132.59 107.14 8.24 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.395 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.77 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -144.15 116.17 5.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.088 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.468 ' HD2' HD13 ' A' ' 92' ' ' LEU . 2.3 Cg_endo -41.16 146.49 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 121.817 1.678 . . . . 0.0 110.2 175.446 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.3 t -97.84 121.69 48.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.9 mt -103.16 117.48 34.64 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.802 0.334 . . . . 0.0 110.469 -178.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -63.62 -48.54 76.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.272 0.558 . . . . 0.0 110.483 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 90.5 p -60.95 102.66 0.21 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.415 -179.637 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 98' ' ' SER . 53.1 p -83.89 91.51 7.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.299 0.571 . . . . 0.0 110.254 -179.937 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.627 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -130.11 144.37 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.939 179.793 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.516 ' HA ' HD12 ' A' ' 103' ' ' LEU . 1.4 tt0 -53.42 -42.94 67.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.951 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -63.57 -46.39 86.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.087 -179.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.627 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 8.8 m-80 -68.11 -35.58 78.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.84 0.352 . . . . 0.0 111.779 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 100' ' ' GLU . 4.6 mt -49.46 -22.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.134 -179.47 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.99 -13.25 61.19 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.717 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.538 ' OG ' HD22 ' A' ' 74' ' ' LEU . 3.2 m -105.03 -11.12 16.78 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.298 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.401 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 167.3 -179.06 41.12 Favored Glycine 0 N--CA 1.468 0.801 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.275 -179.309 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.43 126.06 29.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.785 -0.707 . . . . 0.0 109.941 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.41 150.18 25.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.4 p -76.28 153.8 35.66 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.77 -45.94 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.742 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 113' ' ' ASN . 85.6 tttt -89.2 136.24 33.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.165 0.507 . . . . 0.0 110.486 -178.366 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -62.22 -8.27 5.44 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.109 -178.848 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.468 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 66.1 t30 -146.4 50.31 1.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 -177.94 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -79.9 161.87 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.784 179.655 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.0 127.04 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 -179.314 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.4 mtt -74.19 127.29 32.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.189 179.013 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.496 ' N ' ' OH ' ' A' ' 158' ' ' TYR . . . 90.37 1.71 74.62 Favored Glycine 0 N--CA 1.461 0.326 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -141.58 123.91 15.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.213 0.53 . . . . 0.0 110.974 -179.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.59 -170.65 50.7 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.183 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -85.6 109.07 18.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.23 99.91 10.26 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.66 121.18 32.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.289 0.566 . . . . 0.0 111.323 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -116.58 130.56 56.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.699 178.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.29 137.63 47.77 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.459 0.647 . . . . 0.0 110.433 -179.322 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.39 -177.15 17.18 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.713 -178.902 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 134' ' ' LEU . 54.8 m-70 -90.37 137.06 32.65 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 -179.504 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 129' ' ' SER . 29.2 t-20 -105.91 28.24 7.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 109.891 -179.986 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.7 mmm -44.6 -13.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.859 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.71 40.91 15.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.684 179.481 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 19.1 mmmt -132.03 107.59 8.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.092 -179.131 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -52.36 124.18 12.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.596 0.713 . . . . 0.0 110.297 179.984 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.74 -28.05 9.27 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.946 -178.34 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.734 HG12 ' H ' ' A' ' 134' ' ' LEU . 60.4 t -78.37 178.3 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-N 117.879 0.839 . . . . 0.0 109.047 179.415 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.734 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -70.44 134.2 47.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.239 -178.224 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.411 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.9 m-30 44.59 32.81 0.81 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.258 0.552 . . . . 0.0 110.585 178.529 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 1.0 OUTLIER -82.7 -7.02 59.67 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.464 -178.501 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -145.79 24.02 1.37 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -177.577 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.411 HD13 ' CD2' ' A' ' 135' ' ' PHE . 7.1 pt -70.46 -21.5 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.699 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.24 2.97 7.96 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.6 t -99.21 -10.85 21.91 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.361 0.6 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.513 ' O ' HG21 ' A' ' 163' ' ' VAL . 15.6 mt -64.24 124.12 20.89 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.662 -179.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 17.9 ptpt -97.42 166.31 11.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.69 123.6 19.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 179.638 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.62 26.74 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.633 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 71.4 m-20 -82.51 130.94 35.21 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.985 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -78.3 129.3 34.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 0.0 111.675 -179.118 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.3 mt -127.28 127.44 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.386 179.456 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -109.66 123.83 50.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.146 0.498 . . . . 0.0 110.682 -179.087 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.65 148.74 37.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.222 179.6 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -117.3 131.29 56.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 152' ' ' ASN . 28.2 t70 -114.01 -166.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 151' ' ' ASP . 99.1 m-20 -24.37 -75.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.108 0.48 . . . . 0.0 111.848 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -138.15 29.76 2.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -129.87 145.73 51.6 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.249 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -110.09 123.0 48.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.823 179.334 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.62 132.71 50.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.217 0.532 . . . . 0.0 111.57 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -96.31 116.75 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.62 178.394 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.496 ' OH ' ' N ' ' A' ' 117' ' ' GLY . 44.6 m-85 -117.17 141.59 48.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.55 -179.52 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.76 133.72 54.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.31 0.576 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.33 134.38 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.232 179.446 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.2 p -102.37 -28.57 12.16 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 124.826 1.329 . . . . 0.0 111.048 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 164.31 144.04 3.91 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.113 -1.041 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 141' ' ' LEU . 12.4 t -103.74 149.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -0.616 . . . . 0.0 109.523 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.1 t -153.68 164.25 38.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.137 0.494 . . . . 0.0 111.352 -178.683 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -110.96 117.28 32.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.777 179.728 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.37 160.14 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 169' ' ' ASP . 29.5 p -71.99 134.44 83.3 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.67 -11.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.093 1.862 . . . . 0.0 111.794 -179.093 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 167' ' ' THR . 51.5 t0 -83.4 -10.02 58.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.18 -178.841 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -88.39 70.54 9.06 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 122.573 0.349 . . . . 0.0 110.435 179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -75.43 -6.29 49.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.082 0.467 . . . . 0.0 110.97 -179.642 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.56 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.5 mt-10 -52.77 -50.13 64.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.116 0.484 . . . . 0.0 110.281 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.705 ' O ' HG21 ' A' ' 183' ' ' THR . 18.3 m -69.88 6.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.0 -179.704 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.04 28.76 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.27 131.32 18.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.783 0.801 . . . . 0.0 111.779 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -27.77 121.66 0.1 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.962 179.642 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.56 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 53.2 m80 -107.05 -40.23 5.51 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.091 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 144.6 24.59 0.13 Allowed Glycine 0 N--CA 1.47 0.943 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -153.38 172.9 16.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.974 0.416 . . . . 0.0 111.214 179.582 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -96.21 89.58 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.746 0.784 . . . . 0.0 110.05 178.476 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -125.3 175.87 7.15 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.2 tt -129.48 142.4 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.394 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.705 HG21 ' O ' ' A' ' 173' ' ' VAL . 13.0 m -136.34 124.9 23.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.136 -179.95 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 183' ' ' THR . 10.9 mp -114.02 126.3 54.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.436 0.636 . . . . 0.0 110.463 179.242 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.468 HG22 HG13 ' A' ' 198' ' ' VAL . 28.1 pt -134.61 -169.9 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.738 -179.11 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.422 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 5.1 t -139.39 158.15 44.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.309 -179.461 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.5 m -62.08 162.31 9.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.002 179.151 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 188' ' ' VAL . 10.4 p -120.03 129.6 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.04 -178.751 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.6 p -77.91 165.75 23.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.333 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 26.0 m -61.86 -25.11 36.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.475 -179.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -56.62 142.57 39.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.371 179.695 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -88.33 8.14 28.95 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.301 -179.048 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -62.17 140.87 58.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.272 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.9 t -97.53 106.58 18.92 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.155 -179.499 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -171.24 96.36 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.804 -179.089 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.422 ' NH2' ' O ' ' A' ' 186' ' ' THR . 60.7 ttt180 -146.06 136.8 24.28 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.389 -179.355 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.44 129.47 50.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.037 179.023 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.468 HG13 HG22 ' A' ' 185' ' ' ILE . 42.7 t -130.14 131.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.422 -179.182 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 93.5 t -115.1 127.1 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.358 -179.446 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.38 135.21 54.04 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.282 0.563 . . . . 0.0 110.373 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.94 159.1 25.42 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.765 -179.104 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -112.12 150.66 30.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.676 -0.762 . . . . 0.0 111.456 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.408 HD13 ' CZ ' ' A' ' 158' ' ' TYR . 11.9 tp -73.74 129.78 38.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.251 0.548 . . . . 0.0 110.62 179.721 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.97 -22.97 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.086 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.32 177.84 44.7 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.202 -179.157 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.3 m -151.65 151.17 31.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.356 0.598 . . . . 0.0 110.661 179.248 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -148.96 177.83 9.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.672 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.41 146.99 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.312 0.577 . . . . 0.0 110.735 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.93 79.69 4.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.899 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.4 tptp . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 117.867 -1.063 . . . . 0.0 110.694 178.63 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.528 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.0 t -60.66 -44.77 96.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.865 -179.466 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.654 ' CD2' ' H ' ' A' ' 56' ' ' MET . 23.5 p-80 -62.31 -114.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.837 179.402 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.654 ' H ' ' CD2' ' A' ' 55' ' ' HIS . 37.3 tpp 50.47 -115.38 0.84 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.355 178.626 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.7 113.41 23.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.978 0.418 . . . . 0.0 110.118 179.657 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.64 -52.28 27.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.252 -178.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 m -154.98 57.88 0.66 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.671 0.272 . . . . 0.0 110.766 -178.505 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -99.3 39.69 1.27 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.641 -178.705 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.3 mt -61.83 -49.83 82.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.692 -179.494 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.8 t0 52.23 -99.05 0.08 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.61 85.77 5.2 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.326 -179.544 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.25 149.5 40.58 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.754 2.303 . . . . 0.0 111.226 179.669 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.1 m-20 -79.03 172.93 13.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.543 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.4 mp -60.01 -24.84 64.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.66 -178.414 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -41.34 97.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.499 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.0 mt-10 -74.11 -30.66 62.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.083 179.665 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.868 HG22 HD22 ' A' ' 104' ' ' LEU . 59.9 t -75.47 -47.64 33.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.831 -178.641 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.83 88.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.064 179.379 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -75.73 -31.08 59.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.476 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.98 132.97 53.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.949 179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.7 m -140.2 152.52 46.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.971 -179.283 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.755 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.3 pt? -138.01 171.91 13.71 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.158 -179.231 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 77' ' ' LYS . 97.5 m-20 -97.93 114.8 27.0 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.359 179.001 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 76' ' ' LYS . 1.1 mptm? -46.62 -16.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 110.258 -179.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 75' ' ' ASP . 54.6 mtmt -66.99 -10.06 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -92.78 6.62 46.9 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.247 -178.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.04 125.2 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.657 179.544 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.37 -10.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.385 -178.136 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.07 -173.07 44.03 Favored Glycine 0 C--N 1.316 -0.577 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.45 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.705 HH22 ' NZ ' ' A' ' 209' ' ' LYS . 38.1 mtm-85 -144.82 156.9 44.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.219 0.533 . . . . 0.0 111.567 -179.046 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 92' ' ' LEU . 4.8 tt -128.56 130.69 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 122.034 0.921 . . . . 0.0 109.225 179.751 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.2 t -132.42 133.8 44.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.543 -178.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.54 HG21 HD21 ' A' ' 141' ' ' LEU . 23.9 mt -134.8 126.45 17.91 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.872 -178.543 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -82.46 -35.82 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.48 2.12 . . . . 0.0 112.421 -179.16 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.461 ' CB ' HD23 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -50.52 -39.62 49.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -177.129 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.9 -1.05 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 122.237 0.215 . . . . 0.0 111.132 -178.842 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 t 61.51 49.73 4.99 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.81 131.09 55.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.792 -178.544 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 92' ' ' LEU . 44.8 tt0 -137.74 120.26 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.802 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.2 tp -153.01 112.66 2.69 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.043 -1.063 . . . . 0.0 113.334 -177.413 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.8 Cg_endo -40.71 160.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.849 1.699 . . . . 0.0 110.205 175.83 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.81 122.75 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.065 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -105.68 120.88 42.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.255 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -64.7 -46.94 80.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.004 0.431 . . . . 0.0 111.104 -179.745 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.569 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 13.6 p -65.94 100.21 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.376 -179.709 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.7 p -81.09 94.64 6.65 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.218 0.532 . . . . 0.0 109.871 179.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.3 p -136.66 160.44 38.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.312 -179.272 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -55.32 -42.71 74.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.047 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -67.88 -46.27 72.15 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.294 -179.453 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.569 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.9 m-20 -65.76 -38.39 88.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.2 -179.427 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 14.2 mt -64.88 -27.88 69.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.631 -179.042 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.868 HD22 HG22 ' A' ' 69' ' ' VAL . 50.9 mt -72.98 -17.18 61.49 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -177.606 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -105.33 -10.51 16.97 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.755 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.87 -165.49 34.54 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.568 -179.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.61 124.21 33.84 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.22 144.14 32.42 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.167 -179.356 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.5 p -74.24 152.25 39.76 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.84 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.89 -43.35 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.767 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -91.11 -173.17 3.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.823 0.344 . . . . 0.0 111.25 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -111.32 -58.81 2.06 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.14 -177.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -91.33 43.61 1.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.461 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -98.5 154.34 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 179.621 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.3 t -133.42 132.95 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.095 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.1 mtt -61.48 130.35 45.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.841 178.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.81 6.33 82.81 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -141.23 120.22 12.79 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.012 -178.76 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.29 -170.72 52.01 Favored Glycine 0 CA--C 1.517 0.196 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.858 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -83.12 107.93 16.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.269 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -84.39 101.5 12.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.154 -179.718 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.61 119.52 30.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.43 0.634 . . . . 0.0 111.643 -179.215 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.2 mt -115.94 130.0 56.64 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.242 178.411 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.93 138.28 50.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.643 0.735 . . . . 0.0 110.984 -178.566 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.09 -179.8 18.69 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.769 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -80.26 146.14 31.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.812 0.339 . . . . 0.0 110.204 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 129' ' ' SER . 41.6 p30 -112.59 27.53 9.56 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.07 0.462 . . . . 0.0 110.998 -179.183 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.0 mtt -43.42 -15.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.457 -179.339 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 58.42 39.34 25.32 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.256 179.127 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -135.57 113.83 11.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -52.73 125.92 18.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.669 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.0 -30.28 6.91 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.195 -178.468 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.702 HG12 ' N ' ' A' ' 134' ' ' LEU . 85.7 t -77.98 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.264 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.702 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -72.94 138.85 46.37 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.516 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.487 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.2 m-85 45.26 30.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.196 0.522 . . . . 0.0 110.754 178.303 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 p -83.85 -14.2 51.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -133.71 18.34 3.89 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -176.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.487 HD13 ' CD2' ' A' ' 135' ' ' PHE . 6.9 pt -70.28 -20.89 23.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.869 0.366 . . . . 0.0 111.934 -179.668 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.78 3.42 11.89 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.1 t -98.76 -13.59 20.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.29 0.567 . . . . 0.0 109.987 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 85' ' ' ILE . 16.4 mt -64.62 124.8 22.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.302 179.814 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 143' ' ' LYS . 65.7 tttt -96.5 172.0 8.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.507 -179.814 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 142' ' ' LYS . 77.7 tttt -66.62 128.4 36.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.018 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 92.43 22.02 30.41 Favored Glycine 0 N--CA 1.463 0.46 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.138 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 49.1 m-20 -86.59 130.8 34.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.242 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -77.7 132.58 38.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.257 0.551 . . . . 0.0 111.641 -178.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.6 mt -127.85 125.97 65.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.1 179.458 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -102.8 122.84 45.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.177 0.513 . . . . 0.0 110.621 -178.589 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.42 136.56 52.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.699 -179.391 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.581 ' CB ' HH11 ' A' ' 82' ' ' ARG . 93.8 m-85 -111.37 119.7 39.71 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.396 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.508 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.7 t0 -104.8 -165.42 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.508 ' C ' ' O ' ' A' ' 151' ' ' ASP . 91.2 m-20 -24.01 -76.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.498 0.499 . . . . 0.0 111.667 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -137.6 30.25 2.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.696 178.716 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -128.13 146.77 50.6 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.984 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.96 123.49 49.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.854 179.118 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 206' ' ' THR . 64.6 m-85 -107.46 131.38 54.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.382 0.61 . . . . 0.0 111.3 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.507 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.3 mt-10 -97.34 118.29 33.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.828 177.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -115.96 140.65 49.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.82 -178.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.2 129.31 54.9 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.563 0.697 . . . . 0.0 111.155 179.43 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.21 135.81 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.82 -179.58 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.7 OUTLIER -105.61 -25.13 12.39 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.48 1.112 . . . . 0.0 111.084 -179.094 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.63 165.21 22.58 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.413 -179.539 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.8 p -125.88 151.99 32.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.671 -0.765 . . . . 0.0 109.669 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.6 p -155.6 164.38 38.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.458 . . . . 0.0 111.228 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.457 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 96.2 mt-10 -112.26 113.93 26.42 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.491 -179.735 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.99 157.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.457 -178.381 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 p -65.77 168.63 8.22 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.052 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.27 -7.0 12.0 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.193 1.929 . . . . 0.0 112.105 -179.351 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 30.9 p-10 -82.95 -12.43 57.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.028 -178.762 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -89.44 69.85 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.784 0.434 . . . . 0.0 109.988 179.354 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.77 -5.88 43.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.683 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.546 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.9 mt-10 -53.48 -40.04 65.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.351 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.734 ' O ' HG21 ' A' ' 183' ' ' THR . 74.4 t -72.71 1.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.812 -179.679 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.36 28.92 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.78 129.42 19.19 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.729 0.776 . . . . 0.0 111.854 -177.021 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -29.22 123.07 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.894 179.442 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.546 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 43.2 m80 -104.3 -37.92 7.06 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.626 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.24 24.3 0.32 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.058 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -156.72 178.74 10.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.132 0.491 . . . . 0.0 111.377 179.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -89.68 89.2 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.521 0.677 . . . . 0.0 110.093 178.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.425 ' OE1' ' OD1' ' A' ' 202' ' ' ASP . 23.5 tp10 -121.08 163.3 18.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.308 -179.197 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.6 tt -130.68 142.12 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.644 179.487 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.734 HG21 ' O ' ' A' ' 173' ' ' VAL . 15.7 m -136.36 126.17 25.69 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.812 0.339 . . . . 0.0 111.383 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -112.36 120.32 41.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.562 0.696 . . . . 0.0 110.814 179.77 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 198' ' ' VAL . 42.1 pt -139.83 -176.66 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.81 -178.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.3 p -139.88 166.69 23.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.342 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 52.0 t 48.73 90.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.597 178.871 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.68 -45.68 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.921 -179.45 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 t -58.64 168.82 1.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.882 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 74.2 t -107.17 120.79 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.696 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -139.43 144.61 38.14 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.164 -178.619 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -88.44 87.12 7.18 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.207 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 194' ' ' SER . 54.9 t-20 -155.95 101.51 2.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.444 -178.821 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 193' ' ' ASN . 13.9 p 52.22 178.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.337 179.43 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.95 136.23 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.342 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.439 HH11 HG22 ' A' ' 198' ' ' VAL . 9.2 tmm_? -87.74 142.78 27.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.953 -179.572 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.457 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 4.9 m-85 -80.03 135.72 36.42 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.976 179.571 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.567 HG11 HG11 ' A' ' 173' ' ' VAL . 75.8 t -129.67 130.98 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.087 0.47 . . . . 0.0 110.821 -179.588 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.9 t -119.53 130.56 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.748 -179.423 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.548 ' O ' HG22 ' A' ' 161' ' ' THR . . . -120.36 138.89 53.48 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.621 -179.87 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.82 152.0 19.98 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.215 -179.387 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 181' ' ' GLU . 16.2 m-20 -109.49 139.1 44.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.553 -0.823 . . . . 0.0 111.432 -179.527 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 157' ' ' GLU . 48.0 tp -63.69 125.38 24.1 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.027 0.442 . . . . 0.0 110.928 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 157' ' ' GLU . 2.6 p -107.41 -25.02 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.152 -178.937 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.33 176.32 45.31 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.953 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.447 HG21 ' CE2' ' A' ' 156' ' ' TYR . 24.2 m -153.92 153.13 31.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.432 0.634 . . . . 0.0 111.038 179.842 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -147.23 177.34 9.27 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.382 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.35 146.61 24.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.043 0.449 . . . . 0.0 110.679 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.705 ' NZ ' HH22 ' A' ' 82' ' ' ARG . 63.8 tttp -72.12 78.87 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.586 -179.234 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.747 178.424 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.6 p -75.1 161.28 29.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.711 0.291 . . . . 0.0 110.342 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -74.02 143.56 45.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.035 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.5 mtp -115.07 146.47 41.26 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.803 0.335 . . . . 0.0 110.641 -179.188 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 55.7 t0 -94.13 18.26 11.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.321 0.581 . . . . 0.0 110.89 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.62 -19.1 62.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.075 -179.127 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 1.8 t -150.01 -94.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.704 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' N ' ' OG ' ' A' ' 59' ' ' SER . 29.4 ttpt 47.57 27.27 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.097 178.234 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.53 -44.37 96.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.827 -178.965 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.2 t0 71.72 -126.56 0.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.852 179.896 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -140.62 70.7 31.29 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -42.68 129.57 5.21 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.507 2.138 . . . . 0.0 111.027 -179.538 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -85.79 171.9 11.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.846 179.906 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.8 mt -48.92 -31.22 6.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.654 -179.141 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.475 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -65.52 -38.82 90.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.617 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 81.0 mm-40 -73.97 -27.21 60.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.663 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -82.15 -46.5 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.243 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.5 -48.54 74.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.767 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.625 ' ND2' ' N ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -69.57 -28.56 66.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.983 -179.218 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.625 ' N ' ' ND2' ' A' ' 71' ' ' ASN . . . -61.87 138.3 58.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.986 -179.734 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 p -140.22 133.57 29.87 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.843 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.4 tp -140.9 135.1 30.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.655 -179.037 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 76' ' ' LYS . 67.8 t0 -67.52 137.66 55.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.092 179.136 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.512 ' O ' HG22 ' A' ' 79' ' ' VAL . 70.3 mmtt -65.01 -7.89 13.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.159 0.504 . . . . 0.0 110.22 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -79.96 -10.11 59.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.956 -179.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -78.34 -3.21 41.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.639 -179.268 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 76' ' ' LYS . 6.2 m -85.15 138.6 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.404 -179.627 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 pt -122.74 -4.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.329 -179.183 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.11 -174.04 39.26 Favored Glycine 0 C--N 1.318 -0.469 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -147.19 151.91 37.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.524 -179.027 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 83' ' ' ILE . 20.6 tt -124.31 120.67 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.226 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -118.86 128.09 54.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.665 -179.629 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.584 HG21 HD21 ' A' ' 141' ' ' LEU . 22.5 mt -134.62 122.12 15.46 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.579 -177.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.9 Cg_endo -81.56 -34.17 0.57 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.404 2.069 . . . . 0.0 112.423 -179.492 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.553 ' OG ' HD23 ' A' ' 141' ' ' LEU . 2.0 t -49.81 -39.32 38.09 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.539 -177.496 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.77 -1.59 9.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.458 0.17 . . . . 0.0 111.072 -179.219 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 63.64 49.99 2.86 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.214 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.6 tp -115.71 132.3 56.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.315 -178.661 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.714 ' O ' HD22 ' A' ' 92' ' ' LEU . 82.9 tt0 -139.33 118.0 12.28 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.586 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -148.35 116.72 4.02 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.878 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.528 ' HD2' HD13 ' A' ' 92' ' ' LEU . 2.2 Cg_endo -39.88 161.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.894 1.729 . . . . 0.0 110.307 175.227 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.92 126.98 72.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' CB ' HD22 ' A' ' 102' ' ' ASN . 22.2 mt -102.32 127.63 49.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.982 -179.192 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -71.38 -48.69 48.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.512 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.618 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 3.9 m -69.5 107.44 3.37 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.348 -179.225 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.7 OUTLIER -81.93 99.54 9.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.192 0.52 . . . . 0.0 110.115 179.938 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.513 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 1.9 p -139.74 164.35 30.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 -179.264 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -64.96 -36.59 84.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.456 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -71.74 -47.54 53.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.567 -179.57 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 97' ' ' SER . 1.1 p-10 -65.97 -36.99 84.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.412 -178.766 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.402 ' O ' HD12 ' A' ' 134' ' ' LEU . 18.7 mt -53.16 -24.37 10.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.431 -179.112 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.428 ' O ' HD11 ' A' ' 134' ' ' LEU . 50.0 mt -68.92 -29.37 67.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.319 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.2 t -85.33 -14.31 46.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.365 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.56 ' CA ' HD13 ' A' ' 134' ' ' LEU . . . 162.8 -172.03 38.75 Favored Glycine 0 N--CA 1.465 0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.679 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . . . -71.94 127.94 34.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.921 -179.806 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' A' ' 102' ' ' ASN . . . -104.78 148.68 26.35 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.51 -179.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.45 ' O ' ' OG ' ' A' ' 98' ' ' SER . 44.7 p -75.57 154.23 36.9 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.65 -52.32 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -91.81 138.5 31.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 -178.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -72.84 1.41 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.023 -178.69 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -142.96 36.37 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 0.0 111.047 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.29 159.13 21.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.745 179.76 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.6 t -133.03 130.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.532 -179.672 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 65.7 mtt -73.15 127.86 33.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.48 67.95 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.715 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -138.73 123.95 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.089 -179.133 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.89 -173.39 44.93 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -83.51 109.72 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.122 179.84 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -83.96 101.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.02 129.14 37.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.336 0.589 . . . . 0.0 112.062 -178.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 mt -123.57 132.28 53.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.472 178.544 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.73 138.41 47.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.324 0.583 . . . . 0.0 110.601 -178.973 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.0 -178.54 17.43 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.439 -179.328 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.414 ' HD2' HD12 ' A' ' 134' ' ' LEU . 58.2 m-70 -89.64 145.55 25.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.836 0.351 . . . . 0.0 110.624 -179.691 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 129' ' ' SER . 60.5 t-20 -110.08 28.35 8.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 110.411 -179.754 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.3 mmm -46.19 -12.26 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.789 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 m 56.67 40.38 29.28 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.231 -0.588 . . . . 0.0 109.997 179.069 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -130.74 108.73 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.194 -179.146 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -51.61 124.81 13.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.03 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.31 -29.35 8.39 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.137 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 134' ' ' LEU . 59.6 t -77.05 179.13 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 117.69 0.745 . . . . 0.0 109.044 179.45 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.754 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -70.32 136.61 49.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -178.089 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 107' ' ' ALA . 4.0 m-30 42.55 32.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.165 0.507 . . . . 0.0 111.009 178.339 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 p -82.07 -10.7 59.12 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.36 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -143.23 26.86 1.62 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.537 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.5 pt -71.92 -20.52 20.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.779 0.323 . . . . 0.0 111.838 179.917 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.84 -1.28 24.49 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.815 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 t -94.09 -13.17 27.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 109.923 -179.625 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.584 HD21 HG21 ' A' ' 85' ' ' ILE . 20.3 mt -64.37 123.32 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.432 -179.75 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.494 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 99.3 mttt -96.54 173.13 7.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.734 -179.774 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -70.1 136.36 50.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.661 -179.669 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.82 22.07 56.34 Favored Glycine 0 N--CA 1.463 0.449 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.708 179.663 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.494 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 84.8 m-20 -88.96 130.16 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.37 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -77.48 134.04 38.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -178.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 158' ' ' TYR . 77.3 mt -128.87 121.55 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.272 179.296 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -102.21 122.03 43.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.099 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.0 tp -118.97 143.83 46.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 -178.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.97 133.03 56.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.318 0.58 . . . . 0.0 111.498 -178.946 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.52 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.0 t0 -113.98 -166.42 1.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.282 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 151' ' ' ASP . 15.9 m120 -22.99 -74.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.064 0.459 . . . . 0.0 111.632 179.597 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -138.09 24.45 2.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -123.37 143.91 49.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.863 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -109.71 121.04 44.32 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.688 179.094 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' A' ' 206' ' ' THR . 77.6 m-85 -105.48 131.1 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.521 -178.763 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 204' ' ' VAL . 97.4 mt-10 -94.7 118.04 31.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.399 178.53 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 147' ' ' ILE . 53.0 m-85 -117.88 139.97 50.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.337 -179.424 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.17 135.58 54.92 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.089 0.471 . . . . 0.0 110.563 178.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.66 133.91 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.096 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -108.92 -24.81 11.06 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 124.464 1.102 . . . . 0.0 111.184 -179.185 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.13 157.19 11.99 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.495 -179.648 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.43 HG23 HG22 ' A' ' 199' ' ' VAL . 12.1 p -123.39 151.76 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.866 -0.667 . . . . 0.0 109.548 -179.797 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 26.0 t -161.25 171.76 17.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.0 111.297 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -115.81 110.92 19.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.757 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.3 m -117.14 145.43 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.019 -178.6 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 27.6 p -60.18 132.85 90.24 Favored Pre-proline 0 N--CA 1.446 -0.656 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.569 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 1.4 Cg_endo -47.28 -17.88 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.873 1.715 . . . . 0.0 111.826 -179.035 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -82.1 -17.78 45.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.193 -178.494 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.434 ' O ' HG22 ' A' ' 173' ' ' VAL . 30.0 ttmt -87.29 72.24 9.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.847 0.459 . . . . 0.0 110.946 179.817 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.569 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 47.1 m95 -73.53 -18.52 61.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.004 -179.176 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.549 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 95.7 mt-10 -50.27 -7.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.062 0.458 . . . . 0.0 111.009 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 171' ' ' TRP . 27.9 m -83.79 -21.84 8.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.671 -178.565 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.587 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -114.44 -1.27 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.618 0.723 . . . . 0.0 109.955 -178.744 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.511 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.8 mt-10 -83.96 125.11 31.73 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.065 -178.442 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 41.6 p-10 -30.92 122.32 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.703 178.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 51.0 m80 -112.36 24.25 12.74 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.735 -179.186 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.89 21.42 76.46 Favored Glycine 0 N--CA 1.463 0.453 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.898 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -149.44 166.46 29.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 0.0 111.237 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 29.7 p30 -96.08 87.78 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.561 0.696 . . . . 0.0 110.477 179.469 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.458 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 79.8 tt0 -127.24 128.31 45.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.33 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.3 tt -79.94 147.3 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.238 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.52 ' C ' HD12 ' A' ' 184' ' ' LEU . 5.2 m -138.15 122.37 18.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.179 -179.907 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.52 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -104.82 128.26 52.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.379 0.609 . . . . 0.0 110.987 -179.756 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.587 HD13 HG11 ' A' ' 174' ' ' VAL . 3.1 pt -139.1 175.54 7.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.811 -178.81 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.507 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.3 p -133.4 160.15 38.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.819 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.555 ' C ' HH12 ' A' ' 196' ' ' ARG . 1.7 p -66.79 150.54 48.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.014 179.738 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.563 HG13 ' N ' ' A' ' 189' ' ' SER . 14.7 p -58.64 -45.54 90.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.296 -179.49 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.563 ' N ' HG13 ' A' ' 188' ' ' VAL . 90.9 p 45.16 -168.41 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.424 179.177 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 65.6 t -126.66 127.2 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.432 ' NZ ' ' O ' ' A' ' 195' ' ' LYS . 59.5 pttt -161.89 160.7 28.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.462 -178.598 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.561 ' C ' ' H ' ' A' ' 194' ' ' SER . 96.9 m-20 -78.8 173.01 12.94 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.39 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 1.9 m120 67.56 -25.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.139 179.289 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.561 ' H ' ' C ' ' A' ' 192' ' ' ASP . 13.4 m 43.64 89.62 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.501 179.196 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.432 ' O ' ' NZ ' ' A' ' 191' ' ' LYS . 25.3 pttm -143.17 149.57 38.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.81 -178.938 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.555 HH12 ' C ' ' A' ' 187' ' ' CYS . 0.8 OUTLIER -133.63 140.82 47.32 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.317 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -126.06 132.65 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.505 179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.49 137.86 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.159 0.504 . . . . 0.0 110.969 -179.428 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.43 HG22 HG23 ' A' ' 163' ' ' VAL . 73.2 t -120.01 131.62 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.356 -179.535 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 161' ' ' THR . . . -116.63 135.86 53.44 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.61 -179.551 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -131.02 135.18 8.09 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-O 121.596 0.553 . . . . 0.0 111.762 -179.476 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -90.88 139.46 30.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.839 -0.681 . . . . 0.0 111.293 -179.235 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 11.7 tp -67.21 127.5 32.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.192 0.52 . . . . 0.0 110.632 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 157' ' ' GLU . 4.6 m -109.01 -21.51 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.514 -178.674 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 178.96 175.89 46.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.031 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.423 HG21 ' CE2' ' A' ' 156' ' ' TYR . 23.6 m -155.02 153.43 30.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.188 0.518 . . . . 0.0 110.811 179.503 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -149.39 177.98 9.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.176 179.04 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -98.18 142.14 30.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.859 179.892 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -58.27 80.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 208' ' ' ALA . 49.6 tttp . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.495 178.55 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.593 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -58.55 -41.95 86.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.835 0.35 . . . . 0.0 110.956 -179.544 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.572 ' H ' ' CD2' ' A' ' 55' ' ' HIS . 10.2 p80 -88.16 118.04 27.46 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.483 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtt -96.4 159.41 14.96 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.449 -179.69 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -63.54 140.84 58.91 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.31 -5.26 38.46 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.706 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 94.5 p -84.67 42.9 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.194 -178.046 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -82.55 26.7 0.55 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.107 -179.288 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mt -63.55 -45.77 96.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.126 -178.892 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 46.89 -97.39 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.3 178.827 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -150.74 85.56 5.19 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.653 -179.053 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.32 150.44 36.83 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.908 2.406 . . . . 0.0 110.864 179.442 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.28 167.67 21.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.82 -19.95 65.12 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.403 0.439 . . . . 0.0 111.108 -179.377 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.11 97.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.627 -179.569 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 93.2 mt-10 -72.12 -36.69 69.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.785 179.52 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.3 t -71.9 -45.43 64.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.873 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.38 86.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.19 -27.09 28.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.895 -179.037 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.13 136.77 58.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.331 179.594 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' NZ ' ' A' ' 101' ' ' LYS . 29.3 t -91.08 156.73 17.69 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 105' ' ' SER . 46.2 tp -120.29 125.51 48.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 111.143 -178.823 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -95.21 87.81 4.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 79' ' ' VAL . 1.2 mppt? -48.94 -33.07 10.16 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.029 -179.486 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -51.6 -14.78 0.36 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.243 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -100.77 14.34 31.96 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.853 -178.74 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 79' ' ' VAL . 5.4 p -89.8 126.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.299 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.8 pt -118.5 -6.7 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.319 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.04 -165.08 34.33 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -147.03 157.34 43.58 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.273 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 92' ' ' LEU . 5.9 tt -128.63 132.3 67.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.808 0.814 . . . . 0.0 109.249 179.654 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 t -132.75 133.42 43.44 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.609 -178.167 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 21.5 mt -134.73 126.73 18.14 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.808 -178.465 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.6 Cg_endo -83.09 -34.71 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 122.54 2.16 . . . . 0.0 112.5 -179.694 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.3 t -49.27 -41.43 37.83 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.655 -177.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 88' ' ' VAL . 1.4 p -119.91 -3.59 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 O-C-N 123.245 0.34 . . . . 0.0 111.094 -179.27 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 68.33 50.99 0.7 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.672 -179.585 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -109.27 125.02 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.789 -178.003 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.666 ' N ' HD13 ' A' ' 90' ' ' LEU . 80.1 tt0 -134.88 114.39 12.52 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.408 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.733 HD12 HD11 ' A' ' 90' ' ' LEU . 10.1 mt -148.59 117.39 4.01 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.736 -177.672 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.6 Cg_endo -41.25 151.59 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.971 1.781 . . . . 0.0 110.121 176.41 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.12 121.65 52.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.1 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.9 mt -104.53 128.5 52.49 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.439 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -72.55 -39.92 67.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.942 0.401 . . . . 0.0 111.389 -179.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.9 m -72.69 102.0 3.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.073 -179.375 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.8 p -82.34 93.34 7.15 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 109.913 179.77 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.0 p -132.01 158.25 42.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.186 -178.909 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.471 ' O ' HD21 ' A' ' 104' ' ' LEU . 10.0 tm-20 -60.62 -24.6 65.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.719 -179.261 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 65.3 tttm -83.87 -44.17 14.57 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.815 0.697 . . . . 0.0 112.158 -178.865 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -67.26 -34.89 78.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.844 -179.706 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 108' ' ' ALA . 20.1 mt -68.31 -11.48 59.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.621 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.471 HD21 ' O ' ' A' ' 100' ' ' GLU . 17.2 mt -74.63 -14.26 60.74 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.991 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.455 ' HB3' HD13 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -125.7 -3.86 7.15 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.417 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.534 ' HA2' HD22 ' A' ' 92' ' ' LEU . . . -175.63 172.95 45.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.385 -179.522 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.93 127.44 32.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.531 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -105.4 150.02 25.61 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.048 0.451 . . . . 0.0 110.803 -179.153 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 p -75.35 151.23 38.24 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 122' ' ' ALA . 1.3 p -87.17 -32.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -176.468 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 112' ' ' GLU . 21.2 tptt -90.05 179.99 5.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.964 0.412 . . . . 0.0 110.837 -177.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 111' ' ' LYS . 22.4 pt-20 -105.7 -16.5 14.66 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.058 -178.447 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -144.11 53.19 1.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.546 -177.186 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -91.61 153.64 19.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.612 -179.89 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.59 131.6 72.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.617 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 9.6 mtp -70.19 125.34 26.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.913 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.32 4.95 65.87 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.474 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -143.32 123.72 13.9 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.55 -178.339 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.59 51.84 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -178.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 183' ' ' THR . 6.8 t30 -83.29 108.19 16.34 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.903 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -84.91 102.68 13.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.477 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.469 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -91.53 126.11 36.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.062 0.458 . . . . 0.0 112.186 -179.4 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.82 130.41 53.96 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.468 178.85 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.39 140.02 46.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -178.035 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.94 -177.92 17.53 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.229 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -81.63 155.83 25.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.557 ' ND2' ' CG2' ' A' ' 188' ' ' VAL . 9.3 p30 -123.9 28.05 7.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.029 0.442 . . . . 0.0 111.171 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 32.2 mtt -44.05 -15.91 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.107 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 p 62.19 38.08 13.83 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.843 178.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.52 120.53 19.8 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.601 -179.123 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.2 124.76 21.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.482 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.0 -30.75 6.4 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -177.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 134' ' ' LEU . 94.1 t -72.42 176.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.381 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.701 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -74.1 133.07 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.781 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 48.11 39.2 11.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.796 177.774 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 137' ' ' ASP . 20.8 p -77.55 -68.03 0.66 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.287 -179.266 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.519 ' N ' ' OG ' ' A' ' 136' ' ' SER . 94.1 m-20 -88.3 41.88 1.03 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.1 pt -69.99 -26.21 29.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.293 -179.758 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.24 3.92 9.8 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.751 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.9 m -92.98 -15.1 26.63 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.328 -179.237 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 mt -66.4 121.28 14.93 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.323 -179.554 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.526 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 52.9 mtmt -95.84 153.14 17.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.637 -179.669 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -53.67 121.91 8.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.094 -179.968 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 101.04 16.94 24.22 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.803 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 73.7 m-20 -85.09 135.89 33.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.13 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -82.33 131.4 35.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.795 0.331 . . . . 0.0 111.796 -178.321 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.77 124.44 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.552 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -104.5 120.21 40.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.299 -178.554 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.92 158.47 21.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.956 -178.854 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.56 136.13 53.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.083 0.468 . . . . 0.0 111.708 -178.878 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 152' ' ' ASN . 54.4 t0 -112.81 -166.49 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.656 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 97.2 m-20 -34.73 -67.96 0.13 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.491 0.662 . . . . 0.0 111.042 179.739 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -137.03 29.65 2.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.074 179.643 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.82 147.72 52.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.822 0.82 . . . . 0.0 112.8 -175.495 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.74 123.45 50.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.814 178.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -104.44 133.43 49.34 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.582 -178.765 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -97.57 116.29 29.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.59 177.8 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -116.16 141.07 48.62 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 -178.962 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.63 131.64 54.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 178.879 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 61.3 t -65.67 134.23 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.968 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -30.61 11.21 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.201 1.563 . . . . 0.0 110.916 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.79 157.78 11.92 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.965 -178.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.3 150.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.526 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.9 p -156.51 164.46 38.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.783 -177.704 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.438 ' OE2' ' CZ ' ' A' ' 197' ' ' TYR . 94.9 mt-10 -114.19 115.63 27.78 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.232 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.53 158.3 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 120.622 0.249 . . . . 0.0 111.154 -178.074 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 p -60.49 167.61 3.07 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.301 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.38 -6.97 11.89 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.079 1.853 . . . . 0.0 112.192 -179.815 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -85.39 -6.97 59.18 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.909 -178.088 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -86.49 68.97 10.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.459 ' C ' ' N ' ' A' ' 173' ' ' VAL . 78.4 m95 -69.49 -29.99 67.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.985 -179.299 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 98.3 mt-10 -47.17 -16.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 O-C-N 123.432 0.457 . . . . 0.0 110.666 179.717 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.459 ' N ' ' C ' ' A' ' 171' ' ' TRP . 54.4 t -74.46 -24.93 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.685 -179.055 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.58 -8.61 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.715 0.769 . . . . 0.0 110.041 -177.998 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.409 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.9 mt-10 -80.4 157.79 26.18 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.58 -176.716 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.8 p-10 -66.22 128.59 36.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.339 179.834 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 34.4 m80 -108.07 -44.47 4.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.718 -179.561 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 146.22 24.54 0.1 OUTLIER Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 178.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -153.39 172.5 16.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.955 -179.866 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 6.7 p30 -95.05 86.79 4.71 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 110.211 179.347 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -128.22 125.55 39.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.735 -179.077 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.2 tt -80.82 148.43 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.654 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 120' ' ' ASN . 8.7 m -136.8 118.63 15.14 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.385 -178.231 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 184' ' ' LEU . 10.2 mp -100.32 127.26 46.67 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.183 0.516 . . . . 0.0 111.185 -179.64 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 pt -139.95 -171.92 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -178.6 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 27.9 p -137.13 156.64 48.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.473 -178.77 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 13.7 t -93.41 80.93 4.38 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.65 -179.347 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.557 ' CG2' ' ND2' ' A' ' 127' ' ' ASN . 67.9 t -127.87 130.27 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.821 -178.881 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 46.9 t -160.33 85.3 0.72 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.399 -178.664 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 76.4 t -146.55 85.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.183 -178.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.9 tttm 45.27 -125.9 1.16 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.726 179.16 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -99.43 133.94 43.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.531 ' CG ' ' H ' ' A' ' 194' ' ' SER . 40.2 t-20 -154.82 -148.15 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.562 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.531 ' H ' ' CG ' ' A' ' 193' ' ' ASN . 90.4 p -72.74 158.01 36.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -71.86 131.98 43.77 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -75.85 136.28 40.17 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.198 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.438 ' CZ ' ' OE2' ' A' ' 165' ' ' GLU . 3.8 m-85 -104.51 132.66 50.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.913 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.61 139.37 45.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.183 0.515 . . . . 0.0 110.997 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 80.9 t -125.2 135.81 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 -179.256 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -114.74 134.95 54.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -127.89 134.55 8.26 Favored Glycine 0 C--N 1.347 1.16 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -96.53 137.57 35.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.934 -179.082 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.41 HD23 ' OD2' ' A' ' 180' ' ' ASP . 40.3 tp -64.7 127.2 30.52 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.902 179.92 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -108.26 -23.81 4.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.684 -179.41 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.409 ' O ' HD11 ' A' ' 203' ' ' LEU . . . 177.01 178.26 46.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.511 -179.519 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 152.41 30.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.955 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -147.94 178.16 8.75 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.868 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.45 144.71 25.33 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.467 -179.438 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -73.02 79.75 1.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.538 -179.049 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.388 178.563 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.2 p -74.16 158.2 34.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.823 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.711 ' CG ' ' H ' ' A' ' 56' ' ' MET . 82.7 t60 47.66 -170.7 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.712 179.427 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.711 ' H ' ' CG ' ' A' ' 55' ' ' HIS . 64.8 mtt -130.14 164.21 24.94 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.751 0.31 . . . . 0.0 110.286 -179.377 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 50.1 p-10 -61.47 146.75 47.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.654 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.85 -38.17 82.79 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.617 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.479 ' OG ' ' N ' ' A' ' 60' ' ' LYS . 99.0 p -148.39 -95.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.179 -178.565 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' N ' ' OG ' ' A' ' 59' ' ' SER . 76.5 tttt 50.85 40.32 24.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.225 178.231 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 63' ' ' GLN . 42.2 mt -61.73 -48.21 89.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.825 -178.841 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 47.02 -94.3 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.274 178.835 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 63' ' ' GLN . 2.3 pt20 -150.83 85.29 5.22 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.902 -179.106 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.36 153.81 40.37 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.817 2.344 . . . . 0.0 111.027 179.602 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -76.76 170.83 15.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.883 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.39 -15.35 63.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.826 0.346 . . . . 0.0 111.309 -179.199 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 71' ' ' ASN . . . -64.03 -41.27 97.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.146 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.7 mm-40 -76.35 -19.65 58.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.809 179.518 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -81.01 -55.42 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.273 -178.613 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.77 94.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 67' ' ' ALA . 8.1 m120 -68.78 -32.74 72.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.605 -179.258 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -62.8 129.74 41.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.519 179.579 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.9 p -92.91 159.82 15.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.152 179.858 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.648 HD13 ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -139.4 120.68 14.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.924 0.392 . . . . 0.0 111.105 -178.903 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.648 ' N ' HD13 ' A' ' 74' ' ' LEU . 97.5 m-20 -86.56 106.5 17.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.166 178.846 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -46.64 -16.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.289 0.566 . . . . 0.0 110.69 -179.781 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.481 ' N ' ' C ' ' A' ' 75' ' ' ASP . 63.7 mttp -65.4 -12.02 48.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -97.84 8.73 44.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.463 -178.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.8 t -91.27 125.53 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.763 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.2 pt -122.38 -3.55 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.328 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 171.33 -162.03 34.61 Favored Glycine 0 C--N 1.321 -0.288 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.627 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.576 HH12 ' HZ1' ' A' ' 209' ' ' LYS . 10.8 ptp85 -157.53 164.76 37.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.943 -179.724 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 92' ' ' LEU . 8.6 tt -133.08 144.51 36.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.223 179.738 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 t -134.18 135.2 42.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.82 -178.828 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 mt -129.47 76.33 78.84 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.571 -177.404 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -40.26 -42.05 3.48 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 122.996 2.464 . . . . 0.0 112.565 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -55.18 -42.68 73.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.719 -177.436 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 88' ' ' VAL . 67.8 t -107.97 5.26 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.753 0.311 . . . . 0.0 110.799 -179.075 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 t 56.1 46.23 22.0 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.139 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.595 HD13 ' N ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -109.96 124.56 51.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.874 -178.273 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.636 ' O ' HD12 ' A' ' 92' ' ' LEU . 83.1 tt0 -128.04 113.09 15.36 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.934 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 91' ' ' GLU . 1.0 OUTLIER -145.09 111.01 4.72 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.7 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 1.7 Cg_endo -41.71 157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.888 1.725 . . . . 0.0 109.767 175.697 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.2 t -106.09 117.0 51.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.1 mt -100.47 120.83 40.58 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.843 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -66.65 -48.26 69.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.079 0.466 . . . . 0.0 111.171 -179.709 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.561 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 23.9 p -60.13 100.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 179.874 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.449 ' O ' ' OG ' ' A' ' 98' ' ' SER . 18.6 p -82.73 97.17 8.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.349 0.595 . . . . 0.0 110.32 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.524 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 3.6 p -140.01 158.22 44.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.094 -179.275 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -59.2 -33.26 70.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.469 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.03 -44.47 47.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.105 -179.495 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 98.2 m-20 -65.08 -38.6 91.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.711 -178.903 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 18.6 mt -57.18 -22.32 39.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.492 -179.385 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.34 -32.88 72.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -177.655 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.516 ' OG ' HD23 ' A' ' 74' ' ' LEU . 10.4 m -91.33 -9.65 44.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.924 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.86 -176.87 45.6 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.401 -179.401 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.38 124.4 27.47 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.056 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -105.75 150.48 25.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.061 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.7 p -68.65 148.37 50.54 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.839 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.512 HG21 HD11 ' A' ' 185' ' ' ILE . 84.5 t -88.72 -33.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -177.097 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 170.24 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.388 . . . . 0.0 110.946 -178.851 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -57.17 -47.12 81.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.193 -178.026 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 113' ' ' ASN . 50.4 p30 -158.0 69.76 0.54 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.154 -178.336 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 121' ' ' TYR . 4.4 pt20 -76.38 175.06 9.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.246 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -132.47 125.13 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.856 0.36 . . . . 0.0 110.649 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.488 ' SD ' ' OH ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -70.8 127.44 32.64 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.403 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.85 -5.59 59.85 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -140.37 123.18 16.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.15 -170.24 50.17 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.074 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -83.71 107.74 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.921 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 114' ' ' GLN . 5.8 t80 -84.42 102.67 12.95 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.567 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.45 122.26 33.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.203 0.525 . . . . 0.0 111.827 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -117.67 131.11 56.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.902 178.656 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.83 139.14 46.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.262 0.553 . . . . 0.0 110.768 -178.211 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.47 -178.34 16.5 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.226 -179.785 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.486 ' O ' ' O ' ' A' ' 134' ' ' LEU . 58.9 m-70 -93.74 138.59 31.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.574 -179.424 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 129' ' ' SER . 53.4 p-10 -98.59 28.78 4.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 110.658 -179.481 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.454 ' HB2' HG11 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -40.67 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.199 -179.335 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.4 m 59.21 36.87 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.456 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.56 ' HB3' ' HZ3' ' A' ' 130' ' ' LYS . 10.4 mtpm? -131.94 108.89 9.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.471 -178.898 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -48.95 124.09 8.12 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.084 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.56 -31.01 7.14 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.314 -177.915 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.761 HG12 ' H ' ' A' ' 134' ' ' LEU . 61.0 t -74.67 179.35 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.761 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -71.51 136.78 47.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.958 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CD2' HD13 ' A' ' 138' ' ' ILE . 3.6 m-30 43.63 35.1 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.816 178.069 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.4 p -82.92 -14.15 54.7 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.45 ' O ' HG21 ' A' ' 88' ' ' VAL . 65.7 m-20 -141.17 26.48 2.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.409 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.499 HD13 ' CD2' ' A' ' 135' ' ' PHE . 7.2 pt -75.67 -18.08 15.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 179.479 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.4 18.19 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.644 -179.598 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.2 t -92.26 -14.05 29.48 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.357 0.598 . . . . 0.0 110.037 -179.319 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.415 ' CD2' ' OD2' ' A' ' 145' ' ' ASP . 23.8 mt -63.77 128.55 36.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.359 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -101.85 174.54 5.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.876 -179.83 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -68.89 124.29 23.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.113 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 93.6 16.0 47.67 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.603 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.415 ' OD2' ' CD2' ' A' ' 141' ' ' LEU . 10.4 t70 -78.83 136.42 37.33 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.035 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -82.8 132.55 35.16 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.979 0.419 . . . . 0.0 111.626 -178.163 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 93.7 mt -129.01 127.5 66.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.686 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -104.26 120.68 41.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.027 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.63 145.31 45.54 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -119.34 135.12 54.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -178.089 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.502 ' O ' ' C ' ' A' ' 152' ' ' ASN . 35.8 t0 -110.66 -164.22 0.9 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.542 ' CG ' ' H ' ' A' ' 153' ' ' GLU . 3.5 p-10 -26.37 -77.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.354 0.409 . . . . 0.0 111.29 179.202 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.542 ' H ' ' CG ' ' A' ' 152' ' ' ASN . 78.6 mm-40 -134.02 30.0 3.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.096 178.949 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.479 ' OD1' ' ND2' ' A' ' 152' ' ' ASN . 33.8 m120 -128.85 148.2 50.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.956 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -109.21 123.32 49.05 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.068 179.819 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.4 ' CZ ' HG21 ' A' ' 206' ' ' THR . 48.6 m-85 -106.3 129.72 54.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.655 -178.847 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -94.75 113.59 25.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.338 178.935 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -113.48 143.36 44.64 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.454 -178.901 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.01 132.23 54.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.262 0.553 . . . . 0.0 110.707 178.17 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.6 135.71 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.52 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 200' ' ' ALA . 3.1 p -100.24 -27.27 13.59 Favored 'General case' 0 C--O 1.231 0.113 0 O-C-N 124.593 1.183 . . . . 0.0 111.013 -178.497 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.0 156.45 8.15 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.426 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.34 139.6 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.389 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 198' ' ' VAL . 73.9 m -136.82 151.27 48.96 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.786 0.326 . . . . 0.0 111.091 -178.083 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 165' ' ' GLU . 54.9 mp0 -111.07 102.52 10.97 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.844 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.4 m -134.09 156.59 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -178.212 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 51.2 p -63.02 168.8 4.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.211 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.41 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.4 Cg_endo -82.31 -4.04 11.64 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.179 1.919 . . . . 0.0 112.119 -179.596 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.02 -19.38 44.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.806 -178.569 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -85.96 74.37 10.15 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.817 0.447 . . . . 0.0 110.307 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.41 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 96.6 m95 -74.68 -6.16 47.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.023 -179.279 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.579 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 9.8 pt-20 -52.47 -43.63 65.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.984 0.421 . . . . 0.0 110.919 179.809 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.77 ' O ' HG21 ' A' ' 183' ' ' THR . 16.8 m -71.33 4.04 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.976 -179.52 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.81 -14.95 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.779 0.799 . . . . 0.0 110.215 -178.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 96.7 mt-10 -87.32 172.6 9.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.018 -178.869 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -74.29 125.72 29.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.579 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 48.3 m80 -110.82 22.49 15.3 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.641 -179.37 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.78 20.98 79.27 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.356 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -151.17 168.08 25.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.137 -179.477 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -94.39 87.57 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.174 0.511 . . . . 0.0 110.236 -179.841 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -123.91 124.94 43.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.626 -178.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.4 tt -81.51 146.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.455 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.77 HG21 ' O ' ' A' ' 173' ' ' VAL . 14.5 m -137.28 121.74 18.32 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.395 -179.123 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 183' ' ' THR . 10.0 mp -105.95 123.45 48.0 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.365 0.602 . . . . 0.0 111.024 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 110' ' ' VAL . 12.6 pt -139.01 169.46 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.992 -178.531 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.5 p -135.45 158.65 43.83 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.631 -179.21 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.6 m -84.28 131.53 34.72 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 13.0 p -145.55 153.23 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.746 0.307 . . . . 0.0 110.973 -178.511 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 89.8 p -77.61 -130.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.976 179.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.8 -120.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.528 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -108.32 18.37 21.12 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.775 0.321 . . . . 0.0 111.504 -179.603 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.36 -41.85 94.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.332 -179.134 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -95.71 31.6 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.261 -179.5 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.27 -166.35 0.21 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.426 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -68.87 139.75 55.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.379 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.47 ' NH1' ' CG2' ' A' ' 185' ' ' ILE . 7.9 tmm_? -69.9 142.09 53.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.452 -179.847 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.2 133.0 43.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.977 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 164' ' ' SER . 3.7 p -138.15 141.26 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.335 0.588 . . . . 0.0 111.332 -179.398 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 73.7 t -121.16 131.85 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.185 -179.261 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 161' ' ' THR . . . -117.22 136.46 53.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.485 -179.838 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.25 140.69 11.99 Favored Glycine 0 N--CA 1.466 0.653 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -179.445 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 53.5 p-10 -97.52 144.95 26.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.566 -0.817 . . . . 0.0 111.473 -178.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.3 tp -69.12 126.49 29.97 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.062 0.458 . . . . 0.0 111.166 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.7 -25.35 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.413 -178.755 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 175.87 177.43 44.89 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.74 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.4 HG21 ' CZ ' ' A' ' 156' ' ' TYR . 17.7 m -152.89 152.67 31.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.274 0.559 . . . . 0.0 111.108 -179.78 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -149.36 178.79 8.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.345 179.594 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.78 146.03 24.09 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.403 -179.773 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.576 ' HZ1' HH12 ' A' ' 82' ' ' ARG . 88.4 tttt -77.04 79.02 3.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.748 -179.1 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.562 178.057 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.1 p -63.33 -27.73 69.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.956 0.408 . . . . 0.0 110.474 179.865 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -78.12 127.57 32.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.135 -179.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.4 mtt -138.18 154.21 49.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 111.185 -179.052 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -47.14 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.073 179.747 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.48 -61.92 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.46 -178.742 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.0 m -94.44 -101.48 0.15 Allowed 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 120.928 0.394 . . . . 0.0 110.008 -179.404 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 44.24 25.81 0.13 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.285 178.877 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -65.25 -46.35 90.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.692 -179.141 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 56.24 -98.87 0.09 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -151.15 77.8 7.41 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.419 -179.641 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -43.32 140.84 3.57 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.145 1.897 . . . . 0.0 111.71 -179.553 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -69.18 152.07 45.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.679 179.636 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.1 mm? -56.61 -27.18 57.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.64 -179.099 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.87 91.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.898 0.38 . . . . 0.0 110.411 -179.794 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.8 mm-40 -74.38 -35.1 63.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.872 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.33 -44.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.395 -178.794 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.41 88.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.766 179.661 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.25 -27.55 42.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.307 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -59.24 140.78 55.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.374 -179.505 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.7 t -139.45 147.09 40.88 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.756 -179.463 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.748 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.4 pt? -137.17 173.8 11.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 -179.515 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -99.12 128.5 45.26 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.746 178.489 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.572 ' O ' HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -67.91 -10.17 51.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.9 0.381 . . . . 0.0 110.346 179.996 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 79' ' ' VAL . 1.3 mppt? -63.54 -30.62 71.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.172 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -76.19 13.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.826 -178.964 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.3 p -85.86 123.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.597 179.672 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.99 -5.48 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.86 -178.197 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.24 -160.26 27.04 Favored Glycine 0 C--N 1.318 -0.432 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.43 ' HG3' ' N ' ' A' ' 83' ' ' ILE . 9.3 ttm180 -151.38 157.32 42.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.129 0.49 . . . . 0.0 110.924 -179.812 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.43 ' N ' ' HG3' ' A' ' 82' ' ' ARG . 3.3 tp -125.9 127.21 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.191 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -129.03 130.15 46.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.77 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 44.9 mt -136.68 123.2 13.78 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.817 -178.731 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 2.8 Cg_endo -82.33 -30.54 1.15 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.462 2.108 . . . . 0.0 112.473 -179.867 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.4 t -48.39 -39.99 24.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.052 -176.475 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.582 HG11 HD12 ' A' ' 90' ' ' LEU . 3.3 p -120.53 -4.17 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.578 0.228 . . . . 0.0 111.12 -179.13 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 74.09 50.72 0.11 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.021 0.439 . . . . 0.0 109.967 179.895 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.582 HD12 HG11 ' A' ' 88' ' ' VAL . 18.6 mt -111.37 127.42 55.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.311 179.762 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -134.49 113.14 11.51 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.947 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 mt -146.09 166.48 16.92 Favored Pre-proline 0 N--CA 1.467 0.39 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.395 -177.719 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.82 150.61 8.54 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 109.516 178.105 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.73 108.22 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HB2' HD21 ' A' ' 102' ' ' ASN . 12.9 mt -101.93 121.61 42.46 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -65.03 -48.95 72.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.985 0.421 . . . . 0.0 111.176 -179.653 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.41 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 48.4 m -56.68 98.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.777 -179.411 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 85.3 p -80.6 100.56 8.69 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.393 0.616 . . . . 0.0 110.626 179.675 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.7 p -135.42 157.73 46.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.352 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -54.97 -39.17 68.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.923 179.524 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.93 -39.08 72.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.091 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 108' ' ' ALA . 6.8 t-20 -62.77 -39.55 94.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 -179.406 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.97 -27.45 63.47 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.288 -178.688 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.68 -14.54 62.07 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.37 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.494 ' OG ' HD13 ' A' ' 74' ' ' LEU . 5.9 m -104.98 -13.96 15.59 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.768 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 168.83 -149.98 14.91 Favored Glycine 0 N--CA 1.461 0.341 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.013 -178.326 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.34 125.2 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.114 0.483 . . . . 0.0 110.202 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB2' ' ND2' ' A' ' 102' ' ' ASN . . . -105.84 144.34 32.71 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.719 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 p -76.84 153.32 34.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 185' ' ' ILE . 74.6 t -85.81 -45.03 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.171 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -88.47 -170.97 3.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.222 -178.402 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -124.67 -5.28 7.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.826 -177.739 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.42 41.8 1.62 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.078 0.466 . . . . 0.0 110.675 -177.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.29 161.94 13.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.388 179.679 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.66 132.83 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.543 ' SD ' HD12 ' A' ' 149' ' ' LEU . 67.8 mtt -69.62 129.81 40.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.51 179.13 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.97 75.96 Favored Glycine 0 C--N 1.33 0.244 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -146.46 128.17 15.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.579 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.6 -169.7 47.23 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -85.52 103.48 14.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.506 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -83.94 101.3 11.6 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.8 124.31 35.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.259 0.552 . . . . 0.0 112.042 -178.846 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -120.13 130.14 54.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.693 178.224 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.47 139.97 43.79 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 110.256 -178.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.24 -178.22 18.88 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.939 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -83.62 152.26 24.9 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.112 0.482 . . . . 0.0 110.767 -179.85 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 129' ' ' SER . 48.6 p30 -122.09 28.23 7.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.29 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.6 mtt -44.78 -13.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.944 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 61.24 36.33 17.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.534 -179.9 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.535 ' H ' ' HG ' ' A' ' 136' ' ' SER . 68.1 mttm -135.64 114.75 12.29 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.944 -179.213 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -56.21 126.65 27.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.687 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.1 -30.64 6.67 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 -178.136 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.737 HG12 ' N ' ' A' ' 134' ' ' LEU . 97.0 t -72.36 175.09 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.737 ' N ' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -73.45 128.77 36.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.392 -178.409 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 48.45 42.61 18.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 178.202 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.535 ' HG ' ' H ' ' A' ' 130' ' ' LYS . 2.4 t -75.23 -67.26 0.67 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.36 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -90.27 43.98 1.18 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.183 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.8 pt -68.1 -26.74 35.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.675 179.525 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.16 7.47 4.16 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.246 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.1 t -96.25 -14.47 22.64 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.46 122.24 15.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.136 -179.357 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.429 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 26.6 mtpp -96.3 157.14 16.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.758 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.43 122.13 13.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.622 -179.627 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.63 18.45 23.18 Favored Glycine 0 N--CA 1.465 0.589 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.1 m-20 -83.79 134.98 34.7 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 178.923 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -81.78 126.09 31.43 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.178 -177.335 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.2 mt -120.89 126.78 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.295 178.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -101.94 118.1 36.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.271 -179.101 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.58 HD21 ' CD1' ' A' ' 182' ' ' ILE . 0.7 OUTLIER -106.24 135.92 46.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.973 179.907 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.509 ' O ' ' SD ' ' A' ' 116' ' ' MET . 56.3 m-85 -114.69 127.79 55.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.325 0.583 . . . . 0.0 111.324 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 152' ' ' ASN . 42.8 t0 -113.82 -166.6 1.11 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.348 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.1 m-20 -23.04 -75.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.062 0.458 . . . . 0.0 111.994 179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -139.22 30.64 2.18 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.276 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -127.7 144.13 51.1 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -176.046 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -110.94 121.83 46.35 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.898 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -103.65 132.71 49.66 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.323 -178.874 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -94.79 115.08 27.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.166 178.785 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -114.77 146.67 40.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.574 -179.844 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.1 132.43 53.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.341 0.591 . . . . 0.0 111.022 178.073 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.425 ' HB ' ' H ' ' A' ' 145' ' ' ASP . 62.0 t -67.11 133.41 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.631 179.56 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.82 -29.01 11.72 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 124.739 1.274 . . . . 0.0 110.395 -178.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 168.83 164.07 23.9 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.031 -179.355 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.92 147.45 28.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.911 -0.644 . . . . 0.0 109.765 -179.661 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 35.0 p -151.69 162.15 41.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.195 0.521 . . . . 0.0 111.289 -179.115 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -117.91 111.31 18.83 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.696 179.89 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.8 160.14 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.096 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 p -62.18 166.98 5.66 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.532 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 2.1 Cg_endo -82.21 -5.87 12.0 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.256 1.97 . . . . 0.0 111.605 -179.631 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.76 -17.03 52.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.725 -178.78 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.568 ' O ' HG22 ' A' ' 173' ' ' VAL . 1.8 mptm? -87.37 73.57 9.58 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.508 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 168' ' ' PRO . 70.1 m95 -73.52 -21.51 60.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.362 -179.847 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.545 ' O ' ' NE2' ' A' ' 177' ' ' HIS . 96.3 mt-10 -51.06 -8.82 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.001 0.429 . . . . 0.0 110.825 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 170' ' ' LYS . 19.5 m -83.29 -21.86 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.747 -178.792 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.634 HG11 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -112.89 -0.71 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.591 0.71 . . . . 0.0 109.677 -179.051 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.533 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 97.0 mt-10 -83.55 139.65 32.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.19 -178.253 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -44.51 123.57 3.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.063 179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.545 ' NE2' ' O ' ' A' ' 172' ' ' GLU . 45.7 m80 -114.25 22.84 13.4 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.056 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 75.06 19.73 79.72 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.237 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -147.59 164.27 33.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.065 0.459 . . . . 0.0 111.28 -179.66 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.15 89.08 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.852 179.512 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.487 ' OE2' ' HB1' ' A' ' 200' ' ' ALA . 79.3 tt0 -129.23 125.53 37.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.595 -179.118 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.58 ' CD1' HD21 ' A' ' 149' ' ' LEU . 17.7 tt -79.46 148.09 6.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.269 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.518 ' C ' HD12 ' A' ' 184' ' ' LEU . 10.2 m -135.95 125.44 25.1 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.908 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -106.94 127.42 53.43 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.126 0.489 . . . . 0.0 110.499 179.866 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 110' ' ' VAL . 11.9 pt -136.79 176.71 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.622 -179.233 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.584 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 31.9 p -134.67 166.13 23.64 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 111.163 -179.178 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 15.1 p -53.7 -177.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.202 179.747 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.04 124.18 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.86 0.362 . . . . 0.0 110.679 -179.785 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 48.4 t -81.65 134.36 35.47 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.249 179.798 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 190' ' ' VAL . 8.8 p -105.41 2.43 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.019 0.438 . . . . 0.0 110.952 -179.277 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -72.17 100.75 2.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.347 -179.286 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 68.0 t0 48.23 -107.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.993 179.202 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -85.08 114.16 22.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.168 179.295 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 27.3 m -59.23 134.16 56.75 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.686 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -152.17 147.16 26.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 -178.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.584 ' NH1' ' O ' ' A' ' 186' ' ' THR . 8.6 ptp180 -159.14 168.01 27.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.58 141.68 47.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.06 178.7 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.2 t -132.09 133.99 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.151 0.5 . . . . 0.0 110.99 -179.504 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.24 133.28 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.337 -179.415 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.487 ' HB1' ' OE2' ' A' ' 181' ' ' GLU . . . -116.51 135.89 53.45 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.707 -179.751 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -128.07 135.64 8.75 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -179.757 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -92.13 138.65 31.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.555 -179.24 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.26 127.11 30.39 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.112 0.482 . . . . 0.0 110.543 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 -23.01 4.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.341 -179.036 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 173.43 178.11 43.16 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 119.745 -1.217 . . . . 0.0 112.289 -178.513 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.6 m -151.95 152.29 32.31 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.36 0.6 . . . . 0.0 111.285 178.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -148.74 177.53 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.549 179.655 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -95.06 146.6 24.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.344 0.592 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -76.02 79.8 2.88 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.693 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--N 1.317 -0.824 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.718 178.443 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.473 ' O ' ' ND1' ' A' ' 55' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 t 47.57 19.83 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.463 . . . . 0.0 110.731 179.49 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 53' ' ' GLY . 76.9 m80 -80.0 163.19 24.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.86 -179.672 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.5 mtm -72.68 146.87 46.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.272 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.38 137.47 57.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.548 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.87 -40.48 79.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.471 -178.871 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 61' ' ' ILE . 1.9 p 60.11 15.34 5.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.352 179.276 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -76.66 32.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.41 -179.381 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 59' ' ' SER . 43.9 mt -62.3 -47.78 91.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.19 0.519 . . . . 0.0 110.861 -178.905 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 47.66 -94.76 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.281 179.206 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -149.99 86.2 5.34 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.872 -179.177 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.86 151.55 40.38 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.578 2.185 . . . . 0.0 111.326 179.722 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 66' ' ' LEU . 55.4 t0 -72.6 158.65 35.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.458 179.94 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 3.9 mm? -64.03 -20.53 65.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.766 -179.359 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.0 92.84 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.289 -179.727 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.613 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 72.3 mm-40 -73.8 -32.64 63.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.68 -45.67 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.854 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.91 90.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.026 179.839 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -79.03 -23.53 44.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.253 -179.392 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -61.82 105.1 0.51 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 179.868 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.6 m -96.58 80.74 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.548 HD11 ' NE2' ' A' ' 78' ' ' GLN . 44.7 tp -74.88 148.02 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.182 179.334 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 77' ' ' LYS . 42.4 t0 -81.31 91.13 6.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.511 179.826 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.48 ' O ' HG13 ' A' ' 79' ' ' VAL . 63.7 mttp -52.74 -9.16 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.132 0.491 . . . . 0.0 110.364 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 75' ' ' ASP . 17.5 tptm -79.65 -10.89 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.538 -179.803 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.572 ' NE2' ' OD1' ' A' ' 102' ' ' ASN . 9.0 pt20 -93.6 19.36 8.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.563 -178.785 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 76' ' ' LYS . 33.6 m -83.0 146.26 7.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.855 -179.433 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.68 -6.04 10.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -178.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.83 -165.54 32.94 Favored Glycine 0 C--N 1.317 -0.473 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.912 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.461 ' NH1' ' C ' ' A' ' 92' ' ' LEU . 8.5 ttm-85 -151.52 154.47 36.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.303 0.573 . . . . 0.0 111.326 -179.258 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 83' ' ' ILE . 18.0 tt -127.88 130.01 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.72 179.444 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 m -127.76 129.68 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.022 -179.155 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 37.3 mt -134.78 118.36 13.32 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -177.946 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 85' ' ' ILE . 3.3 Cg_exo -81.25 -33.67 0.7 Allowed 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.736 2.29 . . . . 0.0 112.388 179.869 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.4 t -49.54 -39.41 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.696 -177.052 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 90' ' ' LEU . 3.9 m -119.14 -6.23 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -178.777 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER 75.28 49.9 0.08 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.305 0.574 . . . . 0.0 110.209 179.904 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.503 HD12 HG21 ' A' ' 88' ' ' VAL . 2.5 mt -111.0 125.45 53.75 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.251 -179.365 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -133.25 112.41 11.66 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.461 ' C ' ' NH1' ' A' ' 82' ' ' ARG . 76.6 mt -145.58 162.5 36.21 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 119.849 -0.741 . . . . 0.0 112.908 -177.03 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -88.06 152.05 6.99 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 123.118 2.545 . . . . 0.0 109.119 177.41 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.1 t -98.15 115.63 38.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.757 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 mt -101.66 122.96 44.86 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.066 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -67.23 -45.06 77.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 m -69.62 99.49 1.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.453 -179.51 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 98' ' ' SER . 52.3 p -81.69 96.27 7.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.516 0.674 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.586 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 2.9 p -136.99 157.3 47.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.924 -179.584 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.15 -31.97 65.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.648 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -78.27 -45.28 23.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.617 0.722 . . . . 0.0 111.295 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.662 HD22 ' N ' ' A' ' 102' ' ' ASN . 0.9 OUTLIER -66.25 -35.17 79.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.494 -178.171 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.83 -15.4 58.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.933 -178.797 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 mt -71.37 -27.22 63.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.894 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.6 m -94.31 -8.78 37.99 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.753 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.2 -158.16 28.48 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.814 -178.591 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -92.09 126.58 37.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.875 -0.662 . . . . 0.0 109.941 179.417 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.02 147.46 27.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 -179.779 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 44.5 p -71.02 147.7 48.34 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.35 -43.91 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -89.82 -171.32 3.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.028 -178.721 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -121.58 -9.27 8.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.982 0.42 . . . . 0.0 111.535 -178.212 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -139.36 39.86 2.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.017 0.437 . . . . 0.0 111.393 -177.66 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -91.33 157.45 17.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.098 179.713 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 51.4 t -132.61 131.66 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.639 179.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.421 ' SD ' ' O ' ' A' ' 150' ' ' TYR . 65.6 mtt -66.93 129.3 39.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.006 178.75 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 180' ' ' ASP . . . 89.27 3.37 75.69 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.794 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -141.77 120.98 13.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.858 -178.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.71 -165.75 54.75 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -178.867 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -90.23 109.98 21.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.614 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -84.69 102.26 12.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.922 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.22 129.83 37.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.474 0.654 . . . . 0.0 111.966 -179.177 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -127.04 132.35 50.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.526 178.637 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.24 141.66 45.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.556 0.693 . . . . 0.0 110.76 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.1 -179.04 20.31 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.588 -179.531 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' O ' ' A' ' 134' ' ' LEU . 31.0 m-70 -81.84 145.08 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 129' ' ' SER . 22.9 t-20 -116.87 28.1 8.74 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.543 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmm -46.49 -12.15 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.911 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.6 p 60.59 40.98 16.07 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.078 179.448 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 136' ' ' SER . 88.4 tttt -134.42 115.15 13.67 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.768 -179.087 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -57.46 126.39 27.1 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.668 0.747 . . . . 0.0 110.156 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.49 -22.61 17.05 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.21 -178.8 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.734 HG12 ' H ' ' A' ' 134' ' ' LEU . 55.6 t -84.3 177.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.073 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.734 ' H ' HG12 ' A' ' 133' ' ' VAL . 0.2 OUTLIER -72.19 133.19 44.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.607 0.241 . . . . 0.0 110.4 -178.247 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 46.16 33.0 1.59 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.297 0.57 . . . . 0.0 110.551 178.343 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 130' ' ' LYS . 0.9 OUTLIER -81.86 -4.37 56.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.817 -178.571 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.455 ' OD1' ' OG ' ' A' ' 140' ' ' SER . 22.8 t70 -147.09 39.76 1.02 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -177.605 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.69 -27.29 30.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.927 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.38 3.53 10.87 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.719 -179.604 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.455 ' OG ' ' OD1' ' A' ' 137' ' ' ASP . 69.2 m -95.35 -12.98 25.15 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.406 0.622 . . . . 0.0 109.694 -179.55 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.44 ' O ' HG21 ' A' ' 163' ' ' VAL . 13.8 mt -65.87 125.15 24.47 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.983 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -96.81 158.43 15.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.607 -179.837 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -61.46 128.03 34.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.874 -179.615 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 90.67 20.22 41.33 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.784 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.405 ' H ' ' HB ' ' A' ' 160' ' ' VAL . 37.5 m-20 -85.82 132.33 34.13 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.406 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -79.79 135.69 36.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.812 -178.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 158' ' ' TYR . 84.5 mt -127.66 122.3 58.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.542 179.302 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.443 ' CE2' ' OE1' ' A' ' 157' ' ' GLU . 69.0 m-85 -100.18 117.66 34.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.975 -179.071 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.48 142.37 46.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.967 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.421 ' O ' ' SD ' ' A' ' 116' ' ' MET . 34.5 m-85 -116.06 132.95 56.51 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.447 0.642 . . . . 0.0 111.471 -178.842 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 152' ' ' ASN . 37.0 t0 -113.94 -166.38 1.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.104 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 151' ' ' ASP . 98.6 m-20 -22.54 -75.86 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.539 0.524 . . . . 0.0 111.676 179.797 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -137.81 28.28 2.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.289 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -126.93 143.77 51.19 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.899 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -109.18 121.62 45.56 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.844 179.067 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -104.65 132.01 51.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.418 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.443 ' OE1' ' CE2' ' A' ' 148' ' ' TYR . 70.2 mm-40 -94.62 112.65 24.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.992 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' ILE . 50.5 m-85 -114.39 137.38 51.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.436 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.89 54.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 111.382 178.785 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 144' ' ' GLY . 44.3 t -67.38 132.64 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.959 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -112.26 -29.39 7.57 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 124.619 1.199 . . . . 0.0 111.13 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.19 145.18 8.45 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.498 -179.765 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 141' ' ' LEU . 97.8 t -121.86 138.24 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.784 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.5 m -159.34 171.88 18.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.693 -178.341 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.04 133.27 54.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.718 179.964 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 m -138.78 159.66 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.3 -178.691 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 169' ' ' ASP . 3.6 p -69.11 133.59 89.72 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.146 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -46.07 -13.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.046 1.831 . . . . 0.0 111.794 -178.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 167' ' ' THR . 97.1 m-20 -78.84 -22.36 46.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.903 -177.963 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.699 ' O ' HG22 ' A' ' 173' ' ' VAL . 14.4 mptt -85.67 75.91 10.04 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.545 ' C ' ' H ' ' A' ' 173' ' ' VAL . 83.3 m95 -74.05 -20.03 60.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.992 -179.18 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 57.1 mp0 -52.24 -6.79 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.245 0.545 . . . . 0.0 110.821 179.575 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.712 ' O ' HG21 ' A' ' 183' ' ' THR . 24.4 m -89.81 -3.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.101 -179.009 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 173' ' ' VAL . 1.0 OUTLIER -128.9 -7.24 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.745 0.783 . . . . 0.0 109.012 179.794 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.18 157.03 25.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.239 -176.749 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -66.89 127.52 32.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.092 -179.905 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -102.11 -41.44 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.075 -179.78 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 140.84 28.03 0.19 Allowed Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.498 ' NZ ' ' CD ' ' A' ' 181' ' ' GLU . 19.7 pttp -156.37 178.49 10.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.043 0.449 . . . . 0.0 111.278 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.407 ' CG ' ' O ' ' A' ' 117' ' ' GLY . 4.6 m-20 -92.19 91.06 7.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.72 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.498 ' CD ' ' NZ ' ' A' ' 179' ' ' LYS . 22.4 tt0 -123.18 169.39 11.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.148 -179.287 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.3 tt -130.93 143.01 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.873 179.354 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.712 HG21 ' O ' ' A' ' 173' ' ' VAL . 16.0 m -136.02 123.56 22.18 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 111.489 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 183' ' ' THR . 9.9 mp -111.11 123.72 50.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.405 0.621 . . . . 0.0 110.556 179.334 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 198' ' ' VAL . 8.5 pt -139.77 -171.45 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.932 -178.62 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t -138.81 155.02 48.49 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.717 -179.159 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 10.9 t -105.75 77.98 1.3 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 188' ' ' VAL . 11.4 p -143.43 131.99 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.216 -179.43 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 m 174.25 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.875 -179.428 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.599 HG13 ' N ' ' A' ' 191' ' ' LYS . 7.3 p -149.4 -45.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 111.842 -179.185 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.599 ' N ' HG13 ' A' ' 190' ' ' VAL . 63.3 tttp -93.83 -81.92 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.829 -178.89 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -69.16 140.76 54.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.019 179.399 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 193' ' ' ASN . 53.4 p-10 -94.71 148.99 21.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.465 -179.742 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.4 t 48.28 82.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.071 -0.651 . . . . 0.0 109.708 179.248 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -159.54 70.7 0.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.977 -178.185 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -146.51 144.6 29.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.574 -178.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -108.27 137.65 45.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.209 179.341 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.475 HG22 HG22 ' A' ' 185' ' ' ILE . 78.9 t -129.49 131.27 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.268 0.556 . . . . 0.0 110.824 -179.155 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.2 130.38 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.328 -179.755 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.47 135.86 54.13 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.574 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -130.43 147.97 18.45 Favored Glycine 0 N--CA 1.465 0.619 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.772 -179.791 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -103.32 140.22 37.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.933 -0.633 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.1 tp -66.11 125.76 26.5 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.204 0.526 . . . . 0.0 110.802 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.11 -24.21 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.042 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 177.88 176.63 46.04 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 119.93 -1.128 . . . . 0.0 112.102 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.7 m -153.51 151.48 29.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 110.94 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -150.09 178.39 9.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.677 179.439 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -93.34 144.85 24.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.157 0.503 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -71.45 79.55 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.763 -179.529 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.601 178.479 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 55' ' ' HIS . 50.8 m -58.41 -44.69 89.12 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.3 -0.16 . . . . 0.0 110.619 -179.471 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 56' ' ' MET . 36.9 t-80 51.57 102.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.631 178.816 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.488 ' O ' ' O ' ' A' ' 55' ' ' HIS . 95.5 mmm -56.41 -118.86 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.999 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 58.8 t0 46.1 19.72 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.286 0.565 . . . . 0.0 111.086 178.324 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 56' ' ' MET . . . -73.27 -11.85 60.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.276 -179.005 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 t -149.41 -73.52 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.64 -178.383 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.2 tttt 55.38 17.79 2.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.24 0.543 . . . . 0.0 111.231 178.538 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.4 mt -66.38 -45.27 89.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.726 -179.105 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.442 ' O ' HG13 ' A' ' 188' ' ' VAL . 68.1 t0 53.42 -100.05 0.1 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.109 179.122 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -149.81 88.67 4.82 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.808 -179.119 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.38 153.21 39.84 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 122.454 2.103 . . . . 0.0 111.137 179.476 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -69.09 146.58 52.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.823 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.81 -28.84 66.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.77 91.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.459 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 80.9 mm-40 -73.09 -35.39 66.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.805 179.469 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.8 t -74.87 -43.7 45.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.743 -179.181 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.35 83.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.929 179.718 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -87.89 -15.5 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.563 -178.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -63.39 133.05 53.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.521 179.658 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.1 p -90.9 159.4 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.054 179.598 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 105' ' ' SER . 51.0 tp -125.89 135.55 52.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.956 0.407 . . . . 0.0 111.112 -179.16 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.482 ' C ' ' N ' ' A' ' 77' ' ' LYS . 97.3 m-20 -89.91 89.31 7.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.763 179.756 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 4.6 mptp? -46.8 -16.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.198 0.523 . . . . 0.0 110.18 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.482 ' N ' ' C ' ' A' ' 75' ' ' ASP . 68.6 mttm -65.64 -35.91 82.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.285 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -81.4 18.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.765 -178.563 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.2 123.01 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.888 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.1 pt -118.94 -7.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.016 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.15 38.54 Favored Glycine 0 C--N 1.317 -0.492 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.514 ' O ' HD23 ' A' ' 149' ' ' LEU . 18.6 mtp85 -147.31 153.51 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.194 -0.603 . . . . 0.0 111.068 -178.64 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 92' ' ' LEU . 3.8 tt -126.97 131.05 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.206 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.6 m -130.9 132.36 45.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.211 -178.765 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.0 mt -133.15 129.85 21.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.407 -178.461 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.48 -35.05 0.26 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.397 2.064 . . . . 0.0 112.102 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -47.21 -38.73 12.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.491 -176.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 88' ' ' VAL . 2.0 p -120.58 -0.54 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.845 -178.936 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 53.74 3.07 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.168 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.1 tp -116.06 133.84 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.34 116.37 13.32 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.522 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 83' ' ' ILE . 60.2 mt -144.53 110.87 4.94 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.079 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LEU . 2.1 Cg_endo -41.29 141.01 1.31 Allowed 'Trans proline' 0 N--CA 1.486 1.041 0 C-N-CA 121.79 1.66 . . . . 0.0 110.326 176.206 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.4 t -89.65 125.5 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.036 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.7 mt -108.95 122.45 47.25 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.28 -48.58 72.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.009 0.433 . . . . 0.0 110.974 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 m -71.59 103.78 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.042 -179.613 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 109' ' ' THR . 3.2 m -84.32 101.48 11.98 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.273 0.558 . . . . 0.0 110.078 179.537 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.515 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 6.4 p -132.75 156.19 47.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.099 -179.75 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.449 ' O ' HD21 ' A' ' 104' ' ' LEU . 9.6 tm-20 -55.83 -26.94 49.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.545 -179.505 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.32 -43.73 14.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.374 0.607 . . . . 0.0 111.947 -179.507 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.515 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 98.3 m-20 -66.44 -34.31 77.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.621 -179.138 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 108' ' ' ALA . 15.4 mt -68.94 -12.67 61.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.03 -178.593 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 100' ' ' GLU . 14.6 mt -76.14 -13.14 60.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.121 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB3' HD22 ' A' ' 74' ' ' LEU . 57.8 m -121.35 -7.52 9.26 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.52 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.6 47.58 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.832 -179.742 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.17 129.07 36.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.955 179.375 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.456 ' HB3' HD21 ' A' ' 103' ' ' LEU . . . -106.63 146.65 30.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.986 -179.64 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.522 ' O ' ' OG ' ' A' ' 98' ' ' SER . 32.9 p -75.41 149.92 38.47 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.791 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.46 -40.52 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.845 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -87.82 145.07 26.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 111.044 -178.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -68.16 -16.9 64.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.077 -179.141 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -144.86 52.02 1.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 111.295 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.415 ' CD ' ' H ' ' A' ' 122' ' ' ALA . 1.1 tt0 -80.73 155.55 26.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.656 179.557 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -133.08 127.7 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.607 ' SD ' HD22 ' A' ' 149' ' ' LEU . 66.0 mtt -71.49 126.65 30.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.256 179.482 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.91 70.94 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.521 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -139.2 119.71 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.259 -179.161 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.68 -164.35 54.57 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.25 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.621 HD21 ' CB ' ' A' ' 183' ' ' THR . 1.3 t30 -90.02 109.82 20.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.732 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -84.96 101.1 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.415 ' H ' ' CD ' ' A' ' 114' ' ' GLN . . . -90.39 126.29 35.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.334 0.588 . . . . 0.0 112.135 -178.919 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.4 130.92 53.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.454 178.146 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.2 139.49 45.31 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.46 0.647 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.89 -178.78 19.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.455 -179.32 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 134' ' ' LEU . 36.0 m-70 -85.16 140.65 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 110.66 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' SER . 28.6 t-20 -108.22 28.2 8.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.388 0.614 . . . . 0.0 110.265 -179.91 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.2 mmm -44.28 -13.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.873 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 127' ' ' ASN . 1.2 t 55.45 39.56 31.14 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.942 179.264 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.477 ' O ' ' OG ' ' A' ' 136' ' ' SER . 79.8 tttt -134.7 123.05 23.07 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.607 -178.782 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -64.08 123.64 19.55 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.132 -179.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.59 25.05 5.62 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.546 -177.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 134' ' ' LEU . 3.0 t -137.81 175.56 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.952 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -70.26 131.72 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.43 -177.838 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 47.14 32.74 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.077 0.465 . . . . 0.0 110.893 178.251 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 130' ' ' LYS . 0.1 OUTLIER -81.45 -10.31 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.022 -178.948 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 136' ' ' SER . 87.5 m-20 -144.5 38.08 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.26 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 140' ' ' SER . 10.9 pt -68.12 -35.24 70.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.943 0.401 . . . . 0.0 111.657 179.75 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.58 3.3 1.9 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.88 -179.381 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 138' ' ' ILE . 19.0 m -95.61 -12.61 25.35 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.127 0.489 . . . . 0.0 109.861 -179.447 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -67.42 125.28 25.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.98 159.68 14.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.708 -179.806 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 144' ' ' GLY . 10.1 tmtt? -60.22 128.0 34.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -179.829 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 143' ' ' LYS . . . 91.14 22.32 32.88 Favored Glycine 0 N--CA 1.463 0.444 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.935 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.86 132.4 34.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.221 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -79.93 130.19 35.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.275 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 89.5 mt -125.3 124.64 67.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.31 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -106.7 122.45 46.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.484 -178.651 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.607 HD22 ' SD ' ' A' ' 116' ' ' MET . 0.8 OUTLIER -115.91 148.49 39.96 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.369 -179.584 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -122.92 131.76 53.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.364 0.602 . . . . 0.0 111.438 -179.834 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.507 ' O ' ' C ' ' A' ' 152' ' ' ASN . 26.2 t70 -114.64 -165.46 1.02 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.011 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 151' ' ' ASP . 2.3 t-20 -23.78 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.178 0.514 . . . . 0.0 111.733 179.463 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -139.61 25.6 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.443 -0.799 . . . . 0.0 108.911 178.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -124.05 141.62 51.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.689 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.537 ' OE1' ' NZ ' ' A' ' 207' ' ' LYS . 75.5 tt0 -106.49 121.06 43.51 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.059 179.321 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.408 ' CD2' ' OG1' ' A' ' 206' ' ' THR . 70.5 m-85 -104.29 128.32 52.05 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.539 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -95.01 117.55 30.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.571 178.652 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.52 ' CZ ' HD13 ' A' ' 203' ' ' LEU . 21.5 m-85 -117.78 141.09 48.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.186 -179.346 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.03 136.49 54.86 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.172 0.51 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.13 132.25 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.756 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.5 t -111.8 -26.78 8.78 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 124.799 1.312 . . . . 0.0 111.37 -179.067 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.27 149.66 9.61 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.418 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.575 HG13 HG22 ' A' ' 199' ' ' VAL . 21.8 t -125.74 148.98 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.904 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.6 p -160.3 168.76 24.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.157 0.503 . . . . 0.0 111.365 -177.987 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.453 ' OE1' ' CE1' ' A' ' 197' ' ' TYR . 1.6 pm0 -117.95 124.28 47.85 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.456 179.722 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -134.71 160.32 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.249 -178.412 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 169' ' ' ASP . 15.0 p -71.62 138.23 83.25 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.455 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -46.94 -14.9 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.012 1.808 . . . . 0.0 111.993 -178.7 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 169' ' ' ASP . 65.4 t0 -78.96 -11.5 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.552 -177.86 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.414 ' O ' HG23 ' A' ' 173' ' ' VAL . 31.1 mmtt -84.77 64.53 8.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.182 0.515 . . . . 0.0 110.357 179.476 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.464 ' C ' ' N ' ' A' ' 173' ' ' VAL . 86.3 m95 -70.1 -30.87 68.2 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.218 -179.716 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 41.4 mp0 -47.3 -15.97 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.212 0.53 . . . . 0.0 110.672 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 198' ' ' VAL . 87.4 t -66.13 -43.07 92.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.284 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.477 HG11 HD13 ' A' ' 185' ' ' ILE . 13.4 m -98.94 2.16 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.624 0.725 . . . . 0.0 110.506 -178.221 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.57 120.28 25.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.417 -1.265 . . . . 0.0 112.08 -178.569 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -31.79 122.81 0.28 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.506 178.846 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -105.41 -41.73 5.43 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 143.47 27.1 0.14 Allowed Glycine 0 N--CA 1.471 1.013 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.497 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -154.09 173.75 15.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.654 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 31.5 p30 -96.07 86.94 4.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.51 0.671 . . . . 0.0 110.292 179.016 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -128.07 128.53 45.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.271 -179.286 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 149' ' ' LEU . 20.3 tt -81.43 147.26 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.527 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.621 ' CB ' HD21 ' A' ' 120' ' ' ASN . 7.8 m -136.87 118.1 14.52 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.746 0.307 . . . . 0.0 111.025 -179.608 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 183' ' ' THR . 9.7 mp -103.44 126.18 50.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.381 0.61 . . . . 0.0 110.999 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.477 HD13 HG11 ' A' ' 174' ' ' VAL . 11.8 pt -138.45 -177.13 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.592 -179.06 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.655 HG23 ' HE ' ' A' ' 196' ' ' ARG . 15.2 t -138.45 147.57 43.42 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.527 -179.459 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 72.8 m -104.47 42.16 1.23 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.306 -179.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 62' ' ' ASP . 62.5 t -119.27 130.88 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.288 -179.47 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.9 t -133.56 107.47 8.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.144 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 193' ' ' ASN . 9.1 t -133.38 161.43 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 -179.551 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.94 -41.19 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.928 -179.039 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -59.08 -49.24 78.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 193' ' ' ASN . 42.9 p30 -99.32 79.95 2.36 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.824 -179.575 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.9 t -59.04 -43.99 91.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.041 -179.354 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -122.21 139.74 53.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.99 -179.704 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.655 ' HE ' HG23 ' A' ' 186' ' ' THR . 5.6 ptp85 -95.16 160.78 14.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.876 -179.572 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.453 ' CE1' ' OE1' ' A' ' 165' ' ' GLU . 4.3 m-85 -92.58 140.54 29.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.938 179.158 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 173' ' ' VAL . 45.4 t -132.2 134.54 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.035 0.445 . . . . 0.0 110.831 -179.437 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.575 HG22 HG13 ' A' ' 163' ' ' VAL . 61.1 t -119.4 130.09 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.809 -179.39 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.23 136.14 53.42 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.141 179.505 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.63 140.19 11.6 Favored Glycine 0 N--CA 1.468 0.813 0 CA-C-O 121.648 0.582 . . . . 0.0 111.709 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 66.3 t0 -96.61 140.18 31.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.966 -179.09 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.52 HD13 ' CZ ' ' A' ' 158' ' ' TYR . 12.1 tp -67.45 129.15 39.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.215 0.531 . . . . 0.0 111.004 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 79.6 t -106.93 -23.68 4.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.25 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 169.49 162.53 21.92 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.687 178.774 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.408 ' OG1' ' CD2' ' A' ' 156' ' ' TYR . 48.0 m -138.79 157.49 45.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.246 0.546 . . . . 0.0 109.934 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 155' ' ' GLU . 21.8 pttp -150.33 178.5 8.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.097 179.864 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 210' ' ' LYS . . . -96.11 140.27 31.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.185 0.517 . . . . 0.0 110.768 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -61.97 79.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.482 -179.44 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 208' ' ' ALA . 99.2 mttt . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.518 178.286 . . . . . . . . 1 1 . 1 stop_ save_